Citrus Sinensis ID: 038696
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | 2.2.26 [Sep-21-2011] | |||||||
| P25848 | 1307 | Light-sensor Protein kina | N/A | no | 0.389 | 0.203 | 0.366 | 1e-43 | |
| P18161 | 1155 | Dual specificity protein | yes | no | 0.374 | 0.221 | 0.306 | 4e-23 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.341 | 0.180 | 0.323 | 4e-23 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.366 | 0.186 | 0.295 | 6e-23 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.428 | 0.180 | 0.265 | 8e-23 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.368 | 0.275 | 0.295 | 6e-22 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.297 | 0.520 | 0.316 | 1e-21 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.354 | 0.146 | 0.283 | 1e-20 | |
| Q24592 | 1177 | Tyrosine-protein kinase h | yes | no | 0.303 | 0.175 | 0.313 | 3e-20 | |
| Q6XHB2 | 1726 | Probable serine/threonine | no | no | 0.342 | 0.135 | 0.314 | 5e-20 |
| >sp|P25848|PHY1_CERPU Light-sensor Protein kinase OS=Ceratodon purpureus GN=PHY1 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 178 bits (452), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 108/295 (36%), Positives = 157/295 (53%), Gaps = 29/295 (9%)
Query: 238 QVRRRLGSGSQ--YKEILWLGESFALRHFFG-DIEPLVPEISSLLSLSHPNIMHFLCGFT 294
Q+ LGSGS ++ +WLG A + F+G + E E+ L L HPNI C +
Sbjct: 1005 QITGSLGSGSSATVEKAVWLGTPVAKKTFYGRNNEDFKREVEILAELCHPNITSMFC--S 1062
Query: 295 DEEKKECFLIMELMSRDLCSYIKEICCPRKRI---------PFSLPVAVDLMLQIARGME 345
+++C +IMELM DL + ++ +R+ PFS+ VD++LQ + GM
Sbjct: 1063 PLYRRKCSIIMELMDGDLLALMQ------RRLDRNEDHDSPPFSILEVVDIILQTSEGMN 1116
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTE--GYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
YLH K I H +L NIL+K + GY+H K++ FGLS K+ + +Q+
Sbjct: 1117 YLHEKGIIHRDLKSMNILVKSVKVTKSEIGYVHVKVADFGLSKTKDSSTRYSNQTWNRGT 1176
Query: 404 FIWHAPEVLE------ENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
W APEV+ E E + KY KSDVYSFGM+C+E+LTG VPF + +
Sbjct: 1177 NRWMAPEVINLGYESTEGEISFDGKVPKYPLKSDVYSFGMVCYEVLTGDVPFPEEK-NPN 1235
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIM 512
+ R + G RP P H P + L CW+ DP +RPSF+ IC+ L+Y+K +M
Sbjct: 1236 NVKRMVLEGVRPDLPAHCPIELKALITDCWNQDPLKRPSFAVICQKLKYLKYLLM 1290
|
Regulatory photoreceptor which exists in two forms that are reversibly interconvertible by light: the Pr form that absorbs maximally in the red region of the spectrum and the Pfr form that absorbs maximally in the far-red region. Photoconversion of Pr to Pfr induces an array of morphogenic responses, whereas reconversion of Pfr to Pr cancels the induction of those responses. Pfr controls the expression of a number of nuclear genes including those encoding the small subunit of ribulose-bisphosphate carboxylase, chlorophyll A/B binding protein, protochlorophyllide reductase, rRNA, etc. It also controls the expression of its own gene(s) in a negative feedback fashion. Ceratodon purpureus (taxid: 3225) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 110 bits (275), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 31/287 (10%)
Query: 231 LIKSEDYQVRRRLGSG--SQYKEILWLGESFALRHF--FGDIEPL----VPEISSLLSLS 282
+I D Q +++G G S+ E W G A++ GD E + E+ +L +
Sbjct: 847 IIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKGN 906
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
H NI+ F+ K C + + L + + ++ +S P+ + + +A
Sbjct: 907 HQNIVMFIGACY---KPACIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMAL 963
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF-GPKSPSQSGTT 401
G+ +LHS I H +L NILL G + KIS FGLS K+ G + + G
Sbjct: 964 GLLHLHSITIVHRDLTSQNILLDELG-------NIKISDFGLSREKSREGSMTMTNGGIC 1016
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
+P W PE+ + + YSEK DVY F ++ +EILTG++PF D L G + S
Sbjct: 1017 NPR-WRPPEL--------TKNLGHYSEKVDVYCFSLVVWEILTGEIPFSD--LDGSQASA 1065
Query: 462 NIR-AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
+ AG RP P + + L +CW ADPN RP F+ I L+ I
Sbjct: 1066 QVAYAGLRPPIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKLKEI 1112
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 110 bits (275), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 89/275 (32%), Positives = 132/275 (48%), Gaps = 42/275 (15%)
Query: 242 RLGSGSQYKEIL---WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCG 292
R+G G Y ++ W G A++ F D I L E+ L L HPNI+ F+
Sbjct: 856 RIGRGG-YGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGA 914
Query: 293 FTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK- 351
T E C ++ E +SR + I + I + + L ARGM YLHS+
Sbjct: 915 CT-EPSSPC-IVTEYLSRGSLANI----LLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 352 -IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPE 410
I H +L N+L+ + K++ FGL++VK+ + + GTT W APE
Sbjct: 969 IIIHRDLKTDNLLV-------DDSWQVKVADFGLATVKSHT-FAKTMCGTTG---WVAPE 1017
Query: 411 VLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER-P 469
VL E Y+EK+DVYS+ ++ +E+LT +P+ + ++ R+I GER P
Sbjct: 1018 VLAE---------EGYTEKADVYSYAIVLWELLTRLIPYAGKNTM--QVVRSIDRGERLP 1066
Query: 470 LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + PKY L RCW DP RPSF I I+
Sbjct: 1067 MPAWCPPKYAA-LMNRCWETDPTHRPSFPEILPIM 1100
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 109 bits (273), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHF----FGDIEPLVPEISSLLSLSHPN 285
IK ++ + ++G+GS L W G A++ + E + E+SSL+ HPN
Sbjct: 1052 IKFDEVAIVEKVGAGSFANVFLGIWNGYKVAIKILKNESISNDEKFIKEVSSLIKSHHPN 1111
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
++ F+ D C L L + ++I + + ++ ++ GME
Sbjct: 1112 VVTFMGACID---PPCIFTEYLQGGSLYDVLH-----IQKIKLNPLMMYKMIHDLSLGME 1163
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
+LHS ++ H +L NILL + + + KI+ FGL++ + + SG T+P
Sbjct: 1164 HLHSIQMLHRDLTSKNILL-------DEFKNIKIADFGLATTLS---DDMTLSGITNPR- 1212
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-KMSRNIR 464
W +PE+ Y+EK DVYSFG++ +EI TGK+PFE L G ++
Sbjct: 1213 WRSPEL---------TKGLVYNEKVDVYSFGLVVYEIYTGKIPFEG--LDGTASAAKAAF 1261
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK-RFI 511
RP P P + L +CW +DP+QRPSF+ I L +K +FI
Sbjct: 1262 ENYRPAIPPDCPVSLRKLITKCWASDPSQRPSFTEILTELETMKSKFI 1309
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 109 bits (272), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 89/335 (26%), Positives = 159/335 (47%), Gaps = 42/335 (12%)
Query: 186 WILFNKIQQKKISGSTKQEQG-LIDVLF-KNLDGSGSLSGKLLPSRILIKSEDYQVRRRL 243
++ +N + + + G +ID+ + ++D S R +I ++ + +++
Sbjct: 1311 YVNYNDDTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSANMCRWIINYDEISIGKQI 1370
Query: 244 GSGSQYKEIL---WLGESFALRHFF------GDIEPLVPEISSLLSLSHPNIMHFLCGFT 294
G GS Y + W G A++ F + E++ L L H NI+ F+ G
Sbjct: 1371 GLGS-YGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKHSNIVTFI-GAC 1428
Query: 295 DEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--I 352
++ C + + +L +K P +I F+ + L+ A G++YLHS I
Sbjct: 1429 IKKPNICIVTEYMRMGNLRDVLKN---PDIKITFANKLK--LLYGAAMGIDYLHSSNPMI 1483
Query: 353 YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVL 412
H ++ P+NIL+ + + + KI+ FG + +K + ++ GT W APEV+
Sbjct: 1484 VHRDIKPANILV-------DEHFNVKIADFGFARIKE-DNTTMTRCGTP---CWTAPEVI 1532
Query: 413 EENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFP 472
KY EK+DV+SFG++ +E+LTGK PF + + K+S +I G RP+ P
Sbjct: 1533 R---------GEKYCEKADVFSFGVVMWEVLTGKEPFAECNFM--KVSLDILEGGRPIIP 1581
Query: 473 FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
P L K+CWHA ++RP+ + + + L I
Sbjct: 1582 SDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLI 1616
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 106 bits (265), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 86/291 (29%), Positives = 142/291 (48%), Gaps = 39/291 (13%)
Query: 228 SRILIKSEDYQVRRRLGSGS---QYKEILWLGESFALRHFFGD-------IEPLVPEISS 277
S I I + ++ +LG G+ YK LW G S A++ + +E E++
Sbjct: 653 SDIEISFSELKISSKLGEGTFGVVYKG-LWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
L L HPNI+ + T CF+ L L + K+I ++ + L
Sbjct: 712 LSRLRHPNIVLLMAACT-APPNLCFITEYLPGGSLYDALHS-----KKIKMNMQLYKKLA 765
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YLH + H ++ N+LL + +++ KI FGLS +K+ KS
Sbjct: 766 IQIAQGMNYLHLSGVIHRDIKSLNLLL-------DEHMNVKICDFGLSKLKS---KSTEM 815
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
+ + IW +PE+L + Y+EK DVY+FG+I +E+ TG++P+ + L
Sbjct: 816 TKSIGSPIWMSPELLMGED---------YTEKVDVYAFGIILWELGTGELPY--SGLDSV 864
Query: 458 KMSRNIRAGE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
+++ + RP P P +++L + CWH DP +RPSF+ I +L I
Sbjct: 865 QLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 105 bits (262), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 31/234 (13%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E++ L L HPNI+ F+ + C +I E MS+ +L Y+ K+ P+SL +
Sbjct: 135 EVALLSRLFHPNIVQFIAA-CKKPPVYC-IITEYMSQGNLRMYLN------KKEPYSLSI 186
Query: 333 --AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ L L I+RGMEYLHS+ + H +L +N+LL + K++ FG S ++
Sbjct: 187 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDE-------MRVKVADFGTSCLETQ 239
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
++ GT + W APE+++E Y+ K DVYSFG++ +E+ T +PF+
Sbjct: 240 CREAKGNMGT---YRWMAPEMIKEK---------PYTRKVDVYSFGIVLWELTTALLPFQ 287
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ ERP P + +L KRCW +P++RP FS+I +L
Sbjct: 288 GMTPVQAAFAV-AEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVL 340
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 102 bits (253), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 40/282 (14%)
Query: 229 RILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD------IEPLVPEISSLLS 280
R +I +D Q+ +++G GS + W + A++ F + EI+ L
Sbjct: 1386 RWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQ 1445
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
L HP+I+ + G + C ++ E M + + P ++ + ++ Q
Sbjct: 1446 LRHPHII-LMIGACLKRPNIC-IVTEFMGNGSLRNVIKTTKPEWKLK------IKMLYQT 1497
Query: 341 ARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
A G+ YLH+ I H ++ PSNIL+ + ++ KI+ FG + +K ++
Sbjct: 1498 ALGIGYLHNSDPIIIHRDIKPSNILV-------DDSMNVKIADFGFARIKEEN-SVMTRC 1549
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
GT W APE++ KY+EK DV+SFG++ +E+LT K PF + K
Sbjct: 1550 GTP---CWTAPEIIR---------GEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFM--K 1595
Query: 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+S +I G RP P P T L K+CWHA P++RPS +
Sbjct: 1596 VSMDILEGARPQIPSDCPIDFTKLMKQCWHAKPDKRPSMEDV 1637
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q24592|JAK_DROME Tyrosine-protein kinase hopscotch OS=Drosophila melanogaster GN=hop PE=1 SV=2 | Back alignment and function description |
|---|
Score = 100 bits (250), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 29/236 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI + +LSHPNI+ F EK C ++ L S Y++ P + P
Sbjct: 940 EIGIMRTLSHPNIVKFKYW---AEKSHCIIMEYLQSGSFDIYLR-FTAPN----LNNPRL 991
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
V L IA GM+YL + H +L NIL+ G KIS FGL+ N
Sbjct: 992 VSFALDIANGMKYLSDMGLIHRDLAARNILVDHNGDGD----CVKISDFGLAQFANSDGY 1047
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-----GKVP 448
++S P W++PE + S ++S SDV+S+G+ FE+ + VP
Sbjct: 1048 YYAKSKRDIPIRWYSPEAI---------STCRFSSYSDVWSYGVTLFEMFSRGEEPNLVP 1098
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + Q D ++R +++GER P P ++ +L + CWHA P RPSF++I I+
Sbjct: 1099 IQTS--QEDFLNR-LQSGERLNRPASCPDFIYDLMQLCWHATPRSRPSFATIVDII 1151
|
Tyrosine kinase of the non-receptor type, phosphorylates the marelle protein. Required maternally for the establishment of the normal array of embryonic segments: involved in the control of pair-rule gene transcription in a stripe-specific manner. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum GN=roco4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (248), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 82/261 (31%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 253 LWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRD 311
L LG+S + E+ + +L+HPNI+ L G + ++ME + D
Sbjct: 1057 LILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK-LYGLMHNPPR---MVMEFVPCGD 1112
Query: 312 LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGA 369
L + + K P V + LML IA G+EY+ ++ I H +L NI L+
Sbjct: 1113 LYHRLLD-----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 1167
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429
+ + AK++ FGLS S SG F W APE + E++ Y+EK
Sbjct: 1168 NAP--VCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEES-------YTEK 1213
Query: 430 SDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR-AGERPLFPFHSPKYVTNLTKRCWH 488
+D YSF MI + ILTG+ PF++ K IR G RP P P + N+ + CW
Sbjct: 1214 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 1273
Query: 489 ADPNQRPSFSSICRILRYIKR 509
DP +RP FS I + L ++
Sbjct: 1274 GDPKKRPHFSYIVKELSELRN 1294
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| 255583818 | 685 | serine-threonine protein kinase, putativ | 0.991 | 0.988 | 0.710 | 0.0 | |
| 224127862 | 634 | predicted protein [Populus trichocarpa] | 0.928 | 1.0 | 0.699 | 0.0 | |
| 359489706 | 685 | PREDICTED: mitogen-activated protein kin | 0.997 | 0.994 | 0.692 | 0.0 | |
| 449433053 | 678 | PREDICTED: light-sensor Protein kinase-l | 0.989 | 0.997 | 0.679 | 0.0 | |
| 356560480 | 682 | PREDICTED: uncharacterized protein LOC10 | 0.998 | 1.0 | 0.639 | 0.0 | |
| 8920583 | 1025 | Contains similarity to a photoreceptor f | 0.995 | 0.663 | 0.600 | 0.0 | |
| 297842970 | 970 | predicted protein [Arabidopsis lyrata su | 0.995 | 0.701 | 0.595 | 0.0 | |
| 2505884 | 677 | hypothetical protein [Arabidopsis thalia | 0.923 | 0.932 | 0.605 | 0.0 | |
| 255537715 | 714 | serine-threonine protein kinase, putativ | 0.891 | 0.852 | 0.595 | 0.0 | |
| 225426026 | 640 | PREDICTED: uncharacterized protein LOC10 | 0.929 | 0.992 | 0.593 | 0.0 |
| >gi|255583818|ref|XP_002532661.1| serine-threonine protein kinase, putative [Ricinus communis] gi|223527621|gb|EEF29734.1| serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1017 bits (2629), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/691 (71%), Positives = 580/691 (83%), Gaps = 14/691 (2%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
ME+F +IGEV+GS+KALMVF D+IQIN+RQCCLL+DIF FAYD+IAEEM+QNLRFEE+
Sbjct: 1 MERFRQIGEVLGSLKALMVFHDNIQINKRQCCLLVDIFIFAYDTIAEEMKQNLRFEEKHT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KW+ILEQPL+E+ R FK+GE YIKQCLE +DWWAKA+TLYQNTDCV+ YIHNLL+CIPI+
Sbjct: 61 KWRILEQPLREILRTFKDGEGYIKQCLETKDWWAKAVTLYQNTDCVQLYIHNLLTCIPIV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIET EFSGWD D++ KK+LV+S KY+K+WKD +LF W++ KQ+LIT DFC R D V
Sbjct: 121 IEAIETTGEFSGWDQDEIQKKRLVYSNKYQKQWKDPQLFHWKFAKQHLITQDFCERFDVV 180
Query: 181 WKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVR 240
WKEDRWIL NKI++K + S K E+ L D+L KNL+ + + KLLPS IL+ S+DY VR
Sbjct: 181 WKEDRWILLNKIKEKTVLCSRKYERQLRDLLVKNLEEQDTENAKLLPSSILVGSKDYHVR 240
Query: 241 RRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300
RRLG+GSQYKEILWLGES A+RHFFGDI+PLVPEISSLLSLSHPNI +F CGFTDEEKKE
Sbjct: 241 RRLGNGSQYKEILWLGESLAIRHFFGDIQPLVPEISSLLSLSHPNISYFFCGFTDEEKKE 300
Query: 301 CFLIMELMSRDLCSYIKEICCPRKR-IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
CFL+MELMSRD+CSYIKEIC PRKR +PFSLPVAVD+MLQIARGMEYLHSKKIYHG+LNP
Sbjct: 301 CFLVMELMSRDMCSYIKEICGPRKRSLPFSLPVAVDIMLQIARGMEYLHSKKIYHGDLNP 360
Query: 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTE 419
SNIL+KPR ++TEGY+H K+SGFGLSS K K+PS+ T FIW+APEVLEE EQT
Sbjct: 361 SNILVKPR-STTEGYVHVKVSGFGLSSFK----KNPSKQNGTLSFIWYAPEVLEEQEQTG 415
Query: 420 SASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYV 479
SA NSKY+EKSDVYSFGM+CF ILTGKVPF+D+HLQG+KMSRNIRAGERPLFP +SPKYV
Sbjct: 416 SAPNSKYTEKSDVYSFGMVCFGILTGKVPFDDSHLQGEKMSRNIRAGERPLFPLNSPKYV 475
Query: 480 TNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLR 539
TNLTKRCW ADPNQRPSFSSICRILRY KRF+ MNP YN + DP MP VDY D++S+LLR
Sbjct: 476 TNLTKRCWQADPNQRPSFSSICRILRYTKRFLAMNPDYNRELDPLMPAVDYVDMDSKLLR 535
Query: 540 KFPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKDTSDSGSDKASVSGDENMTTPEDP 599
K+PSW+ + I++IPFQMFV RV+EKEK + K+TS+SGSDKASVSGDENM +DP
Sbjct: 536 KYPSWDAADSSQIAQIPFQMFVCRVIEKEKTRVNQKETSESGSDKASVSGDENMNITDDP 595
Query: 600 SP-PV----TERKFLPSPEAVNKKLSGVKKLSES-KVIKQTGTPKGRAVRPPQLIPCGRS 653
P P T RKFL SP+ +N+K S K+ + + +Q GTPKGR+ RPPQL P GR
Sbjct: 596 FPSPTLPSPTGRKFLTSPDTLNRKPSMSKRSPDVIRSSRQAGTPKGRS-RPPQLAPFGRG 654
Query: 654 LRMSSEGQLMAM-SPRIQRTSSGHVSDSELS 683
LRM+SE QLM M SPR++RTSSGH SDSE+S
Sbjct: 655 LRMNSESQLMMMISPRMRRTSSGHASDSEIS 685
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127862|ref|XP_002320182.1| predicted protein [Populus trichocarpa] gi|222860955|gb|EEE98497.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2607), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/683 (69%), Positives = 560/683 (81%), Gaps = 49/683 (7%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF +IGEV+GS+KALMVFRD+IQIN RQCCLLLD+FSFAYDSIAEEMRQNL+FEE+
Sbjct: 1 MEQFRQIGEVLGSLKALMVFRDNIQINPRQCCLLLDVFSFAYDSIAEEMRQNLKFEEKNE 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KW+ILEQPL+E++RIFKEGE YIKQCLE +DWWAKAITLYQN+ CVEFYIHNLLSCIP++
Sbjct: 61 KWRILEQPLREIYRIFKEGEGYIKQCLETKDWWAKAITLYQNSYCVEFYIHNLLSCIPVV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IE+IE A EFSG D D++ KK+LV+S KY+KEWKD +LFQW++ KQYLI+ + C R +TV
Sbjct: 121 IESIEIAGEFSGLDQDEIQKKRLVYSNKYQKEWKDPRLFQWKFAKQYLISQELCNRYNTV 180
Query: 181 WKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVR 240
WKEDRW+L NKI +KK+SGSTKQE+ L D+L KNL+GS ++GKLLP IL++S+DY VR
Sbjct: 181 WKEDRWVLLNKILEKKMSGSTKQERQLTDILLKNLEGSEPVNGKLLPCSILVRSKDYSVR 240
Query: 241 RRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300
RRLGSGSQYKEILWLGES ALRHFFGDIEPL PEISSLLSLSHPNI+ F CGFTDEEKKE
Sbjct: 241 RRLGSGSQYKEILWLGESLALRHFFGDIEPLFPEISSLLSLSHPNILQFFCGFTDEEKKE 300
Query: 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360
CFL+MELM+RDLCS I+E C PRKRIPFSLP+AVDLMLQI+RGMEYLHSK+IYHGNLNPS
Sbjct: 301 CFLVMELMTRDLCSCIRETCGPRKRIPFSLPIAVDLMLQISRGMEYLHSKEIYHGNLNPS 360
Query: 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES 420
NIL+KPR ++EGYLHAK+SGFGLSS+KNF PK+ S T FIW+APE+LEE EQT S
Sbjct: 361 NILVKPRNITSEGYLHAKVSGFGLSSIKNFTPKNSSNQNETLSFIWYAPEILEEKEQTGS 420
Query: 421 ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT 480
NSKY+EK+DVYSFGM+CF++LTGKVPFED+HLQGD MSRNI AGERPLFPF+SPKYVT
Sbjct: 421 EKNSKYTEKADVYSFGMVCFQLLTGKVPFEDSHLQGDNMSRNILAGERPLFPFYSPKYVT 480
Query: 481 NLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRK 540
NLTKRCWH DPNQRPSFSSICRILRY+KRF++MNP YN +P+PPMP++DY D+E++LLRK
Sbjct: 481 NLTKRCWHTDPNQRPSFSSICRILRYVKRFLIMNPDYNREPEPPMPVIDYGDMETKLLRK 540
Query: 541 FPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKDTSDSGSDKASVSGDENMTTPEDPS 600
FPSW+T +++IPFQMFVYRVVEKEK ++ K+TS+SGSDKAS
Sbjct: 541 FPSWDTAESSMVAQIPFQMFVYRVVEKEKARTTQKETSESGSDKASFR------------ 588
Query: 601 PPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPKGRAVRPPQLIPCGRSLRMSSEG 660
TPKGR+ RPPQL C RSLR SE
Sbjct: 589 -----------------------------------TPKGRS-RPPQL-QCTRSLRTGSES 611
Query: 661 QLMAMSPRIQRTSSGHVSDSELS 683
QLM +SPR +RTSSGH SDSE+S
Sbjct: 612 QLMMISPRPRRTSSGHASDSEIS 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489706|ref|XP_002280598.2| PREDICTED: mitogen-activated protein kinase kinase kinase 7-like [Vitis vinifera] gi|147772008|emb|CAN60248.1| hypothetical protein VITISV_039398 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 982 bits (2538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/687 (69%), Positives = 568/687 (82%), Gaps = 6/687 (0%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF ++GEV+GS+KA MVFR+ IQINQRQCCLLLD+ AY ++AEEM+QNLR +E+
Sbjct: 1 MEQFRQMGEVLGSLKAFMVFREDIQINQRQCCLLLDVLDLAYHTVAEEMKQNLRLDEKHT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KWKILEQPL+EL +FKEGE+Y++QCL+ ++WWAKAI YQNTD VEF+IHNLL C P++
Sbjct: 61 KWKILEQPLRELHGVFKEGEHYVRQCLDTKEWWAKAIIFYQNTDSVEFHIHNLLCCFPVV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIE A E SGWD D++ KK+++ S KY+KEW+D KLFQWR+GKQYLI+ DFC R+D V
Sbjct: 121 IEAIEIAGENSGWDQDEIQKKRVLFSTKYQKEWQDPKLFQWRFGKQYLISKDFCSRVDEV 180
Query: 181 WKEDRWILFNKIQQKKISGS---TKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDY 237
W+EDRWIL NKIQ K+ SGS TK EQ L D+LFKNLD S L+GKLLPS IL+ S+DY
Sbjct: 181 WREDRWILLNKIQGKRPSGSVSLTKYEQRLRDLLFKNLDVSQPLNGKLLPSSILLGSKDY 240
Query: 238 QVRRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297
QVRRRLGSGSQYKEI+WLGESFALRHF+G+IEPLVPEIS LLSLSHPNIM LCGF DEE
Sbjct: 241 QVRRRLGSGSQYKEIMWLGESFALRHFYGEIEPLVPEISQLLSLSHPNIMRLLCGFIDEE 300
Query: 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357
K+ECFL+MELM +DLCS++KEIC PR+R+PFSLPVAVDLMLQ+ARGMEYLHSKKIYHG+L
Sbjct: 301 KRECFLVMELMYKDLCSHLKEICGPRRRLPFSLPVAVDLMLQVARGMEYLHSKKIYHGDL 360
Query: 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQ 417
NPSNIL+K R STEGYLHAK+SGFGLSS KN K+ PFIWHAPEVL + EQ
Sbjct: 361 NPSNILVKARSISTEGYLHAKVSGFGLSSTKNLNQKTSPNQAVNLPFIWHAPEVLADQEQ 420
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPK 477
N KY+EK+DVYSFGM+CFE+LTGKVPFED+HLQGDKMSRNIRAGERPLFP +SPK
Sbjct: 421 LGKTGNFKYTEKADVYSFGMVCFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPSNSPK 480
Query: 478 YVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRL 537
Y+TNLTK+CWH DPNQRPSFSSICRILRY K F+ MNP + SQPD P+PLVD+ DIE+ L
Sbjct: 481 YITNLTKKCWHTDPNQRPSFSSICRILRYTKWFLAMNPDH-SQPDAPVPLVDFCDIEAGL 539
Query: 538 LRKFPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKD-TSDSGSDKASVSGDENMTTP 596
L+ PSW + + LPIS+IPFQ+FVYR VEKEK+ + PK +S+SGSD S GDE +T
Sbjct: 540 LKTIPSWRSSDPLPISDIPFQIFVYRAVEKEKLHAIPKQKSSESGSDGYSTCGDEPLTII 599
Query: 597 EDPSPPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPKGRAVRPPQLIPCGRSLRM 656
+DP PP+TE+K S E +KK+S +KK S KVIKQTGTPKG+ +RPP + PCGR++R+
Sbjct: 600 DDPPPPMTEKKPSVSSETTSKKISVLKKSSSVKVIKQTGTPKGQLLRPPLMSPCGRTIRL 659
Query: 657 SSEGQLMAMSPRIQRTSSGHVSDSELS 683
SSEG L+AM P+ +RT GH SDSELS
Sbjct: 660 SSEGHLVAMIPKPRRT-RGHASDSELS 685
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433053|ref|XP_004134312.1| PREDICTED: light-sensor Protein kinase-like [Cucumis sativus] gi|449480438|ref|XP_004155893.1| PREDICTED: light-sensor Protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/683 (67%), Positives = 560/683 (81%), Gaps = 7/683 (1%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF ++GE +GS+KALM+F+DS+ INQRQCCLLLD+ SFAYDS+AEEM+QNLRFEE+
Sbjct: 1 MEQFRQLGEALGSVKALMLFKDSVHINQRQCCLLLDVLSFAYDSVAEEMKQNLRFEEKHT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
+WK+L+QPL++L R+FKE E YI+QCLE +DWWAK I LYQNTDC+EF+IHNLL I ++
Sbjct: 61 RWKVLDQPLRDLNRVFKEAEWYIRQCLETKDWWAKVIMLYQNTDCIEFHIHNLLYSITVV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
+EAIE A E SG D D++ KKKL++S KY++E KD K+F+W++GKQYL+T DFC RI+ V
Sbjct: 121 VEAIEMAGESSGSDHDELLKKKLINSIKYRREHKDLKIFKWKFGKQYLVTQDFCNRIEAV 180
Query: 181 WKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVR 240
W EDRW L NKI++KK+ S+K EQ L D L KN++GS S +GKLLPS +L+ S+DYQVR
Sbjct: 181 WNEDRWFLLNKIREKKLMASSKYEQRLTDHLLKNINGSESFNGKLLPSLMLVGSKDYQVR 240
Query: 241 RRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300
RRLG GSQYKEILWLGESFA+RHFFG+IE L+PEIS LLSLSHPNI FLCGFTDEEKKE
Sbjct: 241 RRLGVGSQYKEILWLGESFAMRHFFGEIESLIPEISMLLSLSHPNITRFLCGFTDEEKKE 300
Query: 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360
CFLIMELMSRDL Y+KEIC PRKRIPF+LPVA+DLMLQIARGMEYLHSKK+YHG+LNP
Sbjct: 301 CFLIMELMSRDLSGYVKEICGPRKRIPFTLPVALDLMLQIARGMEYLHSKKVYHGDLNPC 360
Query: 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES 420
NIL+KPR ST+GY+H ++SGFGL +VK K+ S + PFIW+APEVLEE +Q+ S
Sbjct: 361 NILVKPRAYSTDGYVHGQVSGFGLPAVKF---KNSSNQNESLPFIWYAPEVLEEQDQSGS 417
Query: 421 ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT 480
A + KY+EKSDVYSFGM+CFE+LTGKVPFED+HLQGDKMSRNIRAGERPLFP PKYVT
Sbjct: 418 AESCKYTEKSDVYSFGMVCFEVLTGKVPFEDSHLQGDKMSRNIRAGERPLFPHSMPKYVT 477
Query: 481 NLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRK 540
NLTKRCW DPNQRPSF+SICRILRY KRF+ MNP YNSQ DP MP VDY DIES LLR+
Sbjct: 478 NLTKRCWQTDPNQRPSFTSICRILRYTKRFVAMNPDYNSQTDPAMPTVDYCDIESGLLRR 537
Query: 541 FPSWETHNVL-PISEIPFQMFVYRVVEKEKISSSPKDTSDSGSDKASVSGDENMTTPEDP 599
PS + PI++IPFQMF YRVVEKE+ ++ KDTS+SGSD AS GDE ++ +DP
Sbjct: 538 LPSCGISDAASPITDIPFQMFAYRVVEKERAGATFKDTSESGSD-ASACGDETASSIDDP 596
Query: 600 SPPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPKGRAVRPPQLIPCGRSLRMSSE 659
P ERK LP+P +++LS K S+ ++ K GTPKGR RPPQ+ P GRS+RM+SE
Sbjct: 597 FPTPVERK-LPAPREGSRRLSLTKNNSDVRLNKLPGTPKGRFSRPPQISPRGRSMRMNSE 655
Query: 660 GQLMAMSPRIQRTSSGHVSDSEL 682
QLMA+SP+I+R SGH SDSEL
Sbjct: 656 SQLMAISPKIRRL-SGHASDSEL 677
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560480|ref|XP_003548520.1| PREDICTED: uncharacterized protein LOC100813704 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2431), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/683 (63%), Positives = 552/683 (80%), Gaps = 1/683 (0%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF ++GE +G +K++MVFR+SIQIN RQCCLLLD+F+FAY+ IA+E+ QNL+FEE+
Sbjct: 1 MEQFRQLGEALGGLKSVMVFRESIQINHRQCCLLLDVFTFAYECIADEIIQNLKFEEKNG 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KWKILEQPL+E+ +IF+EGE YI+ C+E +DWWAK+I + N DCVEF+IHNLL C+P++
Sbjct: 61 KWKILEQPLREIHKIFREGEAYIRHCMETKDWWAKSIVMSHNNDCVEFHIHNLLCCMPVV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIE+A E SGWD ++M +K+L++S KY+KE++D +LFQW++GKQYLIT DFC R DTV
Sbjct: 121 IEAIESAGETSGWDQEEMQRKRLINSDKYRKEYRDMRLFQWKFGKQYLITQDFCRRYDTV 180
Query: 181 WKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVR 240
WKEDRW L+NKI +KK+ G +K E+ LID+L +NL+ S SL GKLLPS IL+ S+DYQVR
Sbjct: 181 WKEDRWFLYNKIHEKKVEGISKYEKKLIDLLLRNLERSESLVGKLLPSSILVGSKDYQVR 240
Query: 241 RRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300
RR+G+ SQYKEI WLGESF +RHF GDIE L PEI LLSLSHPNIM LCGFTDEEKKE
Sbjct: 241 RRMGNASQYKEISWLGESFVIRHFSGDIEALEPEIIELLSLSHPNIMDSLCGFTDEEKKE 300
Query: 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360
CFL+MELMS+ L ++IKEI PRKRIPF L VA+DLMLQIARGMEYLHSKK+YHG LNPS
Sbjct: 301 CFLVMELMSKTLSTHIKEIHGPRKRIPFLLHVAIDLMLQIARGMEYLHSKKVYHGELNPS 360
Query: 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES 420
+IL++PRG S EGYLHAK+ GFGL+SVK+ K + T PFIW++PEVLEE + +
Sbjct: 361 SILVRPRGTSQEGYLHAKVMGFGLTSVKDLTQKGNTNQNGTPPFIWYSPEVLEEQDHSGG 420
Query: 421 ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT 480
+NSKY+EKSDVYSFGM+CFE+LTGKVPFED+HLQG+KMSRNIRAGERPLFP +SPKYV
Sbjct: 421 EANSKYTEKSDVYSFGMVCFELLTGKVPFEDSHLQGEKMSRNIRAGERPLFPPNSPKYVI 480
Query: 481 NLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRK 540
NLTKRCWH DP+QRPSF++ICR+LRYIKRF+ +NP Y++QP+PP+P VDY DIES LLRK
Sbjct: 481 NLTKRCWHIDPHQRPSFATICRVLRYIKRFLALNPGYSNQPEPPVPPVDYCDIESVLLRK 540
Query: 541 FPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKDTSDSGSDKASVSGDENMTTPEDPS 600
FPSW + PFQMF Y+ +E+EK+S+ KD S+SGSD AS GDE +T+ ++P
Sbjct: 541 FPSWGGSESPSVPITPFQMFAYQAIEREKVSTGCKDNSESGSD-ASACGDELVTSGDEPF 599
Query: 601 PPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPKGRAVRPPQLIPCGRSLRMSSEG 660
P ERK L + +N+++ +K + K+ KQ GTPKGR RPPQ+ P R+LR++S+
Sbjct: 600 PSTVERKSLLGHDILNRRIQLTRKSLDLKLTKQPGTPKGRLARPPQMSPRTRTLRITSDN 659
Query: 661 QLMAMSPRIQRTSSGHVSDSELS 683
+++ I+R S GHVSDSELS
Sbjct: 660 HMISSPRAIRRVSPGHVSDSELS 682
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8920583|gb|AAF81305.1|AC061957_1 Contains similarity to a photoreceptor from Ceratodon purpureus gb|Y10901 and contains an eukaryotic protein kinase PF|00069 domain. ESTs gb|N96753, gb|AI993724 come from this gene [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/704 (60%), Positives = 543/704 (77%), Gaps = 24/704 (3%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
M+QF IGEV+GS++ALMVF+DSIQINQRQC LLLD+F+ AY+SI+ MR NLRF+E+
Sbjct: 325 MDQFREIGEVLGSIRALMVFKDSIQINQRQCSLLLDLFTAAYESISVSMRSNLRFKEKNT 384
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIR-DWWAKAITLYQNTDCVEFYIHNLLSCIPI 119
KWKILEQPL+EL + +EGE Y++ LE + +WAKAI L+ N DC E +IHNLLSC+PI
Sbjct: 385 KWKILEQPLRELLWVVREGEAYVRMSLEPKLGFWAKAIVLHSNRDCTELHIHNLLSCLPI 444
Query: 120 LIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDT 179
++EAIETA+E SGWD ++M KK+LVHS KY K+W D ++F W++G++YL+T DFC R ++
Sbjct: 445 IVEAIETASEVSGWDEEEMSKKRLVHSNKYMKQWNDSQMFTWKFGREYLVTEDFCNRFES 504
Query: 180 VWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQV 239
W EDRWIL ++Q+KK SGS+K E+ + D L K+L G G+ S KL PS +L ++DYQV
Sbjct: 505 AWTEDRWILIKELQEKKQSGSSKHERKMADFLLKHL-GDGNESPKLFPSSLLDNTKDYQV 563
Query: 240 RRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299
++RLG+GSQYKEI WLGESFALRHFFGDI+ L+P+I+ LLSLSHPNI+++LCGFTDEEKK
Sbjct: 564 KKRLGNGSQYKEITWLGESFALRHFFGDIDALLPQITPLLSLSHPNIVYYLCGFTDEEKK 623
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
ECFL+MELM + L +IKE+C PRK+ SLPVAVDLMLQIA GMEYLHSK+IYHG LNP
Sbjct: 624 ECFLVMELMRKTLGMHIKEVCGPRKKNTLSLPVAVDLMLQIALGMEYLHSKRIYHGELNP 683
Query: 360 SNILLKPR-GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH--PFIWHAPEVLEENE 416
SNIL+KPR S +GYL KI GFGL+SVK F KS S + PFIW++PEVLEE E
Sbjct: 684 SNILVKPRSNQSGDGYLLGKIFGFGLNSVKGFSSKSASLTSQNENFPFIWYSPEVLEEQE 743
Query: 417 QTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP 476
Q+ +A + KYS+KSDVYSFGM+ FE+LTGKVPFED+HLQGDKMSRNIRAGERPLFPF+SP
Sbjct: 744 QSGTAGSLKYSDKSDVYSFGMVSFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPFNSP 803
Query: 477 KYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNP--HYNSQPDPPM-PLVDYSDI 533
K++TNLTKRCWHADPNQRP+FSSI RILRYIKRF+ +NP + +SQ DP + P VDY +I
Sbjct: 804 KFITNLTKRCWHADPNQRPTFSSISRILRYIKRFLALNPECYSSSQQDPSIAPTVDYCEI 863
Query: 534 ESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEKI--SSSPKDTSDSGSDKASVSGDE 591
E++LL+K SWE+ + +S++PFQMF YRVVE+ K + ++ S+SGS+ AS S DE
Sbjct: 864 ETKLLQKL-SWESTELTKVSQVPFQMFAYRVVERAKTCEKDNLREPSESGSEWASCSEDE 922
Query: 592 NMTTPEDPSPPVTERKFLPSPEAVN---KKLSG-VKKLSESKVIKQTG-------TPKGR 640
++ ER+ S V K++S +K+ S K I++ TP+GR
Sbjct: 923 GGAGSDEQLSYAKERRLSCSSNDVGMSKKQVSNLLKRASSLKPIQKPAFGFCSGTTPRGR 982
Query: 641 AVRPPQLIPC-GRSLRMSSEGQLMAMSPRIQRTSSGHVSDSELS 683
+ PP L PC G+S+R +SE QL+ +SPRI+R++SGH SDSELS
Sbjct: 983 SRHPP-LSPCGGQSMRANSESQLILISPRIRRSNSGHASDSELS 1025
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842970|ref|XP_002889366.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297335208|gb|EFH65625.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/702 (59%), Positives = 540/702 (76%), Gaps = 22/702 (3%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF IGEV+GS++ALMVF+D IQINQRQC LLLD+F+ AY+SI+E MR NLRF+E+
Sbjct: 272 MEQFREIGEVLGSIRALMVFKDDIQINQRQCSLLLDLFTAAYESISESMRSNLRFKEKNT 331
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIR-DWWAKAITLYQNTDCVEFYIHNLLSCIPI 119
KWKILEQPL+EL + +EGE Y++ LE + +WAKAI L+ N DC E +IHNLLSC+PI
Sbjct: 332 KWKILEQPLRELLWVVREGEAYVRMSLEPKLGFWAKAIVLHCNRDCTELHIHNLLSCLPI 391
Query: 120 LIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDT 179
++EAIETA E SGWD ++M KK+LVHS KY K+W D ++F W++G++YL+T DFC R ++
Sbjct: 392 IVEAIETAGEVSGWDEEEMSKKRLVHSNKYMKQWNDSQMFTWKFGREYLVTEDFCNRFES 451
Query: 180 VWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQV 239
W EDRWIL ++Q+KK +K + + D L K+L G G+ S KL PS +L+ ++DYQV
Sbjct: 452 AWTEDRWILIKELQEKKQPSLSKHDWKMADFLLKHL-GDGNESPKLFPSSLLVNTKDYQV 510
Query: 240 RRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299
++RLG+GSQYKEI WLGESFALRHFFGDI+ L+P+++ LLSLSHPNI+++LCGFTDEEKK
Sbjct: 511 KKRLGNGSQYKEITWLGESFALRHFFGDIDTLLPKVTPLLSLSHPNIVYYLCGFTDEEKK 570
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
ECFL+MELMS+ L +IKE+C PRK+ SLPVAVDLMLQIA GMEYLHSK+IYHG LNP
Sbjct: 571 ECFLVMELMSKTLGMHIKEVCGPRKKNTLSLPVAVDLMLQIALGMEYLHSKRIYHGELNP 630
Query: 360 SNILLKPRG-ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH--PFIWHAPEVLEENE 416
SNIL+KPR S +GYL KI GFGL+SVK F KS S + PFIW++PEVLEE E
Sbjct: 631 SNILVKPRSHQSGDGYLLGKIFGFGLNSVKGFSSKSASLTSQNENFPFIWYSPEVLEEQE 690
Query: 417 QTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP 476
Q+ +A + KY++KSDVYSFGM+CFE+LTGKVPFED+HLQGDKMSRNIRAGERPLFPF+SP
Sbjct: 691 QSGTAGSLKYTDKSDVYSFGMVCFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPFNSP 750
Query: 477 KYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYN--SQPDPPM-PLVDYSDI 533
K++TNLTKRCWHADPNQRP+FSSI R+LRYIKRF+ +NP Y+ SQ DP + P VDY +I
Sbjct: 751 KFITNLTKRCWHADPNQRPTFSSISRVLRYIKRFLALNPEYHSSSQQDPSIAPPVDYWEI 810
Query: 534 ESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEKI--SSSPKDTSDSGSDKASVSGDE 591
ES+LL+K SWE+ + +S++PFQMF YRVVE+ + + ++TS+SGS+ AS S DE
Sbjct: 811 ESKLLQKL-SWESTELTQVSQVPFQMFAYRVVERAQTCKKDNLRETSESGSEWASCSEDE 869
Query: 592 NMTTPEDPSPPVTERKFLPSPEA---------VNKKLSGVKKLSESKVIKQTG-TPKGRA 641
++ ER+ S + + K+ S +K + + +G TP+GR+
Sbjct: 870 GGAGSDEQVSYEKERRLSCSSDVGMSKKHVSNLLKRASSLKPIQKPAFGFSSGTTPRGRS 929
Query: 642 VRPPQLIPCGRSLRMSSEGQLMAMSPRIQRTSSGHVSDSELS 683
PP L PCG+S+R +SE QL+ +SPRI+R++SGH SDSELS
Sbjct: 930 RHPP-LSPCGQSMRANSESQLILISPRIRRSNSGHASDSELS 970
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2505884|emb|CAA73313.1| hypothetical protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/647 (60%), Positives = 501/647 (77%), Gaps = 16/647 (2%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
M+QF IGEV+GS++ALMVF+DSIQINQRQC LLLD+F+ AY+SI+ MR NLRF+E+
Sbjct: 1 MDQFREIGEVLGSIRALMVFKDSIQINQRQCSLLLDLFTAAYESISVSMRSNLRFKEKNT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIR-DWWAKAITLYQNTDCVEFYIHNLLSCIPI 119
KWKILEQPL+EL + +EGE Y++ LE + +WAKAI L+ N DC E +IHNLLSC+PI
Sbjct: 61 KWKILEQPLRELLWVVREGEAYVRMSLEPKLGFWAKAIVLHSNRDCTELHIHNLLSCLPI 120
Query: 120 LIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDT 179
++EAIETA+E SGWD ++M KK+LVHS KY K+W D ++F W++G++YL+T DFC R ++
Sbjct: 121 IVEAIETASEVSGWDEEEMSKKRLVHSNKYMKQWNDSQMFTWKFGREYLVTEDFCNRFES 180
Query: 180 VWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQV 239
W EDRWIL ++Q+KK SGS+K E+ + D L K+L G G+ S KL PS +L ++DYQV
Sbjct: 181 AWTEDRWILIKELQEKKQSGSSKHERKMADFLLKHL-GDGNESPKLFPSSLLDNTKDYQV 239
Query: 240 RRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299
++RLG+GSQYKEI WLGESFALRHFFGDI+ L+P+I+ LLSLSHPNI+++LCGFTDEEKK
Sbjct: 240 KKRLGNGSQYKEITWLGESFALRHFFGDIDALLPQITPLLSLSHPNIVYYLCGFTDEEKK 299
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
ECFL+MELM + L +IKE+C PRK+ SLPVAVDLMLQIA GMEYLHSK+IYHG LNP
Sbjct: 300 ECFLVMELMRKTLGMHIKEVCGPRKKNTLSLPVAVDLMLQIALGMEYLHSKRIYHGELNP 359
Query: 360 SNILLKPR-GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH--PFIWHAPEVLEENE 416
SNIL+KPR S +GYL KI GFGL+SVK F KS S + PFIW++PEVLEE E
Sbjct: 360 SNILVKPRSNQSGDGYLLGKIFGFGLNSVKGFSSKSASLTSQNENFPFIWYSPEVLEEQE 419
Query: 417 QTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP 476
Q+ +A + KYS+KSDVYSFGM+ FE+LTGKVPFED+HLQGDKMSRNIRAGERPLFPF+SP
Sbjct: 420 QSGTAGSLKYSDKSDVYSFGMVSFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPFNSP 479
Query: 477 KYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNP--HYNSQPDPPM-PLVDYSDI 533
K++TNLTKRCWHADPNQRP+FSSI RILRYIKRF+ +NP + +SQ DP + P VDY +I
Sbjct: 480 KFITNLTKRCWHADPNQRPTFSSISRILRYIKRFLALNPECYSSSQQDPSIAPTVDYCEI 539
Query: 534 ESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEKI--SSSPKDTSDSGSDKASVSGDE 591
E++LL+K SWE+ + +S++PFQMF YRVVE+ K + ++ S+SGS+ AS S DE
Sbjct: 540 ETKLLQKL-SWESTELTKVSQVPFQMFAYRVVERAKTCEKDNLREPSESGSEWASCSEDE 598
Query: 592 NMTTPEDPSPPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPK 638
++ ER+ S V G+ K S ++K+ + K
Sbjct: 599 GGAGSDEQLSYAKERRLSCSSNDV-----GMSKKQVSNLLKRASSLK 640
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537715|ref|XP_002509924.1| serine-threonine protein kinase, putative [Ricinus communis] gi|223549823|gb|EEF51311.1| serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/613 (59%), Positives = 471/613 (76%), Gaps = 4/613 (0%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF +IGE +GS+KALMV +D IQIN+RQCCLLL+IF+ A+D+IAEE++QNL+ +E+
Sbjct: 1 MEQFRQIGEALGSLKALMVLQDDIQINRRQCCLLLNIFTSAFDTIAEEIKQNLKLDEKNT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KWK LE+PLKEL+R+FKEGE Y+++CL+ +DWW KA+ L+QN D +EF+IHNL+S P +
Sbjct: 61 KWKPLEEPLKELYRVFKEGELYVRRCLDSKDWWGKAVVLHQNKDSIEFHIHNLVSYFPAV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIETA E SG D D+M KK+++ KY + W D KLFQWR+GKQYL++ + C +I+T
Sbjct: 121 IEAIETAGEISGLDQDEMQKKRVMLFKKYDRSWHDQKLFQWRFGKQYLVSREICNQIETA 180
Query: 181 WKEDRWILFNKIQQKKISGS-TKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQV 239
KED W+L I++K +GS TK EQ L D+L K L+G ++GKL PS IL+ +EDYQV
Sbjct: 181 VKEDGWLLVGAIKEKMKAGSLTKNEQRLGDLLQKKLNGQLLINGKLPPSSILLGAEDYQV 240
Query: 240 RRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299
RRRLG GSQYKEI WLGESFALRHFF DIEPL EIS LLSLSHPNI+ +LCGF DEEKK
Sbjct: 241 RRRLGGGSQYKEIQWLGESFALRHFFEDIEPLNSEISVLLSLSHPNIVQYLCGFYDEEKK 300
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
ECFL+MELMS+DL +Y+KE R+++ F LP+ VD+MLQ+ARGME+LHS+KIY G+LNP
Sbjct: 301 ECFLVMELMSKDLYAYMKENSSSRRQVLFPLPIVVDIMLQVARGMEFLHSRKIYVGDLNP 360
Query: 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQT 418
+NI LKPR STEGY H K+SGFGL+ ++N + S S P IWHAPEVL E EQT
Sbjct: 361 TNIFLKPR-KSTEGYFHVKVSGFGLTYIENPSSRHSSSNQNAFDPCIWHAPEVLAEREQT 419
Query: 419 ESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKY 478
S S K+SEK+DVYSFGM+CF++LTGK+PFED HLQGD+M++NIRAGERPLFP SPKY
Sbjct: 420 GSPSTRKHSEKADVYSFGMLCFQLLTGKLPFEDGHLQGDQMAKNIRAGERPLFPSLSPKY 479
Query: 479 VTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLL 538
+ NLTK+CWH DPN RPSFSSI R+LRYIK++++MNP + Q P VDYS++E+ L
Sbjct: 480 LVNLTKKCWHTDPNYRPSFSSISRVLRYIKKYLVMNP-VDGQLVMQSPPVDYSELEAGFL 538
Query: 539 RKFPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKDTSDSGSDKASVSGDENMTTPED 598
+++P + +S+IPFQMFVYR+ EKE+ S S + S+ AS DEN++ ED
Sbjct: 539 KRYPGEMNGGLASVSQIPFQMFVYRISEKERTSLSFRFKQSETSEAASNGWDENISVVED 598
Query: 599 PSPPVTERKFLPS 611
P P ++ + + S
Sbjct: 599 PVVPASDARSISS 611
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426026|ref|XP_002271425.1| PREDICTED: uncharacterized protein LOC100251959 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/688 (59%), Positives = 496/688 (72%), Gaps = 53/688 (7%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF +IGEV GS+KALMVF+D IQIN+RQCCLL DIFS A+ +I EE+RQNLR EE+
Sbjct: 1 MEQFRQIGEVWGSLKALMVFKDDIQINKRQCCLLFDIFSSAFKTIVEEIRQNLRLEEKNT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KWK LEQPL+EL R FK+ E YI+ CL+ +DWW KA++L+QN D VEF+IHNLL PI+
Sbjct: 61 KWKALEQPLRELHRAFKDAELYIRNCLDTKDWWGKAMSLHQNNDSVEFHIHNLLCTFPIV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIETA E SG L + KY+KEW D KLFQW++GKQYL+T + C R+++
Sbjct: 121 IEAIETAGEMSG----------LALATKYEKEWNDPKLFQWKFGKQYLVTREICSRLESA 170
Query: 181 WKEDRWILFNKIQQKKISGST-KQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQV 239
WKEDRW+L I++KK SGS K EQ L D+L K L+GS +GKL P +L+ ++DYQV
Sbjct: 171 WKEDRWLLLEMIREKKSSGSVGKNEQKLGDLLLKKLNGSEKFNGKLSPGSVLVGAKDYQV 230
Query: 240 RRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299
+RRL GSQ KEI WLGE FALR FFG+IEPL EISSLLSLSHPNIM +LCGF DEEKK
Sbjct: 231 KRRLEGGSQCKEIQWLGEGFALRQFFGEIEPLNSEISSLLSLSHPNIMQYLCGFYDEEKK 290
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
EC L+ME+M++DL S IKE C R+RI F LPV VDLMLQIARGMEYLHS K+YHG+LNP
Sbjct: 291 ECLLVMEMMNKDLHSQIKENCGQRRRILFPLPVMVDLMLQIARGMEYLHSVKVYHGDLNP 350
Query: 360 SNILLKPRGASTEGYLHAKISGFGLSSVKN--FGPKSPSQSGTTHPFIWHAPEVLEENEQ 417
SNI LK R +STEGY HAK+SGFGLSS+KN F SP Q+GT P IWHAPEVL E EQ
Sbjct: 351 SNIFLKARNSSTEGYFHAKVSGFGLSSIKNHTFSRSSPGQNGTD-PLIWHAPEVLAEQEQ 409
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPK 477
S+ +SK+SEK+DVYSFGM+CFE+LTGKVPFED+HLQGDKMSRNIRAGERPLFPF S K
Sbjct: 410 LGSSCSSKFSEKADVYSFGMLCFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPFPSHK 469
Query: 478 YVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRL 537
Y+ NL KRCWH DP QRPSFSSICRILRYIKRF++ NP + SQP+ P VDY ++E+
Sbjct: 470 YLANLAKRCWHTDPVQRPSFSSICRILRYIKRFLVQNPDH-SQPELTQPPVDYFELEAGF 528
Query: 538 LRKFPSWETHNVLPISEIPFQMFVYRVVEKEKISSSPKD--TSDSGSDKASVSGDENMTT 595
++K + +P+S+IPFQMF YR+VEKEK S KD + + AS SGDEN+
Sbjct: 529 VKKLTVEGQLDPMPVSQIPFQMFAYRLVEKEKTSLDYKDKSSESASEAAASGSGDENVAL 588
Query: 596 PEDPSPPVTERKFLPSPEAVNKKLSGVKKLSESKVIKQTGTPKGRAVRPPQLIPCGRSLR 655
+DP FL + E GTPK +A +P L PCG ++
Sbjct: 589 VDDP--------FLQASE---------------------GTPKAQAQKPTPLKPCG-GMK 618
Query: 656 MSSEGQLMAMSPRIQRTSSGHVSDSELS 683
++ Q+ + RT SGH DS++S
Sbjct: 619 LNRGAQM-----GLGRT-SGHALDSDVS 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| TAIR|locus:2175065 | 711 | AT5G41730 [Arabidopsis thalian | 0.922 | 0.886 | 0.542 | 1.3e-191 | |
| TAIR|locus:2014255 | 717 | AT1G64300 [Arabidopsis thalian | 0.920 | 0.877 | 0.553 | 1.1e-188 | |
| TAIR|locus:2025356 | 470 | AT1G01450 [Arabidopsis thalian | 0.625 | 0.908 | 0.594 | 1.7e-130 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.294 | 0.603 | 0.325 | 4.8e-24 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.327 | 0.594 | 0.314 | 2.4e-20 | |
| DICTYBASE|DDB_G0285321 | 1155 | splB "protein kinase, TKL grou | 0.379 | 0.224 | 0.302 | 1.2e-19 | |
| UNIPROTKB|E1C2F6 | 507 | FRK "Uncharacterized protein" | 0.352 | 0.475 | 0.298 | 6.3e-19 | |
| ZFIN|ZDB-GENE-070705-132 | 675 | ripk1l "receptor (TNFRSF)-inte | 0.325 | 0.328 | 0.326 | 3.6e-18 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.310 | 0.612 | 0.300 | 5.4e-18 | |
| DICTYBASE|DDB_G0286127 | 1867 | roco8 "LRRK family protein kin | 0.311 | 0.114 | 0.331 | 1e-17 |
| TAIR|locus:2175065 AT5G41730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1801 (639.0 bits), Expect = 1.3e-191, Sum P(2) = 1.3e-191
Identities = 351/647 (54%), Positives = 454/647 (70%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF +IGEV+GS+ ALMV +D I INQRQCCLLL++FS A++++AEE+RQNL+ EE+
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLELFSLAFNTVAEEIRQNLKLEEKHT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KW+ LEQPL+EL+R+FKEGE Y+K C++ DWW K I L+QN DCVEF+IHNL +
Sbjct: 61 KWRALEQPLRELYRVFKEGELYVKHCMDNSDWWGKVINLHQNKDCVEFHIHNLFCYFSAV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
+EAIE A E SG DP +M ++++V S KY +EW D K+FQWR+GKQYL++ D C R +
Sbjct: 121 VEAIEAAGEISGLDPSEMERRRVVFSRKYDREWNDPKMFQWRFGKQYLLSRDICSRFEHS 180
Query: 181 WKEDRWILFNKIQQKKISGST---KQEQGLIDVLFKNLDXXXXXXXXXXPSRILIKSEDY 237
W+EDRW L +Q+K+ S S K E+ L D+L K L PS IL+ S+DY
Sbjct: 181 WREDRWNLVEALQEKRKSDSDDIGKTEKRLADLLLKKLTGLEQFNGKLFPSSILLGSKDY 240
Query: 238 QVRRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297
QV++RL + QYKEI WLG+SFALRHFF D+EPL EISSLL+L H NI+ +LCGF DEE
Sbjct: 241 QVKKRLDADGQYKEIQWLGDSFALRHFFSDLEPLSSEISSLLALCHSNILQYLCGFYDEE 300
Query: 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357
+KECFL+MELM +DL SY+KE C PR+R FS+PV +D+MLQIARGMEYLH I+HG+L
Sbjct: 301 RKECFLVMELMHKDLQSYMKENCGPRRRYLFSIPVVIDIMLQIARGMEYLHGNDIFHGDL 360
Query: 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQ 417
NP NI LK R + TEGY HAKI GFGLSSV +S S+ GT P IW+APEVL E EQ
Sbjct: 361 NPMNIHLKER-SHTEGYFHAKICGFGLSSVVK--AQSSSKPGTPDPVIWYAPEVLAEMEQ 417
Query: 418 TESASN--SKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHS 475
+ SK + K+DVYSF M+CFE++TGKVPFED+HLQG+ M+ NIR GERPLFPF S
Sbjct: 418 DLNGKTPKSKLTHKADVYSFAMVCFELITGKVPFEDSHLQGEPMTINIRMGERPLFPFPS 477
Query: 476 PKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIES 535
PKY+ +L KRCWH++P+QRP+FSSICRILRYIK+F+++NP + P PLVD D+E+
Sbjct: 478 PKYLVSLIKRCWHSEPSQRPNFSSICRILRYIKKFLVVNPDHG-HPQMQTPLVDCWDLEA 536
Query: 536 RLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEXXX-XXXXXXXXXXXXXASVSGDE-N- 592
R LRKFP + +++IPFQ++ YRV+EKE SV D N
Sbjct: 537 RFLRKFPGDAGSHTASVNQIPFQLYSYRVLEKEKMNPNSKESSETSESESVSVVEDPPNA 596
Query: 593 MTTPEDPS---PPVTERKFLPS--PEAVNKKLSGVKKLSESKVIKQT 634
M T + S ++E S EA KK+S +KK E ++++
Sbjct: 597 MITRDTKSLCLDTISEYSDTRSVYSEAPMKKVSALKKSGEMAKLRRS 643
|
|
| TAIR|locus:2014255 AT1G64300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1829 (648.9 bits), Expect = 1.1e-188, P = 1.1e-188
Identities = 358/647 (55%), Positives = 459/647 (70%)
Query: 1 MEQFGRIGEVMGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRA 60
MEQF +IGEV+GS+ ALMV +D I INQRQCCLLLDIFS ++++AEE+R NL+ EE+
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLDIFSLGFNTVAEEIRHNLKLEEKHT 60
Query: 61 KWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPIL 120
KW+ LEQPL+EL+R+FKEGE Y++ C+ +DWW K I +QN DCVEF+IHNLL +
Sbjct: 61 KWRALEQPLRELYRVFKEGEMYVRNCMSNKDWWGKVINFHQNKDCVEFHIHNLLCYFSAV 120
Query: 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180
IEAIETA E SG DP +M ++++V S KY +EW D KLFQWR+GKQYL+ D C R +
Sbjct: 121 IEAIETAGEISGLDPSEMERRRVVFSRKYDREWNDPKLFQWRFGKQYLVPRDICLRFEHS 180
Query: 181 WKEDRWILFNKIQQKKISGST---KQEQGLIDVLFKNLDXXXXXXXXXXPSRILIKSEDY 237
W+EDRW L +Q+K+ S S K E+ L D L K L PS IL+ S+DY
Sbjct: 181 WREDRWNLVEALQEKRKSKSDEIGKTEKRLADFLLKKLTGLEQFNGKLFPSSILVGSKDY 240
Query: 238 QVRRRLGSGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297
QVRRRLG G QYKEI WLG+SF LRHFFGD+EPL EISSLLSL H NI+ +LCGF DEE
Sbjct: 241 QVRRRLGGGGQYKEIQWLGDSFVLRHFFGDLEPLNAEISSLLSLCHSNILQYLCGFYDEE 300
Query: 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357
+KEC L+MELM +DL SY+KE C PR+R FS+PV +D+MLQIARGMEYLHS +I+HG+L
Sbjct: 301 RKECSLVMELMHKDLKSYMKENCGPRRRYLFSVPVVIDIMLQIARGMEYLHSNEIFHGDL 360
Query: 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG-PKSPSQSGTTHPFIWHAPEVLEENE 416
NP NILLK R + TEGY HAKISGFGL+SVKN ++ S+ T P IW+APEVL E E
Sbjct: 361 NPMNILLKER-SHTEGYFHAKISGFGLTSVKNQSFSRASSRPTTPDPVIWYAPEVLAEME 419
Query: 417 QT--ESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFH 474
Q +A SK++ K+DVYSF M+CFE++TGKVPFED HLQGDKM++NIR GERPLFPF
Sbjct: 420 QDLKGTAPRSKFTHKADVYSFAMVCFELITGKVPFEDDHLQGDKMAKNIRTGERPLFPFP 479
Query: 475 SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNP-HYNSQPDPPMPLVDYSDI 533
SPKY+ +L KRCWH++P+QRP+FSSICRILRYIK+F+++NP H + Q P LVD D+
Sbjct: 480 SPKYLVSLIKRCWHSEPSQRPTFSSICRILRYIKKFLVVNPDHGHLQIQNP--LVDCWDL 537
Query: 534 ESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEXXXXXXXXXXXXXXXXASVSGDENM 593
E+R L+KF + +++IPFQ++ YR+ EKE SVS E++
Sbjct: 538 EARFLKKFSMESGSHAGSVTQIPFQLYSYRIAEKEKMSPNFNKEENSDAGE-SVS--ESV 594
Query: 594 TTPEDPSPPVTERKFLPSP--EAVNKKLSGVKKLSESKVIKQTGTPK 638
+ E+P P T + S +A+++ S + + IK+T K
Sbjct: 595 SVVEEP--PTTMPMYTKSLCLDAISE-YSDTRSVYSEAPIKKTSALK 638
|
|
| TAIR|locus:2025356 AT1G01450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
Identities = 262/441 (59%), Positives = 322/441 (73%)
Query: 207 LIDVLFKNLDXXXXXXXXXXPSRILIKSEDYQVRRRLGSGSQYKEILWLGESFALRHFFG 266
+ D L K+L PS +L ++DYQV++RLG+GSQYKEI WLGESFALRHFFG
Sbjct: 1 MADFLLKHLGDGNESPKLF-PSSLLDNTKDYQVKKRLGNGSQYKEITWLGESFALRHFFG 59
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
DI+ L+P+I+ LLSLSHPNI+++LCGFTDEEKKECFL+MELM + L +IKE+C PRK+
Sbjct: 60 DIDALLPQITPLLSLSHPNIVYYLCGFTDEEKKECFLVMELMRKTLGMHIKEVCGPRKKN 119
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG-ASTEGYLHAKISGFGLS 385
SLPVAVDLMLQIA GMEYLHSK+IYHG LNPSNIL+KPR S +GYL KI GFGL+
Sbjct: 120 TLSLPVAVDLMLQIALGMEYLHSKRIYHGELNPSNILVKPRSNQSGDGYLLGKIFGFGLN 179
Query: 386 SVKNFGPKSPSQSGTTH--PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
SVK F KS S + PFIW++PEVLEE EQ+ +A + KYS+KSDVYSFGM+ FE+L
Sbjct: 180 SVKGFSSKSASLTSQNENFPFIWYSPEVLEEQEQSGTAGSLKYSDKSDVYSFGMVSFELL 239
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
TGKVPFED+HLQGDKMSRNIRAGERPLFPF+SPK++TNLTKRCWHADPNQRP+FSSI RI
Sbjct: 240 TGKVPFEDSHLQGDKMSRNIRAGERPLFPFNSPKFITNLTKRCWHADPNQRPTFSSISRI 299
Query: 504 LRYIKRFIMMNPH-YNS-QPDPPM-PLVDYSDIESRLLRKFPSWETHNVLPISEIPFQMF 560
LRYIKRF+ +NP Y+S Q DP + P VDY +IE++LL+K SWE+ + +S++PFQMF
Sbjct: 300 LRYIKRFLALNPECYSSSQQDPSIAPTVDYCEIETKLLQKL-SWESTELTKVSQVPFQMF 358
Query: 561 VYRVVE--KEXXXXXXXXXXXXXXXXASVSGDENMTTPEDPSPPVTERKFLPSPEAVN-- 616
YRVVE K AS S DE ++ ER+ S V
Sbjct: 359 AYRVVERAKTCEKDNLREPSESGSEWASCSEDEGGAGSDEQLSYAKERRLSCSSNDVGMS 418
Query: 617 -KKLSGV-KKLSESKVIKQTG 635
K++S + K+ S K I++ G
Sbjct: 419 KKQVSNLLKRASSLKPIQKPG 439
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 266 (98.7 bits), Expect = 4.8e-24, Sum P(2) = 4.8e-24
Identities = 74/227 (32%), Positives = 114/227 (50%)
Query: 303 LIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361
++ EL+ L Y+ I R ++ LP+A+ L IAR + LH+ I H +L P N
Sbjct: 92 IVTELLPGMSLRKYLTSI---RPQL-LHLPLALSFALDIARALHCLHANGIIHRDLKPDN 147
Query: 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESA 421
+LL TE + K++ FGL+ ++ +++GT + W APE L
Sbjct: 148 LLL------TENHKSVKLADFGLAREESVTEMMTAETGT---YRWMAPE-LYSTVTLRQG 197
Query: 422 SNSKYSEKSDVYSFGMICFEILTGKVPFED-AHLQGDKMSRNIRAGERPLFPFHSPKYVT 480
Y+ K DVYSFG++ +E+LT ++PFE ++LQ + + ERP+ P +
Sbjct: 198 EKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQ--ERPVMPEGISPSLA 255
Query: 481 NLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMPL 527
+ + CW DPN RPSFS I R+L F++ P PP PL
Sbjct: 256 FIVQSCWVEDPNMRPSFSQIIRLLN---EFLL-----TLTPPPPQPL 294
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 262 (97.3 bits), Expect = 2.4e-20, P = 2.4e-20
Identities = 77/245 (31%), Positives = 115/245 (46%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
D + E+ L S+ H NI+ F+ G E + ++ EL+ ++ +
Sbjct: 90 DKQQFQKEVLVLSSMKHENIVRFV-GACIEP--QLMIVTELVRGGT---LQRFMLNSRPS 143
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
P L V++ L I+R MEYLHSK I H +LNP N+L+ T H K++ FGL+
Sbjct: 144 PLDLKVSLSFALDISRAMEYLHSKGIIHRDLNPRNVLV------TGDMKHVKLADFGLAR 197
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
K G + ++GT + W APEV E Y +K DVYSF +I + +LT K
Sbjct: 198 EKTLGGMT-CEAGT---YRWMAPEVCSR-EPLRIGEKKHYDQKIDVYSFALIFWSLLTNK 252
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR- 505
PF + + + + G+RP + P V + + CW AD R F I L
Sbjct: 253 TPFSE--IPSISIPYFVNQGKRPSLS-NIPDEVVPILECCWAADSKTRLEFKDITISLES 309
Query: 506 YIKRF 510
+KRF
Sbjct: 310 LLKRF 314
|
|
| DICTYBASE|DDB_G0285321 splB "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 270 (100.1 bits), Expect = 1.2e-19, P = 1.2e-19
Identities = 86/284 (30%), Positives = 132/284 (46%)
Query: 231 LIKSEDYQVRRRLGSG--SQYKEILWLGESFALRHF--FGDIEPLVPE-ISSLLSLSHPN 285
+I D Q +++G G S+ E W G A++ GD E I + +L N
Sbjct: 847 IIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKGN 906
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ + K C + + L + + ++ +S P+ + + +A G+
Sbjct: 907 HQNIVMFIGACYKPACIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGLL 966
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF-GPKSPSQSGTTHPF 404
+LHS I H +L NILL G + KIS FGLS K+ G + + G +P
Sbjct: 967 HLHSITIVHRDLTSQNILLDELG-------NIKISDFGLSREKSREGSMTMTNGGICNPR 1019
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
W PE+ T++ + YSEK DVY F ++ +EILTG++PF D L G + S +
Sbjct: 1020 -WRPPEL------TKNLGH--YSEKVDVYCFSLVVWEILTGEIPFSD--LDGSQASAQVA 1068
Query: 465 -AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
AG RP P + + L +CW ADPN RP F+ I L+ I
Sbjct: 1069 YAGLRPPIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKLKEI 1112
|
|
| UNIPROTKB|E1C2F6 FRK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 257 (95.5 bits), Expect = 6.3e-19, P = 6.3e-19
Identities = 83/278 (29%), Positives = 140/278 (50%)
Query: 241 RRLGSGSQYKEI---LWLGES-FALRHFF-GDIEP--LVPEISSLLSLSHPNIMHFLCGF 293
++LGSG Q+ E+ LW + A++ G ++P + E + +L HPN++
Sbjct: 241 KKLGSG-QFGEVWEGLWNNTTPVAIKTLKPGSMDPKDFLREAQIMKNLRHPNLIQLYAVC 299
Query: 294 TDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKI 352
T E+ +++ ELM L Y++ SLP +D+ Q+A GM YL S+
Sbjct: 300 TLEDP--IYIVTELMKYGSLIEYLQNDAGSH----ISLPHQIDMAAQVASGMAYLESQNY 353
Query: 353 YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPE 410
H +L N+L+ Y K++ FGL+ V ++ ++ T P W APE
Sbjct: 354 IHRDLAARNVLVGEHSV----Y---KVADFGLARVFKVENENIYEARPETKLPVKWTAPE 406
Query: 411 VLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERP 469
+ N K+S KSDV+SFG++ FEI+T GK+P+ A + G ++ + + G R
Sbjct: 407 AIRYN---------KFSVKSDVWSFGILLFEIITYGKMPY--AGMPGHQVIQMLDKGYRL 455
Query: 470 LFPFHSPKYVTNLTKRCWHADPNQRPSFSSI-CRILRY 506
P PK + L +CW +P++RP+F ++ C++ Y
Sbjct: 456 PQPETCPKALYELMLKCWSTEPSERPTFEALYCQLEDY 493
|
|
| ZFIN|ZDB-GENE-070705-132 ripk1l "receptor (TNFRSF)-interacting serine-threonine kinase 1, like" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 253 (94.1 bits), Expect = 3.6e-18, P = 3.6e-18
Identities = 83/254 (32%), Positives = 132/254 (51%)
Query: 274 EISSLLS-LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331
E SL+S L+H ++ L G E+ + L+MEL+ + +L + ++ + P +
Sbjct: 75 EEGSLMSRLNHQRVVKLL-GVILEDG-DYSLVMELIPKGNLLTMLETVTVP-------IS 125
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
V ++L+I GM YL ++ H +L P NIL+ H KI+ GL++ + +
Sbjct: 126 VKGRIILEILEGMVYLTKNQVIHKDLKPENILVDKN-------FHIKIADLGLATSEVWS 178
Query: 392 P----KSPSQSGTTHPFIWHAPEVL--EENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
+S QS HA L E +S +++ SEKSDVYSF ++ + ILTG
Sbjct: 179 KLTKEESRRQSRLGKKTSAHAAGTLCYMAPEHLKSI-HTRSSEKSDVYSFAIVLWVILTG 237
Query: 446 KVPFEDAHLQGDKMSRNIRAGERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC- 501
+ P+E+A + D++ + GERP L P ++P +T+L K CWH DP QRPSF+ C
Sbjct: 238 REPYENARSE-DQICHCVCQGERPDEALIPPNTPTDITDLMKSCWHQDPLQRPSFTD-CY 295
Query: 502 -RILRYIKRFIMMN 514
R L + K + N
Sbjct: 296 NRFLPFYKEKLAAN 309
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 240 (89.5 bits), Expect = 5.4e-18, P = 5.4e-18
Identities = 73/243 (30%), Positives = 117/243 (48%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEI--CCPRKRIPFSL 330
E+ L + H N++ F+ G E ++ EL+ L Y+ + C R
Sbjct: 68 EVEMLSRVQHKNLVKFI-GACKEPVM--VIVTELLQGGTLRKYLLNLRPACLETR----- 119
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
VA+ L IARGME LHS I H +L P N+LL T + K++ FGL+ ++
Sbjct: 120 -VAIGFALDIARGMECLHSHGIIHRDLKPENLLL------TADHKTVKLADFGLAREESL 172
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
+++GT + W APE L Y+ K D YSF ++ +E+L K+PFE
Sbjct: 173 TEMMTAETGT---YRWMAPE-LYSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFE 228
Query: 451 D-AHLQGDKMS--RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL-RY 506
++LQ + +N+R L P+ + ++ CW+ DPN RP+F+ I +L Y
Sbjct: 229 GMSNLQAAYAAAFKNVRPSAESL-----PEELGDIVTSCWNEDPNARPNFTHIIELLLNY 283
Query: 507 IKR 509
+ +
Sbjct: 284 LSK 286
|
|
| DICTYBASE|DDB_G0286127 roco8 "LRRK family protein kinase Roco8" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 255 (94.8 bits), Expect = 1.0e-17, P = 1.0e-17
Identities = 80/241 (33%), Positives = 125/241 (51%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPV 332
E+ + LSH NI+ + GF E ++ME M L S++K+ + + + +
Sbjct: 1642 EVWLMSGLSHSNIV-LMKGFCFEPYA---IVMEYMDIGSLSSFLKKKKEDGQVLDWQM-- 1695
Query: 333 AVDLMLQIARGMEYLHS--KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS--VK 388
+ ++ IA GM +LH+ + H +L NILL + + AK+S FGLS V+
Sbjct: 1696 LLKIVTDIASGMAFLHNITPPLVHRDLKSPNILLASH-PTNPNEISAKVSDFGLSRSIVQ 1754
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
NF K +P W +PEVL+ E Y+EKSD+YSFGMI +E ++P
Sbjct: 1755 NFSSKV-----VDNP-TWQSPEVLKGME---------YNEKSDIYSFGMILWECYHLELP 1799
Query: 449 FEDAHLQG-DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
F++ + + NI +G RP + + ++L +CW+ADPN RPSF+SI + L I
Sbjct: 1800 FDEFDFKFMSTLEDNILSGLRPSINQNCNRMYSSLITKCWNADPNLRPSFNSILKTLNEI 1859
Query: 508 K 508
K
Sbjct: 1860 K 1860
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XIV000379 | hypothetical protein (634 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 683 | |||
| pfam06760 | 217 | pfam06760, DUF1221, Protein of unknown function (D | 1e-112 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-18 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-17 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.004 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|191604 pfam06760, DUF1221, Protein of unknown function (DUF1221) | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-112
Identities = 134/219 (61%), Positives = 173/219 (78%), Gaps = 5/219 (2%)
Query: 21 RDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRAKWKILEQPLKELFRIFKEGE 80
+D IQINQRQCCLLLD F+ AY+++A EMR NLRF+E+ KWKILEQPL+EL R+F+EGE
Sbjct: 1 KDDIQINQRQCCLLLDAFALAYEAVAGEMRANLRFDEKHTKWKILEQPLRELHRVFREGE 60
Query: 81 NYIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCIPILIEAIETAAEFSGWDPDQMHK 140
Y++QCL+ + WWAKAI + NTDCVEF+IHNLL C+P+++EAIETA E SG DPD++ +
Sbjct: 61 AYVRQCLDPKGWWAKAIAFHHNTDCVEFHIHNLLWCVPVVVEAIETAGEVSGSDPDELAR 120
Query: 141 KKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTVWKEDRWILFNKIQQKKISGS 200
K+LV S KY K+W D KLFQWR+GKQYL+T D C R+D WKEDRWIL ++Q+KK SGS
Sbjct: 121 KRLVLSRKYDKDWLDPKLFQWRFGKQYLVTRDLCARMDMAWKEDRWILSQELQEKKGSGS 180
Query: 201 ---TKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSED 236
+K E L D+L K+LDG+ +GKL PS +L+ S+D
Sbjct: 181 SKLSKHEHRLADLLAKHLDGNE--NGKLHPSSVLLGSKD 217
|
This is a family of plant proteins, most of which are hypothetical and of unknown function. All members contain the pfam00069 domain, suggesting that they may possess kinase activity. Length = 217 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 8e-48
Identities = 74/244 (30%), Positives = 114/244 (46%), Gaps = 25/244 (10%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR-- 323
+ + + E + L HPN++ L G E++ +L++E M DL Y+++
Sbjct: 39 ERKDFLKEARVMKKLGHPNVVRLL-GVC-TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPS 96
Query: 324 -KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
++ SL + +QIA+GMEYL SKK H +L N L+ L KIS F
Sbjct: 97 PEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-------LVVKISDF 149
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
GLS ++G P W APE L++ ++ KSDV+SFG++ +EI
Sbjct: 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEI 200
Query: 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
T G P+ L +++ +R G R P + P + L CW DP RP+FS +
Sbjct: 201 FTLGATPYPG--LSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258
Query: 502 RILR 505
L
Sbjct: 259 ERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 8e-46
Identities = 75/233 (32%), Positives = 110/233 (47%), Gaps = 27/233 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + LSHPNI+ L T E +++ E M DL +++ + +L
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLR-----KHGEKLTLKD 103
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ + LQIA+GMEYL SK H +L N L+ TE L KIS FGLS
Sbjct: 104 LLQMALQIAKGMEYLESKNFVHRDLAARNCLV------TEN-LVVKISDFGLSRDIYEDD 156
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ G P W APE L++ K++ KSDV+SFG++ +EI T G+ P+
Sbjct: 157 YYRKRGGGKLPIKWMAPESLKDG---------KFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ ++ + G R P + P + L +CW DP RP+FS + L
Sbjct: 208 MSNE--EVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 7e-45
Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 46/279 (16%)
Query: 237 YQVRRRLGSGS-------QYKEILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHP 284
Y++ +LG GS + K+ G+ A+ + D E ++ EI L L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHP 57
Query: 285 NIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
NI+ F E++ + +L+ME DL +K KR S A + QI
Sbjct: 58 NIVRLYDVF--EDEDKLYLVMEYCEGGDLFDLLK------KRGRLSEDEARFYLRQILSA 109
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+EYLHSK I H +L P NILL G H K++ FGL+ + G K + GT
Sbjct: 110 LEYLHSKGIVHRDLKPENILLDEDG-------HVKLADFGLARQLDPGEKLTTFVGTPE- 161
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ APEVL Y + D++S G+I +E+LTGK PF Q ++ + I
Sbjct: 162 --YMAPEVLLGK---------GYGKAVDIWSLGVILYELLTGKPPFPGDD-QLLELFKKI 209
Query: 464 RAGERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSI 500
+ P P +L ++ DP +R +
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 79/234 (33%), Positives = 117/234 (50%), Gaps = 30/234 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E + L HPN++ L G EE+ ++ME M DL SY+++ R ++ SL
Sbjct: 51 EARIMRKLDHPNVVKLL-GVCTEEEPLY-IVMEYMEGGDLLSYLRK---NRPKL--SLSD 103
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ LQIARGMEYL SK H +L N L+ L KIS FGLS ++
Sbjct: 104 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-------LVVKISDFGLS--RDLYD 154
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ G P W APE L+E K++ KSDV+SFG++ +EI T G+ P+
Sbjct: 155 DDYYRKRGGKLPIRWMAPESLKE---------GKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ +++ ++ G R P + P + +L +CW DP RP+FS + IL
Sbjct: 206 G--MSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 81/241 (33%), Positives = 112/241 (46%), Gaps = 43/241 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E + L HPNI+ L G EE+ ++ME M DL Y+++ + SL
Sbjct: 51 EARIMRKLDHPNIVKLL-GVCTEEEPLM-IVMEYMPGGDLLDYLRK----NRPKELSLSD 104
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS------- 385
+ LQIARGMEYL SK H +L N L+ L KIS FGLS
Sbjct: 105 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-------LVVKISDFGLSRDLYDDD 157
Query: 386 SVKNFGPKSPSQSGTTHPFI-WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
K G K P I W APE L+E K++ KSDV+SFG++ +EI T
Sbjct: 158 YYKVKGGKLP---------IRWMAPESLKE---------GKFTSKSDVWSFGVLLWEIFT 199
Query: 445 -GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
G+ P+ + ++ ++ G R P + P + L +CW DP RP+FS + I
Sbjct: 200 LGEEPYPG--MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEI 257
Query: 504 L 504
L
Sbjct: 258 L 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 90/285 (31%), Positives = 130/285 (45%), Gaps = 50/285 (17%)
Query: 237 YQVRRRLGSGS-------QYKEILWLGESFALRHFF------GDIEPLVPEISSLLSLSH 283
Y++ R+LGSGS ++K G+ A++ + EI L LSH
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---GKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
PNI+ + E+K +L+ME DL Y+ + P S A + LQI R
Sbjct: 58 PNIVRLID--AFEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILR 109
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
G+EYLHS I H +L P NILL G KI+ FGL+ S + T
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENG-------VVKIADFGLAKKLLKSSSSLTTFVGTP 162
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
++ APEVL + Y K DV+S G+I +E+LTGK PF ++ D++
Sbjct: 163 WYM--APEVL--------LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-DQLQLI 211
Query: 463 IRAGERPLFPFHSPKYVTN------LTKRCWHADPNQRPSFSSIC 501
R PL F PK+ + L K+C + DP++RP+ I
Sbjct: 212 RRILGPPL-EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 63/232 (27%), Positives = 88/232 (37%), Gaps = 58/232 (25%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L L+HPNI+ F DE +L+ME L +K S
Sbjct: 41 EIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDE 93
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ ++LQI G+EYLHS I H +L P NILL K++ FGLS +
Sbjct: 94 ILRILLQILEGLEYLHSNGIIHRDLKPENILL------DSDNGKVKLADFGLSKLLTSDK 147
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
T ++ APEVL YSEKSD++S G+I +E+
Sbjct: 148 SLLKTIVGTPAYM--APEVLLGKG--------YYSEKSDIWSLGVILYEL---------- 187
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ +L ++ DP +RPS I L
Sbjct: 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 29/234 (12%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKR 325
++E L EI L SL HPNI+ + DEEK + +E +S L S +K K
Sbjct: 42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK------KF 95
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
PV QI G+ YLHS I H ++ +NIL+ G K++ FG +
Sbjct: 96 GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-------VVKLADFGCA 148
Query: 386 SVKNFGPKSP---SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
S GT P+ W APEV+ +Y +D++S G E+
Sbjct: 149 KRLGDIETGEGTGSVRGT--PY-WMAPEVI---------RGEEYGRAADIWSLGCTVIEM 196
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
TGK P+ + + + +GE P P H + + ++C DP +RP+
Sbjct: 197 ATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 77/250 (30%), Positives = 107/250 (42%), Gaps = 44/250 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L +L H NI+ + + LIME + L Y+ R R +L
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-----QRHRDQINLKR 110
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ QI +GM+YL S++ H +L NIL+ E KIS FGL+ V
Sbjct: 111 LLLFSSQICKGMDYLGSQRYIHRDLAARNILV-------ESEDLVKISDFGLAKVLPEDK 163
Query: 393 -----KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
K P +S P W+APE L SK+S SDV+SFG+ +E+ T
Sbjct: 164 DYYYVKEPGES----PIFWYAPECLRT---------SKFSSASDVWSFGVTLYELFTYGD 210
Query: 448 PF-----EDAHLQGDKMSRNI--------RAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
P E + G + I + GER P P V +L K CW A+P R
Sbjct: 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270
Query: 495 PSFSSICRIL 504
PSF+ + I+
Sbjct: 271 PSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 33/235 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPV 332
E+ L L+HPNI+ + F EEK + ++ME DL IK+ ++ PF
Sbjct: 49 EVKILKKLNHPNIIKYYESF--EEKGKLCIVMEYADGGDLSQKIKK--QKKEGKPFPEEQ 104
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+D +Q+ ++YLHS+KI H ++ P NI L G K+ FG+S V +
Sbjct: 105 ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-------LVKLGDFGISKVLS--- 154
Query: 393 KSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
S T + + +PE+ + N Y+ KSD++S G + +E+ T K P
Sbjct: 155 -STVDLAKT--VVGTPYYLSPELCQ---------NKPYNYKSDIWSLGCVLYELCTLKHP 202
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
FE +L ++ I G+ P P + NL DP +RPS + I +
Sbjct: 203 FEGENLLE--LALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 38/275 (13%)
Query: 231 LIKSEDYQVRRRLGSGSQYKEIL---WLGESFA---LRHFFGDIEPLVPEISSLLSLSHP 284
I S++ ++ +G G ++ +++ + G+ A L+ + + E S + +L HP
Sbjct: 2 AINSKELKLGATIGKG-EFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP 60
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
N++ L +++ E M++ L Y++ R R +L + L + G
Sbjct: 61 NLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRS----RGRAVITLAQQLGFALDVCEG 114
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
MEYL K H +L N+L+ AK+S FGL+ + G Q P
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLV-------AKVSDFGLAKEASQG-----QDSGKLP 162
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462
W APE L E K+S KSDV+SFG++ +EI + G+VP+ L+ + +
Sbjct: 163 VKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPH 211
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+ G R P P V + K CW DP +RP+F
Sbjct: 212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTF 246
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 47/278 (16%)
Query: 235 EDYQVRRRLGSG--SQYKEILWLGES-FALRHFFGD----IEPLVPEISSLLSLSHPNI- 286
E++ + R+LGSG + E LW A++ D + E+ +L L H ++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 287 -MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVA--VDLMLQIAR 342
+ +C + ++I ELM + L ++++ P + LPVA +D+ Q+A
Sbjct: 66 SLFAVC----SVGEPVYIITELMEKGSLLAFLRS---PEGQ---VLPVASLIDMACQVAE 115
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP--SQSGT 400
GM YL + H +L NIL+ E + K++ FGL+ + K S
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVG------EDLV-CKVADFGLARLI----KEDVYLSSDK 164
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459
P+ W APE +AS+ +S KSDV+SFG++ +E+ T G+VP+ + ++
Sbjct: 165 KIPYKWTAPE---------AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EV 213
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
I AG R P P+ + + CW A+P RPSF
Sbjct: 214 YDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 35/278 (12%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
I E ++ R+LG+G Q+ E+ W G + L+ E + E + L H
Sbjct: 3 IPRESLKLERKLGAG-QFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHD 61
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
++ ++EE +++ E MS+ L ++K K++ LP VD+ QIA G
Sbjct: 62 KLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKS--GEGKKLR--LPQLVDMAAQIAEG 115
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
M YL S+ H +L NIL+ E + KI+ FGL+ + + + G P
Sbjct: 116 MAYLESRNYIHRDLAARNILV------GENLV-CKIADFGLARLIEDDEYTARE-GAKFP 167
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462
W APE +A+ +++ KSDV+SFG++ EI+T G+VP+ ++
Sbjct: 168 IKWTAPE---------AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQ 216
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ G R P + P+ + +L +CW DP +RP+F +
Sbjct: 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 72/248 (29%), Positives = 122/248 (49%), Gaps = 34/248 (13%)
Query: 254 WLGESFALRHFFGDI--EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310
+ G+ A+++ D+ + + E + + L H N++ L +++MELMS+
Sbjct: 27 YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL---HNGLYIVMELMSKG 83
Query: 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370
+L ++++ R R S+ + L +A GMEYL SKK+ H +L NIL+ G
Sbjct: 84 NLVNFLRT----RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV- 138
Query: 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKS 430
AK+S FGL+ V + G + + P W APE L+ + K+S KS
Sbjct: 139 ------AKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALK---------HKKFSSKS 178
Query: 431 DVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHA 489
DV+S+G++ +E+ + G+ P+ L+ ++ + G R P P V L CW
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYRMEPPEGCPADVYVLMTSCWET 236
Query: 490 DPNQRPSF 497
+P +RPSF
Sbjct: 237 EPKKRPSF 244
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 30/179 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS L L HPNI+ L E K +L+ E DL Y+ ++ P S +
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLD-----KRPGPLSPNLI 100
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+M Q+ RG+ Y HS +I H +L P NIL+ + +G L K++ FGL+ + FG
Sbjct: 101 KSIMYQLLRGLAYCHSHRILHRDLKPQNILI-----NRDGVL--KLADFGLA--RAFGIP 151
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ TH + W+ APE+L + YS D++S G I E++TGK F
Sbjct: 152 LRT---YTHEVVTLWYRAPEIL--------LGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L ++HP I+ F EEK +L++E +L S++ K FS A
Sbjct: 47 LSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHL------SKEGRFSEERARFY 98
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSP 395
+I +EYLHS I + +L P NILL G H K++ FGL+ + + G ++
Sbjct: 99 AAEIVLALEYLHSLGIIYRDLKPENILLDADG-------HIKLTDFGLAKELSSEGSRTN 151
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
+ GT + APEVL Y + D +S G++ +E+LTGK PF +
Sbjct: 152 TFCGTPE---YLAPEVLLGKG---------YGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++ I FP +L DP +R
Sbjct: 200 --EIYEKILKDP-LRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 75/248 (30%), Positives = 110/248 (44%), Gaps = 34/248 (13%)
Query: 263 HFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICC 321
H + + E S + L HP I+ L G E L+MEL L Y+K
Sbjct: 35 HIAAGKKEFLREASVMAQLDHPCIVR-LIGVCKGEP--LMLVMELAPLGPLLKYLK---- 87
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
KR + +L Q+A GM YL SK H +L N+LL R AKIS
Sbjct: 88 --KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-------QAKISD 138
Query: 382 FGLSSVKNFGPKSPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
FG+S + G S TT P W+AP E + K+S KSDV+S+G+
Sbjct: 139 FGMS--RALGAGSDYYRATTAGRWPLKWYAP---------ECINYGKFSSKSDVWSYGVT 187
Query: 439 CFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+E + G P+ + ++G ++ + +GER P P+ + ++ CW P RP+F
Sbjct: 188 LWEAFSYGAKPYGE--MKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTF 245
Query: 498 SSICRILR 505
S + R
Sbjct: 246 SELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E + + SL H N++ ++ EL L S + + F +
Sbjct: 46 EAAIMHSLDHENLIRLYGVVLTHPLM---MVTELAP--LGSLLDRLRKDALGH-FLISTL 99
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGP 392
D +QIA GM YL SK+ H +L NILL AS + KI FGL ++
Sbjct: 100 CDYAVQIANGMRYLESKRFIHRDLAARNILL----ASDD---KVKIGDFGLMRALPQNED 152
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ PF W APE L +S SDV+ FG+ +E+ T G+ P+
Sbjct: 153 HYVMEEHLKVPFAWCAPESL---------RTRTFSHASDVWMFGVTLWEMFTYGEEPW-- 201
Query: 452 AHLQGDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
A L G ++ + I + GER P P+ + N+ +CW +P RP+F+++
Sbjct: 202 AGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 30/241 (12%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
+ + E S + L H N++ L G EEK +++ E M++ L Y++ R R
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRS----RGRSV 98
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
+ L + MEYL + H +L N+L+ AK+S FGL+
Sbjct: 99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV-------AKVSDFGLTK- 150
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446
S +Q P W APE L E K+S KSDV+SFG++ +EI + G+
Sbjct: 151 ----EASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGR 197
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506
VP+ L+ + + G + P P V ++ K+CWH D RPSF + L +
Sbjct: 198 VPYPRIPLK--DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255
Query: 507 I 507
I
Sbjct: 256 I 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 33/234 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
E ++ EI L HPNI+ + + K E +++ME S +K++ +
Sbjct: 40 KKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEFCS---GGSLKDLLKSTNQT 94
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
+A + ++ +G+EYLHS I H ++ +NILL +++G K+ FGLS+
Sbjct: 95 LTESQIAY-VCKELLKGLEYLHSNGIIHRDIKAANILL-----TSDG--EVKLIDFGLSA 146
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
+ + GT P+ W APEV+ + Y K+D++S G+ E+ GK
Sbjct: 147 QLSDTKARNTMVGT--PY-WMAPEVI---------NGKPYDYKADIWSLGITAIELAEGK 194
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT----NLTKRCWHADPNQRPS 496
P+ + M + +P+ + + K+C +P +RP+
Sbjct: 195 PPYSELP----PMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 73/233 (31%), Positives = 112/233 (48%), Gaps = 27/233 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E L SHPNI+ + T +K+ +++MEL+ D ++++ PR ++
Sbjct: 43 EARILKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEG-PRLKVK----E 95
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ ++ A GMEYL SK H +L N L+ + KIS FG+S + G
Sbjct: 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV-------LKISDFGMSREEEDGV 148
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ + P W APE L + +YS +SDV+SFG++ +E + G VP+
Sbjct: 149 YASTGGMKQIPVKWTAPEAL---------NYGRYSSESDVWSFGILLWEAFSLGAVPY-- 197
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
A+L + I G R P P V L +RCW DP QRPSFS++ + L
Sbjct: 198 ANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDL 336
L L+HP +++ F DEE +L+++L+ DL ++ +++ FS
Sbjct: 54 LQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLS------QKVKFSEEQVKFW 105
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+ +I +EYLHSK I H ++ P NILL +G H I+ F +++ + S
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-------HVHITDFNIATKVTPDTLTTS 158
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
SGT ++ APEVL YS D +S G+ +E L GK P+
Sbjct: 159 TSGTP-GYM--APEVL---------CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
R + L+P + + DP +R +
Sbjct: 207 RDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNL 249
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 238 QVRRRLGSGSQYKEI---LWLGES----FALRHFFGDIEPLVPEISSLLSLSHPNIMHFL 290
Q+ R+LG+G Q+ E+ LW + L+ D + + E + L HP ++
Sbjct: 9 QLLRKLGAG-QFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS 349
T EE +++ ELM L Y++ LP +D+ Q+A GM YL +
Sbjct: 68 AVCTLEEP--IYIVTELMKYGSLLEYLQG----GAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS-PSQSGTTHPFIWHA 408
+ H +L N+L+ K++ FGL+ V ++ G P W A
Sbjct: 122 QNYIHRDLAARNVLVGENNI-------CKVADFGLARV--IKEDIYEAREGAKFPIKWTA 172
Query: 409 PEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGE 467
PE +A +++S KSDV+SFG++ EI+T G++P+ + ++ + + G
Sbjct: 173 PE---------AALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQQVDQGY 221
Query: 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
R P PK + ++ CW DP+ RP+F ++
Sbjct: 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 269 EPLVPEISSLLSLSHPNIMHF--LCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKR 325
+ + E ++ LSHPN++ +C +++ F++ E M+ L +Y++E RK
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVC----TKQRPIFIVTEYMANGCLLNYLRE----RKG 95
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+D+ + MEYL S H +L N L+ K+S FGL+
Sbjct: 96 K-LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV-------VKVSDFGLA 147
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
+ S GT P W PEV S++S KSDV+SFG++ +E+ +
Sbjct: 148 RYV-LDDQYTSSQGTKFPVKWAPPEVF---------DYSRFSSKSDVWSFGVLMWEVFSE 197
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
GK+P+E ++ ++ AG R P +P V + CWH P RP+F + L
Sbjct: 198 GKMPYER--FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 35/248 (14%)
Query: 267 DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK------E 318
D+ LV E+ + + H NI++ L T E ++++E + +L +++ E
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP--LYVVVEYAAHGNLRDFLRARRPPGE 115
Query: 319 ICCPRKRIP----FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374
P P + V Q+ARGME+L SKK H +L N+L+ TE +
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV------TEDH 169
Query: 375 LHAKISGFGLS-SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVY 433
+ KI+ FGL+ + + + +G P W APE L + Y+ +SDV+
Sbjct: 170 V-MKIADFGLARDIHHIDYYRKTTNGRL-PVKWMAPEALFDR---------VYTHQSDVW 218
Query: 434 SFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPN 492
SFG++ +EI T G P+ ++ ++ + ++ G R P + + + +L + CWH P+
Sbjct: 219 SFGVLLWEIFTLGGSPYPGIPVE--ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS 276
Query: 493 QRPSFSSI 500
QRP+F +
Sbjct: 277 QRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 74/246 (30%), Positives = 110/246 (44%), Gaps = 28/246 (11%)
Query: 261 LRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEI 319
+R E + E ++ LSHP ++ L G E C L+ E M L Y++
Sbjct: 36 IREGAMSEEDFIEEAQVMMKLSHPKLVQ-LYGVCTERSPIC-LVFEFMEHGCLSDYLRA- 92
Query: 320 CCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379
+R FS + + L + GM YL S + H +L N L+ K+
Sbjct: 93 ----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV-------VKV 141
Query: 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439
S FG++ + S +GT P W +PEV S SKYS KSDV+SFG++
Sbjct: 142 SDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVF---------SFSKYSSKSDVWSFGVLM 191
Query: 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
+E+ + GK P+E+ ++ I AG R P + + V L + CW P RPSFS
Sbjct: 192 WEVFSEGKTPYENR--SNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFS 249
Query: 499 SICRIL 504
+ L
Sbjct: 250 LLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.8 bits (234), Expect = 7e-21
Identities = 79/329 (24%), Positives = 120/329 (36%), Gaps = 34/329 (10%)
Query: 274 EISSLLSLSHP-NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPV 332
EI L SL+HP NI+ F DE +L+ME + S + ++ P S
Sbjct: 47 EIQILASLNHPPNIVKLYDFFQDEGS--LYLVMEYVDGG--SLEDLLKKIGRKGPLSESE 102
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A+ ++ QI +EYLHSK I H ++ P NILL G K+ FGL+ +
Sbjct: 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR------VVKLIDFGLAKLLPDPG 156
Query: 393 KSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ S + + APEVL S + S SD++S G+ +E+LTG P
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGL------SLAYASSSSDIWSLGITLYELLTGLPP 210
Query: 449 F--EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHA--------DPNQRP-SF 497
F E + + I P L + DP R S
Sbjct: 211 FEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
Query: 498 SSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPF 557
S + L + + +PD P + L S + +
Sbjct: 271 SDLSHDLLAHLKLKESDLSDLLKPDDSAP--LRLSLPPSLEALISSLNSLAISGSDLKLD 328
Query: 558 QMFVYRVVEKEKISSSPKDTSDSGSDKAS 586
+ + +SSSP ++S AS
Sbjct: 329 DSNFSKELAPNGVSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E L HPNI+ L G +K+ +++MEL+ L ++++ +K+ ++
Sbjct: 42 EAEILKQYDHPNIVK-LIGVC-VQKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKK 94
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ + L A GMEYL SK H +L N L+ L KIS FG+S + G
Sbjct: 95 LLQMSLDAAAGMEYLESKNCIHRDLAARNCLV-----GENNVL--KISDFGMSREEEGGI 147
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ S P W APE L + +Y+ +SDV+S+G++ +E + G P+
Sbjct: 148 YTVSDGLKQIPIKWTAPEAL---------NYGRYTSESDVWSYGILLWETFSLGDTPYPG 198
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ + I +G R P P+ + L +CW DP RPSFS I
Sbjct: 199 --MSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKRIP 327
E + E ++ LSHP ++ T ++K +++ E M L +Y+++ ++
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFMENGCLLNYLRQ-----RQGK 96
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
S + + + + GMEYL H +L N L+ G K+S FG++
Sbjct: 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV-------VKVSDFGMTRY 149
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446
+ S SG P W PEV + KYS KSDV+SFG++ +E+ T GK
Sbjct: 150 V-LDDEYTSSSGAKFPVKWSPPEVFNFS---------KYSSKSDVWSFGVLMWEVFTEGK 199
Query: 447 VPFED-AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+PFE ++ + + I G R P + V + CWH P RP+F+ + R +
Sbjct: 200 MPFEKKSNYE---VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 42/282 (14%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF-----ALRHFFGDIEPLVPEISSLLSLSH 283
++ D ++ +LG G QY E+ +W S L+ ++E + E + + + H
Sbjct: 3 MERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM-LQIA 341
PN++ L T E ++I E M+ +L Y++E C R+ + V + M QI+
Sbjct: 62 PNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRE--CNRQEVN---AVVLLYMATQIS 114
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
MEYL K H +L N L+ E +L K++ FGLS + G + +G
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLV------GENHL-VKVADFGLSRLMT-GDTYTAHAGAK 166
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG--DK 458
P W APE L N K+S KSDV++FG++ +EI T G P+ L +
Sbjct: 167 FPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 217
Query: 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ + R ERP P V L + CW +P+ RPSF+ I
Sbjct: 218 LEKGYRM-ERPE---GCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 71/244 (29%), Positives = 100/244 (40%), Gaps = 39/244 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE-------ICCPRKR 325
E+ L LS PNI L T + +IME M DL ++++ + C K
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPP--LCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ FS + + QIA GM YL S H +L N L+ Y KI+ FG+S
Sbjct: 127 LSFS--TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK------NY-TIKIADFGMS 177
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
Q P W A ES K++ KSDV++FG+ +EILT
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMA---------WESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 445 -GKVPFEDAHLQGDKMSRNI-----RAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPS 496
+ P+E HL ++ N G + P + PK + L CW D RP+
Sbjct: 229 CREQPYE--HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286
Query: 497 FSSI 500
F I
Sbjct: 287 FREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLG-----ESFALRHFF-GDIEP--LVPEISSLLSLSH 283
+ E ++ ++LG+G Q+ E+ W+G A++ G + P + E + + L H
Sbjct: 3 VPRETLKLVKKLGAG-QFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
P ++ T E ++I E M L ++K + I ++ +D+ QIA
Sbjct: 61 PRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAE 113
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
GM ++ K H +L +NIL+ L KI+ FGL+ + + ++ G
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSET-------LCCKIADFGLARLIEDNEYT-AREGAKF 165
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461
P W APE + N T ++ KSDV+SFG++ EI+T G++P+ + ++ +
Sbjct: 166 PIKWTAPEAI--NYGT-------FTIKSDVWSFGILLTEIVTYGRIPYPG--MTNPEVIQ 214
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
N+ G R P + P+ + L + CW P +RP+F + +L
Sbjct: 215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 36/240 (15%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFS 329
LV E++ L L HPNI+ + D + +++ME DL I++ C ++R
Sbjct: 46 LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIE 103
Query: 330 LPVAVDLMLQIARGMEYLH-----SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
++ Q+ + H + H +L P+NI L + K+ FGL
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-------NVKLGDFGL 156
Query: 385 SSVKNFGPKSPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
+ + S T+ P+ +PE L ++ Y EKSD++S G + +E
Sbjct: 157 AKILG----HDSSFAKTYVGTPYYM-SPEQL---------NHMSYDEKSDIWSLGCLIYE 202
Query: 442 ILTGKVPFEDA-HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ PF LQ ++ I+ G+ P+ + + K + DP++RPS +
Sbjct: 203 LCALSPPFTARNQLQ---LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 302 FLIMELMSR-DLCSYIKEICCPRKRI--PFSLPVAVDLM---LQIARGMEYLHSKKIYHG 355
++MELM++ DL SY++ P P + +IA GM YL +KK H
Sbjct: 85 LVVMELMAKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143
Query: 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEEN 415
+L N ++ L KI FG++ P W APE L
Sbjct: 144 DLAARNCMVA-------EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--- 193
Query: 416 EQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFH 474
+ ++ KSDV+SFG++ +E+ T + P++ L +++ + + G P +
Sbjct: 194 ------KDGVFTTKSDVWSFGVVLWEMATLAEQPYQG--LSNEEVLKFVIDGGHLDLPEN 245
Query: 475 SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
P + L + CW +P RP+F I L
Sbjct: 246 CPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+A+GM +L SK H +L N+LL T G + KI FGL+ +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLL------THGKI-VKICDFGLARDIMNDSNYVVKG 201
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457
P W APE + Y+ +SDV+S+G++ +EI + G P+
Sbjct: 202 NARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDS 251
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
K + I+ G R P H+P + ++ K CW ADP +RP+F I +++
Sbjct: 252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 71/241 (29%), Positives = 108/241 (44%), Gaps = 46/241 (19%)
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM-- 337
SHPN++ L E ++ + DL ++I R P DL+
Sbjct: 52 DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI--------RSETHNPTVKDLIGF 103
Query: 338 -LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS---------SV 387
LQ+A+GMEYL SKK H +L N +L E + K++ FGL+ SV
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLD------ESF-TVKVADFGLARDIYDKEYYSV 156
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446
N +G P W A E L QT+ K++ KSDV+SFG++ +E++T G
Sbjct: 157 HN-------HTGAKLPVKWMALESL----QTQ-----KFTTKSDVWSFGVLLWELMTRGA 200
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506
P+ D + ++ + G R L P + P + + CWH P RP+FS + +
Sbjct: 201 PPYPD--VDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258
Query: 507 I 507
I
Sbjct: 259 I 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRI 326
+ ++ E + S+ HP+++ L + + LI +LM L Y++ + I
Sbjct: 53 NKEILDEAYVMASVDHPHVVRLLGICLSSQVQ---LITQLMPLGCLLDYVRN---HKDNI 106
Query: 327 -PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
L ++ +QIA+GM YL K++ H +L N+L+K H KI+ FGL+
Sbjct: 107 GSQYL---LNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-------HVKITDFGLA 156
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
+ + K G P W A E S + Y+ KSDV+S+G+ +E++T
Sbjct: 157 KLLDVDEKEYHAEGGKVPIKWMALE---------SILHRIYTHKSDVWSYGVTVWELMTF 207
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
G P+E + ++ + GER P V + +CW D RP+F +
Sbjct: 208 GAKPYEG--IPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 35/245 (14%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFS 329
L+ E L LSH NI+ L ++ + F++ M+ +L +++ C + +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPP-FVLYPYMNWGNLKLFLQ-QC---RLGEAN 109
Query: 330 LPVA------VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
P A V + +QIA GM YLH + + H ++ N ++ + L KI+
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI-------DEELQVKITDNA 162
Query: 384 LSSVKNFGPKSPSQSG--TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
LS ++ P G P W A E L N +YS SDV+SFG++ +E
Sbjct: 163 LS--RDLFPMDYHCLGDNENRPVKWMALESLV---------NKEYSSASDVWSFGVLLWE 211
Query: 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
++T G+ P+ + + +M+ ++ G R P + P + + CW DP +RPSFS +
Sbjct: 212 LMTLGQTPYVE--IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269
Query: 501 CRILR 505
+ L
Sbjct: 270 VQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKRIPFSLPV 332
E ++ LSH ++ T + + +++ E MS L +Y++E KR F
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTEYMSNGCLLNYLREH---GKR--FQPSQ 101
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+++ + GM YL SK+ H +L N L+ +G K+S FGLS
Sbjct: 102 LLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC-------VKVSDFGLSRYV-LDD 153
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ S G+ P W PEVL SK+S KSDV++FG++ +E+ + GK+P+E
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLLY---------SKFSSKSDVWAFGVLMWEVYSLGKMPYE- 203
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ + G R P + + V + CWH +RP+F +
Sbjct: 204 -RFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 71/250 (28%), Positives = 111/250 (44%), Gaps = 44/250 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI+ L +L H NI+ + +++ K LIME + L S + P+ ++ +
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYL--PKHKLNLA---- 107
Query: 334 VDLML---QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
L+L QI GM YLHS+ H +L N+LL + KI FGL+
Sbjct: 108 -QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL-------DNDRLVKIGDFGLAKAVPE 159
Query: 391 GPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
G + + G + P W+A E L+EN K+S SDV+SFG+ +E+LT
Sbjct: 160 GHEYYRVREDGDS-PVFWYAVECLKEN---------KFSYASDVWSFGVTLYELLTHCDS 209
Query: 449 FEDAHLQGDKM-------------SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
+ + ++M + G R P + P+ V L K CW + RP
Sbjct: 210 KQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP 269
Query: 496 SFSSICRILR 505
+F S+ IL+
Sbjct: 270 TFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 39/242 (16%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKR 325
++ ++ EI L +L HPNI+ ++ G E ++I+E + L IK K
Sbjct: 42 ALKSIMQEIDLLKNLKHPNIVKYI-GSI-ETSDSLYIILEYAENGSLRQIIK------KF 93
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
PF + + Q+ +G+ YLH + + H ++ +NIL + +G K++ FG++
Sbjct: 94 GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VVKLADFGVA 146
Query: 386 SVKNFGPKSPSQSGTTH-----PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
+ K S P+ W APEV+E S S SD++S G
Sbjct: 147 T------KLNDVSKDDASVVGTPY-WMAPEVIE---------MSGASTASDIWSLGCTVI 190
Query: 441 EILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
E+LTG P+ D L I + P P + + +C+ DPN RP+ +
Sbjct: 191 ELLTGNPPYYD--LNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248
Query: 501 CR 502
+
Sbjct: 249 LK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 27/233 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + HPNI+ T + + +I E M L +++E F++
Sbjct: 55 EASIMGQFDHPNIIRLEGVVT--KSRPVMIITEYMENGSLDKFLRE-----NDGKFTVGQ 107
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V ++ IA GM+YL H +L NIL+ L K+S FGLS
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-------LVCKVSDFGLSRRLEDSE 160
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ + G P W APE + + K++ SDV+SFG++ +E+++ G+ P+ D
Sbjct: 161 ATYTTKGGKIPIRWTAPEAI---------AYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + + + G R P P + L CW D N+RP+FS I L
Sbjct: 212 --MSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 37/238 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYI---KEICCPRKRIPFSL 330
E+ LSH N++ L G E + ++ DL ++ K K P S
Sbjct: 58 ELDMFRKLSHKNVVRLL-GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
V L QIA GM++L + + H +L N L+ S++ K+S LS
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLV-----SSQ--REVKVSLLSLS----- 164
Query: 391 GPKSPSQSGTTH------PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
K S P W APE ++E++ +S KSDV+SFG++ +E+ T
Sbjct: 165 --KDVYNSEYYKLRNALIPLRWLAPEAVQEDD---------FSTKSDVWSFGVLMWEVFT 213
Query: 445 -GKVPFEDAHLQGDKMSRNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
G++PF L +++ ++AG+ L P P + L RCW +P RPSFS +
Sbjct: 214 QGELPFYG--LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 43/277 (15%)
Query: 235 EDYQVRRRLGSGSQ---YKEIL-WLGESFALR--HFFGDIEP---LVPEISSLLSLSHPN 285
D + + LG GS YK G+ +AL+ H GD E L+ E+ +L S P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
++ F E E +++E M D S + ++ +K PV + QI +G++
Sbjct: 61 VVKCYGAFYKEG--EISIVLEYM--DGGS-LADLL--KKVGKIPEPVLAYIARQILKGLD 113
Query: 346 YLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-KNFGPKSPSQSGTTHP 403
YLH+K I H ++ PSN+L+ +G KI+ FG+S V +N + + GT
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGE-------VKIADFGISKVLENTLDQCNTFVGTV-- 164
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS--R 461
+ +PE + Q ES YS +D++S G+ E GK PF Q +
Sbjct: 165 -TYMSPERI----QGES-----YSYAADIWSLGLTLLECALGKFPFLPP-GQPSFFELMQ 213
Query: 462 NIRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPS 496
I G P P SP++ + C DP +RPS
Sbjct: 214 AICDGPPPSLPAEEFSPEF-RDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 18/168 (10%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+ARGME+L S+K H +L NILL KI FGL+ P +
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNV-------VKICDFGLARDIYKDPDYVRK 232
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
P W APE S + Y+ +SDV+SFG++ +EI + G P+ +
Sbjct: 233 GDARLPLKWMAPE---------SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ R ++ G R P ++ + ++ CWH +P RP+FS + IL
Sbjct: 284 E-FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 58/176 (32%), Positives = 92/176 (52%), Gaps = 24/176 (13%)
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+L+ Q++ GM+YL H +L N+LL T+ Y AKIS FGLS K G
Sbjct: 98 TELVHQVSMGMKYLEETNFVHRDLAARNVLL-----VTQHY--AKISDFGLS--KALGAD 148
Query: 394 SPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
TH P W+APE + + K+S KSDV+SFG++ +E + G+ P+
Sbjct: 149 ENYYKAKTHGKWPVKWYAPECM---------NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ ++G+++++ I +GER P P + +L K CW ++RP F+ + LR
Sbjct: 200 KG--MKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/244 (24%), Positives = 90/244 (36%), Gaps = 50/244 (20%)
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HP I+ F DEE + ++E +L YI++ +I
Sbjct: 61 HPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGS------LDEKCTRFYAAEIL 112
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
+EYLHSK I H +L P NILL H KI+ FG + K P S +S
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDM-------HIKITDFG--TAKVLDPNSSPESNKG 163
Query: 402 HPFIWH--------------------APEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
+PE+L E + SD+++ G I ++
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------PAGKSSDLWALGCIIYQ 214
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
+LTGK PF ++ + I E FP + P +L ++ DP R +
Sbjct: 215 MLTGKPPFRGSN--EYLTFQKILKLE-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271
Query: 502 RILR 505
L+
Sbjct: 272 DELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 34/243 (13%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFL-CGFTDEEKKEC---FLIMELMSR-DLCSYIKEICC 321
+IE + E + + HPN+M + F ++ +I+ M DL S++
Sbjct: 44 EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---- 99
Query: 322 PRKRI---PFSLPVA--VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376
R+ P LP+ + M+ IA GMEYL ++ H +L N +L+ +
Sbjct: 100 -YSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-------MT 151
Query: 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFG 436
++ FGLS G P W A E L + Y+ KSDV++FG
Sbjct: 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFG 202
Query: 437 MICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
+ +EI T G+ P+ ++ ++ +R G R P + +L CW ADP RP
Sbjct: 203 VTMWEIATRGQTPY--PGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP 260
Query: 496 SFS 498
+F+
Sbjct: 261 TFT 263
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 77/250 (30%), Positives = 111/250 (44%), Gaps = 51/250 (20%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFS 329
EI L SL H NI+ + ++ L+ME + RD +E RK + ++
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-- 387
QI +GMEYL SK+ H +L NIL+ E KI FGL+ V
Sbjct: 115 S--------QICKGMEYLGSKRYVHRDLATRNILV-------ESENRVKIGDFGLTKVLP 159
Query: 388 ---KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ + + P +S P W+APE L E SK+S SDV+SFG++ +E+ T
Sbjct: 160 QDKEYYKVREPGES----PIFWYAPESLTE---------SKFSVASDVWSFGVVLYELFT 206
Query: 445 -----GKVPFEDAHLQG-DKMSRNI--------RAGERPLFPFHSPKYVTNLTKRCWHAD 490
P E + G DK + I + R P P + + K CW+ D
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND 266
Query: 491 PNQRPSFSSI 500
P+QRPSFS +
Sbjct: 267 PSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 38/242 (15%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++ L E+ ++ +HPN++ + F E +L+M +S I + PR +
Sbjct: 42 SVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVMPYLSGGSLLDIMKSSYPRGGL 99
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
++ V + ++ +G+EYLHS H ++ NILL G+ KI+ FG+S+
Sbjct: 100 DEAIIATV--LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS-------VKIADFGVSA 150
Query: 387 VKNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ F+ W APEV+E+ Y K+D++SFG+ E+
Sbjct: 151 --SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG--------YDFKADIWSFGITAIEL 200
Query: 443 LTGKVPFED--------AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
TG P+ LQ D S A + K + C DP++R
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY-----SKSFRKMISLCLQKDPSKR 255
Query: 495 PS 496
P+
Sbjct: 256 PT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L+HPNI+ L F K + +L+ E M DL IK ++ +
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRH--KGDLYLVFEFMDTDLYKLIK-----DRQRGLPESLI 100
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ +G+ + HS I H +L P N+L+ TEG L K++ FGL+ FG
Sbjct: 101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLIN-----TEGVL--KLADFGLARS--FGS- 150
Query: 394 SPSQSGTTHPFI---WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
++ W+ APE+L ++ YS D++S G I E+L+ + F
Sbjct: 151 ---PVRPYTHYVVTRWYRAPELLLGDKG--------YSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 83/280 (29%), Positives = 126/280 (45%), Gaps = 45/280 (16%)
Query: 236 DYQVRRRLGSGSQ---YK-EILWLGESFALRHFFGDIEPL--------VPEISSLLSLSH 283
D++V ++LG GS YK + L + +AL+ D+ + V EI L S++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNH 58
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
PNI+ + F D K ++ME DL I + RK IP + +Q+ R
Sbjct: 59 PNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQE--IWRIFIQLLR 114
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV--KNFGPKSPSQSGT 400
G++ LH +KI H +L +NILL L KI G+S V KN + +Q GT
Sbjct: 115 GLQALHEQKILHRDLKSANILL------VANDL-VKIGDLGISKVLKKNM---AKTQIGT 164
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
H + APEV YS KSD++S G + +E+ T PFE +Q +
Sbjct: 165 PH---YMAPEVW---------KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLR 210
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
++ G+ P P + + N + P RP+ I
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLG--------ESFALRHFFGDIEPLVPEISSLLSLSH 283
I E ++ ++LG+G Q+ E+ W+G L+ ++ + E + + +L H
Sbjct: 3 IPRESIKLVKKLGAG-QFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH 60
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
++ T EE ++I E M++ L ++K + LP +D QIA
Sbjct: 61 DKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAE 114
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
GM Y+ K H +L +N+L+ L KI+ FGL+ V + ++ G
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSES-------LMCKIADFGLARVIE-DNEYTAREGAKF 166
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461
P W APE + + ++ KSDV+SFG++ +EI+T GK+P+ D MS
Sbjct: 167 PIKWTAPEAI---------NFGSFTIKSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMS- 215
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
++ G R + P + ++ K CW +RP+F + +L
Sbjct: 216 ALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)
Query: 235 EDYQVRRRLGSGSQYKEI-----LWLGESFALR--HFFGDIEP-----LVPEISSLLSLS 282
++++ +++G G Q+ + L G AL+ F ++ + EI L L
Sbjct: 2 GNFKIEKKIGKG-QFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPN++ +L F + E +++EL DL IK ++ IP +Q+
Sbjct: 61 HPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIP--ERTIWKYFVQLC 116
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP---SQS 398
+E++HSK+I H ++ P+N+ + G K+ GL + F K+ S
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGV-------VKLGDLGLG--RFFSSKTTAAHSLV 167
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
GT P+ + +PE + EN Y+ KSD++S G + +E+ + PF GDK
Sbjct: 168 GT--PY-YMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFY-----GDK 210
Query: 459 MS-----RNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
M+ + I + P P H + + +L RC + DP +RP S + ++ + +
Sbjct: 211 MNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 70/243 (28%), Positives = 108/243 (44%), Gaps = 36/243 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL-----IMELMSR-DLCSYIKEIC 320
DIE + E + + HPN++ L G + + + L I+ M DL +++
Sbjct: 44 DIEEFLREAACMKEFDHPNVIK-LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--- 99
Query: 321 CPRKRI---PFSLPVA--VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375
RI PF+LP+ V M+ IA GMEYL SK H +L N +L +
Sbjct: 100 --MSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-------M 150
Query: 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435
++ FGLS G + P W A E L +N Y+ SDV++F
Sbjct: 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN---------VYTTHSDVWAF 201
Query: 436 GMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
G+ +EI+T G+ P+ A ++ ++ + G R P + V L +CW +P R
Sbjct: 202 GVTMWEIMTRGQTPY--AGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCR 259
Query: 495 PSF 497
PSF
Sbjct: 260 PSF 262
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 50/183 (27%), Positives = 74/183 (40%), Gaps = 35/183 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L HPNI+ T + K +++ E M DL + + F+
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-----SPEVKFTESQI 102
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
M Q+ G++YLHS I H ++ SNIL+ G K++ FGL+ K
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-------VLKLADFGLARPYT---K 152
Query: 394 SPSQSGT----THPFIWH-APEVL--EENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
S T T +W+ PE+L Y + D++S G I E+ GK
Sbjct: 153 RNSADYTNRVIT---LWYRPPELLLGATR----------YGPEVDMWSVGCILAELFLGK 199
Query: 447 VPF 449
F
Sbjct: 200 PIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 26/229 (11%)
Query: 283 HPNIMHFL--CGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIP-FSLPVAVDLML 338
HPNI+ L C + + ++IMELM DL SY+++ R P +L +D+ L
Sbjct: 58 HPNIVKLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS--VKNFGPKSPS 396
+A+G YL H +L N L+ +G + + KI FGL+ K+ +
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV--KIGDFGLARDIYKSDYYRKEG 171
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455
+ P W APE L + K++ +SDV+SFG++ +EILT G+ P+ L
Sbjct: 172 EG--LLPVRWMAPESL---------LDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALN 218
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
++ +++ AG R P + P + L CW DP++RP+F I IL
Sbjct: 219 NQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 64/247 (25%), Positives = 106/247 (42%), Gaps = 57/247 (23%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI- 326
++ L EI+ L L H NI+ +L D + FL Y+ P +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFL----------EYV-----PGGSVA 94
Query: 327 -------PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379
F + + + QI +G+ YLH++ I H ++ +NIL+ +G KI
Sbjct: 95 ALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG-------IKI 147
Query: 380 SGFGLS--------SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSD 431
S FG+S S K PS G+ W APEV+++ + Y+ K+D
Sbjct: 148 SDFGISKKLEANSLSTKT-NGARPSLQGSVF---WMAPEVVKQ---------TSYTRKAD 194
Query: 432 VYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE--RPLFPFHSPKYVTNLTKRCWHA 489
++S G + E+LTGK PF D ++ + GE P P + + ++ +
Sbjct: 195 IWSLGCLVVEMLTGKHPFPDC----TQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEI 250
Query: 490 DPNQRPS 496
D N+RP+
Sbjct: 251 DHNKRPT 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 48/278 (17%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF--FGDIEPLVPEISSLLSLSHPNIM 287
E + + +LG GS YK I G+ A++ D++ ++ EIS L P I+
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIV 61
Query: 288 HFL-CGFTDEEKKECFLIMELMSRDLCSYIKEICC---PRKRIPFSLPVAVDLMLQIARG 343
+ F + + +++ME S I +I + I L Q +G
Sbjct: 62 KYYGSYFKNTD---LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL-------YQTLKG 111
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGTTH 402
+EYLHS K H ++ NILL + EG AK++ FG+S + + K + GT
Sbjct: 112 LEYLHSNKKIHRDIKAGNILL-----NEEG--QAKLADFGVSGQLTDTMAKRNTVIGT-- 162
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
PF W APEV++E Y+ K+D++S G+ E+ GK P+ D H M
Sbjct: 163 PF-WMAPEVIQE---------IGYNNKADIWSLGITAIEMAEGKPPYSDIH----PMRAI 208
Query: 463 IRAGERPLFPFHSPKYVT----NLTKRCWHADPNQRPS 496
+P P+ + + K+C DP +RPS
Sbjct: 209 FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 68/251 (27%), Positives = 108/251 (43%), Gaps = 40/251 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEIC------------ 320
E + + HPNI+ L G K C L+ E M+ DL +++
Sbjct: 58 EAALMAEFDHPNIVKLL-GVCAVGKPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 321 ----CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376
C +P S + + Q+A GM YL +K H +L N L+ +
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG-------ENMV 168
Query: 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFG 436
KI+ FGLS + P W PE + N +Y+ +SDV+++G
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN---------RYTTESDVWAYG 219
Query: 437 MICFEILT-GKVP-FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++ +EI + G P + AH +++ +R G P + P + NL + CW P+ R
Sbjct: 220 VVLWEIFSYGMQPYYGMAH---EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276
Query: 495 PSFSSICRILR 505
PSF+SI RIL+
Sbjct: 277 PSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 63/241 (26%), Positives = 96/241 (39%), Gaps = 42/241 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L P ++ F KK +L+ME + DL S ++ + VA
Sbjct: 47 LSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGS------LDEDVARIY 98
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-----KNFG 391
+ +I +EYLHS I H +L P NIL+ G H K++ FGLS V +
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-------HLKLTDFGLSKVGLVRRQINL 151
Query: 392 PKSPSQS----GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
+ GT + APEV+ +S+ D +S G I +E L G
Sbjct: 152 NDDEKEDKRIVGTPD---YIAPEVIL---------GQGHSKTVDWWSLGCILYEFLVGIP 199
Query: 448 PFEDAHLQGDKMSRNIRAG--ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
PF + ++ +NI G E P S + + +L + DP +R SI I
Sbjct: 200 PFHGETPE--EIFQNILNGKIEWPEDVEVSDEAI-DLISKLLVPDPEKRLGAKSIEEIKN 256
Query: 506 Y 506
+
Sbjct: 257 H 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 282 SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM--- 337
+H NI+ + E+ F+++ELM+ DL S+++E PR P SL DL+
Sbjct: 67 NHQNIVRLIG--VSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSL-TMKDLLFCA 122
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+A+G +YL H ++ N LL +G AKI+ FG++ ++ S +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV----AKIADFGMA--RDIYRASYYR 176
Query: 398 SG--TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454
G P W PE + ++ K+DV+SFG++ +EI + G +P+
Sbjct: 177 KGGRAMLPIKWMPPEAFLD---------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506
Q ++ + G R P P V + CW P RP+F++I ++Y
Sbjct: 228 Q--EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 30/234 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E L HPNI+ + T +++ +++MEL+ D S+++ +K+
Sbjct: 42 EARILKQYDHPNIVKLIGVCT--QRQPIYIVMELVPGGDFLSFLR-----KKKDELKTKQ 94
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V L A GM YL SK H +L N L+ KIS FG+S ++ G
Sbjct: 95 LVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV-------LKISDFGMSRQEDDGI 147
Query: 393 KSPSQSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
S SG P W APE L + +YS +SDV+S+G++ +E + G P+
Sbjct: 148 YS--SSGLKQIPIKWTAPEAL---------NYGRYSSESDVWSYGILLWETFSLGVCPYP 196
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + + G R P P V + +RCW P RP FS + + L
Sbjct: 197 G--MTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI+ L L HPNI+ +L +E+ FL EL+ + + +K F PV
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFL--ELVPGGSLAKLL-----KKYGSFPEPVI 104
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
QI G+EYLH + H ++ +NIL+ G K++ FG++
Sbjct: 105 RLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-------VKLADFGMAKQVVEFSF 157
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ S G+ + W APEV+ A Y +D++S G E+ TGK P+
Sbjct: 158 AKSFKGSPY---WMAPEVI--------AQQGGYGLAADIWSLGCTVLEMATGKPPWSQ-- 204
Query: 454 LQGDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
L+G I R+ E P P H + +C DP+ RP+
Sbjct: 205 LEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 54/194 (27%), Positives = 82/194 (42%), Gaps = 31/194 (15%)
Query: 260 ALRHFFGDI-EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKE 318
ALR G I + EI +L + HP ++ L F L+ME M DL +++
Sbjct: 34 ALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRD 91
Query: 319 ICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378
R P M + +G+ Y+H+ I H +L P+N+L+ G K
Sbjct: 92 --EER---PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-------VLK 139
Query: 379 ISGFGLSSV-KNFGPKSPS-QSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSF 435
I+ FGL+ + P+ S Q T W+ APE+L KY D+++
Sbjct: 140 IADFGLARLFSEEEPRLYSHQVATR----WYRAPELL--------YGARKYDPGVDLWAV 187
Query: 436 GMICFEILTGKVPF 449
G I E+L G P
Sbjct: 188 GCIFAELLNG-SPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 74/291 (25%), Positives = 113/291 (38%), Gaps = 76/291 (26%)
Query: 235 EDYQVRRRLGSGS---QYKEI-LWLGESFA-----LRHFFGDIEPLVPEISSLLSLSHPN 285
E + + +G GS YK I + A L +IE + EI L P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 286 IMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
I + F K ++IME DL K ++ ++
Sbjct: 61 ITKYYGSFLKGSK--LWIIMEYCGGGSCLDLL----------KPGKLDETYIAFILREVL 108
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGT 400
G+EYLH + H ++ +NILL S EG K++ FG+S + + K + GT
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILL-----SEEG--DVKLADFGVSGQLTSTMSKRNTFVGT 161
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH------- 453
PF W APEV+ S Y EK+D++S G+ E+ G+ P D H
Sbjct: 162 --PF-WMAPEVI---------KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209
Query: 454 --------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
L+G+K S+ + +V+ C + DP +RPS
Sbjct: 210 IPKNNPPSLEGNKFSKPFK------------DFVSL----CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
P ++ + Q+ARGME+L S+K H +L NILL KI FGL+
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-------VKICDFGLAR 222
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445
P + P W AP ES + Y+ +SDV+SFG++ +EI + G
Sbjct: 223 DIYKDPDYVRKGSARLPLKWMAP---------ESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
P+ + + R ++ G R P ++ + + CW DP +RP+FS++ IL
Sbjct: 274 ASPYPGVQINEEFCQR-LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+A+GME+L S+K H +L NILL KI FGL+ P +
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNV-------VKICDFGLARDIYKDPDYVRK 238
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
P W APE + + Y+ +SDV+SFG++ +EI + G P+ +
Sbjct: 239 GDARLPLKWMAPETI---------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 288
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
++ R ++ G R P ++ + CWH +P+QRP+FS +
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
FS V ++ IA GM+YL H +L NIL+ L K+S FGLS V
Sbjct: 104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-------LECKVSDFGLSRV 156
Query: 388 KNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445
P+ + SG P W APE + + K++ SDV+SFG++ +E+++ G
Sbjct: 157 LEDDPEGTYTTSGGKIPIRWTAPEAI---------AYRKFTSASDVWSFGIVMWEVMSFG 207
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ P+ D + ++ + I G R P P V L +CW D +RP F I +L
Sbjct: 208 ERPYWD--MSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 55/183 (30%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS- 385
S V Q+ARGMEYL S++ H +L N+L+ KI+ FGL+
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV-------MKIADFGLAR 182
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
V + + +G P W APE L + Y+ +SDV+SFG++ +EI T
Sbjct: 183 GVHDIDYYKKTSNGRL-PVKWMAPEAL---------FDRVYTHQSDVWSFGILMWEIFTL 232
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
G P+ ++ ++ + +R G R P + + L + CWHA P QRP+F + L
Sbjct: 233 GGSPYPGIPVE--ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
Query: 505 RYI 507
+
Sbjct: 291 DKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 60/190 (31%), Positives = 84/190 (44%), Gaps = 50/190 (26%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKEC---------FLIMELMSRDLCSYIKEICCPRK 324
EI+ LL L HPNI+ KE +++ME + DL S ++
Sbjct: 54 EINILLKLQHPNIVTV---------KEVVVGSNLDKIYMVMEYVEHDLKSLME-----TM 99
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
+ PF LMLQ+ G+ +LH I H +L SN+LL RG KI FGL
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-------LKICDFGL 152
Query: 385 SSVKNFGPKSPSQSGT----THPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMIC 439
+ + +G SP + T T W+ APE+L +YS D++S G I
Sbjct: 153 A--REYG--SPLKPYTQLVVTL---WYRAPELL--------LGAKEYSTAIDMWSVGCIF 197
Query: 440 FEILTGKVPF 449
E+LT K F
Sbjct: 198 AELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 36/248 (14%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRI 326
I L EI L +L H NI+ + T++ LIME L S L Y+ PR +
Sbjct: 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PRNKN 104
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS- 385
+L + +QI +GM+YL S++ H +L N+L++ KI FGL+
Sbjct: 105 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-------VKIGDFGLTK 157
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
+++ + P W+APE L + SK+ SDV+SFG+ +E+LT
Sbjct: 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ---------SKFYIASDVWSFGVTLYELLTY 208
Query: 445 ------------GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPN 492
+ + ++ R + G+R P + P+ V L ++CW P+
Sbjct: 209 CDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPS 268
Query: 493 QRPSFSSI 500
+R +F ++
Sbjct: 269 KRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+A+GM +L SK H +L NILL T G + KI FGL+ +
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILL------THGRI-TKICDFGLARDIRNDSNYVVKG 274
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457
P W APE S N Y+ +SDV+S+G++ +EI + G P+ +
Sbjct: 275 NARLPVKWMAPE---------SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS- 324
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
K + I+ G R L P +P + ++ K CW ADP +RP+F I +++
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
E + E L L I+ + F D+ K ++ME DL +K R R P
Sbjct: 44 EEAIDEARVLAKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKM---QRGR-P 97
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
+QI G+ +LHSKKI H ++ N+ L + Y + KI G++
Sbjct: 98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL-------DAYDNVKIGDLGVA-- 148
Query: 388 KNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
K + + + P+ + +PE+ E+ Y+EKSDV++ G++ +E TGK
Sbjct: 149 KLLSDNTNFANTIVGTPY-YLSPELCEDK---------PYNEKSDVWALGVVLYECCTGK 198
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
PF DA+ QG + + IR P+ +S + + L +C D QRP + R
Sbjct: 199 HPF-DANNQGALILKIIRGVFPPVSQMYSQQ-LAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLG-----ESFALRHFF-GDIEP--LVPEISSLLSLSH 283
I E Q+ ++LG+G Q+ E+ W+G A++ G + P + E + L H
Sbjct: 3 IPRESLQLIKKLGNG-QFGEV-WMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
++ ++E +++ E MS+ L ++K+ + LP VD+ Q+A
Sbjct: 61 DKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKD----GEGRALKLPNLVDMAAQVAA 113
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
GM Y+ H +L +NIL+ L KI+ FGL+ + + Q G
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDG-------LVCKIADFGLARLIEDNEYTARQ-GAKF 165
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461
P W AP E+A +++ KSDV+SFG++ E++T G+VP+ + ++
Sbjct: 166 PIKWTAP---------EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG--MNNREVLE 214
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+ G R P P + L +CW DP +RP+F
Sbjct: 215 QVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 44/196 (22%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCS-YIKEICCPRKRIPFSLP- 331
EI + L HPNI+ ++ F E +++ LM+ C +K P LP
Sbjct: 49 EIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDLLKTHF------PEGLPE 100
Query: 332 VAVDLMLQ-IARGMEYLHSKKIYHGNLNPSNILLKPRGAST------------EGYLHAK 378
+A+ +L+ + ++Y+HSK H ++ S+ILL G G
Sbjct: 101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
+ F SSVKN W +PEVL++N Q Y+EKSD+YS G+
Sbjct: 161 VHDFPKSSVKNLP--------------WLSPEVLQQNLQ-------GYNEKSDIYSVGIT 199
Query: 439 CFEILTGKVPFEDAHL 454
E+ G VPF+D
Sbjct: 200 ACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + HPNI+H T + K ++ E M L ++++ + F++
Sbjct: 55 EASIMGQFDHPNIIHLEGVVT--KSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQ 107
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V ++ IA GM+YL H +L NIL+ L K+S FGLS V P
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-------LVCKVSDFGLSRVLEDDP 160
Query: 393 KSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
++ + G P W APE + + K++ SDV+S+G++ +E+++ G+ P+
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAI---------AYRKFTSASDVWSYGIVMWEVMSYGERPYW 211
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + + + I G R P P + L CW D N+RP F I IL
Sbjct: 212 E--MSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 33/247 (13%)
Query: 267 DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK------- 317
D+ L+ E+ + + H NI++ L T + ++I+E S+ +L Y++
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGM 123
Query: 318 EICCPRKRIPFSLPVAVDLM---LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374
E C ++P DL+ Q+ARGMEYL SKK H +L N+L+ TE
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV------TEDN 177
Query: 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434
+ KI+ FGL+ + + P W APE L + Y+ +SDV+S
Sbjct: 178 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL---------FDRIYTHQSDVWS 227
Query: 435 FGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQ 493
FG++ +EI T G P+ ++ ++ + ++ G R P + + + + CWHA P+Q
Sbjct: 228 FGVLLWEIFTLGGSPYPGVPVE--ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 285
Query: 494 RPSFSSI 500
RP+F +
Sbjct: 286 RPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 70/245 (28%), Positives = 98/245 (40%), Gaps = 34/245 (13%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYI----------KEICCPR 323
E + L HPNI+ L G +E+ C L L DL ++ E
Sbjct: 58 EAELMSDLQHPNIVCLL-GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+ + + +QIA GMEYL S H +L N L+ L KIS FG
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-------LTVKISDFG 169
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
LS QS + P W P E+ K++ +SD++SFG++ +EI
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPP---------EAILYGKFTTESDIWSFGVVLWEIF 220
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSI 500
+ G P+ Q + + IR R L P P V L CW+ P +RP F I
Sbjct: 221 SYGLQPYYGFSNQ-EVIEM-IR--SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
Query: 501 CRILR 505
LR
Sbjct: 277 HTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 22/176 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI+ LL+L HPNI+ + FL+ME +DL S + + P FS
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP-----FSESQV 110
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
LMLQ+ RG++YLH I H +L SN+LL +G KI+ FGL+ + +G
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-------CLKIADFGLA--RTYGLP 161
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ + + APE+L + Y+ D+++ G I E+L K
Sbjct: 162 AKPMTPKVVTLWYRAPELL--------LGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 40/252 (15%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL-----------MSRDL-CSYIKE 318
L+ E + L ++HP+++ + + LI+E SR + SY+
Sbjct: 50 LLSEFNLLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRSFLRESRKVGPSYLGS 107
Query: 319 ICCPRKRIPFS---LPVAVDLML----QIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371
+ + + ++ QI+RGM+YL K+ H +L N+L+
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------A 161
Query: 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSD 431
EG KIS FGLS +S P W A E S + Y+ +SD
Sbjct: 162 EGRK-MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE---------SLFDHIYTTQSD 211
Query: 432 VYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHAD 490
V+SFG++ +EI+T G P+ + +++ ++ G R P + + + NL CW +
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPG--IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQE 269
Query: 491 PNQRPSFSSICR 502
P++RP+F+ I +
Sbjct: 270 PDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 45/273 (16%)
Query: 237 YQVRRRLGSGSQYKEILWLGESFALRHFFG--------DIEPLVPEISSLL-SLSHPNIM 287
Y+VR++ + +L L E FG I +V E++ + L HPNI+
Sbjct: 17 YKVRKKNNGQN----LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72
Query: 288 HFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
+ F + ++ +++M+L+ + + +KE K+ F+ ++ +Q+
Sbjct: 73 RYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKE-----KKQRFTEERIWNIFVQMVLA 125
Query: 344 MEYLH-SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
+ YLH K+I H +L P+NI+L T I+ FGL+ K K S GT
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVT-------ITDFGLAKQKQPESKLTSVVGT-- 176
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
++ PE+++ N Y EK+DV++FG I +++ T + PF ++ +
Sbjct: 177 -ILYSCPEIVK---------NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT-KI 225
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
+ A PL + VT++ C D RP
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
E + E + L H ++ ++E +++ E M + L ++KE
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKE----GDGKY 98
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
LP VD+ QIA GM Y+ H +L +NIL+ L KI+ FGL+ +
Sbjct: 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-------LVCKIADFGLARL 151
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446
+ Q G P W APE +A +++ KSDV+SFG++ E++T G+
Sbjct: 152 IEDNEYTARQ-GAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
VP+ + ++ + G R P P+ + L K CW DP++RP+F I
Sbjct: 202 VPYPG--MVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 35/255 (13%)
Query: 267 DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK------- 317
D+ LV E+ + + H NI++ L T + ++I+E S+ +L Y++
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 318 EICCPRKRIP---FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374
E R+P + V Q+ARGMEYL S+K H +L N+L+ TE
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV------TENN 174
Query: 375 LHAKISGFGLS-SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVY 433
+ KI+ FGL+ V N + +G P W APE L + Y+ +SDV+
Sbjct: 175 V-MKIADFGLARDVNNIDYYKKTTNGRL-PVKWMAPEAL---------FDRVYTHQSDVW 223
Query: 434 SFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPN 492
SFG++ +EI T G P+ ++ ++ + ++ G R P + + + + CWHA P+
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPVE--ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPS 281
Query: 493 QRPSFSSICRILRYI 507
RP+F + L I
Sbjct: 282 HRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 24/176 (13%)
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
V+LM Q++ GM+YL K H +L N+LL + +AKIS FGLS K G
Sbjct: 98 VELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-------YAKISDFGLS--KALGAD 148
Query: 394 S---PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
++S P W+APE + K+S +SDV+S+G+ +E + G+ P+
Sbjct: 149 DSYYKARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGITMWEAFSYGQKPY 199
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ ++G ++ I G+R P P + L K CW RP+F+ + +R
Sbjct: 200 KK--MKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR----DLCSYIKEICCP 322
+ E ++ EI + HPNI+ + + + E +++ME M D+ + +
Sbjct: 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGD--ELWVVMEYMDGGSLTDIITQ-NFVRMN 114
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
+I + + ++ +G+EYLHS+ + H ++ NILL G K++ F
Sbjct: 115 EPQIAY-------VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-------SVKLADF 160
Query: 383 GLSS-VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
G ++ + K S GT + W APEV Y K D++S G++C E
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPY---WMAPEV---------IKRKDYGPKVDIWSLGIMCIE 208
Query: 442 ILTGKVP-FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTK----RCWHADPNQRPS 496
+ G+ P + L+ + I P P +P+ + K +C DP +RPS
Sbjct: 209 MAEGEPPYLREPPLRALFL---ITTKGIP--PLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 18/167 (10%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+ARGME+L SK H +L N+LL +G + KI FGL+ S+
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLL------AQGKI-VKICDFGLARDIMHDSNYVSKG 297
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457
T P W APE + +N Y+ SDV+S+G++ +EI + G P+ +
Sbjct: 298 STFLPVKWMAPESIFDN---------LYTTLSDVWSYGILLWEIFSLGGTPYP-GMIVDS 347
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
I++G R P H+ + V ++ +CW+++P +RPSF + I+
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 65/239 (27%), Positives = 95/239 (39%), Gaps = 38/239 (15%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIK--EI-CCPRK 324
++ L EI +L L H NI+ +L GF E E +L + L Y+ I C R
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYL-GF---ETTEEYLSIFL------EYVPGGSIGSCLRT 101
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
F + Q+ G+ YLHSK I H +L N+L+ G KIS FG+
Sbjct: 102 YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-------CKISDFGI 154
Query: 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
S + + W APEV+ Q YS K D++S G + E+
Sbjct: 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG-------YSAKVDIWSLGCVVLEMFA 207
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTK-------RCWHADPNQRPS 496
G+ P+ D M + P P P NL+ C+ +P+ RP+
Sbjct: 208 GRRPWSDEEAIA-AMFKLGNKRSAPPIP---PDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 62/186 (33%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L HPNI+ L F K L+ E M DL IK K I +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFG--HKSNINLVFEFMETDLEKVIK-----DKSIVLTPADI 104
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
ML RG+EYLHS I H +L P+N+L+ G K++ FGL+ ++FG
Sbjct: 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-------LKLADFGLA--RSFG-- 153
Query: 394 SPSQSGTTHPF-IWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
SP++ T W+ APE+L Y D++S G I E+L PF
Sbjct: 154 SPNRKMTHQVVTRWYRAPELL--------FGARHYGVGVDMWSVGCIFAELLLRV-PF-- 202
Query: 452 AHLQGD 457
L GD
Sbjct: 203 --LPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLGESF--------ALRHFFGDIEPLVPEISSLLSLSH 283
I E ++ ++LG+G Q+ E+ W+ ++ +E + E + + +L H
Sbjct: 3 IPRESLKLEKKLGAG-QFGEV-WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 60
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
++ T K+ ++I E M++ L ++K + P LP +D QIA
Sbjct: 61 DKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSD--EGSKQP--LPKLIDFSAQIAE 113
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
GM ++ + H +L +NIL+ L KI+ FGL+ V + ++ G
Sbjct: 114 GMAFIEQRNYIHRDLRAANILV-------SASLVCKIADFGLARVIE-DNEYTAREGAKF 165
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461
P W APE + + ++ KSDV+SFG++ EI+T G++P+ + ++ R
Sbjct: 166 PIKWTAPEAI---------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPG--MSNPEVIR 214
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ G R P + P+ + N+ RCW P +RP+F I +L
Sbjct: 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 58/177 (32%), Positives = 93/177 (52%), Gaps = 33/177 (18%)
Query: 274 EISSLLSL---SHPNIMHFL--C-GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
EI+ L L HPNI+ L C G + + + L+ E + +DL +Y+ + CP+ +P
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK--CPKPGLP 105
Query: 328 FSLPVAV-DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
P + DLM Q+ RG+++LHS +I H +L P NIL+ +++G + KI+ FGL+
Sbjct: 106 ---PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV-----TSDGQV--KIADFGLAR 155
Query: 387 VKNFGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ +F S T +W+ APEVL S Y+ D++S G I E+
Sbjct: 156 IYSFEMALTSVVVT----LWYRAPEVL---------LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 18/167 (10%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+A GME+L SK H +L N+L+ EG L KI FGL+ S+
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI------CEGKL-VKICDFGLARDIMRDSNYISKG 299
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457
T P W APE S N+ Y+ SDV+SFG++ +EI T G P+ + + +
Sbjct: 300 STFLPLKWMAPE---------SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-E 349
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ I+ G R P H+ + + ++CW RP FS + ++
Sbjct: 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 33/244 (13%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
E + E + HP+I+ L G E +++MEL +L SY++ K
Sbjct: 52 EKFLQEAYIMRQFDHPHIVK-LIGVITENP--VWIVMELAPLGELRSYLQV----NKY-- 102
Query: 328 FSLPVAVDLM--LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
SL +A ++ Q++ + YL SK+ H ++ N+L+ +S + K+ FGLS
Sbjct: 103 -SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV----SSPDC---VKLGDFGLS 154
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
+ S P W APE S + +++ SDV+ FG+ +EIL
Sbjct: 155 RYLEDESYYKA-SKGKLPIKWMAPE---------SINFRRFTSASDVWMFGVCMWEILML 204
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
G PF ++ + + I GER P + P + +L +CW DP++RP F+ + L
Sbjct: 205 GVKPF--QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
Query: 505 RYIK 508
I
Sbjct: 263 SDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 21/169 (12%)
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGP 392
V Q+ARGMEYL S+K H +L N+L+ TE + KI+ FGL+ V N
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLV------TEDNV-MKIADFGLARDVHNIDY 189
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ +G P W APE L + Y+ +SDV+SFG++ +EI T G P+
Sbjct: 190 YKKTTNGRL-PVKWMAPEAL---------FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
++ ++ + ++ G R P + + + + CWHA P+QRP+F +
Sbjct: 240 IPVE--ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 34/244 (13%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
V EI L L+HPN++ +L F E E +++EL DL IK ++ IP
Sbjct: 50 VKEIDLLKQLNHPNVIKYLDSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPER- 106
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+Q+ +E++HS+++ H ++ P+N+ + G K+ GL + F
Sbjct: 107 -TVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV-------VKLGDLGLG--RFF 156
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
K+ + + +PE + EN Y+ KSD++S G + +E+ + PF
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPF- 206
Query: 451 DAHLQGDKMS-----RNIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
GDKM+ + I + P P H + + L C + DP+QRP + +I
Sbjct: 207 ----YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262
Query: 505 RYIK 508
+ +
Sbjct: 263 KQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 23/181 (12%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YL ++ H +L N+L+K H KI+ FGL+ + +
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-------HVKITDFGLARLLDIDETEYHA 168
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
G P W A ES + +++ +SDV+S+G+ +E++T G P++ +
Sbjct: 169 DGGKVPIKWMA---------LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG--IPA 217
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF----SSICRILRYIKRFIM 512
++ + GER P V + +CW D RP F R+ R RF++
Sbjct: 218 REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVV 277
Query: 513 M 513
+
Sbjct: 278 I 278
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSR-DLCSYIKEICC 321
++E + E + HPN+M + + E + +I+ M DL S++ +
Sbjct: 43 EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL--LYS 100
Query: 322 PRKRIPFSLP--VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379
P LP + V M IA GMEYL SK H +L N +L ++ +
Sbjct: 101 RLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-------MNVCV 153
Query: 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439
+ FGLS G P W A ES ++ Y+ KSDV+SFG+
Sbjct: 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIA---------IESLADRVYTTKSDVWSFGVTM 204
Query: 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
+EI T G+ P+ ++ ++ +R G R P + +L CW +P RPSF
Sbjct: 205 WEIATRGQTPYPG--VENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFE 262
Query: 499 SICRIL 504
++ L
Sbjct: 263 TLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E++ L ++ HPNI+ + F EE +++M+ DL I ++ + F
Sbjct: 49 EVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINA----QRGVLFPEDQ 102
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+D +QI ++++H +KI H ++ NI L G K+ FG++ V N
Sbjct: 103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-------IKLGDFGIARVLN-ST 154
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
+++ P+ + +PE+ E N Y+ KSD+++ G + +E+ T K FE
Sbjct: 155 VELARTCIGTPY-YLSPEICE---------NRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+++ + I G P H + NL + + +P RPS +SI
Sbjct: 205 NMK--NLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/244 (27%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYI------KEICCPRKR-- 325
E S + L HPNI+ L G +E+ C L L DL ++ ++ C
Sbjct: 57 EASLMAELHHPNIVCLL-GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 326 -IPFSLPVA--VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
+ SL + + +QIA GMEYL S H +L NIL+ + LH KIS
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-------LHVKISDL 168
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
GLS Q + P W PE + K+S SD++SFG++ +EI
Sbjct: 169 GLSREIYSADYYRVQPKSLLPIRWMPPEAI---------MYGKFSSDSDIWSFGVVLWEI 219
Query: 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
+ G P+ ++ +R + P + +L CW P++RP F I
Sbjct: 220 FSFGLQPYYG--FSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277
Query: 502 RILR 505
LR
Sbjct: 278 TRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 50/281 (17%)
Query: 235 EDYQVRRRLG---SGSQYK-EILWLGESFALRHFFGDIEP-----LVPEISSLLSLSHPN 285
+D + LG SG K G+ A++ +I ++ E+ L + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 286 IMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
I+ F F + + + ME M L +KE+ + RIP + + + + +G+
Sbjct: 61 IVGFYGAFYNN--GDISICMEYMDGGSLDKILKEV---QGRIP--ERILGKIAVAVLKGL 113
Query: 345 EYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT--- 400
YLH K KI H ++ PSNIL+ RG K+ FG+S G S + T
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRG-------QIKLCDFGVS-----GQLVNSLAKTFVG 161
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHLQG-- 456
T ++ APE + + YS KSD++S G+ E+ TG+ P+ E+ G
Sbjct: 162 TSSYM--APERI---------QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF 210
Query: 457 DKMSRNIRAGERPLFPFHS-PKYVTNLTKRCWHADPNQRPS 496
+ + I P P + C DP +RPS
Sbjct: 211 ELLQY-IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/243 (23%), Positives = 109/243 (44%), Gaps = 34/243 (13%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSL 330
+ EI L L+HPN++ + F ++ E +++EL + DL IK ++ IP
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEK- 106
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+Q+ +E++HS+++ H ++ P+N+ + G K+ GL + F
Sbjct: 107 -TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-------VKLGDLGLG--RFF 156
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
K+ + + +PE + EN Y+ KSD++S G + +E+ + PF
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPF- 206
Query: 451 DAHLQGDKMS-----RNIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
GDKM+ + I + P P H + + L C + DP +RP + + +
Sbjct: 207 ----YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262
Query: 505 RYI 507
+ +
Sbjct: 263 KRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 77/309 (24%), Positives = 130/309 (42%), Gaps = 73/309 (23%)
Query: 237 YQVRRRLGSGS-------QYKEILWLGESFALRHF---FGDIEPL--VPEISSLLSL-SH 283
Y+V ++LG G+ + KE GE A++ F E + E+ SL L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKET---GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEH 57
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
PNI+ F E E + + E M +L +K+ RK PFS V ++ QI +G
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKD----RKGKPFSESVIRSIIYQILQG 111
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGPKSPSQSGTTH 402
+ ++H +H +L P N+L+ + + KI+ FGL+ +++ P + S T
Sbjct: 112 LAHIHKHGFFHRDLKPENLLV------SGPEV-VKIADFGLAREIRSRPPYTDYVS--TR 162
Query: 403 PFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK--------------- 446
W+ APE+L ++ YS D+++ G I E+ T +
Sbjct: 163 ---WYRAPEILLR--------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211
Query: 447 -----VPFEDAHLQGDKMSR--NIRAGERP------LFPFHSPKYVTNLTKRCWHADPNQ 493
P + +G K++ R + L P SP+ + +L K DP +
Sbjct: 212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI-DLIKDMLRWDPKK 270
Query: 494 RPSFSSICR 502
RP+ S +
Sbjct: 271 RPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
L+ HP + H C F +E F +ME L DL +I+ R F A
Sbjct: 51 LAWEHPFLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSS----GR--FDEARARFYA 102
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+I G+++LH K I + +L N+LL G H KI+ FG+ G S
Sbjct: 103 AEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-------HIKIADFGMCKENMNGEGKAST 155
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG- 456
T +I APE+L+ KY+E D +SFG++ +E+L G+ PF H +
Sbjct: 156 FCGTPDYI--APEILK---------GQKYNESVDWWSFGVLLYEMLIGQSPF---HGEDE 201
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D++ +I +RP FP K + + + DP +R
Sbjct: 202 DELFDSILN-DRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 28/231 (12%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
E + E + L H ++ ++E +++ E MS+ L ++K R
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLR-- 100
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
LP VD+ QIA GM Y+ H +L +NIL+ L K++ FGL+ +
Sbjct: 101 --LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-------LVCKVADFGLARL 151
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446
+ Q G P W AP E+A +++ KSDV+SFG++ E+ T G+
Sbjct: 152 IEDNEYTARQ-GAKFPIKWTAP---------EAALYGRFTIKSDVWSFGILLTELTTKGR 201
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
VP+ + ++ + G R P P+ + +L +CW +P +RP+F
Sbjct: 202 VPYPG--MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 9e-14
Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 56/296 (18%)
Query: 236 DYQVRRRLGSGSQYKEILWLGESFALRH-----FF------------GDIEPLVPEISSL 278
+Y+V +++G+G GE F ++H FF + LV E++ +
Sbjct: 14 EYEVIKKIGNGR-------FGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
L H NI+ ++ F ++ ++ +++ME + DL I++ C + VD+
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMFGKIEEHAIVDIT 124
Query: 338 LQIARGMEYLHS-------KKIYHGNLNPSNILLK----------PRGASTEGYLHAKIS 380
Q+ + Y H+ +++ H +L P NI L + + G AKI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
FGLS KN G +S + S P+ W +PE+L ++ Y +KSD+++ G I +
Sbjct: 185 DFGLS--KNIGIESMAHSCVGTPYYW-SPELLLHETKS-------YDDKSDMWALGCIIY 234
Query: 441 EILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
E+ +GK PF A+ +S R + P+ K + L K + +RPS
Sbjct: 235 ELCSGKTPFHKANNFSQLISELKRGPDLPI--KGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 50/275 (18%)
Query: 235 EDYQVRRRLGSGS-------QYKEILWLGESFALRHF-FGDI------EPLVPEISSLLS 280
+D++ + LG+GS ++K G+ +AL+ I E ++ E L S
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
+ HP +++ F D+ +L+ME + +L S++ RK F PVA Q
Sbjct: 58 IRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHL------RKSGRFPEPVARFYAAQ 109
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
+ +EYLHS I + +L P N+LL ++GY+ KI+ FG + K ++ + G
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLL-----DSDGYI--KITDFGFA--KRVKGRTYTLCG 160
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T + APE++ + Y + D ++ G++ +E+L G PF D ++
Sbjct: 161 TPE---YLAPEII---------LSKGYGKAVDWWALGILIYEMLAGYPPFFD--DNPIQI 206
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
I G + FP +L + D +R
Sbjct: 207 YEKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 39/193 (20%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECF--LIMELMSRDLCSYIKEICCPRKRIPF 328
+ E+ + + H NIM + + + + F L+M++M+ DL + ++I
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGD----FINLVMDIMASDLKKVVD------RKIRL 116
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ ++LQI G+ LH H +L+P+NI + +G KI+ FGL+
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI-------CKIADFGLARRY 169
Query: 389 NFGPKSPSQSGTTHP-----------FIWH-APEVLEENEQTESASNSKYSEKSDVYSFG 436
+ P S + S +W+ APE+L E KY D++S G
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE--------KYHFAVDMWSVG 221
Query: 437 MICFEILTGKVPF 449
I E+LTGK F
Sbjct: 222 CIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 25/227 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L HPNI+ + F D+ L++E+ + + + +K F +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNT----LLIEMEYAN-GGTLYDKIVRQKGQLFEEEMV 103
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ + QI + Y+H I H ++ NI L G K+ FG+S +
Sbjct: 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-------IKLGDFGISKILG-SEY 155
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
S +++ P+ + +PE+ + KY+ KSD+++ G + +E+LT K F+ +
Sbjct: 156 SMAETVVGTPY-YMSPELCQ---------GVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ I G + +L DP +RP+ +
Sbjct: 206 PL--NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 74/301 (24%), Positives = 113/301 (37%), Gaps = 89/301 (29%)
Query: 235 EDYQVRRRLGSGSQYKEILWLGESFALRHFFG---------------DIEPLVPEISSLL 279
EDY++ +R+GSG+ G+ + R D E + EIS L
Sbjct: 3 EDYELIQRIGSGT-------YGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLK 55
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCS--YIKEICCPRKRIPFSLPVAVDLM 337
HPNI+ + + +K +++ME C +++I R P S
Sbjct: 56 ECRHPNIVAYFGSYLRRDK--LWIVMEY-----CGGGSLQDIYQ-VTRGPLSEL------ 101
Query: 338 LQIA-------RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKN 389
QIA +G+ YLH H ++ +NILL G K++ FG+S+ +
Sbjct: 102 -QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-------DVKLADFGVSAQLTA 153
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
K S GT + W APEV Y K D+++ G+ E+ + P
Sbjct: 154 TIAKRKSFIGTPY---WMAPEVAAVE------RKGGYDGKCDIWALGITAIELAELQPPM 204
Query: 450 EDAHLQGDKMSRNIRAGERPLF-----PFHSPKY---------VTNLTKRCWHADPNQRP 495
D H M R LF F PK + K+C DP +RP
Sbjct: 205 FDLH----PM--------RALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252
Query: 496 S 496
+
Sbjct: 253 T 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ ++ +A GM+YL H L +L+ L KISGF +
Sbjct: 110 MGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-------LVCKISGFRR------LQE 156
Query: 394 SPSQS-----GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447
S++ P +W APE ++ + +S SDV+SFG++ +E+++ G+
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYH---------HFSSASDVWSFGIVMWEVMSYGER 207
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
P+ D + G + + + G R P + P + L CW + +RP FS I IL
Sbjct: 208 PYWD--MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YL +++ H +L N+L+K H KI+ FGL+ + K
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHA 168
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
G P W A ES + Y+ +SDV+S+G+ +E++T G P++ +
Sbjct: 169 EGGKVPIKWMA---------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPA 217
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI----CRILRYIKRFIM 512
++S + GER P V + +CW D + RP F + ++ R +R+++
Sbjct: 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 277
Query: 513 MNPHYNSQPDPPMPLVDYSDIESRL 537
+ Q D M L +D
Sbjct: 278 I------QGDERMHLPSPTDSNFYR 296
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/230 (25%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E+ L + HPNI+ F F +E F++ME DL I ++ + FS
Sbjct: 49 EVILLAKMKHPNIVTFFASF--QENGRLFIVMEYCDGGDLMKRINR----QRGVLFSEDQ 102
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ +QI+ G++++H +KI H ++ NI L G + AK+ FG++ N
Sbjct: 103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG------MVAKLGDFGIARQLN-DS 155
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
+ + P+ + +PE+ + N Y+ K+D++S G + +E+ T K PFE
Sbjct: 156 MELAYTCVGTPY-YLSPEICQ---------NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+L + + + P+ P S + + +L + + P RPS +SI +
Sbjct: 206 NLH-QLVLKICQGYFAPISPNFS-RDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 36/288 (12%)
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
L+ HP + H C F + K+ F +ME L DL +I+ C + F LP A
Sbjct: 51 LAWEHPFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQS--CHK----FDLPRATFYA 102
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+I G+++LHSK I + +L NILL G H KI+ FG+ G
Sbjct: 103 AEIICGLQFLHSKGIVYRDLKLDNILLDTDG-------HIKIADFGMCKENMLGDAKTCT 155
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
T +I APE+L KY+ D +SFG++ +E+L G+ PF +
Sbjct: 156 FCGTPDYI--APEIL---------LGQKYNTSVDWWSFGVLLYEMLIGQSPFHG--HDEE 202
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHY 517
++ ++IR + P +P + ++ + + +P +R R + R I +
Sbjct: 203 ELFQSIRM-DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF-REIDWSALE 260
Query: 518 NSQPDPPM-PLV----DYSDIESRLLRKFPSWETHNVLPISEIPFQMF 560
+ +PP P V D S+ + L + P + + I+ + MF
Sbjct: 261 EREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMF 308
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 56/185 (30%), Positives = 98/185 (52%), Gaps = 30/185 (16%)
Query: 329 SLPVAVDLML----QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
S P+ +D +L Q+A+GM++L SK H ++ N+LL T+G + AKI FGL
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL------TDGRV-AKICDFGL 258
Query: 385 S----SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
+ + N+ K ++ P W APE S + Y+ +SDV+S+G++ +
Sbjct: 259 ARDIMNDSNYVVKGNARL----PVKWMAPE---------SIFDCVYTVQSDVWSYGILLW 305
Query: 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
EI + GK P+ L K + ++ G + P +P + ++ K CW+ +P +RP+FS
Sbjct: 306 EIFSLGKSPYPGI-LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQ 364
Query: 500 ICRIL 504
I +++
Sbjct: 365 ISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 48/318 (15%)
Query: 243 LGSGSQYK----EILWLGESFALRHFF-------GDIEPLVPEISSL-LSLSHPNIMHFL 290
LG GS K E+ GE FA++ D+E + E L L+ +P + H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS 349
C F + K+ F +ME ++ DL +I++ + F L A +I G+++LHS
Sbjct: 63 CTF--QTKEHLFFVMEFLNGGDLMFHIQD------KGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAP 409
K I + +L N++L G H KI+ FG+ FG S T +I AP
Sbjct: 115 KGIIYRDLKLDNVMLDRDG-------HIKIADFGMCKENVFGDNRASTFCGTPDYI--AP 165
Query: 410 EVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERP 469
E+L+ KY+ D +SFG++ +E+L G+ PF D++ +IR + P
Sbjct: 166 EILQ---------GLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRV-DTP 213
Query: 470 LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPM-PLV 528
+P K ++ ++ + DP +R R + K I + DPP P V
Sbjct: 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT-INWTALEKRELDPPFKPKV 272
Query: 529 ----DYSDIESRLLRKFP 542
DYS+ + L + P
Sbjct: 273 KSPSDYSNFDREFLSEKP 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 237 YQVRRRLGSGSQYKEILWL-----GESFALRHF---FGDIEPLV--PEISSLLSLS-HPN 285
Y++ ++G G+ + E+L G+ +A++ F +E + EI +L LS HPN
Sbjct: 1 YKILGKIGEGT-FSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
I+ + D + L+ ELM +L IK RKR P M Q+ + ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG----RKR-PLPEKRVKSYMYQLLKSLD 114
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP-SQSGTTHPF 404
++H I+H ++ P NIL+K K++ FG S + K P ++ +T
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD--------ILKLADFG--SCRGIYSKPPYTEYISTR-- 162
Query: 405 IWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
W+ APE L ++ Y K D+++ G + FEIL+
Sbjct: 163 -WYRAPECL--------LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + HPNI+H T + + +I E M L S++++ F++
Sbjct: 55 EASIMGQFDHPNIIHLEGVVT--KSRPVMIITEFMENGALDSFLRQ-----NDGQFTVIQ 107
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V ++ IA GM+YL H +L NIL+ L K+S FGLS
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-------LVCKVSDFGLSRFLEDDT 160
Query: 393 KSPSQS---GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
P+ + G P W APE + + K++ SDV+S+G++ +E+++ G+ P
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAI---------AYRKFTSASDVWSYGIVMWEVMSYGERP 211
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ D Q D ++ I R P P + L CW D N RP F I L
Sbjct: 212 YWDMSNQ-DVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 22/185 (11%)
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS-- 380
R++ SL +D+ Q+A + YL KK+ HGN+ NIL+ G + K+S
Sbjct: 93 REKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
G ++ + W APE + + + + +D +SFG
Sbjct: 153 GIPITVLSREERVERIP--------WIAPECIRNGQ-------ASLTIAADKWSFGTTLL 197
Query: 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
EI + G+ P + R + R P + NL +CW DP +RPSF +
Sbjct: 198 EICSNGEEPLSTLSSS--EKERFYQDQHR--LPMPDCAELANLINQCWTYDPTKRPSFRA 253
Query: 500 ICRIL 504
I R L
Sbjct: 254 ILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 64/237 (27%), Positives = 96/237 (40%), Gaps = 36/237 (15%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
+E L EI + L+HP+I+ L G T E L +E M+ S++ K
Sbjct: 47 VEALRKEIRLMARLNHPHIIRML-GAT-CEDSHFNLFVEWMAGGSVSHLL-----SKYGA 99
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA-------STEGYLHAKIS 380
F V ++ Q+ RG+ YLH +I H ++ +N+L+ G L AK +
Sbjct: 100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
G G + G T F+ APEVL +Y DV+S G +
Sbjct: 160 GAGEFQGQLLG---------TIAFM--APEVLR---------GEQYGRSCDVWSVGCVII 199
Query: 441 EILTGKVPFE-DAHLQGDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
E+ T K P+ + H + I A P P H + ++T RC P RP
Sbjct: 200 EMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPV 332
E L +HP I+ F D KK +++ME +L + + R R F
Sbjct: 43 EKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTIL------RDRGLFDEYT 94
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A + + EYLH++ I + +L P N+LL + GY+ K+ FG + G
Sbjct: 95 ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL-----DSNGYV--KLVDFGFAKKLKSGQ 147
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF-ED 451
K+ + GT + APE++ N Y D +S G++ +E+LTG+ PF ED
Sbjct: 148 KTWTFCGTPE---YVAPEIIL---------NKGYDFSVDYWSLGILLYELLTGRPPFGED 195
Query: 452 AHLQGDKMS--RNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQR 494
D M +I G L FP + K +L K+ +P +R
Sbjct: 196 ---DEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 51/246 (20%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR----DLCSYIKEICCPR 323
I+ + E+ L L HPN++ + + +++ ++ ME S +L +
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYG--VEVHREKVYIFMEYCSGGTLEELLEH-------- 92
Query: 324 KRIPFSLPVAV--DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
RI L V LQ+ G+ YLHS I H ++ P+NI L G K+
Sbjct: 93 GRI---LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-------IKLGD 142
Query: 382 FGLSSVK------NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435
FG +VK G + S +GT + APEV+ + + +D++S
Sbjct: 143 FG-CAVKLKNNTTTMGEEVQSLAGTP---AYMAPEVITGGKGKG------HGRAADIWSL 192
Query: 436 GMICFEILTGKVPFE--DAHLQGDKMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHAD 490
G + E+ TGK P+ D Q + ++ AG +P P SP+ + RC +D
Sbjct: 193 GCVVLEMATGKRPWSELDNEFQ---IMFHVGAGHKPPIPDSLQLSPE-GKDFLDRCLESD 248
Query: 491 PNQRPS 496
P +RP+
Sbjct: 249 PKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ----IARGMEYLHSKKIYHGN 356
++MELM+ DL SY++ + + P P + M+Q IA GM YL++KK H +
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 144
Query: 357 LNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH--PFIWHAPEVLEE 414
L N ++ KI FG++ ++ + G P W APE L++
Sbjct: 145 LAARNCMVAHDFT-------VKIGDFGMT--RDIYETDYYRKGGKGLLPVRWMAPESLKD 195
Query: 415 NEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPF 473
T S SD++SFG++ +EI + + P++ L +++ + + G P
Sbjct: 196 GVFTTS---------SDMWSFGVVLWEITSLAEQPYQG--LSNEQVLKFVMDGGYLDQPD 244
Query: 474 HSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ P+ VT+L + CW +P RP+F I +L+
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPV 332
E L LSHPNI+ + F E K ++ME L YI++ R
Sbjct: 49 ECQVLKLLSHPNIIEYYENFL--EDKALMIVMEYAPGGTLAEYIQK----RCNSLLDEDT 102
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ +QI + ++H+K I H +L NILL + KI FG+S K
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH------KMVVKIGDFGIS--KILSS 154
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
KS + + P + +PE+ E Y++KSD+++ G + +E+ + K FE A
Sbjct: 155 KSKAYTVVGTP-CYISPELCE---------GKPYNQKSDIWALGCVLYELASLKRAFEAA 204
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+L + + + P+ +SP + L + DP++RP S I
Sbjct: 205 NLPALVL-KIMSGTFAPISDRYSPD-LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 33/230 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKRIPFSLPV 332
EI L HPNI+ + E K ++++E L S + E+ + P
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENK--LWILIEFCDGGALDSIMLEL-----ERGLTEPQ 104
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ Q+ + +LHS K+ H +L NILL G K++ FG+S+ KN
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-------DVKLADFGVSA-KN--- 153
Query: 393 KSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
KS Q T FI W APEV+ E+ ++ Y K+D++S G+ E+ + P
Sbjct: 154 KSTLQKRDT--FIGTPYWMAPEVV----ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
Query: 449 FEDAHLQGDKMSRNIRAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPS 496
+ + ++ I E P P + K C DP+ RP+
Sbjct: 208 HHELNPM--RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ----IARGMEYLHSKKIYHGN 356
+IMELM+R DL SY++ + + P P ++ M+Q IA GM YL++ K H +
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144
Query: 357 LNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH--PFIWHAPEVLEE 414
L N ++ KI FG++ ++ + G P W +PE L++
Sbjct: 145 LAARNCMVAED-------FTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRWMSPESLKD 195
Query: 415 NEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPF 473
++ SDV+SFG++ +EI T + P++ + +++ R + G P
Sbjct: 196 ---------GVFTTYSDVWSFGVVLWEIATLAEQPYQG--MSNEQVLRFVMEGGLLDKPD 244
Query: 474 HSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ P + L + CW +P RPSF I
Sbjct: 245 NCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFS 329
++ E+ S P I+ + F DE + ME L S K++ RI
Sbjct: 46 ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI--G 103
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
V + + +G+ YLHS+KI H ++ PSNILL +G K+ FG+S
Sbjct: 104 EKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-------VKLCDFGVS---- 152
Query: 390 FGPKSPSQSGT-THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
G S +GT T + APE + YS SDV+S G+ E+ + P
Sbjct: 153 -GELVNSLAGTFTGTSFYMAPERI---------QGKPYSITSDVWSLGLTLLEVAQNRFP 202
Query: 449 FE 450
F
Sbjct: 203 FP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 59/187 (31%), Positives = 81/187 (43%), Gaps = 39/187 (20%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSRDLCSYIKEICCPRKRIPFS 329
EI L L H NI+ L E F ++ ELM DL IK
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPP-SPEDFNDVYIVTELMETDLHKVIKS----------P 97
Query: 330 LPVAVD----LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
P+ D + QI RG++YLHS + H +L PSNIL+ S KI FGL+
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNC---DLKICDFGLA 150
Query: 386 SVKNFGPKSPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
P + T + W+ APE+L S+S+Y++ D++S G I E+
Sbjct: 151 RG--VDPDEDEKGFLTEYVVTRWYRAPELL--------LSSSRYTKAIDIWSVGCIFAEL 200
Query: 443 LTGKVPF 449
LT K F
Sbjct: 201 LTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 35/203 (17%)
Query: 256 GESFALRHFFGDIEPL-VP-----EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309
GE AL+ D E VP EIS L L+HPNI+ L E K +L+ E +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLH 82
Query: 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369
+DL ++ P IP LP+ + Q+ +G+ + HS ++ H +L P N+L+ GA
Sbjct: 83 QDLKKFMD--ASPLSGIP--LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI--WH-APEVLEENEQTESASNSKY 426
K++ FGL+ + FG P ++ TH + W+ APE+L Y
Sbjct: 139 -------IKLADFGLA--RAFG--VPVRT-YTHEVVTLWYRAPEIL--------LGCKYY 178
Query: 427 SEKSDVYSFGMICFEILTGKVPF 449
S D++S G I E++T + F
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 19/181 (10%)
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
RK + P + Q+A + YL K + HGN+ NILL G E K+S
Sbjct: 97 RKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
G+ S+ W APE +E+++ A +D +SFG +EI
Sbjct: 157 GIPIT------VLSRQECVERIPWIAPECVEDSKNLSIA--------ADKWSFGTTLWEI 202
Query: 443 -LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
G++P +D L + R + P S K + +L C + DPNQRP F +I
Sbjct: 203 CYNGEIPLKDKTLA--EKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIM 258
Query: 502 R 502
R
Sbjct: 259 R 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 54/306 (17%)
Query: 209 DVLFKNLDGSGSLSGKLLPSRILIKS--EDYQVRRRLGSGSQYKEILWLGESFALRHFFG 266
D+ F+++ G G+ G++L +RI D ++R S+ R F G
Sbjct: 8 DIKFQDVIGEGNF-GQVLKARIKKDGLRMDAAIKRMKEYASKDDH----------RDFAG 56
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
++E L HPNI++ L E + +L +E +L ++++
Sbjct: 57 ELEVLCK------LGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 108
Query: 326 IPFSLP--VAVDLMLQ--------IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375
F++ A L Q +ARGM+YL K+ H +L NIL+ E Y+
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG------ENYV 162
Query: 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435
AKI+ FGLS + K ++ P W A ES + S Y+ SDV+S+
Sbjct: 163 -AKIADFGLSRGQEVYVK---KTMGRLPVRWMA---------IESLNYSVYTTNSDVWSY 209
Query: 436 GMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
G++ +EI++ G P+ + ++ + G R P + V +L ++CW P +R
Sbjct: 210 GVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 267
Query: 495 PSFSSI 500
PSF+ I
Sbjct: 268 PSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 70/240 (29%), Positives = 96/240 (40%), Gaps = 43/240 (17%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI-P 327
E L E+ L SL H NI+ +L D+ F ME + S I R P
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF--MEFVPGGSISSI------LNRFGP 98
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG---- 383
PV QI G+ YLH+ + H ++ +N++L P G K+ FG
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI-------IKLIDFGCARR 151
Query: 384 LSSVKNFGPKS---PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
L+ V G S S GT P+ W APEV+ E S Y KSD++S G F
Sbjct: 152 LAWVGLHGTHSNMLKSMHGT--PY-WMAPEVINE---------SGYGRKSDIWSIGCTVF 199
Query: 441 EILTGKVPFEDAHLQGDKMSRNIRAGER----PLFPFHSPKYVTNLTKRCWHADPNQRPS 496
E+ TGK P D+++ G P P + C D ++RPS
Sbjct: 200 EMATGKPPLASM----DRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 276 SSLLS-LSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAV 334
+ LLS L HP I+ F F E C + RDL ++E S
Sbjct: 53 AQLLSKLDHPAIVKFHASFL-ERDAFCIITEYCEGRDLDCKLEE--LKHTGKTLSENQVC 109
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
+ +Q+ G+ Y+H ++I H +L NI LK KI FG+S + G
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--------LLKIGDFGVSRLL-MGSCD 160
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
+ + T P+ + +PE L + Y KSD++S G I +E+ FE +
Sbjct: 161 LATTFTGTPY-YMSPEAL---------KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
+ I G P P + + ++ + + DP+ RPS + I R +I
Sbjct: 211 LSVVLR--IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN-PFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 63/236 (26%), Positives = 94/236 (39%), Gaps = 35/236 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
++ L EI L +L H I+ + D+E F ME M + +K
Sbjct: 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF--MEYMPGGSVKDQLKAYGA---- 100
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG-- 383
+ V QI G+EYLHS I H ++ +NIL G + K+ FG
Sbjct: 101 --LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-------NVKLGDFGAS 151
Query: 384 --LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
L ++ + G S +GT + W +PEV+ S Y K+DV+S G E
Sbjct: 152 KRLQTICSSGTGMKSVTGTPY---WMSPEVI---------SGEGYGRKADVWSVGCTVVE 199
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGE-RPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
+LT K P+ A + I P P H N +R + + +RPS
Sbjct: 200 MLTEKPPW--AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 232 IKSEDYQVRRRLGSG-----SQYKEILWLGESFALRHFFGDIEPLV-PEISSLLSLSH-- 283
+++ED + LG+G S+ K I G A + + V +I L + H
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 284 --PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
P I+ F F +E + ME M I +K P + + + + +
Sbjct: 61 RSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIY-----KKGGPIPVEILGKIAVAVV 113
Query: 342 RGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-----SVKNFGPKSP 395
G+ YL++ +I H ++ PSNIL+ RG K+ FG+S S+ +
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRG-------QIKLCDFGVSGELINSIAD------ 160
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF----ED 451
+ GT+ + +PE ++ KY+ KSDV+S G+ E+ GK PF D
Sbjct: 161 TFVGTS---TYMSPERIQ---------GGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208
Query: 452 AHLQGDKMS-----RNIRAGERPLFPFHS-PKYVTNLTKRCWHADPNQRPSFSSICR 502
Q D M + I P P P+ + + C DP +RP+ +C
Sbjct: 209 DDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336
S+ S+ P + F E + ++ ME+M L + K++ IP + +
Sbjct: 53 SMRSVDCPYTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIP--EDILGKI 108
Query: 337 MLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-----SVKNF 390
+ I + +EYLHSK + H ++ PSN+L+ G K+ FG+S SV
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-------QVKLCDFGISGYLVDSV--- 158
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
+ + P++ APE + N + Y KSDV+S G+ E+ TG+ P++
Sbjct: 159 ---AKTIDAGCKPYM--APERI--NPELNQKG---YDVKSDVWSLGITMIELATGRFPYD 208
Query: 451 DAHLQGDKMSRNIRAGERPLFPFH--SPKYVTNLTKRCWHADPNQRPSFSSI 500
++ + + P P SP++ + +C + +RP++ +
Sbjct: 209 SWKTPFQQL-KQVVEEPSPQLPAEKFSPEFQ-DFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 85/354 (24%), Positives = 146/354 (41%), Gaps = 69/354 (19%)
Query: 233 KSEDYQVRRRLGSGS-------------QYKEILWLGESFALRHFFGDIEPLVPEISSLL 279
K D+++ LG+GS +Y I L + L+ ++ + E S L+
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILM 73
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
LSHP I++ +C F DE + FL+ ++ +L +++ RK F VA +
Sbjct: 74 ELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHL------RKAGRFPNDVAKFYHAE 126
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
+ EYLHSK I + +L P N+LL +G H K++ FG F K P ++
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKG-------HVKVTDFG------FAKKVPDRTF 173
Query: 400 T---THPFIWHAPEVLEENEQTESASNSKYSEKS-DVYSFGMICFEILTGKVPFEDAHLQ 455
T T ++ APEV++ SK K+ D ++ G++ +E + G PF D
Sbjct: 174 TLCGTPEYL--APEVIQ----------SKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--T 219
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF----- 510
++ I AG R FP +L K D +R ++ + +K
Sbjct: 220 PFRIYEKILAG-RLKFPNWFDGRARDLVKGLLQTDHTKR--LGTLKGGVADVKNHPYFHG 276
Query: 511 ----IMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPFQMF 560
+ +Y P+P+ S ++ K+P + P++ F
Sbjct: 277 ANWDKLYARYYP----APIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEF 326
|
Length = 329 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YL +++ H +L N+L+K H KI+ FGL+ + K +
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPN-------HVKITDFGLARLLEGDEKEYNA 168
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
G P W A E + K++ +SDV+S+G+ +E++T G P++ +
Sbjct: 169 DGGKMPIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPYDG--IPT 217
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC----RILRYIKRFIM 512
++ + GER P V + +CW D + RP F + R+ R +R+++
Sbjct: 218 REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLV 277
Query: 513 M 513
+
Sbjct: 278 I 278
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPV 332
E L +SHP I+ T+ +++ +++ME + +L SY+ R FS
Sbjct: 51 EKRVLKEVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNST 102
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ +I +EYLHSK+I + +L P NILL G H K++ FG + K
Sbjct: 103 GLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-------HIKLTDFGFA--KKLRD 153
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
++ + GT + APEV++ + +++ D ++ G++ +E+L G PF D
Sbjct: 154 RTWTLCGTPE---YLAPEVIQ---------SKGHNKAVDWWALGILIYEMLVGYPPFFDD 201
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ G + I AG+ FP H Y +L K+ D +R
Sbjct: 202 NPFG--IYEKILAGKLE-FPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 39/175 (22%)
Query: 283 HPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
H NI+ L FT EE ++ +L+MELM +LC I ++ +R+ + L+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSY-------LLY 125
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+ G+++LHS I H +L PSNI++K KI FGL+ S
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------LKILDFGLARTAG-------TS 171
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P++ + APEV+ Y E D++S G I E++ G V F
Sbjct: 172 FMMTPYVVTRYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 32/184 (17%)
Query: 272 VPEISSLLSLSHPNIMHF--LCGF--TDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
V + L + HPN++ +C TD E K L+ E + +DL +Y+ ++ P +P
Sbjct: 52 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKV--PEPGVP 108
Query: 328 FSLPVAV-DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
+ D+M Q+ RG+++LHS ++ H +L P NIL+ G K++ FGL+
Sbjct: 109 ---TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------QIKLADFGLAR 158
Query: 387 VKNFGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
+ +F S T +W+ APEVL + S Y+ D++S G I E+
Sbjct: 159 IYSFQMALTSVVVT----LWYRAPEVLLQ---------SSYATPVDLWSVGCIFAEMFRR 205
Query: 446 KVPF 449
K F
Sbjct: 206 KPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
+A GM+YL K+ H +L N+L+ L +KI+ FGLS + K ++
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK---KTM 177
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458
P W A ES + S Y+ KSDV+SFG++ +EI++ G P+ + +
Sbjct: 178 GRLPVRWMA---------IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAE 226
Query: 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC----RILRYIKRFIMM 513
+ + G R P + V L ++CW P +RP F+ I R+L K ++ M
Sbjct: 227 LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNM 285
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 24/157 (15%)
Query: 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYH 354
E K + L+M LM+ DL +I + P F A+ QI G+E+LH ++I +
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEE 414
+L P N+LL G + +IS GL +V+ G K T ++ APEVL+
Sbjct: 119 RDLKPENVLLDDHG-------NVRISDLGL-AVELKGGKKIKGRAGTPGYM--APEVLQG 168
Query: 415 NEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
Y D ++ G +E++ G+ PF
Sbjct: 169 EV---------YDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 32/238 (13%)
Query: 268 IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCS--YIKEICCPRKR 325
I+ EI +L + NI+ D L + L + C+ Y++E+ K
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL---EYCTRGYLREVLDKEKD 118
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
+ F +D+ + +G+ L+ + NL + L+ TE Y KI GL
Sbjct: 119 LSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV------TENYK-LKIICHGL 169
Query: 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ + P + ++ + ++L + S+Y+ K D+YS G++ +EI T
Sbjct: 170 EKILSSPP-----FKNVNFMVYFSYKMLND-------IFSEYTIKDDIYSLGVVLWEIFT 217
Query: 445 GKVPFEDAHLQG--DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
GK+PFE+ + D + L P P + + + C D +RP+ I
Sbjct: 218 GKIPFENLTTKEIYDLIINKN--NSLKL-PLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 66/248 (26%), Positives = 100/248 (40%), Gaps = 42/248 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE--------ICCPRK 324
E L + H NI+ F T+ + ++ E M DL +++
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY-LHAKISGFG 383
+L + + +QIA GM YL S+ H +L N L+ GY L KI FG
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--------GYDLVVKIGDFG 167
Query: 384 LS----SVKNFGPKSPSQSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
+S + + G T P W PE S K++ +SDV+SFG++
Sbjct: 168 MSRDVYTTDYYRVG-----GHTMLPIRWMPPE---------SIMYRKFTTESDVWSFGVV 213
Query: 439 CFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+EI T GK P+ L +++ I G P P V ++ CW DP QR +
Sbjct: 214 LWEIFTYGKQPW--YGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
Query: 498 SSICRILR 505
I L+
Sbjct: 272 KDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 36/207 (17%)
Query: 293 FTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK 351
++ + K +L+ME L D S IK + A + ++ G+E LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 352 IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEV 411
I H ++ P N+L+ G H K++ FGLS G ++ GT + APE
Sbjct: 118 IIHRDIKPENLLIDQTG-------HLKLTDFGLSRN---GLENKKFVGTPD---YLAPET 164
Query: 412 LEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE----DAHLQGDKMSRNIRAGE 467
+ + SD +S G + FE L G PF DA + +SR I E
Sbjct: 165 ILGVGDDKM---------SDWWSLGCVIFEFLFGYPPFHAETPDAVFD-NILSRRINWPE 214
Query: 468 RPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ F SP+ V +L R DP +R
Sbjct: 215 E-VKEFCSPEAV-DLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 40/187 (21%)
Query: 274 EISSLLSLSHPNIMHFL---CGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI L H NI+ L + E + +++ ELM DL IK +
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----------TQ 101
Query: 331 PVAVD----LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
++ D + QI RG++Y+HS + H +L PSN+LL +T L KI FGL+
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-----NTNCDL--KICDFGLAR 154
Query: 387 VKNFGPKSPSQSGTTHPFI---WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ + P+ +G ++ W+ APE++ ++ Y++ D++S G I E+
Sbjct: 155 IAD--PEHD-HTGFLTEYVATRWYRAPEIM--------LNSKGYTKAIDIWSVGCILAEM 203
Query: 443 LTGKVPF 449
L+ + F
Sbjct: 204 LSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 31/192 (16%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YL ++ H NL NILLK +I+ FG++ + K
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILLKSD-------SIVQIADFGVADLLYPDDKKYFY 168
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
S P W A ES +Y+ +SDV+S+G+ +E+++ G P+
Sbjct: 169 SEHKTPIKWMA---------LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH- 218
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPH 516
++ + GER P V + +CW D N RP+F + + R
Sbjct: 219 -EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR------- 270
Query: 517 YNSQPDPPMPLV 528
DPP LV
Sbjct: 271 -----DPPRYLV 277
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 236 DYQVRRRLGSGSQYKEILWLGES----FALRHF-----FGDIEPLVPEISSLLSLSHPNI 286
Y V R +G GS + +L + +A++ +E E L + HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ F F E +++ME DL IK R ++ F + +Q+ G++
Sbjct: 61 VAFKESF--EADGHLYIVMEYCDGGDLMQKIKL---QRGKL-FPEDTILQWFVQMCLGVQ 114
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-KNFGPKSPSQSGTTHPF 404
++H K++ H ++ NI L G K+ FG + + + G + + GT +
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-------KVKLGDFGSARLLTSPGAYACTYVGTPY-- 165
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
+ PE+ E N Y+ KSD++S G I +E+ T K PF+ A+ + + + +
Sbjct: 166 -YVPPEIWE---------NMPYNNKSDIWSLGCILYELCTLKHPFQ-ANSWKNLILKVCQ 214
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+PL P H + +L K+ + +P RPS ++I
Sbjct: 215 GSYKPL-PSHYSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 27/199 (13%)
Query: 256 GESFALRHFFGDIEPLVP-----EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR 310
GE AL+ D E P EIS + L H NI+ E K L+ E M +
Sbjct: 25 GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK--LMLVFEYMDK 82
Query: 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370
DL Y+ Q+ +G+ + H ++ H +L P N+L+ RG
Sbjct: 83 DLKKYMDTHGVRG---ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-- 137
Query: 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKS 430
K++ FGL+ + FG + S + AP+VL + YS
Sbjct: 138 -----ELKLADFGLA--RAFGIPVNTFSNEVVTLWYRAPDVL--------LGSRTYSTSI 182
Query: 431 DVYSFGMICFEILTGKVPF 449
D++S G I E++TG+ F
Sbjct: 183 DIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 92/337 (27%), Positives = 135/337 (40%), Gaps = 73/337 (21%)
Query: 233 KSEDYQVRRRLGSG---------SQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSH 283
K E Y +LG G S+ E L + L H G + E+S L L H
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 284 PNI--MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
NI +H + TD K L+ E + +DL Y+ + C S+ + QI
Sbjct: 64 ANIVTLHDIV-HTD---KSLTLVFEYLDKDLKQYMDD--CGNI---MSMHNVKIFLYQIL 114
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
RG+ Y H +K+ H +L P N+L+ RG K++ FGL+ K+ K+ S T
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERG-------ELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 402 HPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
+W+ P+VL +S+YS + D++ G I FE+ +G
Sbjct: 168 ---LWYRPPDVL--------LGSSEYSTQIDMWGVGCIFFEMASG--------------- 201
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR--PSFSSICRILRYIKRFIMMNPHYN 518
RPLFP + + +L R P + P SS Y F P Y
Sbjct: 202 -------RPLFPGSTVEDELHLIFRLL-GTPTEETWPGISSNDEFKNY--NF----PKYK 247
Query: 519 SQP-DPPMPLVDYSDIESRLLRKFPSWETHNVLPISE 554
QP P +D IE LL KF +E+ + E
Sbjct: 248 PQPLINHAPRLDTEGIE--LLTKFLQYESKKRISAEE 282
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 34/192 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYI-KEICCPRKRIPFSLPVAVD 335
L ++HP I+ F E K +LI++ L DL + + KE+ + + F L
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---- 105
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS--SVKNFGPK 393
++A +++LHS I + +L P NILL G H K++ FGLS S+ + K
Sbjct: 106 ---ELALALDHLHSLGIIYRDLKPENILLDEEG-------HIKLTDFGLSKESIDH-EKK 154
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ S GT + APEV+ T+SA D +SFG++ FE+LTG +PF+
Sbjct: 155 AYSFCGTVE---YMAPEVVNRRGHTQSA---------DWWSFGVLMFEMLTGSLPFQGKD 202
Query: 454 LQGDKMSRNIRA 465
+ + M+ ++A
Sbjct: 203 RK-ETMTMILKA 213
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 39/185 (21%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L ++H NI+ L FT EE ++ +L+MELM +LC I + +R+ +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSY- 127
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G+++LHS I H +L PSNI++K KI FGL+
Sbjct: 128 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------LKILDFGLA---- 170
Query: 390 FGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
++ + P++ + APEV+ Y E D++S G I E++ G
Sbjct: 171 ---RTACTNFMMTPYVVTRYYRAPEVI---------LGMGYKENVDIWSVGCIMGELVKG 218
Query: 446 KVPFE 450
V F+
Sbjct: 219 SVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 76/298 (25%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 235 EDYQVRRRLGSGSQ----YKEILWLGESFALRHFFGDIEPLVP--------EISSLLSLS 282
+ Y + R LGSG+ + + GE FA++ D+E + E+ LL+
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV--DMEGMSEADKNRAQAEVCCLLNCD 89
Query: 283 HPNIM--HFLCGFTDEEKKECFLIMELM-----SRDLCSYIKEICCPRKRI--PFSLPVA 333
+I+ H D E L++ L+ + DL IK R + F A
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS----RAKTNRTFREHEA 145
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
L +Q+ + ++HSK + H ++ +NILL G K+ FG S K +
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-------VKLGDFGFS--KMYAAT 196
Query: 394 SPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
G T P+ + APE+ YS+K+D++S G++ +E+LT K PF+
Sbjct: 197 VSDDVGRTFCGTPY-YVAPEIWRR---------KPYSKKADMFSLGVLLYELLTLKRPFD 246
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS-----ICRI 503
+++ + M + + PL P SP+ + + +DP +RPS S IC++
Sbjct: 247 GENME-EVMHKTLAGRYDPLPPSISPE-MQEIVTALLSSDPKRRPSSSKLLNMPICKL 302
|
Length = 496 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
ARGM+YL K+ H +L NIL+ + KI+ FGLS + K ++
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVA-------KIADFGLSRGQEVYVK---KTMG 171
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459
P W A ES + S Y+ SDV+S+G++ +EI++ G P+ + ++
Sbjct: 172 RLPVRWMA---------IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAEL 220
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ G R P + V +L ++CW P +RPSF+ I
Sbjct: 221 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
L+ HP + F +++ F +ME ++ DL +I+ R F P A
Sbjct: 51 LAGKHPFLTQLHSCFQTKDR--LFFVMEYVNGGDLMFHIQR--SGR----FDEPRARFYA 102
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+I G+++LH + I + +L N+LL +EG H KI+ FG+ G + S
Sbjct: 103 AEIVLGLQFLHERGIIYRDLKLDNVLL-----DSEG--HIKIADFGMCKEGILGGVTTST 155
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
T +I APE+L Y D ++ G++ +E+L G+ PFE D
Sbjct: 156 FCGTPDYI--APEILSY---------QPYGPAVDWWALGVLLYEMLAGQSPFEGD--DED 202
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++ ++I E +P K ++ K +P +R
Sbjct: 203 ELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 63/242 (26%), Positives = 114/242 (47%), Gaps = 30/242 (12%)
Query: 269 EPLVPEISSLLSLS-HPNIMHFLCGFTDEEKK---ECFLIMELMSR-DLCSYIKEICCPR 323
E + E + L +LS HPN++ F + ++ K + +L++EL + + +K
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+R+ P+ ++ + G+++LH K H ++ +NILL +TEG + K+ FG
Sbjct: 119 ERM--EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL-----TTEGGV--KLVDFG 169
Query: 384 LSS-VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+S+ + + + + GT PF W APEV+ +Q +S Y + DV+S G+ E+
Sbjct: 170 VSAQLTSTRLRRNTSVGT--PF-WMAPEVIACEQQLDST----YDARCDVWSLGITAIEL 222
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTN----LTKRCWHADPNQRPSFS 498
G P D H M + P H P+ +N ++C D +RP+ S
Sbjct: 223 GDGDPPLADLH----PMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278
Query: 499 SI 500
+
Sbjct: 279 DL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 41/251 (16%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM----SRDLCSYIKEICCP 322
+IE + EI+ L P I + + K ++IME + + DL
Sbjct: 45 EIEDIQQEITVLSQCDSPYITRYYGSYLKGTK--LWIIMEYLGGGSALDLL--------- 93
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
K P ++ +I +G++YLHS++ H ++ +N+LL +G K++ F
Sbjct: 94 -KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-------DVKLADF 145
Query: 383 GLS-SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
G++ + + K + GT PF W APEV+++ S Y K+D++S G+ E
Sbjct: 146 GVAGQLTDTQIKRNTFVGT--PF-WMAPEVIKQ---------SAYDFKADIWSLGITAIE 193
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
+ G+ P D H ++ I P K + C + DP RP+ +
Sbjct: 194 LAKGEPPNSDLHPM--RVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251
Query: 502 R---ILRYIKR 509
+ I RY K+
Sbjct: 252 KHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 20/120 (16%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I G+E++H++ + + +L P+NILL G H +IS GL+ +F K P S
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLAC--DFSKKKPHAS 155
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
TH ++ APEVL++ + Y +D +S G + F++L G PF H DK
Sbjct: 156 VGTHGYM--APEVLQK--------GTAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 34/238 (14%)
Query: 281 LSHPNIMHFLCGFTDEEKKEC------------FLIMELMSRDLCSYIKEICCPRKRIPF 328
L HPNI+ L T E+ FL+M D+ S + P
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP- 123
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
V ++ QIA GME+L S + H +L N+L+ + L+ KIS GL
Sbjct: 124 --ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-------LNVKISDLGLFREV 174
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447
+ P W +PE + K+S SD++S+G++ +E+ + G
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAI---------MYGKFSIDSDIWSYGVVLWEVFSYGLQ 225
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
P+ + IR + P P +V L CW+ P++RP F I LR
Sbjct: 226 PY--CGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 40/182 (21%)
Query: 278 LLSLSHPNIMHFL--CGF--TDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
L + HPNI+ + C TD E K L+ E + +DL +Y+ ++ P LP
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPP------GLPAE 108
Query: 334 V--DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
DLM Q RG+++LH+ I H +L P NIL+ G K++ FGL+ + +
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-------QVKLADFGLARIYSC- 160
Query: 392 PKSPSQSGTTHPFI---WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
Q T P + W+ APEVL + S Y+ D++S G I E+ K
Sbjct: 161 -----QMALT-PVVVTLWYRAPEVLLQ---------STYATPVDMWSVGCIFAEMFRRKP 205
Query: 448 PF 449
F
Sbjct: 206 LF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/168 (33%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
QIA GM YL S+ H +L N L+ GA+ L KI FG+S
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLV---GAN----LLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP-FEDAHLQG 456
T P W PE S K++ +SDV+SFG+I +EI T GK P F+ ++ +
Sbjct: 184 HTMLPIRWMPPE---------SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ R ERP PK V ++ CW +P QR + I +IL
Sbjct: 235 IECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS- 385
PF ++ +I +G++YLHS+K H ++ +N+LL +G K++ FG++
Sbjct: 97 PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-------DVKLADFGVAG 149
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
+ + K + GT PF W APEV+++ S Y K+D++S G+ E+ G
Sbjct: 150 QLTDTQIKRNTFVGT--PF-WMAPEVIQQ---------SAYDSKADIWSLGITAIELAKG 197
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
+ P D H ++ I P K C + DP+ RP+
Sbjct: 198 EPPNSDMHPM--RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E+ L L H NI+ L ++ + + EL+ DL + ++ I +
Sbjct: 59 ELKLLKHLRHENIIS-LSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY----- 112
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ QI RG++Y+HS + H +L PSNIL+ KI FGL+ +++
Sbjct: 113 --FLYQILRGLKYVHSAGVVHRDLKPSNILINEN-------CDLKICDFGLARIQD---- 159
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P +G + APE++ + KY + D++S G I E+L GK F
Sbjct: 160 -PQMTGYVSTRYYRAPEIM--------LTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 50/210 (23%), Positives = 80/210 (38%), Gaps = 61/210 (29%)
Query: 274 EISSLLSLSHPNIMHFLCGFT--DEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
E+ L H NI+ + K+ +++M+LM DL I P +
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII------HSDQPLTEE 107
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+ Q+ RG++Y+HS + H +L PSN+L+ +I FG++
Sbjct: 108 HIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-------ELRIGDFGMA------ 154
Query: 392 PKSPSQSGTTHPFI--------WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ S S T H + W+ APE+L S +Y+ D++S G I E+
Sbjct: 155 -RGLSSSPTEHKYFMTEYVATRWYRAPELL--------LSLPEYTTAIDMWSVGCIFAEM 205
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFP 472
L G R LFP
Sbjct: 206 L----------------------GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 49/197 (24%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
+ EIS L L HPNI+ E + +LI E +S DL Y+ SLP
Sbjct: 47 IREISLLKELQHPNIVCLQDVLMQESR--LYLIFEFLSMDLKKYLD-----------SLP 93
Query: 332 VA--VDLML------QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+D L QI +G+ + HS+++ H +L P N+L+ +G K++ FG
Sbjct: 94 KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV-------IKLADFG 146
Query: 384 LSSVKNFGPKSPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
L+ + FG P + TH + W+ APEVL + +YS D++S G I
Sbjct: 147 LA--RAFG--IPVRV-YTHEVVTLWYRAPEVL--------LGSPRYSTPVDIWSIGTIFA 193
Query: 441 EILTGKVPFEDAHLQGD 457
E+ T K F GD
Sbjct: 194 EMATKKPLF-----HGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 35/199 (17%)
Query: 268 IEPLVPEISSLLSLS-HPNIMHFLCGFTDE----EKKECFLIMELMS----RDLCSYIKE 318
E + E + L S HPNI F F + + +L+MEL DL +K
Sbjct: 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL---VKG 102
Query: 319 ICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378
+ KR+ +A ++ + RG+ YLH K+ H ++ NILL + K
Sbjct: 103 LRKKGKRLKEEW-IAY-ILRETLRGLAYLHENKVIHRDIKGQNILL-----TKNA--EVK 153
Query: 379 ISGFGLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYS 434
+ FG+S+ + S G + FI W APEV+ +EQ +++ Y +SDV+S
Sbjct: 154 LVDFGVSA------QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDAS----YDARSDVWS 203
Query: 435 FGMICFEILTGKVPFEDAH 453
G+ E+ GK P D H
Sbjct: 204 LGITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 45/195 (23%), Positives = 74/195 (37%), Gaps = 40/195 (20%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKE---CFLIMELMS-RDLCSYIKEICCPRKRI--- 326
E + L HPNI+ L D + F + E + R L R+ +
Sbjct: 28 ETALCARLYHPNIVALL----DSGEAPPGLLFAVFEYVPGRTL----------REVLAAD 73
Query: 327 -PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
LMLQ+ + H++ I H +L P NI++ G HAK+ FG+
Sbjct: 74 GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP----HAKVLDFGIG 129
Query: 386 SV-KNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
++ + T + + APE L + SD+Y++G+I
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR---------GEPVTPNSDLYAWGLIFL 180
Query: 441 EILTGKVPFEDAHLQ 455
E LTG+ + A +
Sbjct: 181 ECLTGQRVVQGASVA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 68/255 (26%), Positives = 101/255 (39%), Gaps = 45/255 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP------ 327
E+ L L PNI+ L G +E C + + + DL ++ K
Sbjct: 69 EVKILSRLKDPNIIRLL-GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 328 -------FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380
S + + LQIA GM+YL S H +L N L+ L KI+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-------ENLTIKIA 180
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
FG+S G Q P W A E + K++ SDV++FG+ +
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI---------LMGKFTTASDVWAFGVTLW 231
Query: 441 EILT--GKVPFEDAHLQGDKMSRNIRAGE------RPLF---PFHSPKYVTNLTKRCWHA 489
EIL + P+ L +++ N AGE R ++ P P+ + L +CW
Sbjct: 232 EILMLCKEQPY--GELTDEQVIEN--AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287
Query: 490 DPNQRPSFSSICRIL 504
D +RPSFS I L
Sbjct: 288 DCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 55/184 (29%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
+ R+P + + V Q+A + YL K + HGN+ NILL G + K+S
Sbjct: 111 KGRVPVAWKITV--AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDP 168
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
G+S F S + P W APE + + S +D +SFG EI
Sbjct: 169 GVS----FTALSREERVERIP--WIAPECVP--------GGNSLSTAADKWSFGTTLLEI 214
Query: 443 -LTGKVPFEDAHLQGDKMSRNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
G+VP L+ S R E+ P S K + L +C +P QRPSF +I
Sbjct: 215 CFDGEVP-----LKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTI 269
Query: 501 CRIL 504
R L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 53/244 (21%)
Query: 233 KSEDYQVRRRLGSG---------SQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSH 283
K E Y +LG G S+ E L + L H G + E+S L +L H
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 284 PNI--MHFLCGFTDEEKKECFLIMELMSRDLCSYIKE----ICCPRKRIPFSLPVAVDLM 337
NI +H + ++ L+ E + DL Y+ + +I M
Sbjct: 63 ANIVTLHDII----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI---------FM 109
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+ RG+ Y H +KI H +L P N+L+ +G K++ FGL+ K+ K+ S
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKG-------ELKLADFGLARAKSVPTKTYSN 162
Query: 398 SGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF------E 450
T +W+ P+VL +++YS D++ G I +E+ TG+ F E
Sbjct: 163 EVVT---LWYRPPDVL--------LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
Query: 451 DAHL 454
+ HL
Sbjct: 212 ELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 39/120 (32%), Positives = 59/120 (49%), Gaps = 20/120 (16%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I G+E++H++ + + +L P+NILL G H +IS GL+ +F K P S
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLAC--DFSKKKPHAS 155
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
TH ++ APEVL Y +D +S G + F++L G PF H DK
Sbjct: 156 VGTHGYM--APEVL--------QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 27/240 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKR 325
++PL EI+ L H NI+ +L +D E + ME + L + ++ P K
Sbjct: 48 YVQPLHEEIALHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ + QI G++YLH +I H ++ N+L+ + G + KIS FG S
Sbjct: 106 ---NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN----TYSGVV--KISDFGTS 156
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
K +P T + APEV+++ + Y +D++S G E+ TG
Sbjct: 157 --KRLAGINPCTETFTGTLQYMAPEVIDKGPR-------GYGAPADIWSLGCTIVEMATG 207
Query: 446 KVPFEDAHLQGDKMSRNIRAG---ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
K PF G+ + + G P P N RC+ DP++R S + +
Sbjct: 208 KPPF---IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 65/244 (26%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME--LMSRDLCSYIKEICCPRKRIPF 328
++ E+ L L HPN + + + E +L+ME L S S I E+ + P
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHT--AWLVMEYCLGS---ASDILEV----HKKPL 112
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ +G+ YLHS + H ++ NILL G K++ FG +S+
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT-------VKLADFGSASL- 164
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
SP+ S P+ W APEV+ ++ +Y K DV+S G+ C E+ K P
Sbjct: 165 ----VSPANSFVGTPY-WMAPEVILAMDE------GQYDGKVDVWSLGITCIELAERKPP 213
Query: 449 FEDAHLQGDKMSR--NIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ MS +I + P L Y N C P RPS S R
Sbjct: 214 L----FNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS-SEELLKHR 268
Query: 506 YIKR 509
++ R
Sbjct: 269 FVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT E F L+ LM DL + +K I F
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF- 122
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ QI RG++Y+HS I H +L PSNI A E KI FGL+ +
Sbjct: 123 ------LVYQILRGLKYIHSAGIIHRDLKPSNI------AVNEDC-ELKILDFGLARHTD 169
Query: 390 FGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ T W+ APE++ + Y++ D++S G I E+LTGK
Sbjct: 170 ---DEMTGYVATR---WYRAPEIM--------LNWMHYNQTVDIWSVGCIMAELLTGKTL 215
Query: 449 F 449
F
Sbjct: 216 F 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 30/179 (16%)
Query: 274 EISSLLSLSHPNI--MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
E S L L H NI +H + KK L+ E + DL Y+ + C S+
Sbjct: 53 EASLLKDLKHANIVTLHDII----HTKKTLTLVFEYLDTDLKQYMDD--CGGG---LSMH 103
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+ Q+ RG+ Y H +++ H +L P N+L+ RG K++ FGL+ K+
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-------ELKLADFGLARAKSVP 156
Query: 392 PKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
K+ S T +W+ P+VL +++YS D++ G I +E+ TG+ F
Sbjct: 157 SKTYSNEVVT---LWYRPPDVL--------LGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 255 LGESFALRHFFGDIEP----LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME-LMS 309
G+ A++ +P ++ EI + L +PNI++FL F + E F++ME L
Sbjct: 43 TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD--ELFVVMEYLAG 100
Query: 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369
L + E C +I + + + +E+LH+ ++ H ++ N+LL G+
Sbjct: 101 GSLTDVVTETCMDEAQI-------AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS 153
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429
K++ FG + P+ +S W APEV+ + Y K
Sbjct: 154 -------VKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV---------TRKAYGPK 195
Query: 430 SDVYSFGMICFEILTGKVPF 449
D++S G++ E++ G+ P+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 29/179 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS L L+HPNI+ L E K +L+ E + DL Y+ P+
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSS----PLTGLDPPLI 101
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ +G+ Y HS ++ H +L P N+L+ GA K++ FGL+ + FG
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA-------LKLADFGLA--RAFG-- 150
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P + TH + W+ APE+L + Q YS D++S G I E++ + F
Sbjct: 151 VPVR-TYTHEVVTLWYRAPEILLGSRQ--------YSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 28/182 (15%)
Query: 274 EISSLLSLSHPNIM---HFLCGFTDEEKKECFLIMELMSRDLCSYIK--EICCPRKRIPF 328
EI L L HP+I+ H + + E K+ +++ ELM DL IK + P F
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF 108
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ Q+ R ++Y+H+ ++H +L P NIL A+ + L KI FGL+ V
Sbjct: 109 --------LYQLLRALKYIHTANVFHRDLKPKNIL-----ANADCKL--KICDFGLARVA 153
Query: 389 -NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
N P + + + APE+ + SKY+ D++S G I E+LTGK
Sbjct: 154 FNDTPTAIFWTDYVATRWYRAPELC-------GSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
Query: 448 PF 449
F
Sbjct: 207 LF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL-SSVKNFGPKSPS 396
L + + + +LH++ + H ++ +ILL G K+S FG + V P+ S
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDG-------RVKLSDFGFCAQVSKEVPRRKS 174
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQ 455
GT P+ W APEV+ S Y + D++S G++ E++ G+ P F + LQ
Sbjct: 175 LVGT--PY-WMAPEVI---------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 456 GDKMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHADPNQR 494
+ IR P SP+ + + R DP QR
Sbjct: 223 A---MKRIRDNLPPKLKNLHKVSPR-LRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 272 VPEISSLLSLSHPNI--MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
+ E+S L L H NI +H + +K L+ E + +DL Y+ + C +
Sbjct: 52 IREVSLLKDLKHANIVTLHDII----HTEKSLTLVFEYLDKDLKQYLDD--CGNS---IN 102
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+ + Q+ RG+ Y H +K+ H +L P N+L+ RG K++ FGL+ K+
Sbjct: 103 MHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-------ELKLADFGLARAKS 155
Query: 390 FGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
K+ S T +W+ P++L ++ YS + D++ G I +E+ TG+
Sbjct: 156 IPTKTYSNEVVT---LWYRPPDIL--------LGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
Query: 449 F 449
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 50/177 (28%), Positives = 72/177 (40%), Gaps = 23/177 (12%)
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
+L + + QIA GM YL S H +L N L+ L KI FG+S
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ-------GLVVKIGDFGMS- 169
Query: 387 VKNFGPKSPSQSG--TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
++ + G T P W PE S K++ +SD++SFG++ +EI T
Sbjct: 170 -RDIYSTDYYRVGGRTMLPIRWMPPE---------SILYRKFTTESDIWSFGVVLWEIFT 219
Query: 445 -GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
GK P+ L + I G P P V + + CW +P QR I
Sbjct: 220 YGKQPW--YQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 45/239 (18%)
Query: 233 KSEDYQVRRRLGSGS---QYKEI-LWLGESFALR----HFFGDIEPLVP--EISSLLSLS 282
K DY++ +LG G+ YK + G AL+ H D P+ EI L L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 283 HPNIMHFLCGFTD------EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336
HPN++ + + ++ +++ M DL ++ + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIKCY 120
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
MLQ+ G+ YLH I H ++ +NIL+ +G L KI+ FGL+ + P +P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILI-----DNQGIL--KIADFGLARPYDGPPPNPK 173
Query: 397 QSGT--THPFI------WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
G T + W+ PE+L +Y+ D++ G + E+ T +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELL--------LGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 63/256 (24%), Positives = 104/256 (40%), Gaps = 40/256 (15%)
Query: 274 EISSLLSLSH-PNIMHFLCGFTDEEK--KEC-FLIMELMSRDLCSYIKEICCPRKRIPFS 329
EIS L LS I+ L EEK K +L+ E + DL ++ R P
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PLP 108
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL-KPRGASTEGYLHAKISGFGLSSVK 388
M Q+ +G+ + H + H +L P N+L+ K +G KI+ GL
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-------LKIADLGLGRAF 161
Query: 389 NFGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
+ KS + T +W+ APEVL ++ YS D++S G I E+ +
Sbjct: 162 SIPVKSYTHEIVT---LWYRAPEVL--------LGSTHYSTPVDIWSVGCIFAEMSRKQP 210
Query: 448 PFE-DAHLQG-DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSI 500
F D+ LQ + + + ++P V+ L R WH P +P + +
Sbjct: 211 LFPGDSELQQLLHIFKLLGTPTEQVWP-----GVSKL--RDWHEFPQWKPQDLSRAVPDL 263
Query: 501 C-RILRYIKRFIMMNP 515
L +++ + +P
Sbjct: 264 SPEGLDLLQKMLRYDP 279
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 46/178 (25%), Positives = 87/178 (48%), Gaps = 25/178 (14%)
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGPKS 394
++ +I +G++YLHS+K H ++ +N+LL G K++ FG++ + + K
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-------EVKLADFGVAGQLTDTQIKR 158
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
+ GT PF W APEV+++ S Y K+D++S G+ E+ G+ P + H
Sbjct: 159 NTFVGT--PF-WMAPEVIKQ---------SAYDSKADIWSLGITAIELAKGEPPHSELHP 206
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR---ILRYIKR 509
K+ I P + K + + C + +P+ RP+ + + I+R+ K+
Sbjct: 207 M--KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 34/174 (19%)
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLML 338
S HP +++ F E+ CF +ME + DL +I FS P AV
Sbjct: 58 SERHPFLVNLFACFQTEDHV-CF-VMEYAAGGDLMMHIHTDV-------FSEPRAVFYAA 108
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+ G++YLH KI + +L N+LL TEG++ KI+ FGL + G ++
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLL-----DTEGFV--KIADFGLCK-EGMGFG--DRT 158
Query: 399 GT---THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
T T F+ APEVL E + Y+ D + G++ +E+L G+ PF
Sbjct: 159 STFCGTPEFL--APEVLTE---------TSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 58/256 (22%), Positives = 93/256 (36%), Gaps = 60/256 (23%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E+ L L H NI++ F K +L+ E + R L ++ P LP
Sbjct: 50 EVKVLRQLRHENIVNLKEAF--RRKGRLYLVFEYVERTLLELLEAS-------PGGLPPD 100
Query: 334 V--DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+ Q+ + + Y HS I H ++ P NIL+ G K+ FG +
Sbjct: 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV-------LKLCDFGFA---RAL 150
Query: 392 PKSPSQSGTTHPFI-WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P+ T + W+ APE+L ++ Y + DV++ G I E+L G+ F
Sbjct: 151 RARPASPLTDYVATRWYRAPELL--------VGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
Query: 450 E-DAHL----------------QGDKMSRNIR-AGER--------PL---FPFHSPKYVT 480
D+ + + S N R AG L +P
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262
Query: 481 NLTKRCWHADPNQRPS 496
+ K C DP +R +
Sbjct: 263 DFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 23/153 (15%)
Query: 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359
E +L ELM DL I R P + + QI G++Y+HS + H +L P
Sbjct: 80 ELYLYEELMEADLHQII------RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKP 133
Query: 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH-PFIWH-APEVLEENEQ 417
N+L+ + + L KI FGL+ + P + T + W+ APE++
Sbjct: 134 GNLLV-----NADCEL--KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM----- 181
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
S Y++ DV+S G I E+L K F+
Sbjct: 182 ---LSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 54/281 (19%)
Query: 235 EDYQVRRRLG---SGSQYKEI-LWLGESFALRHFFGDIEP-----LVPEISSLLSLSHPN 285
+D Q + LG G+ YK L A++ DI ++ E+ L P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 286 IMHFLCGFTDEEKKE-CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
I+ F F E + C M+ S D+ I E V + + + +G+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPE------------HVLGRIAVAVVKGL 108
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
YL S KI H ++ PSN+L+ RG K+ FG+S+ + + + GT
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRG-------QVKLCDFGVST-QLVNSIAKTYVGTN--- 157
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS---- 460
+ APE + S +Y SDV+S G+ E+ G+ P+ +Q ++ S
Sbjct: 158 AYMAPERI---------SGEQYGIHSDVWSLGISFMELALGRFPY--PQIQKNQGSLMPL 206
Query: 461 ---RNIRAGERPLFPFH--SPKYVTNLTKRCWHADPNQRPS 496
+ I + P+ P S K+V +T+ C P +RP+
Sbjct: 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQ-CMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 39/184 (21%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ + ++H NI+ L FT EE ++ +++MELM +LC I ++ +R+ +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-QMELDHERMSY- 130
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G+++LHS I H +L PSNI++K KI FGL+
Sbjct: 131 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------LKILDFGLA---- 173
Query: 390 FGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
++ S P++ + APEV+ Y E D++S G I E++ G
Sbjct: 174 ---RTAGTSFMMTPYVVTRYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMIKG 221
Query: 446 KVPF 449
V F
Sbjct: 222 GVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361
+++ E M DL + +++ P S A M Q+ RG++Y+HS + H +L P+N
Sbjct: 92 YIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 144
Query: 362 ILLKPRGASTEGYLHAKISGFGLSSV--KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTE 419
+ + +TE L KI FGL+ + ++ K G + + +P +L
Sbjct: 145 VFI-----NTED-LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLL------- 190
Query: 420 SASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
S + Y++ D+++ G I E+LTGK F AH
Sbjct: 191 -LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM---SRDLCSYIKEICCPRKR 325
+ ++ E+ L + HPN + + + E +L+ME + DL K+ P +
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHT--AWLVMEYCLGSASDLLEVHKK---PLQE 124
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ + L +G+ YLHS + H ++ NILL G K++ FG +
Sbjct: 125 VEIAAITHGAL-----QGLAYLHSHNMIHRDIKAGNILLTEPG-------QVKLADFGSA 172
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
S+ SP+ S P+ W APEV+ ++ +Y K DV+S G+ C E+
Sbjct: 173 SI-----ASPANSFVGTPY-WMAPEVILAMDE------GQYDGKVDVWSLGITCIELAER 220
Query: 446 KVPFEDAHLQGDKMSR--NIRAGERPLFPFHS-PKYVTNLTKRCWHADPNQRPS 496
K P + MS +I E P + Y N C P RP+
Sbjct: 221 KPPL----FNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 39/184 (21%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ + ++H NI+ L FT EE ++ +L+MELM +LC I ++ +R+ +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMELDHERMSY- 123
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G+++LHS I H +L PSNI++K KI FGL+
Sbjct: 124 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------LKILDFGLA---- 166
Query: 390 FGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
++ S P++ + APEV+ Y E D++S G I E++
Sbjct: 167 ---RTAGTSFMMTPYVVTRYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMVRH 214
Query: 446 KVPF 449
K+ F
Sbjct: 215 KILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E+ L + H I+ F ++K LIME S DL IK+ ++ +PF
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRL--KEHLPFQEYE 170
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
L QI ++ +HS+K+ H +L +NI L P G K+ FG S K +
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-------IKLGDFGFS--KQYSD 221
Query: 393 KSPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
++ P+ + APE+ E +YS+K+D++S G+I +E+LT PF
Sbjct: 222 SVSLDVASSFCGTPY-YLAPELWERK---------RYSKKADMWSLGVILYELLTLHRPF 271
Query: 450 E 450
+
Sbjct: 272 K 272
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 32/157 (20%)
Query: 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVD----LMLQIARGMEYLHSKKIYH 354
+E +++ ELM DL K I P+ P++ D + QI RG++YLHS I H
Sbjct: 77 EEIYVVTELMQSDLH---KIIVSPQ-------PLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP-KSPSQSGTTHPFIWHAPEVLE 413
++ P N+L+ KI FGL+ V+ K +Q T + APE+L
Sbjct: 127 RDIKPGNLLVNSN-------CVLKICDFGLARVEEPDESKHMTQEVVTQ--YYRAPEIL- 176
Query: 414 ENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
+ Y+ D++S G I E+L ++ F+
Sbjct: 177 -------MGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 64/238 (26%)
Query: 237 YQVRRRLGSGSQYKEILW------LGESFALRHFFG------DIEPLVPEISSLLSLS-H 283
Y++ ++LG G+ Y I+W E AL+ F D + EI L L H
Sbjct: 9 YEILQKLGKGA-YG-IVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIK-----EICCPRKRIPFSLPVAVDLML 338
PNI+ L E K+ +L+ E M DL + I+ ++ KR +M
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV---HKRY---------IMY 114
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
Q+ + ++Y+HS + H +L PSNILL +++ K++ FGL+ +S S+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILL-----NSD--CRVKLADFGLA-------RSLSEL 160
Query: 399 GTTHPFI---------WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
W+ APE+L +++Y++ D++S G I E+L GK
Sbjct: 161 EENPENPVLTDYVATRWYRAPEIL--------LGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 33/189 (17%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDE--------EKKECFLIMELMSRDLCSYIKEICCPR 323
+ EI L L+H NI++ TD+ +K +L+ E M DL ++
Sbjct: 54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES----- 108
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+ FS M Q+ G+ Y H K H ++ SNILL +G K++ FG
Sbjct: 109 GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-------QIKLADFG 161
Query: 384 LSSVKNFGPKSPSQSGTTHPFI--WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
L+ + N P T+ I W+ P L E+ +Y DV+S G I E
Sbjct: 162 LARLYNSEESRP----YTNKVITLWYRPPELLLGEE-------RYGPAIDVWSCGCILGE 210
Query: 442 ILTGKVPFE 450
+ T K F+
Sbjct: 211 LFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 38/123 (30%), Positives = 61/123 (49%), Gaps = 18/123 (14%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F P AV +IA G+ +LHSK I + +L N++L G H KI+ FG+
Sbjct: 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-------HIKIADFGMCKE 150
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
FG K+ T +I APE++ + Y + D ++FG++ +E+L G+
Sbjct: 151 NIFGGKTTRTFCGTPDYI--APEII---------AYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 448 PFE 450
PF+
Sbjct: 200 PFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 28/182 (15%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIP 327
E ++ EI + HPNI+++L + + E +++ME L L + E C +I
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQI- 117
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
AV + + +E+LHS ++ H ++ NILL G+ K++ FG +
Sbjct: 118 ----AAV--CRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-------VKLTDFGFCA- 163
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
P+ +S W APEV+ + Y K D++S G++ E++ G+
Sbjct: 164 -QITPEQSKRSTMVGTPYWMAPEVV---------TRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 448 PF 449
P+
Sbjct: 214 PY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 66/249 (26%), Positives = 99/249 (39%), Gaps = 38/249 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSY-----IKEICCPRKRIP- 327
EI + L +PNI+ L ++ C + + + DL + I+ IP
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
S+ + + +QIA GM+YL S H +L N L+ + KI+ FG+S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-------GNHYTIKIADFGMSRN 178
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI----- 442
G Q P W A ES K++ SDV++FG+ +E+
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMA---------WESILLGKFTTASDVWAFGVTLWEMFTLCK 229
Query: 443 ------LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
L+ + E+ R I + PL P SP V L RCW D RP+
Sbjct: 230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP--SP--VFKLMMRCWSRDIKDRPT 285
Query: 497 FSSICRILR 505
F+ I LR
Sbjct: 286 FNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 36/243 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++ L EI L +L H I+ + D +K + ME M +K+ +
Sbjct: 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPG---GSVKDQL--KAYG 101
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG--- 383
+ V QI GM YLHS I H ++ +NIL G + K+ FG
Sbjct: 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-------NVKLGDFGASK 154
Query: 384 -LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
L ++ G S +GT + W +PEV+ S Y K+DV+S G E+
Sbjct: 155 RLQTICMSGTGIRSVTGTPY---WMSPEVI---------SGEGYGRKADVWSLGCTVVEM 202
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
LT K P+ + + M+ + +P P H ++ + C + RPS
Sbjct: 203 LTEKPPWAEY----EAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257
Query: 500 ICR 502
+ R
Sbjct: 258 LLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 17/181 (9%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIK-EICCPRKRIPFSLPV 332
EI+ L L HPN++ F ++ +L+ + DL IK + P LP
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 333 AV--DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
++ L+ QI G+ YLH+ + H +L P+NIL+ G KI+ G + + N
Sbjct: 108 SMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG---RVKIADMGFARLFN- 163
Query: 391 GPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
P P F + APE+L Y++ D+++ G I E+LT +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELL--------LGARHYTKAIDIWAIGCIFAELLTSEPI 215
Query: 449 F 449
F
Sbjct: 216 F 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 256 GESFALRHFFGDIE-------PLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308
G+ +A++ F GD E EI+ L L H N++ + F + K +L+ +
Sbjct: 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86
Query: 309 SRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL---- 364
DL IK KR+ + L+ QI G+ YLHS + H +L P+NIL+
Sbjct: 87 EHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG 145
Query: 365 KPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWH-APEVLEENEQTESASN 423
RG KI GL+ + N K + IW+ APE+L
Sbjct: 146 PERGV-------VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL---------LG 189
Query: 424 SK-YSEKSDVYSFGMICFEILTGKVPF 449
++ Y++ D+++ G I E+LT + F
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEI-CCPRKRIPFSL--PVAVDLMLQI 340
P I+ F G E +C++ MELM L + K + + IP + +AV
Sbjct: 63 PYIVKFY-GALFREG-DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAV----AT 116
Query: 341 ARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-----SVKNFGPKS 394
+ + YL + KI H ++ PSNILL G + K+ FG+S S+ +
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNG-------NIKLCDFGISGQLVDSI------A 163
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
++ P++ APE ++ + + Y +SDV+S G+ +E+ TGK P+ +
Sbjct: 164 KTRDAGCRPYM--APERIDPS------ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYV-----TNLTKRCWHADPNQRPSFSSI 500
D++++ ++ G+ P+ +S + N C D ++RP + +
Sbjct: 216 VFDQLTQVVK-GDPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 17/181 (9%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIK-EICCPRKRIPFSLPV 332
EI+ L L HPN++ F ++ +L+ + DL IK + P LP
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 333 AV--DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ L+ QI G+ YLH+ + H +L P+NIL+ G KI+ G + + N
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG---RVKIADMGFARLFN- 163
Query: 391 GPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
P P F + APE+L Y++ D+++ G I E+LT +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELL--------LGARHYTKAIDIWAIGCIFAELLTSEPI 215
Query: 449 F 449
F
Sbjct: 216 F 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 47/163 (28%)
Query: 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVD----LMLQIARGMEYLHSKKIYH 354
+ +++ ELM DL I+ S ++ D + Q+ RG++Y+HS + H
Sbjct: 82 NDVYIVYELMDTDLHQIIRS----------SQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131
Query: 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI--------W 406
+L PSN+LL A+ + KI FGL+ + F+ +
Sbjct: 132 RDLKPSNLLLN---ANCD----LKICDFGLARTTS----------EKGDFMTEYVVTRWY 174
Query: 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
APE+L + S+Y+ DV+S G I E+L K F
Sbjct: 175 RAPELL--------LNCSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 69/269 (25%), Positives = 104/269 (38%), Gaps = 76/269 (28%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR----DLCSYIKEICCPRKRIPFS 329
EI L L H N+++ + F KK +L+ E + DL Y + R R
Sbjct: 50 EIRMLKQLRHENLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR---- 103
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+ QI RG+E+ HS I H ++ P NIL+ G K+ FG +
Sbjct: 104 -----KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV-------VKLCDFGFARTLA 151
Query: 390 FGPKSPSQSGTTHPFI-WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
+P + T + W+ APE+L ++KY D+++ G + E+LTG
Sbjct: 152 ----APGEVYTDYVATRWYRAPELL--------VGDTKYGRAVDIWAVGCLVTEMLTG-- 197
Query: 448 PFEDAHLQGDK----------------------MSRN-IRAGER--------PL---FPF 473
+ GD +N + AG R PL FP
Sbjct: 198 ---EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK 254
Query: 474 HSPKYVTNLTKRCWHADPNQRPSFSSICR 502
S V +L K+C DP+ RPS S +
Sbjct: 255 LSG-LVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 279 LSLSH--PNIMH-FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPR--KRI--PFSLP 331
+ SH P I+ + TD + C MELMS C + KRI P
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFIC---MELMS---------TCLDKLLKRIQGPIPED 114
Query: 332 VAVDLMLQIARGMEYLHSKK-IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ + + I + + YL K + H ++ PSNILL G + K+ FG+S +
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-------NVKLCDFGISG-RLV 166
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
K+ ++S ++ APE ++ + N KY ++DV+S G+ E+ TG+ P++
Sbjct: 167 DSKAKTRSAGCAAYM--APERIDPPD-----PNPKYDIRADVWSLGISLVELATGQFPYK 219
Query: 451 DAHLQGDKMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHADPNQRPSF 497
+ + + +++ I E P P + SP + + C D +RP +
Sbjct: 220 NCKTEFEVLTK-ILQEEPPSLPPNEGFSPDFC-SFVDLCLTKDHRKRPKY 267
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 19/172 (11%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
QIA GM YL S+ H +L N L+ L KI FG+S
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457
T P W PE S K++ +SDV+S G++ +EI T GK P+ L +
Sbjct: 181 HTMLPIRWMPPE---------SIMYRKFTTESDVWSLGVVLWEIFTYGKQPW--YQLSNN 229
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
++ I G P PK V +L CW +P+ R + I +L+ + +
Sbjct: 230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 40/247 (16%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM---SRDLCSYIKEICCPRKR 325
+ ++ E+ L L HPN + + + E +L+ME + DL K+ P +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKK---PLQE 114
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ + L +G+ YLHS + H ++ NILL G K+ FG +
Sbjct: 115 VEIAAVTHGAL-----QGLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDFGSA 162
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
S+ +P+ P+ W APEV+ ++ +Y K DV+S G+ C E+
Sbjct: 163 SI-----MAPANXFVGTPY-WMAPEVILAMDE------GQYDGKVDVWSLGITCIELAER 210
Query: 446 KVPFEDAHLQGDKMSR--NIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICR 502
K P + MS +I E P H +Y N C P RP+ S +
Sbjct: 211 KPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVLL 265
Query: 503 ILRYIKR 509
R++ R
Sbjct: 266 KHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 241 RRLGSGSQ---YKEILWL-GESFALRHFFGDIEPLVP-----EISSLLSLSHPNIMHFLC 291
+LG GS YK I + G+ AL+ E VP E S L L H NI+ L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV--LL 68
Query: 292 GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK 351
K+ + E M DL Y+ + P P+++ + M Q+ RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQ--HPGGLHPYNVRL---FMFQLLRGLAYIHGQH 123
Query: 352 IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF-IWH-AP 409
I H +L P N+L+ G K++ FGL+ K+ PSQ+ ++ +W+ P
Sbjct: 124 ILHRDLKPQNLLISYLG-------ELKLADFGLARAKSI----PSQTYSSEVVTLWYRPP 172
Query: 410 EVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+VL + YS D++ G I E+L G+ F
Sbjct: 173 DVL--------LGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 71/212 (33%)
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG-LSSVKNFGPKS------ 394
RG+ YLH H N+ S+IL+ G + +SG L S+ G K+
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVS-------LSGLSHLYSLVRNGQKAKVVYDF 164
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
P S + P W +PE+L ++ Y+ KSD+YS G+ E+ TG+VPF+D
Sbjct: 165 PQFSTSVLP--WLSPELLRQDL-------YGYNVKSDIYSVGITACELATGRVPFQDMLR 215
Query: 455 ----------------------QGDKMSRNIRAG--------------------ERPLFP 472
+ +N ++G ER P
Sbjct: 216 TQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP 275
Query: 473 FHSPKYVT----NLTKRCWHADPNQRPSFSSI 500
S K + NL + C DP +RPS SS+
Sbjct: 276 --SSKTFSPAFQNLVELCLQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-KNFGP 392
V+ +QIA ++YLH K I H +L N+ L K+ G++ V +N
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-------IKVGDLGIARVLENQCD 157
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
+ + GT + + +PE+ SN Y+ KSDV++ G +E+ T K F
Sbjct: 158 MASTLIGTPY---YMSPELF---------SNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+ + + I G+ P P + L P +RPS SI R
Sbjct: 206 DM--NSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 286 IMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
I+ F + K + L+M +M+ DL +I + + F P A QI G+
Sbjct: 55 IVSLAYAF--QTKTDLCLVMTIMNGGDLRYHIYNV--DEENPGFPEPRACFYTAQIISGL 110
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGPKSPSQSGTTHP 403
E+LH ++I + +L P N+LL G + +IS GL+ +K+ K+ +GT
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDG-------NVRISDLGLAVELKDGQSKTKGYAGTPG- 162
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ APE+L+ E Y D ++ G+ +E++ + PF
Sbjct: 163 --FMAPELLQGEE---------YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 30/193 (15%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL- 330
+ E S L L H NI+ L K+ L+ E + DLC Y+ + P L
Sbjct: 51 IREASLLKGLKHANIV--LLHDIIHTKETLTLVFEYVHTDLCQYMD-------KHPGGLH 101
Query: 331 PVAVDLML-QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
P V L L Q+ RG+ Y+H + I H +L P N+L+ G K++ FGL+ K+
Sbjct: 102 PENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-------ELKLADFGLARAKS 154
Query: 390 FGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ S T +W+ P+VL +++YS D++ G I E++ G
Sbjct: 155 VPSHTYSNEVVT---LWYRPPDVL--------LGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
Query: 449 FEDAHLQGDKMSR 461
F D++ R
Sbjct: 204 FPGMKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 18/118 (15%)
Query: 274 EISSLLSLSHPNIMHFL--C----GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
EI L L H N+++ + C + K +L+ E DL + K +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-----KNVK 115
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
F+L +M + G+ Y+H KI H ++ +NIL+ + +G L K++ FGL+
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI-----TKDGIL--KLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 269 EPLVPEISSLLSLS-HPNIMHFLCGFTDEEK---KECFLIMELMSR-DLCSYIKEICCPR 323
E + E + L SL HPN++ F F +K + +L++EL + + +K +
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+R+ + ++ G+++LH+ +I H ++ +NILL G K+ FG
Sbjct: 123 QRL--DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFG 173
Query: 384 LSS-VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+S+ + + + + GT PF W APEV+ +Q + + Y + DV+S G+ E+
Sbjct: 174 VSAQLTSTRLRRNTSVGT--PF-WMAPEVIACEQQYDYS----YDARCDVWSLGITAIEL 226
Query: 443 LTGKVPFEDAH 453
G P D H
Sbjct: 227 GDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 49/212 (23%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 244 GSGSQYKEI-LWLGESFALRHFFGDIEP----LVPEISSLLSLSHPNIMHFLCGFTDEEK 298
SG+ Y + + G+ A+R +P ++ EI + +PNI+++L + +
Sbjct: 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD- 90
Query: 299 KECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357
E +++ME L L + E C +I + + + +E+LHS ++ H ++
Sbjct: 91 -ELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHSNQVIHRDI 142
Query: 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQ 417
NILL G+ K++ FG + P+ +S W APEV+
Sbjct: 143 KSDNILLGMDGS-------VKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV----- 188
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ Y K D++S G++ E++ G+ P+
Sbjct: 189 ----TRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 41/239 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I+ +E+LH + I + +L P NILL +G H K++ FGL +S +
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQG-------HVKLTDFGLCK------ESIHEG 154
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
TH F + APE+L S + + D +S G + +++LTG PF +
Sbjct: 155 TVTHTFCGTIEYMAPEIL---------MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR 205
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR----PSFSSICRILRYIKRF 510
+ K I G+ L P+ +P+ +L K+ +P+ R P ++ + + R
Sbjct: 206 K--KTIDKILKGKLNLPPYLTPE-ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF-RH 261
Query: 511 IMMNPHYNSQPDPPM-PLV----DYSDIESRLLRKFP--SWETHNVLPISEIPFQMFVY 562
+ + + +PP PL+ D S +S+ R+ P S + + + F F Y
Sbjct: 262 VNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 267 DIEPLVPEISSL-LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRK 324
D+E + E L L+ +HP + C F ++ F +ME ++ DL +I++ R
Sbjct: 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDR--LFFVMEFVNGGDLMFHIQK--SRR- 92
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
F A +I + +LH K I + +L N+LL G H K++ FG+
Sbjct: 93 ---FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-------HCKLADFGM 142
Query: 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
F K+ S T +I APE+L+E Y D ++ G++ +E+L
Sbjct: 143 CKEGIFNGKTTSTFCGTPDYI--APEILQE---------MLYGPSVDWWAMGVLLYEMLC 191
Query: 445 GKVPFE 450
G PFE
Sbjct: 192 GHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 36/243 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++ L EI L +L H I+ + D ++ + ME M IK+ +
Sbjct: 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPG---GSIKDQL--KSYG 101
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG--- 383
+ V QI G+ YLHS I H ++ +NIL G + K+ FG
Sbjct: 102 ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-------NVKLGDFGASK 154
Query: 384 -LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
L ++ G S +GT + W +PEV+ S Y K+D++S G E+
Sbjct: 155 RLQTICLSGTGMKSVTGTPY---WMSPEVI---------SGEGYGRKADIWSVGCTVVEM 202
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGER---PLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
LT K P+ + + M+ + + P+ P H + + KR + + RPS
Sbjct: 203 LTEKPPWAEF----EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADE 257
Query: 500 ICR 502
+ R
Sbjct: 258 LLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 31/180 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT EE + +L+ LM DL + +K + F
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 124
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ QI RG++Y+HS I H +L PSN+ + KI FGL+
Sbjct: 125 ------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED-------CELKILDFGLAR--- 168
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+G + APE++ + Y++ D++S G I E+LTG+ F
Sbjct: 169 --HTDDEMTGYVATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 31/181 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT + + F L+M M DL +K RI F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF- 122
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ +G++Y+H+ I H +L P N+ + KI FGL+ +
Sbjct: 123 ------LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-------CELKILDFGLARQTD 169
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+G + APEV+ + Y++ D++S G I E+LTGK F
Sbjct: 170 -----SEMTGYVVTRWYRAPEVI--------LNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 450 E 450
+
Sbjct: 217 K 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 69/283 (24%), Positives = 111/283 (39%), Gaps = 77/283 (27%)
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDL 336
+HPNI+ + F + E +++ M+ +DL IC L +A +
Sbjct: 56 FNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL------ICTHFMDGMSELAIAY-I 106
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS----GFGLSSVKNFGP 392
+ + + ++Y+H H ++ S+IL+ G L + +S G L V +F
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF-- 164
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED- 451
P S P W +PEVL++N Q Y KSD+YS G+ E+ G VPF+D
Sbjct: 165 --PKYSVKVLP--WLSPEVLQQNLQ-------GYDAKSDIYSVGITACELANGHVPFKDM 213
Query: 452 -------AHLQGD-----------------KMSR--------------NIRA--GERPLF 471
L G K SR R GE
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273
Query: 472 PFH---SPKYVTNLTKRCWHADPNQRPSFSSICR--ILRYIKR 509
P++ SP + + ++C +P+ RPS S++ + IKR
Sbjct: 274 PYNRTFSPHF-HHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 65/248 (26%), Positives = 98/248 (39%), Gaps = 39/248 (15%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYI-----KEICCPRKR 325
EI + L PNI+ L C +D +I E M DL ++ +E
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ S + + QIA GM+YL S H +L N L+ KI+ FG+S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT-------IKIADFGMS 177
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
G Q P W + ES K++ SDV++FG+ +EILT
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMS---------WESILLGKFTTASDVWAFGVTLWEILTL 228
Query: 445 -GKVPFEDAHLQGDKMSRN----IRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPS 496
+ P+ + L +++ N R R ++ P P + L CW + +RPS
Sbjct: 229 CKEQPY--SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286
Query: 497 FSSICRIL 504
F I L
Sbjct: 287 FQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP----KS 394
+I +++LH I + ++ NILL G H ++ FGLS K F ++
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEG-------HVVLTDFGLS--KEFLAEEEERA 163
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDA 452
S GT + APEV+ + + D +S G++ FE+LTG PF +
Sbjct: 164 YSFCGTIE---YMAPEVIRGGS-------GGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++SR I +P FP + ++ DP +R
Sbjct: 214 QNSQSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 40/269 (14%)
Query: 241 RRLGSGSQ---YKEILW-LGESFALRHFFGDIEPLV-----PEISSLLSLSHPNIMHFLC 291
R+GSG+ YK I G +AL+ +G+ E V EI L ++HPN++ C
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--C 137
Query: 292 GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK 351
+ E +++E M I +A D+ QI G+ YLH +
Sbjct: 138 HDMFDHNGEIQVLLEFMDGG--------SLEGTHIADEQFLA-DVARQILSGIAYLHRRH 188
Query: 352 IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS--GTTHPFIWHAP 409
I H ++ PSN+L+ + KI+ FG+S + P S GT + +P
Sbjct: 189 IVHRDIKPSNLLINSAK-------NVKIADFGVSRILA-QTMDPCNSSVGT---IAYMSP 237
Query: 410 EVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR--NIRAGE 467
E + N + Y+ D++S G+ E G+ PF QGD S I +
Sbjct: 238 ERI--NTDLNHGAYDGYA--GDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQ 292
Query: 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
P P + + + C +P +R S
Sbjct: 293 PPEAPATASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 31/180 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT E E +L+ LM DL + +K + + F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF- 122
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ RG++Y+HS I H +L PSN+ A E +I FGL+ +
Sbjct: 123 ------LIYQLLRGLKYIHSAGIIHRDLKPSNV------AVNED-CELRILDFGLARQAD 169
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+G + APE++ + Y++ D++S G I E+L GK F
Sbjct: 170 -----DEMTGYVATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F AV +I G+E LH ++I + +L P NILL G H +IS GL+
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-------HIRISDLGLAV- 150
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
P+ + G + APEV++ N +Y+ D ++ G + +E++ G+
Sbjct: 151 --HVPEGQTIKGRVGTVGYMAPEVVK---------NERYTFSPDWWALGCLLYEMIAGQS 199
Query: 448 PFED--AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
PF+ ++ +++ R ++ + SP +L K DP +R
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPD-ARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 27/188 (14%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
L +++HP+++ T +++ S DL +Y+ ++ P + A+ +
Sbjct: 111 LQNVNHPSVIRMKD--TLVSGAITCMVLPHYSSDLYTYLT-----KRSRPLPIDQALIIE 163
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
QI G+ YLH+++I H ++ NI + I G + P
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI-------NDVDQVCIGDLGAAQFPVVAPAFLGL 216
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
+GT +APEVL + KY+ K+D++S G++ FE+L FED
Sbjct: 217 AGTVET---NAPEVL---------ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264
Query: 457 DKMSRNIR 464
++ ++
Sbjct: 265 EEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 19/112 (16%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I G+E LH ++I + +L P NILL G H +IS GL+ G +
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYG-------HIRISDLGLAVEIPEGETIRGRV 162
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
GT + APEV++ N +Y+ D + G + +E++ GK PF
Sbjct: 163 GTVG---YMAPEVVK---------NERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 53/193 (27%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++E + EI L + +HP I+ L F + K ++++E CP
Sbjct: 52 ELEDYMVEIEILATCNHPYIVKLLGAFYWDGK--LWIMIEF-------------CPGG-- 94
Query: 327 PFSLPVAVD-LMLQIARGME----------------YLHSKKIYHGNLNPSNILLKPRGA 369
AVD +ML++ RG+ YLHS KI H +L N+LL G
Sbjct: 95 ------AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG- 147
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429
K++ FG+S+ KN S P+ W APEV+ E+ ++ Y K
Sbjct: 148 ------DIKLADFGVSA-KNVKTLQRRDSFIGTPY-WMAPEVV----MCETMKDTPYDYK 195
Query: 430 SDVYSFGMICFEI 442
+D++S G+ E+
Sbjct: 196 ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 32/174 (18%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL-HAKISGFGLSSVKNFGPKSPSQ 397
Q+A + +L K + HGN+ N+LL G K+S G+S +
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS------ITVLPK 161
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
W PE +E + A +D +SFG +EI +G GD
Sbjct: 162 EILLERIPWVPPECIENPQNLSLA--------ADKWSFGTTLWEIFSG----------GD 203
Query: 458 KMSRNIRAGERPLF-----PFHSPKY--VTNLTKRCWHADPNQRPSFSSICRIL 504
K + + ++ F +PK+ + NL +C +P+ RPSF +I R L
Sbjct: 204 KPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 63/258 (24%), Positives = 101/258 (39%), Gaps = 69/258 (26%)
Query: 274 EISSLLSLSHPNIMHF--LCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSL 330
EI+ + L HPNI+ LC +K +LI E + ++L ++ + R+R
Sbjct: 733 EIADMGKLQHPNIVKLIGLC----RSEKGAYLIHEYIEGKNLSEVLRNLSWERRR----- 783
Query: 331 PVAVDLMLQIARGMEYLH---SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
+ + IA+ + +LH S + GNL+P I++ E +L + G +
Sbjct: 784 ----KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLRLSLPGLLCTDT 836
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
K F + + APE E + TE KSD+Y FG+I E+LTGK
Sbjct: 837 KCFISSA-----------YVAPETRETKDITE---------KSDIYGFGLILIELLTGKS 876
Query: 448 P------------------FEDAHLQG--DKM-SRNIRAGERPLFPFHSPKYVTNLTKRC 486
P + D HL D ++ + + V NL C
Sbjct: 877 PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV------EVMNLALHC 930
Query: 487 WHADPNQRPSFSSICRIL 504
DP RP + + + L
Sbjct: 931 TATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 32/184 (17%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM---SRDLCSYIKEICCPRKR 325
+ ++ E+ L L HPN + + + E +L+ME + DL K+ P +
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHT--AWLVMEYCLGSASDLLEVHKK---PLQE 120
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ + L +G+ YLHS + H ++ NILL G K++ FG +
Sbjct: 121 VEIAAITHGAL-----QGLAYLHSHNMIHRDIKAGNILLTEPG-------QVKLADFGSA 168
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
S SP+ S P+ W APEV+ ++ +Y K DV+S G+ C E+
Sbjct: 169 SK-----SSPANSFVGTPY-WMAPEVILAMDE------GQYDGKVDVWSLGITCIELAER 216
Query: 446 KVPF 449
K P
Sbjct: 217 KPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 42/182 (23%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIP 327
E ++ EI + +PNI+++L + + E +++ME L L + E C +I
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQI- 117
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
+ + + +++LHS ++ H ++ NILL G+ K++ FG +
Sbjct: 118 ------AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS-------VKLTDFGFCA- 163
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
P+ +S W APEV+ + Y K D++S G++ E++ G+
Sbjct: 164 -QITPEQSKRSTMVGTPYWMAPEVV---------TRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 448 PF 449
P+
Sbjct: 214 PY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 24/157 (15%)
Query: 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYH 354
E K L+M LM+ DL +I + + + QI G+ +LHS I +
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNV----GERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEE 414
++ P N+LL +G + ++S GL +V+ K+ +Q T+ ++ APE+L+E
Sbjct: 119 RDMKPENVLLDDQG-------NCRLSDLGL-AVELKDGKTITQRAGTNGYM--APEILKE 168
Query: 415 NEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
YS D ++ G +E++ G+ PF+D
Sbjct: 169 ---------EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 48/191 (25%), Positives = 71/191 (37%), Gaps = 35/191 (18%)
Query: 258 SFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIK 317
S ALR EI L L H NI+ + K+ L+ E +DL Y
Sbjct: 44 SSALR-----------EICLLKELKHKNIVRLYDVLHSD--KKLTLVFEYCDQDLKKYFD 90
Query: 318 EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377
C P + M Q+ +G+ + HS + H +L P N+L+ G
Sbjct: 91 S--CNGDIDP---EIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-------EL 138
Query: 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437
K++ FGL+ + FG S + P+VL YS D++S G
Sbjct: 139 KLADFGLA--RAFGIPVRCYSAEVVTLWYRPPDVL--------FGAKLYSTSIDMWSAGC 188
Query: 438 ICFEILTGKVP 448
I E+ P
Sbjct: 189 IFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++E + EI L S HPNI+ L F E ++++E + + + +R
Sbjct: 45 ELEDYMVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAG---GAVDAVMLELER- 98
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
P + P + Q + YLH KI H +L NIL G K++ FG+S+
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-------DIKLADFGVSA 151
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
KN S P+ W APEV+ E++ + Y K+DV+S G+ E+
Sbjct: 152 -KNTRTIQRRDSFIGTPY-WMAPEVV----MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 20/112 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSPSQ 397
+I + YLHS + + +L N++L G H KI+ FGL + G +
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDG-------HIKITDFGLCKEGISDGATMKTF 155
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
GT + APEVLE+N+ Y D + G++ +E++ G++PF
Sbjct: 156 CGTPE---YLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 292 GFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK 350
+ E K L++ +M+ DL +I + P F A+ ++ G+E L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAAELCCGLEDLQRE 121
Query: 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPE 410
+I + +L P NILL RG H +IS GL+ G + GT + APE
Sbjct: 122 RIVYRDLKPENILLDDRG-------HIRISDLGLAVQIPEGETVRGRVGTVG---YMAPE 171
Query: 411 VLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE--DAHLQGDKMSRNIRAGE 467
V+ N KY+ D + G + +E++ G+ PF ++ +++ R ++ +
Sbjct: 172 VIN---------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 82/331 (24%), Positives = 137/331 (41%), Gaps = 58/331 (17%)
Query: 234 SEDYQVRRRLGSGS---QYKEI-LWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHF 289
++ Y++ +G+GS Y+ I + E A++ D + E+ + +L+H NI+
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFL 124
Query: 290 LCGFTDE----EKKECFL--IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM-LQIAR 342
+ E +K FL +ME + + + Y+K +P L V L Q+ R
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL---VKLYSYQLCR 181
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
+ Y+HSK I H +L P N+L+ P + K+ FG S KN S S
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTL------KLCDFG--SAKNLLAGQRSVSYICS 233
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
F + APE++ + Y+ D++S G I E++ G P D++ R
Sbjct: 234 RF-YRAPELM--------LGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRI 283
Query: 463 IRAGERPL---------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY- 506
I+ P FP PK +L K P+ +F I + L+Y
Sbjct: 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINF--ISQFLKYE 338
Query: 507 -IKRF----IMMNPHYNSQPDPPMPLVDYSD 532
+KR + +P ++ DP + L Y D
Sbjct: 339 PLKRLNPIEALADPFFDDLRDPCIKLPKYID 369
|
Length = 440 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 50/245 (20%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLGESFALRH----------FFGDIEPLVPEISSLL-- 279
+K+EDY V + +G G+ GE +RH E + S+
Sbjct: 40 MKAEDYDVVKVIGRGA-------FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 280 ------SLSHPNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPV 332
+ P ++ C F D+ K +++ME M DL + + P K F
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF---- 146
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFG 391
++ ++ +HS + H ++ P N+LL G H K++ FG + G
Sbjct: 147 ---YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-------HLKLADFGTCMKMDETG 196
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
+ T +I +PEVL+ + Y + D +S G+ FE+L G PF
Sbjct: 197 MVRCDTAVGTPDYI--SPEVLKSQ-----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249
Query: 452 AHLQG 456
L G
Sbjct: 250 DSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 33/165 (20%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF----GPKS 394
+I +E+LH I + ++ NILL G H ++ FGLS K F ++
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEG-------HVVLTDFGLS--KEFLSEEKERT 163
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
S GT + APE++ + + D +S G++ FE+LTG PF L
Sbjct: 164 YSFCGTIE---YMAPEIIR--------GKGGHGKAVDWWSLGILIFELLTGASPFT---L 209
Query: 455 QGDK-----MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+G++ +SR I + P F P+ +L + DP +R
Sbjct: 210 EGERNTQSEVSRRILKCDPPFPSFIGPE-AQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 18/123 (14%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F P AV +IA G+ +LHSK I + +L N++L G H KI+ FG+
Sbjct: 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-------HIKIADFGMCKE 150
Query: 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
+ + T +I APE++ + Y + D ++FG++ +E+L G+
Sbjct: 151 NMWDGVTTKTFCGTPDYI--APEII---------AYQPYGKSVDWWAFGVLLYEMLAGQA 199
Query: 448 PFE 450
PFE
Sbjct: 200 PFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 52/188 (27%)
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLML--Q 339
+P ++ C F E K+ ++ME + D + +K I +LPV + M +
Sbjct: 60 NPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIG--------ALPVDMARMYFAE 109
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV------------ 387
+EYLH+ I H +L P N+L+ G H K++ FGLS +
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMG-------HIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 388 ------KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
+ F K Q T +I APEV+ Y + D ++ G+I +E
Sbjct: 163 HIEKDTREFLDK---QVCGTPEYI--APEVILRQ---------GYGKPVDWWAMGIILYE 208
Query: 442 ILTGKVPF 449
L G VPF
Sbjct: 209 FLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 26/115 (22%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I +EYLHS+ + + ++ N++L G H KI+ FGL + S
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITDFGLCK------EGISDG 149
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
T F + APEVLE+N+ Y D + G++ +E++ G++PF
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 28/179 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS L + H NI+ L EK+ +L+ E + DL ++ P + +
Sbjct: 51 EISLLKEMQHGNIVR-LQDVVHSEKR-LYLVFEYLDLDLKKHMDS--SPD--FAKNPRLI 104
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ QI RG+ Y HS ++ H +L P N+L+ R + K++ FGL+ + FG
Sbjct: 105 KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL------KLADFGLA--RAFG-- 154
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P ++ TH + W+ APE+L + YS D++S G I E++ K F
Sbjct: 155 IPVRT-FTHEVVTLWYRAPEIL--------LGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 21/119 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I RG+ +LH K+ H ++ N+LL K+ FG+S+ +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENA-------EVKLVDFGVSA------QLDRTV 165
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
G + FI W APEV+ +E ++ Y KSD++S G+ E+ G P D H
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDAT----YDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 27/128 (21%)
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+E+LH I + +L P NILL G H + FGLS + + + TT+
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATG-------HIALCDFGLSKA------NLTDNKTTNT 155
Query: 404 FI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
F + APEVL + + Y++ D +S G++ FE+ G PF Q +M
Sbjct: 156 FCGTTEYLAPEVLLDEK--------GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QM 205
Query: 460 SRNIRAGE 467
RNI G+
Sbjct: 206 YRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 26/115 (22%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I ++YLHS KI + +L N++L G H KI+ FGL + + +
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDG-------HIKITDFGLCK------EGITDA 149
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
T F + APEVLE+N+ Y D + G++ +E++ G++PF
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 19/109 (17%)
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP-KSPSQSGTTH 402
++Y+H + H ++ +NIL+ + G + K+ FG++++ N K + GT
Sbjct: 114 LKYIHKVGVIHRDIKAANILV-----TNTG--NVKLCDFGVAALLNQNSSKRSTFVGT-- 164
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
P+ W APEV+ E Y K+D++S G+ +E+ TG P+ D
Sbjct: 165 PY-WMAPEVITEG--------KYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 21/127 (16%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL-SSVKNFGPKSPS 396
L + R + YLH++ + H ++ +ILL G K+S FG + V PK S
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDG-------RIKLSDFGFCAQVSKEVPKRKS 177
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQ 455
GT + W APEV+ S Y + D++S G++ E++ G+ P F + LQ
Sbjct: 178 LVGTPY---WMAPEVI---------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225
Query: 456 GDKMSRN 462
+ R+
Sbjct: 226 AMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 21/119 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I RG+ +LH+ K+ H ++ N+LL TE K+ FG+S+ +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLL------TEN-AEVKLVDFGVSA------QLDRTV 175
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
G + FI W APEV+ +E ++ Y +SD++S G+ E+ G P D H
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDAT----YDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 56/260 (21%), Positives = 91/260 (35%), Gaps = 73/260 (28%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E L +L HP + F E C ++ +L ++ P K +
Sbjct: 51 EQEILATLDHPFLPTLYASF-QTETYLCLVMDYCPGGELFRLLQRQ--PGKCLS------ 101
Query: 334 VDLMLQIAR--------GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
++AR +EYLH I + +L P NILL G H +S F LS
Sbjct: 102 ----EEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-------HIMLSDFDLS 150
Query: 386 SVKNFGPKSPSQSGT-----------------------------THPFIWHAPEVLEENE 416
+ P S++ T +I APEV+
Sbjct: 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI--APEVI---- 204
Query: 417 QTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP 476
S + D ++ G++ +E+L G PF+ ++ + NI E FP P
Sbjct: 205 -----SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD--ETFSNILKKE-VTFPGSPP 256
Query: 477 --KYVTNLTKRCWHADPNQR 494
+L ++ DP++R
Sbjct: 257 VSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
++ L EI L +L H I+ + D E+K+ + +E M IK+ +
Sbjct: 47 EVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPG---GSIKDQL--KAYG 101
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS- 385
+ V QI +G+ YLHS I H ++ +NIL G + K+ FG S
Sbjct: 102 ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-------NVKLGDFGASK 154
Query: 386 ---SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
++ G S +GT + W +PEV+ S Y K+DV+S E+
Sbjct: 155 RIQTICMSGTGIKSVTGTPY---WMSPEVI---------SGEGYGRKADVWSVACTVVEM 202
Query: 443 LTGKVPFED 451
LT K P+ +
Sbjct: 203 LTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 32/103 (31%), Positives = 42/103 (40%), Gaps = 21/103 (20%)
Query: 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIW 406
LH H +L P N L+ G H K++ FGLS K + S G+ P +
Sbjct: 117 LHELGYIHRDLKPENFLIDASG-------HIKLTDFGLS--KGIVTYANSVVGS--PD-Y 164
Query: 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
APEVL Y D +S G + +E L G PF
Sbjct: 165 MAPEVLR---------GKGYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL-SSVKNFGPKSPSQS 398
+ + + YLHS+ + H ++ +ILL G K+S FG + + PK S
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDG-------RVKLSDFGFCAQISKDVPKRKSLV 178
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQGD 457
GT + W APEV+ S + Y + D++S G++ E++ G+ P F D+ +Q
Sbjct: 179 GTPY---WMAPEVI---------SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226
Query: 458 KMSRN 462
K R+
Sbjct: 227 KRLRD 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 19/111 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I G+E LH + + +L P NILL G H +IS GL +VK P+ S
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYG-------HIRISDLGL-AVKI--PEGESIR 159
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
G + APEVL N +Y+ D + G + +E++ G+ PF
Sbjct: 160 GRVGTVGYMAPEVLN---------NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGF-TDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
++ E+ L + P I+ F F +D E C M+ S D +K+ RIP
Sbjct: 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV--LKKA----GRIP-- 97
Query: 330 LPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS--- 385
+ + + + RG+ YL K KI H ++ PSNIL+ RG K+ FG+S
Sbjct: 98 ENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCDFGVSGQL 150
Query: 386 --SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
S+ N S GT + +PE L+ + Y+ +SD++S G+ E+
Sbjct: 151 IDSMAN------SFVGTRS---YMSPERLQ---------GTHYTVQSDIWSLGLSLVEMA 192
Query: 444 TGK--VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTK 484
G+ +P DA R + GE + + +
Sbjct: 193 IGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 38/131 (29%), Positives = 56/131 (42%), Gaps = 26/131 (19%)
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
++ F P A +IA + YLHS I + +L P NILL +G H ++ F
Sbjct: 88 QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-------HVVLTDF 140
Query: 383 GLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
GL + +QS TT F + APEV+ + Y D + G +
Sbjct: 141 GLCK------EGIAQSDTTTTFCGTPEYLAPEVIRKQ---------PYDNTVDWWCLGAV 185
Query: 439 CFEILTGKVPF 449
+E+L G PF
Sbjct: 186 LYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 28/163 (17%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS--VKNFGPKSPS 396
+I +E+LH I + ++ NILL G H ++ FGLS ++ ++ S
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNG-------HVVLTDFGLSKEFHEDEVERAYS 165
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
GT + AP+++ + + + D +S G++ +E+LTG PF + G
Sbjct: 166 FCGTIE---YMAPDIV-------RGGDGGHDKAVDWWSMGVLMYELLTGASPFT---VDG 212
Query: 457 DK-----MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+K +SR I E P +P ++ +R DP +R
Sbjct: 213 EKNSQAEISRRILKSEPP-YPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 26/187 (13%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
E L +++HP+I+ FT K C LI+ DL Y+ ++ I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFT-YNKFTC-LILPRYKTDLYCYLAA----KRNIAICDI 184
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+A++ + R ++YLH +I H ++ NI + G G A +++ K +G
Sbjct: 185 LAIER--SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FE 450
+GT +APE+L + Y D++S G++ FE+ T FE
Sbjct: 243 -----WAGTIAT---NAPELL---------ARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
Query: 451 DAHLQGD 457
L GD
Sbjct: 286 KDGLDGD 292
|
Length = 391 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 235 EDYQVRRRLGSGSQYKEI-----LWLGESFALRHFFGDIEP------LVPEISSLLSLSH 283
ED+++ +R+GSG+ Y ++ + GE A++ +EP + EI + H
Sbjct: 9 EDFELIQRIGSGT-YGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCKH 65
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
NI+ + + +K ++ ME I + P + + + +G
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQG 118
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGTTH 402
+ YLHSK H ++ +NILL G H K++ FG+S+ + K S GT +
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDNG-------HVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
W APEV + Y++ D+++ G+ E+ + P D H
Sbjct: 172 ---WMAPEVAAVERK------GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 35/115 (30%), Positives = 49/115 (42%), Gaps = 26/115 (22%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+IA + YLHS I + +L P NILL +G H ++ FGL + S
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILLDSQG-------HVVLTDFGLCK------EGIEHS 150
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
TT F + APEVL + Y D + G + +E+L G PF
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQP---------YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 30/180 (16%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGF-TDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
++ E+ L + P I+ F F +D E C M+ S D +KE KRIP
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--QVLKEA----KRIPEE 103
Query: 330 LPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ V + + RG+ YL K +I H ++ PSNIL+ RG K+ FG+S +
Sbjct: 104 ILGKVSI--AVLRGLAYLREKHQIMHRDVKPSNILVNSRG-------EIKLCDFGVSG-Q 153
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ S GT + +PE L+ + YS +SD++S G+ E+ G+ P
Sbjct: 154 LIDSMANSFVGTRS---YMSPERLQ---------GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 28/186 (15%)
Query: 272 VPEISSLLSLSH-PNIMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFS 329
E +LS+S+ P I F D K +L+ME DL S + R F
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLN-----RYEDQFD 100
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG----LS 385
+A + ++ + +H H ++ P N+L+ G H K++ FG L+
Sbjct: 101 EDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-------HIKLADFGSAARLT 153
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
+ K K P T +I APEVL Y + D +S G+I +E++ G
Sbjct: 154 ANKMVNSKLPV---GTPDYI--APEVLT---TMNGDGKGTYGVECDWWSLGVIAYEMIYG 205
Query: 446 KVPFED 451
+ PF +
Sbjct: 206 RSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 21/127 (16%)
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL-SSVKNFGPKSPS 396
L + + + LH++ + H ++ +ILL G K+S FG + V P+ S
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDG-------RVKLSDFGFCAQVSKEVPRRKS 175
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQ 455
GT + W APE++ S Y + D++S G++ E++ G+ P F + L+
Sbjct: 176 LVGTPY---WMAPELI---------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 456 GDKMSRN 462
KM R+
Sbjct: 224 AMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 23/114 (20%)
Query: 339 QIARGMEYLHSKK-IYHGNLNPSNILLKPRGASTEGYLHAKISGFGL--SSVKNFGPKSP 395
+I ++YLHS+K + + +L N++L G H KI+ FGL +K+ G
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------HIKITDFGLCKEGIKD-GATMK 154
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ GT + APEVLE+N+ Y D + G++ +E++ G++PF
Sbjct: 155 TFCGTPE---YLAPEVLEDND---------YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 26/115 (22%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+IA + YLHS I + +L P NILL +G H ++ FGL +N +
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQG-------HIVLTDFGLCK-ENIEH-----N 150
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
GTT F + APEVL + Y D + G + +E+L G PF
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 30/182 (16%)
Query: 281 LSHPN---IMHFLCGFTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDL 336
++H N I+ F D+ K +++ME M DL + + P K F
Sbjct: 97 MAHANSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNLMSNYDIPEKWARF-------Y 147
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG--LSSVKNFGPKS 394
++ ++ +HS H ++ P N+LL G H K++ FG + N +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HLKLADFGTCMKMDANGMVRC 200
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
+ GT + +PEVL+ + Y + D +S G+ +E+L G PF L
Sbjct: 201 DTAVGTPD---YISPEVLKSQGG-----DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252
Query: 455 QG 456
G
Sbjct: 253 VG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 33/154 (21%)
Query: 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360
+ +ME ++ DL +I+++ F P AV +I+ G+ +LH + I + +L
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLD 130
Query: 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEENE 416
N++L G H KI+ FG+ + TT F + APE++
Sbjct: 131 NVMLDSEG-------HIKIADFGMCK------EHMVDGVTTRTFCGTPDYIAPEII---- 173
Query: 417 QTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
+ Y + D +++G++ +E+L G+ PF+
Sbjct: 174 -----AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 38/190 (20%)
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
S+ + + +I +EY+HSK + H +L P NILL G E I +G + K
Sbjct: 111 SVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGE----VVILDWGAAIFK 163
Query: 389 N----------FGPKSPSQSGTTHP------FIWHAPEVLEENEQTESASNSKYSEKSDV 432
++ S T P + APE L SE +D+
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA---------SESTDI 214
Query: 433 YSFGMICFEILTGKVPFEDAHLQGDKMS-RNIRAGERPLFPFHS-PKYVTNLTKRCWHAD 490
Y+ G+I +++LT P+ +G K+S R++ + P+ P +++ + + D
Sbjct: 215 YALGVILYQMLTLSFPYRRK--KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVD 272
Query: 491 PNQRPSFSSI 500
P +R +SS+
Sbjct: 273 PAER--YSSV 280
|
Length = 932 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 36/126 (28%), Positives = 51/126 (40%), Gaps = 26/126 (20%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F P A ++A + YLHS I + +L P NILL +G H ++ FGL
Sbjct: 93 FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-------HVVLTDFGLCK- 144
Query: 388 KNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ TT F + APEVL + Y D + G + +E+L
Sbjct: 145 -----EGVEPEETTSTFCGTPEYLAPEVLRK---------EPYDRTVDWWCLGAVLYEML 190
Query: 444 TGKVPF 449
G PF
Sbjct: 191 YGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 235 EDYQVRRRLGSGSQYKEI-----LWLGESFALRHFFGDIEP------LVPEISSLLSLSH 283
DY++ +R+GSG+ Y ++ L GE A++ +EP + EI + H
Sbjct: 9 HDYELIQRVGSGT-YGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVKECKH 65
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
NI+ + + EK ++ ME I + P + + + + +G
Sbjct: 66 CNIVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQG 118
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGTTH 402
+ YLHSK H ++ +NILL G K++ FG+++ + K S GT +
Sbjct: 119 LAYLHSKGKMHRDIKGANILLTDNG-------DVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
W APEV N Y++ D+++ G+ E+ + P D H
Sbjct: 172 ---WMAPEV------AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 21/103 (20%)
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
++ LH + I +LNP+NILL RG H +++ F + S G
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRG-------HIQLTYFS-----RWSEVEDSCDGEAVE 145
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
++ APEV +E+TE+ D +S G I FE+LTGK
Sbjct: 146 NMYCAPEVGGISEETEAC---------DWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 42/231 (18%)
Query: 232 IKSEDYQVRRRLGSGSQYKEIL--WLGESF---ALRHF-------FGDIEPLVPEISSLL 279
+K ED+ R LG+GS + IL + E F A++ F ++ + E L
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
++HP ++ F DE +L++E ++ + ++++ KR P V
Sbjct: 87 YINHPFCVNLYGSFKDESY--LYLVLEFVIGGEFFTFLRR----NKRFPND--VGCFYAA 138
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
QI EYL S I + +L P N+LL +G++ K++ FG + V + ++ +
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLL-----DKDGFI--KMTDFGFAKVVD--TRTYTLC 189
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
GT + APE+L N + + +D ++ G+ +EIL G PF
Sbjct: 190 GTPE---YIAPEIL---------LNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 53/243 (21%), Positives = 92/243 (37%), Gaps = 46/243 (18%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWLGESFALRHFF----------GDIEPLVPEISSLLSL 281
+K+EDY+V + +G G+ GE +RH E ++ S
Sbjct: 40 MKAEDYEVVKVIGRGA-------FGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFW 91
Query: 282 SHPNIMHFLCG-------FTDEEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPVA 333
+IM F + ++ + +++ME M DL + + P K F
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF----- 146
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
++ ++ +HS H ++ P N+LL G H K++ FG N
Sbjct: 147 --YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HLKLADFGTCMKMNKEGM 197
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ P + +PEVL+ + Y + D +S G+ +E+L G PF
Sbjct: 198 VRCDTAVGTP-DYISPEVLKSQ-----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 454 LQG 456
L G
Sbjct: 252 LVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 32/133 (24%)
Query: 316 IKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375
+ +I R R P + + LQ + LH + L + LLK +G +
Sbjct: 3 LADILEVRGR-PLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----DGSV 56
Query: 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435
K +P QS F+ APEV++ TE K+D+YS
Sbjct: 57 AFK---------------TPEQSRPDPYFM--APEVIQGQSYTE---------KADIYSL 90
Query: 436 GMICFEILTGKVP 448
G+ +E L ++P
Sbjct: 91 GITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 32/181 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E++ L + H N++ L FT +E ++ +L+M M DL + P S
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--------PLS 115
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G++Y+HS I H +L P N+ A E KI FGL+ +
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL------AVNED-CELKILDFGLARHAD 168
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+G + APEV+ + Y++ D++S G I E+LTGK F
Sbjct: 169 -----AEMTGYVVTRWYRAPEVI--------LNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
Query: 450 E 450
+
Sbjct: 216 K 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 31/161 (19%)
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
++ +E LH + + +L P NILL +G H + FGL + +
Sbjct: 101 ELLCALENLHKFNVIYRDLKPENILLDYQG-------HIALCDFGLCKL------NMKDD 147
Query: 399 GTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
T+ F + APE+L Y++ D ++ G++ +E+LTG PF D ++
Sbjct: 148 DKTNTFCGTPEYLAPELL---------LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198
Query: 455 QGDKMSRNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQR 494
++M R I + PL FP + +L DP +R
Sbjct: 199 --NEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 46/195 (23%), Positives = 69/195 (35%), Gaps = 54/195 (27%)
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSY-IKEICCPRKRIPFSLPVAVDLMLQIA 341
P I+ F DEE +L+ME M DL + I++ P + F +L+L +
Sbjct: 61 PWIVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARF---YIAELVLAL- 114
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS----------SVKNFG 391
+ +H H ++ P NIL+ G H K++ FGL N
Sbjct: 115 ---DSVHKLGFIHRDIKPDNILIDADG-------HIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 392 PKSPSQSGTTHPFIWH-----------------APEVLEENEQTESASNSKYSEKSDVYS 434
+ H APEVL Y + D +S
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP---------YGLECDWWS 215
Query: 435 FGMICFEILTGKVPF 449
G+I +E+L G PF
Sbjct: 216 LGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 30/180 (16%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGF-TDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
++ E+ L + P I+ F F +D E C M+ S D +K+ RIP
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV--LKKA----GRIPEQ 103
Query: 330 LPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ V + + +G+ YL K KI H ++ PSNIL+ RG K+ FG+S +
Sbjct: 104 ILGKVSI--AVIKGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCDFGVSG-Q 153
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ S GT + +PE L+ + YS +SD++S G+ E+ G+ P
Sbjct: 154 LIDSMANSFVGTRS---YMSPERLQ---------GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 7/61 (11%)
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F +AV + ++A ++YLH I H +L P N+L+ S EG H K++ FGLS V
Sbjct: 101 FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI-----SNEG--HIKLTDFGLSKV 153
Query: 388 K 388
Sbjct: 154 T 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 46/232 (19%)
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
P I+ F F E ++ ME M + + IP V + + +G
Sbjct: 59 PYIVDFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIP--EDVLRRITYAVVKG 114
Query: 344 MEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-------SVKNFGPKSP 395
+++L + I H ++ P+N+L+ G K+ FG+S + N G +S
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNG-------QVKLCDFGVSGNLVASLAKTNIGCQS- 166
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED---- 451
+ APE ++ ++ + Y+ +SDV+S G+ E+ G+ P+
Sbjct: 167 ----------YMAPERIKSGGPNQNPT---YTVQSDVWSLGLSILEMALGRYPYPPETYA 213
Query: 452 ---AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
A L I G+ P P + +C + PN+RP+++ +
Sbjct: 214 NIFAQLSA------IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 38/241 (15%)
Query: 281 LSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
L+HPN++ L C E L++E DL +Y++ R + D++
Sbjct: 52 LNHPNVLQCLGQCI----ESIPYLLVLEFCPLGDLKNYLR-----SNRGMVAQMAQKDVL 102
Query: 338 L----QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
++A G+ +LH H +L N L L KI +GL+ +
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-------LSVKIGDYGLALEQYPEDY 155
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDA 452
++ P W APE++E Q ++KS+++S G+ +E+ T P+ D
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQ--DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD- 212
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKR-------CWHADPNQRPSFSSICRILR 505
+ + +R + L P+ + R CW DP RP+ + +L
Sbjct: 213 LSDEQVLKQVVREQDIKL---PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268
Query: 506 Y 506
Y
Sbjct: 269 Y 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 57/251 (22%), Positives = 95/251 (37%), Gaps = 27/251 (10%)
Query: 262 RHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEIC 320
F + +P SL H N++ L T E L+ME DL Y++ C
Sbjct: 40 MKFLEEAQPY-------RSLQHSNLLQCLGQCT--EVTPYLLVMEFCPLGDLKGYLRS-C 89
Query: 321 CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380
+ + + +IA G+ +LH H +L N LL L KI
Sbjct: 90 RKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-------LTVKIG 142
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
+GLS K + P W APE+++E + +++S+V+S G+ +
Sbjct: 143 DYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ--TKESNVWSLGVTIW 200
Query: 441 EILT-GKVPFEDAHLQGDKMSRNIRAGE----RPLFPFHSPKYVTNLTKRCWHADPNQRP 495
E+ G P+ ++ +R + +P + + CW P QRP
Sbjct: 201 ELFELGSQPYRH-LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRP 258
Query: 496 SFSSICRILRY 506
S + +L Y
Sbjct: 259 SAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 17/130 (13%)
Query: 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG--LSSVKNFGPKSPSQSGTTHPF 404
+H H ++ P N+LL G H +++ FG L ++ +S GT
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNG-------HIRLADFGSCLKMNQDGTVQSSVAVGTPD-- 168
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
+ +PE+L+ E KY + D +S G+ +E+L G+ PF L + + +
Sbjct: 169 -YISPEILQAMED----GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMN 222
Query: 465 AGERPLFPFH 474
ER FP H
Sbjct: 223 HEERFQFPSH 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 32/180 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L ++SH I++ + + K ++M DL +Y+ S P+
Sbjct: 136 EIDILKTISHRAIINLIHAYRW--KSTVCMVMPKYKCDLFTYVDR----------SGPLP 183
Query: 334 VDLMLQIARGM----EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
++ + I R + YLH + I H ++ NI L +A + FG + +
Sbjct: 184 LEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-------NAVLGDFGAACKLD 236
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P +P G + ++PE+L + Y K+D++S G++ FE+ V
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALD---------PYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| PF06760 | 217 | DUF1221: Protein of unknown function (DUF1221); In | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.83 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.83 | |
| cd00173 | 94 | SH2 Src homology 2 domains; Signal transduction, i | 97.73 | |
| smart00252 | 84 | SH2 Src homology 2 domains. Src homology 2 domains | 97.73 | |
| PF00017 | 77 | SH2: SH2 domain; InterPro: IPR000980 The Src homol | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.68 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.68 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.38 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.78 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.72 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.66 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.48 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.19 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.1 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.74 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.63 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.37 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.06 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.49 | |
| PLN02236 | 344 | choline kinase | 94.22 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.95 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.86 | |
| KOG0790 | 600 | consensus Protein tyrosine phosphatase Corkscrew a | 93.76 |
| >PF06760 DUF1221: Protein of unknown function (DUF1221); InterPro: IPR010632 This is a group of plant proteins, most of which are hypothetical and of unknown function | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-80 Score=573.32 Aligned_cols=214 Identities=63% Similarity=1.131 Sum_probs=207.9
Q ss_pred ccccccccchhhhHHHHHHHhhHHHHHHHHhcccccccccccccchhhHHHHHHHhhcchhhhhhcccchhHHHHHHHHh
Q 038696 21 RDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRAKWKILEQPLKELFRIFKEGENYIKQCLEIRDWWAKAITLY 100 (683)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (683)
+|||||||||||||+|+|++||+|||+||||||||||||||||+||||||||||||||||+|||||+||+|||+|||+++
T Consensus 1 ~ddiqIN~RQC~LL~d~f~~A~~~va~eir~nLrfeEk~tKWr~LE~PLREl~rvfregE~YvR~CLd~k~WWaka~~~~ 80 (217)
T PF06760_consen 1 QDDIQINPRQCCLLADIFALAFDTVAEEIRQNLRFEEKNTKWRPLEQPLRELHRVFREGEGYVRHCLDPKDWWAKAIALH 80 (217)
T ss_pred CcccccCHHHHHHHHHHHHHHHHHHHHHHHHhhchHhhcCcccccchhHHHHHHHHhhhHHHHHHccCchhHHHHHHHHH
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhHHHHhhcccchhhhHHHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeeechhhhhhhhhh
Q 038696 101 QNTDCVEFYIHNLLSCIPILIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITPDFCYRIDTV 180 (683)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l~~~~~~~~~~~ 180 (683)
||+||||||||||+||+++|+||||++++++|++|+|+++++|+...+|++.|.||++|+|+|||+|++++++|.+|+.+
T Consensus 81 ~n~dcVE~hiHnlL~c~~vviEAIE~AgE~sG~D~dE~~rkRl~~a~kYdk~~~dpklFqw~fGKqYLvs~e~c~R~d~a 160 (217)
T PF06760_consen 81 QNTDCVEFHIHNLLWCFPVVIEAIETAGEISGSDQDEMARKRLVLARKYDKEWLDPKLFQWRFGKQYLVSRELCARMDTA 160 (217)
T ss_pred cCcchHHHHHHHHHHHHHHHHHHHHHHhhccCCCHHHHHHHHHHHHHhhhhhccchHHHHHHhhhhheeHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccchhhhhhhhhhhccCC---chhhhchHHHHhhhcCCCCCCCCCcccceeEeeCCC
Q 038696 181 WKEDRWILFNKIQQKKISGS---TKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSED 236 (683)
Q Consensus 181 ~~~~~~~l~~~~~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (683)
|+||||.|.+.+++++.+.+ .+++++++|.|.+.++++. ++++.|+++.+++++
T Consensus 161 WkEDRW~L~~~l~Ekk~~~s~~ltK~E~rLaDlL~k~l~~~~--ngKL~PsSiLlgskd 217 (217)
T PF06760_consen 161 WKEDRWLLSQLLDEKKGSGSPPLTKNEHRLADLLLKPLNGSE--NGKLHPSSILLGSKD 217 (217)
T ss_pred HHHHHHHHHHHHHHhccCCCCCCchhHHHHHHHHHhhccccc--cCccCchhhhccCCC
Confidence 99999999999999998875 9999999999999997655 899999999887653
|
All members contain the IPR000719 from INTERPRO domain, suggesting that they may possess kinase activity. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=465.52 Aligned_cols=405 Identities=24% Similarity=0.360 Sum_probs=321.3
Q ss_pred Hhhcchh--hhhhcccchhHHHHHHHHhcccchhHHHHhhcccch--hhhHHHHhhhccccCCCchhHHHHHHhh----c
Q 038696 75 IFKEGEN--YIKQCLEIRDWWAKAITLYQNTDCVEFYIHNLLSCI--PILIEAIETAAEFSGWDPDQMHKKKLVH----S 146 (683)
Q Consensus 75 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~i~~~~~~~g~~~~e~~~~~l~~----~ 146 (683)
.|++|+- ++.+|.+.. ||-.........+. ...|-.-=. .=...++++++||||-+.|++|++.|.. .
T Consensus 29 sf~~Gd~~~~~~~~~~~~-Ww~ar~~~~~~~g~---ip~N~v~~~~~~~~~~~l~~~~Wf~~~isR~~ae~~ll~p~~~~ 104 (468)
T KOG0197|consen 29 SFRKGDVVLILLETTNGD-WWRARSLQLGQEGY---IPSNYVARNRGSPAFIKLSDEPWFFGKISREEAERQLLAPENKE 104 (468)
T ss_pred ccccCceEEEeeccCChh-HHHHHHhhcCCCCc---CcCceeeccccCCCccccccCCchhccccHHHHHHhhcCCCCCc
Confidence 3556654 566666555 88766665555551 111211000 0011678999999999999999987773 5
Q ss_pred CCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hh--hhhhhhhhhccCCchhhhchHHHHhhhcCCCCC
Q 038696 147 GKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WI--LFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGS 220 (683)
Q Consensus 147 g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~--l~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 220 (683)
|-|++|.|++.++...+.....- ....++||.|..-.++ ++ +.....|.++.....+++...+.+...+.....
T Consensus 105 G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~ 184 (468)
T KOG0197|consen 105 GAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERELFSSLQQLVNYYSKNADGLCTRLRDPCS 184 (468)
T ss_pred cceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHHhhhhHHHHHhhhhccCcchhhcccCchh
Confidence 88999999988777222111111 1336889999654444 45 888889999999999999999998888866554
Q ss_pred CCC-------CcccceeEeeCCCeEEEeEecccccEEEEE--EcCc-EEEEEEeCC---CcchHHHHHHHHHcCCCCcee
Q 038696 221 LSG-------KLLPSRILIKSEDYQVRRRLGSGSQYKEIL--WLGE-SFALRHFFG---DIEPLVPEISSLLSLSHPNIM 287 (683)
Q Consensus 221 ~~~-------~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~-~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv 287 (683)
..+ .+....|.+..+.+.+++.||+|-|+.|++ |+|. .||+|.++. ..++|.+|+.+|++|+|+|||
T Consensus 185 ~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV 264 (468)
T KOG0197|consen 185 KQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLV 264 (468)
T ss_pred ccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeE
Confidence 322 112467888888889999999998777774 7777 999999975 357899999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC
Q 038696 288 HFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP 366 (683)
Q Consensus 288 ~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~ 366 (683)
++++++..+ ..+|||||||. |+|.+||+. ..+..+...+.+.|+.|||+||+||+++++|||||.+.||||++
T Consensus 265 ~l~gV~~~~--~piyIVtE~m~~GsLl~yLr~----~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~ 338 (468)
T KOG0197|consen 265 KLYGVCTKQ--EPIYIVTEYMPKGSLLDYLRT----REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE 338 (468)
T ss_pred EEEEEEecC--CceEEEEEecccCcHHHHhhh----cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc
Confidence 999999654 47999999997 899999996 34567999999999999999999999999999999999999988
Q ss_pred CCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-C
Q 038696 367 RGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445 (683)
Q Consensus 367 ~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G 445 (683)
+. .|||+|||||+....+ ......+..-++.|.|||.+... +++.++|||||||+||||+| |
T Consensus 339 ~~-------~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~---------~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 339 DL-------VVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYG---------KFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred Cc-------eEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhC---------CcccccceeehhhhHHHHhccC
Confidence 87 8999999999955444 33334455567789999999744 69999999999999999999 9
Q ss_pred CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
+.||.+.+. .++.+.+..|++.+.|..||.++.+|+..||+.+|++||||+.+...|+.+.
T Consensus 402 ~~py~~msn--~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 402 RVPYPGMSN--EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCCH--HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 999998764 4688999999999999999999999999999999999999999888777654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=453.52 Aligned_cols=359 Identities=23% Similarity=0.357 Sum_probs=290.2
Q ss_pred hhhHHHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeee-eech-----hhhhhhhhhhcccchhhhhh
Q 038696 118 PILIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQY-LITP-----DFCYRIDTVWKEDRWILFNK 191 (683)
Q Consensus 118 ~~~~~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y-~l~~-----~~~~~~~~~~~~~~~~l~~~ 191 (683)
......|...+||||++||||++.+|.+.|||++|.+++..+. .+++ +|+. .-++||++.+..+.++....
T Consensus 40 ~~~~~~~~~~~~yHG~l~red~~~lL~~~GDfLvR~s~~~~~~---~~~~~vlSv~~~~~~~~~h~vi~~~~~~~~~~~~ 116 (474)
T KOG0194|consen 40 EFIEKDLRELPYYHGLLPREDAEKLLKNDGDFLVRASEPKEGE---KREFVVLSVKWSVFKKIKHYVIKRNGNLFFFEGL 116 (474)
T ss_pred HHhhhHhhcCccccccccHhHHHHHhCCCCceEEEeecccCCc---ceeEEEEEEEeecCCceeEEEEEEcCCeeEEecc
Confidence 4455666778999999999999999999999999999999887 6665 6633 35779999877775555555
Q ss_pred hhhhhccCCchhhhchHHHHhhhcCCCCCCCCCcccceeEeeCCCeEEEeEecccccEEEEE---E--cC---cEEEEEE
Q 038696 192 IQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYKEIL---W--LG---ESFALRH 263 (683)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l---~--~g---~~vAvK~ 263 (683)
..|.++.....++......+.. ....+...+..+.|.+.+++..+.++||+|+|+.|+. . ++ ..||||.
T Consensus 117 ~~F~si~~li~~~~~~~~~~~~---~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~ 193 (474)
T KOG0194|consen 117 RKFPTISELVNYYKFSKLEITG---KNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKT 193 (474)
T ss_pred ccCCcHHHHHHHHHhcccceec---cceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEe
Confidence 7887776665555433222211 1112334556689999999999999999999766664 2 22 2389999
Q ss_pred eCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHH
Q 038696 264 FFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVD 335 (683)
Q Consensus 264 ~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~ 335 (683)
.+. ...++.+|+++|++++|||||++||+..++ ..+|||||+|. |+|.+||+++ ...++..+...
T Consensus 194 ~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~Pl~ivmEl~~gGsL~~~L~k~-----~~~v~~~ek~~ 266 (474)
T KOG0194|consen 194 TKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EPLMLVMELCNGGSLDDYLKKN-----KKSLPTLEKLR 266 (474)
T ss_pred ecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CccEEEEEecCCCcHHHHHHhC-----CCCCCHHHHHH
Confidence 874 246789999999999999999999988765 78999999998 5999999974 23699999999
Q ss_pred HHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhc
Q 038696 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEEN 415 (683)
Q Consensus 336 i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~ 415 (683)
++++++.||+|||++++|||||..+|||++.++ .+||+|||+++...... .......-+..|+|||.+...
T Consensus 267 ~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-------~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~ 337 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-------VVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTG 337 (474)
T ss_pred HHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-------eEEeCccccccCCccee--eccccccCcceecChhhhccC
Confidence 999999999999999999999999999998877 68999999998764211 111122456789999999643
Q ss_pred cccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH-HcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 038696 416 EQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQ 493 (683)
Q Consensus 416 ~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 493 (683)
.|+.++|||||||++||+++ |..||.+.... .+...| ..+.+...|...|..+..++..||..||++
T Consensus 338 ---------~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 338 ---------IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred ---------ccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhh
Confidence 69999999999999999998 89999987654 455555 789999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 038696 494 RPSFSSICRILRYIKR 509 (683)
Q Consensus 494 RPt~~eil~~L~~i~~ 509 (683)
||+|.++.+.|+.+..
T Consensus 407 R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEK 422 (474)
T ss_pred ccCHHHHHHHHHHHHh
Confidence 9999999999988765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=399.12 Aligned_cols=357 Identities=24% Similarity=0.399 Sum_probs=301.4
Q ss_pred hHHHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeechh---hhhhhhhhhcccc-hhhhhhhh
Q 038696 120 LIEAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLITPD---FCYRIDTVWKEDR-WILFNKIQ 193 (683)
Q Consensus 120 ~~~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~~~---~~~~~~~~~~~~~-~~l~~~~~ 193 (683)
-..+||+..||||=..|.+++-.|. .+|.|+||.||..++| |.|+.. -+.||.|....|. -++...-.
T Consensus 145 PvNSLeKhsWYHGpvSRsaaEy~LsSgInGSFLVRESEsSpgQ------~sISlRyeGRVyHYRINt~~dgK~yvt~Esr 218 (1157)
T KOG4278|consen 145 PVNSLEKHSWYHGPVSRSAAEYILSSGINGSFLVRESESSPGQ------YSISLRYEGRVYHYRINTDNDGKMYVTQESR 218 (1157)
T ss_pred cccchhhcccccCccccchhhhhhhcCcccceEEeeccCCCcc------eeEEEEecceEEEEEeeccCCccEEEeehhh
Confidence 4477899999999999999999998 4999999999999998 777443 3889999776666 66777788
Q ss_pred hhhccCCchhhhchHHHHhhhcCCCCCCCCCc-------ccceeEeeCCCeEEEeEecccc---cEEEEEE-cCcEEEEE
Q 038696 194 QKKISGSTKQEQGLIDVLFKNLDGSGSLSGKL-------LPSRILIKSEDYQVRRRLGSGS---QYKEILW-LGESFALR 262 (683)
Q Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~i~~~LG~G~---~~~v~l~-~g~~vAvK 262 (683)
|.++.++..+....+|.|..-+.-..+-.++- ....|++...+..+..+||.|. +|.+++. -.-.||||
T Consensus 219 F~TLaELVHHHStvADGLittLhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVK 298 (1157)
T KOG4278|consen 219 FRTLAELVHHHSTVADGLITTLHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 298 (1157)
T ss_pred hhHHHHHHhhccccccceeEeeeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehh
Confidence 88888888888888888877665444333221 3378999999999999999885 3444432 23479999
Q ss_pred EeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 038696 263 HFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLML 338 (683)
Q Consensus 263 ~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 338 (683)
.++++ .++|..|+.+|+.+.|||+|+++++|..+ ..+|||+|||. |+|.+||++. .+..++.-..+.++.
T Consensus 299 tLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTEfM~yGNLLdYLRec----nr~ev~avvLlyMAt 372 (1157)
T KOG4278|consen 299 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITEFMCYGNLLDYLREC----NRSEVPAVVLLYMAT 372 (1157)
T ss_pred hhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEEecccCccHHHHHHHh----chhhcchhHHHHHHH
Confidence 99874 68899999999999999999999999766 67999999996 8999999973 345577778899999
Q ss_pred HHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccc
Q 038696 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQT 418 (683)
Q Consensus 339 qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~ 418 (683)
||..||+||..+++|||||...||||+.+. .|||+||||++++..... +...+..-++.|.|||-+.-.
T Consensus 373 QIsSaMeYLEkknFIHRDLAARNCLVgEnh-------iVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyN--- 441 (1157)
T KOG4278|consen 373 QISSAMEYLEKKNFIHRDLAARNCLVGENH-------IVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN--- 441 (1157)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhccccccc-------eEEeeccchhhhhcCCce-ecccCccCcccccCccccccc---
Confidence 999999999999999999999999998876 799999999999876533 344455567889999998533
Q ss_pred ccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 419 ESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 419 ~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
.++.|+|||+|||+|||+.| |-.||.+.... .++..+..++++.-|..||+.+.+|++.||+.+|.+||+|
T Consensus 442 ------tFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsF 513 (1157)
T KOG4278|consen 442 ------TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSF 513 (1157)
T ss_pred ------ccccchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccH
Confidence 58889999999999999998 99999987654 4788889999999999999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 038696 498 SSICRILRYI 507 (683)
Q Consensus 498 ~eil~~L~~i 507 (683)
.+|.+.++.+
T Consensus 514 aeiHqafEtm 523 (1157)
T KOG4278|consen 514 AEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHHH
Confidence 9999888765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=390.64 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=210.0
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.+.|.+.+.||+|+|+.|.+ .+|+.||||++... ...+.+|++||++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 34688999999999777775 38999999999531 12357999999999999999999999654
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...||||||++ |+|.+++-.+ +.+.+..-..+++|++.|+.|||++||+||||||+|||+..+ ...+.+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~----~e~~ll 318 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND----AEDCLL 318 (475)
T ss_pred CceEEEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC----CcceEE
Confidence 67899999997 5999999863 567888889999999999999999999999999999999766 245689
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+|+..... ......+||+.|.|||++.+.+ ...+..++|+||+||+||-+++|.+||.+... ..
T Consensus 319 KItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg------~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-~~ 388 (475)
T KOG0615|consen 319 KITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKG------VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-DP 388 (475)
T ss_pred Eecccchhhccccc---eehhhhcCCccccChhheecCC------eecccchheeeeccceEEEEeccCCCcccccC-Cc
Confidence 99999999987632 3455778999999999998774 23455699999999999999999999987543 23
Q ss_pred HHHHHHHcCCCCCCCCC---CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~---~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+.++|..|.....|.. .+++..+||.+||..||++|||+.++++|-|.
T Consensus 389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 47788888876665544 47889999999999999999999999988654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=384.95 Aligned_cols=244 Identities=28% Similarity=0.444 Sum_probs=212.5
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|++++.||+|++++|++. +|+.+|+|++++ +.+...+|..||..++||+||++++.|++. .
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--E 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC--C
Confidence 356679999999999999888863 788999999853 356788999999999999999999999765 7
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||+||+.| .|..+|++ .+.|++..+..|+.+|+.||.|||++|||||||||+|||||.+| |++
T Consensus 99 kLylVld~~~GGeLf~hL~~------eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-------Hi~ 165 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQR------EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-------HIK 165 (357)
T ss_pred eEEEEEeccCCccHHHHHHh------cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-------cEE
Confidence 89999999985 99999985 36799999999999999999999999999999999999999999 999
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||||+....... .....+||+.|||||++.+.+ |+..+|+||||+++|||++|.+||.+.+.. .
T Consensus 166 LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~g---------y~~~vDWWsLGillYeML~G~pPF~~~~~~--~ 232 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKG---------YDKAVDWWSLGILLYEMLTGKPPFYAEDVK--K 232 (357)
T ss_pred EeccccchhcccCCC--ccccccCCccccChHHHhcCC---------CCcccchHhHHHHHHHHhhCCCCCcCccHH--H
Confidence 999999986544322 334578999999999998774 999999999999999999999999987643 4
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC----CHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP----SFSSICR 502 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP----t~~eil~ 502 (683)
+.+.|..+..+..|...+.+.+++++++|..||.+|. ++.+|.+
T Consensus 233 ~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 7778888776777777999999999999999999996 4555433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=398.64 Aligned_cols=329 Identities=23% Similarity=0.324 Sum_probs=255.1
Q ss_pred hhcccchhhhhhhhhhhccCCchhhhchHHHHhhhcCCCCCCCCCcccceeEeeCCCeEEEeEecccccEEEEEE----c
Q 038696 180 VWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW----L 255 (683)
Q Consensus 180 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~ 255 (683)
-++++++.+...+.....+...+.+ +...+... ....+...+..+..++|++++.||+|+|+.|++. +
T Consensus 94 ~R~er~~~le~~l~~~~~s~~~~~~--~~~~~~~k------Ete~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~T 165 (550)
T KOG0605|consen 94 ERKERRKELEEKLASEDVSEEEQNE--LLKSLLSK------ETEYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDT 165 (550)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHH--HHHHHhhH------HHHHHHhccccCCcccchhheeeccccceeEEEEEEccC
Confidence 4477788888888776433332222 22222111 1122444556778899999999999999888874 8
Q ss_pred CcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCC
Q 038696 256 GESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327 (683)
Q Consensus 256 g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~ 327 (683)
|+.+|+|++++ +.+.+..|-+||...++|+||++|+.|++. .++||||||++| |+..+|.. ...
T Consensus 166 g~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLiMEylPGGD~mTLL~~------~~~ 237 (550)
T KOG0605|consen 166 GEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLIMEYLPGGDMMTLLMR------KDT 237 (550)
T ss_pred CcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEEEEecCCccHHHHHHh------cCc
Confidence 99999999953 467789999999999999999999999765 789999999985 99999985 478
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCC----------------
Q 038696 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG---------------- 391 (683)
Q Consensus 328 l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~---------------- 391 (683)
|++..+..|+.+++.|++.||+.|||||||||+|+|||..| |+||+|||||+.....
T Consensus 238 L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-------HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~ 310 (550)
T KOG0605|consen 238 LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-------HIKLSDFGLSTGLDKKHRIESYRLDEQMQINL 310 (550)
T ss_pred CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-------CEeeccccccchhhhhhhhhhhcchhhhhhhh
Confidence 99999999999999999999999999999999999999999 9999999998532110
Q ss_pred ------CCC-----------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 392 ------PKS-----------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 392 ------~~~-----------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
... .....++|||.|+|||++.+.+ |+..+|+||||||||||
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg---------Y~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 311 SEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG---------YGKECDWWSLGCIMYEM 381 (550)
T ss_pred ccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC---------CCccccHHHHHHHHHHH
Confidence 000 0012678999999999998774 99999999999999999
Q ss_pred HhCCCCCCCCccchhHHHHHHH-cCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhcCCCCCC
Q 038696 443 LTGKVPFEDAHLQGDKMSRNIR-AGERPLFP--FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNS 519 (683)
Q Consensus 443 ltG~~Pf~~~~~~~~~~~~~i~-~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~~~~~~~~ 519 (683)
|.|.+||.+.+.++ ..++|. ......+| ..++.+..+||.+||. ||++|.. ..-++++.....|..++|+...
T Consensus 382 LvGyPPF~s~tp~~--T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 382 LVGYPPFCSETPQE--TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HhCCCCCCCCCHHH--HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhh
Confidence 99999999877652 444433 33223344 3456889999999998 9999975 2222333444566788999888
Q ss_pred CCCCCCCCCCCchHHHHHhhcCCCc
Q 038696 520 QPDPPMPLVDYSDIESRLLRKFPSW 544 (683)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (683)
...+|..+...+..++..+++|+..
T Consensus 458 ~~~apfvP~v~~~~DT~yFddF~e~ 482 (550)
T KOG0605|consen 458 EMPAPFVPQVNSELDTQYFDDFPEE 482 (550)
T ss_pred cCCCCCCCCCCCcccccccccCccc
Confidence 8888887777788888888888874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=398.09 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=210.0
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+|...+.||+|||-+++. .+|+.||+|++.. ..+.+.+||+|.+.|+|||||+++++|. +.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE--Ds~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE--DSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee--cCCceEE
Confidence 4799999999999765553 5899999999843 4577899999999999999999999995 5589999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|.|+|. |+|..+++. +.+|++.++..|++||+.||.|||+++|||||||..|++|+.+- +|||+||
T Consensus 96 vLELC~~~sL~el~Kr------rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-------~VKIgDF 162 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR------RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-------NVKIGDF 162 (592)
T ss_pred EEEecCCccHHHHHHh------cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-------cEEeccc
Confidence 999997 699988873 57899999999999999999999999999999999999997765 8999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|||........ .....+|||.|.|||++... .++..+||||+|||||.||.|++||+..... +....
T Consensus 163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~---------gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--ety~~ 229 (592)
T KOG0575|consen 163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNKS---------GHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--ETYNK 229 (592)
T ss_pred ceeeeecCccc--ccceecCCCcccChhHhccC---------CCCCchhhhhhhhHHHhhhhCCCCcccchHH--HHHHH
Confidence 99998864422 34567899999999999865 3899999999999999999999999987654 35556
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
|..... .+|...+.+..+||..+|+.||.+|||+++|+.|-..
T Consensus 230 Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 230 IKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 655543 3677889999999999999999999999999987443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=389.89 Aligned_cols=262 Identities=36% Similarity=0.585 Sum_probs=224.0
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE--EcCcE-EEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL--WLGES-FALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~-vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..+.+...+..+.+.||.|+++.|+. |.|.. ||||++... .+.|.+|+.+|.+|+|||||+|++++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~- 112 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP- 112 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 44666666778888899999777773 78888 999999642 348999999999999999999999886542
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEeCCCCCCCCCcce
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK-IYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..++|||||++ |+|.+++... ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++ .+
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~------~~ 182 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG------KT 182 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC------CE
Confidence 26899999997 6999999862 3577999999999999999999999999 99999999999998774 28
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... .......||+.|||||++.+. ...|+.|+||||||++||||+||+.||.+... .
T Consensus 183 ~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~-------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~ 252 (362)
T KOG0192|consen 183 LKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGE-------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V 252 (362)
T ss_pred EEECCCccceeecccc--ccccCCCCCccccChhhhcCC-------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H
Confidence 9999999998775432 233346899999999999743 23699999999999999999999999999876 4
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
......+..+.++.+|..+++.+..|+++||+.||..||++.+|+..|+.+...
T Consensus 253 ~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 253 QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 556667778999999999999999999999999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.45 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=213.3
Q ss_pred eeCCCeEEEeEecccc---cEEEEE-EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 232 IKSEDYQVRRRLGSGS---QYKEIL-WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~---~~~v~l-~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+...+.+.++.||+|+ |+++.. ++++.+|+|.+... .+++.+|+++++.++|||||.+|+.|+.+.. .++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEE
Confidence 3445788899999986 344443 47899999999532 3567899999999999999999999987643 699
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||+ |+|.++++.. +.+++.....++.+++.||.|||+ .+||||||||+|||++.+| .||||
T Consensus 155 I~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-------eVKic 221 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-------EVKIC 221 (364)
T ss_pred eehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-------CEEec
Confidence 9999998 5999999863 669999999999999999999995 9999999999999999999 89999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC---ccchh
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA---HLQGD 457 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~---~~~~~ 457 (683)
|||.++..... .....+||..|||||.+.+. .|+.++||||||++++|+++|+.||... ...--
T Consensus 222 DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~---------~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~ 288 (364)
T KOG0581|consen 222 DFGVSGILVNS----IANTFVGTSAYMSPERISGE---------SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF 288 (364)
T ss_pred cccccHHhhhh----hcccccccccccChhhhcCC---------cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH
Confidence 99999887643 44577899999999999765 5999999999999999999999999764 22234
Q ss_pred HHHHHHHcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
++...|..+..|..|.. ++++++.+|..||++||.+|||+.++++|-+-
T Consensus 289 ~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 289 ELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred HHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 56677888888889987 99999999999999999999999999988543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.76 Aligned_cols=245 Identities=30% Similarity=0.480 Sum_probs=201.8
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|.+.+.||.|+|..||. .+|..||||.+.. ..+.+..|+.+|+.++|||||.+++++.+ .+.+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEE
Confidence 35899999999998655553 3788999999843 24567899999999999999999999854 478999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||||+ |||.+||+. ++.+++.++..++.||+.||++||+++||||||||+||||+.... .+....+||+||
T Consensus 87 VMEyC~gGDLs~yi~~------~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~-~~~~~~LKIADF 159 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR------RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR-NDTSPVLKIADF 159 (429)
T ss_pred EEEeCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC-CCCCceEEeccc
Confidence 999998 599999986 357999999999999999999999999999999999999987620 122268999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+....+. .....+|++.|||||++..+ .|+.|+|+||+|+|+|+|++|+.||...+.. ++...
T Consensus 160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~---------~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~--eL~~~ 225 (429)
T KOG0595|consen 160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQ---------QYDAKADLWSIGTILYQCLTGKPPFDAETPK--ELLLY 225 (429)
T ss_pred chhhhCCchh---HHHHhhCCccccCHHHHHhc---------cccchhhHHHHHHHHHHHHhCCCCccccCHH--HHHHH
Confidence 9999886432 34567899999999999755 5999999999999999999999999987654 34445
Q ss_pred HHcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 038696 463 IRAGE--RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501 (683)
Q Consensus 463 i~~~~--~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil 501 (683)
+..+. .+.++......+.+|+...+..|+.+|.++.+..
T Consensus 226 ~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 226 IKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 55443 3444555566678999999999999998877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=362.77 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=209.1
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+|+|+++||.|+|+.++. ++|..||.|.+.- ..+++..|+.+|++|+|||||++|+.-..++..-++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3799999999998755553 6999999998842 34568899999999999999999984444454558999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS--KK--IYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~g--IiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
||||+ |||...++.... .+..+++..+++++.|++.||..+|+ .. |+||||||.||+|+.+| .|||
T Consensus 99 mE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-------vvKL 169 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-------VVKL 169 (375)
T ss_pred HHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-------ceee
Confidence 99997 799999987643 33568999999999999999999999 44 99999999999999998 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+||||++.+... .+.....+|||.||+||++.+. .|+.++||||+||++|||+.-++||.+.+. ..+
T Consensus 170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~---------~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L 236 (375)
T KOG0591|consen 170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHES---------GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSL 236 (375)
T ss_pred ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcC---------CCCcchhHHHHHHHHHHHHhcCCCcccccH--HHH
Confidence 999999988643 2344578999999999999876 499999999999999999999999998754 458
Q ss_pred HHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 038696 460 SRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSIC 501 (683)
Q Consensus 460 ~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil 501 (683)
.+.|.++..++.| ...+.++..||..|+..||..||+...++
T Consensus 237 ~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 237 CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 8999999988777 67799999999999999999999854443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=374.00 Aligned_cols=247 Identities=29% Similarity=0.446 Sum_probs=211.8
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
....||.+++.||+|++..|++. +++.||||++.+ ..+.+..|-.+|..| .||.|++||..|+|+ .
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--E 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--c
Confidence 34569999999999998888864 788999999842 356678899999999 799999999999876 6
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+|+||++ |+|.++|++. +.|++..+..|+.||+.||+|||++|||||||||+||||+.++ ++|
T Consensus 148 sLYFvLe~A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-------hik 214 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-------HIK 214 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-------cEE
Confidence 7999999997 7999999975 7799999999999999999999999999999999999999888 899
Q ss_pred EecccCccccCCCCCC---------CC--CCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC
Q 038696 379 ISGFGLSSVKNFGPKS---------PS--QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447 (683)
Q Consensus 379 L~DFGla~~~~~~~~~---------~~--~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~ 447 (683)
|+|||.|+.+...... .. ....+||-.|.+||+|... ..+..+|+|+||||+|.|+.|.+
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~---------~~~~~sDiWAlGCilyQmlaG~P 285 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS---------PAGPSSDLWALGCILYQMLAGQP 285 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC---------CCCcccchHHHHHHHHHHhcCCC
Confidence 9999999887543221 11 1457899999999999755 58899999999999999999999
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
||.+.+ +..+++.|..-.. .||...++.+.+||+++|..||.+|+|..+|.+|..
T Consensus 286 PFra~N--eyliFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 286 PFRAAN--EYLIFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred CCcccc--HHHHHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 999865 3345566655433 488899999999999999999999999998877743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=344.07 Aligned_cols=231 Identities=27% Similarity=0.436 Sum_probs=205.2
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..-++|++++.||.|+|++|.+. +|..+|+|++.. +.+...+|.++|+.+.||+++++++.|.+. +.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--Ce
Confidence 34469999999999999999874 788999999953 356678999999999999999999988654 78
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| .|.++|++ .++|++..+..|+.||+.||+|||+++|++|||||+|||+|.+| ++||
T Consensus 119 lymvmeyv~GGElFS~Lrk------~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-------~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK------SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-------HIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHHh------cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-------cEEE
Confidence 9999999985 99999986 36799999999999999999999999999999999999999999 8999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+|+.... .+...+|||.|+|||+++.++ |+.++|+|||||++|||+.|.+||.+.+. ..+
T Consensus 186 tDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~---------ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~i 249 (355)
T KOG0616|consen 186 TDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKG---------YNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQI 249 (355)
T ss_pred EeccceEEecC-----cEEEecCCccccChHHhhcCC---------CCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHH
Confidence 99999988743 345678999999999998764 99999999999999999999999988764 457
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 494 (683)
...|..+. ..+|...+.++++|++.+|+.|-.+|
T Consensus 250 Y~KI~~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGK-VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 77777765 34888999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.26 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=204.7
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCc---chH--HHHHHHHHcCC-CCceeeeeeeEEcCCCCeEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDI---EPL--VPEISSLLSLS-HPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~---~~~--~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~ 302 (683)
--++|.++++||.|+|+.|++. +|+.||||.+++.. ++. .+|+..|++|+ |||||++.+++.+.+. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 3468999999999998888874 78899999997642 232 58999999999 9999999999976543 899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+|||||+.+|+++++. ++.+|++..+..|++||+.||+|+|.+|+.||||||+|||+.... .+||+||
T Consensus 87 fVfE~Md~NLYqLmK~-----R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-------~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKD-----RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-------VIKIADF 154 (538)
T ss_pred eeHHhhhhhHHHHHhh-----cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-------eeEeccc
Confidence 9999999999999997 478899999999999999999999999999999999999997554 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+...... .....+.|-+|.|||++... +.|+.++|||++|||++|+++-++.|.+.+.. +++.+.
T Consensus 155 GLARev~Skp---PYTeYVSTRWYRAPEvLLrs--------~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KI 222 (538)
T KOG0661|consen 155 GLAREVRSKP---PYTEYVSTRWYRAPEVLLRS--------GYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKI 222 (538)
T ss_pred ccccccccCC---CcchhhhcccccchHHhhhc--------cccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHH
Confidence 9999886433 33456778899999999854 47999999999999999999999999987643 223322
Q ss_pred HHc-C------------------C-CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRA-G------------------E-RPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~-~------------------~-~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..- | . .|. .-+.++.++.+||.+|++.||++|||+++++++--
T Consensus 223 c~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 223 CEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 210 0 0 011 11236788999999999999999999999998743
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.23 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=207.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
..+|...+.||+|+++.|+++ +|+.+|||.+... .+.+.+|+.+|.+|+|||||++++.....+...++|.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 347888999999998888875 3689999998654 56689999999999999999999864332223799999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCCCCCCcceEEEeccc
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP-RGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~-~g~~~~~~~~vKL~DFG 383 (683)
||++ |+|.++++.+ +..|++..+..+..||++||+|||++|||||||||+|||++. ++ .+||+|||
T Consensus 96 Ey~~~GsL~~~~~~~-----g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-------~~KlaDFG 163 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY-----GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG-------DVKLADFG 163 (313)
T ss_pred eccCCCcHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC-------eEEeccCc
Confidence 9998 5999999874 226999999999999999999999999999999999999998 56 79999999
Q ss_pred CccccCC-CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNF-GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~-~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
+++.... ...........||+.|||||++... .....++|||||||++.||+||..||.........+...
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g--------~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG--------EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI 235 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCC--------CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH
Confidence 9987764 1122234457899999999999732 123359999999999999999999998742223334555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
......|.+|...+.+.++++.+|+..||.+|||+.++++|..-
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 55566678899999999999999999999999999999987543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.82 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=209.3
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~ 298 (683)
.+.-++|.++++||+|+|++|++. +++.+|||++++ +.+..+.|.+|+...+ ||.++.++++|+..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-- 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-- 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC--
Confidence 566679999999999999999974 788999999965 3577899999998885 99999999999765
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
.++|+||||+.| |+..+. ....|++..+..|+..|+.||.|||++||||||||.+|||||.+| ++
T Consensus 442 ~~l~fvmey~~Ggdm~~~~-------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-------h~ 507 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHI-------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-------HV 507 (694)
T ss_pred CeEEEEEEecCCCcEEEEE-------ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-------cE
Confidence 789999999986 633322 236799999999999999999999999999999999999999999 89
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+|+..-.... .+....||+.|||||++.+. .|+.++|+|||||+||||+.|..||.+.+ ++
T Consensus 508 kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~---------~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Ee 574 (694)
T KOG0694|consen 508 KIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQ---------SYTRAVDWWGLGVLLYEMLVGESPFPGDD--EE 574 (694)
T ss_pred EecccccccccCCCCC--ccccccCChhhcChhhhccC---------cccchhhHHHHHHHHHHHHcCCCCCCCCC--HH
Confidence 9999999987653322 45577899999999999866 49999999999999999999999999865 56
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF-----SSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~-----~eil~~ 503 (683)
++...|.... +.+|..++.+..++++++|..||++|..+ .+|..|
T Consensus 575 e~FdsI~~d~-~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 575 EVFDSIVNDE-VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHhcCC-CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 6888777654 56899999999999999999999999754 555444
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=368.03 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=213.5
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+-|++++.||.|+.+.|.+ .+|+.+|||++... ...+.+||-||+.+.||||+++|+++ +++.++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEE
Confidence 3689999999999888886 38999999999654 45688999999999999999999999 55689999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|.||++ |.|+++|.. +++|++.++.+++.||+.|+.|||..+|+||||||+|+||+..+ .+||+||
T Consensus 90 vlEyv~gGELFdylv~------kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-------nIKIADF 156 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR------KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-------NIKIADF 156 (786)
T ss_pred EEEecCCchhHHHHHh------hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-------CEeeecc
Confidence 999997 599999975 47899999999999999999999999999999999999999887 6999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|.....+. .....+|++.|.|||++.+.+ +-+.++||||+|||||.|++|+.||++.+.. .+...
T Consensus 157 GMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~p--------YdG~~sDVWSCGVILfALLtG~LPFdDdNir--~LLlK 223 (786)
T KOG0588|consen 157 GMASLEVPGK---LLETSCGSPHYAAPEIVSGRP--------YDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VLLLK 223 (786)
T ss_pred ceeecccCCc---cccccCCCcccCCchhhcCCC--------CCCCccccchhHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence 9998765442 334567899999999998765 4567999999999999999999999976643 46667
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+..|.. .+|..++.++++||.+||..||.+|.|+++|++|.+..
T Consensus 224 V~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 224 VQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 777764 46788999999999999999999999999999997654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.29 Aligned_cols=261 Identities=25% Similarity=0.477 Sum_probs=210.2
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFT 294 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 294 (683)
|.+..++|++.++||+|+++.|+.. .++.||||++... ...+.+|+.+|..+ +||||+++++.+.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 5677789999999999998777653 2467999998642 34588999999999 8999999998875
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcCC---------------------------------------------------
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICCP--------------------------------------------------- 322 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~~--------------------------------------------------- 322 (683)
. ....+|+||||++ |+|.+++......
T Consensus 82 ~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 82 K-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred C-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 4 3356899999998 5999999753110
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCC
Q 038696 323 -----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397 (683)
Q Consensus 323 -----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~ 397 (683)
....++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-------~~kl~DfG~a~~~~~~~~~~~~ 233 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLARDIYKDPDYVRK 233 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-------cEEEeecccccccccCcchhcc
Confidence 0023588899999999999999999999999999999999998877 7999999999865433222222
Q ss_pred CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCc
Q 038696 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP 476 (683)
Q Consensus 398 ~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~ 476 (683)
....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.... ..+...+..+.....+..++
T Consensus 234 ~~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 303 (338)
T cd05102 234 GSARLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRAPENAT 303 (338)
T ss_pred cCCCCCccccCcHHhhcC---------CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCCCCCCCCCC
Confidence 334456789999999654 48899999999999999997 99999875543 33445566666666677889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 477 KYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 477 ~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=358.05 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=210.8
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|.+...||+|+|+.||. .+.+.||||.+.+ +.+.+.+|++|++.|+|||||.++++| +...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence 5799999999999766664 4778999999843 345589999999999999999999999 556899999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
+||+.|+|..+|.+. ..++++.+..++++++.||.|||+.+|+|||+||+|||++..| ++|++|||+
T Consensus 80 te~a~g~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-------~~KlcdFg~ 146 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-------TLKLCDFGL 146 (808)
T ss_pred ehhhhhhHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-------ceeechhhh
Confidence 999999999999863 6699999999999999999999999999999999999999888 899999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+....+ ........|||.|||||++.+. .|+..+|+||+|||+|||+.|++||...... .+.+.|.
T Consensus 147 Ar~m~~~--t~vltsikGtPlYmAPElv~e~---------pyd~~sDlWslGcilYE~~~G~PPF~a~si~--~Lv~~I~ 213 (808)
T KOG0597|consen 147 ARAMSTN--TSVLTSIKGTPLYMAPELVEEQ---------PYDHTSDLWSLGCILYELYVGQPPFYARSIT--QLVKSIL 213 (808)
T ss_pred hhhcccC--ceeeeeccCcccccCHHHHcCC---------CccchhhHHHHHHHHHHHhcCCCCchHHHHH--HHHHHHh
Confidence 9987653 3455678899999999999866 5999999999999999999999999875533 2445554
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.. ...+|...+.++.++++.+|.+||.+|.|+.+++.|-..-
T Consensus 214 ~d-~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k 255 (808)
T KOG0597|consen 214 KD-PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWK 255 (808)
T ss_pred cC-CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHh
Confidence 43 4456778899999999999999999999999999885443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=357.39 Aligned_cols=247 Identities=31% Similarity=0.448 Sum_probs=207.2
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCC-CCceeeeeeeEEcCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLS-HPNIMHFLCGFTDEE 297 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~ 297 (683)
...+.|.+.+.||+|++++|.+. +|+.||||++... .+.+.+|+.+++.+. ||||++++.++..+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 34569999999999998888863 7899999976432 335668999999999 99999999999765
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CCCCCCcc
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR-GASTEGYL 375 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~-g~~~~~~~ 375 (683)
..+||||||+.| +|.+++.+ .+++.+..+..++.|++.|++|||++||+||||||+|||++.+ +
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~------~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~------- 158 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVN------KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG------- 158 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHH------cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC-------
Confidence 559999999985 99999985 4779999999999999999999999999999999999999988 6
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||++..... .........||+.|+|||++.+.. ..-+.++||||+||+||.|++|+.||.+.+..
T Consensus 159 ~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~-------~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~ 229 (370)
T KOG0583|consen 159 NLKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKG-------TYSGKAADVWSLGVILYVLLCGRLPFDDSNVP 229 (370)
T ss_pred CEEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCC-------CcCCchhhhhhhHHHHHHHHhCCCCCCCccHH
Confidence 799999999987741 222345678999999999998652 12358999999999999999999999985533
Q ss_pred hhHHHHHHHcCCCCCCCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHS-PKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~-~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...|..+. ..+|..+ +.++..|+.+||..||.+|+|+.+|+.+-+
T Consensus 230 --~l~~ki~~~~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 230 --NLYRKIRKGE-FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred --HHHHHHhcCC-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 3555566654 3467777 999999999999999999999999986543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.95 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=204.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------------------CcchHHHHHHHHHcCCCCceeeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------------------DIEPLVPEISSLLSLSHPNIMHFLC 291 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------------------~~~~~~~Ei~iL~~L~HpnIv~l~~ 291 (683)
-++|++++.||+|.+++|.+. +|+.||||++.+ ..+...+||.||++|.|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 458999999999988888774 789999999832 1357889999999999999999999
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIP-FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
+..+.....+|||+|||. |.+. +. ....+ |++.++++|+++++.||+|||.+|||||||||+|+||+.+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~-w~------p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g- 247 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVK-WC------PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG- 247 (576)
T ss_pred eecCcccCceEEEEEeccCCccc-cC------CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-
Confidence 998888889999999998 4443 11 12344 99999999999999999999999999999999999999998
Q ss_pred CCCCcceEEEecccCccccCCCCC---CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPK---SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~ 446 (683)
+|||+|||.+..+..+.. ......++|||.|+|||.+.+.. +....+.+.||||+||+||.|+.|+
T Consensus 248 ------~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~-----~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 248 ------TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN-----SFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred ------cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC-----CccccchhhhhhhhhhhHHHhhhcc
Confidence 899999999987643311 11223588999999999997642 2335678999999999999999999
Q ss_pred CCCCCCccchhHHHHHHHcCCCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 447 VPFEDAHLQGDKMSRNIRAGERPLFPFH--SPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 447 ~Pf~~~~~~~~~~~~~i~~~~~~~~p~~--~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.||.+.... ++...|... +..+|.. ..+.+++||++||.+||++|.++.+|..|.+-
T Consensus 317 ~PF~~~~~~--~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 317 LPFFDDFEL--ELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred CCcccchHH--HHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 999876533 355555443 2334433 57889999999999999999999998777654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=375.53 Aligned_cols=261 Identities=30% Similarity=0.438 Sum_probs=224.8
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGF 293 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~ 293 (683)
....+...+....+.||+|+|++|++. ....||||.++.. ..+|++|+++|..|+|||||+|+++|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 556777789999999999999888862 3347999999763 45799999999999999999999999
Q ss_pred EcCCCCeEEEEEecCC-CCHHHHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe
Q 038696 294 TDEEKKECFLIMELMS-RDLCSYIKEICCPR--------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL 364 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl 364 (683)
. +++.+|||+|||. |||.+||+...... ...+|+..+.+.|+.|||.||+||-++.+|||||..+||||
T Consensus 559 ~--~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 559 R--EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred c--cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 5 4478999999997 89999998643211 13358999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh
Q 038696 365 KPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444 (683)
Q Consensus 365 ~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt 444 (683)
+++- .|||+||||++..-..+.........-+++||+||.+.. ++++.++|||||||+|||+++
T Consensus 637 ge~l-------~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly---------~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 637 GENL-------VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY---------GKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred ccce-------EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc---------Ccccchhhhhhhhhhhhhhhc
Confidence 7664 899999999987755544444445566789999999964 469999999999999999998
Q ss_pred -CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 445 -GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 445 -G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
|..||.+.. .+++.+.|..|.-...|.+||.++.+||..||+.+|.+||+|.+|-..|+...
T Consensus 701 yG~QPy~glS--n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 701 YGKQPYYGLS--NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred cccCcccccc--hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 999999876 45688999999988899999999999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.10 Aligned_cols=243 Identities=21% Similarity=0.381 Sum_probs=196.1
Q ss_pred CCeEEEeEecccccEEEEE-----EcCcEEEEEEeCCCcc------hHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL-----WLGESFALRHFFGDIE------PLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l-----~~g~~vAvK~~~~~~~------~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+.|+.+.++|+|+ |+|+. .+|+.||||+|.+..+ -.++||++|++|.|+|+|.++.+|. .+..++|
T Consensus 2 ekYE~LgkvGEGS-YGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGS-YGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHL 78 (396)
T ss_pred cHHhhhhccccCc-ceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEE
Confidence 4688999999997 55554 3899999999965322 3589999999999999999999994 5588999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|+|||+.++.+.|..+ ...++...+..|++|++.|+.|||++++|||||||+||||+.+| .+||||||
T Consensus 79 VFE~~dhTvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-------vvKLCDFG 146 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-------VVKLCDFG 146 (396)
T ss_pred EeeecchHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-------cEEeccch
Confidence 9999999988888864 35589999999999999999999999999999999999999998 89999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+|+....... .....+.|-+|.|||.+.+. ..|+..+||||+||++.||++|.+.|.+.+.-+ .+....
T Consensus 147 FAR~L~~pgd--~YTDYVATRWYRaPELLvGD--------tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ 215 (396)
T KOG0593|consen 147 FARTLSAPGD--NYTDYVATRWYRAPELLVGD--------TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIR 215 (396)
T ss_pred hhHhhcCCcc--hhhhhhhhhhccChhhhccc--------CcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHH
Confidence 9998764221 23345678899999999864 369999999999999999999999998876432 222111
Q ss_pred H-------------------cCCCCCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 R-------------------AGERPLFP----------FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~-------------------~~~~~~~p----------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .|.+.+.| +..+.-+.++++.||+.||.+|++.++++.|
T Consensus 216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 11111111 1123457899999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.20 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=207.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.......+.|+.+.+||+|+++.|+. .+|+.||+|++.-+ ..-..+||.||++|+||||+++.+...+..
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 33444556899999999999777775 48999999998532 234679999999999999999999888766
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
.+.+|||+|||+.||.-++.. ....|++.++..|+.|++.||+|||++||+|||||.+|||||.+| .+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~-----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-------~L 257 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS-----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-------VL 257 (560)
T ss_pred CceEEEEEecccchhhhhhcC-----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-------CE
Confidence 789999999999999999874 456799999999999999999999999999999999999999999 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||||+++...... .....+-|.+|.|||.+.+. ..|+.++|+||.||||.||+.|++.|.+.+.. +
T Consensus 258 KiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~--------t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-e 327 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGA--------TSYGTAVDLWSVGCILAELFLGKPILQGRTEV-E 327 (560)
T ss_pred EeccccceeeccCCCCc-ccccceEEeeccChHHhcCC--------cccccceeehhhhHHHHHHHcCCCCcCCccHH-H
Confidence 99999999988765433 24456789999999999865 37999999999999999999999999986632 2
Q ss_pred HHHHHHHcCCCC--------CCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERP--------LFP-------------------FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~--------~~p-------------------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
++-.++.....| .+| ...+....+|+..+|..||.+|.|+.++++.
T Consensus 328 Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 328 QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 222222211110 011 1235667899999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=359.95 Aligned_cols=242 Identities=23% Similarity=0.396 Sum_probs=203.4
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
..|....+||+|+.+.|+. .+++.||||++.- ..+-+.+|+.+|+.++|+|||.+++.|... ..+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEe
Confidence 3688889999998666664 3788999999842 345678999999999999999999988654 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.+.+.+ ..+++.++..|+++++.||+|||.+||+|||||.+|||++.+| .+||+|||+|
T Consensus 351 ym~ggsLTDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-------~vKltDFGFc 416 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-------SVKLTDFGFC 416 (550)
T ss_pred ecCCCchhhhhhc-------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-------cEEEeeeeee
Confidence 9985 99998876 4499999999999999999999999999999999999999998 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
..+..... .....+|||.|||||++.... |++++||||||++++||+-|.+||-....-. .+......
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~---------YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-AlyLIa~n 484 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKP---------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN 484 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcc---------cCccccchhhhhHHHHHhcCCCCccCCChHH-HHHHHhhc
Confidence 88765432 345678999999999998764 9999999999999999999999998644332 23333333
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~-~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
|. ....+...+..+++++.+||..|+.+|+++.++++|-
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 33 2235667899999999999999999999999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.29 Aligned_cols=257 Identities=23% Similarity=0.423 Sum_probs=207.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeC-----CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFF-----GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..+.+..++|++...||.|....|++ ..++.||||++. .+.+.+.+|+..|+.++||||++++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-- 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-- 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec--
Confidence 56677788999999999996433333 478999999983 2457889999999999999999999999875
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||.||. |++.+.++... ...|.+..+..|+++++.||.|||++|.||||||+.||||+.+| .|
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~----~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-------~V 165 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYY----PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-------TV 165 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHc----cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-------cE
Confidence 78999999998 69999998753 34599999999999999999999999999999999999999999 79
Q ss_pred EEecccCccccCCCC-CCCCC-CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGP-KSPSQ-SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~-~~~~~-~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
||+|||.+....... +.... ...+||+.|||||++..+. ..|+.|+||||||++..||.+|..||......
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~-------~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL-------HGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcc-------cCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 999999876554332 11111 4568999999999975542 24999999999999999999999999876543
Q ss_pred hhHHHHHHHcCCCCC-----CC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPL-----FP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~-----~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
++...-.++..|. ++ ...+..++.+|..||..||.+|||+++++++-.+
T Consensus 239 --kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 239 --KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred --HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 2333333333331 11 1235678999999999999999999999987544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=355.94 Aligned_cols=250 Identities=31% Similarity=0.443 Sum_probs=208.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.-|.+..+...-++-||.|+.+.|++ ..++.||||+++... ..+|+-|++|+||||+.|.++|... ..+||||
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---ETdIKHLRkLkH~NII~FkGVCtqs--PcyCIiM 191 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---ETDIKHLRKLKHPNIITFKGVCTQS--PCYCIIM 191 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---hhhHHHHHhccCcceeeEeeeecCC--ceeEEee
Confidence 45777777777788899998777775 478899999985422 3589999999999999999999543 6789999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||. |.|...|+. +.+++....+.+..+||.||.|||.+.|||||||.-||||+.+. .|||+|||-
T Consensus 192 EfCa~GqL~~VLka------~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-------~VKIsDFGT 258 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKA------GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-------VVKISDFGT 258 (904)
T ss_pred eccccccHHHHHhc------cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-------eEEeccccc
Confidence 9997 899999985 46789999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++..... .......||..|||||+++.++ ++.|+||||||||||||+||..||.+..... .+.-.=.
T Consensus 259 S~e~~~~---STkMSFaGTVaWMAPEvIrneP---------csEKVDIwSfGVVLWEmLT~EiPYkdVdssA-IIwGVGs 325 (904)
T KOG4721|consen 259 SKELSDK---STKMSFAGTVAWMAPEVIRNEP---------CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-IIWGVGS 325 (904)
T ss_pred hHhhhhh---hhhhhhhhhHhhhCHHHhhcCC---------cccccceehhHHHHHHHHhcCCCccccchhe-eEEeccC
Confidence 9877543 3345678999999999999874 9999999999999999999999998754221 0000001
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.....+.|..||+.++-||+.||+..|..||+|.+|+.||.-..
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 12244578999999999999999999999999999999987654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=339.98 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=214.9
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..+.-++|+++++||.|..+.|++. ++..+|+|++.+ ...+++.|-+||+.++||.++.+|..|.. .
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--D 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--c
Confidence 3445568999999999998888874 457999999953 34567889999999999999999999954 4
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
+..|+|||||+| +|...+++ +....|++..+..|+.+++-||+|||-+|||+|||||+||||.++| ||
T Consensus 150 ~~~cl~meyCpGGdL~~Lrqk----Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-------HI 218 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQK----QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-------HI 218 (459)
T ss_pred ceeEEEEecCCCccHHHHHhh----CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-------cE
Confidence 889999999985 99998887 4667899999999999999999999999999999999999999999 99
Q ss_pred EEecccCccccCC---------------------------------CCC---------------------CCCCCCCCcC
Q 038696 378 KISGFGLSSVKNF---------------------------------GPK---------------------SPSQSGTTHP 403 (683)
Q Consensus 378 KL~DFGla~~~~~---------------------------------~~~---------------------~~~~~~~~gt 403 (683)
.|+||.|+..... ..+ .......+||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 9999998742210 000 0112356789
Q ss_pred cccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHH
Q 038696 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLT 483 (683)
Q Consensus 404 ~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li 483 (683)
-.|+|||++.+.+ .+.++|||+|||++|||++|..||.+.+.. +.+...+.+....+.....+..+++||
T Consensus 299 hEYlAPEvI~G~G---------HgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 299 HEYLAPEVIRGEG---------HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred cccccceeeecCC---------CCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 9999999998775 889999999999999999999999987643 333333333333222235578899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHhcCCCCCCCCCCCC
Q 038696 484 KRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPM 525 (683)
Q Consensus 484 ~~cL~~dP~~RPt~~eil~~L~~i~~~~~~~~~~~~~~~~~~ 525 (683)
+++|.+||.+|.....-...++....|..+||...+...||.
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999999999743333334444556778887766666664
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.54 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=207.1
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+|++.+.||+|.+++|.+ ..|+.||||.++++ .-.+.+||+||+.|+||||+++|.+| +++..+.||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIviv 131 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVIV 131 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEEE
Confidence 899999999999888876 37899999988542 23468999999999999999999999 566889999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||.. |.|++|+.+ ++.|++.++..|++||..|+.|||.++++|||||.+|||+|.++ ++||+|||
T Consensus 132 MEYaS~GeLYDYiSe------r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-------NiKIADFG 198 (668)
T KOG0611|consen 132 MEYASGGELYDYISE------RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-------NIKIADFG 198 (668)
T ss_pred EEecCCccHHHHHHH------hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-------Ceeeeccc
Confidence 99997 699999986 36799999999999999999999999999999999999999988 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
|+..+.... .....+|++.|.+||++++.+ .-++.+|-|||||+||.|+.|..||++... ..+.++|
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~P--------Y~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k~lvrQI 265 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTP--------YKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--KRLVRQI 265 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCC--------CCCCccchhhHHHHHHHHhhcccccCCchH--HHHHHHh
Confidence 998765432 234568899999999998775 456789999999999999999999998653 3577888
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..|.. +.+..|....-||+.||..||++|.|+.+|..|.
T Consensus 266 s~GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAY--REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hcccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 87765 3455577789999999999999999999998774
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.81 Aligned_cols=241 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred eEecccccEEEEE--EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEc--CCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEIL--WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTD--EEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l--~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--e~~~~~~LVmEy~~ 309 (683)
..||+|+++.++. .+|+.||||.+... .+.+.+|+.+|++++|||||++++++.+ +....+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 5678887655553 58999999998642 3556799999999999999999998866 44467899999998
Q ss_pred -CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 310 -RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 310 -gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
|+|.+++.+ ...+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++.
T Consensus 106 ~g~L~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-------~~kl~dfg~~~~ 172 (283)
T PHA02988 106 RGYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-------KLKIICHGLEKI 172 (283)
T ss_pred CCcHHHHHhh------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-------cEEEcccchHhh
Confidence 499999975 24688999999999999999999984 999999999999999887 799999999976
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH-HcC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI-RAG 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i-~~~ 466 (683)
.... .....++..|+|||++.+. ...++.++|||||||++|||++|..||.+.... .+...+ ..+
T Consensus 173 ~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~ 238 (283)
T PHA02988 173 LSSP-----PFKNVNFMVYFSYKMLNDI-------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKN 238 (283)
T ss_pred hccc-----cccccCcccccCHHHhhhc-------cccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcC
Confidence 5322 1234577889999999652 125899999999999999999999999876532 233333 445
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.++..+..++..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 566667778999999999999999999999999999998765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=353.64 Aligned_cols=260 Identities=20% Similarity=0.341 Sum_probs=209.8
Q ss_pred ccceeEeeCCCeEEEeEecccccEEEEEE---cC-cEEEEEEeCC----CcchHHHHHHHHHcCC-CCceeeeeeeE-Ec
Q 038696 226 LPSRILIKSEDYQVRRRLGSGSQYKEILW---LG-ESFALRHFFG----DIEPLVPEISSLLSLS-HPNIMHFLCGF-TD 295 (683)
Q Consensus 226 ~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g-~~vAvK~~~~----~~~~~~~Ei~iL~~L~-HpnIv~l~~~~-~~ 295 (683)
....+.++..+++|.+.|.+|||..||+. .+ ..||+|++.. ....+.+||++|+.|+ |+|||.+++.. ..
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 34778889899999999999998888864 34 8999999853 3456789999999997 99999999832 21
Q ss_pred ---CC-CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCC
Q 038696 296 ---EE-KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRG 368 (683)
Q Consensus 296 ---e~-~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g 368 (683)
.. ..+++|.||||. |+|.+++.+. ....|++.++++|++|+++|+.+||... |||||||.+||||+.+|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~R----lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTR----LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHH----HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 11 257899999998 5999999974 3345999999999999999999999987 99999999999999998
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCC-------CCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPS-------QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~-------~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
+.||||||.|........... .-....|+.|.|||++.-. ++..+++|+|||+|||+||-
T Consensus 184 -------~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly------sg~pI~eKsDIWALGclLYk 250 (738)
T KOG1989|consen 184 -------NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY------SGLPIGEKSDIWALGCLLYK 250 (738)
T ss_pred -------CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh------cCCCCcchhHHHHHHHHHHH
Confidence 799999999876443321111 1134468899999999766 46679999999999999999
Q ss_pred HHhCCCCCCCCccchhHHHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 442 ILTGKVPFEDAHLQGDKMSRNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 442 lltG~~Pf~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
|++...||++.... . |..+... +..+..+..+.+||+.||+.||++||++-+++..+..+.
T Consensus 251 LCy~t~PFe~sg~l-----a-Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 251 LCYFTTPFEESGKL-----A-ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred HHHhCCCcCcCcce-----e-EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 99999999875321 1 2233222 222467888999999999999999999999998888775
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.84 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=194.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.++|++.+.||+|+++.|++. +|+.||||++... ...+.+|+.+++.++||||+++++++.++ ...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEE
Confidence 468999999999997777753 6889999998532 23567899999999999999999988654 689999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 82 ~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~ 149 (303)
T cd07869 82 FEYVHTDLCQYMDK-----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-------ELKLADFGL 149 (303)
T ss_pred EECCCcCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEECCCCc
Confidence 99999999999875 235689999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++...... .......+|+.|+|||++.+. ..++.++|||||||++|||++|..||.+.......+.....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (303)
T cd07869 150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGS--------TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219 (303)
T ss_pred ceeccCCC--ccCCCCcccCCCCChHHHcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 87543221 122345678899999998643 24788999999999999999999999875433222222211
Q ss_pred cCCCC------------C---------CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 465 AGERP------------L---------FP---------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 465 ~~~~~------------~---------~p---------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
....+ . .+ ...+..+.+|+.+||+.||.+|||+.++++|-.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 10000 0 00 012456889999999999999999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=316.02 Aligned_cols=244 Identities=27% Similarity=0.357 Sum_probs=198.9
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+|...++||+|.++.|++ .+|+.||||+++-. .-...+||+.|+.++|+||+.++++|. ....+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence 4788999999997555554 38999999998531 234689999999999999999999994 44779999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
+|||+.||...|++ +...|+...+..|+.+++.||+|||++.|+||||||.|+|++.+| .+||+|||+
T Consensus 80 fEfm~tdLe~vIkd-----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-------~lKiADFGL 147 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKD-----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-------QLKIADFGL 147 (318)
T ss_pred EEeccccHHHHhcc-----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-------cEEeecccc
Confidence 99999999999986 467899999999999999999999999999999999999999999 899999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+.+....... ...+-|-+|.|||.+.| ...|+..+|+||.|||+.||+.|.+-|.+.+.- +++...+.
T Consensus 148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfG--------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~ 216 (318)
T KOG0659|consen 148 ARFFGSPNRIQ--THQVVTRWYRAPELLFG--------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFR 216 (318)
T ss_pred hhccCCCCccc--ccceeeeeccChHHhcc--------chhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHH
Confidence 99987544322 22367889999999975 457999999999999999999999988876543 22322222
Q ss_pred cCCC---------------------CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGER---------------------PL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~---------------------~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.-.. |. .-..++.++.+|+..||..||.+|+|+.++++|
T Consensus 217 ~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 217 ALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1110 00 112235667999999999999999999999876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.82 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=200.4
Q ss_pred CCCeEEEeEecccccEEEEE-----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEc---CCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEIL-----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTD---EEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l-----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---e~~~ 299 (683)
...|..++.||+|+ |+++. .+|+.||||++.. ..++..+|+++|+.++|+||+.+++.+.. ++-+
T Consensus 21 ~~~y~~~~~iG~GA-yGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGA-YGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcc-eeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44677789999997 54553 3789999999852 34667899999999999999999998865 3346
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+|+|+|+.||.+.|+. +..|+...+..+++||+.||+|+|+.||+||||||+|+|++.++ .+||
T Consensus 100 DvYiV~elMetDL~~iik~------~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-------~lKI 166 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS------QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-------DLKI 166 (359)
T ss_pred eeEEehhHHhhHHHHHHHc------CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-------CEEe
Confidence 7999999999999999985 24599999999999999999999999999999999999999887 7899
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch---
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--- 456 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--- 456 (683)
+|||+|+...........+..+.|-+|.|||++.. ...|+.+.||||.|||+.||++|++.|.+.+.-.
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~--------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN--------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhc--------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 99999998764422333456778899999999964 4479999999999999999999999998754211
Q ss_pred ----------hH---------HHHHHHc-CCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 ----------DK---------MSRNIRA-GERPLFP-----FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ----------~~---------~~~~i~~-~~~~~~p-----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
++ ....+.. ...+..| ++.++...+|+++||..||.+|+|++++++|.
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11 1111221 1222211 35567899999999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.17 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=208.0
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..|.+..++|++.+.||+|+++.|+.. ++..||||+++.. .+.+.+|+++|+.+ +|+|||++++.
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 456667779999999999997766642 2247999999642 24578999999999 89999999998
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcC--------------------------------------------------
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICC-------------------------------------------------- 321 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~-------------------------------------------------- 321 (683)
+... ..+|+||||+. |+|.+++.....
T Consensus 111 ~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 111 CTHG--GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred ecCC--CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 8543 67999999997 599999865311
Q ss_pred --------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 322 --------------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 322 --------------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.....++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-------~~kL~DfGla~~ 261 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-------VAKICDFGLARD 261 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-------eEEEeeceeeee
Confidence 01123588999999999999999999999999999999999998777 799999999976
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
..............+++.|+|||++.+. .++.++|||||||++|||++ |+.||...... ..+...+..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~ 331 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRG 331 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcc
Confidence 5433222122233456679999999644 48899999999999999997 99999875433 2344555555
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
..+..+...+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 55666667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=328.50 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=193.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.++||+|+++.|++. +|..||+|.+.. ....+.+|+.+++.++||||+++++++.++ ...|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEE
Confidence 58999999999998777753 678999999853 234678999999999999999999988654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 83 e~~~~~l~~~l~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-------~~kl~DfG~~ 150 (288)
T cd07871 83 EYLDSDLKQYLDN-----CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-------ELKLADFGLA 150 (288)
T ss_pred eCCCcCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-------CEEECcCcce
Confidence 9999999999875 234578999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~ 219 (288)
T cd07871 151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGS--------TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRL 219 (288)
T ss_pred eeccCCCc--cccCceecccccChHHhcCC--------cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 76543221 22344678899999998642 247889999999999999999999998755322 11111110
Q ss_pred -CC----------------CCCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 -GE----------------RPLF-----------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 -~~----------------~~~~-----------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+. ...+ ....+.++.+||.+||..||.+|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 220 LGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0001 12346778999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=349.30 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=199.5
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcC------CCCeEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDE------EKKECF 302 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e------~~~~~~ 302 (683)
..++|++.+.||+|+++.|++. +|+.||||++........+|+.+|+.++|||||+++++|... ....++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3468999999999998777753 678999999876666677899999999999999998776432 123578
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+||
T Consensus 144 lvmE~~~~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~------~vkL~DF 215 (440)
T PTZ00036 144 VVMEFIPQTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH------TLKLCDF 215 (440)
T ss_pred EEEecCCccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC------ceeeecc
Confidence 999999999988886532 23456899999999999999999999999999999999999986541 5999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+...... ......||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+..... .+...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i 283 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGA--------TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRI 283 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 9998764332 12235678899999998643 258899999999999999999999998754321 22222
Q ss_pred HHcCC---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGE---------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~---------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+.... ...+|...+.++.+||.+||..||.+|||+.++++|-+.
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 11100 011344567889999999999999999999999988554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.40 Aligned_cols=238 Identities=26% Similarity=0.433 Sum_probs=198.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.++ +.+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEE
Confidence 358999999999998777753 678999999853 234678999999999999999999988654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 95 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------~~kl~D 161 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK------AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-------HVKVTD 161 (329)
T ss_pred EEEcCCCCChHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-------CEEEee
Confidence 99999975 99999975 25689999999999999999999999999999999999999887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+... .....
T Consensus 162 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~ 225 (329)
T PTZ00263 162 FGFAKKVPDR-----TFTLCGTPEYLAPEVIQSK---------GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYE 225 (329)
T ss_pred ccCceEcCCC-----cceecCChhhcCHHHHcCC---------CCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHH
Confidence 9999865432 1234688999999999755 478899999999999999999999986543 23445
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~ 503 (683)
.+..+. ..+|...+..+.+||.+||+.||.+||+ +.+++.|
T Consensus 226 ~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 226 KILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 555543 4467778899999999999999999986 6777655
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=320.73 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=207.3
Q ss_pred CCCeEEEeEecccccEEEE----EEcCcEEEEEEeC------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEI----LWLGESFALRHFF------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~----l~~g~~vAvK~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+.|++...||+|.|..|. ..+|+.+|+|++. .+.+++.+|++|.+.|+|||||++.+.+..+ ...||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeEE
Confidence 5689999999999753333 2488999999873 2567889999999999999999999988543 78899
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|+|+|.| +|..-|-+. ..+++..+-.++.||++||.|+|.+||||||+||.|+|+.... ...-+||+||
T Consensus 88 vFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~----~~A~vKL~~F 157 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA----KGAAVKLADF 157 (355)
T ss_pred EEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc----CCCceeeccc
Confidence 9999986 888776652 5689999999999999999999999999999999999996543 2336999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|.... ......+..|||.|||||+++.. .|+..+|||+.|||||-|+.|++||.+.+. ..+++.
T Consensus 158 GvAi~l~---~g~~~~G~~GtP~fmaPEvvrkd---------py~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye~ 223 (355)
T KOG0033|consen 158 GLAIEVN---DGEAWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYEQ 223 (355)
T ss_pred ceEEEeC---CccccccccCCCcccCHHHhhcC---------CCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHHH
Confidence 9998876 23355688999999999999876 499999999999999999999999998553 357788
Q ss_pred HHcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|..+.....+ .+.+++.++|+++||..||.+|.|+.+.++|-+-.
T Consensus 224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 8877654433 34578899999999999999999999999886543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.86 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=197.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.+++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 47999999999997777653 588999999842 23457889999999999999999988754 478999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-------~~kl~Df 145 (291)
T cd05612 79 LMEYVPGGELFSYLRN------SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-------HIKLTDF 145 (291)
T ss_pred EEeCCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-------CEEEEec
Confidence 999997 599999975 25689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ......
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~ 209 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSK---------GHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEK 209 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 999765422 1234688899999999754 478899999999999999999999987543 234444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
+..+. ..++...+..+.+||++||..||.+||+ +.++++|-
T Consensus 210 i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 210 ILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 54443 3466777889999999999999999995 88887664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.79 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=207.3
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGF 293 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 293 (683)
.+.+..++|++.+.||+|+|+.|+.. ++..||||+++.. .+.+.+|+.+|..+ +||||+++++.+
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 45555668999999999998777642 3458999998642 34578999999999 899999999988
Q ss_pred EcCCCCeEEEEEecCC-CCHHHHHHHhcCC--------------------------------------------------
Q 038696 294 TDEEKKECFLIMELMS-RDLCSYIKEICCP-------------------------------------------------- 322 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~-------------------------------------------------- 322 (683)
.+ ....|+||||++ |+|.+++......
T Consensus 109 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 109 TV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred cc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 54 367899999998 5999999753210
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 323 -------------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 323 -------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-------~~kl~DfG 259 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFG 259 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-------cEEEecCc
Confidence 0123578899999999999999999999999999999999998776 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||...... ....+.
T Consensus 260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~ 329 (375)
T cd05104 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKM 329 (375)
T ss_pred cceeccCcccccccCCCCCCcceeChhHhcCC---------CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHH
Confidence 99866443222222233456779999999654 48899999999999999998 89999765432 345556
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+..+..+...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 66666666667778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.89 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=201.4
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCCcc------hHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGDIE------PLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~~~------~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+.|+.+++|++|+++.||. .+++.||+|+++-+.+ ...+||.+|.+++|||||.+-.+....+.+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4799999999998666664 3788999999964322 35799999999999999999988887777889999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||||+.||.+.+... ..+|...++.-++.|++.||+|||+..|+|||||++|+|+...| .+||+|||+
T Consensus 156 Me~~EhDLksl~d~m-----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-------~lKiaDFGL 223 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETM-----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-------ILKIADFGL 223 (419)
T ss_pred HHHHHhhHHHHHHhc-----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-------cEEecccch
Confidence 999999999999863 36799999999999999999999999999999999999999999 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+.+....+ .....+-|.+|.|||.+.+. ..|+.++|+||+|||+.||+++++.|.+.... +++.+.+.
T Consensus 224 AR~ygsp~k--~~T~lVVTLWYRaPELLLG~--------~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~ 292 (419)
T KOG0663|consen 224 AREYGSPLK--PYTPLVVTLWYRAPELLLGA--------KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFK 292 (419)
T ss_pred hhhhcCCcc--cCcceEEEeeecCHHHhcCC--------cccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHH
Confidence 998875432 23456778999999999865 36999999999999999999999999886532 22222221
Q ss_pred c-CC-------------------CC---------CCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-GE-------------------RP---------LFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~~-------------------~~---------~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. |. .+ .|+.. .++.-.+|+..+|..||.+|.|+++.++|
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1 10 00 01111 24567899999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.84 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=212.3
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..|.|..+.+.+..+||+|+|+.|+.. =...||||++.- ..+.|.+|+.++++-+|.||+-|.+++..+ .
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---P 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---c
Confidence 788898899999999999999888842 234799999953 357899999999999999999999988543 4
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+.||+-+|+| +|+.+|.. .+..|...+.++|+.||+.||.|||.++|||||||..||+|.+++ .|||
T Consensus 462 ~AIiTqwCeGsSLY~hlHv-----~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-------kVkI 529 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHV-----QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-------KVKI 529 (678)
T ss_pred eeeeehhccCchhhhhccc-----hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-------cEEE
Confidence 5999999998 99999986 346699999999999999999999999999999999999998876 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+||||+................|...|||||+++.++ ...|++.+||||||+++|||++|..||.... . +.+
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd------~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~-dqI 601 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD------DNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R-DQI 601 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcc------cCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h-hhe
Confidence 9999997655443333444556788899999999664 4469999999999999999999999998432 2 222
Q ss_pred HHHHHcCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPL----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 460 ~~~i~~~~~~~----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.=++-.|+-.+ ...++++++++|+..||..++++||.+.+|+..|+.+.
T Consensus 602 ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 602 IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 22233342222 33567899999999999999999999999998777654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=311.95 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=210.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
-++|++.+.||+|.|+.|++. ++-.||+|++.. -...+.+|++|-+.|+||||+++|++|.++ ...|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--ceeE
Confidence 359999999999999888874 677899999853 235688999999999999999999999876 7899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|++||.. |+|...|.. +....|++..+..|+.|++.||.|+|.++||||||||+|+|++.+| .+||+|
T Consensus 99 LilEya~~gel~k~L~~----~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-------~lkiAd 167 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQE----GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-------ELKIAD 167 (281)
T ss_pred EEEEecCCchHHHHHHh----cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-------CeeccC
Confidence 9999997 799999986 2456799999999999999999999999999999999999999998 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||-+.....+ .....+||..|.+||...+. .++..+|+|++|+++||++.|.+||+... ..+..+
T Consensus 168 fGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~---------~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYk 232 (281)
T KOG0580|consen 168 FGWSVHAPSN----KRKTLCGTLDYLPPEMVEGR---------GHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYK 232 (281)
T ss_pred CCceeecCCC----CceeeecccccCCHhhcCCC---------CccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHH
Confidence 9998766432 23456799999999999866 48999999999999999999999999876 344555
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.|.... ..+|...+..+.++|.+|+..+|.+|.+..++++|-+-
T Consensus 233 rI~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 233 RIRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HHHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 555433 34778899999999999999999999999999987553
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.98 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=196.4
Q ss_pred eCCCeEEEeEecccccEEEEEE--------------------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCcee
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW--------------------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIM 287 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~--------------------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv 287 (683)
..++|.+.++||+|+++.|++. .+..||||.+... ...+.+|+++|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 3468999999999998777753 2336999998642 24688999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 038696 288 HFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICC-------------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIY 353 (683)
Q Consensus 288 ~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~-------------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIi 353 (683)
++++++.+. ...+|||||+. |+|.+++..... ......+++..+..++.||+.||.|||+.||+
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999988654 67899999997 599999865321 11123578889999999999999999999999
Q ss_pred cCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHH
Q 038696 354 HGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVY 433 (683)
Q Consensus 354 HrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVw 433 (683)
||||||+|||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++|||
T Consensus 161 H~dlkp~Nill~~~~-------~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~ 224 (304)
T cd05096 161 HRDLATRNCLVGENL-------TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG---------KFTTASDVW 224 (304)
T ss_pred ccCcchhheEEcCCc-------cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC---------CCCchhhhH
Confidence 999999999998887 7999999999765433222222334457789999998644 488999999
Q ss_pred hHHHHHHHHHh--CCCCCCCCccchhHHHHHH----HcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 434 SFGMICFEILT--GKVPFEDAHLQGDKMSRNI----RAG---ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 434 SlGvil~Ellt--G~~Pf~~~~~~~~~~~~~i----~~~---~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
|||+++|||++ |..||...... .+...+ ... .....+..++..+.+|+.+||..||++|||+.+|.+.|
T Consensus 225 slG~~l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 225 AFGVTLWEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred HHHHHHHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 99999999986 66788765432 222211 111 12234567789999999999999999999999998776
Q ss_pred H
Q 038696 505 R 505 (683)
Q Consensus 505 ~ 505 (683)
+
T Consensus 303 ~ 303 (304)
T cd05096 303 T 303 (304)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.32 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=202.6
Q ss_pred eCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|++.+.||+|+++.|+.. .+..||+|.++.. ...+.+|+.+++.++||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 4568999999999997666542 3568999998643 2357899999999999999999998864 367
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.||||||++| +|.+++.. ....+++..++.++.||+.||+|||++|++||||||+|||++.++ .+|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-------~~~l 148 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRK-----HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-------VCKI 148 (266)
T ss_pred cEEEEEeCCCCcHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-------cEEE
Confidence 9999999985 89988875 234689999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
+|||.+........ .......++..|+|||++.+. .++.++|||||||++||+++ |..||.+... ..
T Consensus 149 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~ 216 (266)
T cd05064 149 SGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYH---------HFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QD 216 (266)
T ss_pred CCCcccccccccch-hcccCCCCceeecCHHHHhhC---------CccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HH
Confidence 99998765432211 112233456789999998654 48899999999999999775 9999987543 33
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+.+.+..+.....+..++..+.+++.+||+.+|.+||++.+|.+.|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 556666666666788889999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.85 Aligned_cols=244 Identities=18% Similarity=0.285 Sum_probs=191.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.+++. +++.||||++... .+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 47999999999997777653 5789999998532 3457899999999999999999998854 3789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+++++.+.+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-------~~kl~Dfg~ 146 (287)
T cd07848 79 FEYVEKNMLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-------VLKLCDFGF 146 (287)
T ss_pred EecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------cEEEeeccC
Confidence 99999876666654 235689999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...... ......
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~ 215 (287)
T cd07848 147 ARNLSEGSN-ANYTEYVATRWYRSPELLLGA---------PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQK 215 (287)
T ss_pred ccccccccc-ccccccccccccCCcHHHcCC---------CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 987643221 122234678899999999654 478899999999999999999999987543221 111000
Q ss_pred -cCC-------------------CCC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 -AGE-------------------RPL----------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 -~~~-------------------~~~----------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+. .+. .....+.++.+||++||+.||++|||++++++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 216 VLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000 011256779999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.81 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=206.9
Q ss_pred ceeEeeCCCeEEEeEeccccc---EEEEEEcCcEEEEEEeCC------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFG------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~---~~v~l~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~ 297 (683)
.-+.+....|+++++||.||. |+|...+...+|+|++.. ..+-|.+|+.+|.+|+ |.+||++|++-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d- 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD- 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-
Confidence 346778889999999999985 444444556788887632 2456899999999995 99999999887654
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
+.+||||||-+-||...|++. ..-.+...+..|..|++.++.++|+.||||.||||.|+|+-.+ .+
T Consensus 433 -~~lYmvmE~Gd~DL~kiL~k~-----~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG--------~L 498 (677)
T KOG0596|consen 433 -GYLYMVMECGDIDLNKILKKK-----KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG--------RL 498 (677)
T ss_pred -ceEEEEeecccccHHHHHHhc-----cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee--------eE
Confidence 789999999889999999973 2334444899999999999999999999999999999999655 69
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccccc--CCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESAS--NSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~--~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
||+|||+|..+......-.....+||+.||+||.+.....+.... ..+++.++||||||||||+|+.|+.||......
T Consensus 499 KLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~ 578 (677)
T KOG0596|consen 499 KLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ 578 (677)
T ss_pred EeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH
Confidence 999999999887765555566789999999999998765443322 335889999999999999999999999764422
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKY-VTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~-l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
-..+......+....||...+.+ +.++++.||+.||++|||+.++++|
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222222222333455555444 9999999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.48 Aligned_cols=243 Identities=20% Similarity=0.336 Sum_probs=195.5
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|++.+.||+|+++.|++ .+|+.||||.+... ...+.+|+.+|..++|+||+++++++.+. +.+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 488999999999877765 36899999988421 23467899999999999999999888543 689999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++ |+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~g~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-------~~kl~Dfg 147 (285)
T cd05631 79 LTIMNGGDLKFHIYNM----GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-------HIRISDLG 147 (285)
T ss_pred EEecCCCcHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-------CEEEeeCC
Confidence 99998 5898888642 234689999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSR 461 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~ 461 (683)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+..
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNE---------KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR 215 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCC---------CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH
Confidence 997754321 12345688999999999654 48899999999999999999999998654321 12222
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
.+. .....++...+..+.+|+++||+.||.+||+ ++++++|-
T Consensus 216 ~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 216 RVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred Hhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 232 2233456677889999999999999999997 78887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.72 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=193.3
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC---CeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK---KECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~---~~~~ 302 (683)
+|++.+.||+|+++.++.. +|..||||++.. ....+.+|+++|+.++||||+++++++..... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999997776653 688999999853 23357899999999999999999988754322 3589
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 81 lv~e~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------~~kL~Df 147 (338)
T cd07859 81 VVFELMESDLHQVIKA------NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-------KLKICDF 147 (338)
T ss_pred EEEecCCCCHHHHHHh------cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------cEEEccC
Confidence 9999999999999875 24689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh----
Q 038696 383 GLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD---- 457 (683)
Q Consensus 383 Gla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~---- 457 (683)
|+++........ .......||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+......
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~ 220 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhcc-------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence 999765322111 112345688999999998642 12588999999999999999999999976442110
Q ss_pred ---------H------------HHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 458 ---------K------------MSRNIRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 458 ---------~------------~~~~i~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
. ....+.......+ ....+..+.+++.+||..||++|||+.+++++-+
T Consensus 221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 0 0000001110000 1235677899999999999999999999998744
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.57 Aligned_cols=234 Identities=25% Similarity=0.352 Sum_probs=192.2
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.|++. +|+.||||++.. ....+.+|+.+|+.++||||+++++.+... ..+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCCC
Confidence 46899998777753 688999999853 134567899999999999999999888643 78999999998
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
| +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-------~~kl~DfG~a~~~ 145 (323)
T cd05571 79 GGELFFHLSR------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-------HIKITDFGLCKEG 145 (323)
T ss_pred CCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-------CEEEeeCCCCccc
Confidence 5 99998875 25689999999999999999999999999999999999998887 7999999998754
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+...+..+ .
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~-~ 211 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME-E 211 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCC---------CCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHHcC-C
Confidence 3211 122345689999999999654 488999999999999999999999976542 2344444433 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+|...+.++.+||++||+.||++|| ++.++++|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 456778899999999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.04 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=206.1
Q ss_pred CCCeEEEeEecccccEEEEEE----c-----CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----L-----GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~-----g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.|+.. . +..||+|.+... ...+.+|+.++..++||||+++++++.+. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 358999999999987666642 1 257999998642 24578999999999999999999988643 6
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
..|++|||++ |+|.+++...... .....+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 7899999997 5999999763211 1114688999999999999999999999999999999999998877
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCC
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~ 447 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 162 -------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDv~slG~il~el~~~g~~ 225 (283)
T cd05048 162 -------TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG---------KFTTESDIWSFGVVLWEIFSYGLQ 225 (283)
T ss_pred -------cEEECCCcceeeccccccccccCCCcccccccCHHHhccC---------cCchhhhHHHHHHHHHHHHcCCCC
Confidence 7999999999765433222223344567889999998644 48899999999999999998 999
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
||.+... ..+...+..+..+..+..++.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus 226 p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 226 PYYGFSN--QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCH--HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 9987553 34666677777777788899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=347.68 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=203.3
Q ss_pred CeEEEeEecccccEEEEEE----c-CcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGSQYKEILW----L-GESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~-g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.|.+.+.||+|+++.++.. + +..||+|.+... ...+.+|+.+|+.++|||||++++.|..+ +.+|||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEEE
Confidence 5999999999997777653 3 678999976432 23567899999999999999999998654 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.++|.+.. ....++++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 146 ~~~gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-------~~kL~DFgla 216 (478)
T PTZ00267 146 YGSGGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-------IIKLGDFGFS 216 (478)
T ss_pred CCCCCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-------cEEEEeCcCc
Confidence 997 59999887532 2345789999999999999999999999999999999999999887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..+...+..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~~~~ 285 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERK---------RYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQVLY 285 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCC---------CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence 876543222233445689999999999654 489999999999999999999999986543 334555555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+....++..++..+.++|.+||..||++||++.+++.+
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 66666777888999999999999999999999999865
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.55 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=200.3
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC---eEEEEEecC
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK---ECFLIMELM 308 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~---~~~LVmEy~ 308 (683)
.|+-.+.+|.|+|+.|+. .+++.||||+.-.+.+--.+|+.+|+.++|||||++..+|.....+ ++.+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 688899999999766664 3678999999977766667899999999999999999888654333 456899999
Q ss_pred CCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 309 SRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
+.+|.++++.+.. .+..++.-.+.-|.+||++||.|||+.||+||||||+|+|+|.+.. .+||||||.|+..
T Consensus 105 P~tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg------~LKicDFGSAK~L 176 (364)
T KOG0658|consen 105 PETLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG------VLKICDFGSAKVL 176 (364)
T ss_pred hHHHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC------eEEeccCCcceee
Confidence 9999999986432 2355888899999999999999999999999999999999998842 7999999999988
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc---
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA--- 465 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~--- 465 (683)
..+.. ......|-.|.|||.+.+. ..|+.+.||||.|||+.||+.|++.|.+.+.. +++...+..
T Consensus 177 ~~~ep---niSYicSRyYRaPELifga--------~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~ 244 (364)
T KOG0658|consen 177 VKGEP---NISYICSRYYRAPELIFGA--------TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGT 244 (364)
T ss_pred ccCCC---ceeEEEeccccCHHHHcCc--------cccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCC
Confidence 75532 2345566779999999754 47999999999999999999999999886532 222222211
Q ss_pred --------CCC----------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 --------GER----------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 --------~~~----------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... ..+....++++.+|+.++|..+|++|.++.+++.|-
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 000 013345678899999999999999999999998764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.84 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=206.7
Q ss_pred EeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+...+|.+.+.||+|+++.+++ ..+..||+|.+... .+.+.+|+++++.++|+||+++++.+..+ ..+++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 79 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEE
Confidence 34556899999999998655543 25789999998653 34688999999999999999999888543 67899
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ....+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-------~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLREC----NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------LVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-------cEEeCCC
Confidence 999997 5999998752 234689999999999999999999999999999999999998877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........ .......+++.|+|||++.+. .++.++|||||||++|||++ |..||.+... .....
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~ 216 (263)
T cd05052 149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE 216 (263)
T ss_pred cccccccccee-eccCCCCCccccCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 99987654321 122233345679999998654 47889999999999999998 9999987543 34556
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.+..+..+..+..++..+.+++.+||..||++|||+.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 6666666777888899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.06 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=200.5
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----c-CcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----L-GESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~-g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
..+..++|++.+.||+|+++.|++. . +..||||.+.. ..+.+.+|+.++..++||||+++++++.++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~- 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE- 103 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-
Confidence 3345668999999999997777653 2 25899998842 245678899999999999999999998654
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 104 -~~~~lv~Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------~ 169 (340)
T PTZ00426 104 -SYLYLVLEFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-------F 169 (340)
T ss_pred -CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-------C
Confidence 78999999997 5999999752 4689999999999999999999999999999999999998887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.
T Consensus 170 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-- 233 (340)
T PTZ00426 170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNV---------GHGKAADWWTLGIFIYEILVGCPPFYANEP-- 233 (340)
T ss_pred EEEecCCCCeecCCC-----cceecCChhhcCHHHHhCC---------CCCccccccchhhHHHHHhcCCCCCCCCCH--
Confidence 999999999865421 2345688999999999754 478899999999999999999999987543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
..+...+..+. ..+|...+..+.++|++||+.||.+|+ +++++++|.
T Consensus 234 ~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 234 LLIYQKILEGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 23444555443 346777888999999999999999995 888887663
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.11 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=205.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+...+|++.+.||+|+++.|++. +|. .||||.+... .+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--- 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence 44568999999999997666642 344 4899998632 3467889999999999999999988854
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...++|+||+. |+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-------~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-------HV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-------cE
Confidence 34689999997 6999999862 34588999999999999999999999999999999999998877 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-- 217 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-- 217 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 99999999876543332222334456789999999654 48899999999999999997 9999987543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
..+...+..+.....+..++..+.+++.+||..||++||++.+++..|..+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2345556666666677788899999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.30 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=219.7
Q ss_pred EeeCCCeEEEeEecccccEEEEE---E----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL---W----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l---~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+|......|.++||.|.|+.|.. . ....||||.++. ...+|..|+.||.+++||||++|.++... .
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--S 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--C
Confidence 45555788999999998766663 1 234699999975 35679999999999999999999998854 4
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
+.++||+|||+ |+|..||++ +.+.|+..+.+.++++|+.||+||-++|+|||||...||||+.+ +.+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~-----~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-------LvC 770 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQ-----NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-------LVC 770 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhh-----cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-------eEE
Confidence 78999999997 799999997 34679999999999999999999999999999999999999665 489
Q ss_pred EEecccCccccCCCC-CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGP-KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
||+||||++....+. ......+..-+++|.|||.+. ..+++.++||||||++|||.++ |..||-+++.+
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa---------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA---------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhh---------hcccCchhhccccceEEEEecccCCCcccccchH
Confidence 999999999876554 333444556678999999995 4479999999999999999887 99999987755
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+.+.|..+++.+.|.+||..|..|+..||++|-.+||+|.+|+.+|.++-+
T Consensus 842 --dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 842 --DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 5888999999999999999999999999999999999999999999998754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.29 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=203.1
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
|.+..++|++.+.||+|+++.++.. .+..||||.+... ...+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~- 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS- 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 3456779999999999987666542 2467999998542 235789999999999999999998884
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPR----KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
+....++||||++ |+|.+++....... ....+++..+..++.|++.||.|||+.|++||||||+|||++.++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-- 156 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--
Confidence 4467899999998 59999997532111 123467889999999999999999999999999999999998877
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf 449 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..||
T Consensus 157 -----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 157 -----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred -----CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC---------CcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 7999999998765432221112223456789999998644 48899999999999999999 78999
Q ss_pred CCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+... ....+.+..+..+..+..++..+.+++.+||+.||++|||+.+++++|+
T Consensus 223 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 223 QGMSN--EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 76543 3455555555555667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.57 Aligned_cols=261 Identities=27% Similarity=0.485 Sum_probs=209.3
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFT 294 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 294 (683)
|.+..++|++.+.||+|+++.|+.. +++.||+|++... .+.+..|+.++..+ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 5566779999999999997777642 2468999998642 23567899999999 7999999998776
Q ss_pred cCCCCeEEEEEecCCC-CHHHHHHHhcCC---------------------------------------------------
Q 038696 295 DEEKKECFLIMELMSR-DLCSYIKEICCP--------------------------------------------------- 322 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~g-sL~~~l~~~~~~--------------------------------------------------- 322 (683)
.. ...+++||||++| +|.+++......
T Consensus 82 ~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 82 KP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred cC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 43 4678999999985 999998642110
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCC
Q 038696 323 ----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398 (683)
Q Consensus 323 ----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~ 398 (683)
....++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++............
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-------~vkL~DfG~a~~~~~~~~~~~~~ 233 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLARDIYKDPDYVRKG 233 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-------cEEEeccccchhcccCcchhhcc
Confidence 0013689999999999999999999999999999999999998877 79999999998764433222233
Q ss_pred CCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcH
Q 038696 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPK 477 (683)
Q Consensus 399 ~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 477 (683)
...++..|+|||++.+. .++.++|||||||++|||++ |..||.+.... +.+...+..+..+..+...+.
T Consensus 234 ~~~~~~~y~aPE~~~~~---------~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 303 (337)
T cd05054 234 DARLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRMRAPEYATP 303 (337)
T ss_pred CCCCCccccCcHHhcCC---------CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCCCCCccCCH
Confidence 34556789999999654 48899999999999999998 99999875433 234455566666666777889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 478 YVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 478 ~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
++.+++.+||+.+|++||++.+++++|..+-
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.18 Aligned_cols=245 Identities=25% Similarity=0.415 Sum_probs=191.5
Q ss_pred CCeEEEeEecccccEEEEEE-----cCcEEEEEEeCCC------cchHHHHHHHHHcC---CCCceeeeeeeEEc---CC
Q 038696 235 EDYQVRRRLGSGSQYKEILW-----LGESFALRHFFGD------IEPLVPEISSLLSL---SHPNIMHFLCGFTD---EE 297 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---e~ 297 (683)
++|++.+.||+|+++.|++. .|..||||.+... ...+.+|+.+++.+ +||||+++++++.. +.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37999999999998777753 3578999988531 23466788887766 69999999988752 23
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...+++||||++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-------~~ 149 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------QI 149 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-------CE
Confidence 3568999999999999999752 234589999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.... +
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~ 216 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-D 216 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCC---------CCCCccchHHHHHHHHHHHcCCCCcCCCCHH-H
Confidence 99999999765432 123345688899999999644 4888999999999999999999999875432 1
Q ss_pred HHHHHHHcCCCC-------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERP-------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~-------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+...+.....+ ......+..+.+|+.+||+.||++|||+.++++|
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 222222110000 0112456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=339.01 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=211.4
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEEc---------CcEEEEEEeCCC-----cchHHHHHHHHHcCC-CCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILWL---------GESFALRHFFGD-----IEPLVPEISSLLSLS-HPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~~---------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~-HpnIv~l~~~ 292 (683)
+.+.+..++|.+++.||+|+|+.|+... +..||||++... .+.+.+|+++|+.+. |||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 5788888899999999999987776421 246999998532 346889999999996 9999999998
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcCC-------------------------------------------------
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICCP------------------------------------------------- 322 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~------------------------------------------------- 322 (683)
+.. ...+|||||||+ |+|.++|.+....
T Consensus 110 ~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 110 CTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred Ecc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 854 467999999997 5999998763210
Q ss_pred -----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 038696 323 -----------------------------------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361 (683)
Q Consensus 323 -----------------------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~N 361 (683)
.....+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 011358888999999999999999999999999999999
Q ss_pred EEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 362 ILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++|||||||++||
T Consensus 268 ill~~~~-------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwSlGvil~e 331 (400)
T cd05105 268 VLLAQGK-------IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN---------LYTTLSDVWSYGILLWE 331 (400)
T ss_pred EEEeCCC-------EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC---------CCCchhhHHHHHHHHHH
Confidence 9998876 7999999999866443222233344567789999998644 48899999999999999
Q ss_pred HHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 442 llt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|++ |..||...... ..+...+..+..+..+..++..+.+++.+||+.||++|||+.++.+.|+.+
T Consensus 332 llt~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 332 IFSLGGTPYPGMIVD-STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHCCCCCCcccchh-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 997 99999865432 334455666666667778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.91 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=213.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|..++.+|+|+|+.+++. ++..|++|.+.- .......|+.+++++.|||||.+++.|.. ++..++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceEEEE
Confidence 58999999999998887763 667899999842 23467899999999999999999999965 33459999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|+||+| +|.+.|++. ++..|+++.+..++.||+.|+.|||+++|+|||||+.||+++.++ .|||+|||
T Consensus 83 m~Y~eGg~l~~~i~~~----k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-------~VkLgDfG 151 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ----KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-------KVKLGDFG 151 (426)
T ss_pred EeecCCCCHHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-------ceeecchh
Confidence 999985 999999874 357799999999999999999999999999999999999999888 68999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+|+..+... .......||+.||.||++.+. .|+.|+|||||||++|||++-+++|...+..+ +...|
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~---------pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--Li~ki 218 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDI---------PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--LILKI 218 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCC---------CCCccCcchhhcchHHHHHhcccccCccchHH--HHHHH
Confidence 999887543 244567899999999999766 59999999999999999999999999887663 55666
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+...+.|...+.+++.||+.||..+|..||++.+++.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 6666777888999999999999999999999999999886
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=347.08 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=208.6
Q ss_pred eeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
......++|++.+.||+|+++.|++ .+|+.||||++... ...+.+|+.+|..++|+||++++..+...+.
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 4445567999999999999877764 37899999998431 3457889999999999999998876653221
Q ss_pred ------CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 299 ------KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 299 ------~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
..+++||||+. |+|.++|.... .....+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~--~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--- 180 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--- 180 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---
Confidence 24789999998 59999997532 2235689999999999999999999999999999999999998887
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~ 451 (683)
.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 181 ----~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 181 ----LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK---------PYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred ----CEEEEecccCeeccccccccccccccCCcceeCHHHhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 7999999999876433222223345689999999999654 489999999999999999999999987
Q ss_pred CccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 452 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.... .+...+..+....++..+++.+.+++.+||+.||.+||++.+++++.
T Consensus 248 ~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 248 ENME--EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred CCHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 5532 34455556666667888899999999999999999999999998864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.77 Aligned_cols=252 Identities=25% Similarity=0.470 Sum_probs=204.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
|.+..++|++.++||+|+++.+++ .++..||+|.+.. ..+.+.+|+.+++.++|+||+++++.+.+ ...+|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 345667999999999998665554 4667899998864 24578899999999999999999988754 467899
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+||
T Consensus 79 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-------~~~l~df 147 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-------MCKIADF 147 (261)
T ss_pred EEecCCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-------cEEECCC
Confidence 999997 5999999753 335688999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........ .......++..|+|||++.+. .++.++|||||||++|+|++ |..||..... .....
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~ 215 (261)
T cd05072 148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMS 215 (261)
T ss_pred ccceecCCCce-eccCCCccceecCCHHHhccC---------CCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHH
Confidence 99987643321 122233456779999998643 47889999999999999998 9999976542 23445
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+.+...+..++.++.+++.+||..||++||+++++.+.|+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 216 ALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 555555555556778999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.81 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=197.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+..++|++.+.||+|+++.|++. +|..||+|.+... .+.+.+|+++|+.++||||+++++++.++ ..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEE
Confidence 34679999999999997766652 5789999998643 24688999999999999999999988654 6899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+||||++| +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-------~~kl~ 146 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-------EIKLC 146 (331)
T ss_pred EEeecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-------cEEEc
Confidence 99999985 999999752 4589999999999999999999986 699999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh---
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD--- 457 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~--- 457 (683)
|||++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 147 Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 213 (331)
T cd06649 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213 (331)
T ss_pred cCccccccccc----ccccCCCCcCcCCHhHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99998765332 22345688899999999654 488999999999999999999999965332110
Q ss_pred -----------------------------------------HHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCC
Q 038696 458 -----------------------------------------KMSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRP 495 (683)
Q Consensus 458 -----------------------------------------~~~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RP 495 (683)
.....+.....+..+ ...+.++.+||.+||..||++||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp 293 (331)
T cd06649 214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA 293 (331)
T ss_pred hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC
Confidence 011112222222222 23578899999999999999999
Q ss_pred CHHHHHHHHHH
Q 038696 496 SFSSICRILRY 506 (683)
Q Consensus 496 t~~eil~~L~~ 506 (683)
|+.++++|.+.
T Consensus 294 t~~ell~h~~~ 304 (331)
T cd06649 294 DLKMLMNHTFI 304 (331)
T ss_pred CHHHHhcChHH
Confidence 99999988653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.59 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=196.4
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +|+.||||++.. ....+.+|+.+|..++||||+++++++.+. ..+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEE
Confidence 47999999999998777753 588999999853 234578899999999999999999988643 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~e~~~g~~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kL~Df 145 (333)
T cd05600 79 AMEYVPGGDFRTLLNN------LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-------HIKLTDF 145 (333)
T ss_pred EEeCCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-------CEEEEeC
Confidence 9999975 99999975 25689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~ 209 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGK---------GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWEN 209 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCC---------CCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHH
Confidence 99976543 22345688999999999654 4889999999999999999999999875532 22222
Q ss_pred HHcCC----CCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGE----RPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~----~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+.... .+... ...+.++.++|.+||..+|.+||++.++++|.+
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 32211 11111 245788999999999999999999999988743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=338.10 Aligned_cols=247 Identities=20% Similarity=0.306 Sum_probs=192.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+...+|++++.||+|+++.|++. +++.||||... ...+.+|+++|+.|+|||||+++++|... ...++|||+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~ 164 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLILPR 164 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEEEec
Confidence 34568999999999998777753 68899999763 45678999999999999999999988654 678999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+.++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 165 ~~~~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-------~vkL~DFG~a~~ 231 (391)
T PHA03212 165 YKTDLYCYLAA------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-------DVCLGDFGAACF 231 (391)
T ss_pred CCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-------CEEEEeCCcccc
Confidence 99999999875 24589999999999999999999999999999999999998887 799999999975
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc------chhHHHH
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL------QGDKMSR 461 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~------~~~~~~~ 461 (683)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|..||..... ....+..
T Consensus 232 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 232 PVDIN-ANKYYGWAGTIATNAPELLARD---------PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred ccccc-ccccccccCccCCCChhhhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 43211 1122345789999999999654 489999999999999999999988753210 0011111
Q ss_pred HHH-------------------------cCC--CCC-CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 462 NIR-------------------------AGE--RPL-FP-----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 462 ~i~-------------------------~~~--~~~-~p-----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+. ... .+. .+ ...+.++.+||.+||+.||.+|||+.+++++-+
T Consensus 302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 110 000 000 00 123567899999999999999999999988644
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=342.11 Aligned_cols=241 Identities=23% Similarity=0.395 Sum_probs=204.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|.-++-||.|+|+.||.. +.+.||||++.- ...++..|++.|..|.|||+|.+-+||..+ ...|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHH
Confidence 4677788999998888864 677999999842 245688999999999999999999988765 678999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||||-|+-.|+|.- ...++-+.++..|+.+.+.||.|||+.+.||||||..|||+++.| .|||+|||.
T Consensus 105 MEYClGSAsDlleV-----hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-------~VKLaDFGS 172 (948)
T KOG0577|consen 105 MEYCLGSASDLLEV-----HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-------LVKLADFGS 172 (948)
T ss_pred HHHHhccHHHHHHH-----HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-------eeeeccccc
Confidence 99998876666654 236799999999999999999999999999999999999999998 899999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|.... ..+..+|||.||||||+... ..+.|+-++||||||+++.||.-.++|+.+++.. .....|.
T Consensus 173 Asi~~------PAnsFvGTPywMAPEVILAM------DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIA 238 (948)
T KOG0577|consen 173 ASIMA------PANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA 238 (948)
T ss_pred hhhcC------chhcccCCccccchhHheec------cccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHH
Confidence 97754 33567899999999999876 4667999999999999999999999998876533 2344555
Q ss_pred cCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+..|..+ ..++.++++++..||+.-|.+|||.+++++|-
T Consensus 239 QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 239 QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 66555544 56789999999999999999999999998874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.24 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=199.8
Q ss_pred cccceeEeeCCCeEEEeEeccccc---EEEEEEcCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 225 LLPSRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 225 ~~~~~~~~~~~~y~i~~~LG~G~~---~~v~l~~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+...++..++++|.-.+.||+|+| |++.+.+|..||||++... ..+|.+|+.+|.+++|||+|+++++|.+.+
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 445677778899999999999985 5555667899999988642 356999999999999999999999997542
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEeCCCCCCCC
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRI-PFSLPVAVDLMLQIARGMEYLHSKK---IYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IiHrDLKp~NILl~~~g~~~~ 372 (683)
. ..+||+|||. |+|.++|... .. +++|..+++|+.++|.||+|||... |||||||++|||||.+.
T Consensus 145 ~-~~~LVYEym~nGsL~d~L~~~-----~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~---- 214 (361)
T KOG1187|consen 145 E-HRLLVYEYMPNGSLEDHLHGK-----KGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF---- 214 (361)
T ss_pred c-eEEEEEEccCCCCHHHHhCCC-----CCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC----
Confidence 2 6899999997 7999999852 22 8999999999999999999999854 99999999999998775
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCC-CcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGT-THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~-~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~ 451 (683)
.+||+|||+|+..... ....... .||++|+|||++.. +..+.++|||||||+|.||++|+.+.+.
T Consensus 215 ---~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~---------g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 215 ---NAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYAST---------GKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred ---CEEccCccCcccCCcc--ccceeeecCCCCccCChhhhcc---------CCcCcccccccchHHHHHHHhCCcccCC
Confidence 8999999999665431 1111122 78999999999964 3589999999999999999999988875
Q ss_pred Cccchh-HHH----HHHHcCC-----CCCCC-CCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 452 AHLQGD-KMS----RNIRAGE-----RPLFP-FHS-----PKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 452 ~~~~~~-~~~----~~i~~~~-----~~~~p-~~~-----~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
....+. .+. ..+..+. .+.+. ... -..+..+..+|++.+|.+||+|.++++.|+.+.
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 321111 011 1222211 11111 122 233667888999999999999999998885543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=367.22 Aligned_cols=283 Identities=21% Similarity=0.304 Sum_probs=229.3
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..+..+||+|+++||+|+|+.|.+. +++.||+|++.+ +..-|..|-.+|..-+.+.||++++.|+|+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-- 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-- 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--
Confidence 4456779999999999998777753 688999999853 345688999999999999999999999876
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
.++|||||||+ |||..++.+. .++++..+..|+..|+.||.-||+.|+|||||||+|||||..| |+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-------Hi 214 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-------HI 214 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-------cE
Confidence 78999999997 5999999863 4799999999999999999999999999999999999999999 99
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||.|-.++.... ......+|||.|.+||+++..+. +.+.|+..+|+||+||++|||++|..||...+.. +
T Consensus 215 kLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~----~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-e 288 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGD----GKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-E 288 (1317)
T ss_pred eeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcC----CccccCCccchhhhHHHHHHHHcCCCcchHHHHH-H
Confidence 9999999977764432 23456789999999999987752 2368999999999999999999999999876654 3
Q ss_pred HHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCch
Q 038696 458 KMSRNIRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPS---FSSICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSD 532 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt---~~eil~~L~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (683)
.+.++........|| ...+++.++||.+.+ .+|+.|.+ ++++..|.. |..++|+..+...||.-|.-.++
T Consensus 289 TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpF----F~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPF----FEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred HHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCcc----ccCCChhhhhhcCCCCCCcCCCC
Confidence 344444444455566 567999999999976 57999987 888877754 45667776666666654444444
Q ss_pred HHHHHh
Q 038696 533 IESRLL 538 (683)
Q Consensus 533 ~~~~~~ 538 (683)
.++..+
T Consensus 364 ~DTsnF 369 (1317)
T KOG0612|consen 364 DDTSNF 369 (1317)
T ss_pred Cccccc
Confidence 444444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=321.06 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=208.1
Q ss_pred eCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
...+|.+.+.||+|+++.+++. ++..+|+|.+... .+.+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 4568999999999997777653 2356999998642 3468899999999999999999998864 36
Q ss_pred eEEEEEecCC-CCHHHHHHHhcC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEICC-------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
.+++||||++ |+|.+++..... ......+++..+..++.|++.||+|||++|++||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--- 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--- 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC---
Confidence 7899999998 599999975321 01223589999999999999999999999999999999999998887
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~ 450 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 158 ----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred ----cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7999999999765432222222334456789999998644 48889999999999999998 999997
Q ss_pred CCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.... ......+..+.....+...+..+.+|+.+||+.||.+|||+.++.+.|+.+.+
T Consensus 225 ~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 225 QLSN--NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 6543 33556666666656667788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=360.55 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=212.9
Q ss_pred eCCCeEEEeEecccccEEEEEE-----cCc----EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW-----LGE----SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~-----~g~----~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
...+.++.+.||+|+|+.|+.- .|. .||||.+.. +..+|.+|+.+|+.++|||||++++++.+ .
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--S 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--C
Confidence 4567888999999987666631 333 599999865 35679999999999999999999999976 3
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCP-RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
...+|++|||. |||..||++.... .....++....+.|+.|||.|++||+++++|||||..+||||+.+. .
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-------~ 840 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-------V 840 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-------c
Confidence 67899999997 5999999974211 1245689999999999999999999999999999999999998776 8
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
|||+|||+|+.+-............-+..|||||.+... .++.++|||||||+|||+++ |..||.+.+..
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~---------iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG---------IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhc---------ccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 999999999954433332222223456789999999754 69999999999999999999 99999986643
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
++...+..+.+...|..||..+.+||..||+.+|++||+|..|++.+..+...
T Consensus 912 --~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 912 --EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 35554555668999999999999999999999999999999999988776543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=314.94 Aligned_cols=244 Identities=29% Similarity=0.506 Sum_probs=200.0
Q ss_pred CCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 235 EDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
++|++.+.||+|+++.+++ ..+..+|+|.+... .+.+.+|+.+|+.++||||+++++++.. ...+++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEEcC
Confidence 4799999999998655553 35668999988642 4578899999999999999999988854 46799999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-------~~kl~d~g~~~~ 149 (256)
T cd05114 82 ENGCLLNYLRQR-----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSDFGMTRY 149 (256)
T ss_pred CCCcHHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-------eEEECCCCCccc
Confidence 7 5999998752 24589999999999999999999999999999999999998877 799999999876
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ......+..+
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~ 217 (256)
T cd05114 150 VLDDEY-TSSSGAKFPVKWSPPEVFNFS---------KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRG 217 (256)
T ss_pred cCCCce-eccCCCCCchhhCChhhcccC---------ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC
Confidence 533211 122233456679999998644 47889999999999999999 9999976543 3355566666
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.++..+...+..+.+++.+||+.||++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 66666777788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.75 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=205.8
Q ss_pred eCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..++|.+.+.||+|+++.+++. ++..||||.++.. .+.+.+|+++|+.++|+||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3457999999999997766642 2468999998642 35688999999999999999999988654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 299 KECFLIMELMSR-DLCSYIKEICC--------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
...++||||++| +|.+++..... ......+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~- 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL- 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence 679999999974 99999976421 12234588999999999999999999999999999999999998887
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 160 ------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e~~~~g~~p 224 (280)
T cd05049 160 ------VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred ------eEEECCcccceecccCcceecCCCCcccceecChhhhccC---------CcchhhhHHHHHHHHHHHHhcCCCC
Confidence 8999999999765332221222334457789999999654 48889999999999999998 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|.+... ......+..+.....+...+..+.+++.+||..||++||++.++++.|.
T Consensus 225 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 225 WYGLSN--EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 976543 3455666666666667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.71 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=203.8
Q ss_pred EeeCCCeEEEeEecccccEEEE---EEcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEI---LWLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~---l~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+..++|++.+.||+|+++.++ ...++.||||.++.. .+.+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeee
Confidence 4566789999999999855444 345678999998642 3568899999999999999999988754 3678999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+. ++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 80 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~~l~dfg 148 (261)
T cd05068 80 TELMKYGSLLEYLQGG----AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-------ICKVADFG 148 (261)
T ss_pred eecccCCcHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-------CEEECCcc
Confidence 99996 6999999752 234689999999999999999999999999999999999999887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
+++....... ....+...+..|+|||++.+. .++.++||||||+++|||++ |+.||.+... ..+...
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~ 216 (261)
T cd05068 149 LARVIKEDIY-EAREGAKFPIKWTAPEAALYN---------RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQ 216 (261)
T ss_pred eEEEccCCcc-cccCCCcCceeccCccccccC---------CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH
Confidence 9987653211 112223334579999998644 47889999999999999999 9999986542 234455
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+........+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 55555555667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.23 Aligned_cols=251 Identities=31% Similarity=0.441 Sum_probs=199.3
Q ss_pred CCe-EEEeEecccccEEEEE--------EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 235 EDY-QVRRRLGSGSQYKEIL--------WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 235 ~~y-~i~~~LG~G~~~~v~l--------~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
++| ++.+.||+|+++.|++ .++..||+|.+... .+.+.+|+++|+.++||||+++++++...+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 9999999999877754 25778999998642 346788999999999999999998876655567
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||+.+ +|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~~~l 148 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-------LVKI 148 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-------cEEE
Confidence 8999999985 99999875 3589999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--
Q 038696 380 SGFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-- 456 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-- 456 (683)
+|||+++......... ......++..|+|||++.+. .++.++||||||+++|||++|..||.......
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 219 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN---------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhccc---------CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh
Confidence 9999998765432211 11223345669999998644 47889999999999999999999986432110
Q ss_pred -----------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 -----------DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 -----------~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
......+..+.....+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 220 MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1112223333444456678899999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.94 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=201.0
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.++ .
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~ 116 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--K 116 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 345669999999999998777753 678999999842 223467899999999999999999888543 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------~~k 182 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HLK 182 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-------CEE
Confidence 8999999997 599998864 3588999999999999999999999999999999999999887 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||++........ .......||+.|+|||++.+.. ....++.++|||||||++|||++|+.||.+.... .
T Consensus 183 L~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~ 254 (370)
T cd05596 183 LADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQG-----GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G 254 (370)
T ss_pred EEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCC-----CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--H
Confidence 999999976543211 1223456899999999997542 1234788999999999999999999999876542 2
Q ss_pred HHHHHHcC-CCCCCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 038696 459 MSRNIRAG-ERPLFPF--HSPKYVTNLTKRCWHADPNQ--RPSFSSICRIL 504 (683)
Q Consensus 459 ~~~~i~~~-~~~~~p~--~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~L 504 (683)
....+... ....+|. ..+..+.+||.+||..+|.+ |+|+.++++|.
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 33444332 2233443 46889999999999999987 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.60 Aligned_cols=243 Identities=25% Similarity=0.338 Sum_probs=194.9
Q ss_pred CeEEEeEecccccEEEEEE-------cCcEEEEEEeCC--------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 236 DYQVRRRLGSGSQYKEILW-------LGESFALRHFFG--------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+|++++.||+|+++.|++. +|+.||+|++.. ..+.+..|+.++..+ +||||+++++++..+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 5899999999998777752 578999999853 134577899999999 599999999888543 7
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-------~~k 145 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ------RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-------HVV 145 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-------CEE
Confidence 89999999985 99999875 25689999999999999999999999999999999999999887 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--ch
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~ 456 (683)
|+|||+++....... .......||+.|+|||++.+.. .++.++|||||||++|||++|..||..... ..
T Consensus 146 l~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 216 (332)
T cd05614 146 LTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKG--------GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216 (332)
T ss_pred EeeCcCCccccccCC-CccccccCCccccCHHHhcCCC--------CCCCccccccchhhhhhhhcCCCCCCCCCCCCCH
Confidence 999999976543221 1223456899999999996431 367899999999999999999999964322 12
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+...+.. ..+.++...+..+.+++.+||+.||++|| +++++++|
T Consensus 217 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 217 SEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 233333333 33456677889999999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=317.89 Aligned_cols=243 Identities=38% Similarity=0.659 Sum_probs=197.3
Q ss_pred EEEeEecccccEEEEE--Ec------CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 238 QVRRRLGSGSQYKEIL--WL------GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l--~~------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++.+.||.|+|+.++. +. +..|+||.++.. .+.+.+|++++++++||||+++++++... ..+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc--cccccc
Confidence 5788999999877775 23 568999999542 46789999999999999999999988743 569999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++ |+|.++|... ....+++..+..++.||+.||.|||+++|+|+||+++|||++.++ .+||+|||
T Consensus 80 ~e~~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-------~~Kl~~f~ 148 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-------QVKLSDFG 148 (259)
T ss_dssp EE--TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-------EEEEESTT
T ss_pred cccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccc-------cccccccc
Confidence 99998 6999999973 346799999999999999999999999999999999999999887 89999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
++....................|+|||++.... ++.++||||||+++|||++ |+.||.+.. ...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---------~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~ 217 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE---------YTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEK 217 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE---------ESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccc---------ccccccccccccccccccccccccccccc--ccccccc
Confidence 998763322222233445667899999997663 8999999999999999999 789998764 3446667
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+..+.+...+..++..+.++|..||+.||++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 LKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 778877778888999999999999999999999999998865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.37 Aligned_cols=262 Identities=28% Similarity=0.469 Sum_probs=211.0
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-----------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-----------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-----------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
.++.+..++|.+.+.||+|+++.|+.. .+..+|+|.+... ...+..|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 356677789999999999998777753 1246999999643 23577899999999 799999999
Q ss_pred eeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 291 CGFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+++... ..+|+||||++ |+|.+++...... .....+++.+++.++.|++.||+|||+.|++||||||
T Consensus 91 ~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 91 GACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 988644 67899999997 5999999763211 0123588999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++|||||||++
T Consensus 169 ~Nill~~~~-------~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l 232 (307)
T cd05098 169 RNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLL 232 (307)
T ss_pred HheEEcCCC-------cEEECCCcccccccccchhhccccCCCccceeChHHhccC---------CCCcHHHHHHHHHHH
Confidence 999998877 7999999998765432211112223345679999998654 488999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|||++ |..||..... ..+...+..+.....+..++.++.+|+.+||..+|.+|||+.++++.|..+..
T Consensus 233 ~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 233 WEIFTLGGSPYPGVPV--EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHcCCCCCCCcCCH--HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 99998 8999976543 34666666676666777889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=313.83 Aligned_cols=248 Identities=28% Similarity=0.526 Sum_probs=204.6
Q ss_pred EeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.+...+|++.+.||+|+++.+++ ..|..||+|.+... .+.+.+|+.+++.++|+||+++++++.. +...+|+|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e 80 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE 80 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEE
Confidence 34566899999999998766664 47889999998653 3468899999999999999999987653 3357899999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++.+. ....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-------~~kl~dfg~~ 149 (256)
T cd05082 81 YMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VAKVSDFGLT 149 (256)
T ss_pred CCCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-------cEEecCCccc
Confidence 998 5999999762 234588999999999999999999999999999999999998887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~ 464 (683)
+...... ....++..|+|||++.+. .++.++|||||||++|||++ |+.||..... ......+.
T Consensus 150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~ 213 (256)
T cd05082 150 KEASSTQ-----DTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE 213 (256)
T ss_pred eeccccC-----CCCccceeecCHHHHccC---------CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh
Confidence 7653221 122344579999998654 47889999999999999997 9999986543 33555666
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+..+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 666666777889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.44 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=207.9
Q ss_pred CCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..+|.+.+.||+|+++.+++. ++..+|+|.+... .+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCc
Confidence 458999999999987666642 2456999998653 3568899999999999999999998854 367
Q ss_pred EEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 301 CFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
.++||||++ ++|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~- 160 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL- 160 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-
Confidence 899999997 5999999753210 1124589999999999999999999999999999999999998887
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||++................++..|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 161 ------~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 161 ------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ------cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 7999999999765433222222344567889999998654 48889999999999999998 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|..... ..+...+..+..+..+..++..+.+++.+||+.||++|||+.++++.|..+.+
T Consensus 226 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 226 WFQLSN--TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCH--HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 976543 33555666666666677788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.32 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=211.8
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE-----------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeee
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW-----------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLC 291 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~-----------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~ 291 (683)
.+.+..++|.+.+.||+|+++.|+.. .+..||+|.+... ...+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 35677889999999999998777643 2347999998642 34688999999999 7999999999
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEICCPR----------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~ 360 (683)
.+... ..+|+||||+. |+|.+++....... ....+++.++..++.||+.||.|||++||+||||||+
T Consensus 89 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 89 ACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred EEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 88654 67899999997 59999998632110 1235788999999999999999999999999999999
Q ss_pred cEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHH
Q 038696 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440 (683)
Q Consensus 361 NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ 440 (683)
|||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|
T Consensus 167 Nili~~~~-------~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ 230 (304)
T cd05101 167 NVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLMW 230 (304)
T ss_pred eEEEcCCC-------cEEECCCccceecccccccccccCCCCCceeeCchhhccC---------CCCchhhHHHHHHHHH
Confidence 99998877 7999999999876543222222334456789999999654 4888999999999999
Q ss_pred HHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 441 Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+|++ |..||.+... ..+...+..+.....+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 231 el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 231 EIFTLGGSPYPGIPV--EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHcCCCCCcccCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 9998 8899976543 34566677776666777889999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=335.12 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=193.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ....+.+|+.+|..++||||++++++|.+. ..+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEE
Confidence 48999999999998877753 688999999853 234567899999999999999999988654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~~g~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-------~~kl~Df 145 (364)
T cd05599 79 IMEYLPGGDMMTLLMK------KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-------HIKLSDF 145 (364)
T ss_pred EECCCCCcHHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-------CEEEeec
Confidence 999997 599999875 24699999999999999999999999999999999999999888 7999999
Q ss_pred cCccccCCCCCCC------------------------------------CCCCCCcCcccCChhhhhhccccccccCCCC
Q 038696 383 GLSSVKNFGPKSP------------------------------------SQSGTTHPFIWHAPEVLEENEQTESASNSKY 426 (683)
Q Consensus 383 Gla~~~~~~~~~~------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~ 426 (683)
|+++......... ......||+.|+|||++.+. .+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~ 216 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT---------GY 216 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC---------CC
Confidence 9987543211000 01124689999999998654 48
Q ss_pred CchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-CCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHH
Q 038696 427 SEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-GERPLFPF--HSPKYVTNLTKRCWHADPNQRPS---FSSI 500 (683)
Q Consensus 427 s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPt---~~ei 500 (683)
+.++|||||||++|||++|..||.+.... .....+.. .....++. ..++.+.++|++|+. +|.+|++ +.++
T Consensus 217 ~~~~DiwSlG~il~el~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQ--ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCeeeeecchhHHHHhhcCCCCCCCCCHH--HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 89999999999999999999999876532 23333332 22222333 357889999999996 9999997 8888
Q ss_pred HHH
Q 038696 501 CRI 503 (683)
Q Consensus 501 l~~ 503 (683)
++|
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.46 Aligned_cols=243 Identities=27% Similarity=0.396 Sum_probs=197.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +|+.||||++.. ....+..|++++..++||||+++++++.+. ..+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEE
Confidence 47999999999998777753 588999999853 234678999999999999999999888643 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-------~~kL~Df 145 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-------HIKLADF 145 (350)
T ss_pred EEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-------CEEeecC
Confidence 9999974 999999752 5689999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCC---------------------------CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 383 GLSSVKNFGP---------------------------KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 383 Gla~~~~~~~---------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
|++....... .........||+.|+|||++.+. .++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSl 216 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---------PYGLECDWWSL 216 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---------CCCCceeeEec
Confidence 9997654332 01122345689999999999754 58899999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhHHHHHHHc-CCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC-HHHHHHHH
Q 038696 436 GMICFEILTGKVPFEDAHLQGDKMSRNIRA-GERPLFPF--HSPKYVTNLTKRCWHADPNQRPS-FSSICRIL 504 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPt-~~eil~~L 504 (683)
||++|||++|+.||...... .....+.. .....+|. .+++.+.+||.+||. ||.+||+ +.++++|.
T Consensus 217 G~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 217 GVILYEMLYGFPPFYSDTLQ--ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred chhhhhhccCCCCCCCCCHH--HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 99999999999999876532 22233332 11222332 358999999999997 9999999 99998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.06 Aligned_cols=234 Identities=24% Similarity=0.362 Sum_probs=191.3
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.|++. +|..||+|++.. ....+.+|+++++.++||||++++++|... ..+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 46899998887753 688999999853 234567899999999999999999988654 68999999998
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~kL~Dfg~~~~~ 145 (323)
T cd05595 79 GGELFFHLSR------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITDFGLCKEG 145 (323)
T ss_pred CCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-------CEEecccHHhccc
Confidence 5 99888875 24689999999999999999999999999999999999998887 7999999998754
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+... .
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~~~~~-~ 211 (323)
T cd05595 146 ISDG--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME-E 211 (323)
T ss_pred cCCC--CccccccCCcCcCCcccccCC---------CCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHhcC-C
Confidence 3221 122345688999999999654 4889999999999999999999999765432 233344333 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+|..+++.+.++|.+||..||.+|+ ++.++++|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 346778899999999999999999998 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=334.56 Aligned_cols=242 Identities=23% Similarity=0.369 Sum_probs=206.9
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeC-----CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFF-----GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
...|.....||+|+|+.|+. .+++.||+|++. .++++++.|+.+|.+++++||.++|+.|... ..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHHH
Confidence 34688889999999877775 378899999984 3467889999999999999999999988654 679999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||.| ++.+.|+- ...+.+..+.-++++++.||.|||..+.+|||||+.|||+..+| .+||+|||
T Consensus 90 Mey~~gGsv~~lL~~------~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-------~vkl~Dfg 156 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS------GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-------DVKLADFG 156 (467)
T ss_pred HHHhcCcchhhhhcc------CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-------cEEEEecc
Confidence 999985 89998874 34558889999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
.+-....... .....+||+.|||||++++.+ |+.++||||||++.+||++|.+||.+.+.. .+.-.|
T Consensus 157 Va~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~---------Y~~KADIWSLGITaiEla~GePP~s~~hPm--rvlflI 223 (467)
T KOG0201|consen 157 VAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSG---------YDTKADIWSLGITAIELAKGEPPHSKLHPM--RVLFLI 223 (467)
T ss_pred eeeeeechhh--ccccccccccccchhhhcccc---------ccchhhhhhhhHHHHHHhcCCCCCcccCcc--eEEEec
Confidence 9987765433 226789999999999998653 999999999999999999999999987753 233345
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+|.+...+++.++++|..||..||+.||++.++++|
T Consensus 224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 5556666777889999999999999999999999999876
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.01 Aligned_cols=251 Identities=26% Similarity=0.495 Sum_probs=205.5
Q ss_pred eEeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
|.+..++|+++++||+|+++.+++ .++..||+|.+.. ..+.+.+|+.+++.++|+||+++++.+.. ..+|+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 345677999999999998766654 4678999999864 24578899999999999999999887632 46899
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++... ....+++.++..++.|++.||+|||+.|++||||||+||+++.++ .++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-------~~~l~df 146 (260)
T cd05067 78 ITEYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-------CCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-------CEEEccC
Confidence 999997 5999998752 335689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........ .......+++.|+|||++... .++.++||||||+++|||++ |+.||.+... ..+..
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 214 (260)
T cd05067 147 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ 214 (260)
T ss_pred cceeecCCCCc-ccccCCcccccccCHHHhccC---------CcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH
Confidence 99976643211 122234456789999998643 47889999999999999999 9999986543 33455
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+.....+...+.++.+++.+||..||++|||+++++..|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 556666666677788999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=332.14 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=191.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ....+.+|+.++..++|+||+++++.+.+. ..+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEE
Confidence 48999999999998888763 578999999853 124578899999999999999999988654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+||
T Consensus 79 v~E~~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-------~vkL~DF 145 (363)
T cd05628 79 IMEFLPGGDMMTLLMK------KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-------HVKLSDF 145 (363)
T ss_pred EEcCCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-------CEEEeec
Confidence 9999975 99999975 25699999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCC---------------------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCch
Q 038696 383 GLSSVKNFGPKS---------------------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429 (683)
Q Consensus 383 Gla~~~~~~~~~---------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~k 429 (683)
|+++........ .......||+.|+|||++.+. .++.+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~~~~ 216 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT---------GYNKL 216 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC---------CCCCc
Confidence 998754321100 001235789999999999654 48899
Q ss_pred hHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC-CCCCCCC--CCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 038696 430 SDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG-ERPLFPF--HSPKYVTNLTKRCWHADPN---QRPSFSSICRI 503 (683)
Q Consensus 430 sDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~Li~~cL~~dP~---~RPt~~eil~~ 503 (683)
+|||||||++|||++|+.||.+.... .....+... ....+|. ..+.++.++|.+++. +|. .||++++|++|
T Consensus 217 ~DvwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 217 CDWWSLGVIMYEMLIGYPPFCSETPQ--ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 99999999999999999999875532 233444332 2233443 357789999998664 444 45899998765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.55 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=203.1
Q ss_pred CCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
.++|++.+.||+|+++.+++. .+..||+|.+... ...+.+|+.+++.++||||+++++.+... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 358999999999997666542 4568999998642 24678999999999999999999988654 67
Q ss_pred EEEEEecCC-CCHHHHHHHhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 301 CFLIMELMS-RDLCSYIKEICCP-----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
.|+||||++ |+|.+++...... .....+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 899999998 5999998642100 0123578899999999999999999999999999999999998876
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCC
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~ 447 (683)
.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 162 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~~g~~ 225 (283)
T cd05090 162 -------HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG---------KFSSDSDIWSFGVVLWEIFSFGLQ 225 (283)
T ss_pred -------cEEeccccccccccCCcceecccCCCccceecChHHhccC---------CCCchhhhHHHHHHHHHHHcCCCC
Confidence 7999999999875433222223344456779999998643 48899999999999999998 999
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
||.+... ..+...+.....+..+..++..+.+++.+||+.||.+||++.+|+++|.
T Consensus 226 p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 226 PYYGFSN--QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCCCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 9976542 3455666666666677788999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.43 Aligned_cols=234 Identities=26% Similarity=0.372 Sum_probs=191.9
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.|++. +|+.||||++.. ....+.+|+++|+.++||||+++++++... ..+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence 46899998887753 688999999853 234577899999999999999999888644 78999999997
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
| +|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~g~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-------~~kL~DfG~~~~~ 145 (328)
T cd05593 79 GGELFFHLSR------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-------HIKITDFGLCKEG 145 (328)
T ss_pred CCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-------cEEEecCcCCccC
Confidence 5 89888864 24689999999999999999999999999999999999998887 7999999998764
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .....+... .
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~~~-~ 211 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-D 211 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCC---------CCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhccC-C
Confidence 3221 122345688999999999654 4889999999999999999999999765432 333444333 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+|...+.++.++|.+||..||.+|+ ++.++++|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 346778899999999999999999997 88888766
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.93 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=202.1
Q ss_pred eEEEeEecccccEEEEEE-------cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC----C
Q 038696 237 YQVRRRLGSGSQYKEILW-------LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK----K 299 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~----~ 299 (683)
|++.+.||+|+++.++.. .+..||||.++.. .+.+.+|+.+++.++||||+++++.+...+. .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 578899999997666642 2367999998642 2467899999999999999999987654321 2
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..++||||+. |+|..++...........+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-------~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-------TVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-------eEE
Confidence 4799999998 59999986533222335689999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.+.. ..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~ 222 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NH 222 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCC--HH
Confidence 9999999876443222222223346679999998644 47889999999999999999 999997654 33
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.....+..+.....+..++..+.+++.+||+.||++|||+.+++++|..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 45566666666667788899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=327.21 Aligned_cols=237 Identities=26% Similarity=0.388 Sum_probs=190.6
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHH---HcCCCCceeeeeeeEEcCCCCeEE
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSL---LSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
|++.+.||+|+++.|++. +|+.||||+++. ..+.+.+|++++ ..++||||+++++++.+ ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 788999999998777753 688999999853 234566777665 45679999999998854 47899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||+.| +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 79 lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-------~~kL~D 144 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-------FVKIAD 144 (324)
T ss_pred EEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-------cEEeCc
Confidence 99999985 88887753 4699999999999999999999999999999999999999887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... .......|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ....
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~ 211 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTET---------SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFD 211 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCC---------CCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 99987543221 122345688999999999654 4888999999999999999999999875432 3344
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
.+..+. ..+|...+..+.++|.+||..||.+|| ++.+++++
T Consensus 212 ~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 444433 346777899999999999999999999 45555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.03 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=203.6
Q ss_pred CCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.++|++.+.||+|+++.++.. +...||||.+... ...+.+|+.+++.++||||+++++.+.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence 458999999999997666642 2357999998642 3457889999999999999999998854 3678
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 81 ~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-------~~~l~ 148 (266)
T cd05033 81 MIITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-------VCKVS 148 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-------CEEEC
Confidence 999999975 999999752 34689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~ 459 (683)
|||+++...............+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.... ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~ 217 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDV 217 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccC---------CCccccchHHHHHHHHHHHccCCCCCCCCC--HHHH
Confidence 99999877522222222234456789999998644 47889999999999999998 999997654 2345
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
...+..+.....+..++..+.+++.+||+.+|++||++.+++++|..+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 556666656566778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=336.20 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=191.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||+++++|.+. ..+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEE
Confidence 47999999999998887753 788999998843 234578899999999999999999998654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-------~~kl~Df 145 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-------HIKLSDF 145 (377)
T ss_pred EEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-------CEEEeec
Confidence 999997 5999998752 5689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCC------------C---------------------------------CCCCCCCcCcccCChhhhhhccc
Q 038696 383 GLSSVKNFGPK------------S---------------------------------PSQSGTTHPFIWHAPEVLEENEQ 417 (683)
Q Consensus 383 Gla~~~~~~~~------------~---------------------------------~~~~~~~gt~~Y~APEvl~~~~~ 417 (683)
|+++.+..... . .......||+.|+|||++.+.
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 223 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-- 223 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--
Confidence 99964321000 0 000124689999999999654
Q ss_pred cccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-CCCCCCCC--CCcHHHHHHHHHhhhcCCCCC
Q 038696 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-GERPLFPF--HSPKYVTNLTKRCWHADPNQR 494 (683)
Q Consensus 418 ~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~~~~~~p~--~~~~~l~~Li~~cL~~dP~~R 494 (683)
.++.++|||||||++|||++|..||.+.... .....+.. .....+|. ..+.++.+||.+||. +|.+|
T Consensus 224 -------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 224 -------GYGQECDWWSLGAIMFECLIGWPPFCSENSH--ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred -------CCCCceeeEecchhhhhhhcCCCCCCCCCHH--HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence 4889999999999999999999999875432 23333332 22233333 467889999999997 77776
Q ss_pred ---CCHHHHHHH
Q 038696 495 ---PSFSSICRI 503 (683)
Q Consensus 495 ---Pt~~eil~~ 503 (683)
+++.+++.|
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 588888765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.42 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=196.4
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
..++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++|+||+++++++.. .+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 3458999999999997777753 5889999998542 3457899999999999999999998854 478999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+.| +|.+. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 150 v~e~~~~~~L~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------~~kL~Df 212 (353)
T PLN00034 150 LLEFMDGGSLEGT----------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-------NVKIADF 212 (353)
T ss_pred EEecCCCCccccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-------CEEEccc
Confidence 9999985 76532 2356778889999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~~~~ 461 (683)
|+++....... ......||..|+|||++..... .+...+.++|||||||++|||++|+.||....... .....
T Consensus 213 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 286 (353)
T PLN00034 213 GVSRILAQTMD--PCNSSVGTIAYMSPERINTDLN----HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286 (353)
T ss_pred ccceecccccc--cccccccCccccCccccccccc----cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence 99987643211 1234568899999999854310 12235678999999999999999999997433221 22233
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+.....+..+..++.++.+||.+||+.||++|||+.++++|-+.
T Consensus 287 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 287 AICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred HHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 344445555677788999999999999999999999999987543
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.46 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=206.1
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+..++|++.+.||+|+++.++.. .+..||+|.+... ...+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 455679999999999997776642 2367999998643 23578999999999999999999988543
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCPR----KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
...|+||||++ |+|.+++....... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--- 156 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--- 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---
Confidence 67899999997 59999997532111 123578899999999999999999999999999999999999887
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~ 450 (683)
.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 157 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 157 ----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred ----CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC---------CCCcccchHHHHHHHHHhhccCCCCCc
Confidence 7999999999765443222222334467789999998643 47889999999999999998 999997
Q ss_pred CCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+... ....+.+..+..+..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 224 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 224 GLSN--EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCH--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 6543 3455666666666778888999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=334.76 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=197.4
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
+..++|++.+.||+|+++.|++. +++.||+|++.. ....+.+|+.+++.++||||+++++++.++ ..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 34568999999999998877753 578999999842 234577899999999999999999988654 78
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-------~~kL 183 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-------HLKL 183 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-------CEEE
Confidence 999999997 599999875 3588999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++........ .......||+.|+|||++.+.. ....++.++|||||||++|||++|+.||...... ..
T Consensus 184 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~ 255 (370)
T cd05621 184 ADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQG-----GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GT 255 (370)
T ss_pred EecccceecccCCc-eecccCCCCcccCCHHHHhccC-----CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HH
Confidence 99999987643211 1223456899999999997542 1234788999999999999999999999876533 22
Q ss_pred HHHHHc-CCCCCCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 038696 460 SRNIRA-GERPLFPF--HSPKYVTNLTKRCWHADPNQ--RPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~-~~~~~~p~--~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~L 504 (683)
...+.. .....+|. ..+..+.+++..||..++.+ |+++.++++|-
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 333332 22333443 45888999999999855543 88999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.86 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=209.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..+.+..++|++.+.||+|+++.+++. ....||+|.+... ...+.+|+.++..+ +|+||+++++.
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356777889999999999987666642 1257999998642 23578899999999 79999999998
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICC----------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~N 361 (683)
+.. ...+++||||+. |+|.+++..... ......+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 85 ~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 85 CTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 854 367999999997 599999975310 0223568999999999999999999999999999999999
Q ss_pred EEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 362 ILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++|||||||++||
T Consensus 163 il~~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 226 (293)
T cd05053 163 VLVTEDH-------VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLLWE 226 (293)
T ss_pred EEEcCCC-------eEEeCccccccccccccceeccCCCCCCccccCHHHhccC---------CcCcccceeehhhHHHH
Confidence 9998887 7999999999876543222222233456779999998644 48899999999999999
Q ss_pred HHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 442 llt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|++ |..||..... ..+...+..+.....+..++..+.+|+.+||..||++|||+.++++.|..+
T Consensus 227 l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 227 IFTLGGSPYPGIPV--EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HhcCCCCCCCCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 997 9999986543 345566667766667778889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=305.59 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=209.3
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeC----CCcchHHHHHHHHHcCCCCceeeeeeeEEcC--
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFF----GDIEPLVPEISSLLSLSHPNIMHFLCGFTDE-- 296 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e-- 296 (683)
...+.+..++|.+.+.||+|||-.|++. +++.+|+|++. ++.+..++|++..++++||||+++++....+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3567888999999999999998777764 68899999984 3567789999999999999999998765432
Q ss_pred -CCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCCCCC
Q 038696 297 -EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 297 -~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g~~~~ 372 (683)
.+...||+++|.. |+|.+.+.... .++..+++.+++.|+.+|++||++||+.. +.||||||.|||+++.+
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~---- 166 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG---- 166 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC----
Confidence 2357899999986 89999998642 23456999999999999999999999998 99999999999998877
Q ss_pred CcceEEEecccCccccCCCCCCC-------CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSP-------SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~-------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG 445 (683)
.++|.|||.++...-.-... .......|..|.|||.+.-+ .+...+.++|||||||+||+|+.|
T Consensus 167 ---~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk------~~~ti~ertDIWSLGCtLYa~mf~ 237 (302)
T KOG2345|consen 167 ---LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK------SHCTITERTDIWSLGCTLYAMMFG 237 (302)
T ss_pred ---ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc------cCcccccccchhhhhHHHHHHHHc
Confidence 79999999987543211100 01123356779999999766 355689999999999999999999
Q ss_pred CCCCCCCccchhHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGER-PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
..||+..-.++..+.-.+..+.. -+.....++.+.++|+.||+.||.+||++.+++.++..+
T Consensus 238 ~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 238 ESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 99997644444333333333221 112233688999999999999999999999999887654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=334.07 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=191.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||+++++++.+. ..+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence 6999999999998887763 678999999853 134578999999999999999999998654 789999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ ++||+|||
T Consensus 80 ~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-------~~kL~DFG 146 (381)
T cd05626 80 MDYIPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-------HIKLTDFG 146 (381)
T ss_pred EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-------CEEEeeCc
Confidence 99997 4999998752 4689999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCC---------------------------------------------CCCCCCCCcCcccCChhhhhhcccc
Q 038696 384 LSSVKNFGPK---------------------------------------------SPSQSGTTHPFIWHAPEVLEENEQT 418 (683)
Q Consensus 384 la~~~~~~~~---------------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~ 418 (683)
+++....... ........||+.|+|||++.+.
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--- 223 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--- 223 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC---
Confidence 9864321000 0001234689999999999654
Q ss_pred ccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhh--hcCCCCC
Q 038696 419 ESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPF--HSPKYVTNLTKRCW--HADPNQR 494 (683)
Q Consensus 419 ~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~--~~~~~l~~Li~~cL--~~dP~~R 494 (683)
.++.++|||||||++|||++|..||....... .....+.......++. ..+.++.+||.+|+ ..++..|
T Consensus 224 ------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 224 ------GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE-TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred ------CCCCccceeehhhHHHHHHhCCCCCcCCCHHH-HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 48899999999999999999999998755322 2222222222222332 46788999999854 5566669
Q ss_pred CCHHHHHHHH
Q 038696 495 PSFSSICRIL 504 (683)
Q Consensus 495 Pt~~eil~~L 504 (683)
+++.++++|-
T Consensus 297 ~~~~~~l~hp 306 (381)
T cd05626 297 NGADDIKAHP 306 (381)
T ss_pred CCHHHHhcCc
Confidence 9999998763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.39 Aligned_cols=245 Identities=27% Similarity=0.476 Sum_probs=200.3
Q ss_pred CCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.+++. .+..||||.+... .+.+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence 357999999999987666543 3446999988642 4568999999999999999999998854 3678999999
Q ss_pred CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+. |+|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+|||++.++ .+||+|||+++
T Consensus 81 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-------~~kl~d~g~~~ 148 (256)
T cd05113 81 MSNGCLLNYLREH-----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-------CVKVSDFGLSR 148 (256)
T ss_pred CCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------CEEECCCccce
Confidence 97 5999998752 23689999999999999999999999999999999999998877 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHc
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......++..|++||++.+. .++.++|||||||++|+|++ |..||..... ......+..
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~ 216 (256)
T cd05113 149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYS---------KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQ 216 (256)
T ss_pred ecCCCce-eecCCCccChhhCCHHHHhcC---------cccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhc
Confidence 6543221 122234456779999999643 48889999999999999998 9999976542 335556666
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.+...+...+..+.+++.+||+.||.+||++.++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 666666677789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.28 Aligned_cols=232 Identities=23% Similarity=0.351 Sum_probs=188.7
Q ss_pred ecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||+|+++.|++. +|+.||||++.. ....+.+|+.+|..++||||+++++++.++ ..+|+||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCCC
Confidence 689987777653 578999999853 234577899999999999999999888643 789999999985
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 79 ~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-------~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 79 ELFHHLQR------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-------HIALCDFGLCKLNMK 145 (312)
T ss_pred cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-------cEEEEECcccccCcc
Confidence 99999975 25689999999999999999999999999999999999998887 799999999975432
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... .+...+..+ ...
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~~~~~~-~~~ 211 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGH---------GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYRKILQE-PLR 211 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCC---------CCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHHHHHcC-CCC
Confidence 21 122345688999999999654 4889999999999999999999999875432 344444433 345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 038696 471 FPFHSPKYVTNLTKRCWHADPNQRPS---FSSICRI 503 (683)
Q Consensus 471 ~p~~~~~~l~~Li~~cL~~dP~~RPt---~~eil~~ 503 (683)
++...+..+.+++.+||..||.+||+ +.+++.|
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 67778899999999999999999985 5555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.10 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=192.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++.+.||+|+++.|++. +|..||||++.. ....+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 358999999999998777753 688999999853 2345778999999999999999999886432 13
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 100 ~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-------~~kl 164 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 164 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-------CEEE
Confidence 5799999999998887752 388899999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..... ..
T Consensus 165 ~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~ 231 (359)
T cd07876 165 LDFGLARTACTN---FMMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QW 231 (359)
T ss_pred ecCCCccccccC---ccCCCCcccCCCCCchhccCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999764322 122345678899999999654 48889999999999999999999998653211 01
Q ss_pred HH---------------------HHHcCCCCC--------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 460 SR---------------------NIRAGERPL--------------------FPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 460 ~~---------------------~i~~~~~~~--------------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
.. ..... .+. .....+..+.+||.+||..||++|||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 310 (359)
T cd07876 232 NKVIEQLGTPSAEFMNRLQPTVRNYVEN-RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310 (359)
T ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHhh-CCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence 00 00000 000 0112356789999999999999999999
Q ss_pred HHHHHHHH
Q 038696 499 SICRILRY 506 (683)
Q Consensus 499 eil~~L~~ 506 (683)
++++|-+.
T Consensus 311 e~l~hp~~ 318 (359)
T cd07876 311 EALRHPYI 318 (359)
T ss_pred HHhcCchh
Confidence 99988654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=350.88 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=200.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++++.||+|+|+.|++. .+..||+|.+.. ....+..|+.+|..|+|||||+++++|.+.....+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 359999999999998888763 577899998852 2346889999999999999999999987766678999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEeCCCCC------
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-------KIYHGNLNPSNILLKPRGA------ 369 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------gIiHrDLKp~NILl~~~g~------ 369 (683)
||||++ |+|.++|..... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.+..
T Consensus 92 VMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999998 599999975321 235699999999999999999999984 4999999999999965320
Q ss_pred ----CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC
Q 038696 370 ----STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445 (683)
Q Consensus 370 ----~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG 445 (683)
..++...+||+|||++....... ......||+.|+|||++.+. ...++.++||||||||||||++|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge-------~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHE-------TKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhcc-------CCCCCchhHHHHHHHHHHHHHHC
Confidence 01233469999999998654321 22345689999999998643 22478899999999999999999
Q ss_pred CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..||...... ..+...+..+.. ......+.++.+||..||..+|.+||++.+++.+
T Consensus 240 k~PF~~~~~~-~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 240 KTPFHKANNF-SQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCcCCcH-HHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999765432 223333433322 1223467889999999999999999999999865
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.03 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=202.7
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
..++|++.+.||+|+++.++.. +|. .||+|.+... ..++..|+.++..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 4468999999999997666542 344 4788887432 2456778888999999999999987632 4
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+|
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-------~~k 149 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQ-----HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-------IVQ 149 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-------cEE
Confidence 5789999997 699999975 235689999999999999999999999999999999999998877 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..||.+... .
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~ 218 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG---------RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--H 218 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccC---------CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence 9999999865433222222344567789999999643 48899999999999999998 9999987643 2
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+...+..+..+..+..++..+.+++.+||..||++|||+.++++.|..+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 219 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 3555666777666777788899999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.99 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=195.2
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+..++|++.++||+|+++.|++. +|..+|+|.+... .+.+.+|+++|+.++||||++++++|.+. +.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEE
Confidence 35679999999999998777753 5788999988543 24578999999999999999999998654 6899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|||||+.| +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 80 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-------~~kL~ 146 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLC 146 (333)
T ss_pred EEEecCCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-------CEEEe
Confidence 99999975 99999975 24588999999999999999999985 799999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh---
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD--- 457 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~--- 457 (683)
|||++...... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 147 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 213 (333)
T cd06650 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213 (333)
T ss_pred eCCcchhhhhh----ccccCCCCccccCHHHhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence 99998765322 12334678899999999654 488899999999999999999999975332110
Q ss_pred ---------------------------------------HHHHHHHcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 458 ---------------------------------------KMSRNIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 458 ---------------------------------------~~~~~i~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
.....+.....+..+. ..+.++.+|+.+||+.||++|||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~ 293 (333)
T cd06650 214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL 293 (333)
T ss_pred hcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH
Confidence 0111122222222222 246789999999999999999999
Q ss_pred HHHHHHHH
Q 038696 498 SSICRILR 505 (683)
Q Consensus 498 ~eil~~L~ 505 (683)
.+++++-.
T Consensus 294 ~ell~h~~ 301 (333)
T cd06650 294 KQLMVHAF 301 (333)
T ss_pred HHHhhCHH
Confidence 99987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=327.22 Aligned_cols=234 Identities=25% Similarity=0.363 Sum_probs=190.9
Q ss_pred eEecccccEEEEEE-------cCcEEEEEEeCC--------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 241 RRLGSGSQYKEILW-------LGESFALRHFFG--------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 241 ~~LG~G~~~~v~l~-------~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+.||+|+++.+++. .|+.||||+++. ....+..|+.+|+.++||||++++++|..+ +.+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 67999998777752 577899999853 123467899999999999999999988654 6899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~ 146 (323)
T cd05584 80 EYLSGGELFMHLER------EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-------HVKLTDFGL 146 (323)
T ss_pred eCCCCchHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------CEEEeeCcC
Confidence 99985 99999875 25688999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.
T Consensus 147 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~ 213 (323)
T cd05584 147 CKESIHEGT--VTHTFCGTIEYMAPEILMRS---------GHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKIL 213 (323)
T ss_pred CeecccCCC--cccccCCCccccChhhccCC---------CCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence 875432211 22335688999999999654 4788999999999999999999999875532 2334444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
.+. ..++...+..+.++|.+||+.||++|| ++.+++++
T Consensus 214 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 214 KGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 443 346677889999999999999999999 78887665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=310.01 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=205.2
Q ss_pred CeEEEeEecccccEEEE----EEcCcEEEEEEeCC--------C----cchHHHHHHHHHcCC-CCceeeeeeeEEcCCC
Q 038696 236 DYQVRRRLGSGSQYKEI----LWLGESFALRHFFG--------D----IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEK 298 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~----l~~g~~vAvK~~~~--------~----~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~ 298 (683)
.|.-.+.||.|....+. ..+|..+|+|++.- . .++-.+|+.||+++. ||||+++.++|. ..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye--s~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE--SD 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--Cc
Confidence 56667788888522222 24788999998831 1 245578999999995 999999999994 44
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+++|+|+|+ |.|+++|.. ...+++..+..|++|+++|++|||.++||||||||+|||++++. .+
T Consensus 96 sF~FlVFdl~prGELFDyLts------~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-------~i 162 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS------KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-------NI 162 (411)
T ss_pred chhhhhhhhcccchHHHHhhh------heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-------ce
Confidence 78999999998 899999985 36799999999999999999999999999999999999998776 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++....+.+. ...+|||+|+|||.+...-.. ....|+..+|+|++|||||.|+.|.+||.... ..
T Consensus 163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e---~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qm 234 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYE---NHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QM 234 (411)
T ss_pred EEeccceeeccCCchhH---HHhcCCCcccChhheeeeccc---CCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HH
Confidence 99999999988765432 356789999999999765322 34469999999999999999999999997533 34
Q ss_pred HHHHHHHcCCCCCCCCC---CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~---~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
.+.+.|..|....-.+. .+...++||.+||+.||.+|.|++++++|-..+.-.
T Consensus 235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 56778888875433332 356689999999999999999999999998776543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.58 Aligned_cols=244 Identities=28% Similarity=0.501 Sum_probs=199.9
Q ss_pred CCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 235 EDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
.+|++.+.||+|+++.+++ ..+..+|||.+... .+.+.+|+++++.++||||+++++++.. ....|+||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEEecC
Confidence 4789999999998665554 34568999998642 3468899999999999999999988753 46789999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 82 ~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-------~~kl~dfg~~~~ 149 (256)
T cd05059 82 ANGCLLNYLRER-----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSDFGLARY 149 (256)
T ss_pred CCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-------cEEECCccccee
Confidence 75 999999752 24689999999999999999999999999999999999999887 799999999976
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......++..|+|||++.+. .++.++||||||+++|+|++ |..||..... ......+..+
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~ 217 (256)
T cd05059 150 VLDDQY-TSSQGTKFPVKWAPPEVFDYS---------RFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSAG 217 (256)
T ss_pred cccccc-cccCCCCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHHcC
Confidence 543211 122233345679999998644 48889999999999999999 8999976543 3345566666
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+...+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 66667777899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.16 Aligned_cols=250 Identities=26% Similarity=0.484 Sum_probs=202.8
Q ss_pred EeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+..++|++.++||+|+++.++. ..+..||+|.+.. ..+.+.+|+.+++.++|+||+++++.+.. ...|+|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 34567899999999998655553 3567899999864 34578899999999999999999987632 457999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|.+++.+. ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-------~~~l~dfg 147 (260)
T cd05070 79 TEYMSKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-------VCKIADFG 147 (260)
T ss_pred EEecCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-------eEEeCCce
Confidence 999975 999999752 234589999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
++........ .......++..|+|||++.+. .++.++||||||+++|+|++ |..||.+... ......
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~ 215 (260)
T cd05070 148 LARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ 215 (260)
T ss_pred eeeeccCccc-ccccCCCCCccccChHHHhcC---------CCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH
Confidence 9976543321 122233456679999998644 48889999999999999999 9999976542 234555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+..+..+...+..+.+|+.+||..||++|||+.++.+.|+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 66565666677788999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.17 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=195.3
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+|++.+.||+|+++.|++. +|+.||||++... ...+.+|+.+++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 4899999999998777652 5789999998532 2346789999999999999999988854 3689999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+. |+|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~~l~Dfg 147 (285)
T cd05605 79 LTLMNGGDLKFHIYNM----GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-------HIRISDLG 147 (285)
T ss_pred EeccCCCcHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-------CEEEeeCC
Confidence 99997 5898888642 234689999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSR 461 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~ 461 (683)
++....... ......|++.|+|||++.+. .++.++|||||||++|||++|..||.+..... ..+..
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05605 148 LAVEIPEGE---TIRGRVGTVGYMAPEVVKNE---------RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215 (285)
T ss_pred CceecCCCC---ccccccCCCCccCcHHhcCC---------CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH
Confidence 997654321 11234678899999999644 47889999999999999999999998754321 12222
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
.+. .....++...+..+.+|+.+||..||++|| ++.+++++-
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 216 RVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred Hhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 232 223345666788999999999999999999 788887763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.14 Aligned_cols=254 Identities=26% Similarity=0.478 Sum_probs=214.0
Q ss_pred eeEeeCCCeEEEeEecccccEEEE---EE---cCc--EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEI---LW---LGE--SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~---l~---~g~--~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
.+.+..+...+.+.||+|-|+-|+ .. .|+ -||||.-+. +.+.|..|+.+|++++|||||++++++.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344555556666789998654444 22 343 489998875 35679999999999999999999999954
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
...|||||+++ |.|..||+. +...|+......|++||+.||.|||++.+|||||...|||+....
T Consensus 463 ---~P~WivmEL~~~GELr~yLq~-----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~------ 528 (974)
T KOG4257|consen 463 ---QPMWIVMELAPLGELREYLQQ-----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ------ 528 (974)
T ss_pred ---cceeEEEecccchhHHHHHHh-----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc------
Confidence 57899999998 899999997 346699999999999999999999999999999999999998776
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
.|||+|||+++........... ...-++.|||||-++-. .++.++|||-|||.+||++. |..||.+..
T Consensus 529 -CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfR---------rFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 529 -CVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFR---------RFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred -eeeecccchhhhccccchhhcc-ccccceeecCccccchh---------cccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 7999999999988765443333 44557789999999654 58999999999999999997 999999865
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.. .+.-.+..|.+.+.|++||+.+..|+.+||+.||.+||++.+|...|..+..
T Consensus 598 Ns--DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 598 NS--DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cc--ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 43 3556788999999999999999999999999999999999999998888765
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.76 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=204.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFT 294 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 294 (683)
+.+..++|.+.+.||+|+++.+++. .+..||||.++.. .+.+.+|+.+++.+ +|+||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4455568999999999997777642 2347999998643 24578999999999 7999999999886
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
.. +.+|+||||+. |+|.+++... ....+++.++..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 110 ~~--~~~~lv~e~~~~~~L~~~i~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----- 178 (302)
T cd05055 110 IG--GPILVITEYCCYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----- 178 (302)
T ss_pred cC--CceEEEEEcCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-----
Confidence 54 67899999998 5999999752 223489999999999999999999999999999999999998776
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCC
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDA 452 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~ 452 (683)
.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus 179 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 179 --IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred --eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC---------CCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 7999999999865433221122233456789999998654 47889999999999999998 99999876
Q ss_pred ccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
... ....+.+..+..+..+...+..+.+++.+||..+|++|||+.++++.|..
T Consensus 248 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 248 PVD-SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred Cch-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 543 33445555565555666778899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.18 Aligned_cols=233 Identities=27% Similarity=0.406 Sum_probs=190.0
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCC-ceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHP-NIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~e~~~~~~L 303 (683)
+|++++.||+|+++.|++. +++.||||++.. ..+.+..|++++..++|+ +|+++++++.+. +.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 6899999999998777753 567899999853 234577899999999765 588888887543 68999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~~g~L~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-------~~kL~Df 145 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-------HIKIADF 145 (324)
T ss_pred EEcCCCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-------CEEEeec
Confidence 999997 599998875 24689999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ......
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~ 212 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQS 212 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 99875432211 22345688999999999754 478899999999999999999999987543 234444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
+... ...++...+..+.+++.+||..||.+|++.
T Consensus 213 i~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEH-NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHcC-CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4443 344677788999999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.26 Aligned_cols=242 Identities=25% Similarity=0.417 Sum_probs=200.3
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+-|.+.+.||+|.|..|.+ .+|++||||++.+ ....+..|++.|+.++|||||++|.+.. ....+|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD--TQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID--TQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc--ccceEEEE
Confidence 3699999999997444443 4899999999953 2346789999999999999999998874 44789999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CCCCCCcceEEEecc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR-GASTEGYLHAKISGF 382 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~-g~~~~~~~~vKL~DF 382 (683)
+|+-+ |+|++||.+ ....+.+..+.+|+.||+.|+.|||+.++|||||||+||.+-.. | .|||.||
T Consensus 96 LELGD~GDl~DyImK-----He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG-------lVKLTDF 163 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK-----HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG-------LVKLTDF 163 (864)
T ss_pred EEecCCchHHHHHHh-----hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC-------ceEeeec
Confidence 99997 599999987 34569999999999999999999999999999999999988544 4 6999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++..+..+.+. ...+|+..|-|||++.+.. +-.+++||||||||||.|++|++||+..+.. +.+ ..
T Consensus 164 GFSNkf~PG~kL---~TsCGSLAYSAPEILLGDs--------YDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETL-Tm 230 (864)
T KOG4717|consen 164 GFSNKFQPGKKL---TTSCGSLAYSAPEILLGDS--------YDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETL-TM 230 (864)
T ss_pred cccccCCCcchh---hcccchhhccCchhhhcCc--------cCCcchhhhHHHHHHHHHHhCCCccccccch-hhh-hh
Confidence 999887665432 3457888999999998764 3346899999999999999999999987654 233 33
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
|.... ...|...+.++++||..||..||.+|.+.++|..+-
T Consensus 231 ImDCK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 231 IMDCK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred hhccc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 33332 236888899999999999999999999999987653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=334.89 Aligned_cols=242 Identities=19% Similarity=0.276 Sum_probs=192.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ....+.+|+++|+.++||||+++++.|.+. +.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEE
Confidence 47999999999998887763 578999999853 235578999999999999999999988654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~~g~L~~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-------~ikL~DF 145 (376)
T cd05598 79 VMDYIPGGDMMSLLIR------LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-------HIKLTDF 145 (376)
T ss_pred EEeCCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-------CEEEEeC
Confidence 999997 599999975 24689999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCC-----------------------------------------CCCCCCCCcCcccCChhhhhhccccccc
Q 038696 383 GLSSVKNFGPK-----------------------------------------SPSQSGTTHPFIWHAPEVLEENEQTESA 421 (683)
Q Consensus 383 Gla~~~~~~~~-----------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~ 421 (683)
|+|..+..... ........||+.|+|||++.+.
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------ 219 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT------ 219 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC------
Confidence 99853311000 0001134689999999999754
Q ss_pred cCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-CCCCCC--CCCCcHHHHHHHHHhhhcCCCCCC---
Q 038696 422 SNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-GERPLF--PFHSPKYVTNLTKRCWHADPNQRP--- 495 (683)
Q Consensus 422 ~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RP--- 495 (683)
.++.++|||||||++|||++|+.||.+..... ....+.. .....+ ....+..+.++|.+|+ .+|.+|+
T Consensus 220 ---~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 220 ---GYTQLCDWWSVGVILYEMLVGQPPFLADTPAE--TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred ---CCCcceeeeeccceeeehhhCCCCCCCCCHHH--HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 48889999999999999999999998765332 2222222 111122 2356788999999976 5999999
Q ss_pred CHHHHHHH
Q 038696 496 SFSSICRI 503 (683)
Q Consensus 496 t~~eil~~ 503 (683)
++.++++|
T Consensus 294 t~~ell~h 301 (376)
T cd05598 294 GADEIKAH 301 (376)
T ss_pred CHHHHhCC
Confidence 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.69 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=194.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|.+.+.||+|+++.|+.. +++.||||.+... ...+.+|+.+++.++||||+++++++..+ +.+|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEE
Confidence 58999999999998777753 6788999998532 23577899999999999999999988654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 84 e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~ 151 (309)
T cd07872 84 EYLDKDLKQYMDD-----CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-------ELKLADFGLA 151 (309)
T ss_pred eCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEECccccc
Confidence 9999999998875 234588999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+... .+......
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~ 220 (309)
T cd07872 152 RAKSVPTK--TYSNEVVTLWYRPPDVLLGS--------SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRL 220 (309)
T ss_pred eecCCCcc--ccccccccccccCCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 76533221 12234568889999998643 247889999999999999999999998654321 11111100
Q ss_pred --------------------CCCCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 466 --------------------GERPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 466 --------------------~~~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+. .....+.++.+||.+||..||.+|||+.++++|-+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 00000 012357789999999999999999999999887544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.02 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=208.9
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEEc-----------CcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeee
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILWL-----------GESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLC 291 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~~-----------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~ 291 (683)
.|.+..++|.+.+.||+|+++.+++.. +..||+|.++.. ...+.+|+++++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 355666799999999999977676532 346999998642 23578899999999 6999999999
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~ 360 (683)
++.+ ...+|+||||+. |+|.+++...... .....+++.++..++.||+.||.|||++||+||||||+
T Consensus 86 ~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 86 VCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 8854 367899999997 5999999763211 11245899999999999999999999999999999999
Q ss_pred cEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHH
Q 038696 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440 (683)
Q Consensus 361 NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ 440 (683)
|||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|
T Consensus 164 Nill~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~ 227 (314)
T cd05099 164 NVLVTEDN-------VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGILMW 227 (314)
T ss_pred eEEEcCCC-------cEEEccccccccccccccccccccCCCCccccCHHHHccC---------CcCccchhhHHHHHHH
Confidence 99998877 7999999999866432211112223345679999998644 4888999999999999
Q ss_pred HHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 441 Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
||++ |..||.+... ..+...+..+.....+..++..+.+++.+||..||++|||+.++++.|..+..
T Consensus 228 el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 228 EIFTLGGSPYPGIPV--EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 9999 8999976543 34555666666666777888999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.58 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=196.6
Q ss_pred CCCeEEEeEecccccEEEEEE------cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW------LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~------~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
..+|++++.||+|+++.|++. .+..||||.+... ..+.+|+++|+.++|||||++++.|..+ ..+|+|||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 167 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWK--STVCMVMPK 167 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEEEEehh
Confidence 458999999999998777753 3468999988643 4567899999999999999999988654 689999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+.++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 168 ~~~~l~~~l~~------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-------~~~l~DfG~a~~ 234 (392)
T PHA03207 168 YKCDLFTYVDR------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-------NAVLGDFGAACK 234 (392)
T ss_pred cCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-------CEEEccCccccc
Confidence 99999999853 35699999999999999999999999999999999999998887 799999999976
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHHHHH-
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSRNIR- 464 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~~i~- 464 (683)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... ..+...+.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALD---------PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 6543332233456789999999999654 48899999999999999999999997643221 11111111
Q ss_pred ------------------------cCCCCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 465 ------------------------AGERPLFP-------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 465 ------------------------~~~~~~~p-------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...++.+. ...+.++.++|.+||..||++|||+.+++.+-..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 00111111 1235678899999999999999999999987544
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.43 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=202.6
Q ss_pred CCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
..+|++.+.||+|+++.|+.. .+..||||.+... .+.+.+|+.++..++||||+++++.+... .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence 346888999999987666642 2467999999643 24578899999999999999999988543 6
Q ss_pred eEEEEEecCC-CCHHHHHHHhcC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEICC----------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
..++++||+. ++|.+++..... ......+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 7899999998 599999863210 01124588999999999999999999999999999999999998776
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCC
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~ 447 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 162 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~ 225 (283)
T cd05091 162 -------NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG---------KFSIDSDIWSYGVVLWEVFSYGLQ 225 (283)
T ss_pred -------ceEecccccccccccchheeeccCccCCccccCHHHHhcC---------CCCcchhHHHHHHHHHHHHcCCCC
Confidence 6999999998865433222222334457789999998643 47889999999999999998 889
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
||.+... ......+..+.....+..++.++.+|+..||+.+|.+||++.+|+..|+
T Consensus 226 p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 226 PYCGYSN--QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CCCCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9987543 3456667777666678889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.87 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=203.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+..++|++.++||+|+++.++.. +|+ .||||++... ...+.+|+.++..++||||+++++.+..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 44568999999999986655542 444 4899998542 3457889999999999999999988754
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...+++|||++ |+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-------~~ 148 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVREN-----KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-------HV 148 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-------cE
Confidence 34689999997 6999998752 34689999999999999999999999999999999999998776 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..||.... .
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 217 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKPYDGIP--A 217 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCC--H
Confidence 99999999876543222222334456789999998644 48899999999999999998 999997643 2
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
..+...+..+.....+..++..+.+++.+||..||++||++.++++.|..+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 218 REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3355566666666667788999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=310.22 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=201.3
Q ss_pred eeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+..++|++.++||+|+++.++. ..+..||||.+... .+.+.+|+.+++.++||||+++++.+.. ...|+||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEE
Confidence 4556899999999998655553 34457999998642 3568899999999999999999887632 4579999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ |+|.+++.+. ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-------~~~L~dfg~ 148 (262)
T cd05071 80 EYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-------VCKVADFGL 148 (262)
T ss_pred EcCCCCcHHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-------cEEeccCCc
Confidence 9998 4999999752 234578999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
++....... .......++..|+|||++.+. .++.++||||||+++|||++ |..||.+.... .....+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~~~ 216 (262)
T cd05071 149 ARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV 216 (262)
T ss_pred eeecccccc-ccccCCcccceecCHhHhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHHHH
Confidence 976643322 122234466789999998644 48899999999999999999 89999765432 344555
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+.....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 5555555567788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.12 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=202.3
Q ss_pred CeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 236 DYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
+|++.+.||+|+++.+++. ....+|+|.+... ...+.+|+.+++.++||||+++++.+... ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 5788999999997666542 1246999988643 34688999999999999999999988543 678
Q ss_pred EEEEecCC-CCHHHHHHHhcC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 038696 302 FLIMELMS-RDLCSYIKEICC------------------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNI 362 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NI 362 (683)
|+||||+. |+|.+++..... ......+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999998 599999875311 11224588999999999999999999999999999999999
Q ss_pred EeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 363 LLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 363 Ll~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
|++.++ .+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||
T Consensus 159 ll~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~~l~el 222 (290)
T cd05045 159 LVAEGR-------KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH---------IYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred EEcCCC-------cEEeccccccccccCccchhcccCCCCCccccCHHHHccC---------CcchHhHHHHHHHHHHHH
Confidence 998877 7999999999765332221112233456679999998644 488999999999999999
Q ss_pred Hh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 443 lt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
++ |..||.+... ..+...+..+.....+..++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 223 ~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 223 VTLGGNPYPGIAP--ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HhcCCCCCCCCCH--HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 98 9999976543 3455566666566667778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.99 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=199.0
Q ss_pred eEEEeEecccccEEEEEE----cCc--EEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CCe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGE--SFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KKE 300 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~--~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~~ 300 (683)
|.+.+.||+|+++.|+.. .+. .||||.++.. .+.+.+|+.+++.++|+||+++++.+.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999987666642 233 6999987532 356788999999999999999997654221 235
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.++||||+. |+|.+++...........+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-------NVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-------CEEE
Confidence 789999997 59999886432222334589999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
+|||+++...............+++.|+|||++.+. .++.++||||||+++|||++ |..||.+... ..
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 222 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR---------VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SE 222 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCC---------CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 999999876433221112233456779999998654 48899999999999999999 8999976543 34
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+...+..+.....+..++..+.+++.+||+.||++|||+.++++.|..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 223 IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5566777766667778889999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.83 Aligned_cols=251 Identities=23% Similarity=0.432 Sum_probs=201.7
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.++. .+|+.||||.+.. ....+.+|+++++.++||||+++++.+.+. +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 4899999999998766654 2788999998742 123578899999999999999999988654 68899
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+++ +|.+++.... .....+++..+..++.||+.||.|||++||+|+||||+|||++.++ .++|+||
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-------~~~l~d~ 150 (267)
T cd08228 80 VLELADAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-------VVKLGDL 150 (267)
T ss_pred EEEecCCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-------CEEECcc
Confidence 9999985 9998886431 1234588999999999999999999999999999999999998877 6999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ ......+++.|+|||++.+. .++.++||||||+++|||++|..||.........+...
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccC---------CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH
Confidence 99876543211 12234577889999998654 37889999999999999999999997654433344555
Q ss_pred HHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+.....+..+ ...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 5554433333 35678899999999999999999999999988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.95 Aligned_cols=248 Identities=27% Similarity=0.500 Sum_probs=205.7
Q ss_pred eCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
...+|++.+.||.|+++.++. ..+..+|+|.+... ...+.+|+.+++.++|+||+++++.+.+. ..+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEEE
Confidence 345899999999998655553 45789999998642 45688999999999999999999888543 6789999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+++ +|.+++.+. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-------~~kl~d~g~ 150 (261)
T cd05148 82 ELMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVADFGL 150 (261)
T ss_pred eecccCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-------eEEEccccc
Confidence 99985 999999752 335689999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
+........ ......+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.... .......+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~---------~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~ 217 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHG---------TFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQI 217 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHH
Confidence 977643221 12244456789999998644 47889999999999999998 899997654 23455566
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+.+...+..++..+.+++.+||..||.+|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 6666666778889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.55 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=201.5
Q ss_pred eCCCeEEEeEecccccEEEEE---E------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL---W------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l---~------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..++|.+.+.||+|+++.++. . .+..||+|.+... ...+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 356899999999998655553 2 3467999988532 23578899999999999999999887543
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 299 KECFLIMELMS-RDLCSYIKEICC-PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
...++||||+. |+|.+++..... ......+++..++.++.||+.||.|||+++++||||||+|||++.++ ....
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~----~~~~ 157 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG----PGRV 157 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC----CCcc
Confidence 56799999997 599999976421 11223689999999999999999999999999999999999998654 1236
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
+||+|||+++................++.|+|||++.+. .++.++|||||||++|||++ |..||.+....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG---------IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC---------CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 899999999876322111111222335679999999644 48999999999999999997 99999875533
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...+........+..++..+.+++.+||+.||++|||+.+++++|.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 --EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 345555555566677888999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.37 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=206.6
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFT 294 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 294 (683)
|.+..++|++.+.||+|+++.|++. +++.||||+++.. ...+.+|+.+|..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 5566779999999999998777642 4678999998642 23577899999999 6899999998775
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcCCC--------------------------------------------------
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICCPR-------------------------------------------------- 323 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~-------------------------------------------------- 323 (683)
.. ...+++||||++ |+|.+++.......
T Consensus 82 ~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 82 KP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred cC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 43 357899999998 59999987531100
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCC
Q 038696 324 -----------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392 (683)
Q Consensus 324 -----------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~ 392 (683)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-------~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLARDIYKDP 233 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-------cEEEEecccccccccCc
Confidence 013478889999999999999999999999999999999998777 79999999997653322
Q ss_pred CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCC
Q 038696 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLF 471 (683)
Q Consensus 393 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~ 471 (683)
.........+++.|+|||++.+. .++.++||||||+++|+|++ |..||...... ......+..+.....
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 303 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRA 303 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCC
Confidence 21222233456779999998644 48889999999999999997 99999765433 234455555656556
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 472 PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 472 p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
+...+..+.+++..||+.||++|||+.+|+++|+.+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6667888999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.15 Aligned_cols=247 Identities=30% Similarity=0.572 Sum_probs=204.7
Q ss_pred EeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.+..++|++.+.||.|+++.|+. ..|+.||||.+... .+.+.+|+.+++.++|+||+++++.+.+ ....|+||
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEE
Confidence 34567999999999998766654 46899999999764 3478899999999999999999998865 36789999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ ++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-------~~~l~d~g~ 148 (256)
T cd05039 80 EYMAKGSLVDYLRSR----GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-------VAKVSDFGL 148 (256)
T ss_pred EecCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-------CEEEccccc
Confidence 9998 5999999762 223689999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ....+..|+|||++... .++.++||||||+++|||++ |..||..... ..+...+
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~ 212 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHV 212 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCC---------cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH
Confidence 987632211 23345679999998643 47889999999999999997 9999976543 3345555
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+.....+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 5555556677788999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.43 Aligned_cols=234 Identities=30% Similarity=0.467 Sum_probs=188.4
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +++.||||+++. ..+.+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 46899998777753 577899999853 233456677777654 799999999988643 6899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~gg~L~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-------~~kL~Dfg~a~~ 145 (316)
T cd05592 79 NGGDLMFHIQS------SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-------HIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-------CEEEccCcCCeE
Confidence 74 99988875 24689999999999999999999999999999999999998887 799999999976
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+...+.. .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~-~ 211 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQ---------KYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILN-D 211 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCC---------CCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc-C
Confidence 43322 223345689999999999654 488999999999999999999999987553 234444443 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFS-SICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~-eil~~ 503 (683)
.+.++...+.++.+++.+||+.||.+||++. +++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 4567778899999999999999999999875 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.56 Aligned_cols=235 Identities=25% Similarity=0.358 Sum_probs=191.5
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.|++. +|..||||++.. ....+..|++++..++||||+++++++... ..+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCC
Confidence 46899998888753 688999999853 234567899999999999999999888644 78999999998
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
| +|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-------~~kL~Dfg~~~~ 145 (325)
T cd05594 79 GGELFFHLSR------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------HIKITDFGLCKE 145 (325)
T ss_pred CCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-------CEEEecCCCCee
Confidence 5 89888864 2468999999999999999999997 8999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ......+...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~~- 211 (325)
T cd05594 146 GIKDGA--TMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME- 211 (325)
T ss_pred cCCCCc--ccccccCCcccCCHHHHccC---------CCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhcC-
Confidence 432211 22234688999999999654 488999999999999999999999976543 2333444333
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
...+|...++++.+++.+||+.||++|+ ++.++++|.
T Consensus 212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 3346777889999999999999999996 899988763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=306.93 Aligned_cols=239 Identities=30% Similarity=0.520 Sum_probs=191.8
Q ss_pred EecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-C
Q 038696 242 RLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-D 311 (683)
Q Consensus 242 ~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-s 311 (683)
.||+|+++.++. .+|+.||+|.+... ...+.+|+++++.++||||+++++++... ..+|+||||+.| +
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccCCc
Confidence 588888655553 37889999987542 34688999999999999999999988643 678999999975 9
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCC
Q 038696 312 LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391 (683)
Q Consensus 312 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~ 391 (683)
|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 80 L~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-------~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 80 FLTFLRT-----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-------VLKISDFGMSREEEDG 147 (252)
T ss_pred HHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-------cEEECccccCcccccc
Confidence 9999874 234689999999999999999999999999999999999998877 7999999998765432
Q ss_pred CCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 392 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
...........+..|+|||.+.+. .++.++||||||+++|||++ |..||..... ......+.......
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~~~~~~~~~ 216 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYG---------RYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQGVRLP 216 (252)
T ss_pred cccccCCCCCCceeecCchhhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCCCC
Confidence 111111122234569999998643 48889999999999999998 9999976443 23445555555566
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 471 FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 471 ~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+..++..+.+++.+||..||++|||+.++++.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 77778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.89 Aligned_cols=246 Identities=27% Similarity=0.381 Sum_probs=205.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~ 301 (683)
...|++.+.||.|.|+.++.. +|+.+|+|.+.. +.+.+.+|+.+|+.+. |||||.+++.|.+. ..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence 457999999999998777753 689999999853 2357899999999998 99999999999654 789
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+|||+|. |.|.+.+.+. .+++..+..++.||+.|+.|||+.||+||||||+|+|+.... ++...+|++
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~---~~~~~ik~~ 181 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD---EGSGRIKLI 181 (382)
T ss_pred EEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc---CCCCcEEEe
Confidence 99999998 5999999863 399999999999999999999999999999999999997664 223479999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++..... .......+||+.|+|||++... .|+..+||||+||++|.|++|.+||.+.+.. ...
T Consensus 182 DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~---------~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--~~~ 247 (382)
T KOG0032|consen 182 DFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGR---------PYGDEVDVWSIGVILYILLSGVPPFWGETEF--EIF 247 (382)
T ss_pred eCCCceEccC---CceEeeecCCccccCchhhcCC---------CCCcccchhHHHHHHHHHhhCCCCCcCCChh--HHH
Confidence 9999998765 2244567899999999999754 4999999999999999999999999987643 344
Q ss_pred HHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 461 RNIRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 461 ~~i~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+..+..... -...+..+.++|..|+..||.+|+|+.++++|.|
T Consensus 248 ~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 45665543211 1234788999999999999999999999998743
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.73 Aligned_cols=242 Identities=20% Similarity=0.301 Sum_probs=190.8
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+|+++++||+|+++.|++. +++.||||++.. ....+.+|+++|+.++|||||++++.|.+. ..+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence 6999999999998877763 678999999853 234678999999999999999999999654 689999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||
T Consensus 80 ~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-------~~kL~DFG 146 (382)
T cd05625 80 MDYIPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-------HIKLTDFG 146 (382)
T ss_pred EeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------CEEEeECC
Confidence 99997 5999998752 4689999999999999999999999999999999999999888 79999999
Q ss_pred CccccCCCC---------------------------------------------CCCCCCCCCcCcccCChhhhhhcccc
Q 038696 384 LSSVKNFGP---------------------------------------------KSPSQSGTTHPFIWHAPEVLEENEQT 418 (683)
Q Consensus 384 la~~~~~~~---------------------------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~ 418 (683)
+++...... .........||+.|+|||++.+.
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--- 223 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--- 223 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC---
Confidence 975331100 00001234689999999999754
Q ss_pred ccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC
Q 038696 419 ESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPS 496 (683)
Q Consensus 419 ~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt 496 (683)
.++.++|||||||++|||++|+.||.+.... ......+.......+| ...++++.++|.+|+ .||.+|++
T Consensus 224 ------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 224 ------GYTQLCDWWSVGVILYEMLVGQPPFLAQTPL-ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred ------CCCCeeeEEechHHHHHHHhCCCCCCCCCHH-HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 4889999999999999999999999875432 1222222222222233 346788999998876 59999987
Q ss_pred ---HHHHHHH
Q 038696 497 ---FSSICRI 503 (683)
Q Consensus 497 ---~~eil~~ 503 (683)
+.++++|
T Consensus 296 ~~~~~ei~~h 305 (382)
T cd05625 296 KNGADEIKAH 305 (382)
T ss_pred CCCHHHHhcC
Confidence 8887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.78 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=198.5
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+.+..++|++.+.||+|+++.|++. +++.||+|++.. ....+.+|+.+++.++||||+++++++.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-- 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-- 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence 3445679999999999998877753 678999999842 233467899999999999999999988643
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-------~i 181 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HL 181 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-------CE
Confidence 78999999997 599999875 3488999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++....... .......||+.|+|||++.+.. ....++.++|||||||++|||++|..||...+..
T Consensus 182 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-- 253 (371)
T cd05622 182 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQG-----GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-- 253 (371)
T ss_pred EEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccC-----CCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--
Confidence 9999999987643211 1223456899999999997542 1234789999999999999999999999876532
Q ss_pred HHHHHHHcC-CCCCCC--CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 038696 458 KMSRNIRAG-ERPLFP--FHSPKYVTNLTKRCWHADPNQ--RPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~-~~~~~p--~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~L~ 505 (683)
.....+... ....++ ...+..+.++|..||..++.+ |+++.++++|.+
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 254 GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 233444332 222233 357889999999999843433 679999887754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.59 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=191.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++.+.||+|+++.|+.. .++.||||.+... ...+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 458999999999998777653 6789999998532 345678999999999999999999886432 24
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+||||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 96 ~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-------~~kl 160 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 160 (355)
T ss_pred eeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-------CEEE
Confidence 5799999999999888763 388999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+..... ..
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~ 227 (355)
T cd07874 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QW 227 (355)
T ss_pred eeCcccccCCCcc---ccCCccccCCccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 9999998654321 22345678899999999654 48899999999999999999999997654221 11
Q ss_pred HHHHH----------------------cCCC------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 460 SRNIR----------------------AGER------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 460 ~~~i~----------------------~~~~------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
...+. .... ...+...+..+.+||.+||..||.+|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e 307 (355)
T cd07874 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307 (355)
T ss_pred HHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence 11100 0000 0011123456899999999999999999999
Q ss_pred HHHHHH
Q 038696 500 ICRILR 505 (683)
Q Consensus 500 il~~L~ 505 (683)
+++|-+
T Consensus 308 ll~hp~ 313 (355)
T cd07874 308 ALQHPY 313 (355)
T ss_pred HhcCcc
Confidence 998744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.82 Aligned_cols=241 Identities=25% Similarity=0.422 Sum_probs=200.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+|++.+.||+|+++.+++. +|..||+|.+.. ..+.+.+|+.+++.++|+||+++++.+.+. ..+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEe
Confidence 5899999999997777653 688999998742 235678899999999999999999988644 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++... ....+++..+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++
T Consensus 79 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-------~~~l~dfg~~ 147 (255)
T cd08219 79 YCDGGDLMQKIKLQ----RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-------KVKLGDFGSA 147 (255)
T ss_pred eCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-------cEEEcccCcc
Confidence 997 5999988752 335689999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~ 214 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENM---------PYNNKSDIWSLGCILYELCTLKHPFQANSWK--NLILKVCQ 214 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccC---------CcCchhhhhhhchhheehhhccCCCCCCCHH--HHHHHHhc
Confidence 76543211 12234678889999998654 4888999999999999999999999865432 34445556
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
+.....+..++..+.+++.+||+.||++|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 215 GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 6666667778889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.58 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=197.4
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +|+.||||+++. ..+.+.+|+.+++.++|+||+++++++.+. ..+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEE
Confidence 47999999999998777753 688999999853 234578899999999999999999888643 68999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 79 v~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-------~~kL~Df 146 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY-----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-------HIKLADF 146 (330)
T ss_pred EECCCCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-------CEEeccC
Confidence 999997 5999999752 35699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++......... ......||+.|+|||++...... ....++.++|||||||++|||++|..||...... .....
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~ 220 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGD---GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYNN 220 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhcccccc---ccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HHHHH
Confidence 999876433211 22234688899999998643211 1335788999999999999999999999865432 23333
Q ss_pred HHcCC-CCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGE-RPLFP--FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~-~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.... ...++ ...+..+.+|+..||. ||.+|||+.+++.|
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 221 IMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 33322 22233 3468889999999997 99999999998765
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.31 Aligned_cols=249 Identities=27% Similarity=0.486 Sum_probs=201.2
Q ss_pred eeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+..++|.+...||+|+++.+++ ..+..+|+|.+... .+.+.+|+++++.++|+||+++++++.. ...|+||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEE
Confidence 4456899999999998766654 24457999988542 3568899999999999999999887632 4579999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+.+ +|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||++++++ .++|+|||+
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-------~~~l~dfg~ 148 (260)
T cd05069 80 EFMGKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-------VCKIADFGL 148 (260)
T ss_pred EcCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-------eEEECCCcc
Confidence 99985 999999752 234588999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
++....... .......++..|+|||++.+. .++.++||||||+++|||++ |..||.+.... .....+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~ 216 (260)
T cd05069 149 ARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQV 216 (260)
T ss_pred ceEccCCcc-cccCCCccchhhCCHHHhccC---------CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence 976543321 122234456789999988643 48889999999999999999 99999875432 344555
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+..+..+...+..+.+++.+||..||++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 5555555667788999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.32 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=210.4
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCC-CCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLS-HPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~-HpnIv~l~~~ 292 (683)
..|.+..++|.+.+.||+|+++.|+.. .+..||||+++.. .+.+.+|+++|..+. |||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 457888889999999999998777753 2357999999642 236789999999997 9999999998
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcCC-------------------------------------------------
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICCP------------------------------------------------- 322 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~------------------------------------------------- 322 (683)
+... ...||||||+. |+|.+++......
T Consensus 110 ~~~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 110 CTKG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EccC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 8654 67899999998 5999999753210
Q ss_pred -------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 323 -------------------------------------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 323 -------------------------------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
.....+++..++.|+.||+.||.|||+.||+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 0113478888999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+++.|+|||++.+. .++.++|||||||++
T Consensus 268 ~NiLl~~~~-------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslGvil 331 (401)
T cd05107 268 RNVLICEGK-------LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN---------LYTTLSDVWSFGILL 331 (401)
T ss_pred ceEEEeCCC-------EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC---------CCCcHhHHHHHHHHH
Confidence 999998776 7999999999865432221222334567889999999644 478899999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|||++ |..||...... +.....+..+.++..+..++..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 332 ~e~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 332 WEIFTLGGTPYPELPMN-EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHcCCCCCCCCCch-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99998 89999765432 334455666666667778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.68 Aligned_cols=251 Identities=24% Similarity=0.450 Sum_probs=205.4
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.++.. +|+.||+|.++. ..+.+.+|+++++.++|+||+++++.+.+. +..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 58999999999987666542 788999998742 245688999999999999999999988654 67899
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.... .....+++.++..++.|++.||.|||+.||+||||||+||+++.++ .++|+||
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-------~~~l~d~ 150 (267)
T cd08224 80 VLELADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-------VVKLGDL 150 (267)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-------cEEEecc
Confidence 9999985 9999987531 2235689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+...
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccC---------CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh
Confidence 99876543211 12234577889999998654 47889999999999999999999997655443345555
Q ss_pred HHcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+..+..+..+. ..+..+.++|.+||..+|++|||+.+|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 55555555554 6778899999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.94 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=193.4
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+|++.+.||+|+++.|++. +++.||||++... .+.+..|..++..+ .|++|+++++++.+. ..+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 6899999999998777753 5679999998532 23456788888877 589999998888543 68999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-------~~kL~Df 145 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-------HIKIADF 145 (323)
T ss_pred EEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-------cEEEccC
Confidence 999997 5999988752 4689999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..+...
T Consensus 146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~ 212 (323)
T cd05616 146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS 212 (323)
T ss_pred CCceecCCCC--CccccCCCChhhcCHHHhcCC---------CCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 9997543221 122345688999999999754 488999999999999999999999987553 334444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF-----SSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~-----~eil~~ 503 (683)
+.... ..+|...+.++.+++.+||+.||.+|++. .++.+|
T Consensus 213 i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 213 IMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHhCC-CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 44433 34677789999999999999999999974 555544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.43 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=202.3
Q ss_pred eCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
...+|.+.++||+|+++.++.. ++..+|+|.+... .+.+.+|+++++.++|+||+++++.+.+. .
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 3468899999999997666643 3568999988642 35688999999999999999999888543 6
Q ss_pred eEEEEEecCC-CCHHHHHHHhcC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEICC---------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~---------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
..++||||++ |+|.+++..... ......+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~- 159 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL- 159 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-
Confidence 7899999997 599999875321 01113588999999999999999999999999999999999998876
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||++................+++.|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 160 ------~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~p 224 (280)
T cd05092 160 ------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESDIWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred ------CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC---------CcCchhhHHHHHHHHHHHHcCCCCC
Confidence 7999999999765432221122333456789999998654 48899999999999999998 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|..... ......+..+.....+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 225 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 225 WYQLSN--TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccCCH--HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 976543 2344555566555667778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.73 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=194.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC---CeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK---KECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~---~~~~ 302 (683)
+|++.+.||+|+++.|++. +|+.||||.+... .+.+.+|+++|+.++|+||+++++++...+. ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999998777753 6889999998532 3467899999999999999999998865421 2689
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||+.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 81 lv~e~~~~~l~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-------~~kL~Df 147 (372)
T cd07853 81 VVTELMQSDLHKIIVS------PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-------VLKICDF 147 (372)
T ss_pred EEeeccccCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-------CEEeccc
Confidence 9999999999988864 35699999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH-
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR- 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~- 461 (683)
|+++....... .......+|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+... .+..
T Consensus 148 g~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i 217 (372)
T cd07853 148 GLARVEEPDES-KHMTQEVVTQYYRAPEILMGS--------RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLI 217 (372)
T ss_pred cceeecccCcc-ccCCCCCcCCCcCCHHHHcCC--------CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHH
Confidence 99986543221 122334578889999998643 247889999999999999999999997654321 1111
Q ss_pred ---------------------HHHc-CCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 462 ---------------------NIRA-GERP-------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 462 ---------------------~i~~-~~~~-------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+.. ...+ ......+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0101 1111 122345778999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.39 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=204.0
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
|.+..++|++.+.||+|+++.+++. .+..||||.+... ...+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4566789999999999997777642 2347999988542 2356789999999999999999988854
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCP----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
. ...|+||||+. |+|.+++...... .....+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 81 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-- 156 (288)
T cd05061 81 G--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-- 156 (288)
T ss_pred C--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--
Confidence 3 67899999997 5999999753211 1124567788999999999999999999999999999999998877
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf 449 (683)
.+||+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..||
T Consensus 157 -----~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 157 -----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG---------VFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred -----cEEECcCCccccccccccccccCCCcccccccCHHHhccC---------CCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 7999999999865432221122223456779999998644 48889999999999999998 88999
Q ss_pred CCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.+... ..+...+..+.....+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 223 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 223 QGLSN--EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 76543 335555555555566777889999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=312.00 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=199.0
Q ss_pred CCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..+|++.+.||+|+++.++.. +|..||||.+... .+.+.+|+++++.++||||+++++++...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 358999999999997776642 4779999998643 3467899999999999999999987765555678
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++ |+|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~-----~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-------~~~l~ 150 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK-----HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-------RVKIG 150 (284)
T ss_pred EEEEEecCCCCHHHHHHh-----cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-------eEEEC
Confidence 99999997 599999975 234689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc----
Q 038696 381 GFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ---- 455 (683)
Q Consensus 381 DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~---- 455 (683)
|||++.......... ......++..|+|||++.+. .++.++|||||||++|||++|..++......
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 221 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccC---------CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence 999998764332111 11122234459999998644 4888999999999999999987765432110
Q ss_pred ----------hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 456 ----------GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 456 ----------~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
...+...+..+.....+..++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0112233444444455667889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=334.39 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=192.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
....|.+.+.||+|+++.|++. .++.||||.. ....+.+|+++|+.|+|+|||++++++... +..|||||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~--~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv~e~~ 242 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAG--WYASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLVLPKY 242 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecc--cccCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEEEcc
Confidence 3458999999999997777753 5788999975 345678999999999999999999988644 6789999999
Q ss_pred CCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 309 SRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
.++|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 243 ~~~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-------~vkL~DFGla~~~ 310 (461)
T PHA03211 243 RSDLYTYLGA-----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-------DICLGDFGAACFA 310 (461)
T ss_pred CCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-------CEEEcccCCceec
Confidence 9999999875 234699999999999999999999999999999999999998877 7999999999876
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc------chhHHHHH
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL------QGDKMSRN 462 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~------~~~~~~~~ 462 (683)
.............||+.|+|||++.+. .++.++|||||||++|||++|..|+..... ....+.+.
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~---------~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~ 381 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGD---------PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCC---------CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence 433222223345689999999999654 488999999999999999998765532211 11222333
Q ss_pred HHcCCC--CCCC-------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRAGER--PLFP-------------------------------FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~~~~--~~~p-------------------------------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+..... ..++ ...+..+.+||.+||..||.+|||+.++++|-
T Consensus 382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 322111 0011 01234688999999999999999999998863
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=315.91 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=210.1
Q ss_pred eeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
+.-++|..++.||+|.|++|++ .+|+.+|||+++++ ...-..|-++|...+||.+..+-+.|+.. ..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ce
Confidence 3456899999999999999997 48999999998653 34457899999999999999999999654 78
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||.+| .|.-+|.. ...|++..+..|..+|+.||.|||+++||+||||.+|.|+|.+| ++||
T Consensus 243 lCFVMeyanGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-------HIKi 309 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-------HIKI 309 (516)
T ss_pred EEEEEEEccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-------ceEe
Confidence 9999999985 89888864 36799999999999999999999999999999999999999999 9999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+|+....... .....+|||.|+|||++... .|+.++|+|.+||+||||++|+.||.... .+.+
T Consensus 310 tDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDn---------DYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kL 376 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKL 376 (516)
T ss_pred eecccchhcccccc--eeccccCChhhcCchhhccc---------cccceeehhhhhHHHHHHHhccCcccccc--hhHH
Confidence 99999987543222 34467899999999999766 49999999999999999999999998754 2456
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHHHHHHHhcCCC
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILRYIKRFIMMNPH 516 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~~i~~~~~~~~~ 516 (683)
+..|.... ..||...+++.+.|+..+|..||.+|. .+.+|.+| ..|..+||.
T Consensus 377 FeLIl~ed-~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h----~FF~~v~W~ 433 (516)
T KOG0690|consen 377 FELILMED-LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH----RFFASVDWE 433 (516)
T ss_pred HHHHHhhh-ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh----hhhccCCHH
Confidence 66665543 348999999999999999999999995 35555544 334445544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=321.33 Aligned_cols=262 Identities=26% Similarity=0.458 Sum_probs=210.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEEc-----------CcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILWL-----------GESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~~-----------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
..|.+...+|++++.||+|+++.++... +..||+|.+... .+.+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 4567777799999999999987776531 236999988642 34688999999999 799999999
Q ss_pred eeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 291 CGFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+.+... ..+|+||||++ |+|.+++...... .....+++.+++.++.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 85 GACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred EEEccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 988543 67899999997 5999999763210 1234588899999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............++..|+|||++.+. .++.++||||||+++
T Consensus 163 ~Nill~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 226 (334)
T cd05100 163 RNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLL 226 (334)
T ss_pred ceEEEcCCC-------cEEECCcccceecccccccccccCCCcCceEcCHHHhccC---------CcCchhhhHHHHHHH
Confidence 999998877 7999999999765433222122233445679999999654 488899999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|||++ |..||.+... ......+..+.....+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 227 ~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 227 WEIFTLGGSPYPGIPV--EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 99998 8999977543 34556666666666777888999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.86 Aligned_cols=228 Identities=28% Similarity=0.422 Sum_probs=186.4
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||++.. ..+.+..|+.++..+ +||||+++++++.+. ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 46899987777753 578999999853 234567888888876 699999999988543 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-------~~kL~DfG~~~~ 145 (320)
T cd05590 79 NGGDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-------HCKLADFGMCKE 145 (320)
T ss_pred CCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-------cEEEeeCCCCee
Confidence 85 999888752 4689999999999999999999999999999999999999887 799999999876
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..+...+..+.
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~~ 212 (320)
T cd05590 146 GIFNGK--TTSTFCGTPDYIAPEILQEM---------LYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDE 212 (320)
T ss_pred cCcCCC--cccccccCccccCHHHHcCC---------CCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCC
Confidence 432211 22345689999999999654 488899999999999999999999987553 33445554443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
..++...+.++.+++.+||+.||.+||++
T Consensus 213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 34566788999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.30 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=200.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. +|+.|++|.+.. ..+.+.+|+++++.++||||+++++.+.+. +.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 5889999999987666642 688999998742 245688999999999999999999988543 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .+||+|||+
T Consensus 79 e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-------~~~l~df~~ 147 (256)
T cd08529 79 EYAENGDLHKLLKMQ----RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-------NVKIGDLGV 147 (256)
T ss_pred EeCCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-------CEEEccccc
Confidence 99975 999999863 235689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++....... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~ 214 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDK---------PYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKII 214 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 886653321 12234577889999999654 47889999999999999999999997654 233445556
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 666666666788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.27 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=202.5
Q ss_pred eCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..++|++.+.||+|+++.++.. ++..||||.+... ...+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 4568999999999997766652 4578999998643 24588899999999999999999888543
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCP----------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~N 361 (683)
..+|+||||++ |+|.+++...... .....+++..++.++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 67899999998 5999999753210 112357889999999999999999999999999999999
Q ss_pred EEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 362 ILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
||++.++ .+||+|||++.................++.|+|||++.+. .++.++|||||||++||
T Consensus 161 il~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~e 224 (288)
T cd05050 161 CLVGENM-------VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN---------RYTTESDVWAYGVVLWE 224 (288)
T ss_pred eEecCCC-------ceEECccccceecccCccccccCCCccChhhcCHHHHhcC---------CCCchhHHHHHHHHHHH
Confidence 9998887 7999999998765432211112223345679999998644 48899999999999999
Q ss_pred HHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 442 llt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|++ |..||.+... .+....+..+.....+...+.++.+|+.+||+.||++|||+.++++.|+
T Consensus 225 l~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 225 IFSYGMQPYYGMAH--EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHhCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 997 8899976543 3355566666655566778899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.28 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=188.5
Q ss_pred ecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||+|+++.|++ .+|+.||+|.+.. ....+..|+++++.++||||+++++.+.+ ...+|+||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 68898777764 2689999999853 12345679999999999999999988854 4789999999975
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 79 ~L~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-------~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 79 DLKYHIYNV----GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-------NCRLSDLGLAVELKD 147 (277)
T ss_pred CHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-------CEEEeeceeeeecCC
Confidence 998888652 234588999999999999999999999999999999999998887 799999999876543
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--hhHHHHHHHcCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--GDKMSRNIRAGER 468 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~~~~~~~i~~~~~ 468 (683)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|..||...... ...+.........
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 215 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEE---------PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccC---------CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc
Confidence 21 11234578889999999644 4889999999999999999999999764321 1222233333322
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
.......+.++.+|+.+||+.||++||++.++++.+.....+
T Consensus 216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 222345788899999999999999999997766544443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.93 Aligned_cols=245 Identities=26% Similarity=0.393 Sum_probs=198.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
++|++.+.||+|+++.++.. +|+.||||.+.. ..+.+.+|+++++.++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 57999999999987666542 678999998742 124578899999999999999999988654 689
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+
T Consensus 80 ~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-------~~~l~ 146 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-------NVKLG 146 (263)
T ss_pred EEEEEECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------CEEEe
Confidence 999999985 999998752 4689999999999999999999999999999999999998877 79999
Q ss_pred cccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|||+++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...... ...
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~ 216 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE---------GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAI 216 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccC---------CCCchhhhHHHHHHHHHHHhCCCCccccchH-HHH
Confidence 999997654321111 11234567789999999754 3889999999999999999999999765432 223
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.........+.++...+..+.+++.+||..+|.+|||+.+++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 333344445567778899999999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.95 Aligned_cols=240 Identities=28% Similarity=0.444 Sum_probs=195.0
Q ss_pred EecccccEEEEEE------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-
Q 038696 242 RLGSGSQYKEILW------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS- 309 (683)
Q Consensus 242 ~LG~G~~~~v~l~------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~- 309 (683)
.||+|+++.++.. .+..||||++... .+.+.+|+.+++.++||||+++++++. ...+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence 3789986666531 3457999998643 245789999999999999999998773 246899999997
Q ss_pred CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 310 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
|+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++....
T Consensus 79 ~~L~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-------~~kl~dfg~~~~~~ 146 (257)
T cd05115 79 GPLNKFLSG-----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-------YAKISDFGLSKALG 146 (257)
T ss_pred CCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-------cEEeccCCcccccc
Confidence 499999874 235689999999999999999999999999999999999998877 79999999997654
Q ss_pred CCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCC
Q 038696 390 FGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 390 ~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......+++.|+|||++... .++.++|||||||++|||++ |..||.+... ..+...+..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~ 215 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGK 215 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccC---------CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCC
Confidence 332211 11223345679999998644 47889999999999999996 9999987643 34556677777
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.+..+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 7778888899999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=317.08 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=188.7
Q ss_pred EeEecccccEEEEEE------cCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCCC
Q 038696 240 RRRLGSGSQYKEILW------LGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD 311 (683)
Q Consensus 240 ~~~LG~G~~~~v~l~------~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~gs 311 (683)
.++||+|+++.|++. ++..||||.+... ...+.+|+++|+.++||||+++++.|.......+|+||||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999997777753 4568999998643 34678999999999999999999988766667899999999999
Q ss_pred HHHHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 312 LCSYIKEICCP---RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 312 L~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ +....+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~---~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---PERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC---CCcCcEEEeecCceecc
Confidence 99988643211 1224689999999999999999999999999999999999995432 12227999999999876
Q ss_pred CCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--------hhHH
Q 038696 389 NFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--------GDKM 459 (683)
Q Consensus 389 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--------~~~~ 459 (683)
...... .......+|+.|+|||++.+. ..++.++|||||||++|||++|++||...... ...+
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCC--------CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 533211 122345678999999999643 24788999999999999999999999643211 0111
Q ss_pred HHHHHcCCC------------C------------C------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGER------------P------------L------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~------------~------------~------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+..... + . .....+..+.+||.+||+.||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111110000 0 0 001124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=307.04 Aligned_cols=238 Identities=28% Similarity=0.470 Sum_probs=194.6
Q ss_pred EecccccEEEEEE------cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 242 RLGSGSQYKEILW------LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 242 ~LG~G~~~~v~l~------~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
.||+|+++.++.. ++..||||+++.. .+.+.+|+.+++.++||||+++++.+.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 5899986655531 5678999998542 3467899999999999999999987742 45799999998
Q ss_pred -CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 -RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 -gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-------~~kl~Dfg~~~~~ 145 (257)
T cd05116 79 LGPLNKFLQK------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKISDFGLSKAL 145 (257)
T ss_pred CCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-------eEEECCCcccccc
Confidence 589999874 24689999999999999999999999999999999999998877 7999999999876
Q ss_pred CCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcC
Q 038696 389 NFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 389 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......+++.|+|||++... .++.++|||||||++|||++ |..||..... ......+..+
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~ 214 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESG 214 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC
Confidence 433211 111223345789999998643 47889999999999999998 9999987543 3456667777
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+..|..++.++.++|.+||+.||++||++.+|.+.|+.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 7777888899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.29 Aligned_cols=236 Identities=23% Similarity=0.350 Sum_probs=188.3
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||+++. ..+.+..|+.++..+ +||||++++++|.+. ..+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 46899998777753 688999999863 124577899999998 699999999988654 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-------~~kL~Dfg~~~~ 145 (329)
T cd05588 79 SGGDLMFHMQR------QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-------HIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-------CEEECcCccccc
Confidence 85 99988865 25699999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-------hhHHH
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-------GDKMS 460 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-------~~~~~ 460 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 214 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCC---------CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH
Confidence 32211 122345688999999999754 4888999999999999999999999632211 11233
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS------FSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt------~~eil~~ 503 (683)
+.+... ...+|..++..+.++|.+||+.||.+|++ +.++++|
T Consensus 215 ~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 215 QVILEK-QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 333333 34467778899999999999999999997 5666544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.86 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=191.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++.+.||+|+++.|+.. .++.||||++... ...+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999997777643 6789999998532 345788999999999999999998875432 24
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+||||++++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 103 ~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~kL 167 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 167 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-------cEEE
Confidence 6899999999999988863 378899999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+..... .+
T Consensus 168 ~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~ 234 (364)
T cd07875 168 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QW 234 (364)
T ss_pred EeCCCccccCCCC---cccCCcccCCcCCHHHHhCC---------CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 9999997654321 22345678899999999654 48899999999999999999999997654221 11
Q ss_pred HHHHHcC--------------------CCCCC--------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 460 SRNIRAG--------------------ERPLF--------------------PFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 460 ~~~i~~~--------------------~~~~~--------------------p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
...+..- .++.+ ....+..+.+||.+||..||.+|||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred HHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 1111100 00000 0112456899999999999999999999
Q ss_pred HHHHHH
Q 038696 500 ICRILR 505 (683)
Q Consensus 500 il~~L~ 505 (683)
+++|-+
T Consensus 315 ~L~hp~ 320 (364)
T cd07875 315 ALQHPY 320 (364)
T ss_pred HhcCcc
Confidence 998744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.31 Aligned_cols=242 Identities=22% Similarity=0.375 Sum_probs=192.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ....+..|+.++..++||||+++++.+.+. ..+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 47999999999998877753 688999999842 234578899999999999999999988654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~E~~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-------~vkL~Df 145 (360)
T cd05627 79 IMEFLPGGDMMTLLMK------KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-------HVKLSDF 145 (360)
T ss_pred EEeCCCCccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-------CEEEeec
Confidence 9999985 99999875 25689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCC---------------------------------CCCCCCCCcCcccCChhhhhhccccccccCCCCCch
Q 038696 383 GLSSVKNFGPK---------------------------------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429 (683)
Q Consensus 383 Gla~~~~~~~~---------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~k 429 (683)
|+++....... ........||+.|+|||++.+. .++.+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---------~~~~~ 216 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT---------GYNKL 216 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC---------CCCCc
Confidence 99875432110 0011234689999999999754 48899
Q ss_pred hHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-CCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 038696 430 SDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-GERPLFPF--HSPKYVTNLTKRCWHADPNQRPS---FSSICRI 503 (683)
Q Consensus 430 sDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPt---~~eil~~ 503 (683)
+|||||||++|||++|+.||.+.... .....+.. .....+|. ..+.++.+||.+|+ .||.+|++ +.++++|
T Consensus 217 ~DiwSlGvilyel~tG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 217 CDWWSLGVIMYEMLIGYPPFCSETPQ--ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred ceeccccceeeecccCCCCCCCCCHH--HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99999999999999999999876533 23333332 22223333 35788999999977 49999985 5666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.09 Aligned_cols=234 Identities=31% Similarity=0.490 Sum_probs=188.8
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||.++. ..+.+..|..++..+ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 46899998777753 688999999853 234567788888754 89999999998864 37899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~i~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-------~~kl~Dfg~~~~ 145 (316)
T cd05620 79 NGGDLMFHIQD------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-------HIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-------CEEeCccCCCee
Confidence 85 99998875 25689999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+...+...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~- 211 (316)
T cd05620 146 NVFGDN--RASTFCGTPDYIAPEILQGL---------KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVD- 211 (316)
T ss_pred cccCCC--ceeccCCCcCccCHHHHcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC-
Confidence 322211 22345688999999999754 488999999999999999999999986543 3344555443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFS-SICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~-eil~~ 503 (683)
.+.++...+.++.++|.+||+.||++||++. ++++|
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 212 TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3456677889999999999999999999974 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.00 Aligned_cols=234 Identities=25% Similarity=0.407 Sum_probs=189.7
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||++.. ..+.+..|++++..+ +||||++++++|.+. ..+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 46899998777753 578999999853 224467889998866 799999999998654 6899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-------~~kL~Dfg~~~~ 145 (321)
T cd05591 79 NGGDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-------HCKLADFGMCKE 145 (321)
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-------CEEEeeccccee
Confidence 85 999888752 4689999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~~i~~~~ 212 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQEL---------EYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFESILHDD 212 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCC---------CCCCccceechhHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC
Confidence 432211 22345688999999999654 488899999999999999999999987653 33445554443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRP-------SFSSICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RP-------t~~eil~~ 503 (683)
..+|..++.++.+++.+||..||++|| ++.++++|
T Consensus 213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 345667789999999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.76 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=203.5
Q ss_pred CCCeEEEe-EecccccEEEEE----EcCcEEEEEEeCCCcchHHHHHHHHHcCC-CCceeeeeeeEEc--CCCCeEEEEE
Q 038696 234 SEDYQVRR-RLGSGSQYKEIL----WLGESFALRHFFGDIEPLVPEISSLLSLS-HPNIMHFLCGFTD--EEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~-~LG~G~~~~v~l----~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~--e~~~~~~LVm 305 (683)
+++|.+.. +||-|--++|+. .+|+.+|+|++. +.....+|+++--..+ |||||.++++|.+ ...+.+.+||
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 56888755 688886566663 589999999986 3456789999877774 9999999998853 2346789999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|+|+| .|++.+++ +....|++.++..|+.||+.|+.|||+.+|.||||||+|+|....+ .+..+||+|||+
T Consensus 139 E~meGGeLfsriq~----~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~----~na~lKLtDfGF 210 (400)
T KOG0604|consen 139 ECMEGGELFSRIQD----RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS----PNAPLKLTDFGF 210 (400)
T ss_pred ecccchHHHHHHHH----cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC----CCcceEeccccc
Confidence 99985 99999987 4567899999999999999999999999999999999999997664 345799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--hhHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--GDKMSRN 462 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~~~~~~~ 462 (683)
|+..... .......-|+.|.|||++..+ +|+..+|+||+||++|-|++|.+||...+-. ...+...
T Consensus 211 AK~t~~~---~~L~TPc~TPyYvaPevlg~e---------KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r 278 (400)
T KOG0604|consen 211 AKETQEP---GDLMTPCFTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR 278 (400)
T ss_pred ccccCCC---ccccCCcccccccCHHHhCch---------hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH
Confidence 9876432 223345678999999999654 6999999999999999999999999876532 1346677
Q ss_pred HHcCCCCCCCCC---CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERPLFPFH---SPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~~p~~---~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|..|......+. .++..+++|+.+|..+|.+|.|+.+++.|-+
T Consensus 279 I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 279 IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 888875433333 3677899999999999999999999987744
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.45 Aligned_cols=251 Identities=28% Similarity=0.497 Sum_probs=204.4
Q ss_pred EeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+..++|++.+.||+|+++.++. ..+..||||.+... .+.+.+|+.+++.++|+||+++++.+.. ....++|
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEE
Confidence 45677999999999998766654 34568999998642 4578999999999999999999988754 3678999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|.+++.+. ....+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||
T Consensus 80 ~e~~~~~~L~~~i~~~----~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-------~~~l~d~g 148 (261)
T cd05034 80 TEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-------VCKIADFG 148 (261)
T ss_pred EeccCCCCHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-------CEEECccc
Confidence 999985 999999762 234689999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
++........ .......++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+... ......
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~ 216 (261)
T cd05034 149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYG---------RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQ 216 (261)
T ss_pred cceeccchhh-hhhhccCCCccccCHHHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9876643211 111223345679999998654 47889999999999999998 9999976542 335555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+.....+...+.++.+++.+||..||++||++.++.+.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 66665556677778999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.63 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=189.8
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcC---CCCceeeeeeeEEcC---CCC
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSL---SHPNIMHFLCGFTDE---EKK 299 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~e---~~~ 299 (683)
+|++.+.||+|+++.|++. +|+.||||.+... ...+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999997777653 6889999988531 23466788887766 699999999887542 235
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+++||||+.++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-------~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV----PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-------QVKL 149 (288)
T ss_pred eEEEEEcccccCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------CEEE
Confidence 68999999999999998752 234589999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|+|++|.+||.+..... .+
T Consensus 150 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~ 216 (288)
T cd07863 150 ADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QL 216 (288)
T ss_pred CccCccccccCcc---cCCCccccccccCchHhhCC---------CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HH
Confidence 9999997664321 22334678889999999644 48899999999999999999999997654321 12
Q ss_pred HHHHHcC-C--C-----------C-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAG-E--R-----------P-----------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~-~--~-----------~-----------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.+... . . . ......+..+.+++.+||+.||++|||+.+++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 217 GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1211100 0 0 0 0112456778999999999999999999999765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.77 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=207.7
Q ss_pred EeeCCCeEEEeEecccccEEEEE---Ec-----CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL---WL-----GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l---~~-----g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.+..++|++.+.||+|+++.|+. .. +..||+|.+... .+.+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~- 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED- 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 34567999999999998665553 23 578999998643 34578999999999999999999876543
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCP--RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
....++++||++ |+|.+++...... .....+++..+..++.|++.||.|||+.|++||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~------ 154 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL------ 154 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC------
Confidence 467899999997 5999999763211 0124689999999999999999999999999999999999998876
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++||+++ |+.||....
T Consensus 155 -~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 155 -QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK---------EYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred -cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC---------CCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 7999999999865433221122233456679999999654 48899999999999999998 999997654
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
. ..+...+..+.....+..++.++.+++.+||..||++|||+.++++.|..+.+
T Consensus 225 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 225 P--FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred H--HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3 33555556666555666778999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.91 Aligned_cols=251 Identities=27% Similarity=0.504 Sum_probs=204.0
Q ss_pred eEeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
|.+..++|++.+.||+|+++.+++ ..+..||+|.+... .+.+.+|+.+++.++|+||+++++.+.. ..+|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 345667999999999999766664 35678999988643 3568899999999999999999888754 56899
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-------~~~l~d~ 146 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-------VCKIADF 146 (260)
T ss_pred EEEeCCCCcHHHHHHhC----CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-------cEEECCC
Confidence 999997 5999999762 234578899999999999999999999999999999999998877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........ .......++..|+|||++... .++.++|+|||||++|++++ |..||.+.... .+..
T Consensus 147 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~ 214 (260)
T cd05073 147 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR 214 (260)
T ss_pred cceeeccCCCc-ccccCCcccccccCHhHhccC---------CcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH
Confidence 99976543221 122334456779999998643 47889999999999999998 99999865432 3445
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+.....+...+.++.+++.+||+.||++||++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 555555555566778899999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.40 Aligned_cols=250 Identities=29% Similarity=0.487 Sum_probs=201.0
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCc---EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGE---SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~---~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|+..+.||+|+++.++.. ++. .+|||.+... .+.+..|+++++.++|+||+++++++.+. ..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CC
Confidence 3458999999999986665532 333 7999998643 34578899999999999999999988543 67
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.|+||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-------~~kl 148 (268)
T cd05063 81 AMIITEYMENGALDKYLRD-----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-------ECKV 148 (268)
T ss_pred cEEEEEcCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-------cEEE
Confidence 8999999985 99999875 235689999999999999999999999999999999999998776 7999
Q ss_pred ecccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 380 SGFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
+|||++.......... .......++.|+|||++.+. .++.++|||||||++|||++ |..||..... .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~ 217 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--H 217 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhhcC---------CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--H
Confidence 9999997654322111 11122334579999998644 47889999999999999997 9999976542 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.....+..+.....+..++..+.+++.+||+.+|++||++.++++.|..+
T Consensus 218 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45566666655556667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.63 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=201.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc--EEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE--SFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~--~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++.+.||+|+++.+++. +|. .+|+|.++.. ...+.+|+.++..+ +|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CC
Confidence 34569999999999997766653 344 4688877542 23577899999999 89999999998854 46
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
.+|+||||++ |+|.+++...... .....+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 7999999997 5999999763210 1123689999999999999999999999999999999999998877
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCC
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~ 447 (683)
.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 162 -------~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~ 222 (303)
T cd05088 162 -------VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGT 222 (303)
T ss_pred -------cEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc---------CCcccccchhhhhHHHHHHhcCCC
Confidence 79999999986432211 11122345679999998644 47889999999999999998 999
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
||..... ......+..+.....+...+..+.+|+.+||+.+|++||++.+++..|..+.
T Consensus 223 p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 223 PYCGMTC--AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CcccCCh--HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9976543 2344555555555566677889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.36 Aligned_cols=234 Identities=27% Similarity=0.400 Sum_probs=189.7
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. ++..||||++.. ..+.+..|+.++..+ +||||+++++++.+ .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 46899997777653 578999999853 234567899999888 69999999998864 36899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~~~ 145 (318)
T cd05570 79 NGGDLMFHIQR------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-------HIKIADFGMCKE 145 (318)
T ss_pred CCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-------cEEecccCCCee
Confidence 75 99988875 24699999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ..+...+...
T Consensus 146 ~~~~~~--~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~- 211 (318)
T cd05570 146 GILGGV--TTSTFCGTPDYIAPEILSYQ---------PYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILED- 211 (318)
T ss_pred cCcCCC--cccceecCccccCHHHhcCC---------CCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC-
Confidence 322211 22234588899999999654 488999999999999999999999986542 3344444443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSF-----SSICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~-----~eil~~ 503 (683)
...++...+..+.+||++||..||.+||++ .+++++
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 344677789999999999999999999998 666544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.76 Aligned_cols=230 Identities=22% Similarity=0.340 Sum_probs=183.9
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +++.||+|+++.. .+.+..|+.++..+ +||||+++++++.+. ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 46899998777753 6789999998532 23467899888877 799999999988654 7899999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-------~~kL~DfG~~~~ 145 (329)
T cd05618 79 NGGDLMFHMQR------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------HIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-------CEEEeeCCcccc
Confidence 8 499888865 25699999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-------chhHHH
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL-------QGDKMS 460 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~-------~~~~~~ 460 (683)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 214 (329)
T cd05618 146 GLRPGD--TTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214 (329)
T ss_pred ccCCCC--ccccccCCccccCHHHHcCC---------CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH
Confidence 422111 22345688999999999754 478899999999999999999999953211 111223
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
..+.. ....+|...+..+.++|++||+.||.+||++
T Consensus 215 ~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 215 QVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 33333 3345677888999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.83 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=200.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCc--EEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGE--SFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~--~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~ 302 (683)
++|++.+.||+|+++.++.. +|. .+|+|.++.. .+.+.+|+.++.++ +||||+++++++.. ...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 58999999999997666642 333 4789888642 24678899999999 79999999998854 36789
Q ss_pred EEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 303 LIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
+||||++ |+|.+++.+.... .....+++..+..++.||+.||+|||+.||+||||||+|||++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--- 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--- 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC---
Confidence 9999997 5999999753211 1123588999999999999999999999999999999999998877
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~ 450 (683)
.+||+|||++....... .......+..|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 157 ----~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 157 ----ASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred ----eEEECCcCCCcccccee---ccCCCCcCccccCchhhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 79999999986432211 11122234569999998644 48899999999999999997 999998
Q ss_pred CCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+.... .+...+..+..+..+..++..+.+|+.+||..||.+||++.++++.|..+..
T Consensus 221 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 221 GMTCA--ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 75532 3455566665666677789999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.00 Aligned_cols=244 Identities=27% Similarity=0.329 Sum_probs=195.2
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCCc---chHHHHHHHHHcCC-C-----CceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGDI---EPLVPEISSLLSLS-H-----PNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~~---~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~e~~~~~~ 302 (683)
+|+|++.||+|+|+.|+. .+++.||||+++... .+...|++||..|+ | -|||+++++|... +++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--NHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--ccee
Confidence 899999999999998886 378999999998753 44568999999997 4 4899999999654 7899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||+|++.-+|.++|+++ +..+|+...+..|+.||+.||.+||+.||||+||||+||||..-+. ..|||+||
T Consensus 265 iVfELL~~NLYellK~n----~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-----~~vKVIDF 335 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNN----KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-----SRIKVIDF 335 (586)
T ss_pred eeehhhhhhHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-----CceeEEec
Confidence 99999999999999984 5567999999999999999999999999999999999999976652 27999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|.|........ ...-+..|.|||++.+. .|+.+.||||||||+.||++|.+.|.+.+..+ .+..+
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGl---------pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D-Ql~~I 400 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPEVILGL---------PYDTAIDMWSLGCILAELFTGEPLFPGDNEYD-QLARI 400 (586)
T ss_pred ccccccCCcce-----eeeeccccccchhhccC---------CCCCccceeehhhhHHhHhcCccccCCCCHHH-HHHHH
Confidence 99988754322 33344569999999876 59999999999999999999999998754321 11111
Q ss_pred HH---------------------c-----------------------------CCCCCCC-----------CCCcHHHHH
Q 038696 463 IR---------------------A-----------------------------GERPLFP-----------FHSPKYVTN 481 (683)
Q Consensus 463 i~---------------------~-----------------------------~~~~~~p-----------~~~~~~l~~ 481 (683)
+. . ......| ......+.+
T Consensus 401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 10 0 0000011 011245789
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 482 LTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 482 Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
++++||..||.+|+|..++++|-+
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcc
Confidence 999999999999999999988743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.36 Aligned_cols=252 Identities=30% Similarity=0.515 Sum_probs=216.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE--E---cC--cEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL--W---LG--ESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l--~---~g--~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
..-+|..++..+.+.||+|+|+.|.. | .| ..||||.+.. ..++|.+|+.+|.+|+|+|++++|+++.+
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 45667778888999999998655553 4 23 3699999964 35689999999999999999999998865
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
..+.||||+++ |+|.+.|.+ ..+..|......+|+.||+.||.||..+++|||||...|+||....
T Consensus 183 ---qp~mMV~ELaplGSLldrLrk----a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr------ 249 (1039)
T KOG0199|consen 183 ---QPAMMVFELAPLGSLLDRLRK----AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR------ 249 (1039)
T ss_pred ---chhhHHhhhcccchHHHHHhh----ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc------
Confidence 57899999998 799999987 2456799999999999999999999999999999999999997765
Q ss_pred ceEEEecccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCC
Q 038696 375 LHAKISGFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDA 452 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~ 452 (683)
.|||+||||.+....+.... ......-.+.|+|||.++.. .++.++|||+|||++|||++ |..||.+.
T Consensus 250 -tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~---------kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 250 -TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR---------KFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred -eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc---------cccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 79999999999877655333 33345567889999999755 69999999999999999998 99999986
Q ss_pred ccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
. +..+.++|..+.+...|..|++++.++++.||..+|.+||||..|.+.+
T Consensus 320 ~--g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 320 R--GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred C--HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 5 4568889999999999999999999999999999999999999997544
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.32 Aligned_cols=245 Identities=31% Similarity=0.581 Sum_probs=201.0
Q ss_pred EeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.+..++|++.+.||+|+++.++. ..|+.||+|.+... .+.+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e 78 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME 78 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence 34456899999999998766664 47889999998643 3568899999999999999999988854 34799999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|+. |+|.+++... ....+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-------~~kl~Dfg~~ 147 (254)
T cd05083 79 LMSKGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-------VAKVSDFGLA 147 (254)
T ss_pred CCCCCCHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------cEEECCCccc
Confidence 998 4999999752 234588999999999999999999999999999999999998877 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~ 464 (683)
...... ......+..|+|||++.+. .++.++||||||+++|||++ |+.||...... .....+.
T Consensus 148 ~~~~~~-----~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~ 211 (254)
T cd05083 148 RVGSMG-----VDNSKLPVKWTAPEALKHK---------KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVE 211 (254)
T ss_pred eecccc-----CCCCCCCceecCHHHhccC---------CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHh
Confidence 764321 1122334679999998643 48889999999999999997 99999876543 3455566
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+..+..+..++..+.+++.+||+.+|++||++.+++..|+
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 66665566678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.61 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=195.0
Q ss_pred CCCeEEEeEecccccEEEEEE--------------------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--------------------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMH 288 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--------------------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~ 288 (683)
.++|++.+.||+|+++.+++. ++..||||.+... ...+.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 458999999999998777753 2346999998643 246889999999999999999
Q ss_pred eeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 038696 289 FLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCP-----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNI 362 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NI 362 (683)
+++++... ...|+||||+. |+|.+++...... .....+++.++..++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99988654 67899999997 5999999763211 1123578889999999999999999999999999999999
Q ss_pred EeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 363 LLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 363 Ll~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
|++.++ .++|+|||+++...............+++.|++||+..+. .++.++|||||||++|||
T Consensus 162 li~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 162 LVGKNY-------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG---------KFTTASDVWAFGVTLWEI 225 (296)
T ss_pred EEcCCC-------CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC---------CccchhhhhHHHHHHHHH
Confidence 998777 7999999999765432211122223446779999987643 488999999999999999
Q ss_pred Hh--CCCCCCCCccchhHHHHHH----H---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 443 LT--GKVPFEDAHLQGDKMSRNI----R---AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 443 lt--G~~Pf~~~~~~~~~~~~~i----~---~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
++ |..||....... ..... . .......+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 226 ~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 226 LTLCKEQPYSQLSDEQ--VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHhCCCCCccccChHH--HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 98 778987644321 11111 1 11122234567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.14 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=191.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. +|..||||.+... .+.+.+|+.+++.++||||+++++.+.++ ..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 5899999999986666643 6889999998531 24578999999999999999999998654 6899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.++|.+++... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-------~~~l~dfg~~ 148 (285)
T cd07861 79 EFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-------VIKLADFGLA 148 (285)
T ss_pred ecCCCCHHHHHhcC---CCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-------cEEECcccce
Confidence 99999999988753 1235689999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... ........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~ 217 (285)
T cd07861 149 RAFGIPVR--VYTHEVVTLWYRAPEVLLGS--------PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRI 217 (285)
T ss_pred eecCCCcc--cccCCcccccccChHHhcCC--------CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHH
Confidence 76543211 12234567889999998643 247889999999999999999999998654221 11111100
Q ss_pred C---------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 G---------------------------ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~---------------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .........+.++.++|.+||..||.+|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 218 LGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000123357888999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=307.86 Aligned_cols=251 Identities=22% Similarity=0.441 Sum_probs=201.9
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.+++ .+|+.||||.+.. ....+.+|+.+++.++|+||+++++++... +.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 4789999999998766654 3788999998742 234678899999999999999999988654 68999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.... .....+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-------~~~l~df 150 (267)
T cd08229 80 VLELADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-------VVKLGDL 150 (267)
T ss_pred EEEecCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------CEEECcc
Confidence 9999985 9999887532 2235689999999999999999999999999999999999998877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+.........+.
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08229 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred hhhhccccCC--cccccccCCcCccCHHHhcCC---------CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh
Confidence 9987654322 122234578889999999654 47889999999999999999999997655433344445
Q ss_pred HHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+.....+..+ ...+..+.+++.+||..||++|||+.+|++.+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 5444333333 45678899999999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.46 Aligned_cols=230 Identities=26% Similarity=0.380 Sum_probs=187.6
Q ss_pred eEecccccEEEEE-------EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 241 RRLGSGSQYKEIL-------WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 241 ~~LG~G~~~~v~l-------~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+.||+|+++.|++ .+|+.||||++.. ....+..|+++|+.++||||+++++++.++ ..+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcC
Confidence 5799998777764 2578999999853 234467899999999999999999988654 789999999
Q ss_pred CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+. |+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~~~~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~kL~Dfg~~~ 146 (318)
T cd05582 80 LRGGDLFTRLSK------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-------HIKLTDFGLSK 146 (318)
T ss_pred CCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-------cEEEeeccCCc
Confidence 97 599999875 25689999999999999999999999999999999999998887 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...
T Consensus 147 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i~~~ 213 (318)
T cd05582 147 ESIDHE--KKAYSFCGTVEYMAPEVVNRR---------GHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMILKA 213 (318)
T ss_pred ccCCCC--CceecccCChhhcCHHHHcCC---------CCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHHHcC
Confidence 654321 122345688899999999754 478899999999999999999999986543 2233334333
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
. ..+|...+..+.+||.+||+.||.+||++.+
T Consensus 214 ~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 K-LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2 3456778899999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.37 Aligned_cols=239 Identities=23% Similarity=0.334 Sum_probs=188.2
Q ss_pred ecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||+|+++.|++ .+|+.||||.+.. ..+.+..|+++|+.++|+||+++++++.. ...+|+||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 68888777764 3688999999853 12456789999999999999999888854 3679999999984
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~L~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~~~l~dfg~~~~~~~ 149 (280)
T cd05608 79 DLRYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-------NVRISDLGLAVELKD 149 (280)
T ss_pred CHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEEeeCccceecCC
Confidence 8988875421 1235689999999999999999999999999999999999998877 799999999976543
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--hhHHHHHHHcCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--GDKMSRNIRAGER 468 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~~~~~~~i~~~~~ 468 (683)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .......+... .
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~ 217 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGE---------EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-S 217 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-C
Confidence 321 22345688899999999754 4788999999999999999999999764322 11222222222 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
..++...+..+.+++.+||+.||++|| +++++++|-
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 345667889999999999999999999 667777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.89 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=198.8
Q ss_pred CCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..|++++.||+|+++.+++. ++..||+|.++.. .+.+.+|+.+++.++||||+++++++.+.+...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 46899999999998777642 4778999998632 3568899999999999999999988876545678
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-------~~~l~ 151 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-------QVKIG 151 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-------CEEEC
Confidence 999999975 999998752 24589999999999999999999999999999999999998877 79999
Q ss_pred cccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-----
Q 038696 381 GFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL----- 454 (683)
Q Consensus 381 DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~----- 454 (683)
|||+++........ .......++..|+|||++.+. .++.++||||||+++|||++++.|+.....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~ 222 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS---------KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM 222 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccC---------CCCccccchhhhhhhhhhhcCCCCCccccchhhhh
Confidence 99999866433211 112234456679999998643 478899999999999999998776532110
Q ss_pred --------chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 455 --------QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 455 --------~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
........+..+.....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 223 IGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00112233344444445667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.12 Aligned_cols=239 Identities=27% Similarity=0.388 Sum_probs=199.0
Q ss_pred EecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CH
Q 038696 242 RLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DL 312 (683)
Q Consensus 242 ~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL 312 (683)
+||+|.++.|+- .+...+|||-+.. ..+.+..||.+-+.|+|.|||++++++ .+++.+-|.||-++| +|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCCcH
Confidence 699997444442 3566899999853 456789999999999999999999987 455788899999985 99
Q ss_pred HHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 313 CSYIKEICCPRKRIPF--SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 313 ~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
.++|+. +.+|+ ++.++-.|..||++||.|||++.|||||||-+||||+.-.. .+||+|||-++....
T Consensus 660 SsLLrs-----kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG------vlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 660 SSLLRS-----KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG------VLKISDFGTSKRLAG 728 (1226)
T ss_pred HHHHHh-----ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc------eEEecccccchhhcc
Confidence 999986 45777 78899999999999999999999999999999999965421 799999999987643
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
-...+....||..|||||++... ...|+.++|||||||++.||.||++||.........+++.=.-...|+
T Consensus 729 --inP~TETFTGTLQYMAPEvIDqG-------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 729 --INPCTETFTGTLQYMAPEVIDQG-------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP 799 (1226)
T ss_pred --CCccccccccchhhhChHhhccC-------CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC
Confidence 23355677899999999999764 345999999999999999999999999876554445555444455677
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 471 FPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 471 ~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
+|...+.+.+++|.+|+.+||.+||++.+++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 88888999999999999999999999999864
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.18 Aligned_cols=249 Identities=27% Similarity=0.490 Sum_probs=199.8
Q ss_pred CCCeEEEeEecccccEEEEE---E-c---CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL---W-L---GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l---~-~---g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..+|++.+.||+|+++.+++ . + +..+|+|.++.. .+.+.+|+.+++.++||||+++++++.. .+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 45899999999998655543 2 2 237999998642 3467899999999999999999988854 3678
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++| +|.+++... ...+++.++..++.|++.||.|||++|++||||||+|||++.++ .+||+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-------~~~l~ 148 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-------VCKVS 148 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-------eEEeC
Confidence 999999975 999999752 34689999999999999999999999999999999999998877 79999
Q ss_pred cccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 381 GFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 381 DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
|||++.......... ......++..|+|||++.+. .++.++||||||+++||+++ |..||.+.... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~ 217 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--D 217 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhccC---------ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--H
Confidence 999998764332111 11222335679999999654 48899999999999999886 99999765432 3
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
....+..+.....+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4455555555556667889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.15 Aligned_cols=248 Identities=19% Similarity=0.308 Sum_probs=192.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.++..++|+||++++++|.++ ..+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 48999999999998777753 588999999852 234578899999999999999999988644 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-------~~kl~Df 146 (331)
T cd05597 79 VMDYYVGGDLLTLLSK-----FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-------HIRLADF 146 (331)
T ss_pred EEecCCCCcHHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-------CEEEEEC
Confidence 999997 599999975 235689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ .......||+.|+|||++..... +...++.++|||||||++|||++|+.||.+.... .....
T Consensus 147 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~~~ 219 (331)
T cd05597 147 GSCLRLLADGT-VQSNVAVGTPDYISPEILQAMED----GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGK 219 (331)
T ss_pred CceeecCCCCC-ccccceeccccccCHHHHhhccc----cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHHHH
Confidence 99876543221 11223468899999999974321 1234788999999999999999999999875432 22222
Q ss_pred HHc-CCCCCC---CCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 038696 463 IRA-GERPLF---PFHSPKYVTNLTKRCWHADPNQ--RPSFSSICRI 503 (683)
Q Consensus 463 i~~-~~~~~~---p~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~ 503 (683)
+.. .....+ ....+..+.+++++||..++++ |+++.++++|
T Consensus 220 i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 322 221222 2346888999999988654433 7899988766
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.42 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=198.5
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. +++.||||.+.. ..+.+.+|+++++.++|+||+++++.+.. ....+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 5899999999987766642 578899999843 23457889999999999999999887753 335689999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ....+++.++..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+
T Consensus 80 e~~~~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-------~~~l~df~~ 148 (257)
T cd08223 80 GFCEGGDLYHKLKEQ----KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-------IIKVGDLGI 148 (257)
T ss_pred cccCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-------cEEEecccc
Confidence 99985 999999762 335689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...... .....+.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~ 215 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNK---------PYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRII 215 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH
Confidence 976643211 22334578889999998654 4788999999999999999999999865432 2334455
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 555555667788999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.93 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=194.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.++.. +++.||+|.+... ...+.+|+.+++.++||||+++++++..+ ..+|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEEEE
Confidence 58999999999997776653 6789999998531 23577899999999999999999998654 6899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++++|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 84 e~~~~~l~~~l~~-----~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-------~~kl~dfg~~ 151 (301)
T cd07873 84 EYLDKDLKQYLDD-----CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-------ELKLADFGLA 151 (301)
T ss_pred eccccCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-------cEEECcCcch
Confidence 9999999999875 234688999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||...+... .+......
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~ 220 (301)
T cd07873 152 RAKSIPTK--TYSNEVVTLWYRPPDILLGS--------TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRI 220 (301)
T ss_pred hccCCCCC--cccccceeecccCcHHHhCC--------CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 76543221 12234567889999998643 247889999999999999999999998654321 11110000
Q ss_pred --------------------CCCCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 466 --------------------GERPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 466 --------------------~~~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+. .....+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00000 112457789999999999999999999999876443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.50 Aligned_cols=247 Identities=22% Similarity=0.362 Sum_probs=202.0
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.|+|+.-||.|+|++|+.. ++-..|-|++.. ..+++.-||+||..++||+||++++.|+.+ +.++|+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEee
Confidence 5778889999999998864 333466677632 467889999999999999999999888776 679999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|+| .....+.+. ..+|++.++..+++|++.||.|||+++|||||||..|||++-+| .|+|+|||.+.
T Consensus 111 C~GGAVDaimlEL-----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-------dirLADFGVSA 178 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL-----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-------DIRLADFGVSA 178 (1187)
T ss_pred cCCchHhHHHHHh-----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-------cEeeecccccc
Confidence 986 566666653 46799999999999999999999999999999999999999998 79999999975
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
.... .........|||+|||||+.... .+....|+.++||||||++|.||..+.+|....+... +...|...
T Consensus 179 Kn~~--t~qkRDsFIGTPYWMAPEVvmCE----T~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKiaKS 250 (1187)
T KOG0579|consen 179 KNKS--TRQKRDSFIGTPYWMAPEVVMCE----TFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS 250 (1187)
T ss_pred cchh--HHhhhccccCCcccccchheeec----cccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHhhc
Confidence 4321 11233567899999999998644 4556689999999999999999999999988766442 33334333
Q ss_pred CCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 467 ERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 467 ~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+| ..|..++..+.+++++||..||..||++.++++|-
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 333 45778899999999999999999999999998763
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=317.83 Aligned_cols=234 Identities=29% Similarity=0.477 Sum_probs=188.5
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHc-CCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLS-LSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +++.||||+++.. ...+..|..++.. ++||||+++++++.+. ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 46899998777753 5789999998532 3345678888876 4899999999988654 6899999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-------~~kl~Dfg~~~~ 145 (316)
T cd05619 79 NGGDLMFHIQS------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-------HIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-------CEEEccCCcceE
Confidence 7 599999875 24689999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+...+....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~ 212 (316)
T cd05619 146 NMLGD--AKTCTFCGTPDYIAPEILLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDN 212 (316)
T ss_pred CCCCC--CceeeecCCccccCHHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC
Confidence 43221 122345688999999999654 488999999999999999999999987543 23444444433
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFS-SICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~-eil~~ 503 (683)
+.++...+..+.+++.+||+.||++||++. ++.+|
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 213 -PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 446667889999999999999999999986 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=300.31 Aligned_cols=245 Identities=30% Similarity=0.530 Sum_probs=200.1
Q ss_pred CCCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
..+|++.+.||+|+++.+++ ..+..+|||.+... ...+.+|+++++.++||||+++++.+.. ....++||||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEEEc
Confidence 35899999999998655553 35789999998643 3578999999999999999999988854 3678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+.| +|.+++.. ....+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-------~~~l~d~g~~~ 148 (256)
T cd05112 81 MEHGCLSDYLRA-----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKVSDFGMTR 148 (256)
T ss_pred CCCCcHHHHHHh-----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-------eEEECCCccee
Confidence 985 89998875 234688999999999999999999999999999999999998777 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHc
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......++..|+|||++.+. .++.++||||||+++|||++ |..||..... ..+...+..
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~ 216 (256)
T cd05112 149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFS---------KYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINA 216 (256)
T ss_pred ecccCcc-cccCCCccchhhcCHhHhccC---------CcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhC
Confidence 6533211 112233456789999998643 48889999999999999998 9999976542 345556666
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.....+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 655556666789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.83 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=190.4
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. +|+.||+|.+... ...+.+|+.+++.++||||+++++.+.+. ..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 5899999999987666642 6889999998531 24578899999999999999999988644 6899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 79 e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-------~~~l~dfg~~ 146 (284)
T cd07839 79 EYCDQDLKKYFDS-----CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-------ELKLADFGLA 146 (284)
T ss_pred ecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-------cEEECccchh
Confidence 9999999998875 235689999999999999999999999999999999999999887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......+++.|+|||++.+. ..++.++|||||||++|+|++|..||.........+......
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (284)
T cd07839 147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216 (284)
T ss_pred hccCCCCC--CcCCCccccCCcChHHHhCC--------cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH
Confidence 76543221 12234567889999998643 247889999999999999999988864332222211111110
Q ss_pred ------------------CCCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 ------------------GERPL---------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ------------------~~~~~---------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+. .....+.++.++|.+||+.||.+|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 217 LGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 112356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.18 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=205.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+...+|++.+.||+|+++.++.. +|+ .||+|.+... ...+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 34568999999999997666643 333 5999988643 2467899999999999999999988854
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...++||||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-------~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH-----KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-------HV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-------eE
Confidence 57899999997 5999999752 34589999999999999999999999999999999999998877 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............++..|+|||.+... .++.++||||||+++||+++ |..||.+...
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 217 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR---------IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-- 217 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcC---------CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--
Confidence 99999999876533222222233345679999998643 47889999999999999998 9999987653
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+...+..+.....+..++..+.+++.+||..||++||++.++++.|..+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 34556666666666777788999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=308.20 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=196.3
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCc-eeeeeeeEEcCC----CC
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPN-IMHFLCGFTDEE----KK 299 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~e~----~~ 299 (683)
..|+.+++||+|+++.|+. .+|+.||+|++.-+ .....+|+.+|+.|+|+| ||.+++++..++ ..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3677788899998655553 48999999998532 234689999999999999 999999997653 13
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.++|||||++-+|..++....... ..++...+..+++||+.||+|||+++|+||||||+||||+.+| .+||
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-------~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-------VLKL 161 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-------cEee
Confidence 789999999999999998742111 3577789999999999999999999999999999999999988 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+|+.+...... ....++|.+|.|||++.+. ..|+..+||||+|||++||++++..|.+.... +.+
T Consensus 162 aDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs--------~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql 230 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGS--------TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQL 230 (323)
T ss_pred eccchHHHhcCCccc--ccccEEEeeccCHHHhcCC--------CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHH
Confidence 999999976543332 3345678899999999754 36999999999999999999999999887642 233
Q ss_pred HHHHHcCCCC----------------CCCC------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERP----------------LFPF------------HSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~----------------~~p~------------~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
......-..| .++. ....+..+++.+||+.+|.+|.|+..++.|
T Consensus 231 ~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 231 FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 3322211110 1111 011367899999999999999999999876
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.36 Aligned_cols=252 Identities=29% Similarity=0.381 Sum_probs=196.9
Q ss_pred CCCeEEEeEecccccEEEEEEc--------------------CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceee
Q 038696 234 SEDYQVRRRLGSGSQYKEILWL--------------------GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMH 288 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~~--------------------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~ 288 (683)
.++|++++.||+|+++.+++.. +..||+|.+... .+.+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4589999999999977766421 245899998643 346788999999999999999
Q ss_pred eeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 038696 289 FLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCP-----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNI 362 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NI 362 (683)
+++++..+ ...++||||+. ++|.+++...... .....+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99988654 67899999997 5999999763211 1123689999999999999999999999999999999999
Q ss_pred EeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 363 LLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 363 Ll~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
+++.++ .++|+|||+++...............+++.|+|||++.+. .++.++|||||||++|||
T Consensus 162 li~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el 225 (296)
T cd05051 162 LVGKNY-------TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG---------KFTTKSDVWAFGVTLWEI 225 (296)
T ss_pred eecCCC-------ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC---------CCCccchhhhhHHHHHHH
Confidence 998887 7999999999765433222223344567789999998643 488999999999999999
Q ss_pred Hh--CCCCCCCCccchhHHHHHHHcC-------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 443 LT--GKVPFEDAHLQGDKMSRNIRAG-------ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 443 lt--G~~Pf~~~~~~~~~~~~~i~~~-------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
++ |..||...... .+...+... .....+..++.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 226 ~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 226 LTLCREQPYEHLTDQ--QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HhcCCCCCCCCcChH--HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 98 77888765432 222222211 112234556789999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.86 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=189.6
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~L 303 (683)
+|++.+.||+|+++.|++. +|+.||||++.. ..+.+..|+.++..+. |++|+++++++.++ ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 5788999999998887753 688999999853 2245678999998886 57788888888654 67999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~Ey~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-------~ikL~Df 145 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-------HIKIADF 145 (323)
T ss_pred EEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-------CEEEecc
Confidence 999997 5999998752 5699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..+...
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~ 212 (323)
T cd05615 146 GMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQS 212 (323)
T ss_pred ccccccCCCC--ccccCccCCccccCHHHHcCC---------CCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 9987543221 122344688999999999654 488999999999999999999999987543 334444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
+.... ..+|...+..+.+++.+||+.||.+|++.
T Consensus 213 i~~~~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHN-VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCC-CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 44433 34667788999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.98 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=193.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||+|+++.++.. +|+.||+|++.. ....+.+|+.+++.++||||+++++++..+ ..+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEE
Confidence 458999999999997766653 678999999853 234577899999999999999999988654 6899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+++ +|.+++.. ..++++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-------~~~l~dfg~ 152 (267)
T cd06646 86 EYCGGGSLQDIYHV------TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-------DVKLADFGV 152 (267)
T ss_pred eCCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-------CEEECcCcc
Confidence 99985 99998864 25689999999999999999999999999999999999998887 699999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+....... .......+++.|+|||++.... ...++.++|||||||++|||++|..||....... .......
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~------~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~~~~ 223 (267)
T cd06646 153 AAKITATI--AKRKSFIGTPYWMAPEVAAVEK------NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMSK 223 (267)
T ss_pred ceeecccc--cccCccccCccccCHhHccccc------CCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hheeeec
Confidence 98654221 1123346778899999985431 2347789999999999999999999996543221 1111111
Q ss_pred cCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
....+ .....++..+.+++.+||..||++|||+++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11111 11234578899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.89 Aligned_cols=230 Identities=22% Similarity=0.320 Sum_probs=184.8
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +++.||||++... .+.+..|+.++..+ +||||+++++++.+. ..+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 46999998777753 5789999999632 34577899999888 599999999988644 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-------~~kl~Dfg~~~~ 145 (327)
T cd05617 79 NGGDLMFHMQR------QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-------HIKLTDYGMCKE 145 (327)
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-------CEEEecccccee
Confidence 75 99988875 24699999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-----chhHHHHH
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL-----QGDKMSRN 462 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~-----~~~~~~~~ 462 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ....+...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 214 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGE---------EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCC---------CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH
Confidence 32211 122345688999999999654 488999999999999999999999964221 11223333
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
+.. ....+|...+..+.+++.+||..||.+|+++
T Consensus 215 ~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 215 ILE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 333 3344677788999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.39 Aligned_cols=248 Identities=27% Similarity=0.473 Sum_probs=198.4
Q ss_pred CCeEEEeEecccccEEEEEE----cC---cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LG---ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g---~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.+|++.+.||+|+++.++.. +| ..||||.+... ...+..|+.+++.++||||+++++++.+ ...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCceE
Confidence 47999999999987666542 23 36999998642 3468899999999999999999988854 46789
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++.. ....+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-------~~kl~d 149 (269)
T cd05065 82 IITEFMENGALDSFLRQ-----NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-------VCKVSD 149 (269)
T ss_pred EEEecCCCCcHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-------cEEECC
Confidence 99999985 89999875 235689999999999999999999999999999999999998776 799999
Q ss_pred ccCccccCCCCCCCC---CCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 382 FGLSSVKNFGPKSPS---QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 382 FGla~~~~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
||++........... ......+..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-- 218 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-- 218 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccC---------cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--
Confidence 999876543221111 1112224579999998644 48889999999999999886 99999765432
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.+...+........+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 219 ~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 34455555555556677889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.28 Aligned_cols=229 Identities=24% Similarity=0.349 Sum_probs=183.5
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHH-HHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEIS-SLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||++.. ....+..|.. +++.++||||+++++.+.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 46899997777753 688999999853 1233455555 5678999999999988854 37899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-------~~kl~Dfg~~~~ 145 (323)
T cd05575 79 NGGELFFHLQR------ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-------HVVLTDFGLCKE 145 (323)
T ss_pred CCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-------cEEEeccCCCcc
Confidence 85 99998875 25689999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .+...+..+.
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~ 212 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDNILNKP 212 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCC---------CCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHHHHcCC
Confidence 43221 122345688999999999654 4888999999999999999999999875432 3444444443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
...+...+..+.++|.+||+.||.+||++.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 335566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.56 Aligned_cols=244 Identities=31% Similarity=0.516 Sum_probs=200.8
Q ss_pred eEecccccEEEEEE----c---CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----L---GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~---g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.++.. . +..||||.+... .+.+.+|++++..++|+||+++++++.+ ...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 46899987666542 2 778999998643 4578899999999999999999988864 47899999999
Q ss_pred C-CCHHHHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 309 S-RDLCSYIKEICCP---RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
+ |+|.+++...... .....+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-------~~~l~dfg~ 151 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-------VVKISDFGL 151 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-------cEEEccccc
Confidence 6 5999999862100 0136799999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
+................+++.|+|||++... .++.++||||||+++|+|++ |..||.... ...+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~ 220 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYL 220 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccC---------CcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH
Confidence 9876543322233445677889999998644 48899999999999999999 699998764 33456666
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..+.....+..++.++.+++.+||..||.+|||+.+++++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 66777777888899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.18 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=187.8
Q ss_pred EeEecccccEEEEEE------cCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCCC
Q 038696 240 RRRLGSGSQYKEILW------LGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD 311 (683)
Q Consensus 240 ~~~LG~G~~~~v~l~------~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~gs 311 (683)
..+||+|+++.|++. ++..||+|.+... ...+.+|+.+|+.++||||+++++++.......+|+||||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 468999998777753 3468999998653 34678999999999999999999988766667899999999999
Q ss_pred HHHHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 312 LCSYIKEICCP---RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 312 L~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||+..++ +....+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~---~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---PERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC---CCCCcEEEeeccceecc
Confidence 99988643211 1234588999999999999999999999999999999999995432 12227999999999876
Q ss_pred CCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--------hhHH
Q 038696 389 NFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--------GDKM 459 (683)
Q Consensus 389 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--------~~~~ 459 (683)
...... .......+|+.|+|||++.+. ..++.++|||||||++|||++|.+||...... ...+
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCC--------CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 543221 122345678899999998643 24789999999999999999999999643211 0011
Q ss_pred HHHHHcCC------------C------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGE------------R------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~------------~------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+.... . .......+..+.+|+.+||..||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 11110000 0 00011224557889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.20 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=193.9
Q ss_pred CCCeEEEeEecccccEEEEEEc----------------C--cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEILWL----------------G--ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFL 290 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~~----------------g--~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~ 290 (683)
.++|++.+.||+|+++.+++.. + ..||||.+... .+.+.+|+++|+.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4589999999999987777532 1 25999998643 24578899999999999999999
Q ss_pred eeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 038696 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCP------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNIL 363 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NIL 363 (683)
+++... ...++||||+.| +|.+++...... .....+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 988543 678999999985 999998652110 11124788999999999999999999999999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
++.++ .+||+|||++................++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 162 l~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 162 VGNHY-------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred EcCCC-------cEEecccccccccccCcceeccCcCcCceeecChhhhccC---------CcCchhhHHHHHHHHHHHH
Confidence 98776 7999999999765432222222233456789999998644 4889999999999999999
Q ss_pred h--CCCCCCCCccchhHHHHHH----H---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 444 T--GKVPFEDAHLQGDKMSRNI----R---AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 444 t--G~~Pf~~~~~~~~~~~~~i----~---~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+ |..||...... .....+ . .......+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 226 ~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 226 TLCKEQPYSLLSDE--QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HcCCCCCCcccChH--HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 8 67788765432 122211 1 11112234557889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.91 Aligned_cols=244 Identities=27% Similarity=0.411 Sum_probs=195.5
Q ss_pred CeEEEeEecccccEEEEE---EcCcEEEEEEeCCC----------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD----------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~----------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+|++.+.||.|+++.++. .+|+.+|||.+... ...+.+|+++++.++|+||+++++++.+. ..+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 578899999998766664 47889999988532 24578899999999999999999988654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... .++++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .+||+|
T Consensus 79 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-------~~~l~d 145 (265)
T cd06631 79 IFMEFVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-------IIKLID 145 (265)
T ss_pred EEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-------eEEecc
Confidence 99999985 999999752 4689999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCC----CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 382 FGLSSVKNFGP----KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 382 FGla~~~~~~~----~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||++....... .........++..|+|||++.+. .++.++||||||+++|+|++|..||........
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES---------GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCC---------CCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 99987643211 11112234578889999998654 478899999999999999999999976543322
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
........+..+..+...+..+.++|++||..+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111112234455677788999999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.89 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=190.7
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCC------CceeeeeeeEEcC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSH------PNIMHFLCGFTDE 296 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~H------pnIv~l~~~~~~e 296 (683)
+.+..++|++.+.||+|+++.|++. .++.||||+++.. ...+..|+.++..++| .+|++++++|..+
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3345678999999999998888763 5788999998542 3345678888877754 4588888888653
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCC----
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGAST---- 371 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~---- 371 (683)
...+|||||+++++|.+++.+ ...+++..+..|+.||+.||.|||+ .|||||||||+|||++.++...
T Consensus 204 -~~~~~iv~~~~g~~l~~~l~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 -TGHMCIVMPKYGPCLLDWIMK------HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred -CceEEEEEeccCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 467999999998899999875 2569999999999999999999998 5999999999999998664110
Q ss_pred -----CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCC
Q 038696 372 -----EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446 (683)
Q Consensus 372 -----~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~ 446 (683)
.....+||+|||++..... ......||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~---------~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL---------GWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcC---------CCCcHHHHHHHHHHHHHHHhCC
Confidence 1223599999998864321 22345789999999999755 4899999999999999999999
Q ss_pred CCCCCCccchhHHHHHHHc-CC------------------------CCCC---------------CCCCcHHHHHHHHHh
Q 038696 447 VPFEDAHLQGDKMSRNIRA-GE------------------------RPLF---------------PFHSPKYVTNLTKRC 486 (683)
Q Consensus 447 ~Pf~~~~~~~~~~~~~i~~-~~------------------------~~~~---------------p~~~~~~l~~Li~~c 486 (683)
.||.+..... .+...... +. .+.. .......+.+||.+|
T Consensus 343 ~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 343 LLYDTHDNLE-HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCChHH-HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 9997654221 11100000 00 0000 001134577999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 038696 487 WHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 487 L~~dP~~RPt~~eil~~L~~ 506 (683)
|..||.+|||+.++++|-+.
T Consensus 422 L~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCcChhhCCCHHHHhcCccc
Confidence 99999999999999987544
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.15 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=188.7
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+...+|++++.||+|+++.|++. ++..||+|+... .....|+.+++.++||||+++++++... ...|+||||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 138 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMVLPH 138 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--cccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEEEEc
Confidence 34458999999999998777753 567899998643 3456799999999999999999988654 678999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+.|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 139 ~~~~l~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-------~~kl~DfG~a~~ 206 (357)
T PHA03209 139 YSSDLYTYLTK-----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-------QVCIGDLGAAQF 206 (357)
T ss_pred cCCcHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEEecCccccc
Confidence 99999999875 345699999999999999999999999999999999999998887 799999999975
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCC-CCCCCCccch--------hH
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK-VPFEDAHLQG--------DK 458 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~-~Pf~~~~~~~--------~~ 458 (683)
.... .......||+.|+|||++.+. .++.++|||||||++|||+++. .+|....... ..
T Consensus 207 ~~~~---~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~ 274 (357)
T PHA03209 207 PVVA---PAFLGLAGTVETNAPEVLARD---------KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274 (357)
T ss_pred cccC---cccccccccccccCCeecCCC---------CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHH
Confidence 4322 122345688999999999654 4889999999999999999854 4444322110 01
Q ss_pred HHHHHHc-CC-CCCCC------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 459 MSRNIRA-GE-RPLFP------------------------------FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 459 ~~~~i~~-~~-~~~~p------------------------------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+...+.. +. ...++ ...+..+.+||.+||+.||.+|||+.++++|-
T Consensus 275 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp 352 (357)
T PHA03209 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352 (357)
T ss_pred HHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence 1111111 00 00011 13355677899999999999999999998873
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.43 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=202.1
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCCCc-----chHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFGDI-----EPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
..++|++.+.||+|+++.++.. +|+ .||+|.+.... ..+.+|+.+++.++||||+++++.+.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~ 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---P 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---C
Confidence 4568999999999987666542 444 57999886432 257889999999999999999988754 3
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-------~~k 149 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHE-----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-------HVK 149 (303)
T ss_pred CceeeehhcCCCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-------ceE
Confidence 4679999997 699999875 234589999999999999999999999999999999999998776 699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.+... .
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~ 218 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--R 218 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccC---------CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 9999999876543322223334456789999998644 48899999999999999997 9999976542 2
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.....+..+.....+..++..+.+++..||..+|++||++.++++.|..+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 219 EIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 344556666666666778889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.92 Aligned_cols=243 Identities=21% Similarity=0.371 Sum_probs=194.8
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
..+|++.+.||+|+++.+++ .+|..||+|.+.. ..+.+.+|+.+++.++|+||+++++.|... ...|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEee
Confidence 34899999999998666654 2678999998853 235678999999999999999999988653 6899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+.| +|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 97 e~~~~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-------~~kl~dfg~ 162 (296)
T cd06654 97 EYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGF 162 (296)
T ss_pred cccCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-------CEEECcccc
Confidence 99985 99999864 3588999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... .......
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~ 230 (296)
T cd06654 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIAT 230 (296)
T ss_pred chhcccccc--ccCcccCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhc
Confidence 876543221 12234678889999998644 47889999999999999999999997655332 1222222
Q ss_pred cCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGER-PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~-~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+.. ...+...+..+.+++.+||..||++|||+.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 2211 123455678899999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.66 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=200.2
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||.|+++.+++ .+|+.+++|.+.. ....+.+|+.+++.++|+||+++++++.+. ..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 589999999998765554 2678999998742 234678999999999999999999998653 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||+
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-------~~kl~d~~~ 147 (256)
T cd08221 79 EYANGGTLYDKIVRQ----KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-------LIKLGDFGI 147 (256)
T ss_pred EecCCCcHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-------CEEECcCcc
Confidence 99985 999999752 235689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.+. .++.++||||||+++|||++|..||...... .....+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~ 214 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGV---------KYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVKIV 214 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCC---------CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 987644321 22345678899999998644 3778999999999999999999999865432 3444555
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+.....+...+.++.+++.+||..||.+||++.++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 5555555667789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=302.34 Aligned_cols=251 Identities=26% Similarity=0.454 Sum_probs=203.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE---c----CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW---L----GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~---~----g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|.+.+.||+|+++.++.. . ...||||..... .+.+.+|+.+++.++||||+++++.+.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---C
Confidence 45568999999999987666542 2 236999988643 3468899999999999999999988753 4
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..|+||||++ |+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-------~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-------CVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-------CeE
Confidence 5789999997 5999999752 34589999999999999999999999999999999999998877 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||+++....... .......+++.|+|||++... .++.++||||||+++|||++ |..||......
T Consensus 148 l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-- 215 (270)
T cd05056 148 LGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-- 215 (270)
T ss_pred EccCceeeecccccc-eecCCCCccccccChhhhccC---------CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--
Confidence 999999976543321 112233345679999998644 47889999999999999996 99999766532
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.....+..+.+...+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 216 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3445566666667778889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=300.57 Aligned_cols=240 Identities=29% Similarity=0.494 Sum_probs=195.4
Q ss_pred eEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
++||+|+++.+++. .+..||+|.+... .+.+.+|+.+++.++|+||+++++++. ...+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence 46899987666532 2368999998643 246789999999999999999998764 24689999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
. |+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||+++.
T Consensus 78 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-------~~kl~df~~~~~ 144 (257)
T cd05060 78 PLGPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-------QAKISDFGMSRA 144 (257)
T ss_pred CCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-------cEEeccccccce
Confidence 7 5999999752 3689999999999999999999999999999999999998887 799999999986
Q ss_pred cCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHc
Q 038696 388 KNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 388 ~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.... ...+...+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~ 213 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYG---------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLES 213 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCC---------CCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHc
Confidence 64332211 11222345679999998643 48889999999999999998 999997654 3345666666
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+.....+..++..+.+++.+||..||++||++.++++.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 666667778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.72 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=197.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---CcchHHHHHHHHHcC-CCCceeeeeeeEEcCC----CCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEE----KKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~----~~~~ 301 (683)
.+.|++.+.||+|+++.++.. +++.||||.+.. ....+..|+.+++.+ +|+||+++++.|...+ ...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 457999999999987666642 678999999853 245688999999998 6999999999886532 2468
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||+++ +|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-------~~~l~ 153 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-------EVKLV 153 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-------CEEEc
Confidence 999999984 999998752 235689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++....... .......|++.|+|||++.+... ....++.++|||||||++|||++|..||....... ...
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-~~~ 226 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDEN----PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALF 226 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccC----cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-HHH
Confidence 999997654321 12234567888999999864320 12358889999999999999999999997654322 122
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...........+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 2222222333445678899999999999999999999999765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=298.01 Aligned_cols=238 Identities=30% Similarity=0.508 Sum_probs=192.9
Q ss_pred EecccccEEEE---EEcCcEEEEEEeCCCc-----chHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCH
Q 038696 242 RLGSGSQYKEI---LWLGESFALRHFFGDI-----EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDL 312 (683)
Q Consensus 242 ~LG~G~~~~v~---l~~g~~vAvK~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL 312 (683)
.||+|+++.++ ..++..||+|.+.... ..+.+|+++++.++||||+++++.+... ...++||||++ |+|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCCCcH
Confidence 58888865554 3467889999986532 3578999999999999999999988644 67899999997 599
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCC
Q 038696 313 CSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392 (683)
Q Consensus 313 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~ 392 (683)
.+++.. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 80 ~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-------~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 80 LSFLRK-----KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKISDFGMSRQEDDGI 147 (250)
T ss_pred HHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-------eEEECCCccceeccccc
Confidence 998874 234588999999999999999999999999999999999998877 79999999987543321
Q ss_pred CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCC
Q 038696 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLF 471 (683)
Q Consensus 393 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~ 471 (683)
. .......+++.|+|||++.+. .++.++||||||+++|+|++ |..||...... .....+..+.+...
T Consensus 148 ~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 215 (250)
T cd05085 148 Y-SSSGLKQIPIKWTAPEALNYG---------RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRMSC 215 (250)
T ss_pred c-ccCCCCCCcccccCHHHhccC---------CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCCCC
Confidence 1 111222345679999998643 47889999999999999998 99999876432 34455666666667
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 472 PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 472 p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7788999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.11 Aligned_cols=245 Identities=26% Similarity=0.386 Sum_probs=196.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.+|++.+.||+|+++.++.. +|..||+|.+... .+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37999999999987666542 6889999987421 2357889999999999999999988876555788
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-------~~~l~ 148 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-------NVKLG 148 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-------CEEEc
Confidence 999999985 999998752 4589999999999999999999999999999999999998876 79999
Q ss_pred cccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~ 218 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE---------GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAI 218 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHHCCCCccccchH-HHH
Confidence 9999876532211 1112234577889999999654 4788999999999999999999999865432 233
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.........+.++...++.+.+++ +||..+|++||++.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 334444445566777788899998 6888899999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=304.96 Aligned_cols=252 Identities=21% Similarity=0.390 Sum_probs=195.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHH-HHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISS-LLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.+++. +|+.||||.+... ...+..|+.+ ++.++||||+++++++..+ ..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 48999999999997777653 6899999998542 2245556665 5667899999999988643 679999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++|+|.+++..... ....+++..+..++.||+.||.|||++ +++||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-------~~kl~dfg 149 (283)
T cd06617 79 MEVMDTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-------QVKLCDFG 149 (283)
T ss_pred hhhhcccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-------CEEEeecc
Confidence 99999999998876322 235689999999999999999999997 999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......++..|+|||++.+.. ....++.++|+|||||++|+|++|+.||.......+.+...
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 220 (283)
T cd06617 150 ISGYLVDSV---AKTIDAGCKPYMAPERINPEL-----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV- 220 (283)
T ss_pred ccccccccc---ccccccCCccccChhhcCCcc-----cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH-
Confidence 987653221 122345778899999986432 11347889999999999999999999997543222223333
Q ss_pred HcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+..+.++ ..++.++.++|.+||..+|++||++.+++++-..
T Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 333333333 3468899999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=311.88 Aligned_cols=242 Identities=23% Similarity=0.433 Sum_probs=202.0
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeC--CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFF--GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
-|.++.+||+|+++.|+. ..|..||||.+. .+.+++..|+.||.+++.|++|++|+.|... ..+|||||||+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeehhhcC
Confidence 478899999998554543 489999999985 4678899999999999999999999988643 67999999997
Q ss_pred -CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 -RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 -gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+..+.++- ++.+|++.++..++...+.||+|||...-||||||..|||++.+| +.||+|||.|-..
T Consensus 112 AGSiSDI~R~-----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-------~AKLADFGVAGQL 179 (502)
T KOG0574|consen 112 AGSISDIMRA-----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-------IAKLADFGVAGQL 179 (502)
T ss_pred CCcHHHHHHH-----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-------hhhhhhccccchh
Confidence 899999985 568899999999999999999999999999999999999999998 8999999999765
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
... ....+...||+-|||||++..-+ |+.++||||||++..||.-|++||.+.+..... -.|-...+
T Consensus 180 TDT--MAKRNTVIGTPFWMAPEVI~EIG---------Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--FMIPT~PP 246 (502)
T KOG0574|consen 180 TDT--MAKRNTVIGTPFWMAPEVIEEIG---------YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--FMIPTKPP 246 (502)
T ss_pred hhh--HHhhCccccCcccccHHHHHHhc---------cchhhhHhhhcchhhhhhcCCCCccccccccee--EeccCCCC
Confidence 432 12335678999999999998764 899999999999999999999999987754211 11222222
Q ss_pred CCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 469 PLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 469 ~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
|.| |..++.++.++++.||..+|++|-|+-++++|-
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 222 445678899999999999999999999998873
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.42 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=191.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CCe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KKE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~~ 300 (683)
++|++++.||+|+++.|+.. ++..||||++... .+.+.+|+++|+.++||||++++++|.... ...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 58999999999998777653 6789999998642 245678999999999999999998875322 245
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|++||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 95 ~~~~~~~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-------~~kl~ 160 (343)
T cd07878 95 VYLVTNLMGADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-------ELRIL 160 (343)
T ss_pred EEEEeecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-------CEEEc
Confidence 799999998899888753 4599999999999999999999999999999999999999887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+.
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~ 226 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLK 226 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCC--------ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHH
Confidence 99999865432 2344678899999998642 248889999999999999999999997643211 111
Q ss_pred HHHHc-C--------------------CCCCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 461 RNIRA-G--------------------ERPLFP--------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 461 ~~i~~-~--------------------~~~~~p--------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..... + ..+..+ ...++.+.+|+.+||..||.+|||+.++++|-+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 11000 0 000011 1245568899999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=307.76 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|++.+.||+|+++.+++ .+++.||||.+... ...+.+|+.+++.++|+||+++++.+.+. ..+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 478889999999777764 36889999988431 23467899999999999999999888543 689999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~g~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-------~~~l~Dfg 147 (285)
T cd05630 79 LTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-------HIRISDLG 147 (285)
T ss_pred EEecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-------CEEEeecc
Confidence 999975 999988652 234589999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~~~~~ 462 (683)
++....... ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ......
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~ 215 (285)
T cd05630 148 LAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215 (285)
T ss_pred ceeecCCCc---cccCCCCCccccChHHHcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh
Confidence 987653221 11234688899999999654 48889999999999999999999998643221 111122
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L~ 505 (683)
+.......++...+.++.+|+.+||+.||++||| +.++++|-+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 216 LVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred hhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 2222223356677889999999999999999999 888887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=299.28 Aligned_cols=246 Identities=23% Similarity=0.408 Sum_probs=205.7
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||.|+++.++. .+|..||+|.+.. ..+.+..|+.+++.++|+||+++++.+.......+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 589999999998776664 3678999998853 134577899999999999999999888766667889999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH-----SKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-----~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
||+++ +|.+++.... ....++++..++.++.||+.||.||| +.+|+|+||||+||+++.++ .+||
T Consensus 81 e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-------~~kl 151 (265)
T cd08217 81 EYCEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-------NVKL 151 (265)
T ss_pred hhccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-------CEEE
Confidence 99975 9999997632 12457899999999999999999999 89999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|..||.... ...+
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~ 218 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHM---------SYDEKSDIWSLGCLIYELCALSPPFTARN--QLQL 218 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCC---------CCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHH
Confidence 99999987654321 12234678889999998644 47889999999999999999999998765 3456
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.+..+..+.++...+..+.+++.+||..+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 219 ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 66777777667788889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.87 Aligned_cols=248 Identities=20% Similarity=0.324 Sum_probs=192.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.++||+|+++.|++. +++.||+|++.. ....+..|+.++..++|+||+++++++.++ ..+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 48999999999998777653 577899999842 123478899999999999999999988654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~ey~~~g~L~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-------~~kL~Df 146 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-------HIRLADF 146 (332)
T ss_pred EEeccCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-------CEEEeec
Confidence 999997 5999999752 34689999999999999999999999999999999999998877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ .......||+.|+|||++.+... ....++.++|||||||++|||++|+.||...... .....
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~~~ 219 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMED----GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGK 219 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhcccc----CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 99876532211 12223568999999999964310 1235788999999999999999999999875432 23333
Q ss_pred HHcC-CCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 038696 463 IRAG-ERPLFP---FHSPKYVTNLTKRCWHADPNQ--RPSFSSICRI 503 (683)
Q Consensus 463 i~~~-~~~~~p---~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~ 503 (683)
+... ....+| ..++..+.+|+.+|+..++++ |+++.++++|
T Consensus 220 i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 3322 222233 356889999999999665444 6788888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=300.44 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=194.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||.|+++.++.. +++.+|+|.+.. ..+.+.+|+.+++.++||||+++++.+.+. ..+|+||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEEE
Confidence 358999999999987666643 567899999853 345788999999999999999999888543 6899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ...+++.++..++.|++.||.|||+.||+|+||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------~~~l~d~g~ 147 (262)
T cd06613 80 EYCGGGSLQDIYQVT-----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-------DVKLADFGV 147 (262)
T ss_pred eCCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-------CEEECcccc
Confidence 99985 899888752 25689999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......++..|+|||++.+.. ...++.++||||||+++|+|++|..||........ ......
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~------~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~ 218 (262)
T cd06613 148 SAQLTATIA--KRKSFIGTPYWMAPEVAAVER------KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISK 218 (262)
T ss_pred chhhhhhhh--ccccccCCccccCchhhcccc------cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh
Confidence 876543211 122345777899999986431 12478899999999999999999999987553321 222212
Q ss_pred cCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+ ..+...+.++.+++.+||..||.+|||+.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 21111 1223446789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.53 Aligned_cols=229 Identities=24% Similarity=0.359 Sum_probs=183.4
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHH-HHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEIS-SLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||++.. ....+..|+. +++.++||||+++++.+.+. +.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 46899998777753 678999999853 1233455554 57889999999999888543 6899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg~~~~ 145 (321)
T cd05603 79 NGGELFFHLQR------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-------HVVLTDFGLCKE 145 (321)
T ss_pred CCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-------CEEEccCCCCcc
Confidence 85 89888864 25689999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...+. ..+...+...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~- 211 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKE---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILHK- 211 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCC---------CCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhcC-
Confidence 42221 122345688999999999654 488899999999999999999999987643 2344444443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
...++...+..+.+++.+||+.||.+||+..
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3446667788999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=301.75 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=195.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.+|++.+.||+|+++.++.. +|..||||.+... .+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 48999999999997777652 5889999987421 2357789999999999999999998866545678
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++ .+||+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-------~~~l~ 148 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-------NVKLG 148 (265)
T ss_pred EEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-------CEEEC
Confidence 999999985 999998752 4588999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|||++........ ........++..|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~ 218 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE---------GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAI 218 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCC---------CCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHH
Confidence 9999876532111 1112234578889999998644 4788999999999999999999999865322 223
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.........+..|...+..+.+++.+||. +|++||++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 33333333455566677889999999994 99999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.63 Aligned_cols=248 Identities=20% Similarity=0.314 Sum_probs=192.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +++.||||++.. ....+..|+.++..++|+||+++++++.++ +..||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 48999999999998777653 678899999853 233477899999999999999999988644 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 79 v~Ey~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-------~~kl~Df 146 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF-----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-------HIRLADF 146 (331)
T ss_pred EEeCCCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-------CEEEEec
Confidence 999997 5999999752 34689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++....... .......||+.|+|||++.+... ....++.++|||||||++|||++|+.||...... .....
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~ 219 (331)
T cd05624 147 GSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMED----GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGK 219 (331)
T ss_pred cceeeccCCCc-eeeccccCCcccCCHHHHhcccc----CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHHHH
Confidence 99976543221 11223468999999999975310 1124788999999999999999999999865432 22333
Q ss_pred HHc-CCCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 038696 463 IRA-GERPLFP---FHSPKYVTNLTKRCWHADPNQ--RPSFSSICRI 503 (683)
Q Consensus 463 i~~-~~~~~~p---~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~ 503 (683)
+.. ..+..+| ...+..+.+++.+||..++.+ |+++.++++|
T Consensus 220 i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 220 IMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 332 2222233 335788999999999865544 3577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.09 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=195.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.++.. ++..||+|.+... .+.+.+|+++++.++|+||+++++.+.+. ..+|+||||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEEec
Confidence 368999999999986665542 4789999998643 56789999999999999999999988654 789999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|.+++.. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||++.
T Consensus 80 ~~~~~L~~~l~~-----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-------~~~l~dfg~~~ 147 (256)
T cd06612 80 CGAGSVSDIMKI-----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-------QAKLADFGVSG 147 (256)
T ss_pred CCCCcHHHHHHh-----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-------cEEEcccccch
Confidence 985 99999875 235689999999999999999999999999999999999998887 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ...+...
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~~~~ 214 (256)
T cd06612 148 QLTDTMA--KRNTVIGTPFWMAPEVIQEI---------GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIPNK 214 (256)
T ss_pred hcccCcc--ccccccCCccccCHHHHhcC---------CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhhccC
Confidence 7643321 12234467789999998654 488899999999999999999999986543221 1111111
Q ss_pred CC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ER--PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~--~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11 12234567789999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.64 Aligned_cols=252 Identities=30% Similarity=0.465 Sum_probs=201.4
Q ss_pred CCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
++|++.+.||+|+++.++.. ++..||||.+... .+.+.+|+++++.++|+||+++++++........
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 47889999999997766643 2678999999643 3468999999999999999999988866556789
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++ |+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-------~~~l~ 151 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH-----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-------LVKIS 151 (284)
T ss_pred EEEEecCCCCCHHHHHHhC-----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-------CEEEc
Confidence 99999997 5999999752 23589999999999999999999999999999999999998877 79999
Q ss_pred cccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch---
Q 038696 381 GFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--- 456 (683)
Q Consensus 381 DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--- 456 (683)
|||++......... .......++..|++||.+.+. .++.++||||||+++|||++|..||.......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 222 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS---------KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM 222 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccC---------CCCcccchHHHhhhhheeeccCCCcccccchhccc
Confidence 99999876532211 111123345569999998644 47889999999999999999999986532211
Q ss_pred ----------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 457 ----------DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 457 ----------~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
..+...+........+..++.++.+|+.+||..||++|||+.++++.|..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 223 IGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 122333444444455667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=300.34 Aligned_cols=242 Identities=26% Similarity=0.455 Sum_probs=195.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+|.+...||+|+++.++.. ++..||+|.+... .+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 4677889999987666643 5789999988431 13578899999999999999999988654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...++||||++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-------~~ 145 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-------GI 145 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-------CE
Confidence 678999999985 999999752 5689999999999999999999999999999999999998877 79
Q ss_pred EEecccCccccCCCCCCC----CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 378 KISGFGLSSVKNFGPKSP----SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
||+|||+++......... ......++..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT---------SYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccC---------CCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 999999998765321111 11223577889999998644 47889999999999999999999998654
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. .....+.....+..+...+..+.++|++||+.||.+||++.+++++
T Consensus 217 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 217 QL--QAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HH--HHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 22 2223344455566777889999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.20 Aligned_cols=242 Identities=22% Similarity=0.387 Sum_probs=195.4
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.+|++.+.||.|+++.++. .+|+.||||.+.. ..+.+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEEEE
Confidence 4799999999998766654 3688999998843 245678899999999999999999988643 68999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|+.| +|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++
T Consensus 97 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-------~~kl~dfg~~ 162 (296)
T cd06655 97 YLAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-------SVKLTDFGFC 162 (296)
T ss_pred ecCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEEccCccc
Confidence 9985 89888864 3589999999999999999999999999999999999998887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... .+. .+..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~~-~~~~ 229 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALY-LIAT 229 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHh
Confidence 76543221 12234577889999998644 47889999999999999999999998755322 222 2222
Q ss_pred CCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GER--PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~--~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
... ...+..++..+.++|.+||..||.+||++.+++.+=+
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 222 2245567888999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.23 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=200.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC---cchHHHHHHHHHcC-CCCceeeeeeeEEc---C
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD---IEPLVPEISSLLSL-SHPNIMHFLCGFTD---E 296 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~---e 296 (683)
..+....++|++.+.||+|+++.++. ..|+.+|+|.+... ...+.+|+.+++.+ +||||+++++.+.. .
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 44445678999999999998766664 36789999988542 34678899999999 69999999987743 2
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
....+|+||||++| +|.+++.... .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~------- 161 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG------- 161 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-------
Confidence 34578999999985 9998886432 1235688999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||+++....... ......|++.|+|||++..... ....++.++|||||||++|||++|..||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQ----LDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhh----ccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 699999999876543211 2223457888999999864310 1234788999999999999999999999765432
Q ss_pred hhHHHHHHHcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 456 GDKMSRNIRAGER--PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 456 ~~~~~~~i~~~~~--~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
. .+. .+..... ...+..++..+.+|+.+||+.||++|||+.++++++
T Consensus 236 ~-~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 R-ALF-KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred H-HHh-hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 111 1112211 113444678899999999999999999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.02 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=196.8
Q ss_pred eEEEeEecccccEEEEE---E----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC----C
Q 038696 237 YQVRRRLGSGSQYKEIL---W----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK----K 299 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l---~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~----~ 299 (683)
|++.+.||+|+++.++. . +|..||||++... .+.+.+|+++|+.++||||+++++.+...+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 67788999998654443 2 3678999998643 3457899999999999999999987754322 1
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..++++||+. |+|.+++...........+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-------~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-------TVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-------CEE
Confidence 3478899997 69988875422212234588999999999999999999999999999999999998776 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||+++...............+++.|++||.+... .++.++||||||+++|||++ |..||.+... .
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~ 222 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN---------VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--S 222 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcC---------ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--H
Confidence 9999999865433222122233456679999998654 37889999999999999999 8999976543 2
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.....+..+.....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 34445555555556667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.40 Aligned_cols=231 Identities=23% Similarity=0.325 Sum_probs=183.3
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHH-HHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEIS-SLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +++.||+|++... ...+..|.. +++.++||||+++++++... +.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 46899997777753 5778999998531 223444444 56788999999999888644 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-------~~kl~DfG~a~~ 145 (325)
T cd05602 79 NGGELFYHLQR------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-------HIVLTDFGLCKE 145 (325)
T ss_pred CCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-------CEEEccCCCCcc
Confidence 85 99998875 24588999999999999999999999999999999999998887 799999999975
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... .+...+....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~ 212 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNKP 212 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCC---------CCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC
Confidence 43221 122345689999999999754 4888999999999999999999999865432 3334444332
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
..++...+..+.+++.+||+.||.+|+++.+.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 213 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 33556788999999999999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.95 Aligned_cols=244 Identities=27% Similarity=0.432 Sum_probs=191.1
Q ss_pred eEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.++.. .+..||||.+... .+.+.+|+.+++.++||||+++++.+... ....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 35899886665532 2347999998532 34678899999999999999999866533 35678999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-------~~kl~dfg~~~~ 147 (262)
T cd05058 80 KHGDLRNFIRSE-----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-------TVKVADFGLARD 147 (262)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-------cEEECCcccccc
Confidence 7 5999999752 23467788899999999999999999999999999999998877 799999999976
Q ss_pred cCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH
Q 038696 388 KNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 388 ~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~ 464 (683)
...... ........+++.|+|||++.+. .++.++|||||||++|||++ |.+||..... ......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~ 216 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLL 216 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccC---------ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh
Confidence 533211 1111233456789999998644 48889999999999999999 5667765432 23455566
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.+..+..+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 66666666777899999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=304.81 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=192.6
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|+..+.||+|+++.++. .+|+.||+|.+... ...+.+|+++|+.++|+||+++++.+..+ ...|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 378889999999877765 26889999998431 23467899999999999999998888543 689999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-------~~kl~Dfg 147 (285)
T cd05632 79 LTIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-------HIRISDLG 147 (285)
T ss_pred EEeccCccHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-------CEEEecCC
Confidence 999985 898888652 234699999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSR 461 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~ 461 (683)
++....... ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||....... ..+..
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~ 215 (285)
T cd05632 148 LAVKIPEGE---SIRGRVGTVGYMAPEVLNNQ---------RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215 (285)
T ss_pred cceecCCCC---cccCCCCCcCccChHHhcCC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 987653221 12234688899999999644 48889999999999999999999998654321 11222
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~ 503 (683)
.+... ...++...+..+.+|+.+||+.||++||+ +.+++.+
T Consensus 216 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 RVLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred hhhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 22222 23455667888999999999999999999 6676655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=298.78 Aligned_cols=242 Identities=26% Similarity=0.450 Sum_probs=199.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.+++. +|+.||||.+.. ..+.+.+|+.+++.++||||+++++++. +....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence 5899999999998777653 678999998842 2346889999999999999999999885 447899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+.| +|.+++... ....+++.++..++.|++.||.|||++|++|+||+|+|||++.++ .++|+|||+
T Consensus 79 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-------~~~l~d~~~ 147 (256)
T cd08218 79 DYCEGGDLYKKINAQ----RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-------TIKLGDFGI 147 (256)
T ss_pred ecCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-------CEEEeeccc
Confidence 99975 999998752 234588999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~ 214 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENR---------PYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKII 214 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCC---------CCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHh
Confidence 976543211 11223467789999998644 477899999999999999999999976543 23445555
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+..+...+.++.++|.+||+.+|.+||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 666666777889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.15 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=196.3
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
..+.|++++.||.|+++.+++. +|..||+|.+... .+.+.+|+.+++.++||||+++++.+..+ ..+|+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEE
Confidence 3568999999999997777653 5789999998643 34578899999999999999999988654 689999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|..++.+ ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~~~~l~~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~~kl~dfg 155 (292)
T cd06644 88 IEFCPGGAVDAIMLE-----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-------DIKLADFG 155 (292)
T ss_pred EecCCCCcHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-------CEEEccCc
Confidence 999986 78777764 234689999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... .......+++.|+|||++.+... ....++.++|||||||++|||++|..||...... .....+
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~ 227 (292)
T cd06644 156 VSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETM----KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKI 227 (292)
T ss_pred cceeccccc--cccceecCCccccCceeeccccc----cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHH
Confidence 987543221 11223457788999999854321 1234788999999999999999999999765432 222333
Q ss_pred HcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RAGERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.....+ ..+..++.++.+++.+||..||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 333222 2345567889999999999999999999999765
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.77 Aligned_cols=234 Identities=23% Similarity=0.331 Sum_probs=184.5
Q ss_pred ecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC---CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 243 LGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL---SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 243 LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
||+|+++.|++. +|+.||||++.. ....+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 689987777753 688999999843 122345677777665 699999999888543 7899999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
. |+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~g~L~~~l~~------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-------~~kl~Dfg~a~~ 145 (330)
T cd05586 79 SGGELFWHLQK------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-------HIALCDFGLSKA 145 (330)
T ss_pred CCChHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-------CEEEecCCcCcC
Confidence 7 499988875 25689999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ..+...+..+.
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~~~~i~~~~ 213 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDE--------KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQMYRNIAFGK 213 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCC--------CCCCCccceeccccEEEEeccCCCCCCCCCH--HHHHHHHHcCC
Confidence 432211 22345688999999998643 2378899999999999999999999987543 23445555554
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRP----SFSSICRI 503 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RP----t~~eil~~ 503 (683)
........+.++.+++++||..||.+|| ++.++++|
T Consensus 214 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 214 VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 4333345688999999999999999998 56666544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=318.98 Aligned_cols=230 Identities=22% Similarity=0.351 Sum_probs=183.7
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHH-HHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEIS-SLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.|++. +|+.||||++... ...+..|.. +++.++||||+++++.+... +.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCC
Confidence 46899998777753 6889999998531 234455554 46778999999999888543 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-------~~kL~DfG~~~~ 145 (325)
T cd05604 79 NGGELFFHLQR------ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-------HVVLTDFGLCKE 145 (325)
T ss_pred CCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-------CEEEeecCCccc
Confidence 85 89888864 35689999999999999999999999999999999999999887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .+...+....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~~~~~~ 212 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQ---------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYDNILHKP 212 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCC---------CCCCcCccccccceehhhhcCCCCCCCCCHH--HHHHHHHcCC
Confidence 43211 122345688999999999654 4788999999999999999999999875432 3444444433
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
...+...+..+.+++.+||..||.+||++.+
T Consensus 213 -~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 -LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2345567888999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.86 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=199.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||.|+++.++.. ++..||+|.+... .+.+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEEe
Confidence 467999999999986666542 5789999998532 3467899999999999999999998864 36899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.+ ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||+
T Consensus 82 e~~~~~~L~~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-------~~~l~d~g~ 149 (280)
T cd06611 82 EFCDGGALDSIMLE-----LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-------DVKLADFGV 149 (280)
T ss_pred eccCCCcHHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-------CEEEccCcc
Confidence 99985 99988875 235699999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.... .....++.++||||||+++|+|++|..||...... .....+.
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~----~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~ 221 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACET----FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKIL 221 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcc----cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHh
Confidence 865432211 223345788899999986432 11234788999999999999999999999765432 2333444
Q ss_pred cCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 465 AGERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 465 ~~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+..+. .+..++..+.+++.+||+.||.+||++.+++++-+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 222 KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred cCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 443332 34567889999999999999999999999987633
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.45 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=193.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||+|+++.++.. +++.||+|.++.. ...+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEE
Confidence 458999999999997766643 6889999998532 33577899999999999999999988654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+++ +|.+++.. ...+++.++..++.|++.||.|||+.||+|+||||+||+++.++ .+||+|||+
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-------~~~l~dfg~ 152 (267)
T cd06645 86 EFCGGGSLQDIYHV------TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-------HVKLADFGV 152 (267)
T ss_pred eccCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEECccee
Confidence 99985 99998875 25689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+...... ........|++.|+|||++... ....++.++|||||||++|+|++|..||....... .+.....
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~ 223 (267)
T cd06645 153 SAQITAT--IAKRKSFIGTPYWMAPEVAAVE------RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK 223 (267)
T ss_pred eeEccCc--ccccccccCcccccChhhhccc------cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc
Confidence 8765432 1122345688899999998532 12347889999999999999999999997544221 1222111
Q ss_pred cCCCCC-C--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPL-F--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~-~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+. . ...++..+.+++.+||+.||++|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111111 1 12456789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.48 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=199.5
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||.|+++.++. .+|+.||+|.+... ...+.+|+++++.++|+||+++++.+.++ ..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEE
Confidence 4789999999998766664 26889999998532 34678999999999999999999988654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.. .++++..+..++.|++.||.|||+++++||||+|+||+++.++ .++|+|||+
T Consensus 79 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------~~~l~d~g~ 144 (274)
T cd06609 79 EYCGGGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-------DVKLADFGV 144 (274)
T ss_pred EeeCCCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-------CEEEccccc
Confidence 99985 99999874 2689999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||...+. ......+.
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~---------~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~ 211 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQS---------GYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIP 211 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhh
Confidence 98765432 122345677889999999654 488999999999999999999999976542 23344455
Q ss_pred cCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
....+..+.. .+..+.+++.+||..||++|||+++++++-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 212 KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 5555555555 788899999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=305.49 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=194.1
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
-|++.+.||+|+++.++.. ++..+|+|.+... .+.+.+|+++++.++||||+++++.+... ...|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEe
Confidence 3688899999987776642 5778999998532 34678899999999999999999988654 689999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|..++.. ...++++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 84 ~~~~~l~~~~~~-----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-------~~kl~dfg~~~ 151 (282)
T cd06643 84 CAGGAVDAVMLE-----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-------DIKLADFGVSA 151 (282)
T ss_pred cCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-------CEEEccccccc
Confidence 985 88777764 235699999999999999999999999999999999999998887 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......+++.|+|||++..... ....++.++|||||||++|||++|..||....... ....+...
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~ 223 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETS----KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS 223 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCC----CCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhc
Confidence 653221 12234467888999999853210 12357889999999999999999999998654322 22222222
Q ss_pred C--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 467 E--RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 467 ~--~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
. ....+..++..+.++|.+||+.||.+||++.+++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 2 2234556788999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.31 Aligned_cols=241 Identities=21% Similarity=0.373 Sum_probs=193.7
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.+|++.+.||+|+++.+++ .+|+.||||.+.. ..+.+.+|+.+++.++|+||+++++.|.. ...+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEeec
Confidence 5899999999998666654 3688999999853 23557889999999999999999998864 368999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++
T Consensus 97 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-------~~~l~Dfg~~ 162 (297)
T cd06656 97 YLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGFC 162 (297)
T ss_pred ccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEECcCccc
Confidence 9975 99998865 4588999999999999999999999999999999999998887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... ........
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~~~ 230 (297)
T cd06656 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN 230 (297)
T ss_pred eEccCCcc--CcCcccCCccccCHHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeeccC
Confidence 76543321 12234577889999998654 47889999999999999999999997654321 11111111
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~-~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+. ....+...+..+.+++.+||..||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21 112345567889999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.63 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=197.7
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++. .++..+|||.+.. ....+.+|+++|+.++||||+++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 589999999998666654 3678999998843 23468899999999999999999988854 37899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.+. ....+++..+..++.|++.||.|||++||+|+||||+||+++.++. .+||+|||+
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~------~~~l~d~~~ 148 (256)
T cd08220 79 EYAPGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM------VVKIGDFGI 148 (256)
T ss_pred ecCCCCCHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC------EEEEccCCC
Confidence 99985 999999763 2345899999999999999999999999999999999999976541 689999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+.
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~ 214 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGK---------PYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIM 214 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCC---------CCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHH
Confidence 98764332 12234577889999998644 4788999999999999999999999876543 2344444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.....+...+..+.+++.+||..||++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 454555667788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=300.72 Aligned_cols=250 Identities=29% Similarity=0.484 Sum_probs=195.8
Q ss_pred eEecccccEEEEEEc----------CcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 241 RRLGSGSQYKEILWL----------GESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 241 ~~LG~G~~~~v~l~~----------g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+.||+|+++.|+... +..||||.+.. ....+.+|+.+++.++||||+++++++.+. ...++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEE
Confidence 358998876666421 25799998753 244678999999999999999999888543 6789999
Q ss_pred ecCC-CCHHHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMS-RDLCSYIKEICCPR-KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||++ |+|.+++....... ....+++..+..++.|++.||.|||+++++|+||||+|||++.++. +....+||+|||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~~~~~l~dfg 156 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY--DADRVVKIGDFG 156 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC--CCCcceEECCcc
Confidence 9997 59999997643222 2345889999999999999999999999999999999999987641 233469999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~ 225 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG---------KFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH 225 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccC---------CcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH
Confidence 99765433222222233456789999999644 48899999999999999998 9999976442 335555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+.....+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 5566566667778999999999999999999999999988775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.06 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=194.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.++||+|+++.|++. +|+.||||++... .+.+.+|+++++.++||||+++++++.+ .+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 58999999999998777764 5889999998642 2457899999999999999999988854 378999
Q ss_pred EEecCCC-CHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 304 IMELMSR-DLCSYIKEICCP-----RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
||||++| +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-------~v 152 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-------EV 152 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-------CE
Confidence 9999985 999998752111 1123466778899999999999999999999999999999999887 79
Q ss_pred EEecccCccccCCCCC----------------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 378 KISGFGLSSVKNFGPK----------------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 378 KL~DFGla~~~~~~~~----------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++||
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~---------~~S~kSDIWSLGVILyE 223 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV---------PASESTDIYALGVILYQ 223 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC---------CCCcHhHHHHHHHHHHH
Confidence 9999999986521110 0111234689999999998654 48899999999999999
Q ss_pred HHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHH
Q 038696 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-SFSSICRILRYI 507 (683)
Q Consensus 442 lltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-t~~eil~~L~~i 507 (683)
|++|..||.............+............+..+.+++.+||+.||++|| +++++.+.|+..
T Consensus 224 LLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 224 MLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999997643221111111111111111235678899999999999999997 566666666554
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.73 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=194.2
Q ss_pred CeEEEeEecccccEEEEE----E--cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----W--LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~--~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.|++.+.||+|+++.++. . .|..||||.+... .+.+.+|+.+++.++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999998766664 2 4789999998652 34678899999999999999999999776557899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++..... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ +....+||+||
T Consensus 81 lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~---~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG---PERGVVKIGDL 156 (316)
T ss_pred EEEeCCCcCHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC---CccceEEECCC
Confidence 9999999999888865322 1224789999999999999999999999999999999999998832 11227999999
Q ss_pred cCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-----
Q 038696 383 GLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG----- 456 (683)
Q Consensus 383 Gla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~----- 456 (683)
|+++....... ........+++.|+|||++.+. ..++.++||||||+++|+|++|+.||.+.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 228 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence 99987644322 1122344678889999998643 247889999999999999999999997654321
Q ss_pred ---hHHHHHHH------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 457 ---DKMSRNIR------------------------AGERPLFP-----------FHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 457 ---~~~~~~i~------------------------~~~~~~~p-----------~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
..+...+. ......++ ...+..+.+++.+||+.||++|||+.
T Consensus 229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 308 (316)
T cd07842 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308 (316)
T ss_pred hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 01110000 01111111 03456789999999999999999999
Q ss_pred HHHHH
Q 038696 499 SICRI 503 (683)
Q Consensus 499 eil~~ 503 (683)
+++++
T Consensus 309 eil~~ 313 (316)
T cd07842 309 EALEH 313 (316)
T ss_pred HHhcC
Confidence 99765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.46 Aligned_cols=237 Identities=27% Similarity=0.426 Sum_probs=196.4
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.++.. +++.||||.+.. ..+.+.+|+++|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 47999999999997766642 678999999853 24567899999999999999999998854 378999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++ .+||+||
T Consensus 79 v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-------~~kl~df 145 (290)
T cd05580 79 VMEYVPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-------YIKITDF 145 (290)
T ss_pred EEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-------CEEEeeC
Confidence 999996 5999999752 5689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++...... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.... .....+.
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~ 209 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSK---------GYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEK 209 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Confidence 999876433 2334578889999998644 47789999999999999999999997654 2233444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
+..+ ...++...+..+.+++.+||..||.+|+ ++.+++++
T Consensus 210 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 4433 3456777789999999999999999998 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.90 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=189.2
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.+++ .++..||||.+... ...+.+|+++++.++||||+++++.+... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 4789999999998766664 36789999998532 24578999999999999999999988654 6789999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++ .+||+|||+
T Consensus 79 e~~~~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-------~~~l~dfg~ 141 (279)
T cd06619 79 EFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-------QVKLCDFGV 141 (279)
T ss_pred ecCCCCChHHh----------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-------CEEEeeCCc
Confidence 99986 66433 2378889999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-----hhHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-----GDKM 459 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-----~~~~ 459 (683)
+...... ......+|..|+|||++.+. .++.++||||||+++|+|++|..||...... ....
T Consensus 142 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 142 STQLVNS----IAKTYVGTNAYMAPERISGE---------QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred ceecccc----cccCCCCChhhcCceeecCC---------CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 9765432 22345678889999999654 4788999999999999999999999653211 1122
Q ss_pred HHHHHcCCCCCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 460 SRNIRAGERPLF-PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 460 ~~~i~~~~~~~~-p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+.....+.. ....+.++.+++.+||+.||++||++.+++++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 209 LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 222222222222 2346788999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.07 Aligned_cols=240 Identities=28% Similarity=0.493 Sum_probs=192.3
Q ss_pred eEecccccEEEEE---EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-C
Q 038696 241 RRLGSGSQYKEIL---WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-D 311 (683)
Q Consensus 241 ~~LG~G~~~~v~l---~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-s 311 (683)
++||+|+++.++. ..|+.||+|.+... .+.+.+|+++++.++|+||+++++++.+. ...|+||||+.| +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCCCc
Confidence 3688887555543 34899999988642 34688999999999999999999888644 678999999975 8
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCC
Q 038696 312 LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391 (683)
Q Consensus 312 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~ 391 (683)
|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 79 l~~~l~~-----~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-------~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 79 LLTFLRK-----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKISDFGMSREEEGG 146 (251)
T ss_pred HHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-------cEEEeeccccccccCC
Confidence 9999875 234688999999999999999999999999999999999998887 7999999999765432
Q ss_pred CCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 392 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
...........+..|+|||++.+. .++.++||||||+++|||++ |..||..... ......+.......
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~~~~ 215 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYG---------RYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMP 215 (251)
T ss_pred cceeccccCcceeccCChHhhccC---------CCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCCCCC
Confidence 211111222335679999998643 48889999999999999999 8999976543 23445555555555
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 471 FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 471 ~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 66778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.83 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=197.1
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcC-CCCceeeeeeeEEcCC----CCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSL-SHPNIMHFLCGFTDEE----KKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~----~~~ 300 (683)
..++|++.+.||+|+++.+++. +++.||+|++... .+.+.+|+.+++.+ +|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3579999999999986666542 5688999998542 45688999999999 6999999999886532 356
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||+++ +|.+++.... .....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-------~~~l 154 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-------EVKL 154 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-------eEEE
Confidence 8999999985 8998887531 1235689999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++....... .......++..|+|||++..... ....++.++|||||||++|+|++|..||...... ...
T Consensus 155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~ 227 (275)
T cd06608 155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQ----PDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL 227 (275)
T ss_pred CCCccceecccch--hhhcCccccccccCHhHhccccc----ccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH
Confidence 9999987654321 12233457888999999864321 1335788999999999999999999999764322 222
Q ss_pred HHHHHcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+.....+.. +..++..+.+++.+||..||++|||+.+++++
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 -FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22333322222 22357789999999999999999999999764
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.05 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=193.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.+++. +|+.||||.+... .+.+..|++++..++|+||+++++.+.+ ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 47999999999987766653 5789999998532 2357889999999999999999988854 478999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+.| +|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+||
T Consensus 79 v~e~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~~~l~df 147 (316)
T cd05574 79 VMDYCPGGELFRLLQRQ----PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-------HIMLSDF 147 (316)
T ss_pred EEEecCCCCHHHHHHhC----CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-------CEEEeec
Confidence 9999975 999998752 335699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCC---------------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 383 GLSSVKNFGPKS---------------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 383 Gla~~~~~~~~~---------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
|++......... .......||..|+|||++.+. .++.++|||||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~Di~sl 218 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---------GHGSAVDWWTL 218 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC---------CCCchHHHHHH
Confidence 998754322110 011234678889999999654 47889999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 038696 436 GMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPF--HSPKYVTNLTKRCWHADPNQRPS----FSSICRI 503 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPt----~~eil~~ 503 (683)
|+++|+|++|..||.+.... .....+.... ..++. ..+..+.+++.+||..||++||| +.+++.+
T Consensus 219 G~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNRD--ETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhhCCCCCCCCchH--HHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99999999999999765432 2222222221 22232 25889999999999999999999 7777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=300.07 Aligned_cols=242 Identities=31% Similarity=0.466 Sum_probs=190.8
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCCc------chHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGDI------EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~------~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++++.||+|+++.|++. +++.||+|.+.... ....+|+.+++.++||||+++++.+.+ ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 889999999998888764 56789999996532 123459999999999999999998865 378999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|+.+ +|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||.+
T Consensus 79 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-------~~~l~Dfg~~ 145 (260)
T PF00069_consen 79 YCPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-------EVKLIDFGSS 145 (260)
T ss_dssp EETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-------EEEESSGTTT
T ss_pred cccccccccccccc------ccccccccccccccccccccccccccccccccccccccccccc-------cccccccccc
Confidence 9997 999999842 5689999999999999999999999999999999999999877 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hHHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DKMSRNIR 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~~~~~i~ 464 (683)
..... .........++..|+|||++.. +..++.++||||||+++|+|++|..||....... ........
T Consensus 146 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~ 215 (260)
T PF00069_consen 146 VKLSE--NNENFNPFVGTPEYMAPEVLQQ--------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL 215 (260)
T ss_dssp EESTS--TTSEBSSSSSSGGGSCHHHHTT--------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred ccccc--cccccccccccccccccccccc--------cccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 76411 1223345667888999999861 2258999999999999999999999998762111 11111111
Q ss_pred cCCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGER---PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~---~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... .......+..+.+++.+||+.||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100 00111224789999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.56 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=185.2
Q ss_pred eEecccccEEEEEE------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEILW------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l~------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.|+.. .+..+|+|.+... ...+.+|+.+++.++||||+++++.+.+ ...+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence 35899987666542 3357999988542 2357889999999999999999988854 367899999998
Q ss_pred -CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 -RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 -gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+|.+++..... .....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++..
T Consensus 79 ~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-------~~kL~dfg~~~~~ 150 (269)
T cd05087 79 LGDLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-------TVKIGDYGLSHNK 150 (269)
T ss_pred CCcHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-------cEEECCccccccc
Confidence 599999975321 1223467778889999999999999999999999999999998876 7999999999754
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
.............++..|+|||++.+... ......++.++||||||+++|||++ |..||....... .....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~ 227 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHG--NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-VLTYTVREQQ 227 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccc--cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHhhccc
Confidence 33222222233456778999999864310 0011246789999999999999996 999997654332 2222222211
Q ss_pred ----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 468 ----RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 468 ----~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+......+..+.+++.+|| .+|++|||+.+|.+.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11222345778999999999 68999999999987764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.48 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=189.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.+++. +|+.||||.+... ...+.+|+++++.++|+||+++++++.+. ...|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEEEE
Confidence 58999999999986666542 6789999998532 23467899999999999999999988643 7899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 83 e~~~~~L~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-------~~kl~dfg~~ 150 (291)
T cd07844 83 EYLDTDLKQYMDDC-----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-------ELKLADFGLA 150 (291)
T ss_pred ecCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-------CEEECccccc
Confidence 99999999998752 34689999999999999999999999999999999999998887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||.+.....+.+......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 220 (291)
T cd07844 151 RAKSVPSK--TYSNEVVTLWYRPPDVLLGS--------TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220 (291)
T ss_pred cccCCCCc--cccccccccccCCcHHhhcC--------cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHh
Confidence 75432211 11223457789999998642 247889999999999999999999997654222211111110
Q ss_pred CCC--------------------CCC--------CCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GER--------------------PLF--------PFHSP--KYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~--------------------~~~--------p~~~~--~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
-.. ... ..... ..+.+++.+||+.||.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 000 01122 678899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=299.89 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=190.2
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.++|.+.+.||+|+++.++.. +|..||||.+... ...+.+|+.+++.++|+||+++++++.++ ...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEEEE
Confidence 468999999999987666642 6889999998532 23567899999999999999999988643 678999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+.++|.+++.. ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++ .+||+|||+
T Consensus 82 ~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-------~~~l~Dfg~ 149 (291)
T cd07870 82 FEYMHTDLAQYMIQ-----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-------ELKLADFGL 149 (291)
T ss_pred EecccCCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-------cEEEecccc
Confidence 99999999888764 234578889999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++....... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||.......+.+.....
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 219 (291)
T cd07870 150 ARAKSIPSQ--TYSSEVVTLWYRPPDVLLGA--------TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219 (291)
T ss_pred ccccCCCCC--CCCCccccccccCCceeecC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence 876433211 12234567889999998642 23778999999999999999999999865433222222111
Q ss_pred c-C---------------CCCC-C----C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-G---------------ERPL-F----P---------FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~---------------~~~~-~----p---------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. + .... + + ...+..+.+++.+|+..||.+|||+.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0 0000 0 0 0124678999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.10 Aligned_cols=244 Identities=22% Similarity=0.357 Sum_probs=192.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.+++. +|..+|+|.+... ...+.+|++++..++||||++++++|.++ +.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEe
Confidence 47999999999997766653 6788999998643 23578899999999999999999998654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||++| +|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 79 ey~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-------~~~l~dfg 145 (308)
T cd06615 79 EHMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCDFG 145 (308)
T ss_pred eccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-------cEEEccCC
Confidence 99985 999999752 568999999999999999999998 5999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH-----
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK----- 458 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~----- 458 (683)
++...... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 212 (308)
T cd06615 146 VSGQLIDS----MANSFVGTRSYMSPERLQGT---------HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212 (308)
T ss_pred Cccccccc----ccccCCCCcCccChhHhcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC
Confidence 98755322 22344678889999998643 4788999999999999999999999643321100
Q ss_pred -----------------------------HHHHHHcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 459 -----------------------------MSRNIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 459 -----------------------------~~~~i~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
....+.....+..+. ..+.++.+++.+||..||++|||+.+++++.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 001111111122221 256789999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.78 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=194.6
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
++..+++.....||+|+++.++.. ++..||+|.+... .+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEE
Confidence 344555656678999987666542 5678999988542 34688999999999999999999988543 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCCCCCCcceEE
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPF--SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP-RGASTEGYLHAK 378 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~-~g~~~~~~~~vK 378 (683)
+||||++| +|.+++... ..++ ++..+..++.||+.||.|||++||+||||||+||+++. ++ .+|
T Consensus 82 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-------~~~ 149 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK-----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-------VVK 149 (268)
T ss_pred EEEecCCCCCHHHHHHHh-----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-------eEE
Confidence 99999985 999999752 2345 78889999999999999999999999999999999976 33 699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||++........ ......+++.|+|||++.+. ...++.++||||||+++|+|++|+.||.........
T Consensus 150 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-------~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~ 220 (268)
T cd06624 150 ISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKG-------PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220 (268)
T ss_pred EecchhheecccCCC--ccccCCCCccccChhhhccc-------cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh
Confidence 999999876533211 12234577889999998543 123778999999999999999999999764432222
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..........+.++...+.++.+++.+||+.+|++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 222222334455677788999999999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.31 Aligned_cols=244 Identities=20% Similarity=0.337 Sum_probs=187.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.+++. +|+.||+|++... .+.+.+|+.+++.++|+||+++++.+... ..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEE
Confidence 47999999999987666542 5889999988421 23568899999999999999999988643 689999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+++++.+.+.. ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-------~~~l~dfg~ 146 (286)
T cd07847 79 FEYCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-------QIKLCDFGF 146 (286)
T ss_pred EeccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-------cEEECcccc
Confidence 99999754444432 234589999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......++..|+|||++.+. ..++.++||||||+++|+|++|..||.+....+. ......
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~ 215 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGD--------TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRK 215 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCC--------CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH
Confidence 987644321 12234567789999998642 2478899999999999999999999986543221 111110
Q ss_pred c-C------------------C-CCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-G------------------E-RPL---------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~------------------~-~~~---------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. + . .+. .....+..+.+|+.+||+.||++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 0 0 000 012346778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.41 Aligned_cols=244 Identities=25% Similarity=0.399 Sum_probs=191.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++++.||.|+++.+++. +|..||||.+... .+.+.+|+++++.++||||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 5899999999987666653 6889999988532 2467899999999999999999998854 46799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.++|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++
T Consensus 79 e~~~~~l~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-------~~~l~dfg~~ 147 (284)
T cd07860 79 EFLHQDLKKFMDAS----PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-------AIKLADFGLA 147 (284)
T ss_pred eccccCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEEeeccch
Confidence 99998999988752 335689999999999999999999999999999999999999887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||++.+. ..++.++||||||+++|||++|+.||...... ....+.+..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~ 216 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGC--------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRT 216 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHH
Confidence 76543221 12233457789999988543 23678999999999999999999999765432 122222211
Q ss_pred CCCC----------------C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERP----------------L-----------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~----------------~-----------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+ . .....+..+.++|.+||+.||.+|||+.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 1000 0 112356778999999999999999999999765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.13 Aligned_cols=249 Identities=27% Similarity=0.354 Sum_probs=195.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++.+.||+|+++.++.. +|+.||+|.++.. ...+.+|+.+++.++|+||+++++++.+.....+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 458999999999987666642 6889999998531 224568999999999999999999987655567899
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||+.++|.+++... ...+++.++..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||
T Consensus 86 v~e~~~~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-------~~kL~dfg 153 (309)
T cd07845 86 VMEYCEQDLASLLDNM-----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-------CLKIADFG 153 (309)
T ss_pred EEecCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------CEEECccc
Confidence 9999999999988752 35689999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++........ ......++..|+|||++.+. ..++.++||||||+++|||++|..||...+... ....+
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~ 221 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGC--------TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLI 221 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCC--------CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 9987653321 11223456789999998643 247889999999999999999999998654322 11111
Q ss_pred HcCC------------------C---CCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGE------------------R---PLFP--------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~------------------~---~~~p--------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.... . ...+ ...++.+.++|.+||..||++|||+.++++|-+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred HHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 1100 0 0000 1236778999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.19 Aligned_cols=244 Identities=23% Similarity=0.382 Sum_probs=191.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.+++. +++.||||.+... .+.+.+|+++++.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 47999999999987777643 5789999988532 3457789999999999999999988854 468999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+||
T Consensus 79 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-------~~~l~df 145 (305)
T cd05609 79 VMEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-------HIKLTDF 145 (305)
T ss_pred EEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-------CEEEeeC
Confidence 9999985 999999752 4689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCC-------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 383 GLSSVKNFGPKS-------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 383 Gla~~~~~~~~~-------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
|+++........ .......++..|+|||++.+. .++.++|+|||||++|||++|..||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~vl~el~~g~~pf 216 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWAMGIILYEFLVGCVPF 216 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCC---------CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 998742211100 011123567789999998644 4789999999999999999999999
Q ss_pred CCCccchhHHHHHHHcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGE--RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+.... .+...+..+. .+......+.++.++|.+||+.||++||++.++.+.|
T Consensus 217 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 217 FGDTPE--ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CCCCHH--HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 865432 3334443332 2222335788899999999999999999865554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.85 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=206.0
Q ss_pred EeeCCCeEEEeEecccccEEEEE--EcC-cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL--WLG-ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l--~~g-~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
++..+...+.++||+|-|+.+.+ ..| .+||||.++.+ ..+|.+||++|.+|+|||||.++++|..+ +.++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchH
Confidence 44555678889999997665554 344 89999999753 46799999999999999999999999765 6799
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||||+ |+|.+||.+...+. +.-...+.|+.||+.||+||.+.++|||||.+.|||++.+. ++||+|
T Consensus 612 mI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-------~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-------TIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-------cEEecC
Confidence 9999997 89999998742221 34455677999999999999999999999999999997666 899999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh--CCCCCCCCccchhHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT--GKVPFEDAHLQGDKM 459 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt--G~~Pf~~~~~~~~~~ 459 (683)
||+++..-.+.....+...+-+++|||+|.+... +++.++|||+||+++||+++ ...||...+.. .+
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillg---------kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~v 749 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QV 749 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhc---------cccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HH
Confidence 9999977666555566666778899999999754 59999999999999999875 88899876532 33
Q ss_pred HHHHHc----C---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 460 SRNIRA----G---ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 460 ~~~i~~----~---~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.++... + ..+..|..||..+.++|.+||..|-.+||+|+++..+|+..
T Consensus 750 ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 333221 1 13446788999999999999999999999999998887653
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=294.74 Aligned_cols=240 Identities=28% Similarity=0.479 Sum_probs=190.5
Q ss_pred eEecccccEEEEE---E--cC--cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEIL---W--LG--ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l---~--~g--~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.++. . .+ ..||||.+... .+.+.+|+.+++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 3578887655553 2 22 26999998653 3467899999999999999999988854 6789999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|.+++.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.
T Consensus 78 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-------~~kl~dfg~~~~ 146 (257)
T cd05040 78 PLGSLLDRLRKDA----LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-------KVKIGDFGLMRA 146 (257)
T ss_pred CCCcHHHHHHhcc----cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-------EEEecccccccc
Confidence 7 59999998631 14689999999999999999999999999999999999998887 799999999987
Q ss_pred cCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH-
Q 038696 388 KNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR- 464 (683)
Q Consensus 388 ~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~- 464 (683)
....... .......++..|+|||++.+. .++.++|||||||++|||++ |..||...+.. .+...+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~ 215 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTR---------TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDK 215 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhccc---------CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh
Confidence 6542211 112234567789999998654 48889999999999999998 99999765432 2333333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 34444455667899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.76 Aligned_cols=243 Identities=26% Similarity=0.441 Sum_probs=191.1
Q ss_pred EecccccEEEEEE----cCc--EEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 242 RLGSGSQYKEILW----LGE--SFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 242 ~LG~G~~~~v~l~----~g~--~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
.||+|+++.++.. +|. .+|+|.++.. .+.+.+|+.++..+ +||||+++++++.. ...+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCC
Confidence 5889987666542 333 5789988642 24677899999999 79999999998854 367899999997
Q ss_pred -CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 310 -RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 310 -gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
|+|.+++.+.... .....+++.++..++.|++.||+|||+.|++||||||+|||++.++ .+|
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-------~~k 152 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-------VAK 152 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-------eEE
Confidence 5999999763210 1123588999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~ 457 (683)
|+|||++....... .......++.|+|||++... .++.++||||||+++|||++ |..||.+... .
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~ 218 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--A 218 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCccccCH--H
Confidence 99999986432211 11122335679999998644 48889999999999999997 9999976543 2
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.....+..+.....+..++..+.+|+.+||..||.+|||+.+++..|..+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 219 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 34555555555556667888999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.50 Aligned_cols=250 Identities=21% Similarity=0.367 Sum_probs=185.8
Q ss_pred eEecccccEEEEE---Ec---CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 241 RRLGSGSQYKEIL---WL---GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~~~~v~l---~~---g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.||+|+++.+++ .. ...+|+|.+... ...+.+|+.+++.++|+||+++++.+.. ...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 3589998766664 22 346888877532 2357889999999999999999998854 367999999998
Q ss_pred -CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 -RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 -gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 79 ~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-------~~kl~dfg~~~~~ 150 (269)
T cd05042 79 LGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-------SVKIGDYGLALEQ 150 (269)
T ss_pred CCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-------cEEEecccccccc
Confidence 5999999864221 123356788899999999999999999999999999999998887 7999999998754
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
.............+++.|+|||++...... .....++.++|||||||++|||++ |..||...... +.....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~ 227 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQD--LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQD 227 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhcccc--ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccC
Confidence 332211122334456779999998643210 112357889999999999999999 88899765432 22333333322
Q ss_pred ----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 468 ----RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 468 ----~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+..+...+..+.+++..|| .||++|||+.+|++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12234456788899999999 5999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=297.94 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=195.9
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|+..++||.|+++.++. .+++.||+|.+... ...+.+|+++++.++||||++++++|.++..+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4799999999998655554 25789999998632 34688999999999999999999988776667899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-------~~~l~dfg~ 151 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-------QVKLCDFGV 151 (287)
T ss_pred EecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-------eEEEeeccc
Confidence 99985 99988765321 335689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc---chhHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL---QGDKMSR 461 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~---~~~~~~~ 461 (683)
+....... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... .......
T Consensus 152 ~~~~~~~~----~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 152 SGELVNSL----AGTFTGTSFYMAPERIQGK---------PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred cccccccc----cccccCCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 87653321 1233467789999998644 488899999999999999999999976521 1122333
Q ss_pred HHHcCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 462 NIRAGERPLFP------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 462 ~i~~~~~~~~p------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+.....+..+ ...++.+.+++.+||..||.+|||+.+++++-+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 33332222222 124578999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.54 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=200.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++++.||+|+++.++.. +|..||+|.+... ...+.+|+.++..++|+||+++++.+... +.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 47899999999987666542 6889999988532 34678899999999999999999988653 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||++| +|.+++... .....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 79 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-------~~~l~dfg 148 (286)
T cd06622 79 EYMDAGSLDKLYAGG---VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-------QVKLCDFG 148 (286)
T ss_pred eecCCCCHHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-------CEEEeecC
Confidence 99986 898888642 112468999999999999999999997 5999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh-HHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-KMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~-~~~~~ 462 (683)
++...... ......+++.|+|||++.+.... ....++.++|||||||++|+|++|..||........ .....
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 221 (286)
T cd06622 149 VSGNLVAS----LAKTNIGCQSYMAPERIKSGGPN---QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221 (286)
T ss_pred CcccccCC----ccccCCCccCccCcchhcCCCCC---ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence 98765322 12234567789999998654210 123468899999999999999999999976443221 12223
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+..+..+..++.++.++|.+||..+|++||++.+++.+-+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 44455566777789999999999999999999999999886543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.84 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=199.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
..|+..+.||.|+++.++.. .+..||||.+... .+.+.+|+.+++.++|+||+++++++.+. ...|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEE
Confidence 36888899999997766652 5789999988532 34678999999999999999999988654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.. .++++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||+
T Consensus 82 e~~~~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-------~~~l~dfg~ 147 (277)
T cd06640 82 EYLGGGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-------DVKLADFGV 147 (277)
T ss_pred ecCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-------CEEEccccc
Confidence 99985 99998864 4588999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......++..|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~ 214 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQS---------AYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVLFLIP 214 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccC---------CCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHhhhhh
Confidence 976543221 12234567789999998644 4788999999999999999999999865432 2333444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+..+...+..+.+++.+||..+|++||++.+++.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 455555666778899999999999999999999999887554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.08 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=184.5
Q ss_pred EEeEeccc--ccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 239 VRRRLGSG--SQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 239 i~~~LG~G--~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+++.||+| +++.+++ .+|+.||||.+... .+.+.+|+.+++.++||||++++++|..+ +.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 46789999 4555554 36889999998632 23567899999999999999999988654 68999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .++++|||.+
T Consensus 80 ~~~~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-------~~~l~~~~~~ 148 (327)
T cd08227 80 FMAYGSAKDLICTH----FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-------KVYLSGLRSN 148 (327)
T ss_pred ccCCCcHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-------cEEEcccchh
Confidence 998 5999998752 234589999999999999999999999999999999999998887 7999999875
Q ss_pred cccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 386 SVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 386 ~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
......... .......++..|+|||++.+. ...++.++|||||||++|||++|+.||........ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~ 220 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN-------LQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LL 220 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HH
Confidence 433211100 011123456779999999642 12488999999999999999999999976432211 11
Q ss_pred HHHHcCCCC---------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCC
Q 038696 461 RNIRAGERP---------------------------------------------LFPFHSPKYVTNLTKRCWHADPNQRP 495 (683)
Q Consensus 461 ~~i~~~~~~---------------------------------------------~~p~~~~~~l~~Li~~cL~~dP~~RP 495 (683)
..+ .+..+ ......+..+.+|+.+||+.||++||
T Consensus 221 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 221 EKL-NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred HHh-cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 111 11000 01112356789999999999999999
Q ss_pred CHHHHHHHHHH
Q 038696 496 SFSSICRILRY 506 (683)
Q Consensus 496 t~~eil~~L~~ 506 (683)
|+.+++++.+.
T Consensus 300 t~~ell~~p~f 310 (327)
T cd08227 300 SASTLLNHSFF 310 (327)
T ss_pred CHHHHhcChhh
Confidence 99999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.92 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=195.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+.|++.+.||+|+++.++.. +|+.||+|.+... .+.+.+|+.+++.++||||+++++++.+. ...|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 46999999999987666643 6889999988421 24578999999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||+.|+|.+++.. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||
T Consensus 93 v~e~~~g~l~~~~~~-----~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-------~~kL~dfg 160 (307)
T cd06607 93 VMEYCLGSASDILEV-----HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-------TVKLADFG 160 (307)
T ss_pred EHHhhCCCHHHHHHH-----cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-------CEEEeecC
Confidence 999999999888764 234689999999999999999999999999999999999999887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++...... ....+++.|+|||++.+. ....++.++||||||+++|||++|..||.+..... ....+
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~------~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~ 226 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI 226 (307)
T ss_pred cceecCCC------CCccCCccccCceeeecc------CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHH
Confidence 98765322 234567789999998532 12347889999999999999999999997654322 22223
Q ss_pred HcCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~-~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.....+. .+..++..+.+++.+||..||++||++.+++.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 3222222 234467889999999999999999999999887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.10 Aligned_cols=238 Identities=25% Similarity=0.359 Sum_probs=180.7
Q ss_pred EecccccEEEEEE----------------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 242 RLGSGSQYKEILW----------------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 242 ~LG~G~~~~v~l~----------------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.||+|+++.++.. ....||+|.+... ...+.+|+.++..++||||+++++++..+ ...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CCC
Confidence 5788886555532 1225899987542 34677899999999999999999988654 567
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++........+|++
T Consensus 80 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR-----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEEecccCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999985 78877764 235689999999999999999999999999999999999998765322333458999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH-hCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL-TGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell-tG~~Pf~~~~~~~~~~ 459 (683)
|||++..... .....++..|+|||++... ..++.++|||||||++|||+ +|..||....... .
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~ 218 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDS--------KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--K 218 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--H
Confidence 9999865432 1234567789999998532 25888999999999999998 5899987654322 1
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.....+... .....+.++.+|+.+||+.||.+||++.+|++++
T Consensus 219 -~~~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -ERFYEGQCM-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHHhcCcc-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122222211 2233467899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=296.96 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=197.5
Q ss_pred CCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.+++. ....||+|.+... .+.+.+|+++++.++|+||+++++.+.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 358999999999998777753 2457999988542 2468899999999999999999988754 36
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPR---KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..|+||||++ |+|.+++....... ....+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~------- 154 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR------- 154 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-------
Confidence 7899999998 59999997632110 112689999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCcc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~ 454 (683)
.++|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...
T Consensus 155 ~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 155 EVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQED---------DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred cEEEcccccccccCccc-ccccCCceeEEeecChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 79999999987543221 1122334556779999998644 37789999999999999998 8899976442
Q ss_pred chhHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 455 QGDKMSRNIRAGER-PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 455 ~~~~~~~~i~~~~~-~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+...+..+.. ...+..++..+.+++.+||+.||.+|||+.+++..|.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 225 --EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 234444443332 2345567899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.20 Aligned_cols=243 Identities=34% Similarity=0.564 Sum_probs=198.6
Q ss_pred eEEEeEecccccEEEEEE----c----CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 237 YQVRRRLGSGSQYKEILW----L----GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~----g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+++.+.||.|+++.++.. . +..||+|.+... .+.+..|+.++..++|+||+++++.+.+. +..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEE
Confidence 356788999987666642 2 378999999643 34788999999999999999999988654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+||
T Consensus 79 i~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-------~~~l~df 147 (258)
T smart00219 79 VMEYMEGGDLLDYLRKN----RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-------VVKISDF 147 (258)
T ss_pred EEeccCCCCHHHHHHhh----hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-------eEEEccc
Confidence 9999985 999999752 112289999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.... ...+..
T Consensus 148 g~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~ 215 (258)
T smart00219 148 GLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDG---------KFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLE 215 (258)
T ss_pred CCceeccccccccc-ccCCCcccccChHHhccC---------CCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence 99987654322111 123467889999998533 58899999999999999998 899997643 344566
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+..+.....+...+.++.+++.+||..||++|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6777777777778899999999999999999999999998653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.11 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=187.9
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCCc-----chHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGDI-----EPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~-----~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||+|+++.++.. ++..||||.++... ....+|+.++..+. |+||+++++++.+...+.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678999999987666642 68899999986421 23457899999885 999999999987655578999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++|+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++. + .+||+|||+++
T Consensus 81 ~~~~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-------~~kl~dfg~~~ 147 (282)
T cd07831 81 LMDMNLYELIKGR-----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-------ILKLADFGSCR 147 (282)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-------CeEEEeccccc
Confidence 9999999988752 356899999999999999999999999999999999999988 6 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH---
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI--- 463 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i--- 463 (683)
....... .....++..|+|||++... ..++.++|||||||++|||++|..||.+.+..+ .+....
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~ 215 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPECLLTD--------GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVL 215 (282)
T ss_pred ccccCCC---cCCCCCCcccCChhHhhcC--------CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHc
Confidence 6643221 1223567889999987532 246889999999999999999999997654321 111100
Q ss_pred -----------HcCC--CCCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 -----------RAGE--RPLF-----------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 -----------~~~~--~~~~-----------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... ...+ ....+..+.++|.+||..||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0001 12457889999999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.55 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=192.0
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++. .+|..||||++... .+.+.+|+.+++.++||||+++++.+.+ ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 589999999998766654 26889999998532 3568899999999999999999998865 37899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.++|.+++... ..++++.++..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-------~~~l~dfg~~ 146 (286)
T cd07832 79 EYMPSDLSEVLRDE-----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-------VLKIADFGLA 146 (286)
T ss_pred cccCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-------cEEEeeeeec
Confidence 99966999998752 35699999999999999999999999999999999999998877 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ .......++..|+|||++.+. ..++.++||||||+++|||++|.+||.+.... ......+..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~ 216 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGA--------RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRT 216 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeecc--------ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHH
Confidence 87654321 112334678889999998543 24688999999999999999998888654321 111111111
Q ss_pred CCCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERP----------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~----------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+ ......+..+.+++.+||..||.+|||++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 217 LGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0112346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.10 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=196.8
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
..++|++.+.||+|+++.+++. +|..||+|++... .+.+.+|+++++.++||||+++++.+.+. ..+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEE
Confidence 4568999999999997777652 5889999987432 34678999999999999999999998654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||++| +|.+++.+ ..++++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|
T Consensus 81 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-------~~~l~d 147 (284)
T cd06620 81 CMEFMDCGSLDRIYKK------GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-------QIKLCD 147 (284)
T ss_pred EEecCCCCCHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-------cEEEcc
Confidence 9999985 89888875 2468999999999999999999997 5999999999999998877 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc------
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ------ 455 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~------ 455 (683)
||++...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 148 ~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~ 214 (284)
T cd06620 148 FGVSGELINS----IADTFVGTSTYMSPERIQGG---------KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214 (284)
T ss_pred CCcccchhhh----ccCccccCcccCCHHHHccC---------CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh
Confidence 9998654322 12234678889999998643 4788999999999999999999999764321
Q ss_pred hh---HHHHHHHcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 456 GD---KMSRNIRAGERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 456 ~~---~~~~~i~~~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.. .....+.....+.++.. .+..+.+|+.+||..||++|||+.+++++...+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 215 PMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred hhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 00 11222222333333333 678899999999999999999999999876554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.78 Aligned_cols=236 Identities=27% Similarity=0.412 Sum_probs=203.1
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~ 298 (683)
.+...+|..+.+||+|+|++|.+. +.+.+|||+++.+ .+--+.|-++|... +-|.++++..+|+.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-- 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-- 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--
Confidence 566679999999999999999985 4568999999753 34457788888777 478999999988654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
+.+|+||||+.| +|.-+|++. +.|.+..++.|+.+|+-||-|||++|||+||||.+|||++.+| ++
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-------Hi 489 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-------HI 489 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-------ce
Confidence 679999999985 999999875 6799999999999999999999999999999999999999999 99
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++.-..... .+....||+.|+|||++.-+ .|+.++|+|||||+||||+.|++||++.. ++
T Consensus 490 Ki~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~Yq---------PYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~ 556 (683)
T KOG0696|consen 490 KIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQPPFDGED--ED 556 (683)
T ss_pred EeeecccccccccCCc--ceeeecCCCcccccceEEec---------ccccchhHHHHHHHHHHHHcCCCCCCCCC--HH
Confidence 9999999987554433 33467899999999999655 59999999999999999999999999865 45
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP 495 (683)
++.+.|.... ..+|...+.+..++.+..|...|.+|.
T Consensus 557 elF~aI~ehn-vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ELFQAIMEHN-VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHcc-CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 6777776643 458889999999999999999999995
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.36 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=205.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
...|.+.+.||+|.|.+|.+. +|..||||.+.+. ...+.+|+++|+.|+|||||+++.+... ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 458999999999987777763 7899999998642 3457899999999999999999988854 478999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |.+++||.++ +.+.+..+..++.|+..|++|||+++|+|||||++||||+.+. .+||+||
T Consensus 133 V~eya~~ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-------nikIaDf 199 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-------NIKIADF 199 (596)
T ss_pred EEEeccCchhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-------ceeeecc
Confidence 999996 5999999874 5577789999999999999999999999999999999998775 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++.++..+. .....+|++-|.|||++.+.. ..++.+|+||+|+++|-|+.|..||++.+..+ +...
T Consensus 200 gfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~--------y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr~r 266 (596)
T KOG0586|consen 200 GFSTFFDYGL---MLQTFCGSPPYAAPELFNGKK--------YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LRPR 266 (596)
T ss_pred ccceeecccc---cccccCCCCCccChHhhcCcc--------cCCcceehhhhhhhheeeeecccccCCccccc--ccch
Confidence 9999887443 334567888999999998764 46789999999999999999999999877653 3222
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+..+. ..+|..++.++.+||+++|.++|.+|++++++.++-+..
T Consensus 267 vl~gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 267 VLRGK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred heeee-ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 32222 225677788899999999999999999999998775543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.03 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=195.6
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+|++.+.||.|+++.++.. +|+.||+|.+.. ..+.+.+|+++++.++||||+++++.+. +...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 5899999999987666642 588999999852 2457889999999999999999998885 44789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++... .++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-------~~~l~d~~ 145 (258)
T cd05578 79 VDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-------HVHITDFN 145 (258)
T ss_pred EeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-------CEEEeecc
Confidence 999985 999999752 5789999999999999999999999999999999999999887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||..............
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQ---------GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHccc---------CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH
Confidence 987654322 22345577789999999654 378899999999999999999999987553211222222
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF--SSICR 502 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~--~eil~ 502 (683)
........+...+..+.++|.+||..||.+||++ .++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 214 QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred hccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 2224556777889999999999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.52 Aligned_cols=241 Identities=27% Similarity=0.419 Sum_probs=195.1
Q ss_pred CeEEEeEecccccEEEEE---E-cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL---W-LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l---~-~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+|+..+.||+|+++.++. . +|+.|++|.+.. ..+.+.+|+.+++.++|+||+++++.+.+ ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 477788999998655553 2 688999998742 23468899999999999999999988854 36899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .+||+|
T Consensus 79 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-------~~kl~d 145 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-------VVKLAD 145 (258)
T ss_pred EEEEecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEEcc
Confidence 99999985 999998752 4589999999999999999999999999999999999998877 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||++....... ......++..|++||.+... ..++.++|+||||+++|+|++|..||..... ......
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~--------~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~~~ 213 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQ--------GGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFK 213 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCC--------CCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHHHH
Confidence 99987654332 22345578889999998643 1378899999999999999999999976542 222223
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.......+.++...+..+.+++.+||..+|.+||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 233244555677788999999999999999999999999764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=295.51 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=195.2
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC----------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD----------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~----------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
+|+..+.||+|+++.++. .+|+.||+|++... .+.+.+|+++++.++|+||+++++.+.+ .+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 478889999998776664 36889999998531 3467899999999999999999998854 4689
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||+.| +|.+++.+. .++++..+..++.|++.||.|||++|++|+||||+||+++.++. .+||+
T Consensus 79 ~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~------~~~l~ 146 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ------RLRIA 146 (268)
T ss_pred EEEEeccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC------EEEEc
Confidence 999999985 999998752 46899999999999999999999999999999999999976641 59999
Q ss_pred cccCccccCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--
Q 038696 381 GFGLSSVKNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-- 456 (683)
Q Consensus 381 DFGla~~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-- 456 (683)
|||++........ ........++..|+|||++.+. .++.++||||+|+++|+|++|..||.......
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE---------QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 9999876643211 1112234578889999998654 47889999999999999999999997543321
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+.........+..+...+..+.+++.+||..||++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11112222334455666778899999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=294.49 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=198.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.+|++.+.||+|+++.+++. +|..||+|.+.. ....+.+|+.+++.++|+||+++++.+.+.+...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 48999999999987666653 688999998731 12367889999999999999999998876555778
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+
T Consensus 82 ~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-------~~~l~ 148 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-------NVKLG 148 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-------CEEEC
Confidence 999999985 999998752 4588999999999999999999999999999999999998877 79999
Q ss_pred cccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|||+++....... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~ 218 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE---------GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAI 218 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHH
Confidence 9999986543211 1111234578889999998654 4788999999999999999999999865433 233
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.......+.+|...++.+.+++.+||. +|..||+..+++.|
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 44444455566788888999999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=295.56 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=193.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC--------------cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD--------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~--------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+|.+.+.||+|+++.++.. +|+.||||.+... .+.+.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 5888999999997777653 6889999987421 2357789999999999999999988754
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
....++||||++| +|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++ .
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-------~ 146 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-------I 146 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-------e
Confidence 4788999999975 999998752 5689999999999999999999999999999999999998887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
++|+|||+++...............++..|+|||++.... ..++.++||||||+++|+|++|..||......
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~- 218 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS-------QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI- 218 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhcccc-------CCCCccchhHHHHHHHHHHHhCCCCCcCcchH-
Confidence 9999999997654322222223445788899999986431 13788999999999999999999999754322
Q ss_pred hHHHHHHHcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
............+.++ ..++..+.+++.+||..+|++|||+.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1222222222222233 2457889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.80 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=196.6
Q ss_pred eCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC---CcchHHHHHHHHHcC-CCCceeeeeeeEEcC----CCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG---DIEPLVPEISSLLSL-SHPNIMHFLCGFTDE----EKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e----~~~~ 300 (683)
..+.|++.+.||.|+++.+++ .+++.||+|++.. ....+..|+.+++.+ +|+||+++++++... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 456899999999999766664 2678999999853 234678899999998 699999999887532 2467
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||+++ +|.+++... ....+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-------~~~l 162 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNT----KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-------EVKL 162 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEE
Confidence 8999999985 999988753 234588999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++........ ......+++.|+|||++.... .....++.++|||||||++|||++|..||...... ..+
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~----~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~ 235 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDE----NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RAL 235 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCccc----CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhh
Confidence 99999876532211 223456788899999986321 11335788999999999999999999999765422 122
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...............++..+.++|.+||..||.+|||+.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 22222222222334578899999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.41 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=197.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC---cchHHHHHHHHHcC-CCCceeeeeeeEEcCC---C
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD---IEPLVPEISSLLSL-SHPNIMHFLCGFTDEE---K 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~---~ 298 (683)
+....++|++.+.||+|+++.++. .+|+.+|+|.+... .+.+.+|+.++..+ +||||+++++.+...+ .
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 333467899999999998766654 26789999998542 35677899999999 7999999998886432 2
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||||++| +|.++++... .....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-------~~ 167 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-------GV 167 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-------CE
Confidence 468999999975 9999886432 1235689999999999999999999999999999999999998877 69
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||++........ ......++..|+|||++..... ....++.++|||||||++|||++|+.||...... .
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~ 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQ----YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-K 240 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCC----cccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-H
Confidence 9999999876543221 1223457788999999864310 1223688999999999999999999999865432 1
Q ss_pred HHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+. .+.....+ ..+...+..+.++|.+||+.||++||++.++++|
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLF-KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHH-HHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 222 22222222 2244566789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.76 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=191.1
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.+++ .+|+.||||.+... .+.+.+|+++++.++||||+++++++.+. ..+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 5899999999998666654 26889999988531 24578999999999999999999988654 689999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++++|.+++... ....+++..+..++.||+.||.|||++||+||||+|+||+++.++. .+||+|||+
T Consensus 80 ~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~------~~kl~dfg~ 149 (294)
T PLN00009 80 FEYLDLDLKKHMDSS----PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN------ALKLADFGL 149 (294)
T ss_pred EecccccHHHHHHhC----CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC------EEEEccccc
Confidence 999999999888652 2334688899999999999999999999999999999999975431 699999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||......+ .+.+.+.
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~ 218 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGS--------RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR 218 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 976543211 11233567889999998642 247889999999999999999999998654322 2222111
Q ss_pred c-CC------------------CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 A-GE------------------RPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~-~~------------------~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
. +. .+. .....+.++.+++.+||+.||++||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 219 ILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred HhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 00 000 1134567799999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.69 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=190.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE------ 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~------ 297 (683)
.++|++.+.||+|+++.++.. +|+.||||.+... ...+.+|+++++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 358999999999997777653 6889999988421 224568999999999999999998876432
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
....|+||||+.++|.+++.. ....+++.++..++.||+.||.|||++|++|+||||+|||++.++ .+
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-------~~ 158 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSN-----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-------IL 158 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-------cE
Confidence 245799999999999988875 234689999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
||+|||++......... .......++..|+|||++.+. ..++.++||||||+++|||++|+.||.+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE--------RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC--------cccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999766433211 112234567889999998643 23678999999999999999999999765432
Q ss_pred hhH-HHHHHHcCCCC---------------CC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 456 GDK-MSRNIRAGERP---------------LF-------------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 456 ~~~-~~~~i~~~~~~---------------~~-------------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
... ....+.....+ .+ +...+..+.+||.+||..||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110 00111000000 00 11124567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.35 Aligned_cols=242 Identities=23% Similarity=0.390 Sum_probs=195.2
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.|++.+.||+|+++.++. .+|..||||.+... .+.+.+|+.+++.++||||+++++++.+ ....|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEE
Confidence 466677899998655554 25789999998532 2467899999999999999999998854 367999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 83 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-------~~~l~dfg~~ 148 (277)
T cd06642 83 YLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-------DVKLADFGVA 148 (277)
T ss_pred ccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-------CEEEcccccc
Confidence 9985 89888853 4589999999999999999999999999999999999998877 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......++..|+|||++.+. .++.++|||||||++|||++|..||...... .....+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~ 215 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQS---------AYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFLIPK 215 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcC---------CCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhhhhc
Confidence 76543211 11234567789999999654 4788999999999999999999999764422 23333444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+..+...+..+.+++.+||+.+|++||++.+++++-..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 44555566678889999999999999999999999987553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=297.97 Aligned_cols=222 Identities=24% Similarity=0.333 Sum_probs=172.2
Q ss_pred EEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHH
Q 038696 258 SFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332 (683)
Q Consensus 258 ~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~ 332 (683)
.||+|++... ...+.+|+.+++.++||||+++++++... ...||||||++| +|..++.. ....+++..
T Consensus 46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~ 118 (274)
T cd05076 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRK-----EKGRVPVAW 118 (274)
T ss_pred eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CceEEEEecCCCCcHHHHHHh-----cCCCCCHHH
Confidence 5899988542 34578899999999999999999988654 678999999985 88888864 235689999
Q ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhh
Q 038696 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVL 412 (683)
Q Consensus 333 ~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl 412 (683)
+..++.||+.||+|||++||+||||||+|||++..+........+|++|||++...... ....++..|+|||++
T Consensus 119 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~ 192 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECV 192 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhh
Confidence 99999999999999999999999999999999876522122335899999997643211 123466779999998
Q ss_pred hhccccccccCCCCCchhHHHhHHHHHHHHH-hCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 038696 413 EENEQTESASNSKYSEKSDVYSFGMICFEIL-TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADP 491 (683)
Q Consensus 413 ~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell-tG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP 491 (683)
.+. ..++.++||||||+++|||+ +|..||....... ....+... ...+......+.++|.+||+.+|
T Consensus 193 ~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p 260 (274)
T cd05076 193 PGG--------NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KERFYEKK--HRLPEPSCKELATLISQCLTYEP 260 (274)
T ss_pred cCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HHHHHHhc--cCCCCCCChHHHHHHHHHcccCh
Confidence 642 24789999999999999995 6999998654322 22222222 22344456779999999999999
Q ss_pred CCCCCHHHHHHHH
Q 038696 492 NQRPSFSSICRIL 504 (683)
Q Consensus 492 ~~RPt~~eil~~L 504 (683)
++|||+.++++.|
T Consensus 261 ~~Rps~~~il~~L 273 (274)
T cd05076 261 TQRPSFRTILRDL 273 (274)
T ss_pred hhCcCHHHHHHhh
Confidence 9999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.14 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=191.1
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCC---CCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE---KKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~---~~~~ 301 (683)
+++|++.+.||+|+++.++. .+|+.||||.+.. ....+.+|+.+++.++|+||+++++.+.... ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 36899999999998766664 2688999999853 2345778999999999999999998765322 2468
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 302 ~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|+||||+.++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 84 ~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-------~~kl~d 149 (336)
T cd07849 84 YIVQELMETDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-------DLKICD 149 (336)
T ss_pred EEEehhcccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-------CEEECc
Confidence 99999999999988864 4699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh---
Q 038696 382 FGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD--- 457 (683)
Q Consensus 382 FGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~--- 457 (683)
||++......... .......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS--------KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999765432211 122234678889999987532 2478899999999999999999999976432110
Q ss_pred ----------HHHHHH---------HcCC-CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 458 ----------KMSRNI---------RAGE-RPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 458 ----------~~~~~i---------~~~~-~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+....+ .... ... .....+.++.+++.+||+.||++|||+.+++++-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 000000 0000 000 0123467799999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=292.21 Aligned_cols=247 Identities=24% Similarity=0.426 Sum_probs=195.7
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||.|+++.++. .+|..+|+|++.. ..+.+.+|+.+|+.++|+||+++++.+... ..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 4799999999998665553 2678999999853 245688999999999999999999888543 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.... ....+++..+..++.|++.||.|||+.||+||||+|+||++++++ .+||+|||+
T Consensus 79 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-------~~~l~df~~ 148 (267)
T cd06610 79 PYLSGGSLLDIMKSSY---PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-------SVKIADFGV 148 (267)
T ss_pred eccCCCcHHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-------CEEEcccch
Confidence 99985 9999987531 124589999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCC--CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 385 SSVKNFGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 385 a~~~~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
+.......... ......++..|+|||++... ..++.++||||||+++|+|++|+.||....... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~ 218 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV--------HGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML 218 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccc--------cCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH
Confidence 87765432221 22334578889999998643 147889999999999999999999997654321 2222
Q ss_pred HHcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
......+.++. ..+..+.+++.+||..||++||++.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 219 TLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22222222222 456889999999999999999999999865
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=291.09 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=196.0
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++. .+|..||+|.+.. ..+.+.+|+.+++.++|+||+++++.+.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 589999999998655553 2678999999842 34567899999999999999999998854 47899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+.| +|.+++... ....+++..+..++.|++.||.|||+.+|+|+||||+||+++.++. .+||+|||.
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~------~~~l~d~~~ 148 (257)
T cd08225 79 EYCDGGDLMKRINRQ----RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM------VAKLGDFGI 148 (257)
T ss_pred ecCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC------eEEeccccc
Confidence 99975 999998752 2345899999999999999999999999999999999999987651 579999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......|++.|+|||++.+. .++.++||||||+++|||++|..||...... .....+.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~ 215 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNR---------PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--QLVLKIC 215 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHh
Confidence 976643221 12234578889999998643 4788999999999999999999999765432 2333444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.....+...+..+.+++.+||..+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 216 QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 444444556678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.65 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=196.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||.|+++.++.. +++.||+|.+... .+.+.+|+++++.++||||+++++.+... ..+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 47888999999987666542 5889999988543 24578999999999999999999888654 7899999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||++ ++|.+++... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||
T Consensus 79 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-------~~~l~d~g 146 (265)
T cd06605 79 EYMDGGSLDKILKEV-----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-------QIKLCDFG 146 (265)
T ss_pred EecCCCcHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-------CEEEeecc
Confidence 9998 5999998752 2578999999999999999999999 9999999999999999887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc---chhHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL---QGDKMS 460 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~---~~~~~~ 460 (683)
++........ ....++..|+|||++.+. .++.++||||||+++|+|++|..||..... ......
T Consensus 147 ~~~~~~~~~~----~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (265)
T cd06605 147 VSGQLVNSLA----KTFVGTSSYMAPERIQGN---------DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL 213 (265)
T ss_pred cchhhHHHHh----hcccCChhccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH
Confidence 9876532211 115577789999998654 488999999999999999999999976421 111233
Q ss_pred HHHHcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 461 RNIRAGERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 461 ~~i~~~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.+.....+..+.. .+..+.++|.+||..||.+|||+.+++.+-
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 214 QYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred HHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 33444444455554 788899999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.56 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=201.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.+++. +|+.||||++... ...+.+|+.++..++|+||+++++.+... ..+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 47999999999986665542 5889999998643 45688999999999999999999988544 7899999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||++ ++|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||
T Consensus 79 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-------~~~l~df~ 145 (264)
T cd06623 79 EYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-------EVKIADFG 145 (264)
T ss_pred EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-------CEEEccCc
Confidence 9998 5999999752 568999999999999999999999 9999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-chhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL-QGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~-~~~~~~~~ 462 (683)
++........ ......++..|+|||.+... .++.++||||||+++|+|++|..||..... ........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 146 ISKVLENTLD--QCNTFVGTVTYMSPERIQGE---------SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred cceecccCCC--cccceeecccccCHhhhCCC---------CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 9987643322 11234567889999998644 488899999999999999999999977641 22334455
Q ss_pred HHcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.....+..+.. .+..+.++|..||..+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 555555556666 78999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.21 Aligned_cols=246 Identities=22% Similarity=0.388 Sum_probs=196.9
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|+..+.||+|+++.+++. +|..||||.+... ...+.+|+++++.++||||+++++++.++ ...|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEEE
Confidence 4888999999987666542 6789999998531 23578899999999999999999988654 678999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+.|+|.+++.. ...++++.++..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||+
T Consensus 104 ~e~~~g~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-------~~kl~dfg~ 171 (317)
T cd06635 104 MEYCLGSASDLLEV-----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-------QVKLADFGS 171 (317)
T ss_pred EeCCCCCHHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-------CEEEecCCC
Confidence 99999999888764 235689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+..... .....+++.|+|||++... ....++.++|||||||++|||++|..||...... ........
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~ 238 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ 238 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcC------CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh
Confidence 865432 2234577889999998532 1234788999999999999999999999765322 22333333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
..........++..+.+++.+||+.+|.+||++.++++++..+.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 33333334567888999999999999999999999998876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.98 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=190.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCC-CCceeeeeeeEEcCCC---Ce
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEK---KE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~---~~ 300 (683)
++|++.+.||+|+++.+++. +|+.||||.+... ...+.+|+.+++.+. ||||+++++++...+. ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999987766653 6889999987532 246788999999995 6999999988765322 23
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCCCCCCcceEEE
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP-RGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~-~g~~~~~~~~vKL 379 (683)
+|+||||++++|.+++...... ....+++..+..++.||+.||.|||++||+||||||+||+++. ++ .+||
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~-------~~kl 152 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-------LLKI 152 (295)
T ss_pred EEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC-------eEEE
Confidence 7999999999999998753211 1356899999999999999999999999999999999999987 55 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++........ ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+..... ..
T Consensus 153 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~ 221 (295)
T cd07837 153 ADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGS--------THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QL 221 (295)
T ss_pred eecccceecCCCcc--ccCCcccccCCCChHHhhCC--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HH
Confidence 99999976543211 11223467789999998642 247889999999999999999999997654321 11
Q ss_pred HHHHHcCC------------------CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGE------------------RPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~------------------~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
......-. .+. .....+..+.++|.+||..||.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 11111000 000 012457789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.86 Aligned_cols=249 Identities=14% Similarity=0.229 Sum_probs=184.8
Q ss_pred eeCCCeEEEeEecccccEEEEEE----c---CcEEEEEEeCCCcchH---------------HHHHHHHHcCCCCceeee
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----L---GESFALRHFFGDIEPL---------------VPEISSLLSLSHPNIMHF 289 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~---g~~vAvK~~~~~~~~~---------------~~Ei~iL~~L~HpnIv~l 289 (683)
+..++|++.+.||+|+|+.|+.. + +..+|+|+.....+.+ ..+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 44578999999999998777753 2 4567777643222212 123334556789999999
Q ss_pred eeeEEcCCC--CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 038696 290 LCGFTDEEK--KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR 367 (683)
Q Consensus 290 ~~~~~~e~~--~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~ 367 (683)
++++..... ...+++||++..++.+.+... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 976544322 244788998887887777642 346788899999999999999999999999999999999877
Q ss_pred CCCCCCcceEEEecccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 368 GASTEGYLHAKISGFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 368 g~~~~~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
+ .+||+|||+|+........ .......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 163 ~-------~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---------~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 163 N-------RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---------CVTRRGDLESLGYCMLKW 226 (294)
T ss_pred C-------cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC---------CCCcHHHHHHHHHHHHHH
Confidence 6 7999999999876432111 112334689999999998654 489999999999999999
Q ss_pred HhCCCCCCCCccchhH-------HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 443 LTGKVPFEDAHLQGDK-------MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 443 ltG~~Pf~~~~~~~~~-------~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
++|..||.+....... ....+..+. .....+++.+.+++..||..+|++||++.++.+.|
T Consensus 227 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhCCCCCCccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999999876332211 112222222 13456689999999999999999999999998754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.66 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred EeeCCCeEEEeEecccccEEEE----EEcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEI----LWLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~----l~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+.-+.|..-++||+|||+.|. ..+|+.+|+|.+.+ ......+|-.||..++.+.||.+-+.| +.++
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCC
Confidence 3445688999999999976665 25899999998732 234467899999999999999998888 5668
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||.+|+| ||.-+|.+. ....|++..++.|+.+|+.||++||+.+||+|||||+|||+|+.| +|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~----g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-------hvR 327 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNH----GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-------HVR 327 (591)
T ss_pred ceEEEEEeecCCceeEEeecc----CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-------CeE
Confidence 89999999985 999888764 225699999999999999999999999999999999999999999 899
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--ch
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~ 456 (683)
|+|+|||..+..+. ...+.+||.+|||||++++. .|+.+.|+|||||++|||+.|+.||..... ..
T Consensus 328 ISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne---------~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~ 395 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNE---------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR 395 (591)
T ss_pred eeccceEEecCCCC---ccccccCcccccCHHHHcCC---------cccCCccHHHHHhHHHHHHcccCchhhhhhhhhH
Confidence 99999998886553 23455899999999999865 499999999999999999999999976432 22
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
+++.+.+... ...++...++++++|.+.+|+.||.+|....
T Consensus 396 eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 EEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3344444333 3446788899999999999999999997443
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.88 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=191.5
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+|++.++||.|+++.++.. +|..||||.+... .+.+.+|+.+++.++|+||+++++.+.+. +..+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEEe
Confidence 5899999999987666642 5889999988532 34567899999999999999999998654 67899999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++|+|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 79 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-------~~~l~d~g~~~ 148 (284)
T cd07836 79 YMDKDLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-------ELKLADFGLAR 148 (284)
T ss_pred cCCccHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-------cEEEeecchhh
Confidence 99999999987531 234689999999999999999999999999999999999998887 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... ......+++.|++||++.+. ..++.++||||||+++|+|++|..||.+....+ .....+...
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~ 217 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGS--------RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIM 217 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHh
Confidence 6543211 12234567889999998643 247889999999999999999999998654321 111111100
Q ss_pred C----------------CCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 E----------------RPL-----------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~----------------~~~-----------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. ... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 218 GTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000 112346778999999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=298.75 Aligned_cols=246 Identities=28% Similarity=0.366 Sum_probs=193.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||.|+++.++.. +|+.||||.++.. ...+.+|+.+++.++||||+++++++.+.+...+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47999999999987666642 5789999998532 2245789999999999999999998876555789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 85 ~e~~~~~L~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-------~~~l~d~g~ 152 (293)
T cd07843 85 MEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-------ILKICDFGL 152 (293)
T ss_pred ehhcCcCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-------cEEEeecCc
Confidence 999999999988752 23689999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......+++.|+|||++.+.. .++.++|+||||+++|+|++|..||....... ...+...
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~ 221 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAK--------EYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFK 221 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCc--------cccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 987654321 122345678899999986432 36789999999999999999999997654321 1111110
Q ss_pred c-----------------------------CCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-----------------------------GERPLFPFH-SPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-----------------------------~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .....++.. .++.+.++|++||+.||++|||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000112222 47789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=307.37 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=191.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++.+.||+|+++.+++. +|+.||||.+... .+.+.+|+.+++.++||||++++++|.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 358999999999998777753 7889999998531 245678999999999999999998886432 23
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+||||+.++|.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 95 ~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-------~~kL 159 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 159 (353)
T ss_pred cEEEEEeccCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-------CEEE
Confidence 5799999999999998863 288999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ...
T Consensus 160 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~ 226 (353)
T cd07850 160 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQW 226 (353)
T ss_pred ccCccceeCCCCC---CCCCCcccccccCHHHHhCC---------CCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHH
Confidence 9999998654321 12234567889999999654 4889999999999999999999999754321 111
Q ss_pred HHHHHcC--------------------CCC--------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 460 SRNIRAG--------------------ERP--------------LF-------PFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 460 ~~~i~~~--------------------~~~--------------~~-------p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
...+..- ..+ .+ +...+..+.++|.+||+.||.+|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 1110000 000 00 112356789999999999999999999
Q ss_pred HHHHHHHH
Q 038696 499 SICRILRY 506 (683)
Q Consensus 499 eil~~L~~ 506 (683)
+++++-+.
T Consensus 307 eiL~~~~~ 314 (353)
T cd07850 307 DALQHPYI 314 (353)
T ss_pred HHhcChhH
Confidence 99987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.39 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=189.3
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+|++.+.||+|+++.+++. +|+.||||.+... ...+..|+++++.++|+||+++++++.+ ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 4889999999987666642 5789999998532 1245789999999999999999998865 37899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||+.|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+||+||
T Consensus 79 lv~e~~~~~L~~~i~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-------~~~l~df 146 (298)
T cd07841 79 LVFEFMETDLEKVIKDK-----SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-------VLKLADF 146 (298)
T ss_pred EEEcccCCCHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-------CEEEccc
Confidence 99999977999999752 23699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++....... ......+++.|+|||++.+. ..++.++|||||||++|||++|.+||.+.... +.+.+.
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~ 215 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGA--------RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKI 215 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHH
Confidence 99987644321 12233456789999998532 24788999999999999999998888764432 111111
Q ss_pred HHcCC---------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGE---------------------RPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~---------------------~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..... .+. .....+..+.++|.+||..||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11000 000 112346778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.66 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=190.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.++.. +++.||||.++. ..+.+.+|+++++.++|+||+++++.+.+ .+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 47999999999987666542 578999998753 23568899999999999999999999865 3689999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+++++.+.+.. ....+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-------~~kl~d~g~ 146 (288)
T cd07833 79 FEYVERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-------VLKLCDFGF 146 (288)
T ss_pred EecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------CEEEEeeec
Confidence 99999866655543 235589999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+......... ......++..|+|||++.+. ..++.++||||||+++|+|++|..||.+..... .+.....
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~ 216 (288)
T cd07833 147 ARALRARPAS-PLTDYVATRWYRAPELLVGD--------TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQK 216 (288)
T ss_pred ccccCCCccc-cccCcccccCCcCCchhcCC--------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9876543221 12234567889999998643 147889999999999999999999997643221 1111000
Q ss_pred --c-----------------C-CC----------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 --A-----------------G-ER----------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 --~-----------------~-~~----------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. + .. ..++..++..+.++|++||..||++|||+++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 217 CLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0 00 01233347889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.12 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=196.0
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. ++..||||.++.. .+.+.+|+.+++.++|+||+++++.+.+ ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5899999999987666542 6789999998532 3467899999999999999999988754 47899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||+++ +|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .+||+|||+
T Consensus 79 e~~~~~~L~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-------~~kl~d~g~ 145 (264)
T cd06626 79 EYCSGGTLEELLEH------GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-------VIKLGDFGC 145 (264)
T ss_pred ecCCCCcHHHHHhh------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEEccccc
Confidence 99985 99998874 24588999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCC--CCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 385 SSVKNFGPKSPS--QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 385 a~~~~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
+........... .....+++.|+|||++.+.. ...++.++||||||+++|+|++|..||...... ......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~ 218 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK------GKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFH 218 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCC------CCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHH
Confidence 987644322111 12345678899999996541 123788999999999999999999999765322 223333
Q ss_pred HHcCCCCCCCCCC--cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~~--~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+..+..+.+|... +..+.+++.+||+.||.+|||+.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 3444455555544 8889999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=294.79 Aligned_cols=240 Identities=23% Similarity=0.387 Sum_probs=192.3
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC-----CcchHHHHHHHHHcCC---CCceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-----DIEPLVPEISSLLSLS---HPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~~~~~~L 303 (683)
.|++.+.||+|+++.++. .+|+.||||.+.. ..+.+.+|+.+++.++ ||||+++++++.+ ...+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 588889999998666554 3688999998853 2356788999999996 9999999998854 368999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+||
T Consensus 80 v~e~~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-------~~~l~df 145 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-------NVKLCDF 145 (277)
T ss_pred EEecCCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-------CEEEccC
Confidence 9999975 99988864 3689999999999999999999999999999999999999877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ ......|+..|+|||++.+. ..++.++||||||+++|+|++|..||....... ....
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~ 213 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEG--------KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--AMML 213 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccC--------CccccchhHHHHHHHHHHHHhCCCCCCCCChhh--hhhc
Confidence 99987654321 22334678889999998532 247889999999999999999999997654321 1122
Q ss_pred HHcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.....+.++. ..+.++.+++.+||..||++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 22222233333 367889999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.90 Aligned_cols=241 Identities=21% Similarity=0.396 Sum_probs=196.9
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
-|++.+.||.|+++.++. .+++.||||.+... ...+.+|+.++..++||||+++++.+.+. ...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEE
Confidence 477889999998766664 26789999987532 24678899999999999999999988643 68999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus 83 ~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-------~~~l~dfg~~ 148 (277)
T cd06641 83 YLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-------EVKLADFGVA 148 (277)
T ss_pred eCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-------CEEEeecccc
Confidence 9985 89888863 4589999999999999999999999999999999999998887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......++..|+|||++.+. ..+.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~ 215 (277)
T cd06641 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPK 215 (277)
T ss_pred eecccch--hhhccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhc
Confidence 7654321 112234567789999998643 477899999999999999999999976442 233444555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+..+...+.++.+++.+||..+|.+||++.+++++-.
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 5556667778899999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.64 Aligned_cols=243 Identities=27% Similarity=0.414 Sum_probs=187.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.++.. .|+.||+|.+... .+.+.+|+++++.++||||+++++++.+ ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 47999999999987666642 5789999987431 3457899999999999999999998854 4789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+++ .|..+... ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-------~~~l~dfg 145 (286)
T cd07846 79 FEFVDHTVLDDLEKY------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVKLCDFG 145 (286)
T ss_pred EecCCccHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-------cEEEEeee
Confidence 999997 55554432 24589999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++........ ......++..|+|||++.+. ..++.++||||||+++|||++|+.||...... +......
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~ 214 (286)
T cd07846 146 FARTLAAPGE--VYTDYVATRWYRAPELLVGD--------TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHII 214 (286)
T ss_pred eeeeccCCcc--ccCcccceeeccCcHHhccc--------cccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHH
Confidence 9876543321 22234577889999998642 24778999999999999999999999754421 1111111
Q ss_pred Hc-------------------C-CCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RA-------------------G-ERPL---------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~-------------------~-~~~~---------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. + ..+. .....+..+.+++.+||..||++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0 0000 123457789999999999999999999999765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=285.10 Aligned_cols=246 Identities=28% Similarity=0.441 Sum_probs=199.9
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. +|..|++|++... .+.+.+|+.+++.++|+||+++++.+.+.....+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999986666542 5889999998542 45688999999999999999999888654336899999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus 81 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-------~~~l~d~~~ 147 (260)
T cd06606 81 EYVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-------VVKLADFGC 147 (260)
T ss_pred EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-------CEEEccccc
Confidence 9996 5999998762 3799999999999999999999999999999999999999877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+................++..|++||.+.+. .++.++||||||+++|+|++|..||.........+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGE---------EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc
Confidence 9877554321112345677889999998654 3788999999999999999999999876522222222222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+..+...+..+.+++.+||..||++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 244555677778999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.46 Aligned_cols=241 Identities=20% Similarity=0.358 Sum_probs=190.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+.|.....||+|+++.++.. ++..||||.+.. ..+.+.+|+.+++.++|+||+++++.+... +..|+|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEe
Confidence 35566678999987666643 678999999853 234678999999999999999999888643 68899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 100 ~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-------~~kL~dfg~~ 165 (292)
T cd06658 100 FLEGGALTDIVTH-------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-------RIKLSDFGFC 165 (292)
T ss_pred CCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-------CEEEccCcch
Confidence 9985 88887753 3589999999999999999999999999999999999998877 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......++..|+|||++.+. .++.++||||||+++|||++|..||...... .....+..
T Consensus 166 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~ 232 (292)
T cd06658 166 AQVSKEV--PKRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRD 232 (292)
T ss_pred hhccccc--ccCceeecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 7653321 122334578889999998644 4788999999999999999999999865432 12223332
Q ss_pred CCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
...+. .....+..+.+++.+||..||.+|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 22222 2234577899999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.21 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=189.6
Q ss_pred eEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||.|+++.++. .+|..||||++... .+.+.+|+++++.++||||+++++.+.+. ...|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 67889999998665554 37899999988532 24578899999999999999999988643 78999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++++|.+++... ....+++..+..++.|++.||.|||+++++||||+|+||+++.++ .++|+|||++.
T Consensus 79 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-------~~~l~df~~~~ 147 (283)
T cd07835 79 FLDLDLKKYMDSS----PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-------ALKLADFGLAR 147 (283)
T ss_pred ccCcCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-------cEEEeeccccc
Confidence 9988999998752 224689999999999999999999999999999999999998877 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||....... .........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~ 216 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGS--------RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTL 216 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecC--------cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 6543211 11223457789999988542 246889999999999999999999997654321 111111110
Q ss_pred C---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 E---------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~---------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. ........+..+.++|.+||+.||.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 001123456789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.95 Aligned_cols=240 Identities=24% Similarity=0.437 Sum_probs=194.1
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+|++.+.||+|+++.++.. +|..|++|++... ...+.+|+++++.++|+||+++++.+... ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEec
Confidence 5889999999986655542 5889999998653 35688999999999999999999988654 678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||.+.
T Consensus 79 ~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------~~~l~d~~~~~ 146 (253)
T cd05122 79 CSGGSLKDLLKST-----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-------EVKLIDFGLSA 146 (253)
T ss_pred CCCCcHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-------eEEEeeccccc
Confidence 985 999988752 25689999999999999999999999999999999999998877 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... .....++..|++||++.+. .++.++||||||+++|+|++|..||........ .. .....
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~-~~~~~ 212 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGK---------PYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LF-KIATN 212 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HH-HHHhc
Confidence 7654321 2344577789999998644 378899999999999999999999986543221 21 22223
Q ss_pred CCCCCCCCC--cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~~~~p~~~--~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+..+... +..+.+++.+||..||++|||+.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 333333333 7889999999999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=305.72 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=193.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++.+.||+|+++.++.. +|+.||||.+.. ....+.+|+.+++.+ +||||++++++|...+...+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 358999999999987665542 578999998743 234577899999999 999999999988665556789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 86 lv~e~~~~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-------~~kl~d~ 151 (337)
T cd07852 86 LVFEYMETDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-------RVKLADF 151 (337)
T ss_pred EEecccccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------cEEEeec
Confidence 9999999999998874 2688999999999999999999999999999999999999888 7999999
Q ss_pred cCccccCCCCCC---CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 383 GLSSVKNFGPKS---PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 383 Gla~~~~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|++......... .......+++.|+|||++.+. ..++.++||||||+++|+|++|+.||.+..... ..
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~ 222 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGS--------TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QL 222 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeecc--------ccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HH
Confidence 999866433211 122234578889999988532 247789999999999999999999997643221 11
Q ss_pred HHHHHc--------------------------CCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRA--------------------------GERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~--------------------------~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.+.. .... ......+.++.++|.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 111110 0000 1112357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.33 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=191.8
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC-----
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----- 297 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----- 297 (683)
..++|++.+.||+|+++.+++. +|+.||||.+... ...+.+|+.+++.++||||+++++.+.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3468999999999987666642 5789999998532 235678999999999999999998886532
Q ss_pred ---CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 298 ---KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 298 ---~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
...+|+||||++++|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+||+++.++
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~------ 153 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLES-----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG------ 153 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------
Confidence 237899999999998888864 234689999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||++......... ......++..|+|||++.+. ..++.++|||||||++|||++|+.||.....
T Consensus 154 -~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 154 -QIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGE--------ERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred -cEEeCcccccccccCCccc-ccccceeccCccChHHhcCC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 7999999999876543211 11223456789999998543 2467899999999999999999999976543
Q ss_pred chhHHHHHHHc---CCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 QGDKMSRNIRA---GERP--------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ~~~~~~~~i~~---~~~~--------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. .+ ..+.. ...+ ......+..+.+++.+||..||.+||++.+++.+
T Consensus 224 ~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 224 LA-QL-ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HH-HH-HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21 11 11111 1000 0012357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.15 Aligned_cols=242 Identities=22% Similarity=0.390 Sum_probs=193.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++.+.||+|+++.++.. ++..||+|.+.. ..+.+.+|+.+++.++||||+++++.+... ...|+|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEEEe
Confidence 58999999999987666542 678899999853 234678899999999999999999988654 67899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 97 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-------~~kL~dfg~~ 162 (293)
T cd06647 97 YLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGFC 162 (293)
T ss_pred cCCCCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-------CEEEccCcce
Confidence 9975 99999875 3578999999999999999999999999999999999998877 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... .+. .+..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~-~~~~ 229 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALY-LIAT 229 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-hee-ehhc
Confidence 76543221 22234578889999998643 47889999999999999999999997654321 111 1111
Q ss_pred CCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+.+ +...+..+.+++.+||..+|++||++.+++.|-.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 222222 2345678999999999999999999999988743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.59 Aligned_cols=237 Identities=21% Similarity=0.280 Sum_probs=182.8
Q ss_pred EecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHHHHH---cCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 242 RLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEISSLL---SLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 242 ~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~iL~---~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.||+|+++.+++ .+|+.||||.+... ...+.+|..++. ..+||||+.+++.+..+ +.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 378998777664 25789999988432 122344544443 34799999999888644 678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 79 ~~~~~L~~~i~~------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-------~~~l~dfg~~~ 145 (279)
T cd05633 79 MNGGDLHYHLSQ------HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLAC 145 (279)
T ss_pred CCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-------CEEEccCCcce
Confidence 985 99988875 25699999999999999999999999999999999999998887 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
..... ......|+..|+|||++... ..++.++|||||||++|+|++|..||.................
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 213 (279)
T cd05633 146 DFSKK----KPHASVGTHGYMAPEVLQKG--------TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213 (279)
T ss_pred ecccc----CccCcCCCcCccCHHHhcCC--------CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc
Confidence 55322 12234678899999998532 2478899999999999999999999976443322222222333
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
.....+...+.++.++|.+||..||.+|| |+.++++|..
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 34446667889999999999999999999 5888877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=322.39 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=183.3
Q ss_pred CCeEEEeEecccccEEEEEE-----cCcEEEEE------------------EeCC---CcchHHHHHHHHHcCCCCceee
Q 038696 235 EDYQVRRRLGSGSQYKEILW-----LGESFALR------------------HFFG---DIEPLVPEISSLLSLSHPNIMH 288 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK------------------~~~~---~~~~~~~Ei~iL~~L~HpnIv~ 288 (683)
++|++++.||+|+|+.|++. .+..+++| .+.. ....+.+|+.+|+.++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999998888753 12222222 1111 1235789999999999999999
Q ss_pred eeeeEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 289 FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
+++++.++ ...|+|||++.++|.+++...... .........+..|+.||+.||.|||++||+||||||+|||++.++
T Consensus 228 l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 228 IEEILRSE--ANTYMITQKYDFDLYSFMYDEAFD-WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred EeEEEEEC--CeeEEEEeccccCHHHHHhhcccc-ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99998654 678999999999999988652211 112344677889999999999999999999999999999998887
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC-
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV- 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~- 447 (683)
.+||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 305 -------~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 305 -------KIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGD---------GYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred -------CEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCC---------CCCcHHHHHHHHHHHHHHHHCCCC
Confidence 799999999987653321 122345789999999999754 48899999999999999999875
Q ss_pred CCCCCccc-hhHHHHHHHcCC---------------------CCCC---------CCCCcHHHHHHHHHhhhcCCCCCCC
Q 038696 448 PFEDAHLQ-GDKMSRNIRAGE---------------------RPLF---------PFHSPKYVTNLTKRCWHADPNQRPS 496 (683)
Q Consensus 448 Pf~~~~~~-~~~~~~~i~~~~---------------------~~~~---------p~~~~~~l~~Li~~cL~~dP~~RPt 496 (683)
||...... ...+.+.+.... .... ....+.++.++|.+||+.||.+|||
T Consensus 368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps 447 (501)
T PHA03210 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG 447 (501)
T ss_pred CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence 44332211 112222111100 0000 1123556788899999999999999
Q ss_pred HHHHHHHHH
Q 038696 497 FSSICRILR 505 (683)
Q Consensus 497 ~~eil~~L~ 505 (683)
+.+++.|-+
T Consensus 448 a~elL~hp~ 456 (501)
T PHA03210 448 AAELLALPL 456 (501)
T ss_pred HHHHhhChh
Confidence 999987644
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=299.42 Aligned_cols=241 Identities=18% Similarity=0.334 Sum_probs=190.7
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
|.....||+|+++.++.. +|..||||.+.. ..+.+.+|+.++..++||||+++++.+..+ ..+|+||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEecC
Confidence 444557899987666542 688999999842 245678999999999999999999988654 6899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 101 ~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-------~~kL~dfg~~~~ 166 (297)
T cd06659 101 QGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-------RVKLSDFGFCAQ 166 (297)
T ss_pred CCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-------cEEEeechhHhh
Confidence 85 88887754 4589999999999999999999999999999999999998887 799999999875
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
...... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~ 233 (297)
T cd06659 167 ISKDVP--KRKSLVGTPYWMAPEVISRT---------PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSP 233 (297)
T ss_pred cccccc--cccceecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccC
Confidence 533211 22335678889999999654 4788999999999999999999999764422 2223333222
Q ss_pred CC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 468 RP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 468 ~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.. ..+...+..+.+++.+||+.+|++||++.+++++-..
T Consensus 234 ~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 234 PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 11 1234567889999999999999999999999887443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.52 Aligned_cols=238 Identities=24% Similarity=0.322 Sum_probs=182.0
Q ss_pred EecccccEEEEEE-----------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 242 RLGSGSQYKEILW-----------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 242 ~LG~G~~~~v~l~-----------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.||.|+++.|+.. ....||+|.+... .+.+..|+.+++.++||||+++++.+... ...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEEEe
Confidence 5889886555532 1234888887532 35678899999999999999999988654 56899999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC-CCCcceEEEecccC
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS-TEGYLHAKISGFGL 384 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~-~~~~~~vKL~DFGl 384 (683)
|++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. ......++++|||+
T Consensus 80 ~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 80 YVKFGSLDTYLKKN-----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred cCCCCcHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 998 5999999752 3468999999999999999999999999999999999999877521 01223489999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC-CCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG-KVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG-~~Pf~~~~~~~~~~~~~i 463 (683)
+..... .....+++.|+|||++.+. ..++.++||||||+++|||++| ..||....... .....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~ 218 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENP--------QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFY 218 (258)
T ss_pred ccccCC------chhccccCCccCchhccCC--------CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHH
Confidence 865432 1224567789999999642 2478899999999999999998 46665543221 11111
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.....+|.....++.+|+.+||+.||++|||+.++++.|
T Consensus 219 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 --EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 123345666678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.54 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=191.0
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC-----cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD-----IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|+..+.||+|+++.++. .+|+.||||.+... ...+.+|+.++.++. |+||+++++++..+ ...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 4677888999998766664 26789999998532 345788999999996 99999999988654 678999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.++|.++...... .....+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 82 ~e~~~~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-------~~kl~dfg 153 (288)
T cd06616 82 MELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-------NIKLCDFG 153 (288)
T ss_pred EecccCCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-------cEEEeecc
Confidence 99998776665432110 1235699999999999999999999975 999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++...... ......+++.|+|||++.+.. ...++.++|||||||++|+|++|+.||.........+ ..+
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~ 223 (288)
T cd06616 154 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSA------RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-TQV 223 (288)
T ss_pred hhHHhccCC---ccccccCccCccCHHHhcccc------ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH-hhh
Confidence 997654321 112335778899999986431 1258889999999999999999999997644211111 222
Q ss_pred HcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+..+..+ ..++..+.+|+.+||+.||++|||+.+|+++-.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 222222222 246788999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.24 Aligned_cols=242 Identities=29% Similarity=0.416 Sum_probs=200.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.+++. +|+.+|||.+.. ....+.+|+++++.++|+||+++++++.+. ..+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 5899999999986666542 678999999853 234577899999999999999999888654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.... .....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||+
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-------~~kl~d~g~ 149 (256)
T cd08530 79 EYAPFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-------LVKIGDLGI 149 (256)
T ss_pred hhcCCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-------cEEEeeccc
Confidence 99985 9999987632 1235689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+...... ......+++.|++||.+.+. .++.++|+||||+++|+|++|+.||..... ..+...+.
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 214 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGR---------PYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQ 214 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 9776543 22234577889999998654 478899999999999999999999987653 23455566
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+..+...+.++.+++.+||..+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 666666667788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=288.81 Aligned_cols=249 Identities=19% Similarity=0.367 Sum_probs=183.2
Q ss_pred EecccccEEEEE---EcC---cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-
Q 038696 242 RLGSGSQYKEIL---WLG---ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS- 309 (683)
Q Consensus 242 ~LG~G~~~~v~l---~~g---~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~- 309 (683)
.||+|+++.+++ .++ ..+++|.+... .+.+.+|+.+++.++||||+++++.+.+ ....|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCC
Confidence 589998766664 233 24667766432 3568899999999999999999998864 367899999998
Q ss_pred CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 310 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
|+|.+++.+... ....++...+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++....
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-------~~~l~Dfg~~~~~~ 150 (268)
T cd05086 80 GDLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-------TVKVGDYGIGPSRY 150 (268)
T ss_pred CcHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-------cEEecccccccccC
Confidence 599999976321 123467778889999999999999999999999999999998877 79999999986432
Q ss_pred CCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCC-
Q 038696 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGE- 467 (683)
Q Consensus 390 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~- 467 (683)
............++..|+|||++...... .....++.++||||||+++|||++ |..||...... +.+...+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~ 227 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGG--LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQV 227 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCc--cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhccc
Confidence 22111222345677889999998542110 012346789999999999999997 67788754432 22222222221
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 468 ---RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 468 ---~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+..+...+..+.+++..|| .+|++||++.+|++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 23344456788999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.53 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=189.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE------ 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~------ 297 (683)
.++|++.+.||+|+++.+++. +|+.||||.+.. ....+.+|+++++.++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 369999999999987666642 678999998842 1235788999999999999999998775432
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...+|+||||+.++|...+.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~-----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-------~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-------IL 154 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------CE
Confidence 235799999999998888764 235699999999999999999999999999999999999999887 79
Q ss_pred EEecccCccccCCCCCCC---------CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCC
Q 038696 378 KISGFGLSSVKNFGPKSP---------SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~---------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~P 448 (683)
||+|||++.......... ......+++.|+|||++.+. ..++.++|||||||++|||++|++|
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--------RRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--------CccCchhHhHHHHHHHHHHHhCCCC
Confidence 999999997654322111 11223567889999998642 2478899999999999999999999
Q ss_pred CCCCccchhHHHHHHHcCCC------------C---------CCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGER------------P---------LFP-------FHSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~------------~---------~~p-------~~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
|.+.+... ........... + ..+ ......+.+++.+||..||.+|||+.++
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 227 LQGKSDID-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCHHH-HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 97654321 11111110000 0 000 1223568899999999999999999998
Q ss_pred HHH
Q 038696 501 CRI 503 (683)
Q Consensus 501 l~~ 503 (683)
+.+
T Consensus 306 l~~ 308 (311)
T cd07866 306 LEH 308 (311)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.07 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=191.3
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||+|+++.+++. +|+.||||.+... ...+.+|+.+++.++|+||+++++.+.+...+.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999987666653 5789999999643 235788999999999999999999886543468999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-------~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDHDLTGLLDS-----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-------VLKLADFGLAR 148 (287)
T ss_pred cccccHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-------CEEEcccccee
Confidence 999999998874 224689999999999999999999999999999999999999887 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...... ..+.......
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~ 218 (287)
T cd07840 149 PYTKRNS-ADYTNRVITLWYRPPELLLGA--------TRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELC 218 (287)
T ss_pred eccCCCc-ccccccccccccCCceeeEcc--------ccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence 7654321 112234567789999987543 24788999999999999999999999765422 1111111100
Q ss_pred CCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ERP-----------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~~-----------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+ .+...++..+.+++++||..||.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 0111137788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=284.81 Aligned_cols=244 Identities=29% Similarity=0.483 Sum_probs=201.5
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||.|+++.++.. ++..||+|.+.. ....+.+|+++++.++|+|++++++.+... ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 5899999999987666642 588999999853 234678999999999999999999988654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++..... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus 79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-------~~~l~d~~~ 149 (258)
T cd08215 79 EYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-------LVKLGDFGI 149 (258)
T ss_pred EecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-------cEEECCccc
Confidence 99985 99999986311 236799999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+.
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 216 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNK---------PYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKIL 216 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccC---------CCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHh
Confidence 97764432 122334678889999998654 478899999999999999999999976542 23444455
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.......+...+..+.+++.+||..+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 555566677889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.12 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=194.3
Q ss_pred CCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC--CCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE--EKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e--~~~~~~ 302 (683)
++|++.+.||+|+++.++. .+|..||+|.+... .+.+.+|+.+|+.++||||++++++|... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999998766654 36889999998532 34577899999999999999998877532 335789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||+.|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 85 lv~e~~~~~l~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-------~~kl~df 151 (334)
T cd07855 85 VVMDLMESDLHHIIHS------DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-------ELRIGDF 151 (334)
T ss_pred EEEehhhhhHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------cEEeccc
Confidence 9999999999988863 34599999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 383 GLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 383 Gla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|++......... .......++..|+|||++.+. ..++.++|||||||++|||++|+.||.+..... .+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~ 222 (334)
T cd07855 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL--------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLK 222 (334)
T ss_pred ccceeecccCcCCCcccccccccccccChHHhcCC--------cccccccchHHHHHHHHHHHcCCCccCCCChHH-HHH
Confidence 999765432211 111234678889999998542 247889999999999999999999997654221 010
Q ss_pred H-----------------------HHHc-CCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 461 R-----------------------NIRA-GERPLF-----PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 461 ~-----------------------~i~~-~~~~~~-----p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
. .+.. ...... ....+.++.++|++||+.||.+|||+.+++.+.+.
T Consensus 223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0 0000 111111 13457889999999999999999999999887554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.66 Aligned_cols=240 Identities=26% Similarity=0.464 Sum_probs=197.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|++.+.||+|+++.++.. .|..||||.+... .+.+.+|+++++.++|+||+++++++.+. ..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 5889999999987666643 6789999998543 34688999999999999999999888653 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||+
T Consensus 79 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-------~~~l~d~~~ 145 (254)
T cd06627 79 EYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-------VVKLADFGV 145 (254)
T ss_pred ecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-------CEEEecccc
Confidence 99986 999998752 5689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+......... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... .......
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~ 212 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMS---------GASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIV 212 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCC---------CCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHh
Confidence 9876543221 2334577889999998644 3788999999999999999999999765422 1222233
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+.++...+..+.+++.+||..+|++|||+.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 445556677788999999999999999999999998753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.26 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=198.3
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++.+++.-||.|+.+.|+. .+|...|||.+.. +.+++...++++... ++|+||+.+++|..+ ..++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHH
Confidence 34667778899998776664 4789999999954 244566677766555 499999999999765 56889
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
.||+|.--+..+++. ...++++..+-++...++.||.||..+ ||||||+||+|||+|..| .+|||||
T Consensus 169 cMelMs~C~ekLlkr-----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-------niKlCDF 236 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKR-----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-------NIKLCDF 236 (391)
T ss_pred HHHHHHHHHHHHHHH-----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-------CEEeecc
Confidence 999998666666654 346799999999999999999999875 899999999999999999 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++-...... ......|-+.|||||.+.-. ...+|+-++||||||+.++||.||+.||.+....-+.+.+
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk- 306 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPP------DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK- 306 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCC------CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-
Confidence 9997765442 23344567789999999754 2557999999999999999999999999987765444444
Q ss_pred HHcCCCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRAGERPLFPFH--SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~--~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+....+|..+.. .++.+.+++..||..|+.+||.+.++++|-
T Consensus 307 vln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 307 VLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 444555665544 588999999999999999999999998763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.15 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=192.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC---CeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK---KEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~---~~~ 301 (683)
++|.+.+.||+|+++.++.. +|..||||.+.. ....+.+|+.+++.++|+||+++++++..... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 48999999999987666642 688999998853 23456789999999999999999987754321 358
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 302 ~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||||+.++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|
T Consensus 85 ~lv~e~~~~~L~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-------~~kL~D 151 (337)
T cd07858 85 YIVYELMDTDLHQIIRS------SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-------DLKICD 151 (337)
T ss_pred EEEEeCCCCCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-------CEEECc
Confidence 99999999999998874 25699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH---
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK--- 458 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~--- 458 (683)
||++....... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.......
T Consensus 152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 221 (337)
T cd07858 152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNC--------SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221 (337)
T ss_pred CccccccCCCc--ccccccccccCccChHHHhcC--------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence 99997654321 112234567889999998642 24788999999999999999999999764321100
Q ss_pred -------------------HHHHHHcCC---CC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 459 -------------------MSRNIRAGE---RP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 459 -------------------~~~~i~~~~---~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
....+.... .+ ......+..+.++|++||+.||++|||+.++++|-+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred HHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 000000000 00 012346788999999999999999999999998843
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=293.77 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=195.4
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCC-CCceeeeeeeEEcCCC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEK 298 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~ 298 (683)
.+.+..++|++.+.||+|+++.+++. +|..||||.+... ...+..|+.++..+. |+||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-- 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--
Confidence 34556679999999999987666542 3889999998632 234566777676664 99999999988653
Q ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||||++++|.+++... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-------~~ 154 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-------NV 154 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-------CE
Confidence 689999999998888877652 3478999999999999999999997 5999999999999998877 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||++....... ......++..|+|||++.+.. ....++.++||||||+++|+|++|+.||.......
T Consensus 155 kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~- 225 (296)
T cd06618 155 KLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPD-----PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF- 225 (296)
T ss_pred EECccccchhccCCC---cccCCCCCccccCHhhcCCCC-----CccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-
Confidence 999999987654321 112334677899999986442 12347889999999999999999999997643222
Q ss_pred HHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPF--HSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.....+.....+..+. .++.++.+++.+||..||.+||++.+++++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 2223333333232332 36888999999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=322.49 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=216.9
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE-------c----CcEEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeee
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW-------L----GESFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLC 291 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~-------~----g~~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~ 291 (683)
.|++..++..+.+.||+|.|++++.. . ...||||.++. +.+.+..|+++|+.+ .|+||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 79999888899999999998777742 1 34699999864 346789999999999 5999999999
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhc---CCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEIC---CPRKR-------IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~ 360 (683)
++.. ++.+++|+||+. |+|.+||++.. ..... ..++..+.+.++.||+.||+||+++++|||||..+
T Consensus 370 ~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 370 ACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 8865 578999999997 89999999753 00001 24899999999999999999999999999999999
Q ss_pred cEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCC-CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ-SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 361 NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~-~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
|||+..+. .+||+|||+|+........... ....-+..|||||.+... .|+.++||||||++|
T Consensus 448 NVLi~~~~-------~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~---------~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 448 NVLITKNK-------VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR---------VFTSKSDVWSFGILL 511 (609)
T ss_pred hEEecCCC-------EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC---------cccccchhhHHHHHH
Confidence 99998887 7999999999865443322211 111145679999999754 699999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|||++ |..||.+.... ..+.+.+..|.+...|..|+.++.++++.||+.+|++||+|.++.+.+...
T Consensus 512 ~EifsLG~~PYp~~~~~-~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPT-EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHhhCCCCCCCCCCcH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99999 99999985433 345678999999999999999999999999999999999999999988874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=289.34 Aligned_cols=235 Identities=25% Similarity=0.343 Sum_probs=185.0
Q ss_pred ecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||+|+++.++. .+|+.||+|.+.. ....+..|+++|+.++||||+++++.+.. .+.+|+||||++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 57888766664 3688999998842 13346789999999999999999988854 3689999999985
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++.....
T Consensus 79 ~L~~~l~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-------~~~l~dfg~~~~~~~ 147 (277)
T cd05577 79 DLKYHIYNV----GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-------NVRISDLGLAVELKG 147 (277)
T ss_pred cHHHHHHHc----CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-------CEEEccCcchhhhcc
Confidence 999998763 224689999999999999999999999999999999999998887 799999999876543
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--chhHHHHHHHcCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QGDKMSRNIRAGER 468 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~~~~~~~i~~~~~ 468 (683)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ....+...+. ...
T Consensus 148 ~~---~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 214 (277)
T cd05577 148 GK---KIKGRAGTPGYMAPEVLQGE---------VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMA 214 (277)
T ss_pred CC---ccccccCCCCcCCHHHhcCC---------CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-ccc
Confidence 21 22234567789999998644 378899999999999999999999976543 1122222222 223
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
...+...+..+.++|.+||+.||.+|| ++.+++.|
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 345566788999999999999999999 66666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=286.59 Aligned_cols=235 Identities=25% Similarity=0.365 Sum_probs=188.7
Q ss_pred ecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||.|+++.++. .++..||||.+.. ..+.+.+|+.+++.++||||+++++.+.+. ..+|+||||++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 57776544443 2488999999843 234688999999999999999999988543 679999999974
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 79 ~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-------~~~l~df~~~~~~~~ 145 (262)
T cd05572 79 ELWTILRDR------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-------YVKLVDFGFAKKLKS 145 (262)
T ss_pred cHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-------CEEEeeCCcccccCc
Confidence 999999752 4589999999999999999999999999999999999998887 799999999987654
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH-cCCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR-AGERP 469 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~-~~~~~ 469 (683)
.. ......++..|++||++.+. .++.++|+||||+++|+|++|..||.............+. .....
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 213 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNK---------GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213 (262)
T ss_pred cc---ccccccCCcCccChhHhcCC---------CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC
Confidence 32 12234577889999998644 4788999999999999999999999866532233333333 24455
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 470 LFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 470 ~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
.+|...+.++.++|.+||..||++||+ +.+++++-
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence 567777899999999999999999999 77777653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.24 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=190.9
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
|...++||+|+++.++.. +|..||||.+... ...+.+|+++++.++||||+++++++.+. ...|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 666788999987666653 6789999998521 23578899999999999999999988654 6789999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.|+|.+++.. ...++++.++..++.||+.||.|||++||+||||+|+||+++.++ .+||+|||++
T Consensus 101 e~~~~~l~~~l~~-----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-------~~kL~dfg~~ 168 (313)
T cd06633 101 EYCLGSASDLLEV-----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-------QVKLADFGSA 168 (313)
T ss_pred ecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-------CEEEeecCCC
Confidence 9999999888864 235689999999999999999999999999999999999998877 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
.... ......++..|+|||++... ....++.++|||||||++|+|++|..||...... .........
T Consensus 169 ~~~~------~~~~~~~~~~y~aPE~~~~~------~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~ 235 (313)
T cd06633 169 SKSS------PANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN 235 (313)
T ss_pred cccC------CCCCccccccccChhhcccc------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc
Confidence 6432 12234678889999998532 1234788999999999999999999999765432 222222222
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.........++..+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222334567789999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=309.00 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=198.1
Q ss_pred Ce-EEEeEecccccEEEEEE----cCcEEEEEEe------C--CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DY-QVRRRLGSGSQYKEILW----LGESFALRHF------F--GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y-~i~~~LG~G~~~~v~l~----~g~~vAvK~~------~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+| +....||+|+|-.||.. +|..||=-.+ + ...++|..|+.+|+.|+|||||++|+++.+..++.+-
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 44 45668999986555543 4555553222 1 2357899999999999999999999999988888899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK--KIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+|++. |+|..|+++. ..++...+..+++||+.||.|||++ .|||||||-+||+|+.+-. .|||
T Consensus 120 ~iTEL~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G------~VKI 187 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG------EVKI 187 (632)
T ss_pred eeeecccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC------ceee
Confidence 9999997 8999999974 5688889999999999999999987 6999999999999965521 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|+|||+..... ......|||-|||||+.... |+..+|||||||.|+||+|+..||...... .++
T Consensus 188 GDLGLAtl~r~s----~aksvIGTPEFMAPEmYEE~----------YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-AQI 252 (632)
T KOG0584|consen 188 GDLGLATLLRKS----HAKSVIGTPEFMAPEMYEEN----------YNELVDVYAFGMCMLEMVTSEYPYSECTNP-AQI 252 (632)
T ss_pred cchhHHHHhhcc----ccceeccCccccChHHHhhh----------cchhhhhhhhhHHHHHHHhccCChhhhCCH-HHH
Confidence 999999987543 33347899999999999743 999999999999999999999999876544 567
Q ss_pred HHHHHcCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 460 SRNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~~~~~~-~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
++.+..|..|. +..--.++++++|.+||.. ..+|+|+.+++.+-
T Consensus 253 YKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 253 YKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred HHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 78888887654 3333467899999999999 99999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=290.89 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=190.4
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.|...+.||+|+++.++. .+++.||||.+.. ..+.+.+|+.+++.++||||+++++.+... ...|+||||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence 455567899998655553 2678899998842 234578999999999999999999988643 678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+.| +|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++.
T Consensus 98 ~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~~l~d~g~~~ 163 (285)
T cd06648 98 LEGGALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-------RVKLSDFGFCA 163 (285)
T ss_pred cCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-------cEEEcccccch
Confidence 975 99998874 4589999999999999999999999999999999999998887 79999999887
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+...
T Consensus 164 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~ 230 (285)
T cd06648 164 QVSKEV--PRRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDN 230 (285)
T ss_pred hhccCC--cccccccCCccccCHHHhcCC---------CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhc
Confidence 553321 122234578889999998644 4788999999999999999999999764422 233344444
Q ss_pred CCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+.. +...+..+.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 32222 23367889999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=283.49 Aligned_cols=239 Identities=25% Similarity=0.372 Sum_probs=181.2
Q ss_pred eEecccccEEEEE---Ec-C----------cEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 241 RRLGSGSQYKEIL---WL-G----------ESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 241 ~~LG~G~~~~v~l---~~-g----------~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+.||+|+++.++. .. + ..|++|.+... ...+.+|+.+|+.++||||+++++.+.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR---DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec---CCcEE
Confidence 3689988655543 22 2 25888887542 4578899999999999999999988754 45799
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++...+....+||+||
T Consensus 78 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEcCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999998 5999999863 2368999999999999999999999999999999999999876522123346999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++..... .....++..|+|||++.+. ...++.++||||||+++|||++ |..||....... ...
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~-------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~ 217 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNG-------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KER 217 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCC-------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHH
Confidence 99976543 1223455679999998643 1247889999999999999999 688887654221 112
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
...... ..+......+.+++.+||..||.+|||+.++++.|
T Consensus 218 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 218 FYQDQH--RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHhcCC--CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 222221 12233347899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=298.32 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=189.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC-------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK------- 298 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~------- 298 (683)
..+|.+.+.||.|+++.+++. +|..||+|.+.. ..+.+.+|+++++.++||||+++++.+.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 358999999999997666643 688999998843 24567899999999999999999876654321
Q ss_pred -----CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 299 -----KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 299 -----~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
..+|+||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~---- 152 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL---- 152 (342)
T ss_pred cccccceEEEEeecccccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc----
Confidence 35799999999999988864 45899999999999999999999999999999999999975431
Q ss_pred cceEEEecccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 374 YLHAKISGFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||+++......... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||...
T Consensus 153 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 153 --VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--------NNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred --eEEECCcccceecCCccccccccccccccccccCHHHHhCc--------cccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 68999999997654321111 11223567789999987532 24788999999999999999999999765
Q ss_pred ccchhHHHHHHHc-----------------------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 453 HLQGDKMSRNIRA-----------------------GERPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 453 ~~~~~~~~~~i~~-----------------------~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+... .....+.. ..... .....+.++.+++.+||..||.+|||+.+++.+
T Consensus 223 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 223 HELE-QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CHHH-HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 4221 11111100 00000 112456789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=294.87 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=193.9
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
...|+..+.||+|+++.++. .+|..||||.+.. ...++.+|+++++.++|+||+++++++... ...|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeE
Confidence 34588888999998766664 2678899998742 123567899999999999999999888654 6789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||+.|+|.+++.. ...++++.++..++.|++.||.|||+.|++||||||+|||++.++ .+||+||
T Consensus 92 lv~e~~~~~l~~~~~~-----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-------~~kl~df 159 (308)
T cd06634 92 LVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDF 159 (308)
T ss_pred EEEEccCCCHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-------cEEECCc
Confidence 9999999999888764 235689999999999999999999999999999999999998877 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++...... ....+++.|+|||++.+.. ...++.++|||||||++|+|++|..||...... .....
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~ 225 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH 225 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcc------cCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHH
Confidence 998765321 2345678899999985421 224788999999999999999999999764322 12222
Q ss_pred HHcCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~-~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+..+. .+...+..+.+||.+||..+|++||++.+++++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 33333322 344678889999999999999999999999887544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=336.82 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=205.9
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+++-..+||.|.|++|+. .+|+..|||-++- ....+.+|..+|..|+|||+|++|++-.. +..++|.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHH
Confidence 667778899998888885 4899999998742 34567899999999999999999987654 36789999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||. |+|.+.+.. ..-.++.....|..|++.|+.|||+.|||||||||.||+|+.+| .+|++|||.
T Consensus 1314 EyC~~GsLa~ll~~------gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-------~iK~~DFGs 1380 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH------GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-------LIKYGDFGS 1380 (1509)
T ss_pred HHhccCcHHHHHHh------cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-------cEEeecccc
Confidence 9997 599998874 34477888889999999999999999999999999999999998 799999999
Q ss_pred ccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 385 SSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 385 a~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|..+...... .......||+.|||||++.+.. +.....++||||+|||+.||+||+.||...... -.+...
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~------~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~ 1453 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK------GKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYH 1453 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccc------cCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhH
Confidence 9876544211 1224678999999999997652 334567899999999999999999999765432 345567
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+..|..|.+|...+.+-.++|.+||..||++|.++.|++++
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 78899999999999999999999999999999999888765
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=290.97 Aligned_cols=245 Identities=24% Similarity=0.431 Sum_probs=196.0
Q ss_pred CCCeEEEeEecccccEEEEE---E-cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEIL---W-LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l---~-~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.+.|++.+.||+|+++.++. . ++..||+|.+... .+.+.+|+++++.++|+||+++++.+..+ ..+|+|||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 95 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVVME 95 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEEEEe
Confidence 45789999999998665553 2 5889999998643 45688999999999999999999988765 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ ++|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++
T Consensus 96 ~~~~~~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-------~~~l~d~~~~ 163 (286)
T cd06614 96 YMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-------SVKLADFGFA 163 (286)
T ss_pred ccCCCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-------CEEECccchh
Confidence 998 5999999863 13799999999999999999999999999999999999999887 7999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
........ ......++..|++||++.+. .++.++||||||+++|+|++|..||...... .....+..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~ 230 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRK---------DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITT 230 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 65543211 11233467789999998644 4788999999999999999999999765432 12222222
Q ss_pred CCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+.. +..++..+.++|.+||+.+|.+||++.+++++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 222222 2237889999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.41 Aligned_cols=236 Identities=21% Similarity=0.272 Sum_probs=183.0
Q ss_pred EecccccEEEEE----EcCcEEEEEEeCCC-------cchHHHHHH---HHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 242 RLGSGSQYKEIL----WLGESFALRHFFGD-------IEPLVPEIS---SLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 242 ~LG~G~~~~v~l----~~g~~vAvK~~~~~-------~~~~~~Ei~---iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.||+|+++.|+. .+|+.||||.+... ...+..|.. ++....||||+++++.+... ..+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 378988766664 35789999988431 112334443 34456799999999888644 689999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+.| +|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||++.
T Consensus 79 ~~g~~L~~~l~~------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-------~~kl~dfg~~~ 145 (278)
T cd05606 79 MNGGDLHYHLSQ------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLAC 145 (278)
T ss_pred CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-------CEEEccCcCcc
Confidence 985 89888864 25699999999999999999999999999999999999998877 79999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
..... ......|+..|+|||++.+. ..++.++||||||+++|||++|+.||.+...............
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 213 (278)
T cd05606 146 DFSKK----KPHASVGTHGYMAPEVLQKG--------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213 (278)
T ss_pred ccCcc----CCcCcCCCcCCcCcHHhcCC--------CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc
Confidence 55322 12234678899999998632 2478899999999999999999999987543222222222333
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 467 ERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 467 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
..+..+...+..+.+++.+||..||.+|| ++.+++++-
T Consensus 214 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 34556667789999999999999999999 899987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=286.21 Aligned_cols=245 Identities=24% Similarity=0.454 Sum_probs=192.1
Q ss_pred CeEEEeEecccccEEEEE---E--cCcEEEEEEeCC--------------CcchHHHHHHHHHc-CCCCceeeeeeeEEc
Q 038696 236 DYQVRRRLGSGSQYKEIL---W--LGESFALRHFFG--------------DIEPLVPEISSLLS-LSHPNIMHFLCGFTD 295 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l---~--~g~~vAvK~~~~--------------~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~ 295 (683)
+|++.+.||+|+++.++. . .+..+|||.+.. ...++..|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 488899999998655553 2 357899998742 12346778888865 799999999998854
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCC
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
...+++||||++| +|.+++.... .....+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~----- 151 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD----- 151 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-----
Confidence 4789999999985 9998886421 123568999999999999999999996 7899999999999998887
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
.+||+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 152 --~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 152 --KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE---------PYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred --cEEEecccceeeccccc---ccccccCcccCcChhhhcCC---------CCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 79999999998754332 22345678889999999643 47889999999999999999999997654
Q ss_pred cchhHHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.. .....+..+.....+ ...+..+.+++.+||+.||++||++.++..++.
T Consensus 218 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 ML--SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HH--HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 32 233333333333222 356788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.04 Aligned_cols=278 Identities=24% Similarity=0.326 Sum_probs=223.6
Q ss_pred CCCeEEEeEecccccEEEEEE--cCcE--EEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--LGES--FALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--~g~~--vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
-.+++++..||-|||+.|-+. .++. +|+|++++ ..+.+..|-+||..++.|+||++|-.|.++ +++|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhh
Confidence 348888999999999888763 4444 89998853 356788999999999999999999999654 8899
Q ss_pred EEEecC-CCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~-~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|+||-| +|.|...|++ ++.|...++..|+..+++|++|||++|||+|||||+|+|++.+| -+||.|
T Consensus 497 mLmEaClGGElWTiLrd------Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-------y~KLVD 563 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD------RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-------YLKLVD 563 (732)
T ss_pred hhHHhhcCchhhhhhhh------cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-------ceEEee
Confidence 999988 5699999985 47799999999999999999999999999999999999999998 699999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+|+.+..+.+ +...+||+.|.|||++.+++ .+.++|.||||+++|||++|.+||.+.+.. ..+.
T Consensus 564 FGFAKki~~g~K---TwTFcGTpEYVAPEIILnKG---------HD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn 629 (732)
T KOG0614|consen 564 FGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKG---------HDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYN 629 (732)
T ss_pred hhhHHHhccCCc---eeeecCCcccccchhhhccC---------cchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHH
Confidence 999999876543 34578999999999998775 889999999999999999999999986643 2344
Q ss_pred HHHcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHHHHhcCCCCCC--CCCCCCCCCCCchH
Q 038696 462 NIRAG-ERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRILRYIKRFIMMNPHYNS--QPDPPMPLVDYSDI 533 (683)
Q Consensus 462 ~i~~~-~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L~~i~~~~~~~~~~~~--~~~~~~~~~~~~~~ 533 (683)
.|..| ....+|...++...+||+++...+|.+|.. +.+|.+| .+|..+||.... ...||..+.-.++.
T Consensus 630 ~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH----~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 630 LILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH----RWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred HHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh----hhhhcCChhhhhhccCCCCccccCCCcc
Confidence 44444 344588889999999999999999999974 5666555 445556666432 22344333344556
Q ss_pred HHHHhhcCCCc
Q 038696 534 ESRLLRKFPSW 544 (683)
Q Consensus 534 ~~~~~~~~~~~ 544 (683)
+...++.++..
T Consensus 706 D~s~Fd~~p~d 716 (732)
T KOG0614|consen 706 DVSNFDNFPPD 716 (732)
T ss_pred cchhccCCCcc
Confidence 66777777764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=291.05 Aligned_cols=283 Identities=25% Similarity=0.406 Sum_probs=215.9
Q ss_pred hHHHHhhhcCCCCCCCCCcccceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC-CcchHHHHHHHHHc--C
Q 038696 207 LIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-DIEPLVPEISSLLS--L 281 (683)
Q Consensus 207 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-~~~~~~~Ei~iL~~--L 281 (683)
+.|. ...+..+||..|..+.-+.+++ .+..+.+.||+|.|+.|+. |.|+.||||+|.. +...+.+|.+|... |
T Consensus 185 l~Dl-l~~~~tSGSGSGlplLVQRTia-rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmL 262 (513)
T KOG2052|consen 185 LKDL-LDDLETSGSGSGLPLLVQRTIA-RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVML 262 (513)
T ss_pred HHHH-HHhhccCCCCCCchhHhHHhhh-heeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHh
Confidence 4444 3445567777776666555554 4899999999998666663 8999999999975 56678888888865 5
Q ss_pred CCCceeeeeeeEEcCC--CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q 038696 282 SHPNIMHFLCGFTDEE--KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-------- 350 (683)
Q Consensus 282 ~HpnIv~l~~~~~~e~--~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------- 350 (683)
+|+||+.|++.-..++ -.++|||++|.+ |+|+|||.. ..++.+..+++++.++.||++||..
T Consensus 263 RHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 263 RHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred ccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 9999999986433222 247999999998 899999985 6799999999999999999999953
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCc
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSE 428 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ 428 (683)
.|.|||||..||||..++ .+-|+|+|||........ ....+..+||-+|||||++...-+..-| .--.
T Consensus 336 aIAHRDlKSKNILVKkn~-------~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~F---esyk 405 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNG-------TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHF---ESYK 405 (513)
T ss_pred hhhccccccccEEEccCC-------cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhh---hhhh
Confidence 599999999999999998 899999999977655421 2244567899999999999765332222 1224
Q ss_pred hhHHHhHHHHHHHHHhC----------CCCCCCCcc---chhHHHHHH-HcCCCCCCCCCCc-----HHHHHHHHHhhhc
Q 038696 429 KSDVYSFGMICFEILTG----------KVPFEDAHL---QGDKMSRNI-RAGERPLFPFHSP-----KYVTNLTKRCWHA 489 (683)
Q Consensus 429 ksDVwSlGvil~ElltG----------~~Pf~~~~~---~~~~~~~~i-~~~~~~~~p~~~~-----~~l~~Li~~cL~~ 489 (683)
.+||||||.|+||++.. .+||.+... +.+++.+.+ ....+|.+|..+. ..+..||+.||..
T Consensus 406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~ 485 (513)
T KOG2052|consen 406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA 485 (513)
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC
Confidence 69999999999999863 468876432 334455443 3455666665542 4578899999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 038696 490 DPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 490 dP~~RPt~~eil~~L~~i~ 508 (683)
||.-|.|+-.|.+.|.++.
T Consensus 486 Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 486 NPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CchhhhHHHHHHHHHHHHh
Confidence 9999999988888777764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.47 Aligned_cols=242 Identities=19% Similarity=0.300 Sum_probs=191.8
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+-.+...-|-.++.||-|+|+.|.+. +...+|+|.+.+ ....+..|.+||..-+++.||+||+.|+|.
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 333444557889999999999888874 456799998743 355678999999999999999999999754
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..+|+||+|++| |+..+|.+. +-|.+..+..|+.++..|+++.|.+|+|||||||+|||||.+|
T Consensus 702 --dnLYFVMdYIPGGDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG------- 766 (1034)
T KOG0608|consen 702 --DNLYFVMDYIPGGDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG------- 766 (1034)
T ss_pred --CceEEEEeccCCccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-------
Confidence 789999999985 999998863 6699999999999999999999999999999999999999999
Q ss_pred eEEEecccCccccCCCC--CC--------------------------------------CCCCCCCcCcccCChhhhhhc
Q 038696 376 HAKISGFGLSSVKNFGP--KS--------------------------------------PSQSGTTHPFIWHAPEVLEEN 415 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~--~~--------------------------------------~~~~~~~gt~~Y~APEvl~~~ 415 (683)
+|||+|||||+-+.... +. ......+||+.|+|||++...
T Consensus 767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~ 846 (1034)
T KOG0608|consen 767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART 846 (1034)
T ss_pred ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence 99999999997442110 00 001256799999999999765
Q ss_pred cccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH--cCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 038696 416 EQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR--AGERPLFPFHSPKYVTNLTKRCWHADPNQ 493 (683)
Q Consensus 416 ~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~--~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 493 (683)
+ |+..+|+||.|||||||+.|++||-..+..+. ..+.+. ......+..+.++++.+||.++ ..+++.
T Consensus 847 g---------~~q~cdwws~gvil~em~~g~~pf~~~tp~~t-q~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~ 915 (1034)
T KOG0608|consen 847 G---------YTQLCDWWSVGVILYEMLVGQPPFLADTPGET-QYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADS 915 (1034)
T ss_pred C---------ccccchhhHhhHHHHHHhhCCCCccCCCCCcc-eeeeeehhhccccccccccCHHHHHHHHHH-hcChhh
Confidence 4 89999999999999999999999987664432 222222 2222334456788888988874 457888
Q ss_pred CC
Q 038696 494 RP 495 (683)
Q Consensus 494 RP 495 (683)
|.
T Consensus 916 RL 917 (1034)
T KOG0608|consen 916 RL 917 (1034)
T ss_pred hh
Confidence 86
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.23 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=191.5
Q ss_pred CeEEEeEecccccEEEEE-------EcCcEEEEEEeCC--------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 236 DYQVRRRLGSGSQYKEIL-------WLGESFALRHFFG--------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l-------~~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+|++.+.||+|+++.++. .+|..||+|++.. ..+.+.+|+++|..+ +|+||++++++|..+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 589999999998766654 2678999999853 134578899999999 599999999888543 6
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||++| +|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+|||++.++ .+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-------~~k 145 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-------HVV 145 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-------CEE
Confidence 78999999985 99999975 24688999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--h
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--G 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~ 456 (683)
|+|||++........ .......|+..|+|||++.+. ...++.++||||||+++|+|++|..||...... .
T Consensus 146 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 217 (290)
T cd05613 146 LTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGG-------DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217 (290)
T ss_pred EeeCccceecccccc-cccccccCCcccCChhhccCC-------CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence 999999976543221 122234578889999998642 123678899999999999999999999643221 1
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+...+... .+.++..++..+.+++.+||..||++|| ++.+++.+
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 218 AEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2233333333 3345667888999999999999999997 56666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.22 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=191.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC----C
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK----K 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~----~ 299 (683)
.++|++.+.||+|+++.++.. +|..||||.+... .+.+.+|+.+|+.++||||+++++++..+.. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 458999999999987666643 6889999998532 2357789999999999999999998865322 2
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+++||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||
T Consensus 94 ~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-------~~kl 159 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-------ELKI 159 (343)
T ss_pred eEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------CEEE
Confidence 5699999998899888763 4689999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++...... .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+..... ..
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~ 225 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNW--------MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QL 225 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999765322 1234567889999998642 247889999999999999999999997654221 11
Q ss_pred HHHHHcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 460 SRNIRAGER-----------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 460 ~~~i~~~~~-----------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+..... .......+..+.++|.+||+.||.+|||+.+++.+-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 111110000 0012345677999999999999999999999987633
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=285.17 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=196.4
Q ss_pred eEecccccEEEE----EEcCcEEEEEEeCC----CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCC-C
Q 038696 241 RRLGSGSQYKEI----LWLGESFALRHFFG----DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMS-R 310 (683)
Q Consensus 241 ~~LG~G~~~~v~----l~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~-g 310 (683)
..||+|+...|. +.+|..+|||++.+ ...++.+|++++.+++ |+||++++++|.++ ..+|||||-|. |
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence 468999854444 46899999999954 3567899999999996 99999999999654 78999999997 5
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
.|.++|.+ +..|++.++..+..+|+.||.|||.+||.||||||+|||-...+ .-.-|||+||.|......
T Consensus 162 plLshI~~------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn----~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 162 PLLSHIQK------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN----KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred hHHHHHHH------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC----CcCceeeecccccccccc
Confidence 99999986 36799999999999999999999999999999999999985443 223589999999765433
Q ss_pred CC-----CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc----------
Q 038696 391 GP-----KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ---------- 455 (683)
Q Consensus 391 ~~-----~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~---------- 455 (683)
.. ........+|+..|||||+..-.-. ....|+.++|.||||||+|-|++|.+||.+....
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~----qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVD----QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhcc----ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 22 1122335667888999999754321 2346999999999999999999999999875422
Q ss_pred ---hhHHHHHHHcCCCCCCCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 456 ---GDKMSRNIRAGERPLFPF---HSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 456 ---~~~~~~~i~~~~~~~~p~---~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
...++..|..|....... .++.+..+|+..+|..|+.+|.++.+++.|-
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 135677788886543222 2477889999999999999999988887653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.88 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=190.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
...++|++.+.||.|+++.+++. +|+.||||.+.. ..+.+..|+.+++.++||||++++++|... ...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcE
Confidence 34678999999999987777653 788999998742 235678999999999999999999988643 3578
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 302 ~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|+||||++++|.++++. .++++..+..++.|++.||.|||++||+||||+|+|||++.++ .+||+|
T Consensus 86 ~lv~e~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-------~~~l~d 151 (328)
T cd07856 86 YFVTELLGTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-------DLKICD 151 (328)
T ss_pred EEEeehhccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-------CEEeCc
Confidence 99999998899988864 4588899999999999999999999999999999999998877 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh----
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD---- 457 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~---- 457 (683)
||++...... .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||........
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTW--------QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeecc--------CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9998754321 1233567789999987532 2478999999999999999999999976432110
Q ss_pred ---------HHHH---------HHHc-CCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 ---------KMSR---------NIRA-GERPLF-----PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ---------~~~~---------~i~~-~~~~~~-----p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... .+.. ...... ....+..+.++|.+||+.+|++|||+.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 000001 12456889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=325.11 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=187.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcC---------
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDE--------- 296 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e--------- 296 (683)
.+|+.+..||+|||+.|++. +|+.||||++.- ....+.+|+.+|.+|+|||||++|..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 47888999999999888864 899999999842 234578999999999999999998522110
Q ss_pred -------------------------------------------------------------------CC-----------
Q 038696 297 -------------------------------------------------------------------EK----------- 298 (683)
Q Consensus 297 -------------------------------------------------------------------~~----------- 298 (683)
+.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 00
Q ss_pred ------------------------------CeEEEEEecCCCCHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHH
Q 038696 299 ------------------------------KECFLIMELMSRDLCSYIKEICCPRKRIPF--SLPVAVDLMLQIARGMEY 346 (683)
Q Consensus 299 ------------------------------~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~y 346 (683)
..+||-||||+.+|..++... ..+ ....++++++||++||.|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~------N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR------NHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh------cccchhhHHHHHHHHHHHHHHHH
Confidence 247899999998555544431 123 367889999999999999
Q ss_pred HHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC----------------CCCCCCCCCCCCcCcccCChh
Q 038696 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN----------------FGPKSPSQSGTTHPFIWHAPE 410 (683)
Q Consensus 347 LH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~APE 410 (683)
+|++|||||||||.||+++.++ .|||+|||+|+... .+.......+.+||..|+|||
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~-------~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRN-------SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCC-------CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 9999999999999999999887 79999999998721 011122345778999999999
Q ss_pred hhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCC---CCCCcHHHHHHHHHhh
Q 038696 411 VLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLF---PFHSPKYVTNLTKRCW 487 (683)
Q Consensus 411 vl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~Li~~cL 487 (683)
++.+.. +..|+.|+|+||||||++||+. ||... +....+..+++.+..|.. .....+.-..+|+.|+
T Consensus 786 ll~~~~------~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 786 LLSDTS------SNKYNSKIDMYSLGIVLFEMLY---PFGTS-MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred Hhcccc------cccccchhhhHHHHHHHHHHhc---cCCch-HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 997652 3479999999999999999995 46543 333445556665554443 2223344678999999
Q ss_pred hcCCCCCCCHHHHHH
Q 038696 488 HADPNQRPSFSSICR 502 (683)
Q Consensus 488 ~~dP~~RPt~~eil~ 502 (683)
+.||.+|||+.+++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.75 Aligned_cols=242 Identities=25% Similarity=0.369 Sum_probs=190.3
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||+|+++.++.. +|+.+|+|.+... ...+.+|+.+|+.++|+||+++++.+.+. ..+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 677889999987666543 6889999998542 24578899999999999999999888544 78999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .+||+|||.+.
T Consensus 79 ~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-------~~~l~df~~~~ 146 (283)
T cd05118 79 FMDTDLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-------VLKLADFGLAR 146 (283)
T ss_pred ccCCCHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-------cEEEeeeeeeE
Confidence 9999999988752 25789999999999999999999999999999999999998877 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...+.. +.+.......
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~--------~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~ 215 (283)
T cd05118 147 SFGSPVR--PYTHYVVTRWYRAPELLLGD--------KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTL 215 (283)
T ss_pred ecCCCcc--cccCccCcccccCcHHHhcC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHc
Confidence 7654321 11234567789999998643 24788999999999999999999999765432 1111111110
Q ss_pred CCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ERP----------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~~----------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+ ......+.++.++|.+||+.||.+||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0112356789999999999999999999999764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.73 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=196.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~ 302 (683)
++|.+.+.||.|+++.++.. +|..||+|++.. ..+.+.+|+.++..++ |+||+++++++.+ .+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 47999999999987666642 688999999853 1345788999999998 9999999988854 47899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||+. ++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|
T Consensus 79 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-------~~~l~d 145 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-------HIKITD 145 (280)
T ss_pred EEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-------CEEecC
Confidence 9999996 5999999862 4699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCC------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 382 FGLSSVKNFGPKS------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 382 FGla~~~~~~~~~------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
||++......... .......++..|+|||++... .++.++||||||+++++++
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~~l~ 216 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------PAGKSSDLWALGCIIYQML 216 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC---------CCChhhhHHHHHHHHHHHH
Confidence 9998765433211 112234567889999998643 4788999999999999999
Q ss_pred hCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 038696 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF----SSICRI 503 (683)
Q Consensus 444 tG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~----~eil~~ 503 (683)
+|..||...... .....+.. ....++...++.+.+++.+||+.||++||++ .++++|
T Consensus 217 ~g~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 217 TGKPPFRGSNEY--LTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred hCCCCCCCccHH--HHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 999999875522 22333332 2334667778999999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.81 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=185.4
Q ss_pred eEEEeEecccccEEEEE--EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 237 YQVRRRLGSGSQYKEIL--WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
|.+.+.+|.|++..++. .+|+.||||++... .+.+..|+++++.++|+||++++++|.+. ..+|++|||+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~ 81 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLM 81 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEecc
Confidence 34455555555443333 36899999998532 35688999999999999999999988654 6789999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||.+..
T Consensus 82 ~~~~l~~~l~~~----~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-------~~kl~d~~~~~~ 150 (314)
T cd08216 82 AYGSCEDLLKTH----FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-------KVVLSGLRYSVS 150 (314)
T ss_pred CCCCHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-------ceEEecCcccee
Confidence 8 5899998763 234588999999999999999999999999999999999999877 799999999875
Q ss_pred cCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 388 KNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 388 ~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
....... .......++..|+|||++... ...++.++|||||||++|||++|..||........ ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~ 222 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN-------LQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEK 222 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 5322111 111233466789999999643 12378899999999999999999999986543221 1111
Q ss_pred HHcCCC--------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGER--------------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~--------------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..... .......+.++.+++.+||..||++|||+.+++++-..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 111000 00011123568899999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=293.62 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=189.6
Q ss_pred CCeE-EEeEecccccEEEEEE----cCcEEEEEEeCCCc------------------chHHHHHHHHHcCCCCceeeeee
Q 038696 235 EDYQ-VRRRLGSGSQYKEILW----LGESFALRHFFGDI------------------EPLVPEISSLLSLSHPNIMHFLC 291 (683)
Q Consensus 235 ~~y~-i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~------------------~~~~~Ei~iL~~L~HpnIv~l~~ 291 (683)
++|. +.+.||.|+++.+++. .|+.||||.+.... ..+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4665 4577999987666653 68899999885311 14678999999999999999999
Q ss_pred eEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
++..+ ...|+||||+.|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++
T Consensus 88 ~~~~~--~~~~lv~e~~~~~l~~~l~~------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--- 156 (335)
T PTZ00024 88 VYVEG--DFINLVMDIMASDLKKVVDR------KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--- 156 (335)
T ss_pred EEecC--CcEEEEEeccccCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC---
Confidence 88654 68999999999999999864 34589999999999999999999999999999999999998887
Q ss_pred CCcceEEEecccCccccCCCC------------CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 372 EGYLHAKISGFGLSSVKNFGP------------KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
.+||+|||++....... .........++..|+|||++.+. ..++.++|||||||++
T Consensus 157 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 157 ----ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--------EKYHFAVDMWSVGCIF 224 (335)
T ss_pred ----CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--------CCCCcHHHHHHHHHHH
Confidence 79999999997654111 01111233457789999998643 2468899999999999
Q ss_pred HHHHhCCCCCCCCccchhHHHHHHHcCC---CC-----------------------CCCCCCcHHHHHHHHHhhhcCCCC
Q 038696 440 FEILTGKVPFEDAHLQGDKMSRNIRAGE---RP-----------------------LFPFHSPKYVTNLTKRCWHADPNQ 493 (683)
Q Consensus 440 ~ElltG~~Pf~~~~~~~~~~~~~i~~~~---~~-----------------------~~p~~~~~~l~~Li~~cL~~dP~~ 493 (683)
|||++|..||.+.... +.+........ .. ......+..+.++|.+||+.||++
T Consensus 225 ~el~tg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 303 (335)
T PTZ00024 225 AELLTGKPLFPGENEI-DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303 (335)
T ss_pred HHHHhCCCCCCCCCHH-HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchh
Confidence 9999999999865432 11211111000 00 001234677899999999999999
Q ss_pred CCCHHHHHHHHH
Q 038696 494 RPSFSSICRILR 505 (683)
Q Consensus 494 RPt~~eil~~L~ 505 (683)
|||+.+++.+.+
T Consensus 304 R~s~~~~l~~~~ 315 (335)
T PTZ00024 304 RISAKEALKHEY 315 (335)
T ss_pred ccCHHHHhcCcc
Confidence 999999987643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.58 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=194.7
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC---CCeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE---KKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~---~~~~~ 302 (683)
+|++.+.||.|+++.+++. .|+.||||.+... .+.+.+|+.+++.++|+||+++++++.+.. ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999987666643 4789999988542 356889999999999999999998886542 23689
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+||
T Consensus 81 lv~e~~~~~l~~~l~~------~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-------~~~L~df 147 (330)
T cd07834 81 IVTELMETDLHKVIKS------PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-------DLKICDF 147 (330)
T ss_pred EEecchhhhHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------CEEEccc
Confidence 9999999999998874 24799999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
|++......... .......++..|+|||++.+.. .++.++||||||+++|+|++|..||.+..... .+..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~ 218 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS--------RYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNL 218 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeeccc--------CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH
Confidence 999876543210 1223446788899999986541 48889999999999999999999997654321 1111
Q ss_pred HHHcCCC------------------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 462 NIRAGER------------------------P-----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 462 ~i~~~~~------------------------~-----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
....... . ......+..+.++|.+||+.||.+|||+.+++.+-+
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 1110000 0 011235778999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.58 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=190.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC----C
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK----K 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~----~ 299 (683)
.++|++.+.||+|+++.+++. ++..||||++.. ..+.+.+|+.+++.++||||+++++++...+. .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 558999999999987666642 578999999853 12456789999999999999999887754321 3
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+||||++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-------~~kL 159 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-------ELKI 159 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------CEEE
Confidence 4899999998899998874 4699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++...... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.... ..+
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~ 225 (343)
T cd07851 160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQL 225 (343)
T ss_pred cccccccccccc-----ccCCcccccccCHHHHhCC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence 999999765432 2234567789999998642 24788999999999999999999999765432 111
Q ss_pred HHHHHcCC--------------------------CCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 460 SRNIRAGE--------------------------RPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~~~--------------------------~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
...+.... ... .....+..+.++|.+||+.||++|||+.+|+++-
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 11111000 000 0123477899999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=282.77 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=192.8
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
+|.+.+.||+|+++.+++. .+..+++|+++. ....+..|+.+++.++||||+++++.+.+. ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 5889999999997777642 344566666542 122466799999999999999999888543 6789
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||+++ +|.+++.+.. .....+++..+..++.|++.||.|||+.|++|+||||+||+++.+ .+||+|
T Consensus 79 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--------~~~l~d 148 (260)
T cd08222 79 IITEYCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--------LLKIGD 148 (260)
T ss_pred EEEEeCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--------CEeecc
Confidence 99999985 9998887532 123568999999999999999999999999999999999999753 499999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... .....
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~ 215 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQ---------GYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVL 215 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHH
Confidence 999876543221 22234567789999998644 377899999999999999999999976443 23344
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+..+..+...+.++.++|.+||..||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 455566666777788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=294.21 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=189.0
Q ss_pred eEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC--
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE-- 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~-- 297 (683)
|.+ .++|.+.+.||+|+++.++. .+|+.||||.+... ...+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 444 35899999999998766654 36889999998531 235789999999999999999998875432
Q ss_pred --CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 298 --KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 298 --~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
...+|+||||+.++|.+++. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~------- 154 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC------- 154 (342)
T ss_pred CCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------
Confidence 13579999999888876653 3589999999999999999999999999999999999999887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||+++..... .....++..|+|||++.+. ..++.++|||||||++|||++|+.||.+....
T Consensus 155 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 155 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNW--------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred CEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCc--------cccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7999999998764321 2234567889999998642 24788999999999999999999999865422
Q ss_pred hhHHHHHHHcC---------------------CCCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 456 GDKMSRNIRAG---------------------ERPLF--------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 456 ~~~~~~~i~~~---------------------~~~~~--------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .+...+... ..+.. ....+..+.++|.+||+.||.+||++.+++.|
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 222 D-QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred H-HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 111111100 00001 12356778999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.61 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=190.7
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++.+.||+|+++.++. .+|+.||||++... .+.+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 46899999999999776664 36889999998542 245778999999999999999998875421 24
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
..|+|+++++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------~~kl 161 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-------ELKI 161 (345)
T ss_pred cEEEEehhcccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-------CEEE
Confidence 5789999998899888763 3589999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++..... ......++..|+|||++.+. ..++.++|||||||++|||++|+.||....... ..
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~ 227 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QL 227 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCc--------cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 99999876432 12234577889999998642 247889999999999999999999997543211 11
Q ss_pred HHHHH-----------------------c-CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 460 SRNIR-----------------------A-GERPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 460 ~~~i~-----------------------~-~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+. . ...+. .....+..+.++|.+||+.||.+||++.+++++-..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 11000 0 00000 011346779999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=290.67 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=189.5
Q ss_pred CeEEEeEecccccEEEEEE----c--CcEEEEEEeCCC------cchHHHHHHHHHcC-CCCceeeeeeeEEc--CCCCe
Q 038696 236 DYQVRRRLGSGSQYKEILW----L--GESFALRHFFGD------IEPLVPEISSLLSL-SHPNIMHFLCGFTD--EEKKE 300 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~--g~~vAvK~~~~~------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--e~~~~ 300 (683)
+|++.+.||+|+++.+++. . +..||||.+... .+.+.+|+.+++.+ +||||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5899999999997776653 3 678999988532 34578899999999 59999999876432 22346
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|++|||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 81 ~~~~~e~~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-------~~kl~ 147 (332)
T cd07857 81 LYLYEELMEADLHQIIRS------GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-------ELKIC 147 (332)
T ss_pred EEEEEecccCCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-------CEEeC
Confidence 799999999999998864 35689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 381 GFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 381 DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|||+++........ .......||..|+|||++.+. ..++.++||||||+++|+|++|..||....... .
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~ 218 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF--------QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-Q 218 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-H
Confidence 99999865432211 112334678899999998642 247889999999999999999999997643210 0
Q ss_pred HHHHH-----------------------H---cCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 459 MSRNI-----------------------R---AGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 459 ~~~~i-----------------------~---~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+...+ . ...... .....+..+.+++.+||+.||.+|||+.+++.+-+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000 0 000011 11234678999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.44 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=192.2
Q ss_pred CCCeEEEeEecccccEEEE-----EEcCcEEEEEEeCCCcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEI-----LWLGESFALRHFFGDIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~-----l~~g~~vAvK~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.+.|++...+|.|+ |+++ ..++..+|||++.....+..+|+.++... +||||+++.+.+. +..+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs-~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGS-FSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCC-ccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceec--CCceeeeeehh
Confidence 56899999999996 3333 24788999999987767778899777766 6999999999884 55899999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe-CCCCCCCCCcceEEEecccCc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL-KPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl-~~~g~~~~~~~~vKL~DFGla 385 (683)
+.| -|.+.+.. .+....++..|++||+.|+.|||++|+|||||||+|||+ +..+ +++|+|||.+
T Consensus 398 l~g~ell~ri~~-------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-------~lrltyFG~a 463 (612)
T KOG0603|consen 398 LDGGELLRRIRS-------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-------HLRLTYFGFW 463 (612)
T ss_pred ccccHHHHHHHh-------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-------cEEEEEechh
Confidence 986 55555543 223337888899999999999999999999999999999 4666 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+..... .....-|..|.|||++...+ |++++||||||++||+|++|+.||.....+ .++...+..
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~---------yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~ 528 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPEVLAIQE---------YTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQM 528 (612)
T ss_pred hhCchh-----hcccchhhcccChhhhccCC---------CCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcC
Confidence 876543 12234567799999998654 999999999999999999999999875533 344444443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+ .+....+...++|+..||+.||.+|+++.++..|-+.
T Consensus 529 ~---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 P---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred C---ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3 3557789999999999999999999999999877543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=284.26 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=187.6
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCCc-----chHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGDI-----EPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~-----~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||+|+++.++.. +++.||||.+.... ....+|+..++.++ |+||+++++.+.+ ....|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 678899999987666642 57889999985432 23457999999999 9999999998855 478999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++|+|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.
T Consensus 79 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-------~~~l~d~~~~~ 147 (283)
T cd07830 79 YMEGNLYQLMKDR----KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-------VVKIADFGLAR 147 (283)
T ss_pred cCCCCHHHHHHhc----ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-------CEEEeecccce
Confidence 9988999998763 224689999999999999999999999999999999999999887 79999999997
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... .....++..|+|||++... ..++.++|+||||+++|||++|+.||....... .+.......
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~ 215 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRS--------TSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVL 215 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecC--------cCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhc
Confidence 6643221 1234567789999998532 247889999999999999999999997654321 111111100
Q ss_pred CCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 ERP----------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 ~~~----------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+ ......+..+.+++.+||+.||++|||+.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000 0011225779999999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.99 Aligned_cols=237 Identities=20% Similarity=0.345 Sum_probs=188.1
Q ss_pred EEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 238 QVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
....+||+|+++.++. .+|+.||||.+.. ..+.+.+|+.+++.++|+||+++++.+... ...|+||||++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecCC
Confidence 3345789998766654 2688999998743 234578899999999999999999988654 68999999998
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
+ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++...
T Consensus 101 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-------~~~l~dfg~~~~~ 166 (292)
T cd06657 101 GGALTDIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-------RVKLSDFGFCAQV 166 (292)
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------CEEEcccccceec
Confidence 5 88887753 3589999999999999999999999999999999999998887 7999999998755
Q ss_pred CCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC
Q 038696 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 389 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
.... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+.....
T Consensus 167 ~~~~--~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~ 233 (292)
T cd06657 167 SKEV--PRRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP 233 (292)
T ss_pred cccc--ccccccccCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCC
Confidence 3321 122334578889999998543 4788999999999999999999999764322 22333333322
Q ss_pred CC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 469 PL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 469 ~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. .....+..+.+++.+||..||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22 234567889999999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=280.09 Aligned_cols=233 Identities=27% Similarity=0.429 Sum_probs=184.2
Q ss_pred ecccccEEEEE---E-cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 243 LGSGSQYKEIL---W-LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 243 LG~G~~~~v~l---~-~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
||.|+++.++. . +|+.||+|.+... .+.+.+|+++++.++||||+++++.+.. ...+|+||||+.|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 57777655554 2 4889999998532 3467889999999999999999988854 4789999999975
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .+||+|||++.....
T Consensus 79 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-------~~~l~dfg~~~~~~~ 145 (265)
T cd05579 79 DLASLLENV------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-------HLKLTDFGLSKVGLV 145 (265)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-------CEEEEecccchhccc
Confidence 999999752 3689999999999999999999999999999999999999887 799999999876543
Q ss_pred CCC------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 391 GPK------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 391 ~~~------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
... ........++..|++||++... .++.++||||||+++|+|++|..||..... ......+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 214 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQ---------GHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQNIL 214 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 211 1122344567789999998654 378899999999999999999999976543 23444444
Q ss_pred cCCCCCCCCCC--cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 465 AGERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 465 ~~~~~~~p~~~--~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
.+. ..++..+ +..+.+++.+||+.+|.+|||+..+.+
T Consensus 215 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 215 NGK-IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred cCC-cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 433 2334444 889999999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=284.08 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=192.0
Q ss_pred CeEEEeEecccccEEEEE-------EcCcEEEEEEeCC--------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 236 DYQVRRRLGSGSQYKEIL-------WLGESFALRHFFG--------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l-------~~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+|++.+.||+|+++.+++ .+++.||||.++. ..+.+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 588999999998666654 2567899999853 134577899999999 59999999988854 36
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-------~~~ 145 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ------REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-------HVV 145 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh------cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-------CEE
Confidence 78999999985 99998864 24689999999999999999999999999999999999998877 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--ch
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~ 456 (683)
|+|||+++....... .......++..|+|||++.+.. ...+.++||||||+++|||++|..||..... ..
T Consensus 146 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 217 (288)
T cd05583 146 LTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGS-------GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217 (288)
T ss_pred EEECccccccccccc-cccccccCCccccCHHHhcCCC-------CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence 999999876543321 1222345778899999986431 1267899999999999999999999964321 11
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+.+.+... .+..+...+..+.+++.+||+.||++|||+.++.+.|.
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 218 SEISRRILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 2233333333 33456667889999999999999999999877765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=281.39 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=186.0
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcC---CCCceeeeeeeEEcCCC---Ce
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSL---SHPNIMHFLCGFTDEEK---KE 300 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~e~~---~~ 300 (683)
|++.+.||+|+++.+++. +|..||||.+... ...+.+|+.+++.+ +|+||+++++++.+.+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 788999999987666542 4789999998531 23466788877666 59999999998865422 23
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++++|||++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-------~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKC----PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-------QVKIA 149 (287)
T ss_pred eEEEehhcccCHHHHHHHc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-------CEEEe
Confidence 8999999999999988753 223589999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.... +.+.
T Consensus 150 dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~ 216 (287)
T cd07838 150 DFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLD 216 (287)
T ss_pred ccCcceeccCCc---ccccccccccccChHHhccC---------CCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHH
Confidence 999997764332 11233467889999999654 4788999999999999999999999865432 1121
Q ss_pred HHHHcCCC--------------CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 461 RNIRAGER--------------PLF-----------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~--------------~~~-----------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.+..... ..+ ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 11111000 000 01234667899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=291.64 Aligned_cols=246 Identities=25% Similarity=0.341 Sum_probs=182.0
Q ss_pred eEeccc--ccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSG--SQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G--~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
..||.| +++.|++. +|+.||||++... .+.+.+|+.+++.++||||++++++|... ..+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecc
Confidence 346666 65555542 7899999998532 35678999999999999999999999654 6789999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.+ +|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|++|||.+..
T Consensus 82 ~~~~l~~~l~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-------~~~~~~~~~~~~ 150 (328)
T cd08226 82 AYGSANSLLKTY----FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-------LVSLSGLSHLYS 150 (328)
T ss_pred cCCCHHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-------cEEEechHHHhh
Confidence 84 999988863 223589999999999999999999999999999999999998877 799999986533
Q ss_pred cCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 388 KNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 388 ~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
....... .......++..|+|||++.+. ...++.++|||||||++|||++|..||.+..... .+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~ 222 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD-------LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQK 222 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHH
Confidence 2211100 001112345669999999643 1247889999999999999999999997654221 11111
Q ss_pred HHcCC---------------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 463 IRAGE---------------------------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 463 i~~~~---------------------------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
+.... ....+..++..+.+|+.+||..||++|||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta 302 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH
Confidence 11000 000112245678999999999999999999
Q ss_pred HHHHHHHHHH
Q 038696 498 SSICRILRYI 507 (683)
Q Consensus 498 ~eil~~L~~i 507 (683)
.+++++-+..
T Consensus 303 ~e~l~~~~~~ 312 (328)
T cd08226 303 SSLLSHAFFK 312 (328)
T ss_pred HHHhhCHHHH
Confidence 9999886653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=280.37 Aligned_cols=235 Identities=18% Similarity=0.293 Sum_probs=180.7
Q ss_pred CeEEEeEe--cccccEEEEE----EcCcEEEEEEeCCC-cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRL--GSGSQYKEIL----WLGESFALRHFFGD-IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~L--G~G~~~~v~l----~~g~~vAvK~~~~~-~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+|++.+.+ |+|+++.+++ .+|..+|+|.+... .... |+.+...+ +||||+++++.|... +.+|+||||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e~ 90 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMDY 90 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEEc
Confidence 56666655 9998776665 36788999998542 1211 33333323 799999999998654 689999999
Q ss_pred CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++ |+|.+++... ..+++.++..++.||+.||.|||+.|++||||||+||+++.++. .++|+|||++.
T Consensus 91 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~------~~~l~dfg~~~ 158 (267)
T PHA03390 91 IKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD------RIYLCDYGLCK 158 (267)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC------eEEEecCccce
Confidence 97 5999999752 37999999999999999999999999999999999999977651 59999999987
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh---HHHHHH
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD---KMSRNI 463 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~---~~~~~i 463 (683)
..... ....++..|+|||++.+. .++.++||||||+++|+|++|..||........ .+....
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGH---------NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ 223 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh
Confidence 65422 223577889999999654 478899999999999999999999985433211 111111
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-FSSICRI 503 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-~~eil~~ 503 (683)
......+...+..+.++|.+||+.||.+||+ ++++++|
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 --QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2222344567899999999999999999995 6988765
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=305.83 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=198.8
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCC----CCeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~~~~ 302 (683)
.+...+.||+||++.|+.+ +|+.||||.+.. ..+...+|+++|++|+|+|||+++++-.+.. .....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4567789999998888865 799999999854 4677899999999999999999987553322 34568
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+|||||. |||...|.+ +.+...|++.+.+.++..++.||.|||++||+||||||.||++-... ++....||+|
T Consensus 94 lvmEyC~gGsL~~~L~~---PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge---dgq~IyKLtD 167 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS---PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE---DGQSIYKLTD 167 (732)
T ss_pred EEEeecCCCcHHHHhcC---cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC---CCceEEeeec
Confidence 9999997 599999975 34556799999999999999999999999999999999999996654 5666889999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch---hH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG---DK 458 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~---~~ 458 (683)
||.|+....+. .....+||..|++||.+..+ ..|+..+|.|||||++|+++||..||....... +.
T Consensus 168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q--------~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQ--------KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred ccccccCCCCC---eeeeecCchhhcChHHHhhc--------cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 99999987654 45578899999999999742 269999999999999999999999996432211 11
Q ss_pred HHHHHHcCC-------------------CCCCCCCCc----HHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGE-------------------RPLFPFHSP----KYVTNLTKRCWHADPNQRP--SFSSICRILRYIKRFI 511 (683)
Q Consensus 459 ~~~~i~~~~-------------------~~~~p~~~~----~~l~~Li~~cL~~dP~~RP--t~~eil~~L~~i~~~~ 511 (683)
+...+.... ..++|...+ ..+...+..+|..||.+|- .+.+....+..|....
T Consensus 237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 222111111 111222222 2355677788889999997 6777766666665543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=279.03 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred CeEEEeEecccccEEEEEE------c--CcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 236 DYQVRRRLGSGSQYKEILW------L--GESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~------~--g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.|++++.||+|++++|++. + ...+|||+|+.+ .....+|+.+++.|+||||+.+..+|... ...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence 7999999999987777753 1 236999999754 34578999999999999999999888753 4789
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 302 ~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+|++||.+.||...|+-....+. ..++...+..|+.||+.|+.|||++-|+||||||.||||..+| ...-.|||+|
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg---perG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG---PERGRVKIAD 179 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---CccCeeEeec
Confidence 99999999999999986544433 5789999999999999999999999999999999999998885 2233899999
Q ss_pred ccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc------
Q 038696 382 FGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL------ 454 (683)
Q Consensus 382 FGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~------ 454 (683)
||+++.+...-... .....+-|++|.|||.+.+. ..|+.+.|||+.|||+.||++-.+.|.+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa--------~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~ 251 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA--------RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN 251 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc--------ccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence 99999987654433 34566789999999999865 4799999999999999999999888865321
Q ss_pred --chhHHHHHHHcCCCCC---------CC--------------CC------------CcHHHHHHHHHhhhcCCCCCCCH
Q 038696 455 --QGDKMSRNIRAGERPL---------FP--------------FH------------SPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 455 --~~~~~~~~i~~~~~~~---------~p--------------~~------------~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
+.+.+.+.+.--..|. +| .+ -++...+|+.++|..||.+|.|+
T Consensus 252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 1122222221100000 00 00 12336789999999999999999
Q ss_pred HHHHHHH
Q 038696 498 SSICRIL 504 (683)
Q Consensus 498 ~eil~~L 504 (683)
++.+++.
T Consensus 332 ~qAleh~ 338 (438)
T KOG0666|consen 332 EQALEHP 338 (438)
T ss_pred HHHhccc
Confidence 9998764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=278.29 Aligned_cols=231 Identities=24% Similarity=0.326 Sum_probs=178.9
Q ss_pred eEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHH-HcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSL-LSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+.||+|+++.++.. +|+.||||.+... ...+..|..++ ..++|+||+++++.+.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 46899986666643 6789999998532 12234454444 45589999999998854 46899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||+++.
T Consensus 80 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-------~~~l~dfg~~~~ 146 (260)
T cd05611 80 NGGDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-------HLKLTDFGLSRN 146 (260)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------cEEEeeccccee
Confidence 75 999998752 4689999999999999999999999999999999999998877 799999999876
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+..+.
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 209 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGV---------GDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILSRR 209 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCC---------CCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcc
Confidence 432 2234567789999998644 378899999999999999999999976543 23333333332
Q ss_pred C---CCCCCCCcHHHHHHHHHhhhcCCCCCCCH---HHHHHH
Q 038696 468 R---PLFPFHSPKYVTNLTKRCWHADPNQRPSF---SSICRI 503 (683)
Q Consensus 468 ~---~~~p~~~~~~l~~Li~~cL~~dP~~RPt~---~eil~~ 503 (683)
. ......++..+.+++.+||..||++||++ .+++.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1 22334578899999999999999999965 455544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.31 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=200.4
Q ss_pred eEE--EeEecccccEEEE----EEcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 237 YQV--RRRLGSGSQYKEI----LWLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 237 y~i--~~~LG~G~~~~v~----l~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
|+| .+.||.|.|+.|+ ..+|+.||||++.+ ..+.+.+|+.||.++.||.||.+-..| +....+++|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEE
Confidence 444 4579999765555 36899999999843 456789999999999999999998777 455789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||-+.||+.+.|.. ...+.|++.....++.||+.||.|||.++|+|+||||+|||+... +....+||||||+
T Consensus 642 MEKl~GDMLEMILS----sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 642 MEKLHGDMLEMILS----SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----SPFPQVKLCDFGF 713 (888)
T ss_pred ehhhcchHHHHHHH----hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----CCCCceeeccccc
Confidence 99999998888765 245779999999999999999999999999999999999999765 4556899999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+.+.... .....+||+.|+|||+++.++ |+..-|+||.|||+|--++|..||.... .+..+|.
T Consensus 714 ARiIgEks---FRrsVVGTPAYLaPEVLrnkG---------yNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQ 777 (888)
T KOG4236|consen 714 ARIIGEKS---FRRSVVGTPAYLAPEVLRNKG---------YNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQ 777 (888)
T ss_pred eeecchhh---hhhhhcCCccccCHHHHhhcc---------ccccccceeeeEEEEEEecccccCCCcc----chhHHhh
Confidence 99987532 334678999999999999875 8899999999999999999999997533 3555555
Q ss_pred cCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 465 AGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 465 ~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
....+..| ...+....+||..+|+..=.+|.|....+.|.+
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 54433222 335678899999999999999999988877654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=297.58 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=213.7
Q ss_pred CeEEEeEecccccEEEEE--E--cC----cEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL--W--LG----ESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l--~--~g----~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.....++||+|+|+.|+. | .| -+||||++.. ..+++..|+-+|.+|+|||++++++++... .+.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHH
Confidence 456678999998655552 2 34 3799999853 356789999999999999999999988653 488
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||++|++ |+|.+|++. .+..+-....+.|.+||+.||.|||.+.++||||..+||||..-. ++||.|
T Consensus 774 lvtq~mP~G~LlDyvr~-----hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-------hvkitd 841 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVRE-----HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-------HVKITD 841 (1177)
T ss_pred HHHHhcccchHHHHHHH-----hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-------eEEEEe
Confidence 9999998 699999997 356788899999999999999999999999999999999998776 899999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~ 460 (683)
||+++............+..-.+.|||-|.+... .|+.++|||||||++||++| |..||.+.. .+++-
T Consensus 842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~---------~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~ 910 (1177)
T KOG1025|consen 842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR---------KYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIP 910 (1177)
T ss_pred cchhhccCcccccccccccccCcHHHHHHHhhcc---------CCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhh
Confidence 9999998776665555666667889999998654 69999999999999999998 999999866 35688
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+..+.+...|+.++-++..++.+||..|+..||+|+++...+..+.+
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 8899999999999999999999999999999999999999888776654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=313.02 Aligned_cols=137 Identities=26% Similarity=0.442 Sum_probs=120.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|.++++||+|+++.|++. .|+.||||++... ...+..|+.++..++||||+++++++... ..+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEEE
Confidence 58999999999998777753 5789999998642 25678999999999999999999888544 68999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+.| +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 82 VmEy~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-------~vkL~DF 148 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-------HIKLTDF 148 (669)
T ss_pred EEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-------CEEEEeC
Confidence 9999974 999998752 4588999999999999999999999999999999999998877 7999999
Q ss_pred cCcc
Q 038696 383 GLSS 386 (683)
Q Consensus 383 Gla~ 386 (683)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=272.27 Aligned_cols=231 Identities=28% Similarity=0.396 Sum_probs=187.2
Q ss_pred ecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-C
Q 038696 243 LGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-R 310 (683)
Q Consensus 243 LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-g 310 (683)
||.|+++.++.. +|+.||+|.+... .+.+..|+.+++.++|+||+++++.+.. ...+|+||||+. +
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 578876655542 5889999998532 3468899999999999999999988854 478999999995 6
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~ 390 (683)
+|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 79 ~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-------~~~l~d~~~~~~~~~ 145 (250)
T cd05123 79 ELFSHLSKE------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-------HIKLTDFGLAKELSS 145 (250)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-------cEEEeecCcceeccc
Confidence 999999752 3689999999999999999999999999999999999998887 799999999977643
Q ss_pred CCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 391 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
.. .......++..|++||.+.+. ..+.++|+||||+++|+|++|..||..... ......+.. ....
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~ 211 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGK---------GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-DPLR 211 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-CCCC
Confidence 21 122344567789999998654 378899999999999999999999976542 234444444 3455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH---HHHHH
Q 038696 471 FPFHSPKYVTNLTKRCWHADPNQRPSF---SSICR 502 (683)
Q Consensus 471 ~p~~~~~~l~~Li~~cL~~dP~~RPt~---~eil~ 502 (683)
++...+..+.+++++||..||++||++ .+++.
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 777778999999999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=280.37 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=188.1
Q ss_pred eEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|++.+.||+|+++.++. .+|+.||+|.+... .+.+..|+.+++.++|+||+++++.+.+. ..+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 67788999998665554 25889999998642 24577899999999999999999888543 78999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++++|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||+++
T Consensus 79 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-------~~~l~d~g~~~ 146 (282)
T cd07829 79 YCDMDLKKYLDKR-----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-------VLKLADFGLAR 146 (282)
T ss_pred CcCcCHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-------CEEEecCCccc
Confidence 9999999999862 14699999999999999999999999999999999999998887 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH--
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR-- 464 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~-- 464 (683)
....... ......++..|+|||++.+. ..++.++|||||||++|||++|..||....... .+.....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~ 215 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGS--------KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQIL 215 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCC--------cCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHh
Confidence 7644322 12233456779999998643 247889999999999999999999997654221 1111110
Q ss_pred -----------------cCCCCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 -----------------AGERPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 -----------------~~~~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+. .....+..+.+++++||..||++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 011236789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=286.50 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=203.4
Q ss_pred CCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC-CcchHHHHHHHHHc--CCCCceeeeeeeEEc--CCCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-DIEPLVPEISSLLS--LSHPNIMHFLCGFTD--EEKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~--e~~~~~~LVmE 306 (683)
-...++...||+|.|+.|+. .+++.||||+|.. +.+.|++|-+|.+. +.|+||++|++.-.. ..+..++||+|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45678888999999777774 4789999999964 56778999888776 479999999864321 11347999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS---------KKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---------~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
|.+ |+|.+||+. ...+|....+|+..+++||.|||+ .+|+|||||..||||..|+ +
T Consensus 289 fh~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-------T 354 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-------T 354 (534)
T ss_pred eccCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-------c
Confidence 997 899999987 568999999999999999999996 3799999999999999887 8
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC---------
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV--------- 447 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~--------- 447 (683)
+.|+|||+|..+..+.......+.+||.+|||||++.+.- ++.....-...||||+|.|||||++...
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgai---nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI---NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhc---ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 9999999998887665555555689999999999997652 1111123357999999999999998533
Q ss_pred ---CCC---CCccchhHHHH-HHHcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 448 ---PFE---DAHLQGDKMSR-NIRAGERPLFPFHS-----PKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 448 ---Pf~---~~~~~~~~~~~-~i~~~~~~~~p~~~-----~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
||+ +.+..-+++.. .+....+|.+|..+ ..-+.+.+..||..||+-|.|+.-+.+.+..+.
T Consensus 432 Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 432 YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 333 22233344444 35567788877654 456899999999999999999999988877764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=286.61 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=195.4
Q ss_pred CCCeEEEeEecccccEEEEE-E---cCcEEEEEEeCC---CcchHHHHHHHHHcCC--CC----ceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEIL-W---LGESFALRHFFG---DIEPLVPEISSLLSLS--HP----NIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l-~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~--Hp----nIv~l~~~~~~e~~~~ 300 (683)
+++|.+++.+|+|+|++|+. | .+..||||+++. -.++..-|+++|.++. -| -+|++.++| +-+++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccCc
Confidence 66999999999999988885 3 467899999974 3566788999999994 22 267887888 45588
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC-----------
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA----------- 369 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~----------- 369 (683)
.|||+|.++-++.++|+++ ...+|+...+..|++|++.+++|||+.+++|-||||+|||+.+...
T Consensus 166 iCivfellG~S~~dFlk~N----~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKEN----NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEeccChhHHHHhccC----CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999999999999873 5678999999999999999999999999999999999999854320
Q ss_pred --CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC
Q 038696 370 --STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447 (683)
Q Consensus 370 --~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~ 447 (683)
.......|||+|||.|+...... ...+.|-.|.|||++.+-+ ++.++||||+||||+|+++|..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLG---------wS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLG---------WSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccC---------cCCccCceeeeeEEEEeeccce
Confidence 11235679999999998765432 3456677899999998775 9999999999999999999999
Q ss_pred CCCCCccchh-HHHHHHH------------------cCCCCCCCCC-------------------------CcHHHHHHH
Q 038696 448 PFEDAHLQGD-KMSRNIR------------------AGERPLFPFH-------------------------SPKYVTNLT 483 (683)
Q Consensus 448 Pf~~~~~~~~-~~~~~i~------------------~~~~~~~p~~-------------------------~~~~l~~Li 483 (683)
.|+.....+. .+.+.|. .+ +..++.. ....+.+|+
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9987652221 0111111 11 1111100 113478999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 038696 484 KRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 484 ~~cL~~dP~~RPt~~eil~~L~ 505 (683)
++||..||.+|+|+.|++.|-.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHHHccCccccccHHHHhcCHH
Confidence 9999999999999999987743
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=273.94 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=204.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEc
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTD 295 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 295 (683)
.++.+.-++|.++++||+|++.+|++ .+.+.+|+|++++ +++-++.|-.+..+. +||.+|-+..+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 56677778999999999999766664 4778999999863 345568888888776 69999999999977
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
+ ..+++|.||++| +|.-+++. +..++++.+..|-.+|+.||.|||+.|||+||||.+|+|++..|
T Consensus 323 e--srlffvieyv~ggdlmfhmqr------qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg------ 388 (593)
T KOG0695|consen 323 E--SRLFFVIEYVNGGDLMFHMQR------QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG------ 388 (593)
T ss_pred c--ceEEEEEEEecCcceeeehhh------hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC------
Confidence 6 679999999985 99888874 35699999999999999999999999999999999999999999
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
++||+|+|+++....... .+....||+.|.|||++++.+ |+.++|+|+|||+|+||+.|+.||.-...
T Consensus 389 -hikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgee---------ygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 389 -HIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEE---------YGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred -ceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccc---------cCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 899999999987654322 345678999999999998874 99999999999999999999999963211
Q ss_pred ------chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC------CHHHHHHH
Q 038696 455 ------QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP------SFSSICRI 503 (683)
Q Consensus 455 ------~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP------t~~eil~~ 503 (683)
.++.+++.|..... .+|...+-....+++..|.+||.+|. .+.++..|
T Consensus 457 ~n~d~ntedylfqvilekqi-riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQI-RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred CCcccchhHHHHHHHhhhcc-cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 22445555555443 36777777788999999999999994 35555443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=270.91 Aligned_cols=207 Identities=23% Similarity=0.296 Sum_probs=165.4
Q ss_pred EcCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHH
Q 038696 254 WLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332 (683)
Q Consensus 254 ~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~ 332 (683)
.+|+.||+|.+.... .+..|...+....||||+++++.+.+. ...|+||||++| +|.+++.+. ..+++..
T Consensus 16 ~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~ 86 (237)
T cd05576 16 RTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISKF------LNIPEEC 86 (237)
T ss_pred cCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHHh------cCCCHHH
Confidence 378899999996532 345566666677899999999988643 789999999985 999998753 4589999
Q ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhh
Q 038696 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVL 412 (683)
Q Consensus 333 ~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl 412 (683)
+..++.|++.||.|||++||+||||||+||+++.++ .++++|||++...... .....++..|+|||++
T Consensus 87 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-------HIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVG 154 (237)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-------CEEEecccchhccccc-----cccCCcCccccCCccc
Confidence 999999999999999999999999999999999887 7999999988665432 1223445679999988
Q ss_pred hhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 038696 413 EENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPN 492 (683)
Q Consensus 413 ~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~ 492 (683)
.+. .++.++||||+|+++|||++|+.||...... +........|...+..+.++|.+||+.||+
T Consensus 155 ~~~---------~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 155 GIS---------EETEACDWWSLGAILFELLTGKTLVECHPSG-------INTHTTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CCC---------CCCchhhHHHHHHHHHHHHHCcchhhcCchh-------cccccccCCcccCCHHHHHHHHHHccCCHH
Confidence 543 4788999999999999999999988643211 111112235566788899999999999999
Q ss_pred CCCCH
Q 038696 493 QRPSF 497 (683)
Q Consensus 493 ~RPt~ 497 (683)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=250.05 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=193.5
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.|...++||+|.++.|+. .+++.||+|.+.-+ .....+||-+|+.|.|.|||++++....+ +.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd--kkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeH
Confidence 567778999998655554 26789999998522 34578999999999999999999988654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|||+.+|..|.... .+.++.+.+..++.|++.||.|+|+.++.||||||+|.||+.+| .+||+|||++
T Consensus 81 e~cdqdlkkyfdsl-----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-------elkladfgla 148 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSL-----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-------ELKLADFGLA 148 (292)
T ss_pred HHhhHHHHHHHHhc-----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-------cEEecccchh
Confidence 99999999998763 46689999999999999999999999999999999999999998 8999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~ 464 (683)
+.+...-+ .....+-|.+|.+|.++.+. .-|+.+.|+||.|||+.|+.. |++.|.+.... +++.+...
T Consensus 149 rafgipvr--cysaevvtlwyrppdvlfga--------kly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~ 217 (292)
T KOG0662|consen 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFR 217 (292)
T ss_pred hhcCCceE--eeeceeeeeeccCcceeeee--------ehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHH
Confidence 98765432 23345678899999999754 469999999999999999997 89889887643 33333332
Q ss_pred cCC------------------CCCCCCCC---------cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGE------------------RPLFPFHS---------PKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~------------------~~~~p~~~---------~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.-. .|.+|... ...-++|++.+|..+|.+|.+++..+++
T Consensus 218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 11122111 1224789999999999999999988765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=322.04 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=181.7
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-C
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-R 310 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-g 310 (683)
.|...+.||+|+++.|+. .+|..||||.+.........|+++|++++|||||++++++.++ ...|+||||++ |
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~Ey~~~g 768 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHEYIEGK 768 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEeCCCCC
Confidence 466677899998766664 3688999999875444456789999999999999999998654 67899999998 5
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH---SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++ ..++. ||....
T Consensus 769 ~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-------~~~~~-~~~~~~ 831 (968)
T PLN00113 769 NLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-------EPHLR-LSLPGL 831 (968)
T ss_pred cHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-------ceEEE-eccccc
Confidence 99999863 789999999999999999999 67999999999999998776 45554 665543
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC-
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG- 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~- 466 (683)
... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.........+.......
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~---------~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETK---------DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred ccc------CCCccccccccCcccccCC---------CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 221 1223578889999998644 489999999999999999999999954322111111111100
Q ss_pred --------CCCCC------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 467 --------ERPLF------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 467 --------~~~~~------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+.. +.....++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00111 11123357789999999999999999999999987643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=302.67 Aligned_cols=247 Identities=30% Similarity=0.459 Sum_probs=189.1
Q ss_pred EEEeEecccccEEEEE---EcCcEEEEEEeCCC-cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCCCCH
Q 038696 238 QVRRRLGSGSQYKEIL---WLGESFALRHFFGD-IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSRDL 312 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~gsL 312 (683)
.-.+.+|.|+-+.++. ..|+.||||.+-.+ .+-..+||.+|+.-+ |||||++|+.- .+....||..|+|..+|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~~sL 589 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCACSL 589 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhhhhH
Confidence 3345678886444432 58999999998554 345689999999885 99999987655 44588999999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCC
Q 038696 313 CSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392 (683)
Q Consensus 313 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~ 392 (683)
.+++... .. ..........+.++.|++.||.+||+.+||||||||+||||+... .++.+.++|+|||+|+....+.
T Consensus 590 ~dlie~~-~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~--~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESS-GL-DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS--ADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhcc-cc-chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC--CCcceeEEecccccccccCCCc
Confidence 9999862 00 001111145578899999999999999999999999999997643 3566789999999999887665
Q ss_pred CC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCC
Q 038696 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPL 470 (683)
Q Consensus 393 ~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~ 470 (683)
.. ....+..||-+|+|||++.... -+.++||||+||++|+.++ |..||.+.... ..+|..+....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~---------~~~avDiFslGCvfyYvltgG~HpFGd~~~R----~~NIl~~~~~L 732 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDR---------KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----QANILTGNYTL 732 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccc---------cCcccchhhcCceEEEEecCCccCCCchHHh----hhhhhcCccce
Confidence 33 2346778999999999998663 4568999999999999998 59999875432 23455554333
Q ss_pred CCCCCcH--HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 471 FPFHSPK--YVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 471 ~p~~~~~--~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....... +..+||.+|++.+|..||++.+|+.|
T Consensus 733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 3222222 78999999999999999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=293.72 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=206.5
Q ss_pred EeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC---CcchHHHHHHHHHcC-CCCceeeeeeeEEcC---CCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG---DIEPLVPEISSLLSL-SHPNIMHFLCGFTDE---EKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e---~~~ 299 (683)
-..++.|++...||.|..++|+. .+|+..|||+..- ..+++..|.++|+.+ .|||++.+|++|.-. .++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34466899999999998666664 4778899998853 356678889999988 599999999888642 346
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||||||+ |+..|+++... ...+.|..+..|++.++.||.+||...++|||||-.|||++.++ .||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-------~VK 163 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-------EVK 163 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-------cEE
Confidence 8999999998 59999998753 56799999999999999999999999999999999999999998 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||++...+.. ....+..+||+.|||||++...++. ...|+..+|+||||++..||.-|.+|+.+++... .
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~----d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-a 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESP----DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-A 236 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCC----CCCcccccchhhccceeehhcCCCCCccCcchhh-h
Confidence 9999999876543 2244567899999999999876543 4468999999999999999999999999887542 2
Q ss_pred HHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 459 MSRNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
++...+...+. .-|..+.+++.++|..||..|..+||++.++++|
T Consensus 237 LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 22222221111 1245677889999999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=265.93 Aligned_cols=254 Identities=19% Similarity=0.330 Sum_probs=195.6
Q ss_pred eCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEc------C
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTD------E 296 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------e 296 (683)
..+.|+-+.+||+|.|+.|++ ..|+.||+|+..- -.....+|+++|..|.|+|++.++..|.. .
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345788889999998665654 3678899987621 23456899999999999999998866532 1
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
.+..+||||.+|+.||...|.. ....|+..++.+++.+++.||.|+|+..|+|||+||.|+||+.+| .
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn-----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-------i 162 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSN-----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-------I 162 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcC-----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-------e
Confidence 2346899999999999999874 346799999999999999999999999999999999999999998 8
Q ss_pred EEEecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 377 AKISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
+||+|||+++.+...... ......+-|.+|.+||.+.+.. .|+++.|||..|||+.||.+|.+.|.+.+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r--------~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR--------EYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhccc--------ccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 999999999876543321 1223455689999999998654 699999999999999999999999987664
Q ss_pred chhHHHHHHHcCC-------------------CCCC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 455 QGDKMSRNIRAGE-------------------RPLF-------------PFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 455 ~~~~~~~~i~~~~-------------------~~~~-------------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
+.....-....|. .++. |..-.++..+|+..++..||.+|+++.+++.
T Consensus 235 qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 235 QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 4211100000000 0001 1112356789999999999999999999988
Q ss_pred HHHH
Q 038696 503 ILRY 506 (683)
Q Consensus 503 ~L~~ 506 (683)
|-.+
T Consensus 315 h~~F 318 (376)
T KOG0669|consen 315 HDFF 318 (376)
T ss_pred hhhh
Confidence 7554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=271.34 Aligned_cols=256 Identities=22% Similarity=0.394 Sum_probs=195.6
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC-----CcchHHHHHHHHH-cCCCCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG-----DIEPLVPEISSLL-SLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~-----~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~e~ 297 (683)
.-+.+.+++.+-+..||.|+|+.|.. ..|+..|||++.. +.+++..|.+... .=++||||++|+....|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E- 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE- 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-
Confidence 44566677888888999998655553 4799999999853 3456777877554 44799999999988765
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+||.||+|+-+|..+-+.... .....++++.+-.|..-.+.||.||-. ..||||||||+|||++..| .
T Consensus 136 -GdcWiCMELMd~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-------~ 206 (361)
T KOG1006|consen 136 -GDCWICMELMDISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-------D 206 (361)
T ss_pred -CceeeeHHHHhhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-------C
Confidence 67999999999776654432211 123568999999999999999999986 5899999999999999998 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
|||||||++-....+. ......|-..|||||.+.... ..|+-++||||||++|||+.||..||......-
T Consensus 207 vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~-------~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf 276 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSD-------KGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF 276 (361)
T ss_pred EeeecccchHhHHHHH---HhhhccCCccccChhccCCcc-------CCcchhhhhhhhcceEeeeecCCCCcchHHHHH
Confidence 9999999997654332 222334445699999997542 248999999999999999999999998765443
Q ss_pred hHHHHHHHcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.+ .++..|..|.... +.+..+..+|..||.+|-..||.+.++.++-
T Consensus 277 eql-~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 277 EQL-CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred HHH-HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 333 3444555554332 2467799999999999999999999987653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.10 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=198.1
Q ss_pred eCCCeEEEeEecccccEEEE----EEcCcEEEEEEeC--C---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEI----LWLGESFALRHFF--G---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~----l~~g~~vAvK~~~--~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
-+++|-++..||+|||..|+ +...+.||||+-. . ..+...+|-+|-+.|+||.||++|++|.-+.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 35689999999999964444 2467899999862 1 1234679999999999999999999997643
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEeCCCCCCCCCc
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK--KIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
..+|-|+|||+| ||.-||++. ..+++.++..|+.||+.||.||... .|||-||||.|||+..... -|
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta--cG- 610 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA--CG- 610 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc--cc-
Confidence 578999999998 899999874 5689999999999999999999976 6999999999999965531 12
Q ss_pred ceEEEecccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 375 LHAKISGFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
.+||+||||++.++..... ..+....||++|++||.+.-.. -..+.+.++||||.|||+|.+++|+.||
T Consensus 611 -eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-----ePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 611 -EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-----EPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred -eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC-----CCCccccceeeEeeehhhhhhhccCCCC
Confidence 6999999999998765432 2234678999999999985321 1346889999999999999999999999
Q ss_pred CCCccchhHHHHH-HHcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 038696 450 EDAHLQGDKMSRN-IRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPSFSSIC 501 (683)
Q Consensus 450 ~~~~~~~~~~~~~-i~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil 501 (683)
.....+.+.+..+ |.......|| +..+.+..++|++||+..-++|....++.
T Consensus 685 GhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 685 GHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 8776555544433 2222222233 34577899999999999999998877664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=293.38 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=169.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE----c----CcEEEEEEeCCCc--chHHHHHHHHHcCCCCceeeeeeeEEc----CC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----L----GESFALRHFFGDI--EPLVPEISSLLSLSHPNIMHFLCGFTD----EE 297 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~----g~~vAvK~~~~~~--~~~~~Ei~iL~~L~HpnIv~l~~~~~~----e~ 297 (683)
...++|++.+.||+|+|+.|++. + +..||||++.... +....| .+....+.+++.++..|.. ..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 34679999999999998777753 4 7899999986422 111111 2223334444443333221 34
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPR--------------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNI 362 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NI 362 (683)
...++|||||+++ +|.+++....... .........+..++.||+.||.|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 4678999999984 8999887521000 001112345668999999999999999999999999999
Q ss_pred EeCCC-CCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccccc-------------CCCCCc
Q 038696 363 LLKPR-GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESAS-------------NSKYSE 428 (683)
Q Consensus 363 Ll~~~-g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~-------------~~~~s~ 428 (683)
|++.+ + .+||+|||+|+....... .......+++.|+|||++.....+.... ...++.
T Consensus 287 Ll~~~~~-------~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 287 IFSEGSG-------SFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred EEeCCCC-------cEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99853 4 699999999986543321 2233456788999999875432211100 113556
Q ss_pred hhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC----------CCCCC----------CCCcHHHHHHHHHhhh
Q 038696 429 KSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE----------RPLFP----------FHSPKYVTNLTKRCWH 488 (683)
Q Consensus 429 ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~----------~~~~p----------~~~~~~l~~Li~~cL~ 488 (683)
++|||||||++|||+++..++...... +...+.... ..... ........+||.+||+
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQ---FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHH---HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 789999999999999987776532211 111111110 00000 0112335589999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 038696 489 ADPNQRPSFSSICRILR 505 (683)
Q Consensus 489 ~dP~~RPt~~eil~~L~ 505 (683)
.||.+|||+.++++|-+
T Consensus 436 ~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 436 FKGRQRISAKAALAHPY 452 (566)
T ss_pred CCcccCCCHHHHhCCcC
Confidence 99999999999998743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=253.80 Aligned_cols=247 Identities=19% Similarity=0.310 Sum_probs=193.6
Q ss_pred CCCeEEEeEecccc---cEEEE-EEcCcEEEEEEeCC-CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGS---QYKEI-LWLGESFALRHFFG-DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~---~~~v~-l~~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+++|+|. +|.+. ..+.++++||+++. ..+.+.+|+.||..|. ||||+++++...+...+...||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 45899999999997 33333 25788999999976 4567899999999997 9999999999999888899999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++. +...+.. .|+...+..++.|++.||.|||++||+|||+||.|+|++.... .++|+|+|+|.
T Consensus 117 v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r------kLrlIDWGLAE 181 (338)
T KOG0668|consen 117 VNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR------KLRLIDWGLAE 181 (338)
T ss_pred hccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc------eeeeeecchHh
Confidence 987 6555443 3888899999999999999999999999999999999987653 69999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH--
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR-- 464 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~-- 464 (683)
+.-.+... +..+.+-.|--||.+.... .|+.+-|+|||||++..|+..+.||...+...+++.+...
T Consensus 182 FYHp~~eY---nVRVASRyfKGPELLVdy~--------~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 182 FYHPGKEY---NVRVASRYFKGPELLVDYQ--------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred hcCCCcee---eeeeehhhcCCchheeech--------hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 87554322 2233445578999997543 5888999999999999999999999765544433332110
Q ss_pred -------------------------cCCCCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 465 -------------------------AGERPLF--------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 465 -------------------------~~~~~~~--------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+..+ ....++++.+|+.++|..|-.+|+|+.+.+.|--+
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 0001000 01124778999999999999999999999877543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-29 Score=251.19 Aligned_cols=231 Identities=31% Similarity=0.425 Sum_probs=186.6
Q ss_pred ccccEEEEEE-cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHH
Q 038696 245 SGSQYKEILW-LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK 317 (683)
Q Consensus 245 ~G~~~~v~l~-~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~ 317 (683)
-|.+|.+... +|+.||+|++... .+.+.+|++.++.++|+||+++++.+... ...++||||+++ +|.+++.
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHHH
Confidence 3556776654 5899999998642 46789999999999999999999888543 688999999986 9999987
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCC
Q 038696 318 EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397 (683)
Q Consensus 318 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~ 397 (683)
.. ..+++..+..++.+++.+|.|||+.||+|+||+|+||+++.++ .++|+|||.+....... ..
T Consensus 80 ~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-------~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 80 KR------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-------HVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred hc------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-------cEEEccccceeeecccc---cc
Confidence 52 2389999999999999999999999999999999999998887 79999999998765432 22
Q ss_pred CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCC--C
Q 038696 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFH--S 475 (683)
Q Consensus 398 ~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~--~ 475 (683)
....+++.|++||.+.+. .++.++||||||+++|+|++|..||...... ..+...+..+.....+.. .
T Consensus 144 ~~~~~~~~~~~pE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGK---------GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred ccccCCcCCCCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCccccccC
Confidence 344567789999998643 4788999999999999999999999763222 334444444443332222 7
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 476 PKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 476 ~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+..+.+++.+||..||++||++.+++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 8899999999999999999999999763
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.65 Aligned_cols=263 Identities=23% Similarity=0.378 Sum_probs=214.4
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE--E-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL--W-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGF 293 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l--~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~ 293 (683)
+.+.+...++++...+-+|.|+.++. | +.+.|-||.+++. ...+..|.-++..+.|||+..+.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 45556666788888889998766553 2 2345777877653 34577899999999999999998877
Q ss_pred EcCCCCeEEEEEecCC-CCHHHHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 294 TDEEKKECFLIMELMS-RDLCSYIKEICC--PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~-gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
.. +....++++.+++ |+|..||....+ +.....++-.+.+.++.|++.||+|||+.||||.||...|++|++.
T Consensus 357 ie-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--- 432 (563)
T KOG1024|consen 357 IE-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--- 432 (563)
T ss_pred ee-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---
Confidence 64 5567888999998 899999984322 2233457788899999999999999999999999999999999765
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf 449 (683)
+.|||+|=.+++-.-..+......+...+..||+||.+.... |+.++|||||||+||||+| |+.||
T Consensus 433 ----LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~---------yssasDvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 433 ----LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH---------YSSASDVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred ----eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh---------hcchhhhHHHHHHHHHHHhcCCCCc
Confidence 489999999998765544333333444567799999998774 9999999999999999998 99999
Q ss_pred CCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+ ..++...+..|++...|.+||.++..++..||+.+|++||+++++..-|..+..
T Consensus 500 aeID--PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 500 AEID--PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred cccC--HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 8765 346888999999999999999999999999999999999999999988877653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=245.24 Aligned_cols=223 Identities=23% Similarity=0.393 Sum_probs=171.7
Q ss_pred ceeEeeCCCeEEEeEecccccEEEE-----EEcCcEEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeeeEEcC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEI-----LWLGESFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCGFTDE 296 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~-----l~~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e 296 (683)
+.+.+..++...+..||+|+ |+++ ..+|...|+|.+.. ..+++..|+++.... .+|++|.||+.+..+
T Consensus 39 ~~~eV~ad~L~~i~elGrGa-yG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGA-YGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred CccccchhhhhhhhhhcCCc-cchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 34666667777788999997 4333 14899999999853 245577888876554 699999999988765
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..++|.||.|+-+|..+-++.. ......++..+-+|+..++.||.|||++ .+||||+||+|||++.+|
T Consensus 118 --gdvwIcME~M~tSldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G------- 186 (282)
T KOG0984|consen 118 --GDVWICMELMDTSLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG------- 186 (282)
T ss_pred --ccEEEeHHHhhhhHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-------
Confidence 6799999999999888776643 3456789999999999999999999986 899999999999999999
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
+||+||||++-....+-.. ....|--.|||||.+..+. ....|+-++||||||++++||.+++.||......
T Consensus 187 qVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~-----n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPEL-----NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred cEEEcccccceeehhhhHH---HHhcCCCccCChhhcCccc-----CcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 8999999999776543211 1223444599999998764 2336999999999999999999999999876544
Q ss_pred hhHHHHHHHcCCCCCC
Q 038696 456 GDKMSRNIRAGERPLF 471 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~ 471 (683)
-..+ +++.....|..
T Consensus 259 F~qL-kqvVeep~P~L 273 (282)
T KOG0984|consen 259 FQQL-KQVVEEPSPQL 273 (282)
T ss_pred HHHH-HHHhcCCCCCC
Confidence 3333 33333333333
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.06 Aligned_cols=242 Identities=27% Similarity=0.406 Sum_probs=187.7
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
..+|.-++.+|.|.. .++- ..++.||+|++.. ..++..+|..++..++|+||++++.+|.... -.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 348888899999986 3332 4789999998742 3567889999999999999999998886422 24
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|+|||||.++|.+.+.. .++-.++..+++|++.|++|||+.||+||||||+||++..++ .+||
T Consensus 95 e~y~v~e~m~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-------~lKi 159 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILM--------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-------TLKI 159 (369)
T ss_pred hHHHHHHhhhhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-------heee
Confidence 6899999999999998873 367788999999999999999999999999999999998888 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch---
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--- 456 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--- 456 (683)
.|||+|+..... ......+.|-.|.|||++.+.+ |...+||||+||++.||++|...|.+...-.
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~---------~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMG---------YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccC---------CcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 999999876433 2344556777899999998763 8999999999999999999999997632110
Q ss_pred ----------hHHH-------HHHHcC-C-------CCCCC-----C------CCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 457 ----------DKMS-------RNIRAG-E-------RPLFP-----F------HSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 457 ----------~~~~-------~~i~~~-~-------~~~~p-----~------~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
.... ++.... . ...+| . .-..-+++++.+||..||++|.++.++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 0000 110000 0 00011 0 112347899999999999999999999
Q ss_pred HHH
Q 038696 501 CRI 503 (683)
Q Consensus 501 l~~ 503 (683)
++|
T Consensus 308 L~H 310 (369)
T KOG0665|consen 308 LRH 310 (369)
T ss_pred hcC
Confidence 987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=268.19 Aligned_cols=266 Identities=19% Similarity=0.179 Sum_probs=179.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE--------------------cCcEEEEEEeCCC------------------cchHHH
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW--------------------LGESFALRHFFGD------------------IEPLVP 273 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~--------------------~g~~vAvK~~~~~------------------~~~~~~ 273 (683)
...++|++.++||+|+|+.|+.. .++.||||++... .+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35779999999999997766631 3467999998532 122345
Q ss_pred HHHHHHcCCCCce-----eeeeeeEEcC------CCCeEEEEEecCC-CCHHHHHHHhcCCC------------------
Q 038696 274 EISSLLSLSHPNI-----MHFLCGFTDE------EKKECFLIMELMS-RDLCSYIKEICCPR------------------ 323 (683)
Q Consensus 274 Ei~iL~~L~HpnI-----v~l~~~~~~e------~~~~~~LVmEy~~-gsL~~~l~~~~~~~------------------ 323 (683)
|+.++..++|.++ ++++++|... +....||||||++ |+|.++|.......
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776654 5565555321 2346899999998 59999887421110
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcC
Q 038696 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403 (683)
Q Consensus 324 ~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt 403 (683)
....+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++........ .......+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-------~~kL~DFGla~~~~~~~~-~~~~~g~~t 373 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-------QVKIIDFGAAVDMCTGIN-FNPLYGMLD 373 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-------cEEEEeCcCccccccCCc-cCccccCCC
Confidence 112356788999999999999999999999999999999998877 799999999976543211 112223457
Q ss_pred cccCChhhhhhcccccccc-------------CCCCCchhHHHhHHHHHHHHHhCCC-CCCCCccchhHHH---------
Q 038696 404 FIWHAPEVLEENEQTESAS-------------NSKYSEKSDVYSFGMICFEILTGKV-PFEDAHLQGDKMS--------- 460 (683)
Q Consensus 404 ~~Y~APEvl~~~~~~~~~~-------------~~~~s~ksDVwSlGvil~ElltG~~-Pf~~~~~~~~~~~--------- 460 (683)
+.|+|||++.....+.... ......+.||||+|||+|+|++|.. ||.+......+..
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 8899999986432110000 0011235799999999999999875 7754321111110
Q ss_pred HHHHc-CCCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHHHHH
Q 038696 461 RNIRA-GERPLFPFHSPKYVTNLTKRCWHADP---NQRPSFSSICRILR 505 (683)
Q Consensus 461 ~~i~~-~~~~~~p~~~~~~l~~Li~~cL~~dP---~~RPt~~eil~~L~ 505 (683)
+.+.. ..........+....+|+.+||..+| .+|+|+.++++|-+
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 11111 11111223457789999999999866 68999999988744
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=265.13 Aligned_cols=192 Identities=24% Similarity=0.406 Sum_probs=165.1
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------------cchHHHHHHHHHcCC---CCceeeeeeeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------------IEPLVPEISSLLSLS---HPNIMHFLCGF 293 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~---HpnIv~l~~~~ 293 (683)
...+|..++.+|+|++++|.+. +...|+||.++++ .-.+-.||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999998888874 4557999988542 223568999999997 99999999999
Q ss_pred EcCCCCeEEEEEecCC-C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 294 TDEEKKECFLIMELMS-R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~-g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
. +.+++||+||-.+ | ||+++|.- ...+++.++..|+.||+.|+++||++||||||||-+|+.++.+|
T Consensus 639 E--ddd~yyl~te~hg~gIDLFd~IE~------kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--- 707 (772)
T KOG1152|consen 639 E--DDDYYYLETEVHGEGIDLFDFIEF------KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--- 707 (772)
T ss_pred e--cCCeeEEEecCCCCCcchhhhhhc------cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC---
Confidence 5 4489999999885 7 99999973 46699999999999999999999999999999999999999998
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~ 451 (683)
.+||+|||.|.....+ .....+||..|.|||++.+.. ..+...|||++|++||.++...-||.+
T Consensus 708 ----~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~--------y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 ----FVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEK--------YLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ----eEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCc--------cCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8999999999776443 445678999999999998664 467789999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-30 Score=252.18 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=188.1
Q ss_pred CeEEEeEecccccEEEEE----EcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC---CeEE
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK---KECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~---~~~~ 302 (683)
+.+-.+.||-|+|+.||- .+|+.||+|++.. ..+.+.+|+++|..++|.|++..++..+.... .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 555677899997554442 3799999999853 35678899999999999999998877654322 2468
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+|+|+|..||...|-. ..+++.+.+.-+++||++||+|||+.||+||||||.|.|++.+. .+||+||
T Consensus 134 V~TELmQSDLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-------vLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-------ILKICDF 200 (449)
T ss_pred HHHHHHHhhhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-------eEEeccc
Confidence 9999999999988763 46789999999999999999999999999999999999998887 8999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch------
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG------ 456 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~------ 456 (683)
|+++..+..... .....+-|-.|.|||++.+. ..|+.++||||.|||+.||+..+..|.....-+
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPEiLMGa--------RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPELLMGA--------RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHHHhhcc--------hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 999987655332 22334557789999999854 479999999999999999999999887543211
Q ss_pred --------hHHH--------HHHHcCCCCC-CC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 457 --------DKMS--------RNIRAGERPL-FP--------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 457 --------~~~~--------~~i~~~~~~~-~p--------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+.+. ..++.+.+++ ++ ..-..+...++..++..||++|.+..+.+.++.
T Consensus 272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 0111121111 11 111244677888899999999999888877643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=260.83 Aligned_cols=196 Identities=20% Similarity=0.322 Sum_probs=161.6
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC---cchHHHHHHHHHcCC------CCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD---IEPLVPEISSLLSLS------HPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~------HpnIv~l~~~~~~e~~~~ 300 (683)
.++|.+....|+|-|..|+. ..|..||||++... .+.=..|++||++|+ --|+++|+..|. .+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--HKNH 508 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--hcce
Confidence 45899999999996666664 35779999999653 234468999999995 347899988884 4589
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|||+|-+.-+|.+.|+++. ....|....+..|+.|++.||..|-..||+|.||||+||||+... ..+|||
T Consensus 509 LClVFE~LslNLRevLKKyG---~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k------~iLKLC 579 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYG---RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK------NILKLC 579 (752)
T ss_pred eEEEehhhhchHHHHHHHhC---cccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc------ceeeec
Confidence 99999999999999999873 446688899999999999999999999999999999999997665 379999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
|||.|.....+.-+. ..-+--|.|||++.|. .|+...|+||.||.||||+||+..|.+.+
T Consensus 580 DfGSA~~~~eneitP----YLVSRFYRaPEIiLG~---------~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 580 DFGSASFASENEITP----YLVSRFYRAPEIILGL---------PYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCccccccccccccH----HHHHHhccCcceeecC---------cccCCccceeeceeeEEeeccceecCCCC
Confidence 999998775443221 1122349999999876 49999999999999999999999998755
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=247.75 Aligned_cols=131 Identities=24% Similarity=0.383 Sum_probs=112.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC-----C---CceeeeeeeEEc
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS-----H---PNIMHFLCGFTD 295 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~~~ 295 (683)
.+.+.+|.+.++||=|.|..|++. ..+.||+|+.+.. .+....||++|++++ | .+||+|++.|..
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 345579999999999998888873 5678999999763 466789999999983 3 469999998853
Q ss_pred --CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeC
Q 038696 296 --EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLK 365 (683)
Q Consensus 296 --e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~ 365 (683)
.++.++|||+|+++.+|..+|+.. ....++...+..|++||+.||.|||.. ||||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s----~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYS----NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHh----CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 456799999999999999999874 345699999999999999999999975 999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=218.65 Aligned_cols=203 Identities=35% Similarity=0.522 Sum_probs=167.2
Q ss_pred ecccccEEEEE---E-cCcEEEEEEeCCCc-----chHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCH
Q 038696 243 LGSGSQYKEIL---W-LGESFALRHFFGDI-----EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDL 312 (683)
Q Consensus 243 LG~G~~~~v~l---~-~g~~vAvK~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL 312 (683)
||+|+++.++. . .|+.++||++.... +.+.+|++.++.++|++|+++++.+... ...++||||++ ++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence 46676544443 2 38899999997643 5689999999999999999999888543 67899999999 599
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCCCCCCcceEEEecccCccccCCC
Q 038696 313 CSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP-RGASTEGYLHAKISGFGLSSVKNFG 391 (683)
Q Consensus 313 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~-~g~~~~~~~~vKL~DFGla~~~~~~ 391 (683)
.+++... ...++...+..++.+++.+|.|||+.|++|+||+|.||+++. ++ .++|+|||.+......
T Consensus 79 ~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-------~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 79 KDLLKEN-----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-------KVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-------cEEEecCCceEEccCC
Confidence 9998752 146899999999999999999999999999999999999988 55 7999999999766433
Q ss_pred CCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCC
Q 038696 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLF 471 (683)
Q Consensus 392 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~ 471 (683)
.. ......+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~--------~~~~~~~D~~~lg~~~~~l----------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGK--------GYYSEKSDIWSLGVILYEL----------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhccc--------CCCCchhhhHHHHHHHHHH-----------------------------
Confidence 21 12234456679999998643 1478899999999999999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 472 PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 472 p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+.+++..|+..||++||++.+++++
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468999999999999999999998765
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=278.91 Aligned_cols=210 Identities=18% Similarity=0.171 Sum_probs=148.3
Q ss_pred HcCCC-CceeeeeeeEEc----C-CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 038696 279 LSLSH-PNIMHFLCGFTD----E-EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKI 352 (683)
Q Consensus 279 ~~L~H-pnIv~l~~~~~~----e-~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI 352 (683)
+.++| +||+.+++.|.. . +...++++|||++++|.++|.. ....+++.+++.|++||+.||.|||++||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN-----PDRSVDAFECFHVFRQIVEIVNAAHSQGI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc-----ccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45566 688888877621 1 1245778899999999999974 23569999999999999999999999999
Q ss_pred ccCCCCCCcEEeCCCCCC------------CCCcceEEEecccCccccCCCCC--------------CCCCCCCCcCccc
Q 038696 353 YHGNLNPSNILLKPRGAS------------TEGYLHAKISGFGLSSVKNFGPK--------------SPSQSGTTHPFIW 406 (683)
Q Consensus 353 iHrDLKp~NILl~~~g~~------------~~~~~~vKL~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y 406 (683)
+||||||+||||+..+.. .+....+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999653300 01223578888888764321000 0011124578899
Q ss_pred CChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHh
Q 038696 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRC 486 (683)
Q Consensus 407 ~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~c 486 (683)
+|||++.+. .|+.++|||||||+||||++|..|+..... ....+.....+............++.+|
T Consensus 182 ~APE~~~~~---------~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGS---------SSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRVLPPQILLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccC---------CCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhhcChhhhhcCHHHHHHHHHh
Confidence 999998754 489999999999999999999988764221 1122222221211112234567899999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 038696 487 WHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 487 L~~dP~~RPt~~eil~~L~~ 506 (683)
|+.||.+||++.+++++...
T Consensus 249 L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 249 LHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred CCCChhhCcChHHHhhchhh
Confidence 99999999999999987543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=247.00 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=197.0
Q ss_pred CCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|+++.++|.|+.+-|+. .+|+..|||+++- +..-++.|+-+++.++|||||.+++.+... ..++|.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh--cCcEEEE
Confidence 46899999999998544443 4789999999863 455678899999999999999999988543 6789999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+| +|.+.-. -.+++++.++..+++..+.||+|||++|=+|||||-.|||+++.| .+|++|||.
T Consensus 92 EycgggslQdiy~------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-------DvklaDfgv 158 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-------DVKLADFGV 158 (829)
T ss_pred EecCCCcccceee------ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-------ceeecccCc
Confidence 99985 7776443 347899999999999999999999999999999999999999998 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+-.+... ........||+.|||||+..-.. .+-|...+|||++|+...|+---++|-.+.+... .++..-.
T Consensus 159 saqitat--i~KrksfiGtpywmapEvaaver------kggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTk 229 (829)
T KOG0576|consen 159 SAQITAT--IAKRKSFIGTPYWMAPEVAAVER------KGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMTK 229 (829)
T ss_pred hhhhhhh--hhhhhcccCCccccchhHHHHHh------cccccccccccccccchhhhhhcCCcccccchHH-HHHHhhc
Confidence 8665422 11223578999999999976542 4459999999999999999998888876665442 2333333
Q ss_pred cCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..++ .+..+.+.+.++++.||..+|++||+++.++.|
T Consensus 230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 443332 334567889999999999999999999887764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=215.87 Aligned_cols=162 Identities=21% Similarity=0.279 Sum_probs=126.5
Q ss_pred CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 310 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
|+|.+++.. ...++++.++..++.||+.||.|||+.+ ||+|||++.++ .+|+ ||+++...
T Consensus 1 GsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-------~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEV-----RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-------LLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-------ceee--ccceEeec
Confidence 689999975 2356999999999999999999999998 99999998887 6888 99997754
Q ss_pred CCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCC
Q 038696 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERP 469 (683)
Q Consensus 390 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~ 469 (683)
.. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.........+ ..+......
T Consensus 61 ~~-------~~~g~~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~ 123 (176)
T smart00750 61 PE-------QSRVDPYFMAPEVIQGQ---------SYTEKADIYSLGITLYEALDYELPYNEERELSAIL-EILLNGMPA 123 (176)
T ss_pred cc-------cCCCcccccChHHhcCC---------CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-HHHHHHhcc
Confidence 32 12578899999999754 48899999999999999999999997654322222 222222111
Q ss_pred CC------CCCCcH--HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 470 LF------PFHSPK--YVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 470 ~~------p~~~~~--~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.. +...+. .+.+++.+||..||.+||++.++++++..+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 124 DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 11 111223 6899999999999999999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=218.16 Aligned_cols=213 Identities=31% Similarity=0.438 Sum_probs=167.8
Q ss_pred eEEEeEecccccEEEEE---E-cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 237 YQVRRRLGSGSQYKEIL---W-LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l---~-~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
|.+.+.||.|+++.++. . +++.+|||.+.. ..+.+.+|++.+..++|+|++++++.+... ...+++|||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEec
Confidence 56788899987555443 3 478999999964 355788999999999999999999887543 678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+++ +|.+++... ...+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++ .++|+|||++.
T Consensus 79 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-------~~~l~d~g~~~ 146 (225)
T smart00221 79 CEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-------LVKLADFGLAR 146 (225)
T ss_pred cCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------CEEEeeCceee
Confidence 986 999999752 11188999999999999999999999999999999999998876 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
....... .......++..|++||.+. . ...++.++|||+||+++++|++|+.||.........+.+.+..+
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~-~-------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLL-G-------GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhc-C-------CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 7654320 0122345667799999984 1 22477799999999999999999999976233344566777776
Q ss_pred CCCCCC
Q 038696 467 ERPLFP 472 (683)
Q Consensus 467 ~~~~~p 472 (683)
....+|
T Consensus 218 ~~~~~~ 223 (225)
T smart00221 218 VPLLWE 223 (225)
T ss_pred Cccccc
Confidence 654443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=223.75 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=182.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.+.|.|.+.||+|.|++..+. +...+++|.+.. ...+|.+|...--.|. |.||+.-|++.. +..+.++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence 357999999999988777764 566899999865 4678999988777775 999998875533 2346888999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ |||.+-+.. ..+-+.....++.|+++||.|+|++++||||||.+||||-..+ ...|||||||+
T Consensus 102 E~aP~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-----f~rvKlcDFG~ 169 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-----FYRVKLCDFGL 169 (378)
T ss_pred ccCccchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-----ccEEEeeeccc
Confidence 9998 899987654 4477888899999999999999999999999999999995432 22899999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH--HH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS--RN 462 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~--~~ 462 (683)
.+..+..- .....+..|.+||++..... ....+.+.+|||.||+|+|.+++|.+||+........+. ..
T Consensus 170 t~k~g~tV-----~~~~~~~~y~~pe~~~~~~n----e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 170 TRKVGTTV-----KYLEYVNNYHAPELCDTVVN----EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred ccccCcee-----hhhhhhcccCCcHHHhhccc----cceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence 87654211 11222345899999865421 233578899999999999999999999985443322222 22
Q ss_pred HHcCCCCCCCCC---CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 463 IRAGERPLFPFH---SPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 463 i~~~~~~~~p~~---~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
...+..+..|.. .++.+..+.++-|..++++|=.+-+..+
T Consensus 241 w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 241 WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 333333333432 3566888899999999999944444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=235.00 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=185.2
Q ss_pred CCCeEEEeEecccccEEEEE----E---cCcEEEEEEeC--CCcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEIL----W---LGESFALRHFF--GDIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l----~---~g~~vAvK~~~--~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+.|.++++||+|+|..|+. . .++.||+|.+. .....+.+|+++|..+. +.||+++.+++.. .+...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence 34789999999998655553 1 46789999985 35678999999999995 9999999998854 478999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++. +..++... ++..++..|++.++.||.++|.+|||||||||+|+|.+.... .-.|+||
T Consensus 113 vlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~------rg~LvDF 177 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ------RGVLVDF 177 (418)
T ss_pred EecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC------CceEEec
Confidence 9999986 77777764 788999999999999999999999999999999999987642 5789999
Q ss_pred cCccccCCCC------------------------------------------CCCCCCCCCcCcccCChhhhhhcccccc
Q 038696 383 GLSSVKNFGP------------------------------------------KSPSQSGTTHPFIWHAPEVLEENEQTES 420 (683)
Q Consensus 383 Gla~~~~~~~------------------------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~ 420 (683)
|+|....... .........||++|.|||++...
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~----- 252 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC----- 252 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-----
Confidence 9986111000 00011245689999999999754
Q ss_pred ccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH------------HHHHH-cCC--------------------
Q 038696 421 ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM------------SRNIR-AGE-------------------- 467 (683)
Q Consensus 421 ~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~------------~~~i~-~~~-------------------- 467 (683)
...+.++||||.|||+..+++++.||......-+.+ .+... .|.
T Consensus 253 ---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 253 ---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE 329 (418)
T ss_pred ---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence 367889999999999999999999996433211111 00000 000
Q ss_pred -----------C-----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 468 -----------R-----PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 468 -----------~-----~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .......+..+.+|+.+|+..||.+|.|+++.++|
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00011124578899999999999999999999876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-22 Score=212.64 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=195.4
Q ss_pred CeEEEeEecccccEEEEEEc-----CcEEEEEEeCCC----cchHHHHHHHHHcCCC----CceeeeeeeEEcCCCCeEE
Q 038696 236 DYQVRRRLGSGSQYKEILWL-----GESFALRHFFGD----IEPLVPEISSLLSLSH----PNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~~-----g~~vAvK~~~~~----~~~~~~Ei~iL~~L~H----pnIv~l~~~~~~e~~~~~~ 302 (683)
+|.+.+.||+|+|+.+++.. ...+|+|..... ...+..|+.+|..+.. .++..+++... ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 89999999999988888642 247999987532 2268889999999973 57888877663 2346789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||++++.+|.++.+.. ....|+..++..++.|++.+|++||+.|++||||||+|++++..+ ......+.|+||
T Consensus 98 iVM~l~G~sL~dl~~~~----~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~--~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRN----PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS--RSEVRTLYLLDF 171 (322)
T ss_pred EEEeccCccHHHHHHhC----CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC--CcccceEEEEec
Confidence 99999999999988653 246799999999999999999999999999999999999997653 011237999999
Q ss_pred cCccccC--CCC----CCC--CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 383 GLSSVKN--FGP----KSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 383 Gla~~~~--~~~----~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
|+++.+. ... ... ......||..|+++.+..+.+ .+.+.|+||++.++.|++.|..||.....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e---------~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE---------QGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc---------cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 9998322 111 111 123456999999999987664 78899999999999999999999977553
Q ss_pred chh--HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 455 QGD--KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 455 ~~~--~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
... .+...........+....+.++..+...+-..+...+|....+...|+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 243 TDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 221 11111111111113345677888888888889999999999999988776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-22 Score=201.97 Aligned_cols=265 Identities=17% Similarity=0.241 Sum_probs=203.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEE----EEcCcEEEEEEeC--CCcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEI----LWLGESFALRHFF--GDIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~----l~~g~~vAvK~~~--~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~ 300 (683)
+...+-+-+|+++++||+|+|+... +.+++.||||.-. .+.-.+..|-+..+.|. .+.|..+|++- .++.+
T Consensus 21 s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~ 98 (449)
T KOG1165|consen 21 SGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKY 98 (449)
T ss_pred CCceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccch
Confidence 3444556699999999999865444 3589999999864 34556888999998885 89999987544 45677
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
-.||||+++.+|.|++.- ....|+..++..++.|++.-++|+|++.+|+|||||+|+||+.-+. .+.+ .|.|+
T Consensus 99 NiLVidLLGPSLEDLFD~-----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~-k~~n-~Ihii 171 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDL-----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT-KDAN-VIHII 171 (449)
T ss_pred hhhhhhhhCcCHHHHHHH-----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC-CCCc-eEEEE
Confidence 899999999888887764 3466999999999999999999999999999999999999987662 2333 68999
Q ss_pred cccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 381 GFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 381 DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
|||+|+.+...... .......||.+||+-....+.+ .+...|+-|||.++++.+.|..||.+....
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE---------QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE---------QSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccch---------hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 99999987654321 1224667999999998887765 677899999999999999999999986533
Q ss_pred h-hHHHHHHHcCCCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 456 G-DKMSRNIRAGERP----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 456 ~-~~~~~~i~~~~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
. .+-.+.|-...+. ....+.|.++..-+...-..+-.+-|.++-+...+..+-..
T Consensus 243 tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 243 TNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred chHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 2 1222333332221 12345688888888888888999999999888777666443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=195.69 Aligned_cols=258 Identities=19% Similarity=0.207 Sum_probs=194.6
Q ss_pred eCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCCC--cchHHHHHHHHHcCCC-CceeeeeeeEEcCCCCeEEEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFGD--IEPLVPEISSLLSLSH-PNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~e~~~~~~LVm 305 (683)
-.+.|.++++||.|+|+-.++ .+|+.||||+-... .-.+.-|.++...|++ ..|..+..++ .++.+-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc--cccccceeee
Confidence 345999999999999866654 48999999998653 3457889999999974 4455554434 3446779999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
++++.+|.+++.- ....|+..+++-++-|++.-++|+|.+++|||||||+|+|.+-+-. --.+.|+|||+|
T Consensus 91 dLLGPsLEdLfnf-----C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh----~~kl~LIDFGLa 161 (341)
T KOG1163|consen 91 DLLGPSLEDLFNF-----CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH----CNKLYLIDFGLA 161 (341)
T ss_pred eccCccHHHHHHH-----HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc----cceEEEEeccch
Confidence 9999888887763 2356999999999999999999999999999999999999865431 115899999999
Q ss_pred cccCCCCC-----CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH-H
Q 038696 386 SVKNFGPK-----SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK-M 459 (683)
Q Consensus 386 ~~~~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~-~ 459 (683)
+.+..... ........||.+|.+-....+.+ .+...|+-|+|.+|.++..|..||++....... -
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e---------qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE---------QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhh---------hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 87654321 11234567899999887776543 567899999999999999999999986543211 1
Q ss_pred HHHHHcCC----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 460 SRNIRAGE----RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 460 ~~~i~~~~----~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
.+.|.+.. ........|.++...+..|-..--++-|...-+.+.++-+-..
T Consensus 233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 22222221 1223456688999999999999999999998888777666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=212.54 Aligned_cols=164 Identities=20% Similarity=0.136 Sum_probs=123.8
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGF 293 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~ 293 (683)
+......++|.+.+.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|+||+..+..+
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344555678999999999998777753 4677899986422 23588999999999999998633322
Q ss_pred EcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEeCCCCCCC
Q 038696 294 TDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL-NPSNILLKPRGAST 371 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDL-Kp~NILl~~~g~~~ 371 (683)
+..||||||++| +|. .+.. .. ...++.|++.||.|||++||+|||| ||+|||++.++
T Consensus 91 -----~~~~LVmE~~~G~~L~-~~~~---------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--- 149 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLH-LARP---------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--- 149 (365)
T ss_pred -----CCcEEEEEccCCCCHH-HhCc---------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC---
Confidence 347999999987 675 2211 11 1467899999999999999999999 99999998776
Q ss_pred CCcceEEEecccCccccCCCCCCC------CCCCCCcCcccCChhhhhhcc
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSP------SQSGTTHPFIWHAPEVLEENE 416 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~------~~~~~~gt~~Y~APEvl~~~~ 416 (683)
.+||+|||+|+.+....... ......+++.|+|||++...+
T Consensus 150 ----~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 150 ----EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ----CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 69999999998765432111 112456788899999998765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-20 Score=190.53 Aligned_cols=250 Identities=32% Similarity=0.414 Sum_probs=188.6
Q ss_pred eEEEeEecccccEEEEEE-cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCC-ceeeeeeeEEcCCCCeEEEEEec
Q 038696 237 YQVRRRLGSGSQYKEILW-LGESFALRHFFG-------DIEPLVPEISSLLSLSHP-NIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~e~~~~~~LVmEy 307 (683)
|.+.+.||.|+++.++.. ....+|+|.+.. ....+.+|+.++..+.|+ +|+++++.+... ...+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEEEec
Confidence 788999999987555542 336889998853 144688999999999988 799999988443 558999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+.| ++.+++...... ..++...+..++.|++.++.|+|+.|++||||||+||+++..+. .++++|||+++
T Consensus 80 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~------~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR------VVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC------eEEEeccCcce
Confidence 985 888676642100 36899999999999999999999999999999999999987651 59999999998
Q ss_pred ccCCCCCCC----CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--chhHHH
Q 038696 387 VKNFGPKSP----SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QGDKMS 460 (683)
Q Consensus 387 ~~~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~~~~~ 460 (683)
......... ......||..|+|||.+.+.. ...++...|+||+|++++++++|..||..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS------LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence 554432211 235667899999999997520 02588899999999999999999999876553 123344
Q ss_pred HHHHcCCCC-C---CCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 461 RNIRAGERP-L---FPFHS----PKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~-~---~p~~~----~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+.....+ . ..... ...+.+++..|+..+|..|.+..+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 444443332 1 11111 1578999999999999999988877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-22 Score=226.61 Aligned_cols=210 Identities=27% Similarity=0.330 Sum_probs=162.5
Q ss_pred HHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038696 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK 350 (683)
Q Consensus 271 ~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 350 (683)
+..|.-+-..|.|||++..+..+++- ...+-+||||++||..++... ..++..++--++.|++.|+.|||+.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~mE~~~~Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~ 439 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEI--DGILQSMEYCPYDLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM 439 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhc--ccchhhhhcccHHHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc
Confidence 55677777788999998876655432 334445999999999999752 4688999999999999999999999
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCc
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSE 428 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ 428 (683)
||.|||||++|+|+..+| .+||+|||.+..+...... ....+..|+-.|+|||++.+.. .-..
T Consensus 440 GiahrdlK~enll~~~~g-------~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~--------ydpr 504 (601)
T KOG0590|consen 440 GLAHRDLKLENLLVTENG-------ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKE--------YDPR 504 (601)
T ss_pred CceeccCccccEEEecCC-------ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccc--------cCcc
Confidence 999999999999999998 7999999999877554433 4556788888999999998664 2334
Q ss_pred hhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 429 KSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 429 ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
..||||.|++++.|++|+.||................... .......|...+.+|.+||+.||.+|.|+++|++
T Consensus 505 ~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 505 AVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 6899999999999999999997655443221111111111 1122345777899999999999999999999976
Q ss_pred H
Q 038696 503 I 503 (683)
Q Consensus 503 ~ 503 (683)
.
T Consensus 585 d 585 (601)
T KOG0590|consen 585 D 585 (601)
T ss_pred C
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=215.25 Aligned_cols=216 Identities=24% Similarity=0.383 Sum_probs=176.9
Q ss_pred ecccccEEEEEE-------cCcEEEEEEeCC------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 243 LGSGSQYKEILW-------LGESFALRHFFG------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 243 LG~G~~~~v~l~-------~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
+|+|++++|.+. .|..+|+|+.+. .......|..++..++ ||.+|++.+.|+.+ ..++++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence 688887777752 466789988753 2224567888999887 99999999988654 6789999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|...+.+ ...+++.....+...++-+++++|+.||+|||+|++||+++.+| ++|+.|||+++.
T Consensus 80 rgg~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-------hi~~tdfglske 146 (612)
T KOG0603|consen 80 RGGDLFTRLSK------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-------HIKLTDFGLSKE 146 (612)
T ss_pred ccchhhhcccc------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-------ccccCCchhhhH
Confidence 75 89888874 35688888999999999999999999999999999999999999 899999999988
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~ 467 (683)
....... +||+.|||||++++ ....+|+||||++++||++|..||.. + +...|...
T Consensus 147 ~v~~~~~------cgt~eymApEI~~g-----------h~~a~D~ws~gvl~felltg~~pf~~-----~-~~~~Il~~- 202 (612)
T KOG0603|consen 147 AVKEKIA------CGTYEYRAPEIING-----------HLSAADWWSFGVLAFELLTGTLPFGG-----D-TMKRILKA- 202 (612)
T ss_pred hHhhhhc------ccchhhhhhHhhhc-----------cCCcccchhhhhhHHHHhhCCCCCch-----H-HHHHHhhh-
Confidence 7543221 78999999999973 57789999999999999999999986 2 33333332
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 468 RPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 468 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
...+|......+.+++..++..+|..|...
T Consensus 203 ~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 344677788889999999999999999643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-21 Score=189.72 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=185.7
Q ss_pred CeEEEeEecccc---cEEEEEEcCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVRRRLGSGS---QYKEILWLGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~~~LG~G~---~~~v~l~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+..++-+|.+.. .+++. |.|..+++|++.- ...+|..|.-.|+-+.||||+.+++.+... ..+.++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgr-wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR-WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCccccccc-ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeee
Confidence 344444555432 23332 7888888898742 346789999999999999999999998543 67899999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCCCCCCcceEEE--ec
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKI--SG 381 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g~~~~~~~~vKL--~D 381 (683)
||+ |+|+..|.+. .....+..++++++..|+.|+.|||+.. |.--.|....+++|++- +.+| +|
T Consensus 268 ~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-------tarismad 336 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-------TARISMAD 336 (448)
T ss_pred eccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-------hhheeccc
Confidence 998 8999999873 4455677899999999999999999873 44446888999998764 4444 33
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
--++ ....+....+.||+||.++..+.. .--.++|+|||++++|||.|...||.+....+. -.+
T Consensus 337 ~kfs---------fqe~gr~y~pawmspealqrkped------~n~raadmwsfaillwel~trevpfadlspmec-gmk 400 (448)
T KOG0195|consen 337 TKFS---------FQEVGRAYSPAWMSPEALQRKPED------LNIRAADMWSFAILLWELNTREVPFADLSPMEC-GMK 400 (448)
T ss_pred ceee---------eeccccccCcccCCHHHHhcCchh------cchhhhhHHHHHHHHHHhhccccccccCCchhh-hhh
Confidence 2211 122344556789999999877422 234589999999999999999999988765432 235
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
....|.+..+|+..+..+..|+.-|+..||.+||.|..|+-.|+.+
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 5677899999999999999999999999999999999998888764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-21 Score=211.78 Aligned_cols=279 Identities=27% Similarity=0.414 Sum_probs=191.6
Q ss_pred HHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccC
Q 038696 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKI-YHG 355 (683)
Q Consensus 278 L~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI-iHr 355 (683)
|+.+.|.|+.++++.+.+. ...++|.+||. |+|.+.+.. ....+++.....+++.|+.||.|||...| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~-----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSN-----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhc-----cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4678999999999988765 78899999997 899999985 34668888899999999999999999877 999
Q ss_pred CCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 356 DLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
.|+..|++++.. +.+||+|||+.................-...|.|||.+....... .....+.+.|||||
T Consensus 74 ~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~--~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 74 ALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS--LESALTQKGDIYSF 144 (484)
T ss_pred eeccccceeeee-------EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc--ccccccccCCeehH
Confidence 999999999655 589999999987764211111111222345699999998752111 01125778999999
Q ss_pred HHHHHHHHhCCCCCCCCccch--hHHHHHHHc-CCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 436 GMICFEILTGKVPFEDAHLQG--DKMSRNIRA-GERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~--~~~~~~i~~-~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|++++|+++...||....... +++...+.. +..+..|. ..++++..+++.||..+|.+||++.++...++.+
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999999999998744332 344445555 33222222 3455799999999999999999999998877665
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCCchHHHHHhhcCCCcccCCCCCCCCCccccchhhhhhhcccCCCC
Q 038696 508 KRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEKISSSP 574 (683)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 574 (683)
.+.... ..+.......-...|.+-.....++.......++.+...+..++++..++++.+.+...
T Consensus 225 ~~~~~~--~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v 289 (484)
T KOG1023|consen 225 NKGGSS--KGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTV 289 (484)
T ss_pred cccccc--cchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcC
Confidence 431100 00000000000001111111222223333345667777889999999999999988753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=188.04 Aligned_cols=210 Identities=22% Similarity=0.314 Sum_probs=156.3
Q ss_pred CCCceeeeeeeEEcC-------------------------CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHH
Q 038696 282 SHPNIMHFLCGFTDE-------------------------EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336 (683)
Q Consensus 282 ~HpnIv~l~~~~~~e-------------------------~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i 336 (683)
.|||||+++..|+++ +...+|+||.-+..+|..|+-. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-------CCCchHHHHHH
Confidence 599999999888763 2357899999999999999975 34677788889
Q ss_pred HHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCC----CCCCCCCCCCcCcccCChhhh
Q 038696 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG----PKSPSQSGTTHPFIWHAPEVL 412 (683)
Q Consensus 337 ~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~----~~~~~~~~~~gt~~Y~APEvl 412 (683)
+.|+++|+.|||++||.|||+|.+|||+.-+. |+-..+.|+|||.|-.-+.- ...+.....-|.-.-||||+.
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecC---CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999999999999999996554 55568999999988543220 111222233455568999998
Q ss_pred hhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 038696 413 EENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPN 492 (683)
Q Consensus 413 ~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~ 492 (683)
...+-.. .-.. -.++|.|+.|.+.||+++..-||....... .-.+...+..-|..|..+|+.+++|+..+|+.||+
T Consensus 424 ta~PGp~--avvn-y~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 424 TAVPGPN--AVVN-YEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred hcCCCCc--eeec-cchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhCCCCcccCChHHHHHHHHHhcCCcc
Confidence 7553111 1112 248999999999999999999997622110 01123445566778899999999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 038696 493 QRPSFSSICRILR 505 (683)
Q Consensus 493 ~RPt~~eil~~L~ 505 (683)
+|++..-....|.
T Consensus 500 kRvsp~iAANvl~ 512 (598)
T KOG4158|consen 500 KRVSPNIAANVLN 512 (598)
T ss_pred ccCCccHHHhHHH
Confidence 9988665544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=214.78 Aligned_cols=241 Identities=17% Similarity=0.240 Sum_probs=172.8
Q ss_pred CeEEEeEecccccEEEEEE--cCcEEEEEEeCCC-----cchHH---HHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW--LGESFALRHFFGD-----IEPLV---PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~--~g~~vAvK~~~~~-----~~~~~---~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+|...+.||.+.|+++... ....|+||+|... ...+. .|++ ...++|||++++.-+. +..+..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHH
Confidence 6888999999999888853 3335999998432 23343 4444 5566899999987654 3336789999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
+|+..+|+|.|.. +.-+..-+...|+.|++.||.-+|..||+|||||.+||||+.=+ .+.|+||...
T Consensus 101 qyvkhnLyDRlST------RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-------W~~LtDFAsF 167 (1431)
T KOG1240|consen 101 QYVKHNLYDRLST------RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-------WLYLTDFASF 167 (1431)
T ss_pred HHHhhhhhhhhcc------chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-------hhhhhccccc
Confidence 9999999999964 34467788899999999999999999999999999999997665 6999999876
Q ss_pred cccCCCCCCC-----CCCCCCcCcccCChhhhhhccccc--cccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCcc---
Q 038696 386 SVKNFGPKSP-----SQSGTTHPFIWHAPEVLEENEQTE--SASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL--- 454 (683)
Q Consensus 386 ~~~~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~--~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~--- 454 (683)
+..-...... -......--.|+|||.+....... .......+++.||||+||++.||++ |++||.-..+
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY 247 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY 247 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH
Confidence 5432111000 001111122499999997643111 1112237889999999999999998 8999963221
Q ss_pred ------chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 ------QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ------~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+...+. -.+..+++||..|++.||.+|.++++.++.
T Consensus 248 r~~~~~~~e~~Le~-----------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEK-----------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHh-----------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111111 113468999999999999999999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=181.87 Aligned_cols=165 Identities=15% Similarity=0.152 Sum_probs=124.3
Q ss_pred CCCeEEEeEecccccEEEEEE--cCcEEEEEEeCCC---cc----------hHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--LGESFALRHFFGD---IE----------PLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--~g~~vAvK~~~~~---~~----------~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.++|++.+.||+|+++.|++. ++..+|||++... .+ .+.+|++.+.++.|++|..+.+.+.+.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 358999999999998888864 5668999999532 11 15789999999999999998877654331
Q ss_pred ------CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 299 ------KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 299 ------~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
...+|||||++| +|.++.. ++. ....+++.+|..||+.|++|||+||+||+++++|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--- 172 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--- 172 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---
Confidence 357999999998 8877632 232 2466999999999999999999999999998765
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
++|+|||..+....... ...++... .|+.++|+||||+++..+.
T Consensus 173 -----i~liDfg~~~~~~e~~a--------------~d~~vler---------~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -----LRIIDLSGKRCTAQRKA--------------KDRIDLER---------HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -----EEEEECCCcccccchhh--------------HHHHHHHh---------HhcccccccceeEeehHHH
Confidence 99999998865422110 01122222 2667899999999876544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-19 Score=173.86 Aligned_cols=131 Identities=21% Similarity=0.208 Sum_probs=99.1
Q ss_pred EeEecccccEEEEE---EcCcEEEEEEeCCCc-------------chH-----------------HHHHHHHHcCCCCce
Q 038696 240 RRRLGSGSQYKEIL---WLGESFALRHFFGDI-------------EPL-----------------VPEISSLLSLSHPNI 286 (683)
Q Consensus 240 ~~~LG~G~~~~v~l---~~g~~vAvK~~~~~~-------------~~~-----------------~~Ei~iL~~L~HpnI 286 (683)
...||+|+++.|+. .+|+.||||+++... ..| ..|+++|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45799999766665 368999999985321 122 249999999988776
Q ss_pred eeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEe
Q 038696 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYL-HSKKIYHGNLNPSNILL 364 (683)
Q Consensus 287 v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~gIiHrDLKp~NILl 364 (683)
........ . ..+|||||++| ++...+.+ ..+++...+..++.|++.+|.|| |+.||+||||||+|||+
T Consensus 82 ~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL-K---SHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe-c---CCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 44322221 1 23899999997 55444322 25689999999999999999999 79999999999999999
Q ss_pred CCCCCCCCCcceEEEecccCcccc
Q 038696 365 KPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 365 ~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
+. + .++|+|||+|...
T Consensus 152 ~~-~-------~v~LiDFG~a~~~ 167 (190)
T cd05147 152 HD-G-------KLYIIDVSQSVEH 167 (190)
T ss_pred EC-C-------cEEEEEccccccC
Confidence 84 3 5999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=179.69 Aligned_cols=239 Identities=21% Similarity=0.320 Sum_probs=143.5
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCC----------CceeeeeeeEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSH----------PNIMHFLCGFT 294 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~H----------pnIv~l~~~~~ 294 (683)
.+.....||.|+++.++.. +|+.+|||++. ...+.+.+|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3556778999997777753 67999999983 234556666544444322 11111112221
Q ss_pred cC---------C-CC-----eEEEEEecCCCCHHHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 038696 295 DE---------E-KK-----ECFLIMELMSRDLCSYIKEICCPRK-RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLN 358 (683)
Q Consensus 295 ~e---------~-~~-----~~~LVmEy~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLK 358 (683)
.+ . .. ..+++|+-+.+||.+++........ ...+.......+..|++..+++||+.|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 0 11 2377888888898887653211111 1223333445666899999999999999999999
Q ss_pred CCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHH
Q 038696 359 PSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438 (683)
Q Consensus 359 p~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvi 438 (683)
|+|++++.+| .++|+||+.....+.... . ...+..|.+||.......-.. ....++.+.|.|+||++
T Consensus 173 ~~nfll~~~G-------~v~Lg~F~~~~r~g~~~~--~---~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLLDQDG-------GVFLGDFSSLVRAGTRYR--C---SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE-TTS--------EEE--GGGEEETTEEEE--G---GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHH
T ss_pred eeeEEEcCCC-------CEEEcChHHHeecCceee--c---cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHH
Confidence 9999999999 799999988765443211 1 223356899998765311000 12358899999999999
Q ss_pred HHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 038696 439 CFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494 (683)
Q Consensus 439 l~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 494 (683)
+|.|.+|..||........... ...... +.|+.++.||..+|+.||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543211100 011123 679999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=167.90 Aligned_cols=183 Identities=15% Similarity=0.074 Sum_probs=132.0
Q ss_pred eEEEeEecccccEEEEEE--cCcEEEEEEeCCCc---c-----hHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEE
Q 038696 237 YQVRRRLGSGSQYKEILW--LGESFALRHFFGDI---E-----PLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~--~g~~vAvK~~~~~~---~-----~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+.+...|+.|+|+.+++. .+.+++.+.+.... . .+.+|+++|++|. |++|++++++ ...|+||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 345678999987777764 56788888775432 1 4789999999995 5889998764 2369999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL-NPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDL-Kp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||+.| +|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||
T Consensus 78 eyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-------~i~LIDFG 137 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-------SPAVIDFQ 137 (218)
T ss_pred eeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-------CEEEEECC
Confidence 99998 66543221 11357889999999999999999999 79999998777 79999999
Q ss_pred CccccCCCCCC---CC--------CCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 384 LSSVKNFGPKS---PS--------QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 384 la~~~~~~~~~---~~--------~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
+|......... .. ..-...++.|++|+...-.. ..--...++++-|+.+|.++|+..++-+.
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-------~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK-------RTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-------cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99865432210 00 00112456788887654321 11225689999999999999998887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=165.59 Aligned_cols=131 Identities=19% Similarity=0.202 Sum_probs=100.6
Q ss_pred EeEecccccEEEEE---EcCcEEEEEEeCCCc------------------------------chHHHHHHHHHcCCCCce
Q 038696 240 RRRLGSGSQYKEIL---WLGESFALRHFFGDI------------------------------EPLVPEISSLLSLSHPNI 286 (683)
Q Consensus 240 ~~~LG~G~~~~v~l---~~g~~vAvK~~~~~~------------------------------~~~~~Ei~iL~~L~HpnI 286 (683)
.+.||+|+++.|++ .+|+.||||++.... ..+..|.+.+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999766664 368999999985321 113578999999999987
Q ss_pred eeeeeeEEcCCCCeEEEEEecCCC-CHHHH-HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEE
Q 038696 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSY-IKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNIL 363 (683)
Q Consensus 287 v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NIL 363 (683)
......... ..||||||++| ++... +.+ ..++...+..++.|++.+|.+||+ .||+||||||+|||
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 543322221 23899999987 34333 332 457888999999999999999999 99999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCccccC
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
++ ++ .++|+|||+++...
T Consensus 151 l~-~~-------~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DG-------KPYIIDVSQAVELD 168 (190)
T ss_pred EE-CC-------CEEEEEcccceecC
Confidence 98 55 69999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=192.72 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=174.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC-CcchHHHHHHHHHcCC---CCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG-DIEPLVPEISSLLSLS---HPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~~~~ 300 (683)
....+.++.|.|.+.||+|++++|++. +|+.||||+-+. ..-+|.-=.+++.+|+ -+.|+.+...+... +.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~--~~ 768 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ--NA 768 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccC--Cc
Confidence 677888999999999999998888863 689999999754 2222222223344443 23455544444333 44
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+||+||.+ |+|.+++.. ...+++..++.+..|++.-++.||..+|||+||||+|+||...-....+...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 699999998 899999973 3568999999999999999999999999999999999999644322334567999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||.+--+..-.......+..+|-.+-.+|...|. .++..+|.|.|+.++|-||.|+.-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr---------pWtYq~DyfGlAa~~h~mLFG~y~----------- 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR---------PWTYQIDYFGLAATVHVMLFGKYM----------- 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCC---------CCchhhhhHHHHHHHHHHHHHHHH-----------
Confidence 999998554332222334455667778899999655 599999999999999999998631
Q ss_pred HHHHHcCCCCC----CCCCCcHHH-HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 460 SRNIRAGERPL----FPFHSPKYV-TNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 460 ~~~i~~~~~~~----~p~~~~~~l-~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+ ...|..-. ++..+..++ .+++..+|..|-..=|...++...|+.
T Consensus 903 -q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 903 -E-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred -H-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHH
Confidence 1 22222211 222233333 467777777444444666666555544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=165.92 Aligned_cols=134 Identities=15% Similarity=0.204 Sum_probs=102.0
Q ss_pred EEeEecccccEEEEEE--cCcEEEEEEeCC----CcchHHHHHHHHHcC-----CCCceeeeeeeEEcCCC-CeEE-EEE
Q 038696 239 VRRRLGSGSQYKEILW--LGESFALRHFFG----DIEPLVPEISSLLSL-----SHPNIMHFLCGFTDEEK-KECF-LIM 305 (683)
Q Consensus 239 i~~~LG~G~~~~v~l~--~g~~vAvK~~~~----~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~e~~-~~~~-LVm 305 (683)
-...||+|++..|+.. ++.. +||++.. ..+.+.+|+++++.+ +||||+++++++.++.+ +.++ +||
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred CcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 3467999998888753 3334 6888753 345789999999999 57999999999976432 3434 789
Q ss_pred ecCC---CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 306 ELMS---RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM-EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 306 Ey~~---gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||++ |+|.+++++ ..+++. ..++.|++.++ +|||+++|+||||||+|||++..+ ++...++|+|
T Consensus 85 e~~G~~~~tL~~~l~~-------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~---~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS---ESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHc-------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC---CCCCcEEEEE
Confidence 9954 599999975 235555 36688888888 999999999999999999997644 3344799999
Q ss_pred ccCc
Q 038696 382 FGLS 385 (683)
Q Consensus 382 FGla 385 (683)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-18 Score=194.81 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=145.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
..+|+.++.|-.|+.+.|++. +.+.+|+|+-++.. ||+ ||.. |.+ ..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilR-----nilt----~a~----npfvv----- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILR-----NILT----FAG----NPFVV----- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhh-----cccc----ccC----Cccee-----
Confidence 458999999999986666654 35678885543211 122 1222 211 12333
Q ss_pred CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 310 RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 310 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
||-...++. -++++.+- +.+++|||+.||+|||+||+|.||+.-| ++|+.|||+++...
T Consensus 136 gDc~tllk~------~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG-------hiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 GDCATLLKN------IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG-------HIKLTDFGLSKKGL 194 (1205)
T ss_pred chhhhhccc------CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc-------cccccchhhhhhhh
Confidence 555555543 23444332 7899999999999999999999999998 89999999987543
Q ss_pred CCC-------------CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 390 FGP-------------KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 390 ~~~-------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
... ........+||+.|.||||+..++ |+..+|||++|+|+||.+-|..||.+.+..
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg---------ygkpvdwwamGiIlyeFLVgcvpffGdtpe- 264 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG---------YGKPVDWWAMGIILYEFLVGCVPFFGDTPE- 264 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc---------cCCCccHHHHHHHHHHHheeeeeccCCCHH-
Confidence 221 112223668999999999998875 999999999999999999999999987643
Q ss_pred hHHHHHHHcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 038696 457 DKMSRNIRAGE--RPLFPFHSPKYVTNLTKRCWHADPNQRP 495 (683)
Q Consensus 457 ~~~~~~i~~~~--~~~~p~~~~~~l~~Li~~cL~~dP~~RP 495 (683)
+++..+...+ .+.-....+.++++++.++|..+|..|-
T Consensus 265 -elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 265 -ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 3444443322 2222345678899999999999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.6e-18 Score=181.94 Aligned_cols=173 Identities=29% Similarity=0.476 Sum_probs=133.7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
++||.|++|. ++|.++|... +....-++.....++.|++.|++| +|.+|||+||.||.+..++ .+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr---~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-------q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR---RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-------QLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC---CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-------hhh
Confidence 5899999998 6999999742 233456778899999999999999 9999999999999998876 799
Q ss_pred EecccCccccCCCC----CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 379 ISGFGLSSVKNFGP----KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 379 L~DFGla~~~~~~~----~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
|.|||+........ ........+||..||+||.+.++ .|+.++||||||+||+|+++ -...|+.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~---------~y~~kvdIyaLGlil~EL~~~f~T~~er-- 465 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ---------QYSEKVDIYALGLILAELLIQFSTQFER-- 465 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh---------hhhhhcchhhHHHHHHHHHHHhccHHHH--
Confidence 99999987765543 12234567899999999999877 49999999999999999997 3333332
Q ss_pred cchhHHHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 454 LQGDKMSRNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
......++.+..| .+-.+.|. -..|+..++...|.+||++.+.
T Consensus 466 ---~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 ---IATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---HHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 2233455566544 23333443 4689999999999999954443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=150.36 Aligned_cols=127 Identities=23% Similarity=0.329 Sum_probs=101.2
Q ss_pred eEecccccEEEEE--EcCcEEEEEEeCCC------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 241 RRLGSGSQYKEIL--WLGESFALRHFFGD------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 241 ~~LG~G~~~~v~l--~~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+.||+|+++.++. +.|..|+||+.... ...+.+|++++..+.|++|+.....+.+. ...++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEEE
Confidence 5789998666664 47889999986431 13467899999999999886654444433 45789999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++... .. ....++.+++.+|.+||+.|++|||++|.|||++ ++ .++|+|||++
T Consensus 80 ~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-------~~~liDf~~a 141 (211)
T PRK14879 80 YIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-------KIYLIDFGLA 141 (211)
T ss_pred EeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-------CEEEEECCcc
Confidence 9987 999888641 12 7889999999999999999999999999999998 44 5999999988
Q ss_pred cc
Q 038696 386 SV 387 (683)
Q Consensus 386 ~~ 387 (683)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 54
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.2e-16 Score=158.83 Aligned_cols=133 Identities=17% Similarity=0.141 Sum_probs=101.0
Q ss_pred CeEEEeEecccccEEEEE-----EcCcEEEEEEeCCCc----------------------------chHHHHHHHHHcCC
Q 038696 236 DYQVRRRLGSGSQYKEIL-----WLGESFALRHFFGDI----------------------------EPLVPEISSLLSLS 282 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l-----~~g~~vAvK~~~~~~----------------------------~~~~~Ei~iL~~L~ 282 (683)
.|.+.+.||+|+++.++. .+|+.||||++.... ..+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 688999999998655553 368899999985321 12468999999997
Q ss_pred CCc--eeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCC
Q 038696 283 HPN--IMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK-IYHGNLN 358 (683)
Q Consensus 283 Hpn--Iv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IiHrDLK 358 (683)
+.+ +.+++. . ...+|||||++| +|...+.. ...+....+..++.||+.+|.|||+.| |+|||||
T Consensus 109 ~~~i~~p~~~~---~---~~~~lV~E~~~g~~L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIA---W---RRNVLVMEFIGGDGLPAPRLK------DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeE---e---cCceEEEEEecCCcccccccc------cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 633 334432 1 124899999998 66554322 234666778899999999999999999 9999999
Q ss_pred CCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 359 PSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 359 p~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+|||++ ++ .++|+|||.+...
T Consensus 177 p~NIli~-~~-------~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DG-------KVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CC-------CEEEEEChhhhcc
Confidence 9999998 44 6999999998654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=148.06 Aligned_cols=133 Identities=22% Similarity=0.320 Sum_probs=100.7
Q ss_pred CeEEEeEecccccEEEEEEcCcEEEEEEeCC-----------------CcchHHHHHHHHHcCCCCce--eeeeeeEEcC
Q 038696 236 DYQVRRRLGSGSQYKEILWLGESFALRHFFG-----------------DIEPLVPEISSLLSLSHPNI--MHFLCGFTDE 296 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~~g~~vAvK~~~~-----------------~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~e 296 (683)
.|.+.+..|.|+++.+.. .|..++||++.. ....+.+|++++..|+|++| +..++....+
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 566667788888777764 688999998732 11346789999999998875 5565543322
Q ss_pred CCC--eEEEEEecCCC--CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 297 EKK--ECFLIMELMSR--DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 297 ~~~--~~~LVmEy~~g--sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
... ..+|||||++| +|.+++.+ .+++.. .+.||+.+|.+||+.||+||||||.|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---- 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG---- 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----
Confidence 211 23599999985 88888764 345543 367899999999999999999999999998776
Q ss_pred CcceEEEecccCccc
Q 038696 373 GYLHAKISGFGLSSV 387 (683)
Q Consensus 373 ~~~~vKL~DFGla~~ 387 (683)
.++|+|||.+..
T Consensus 180 ---~v~LIDfg~~~~ 191 (239)
T PRK01723 180 ---KFWLIDFDRGEL 191 (239)
T ss_pred ---CEEEEECCCccc
Confidence 699999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.7e-15 Score=145.25 Aligned_cols=122 Identities=23% Similarity=0.269 Sum_probs=93.5
Q ss_pred ecccccEEEEE--EcCcEEEEEEeCCC------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 243 LGSGSQYKEIL--WLGESFALRHFFGD------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 243 LG~G~~~~v~l--~~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
||+|+++.++. ++|..|+||..... .+.+.+|++++..+.|+++......+.++ ...++||||+
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEEEE
Confidence 78888655554 57889999986421 13466899999999987654332223323 3468999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.+++... . . .++.|++.+|.+||+.|++|||++|.|||++ ++ .++++|||++..
T Consensus 80 ~g~~l~~~~~~~------~---~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-------~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG------N---D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-------KLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc------H---H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-------cEEEEECCCCcC
Confidence 86 888877541 1 0 7899999999999999999999999999998 44 699999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=144.60 Aligned_cols=128 Identities=17% Similarity=0.144 Sum_probs=97.9
Q ss_pred CeEEEeEecccccEEEEE---EcCcEEEEEEeCCCc--------------------------chHHHHHHHHHcCCCCc-
Q 038696 236 DYQVRRRLGSGSQYKEIL---WLGESFALRHFFGDI--------------------------EPLVPEISSLLSLSHPN- 285 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~~--------------------------~~~~~Ei~iL~~L~Hpn- 285 (683)
.|.+.+.||+|+++.++. .+|+.||||++.... ..+..|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 478889999999766653 368999999864211 12567899999998874
Q ss_pred -eeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 038696 286 -IMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNIL 363 (683)
Q Consensus 286 -Iv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NIL 363 (683)
++..++ . ...++||||++| +|..... ......++.+++.++.++|+.||+||||||+||+
T Consensus 96 ~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 96 PVPKPID----W--NRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred CCCceee----c--CCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 444432 1 345899999987 6654322 0245678899999999999999999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCcccc
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
++.++ .++|+|||++...
T Consensus 158 l~~~~-------~~~liDfg~~~~~ 175 (198)
T cd05144 158 VDDDE-------KIYIIDWPQMVST 175 (198)
T ss_pred EcCCC-------cEEEEECCccccC
Confidence 98776 7999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=165.05 Aligned_cols=129 Identities=19% Similarity=0.255 Sum_probs=100.0
Q ss_pred CeEEEeEecccccEEEEE--EcCcEEEEEEeC-C-----------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 236 DYQVRRRLGSGSQYKEIL--WLGESFALRHFF-G-----------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~-~-----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.|...+.||+|+++.|++ +.+..+++|+.. . ..+.+.+|++++..++|++|+..+..+.++ ...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--EEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--CCC
Confidence 345678999999777765 455566665431 1 023578999999999999988765444433 456
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++. ....++.|++.+|.|||+.||+||||||+|||++ ++ .++|+
T Consensus 412 ~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-------~~~li 469 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-------RLYLI 469 (535)
T ss_pred EEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-------cEEEE
Confidence 899999986 8988875 2467899999999999999999999999999994 33 59999
Q ss_pred cccCcccc
Q 038696 381 GFGLSSVK 388 (683)
Q Consensus 381 DFGla~~~ 388 (683)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-15 Score=174.43 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=183.6
Q ss_pred CCCeEEEeEecccccEEEEEE-----cCcEEEEEEeCCC------cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-----LGESFALRHFFGD------IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~ 301 (683)
...|.+.+.||+|++..+.+. ....+|+|.+... .+....|..+=..+. |.|++.+++.. .+....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCccc
Confidence 557899999999986666542 2335777766321 233445777777777 99999999876 344778
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH-SKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+++++|..| ++.+.+.. ......+...+..++.|+..++.|+| ..++.||||||+|.+++..+. .+|+
T Consensus 97 ~~~~~~s~g~~~f~~i~~----~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~------~l~~ 166 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISH----PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS------ALKI 166 (601)
T ss_pred ccccCccccccccccccc----CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC------cccC
Confidence 999999875 88877731 11225677788999999999999999 999999999999999987762 5999
Q ss_pred ecccCccccCC-CCCCCCCCCCCc-CcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 380 SGFGLSSVKNF-GPKSPSQSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 380 ~DFGla~~~~~-~~~~~~~~~~~g-t~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
+|||+|..+.. ...........| ++.|+|||...+.. ...+..|+||.|+++.-+++|..|+........
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~--------~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~ 238 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA--------YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG 238 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchh--------hcCCCcccccccccccccccCCCCccccccccc
Confidence 99999988765 333334445566 88999999997632 467789999999999999999999986554432
Q ss_pred HHHHHHHcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 458 KMSRNIRAGER--PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 458 ~~~~~i~~~~~--~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
.....+..... ............+++.+++..+|..|.+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 239 RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 22222222211 1223345667889999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.6e-13 Score=123.35 Aligned_cols=127 Identities=21% Similarity=0.210 Sum_probs=100.1
Q ss_pred EEeEecccccEEEEE--EcCcEEEEEEeCCCc--chHHHHHHHHHcCCC--CceeeeeeeEEcCCCCeEEEEEecCCC-C
Q 038696 239 VRRRLGSGSQYKEIL--WLGESFALRHFFGDI--EPLVPEISSLLSLSH--PNIMHFLCGFTDEEKKECFLIMELMSR-D 311 (683)
Q Consensus 239 i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~~--~~~~~Ei~iL~~L~H--pnIv~l~~~~~~e~~~~~~LVmEy~~g-s 311 (683)
+++.||+|+...++. ..+..++||.+.... ..+..|+.++..++| .++++++..+.. .+..+++|||+.| .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCCee
Confidence 457789987555553 345789999986654 478999999999976 588888776643 3678999999987 4
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 312 LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK---KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 312 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+ .++++|||.+..
T Consensus 80 ~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-------~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-------ILGIIDWEYAGY 138 (155)
T ss_pred cccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-------EEEEEecccccC
Confidence 4321 4456677899999999999985 799999999999998765 799999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-12 Score=126.97 Aligned_cols=127 Identities=20% Similarity=0.227 Sum_probs=88.2
Q ss_pred EeEecccccEEEEE---EcCcEEEEEEeCCCc------chH----------------------HHHHHHHHcCCCCc--e
Q 038696 240 RRRLGSGSQYKEIL---WLGESFALRHFFGDI------EPL----------------------VPEISSLLSLSHPN--I 286 (683)
Q Consensus 240 ~~~LG~G~~~~v~l---~~g~~vAvK~~~~~~------~~~----------------------~~Ei~iL~~L~Hpn--I 286 (683)
.+.||+|+++.++. .+|+.||||++.... ..+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46789998766654 368999999875321 111 34566666664332 3
Q ss_pred eeeeeeEEcCCCCeEEEEEecCCC-CHH-HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEE
Q 038696 287 MHFLCGFTDEEKKECFLIMELMSR-DLC-SYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNIL 363 (683)
Q Consensus 287 v~l~~~~~~e~~~~~~LVmEy~~g-sL~-~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NIL 363 (683)
.+.++. ...++||||++| ++. ..+... ... ..+..++.+++.++.++|. .||+||||||+||+
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEE
Confidence 444321 235899999986 322 222221 011 5678999999999999999 99999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCcccc
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
++ ++ .++|+|||.+...
T Consensus 148 i~-~~-------~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DG-------KVYIIDVPQAVEI 164 (187)
T ss_pred EE-CC-------cEEEEECcccccc
Confidence 98 55 6999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.3e-12 Score=138.29 Aligned_cols=247 Identities=22% Similarity=0.230 Sum_probs=176.9
Q ss_pred CCeEEEeEecc--cccEEEEE------EcCcEEEEEEeCC------CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCC
Q 038696 235 EDYQVRRRLGS--GSQYKEIL------WLGESFALRHFFG------DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 235 ~~y~i~~~LG~--G~~~~v~l------~~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~ 299 (683)
..+.+.+.+|. |+.+.++. .++..+|+|.-+. ....=.+|+...+.++ |+|.|+.+..+ ++++
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCC
Confidence 35677888999 87555553 3567899998421 2233456777777775 99999977777 5568
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR----GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
.+|+-+|+++.+|.++.... ...++...++.++.+... ||..+|..+++|-|+||.||++..+. .
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~-----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~------~ 260 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTP-----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW------T 260 (524)
T ss_pred cceeeeccccchhHHhhhcc-----cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc------c
Confidence 89999999999999888753 344788888889999999 99999999999999999999998772 2
Q ss_pred eEEEecccCccccCCCCCCCCC---CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQ---SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.++++|||+...+....-.... ....|...|++||.+++. ++...|+|++|.+..+..+|..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l----------~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL----------ATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc----------cchHhhhcchhhhhHhhHhhcccccCC
Confidence 7999999998876554311111 122455679999999765 899999999999999999886655432
Q ss_pred ccchhHHHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
... .-..++.++.+ .+......++...+..+++.+|-.|++.+.+.. +..|.
T Consensus 331 ~~~---~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~-l~~i~ 383 (524)
T KOG0601|consen 331 KNS---SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA-LNVIH 383 (524)
T ss_pred CCC---CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc-ccccc
Confidence 111 01112222211 123334566777999999999999998776654 34443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.1e-11 Score=137.82 Aligned_cols=243 Identities=22% Similarity=0.280 Sum_probs=178.4
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEe-------CCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHF-------FGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.....+.+.+.+-+-.|++..+... .|...++|+. ..+.+....+-.++-...||.++.....| ...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCC
Confidence 3455668888888888876666642 4555555544 23455555555555555678888766554 344
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...+|||+|++| +|...|... .+.+.+-+..++..+..+++|||...+.|||++|.|+|...++ +.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-------h~ 943 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNS------GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-------HR 943 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcC------CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-------Cc
Confidence 678999999975 899888752 3566667778888999999999999999999999999999888 89
Q ss_pred EEecccCccccCCC---------------------CC--------CCCCCCCCcCcccCChhhhhhccccccccCCCCCc
Q 038696 378 KISGFGLSSVKNFG---------------------PK--------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSE 428 (683)
Q Consensus 378 KL~DFGla~~~~~~---------------------~~--------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ 428 (683)
+++|||........ .. ........+|+.|.+||.+.+.. .+.
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~---------hgs 1014 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR---------HGS 1014 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc---------CCC
Confidence 99999843221100 00 01123557899999999998663 788
Q ss_pred hhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 429 KSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 429 ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
.+|+|++|++++|.++|.+||.....+ .+++++..+..+. -+...+...++++...+..+|.+|..+.
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq--~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQ--QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchh--hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 899999999999999999999887654 4566666555432 3445678899999999999999997655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=128.71 Aligned_cols=130 Identities=20% Similarity=0.250 Sum_probs=87.3
Q ss_pred eEecccc---cEEEEEEcCcEEEEEEeCCCc-c-------------------------------------------hHHH
Q 038696 241 RRLGSGS---QYKEILWLGESFALRHFFGDI-E-------------------------------------------PLVP 273 (683)
Q Consensus 241 ~~LG~G~---~~~v~l~~g~~vAvK~~~~~~-~-------------------------------------------~~~~ 273 (683)
+.||.|+ +|++.+.+|+.||||+.+... + ++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4588887 455556789999999974321 0 2445
Q ss_pred HHHHHHcCC-----CCce--eeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HH
Q 038696 274 EISSLLSLS-----HPNI--MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR-GM 344 (683)
Q Consensus 274 Ei~iL~~L~-----HpnI--v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-aL 344 (683)
|++.+..+. +++| .+++..+ ....+|||||++| +|.++.... ...+. ...++.+++. .+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~-----~~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALD-----EAGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHH-----hcCCC---HHHHHHHHHHHHH
Confidence 665555552 3333 2333222 1345999999987 887766431 01122 3445666665 47
Q ss_pred HHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 345 ~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
..+|..|++|+|+||.||+++.++ .++|+|||++....
T Consensus 271 ~ql~~~g~~H~D~hPgNilv~~~g-------~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLRDGFFHADLHPGNIFVLKDG-------KIIALDFGIVGRLS 308 (437)
T ss_pred HHHHhCCceeCCCCcccEEECCCC-------cEEEEeCCCeeECC
Confidence 889999999999999999998887 79999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.4e-10 Score=111.75 Aligned_cols=122 Identities=19% Similarity=0.198 Sum_probs=86.4
Q ss_pred EeEecccccEEEEE--EcCcEEEEEEeCCCc---chHHHHHHHHHcCCCCcee-eeeeeEEcCCCCeEEEEEecCCC-CH
Q 038696 240 RRRLGSGSQYKEIL--WLGESFALRHFFGDI---EPLVPEISSLLSLSHPNIM-HFLCGFTDEEKKECFLIMELMSR-DL 312 (683)
Q Consensus 240 ~~~LG~G~~~~v~l--~~g~~vAvK~~~~~~---~~~~~Ei~iL~~L~HpnIv-~l~~~~~~e~~~~~~LVmEy~~g-sL 312 (683)
++.|+.|....++. ..|..|+||+..... ..+..|+.++..+.+.+++ ++++.. . ...++||||++| ++
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCCcc
Confidence 34567775433332 468899999986542 4578999999999765554 444332 2 224899999998 55
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 313 CSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKI-----YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 313 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI-----iHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.+. . . ....++.+++.+|..||..++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 79 ~~~--~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-------~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-------RLWLIDWEYAGM 136 (170)
T ss_pred ccc--c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-------eEEEEecccccC
Confidence 432 0 1 113456899999999999985 9999999999998 33 589999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5e-11 Score=122.25 Aligned_cols=210 Identities=25% Similarity=0.318 Sum_probs=138.5
Q ss_pred hHHHHHHHHHcCCCCceeeeeeeEEc---CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038696 270 PLVPEISSLLSLSHPNIMHFLCGFTD---EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345 (683)
Q Consensus 270 ~~~~Ei~iL~~L~HpnIv~l~~~~~~---e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 345 (683)
....-..-|.++.|-|||+++.++.+ ++.....++.|||. |+|.++|++.. +....+......+++.||+.||.
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~--~~~~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK--KNQKALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH--HhhhhhhHHHHHHHHHHHHhhhh
Confidence 33344556677789999999877754 23456788999997 89999998743 23456788888999999999999
Q ss_pred HHHhC--CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC--CCCCCCCCCCCCcCcccCChhhhhhccccccc
Q 038696 346 YLHSK--KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN--FGPKSPSQSGTTHPFIWHAPEVLEENEQTESA 421 (683)
Q Consensus 346 yLH~~--gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~--~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~ 421 (683)
|||+. .|+|+++.-+-|++..+| -+|+.--.-..... ............+-++|.|||.=.
T Consensus 191 yLhs~~PpiihgnlTc~tifiq~ng-------LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-------- 255 (458)
T KOG1266|consen 191 YLHSCDPPIIHGNLTCDTIFIQHNG-------LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-------- 255 (458)
T ss_pred hhhccCCccccCCcchhheeecCCc-------eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------
Confidence 99986 699999999999999887 56654211111000 000011111223456689998642
Q ss_pred cCCCCCchhHHHhHHHHHHHHHhCCCC-CCCCccc-hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 422 SNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQ-GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 422 ~~~~~s~ksDVwSlGvil~ElltG~~P-f~~~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
..+.+.++|||+||+...||..|..- -...... .++...++..+. ...--+.++..|+...|..||++..
T Consensus 256 -~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~ 327 (458)
T KOG1266|consen 256 -TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARL 327 (458)
T ss_pred -ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhh
Confidence 22467789999999999999987653 2221111 011111111111 1111356889999999999999999
Q ss_pred HHHHH
Q 038696 500 ICRIL 504 (683)
Q Consensus 500 il~~L 504 (683)
++.|.
T Consensus 328 llfHp 332 (458)
T KOG1266|consen 328 LLFHP 332 (458)
T ss_pred hhcCc
Confidence 87664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6e-11 Score=131.10 Aligned_cols=243 Identities=21% Similarity=0.233 Sum_probs=167.9
Q ss_pred EeeCCCeEEEeEecccccEEEEE-----EcCcEEEEEEeCCCcch------HHHHHHHHHcC-CCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL-----WLGESFALRHFFGDIEP------LVPEISSLLSL-SHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l-----~~g~~vAvK~~~~~~~~------~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~ 298 (683)
.....+|..+..||.|.+..++. ..+..|++|.+.+.... -..|+-+...+ .|.+++.++..+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-- 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-- 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--
Confidence 34456899999999998544443 35678999988653222 24566666666 499999887766433
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...||=-|||.| ++...+.- ...+.+...+++..|++.++.++|++.++|+|+||+||++..++ +..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~------~~~ 406 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG------FFS 406 (524)
T ss_pred ccccCchhhhcCcchhhhhHH------HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch------hhh
Confidence 456788999974 44433321 13477788899999999999999999999999999999997753 378
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccC-ChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~-APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
++.|||+++.+.... .... ..-+++ ..|++... ..+..++|+||||.-+.+.++|...-....
T Consensus 407 ~~~~~~~~t~~~~~~----~~~~-~~~r~~p~~~~~~e~--------~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--- 470 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS----GVFH-HIDRLYPIAEILLED--------YPHLSKADIFSLGLSVDEAITGSPLSESGV--- 470 (524)
T ss_pred hccccccccccceec----cccc-ccccccccchhhccc--------cccccccccccccccccccccCcccCcccc---
Confidence 999999987532211 1111 112244 25555432 257889999999999999999865322211
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
....+..+..+..+... .++..+.+.+...++..||.+.++..+...
T Consensus 471 --~~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 --QSLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --cceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11334455544444444 788899999999999999998887665544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.8e-10 Score=108.99 Aligned_cols=95 Identities=15% Similarity=0.153 Sum_probs=72.6
Q ss_pred HHHHHHHcCC--CCceeeeeeeEEcCCCCeEEEEEecCCC-CHH-HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-
Q 038696 273 PEISSLLSLS--HPNIMHFLCGFTDEEKKECFLIMELMSR-DLC-SYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYL- 347 (683)
Q Consensus 273 ~Ei~iL~~L~--HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~-~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL- 347 (683)
+|++.|.++. .-++.+.+++ ..-+|||||++| ++. ..+++ ..++..+...+..+++.+|..|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHH
Confidence 8999999985 3456666643 124899999986 332 23332 2355667778899999999999
Q ss_pred HhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 348 HSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 348 H~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+.||||+||++.|||++.+ .+.|+|||.+...
T Consensus 142 H~~glVHGDLs~~NIL~~~~--------~v~iIDF~qav~~ 174 (197)
T cd05146 142 KECNLVHADLSEYNMLWHDG--------KVWFIDVSQSVEP 174 (197)
T ss_pred HhCCeecCCCCHHHEEEECC--------cEEEEECCCceeC
Confidence 89999999999999999754 4999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.5e-09 Score=118.35 Aligned_cols=162 Identities=20% Similarity=0.270 Sum_probs=120.2
Q ss_pred EEEcCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCC
Q 038696 252 ILWLGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327 (683)
Q Consensus 252 ~l~~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~ 327 (683)
...+|.+|.|...+.. .+...+-++-|+.|+||||+++++.+. ..+.+|||+|-+.. |..++++
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~P-l~~~lk~--------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVRP-LETVLKE--------- 100 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeecccc-HHHHHHH---------
Confidence 3457888888888643 234677889999999999999999884 44789999998753 3445554
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCccc
Q 038696 328 FSLPVAVDLMLQIARGMEYLH-SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIW 406 (683)
Q Consensus 328 l~~~~~~~i~~qi~~aL~yLH-~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y 406 (683)
+....+..-+.||+.||.||| +.+++|++|.-+-|+|+..| ..||++|-++........ .......-..|
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-------eWkLggle~v~~~~~~~~--~~~~~~~~~s~ 171 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-------EWKLGGLELVSKASGFNA--PAKSLYLIESF 171 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-------cEEEeeeEEEeccccCCc--ccccchhhhcc
Confidence 346677788999999999997 67899999999999999998 899999998755432211 00111111236
Q ss_pred CChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC
Q 038696 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445 (683)
Q Consensus 407 ~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG 445 (683)
..|+.+... .-..|.|-|||+++|++.|
T Consensus 172 ~~P~~~~~s-----------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPS-----------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCcc-----------ccchhhhhHHHHHHHHhCc
Confidence 677765321 1357999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.5e-10 Score=125.11 Aligned_cols=140 Identities=17% Similarity=0.203 Sum_probs=85.1
Q ss_pred CeEEEeEecccccEEEE---EEc-CcEEEEEEeCCCc-------------------------------------------
Q 038696 236 DYQVRRRLGSGSQYKEI---LWL-GESFALRHFFGDI------------------------------------------- 268 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~---l~~-g~~vAvK~~~~~~------------------------------------------- 268 (683)
+|+. +.||.|+++.|+ +.+ |+.||||+.....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 5665 679999865555 445 9999999985321
Q ss_pred -chHHHHHHHHHcCC----CCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHH--HHHhcCCCCCCCCCHHHHHHHHHHH
Q 038696 269 -EPLVPEISSLLSLS----HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSY--IKEICCPRKRIPFSLPVAVDLMLQI 340 (683)
Q Consensus 269 -~~~~~Ei~iL~~L~----HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~--l~~~~~~~~~~~l~~~~~~~i~~qi 340 (683)
-++.+|+..+.++. +.+.+.+-.++.+ -...-+|||||++| .+.++ +.... .....+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAG--TDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcC--CCHHHHHHHHHHHHHHHH
Confidence 02344555554442 3322222222211 11345899999997 78764 32210 001124444445555555
Q ss_pred HHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 341 ~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
+ ..|++|+|+||.||+++.+| .....++++|||++....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g---~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDP---PENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCC---CCCCeEEEEecceEEECC
Confidence 4 58999999999999998775 223369999999987654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.8e-09 Score=99.42 Aligned_cols=137 Identities=23% Similarity=0.276 Sum_probs=97.1
Q ss_pred EEeEecccccEEEEE--EcCcEEEEEEeCC------------CcchHHHHHHHHHcCCCCce--eeeeeeEEcCCCCeEE
Q 038696 239 VRRRLGSGSQYKEIL--WLGESFALRHFFG------------DIEPLVPEISSLLSLSHPNI--MHFLCGFTDEEKKECF 302 (683)
Q Consensus 239 i~~~LG~G~~~~v~l--~~g~~vAvK~~~~------------~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~e~~~~~~ 302 (683)
.+..|-+|+-..+.. +.|+.+.||.-.. ...+..+|+++|.++.--.| .++ +|.|.. .-.
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l--~~~D~~--~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL--IFIDTY--GGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE--EEEecC--CCe
Confidence 445566776444442 6899999986421 13456789999998853333 233 233332 337
Q ss_pred EEEecCCC--CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 303 LIMELMSR--DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 303 LVmEy~~g--sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+|||++| ++.+++...... .........++.+|-+.+.-||..+|||+||..+||++.+++ +.+.+.++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~----~~~~~~lI 158 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG----NQITPILI 158 (229)
T ss_pred EEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC----CcCceEEE
Confidence 89999998 899999875432 222333478888999999999999999999999999998776 33467999
Q ss_pred cccCccc
Q 038696 381 GFGLSSV 387 (683)
Q Consensus 381 DFGla~~ 387 (683)
|||++..
T Consensus 159 dfgls~~ 165 (229)
T KOG3087|consen 159 DFGLSSV 165 (229)
T ss_pred eecchhc
Confidence 9999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-08 Score=104.21 Aligned_cols=131 Identities=17% Similarity=0.143 Sum_probs=90.8
Q ss_pred EEcCcEEEEEEeCCCc---------------chHHHHHHHHHcCCCCce--eeeeeeEEc---CCCCeEEEEEecCCC--
Q 038696 253 LWLGESFALRHFFGDI---------------EPLVPEISSLLSLSHPNI--MHFLCGFTD---EEKKECFLIMELMSR-- 310 (683)
Q Consensus 253 l~~g~~vAvK~~~~~~---------------~~~~~Ei~iL~~L~HpnI--v~l~~~~~~---e~~~~~~LVmEy~~g-- 310 (683)
.+.|+.|.||...... ..+.+|.+.+..|..-+| +..+++... ......+||||+++|
T Consensus 42 ~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~ 121 (268)
T PRK15123 42 ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTI 121 (268)
T ss_pred EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCc
Confidence 3577888888764311 137799999888743333 233323321 112457899999987
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+|.+++.+.. ..+.+......++.+++..+.-||+.||+|+|++++|||++.+....++...+.|+||+.+..
T Consensus 122 sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 122 SLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 7888886421 134566778899999999999999999999999999999975200012334799999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.9e-09 Score=99.84 Aligned_cols=121 Identities=21% Similarity=0.238 Sum_probs=84.1
Q ss_pred EecccccEEEE--EEcCcEEEEEEeC-C-----C------cchHHHHHHHHHcCCCC--ceeeeeeeEEcCCCCeEEEEE
Q 038696 242 RLGSGSQYKEI--LWLGESFALRHFF-G-----D------IEPLVPEISSLLSLSHP--NIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 242 ~LG~G~~~~v~--l~~g~~vAvK~~~-~-----~------~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~e~~~~~~LVm 305 (683)
.+++|+--.++ .+.|..+.+|.=. + . .+...+|+++|..+.-- ++..+|++. . ....|+|
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCEEEE
Confidence 35666532222 2467677777532 1 1 24567899999988533 334444322 3 4468999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| .|.+++... ...++..+-.-+.-||..||+|+||.++||+++.++ +.++||||
T Consensus 79 e~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~--------i~~IDfGL 137 (204)
T COG3642 79 EYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR--------IYFIDFGL 137 (204)
T ss_pred EEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc--------EEEEECCc
Confidence 99999 677788651 245666677777889999999999999999998774 99999999
Q ss_pred ccc
Q 038696 385 SSV 387 (683)
Q Consensus 385 a~~ 387 (683)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.5e-09 Score=101.51 Aligned_cols=120 Identities=23% Similarity=0.214 Sum_probs=79.3
Q ss_pred cEEEEEEcCcEEEEEEeCCC------------------------------cchHHHHHHHHHcCCCC--ceeeeeeeEEc
Q 038696 248 QYKEILWLGESFALRHFFGD------------------------------IEPLVPEISSLLSLSHP--NIMHFLCGFTD 295 (683)
Q Consensus 248 ~~~v~l~~g~~vAvK~~~~~------------------------------~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~ 295 (683)
+|.++-.+|..+|||+.+.. .....+|.+.|..+..- ++.+.+++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 45555567889999987310 12357899999999755 566665432
Q ss_pred CCCCeEEEEEecCC--CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 296 EEKKECFLIMELMS--RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEY-LHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 296 e~~~~~~LVmEy~~--gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
. -+|||||++ |.....|.+ ..++......++.+++..+.. +|..||+|+||.+.|||++.++
T Consensus 80 ~----~~ivME~I~~~G~~~~~l~~-------~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~---- 144 (188)
T PF01163_consen 80 R----NVIVMEYIGEDGVPLPRLKD-------VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGK---- 144 (188)
T ss_dssp T----TEEEEE--EETTEEGGCHHH-------CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTC----
T ss_pred C----CEEEEEecCCCccchhhHHh-------ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecce----
Confidence 2 279999998 743344444 112234567788888886666 5799999999999999998774
Q ss_pred CcceEEEecccCcccc
Q 038696 373 GYLHAKISGFGLSSVK 388 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~ 388 (683)
+.|+|||.+...
T Consensus 145 ----~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 ----VYIIDFGQAVDS 156 (188)
T ss_dssp ----EEE--GTTEEET
T ss_pred ----EEEEecCcceec
Confidence 999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.9e-08 Score=100.88 Aligned_cols=133 Identities=21% Similarity=0.234 Sum_probs=91.0
Q ss_pred eEecccc---cEEEEEEcCcEEEEEEeCCC-----cchHHHHHHHHHcCCC--CceeeeeeeEEcCC-CCeEEEEEecCC
Q 038696 241 RRLGSGS---QYKEILWLGESFALRHFFGD-----IEPLVPEISSLLSLSH--PNIMHFLCGFTDEE-KKECFLIMELMS 309 (683)
Q Consensus 241 ~~LG~G~---~~~v~l~~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~e~-~~~~~LVmEy~~ 309 (683)
+.||.|. +|++...+|+.++||..... ...+..|++++..+.+ .++.+++....... .+..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 4567775 35544445689999997542 4578999999999975 34566655442211 125689999998
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS--------------------------------------- 349 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------------------------------------- 349 (683)
| ++.+.+.. ..++......++.+++.+|.+||+
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 7 56543320 235666666777777777777773
Q ss_pred -----------------CCcccCCCCCCcEEeCC--CCCCCCCcceEEEecccCccc
Q 038696 350 -----------------KKIYHGNLNPSNILLKP--RGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 350 -----------------~gIiHrDLKp~NILl~~--~g~~~~~~~~vKL~DFGla~~ 387 (683)
..++|+|+++.|||++. ++ .+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~-------~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR-------VVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc-------EEEEEecccccc
Confidence 24689999999999987 44 589999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.1e-07 Score=100.15 Aligned_cols=212 Identities=17% Similarity=0.234 Sum_probs=145.8
Q ss_pred cEEEEE-EcCcEEEEEEeCCCcc----hHHHHHHHHHcCCCCceeeeeeeEEcC--CCCeEEEEEecCCC--CHHHHHHH
Q 038696 248 QYKEIL-WLGESFALRHFFGDIE----PLVPEISSLLSLSHPNIMHFLCGFTDE--EKKECFLIMELMSR--DLCSYIKE 318 (683)
Q Consensus 248 ~~~v~l-~~g~~vAvK~~~~~~~----~~~~Ei~iL~~L~HpnIv~l~~~~~~e--~~~~~~LVmEy~~g--sL~~~l~~ 318 (683)
.|+++- .+|..|.+|+++++.. ....-++.++++.|+|||++..+|... ...-+++|++|+++ +|.++--.
T Consensus 292 tyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~ 371 (655)
T KOG3741|consen 292 TYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFA 371 (655)
T ss_pred eEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHcc
Confidence 466664 5899999999965432 234557889999999999998877621 22468999999984 88876543
Q ss_pred hcC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 319 ICC---------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 319 ~~~---------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
... +......++..++.|+.|+..||.++|+.|+.-+-|.+.+||++.+. .++|+.-|+.....
T Consensus 372 ~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-------RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 372 NPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-------RIRISGCGIMDVLQ 444 (655)
T ss_pred CCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-------eEEEecccceeeec
Confidence 211 11233567889999999999999999999999999999999996553 68888777665443
Q ss_pred CCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCC-CCCCccchhHHHHHHHcCCC
Q 038696 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP-FEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 390 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~P-f~~~~~~~~~~~~~i~~~~~ 468 (683)
... + |-+.+ -.+-|.=.||.+++.|.||..- +.....+. .-.+.
T Consensus 445 ~d~---------~-------~~le~------------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~~------ 489 (655)
T KOG3741|consen 445 EDP---------T-------EPLES------------QQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLTR------ 489 (655)
T ss_pred CCC---------C-------cchhH------------HhhhhHHHHHHHHHHHhhcccccccccchHH-HHHHH------
Confidence 221 1 11221 2356888999999999999643 11111110 00111
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.....+.+++++|......++.+ -++.+++.++
T Consensus 490 --I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 --ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 22345777889999888888886 4677766554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.6e-07 Score=96.45 Aligned_cols=260 Identities=14% Similarity=0.199 Sum_probs=160.7
Q ss_pred EEEeEecccccEEEEEEcCc--EEEEEEeCCCcc-hHHHHHHHHHcC-CCCceeeee----eeEEcC-CCCeEEEEEecC
Q 038696 238 QVRRRLGSGSQYKEILWLGE--SFALRHFFGDIE-PLVPEISSLLSL-SHPNIMHFL----CGFTDE-EKKECFLIMELM 308 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l~~g~--~vAvK~~~~~~~-~~~~Ei~iL~~L-~HpnIv~l~----~~~~~e-~~~~~~LVmEy~ 308 (683)
...+-||+|+-.-++ ..|+ ..+-|++..-.- .-..-+..|... .||-+-.-+ ...... .+...-+.|..+
T Consensus 14 ~~gr~LgqGgea~ly-~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 14 PPGRPLGQGGEADLY-TLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCCccccCCccceee-ecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 445678888733333 1222 233477654221 112223334443 466543311 111112 223477889988
Q ss_pred CC--CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 309 SR--DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 309 ~g--sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.| ....++.-...-+....+.|+.+++.++.++.+...||..|.+-+|++++|+|+++++ .|.|.|=..-.
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-------~V~LVdsDsfq 165 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-------KVVLVDSDSFQ 165 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-------eEEEEccccee
Confidence 76 4555543221112234578999999999999999999999999999999999999887 78888733221
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC-CCCCCCCccch------h-H
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG-KVPFEDAHLQG------D-K 458 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG-~~Pf~~~~~~~------~-~ 458 (683)
... ......+.+|...|.+||.-.- .++.+-.-+...|.|.||+++++++.| +.||.+..... + .
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~----~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTL----PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhcc----ccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 111 1123345677788999997542 234455577889999999999999985 99998643211 1 0
Q ss_pred H-------HHHHHcCCCCC---CC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHh
Q 038696 459 M-------SRNIRAGERPL---FP-FHSPKYVTNLTKRCWHA--DPNQRPSFSSICRILRYIKRFIM 512 (683)
Q Consensus 459 ~-------~~~i~~~~~~~---~p-~~~~~~l~~Li~~cL~~--dP~~RPt~~eil~~L~~i~~~~~ 512 (683)
+ ...-..+.++. .| ...++++..|..+|+.. ++.-|||.+.-+..|..+...+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 1 01111122111 11 12368899999999965 46789999999988888876654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.4e-07 Score=88.97 Aligned_cols=109 Identities=24% Similarity=0.309 Sum_probs=81.7
Q ss_pred chHHHHHHHHHcCCCCc--eeeeeeeEEcCC--CCeEEEEEecCCC--CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 038696 269 EPLVPEISSLLSLSHPN--IMHFLCGFTDEE--KKECFLIMELMSR--DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342 (683)
Q Consensus 269 ~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~e~--~~~~~LVmEy~~g--sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~ 342 (683)
....+|.+.+..|..-. +.+.+++..... ....+||||+++| +|.+++... ..++......++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~------~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW------EQLDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh------cccchhhHHHHHHHHHH
Confidence 35778888888774322 233333332211 1346899999986 799998752 22566778899999999
Q ss_pred HHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 343 aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.+.-||+.||+|+|+++.|||++.++ +...+.|+||+.++.
T Consensus 130 ~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 99999999999999999999998774 445799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-06 Score=85.43 Aligned_cols=125 Identities=18% Similarity=0.223 Sum_probs=91.2
Q ss_pred EcCcEEEEEEeCC----------CcchHHHHHHHHHcCCCC--ceeeeeeeEE--cCCCCeEEEEEecCCC--CHHHHHH
Q 038696 254 WLGESFALRHFFG----------DIEPLVPEISSLLSLSHP--NIMHFLCGFT--DEEKKECFLIMELMSR--DLCSYIK 317 (683)
Q Consensus 254 ~~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~--~e~~~~~~LVmEy~~g--sL~~~l~ 317 (683)
..|..+-||.-.+ ....|.+|+..|..|..- .+.+...+-. .......+||+|-++| +|.+++.
T Consensus 39 ~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~ 118 (216)
T PRK09902 39 RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYA 118 (216)
T ss_pred eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHh
Confidence 3566788887532 245689999999998532 2444432211 1112346899998885 9999886
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 318 EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 318 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+. ...+.+......++.+|+..+.-||+.|+.|+|+.+.|||++.+| .+.|+++||.-++.
T Consensus 119 ~~----~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-----~~~v~lIDlEk~r~ 179 (216)
T PRK09902 119 QH----AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-----KAEAGFLDLEKSRR 179 (216)
T ss_pred cC----CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-----CeeEEEEEhhccch
Confidence 51 223457777889999999999999999999999999999998554 24699999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.8e-06 Score=86.35 Aligned_cols=130 Identities=16% Similarity=0.220 Sum_probs=82.5
Q ss_pred CCeEEEeEecccccEEEE--EEcCcEEEEEEeCCCc-------------chHHHHHHHHHcC---CCCceeeeeeeEEc-
Q 038696 235 EDYQVRRRLGSGSQYKEI--LWLGESFALRHFFGDI-------------EPLVPEISSLLSL---SHPNIMHFLCGFTD- 295 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~--l~~g~~vAvK~~~~~~-------------~~~~~Ei~iL~~L---~HpnIv~l~~~~~~- 295 (683)
++|.+.+.+-....-.|. ..+|..+.+|...... ....+++..+..+ .--..+.++.+..-
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 478887777665433333 3589999999875421 1223444433333 22233332222110
Q ss_pred --CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 296 --EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 296 --e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
.-....+|||||++| .|.++.. +++ .+...|..+|.-||+.|++|+|.+|+|++++.++
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---- 172 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---- 172 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----
Confidence 111345689999999 6665432 222 2445677889999999999999999999998775
Q ss_pred CcceEEEecccCcc
Q 038696 373 GYLHAKISGFGLSS 386 (683)
Q Consensus 373 ~~~~vKL~DFGla~ 386 (683)
++++||+..+
T Consensus 173 ----i~iID~~~k~ 182 (229)
T PF06176_consen 173 ----IRIIDTQGKR 182 (229)
T ss_pred ----EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.2e-08 Score=107.98 Aligned_cols=148 Identities=24% Similarity=0.373 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCC-------CCCCCCcCcccCCh
Q 038696 338 LQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP-------SQSGTTHPFIWHAP 409 (683)
Q Consensus 338 ~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~-------~~~~~~gt~~Y~AP 409 (683)
.+++.||.|+|.. ++||++|-|++|.++..+ ..||+.|+.+.......... ..........|.||
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-------~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-------DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCc-------ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3455999999965 899999999999999888 79999999986554421111 11112234569999
Q ss_pred hhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc-hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhh
Q 038696 410 EVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ-GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCW 487 (683)
Q Consensus 410 Evl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL 487 (683)
|++.+. ..+.++|+||+|+++|.+.. |+.-+...... ...............+....|.++++=+.+++
T Consensus 179 E~~~~~---------~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 179 EYLLGT---------TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred hhhccc---------cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 999754 47889999999999999994 66655443211 11111111222223345678999999999999
Q ss_pred hcCCCCCCCHHHHH
Q 038696 488 HADPNQRPSFSSIC 501 (683)
Q Consensus 488 ~~dP~~RPt~~eil 501 (683)
..++.-||++..+.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-06 Score=88.80 Aligned_cols=125 Identities=17% Similarity=0.223 Sum_probs=89.1
Q ss_pred eEEEeEecccc---cEEEEEEcCcEEEEEEeCC--------------------------CcchHHHHHHHHHcCCCC--c
Q 038696 237 YQVRRRLGSGS---QYKEILWLGESFALRHFFG--------------------------DIEPLVPEISSLLSLSHP--N 285 (683)
Q Consensus 237 y~i~~~LG~G~---~~~v~l~~g~~vAvK~~~~--------------------------~~~~~~~Ei~iL~~L~Hp--n 285 (683)
+.+...||-|. +|.++...|.++|||.-.- .....++|.++|..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45667788775 6777766799999996420 012457899999999754 6
Q ss_pred eeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe
Q 038696 286 IMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL 364 (683)
Q Consensus 286 Iv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl 364 (683)
|.+-+++ +.-.+||||++| -|.. .+++....-.++..|+.-+.-+-..||||+|+.+=|||+
T Consensus 173 VP~P~~~------nRHaVvMe~ieG~eL~~-----------~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW------NRHAVVMEYIEGVELYR-----------LRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc------ccceeeeehcccceeec-----------ccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence 7766542 345899999999 3332 112344455556666666666668999999999999999
Q ss_pred CCCCCCCCCcceEEEecccCc
Q 038696 365 KPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 365 ~~~g~~~~~~~~vKL~DFGla 385 (683)
+.+| .+.++||--+
T Consensus 236 ~~dg-------~~~vIDwPQ~ 249 (304)
T COG0478 236 TEDG-------DIVVIDWPQA 249 (304)
T ss_pred ecCC-------CEEEEeCccc
Confidence 9997 6999998544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.2e-06 Score=96.66 Aligned_cols=130 Identities=18% Similarity=0.270 Sum_probs=82.3
Q ss_pred Eecccc---cEEEEEEcCcEEEEEEeCCCc--------------------------------------------chHHHH
Q 038696 242 RLGSGS---QYKEILWLGESFALRHFFGDI--------------------------------------------EPLVPE 274 (683)
Q Consensus 242 ~LG~G~---~~~v~l~~g~~vAvK~~~~~~--------------------------------------------~~~~~E 274 (683)
-|+.++ |+.+.+.+|+.||||+..... =++.+|
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 345544 788888899999999973110 034567
Q ss_pred HHHHHcCC-----CCce--eeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 038696 275 ISSLLSLS-----HPNI--MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEY 346 (683)
Q Consensus 275 i~iL~~L~-----HpnI--v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y 346 (683)
+..+..+. .++| .++|--++ +.-.|+|||++| .+.+...-. ...++...+...+.++. +..
T Consensus 212 A~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~-----~~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 212 AANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALK-----SAGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHH-----hcCCCHHHHHHHHHHHH--HHH
Confidence 77766652 4443 33332222 234899999998 677663221 12344333333222222 233
Q ss_pred HHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 347 LH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
+=..|++|.|.+|.||+++.+| .+.+.|||+.....
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g-------~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDG-------RIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcCccccCCCccceEEecCC-------cEEEEcCcceecCC
Confidence 3348999999999999999998 79999999986554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-05 Score=78.37 Aligned_cols=68 Identities=16% Similarity=0.112 Sum_probs=47.3
Q ss_pred eEecccccEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCce--eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 241 RRLGSGSQYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHPNI--MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 241 ~~LG~G~~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
..||+|....++...|..+++|..... .....+|.+++..+..-.+ .+.++... ..+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeecCC
Confidence 457888755666556778889998642 3567899999998864333 44554443 33567899999998
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.3e-05 Score=79.26 Aligned_cols=126 Identities=19% Similarity=0.204 Sum_probs=87.5
Q ss_pred EecccccEEEEE---EcCcEEEEEEeCCCc-----------------------c-----hHHHHHHHHHcCC--CCceee
Q 038696 242 RLGSGSQYKEIL---WLGESFALRHFFGDI-----------------------E-----PLVPEISSLLSLS--HPNIMH 288 (683)
Q Consensus 242 ~LG~G~~~~v~l---~~g~~vAvK~~~~~~-----------------------~-----~~~~Ei~iL~~L~--HpnIv~ 288 (683)
.|..|.--.|++ .++..||||+++... . -..+|.+-|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 555564333333 568999999984211 0 1357888888874 556666
Q ss_pred eeeeEEcCCCCeEEEEEecCCCC--HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeC
Q 038696 289 FLCGFTDEEKKECFLIMELMSRD--LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLK 365 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~gs--L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~ 365 (683)
-+.+. .-.|||||++.. -.-.|++ .++...++..+..+++..+.-|-. .++||+||..=|||+.
T Consensus 135 Pi~~~------~nVLvMEfIg~~g~pAP~LkD-------v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR------NNVLVMEFIGDDGLPAPRLKD-------VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec------CCeEEEEeccCCCCCCCCccc-------CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 65544 137999999743 1222222 344555788889999999998877 8999999999999998
Q ss_pred CCCCCCCCcceEEEecccCcccc
Q 038696 366 PRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 366 ~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
++ .+.|+|||-|...
T Consensus 202 ~~--------~p~iID~~QaV~~ 216 (268)
T COG1718 202 DG--------EPYIIDVSQAVTI 216 (268)
T ss_pred CC--------eEEEEECcccccc
Confidence 44 5999999987544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.7e-05 Score=85.15 Aligned_cols=126 Identities=17% Similarity=0.202 Sum_probs=81.3
Q ss_pred cEEEEEEcCcEEEEEEeCCCc-----------------------------------------chHHHHHHHHHcC----C
Q 038696 248 QYKEILWLGESFALRHFFGDI-----------------------------------------EPLVPEISSLLSL----S 282 (683)
Q Consensus 248 ~~~v~l~~g~~vAvK~~~~~~-----------------------------------------~~~~~Ei~iL~~L----~ 282 (683)
|++..+.+|+.||||+-+.+. =+|.+|++....+ .
T Consensus 177 VhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~ 256 (538)
T KOG1235|consen 177 VHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFK 256 (538)
T ss_pred eEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHH
Confidence 788888999999999863211 1345666554443 4
Q ss_pred CCc------eeeeeeeEEcCCCCeEEEEEecCCC---CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 038696 283 HPN------IMHFLCGFTDEEKKECFLIMELMSR---DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIY 353 (683)
Q Consensus 283 Hpn------Iv~l~~~~~~e~~~~~~LVmEy~~g---sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIi 353 (683)
|-+ |.++|-.+. ..-.|+||||+| +=.++|.+ ..++...+...+.++..- -|-..|++
T Consensus 257 ~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~-------~gi~~~~i~~~l~~~~~~--qIf~~Gff 323 (538)
T KOG1235|consen 257 DFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK-------RGISPHDILNKLVEAYLE--QIFKTGFF 323 (538)
T ss_pred hcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHH-------cCCCHHHHHHHHHHHHHH--HHHhcCCc
Confidence 555 555543332 345899999987 32355654 235555444444443322 23346799
Q ss_pred cCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 354 HGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 354 HrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
|+|-+|.||++..++ .+...+.+.|||+.....
T Consensus 324 HaDPHPGNilv~~~~---~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 324 HADPHPGNILVRPNP---EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCCCCCcEEEecCC---CCCccEEEEccccccccc
Confidence 999999999998654 344589999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00024 Score=70.70 Aligned_cols=125 Identities=20% Similarity=0.228 Sum_probs=89.2
Q ss_pred eEecccccEEEEEE-cCcEEEEEEeCCC--------------------cchHHHHHHHHHcCC------CCceeeeeeeE
Q 038696 241 RRLGSGSQYKEILW-LGESFALRHFFGD--------------------IEPLVPEISSLLSLS------HPNIMHFLCGF 293 (683)
Q Consensus 241 ~~LG~G~~~~v~l~-~g~~vAvK~~~~~--------------------~~~~~~Ei~iL~~L~------HpnIv~l~~~~ 293 (683)
..||+|+.-.++.. ......||+.... ..+..+|+.-...+. +.+|.++++..
T Consensus 7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v 86 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV 86 (199)
T ss_pred cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence 45788886555543 5566778887543 356778887777666 88899999888
Q ss_pred EcCCCCeEEEEEecC---CC----CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC
Q 038696 294 TDEEKKECFLIMELM---SR----DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP 366 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~---~g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~ 366 (683)
..+ ..+-+|+|.+ +| +|.+++++ ..++. .+...+-+-..||-+.+|+.+||+|.||++..
T Consensus 87 eT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 87 ETN--LGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred ecC--CceEEEEEEEECCCCCcCccHHHHHHc-------CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 554 5578888876 23 68888864 34555 23334445567888999999999999999987
Q ss_pred CCCCCCCcceEEEec
Q 038696 367 RGASTEGYLHAKISG 381 (683)
Q Consensus 367 ~g~~~~~~~~vKL~D 381 (683)
.+ ++...+.|+|
T Consensus 154 ~~---~~~~~lvlID 165 (199)
T PF10707_consen 154 RD---SGEFRLVLID 165 (199)
T ss_pred cC---CCceEEEEEe
Confidence 75 4445788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr) | Back alignment and domain information |
|---|
Probab=97.73 E-value=6.5e-06 Score=71.39 Aligned_cols=63 Identities=10% Similarity=0.060 Sum_probs=49.3
Q ss_pred ccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhh-hhhhhh
Q 038696 128 AEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFN-KIQQKK 196 (683)
Q Consensus 128 ~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~-~~~~~~ 196 (683)
+||||.++|++|+.+|. .+|+|++|.++...+. |+| ..+.++|+.|....+.|++.. ...+.+
T Consensus 1 ~w~~g~i~r~~Ae~~L~~~~~G~FLiR~s~~~~~~------~~Lsv~~~~~v~H~~I~~~~~~~~~~~~~~~f~s 69 (94)
T cd00173 1 PWYHGPISREEAEELLKKKPDGTFLVRDSESSPGD------YVLSVRVKGKVKHYRIERTDDGYYLLGEGRSFPS 69 (94)
T ss_pred CccccCCCHHHHHHHHhcCCCceEEEEecCCCCCC------EEEEEEECCEEEEEEEEECCCCeEEecCCCccCC
Confidence 69999999999999999 8999999999854444 777 344688999987777776654 334433
|
SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. |
| >smart00252 SH2 Src homology 2 domains | Back alignment and domain information |
|---|
Probab=97.73 E-value=6.1e-06 Score=70.18 Aligned_cols=67 Identities=10% Similarity=0.105 Sum_probs=49.6
Q ss_pred hccccCCCchhHHHHHHhhc--CCceeeeccccccccccCeeeee---chhhhhhhhhhhcc-cchhhhhhhhhhhccC
Q 038696 127 AAEFSGWDPDQMHKKKLVHS--GKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKE-DRWILFNKIQQKKISG 199 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~~~--g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~ 199 (683)
++||||.++|++|+.+|... |+|++|.|+...+. |+| ....++|+.|...+ +.|.+.....+.++.+
T Consensus 1 ~~w~~g~i~r~~Ae~lL~~~~~G~FLvR~s~~~~~~------~~Lsv~~~~~~~h~~I~~~~~~~~~l~~~~~F~sl~e 73 (84)
T smart00252 1 QPWYHGFISREEAEKLLKNEGDGDFLVRDSESEPGD------YVLSVRVKGKVKHYRIRRNEDGKFYLDGGRKFPSLVE 73 (84)
T ss_pred CCeecccCCHHHHHHHHhcCCCcEEEEEcCCCCCCC------EEEEEEECCEEEEEEEEECCCCcEEECCCCccCCHHH
Confidence 47999999999999999986 99999999854444 777 33458899887666 4577665445544333
|
Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae. |
| >PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps [] | Back alignment and domain information |
|---|
Probab=97.72 E-value=4.3e-06 Score=69.89 Aligned_cols=63 Identities=14% Similarity=0.169 Sum_probs=50.7
Q ss_pred cccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hhhhhhhhhhhc
Q 038696 129 EFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WILFNKIQQKKI 197 (683)
Q Consensus 129 ~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~l~~~~~~~~~ 197 (683)
||||.++|++|+++|+. +|.|+||.|+..++. |+| ....++|+.|.+.+++ |++.....+.++
T Consensus 1 W~~g~isr~~Ae~~L~~~~~~G~FLvR~s~~~~~~------~~Lsv~~~~~v~h~~I~~~~~~~~~~~~~~~F~sl 70 (77)
T PF00017_consen 1 WFHGFISRQEAERLLMQGKPDGTFLVRPSSSKPGK------YVLSVRFDGKVKHFRINRTENGGYFLSDGKKFPSL 70 (77)
T ss_dssp TBEESSHHHHHHHHHHTTSSTTEEEEEEESSSTTS------EEEEEEETTEEEEEEEEEETTSEEESSTSSEBSSH
T ss_pred CcCCCCCHHHHHHHHHhcCCCCeEEEEeccccccc------cccccccccccEEEEEEecCCceEEccCCCcCCCH
Confidence 89999999999999998 999999999866666 777 3446889999887777 666655455443
|
Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00014 Score=74.38 Aligned_cols=72 Identities=14% Similarity=0.063 Sum_probs=41.6
Q ss_pred eEecccccEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCCCC---ceeeeeeeEEcCCC-CeEEEEEecCCC-CH
Q 038696 241 RRLGSGSQYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHP---NIMHFLCGFTDEEK-KECFLIMELMSR-DL 312 (683)
Q Consensus 241 ~~LG~G~~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~e~~-~~~~LVmEy~~g-sL 312 (683)
..|+.|+....+...+..+.+|..... ...+.+|+++|..|... -+.++++.....+. ...|+||++++| ++
T Consensus 3 ~~~~~gG~~n~vy~~~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l 81 (235)
T cd05155 3 EPVDSGGTDNATFRLGDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETA 81 (235)
T ss_pred eeccCCCcccceEEcCCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCC
Confidence 456666543322223556778887542 34688999999888532 23344332221111 245889999987 44
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00042 Score=70.99 Aligned_cols=57 Identities=12% Similarity=0.042 Sum_probs=39.1
Q ss_pred cCcEEEEEEeCCC-cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCCC-CHH
Q 038696 255 LGESFALRHFFGD-IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLC 313 (683)
Q Consensus 255 ~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~ 313 (683)
.+..+.||+.... ...+.+|++++..+. +--+.++++..... +..++|||+++| +|.
T Consensus 21 ~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 21 KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAA 80 (244)
T ss_pred CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHh
Confidence 3467888887542 345788999998884 44455666655432 457899999988 554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0004 Score=69.66 Aligned_cols=75 Identities=20% Similarity=0.153 Sum_probs=47.9
Q ss_pred EeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCC--ceeeeeeeEEcC-CCCeEEEEEecCCC-C
Q 038696 240 RRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHP--NIMHFLCGFTDE-EKKECFLIMELMSR-D 311 (683)
Q Consensus 240 ~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~e-~~~~~~LVmEy~~g-s 311 (683)
++.|+.|....++. ..+..+++|..... ...+.+|..++..|... .+.+++...... .....+++|++++| .
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 46778876444443 24469999998654 45678999999888533 345565433222 22457999999998 5
Q ss_pred HHH
Q 038696 312 LCS 314 (683)
Q Consensus 312 L~~ 314 (683)
+..
T Consensus 82 ~~~ 84 (239)
T PF01636_consen 82 LDD 84 (239)
T ss_dssp HHH
T ss_pred ccc
Confidence 555
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0002 Score=80.88 Aligned_cols=13 Identities=23% Similarity=0.593 Sum_probs=6.7
Q ss_pred HHHHHHHHHHHHH
Q 038696 336 LMLQIARGMEYLH 348 (683)
Q Consensus 336 i~~qi~~aL~yLH 348 (683)
-+.-|++||.++.
T Consensus 288 RF~piv~gl~~~e 300 (1102)
T KOG1924|consen 288 RFRPIVEGLDFLE 300 (1102)
T ss_pred hhhhHHHHHhccc
Confidence 3445555555553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00027 Score=84.28 Aligned_cols=202 Identities=22% Similarity=0.223 Sum_probs=128.6
Q ss_pred HHHHHHHHHcCCCCceeeeeeeEEcCC-CC-eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038696 271 LVPEISSLLSLSHPNIMHFLCGFTDEE-KK-ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYL 347 (683)
Q Consensus 271 ~~~Ei~iL~~L~HpnIv~l~~~~~~e~-~~-~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL 347 (683)
..-|...+..+.|+|++.++.+-.... .+ ...+..++|.+ ++.+.+.. -...+..+++.+..++..||.|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~------v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS------VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh------ccccCHHHHHHHHHHHhhhHHHH
Confidence 345677788889999999875443211 11 12334578876 88888775 36688999999999999999999
Q ss_pred HhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe--cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCC
Q 038696 348 HSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS--GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSK 425 (683)
Q Consensus 348 H~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~ 425 (683)
|+....|.-|..+-..-. ..++...+.++ ||+..+.......... ...+..|.++|...... ..
T Consensus 303 h~~~l~~v~L~~s~~~~~----~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~-------~~ 368 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKES----TVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENT-------AK 368 (1351)
T ss_pred HHhccceeEEeccccccc----ccCccceeecchhhhcccccCCCcccchh---hcCcccccccccccccc-------ch
Confidence 999655554444411111 11222255555 8888876654432221 12233477888876542 12
Q ss_pred CCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 426 YSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 426 ~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.....|+|.+|.....+..|..+-..... + . ...+......+.+....|+..++++|++..+++.+.
T Consensus 369 ~~r~~dL~~lgll~~~~~~~~~i~~~~~~----~-~-------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 369 KSRLTDLWCLGLLLLQLSQGEDISEKSAV----P-V-------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhHHHHHHHHHhhhhhcCcccccccc----h-h-------hhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 33447999999999999987654321110 0 0 012222233578888999999999999999998764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0007 Score=65.29 Aligned_cols=127 Identities=24% Similarity=0.274 Sum_probs=87.8
Q ss_pred CeEEEeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-
Q 038696 236 DYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR- 310 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g- 310 (683)
..++.+.||+|+...|++ |.|..+|+|+-..+ ...+..|+++|..+.--++.+=+..+ ++ -+++|||+.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g~----~~i~me~i~G~ 97 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-GE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-ch----hhhhhhhhcCc
Confidence 345567799998666665 78889999998654 56789999999999877775533233 22 3677999998
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC--CcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP--SNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp--~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
.|.+.-.. .+- +-...+++.---|-..||-|+.|.- .||++.++ .+.|+||.-|+..
T Consensus 98 ~L~~~~~~---------~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~--------~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG---------GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR--------DVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc---------ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC--------cEEEEEccchhhc
Confidence 88765442 122 2234455554445678999999964 36666554 4999999988743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=3.2e-05 Score=86.67 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=123.2
Q ss_pred CCCeEEEeEecccccEEEEEE--cC-cEEEEEEeCCCcchHHHHHHHHHcCCCCc-eeeeeeeEEcCCCCeEEEEEecCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--LG-ESFALRHFFGDIEPLVPEISSLLSLSHPN-IMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--~g-~~vAvK~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.-|....-+++|+..+.... +. +....+.+... ....-++++|.+++||| .+..++.+. .....+++|+++.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPMRICS 317 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-hhhHHHHHHHHHccCCCCcccccccCC--cccccchhhhhhc
Confidence 444555556677765554432 11 11223333322 44556899999999999 565555443 3367899999997
Q ss_pred CC--HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 310 RD--LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 310 gs--L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+. ....... ....|...+...+.+.-+++++|+|+.-=+|+| |||.... ..|..||+....
T Consensus 318 ~~rs~~~~~~~-----se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--------~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 318 TGRSSALEMTV-----SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--------EVKLLDFAVPPQ 380 (829)
T ss_pred CCccccccCCh-----hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--------ccccccccCCcc
Confidence 42 2211110 112233445556677788899999998778999 8988765 489999999876
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
..... ......+|+.|+|||+.... .+..+.|+|++|+-..+|.-|.+|-.
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~---------~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQEN---------TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhccc---------ccccCCCccCCCcchhhcCCCCCCCC
Confidence 65432 34456788999999998755 48889999999987777777777654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0011 Score=80.29 Aligned_cols=72 Identities=22% Similarity=0.327 Sum_probs=44.9
Q ss_pred EeEeccccc---EEEEEEcC---cEEEEEEeCC-----CcchHHHHHHHHHcCC-CCce--eeeeeeEEcCC-CCeEEEE
Q 038696 240 RRRLGSGSQ---YKEILWLG---ESFALRHFFG-----DIEPLVPEISSLLSLS-HPNI--MHFLCGFTDEE-KKECFLI 304 (683)
Q Consensus 240 ~~~LG~G~~---~~v~l~~g---~~vAvK~~~~-----~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~e~-~~~~~LV 304 (683)
++.|+.|.. |.+....+ ..+++|+... ....+.+|+++|+.|. |.+| .+++..+.+.+ .+..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 455666643 33222222 3677787632 2346889999999995 7765 66666554321 1457899
Q ss_pred EecCCCC
Q 038696 305 MELMSRD 311 (683)
Q Consensus 305 mEy~~gs 311 (683)
|||++|.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=65.81 Aligned_cols=121 Identities=21% Similarity=0.243 Sum_probs=87.2
Q ss_pred CCeEEEeEeccccc-EEEEE--EcCcEEEEEEeCC-------------------------CcchHHHHHHHHHcCC---C
Q 038696 235 EDYQVRRRLGSGSQ-YKEIL--WLGESFALRHFFG-------------------------DIEPLVPEISSLLSLS---H 283 (683)
Q Consensus 235 ~~y~i~~~LG~G~~-~~v~l--~~g~~vAvK~~~~-------------------------~~~~~~~Ei~iL~~L~---H 283 (683)
.+++.++.||.|+. +.|+. ..|+.+|||+++. ..+.|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 69999999999986 66665 4899999999421 1235788998877774 5
Q ss_pred Cce--eeeeeeEEcCC----------------CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038696 284 PNI--MHFLCGFTDEE----------------KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345 (683)
Q Consensus 284 pnI--v~l~~~~~~e~----------------~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 345 (683)
.++ |+.++++.-.. .....||.||+...- .++ ..-+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHHH
Confidence 566 88887764221 012367888876421 122 233567888899
Q ss_pred HHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 346 yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
.+|..||+-+|+++.|.. + -||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~---~---------G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR---G---------GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc---C---------CEEEecccC
Confidence 999999999999999987 2 499999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00036 Score=68.93 Aligned_cols=98 Identities=17% Similarity=0.190 Sum_probs=77.0
Q ss_pred HHHHHHHHcCCC-CceeeeeeeEEcCCCCeEEEEEecCC-CCHHHH---HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 038696 272 VPEISSLLSLSH-PNIMHFLCGFTDEEKKECFLIMELMS-RDLCSY---IKEICCPRKRIPFSLPVAVDLMLQIARGMEY 346 (683)
Q Consensus 272 ~~Ei~iL~~L~H-pnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~---l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y 346 (683)
..|.-+|+.+++ +++++++|+| +. ++|+||++ +++... +.+ ....+|..+.+|+.++++.+++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G~-~~v~E~~~~~~~~~~~~~l~~------~~~~~w~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----GR-FYVVEYVGAGSLYGIYRPLSQ------FLQSPWEQRAKIALQLLELLEE 74 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----CC-EEEEEeecCcccccccccccc------ccccCHHHHHHHHHHHHHHHHH
Confidence 458888999976 6999999888 12 67889998 455321 111 1236899999999999999999
Q ss_pred HHh---CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 347 LHS---KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 347 LH~---~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+. ..+.-.|++++|+-++.++ .+|++|...+...
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~~~~-------~lk~iDld~v~~~ 112 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVNDDG-------RLKLIDLDDVFVE 112 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEeCCC-------cEEEEechhcchh
Confidence 997 3588899999999999887 7999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.29 E-value=4.9e-05 Score=91.94 Aligned_cols=195 Identities=15% Similarity=0.076 Sum_probs=132.8
Q ss_pred CCeEEEeEecccccEEEEEEcCc---EEEEEEeCC-C--------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILWLGE---SFALRHFFG-D--------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~~g~---~vAvK~~~~-~--------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.+|++.=-+|.|..++.. |.+. -+-+|+.+. + .+....|.+.++...|++++..+.-....+..+.|
T Consensus 1229 e~~EV~l~i~~~~~~R~k-~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~ 1307 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNK-WLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEY 1307 (2724)
T ss_pred hhhheeeecccceeeccc-hHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHH
Confidence 355555455555433333 3222 244555532 1 23345566667778999998877666555567789
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-----KIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
.+|+|+. |++.+.|.+. ..+..++...-+.....+.+.+..-+|+. -.+|++||+-|.+|..+. .
T Consensus 1308 ~r~~~~~~g~~f~iIikg--~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-------~ 1378 (2724)
T KOG1826|consen 1308 IRSLYVEFGKLFSIIIKG--LEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-------N 1378 (2724)
T ss_pred HHHHHHHHhHHHHHHHhc--cccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC-------c
Confidence 9999997 6999988762 23334444444444444447788888864 258999999999997665 6
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
+|+.++|+.+..... ........+++.|+.|++.+.- .++.++|+|..|+-+|+...|..+|-
T Consensus 1379 v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~i---------k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEI---------KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHH---------hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999999844332 1123345677889999998765 47888999999999999999988774
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0082 Score=63.89 Aligned_cols=139 Identities=11% Similarity=0.142 Sum_probs=74.5
Q ss_pred EeEecccc---cEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCCCC--ceeeeeeeE----EcCCCCeEEEEEecC
Q 038696 240 RRRLGSGS---QYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHP--NIMHFLCGF----TDEEKKECFLIMELM 308 (683)
Q Consensus 240 ~~~LG~G~---~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~Hp--nIv~l~~~~----~~e~~~~~~LVmEy~ 308 (683)
++.++.|. +|.+. .++..+.+|++... .+.+..|++++..|... .+.+++... .....+..++||+|+
T Consensus 27 i~~~~~G~~n~~y~v~-t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 27 LKGIAEGVENSNYLLT-TDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccccCCccccceEEEE-eCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 44455553 35443 23456778987542 45667788888877422 234443211 111235678999999
Q ss_pred CC-CHH-----------HHHHHhcCCCCCC--------CCC-HHHHH------------HHHHHHHHHHHHHH-------
Q 038696 309 SR-DLC-----------SYIKEICCPRKRI--------PFS-LPVAV------------DLMLQIARGMEYLH------- 348 (683)
Q Consensus 309 ~g-sL~-----------~~l~~~~~~~~~~--------~l~-~~~~~------------~i~~qi~~aL~yLH------- 348 (683)
+| .+. ..+.+........ .+. |.... .....+...++++.
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 87 321 1111111000000 011 11100 01122334455554
Q ss_pred hCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 349 SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 349 ~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~-------~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDS-------VKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCc-------eEEEeeccccc
Confidence 26899999999999998776 56899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0084 Score=63.66 Aligned_cols=73 Identities=10% Similarity=-0.134 Sum_probs=50.2
Q ss_pred EEEeEecccccEEEEEE--cCcEEEEEEeCCC--cchHHHHHHHHHcCCC---CceeeeeeeEEcC-CCCeEEEEEecCC
Q 038696 238 QVRRRLGSGSQYKEILW--LGESFALRHFFGD--IEPLVPEISSLLSLSH---PNIMHFLCGFTDE-EKKECFLIMELMS 309 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l~--~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~e-~~~~~~LVmEy~~ 309 (683)
.-.+.||.|....++.. .+..+.+|..+.. ...+..|++.|+.|.- -.+.++++.+.++ ..+..+||||+++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 34567888876666653 2346777887652 3578999999999852 3577777665432 2355899999998
Q ss_pred C
Q 038696 310 R 310 (683)
Q Consensus 310 g 310 (683)
|
T Consensus 97 G 97 (297)
T PRK10593 97 G 97 (297)
T ss_pred C
Confidence 6
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0084 Score=60.87 Aligned_cols=30 Identities=17% Similarity=0.327 Sum_probs=25.2
Q ss_pred CCcccCCCCCCcEEeCC-CCCCCCCcceEEEecccCcc
Q 038696 350 KKIYHGNLNPSNILLKP-RGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 ~gIiHrDLKp~NILl~~-~g~~~~~~~~vKL~DFGla~ 386 (683)
.+++|+|+++.|||++. ++ .+.|+||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~-------~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKN-------SVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCC-------CEEEEEcccCC
Confidence 36899999999999987 34 59999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.021 Score=59.05 Aligned_cols=119 Identities=21% Similarity=0.219 Sum_probs=66.4
Q ss_pred EcCcEEEEEEeCCCc----chHHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC-CHH--------------
Q 038696 254 WLGESFALRHFFGDI----EPLVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR-DLC-------------- 313 (683)
Q Consensus 254 ~~g~~vAvK~~~~~~----~~~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g-sL~-------------- 313 (683)
.+|..+++|...... -...+|.++++.+..-.+ .++++.. + -++||||++| .+.
T Consensus 17 ~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~~~~~~~~~~~~~~la 90 (256)
T TIGR02721 17 HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVITLDQFVALDLLLELA 90 (256)
T ss_pred eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCcccccccccCchhHHHHH
Confidence 456678888764322 235789999999864334 3343322 2 2689999987 432
Q ss_pred HHHHHhcCCC-CCCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 314 SYIKEICCPR-KRIPFSLP-VAVDLMLQI---------ARGMEYLHS--------KKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 314 ~~l~~~~~~~-~~~~l~~~-~~~~i~~qi---------~~aL~yLH~--------~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
+.+.+..... ...+++.. .+..+..++ ...+..+-. ..++|+|+.|.|||++.++
T Consensus 91 ~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~------ 164 (256)
T TIGR02721 91 ALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG------ 164 (256)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC------
Confidence 2223222211 11223322 222222222 111222211 2589999999999998765
Q ss_pred ceEEEecccCcc
Q 038696 375 LHAKISGFGLSS 386 (683)
Q Consensus 375 ~~vKL~DFGla~ 386 (683)
+.|+||..|.
T Consensus 165 --~~lIDwE~a~ 174 (256)
T TIGR02721 165 --LKLIDWEYAS 174 (256)
T ss_pred --CEEEeccccC
Confidence 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.019 Score=61.25 Aligned_cols=30 Identities=17% Similarity=0.313 Sum_probs=25.2
Q ss_pred CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 ~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.|+||+|++|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-------~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-------LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-------eEEEEeccccc
Confidence 4899999999999998654 45899999763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.016 Score=63.90 Aligned_cols=66 Identities=18% Similarity=0.200 Sum_probs=42.6
Q ss_pred eEeccccc---EEEEEEcC-cEEEEEEeCC-----------CcchHHHHHHHHHcCC---CCceeeeeeeEEcCCCCeEE
Q 038696 241 RRLGSGSQ---YKEILWLG-ESFALRHFFG-----------DIEPLVPEISSLLSLS---HPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 241 ~~LG~G~~---~~v~l~~g-~~vAvK~~~~-----------~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~~~~~~ 302 (683)
+.||.|.+ |.+...+| +.|.||.... ..+....|.+.|..+. -.++++++.+ ++ ...+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~--~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE--ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC--CCCE
Confidence 46777764 44444455 4899998431 2345678888888873 3456666543 23 4468
Q ss_pred EEEecCCC
Q 038696 303 LIMELMSR 310 (683)
Q Consensus 303 LVmEy~~g 310 (683)
+||||+++
T Consensus 108 lVME~L~~ 115 (401)
T PRK09550 108 TVMEDLSD 115 (401)
T ss_pred EEEecCCC
Confidence 99999975
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=63.52 Aligned_cols=71 Identities=17% Similarity=0.210 Sum_probs=43.0
Q ss_pred ecccc---cEEEEEEcC-cEEEEEEeCC-----------CcchHHHHHHHHHcCC--CC-ceeeeeeeEEcCCCCeEEEE
Q 038696 243 LGSGS---QYKEILWLG-ESFALRHFFG-----------DIEPLVPEISSLLSLS--HP-NIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 243 LG~G~---~~~v~l~~g-~~vAvK~~~~-----------~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~e~~~~~~LV 304 (683)
||.|. +|.|....| +.|.||.... ..++..-|.+.|+... -| .+.++| .| ++ ....+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~-D~--e~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HF-DT--EMAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EE-cc--ccceeh
Confidence 56665 355544333 5799997521 2345667888887764 45 345554 34 22 456799
Q ss_pred EecCCC--CHHHHHH
Q 038696 305 MELMSR--DLCSYIK 317 (683)
Q Consensus 305 mEy~~g--sL~~~l~ 317 (683)
||+++. .|.+.|.
T Consensus 79 MEdL~~~~ilR~~Li 93 (370)
T TIGR01767 79 MEDLSHHKIARKGLI 93 (370)
T ss_pred HhhCccchHHHHHHH
Confidence 999963 5666554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.011 Score=62.47 Aligned_cols=139 Identities=12% Similarity=0.097 Sum_probs=75.2
Q ss_pred EeEecccc---cEEEEEEcCcEEEEEEeCC-CcchHHHHHHHHHcCCCC--ceeeeeeeE----EcCCCCeEEEEEecCC
Q 038696 240 RRRLGSGS---QYKEILWLGESFALRHFFG-DIEPLVPEISSLLSLSHP--NIMHFLCGF----TDEEKKECFLIMELMS 309 (683)
Q Consensus 240 ~~~LG~G~---~~~v~l~~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~----~~e~~~~~~LVmEy~~ 309 (683)
.+.|..|. .|.+. ..+..+++|++.. ..+.+..|++++..|.+- .+.+++... .....+..++||+|++
T Consensus 19 i~~i~~G~~n~~y~v~-~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVT-TDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEE-eCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 33455553 34443 3556788998863 345677899988888532 244444311 0011245689999998
Q ss_pred C-CHH-----------HHHHHhc---CC-CC----CCCCCHHHHH----------HHHHHHHHHHHHHHh-------CCc
Q 038696 310 R-DLC-----------SYIKEIC---CP-RK----RIPFSLPVAV----------DLMLQIARGMEYLHS-------KKI 352 (683)
Q Consensus 310 g-sL~-----------~~l~~~~---~~-~~----~~~l~~~~~~----------~i~~qi~~aL~yLH~-------~gI 352 (683)
| .+. ..|.+.. .. .. .....+.... .....+..++.++.. .++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 7 321 1111111 00 00 0011111110 111223344455443 479
Q ss_pred ccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 353 YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 353 iHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+|+|++|.|||++.++ .+.|+||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~-------~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDE-------LSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCc-------eEEEeehhhhc
Confidence 9999999999998775 56899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.033 Score=59.05 Aligned_cols=62 Identities=16% Similarity=0.070 Sum_probs=37.1
Q ss_pred cEEEEEEcCcEEEEEEeCCCcchHHHHHHHHHcCCCC--ceeeeeeeE----EcCCCCeEEEEEecCCC
Q 038696 248 QYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHP--NIMHFLCGF----TDEEKKECFLIMELMSR 310 (683)
Q Consensus 248 ~~~v~l~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~----~~e~~~~~~LVmEy~~g 310 (683)
+|.+.. ++..+++|++....+.+..|+.++..|... .+++++..- .....+..++|+||++|
T Consensus 12 v~~v~t-~~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G 79 (313)
T TIGR02906 12 VYKVET-DSGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEG 79 (313)
T ss_pred EEEEEe-CCCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccC
Confidence 455442 344688999865555677788888777422 334443210 00113568999999987
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.023 Score=62.17 Aligned_cols=74 Identities=16% Similarity=0.109 Sum_probs=46.1
Q ss_pred EeEecccc---cEEEEEEc-CcEEEEEEeCC----------CcchHHHHHHHHHcCC--CCc-eeeeeeeEEcCCCCeEE
Q 038696 240 RRRLGSGS---QYKEILWL-GESFALRHFFG----------DIEPLVPEISSLLSLS--HPN-IMHFLCGFTDEEKKECF 302 (683)
Q Consensus 240 ~~~LG~G~---~~~v~l~~-g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~--Hpn-Iv~l~~~~~~e~~~~~~ 302 (683)
.+.||.|. +|.|...+ ++.|.||.-.. ..++..-|.+.|+.+. .|. +.++| .| ++ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy-~~-D~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY-LF-DS--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE-EE-Cc--HHhh
Confidence 56678886 34444322 56899997521 2456677888888774 454 55554 34 22 4568
Q ss_pred EEEecCCC--CHHHHHH
Q 038696 303 LIMELMSR--DLCSYIK 317 (683)
Q Consensus 303 LVmEy~~g--sL~~~l~ 317 (683)
+|||+++. .|.+.|.
T Consensus 110 ~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 110 CVMEDLSDHTILRTALI 126 (409)
T ss_pred HHHHhCcccHHHHHHHH
Confidence 99999963 5666543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0027 Score=66.65 Aligned_cols=125 Identities=17% Similarity=0.131 Sum_probs=84.4
Q ss_pred CeEEEeEecccc---cEEEEEEcCcEEEEEEeC----------CC----------------cchHHHHHHHHHcCC-CCc
Q 038696 236 DYQVRRRLGSGS---QYKEILWLGESFALRHFF----------GD----------------IEPLVPEISSLLSLS-HPN 285 (683)
Q Consensus 236 ~y~i~~~LG~G~---~~~v~l~~g~~vAvK~~~----------~~----------------~~~~~~Ei~iL~~L~-Hpn 285 (683)
-+.+++.||-|. .|.|....|+..++|.-. .. .-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356777788775 577776678899998631 00 113468999999884 544
Q ss_pred e-eeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 038696 286 I-MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNIL 363 (683)
Q Consensus 286 I-v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NIL 363 (683)
= .+.++ .+.-++|||++.| .|...-+ ..+ +-.+...+..-+.-|-..|+||+|.+-=||+
T Consensus 173 pVPkpiD------~~RH~Vvmelv~g~Pl~~v~~---------v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 173 PVPKPID------HNRHCVVMELVDGYPLRQVRH---------VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred CCCCccc------ccceeeHHHhhcccceeeeee---------cCC---hHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 3 33333 2446899999998 6654221 111 2234445555566778899999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCc
Q 038696 364 LKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla 385 (683)
+++++ .++++||--+
T Consensus 235 v~dd~-------~i~vIDFPQm 249 (465)
T KOG2268|consen 235 VKDDD-------KIVVIDFPQM 249 (465)
T ss_pred EecCC-------CEEEeechHh
Confidence 99877 7999999644
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.04 Score=58.69 Aligned_cols=65 Identities=17% Similarity=0.226 Sum_probs=40.2
Q ss_pred ccccEEEEEEcCcEEEEEEeCCCcchHHHHHHHHHcCC---CCceeeeeee----EEcCCCCeEEEEEecCCC
Q 038696 245 SGSQYKEILWLGESFALRHFFGDIEPLVPEISSLLSLS---HPNIMHFLCG----FTDEEKKECFLIMELMSR 310 (683)
Q Consensus 245 ~G~~~~v~l~~g~~vAvK~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~----~~~e~~~~~~LVmEy~~g 310 (683)
.|++|.+.. ++..+++|.+....+.+...+.++..|. -+++++++.. .....++..|++|++++|
T Consensus 19 ~~~v~~v~T-~~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G 90 (309)
T TIGR02904 19 TGKLFKVYT-DQGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDI 90 (309)
T ss_pred cCcEEEEEe-CCCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCccc
Confidence 566677664 5557999999766666656666666663 2455665321 111122456999999887
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.048 Score=57.71 Aligned_cols=49 Identities=18% Similarity=0.135 Sum_probs=32.6
Q ss_pred CcEEEEEEeCCC---cchHHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 256 GESFALRHFFGD---IEPLVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 256 g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
++.+++|+.... .....+|.+++..+....+ .++++.+ ++ .+||||++|
T Consensus 29 ~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v~e~i~G 81 (302)
T cd05156 29 PRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRIEEFIPS 81 (302)
T ss_pred CCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe--CC----CchhheeCC
Confidence 578999998643 2456789999998853333 4455444 22 358999887
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.022 Score=61.04 Aligned_cols=131 Identities=22% Similarity=0.244 Sum_probs=88.5
Q ss_pred EEeEecccc---cEEEEEEcCcEEEEEEeCCC------c--------------------c----hHHHHHHHHHcCCCCc
Q 038696 239 VRRRLGSGS---QYKEILWLGESFALRHFFGD------I--------------------E----PLVPEISSLLSLSHPN 285 (683)
Q Consensus 239 i~~~LG~G~---~~~v~l~~g~~vAvK~~~~~------~--------------------~----~~~~Ei~iL~~L~Hpn 285 (683)
|..+|..|. +|-+.-.+|..+|||+++.. . + -...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445566664 66666678999999998421 0 0 1357888888886544
Q ss_pred eeeeeeeEEcCCCCeEEEEEecCCCC--HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcE
Q 038696 286 IMHFLCGFTDEEKKECFLIMELMSRD--LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYL-HSKKIYHGNLNPSNI 362 (683)
Q Consensus 286 Iv~l~~~~~~e~~~~~~LVmEy~~gs--L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~gIiHrDLKp~NI 362 (683)
|.----... ..-.|||+|++++ -.-.|+. ..++...+..+-.|++.-|.-| |..++||.||.-=|+
T Consensus 228 IP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd-------~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 228 IPCPEPILL----KNHVLVMEFLGRDGWAAPKLKD-------ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCCceee----ecceEeeeeccCCCCcCccccc-------ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 421100111 2237999999752 2223332 5678888888888888888777 456899999999999
Q ss_pred EeCCCCCCCCCcceEEEecccCcccc
Q 038696 363 LLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 363 Ll~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
|+-.+ .+.|+|.+-+...
T Consensus 297 LyhdG--------~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYHDG--------KLYIIDVSQSVEH 314 (520)
T ss_pred eEECC--------EEEEEEccccccC
Confidence 99655 5999998766443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.048 Score=57.27 Aligned_cols=31 Identities=23% Similarity=0.458 Sum_probs=24.8
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.++|+|++|.|||++.++. .+-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~------~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR------VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC------EEEEECcHhccc
Confidence 4899999999999986431 467999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.025 Score=62.90 Aligned_cols=49 Identities=20% Similarity=0.275 Sum_probs=39.1
Q ss_pred chHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCCCHHHHHHH
Q 038696 269 EPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKE 318 (683)
Q Consensus 269 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~gsL~~~l~~ 318 (683)
.++..-..+++.+.|+|...++++-.. ......+|||+++-+|.++++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHYTMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhhccchHHHHHh
Confidence 345567788999999999998865543 3456899999999999999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.12 Score=55.52 Aligned_cols=64 Identities=13% Similarity=0.030 Sum_probs=37.8
Q ss_pred ccEEEEEEcCcEEEEEEeCC---CcchHHHHHHHHHcCCCC--ceeeee---eeEEcCCCCeEEEEEecCCC
Q 038696 247 SQYKEILWLGESFALRHFFG---DIEPLVPEISSLLSLSHP--NIMHFL---CGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 247 ~~~~v~l~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~Hp--nIv~l~---~~~~~e~~~~~~LVmEy~~g 310 (683)
.+|.+...+|..+++|+... ....+..|++.+..|... .++... +.....-.+..+.|+++++|
T Consensus 40 ~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 40 RVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred eEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 35666655678899998853 345677888888877321 122211 10000112467889999886
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.082 Score=56.40 Aligned_cols=32 Identities=19% Similarity=0.555 Sum_probs=27.6
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
.++|+|+++.|+++++++ -+-|+||+++...+
T Consensus 199 ~lvHGD~~~gNlii~~~~-------~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-------PTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCC-------eeEEEeccccccCC
Confidence 589999999999998887 48999999986543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.24 Score=54.65 Aligned_cols=67 Identities=12% Similarity=0.079 Sum_probs=41.2
Q ss_pred EeEecccccEEEEE--EcCcEEEEEEeCC-----------CcchHHHHHHHHHcCC---CCceeeeeeeEEcCCCCeEEE
Q 038696 240 RRRLGSGSQYKEIL--WLGESFALRHFFG-----------DIEPLVPEISSLLSLS---HPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 240 ~~~LG~G~~~~v~l--~~g~~vAvK~~~~-----------~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+.||.|..-.++. ..+..|.||+-.. ..++...|.+.|+.+. ..++.++|.+. + ...++
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCCEE
Confidence 55677776333332 2455788997631 3344566777777664 24677776544 3 34688
Q ss_pred EEecCCC
Q 038696 304 IMELMSR 310 (683)
Q Consensus 304 VmEy~~g 310 (683)
||||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999975
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.047 Score=54.66 Aligned_cols=49 Identities=20% Similarity=0.129 Sum_probs=29.8
Q ss_pred CcEEEEEEeCCCcc---hHHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 256 GESFALRHFFGDIE---PLVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 256 g~~vAvK~~~~~~~---~~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
++.|.||+.....+ .-..|..+++.+..-.+ .++++.+ ++ .+|.+|++|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~--~~----g~v~e~i~g 54 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFF--EN----GRVEEFIEG 54 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEE--TT----EEEEE--SS
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEc--CC----CcEEEEecc
Confidence 46788898865533 34678899988864444 5565555 32 257788876
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.12 Score=55.59 Aligned_cols=74 Identities=19% Similarity=0.237 Sum_probs=57.8
Q ss_pred CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
++..+.|++|++..+.+.-. ..-.+.++..|+.+.+.-+.-+..+ .+-|||+.-.||||+ +|
T Consensus 296 de~~y~yl~~kdhgt~is~i----------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G------ 358 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII----------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG------ 358 (488)
T ss_pred CCceEEEEEEecCCceeeee----------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC------
Confidence 34467889999988765421 1235778899999988877777654 689999999999999 66
Q ss_pred ceEEEecccCccc
Q 038696 375 LHAKISGFGLSSV 387 (683)
Q Consensus 375 ~~vKL~DFGla~~ 387 (683)
.|.|+||-+++.
T Consensus 359 -nvtLIDfklsRl 370 (488)
T COG5072 359 -NVTLIDFKLSRL 370 (488)
T ss_pred -ceEEEEeeeeec
Confidence 699999999984
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.31 Score=52.82 Aligned_cols=118 Identities=15% Similarity=0.203 Sum_probs=65.2
Q ss_pred CcEEEEEEeCCCcch---HHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC-CHHH--------------HH
Q 038696 256 GESFALRHFFGDIEP---LVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR-DLCS--------------YI 316 (683)
Q Consensus 256 g~~vAvK~~~~~~~~---~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g-sL~~--------------~l 316 (683)
++.|.+|+.....+. -.+|..++..+..-++ .++++.+ ++ + .|++|++| +|.. .+
T Consensus 65 ~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L 138 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PN-G---RVEEFIHARTLSAADLRDPEISALIAAKL 138 (344)
T ss_pred CCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHH
Confidence 367999988543322 3679999998864444 3455555 22 2 57899876 4431 11
Q ss_pred HHhcCCC---CCCCCCHHHHHHHHHHHH-----------------HHHHHH----H----hCCcccCCCCCCcEEeCCC-
Q 038696 317 KEICCPR---KRIPFSLPVAVDLMLQIA-----------------RGMEYL----H----SKKIYHGNLNPSNILLKPR- 367 (683)
Q Consensus 317 ~~~~~~~---~~~~l~~~~~~~i~~qi~-----------------~aL~yL----H----~~gIiHrDLKp~NILl~~~- 367 (683)
.+..... ...+..+..+..+..++. ..+..| . ...++|+|+++.|||++.+
T Consensus 139 ~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~ 218 (344)
T PLN02236 139 REFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEET 218 (344)
T ss_pred HHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCC
Confidence 2211111 111112233333332211 111111 1 2368999999999999753
Q ss_pred CCCCCCcceEEEecccCcc
Q 038696 368 GASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 368 g~~~~~~~~vKL~DFGla~ 386 (683)
+ .+.|+||..+.
T Consensus 219 ~-------~~~lID~Eya~ 230 (344)
T PLN02236 219 R-------AITIIDYEYAS 230 (344)
T ss_pred C-------cEEEEeehhcc
Confidence 3 59999998763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.36 Score=51.92 Aligned_cols=135 Identities=15% Similarity=0.182 Sum_probs=75.4
Q ss_pred ccccEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCc---eee---eeeeEEcCCC--CeEEEEEecCCC-CHH
Q 038696 245 SGSQYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHPN---IMH---FLCGFTDEEK--KECFLIMELMSR-DLC 313 (683)
Q Consensus 245 ~G~~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~Hpn---Iv~---l~~~~~~e~~--~~~~LVmEy~~g-sL~ 313 (683)
+..+|.+...+|+. ++|+.... ..++.-|+..|..|.-.. .++ +=+.....-. ...+-|++|++| .+.
T Consensus 38 eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~ 116 (331)
T COG2334 38 ENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE 116 (331)
T ss_pred cCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence 34466666555555 89998653 456778888888873211 122 1111111111 367889999998 444
Q ss_pred -H-----------HH---HHhc------CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC--------C
Q 038696 314 -S-----------YI---KEIC------CPRKRIPFSLPV-------------AVDLMLQIARGMEYLHSK--------K 351 (683)
Q Consensus 314 -~-----------~l---~~~~------~~~~~~~l~~~~-------------~~~i~~qi~~aL~yLH~~--------g 351 (683)
+ ++ .... .+.......|.. -.....++...+..+.+. +
T Consensus 117 ~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~ 196 (331)
T COG2334 117 RDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALG 196 (331)
T ss_pred CCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCccc
Confidence 1 11 1100 001111122220 012344555556665542 3
Q ss_pred --cccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 352 --IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 352 --IiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
+||+|+.|.||+++.++ + .+.++|||-+.
T Consensus 197 ~~iIH~D~~~~NVl~d~~~---~---~~g~iDFdDa~ 227 (331)
T COG2334 197 DQIIHGDLHPDNVLFDDDT---D---VSGFIDFDDAG 227 (331)
T ss_pred ceeeecCCCccceeEcCCC---C---eeeEEEccccc
Confidence 99999999999998775 1 48999999763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.38 Score=51.81 Aligned_cols=47 Identities=19% Similarity=0.249 Sum_probs=30.9
Q ss_pred EEEEEEeCCCcch---HHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 258 SFALRHFFGDIEP---LVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 258 ~vAvK~~~~~~~~---~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
.|.+|+.....+. -.+|..+++.+..-++ .++++.+ .+ + +|.+|++|
T Consensus 44 ~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~-G---~i~~fi~g 94 (330)
T PLN02421 44 SVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GN-G---MIQSFINA 94 (330)
T ss_pred eEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CC-c---EeehhhcC
Confidence 7899988543332 3589999999875555 4455444 22 2 58889876
|
|
| >KOG0790 consensus Protein tyrosine phosphatase Corkscrew and related SH2 domain enzymes [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.015 Score=62.54 Aligned_cols=98 Identities=8% Similarity=0.049 Sum_probs=0.0
Q ss_pred HhcccchhHHHHhhcccchhhhHHHHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeee------
Q 038696 99 LYQNTDCVEFYIHNLLSCIPILIEAIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLI------ 169 (683)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l------ 169 (683)
+.+-+.-...++-..+.|-.- ..+.||||.++-..|+++|. ++|.||||.|+.++|. |||
T Consensus 87 ~lkekng~~ielK~pl~cAdp-----tserWfHG~LsgkeAekLl~ekgk~gsfLvReSqs~PGd------fVlSvrTdd 155 (600)
T KOG0790|consen 87 QLKEKNGDVIELKYPLNCADP-----TSERWFHGHLSGKEAEKLLQEKGKHGSFLVRESQSHPGD------FVLSVRTDD 155 (600)
T ss_pred HHHhcCCCEEEecCCCccCCc-----hhhhhhccCCCchhHHHHHHhcCCCccEEEeccccCCCc------eEEEEEcCC
Q ss_pred ------chhhhhhhhhhhcccchhhhhhhhhhhccCCchhhhch
Q 038696 170 ------TPDFCYRIDTVWKEDRWILFNKIQQKKISGSTKQEQGL 207 (683)
Q Consensus 170 ------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 207 (683)
+.--+-|+.|.|.+.+|-+-..-.|.+...+..++.++
T Consensus 156 ~~~~~~~~~kVtHvmI~~q~~kydVGgge~F~sltdLidhykkn 199 (600)
T KOG0790|consen 156 KKESNDSKLKVTHVMIRCQEGKYDVGGGERFDSLTDLVEHYKKN 199 (600)
T ss_pred cccCCCCccceEEEEEEecccccccCCccccchHHHHHHHhccC
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 683 | ||||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-15 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 8e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-04 |
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-60
Identities = 82/333 (24%), Positives = 137/333 (41%), Gaps = 40/333 (12%)
Query: 228 SRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD--IEPLVPEISSLLSLS 282
S +I ++ +V +G G+ K W + A++ + + + E+ L ++
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAK-WRAKDVAIKQIESESERKAFIVELRQLSRVN 59
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNI+ G L+ME L + + ++ A+ LQ +
Sbjct: 60 HPNIVKLY-GAC---LNPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCS 112
Query: 342 RGMEYLHS---KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+G+ YLHS K + H +L P N+LL G KI FG + +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLL------VAGGTVLKICDFGTACDIQT--HMTNNK 164
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
G+ W APEV E S YSEK DV+S+G+I +E++T + PF++ +
Sbjct: 165 GSAA---WMAPEVFE---------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI---MMNP 515
+ + G RP + PK + +L RCW DP+QRPS I +I+ ++ R+
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272
Query: 516 HYNSQPDPPMPLVDYSDIESRLLRKFPSWETHN 548
Y Q P + + W +
Sbjct: 273 QYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-58
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 44/310 (14%)
Query: 219 GSLSGKLLPSRIL--IKSEDYQVRRRLGSGS-------QYKE--------ILWLGESFAL 261
G++ G P L + + + +++G G + + L LG+S
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 262 RHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEIC 320
+ E+ + +L+HPNI+ G ++ME + DL +
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLY-GLM---HNPPRMVMEFVPCGDLYHRLL--- 113
Query: 321 CPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAK 378
K P V + LML IA G+EY+ ++ I H +L NI L+ + + AK
Sbjct: 114 --DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAK 169
Query: 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
++ FGLS G W APE + A Y+EK+D YSF MI
Sbjct: 170 VADFGLSQQSVH--SVSGLLGNFQ---WMAPETI-------GAEEESYTEKADTYSFAMI 217
Query: 439 CFEILTGKVPFED-AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+ ILTG+ PF++ ++ + ++ G RP P P + N+ + CW DP +RP F
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 498 SSICRILRYI 507
S I + L +
Sbjct: 278 SYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 33/292 (11%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD------IEPLVPEISSLLSLS 282
I E ++ +G G Y W GE A+R + ++ E+ +
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGR-WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
H N++ F+ +I L L S ++ +I + + +I
Sbjct: 88 HENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIV 140
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
+GM YLH+K I H +L N+ I+ FGL S+ +
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY--------DNGKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 402 HP---FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
APE++ + +S+ SDV++ G I +E+ + PF+ +
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--QPAEA 250
Query: 459 MSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ + G +P K ++++ CW + +RP+F+ + +L + +
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-55
Identities = 77/299 (25%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD------IEPLVPEISSLLSLS 282
I D ++ ++G+GS ++ W G A++ + + E++ + L
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNI+ F+ G + ++ E +SR L + + R + + +A
Sbjct: 93 HPNIVLFM-GAVTQPPNLS-IVTEYLSRGSLYRLLHK---SGAREQLDERRRLSMAYDVA 147
Query: 342 RGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP-SQS 398
+GM YLH++ I H NL N+L+ + K+ FGLS +K S S +
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLV-------DKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
GT W APEVL + +EKSDVYSFG+I +E+ T + P+ + L +
Sbjct: 201 GTPE---WMAPEVLR---------DEPSNEKSDVYSFGVILWELATLQQPWGN--LNPAQ 246
Query: 459 MSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPH 516
+ + +R P + V + + CW +P +RPSF++I +LR + + + P+
Sbjct: 247 VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 40/291 (13%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD------IEPLVPEISSLLSLS 282
I + +L +K W G ++ E L S
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPN++ L LI M L + + E AV L +A
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE----GTNFVVDQSQAVKFALDMA 121
Query: 342 RGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
RGM +LH+ + I LN ++++ + + A+IS + +SP +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMI-------DEDMTARISMADVKFSF----QSPGRMY 170
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
W APE L++ +D++SF ++ +E++T +VPF D L ++
Sbjct: 171 APA---WVAPEALQKKP------EDTNRRSADMWSFAVLLWELVTREVPFAD--LSNMEI 219
Query: 460 SRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ G RP P +V+ L K C + DP +RP F I IL ++
Sbjct: 220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 82/293 (27%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGDIEPLVP--------EISSLLS 280
I + + +G G Y+ W+G+ A++ D + + E
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNI+ E L+ME L + KRIP + V+ +Q
Sbjct: 63 LKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLS-----GKRIP--PDILVNWAVQ 113
Query: 340 IARGMEYLHSKK---IYHGNLNPSNILL-KPRGASTEGYLHAKISGFGLSSVKNFGPKSP 395
IARGM YLH + I H +L SNIL+ + KI+ FGL+ + K
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM- 172
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
S +G W APEV+ S +S+ SDV+S+G++ +E+LTG+VPF +
Sbjct: 173 SAAGAYA---WMAPEVIR---------ASMFSKGSDVWSYGVLLWELLTGEVPFRG--ID 218
Query: 456 GDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
G ++ + P P+ L + CW+ DP+ RPSF++I L I
Sbjct: 219 GLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 44/295 (14%)
Query: 232 IKSEDYQVRRRLGSGSQ---Y----------KEILWLGESFALRHFFGDIEPLVPEISSL 278
I V +R+GSGS Y K + + F + E+ L
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKN------EVGVL 74
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
H NI+ F+ G++ + ++ + L ++ F + +D+
Sbjct: 75 RKTRHVNILLFM-GYSTAPQ--LAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIA 126
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q ARGM+YLH+K I H +L +NI L KI FGL++ K+ S
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFL-------HEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG- 456
+ +W APEV+ + ++ YS +SDVY+FG++ +E++TG++P+ + + +
Sbjct: 180 EQLSGSILWMAPEVIRMQD------SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
Query: 457 --DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ + R + + + PK + L C ++RPSF I + + R
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 61/269 (22%), Positives = 98/269 (36%), Gaps = 40/269 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E+ + L HPN++ F+ +++ I E + L IK +
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIK-----SMDSQYPWSQ 109
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V IA GM YLHS I H +LN N L++ + ++ FGL+ +
Sbjct: 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-------KNVVVADFGLARLMVDEK 162
Query: 393 KSPSQSGTTHPFI------------WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
P + W APE++ Y EK DV+SFG++
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN---------GRSYDEKVDVFSFGIVLC 213
Query: 441 EILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
EI+ D + N+R P + P +T RC DP +RPSF +
Sbjct: 214 EIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273
Query: 501 CRILRYIKRFIMMNPHYNSQPDPPMPLVD 529
L ++ + + P + +D
Sbjct: 274 EHWLETLRM----HLAGHLPLGPQLEQLD 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 68/315 (21%), Positives = 122/315 (38%), Gaps = 62/315 (19%)
Query: 234 SEDYQVRRRLGSGSQYKEI---LWLGESFALRHFFGDIEPLV---PEISSLLSLSHPNIM 287
+ D + +G G Y E+ W GE+ A++ F E E+ + + L H NI+
Sbjct: 7 ARDITLLECVGKGR-YGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL 65
Query: 288 HFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
F+ + + +LI L Y++ + ++L IA G+
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-------LTTLDTVSCLRIVLSIASGL 118
Query: 345 EYLHSK--------KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP---- 392
+LH + I H +L NIL+K G I+ GL+ + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-------QCCIADLGLAVMHSQSTNQLD 171
Query: 393 -KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG------ 445
+ + GT + APEVL+E Q + ++ D+++FG++ +E+
Sbjct: 172 VGNNPRVGTKR---YMAPEVLDETIQVDCFD---SYKRVDIWAFGLVLWEVARRMVSNGI 225
Query: 446 ----KVPFED---AHLQGDKMSRNI-RAGERPLFPFH-----SPKYVTNLTKRCWHADPN 492
K PF D + M + + +RP P + + L K CW+ +P+
Sbjct: 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 493 QRPSFSSICRILRYI 507
R + I + L I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 73/334 (21%), Positives = 127/334 (38%), Gaps = 65/334 (19%)
Query: 218 SGSLSGK-LLPSRILIKSEDYQVRRRLGSGSQYKEI---LWLGESFALRHFFGDIEPLVP 273
SGS SG LL R + ++ Q+ +++G G Y E+ W GE A++ FF E
Sbjct: 21 SGSGSGLPLLVQRTI--AKQIQMVKQIGKGR-YGEVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 274 ---EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
EI + + H NI+ F+ + +LI + L Y+K
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-------STT 130
Query: 328 FSLPVAVDLMLQIARGMEYLHSK--------KIYHGNLNPSNILLKPRGASTEGYLHAKI 379
+ L G+ +LH++ I H +L NIL+K G I
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-------TCCI 183
Query: 380 SGFGLSSVKNFGPKSP-----SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434
+ GL+ ++ GT + PEVL+E + + ++ + +D+YS
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKR---YMPPEVLDE---SLNRNHFQSYIMADMYS 237
Query: 435 FGMICFEILTG----------KVPFED---AHLQGDKMSRNI-RAGERPLFPFHS----- 475
FG+I +E+ ++P+ D + + M + RP FP
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297
Query: 476 PKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ + L CW +P R + + + L +
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-45
Identities = 70/344 (20%), Positives = 137/344 (39%), Gaps = 65/344 (18%)
Query: 208 IDVLFKNLDGSGSLSGK-LLPSRILIKSEDYQVRRRLGSGSQYKEI---LWLGESFALRH 263
+ L ++ SGS SG LL R + + ++ +G G + E+ W GE A++
Sbjct: 16 LKDLIYDMTTSGSGSGLPLLVQRTI--ARTIVLQESIGKGR-FGEVWRGKWRGEEVAVKI 72
Query: 264 FFGDIEPLVP---EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIK 317
F E EI + L H NI+ F+ + + +L+ + L Y+
Sbjct: 73 FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 318 EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK--------KIYHGNLNPSNILLKPRGA 369
R ++ + L L A G+ +LH + I H +L NIL+K G
Sbjct: 133 -------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG- 184
Query: 370 STEGYLHAKISGFGLSSVKNFGP-----KSPSQSGTTHPFIWHAPEVLEENEQTESASNS 424
I+ GL+ + + GT + APEVL++ + + +
Sbjct: 185 ------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKR---YMAPEVLDD---SINMKHF 232
Query: 425 KYSEKSDVYSFGMICFEILTG----------KVPFED---AHLQGDKMSRNI-RAGERPL 470
+ +++D+Y+ G++ +EI ++P+ D + ++M + + RP
Sbjct: 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 292
Query: 471 FPFH-----SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
P + + + + + CW+A+ R + I + L + +
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 228 SRILIKSEDYQVRRRLGSGS---QYKEILWLGESFA----LRHFFGDIEPLVPEISSLLS 280
S +++ + + LG G+ ++ A L F + E+ L
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRE 73
Query: 281 LS-HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
HPN++ + C D + + ++ +EL + L Y++ +K + L+ Q
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQ--YIAIELCAATLQEYVE-----QKDFAHLGLEPITLLQQ 126
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS- 398
G+ +LHS I H +L P NIL+ A G + A IS FGL G S S+
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNA--HGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 399 ---GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454
GT W APE+L E+ + D++S G + + +++ G PF +
Sbjct: 185 GVPGTEG---WIAPEMLSED------CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL- 234
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVT----NLTKRCWHADPNQRPS 496
+ NI G L H K+ L ++ DP +RPS
Sbjct: 235 ---QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 57/272 (20%), Positives = 99/272 (36%), Gaps = 57/272 (20%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E+ SL + H NI+ F+ + +LI + L ++K S
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-------ANVVSW 120
Query: 331 PVAVDLMLQIARGMEYLHSK----------KIYHGNLNPSNILLKPRGASTEGYLHAKIS 380
+ +ARG+ YLH I H ++ N+LLK A I+
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-------TACIA 173
Query: 381 GFGLSSVKNFGPKSP---SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437
FGL+ G + Q GT + APEVLE + + D+Y+ G+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGT---RRYMAPEVLEGAINFQR----DAFLRIDMYAMGL 226
Query: 438 ICFEILTGK-----------VPFEDA---HLQGDKMSRNI-RAGERPLFPFHSPKY---- 478
+ +E+ + +PFE+ H + M + +RP+ + K+
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286
Query: 479 -VTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ + CW D R S + + ++R
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 70/315 (22%), Positives = 123/315 (39%), Gaps = 35/315 (11%)
Query: 213 KNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFFG-- 266
+ SG + ++I ++ Y ++LG G E L G +AL+
Sbjct: 7 HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE 66
Query: 267 --DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE--KKECFLIMELMSR-DLCSYIKEICC 321
D E E +HPNI+ + E K E +L++ R L + I+
Sbjct: 67 QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER--L 124
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
K + + L+L I RG+E +H+K H +L P+NILL G +
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-------QPVLMD 177
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWH-------APEVLEENEQTESASNSKYSEKSDVYS 434
G + + Q+ T + APE+ S+ E++DV+S
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ------SHCVIDERTDVWS 231
Query: 435 FGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER-PLFPFHSPKYVTNLTKRCWHADPNQ 493
G + + ++ G+ P++ +GD ++ ++ P P HS + L DP+Q
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA-LWQLLNSMMTVDPHQ 290
Query: 494 RPSFSSICRILRYIK 508
RP + L ++
Sbjct: 291 RPHIPLLLSQLEALQ 305
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E + S+ +P++ L C LI +LM L Y++E +
Sbjct: 67 EAYVMASVDNPHVCRLLGIC-----LTSTVQLITQLMPFGCLLDYVRE-----HKDNIGS 116
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
++ +QIA+GM YL +++ H +L N+L+K H KI+ FGL+ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-------QHVKITDFGLAKLLGA 169
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
K G P W A E S + Y+ +SDV+S+G+ +E++T G P+
Sbjct: 170 EEKEYHAEGGKVPIKWMALE---------SILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ + ++S + GER P V + ++CW D + RP F + + R
Sbjct: 221 DG--IPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/306 (21%), Positives = 122/306 (39%), Gaps = 35/306 (11%)
Query: 213 KNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFAL------RH 263
+ G + L + +K Y + +++GSG ++ + + +A+
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 264 FFGDIEPLVPEISSLLSLSHPN--IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICC 321
++ EI+ L L + I+ ++ +++ME + DL S++K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLK---- 119
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
K+ + + +H I H +L P+N L+ +G L K+
Sbjct: 120 --KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI------VDGML--KLID 169
Query: 382 FGLSSVKNFGPKSP---SQSGTTHPFIWHAPEVLEE--NEQTESASNSKYSEKSDVYSFG 436
FG+++ S SQ GT + + PE +++ + + S SK S KSDV+S G
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVN---YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226
Query: 437 MICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
I + + GK PF+ Q K+ I FP K + ++ K C DP QR S
Sbjct: 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286
Query: 497 FSSICR 502
+
Sbjct: 287 IPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 35/289 (12%)
Query: 230 ILIKSEDYQVRRRLGSGSQ---YKEILWLGESFAL------RHFFGDIEPLVPEISSLLS 280
I +K Y + +++GSG ++ + + +A+ ++ EI+ L
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 281 LSHPN--IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
L + I+ ++ +++ME + DL S++K K+
Sbjct: 64 LQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLK------KKKSIDPWERKSYWK 115
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP--- 395
+ + +H I H +L P+N L+ +G L K+ FG+++ S
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLI------VDGML--KLIDFGIANQMQPDTTSVVKD 167
Query: 396 SQSGTTHPFIWHAPEVLEE--NEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
SQ GT + + PE +++ + + S SK S KSDV+S G I + + GK PF+
Sbjct: 168 SQVGTVN---YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
Q K+ I FP K + ++ K C DP QR S +
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 69/245 (28%), Positives = 111/245 (45%), Gaps = 41/245 (16%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E L SHPNI+ + C T ++ +++MEL+ D ++++ + +
Sbjct: 162 EARILKQYSHPNIVRLIGVC--TQKQ--PIYIVMELVQGGDFLTFLRT-----EGARLRV 212
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ ++ A GMEYL SK H +L N L+ + KIS FG+S +
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-------NVLKISDFGMSREEAD 265
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
G + S P W APE L +YS +SDV+SFG++ +E + G P+
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYG---------RYSSESDVWSFGILLWETFSLGASPY 316
Query: 450 EDAHLQGDKMS-----RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ +S + G R P P V L ++CW +P QRPSFS+I + L
Sbjct: 317 PN-------LSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
Query: 505 RYIKR 509
+ I++
Sbjct: 370 QSIRK 374
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 61/276 (22%), Positives = 106/276 (38%), Gaps = 31/276 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
+ + + ++ SL H +I+ L L+ + + L ++++ R
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQ-----HR 109
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ ++ +QIA+GM YL + H NL N+LLK +++ FG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-------SQVQVADFGVA 162
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
+ K S P W A E S KY+ +SDV+S+G+ +E++T
Sbjct: 163 DLLPPDDKQLLYSEAKTPIKWMALE---------SIHFGKYTHQSDVWSYGVTVWELMTF 213
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
G P+ L+ ++ + GER P V + +CW D N RP+F +
Sbjct: 214 GAEPYAG--LRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
Query: 505 RYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRK 540
R P Y P + L K
Sbjct: 272 T---RMARDPPRYLVIKRESGPGIAPGPEPHGLTNK 304
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 34/252 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E + + L +P I+ + C E + L+ME+ L Y+ ++
Sbjct: 68 EANVMQQLDNPYIVRMIGIC-----EAESWMLVMEMAELGPLNKYL------QQNRHVKD 116
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
++L+ Q++ GM+YL H +L N+LL + +AKIS FGLS
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-------HYAKISDFGLSKALRA 169
Query: 391 GPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
+Q+ P W+APE + K+S KSDV+SFG++ +E + G+ P
Sbjct: 170 DENYYKAQTHGKWPVKWYAPE---------CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508
+ ++G +++ + GER P P+ + +L CW D RP F+++ LR
Sbjct: 221 YRG--MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278
Query: 509 RFIMMNPHYNSQ 520
++ H++
Sbjct: 279 YDVVNEGHHHHH 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 75/373 (20%), Positives = 141/373 (37%), Gaps = 47/373 (12%)
Query: 228 SRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFAL------RHFFGDIEPLVPEISSL 278
I +K Y + +++GSG ++ + + +A+ ++ EI+ L
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 279 LSLSHPN--IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336
L + I+ + + + +++ME + DL S++K K+
Sbjct: 109 NKLQQHSDKIIRLY-DY-EITDQYIYMVMECGNIDLNSWLK------KKKSIDPWERKSY 160
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP- 395
+ + +H I H +L P+N L+ +G L K+ FG+++ S
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLI------VDGML--KLIDFGIANQMQPDTTSVV 212
Query: 396 --SQSGTTHPFIWHAPEVLEE--NEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
SQ G + PE +++ + + S SK S KSDV+S G I + + GK PF+
Sbjct: 213 KDSQVGA--VN-YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511
Q K+ I FP K + ++ K C DP QR S + ++
Sbjct: 270 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA-----HPYV 324
Query: 512 MMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPFQMFVYRVVEKEKIS 571
+ H +Q ++ +L + + N I + ++ + + S
Sbjct: 325 QIQTHPVNQMAKGT-----TEEMKYVLGQLVGLNSPN--SILKAAKTLYEHYSGGESHNS 377
Query: 572 SSPKDTSDSGSDK 584
SS K K
Sbjct: 378 SSSKTFEKKRGKK 390
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 58/290 (20%), Positives = 97/290 (33%), Gaps = 58/290 (20%)
Query: 274 EISSLLSLSHPNIMHFL---CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFS 329
I + + H NI F+ T + + E L+ME L Y+
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-------LHTSD 109
Query: 330 LPVAVDLMLQIARGMEYLHS---------KKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380
+ L + RG+ YLH+ I H +LN N+L+K G IS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-------TCVIS 162
Query: 381 GFGLSSVK--NFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYS 434
FGLS N + + + + APEVLE + ++ D+Y+
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES--ALKQVDMYA 220
Query: 435 FGMICFEILTG-------------KVPFED---AHLQGDKMSRNI-RAGERPLFPFH--- 474
G+I +EI ++ F+ H + M + R +RP FP
Sbjct: 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
Query: 475 ---SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQP 521
+ + + + CW D R + + + N +
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 29/275 (10%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + HPNI+ T + ++ E M L S++++ F++
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPV--MIVTEYMENGSLDSFLRK-----HDAQFTVIQ 148
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
V ++ IA GM+YL H +L NIL+ L K+S FGL V P
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-------LVCKVSDFGLGRVLEDDP 201
Query: 393 KSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
++ + G P W +PE + K++ SDV+S+G++ +E+++ G+ P+
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYR---------KFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL-RYIKR 509
+ + + + + G R P P + L CW D N RP F I IL + I+
Sbjct: 253 E--MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 510 FIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSW 544
+ ++ P L+D S+++ R W
Sbjct: 311 PGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDW 345
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-35
Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESFA-----LRHFFGDIEPLVPEISSLLSLSH 283
++ D ++ +LG G QY E+ +W S L+ ++E + E + + + H
Sbjct: 217 MERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 284 PNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
PN++ L C + ++I E M+ +L Y++E R S V + + QI
Sbjct: 276 PNLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQI 327
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
+ MEYL K H NL N L+ E K++ FGLS + G + +G
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLV------GEN-HLVKVADFGLSRLMT-GDTYTAHAGA 379
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459
P W APE L N K+S KSDV++FG++ +EI T G P+ L ++
Sbjct: 380 KFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV 428
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ R P P+ V L + CW +P+ RPSF+ I +
Sbjct: 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 36/285 (12%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESFALRHFFGDIEP--LVPEISSLLSLSHPNI 286
+ ++ ++ + +G G ++ ++ + G A++ D + E S + L H N+
Sbjct: 18 LNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL 76
Query: 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ L G EEK +++ E M++ L Y++ R R + L + ME
Sbjct: 77 VQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCEAME 131
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YL H +L N+L+ +E + AK+S FGL+ + +Q P
Sbjct: 132 YLEGNNFVHRDLAARNVLV------SEDNV-AKVSDFGLTKEASS-----TQDTGKLPVK 179
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464
W APE L E K+S KSDV+SFG++ +EI + G+VP+ L+ + +
Sbjct: 180 WTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE 228
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
G + P P V + K CWH D RPSF + L +IK
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 37/269 (13%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR 323
+ ++ E + S+ +P++ L C LI +LM L Y++E
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGIC-----LTSTVQLITQLMPFGCLLDYVRE----- 109
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+ ++ +QIA+GM YL +++ H +L N+L+K H KI+ FG
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-------QHVKITDFG 162
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
L+ + K G P W A E S + Y+ +SDV+S+G+ +E++
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWMALE---------SILHRIYTHQSDVWSYGVTVWELM 213
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T G P++ + ++S + GER P V + +CW D + RP F +
Sbjct: 214 TFGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 271
Query: 503 ILRYIKR-----FIMMNPHYNSQPDPPMP 526
+ R ++ P P
Sbjct: 272 EFSKMARDPQRYLVIQGDERMHLPSPTDS 300
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 71/276 (25%), Positives = 113/276 (40%), Gaps = 36/276 (13%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFL--CGFTDEEKKEC----FLIMELMSR-DLCSYIKEI 319
DIE + E + + HP++ + K +I+ M DL +++
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVS--LRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 320 CCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379
L V M+ IA GMEYL S+ H +L N +L E +
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML------AEDMT-VCV 178
Query: 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439
+ FGLS G + P W A E L +N Y+ SDV++FG+
Sbjct: 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN---------LYTVHSDVWAFGVTM 229
Query: 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
+EI+T G+ P+ A ++ ++ + G R P + V +L +CW ADP QRPSF+
Sbjct: 230 WEIMTRGQTPY--AGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT 287
Query: 499 SICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIE 534
+ L + + ++ DP Y +IE
Sbjct: 288 CLRMEL---ENILGHLSVLSTSQDP-----LYINIE 315
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 79/330 (23%), Positives = 136/330 (41%), Gaps = 37/330 (11%)
Query: 184 DRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRL 243
FN +QQ ++ +K GL L S + L I E ++ +L
Sbjct: 134 TSRTQFNSLQQL-VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKL 192
Query: 244 GSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDE 296
G G + E+ W G + L+ E + E + L H ++ ++E
Sbjct: 193 GQG-CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHG 355
+++ E MS+ L ++K LP VD+ QIA GM Y+ H
Sbjct: 252 P---IYIVTEYMSKGSLLDFLKG----ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEEN 415
+L +NIL+ L K++ FGL+ + + ++ G P W APE
Sbjct: 305 DLRAANILVGEN-------LVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 416 EQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFH 474
+++ KSDV+SFG++ E+ T G+VP+ + ++ + G R P
Sbjct: 357 ---------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPE 405
Query: 475 SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
P+ + +L +CW +P +RP+F + L
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 40/285 (14%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESFA-----LRHFFGDIEPLVPEISSLLSLSH 283
++ D ++ +LG G QY E+ +W S L+ ++E + E + + + H
Sbjct: 10 MERTDITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 284 PNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
PN++ L C T E ++I E M+ +L Y++E R S V + + QI
Sbjct: 69 PNLVQLLGVC--TREPP--FYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQI 120
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
+ MEYL K H +L N L+ E +L K++ FGLS + + + +G
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLV------GENHL-VKVADFGLSRLMTGDTYT-AHAGA 172
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459
P W APE L N K+S KSDV++FG++ +EI T G P+ L ++
Sbjct: 173 KFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV 221
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ R P P+ V L + CW +P+ RPSF+ I +
Sbjct: 222 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 63/264 (23%), Positives = 105/264 (39%), Gaps = 30/264 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR 323
D + E + +H NI+ + F++MELM+ DL S+++E PR
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVS--LQSLP--RFILMELMAGGDLKSFLRE-TRPR 130
Query: 324 KRIPFSLPVA--VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
P SL + + + IA G +YL H ++ N LL G AKI
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG----RVAKIGD 186
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
FG++ P W PE E ++ K+D +SFG++ +E
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWE 237
Query: 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
I + G +P+ ++ + +G R P + P V + +CW P RP+F+ I
Sbjct: 238 IFSLGYMPYPS--KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 295
Query: 501 CRILRYIKRFIMMNPHYNSQPDPP 524
+ Y + +P + P
Sbjct: 296 LERIEYCTQ----DPDVINTALPI 315
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 75/304 (24%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
I E ++ ++LG+G Q+ E+ + + ++ +E + E + + +L H
Sbjct: 185 IPRESLKLEKKLGAG-QFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
++ T K+ ++I E M++ L ++K + LP +D QIA G
Sbjct: 244 KLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKS----DEGSKQPLPKLIDFSAQIAEG 296
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
M ++ + H +L +NIL+ L KI+ FGL+ V + ++ G P
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSAS-------LVCKIADFGLARVIE-DNEYTAREGAKFP 348
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS-- 460
W APE + ++ KSDV+SFG++ EI+T G++P+ MS
Sbjct: 349 IKWTAPEAINFG---------SFTIKSDVWSFGILLMEIVTYGRIPYPG-------MSNP 392
Query: 461 ---RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHY 517
R + G R P + P+ + N+ RCW P +RP+F I +L + Y
Sbjct: 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF--YTATESQY 450
Query: 518 NSQP 521
P
Sbjct: 451 EEIP 454
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 28/237 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
S + LSH +++ + E L+ E + L +Y+K+ + ++
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKK-----NKNCINILW 114
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY-LHAKISGFGLSSVKNFG 391
+++ Q+A M +L + HGN+ NILL G K+S G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL-- 172
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ W PE +E + +D +SFG +EI + G P
Sbjct: 173 ----PKDILQERIPWVPPECIEN--------PKNLNLATDKWSFGTTLWEICSGGDKPLS 220
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
L + + + P + NL C +P+ RPSF +I R L +
Sbjct: 221 A--LDSQRKLQFYEDRHQLPAPKAAELA--NLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 68/310 (21%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 226 LPSRILIKSEDYQVRRRLGSGS--------------QY--KEILWLGESFALRHFFGDIE 269
+PSR EDY+V +G+GS KE+ + + A + +
Sbjct: 1 MPSRA----EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------EKQ 50
Query: 270 PLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPF 328
LV E++ L L HPNI+ + D +++ME DL S I + ++R
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYL 108
Query: 329 SLPVAVDLMLQIARGMEYLHSKK-----IYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+ +M Q+ ++ H + + H +L P+N+ L + + K+ FG
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------NVKLGDFG 161
Query: 384 LSSV-KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
L+ + + + + GT P+ + +PE + Y+EKSD++S G + +E+
Sbjct: 162 LARILNHDTSFAKTFVGT--PY-YMSPEQMNRM---------SYNEKSDIWSLGCLLYEL 209
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
PF + ++ IR G+ P+ + + R + RPS I
Sbjct: 210 CALMPPFTAFSQKE--LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
Query: 503 ---ILRYIKR 509
IL +
Sbjct: 268 NPLILEHHHH 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 65/259 (25%), Positives = 116/259 (44%), Gaps = 29/259 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
+E + E + L+HPN++ + G + +++ M DL +I+ +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALI-GIMLPPEGLPHVLLPYMCHGDLLQFIRS-----PQ 118
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
++ + LQ+ARGMEYL +K H +L N +L E + K++ FGL+
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML------DESFT-VKVADFGLA 171
Query: 386 -SVKNFGPKSPSQSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ + S Q P W A E L+ +++ KSDV+SFG++ +E+L
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTY---------RFTTKSDVWSFGVLLWELL 222
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T G P+ + ++ + G R P + P + + ++CW ADP RP+F +
Sbjct: 223 TRGAPPYRH--IDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280
Query: 503 ILRYIKRFIMMNPHYNSQP 521
+ I ++ HY P
Sbjct: 281 EVEQIVS-ALLGDHYVQLP 298
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 73/338 (21%), Positives = 141/338 (41%), Gaps = 46/338 (13%)
Query: 235 EDYQVRRRLGSGSQYKEILWL------GESFAL------RHFFGDIEPLVPEISSLLSLS 282
E Y +++G GS + + L G + + R + E E++ L ++
Sbjct: 24 EKYVRLQKIGEGS-FGKA-ILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNI+ + F EE +++M+ DL I +K + F +D +QI
Sbjct: 82 HPNIVQYRESF--EENGSLYIVMDYCEGGDLFKRINA----QKGVLFQEDQILDWFVQIC 135
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-KNFGPKSPSQSGT 400
++++H +KI H ++ NI L G ++ FG++ V + + + GT
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG-------TVQLGDFGIARVLNSTVELARACIGT 188
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
P+ + +PE+ E N Y+ KSD+++ G + +E+ T K FE ++ +
Sbjct: 189 --PY-YLSPEICE---------NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LV 234
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI--MMNPHYN 518
I +G P H + +L + + +P RPS +SI +I + I ++P
Sbjct: 235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE-KGFIAKRIEKFLSPQLI 293
Query: 519 SQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIP 556
++ + R + +V+P +I
Sbjct: 294 AEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKIT 331
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 42/301 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
+ E ++ RLG+G Q+ E+ + G + +L+ + + E + + L H
Sbjct: 10 VPRETLKLVERLGAG-QFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 285 NIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
++ ++ ++I E M L ++K I ++ +D+ QIA
Sbjct: 69 RLVRLYAVV-----TQEPIYIITEYMENGSLVDFLKT----PSGIKLTINKLLDMAAQIA 119
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
GM ++ + H +L +NIL+ + KI+ FGL+ + + + G
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLS-------CKIADFGLARLIEDNEYTARE-GAK 171
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460
P W APE + ++ KSDV+SFG++ EI+T G++P+ ++
Sbjct: 172 FPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI 220
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQ 520
+N+ G R + P + P+ + L + CW P RP+F + +L F Y Q
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF--FTATEGQYQPQ 278
Query: 521 P 521
P
Sbjct: 279 P 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 36/251 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L +L H NI+ + T++ LIME + L Y+ + + +L
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-----KNKNKINLKQ 127
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ +QI +GM+YL S++ H +L N+L+ E KI FGL+
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-------ESEHQVKIGDFGLTKAIETDK 180
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ + P W+APE L ++ K+ SDV+SFG+ E+LT
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQS---------KFYIASDVWSFGVTLHELLTYCDSDSS 231
Query: 451 DAHLQGDKMS------------RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
L + ++ G+R P + P V L ++CW P+ R SF
Sbjct: 232 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ 291
Query: 499 SICRILRYIKR 509
++ + +
Sbjct: 292 NLIEGFEALLK 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 73/303 (24%), Positives = 117/303 (38%), Gaps = 39/303 (12%)
Query: 226 LPSRILIKSEDYQVRRRLGSGSQ---YKEILWLGESFA----LRHFFGDIEPLVPEISSL 278
+P+ + LG GS + + G A L F EI L
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLL 62
Query: 279 L-SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP-FSLPVAVDL 336
S HPN++ + C T + ++ +EL + +L ++ + + + L
Sbjct: 63 TESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY------LHAKISGFGLSSVKNF 390
+ QIA G+ +LHS KI H +L P NIL+ T L IS FGL K
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC--KKL 178
Query: 391 GPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445
S + W APE+LEE+ + + + + D++S G + + IL+ G
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ--TKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT------NLTKRCWHADPNQRPSFSS 499
K PF D + + NI G L + +L + DP +RP+
Sbjct: 237 KHPFGDKYSR----ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
Query: 500 ICR 502
+ R
Sbjct: 293 VLR 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 23/246 (9%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE---KKECFLIMELMSR-DLCSYIKEICCP 322
+IE + E + + SHPN++ L + + +I+ M DL +Y+
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
L + M+ IA GMEYL ++ H +L N +L + ++ F
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML------RDDMT-VCVADF 191
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
GLS G P W A E L + Y+ KSDV++FG+ +EI
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEI 242
Query: 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
T G P+ +Q +M + G R P + + CW DP RP+FS +
Sbjct: 243 ATRGMTPYPG--VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300
Query: 502 RILRYI 507
L +
Sbjct: 301 LQLEKL 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 64/254 (25%), Positives = 101/254 (39%), Gaps = 41/254 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L SL H NI+ + ++ LIME + L Y++ + +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----KHKERIDHIK 115
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ QI +GMEYL +K+ H +L NIL+ E KI FGL+ V
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILV-------ENENRVKIGDFGLTKVLPQDK 168
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT------- 444
+ + P W+APE L E+ K+S SDV+SFG++ +E+ T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 445 ---------GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
G + + ++ R P P + + CW+ + NQRP
Sbjct: 220 PPAEFMRMIGNDKQGQ--MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277
Query: 496 SFSSICRILRYIKR 509
SF + + I+
Sbjct: 278 SFRDLALRVDQIRD 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 35/255 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E + L +P I+ + C + + L+ME+ L ++ KR +
Sbjct: 60 EAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVG-----KREEIPV 109
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKN 389
+L+ Q++ GM+YL K H +L N+LL R +AKIS FGLS ++
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-------HYAKISDFGLSKALGA 162
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
++S P W+APE + K+S +SDV+S+G+ +E L+ G+ P
Sbjct: 163 DDSYYTARSAGKWPLKWYAPE---------CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508
++ ++G ++ I G+R P P + L CW RP F ++ + +R
Sbjct: 214 YKK--MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC- 270
Query: 509 RFIMMNPHYNSQPDP 523
+ +
Sbjct: 271 -YYSLASKVEGHHHH 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EIS SL+H +++ F F D + F+++EL R L K RK + P
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKR----RKA--LTEPE 116
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A + QI G +YLH ++ H +L N+ L KI FGL++
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-------EVKIGDFGLATK----V 165
Query: 393 KSPSQSGTTH----PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ + +I APEVL S +S + DV+S G I + +L GK P
Sbjct: 166 EYDGERKKVLCGTPNYI--APEVL---------SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
FE + L+ + I+ E P H +L ++ DP RP+ + +
Sbjct: 215 FETSCLK--ETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 36/287 (12%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
I + + +GSG Q+ + WL + +R E + E ++ LSHP
Sbjct: 5 IDPSELTFVQEIGSG-QFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
++ ++ L+ E M L Y++ +R F+ + + L + G
Sbjct: 64 KLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEG 116
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
M YL + H +L N L+ K+S FG++ + S GT P
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGEN-------QVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462
W +PEV + +YS KSDV+SFG++ +E+ + GK+P+E+ ++ +
Sbjct: 169 VKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED 217
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
I G R P + +V + CW P RP+FS + R L I
Sbjct: 218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 34/272 (12%)
Query: 271 LVPEISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327
+ E + +H NI+ + F+++ELM+ DL S+++E PR P
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVS--LQSLP--RFILLELMAGGDLKSFLRE-TRPRPSQP 175
Query: 328 FSLPVA--VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
SL + + + IA G +YL H ++ N LL G AKI FG++
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG----RVAKIGDFGMA 231
Query: 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT- 444
P W PE E ++ K+D +SFG++ +EI +
Sbjct: 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWEIFSL 282
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
G +P+ ++ + +G R P + P V + +CW P RP+F+ I +
Sbjct: 283 GYMPYPS--KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 505 RYIKRFIMMNPHYNSQPDPPMPLVDYSDIESR 536
Y + +P + +P ++Y +
Sbjct: 341 EYCTQ----DPDV---INTALP-IEYGPLVEE 364
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 54/304 (17%), Positives = 97/304 (31%), Gaps = 50/304 (16%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWL----GESFAL-----RHFFGDIEPLVPEISSLLSLS 282
+ + + LG G+ G+ FA+ F ++ + E L L+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
H NI+ + + LIME L + ++E P + ++ +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLRDVV 122
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS--G 399
GM +L I H N+ P NI+ +G K++ FG + + S G
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVI---GEDGQSVYKLTDFGAA--RELEDDEQFVSLYG 177
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-- 457
T + P++ E KY D++S G+ + TG +PF
Sbjct: 178 TEE---YLHPDMY-ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 458 KMSRNIRAGERPL--------------FPFHSP----------KYVTNLTKRCWHADPNQ 493
++ I G+ + P +T + AD +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 494 RPSF 497
F
Sbjct: 294 CWGF 297
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-33
Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 36/285 (12%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESFALRHFFGDIEP--LVPEISSLLSLSHPNI 286
+ ++ ++ + +G G ++ ++ + G A++ D + E S + L H N+
Sbjct: 190 LNMKELKLLQTIGKG-EFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL 248
Query: 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ L G EEK +++ E M++ L Y++ R R + L + ME
Sbjct: 249 VQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCEAME 303
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YL H +L N+L+ AK+S FGL+ + +Q P
Sbjct: 304 YLEGNNFVHRDLAARNVLVSED-------NVAKVSDFGLTKEASS-----TQDTGKLPVK 351
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464
W APE L E K+S KSDV+SFG++ +EI + G+VP+ L+ + +
Sbjct: 352 WTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE 400
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
G + P P V ++ K CWH D RP+F + L +I+
Sbjct: 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 36/249 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L +L I+ + ++ L+ME + L +++ R R
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDASR 128
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ QI +GMEYL S++ H +L NIL++ H KI+ FGL+ +
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-------AHVKIADFGLAKLLPLDK 181
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ P W+APE L +N +S +SDV+SFG++ +E+ T
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDN---------IFSRQSDVWSFGVVLYELFTYCDKSCS 232
Query: 451 DAHLQGDKMSRN------------IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
+ M + G+R P P V L K CW P RPSFS
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS 292
Query: 499 SICRILRYI 507
++ L +
Sbjct: 293 ALGPQLDML 301
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-33
Identities = 75/313 (23%), Positives = 129/313 (41%), Gaps = 36/313 (11%)
Query: 201 TKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYKEI---LWLGE 257
+K GL L S + L I E ++ +LG G + E+ W G
Sbjct: 233 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQG-CFGEVWMGTWNGT 291
Query: 258 SF----ALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DL 312
+ L+ E + E + L H ++ ++E +++ E MS+ L
Sbjct: 292 TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSL 348
Query: 313 CSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372
++K LP VD+ QIA GM Y+ H +L +NIL+
Sbjct: 349 LDFLKG----ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN----- 399
Query: 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDV 432
L K++ FGL+ + + ++ G P W APE +++ KSDV
Sbjct: 400 --LVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG---------RFTIKSDV 447
Query: 433 YSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADP 491
+SFG++ E+ T G+VP+ + ++ + G R P P+ + +L +CW +P
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 492 NQRPSFSSICRIL 504
+RP+F + L
Sbjct: 506 EERPTFEYLQAFL 518
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 65/255 (25%), Positives = 117/255 (45%), Gaps = 29/255 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
++ + E + SHPN++ L G + +++ M DL ++I+ +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLL-GICLRSEGSPLVVLPYMKHGDLRNFIRN-----ET 122
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
++ + LQ+A+GM+YL SKK H +L N +L E + K++ FGL+
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML------DEKFT-VKVADFGLA 175
Query: 386 -SVKNFGP-KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ + +++G P W A E L+ K++ KSDV+SFG++ +E++
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELM 226
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T G P+ D + ++ + G R L P + P + + +CWH RPSFS +
Sbjct: 227 TRGAPPYPD--VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284
Query: 503 ILRYIKRFIMMNPHY 517
+ I + HY
Sbjct: 285 RISAIFS-TFIGEHY 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 41/249 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L SL H NI+ + ++ LIME + L Y++ + +
Sbjct: 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----KHKERIDHIK 146
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ QI +GMEYL +K+ H +L NIL++ KI FGL+ V
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-------NRVKIGDFGLTKVLPQDK 199
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT------- 444
+ + P W+APE L E+ K+S SDV+SFG++ +E+ T
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 445 ---------GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
G + + ++ R P P + + CW+ + NQRP
Sbjct: 251 PPAEFMRMIGNDKQGQ--MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
Query: 496 SFSSICRIL 504
SF + +
Sbjct: 309 SFRDLALRV 317
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/289 (22%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
+K E+ + + LGSG Q+ + W G+ ++ + E +++ LSHP
Sbjct: 5 LKREEITLLKELGSG-QFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 285 NIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
++ F C + E +++ E +S L +Y++ +++ +
Sbjct: 64 KLVKFYGVC--SKEYPI--YIVTEYISNGCLLNYLRS-----HGKGLEPSQLLEMCYDVC 114
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
GM +L S + H +L N L+ L K+S FG++ S GT
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRD-------LCVKVSDFGMTRYVLDDQYVSSV-GTK 166
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460
P W APEV KYS KSDV++FG++ +E+ + GK+P++ ++
Sbjct: 167 FPVKWSAPEVFHYF---------KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVV 215
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ G R P + + + CWH P +RP+F + + ++
Sbjct: 216 LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EIS SL+H +++ F F D + F+++EL R L K RK + P
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKR----RKA--LTEPE 142
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A + QI G +YLH ++ H +L N+ L KI FGL++
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-------EVKIGDFGLATK----V 191
Query: 393 KSPSQSGTTH----PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ + +I APEVL S +S + DV+S G I + +L GK P
Sbjct: 192 EYDGERKKVLCGTPNYI--APEVL---------SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
FE + L+ + I+ E P H +L ++ DP RP+ + +
Sbjct: 241 FETSCLK--ETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK----EICC 321
+ + E S + + +++ L + + +IMELM+R DL SY++ +
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
P SL + + +IA GM YL++ K H +L N ++ E + KI
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV------AEDFT-VKIGD 181
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
FG++ P W +PE L++ ++ SDV+SFG++ +E
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWE 232
Query: 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
I T + P++ L +++ R + G P + P + L + CW +P RPSF I
Sbjct: 233 IATLAEQPYQG--LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 501 CRILRYI--KRFIMMNPHYNSQPDPPMP 526
++ F ++ +Y+ + P P
Sbjct: 291 ISSIKEEMEPGFREVSFYYSEENKLPEP 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 33/236 (13%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL--IMELMSR-DLCSYIKEICCPR 323
+ + E L L HPNI+ F + K + + + ELM+ L +Y+K
Sbjct: 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--- 124
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKISG 381
+ V QI +G+++LH++ I H +L NI + G KI
Sbjct: 125 ---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT----GPTG--SVKIGD 175
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
GL+++K + + GT + APE+ EE KY E DVY+FGM E
Sbjct: 176 LGLATLKR-ASFAKAVIGTPE---FMAPEMYEE----------KYDESVDVYAFGMCMLE 221
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPL-FPFHSPKYVTNLTKRCWHADPNQRPS 496
+ T + P+ + + R + +G +P F + V + + C + ++R S
Sbjct: 222 MATSEYPYSECQNAAQ-IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 55/321 (17%), Positives = 103/321 (32%), Gaps = 50/321 (15%)
Query: 232 IKSEDYQVRRRLGSGSQYKEILWL----GESFAL-----RHFFGDIEPLVPEISSLLSLS 282
+ + + LG G+ G+ FA+ F ++ + E L L+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
H NI+ + + LIME L + ++E P + ++ +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLRDVV 122
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS--G 399
GM +L I H N+ P NI+ +G K++ FG + + S G
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVI---GEDGQSVYKLTDFGAA--RELEDDEQFVSLYG 177
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-- 457
T + P++ E + KY D++S G+ + TG +PF
Sbjct: 178 TEE---YLHPDMYERAVLRKDHQK-KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 458 KMSRNIRAGERP--------------LFPFHSP----------KYVTNLTKRCWHADPNQ 493
++ I G+ + P +T + AD +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 494 RPSFSSICRILRYIKRFIMMN 514
F I ++++
Sbjct: 294 CWGFDQFFAETSDILHRMVIH 314
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E++++ SL H N++ ++ EL L +++ + F L
Sbjct: 71 EVNAMHSLDHRNLIRLYGVV-----LTPPMKMVTELAPLGSLLDRLRK-----HQGHFLL 120
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+Q+A GM YL SK+ H +L N+LL R KI FGL
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-------DLVKIGDFGLMRALPQ 173
Query: 391 GPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
Q PF W APE S +S SD + FG+ +E+ T G+ P
Sbjct: 174 NDDHYVMQEHRKVPFAWCAPE---------SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + + + + GER P P+ + N+ +CW P RP+F ++ L
Sbjct: 225 WIGLNGS-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 59/287 (20%), Positives = 100/287 (34%), Gaps = 45/287 (15%)
Query: 235 EDYQVRRRLGSGSQ---YKEILWL-GESFAL----RHFFG--DIEPLVPEISSLLSL-SH 283
+ +Q RLG GS +K G +A+ F G D + E+ S + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
P + + EE +L EL L + + +
Sbjct: 117 PCCVRLEQAW--EEGGILYLQTELCGPSLQQHCE-----AWGASLPEAQVWGYLRDTLLA 169
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+ +LHS+ + H ++ P+NI L PRG K+ FGL Q G P
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRG-------RCKLGDFGLLVELGTAGAGEVQEGD--P 220
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ APE+L+ Y +DV+S G+ E+ G+ + +
Sbjct: 221 R-YMAPELLQG----------SYGTAADVFSLGLTILEVACNMELPH----GGEGW-QQL 264
Query: 464 RAGE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
R G P F + ++ DP R + ++ L +++
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA-LPVLRQ 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 29/262 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E + SH NI+ + + +I E M L +++E K FS+
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPM--MIITEYMENGALDKFLRE-----KDGEFSVLQ 148
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFG 391
V ++ IA GM+YL + H +L NIL+ L K+S FGLS +++
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-------LVCKVSDFGLSRVLEDDP 201
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ + SG P W APE + K++ SDV+SFG++ +E++T G+ P+
Sbjct: 202 EATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYW 252
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL-RYIKR 509
+ L ++ + I G R P P + L +CW + +RP F+ I IL + I+
Sbjct: 253 E--LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
Query: 510 FIMMNPHYNSQPDPPMPLVDYS 531
+ + P + L S
Sbjct: 311 PDSLKTLADFDPRVSIRLPSTS 332
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 65/247 (26%), Positives = 97/247 (39%), Gaps = 38/247 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI L +L H +I+ + D L+ME + L Y+ R I L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSI--GLAQ 135
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ QI GM YLH++ H +L N+LL KI FGL+ G
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-------RLVKIGDFGLAKAVPEGH 188
Query: 393 KS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ + P W+APE L+E K+ SDV+SFG+ +E+LT
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEY---------KFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 451 DAHLQGDKMS------------RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS 498
+ + + GER P P V +L K CW + + RP+F
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299
Query: 499 SICRILR 505
++ IL+
Sbjct: 300 NLIPILK 306
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 70/287 (24%), Positives = 125/287 (43%), Gaps = 36/287 (12%)
Query: 232 IKSEDYQVRRRLGSGSQYKEI---LWLGESF----ALRHFFGDIEPLVPEISSLLSLSHP 284
I +D + LG+G Q+ + W G+ ++ + + E +++LSH
Sbjct: 21 IDPKDLTFLKELGTG-QFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
++ T + F+I E M+ L +Y++E R F +++ +
Sbjct: 80 KLVQLYGVCTKQR--PIFIITEYMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEA 132
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
MEYL SK+ H +L N L+ + K+S FGLS + S G+ P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQ-------GVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462
W PEVL + K+S KSD+++FG++ +EI + GK+P+E + + +
Sbjct: 185 VRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH 233
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
I G R P + + V + CWH ++RP+F + + +
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 52/297 (17%)
Query: 235 EDYQVRRRLGSGS-----QYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHF 289
D++ +GSG + K + G+++ ++ + E E+ +L L H NI+H+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHY 69
Query: 290 LCGFTDEEKKEC--------------FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAV 334
+ + F+ ME + L +I++ R+ +A+
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK----RRGEKLDKVLAL 125
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
+L QI +G++Y+HSKK+ + +L PSNI L KI FGL + K
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-------QVKIGDFGLVTSLKNDGKR 178
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
GT + +PE + + Y ++ D+Y+ G+I E+L +
Sbjct: 179 TRSKGT--LR-YMSPEQIS---------SQDYGKEVDLYALGLILAELLHVCDTAFE--- 223
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511
S+ + K L ++ P RP+ S I R L + +
Sbjct: 224 ----TSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL-TVWKKS 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 37/242 (15%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE------------ICCPRKRI 326
+H NI++ L C T +I E DL ++++ +
Sbjct: 85 NHMNIVNLLGAC--TIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
L + Q+A+GM +L SK H +L NILL T G + KI FGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL------THGRI-TKICDFGLAR 193
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445
+ P W APE + Y+ +SDV+S+G+ +E+ + G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGIFLWELFSLG 244
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
P+ + + I+ G R L P H+P + ++ K CW ADP +RP+F I +++
Sbjct: 245 SSPYPGMPVDSKFY-KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 506 YI 507
Sbjct: 304 KQ 305
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E S + HPNI+ T ++ E M L ++++ F++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLA--MIVTEYMENGSLDTFLRT-----HDGQFTIMQ 152
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFG 391
V ++ + GM YL H +L N+L+ L K+S FGLS +++
Sbjct: 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-------LVCKVSDFGLSRVLEDDP 205
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+ + +G P W APE + +S SDV+SFG++ +E+L G+ P+
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFR---------TFSSASDVWSFGVVMWEVLAYGERPYW 256
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
+ + + ++ G R P P + L CWH D QRP FS I +L
Sbjct: 257 N--MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 48/300 (16%)
Query: 234 SEDYQVRRRLGSGSQ---YKEILWL-GESFAL----RHFFG--DIEPLVPEISSLLSLS- 282
+ ++ ++GSG +K + L G +A+ + G D + + E+ + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
H +++ + + +++ + E + L I E R F DL+LQ+
Sbjct: 70 HSHVVRYFSAWAEDDH--MLIQNEYCNGGSLADAISE--NYRIMSYFKEAELKDLLLQVG 125
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH------------AKISGFGLSSVKN 389
RG+ Y+HS + H ++ PSNI + KI G + +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ G + A EVL+EN + K+D+++ + +
Sbjct: 186 ---SPQVEEGD--SR-FLANEVLQENYT--------HLPKADIFALALTVVCAAGAEPLP 231
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ IR G P P + T L K H DP +RPS ++ + +
Sbjct: 232 RNGD-----QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK-HSVLLS 285
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 29/261 (11%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
++ + E + SHPN++ L G + +++ M DL ++I+ +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLL-GICLRSEGSPLVVLPYMKHGDLRNFIRN-----ET 186
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
++ + LQ+A+GM++L SKK H +L N +L E + K++ FGL+
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------DEKFT-VKVADFGLA 239
Query: 386 -SVKNFGPKSPSQSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ + S P W A E L+ K++ KSDV+SFG++ +E++
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELM 290
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T G P+ D + ++ + G R L P + P + + +CWH RPSFS +
Sbjct: 291 TRGAPPYPD--VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348
Query: 503 ILRYIKRFIMMNPHYNSQPDP 523
+ I + HY
Sbjct: 349 RISAIFS-TFIGEHYVHVNAT 368
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 47/308 (15%), Positives = 82/308 (26%), Gaps = 65/308 (21%)
Query: 233 KSEDYQVRRRLGSGSQYKEILWL------GESFALRHFF-------GDIEPLVPEISSLL 279
++ L G + ++L E FAL+ F ++E L +
Sbjct: 60 GERKLKLVEPLRVGDRSV--VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 280 SLSHPN------------------------IMHFLCGFTDEEKKECFLIMELMSRDLCSY 315
L + G D L+M S DL
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177
Query: 316 IKEI-CCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374
+ R + L Q+ R L SK + HG+ P N+ + P G
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG------ 231
Query: 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434
+ G + P+ S + E L AS + ++ + +
Sbjct: 232 -RLMLGDVSAL--WKVGTRGPA-SSVPVTYA--PREFLN-------ASTATFTHALNAWQ 278
Query: 435 FGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPF------HSPKYVTNLTKRCWH 488
G+ + + +PF + P +V L R +
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN 338
Query: 489 ADPNQRPS 496
D +R
Sbjct: 339 FDRRRRLL 346
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 226 LPSRILIKSEDYQVRRRLGSGS-----QYKEILWLGESFALRHFF-------GDIEPLVP 273
L + I K ED++V LG GS + + I G A++ G ++ +
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E+ L HP+I+ F D +L++E+ ++ Y+K + PFS
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLK-----NRVKPFSENE 113
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A M QI GM YLHS I H +L SN+LL + KI+ FGL++
Sbjct: 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-------NIKIADFGLATQ----L 162
Query: 393 KSPSQS-----GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
K P + GT + +I +PE+ + S + +SDV+S G + + +L G+
Sbjct: 163 KMPHEKHYTLCGTPN-YI--SPEIA---------TRSAHGLESDVWSLGCMFYTLLIGRP 210
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
PF+ ++ + + P +L + +P R S SS+
Sbjct: 211 PFDTDTVK--NTLNKVVLADYE-MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 29/238 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E ++ HP+I+ + T+ ++IMEL + +L S+++ ++ L
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENPV---WIIMELCTLGELRSFLQV-----RKYSLDLAS 117
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ Q++ + YL SK+ H ++ N+L+ K+ FGLS
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-------DCVKLGDFGLSRYMEDST 170
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
S P W APE + +++ SDV+ FG+ +EIL G PF+
Sbjct: 171 YY-KASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQG 220
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
++ + + I GER P + P + +L +CW DP++RP F+ + L I
Sbjct: 221 --VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 33/233 (14%), Positives = 67/233 (28%), Gaps = 23/233 (9%)
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEIC-CPRKRIPFS 329
+ + ++ D F + M +L ++ + +
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+ L LQ+ R + LH + H L P +I+L RG ++GF
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-------GVFLTGFEHLVRDG 257
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSK--YSEKSDVYSFGMICFEILTGKV 447
S + + PE+ + + + D ++ G++ + I +
Sbjct: 258 ---ARVVSSVSRG---FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
P G S I + + P+ V L + R
Sbjct: 312 PITKDAALG--GSEWIFRSCKNI-----PQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 36/250 (14%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----------IC 320
E L +L H +I+ F C D + ++ E M DL +++
Sbjct: 67 EAELLTNLQHEHIVKFYGVC--GDGDPL--IMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 321 CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380
+ + L + + QIA GM YL S+ H +L N L+ L KI
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV------GANLL-VKIG 175
Query: 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440
FG+S T P W PE + K++ +SDV+SFG+I +
Sbjct: 176 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVILW 226
Query: 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
EI T GK P+ L ++ I G P PK V ++ CW +P QR +
Sbjct: 227 EIFTYGKQPWFQ--LSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284
Query: 500 ICRILRYIKR 509
I +IL + +
Sbjct: 285 IYKILHALGK 294
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 57/307 (18%), Positives = 120/307 (39%), Gaps = 51/307 (16%)
Query: 235 EDYQVRRRLGSGS--------------QY--KEILWLGESFALRHFFGDIEPLVPEISSL 278
++++ +++G G K++ A + EI L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-----KARADCIKEIDLL 86
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
L+HPN++ + F E E +++EL DL IK +++
Sbjct: 87 KQLNHPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYF 142
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV-KNFGPKSPS 396
+Q+ +E++HS+++ H ++ P+N+ + G K+ GL + + S
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATG-------VVKLGDLGLGRFFSSKTTAAHS 195
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
GT P+ + +PE + + Y+ KSD++S G + +E+ + PF +
Sbjct: 196 LVGT--PY-YMSPERIH---------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243
Query: 457 DKMSRNIRAGERPLFPFHSPKY---VTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMM 513
+ + I + P P S Y + L C + DP +RP + + + + +
Sbjct: 244 YSLCKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
Query: 514 NPHYNSQ 520
+ ++
Sbjct: 302 SLEHHHH 308
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 282 SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCPRKRIPFSL 330
H N+++ L G + +I+E +L +Y++ + +L
Sbjct: 89 HHLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ Q+A+GME+L S+K H +L NILL +E + KI FGL+
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILL------SEKNV-VKICDFGLARDIYK 200
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
P + P W APE + + Y+ +SDV+SFG++ +EI + G P+
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
+ ++ R ++ G R P ++ + CWH +P+QRP+FS + L +
Sbjct: 252 PGVKI-DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 61/247 (24%), Positives = 93/247 (37%), Gaps = 31/247 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE---------ICCPR 323
E L L H +I+ F T+ ++ E M DL +++
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPL--LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
P L + + Q+A GM YL H +L N L+ +G L KI FG
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------GQG-LVVKIGDFG 203
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+S T P W PE + K++ +SDV+SFG++ +EI
Sbjct: 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESDVWSFGVVLWEIF 254
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T GK P+ L + I G P P V + + CW +P QR S +
Sbjct: 255 TYGKQPWYQ--LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 503 ILRYIKR 509
L+ + +
Sbjct: 313 RLQALAQ 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 62/306 (20%), Positives = 110/306 (35%), Gaps = 69/306 (22%)
Query: 235 EDYQVRRRLGSGS--------------QY--KEILWLGESFALRHFFGDIEPLVPEISSL 278
D++ + LG G Y K I L + E ++ E+ +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-------RLPNRELAREKVMREVKAL 57
Query: 279 LSLSHPNIMHFLCGFTDEEKKEC----------FLIMELMSR-DLCSYIKEICCPRKRIP 327
L HP I+ + + ++ E ++ M+L + +L ++ R I
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG----RCTIE 113
Query: 328 FS-LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
V + + LQIA +E+LHSK + H +L PSNI K+ FGL +
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-------VVKVGDFGLVT 166
Query: 387 VKNFGPKSPSQSGTTHPFIWH----------APEVLEENEQTESASNSKYSEKSDVYSFG 436
+ + + + H +PE + + YS K D++S G
Sbjct: 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH---------GNSYSHKVDIFSLG 217
Query: 437 MICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
+I FE+L PF + + ++R + P + + P +RP
Sbjct: 218 LILFELLY---PFSTQMERVRTL-TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273
Query: 497 FSSICR 502
+I
Sbjct: 274 AINIIE 279
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 33/238 (13%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIK--------EICCPRKRIPFSL 330
H NI++ L C T +I E DL ++++ + S
Sbjct: 108 QHENIVNLLGAC--THGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ Q+A+GM +L SK H ++ N+LL T G++ AKI FGL+
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL------TNGHV-AKIGDFGLARDIMN 216
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
+ P W APE + + Y+ +SDV+S+G++ +EI + G P+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
L K + ++ G + P +PK + ++ + CW +P RP+F IC L+
Sbjct: 268 P-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 36/240 (15%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCPRKRIPF 328
H NI++ L C T + ++I+E S+ +L Y++
Sbjct: 99 KHKNIINLLGAC--TQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ V Q+ARGMEYL S+K H +L N+L+ TE + KI+ FGL+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV-MKIADFGLARDI 207
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447
N + P W APE L + Y+ +SDV+SFG++ +EI T G
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
P+ + +++ + ++ G R P + + + + CWHA P+QRP+F + L I
Sbjct: 259 PYPG--IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 49/281 (17%)
Query: 235 EDYQVRRRLGSGS-------QYKEILWLGESFALRHFF-------GDIEPLVPEISSLLS 280
ED+++ R LG G + K+ AL+ F G L E+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNI+ F D + +LI+E + + +K F + +
Sbjct: 66 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYREL------QKLSKFDEQRTATYITE 117
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
+A + Y HSK++ H ++ P N+LL G KI+ FG SV + G
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAG-------ELKIADFGW-SVHAPSSRRTDLCG 169
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T + PE++E + EK D++S G++C+E L GK PFE Q +
Sbjct: 170 TLD---YLPPEMIE---------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ET 215
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ I E FP + +L R +P+QRP +
Sbjct: 216 YKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 60/304 (19%), Positives = 108/304 (35%), Gaps = 60/304 (19%)
Query: 234 SEDYQVRRRLGSGS-----QYKEILWLGESFA---LRHFFGDIEPLVPEISSLLSLSHPN 285
+ D++ LG G+ + + L +A +RH + ++ E+ L SL+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY 63
Query: 286 IMHFLCGFTD-----------EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVA 333
++ + + + ++K F+ ME L I + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-----ENLNQQRDEY 118
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
L QI + Y+HS+ I H +L P NI + + KI FGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-------NVKIGDFGLAKNVHRSLD 171
Query: 394 SPSQSGTTHPFI------------WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
P + A EVL+ Y+EK D+YS G+I FE
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD--------GTGHYNEKIDMYSLGIIFFE 223
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKY---VTNLTKRCWHADPNQRPSFS 498
++ PF + + + +R+ P + + DPN+RP
Sbjct: 224 MIY---PFSTGMER-VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
Query: 499 SICR 502
++
Sbjct: 280 TLLN 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 33/239 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E + L +P I+ + C + + L+ME+ L ++ KR +
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVG-----KREEIPV 435
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKN 389
+L+ Q++ GM+YL K H NL N+LL R +AKIS FGLS ++
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-------HYAKISDFGLSKALGA 488
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
++S P W+APE + K+S +SDV+S+G+ +E L+ G+ P
Sbjct: 489 DDSYYTARSAGKWPLKWYAPE---------CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
++ ++G ++ I G+R P P + L CW RP F ++ + +R
Sbjct: 540 YKK--MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 36/240 (15%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCPRKRIPF 328
H NI++ L C T + ++I+E S+ +L Y++
Sbjct: 133 KHKNIINLLGAC--TQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
S V Q+ARGMEYL SKK H +L N+L+ TE + KI+ FGL+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV------TEDNV-MKIADFGLARDI 241
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447
+ + P W APE L + Y+ +SDV+SFG++ +EI T G
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLLWEIFTLGGS 292
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
P+ + +++ + ++ G R P + + + + CWHA P+QRP+F + L I
Sbjct: 293 PY--PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 45/270 (16%)
Query: 283 HPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCPRKRIPFS 329
HPNI++ L C E + +L +E +L ++++ S
Sbjct: 85 HPNIINLLGAC----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+ +ARGM+YL K+ H +L NIL+ E Y+ AKI+ FGLS +
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------GENYV-AKIADFGLSRGQE 193
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448
K + P W A E L + Y+ SDV+S+G++ +EI++ G P
Sbjct: 194 VYVKK---TMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508
+ + ++ + G R P + V +L ++CW P +RPSF+ I L
Sbjct: 242 YCG--MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL---N 296
Query: 509 RFIMMNPHY--NSQPDPPMPL-VDYSDIES 535
R + Y + + +D S E+
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 54/253 (21%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE-----------------ICC 321
SH NI++ L C T +LI E DL +Y++ +
Sbjct: 107 SHENIVNLLGAC--TLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
+ + Q+A+GME+L K H +L N+L+ T G + KI
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV------THGKV-VKICD 215
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
FGL+ + P W APE L E Y+ KSDV+S+G++ +E
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---------IYTIKSDVWSYGILLWE 266
Query: 442 ILT-GKVPFEDAHLQGDKMSRN------IRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
I + G P+ G + + I+ G + PF++ + + + + CW D +R
Sbjct: 267 IFSLGVNPY-----PG--IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319
Query: 495 PSFSSICRILRYI 507
PSF ++ L
Sbjct: 320 PSFPNLTSFLGCQ 332
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 33/240 (13%)
Query: 274 EISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
E + +L HP+I+ + E++ ++IMEL +L Y++ + +
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-----EEEPTWIIMELYPYGELGHYLER-----NKNSLKV 112
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
V LQI + M YL S H ++ NIL+ K+ FGLS
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-------ECVKLGDFGLSRYIE- 164
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449
S T P W +PE S + +++ SDV+ F + +EIL+ GK PF
Sbjct: 165 DEDYYKASVTRLPIKWMSPE---------SINFRRFTTASDVWMFAVCMWEILSFGKQPF 215
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
L+ + + G+R P P + L RCW DP+ RP F+ + L + +
Sbjct: 216 FW--LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 36/240 (15%)
Query: 282 SHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCPRKRIPF 328
H NI++ L C T + ++I+E S+ +L Y++
Sbjct: 145 KHKNIINLLGAC--TQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
+ V Q+ARGMEYL S+K H +L N+L+ TE + KI+ FGL+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV-MKIADFGLARDI 253
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKV 447
N + P W APE L + Y+ +SDV+SFG++ +EI T G
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
P+ + +++ + ++ G R P + + + + CWHA P+QRP+F + L I
Sbjct: 305 PY--PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 44/263 (16%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSYIKE----- 318
++ L+ E + L ++HP+++ C + + LI+E L +++E
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYGAC--SQDG--PLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 319 -------------ICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK 365
++ + QI++GM+YL K+ H +L NIL+
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV- 183
Query: 366 PRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSK 425
EG KIS FGLS +S P W A E L ++
Sbjct: 184 -----AEGRK-MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---------I 228
Query: 426 YSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTK 484
Y+ +SDV+SFG++ +EI+T G P+ + +++ ++ G R P + + + L
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYPG--IPPERLFNLLKTGHRMERPDNCSEEMYRLML 286
Query: 485 RCWHADPNQRPSFSSICRILRYI 507
+CW +P++RP F+ I + L +
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKM 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 29/238 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E ++ HP+I+ + T+ ++IMEL + +L S+++ ++ L
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV---WIIMELCTLGELRSFLQV-----RKFSLDLAS 492
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ Q++ + YL SK+ H ++ N+L+ K+ FGLS
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-------DCVKLGDFGLSRYMEDST 545
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451
+ G P W APE + +++ SDV+ FG+ +EIL G PF+
Sbjct: 546 YYKASKGKL-PIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
++ + + I GER P + P + +L +CW DP++RP F+ + L I
Sbjct: 596 --VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 49/281 (17%)
Query: 235 EDYQVRRRLGSGS-------QYKEILWLGESFALRHFF-------GDIEPLVPEISSLLS 280
+D+ + R LG G + K+ AL+ F G L EI
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNI+ F D ++ +L++E R +L + +K F + M +
Sbjct: 71 LRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKEL------QKHGRFDEQRSATFMEE 122
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
+A + Y H +K+ H ++ P N+L+ +G KI+ FG SV + + G
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKG-------ELKIADFGW-SVHAPSLRRRTMCG 174
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T + PE++E + EK D++ G++C+E L G PF+ +
Sbjct: 175 TLD---YLPPEMIE---------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ET 220
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
R I + FP +L + P QR +
Sbjct: 221 HRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 88/281 (31%), Positives = 124/281 (44%), Gaps = 49/281 (17%)
Query: 234 SEDYQVRRRLGSGSQYKEILW-----LGESFAL------RHFFGDIEPLVPEISSLLSLS 282
SE YQ ++LGSG Y E+L A+ L+ E++ L L
Sbjct: 36 SEMYQRVKKLGSG-AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNIM F E+K+ +L+ME +L I R+ F+ A ++ Q+
Sbjct: 95 HPNIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIH------RMKFNEVDAAVIIKQVL 146
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G+ YLH I H +L P N+LL S E KI FGLS+V K + GT
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLL----ESKEKDALIKIVDFGLSAVFENQKKMKERLGTA 202
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
+ +I APEVL + Y EK DV+S G+I F +L G PF Q + R
Sbjct: 203 Y-YI--APEVLRKK----------YDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILR 247
Query: 462 NIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ G+ + F SP K V+ +L K+ D +R S
Sbjct: 248 KVEKGK---YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 32/244 (13%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCP 322
E L HPN++ L T ++ +I S DL ++
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPL--SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
+ P V L+ QIA GMEYL S + H +L N+L+ + L+ KIS
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV------YDK-LNVKISDL 172
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
GL + P W APE + K+S SD++S+G++ +E+
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---------KFSIDSDIWSYGVVLWEV 223
Query: 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
+ G P+ Q + IR + P P +V L CW+ P++RP F I
Sbjct: 224 FSYGLQPYCGYSNQ--DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 502 RILR 505
LR
Sbjct: 282 SRLR 285
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 234 SEDYQVRRRLGSGSQYKEILW-----LGESFAL-----RHFFG--DIEPLVPEISSLLSL 281
S+ Y+ +R LG G + E++ G+ A+ R D E L+ E+ L L
Sbjct: 25 SDRYKGQRVLGKG-SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 282 SHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
HPNIM F E+K +L+ E+ + +L I R FS A ++ Q+
Sbjct: 84 DHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIIS------RKRFSEVDAARIIRQV 135
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
G+ Y+H KI H +L P N+LL S + +I FGLS+ K + GT
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLL----ESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 191
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
+ +I APEVL Y EK DV+S G+I + +L+G PF A+ +
Sbjct: 192 AY-YI--APEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNGANEYD--IL 236
Query: 461 RNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ + G+ + F P K V+ +L ++ P+ R S
Sbjct: 237 KKVEKGK---YTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 82/291 (28%), Positives = 122/291 (41%), Gaps = 58/291 (19%)
Query: 234 SEDYQVRRRLGSGS--------------QY-------KEILWLGESFALRHFFGDIEPLV 272
E Y R+LGSG+ + + S ++ E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 273 PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLP 331
EIS L SL HPNI+ F E+KK +L+ E +L I R F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIIN------RHKFDEC 146
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
A ++M QI G+ YLH I H ++ P NILL + L+ KI FGLSS +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILL----ENKNSLLNIKIVDFGLSSFFSKD 202
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
K + GT + +I APEVL++ Y+EK DV+S G+I + +L G PF
Sbjct: 203 YKLRDRLGTAY-YI--APEVLKKK----------YNEKCDVWSCGVIMYILLCGYPPFGG 249
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ Q + + + G+ + F K ++ L K D N+R +
Sbjct: 250 QNDQD--IIKKVEKGK---YYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 19/237 (8%)
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
+ + ++ L T + +E +E + +L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE-EKSLSDVEEEEAPEDLYKDFLTLE 193
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+ Q+A+GME+L S+K H +L NILL +E + KI FGL+
Sbjct: 194 HLICYSFQVAKGMEFLASRKCIHRDLAARNILL------SEKNV-VKICDFGLARDIYKD 246
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
P + P W APE + + Y+ +SDV+SFG++ +EI + G P+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
+ ++ R ++ G R P ++ + CWH +P+QRP+FS + L +
Sbjct: 298 GVKI-DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 44/261 (16%)
Query: 271 LVPEISSLLSLSHPNIMHFL--CGFTDEEKKECFLIMELMSR-DLCSY------------ 315
E + + +PNI+ L C + L+ E M+ DL +
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVC--AVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 316 ------IKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369
+ P S + + Q+A GM YL +K H +L N L+
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----- 207
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429
E + KI+ FGLS + P W PE + N +Y+ +
Sbjct: 208 -GENMV-VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTE 256
Query: 430 SDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWH 488
SDV+++G++ +EI + G P+ + +++ +R G P + P + NL + CW
Sbjct: 257 SDVWAYGVVLWEIFSYGLQPYYG--MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWS 314
Query: 489 ADPNQRPSFSSICRILRYIKR 509
P RPSF SI RIL+ +
Sbjct: 315 KLPADRPSFCSIHRILQRMCE 335
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 39/250 (15%), Positives = 70/250 (28%), Gaps = 30/250 (12%)
Query: 257 ESFALRHFFGDIEP--------LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308
E LR G + + ++ D F + M
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 309 SRDLCSYIKEIC-CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR 367
+L ++ + + + L LQ+ R + LH + H L P +I+L R
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 247
Query: 368 GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLE-ENEQTESASNSKY 426
G ++GF + + S F PE +
Sbjct: 248 G-------GVFLTGFEHLVRDG----ASAVSPIGRGFA--PPETTAERMLPFGQHHPTLM 294
Query: 427 SEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRC 486
+ D ++ G+ + I +P D G S I + + P+ V L +
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALG--GSEWIFRSCKNI-----PQPVRALLEGF 347
Query: 487 WHADPNQRPS 496
R
Sbjct: 348 LRYPKEDRLL 357
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 68/284 (23%), Positives = 109/284 (38%), Gaps = 47/284 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS---RDLCSYIKEICCPRKRIPFSL 330
EI L L H N++ + +EEK++ +++ME +++ + P KR F +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-----PEKR--FPV 108
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
A Q+ G+EYLHS+ I H ++ P N+LL G KIS G++
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-------TLKISALGVAEA--- 158
Query: 391 GPKSPSQSGTTH------PFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEIL 443
+ T F PE+ + +S K D++S G+ + I
Sbjct: 159 -LHPFAADDTCRTSQGSPAFQ--PPEIANGLD--------TFSGFKVDIWSAGVTLYNIT 207
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
TG PFE ++ K+ NI G P +++L K +P +R S I +
Sbjct: 208 TGLYPFEGDNIY--KLFENIGKGSYA-IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ- 263
Query: 504 LRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETH 547
+ P P P D D R + P E
Sbjct: 264 ----HSWFRKKHPPAEAPVPIPPSPDTKD-RWRSMTVVPYLEDL 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 65/310 (20%), Positives = 106/310 (34%), Gaps = 40/310 (12%)
Query: 223 GKLLPSRILIKSEDYQVRRRLGSGSQYKEILWL----GESFALRHF-----FGDIEPLVP 273
G PS ++++ RLG+G + W+ GE A++ + E
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEK----KECFLIMELMSR-DLCSYIKEICCPRKRIPF 328
EI + L+HPN++ +K L ME DL Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ---FENCCGL 118
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
L+ I+ + YLH +I H +L P NI+L+ L KI G + K
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ----PGPQRLIHKIIDLGYA--K 172
Query: 389 NFGPKSPSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
GT + APE+LE KY+ D +SFG + FE +TG
Sbjct: 173 ELDQGELCTEFVGTLQ---YLAPELLE---------QKKYTVTVDYWSFGTLAFECITGF 220
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506
PF + + PN + ++ R+
Sbjct: 221 RPFLPNWQP--VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG-KLERW 277
Query: 507 IKRFIMMNPH 516
++ +M +
Sbjct: 278 LQCMLMWHQR 287
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 69/341 (20%), Positives = 125/341 (36%), Gaps = 59/341 (17%)
Query: 217 GSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYK----EILWLGESFALRHFFG----DI 268
SG + + + +VRR L G + + G +AL+
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN 69
Query: 269 EPLVPEISSLLSLS-HPNIMHFLCGF------TDEEKKECFLIMELMSRDLCSYIKEICC 321
++ E+ + LS HPNI+ F +D + E L+ EL L ++K++
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-- 127
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKI 379
R P S + + Q R ++++H +K I H +L N+LL +G K+
Sbjct: 128 -ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-------TIKL 179
Query: 380 SGFGLSSVKNFGPKSPSQSG------------TTHPFIWHAPEVLEENEQTESASNSKYS 427
FG ++ + P + TT + PE+++ SN
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYR--TPEIID------LYSNFPIG 231
Query: 428 EKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKY--VTNLTKR 485
EK D+++ G I + + + PFED I G+ P H +Y +L +
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKL------RIVNGKYS-IPPHDTQYTVFHSLIRA 284
Query: 486 CWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPMP 526
+P +R SI ++ ++ P +
Sbjct: 285 MLQVNPEERL---SIAEVVHQLQEIAAARNVNPKSPITELL 322
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 49/281 (17%)
Query: 234 SEDYQVRRRLGSGSQYKEILW-----LGESFAL------RHFFGDIEPLVPEISSLLSLS 282
+E Y + LG G + E+L + +A+ D ++ E+ L L
Sbjct: 21 AERYNIVCMLGKG-SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNIM E+ +++ EL + +L I + R FS A ++ Q+
Sbjct: 80 HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIK------RKRFSEHDAARIIKQVF 131
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G+ Y+H I H +L P NILL S E KI FGLS+ K + GT
Sbjct: 132 SGITYMHKHNIVHRDLKPENILL----ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
+ +I APEVL Y EK DV+S G+I + +L+G PF + + +
Sbjct: 188 Y-YI--APEVLRGT----------YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK 232
Query: 462 NIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ G+ + F P + ++ +L ++ P+ R +
Sbjct: 233 RVETGK---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 45/248 (18%), Positives = 84/248 (33%), Gaps = 35/248 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYI--KEICCPRKRIPFSL 330
E+ + + + + T+ E ++I E M + + + +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 331 PVAVDLMLQIARGMEYLHSKK-IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
V ++ + Y+H++K I H ++ PSNIL+ G K+S FG S
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-------RVKLSDFGES---E 200
Query: 390 FGPKSPSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447
+ + GT + PE K D++S G+ + + V
Sbjct: 201 YMVDKKIKGSRGTYE---FMPPEFFSNESSY-------NGAKVDIWSLGICLYVMFYNVV 250
Query: 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
PF ++ NIR +P ++ LT + S+ +
Sbjct: 251 PFSLKISL-VELFNNIRTKN-IEYPLDRNHFLYPLTNK---KSTCSNNFLSNEDIDF--L 303
Query: 508 KRFIMMNP 515
K F+ NP
Sbjct: 304 KLFLRKNP 311
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 48/241 (19%), Positives = 88/241 (36%), Gaps = 36/241 (14%)
Query: 273 PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331
+I + S N + L K ++ M+L + +L ++
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRR---CSLEDREHG 164
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
V + + +QIA +E+LHSK + H +L PSNI K+ FGL + +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-------VVKVGDFGLVTAMDQD 217
Query: 392 PKSPSQSGTTHPFIWH----------APEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
+ + + H +PE + + YS K D++S G+I FE
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQI---------HGNNYSHKVDIFSLGLILFE 268
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
+L F + ++ ++R + PL + + P +RP + I
Sbjct: 269 LLY---SFSTQMERVRIIT-DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
Query: 502 R 502
Sbjct: 325 E 325
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 59/325 (18%), Positives = 105/325 (32%), Gaps = 87/325 (26%)
Query: 234 SEDYQVRRRLGSGSQYKEILWL-----GESFAL---------RHFFGDIEPLVPEISSLL 279
+ Y ++ +G G Y + A+ + D+E + E+ +
Sbjct: 25 QKKYHLKGAIGQG-SYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMS------------------------------ 309
L HPNI + E+++ L+MEL
Sbjct: 84 KLHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 310 -----RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL 364
+ + + ++M QI + YLH++ I H ++ P N L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 365 KPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS-------GTTHPFIWHAPEVLEENEQ 417
+ K+ FGLS K F + + GT + F+ APEVL +
Sbjct: 202 STNKSF-----EIKLVDFGLS--KEFYKLNNGEYYGMTTKAGTPY-FV--APEVLNTTNE 251
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPK 477
Y K D +S G++ +L G VPF + + + F +P
Sbjct: 252 -------SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TISQVLNKK---LCFENPN 299
Query: 478 YVT------NLTKRCWHADPNQRPS 496
Y +L + + ++R
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFD 324
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 43/279 (15%)
Query: 234 SEDYQVRRRLGSGSQYKEILW-----LGESFAL-----RHFFGDIEPLVPEISSLLSLSH 283
+ + +R+LGSG + ++ G + +E + EI L SL H
Sbjct: 21 DDLFIFKRKLGSG-AFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
PNI+ F E+ +++ME +L I K S +LM Q+
Sbjct: 80 PNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMN 135
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
+ Y HS+ + H +L P NIL T + KI FGL+ + S + +GT
Sbjct: 136 ALAYFHSQHVVHKDLKPENILF----QDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT-- 189
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
+ APEV + K D++S G++ + +LTG +PF L+ + +
Sbjct: 190 AL-YMAPEVF----------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQK 236
Query: 463 IRAGERPLFPFHS-PKYVT----NLTKRCWHADPNQRPS 496
E + + +T +L K+ DP +RPS
Sbjct: 237 ATYKE---PNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 70/290 (24%), Positives = 112/290 (38%), Gaps = 57/290 (19%)
Query: 234 SEDYQVRRRLGSGSQYKEILWL------GESFALRHF------------FGDIEPLVPEI 275
++Y + + LGSG E+ L + A+R + EI
Sbjct: 134 RDEYIMSKTLGSG-ACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 276 SSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAV 334
L L+HP I+ F + ++ ++++ELM +L +
Sbjct: 192 EILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVG------NKRLKEATCK 242
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
Q+ ++YLH I H +L P N+LL +S E KI+ FG S K G S
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLL----SSQEEDCLIKITDFGHS--KILGETS 296
Query: 395 PSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
++ GT P + APEVL Y+ D +S G+I F L+G PF +
Sbjct: 297 LMRTLCGT--PT-YLAPEVLVSVGTA------GYNRAVDCWSLGVILFICLSGYPPFSEH 347
Query: 453 HLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
Q + I +G+ + F V+ +L K+ DP R +
Sbjct: 348 RTQ-VSLKDQITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 393
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 36/251 (14%), Positives = 69/251 (27%), Gaps = 30/251 (11%)
Query: 232 IKSEDYQVRRRLGSGS---------QYKEILWLGESFAL----RHFFGDIEPLVPEISSL 278
+ S+ V LG G+ + F L + + L
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL 121
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
M F + L+ EL S L + I ++ + +
Sbjct: 122 KPSMQHMFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEK-VMPQGLVISFA 178
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL----HAKISGFGLSSVKNFGPK 393
+++ +E +H +I HG++ P N +L + + G S PK
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + E+L N ++ + D + + +L G
Sbjct: 239 GTIFTAKCETSGFQCVEMLS---------NKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
Query: 454 LQGDKMSRNIR 464
K R
Sbjct: 290 GGECKPEGLFR 300
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKR 325
E L E S L HP+I+ L + +++ E M DLC I +
Sbjct: 69 STEDLKREASICHMLKHPHIVELLETY--SSDGMLYMVFEFMDGADLCFEIVKR--ADAG 124
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+S VA M QI + Y H I H ++ P +LL AS E K+ GFG++
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL----ASKENSAPVKLGGFGVA 180
Query: 386 -SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ G + + GT H F+ APEV++ Y + DV+ G+I F +L+
Sbjct: 181 IQLGESGLVAGGRVGTPH-FM--APEVVKREP---------YGKPVDVWGCGVILFILLS 228
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
G +PF +++ I G+ + + +++ +L +R DP +R +
Sbjct: 229 GCLPFYG---TKERLFEGIIKGK---YKMNPRQWSHISESAKDLVRRMLMLDPAERIT 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 48/237 (20%), Positives = 91/237 (38%), Gaps = 36/237 (15%)
Query: 234 SEDYQVRRRLGSGSQ-----YKEI-LWLGESFALRHFF------GDIEPLVPEISSLLSL 281
Y++ +G G + GE +R + L E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 282 SHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
+HPNI+ + F + E +++ M+ ++ C + ++ +
Sbjct: 84 NHPNIVPYRATFIADN--ELWVVTSFMAYGSAK---DLICTHFMDGMNELAIAYILQGVL 138
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGPKSPSQSGT 400
+ ++Y+H H ++ S+IL+ S +G +SG + S+ + G +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILI-----SVDG--KVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 401 THPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ W +PEVL++N Q Y KSD+YS G+ E+ G VPF+D
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQG-------YDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 57/285 (20%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL------RHFFGDIEPLVPEISSLLS 280
+E Y + LG GS + + + +A+ D ++ E+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNIM E+ +++ EL + +L I + R FS A ++ Q
Sbjct: 78 LDHPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIK------RKRFSEHDAARIIKQ 129
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS- 398
+ G+ Y+H I H +L P NILL S E KI FGLS F + +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILL----ESKEKDCDIKIIDFGLS--TCFQQNTKMKDR 183
Query: 399 -GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
GT + + APEVL Y EK DV+S G+I + +L+G PF +
Sbjct: 184 IGT--AY-YIAPEVLRG----------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD- 229
Query: 458 KMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ + + G+ + F P + ++ +L ++ P+ R +
Sbjct: 230 -ILKRVETGK---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 73/290 (25%), Positives = 115/290 (39%), Gaps = 57/290 (19%)
Query: 234 SEDYQVRRRLGSGSQYKEILWL------GESFAL-----RHFFG-------DIEPLVPEI 275
++Y + + LGSG E+ L + A+ R F + EI
Sbjct: 9 RDEYIMSKTLGSG-ACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 276 SSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAV 334
L L+HP I+ F + ++ ++++ELM +L + KR
Sbjct: 67 EILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVG----NKR--LKEATCK 117
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
Q+ ++YLH I H +L P N+LL +S E KI+ FG S K G S
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLL----SSQEEDCLIKITDFGHS--KILGETS 171
Query: 395 PSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
++ GT P + APEVL Y+ D +S G+I F L+G PF +
Sbjct: 172 LMRTLCGT--PT-YLAPEVLVSVGTA------GYNRAVDCWSLGVILFICLSGYPPFSEH 222
Query: 453 HLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
Q + I +G+ + F V+ +L K+ DP R +
Sbjct: 223 RTQ-VSLKDQITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 268
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 52/283 (18%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL-----RHFFG-DIEPLVPEISSLLS 280
S++Y V+ LG G+ +K G FA + D + L E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNI+ +E+ +L+ +L++ +L I R +S A + Q
Sbjct: 62 LQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVA------REFYSEADASHCIQQ 113
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
I + Y HS I H NL P N+LL AS K++ FGL+ N +G
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLL----ASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T P + +PEVL+++ YS+ D+++ G+I + +L G PF D +
Sbjct: 170 T--PG-YLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L 215
Query: 460 SRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
I+AG + + SP VT +L +P +R +
Sbjct: 216 YAQIKAGA---YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 47/279 (16%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFALRHFF--GDIEPLVPEISSLLSLSHP 284
S+ ++V LG G+ + K + +AL+ D + + EI LL LSHP
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGT---QKPYALKVLKKTVDKKIVRTEIGVLLRLSHP 108
Query: 285 NIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
NI+ F E E L++EL++ +L I E + +S A D + QI
Sbjct: 109 NIIKLKEIF--ETPTEISLVLELVTGGELFDRIVE------KGYYSERDAADAVKQILEA 160
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+ YLH I H +L P N+L A+ KI+ FGLS + + GT P
Sbjct: 161 VAYLHENGIVHRDLKPENLLY----ATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT--P 214
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ APE+L Y + D++S G+I + +L G PF D M R I
Sbjct: 215 G-YCAPEILRG---------CAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRI 263
Query: 464 RAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
E + F SP V+ +L ++ DP +R +
Sbjct: 264 LNCE---YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI+ L L HPN++ + D + +++ EL+++ + P S
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQ 138
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A + +G+EYLH +KI H ++ PSN+L+ G H KI+ FG+S+
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-------HIKIADFGVSNEFKGSD 191
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFED 451
S + T F+ APE L S + +S + DV++ G+ + + G+ PF D
Sbjct: 192 ALLSNTVGTPAFM--APESL-------SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 452 AHLQGDKMSRNIRAGE--RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+ + I++ P P + + +L R +P R I
Sbjct: 243 ERIM--CLHSKIKSQALEFPDQPDIAED-LKDLITRMLDKNPESRIVVPEIKL 292
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 51/281 (18%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL----RHFFGDIEPLVPEISSLLSLS 282
++ Y + +G GS K A ++F D++ EI + SL
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNI+ F E+ + +L+MEL + +L + ++ F A +M +
Sbjct: 65 HPNIIRLYETF--EDNTDIYLVMELCTGGELFERVVH----KRV--FRESDAARIMKDVL 116
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
+ Y H + H +L P N L + K+ FGL++ G ++ GT
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLF----LTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT- 171
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
P+ + +P+VLE Y + D +S G++ + +L G PF +
Sbjct: 172 -PY-YVSPQVLEG----------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VML 217
Query: 462 NIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
IR G F F V+ +L +R P QR +
Sbjct: 218 KIREGT---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 36/240 (15%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTD--EEKKECFLIMELMS-RDLCSYIKEICCPR 323
++ L E+ + L+HPNI+ + E +K +LIME S ++ Y+
Sbjct: 57 SLQKLFREVRIMKILNHPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVA----H 108
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
R+ A QI ++Y H K+I H +L N+LL + ++ KI+ FG
Sbjct: 109 GRM--KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL-------DADMNIKIADFG 159
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEI 442
S+ G K + G + APE+ KY + DV+S G+I + +
Sbjct: 160 FSNEFTVGGKLDAFCGAPP---YAAPELF---------QGKKYDGPEVDVWSLGVILYTL 207
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
++G +PF+ +L+ ++ + G+ + PF+ NL KR +P +R + I +
Sbjct: 208 VSGSLPFDGQNLK--ELRERVLRGKYRI-PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 52/283 (18%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL-----RHFFG-DIEPLVPEISSLLS 280
S++Y V+ LG G+ +K G FA + D + L E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HPNI+ +E+ +L+ +L++ +L I R +S A + Q
Sbjct: 85 LQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVA------REFYSEADASHCIQQ 136
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
I + Y HS I H NL P N+LL AS K++ FGL+ N +G
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLL----ASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T ++ +PEVL+++ YS+ D+++ G+I + +L G PF D +
Sbjct: 193 TPG-YL--SPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L 238
Query: 460 SRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
I+AG + + SP VT +L +P +R +
Sbjct: 239 YAQIKAGA---YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 47/302 (15%)
Query: 215 LDGSGSLSGKLLPS--RILIKSEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHFFGDI 268
SG +G L R + D + +GSG+ +K G A++
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 269 EP-----LVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCP 322
++ ++ +L P I+ F F+ MELM K
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKK----- 115
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
R + P + + + I + + YL K + H ++ PSNILL RG K+
Sbjct: 116 RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-------QIKLCD 168
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437
FG+S G ++ + APE + + Y ++DV+S G+
Sbjct: 169 FGIS-----GRLVDDKAKDR--SAGCAAYMAPERI----DPPDPTKPDYDIRADVWSLGI 217
Query: 438 ICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFH---SPKYVTNLTKRCWHADPNQR 494
E+ TG+ P+++ + +++ + E PL P H S + + K C D +R
Sbjct: 218 SLVELATGQFPYKNCKTDFEVLTK-VLQEEPPLLPGHMGFSGDFQ-SFVKDCLTKDHRKR 275
Query: 495 PS 496
P
Sbjct: 276 PK 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD--EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLP 331
EIS L L HP+I+ D + +++E +L YI E +KR+
Sbjct: 59 EISYLKLLRHPHIIKLY----DVITTPTDIVMVIEYAGGELFDYIVE----KKRMT--ED 108
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
QI +EY H KI H +L P N+LL + L+ KI+ FGLS++ G
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL-------DDNLNVKIADFGLSNIMTDG 161
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFE 450
+ G+ + + APEV+ + Y+ + DV+S G++ + +L G++PF+
Sbjct: 162 NFLKTSCGSPN---YAAPEVI---------NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
D + + + + + + P +L +R ADP QR + I R
Sbjct: 210 DEFIP--NLFKKVNSCVYVM-PDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 51/283 (18%)
Query: 234 SEDYQVRRRLGSGSQYKEILWL------GESFAL------RHFFGDIEPLVPEISSLLSL 281
+E+YQ+ LG G + + G+ +A + D + L E L
Sbjct: 10 TEEYQLFEELGKG-AFSVV-RRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 282 SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
HPNI+ E+ +LI +L++ +L I R +S A + QI
Sbjct: 68 KHPNIVRLHDSI--SEEGHHYLIFDLVTGGELFEDIVA------REYYSEADASHCIQQI 119
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSG 399
+ + H + H NL P N+LL AS K++ FGL+ V+ +G
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLL----ASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T ++ +PEVL ++ Y + D+++ G+I + +L G PF D +
Sbjct: 176 TPG-YL--SPEVLRKD---------PYGKPVDLWACGVILYILLVGYPPFWDEDQHR--L 221
Query: 460 SRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
+ I+AG + F SP VT +L + +P++R +
Sbjct: 222 YQQIKAGA---YDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 70/302 (23%)
Query: 220 SLSGKLLPSRILIKSEDYQVRRRLGSG---SQYKEI-LWLGESFA---LRHFFGDIEPLV 272
+ GK++ R Y++ +LG G + Y L A + + E +
Sbjct: 3 HMIGKIINER-------YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL 55
Query: 273 P----EISSLLSLSHPNIMHFLCGFTD--EEKKECFLIMELMS-RDLCSYIKEICCPRKR 325
E+ + LSH NI+ + D EE +L+ME + L YI
Sbjct: 56 KRFEREVHNSSQLSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYI------ESH 105
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
P S+ A++ QI G+++ H +I H ++ P NIL+ KI FG++
Sbjct: 106 GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-------TLKIFDFGIA 158
Query: 386 SVKNFGPKSPSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ + + GT F +PE Q A E +D+YS G++ +E+L
Sbjct: 159 KALSETSLTQTNHVLGTVQYF---SPE------Q---AKGEATDECTDIYSIGIVLYEML 206
Query: 444 TGKVPFED--------AHLQGD--KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQ 493
G+ PF H+Q ++ ++R P+ ++N+ R D
Sbjct: 207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD--------IPQSLSNVILRATEKDKAN 258
Query: 494 RP 495
R
Sbjct: 259 RY 260
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 25/233 (10%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI-MELMSRD-LCSYIKEICCPRK 324
+PL EI+ L H NI+ +L G + I ME + L + ++
Sbjct: 62 YSQPLHEEIALHKHLKHKNIVQYL-GS--FSENGFIKIFMEQVPGGSLSALLRSKW---G 115
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
+ + QI G++YLH +I H ++ N+L+ G KIS FG
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISDFGT 169
Query: 385 SS-VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
S + P + + +GT + APE++++ + Y + +D++S G E+
Sbjct: 170 SKRLAGINPCTETFTGT--LQ-YMAPEIIDKGPR-------GYGKAADIWSLGCTIIEMA 219
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
TGK PF + M + P P +C+ DP++R
Sbjct: 220 TGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 36/233 (15%)
Query: 274 EISSLLSLSHPNIMHFLCGFTD--EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSL 330
EI +L HP+I+ + F++ME +S +L YI + R+
Sbjct: 61 EIQNLKLFRHPHIIKLY----QVISTPTDFFMVMEYVSGGELFDYICK----HGRVE--E 110
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
A L QI ++Y H + H +L P N+LL + +++AKI+ FGLS++ +
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL-------DAHMNAKIADFGLSNMMSD 163
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPF 449
G + G+ + + APEV+ S Y+ + D++S G+I + +L G +PF
Sbjct: 164 GEFLRTSCGSPN---YAAPEVI---------SGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+D H+ + + IR G P + + V L DP +R + I
Sbjct: 212 DDEHVP--TLFKKIRGGVFY-IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 49/280 (17%)
Query: 234 SEDYQVRRRLGSGSQYKEILWL------GESFAL----RHFFGDIEPLVPEISSLLSLSH 283
+ + LGSG + E+ +L G+ FAL + L EI+ L + H
Sbjct: 8 RKTFIFMEVLGSG-AFSEV-FLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
NI+ + E +L+M+L+S +L I E R ++ A ++ Q+
Sbjct: 66 ENIVTLEDIY--ESTTHYYLVMQLVSGGELFDRILE------RGVYTEKDASLVIQQVLS 117
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
++YLH I H +L P N+L + E I+ FGLS ++ G S + GT
Sbjct: 118 AVKYLHENGIVHRDLKPENLLY----LTPEENSKIMITDFGLSKMEQNGIMS-TACGT-- 170
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
+ APEVL + YS+ D +S G+I + +L G PF + +
Sbjct: 171 -PGYVAPEVLAQK---------PYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEK 218
Query: 463 IRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
I+ G + F SP ++ + DPN+R +
Sbjct: 219 IKEGY---YEFESPFWDDISESAKDFICHLLEKDPNERYT 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 58/306 (18%), Positives = 104/306 (33%), Gaps = 67/306 (21%)
Query: 217 GSGSLSGKLLPSRILIKSEDYQVRRRLGSG---SQYKEI-LWLGESFA---LRHFFGDIE 269
GS + L R Y++ LG G + L A LR
Sbjct: 1 GSHMTTPSHLSDR-------YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP 53
Query: 270 PLVP----EISSLLSLSHPNIMH-FLCGFTDEEKKEC-FLIMELMS-RDLCSYIKEICCP 322
E + +L+HP I+ + G + +++ME + L +
Sbjct: 54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------ 107
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
P + A++++ + + + H I H ++ P+NI++ A K+ F
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-------VKVMDF 160
Query: 383 GLSSVKNFGPKSPSQS----GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
G++ S +Q+ GT +PE Q A +SDVYS G +
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYL---SPE------Q---ARGDSVDARSDVYSLGCV 208
Query: 439 CFEILTGKVPFED--------AHLQGDKMS-RNIRAGERPLFPFHSPKYVTNLTKRCWHA 489
+E+LTG+ PF H++ D + G + + +
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG--------LSADLDAVVLKALAK 260
Query: 490 DPNQRP 495
+P R
Sbjct: 261 NPENRY 266
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 86/381 (22%), Positives = 148/381 (38%), Gaps = 53/381 (13%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
EI +L HP+I+ + F++ME +S +L YI C R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYI----CKNGRLD--EKE 117
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ L QI G++Y H + H +L P N+LL + +++AKI+ FGLS++ + G
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLL-------DAHMNAKIADFGLSNMMSDGE 170
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFED 451
+ G+ + + APEV+ S Y+ + D++S G+I + +L G +PF+D
Sbjct: 171 FLRTSCGSPN---YAAPEVI---------SGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511
H+ + + I G P + V +L K DP +R + I +
Sbjct: 219 DHVP--TLFKKICDGIFYT-PQYLNPSVISLLKHMLQVDPMKRATIKDIRE-----HEW- 269
Query: 512 MMNPHYNSQPDPPMPLVDYSDIESRLLRK------FPSWETHNVLPISEI--PFQMFVYR 563
P P + I+ L++ E + L P + +
Sbjct: 270 -FKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHL 328
Query: 564 VVEKEKISSSPKDTSDSGSDKASVSGDENMTTPEDPSPPVT------ERKFLPSPEAVNK 617
+++ +I + KD + S S D ++T P P R L
Sbjct: 329 IIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKS 388
Query: 618 KLSGVKKLSESKVIKQTGTPK 638
K GV+K I+ P
Sbjct: 389 KHQGVRKAKWHLGIRSQSRPN 409
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 49/292 (16%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEI-LWLGESFA-----LRHFFGDIEPLVPEISSLLSLS 282
I +DY+++ +GSG+ E A L ++ L+ EI ++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLML 338
HPNI+ + F +++ +L+M+L+S D+ +I K ++
Sbjct: 72 HPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVA-KGEHKSGVLDESTIATILR 128
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
++ G+EYLH H ++ NILL G +I+ FG+S+ G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDG-------SVQIADFGVSAFLATGGDITRNK 181
Query: 399 ------GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
GT P W APEV+E+ Y K+D++SFG+ E+ TG P+
Sbjct: 182 VRKTFVGT--PC-WMAPEVMEQVRG--------YDFKADIWSFGITAIELATGAAPYHKY 230
Query: 453 H--------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
LQ D S ++ + + + + C DP +RP+
Sbjct: 231 PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF-RKMISLCLQKDPEKRPT 281
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 81/336 (24%), Positives = 123/336 (36%), Gaps = 47/336 (13%)
Query: 219 GSLSGKLLPSRILIKSEDYQVRRRLGSGS----QYKEILWLGESFALRHFFGDIEPLVP- 273
++ L I+ S+ Y + +GSG+ + E A++ + + +
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDE 61
Query: 274 ----EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPF 328
EI + SL HPNI+ F +IME S +L I C R F
Sbjct: 62 NVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIIMEYASGGELYERI----CNAGR--F 113
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388
S A Q+ G+ Y HS +I H +L N LL KI FG S
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-----DGSPAPRLKICDFGYSKSS 168
Query: 389 NFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKV 447
+ S GT + APEVL +Y + +DV+S G+ + +L G
Sbjct: 169 VLHSQPKSTVGTPA---YIAPEVL---------LRQEYDGKIADVWSCGVTLYVMLVGAY 216
Query: 448 PFEDAHLQGD--KMSRNIRAGE--RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR- 502
PFED D K + I + + P SP+ +L R + ADP R S I
Sbjct: 217 PFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE-CCHLISRIFVADPATRISIPEIKTH 275
Query: 503 ---ILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIES 535
+ + + + +P P+ I
Sbjct: 276 SWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTDE--EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFS 329
E+ S P+I+ L + + K+ +IME M +L S I+E R F+
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFT 126
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
A ++M I +++LHS I H ++ P N+L S E K++ FG + K
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY----TSKEKDAVLKLTDFGFA--KE 180
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ T ++ APEVL KY + D++S G+I + +L G PF
Sbjct: 181 TTQNALQTPCYTPYYV--APEVLGP---------EKYDKSCDMWSLGVIMYILLCGFPPF 229
Query: 450 --EDAHLQGDKMSRNIRAGERPLFPFHSP--KYVTN----LTKRCWHADPNQRPS 496
M R IR G+ + F +P V+ L + DP +R +
Sbjct: 230 YSNTGQAISPGMKRRIRLGQ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 52/294 (17%)
Query: 224 KLLPSRILIKSED----YQVRRRLGSGSQ---YK--EILWLGESFAL----RHFFGDIEP 270
K +P + +K Y + LGSG+ ++ E G F + D
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYT 94
Query: 271 LVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFS 329
+ EIS + L HP +++ F E+K E LI+E +S +L I + S
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDRIAA-----EDYKMS 147
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
++ M Q G++++H I H ++ P NI+ + + AS+ KI FGL+
Sbjct: 148 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-----VKIIDFGLA--TK 200
Query: 390 FGPKSPSQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
P + T F APE+++ +D+++ G++ + +L+G P
Sbjct: 201 LNPDEIVKVTTATAEFA--APEIVDREP---------VGFYTDMWAIGVLGYVLLSGLSP 249
Query: 449 FEDAHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
F +N++ + + F V+ + K +P +R +
Sbjct: 250 FAGEDDLE--TLQNVKRCD---WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 235 EDYQVRRRLGSGS----QYKEILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHPN 285
ED+ + + LG G+ Q E+ A+ + E + EI L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 286 IMHFLCGFTD--EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
++ F E +L +E S +L I P P A Q+
Sbjct: 67 VVKFY----GHRREGNIQYLFLEYCSGGELFDRI----EPDIG--MPEPDAQRFFHQLMA 116
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP---SQSG 399
G+ YLH I H ++ P N+LL + + KIS FGL++V + + G
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------DERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458
T + APE+L ++ E DV+S G++ +L G++P++ +
Sbjct: 170 TLP---YVAPELL---------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQ 216
Query: 459 MSRNIRAGERPLFPF-HSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+ + + L P+ L + +P+ R + I +
Sbjct: 217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 57/282 (20%), Positives = 113/282 (40%), Gaps = 42/282 (14%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHFFGDIEP-----LVPEISSLLSLS 282
+K++D + LG G+ K + G+ A++ + L+ ++ +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 283 -HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
P + F E + ++ MELM L + K++ + IP + + + I
Sbjct: 64 DCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIP--EDILGKIAVSIV 119
Query: 342 RGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
+ +E+LHSK + H ++ PSN+L+ G K+ FG+S G +
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALG-------QVKMCDFGIS-----GYLVDDVAKD 167
Query: 401 THPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
+ APE + YS KSD++S G+ E+ + P++
Sbjct: 168 I--DAGCKPYMAPERINPELN-----QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 457 DKMSRNIRAGERPLFPFH--SPKYVTNLTKRCWHADPNQRPS 496
++ + + P P S ++V + T +C + +RP+
Sbjct: 221 QQLKQ-VVEEPSPQLPADKFSAEFV-DFTSQCLKKNSKERPT 260
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331
EI++L HPNI+ F ++ FL+MEL++ +L IK+ + FS
Sbjct: 55 EITALKLCEGHPNIVKLHEVF--HDQLHTFLVMELLNGGELFERIKK------KKHFSET 106
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
A +M ++ + ++H + H +L P N+L L KI FG + +
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF----TDENDNLEIKIIDFGFA--RLKP 160
Query: 392 PKSPSQSGT--THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P + T + APE+L +N Y E D++S G+I + +L+G+VPF
Sbjct: 161 PDNQPLKTPCFTLHYA--APELLNQN---------GYDESCDLWSLGVILYTMLSGQVPF 209
Query: 450 -----EDAHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
++ + I+ G+ F F K V+ +L + DPN+R
Sbjct: 210 QSHDRSLTCTSAVEIMKKIKKGD---FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 48/238 (20%), Positives = 78/238 (32%), Gaps = 49/238 (20%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLI-MELMS----RDLCSYIKEICCPRKRIPF 328
E+ + LS P I+ G + I MEL+ L ++
Sbjct: 100 ELVACAGLSSPRIVPLY-GA--VREGPWVNIFMELLEGGSLGQLI---------KQMGCL 147
Query: 329 SLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS--- 385
A+ + Q G+EYLH+++I HG++ N+LL G+ A + FG +
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS------RAALCDFGHALCL 201
Query: 386 ---SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ GT APEV+ K D++S + +
Sbjct: 202 QPDGLGKSLLTGDYIPGT--ET-HMAPEVVM---------GKPCDAKVDIWSSCCMMLHM 249
Query: 443 LTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTK----RCWHADPNQRPS 496
L G P+ + I + P+ P LT +P R S
Sbjct: 250 LNGCHPW--TQYFRGPLCLKIASEPPPIRE--IPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 55/287 (19%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL----------RHFFGDIEPLVPEIS 276
+ Y + LGSG + K G +A E + E+S
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVD 335
L + H N++ + E + + LI+EL+S +L ++ + + S A
Sbjct: 68 ILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQ------KESLSEEEATS 119
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP 395
+ QI G+ YLH+KKI H +L P NI+L + H K+ FGL+ G +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDK---NIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
+ GT F+ APE++ ++D++S G+I + +L+G PF Q
Sbjct: 177 NIFGTPE-FV--APEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 456 GDKMSRNIRAG----ERPLFPFHSP--KYVTNLTKRCWHADPNQRPS 496
NI + + F S K + ++ + +R +
Sbjct: 225 E--TLANITSVSYDFDEEFFSHTSELAK---DFIRKLLVKETRKRLT 266
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 65/302 (21%), Positives = 124/302 (41%), Gaps = 43/302 (14%)
Query: 214 NLDGSGSLSGKLLPSRIL-IKSEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHFFGDI 268
+++ SG L K+ P + +ED + +G G+ K + G+ A++ +
Sbjct: 2 SIESSGKL--KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59
Query: 269 EP-----LVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCP 322
+ L+ ++ ++ S P I+ F E C++ MELMS + K +
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSV 117
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
+ + L + + +L KI H ++ PSNILL G + K+
Sbjct: 118 LDD-VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-------NIKLCD 169
Query: 382 FGLSSVKNFGPKSPSQSGTTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
FG+S G S + T + APE ++ + + Y +SDV+S G+
Sbjct: 170 FGIS-----GQLVDSIAKTRDAGCRP-YMAPERIDPSASRQG-----YDVRSDVWSLGIT 218
Query: 439 CFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVT----NLTKRCWHADPNQR 494
+E+ TG+ P+ + D++++ + G+ P + + N C D ++R
Sbjct: 219 LYELATGRFPYPKWNSVFDQLTQ-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277
Query: 495 PS 496
P
Sbjct: 278 PK 279
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 49/258 (18%)
Query: 267 DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRK 324
+ E+ L H N++ + F EE+ +L+ E M + S+I K
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFF--EEEDRFYLVFEKMRGGSILSHI------HK 104
Query: 325 RIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384
R F+ A ++ +A +++LH+K I H +L P NIL KI F L
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC----EHPNQVSPVKICDFDL 160
Query: 385 SSVKNFGPKSPSQSGT-------THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437
S S + ++ APEV+E S S Y ++ D++S G+
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYM--APEVVE----AFSEEASIYDKRCDLWSLGV 214
Query: 438 ICFEILTGKVPFEDAHLQG-------------DKMSRNIRAGERPLFPFHSP--KYVT-- 480
I + +L+G PF + + +I+ G+ + F +++
Sbjct: 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK---YEFPDKDWAHISCA 271
Query: 481 --NLTKRCWHADPNQRPS 496
+L + D QR S
Sbjct: 272 AKDLISKLLVRDAKQRLS 289
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 67/328 (20%), Positives = 116/328 (35%), Gaps = 61/328 (18%)
Query: 235 EDYQVRRRLGSGS----QYKEILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHPN 285
ED+ + + LG G+ Q E+ A+ + E + EI L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 286 IMHFLCGFTD--EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
++ F E +L +E S +L I P P A Q+
Sbjct: 67 VVKFY----GHRREGNIQYLFLEYCSGGELFDRI----EPDIG--MPEPDAQRFFHQLMA 116
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK--------- 393
G+ YLH I H ++ P N+LL + + KIS FGL++V + +
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------DERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFEDA 452
+ P++ APE+L ++ E DV+S G++ +L G++P++
Sbjct: 170 TL-------PYV--APELL---------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR---ILRYIKR 509
+ S L + +P+ R + I + + +K+
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
Query: 510 FIMMNPHYNSQPDPPMPLVDYSDIESRL 537
P S P I+S L
Sbjct: 272 GA-KRPRVTSGGVSESPSGFSKHIQSNL 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 71/327 (21%), Positives = 130/327 (39%), Gaps = 52/327 (15%)
Query: 191 KIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSED----YQVRRRLGSG 246
+ + + K +G V + + + P + IK + Y + LG+G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168
Query: 247 SQ---YK--EILWLGESFAL----RHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297
+ ++ E G +FA D E + EI ++ L HP +++ F E+
Sbjct: 169 AFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF--ED 225
Query: 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGN 356
E +I E MS +L + + + S AV+ M Q+ +G+ ++H H +
Sbjct: 226 DNEMVMIYEFMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280
Query: 357 LNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP-FIWHAPEVLEEN 415
L P NI+ + ++ K+ FGL+ + PK + T F APEV E
Sbjct: 281 LKPENIMFTTKRSNE-----LKLIDFGLT--AHLDPKQSVKVTTGTAEFA--APEVAE-- 329
Query: 416 EQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG----ERPLF 471
+D++S G++ + +L+G PF + RN+++ + F
Sbjct: 330 -------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKSCDWNMDDSAF 380
Query: 472 PFHSP--KYVTNLTKRCWHADPNQRPS 496
S K + ++ ADPN R +
Sbjct: 381 SGISEDGK---DFIRKLLLADPNTRMT 404
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 38/241 (15%)
Query: 266 GDIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR 323
E + E+ L +S HPNI+ + E FL+ +LM + +L Y+ E
Sbjct: 65 ELREATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTE----- 117
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
++ S +M + + LH I H +L P NILL ++ K++ FG
Sbjct: 118 -KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-------MNIKLTDFG 169
Query: 384 LSSVKNFGPKSPSQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
S P + GT P + APE++ E + + ++ Y ++ D++S G+I +
Sbjct: 170 FS--CQLDPGEKLREVCGT--PS-YLAPEII---ECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRP 495
+L G PF M R I +G + F SP + +L R P +R
Sbjct: 222 LLAGSPPFWHRKQML--MLRMIMSGN---YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 496 S 496
+
Sbjct: 277 T 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331
EI LL HPNI+ + ++ K +++ ELM +L I + FS
Sbjct: 65 EIEILLRYGQHPNIITLKDVY--DDGKYVYVVTELMKGGELLDKILR------QKFFSER 116
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
A ++ I + +EYLH++ + H +L PSNIL + +I FG +
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV---DESGNPESIRICDFGFAKQLRAE 173
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
T F+ APEVLE Y D++S G++ + +LTG PF +
Sbjct: 174 NGLLMTPCYTANFV--APEVLERQ---------GYDAACDIWSLGVLLYTMLTGYTPFAN 222
Query: 452 AHLQGD-KMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQRPS 496
++ I +G+ F V+ +L + H DP+QR +
Sbjct: 223 GPDDTPEEILARIGSGK---FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 69/285 (24%), Positives = 113/285 (39%), Gaps = 51/285 (17%)
Query: 234 SEDYQVRRRLGSGSQ---YKEILWL-GESFAL----------RHFFGDIEPLVPEISSLL 279
+ Y + LGSG K G +A E + E+S L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLML 338
+ HPNI+ + E + + LI+EL+S +L ++ + + S A +
Sbjct: 71 QVLHPNIITLHDVY--ENRTDVVLILELVSGGELFDFLAQ------KESLSEEEATSFIK 122
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
QI G+ YLH+KKI H +L P NI+L + H K+ FGL+ G + +
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDK---NIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 399 GTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
GT P F+ APE++ ++D++S G+I + +L+G PF Q
Sbjct: 180 GT--PEFV--APEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQE- 225
Query: 458 KMSRNIRAGERPLFPFHSP--KYVTNLTK----RCWHADPNQRPS 496
NI A + F + L K + + +R +
Sbjct: 226 -TLANITAVS---YDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 34/187 (18%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L H NI+ ++K L+ E +DL Y +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFD-----SCNGDLDPEIV 103
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ +G+ + HS+ + H +L P N+L+ G K++ FGL+ + FG
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-------ELKLANFGLA--RAFG-- 152
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
P + + + W+ P+VL + YS D++S G I E+ P
Sbjct: 153 IPVRC-YSAEVVTLWYRPPDVLFGAKL--------YSTSIDMWSAGCIFAELANAGRPL- 202
Query: 451 DAHLQGD 457
G+
Sbjct: 203 ---FPGN 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 53/274 (19%), Positives = 93/274 (33%), Gaps = 54/274 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR--DLCSYIKEICCPRKRIPFSLP 331
EI+ L + H NI+ L F E + L+ME DL ++I R P
Sbjct: 79 EIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDR----HPR--LDEP 130
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
+A + Q+ + YL K I H ++ NI++ K+ FG ++ G
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-------TIKLIDFGSAAYLERG 183
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFE 450
+ GT + APEVL + Y + +++S G+ + ++ + PF
Sbjct: 184 KLFYTFCGTIE---YCAPEVL---------MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVT----NLTKRCWHADPNQRPSFSSICRILRY 506
+ H P V+ +L P +R + L
Sbjct: 232 EL--------EETVEAA-----IHPPYLVSKELMSLVSGLLQPVPERRTT-------LEK 271
Query: 507 IKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRK 540
+ + N + + ES +L
Sbjct: 272 LVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 38/226 (16%), Positives = 72/226 (31%), Gaps = 51/226 (22%)
Query: 277 SLLSLSHPNIMH-FLCGFTDEEKKEC--FLIMELMS-RDLCSYIKEICCPRKRIPFSLPV 332
L + HP+I+ F + + +++ME + + L + +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAE 183
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
A+ +L+I + YLHS + + +L P NI+L K+ G
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKLIDLGAV------- 228
Query: 393 KSPSQSGT---THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ G T F APE++ + + +D+Y+ G +
Sbjct: 229 SRINSFGYLYGTPGFQ--APEIVR----------TGPTVATDIYTVGRTLAALTLDLPTR 276
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
++ G + L +R DP QR
Sbjct: 277 NGRYVDGL---------PEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 57/288 (19%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL----------RHFFGDIEPLVPEIS 276
+ Y++ LGSG + K G+ +A E + E++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVD 335
L + HPNI+ F E K + LI+EL+S +L ++ E + + A
Sbjct: 61 ILREIRHPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAE------KESLTEDEATQ 112
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP 395
+ QI G+ YLHSK+I H +L P NI+L + K+ FG++ G +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFK 169
Query: 396 SQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
+ GT P F+ APE++ ++D++S G+I + +L+G PF
Sbjct: 170 NIFGT--PEFV--APEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGETK 216
Query: 455 QGDKMSRNIRAG----ERPLFPFHSP--KYVTNLTKRCWHADPNQRPS 496
Q NI A + F S K + +R DP +R +
Sbjct: 217 QE--TLTNISAVNYDFDEEYFSNTSELAK---DFIRRLLVKDPKRRMT 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 25/179 (13%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS + L H NI+ E K L+ E M DL Y+ L +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
Q+ +G+ + H KI H +L P N+L+ RG K+ FGL+ + FG
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-------QLKLGDFGLA--RAFG-- 159
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P + + + W+ AP+VL + YS D++S G I E++TGK F
Sbjct: 160 IPVNT-FSSEVVTLWYRAPDVLMGSRT--------YSTSIDIWSCGCILAEMITGKPLF 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 52/179 (29%), Positives = 74/179 (41%), Gaps = 26/179 (14%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E+S L L H NI+ + LI E DL Y+ K S+ V
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMD------KNPDVSMRVI 134
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ G+ + HS++ H +L P N+LL AS L KI FGL+ + FG
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL--KIGDFGLA--RAFG-- 188
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P + TH I W+ PE+L + YS D++S I E+L F
Sbjct: 189 IPIRQ-FTHEIITLWYRPPEILLGSRH--------YSTSVDIWSIACIWAEMLMKTPLF 238
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTD--EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFS 329
E+ S P+I+ + + + +K ++ME + +L S I++ R F+
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFT 159
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
A ++M I ++YLHS I H ++ P N+L S K++ FG +
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY----TSKRPNAILKLTDFGFAKETT 215
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ T + ++ APEVL KY + D++S G+I + +L G PF
Sbjct: 216 SHNSLTTPCYTPY-YV--APEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPF 263
Query: 450 EDAHLQG--DKMSRNIRAGERPLFPFHSP--KYVTN----LTKRCWHADPNQRPS 496
H M IR G+ + F +P V+ L + +P QR +
Sbjct: 264 YSNHGLAISPGMKTRIRMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 315
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 54/244 (22%), Positives = 88/244 (36%), Gaps = 47/244 (19%)
Query: 267 DIEPLVPEISSLLSLSH-PNIMHFLCGFTDEEKKECFLIMELMS------RDLCSYIKEI 319
++ EI+ L P +++ + E E LI+E +
Sbjct: 71 CRAEILHEIAVLELAKSCPRVINLHEVY--ENTSEIILILEYAAGGEIFSL--------- 119
Query: 320 CCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379
C P S + L+ QI G+ YLH I H +L P NILL +S KI
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL----SSIYPLGDIKI 175
Query: 380 SGFGLSSVKNFGPKSPSQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
FG+S + GT P ++ APE+L + + +D+++ G+I
Sbjct: 176 VDFGMSRKIGHACELREIMGT--PEYL--APEILNYD---------PITTATDMWNIGII 222
Query: 439 CFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP--KYVTN----LTKRCWHADPN 492
+ +LT PF Q NI + V+ + +P
Sbjct: 223 AYMLLTHTSPFVGEDNQE--TYLNISQVN---VDYSEETFSSVSQLATDFIQSLLVKNPE 277
Query: 493 QRPS 496
+RP+
Sbjct: 278 KRPT 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 38/238 (15%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKR 325
D + EIS L H NI+H F E +E +I E +S D+ I
Sbjct: 44 DQVLVKKEISILNIARHRNILHLHESF--ESMEELVMIFEFISGLDIFERINT-----SA 96
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ V + Q+ +++LHS I H ++ P NI+ + R +ST KI FG +
Sbjct: 97 FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST-----IKIIEFGQA 151
Query: 386 SVKNFGPKSPSQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ P + T P + APEV + + S +D++S G + + +L+
Sbjct: 152 --RQLKPGDNFRLLFTAPEYY--APEVHQHDV---------VSTATDMWSLGTLVYVLLS 198
Query: 445 GKVPFEDAHLQGDKMSRNIRAG----ERPLFPFHSP--KYVTNLTKRCWHADPNQRPS 496
G PF Q + NI + F S + R + R +
Sbjct: 199 GINPFLAETNQQ--IIENIMNAEYTFDEEAFKEISIEAM---DFVDRLLVKERKSRMT 251
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 55/287 (19%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFAL----------RHFFGDIEPLVPEIS 276
+ Y LGSG + K G +A E + E+S
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVD 335
L + HPN++ + E K + LI+EL++ +L ++ E + + A +
Sbjct: 67 ILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAE------KESLTEEEATE 118
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA-KISGFGLSSVKNFGPKS 394
+ QI G+ YLHS +I H +L P NI+L KI FGL+ +FG +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIML----LDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 395 PSQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ GT P F+ APE++ ++D++S G+I + +L+G PF
Sbjct: 175 KNIFGT--PEFV--APEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 454 LQGDKMSRNIRAG----ERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
Q N+ A E F S + +R DP +R +
Sbjct: 222 KQE--TLANVSAVNYEFEDEYFSNTSAL-AKDFIRRLLVKDPKKRMT 265
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 30/179 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS L L HPNI+ + E L+ E M +DL + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLD-----ENKTGLQDSQI 121
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ RG+ + H +I H +L P N+L+ G K++ FGL+ + FG
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-------ALKLADFGLA--RAFG-- 170
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P +S TH + W+ AP+VL +++ YS D++S G I E++TGK F
Sbjct: 171 IPVRS-YTHEVVTLWYRAPDVLMGSKK--------YSTSVDIWSIGCIFAEMITGKPLF 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 68/332 (20%), Positives = 125/332 (37%), Gaps = 57/332 (17%)
Query: 191 KIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGS--- 247
+ + + Q +G ++ F+++ L + Y + +G G
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF---YQKYDPKDVIGRGVSSV 109
Query: 248 -----------QY--KEILWLGESFALRHFFGDIEPLVPEISSLLSLS-HPNIMHFLCGF 293
++ K + E + E E L ++ HP+I+ + +
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 294 TDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKI 352
E FL+ +LM + +L Y+ E + S +M + + +LH+ I
Sbjct: 170 --ESSSFMFLVFDLMRKGELFDYLTE----KVA--LSEKETRSIMRSLLEAVSFLHANNI 221
Query: 353 YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS--GTTHPFIWHAPE 410
H +L P NILL + ++S FG S + P + GT P + APE
Sbjct: 222 VHRDLKPENILLDDN-------MQIRLSDFGFS--CHLEPGEKLRELCGT--PG-YLAPE 269
Query: 411 VLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPL 470
+L + + ++ Y ++ D+++ G+I F +L G PF M R I G+
Sbjct: 270 IL---KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLRMIMEGQ--- 321
Query: 471 FPFHSP--KYVTN----LTKRCWHADPNQRPS 496
+ F SP ++ L R DP R +
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 38/238 (15%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKR 325
D E + EIS + L H N++ F E K + L+ME + +L I + +
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGGELFDRIID-----ES 181
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ + M QI G+ ++H I H +L P NIL R A KI FGL+
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-----IKIIDFGLA 236
Query: 386 SVKNFGPKSPSQSGTTHP-FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ + P+ + P F+ APEV+ + S +D++S G+I + +L+
Sbjct: 237 --RRYKPREKLKVNFGTPEFL--APEVVNYDF---------VSFPTDMWSVGVIAYMLLS 283
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSP--KYVTN----LTKRCWHADPNQRPS 496
G PF + NI A + + ++ + + + R S
Sbjct: 284 GLSPFLGDNDAE--TLNNILACR---WDLEDEEFQDISEEAKEFISKLLIKEKSWRIS 336
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 53/242 (21%), Positives = 89/242 (36%), Gaps = 56/242 (23%)
Query: 267 DIEPLVPEISSLLSLS-HPNIMHFLCGFTDE--EKKECFLIMELMS-RDLCSYIKEICCP 322
D E+ S P+I+ + + + +K ++ME + +L S I++
Sbjct: 53 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---- 108
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
R F+ A ++M I ++YLHS I H ++ P N+L S K++ F
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY----TSKRPNAILKLTDF 164
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
G A E E KY + D++S G+I + +
Sbjct: 165 GF-----------------------AKETTGE----------KYDKSCDMWSLGVIMYIL 191
Query: 443 LTGKVPF--EDAHLQGDKMSRNIRAGERPLFPFHSP--KYVT----NLTKRCWHADPNQR 494
L G PF M IR G+ + F +P V+ L + +P QR
Sbjct: 192 LCGYPPFYSNHGLAISPGMKTRIRMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248
Query: 495 PS 496
+
Sbjct: 249 MT 250
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 39/196 (19%), Positives = 78/196 (39%), Gaps = 53/196 (27%)
Query: 280 SLSHPNI--MHFLCGFTD--EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAV 334
L P++ +H D E + ++ M L++ DL + ++ + P + P AV
Sbjct: 90 RLQEPHVVPIH------DFGEIDGQLYVDMRLINGVDLAAMLRR------QGPLAPPRAV 137
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
++ QI ++ H+ H ++ P NIL+ A + FG++ +
Sbjct: 138 AIVRQIGSALDAAHAAGATHRDVKPENILVSADD-------FAYLVDFGIA-------SA 183
Query: 395 PSQSGTTHP--FI--WH--APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
+ T + + AP E+ S S + ++D+Y+ + +E LTG P
Sbjct: 184 TTDEKLTQLGNTVGTLYYMAP------ER---FSESHATYRADIYALTCVLYECLTGSPP 234
Query: 449 FED-------AHLQGD 457
++ AH+
Sbjct: 235 YQGDQLSVMGAHINQA 250
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 59/261 (22%), Positives = 95/261 (36%), Gaps = 59/261 (22%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFS--L 330
EI +L HP+++ L GF DE E LI + M +L ++ P + + L
Sbjct: 85 EIETLSFCRHPHLVS-LIGFCDERN-EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ + ARG+ YLH++ I H ++ NILL + KI+ FG+S
Sbjct: 143 EICIG----AARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITDFGIS----- 186
Query: 391 GPKSPSQSGTTH-------PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
K ++ TH + PE + +EKSDVYSFG++ FE+L
Sbjct: 187 --KKGTELDQTHLSTVVKGTLGYIDPEY---------FIKGRLTEKSDVYSFGVVLFEVL 235
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPL-----------------FPFHSPKYVTNLTKRC 486
+ + + N+ S + + +C
Sbjct: 236 CARSAIVQSLPREMV---NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 487 WHADPNQRPSFSSICRILRYI 507
RPS + L Y
Sbjct: 293 LALSSEDRPSMGDVLWKLEYA 313
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 7e-20
Identities = 57/288 (19%), Positives = 108/288 (37%), Gaps = 45/288 (15%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEIL-WLGESFALRHFFGDIEP-----LVPEISSLLSLS 282
+K +D++ LG+G+ +K G A + +I+P ++ E+ L +
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
P I+ F F + E + ME M + +K + + + + +
Sbjct: 90 SPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIK 142
Query: 343 GMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G+ YL K KI H ++ PSNIL+ RG K+ FG+S G S + +
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCDFGVS-----GQLIDSMANS- 189
Query: 402 HPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
F+ + +PE L+ + YS +SD++S G+ E+ G+ P +
Sbjct: 190 --FVGTRSYMSPERLQG---------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
++ + P+ + F + I+
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN 286
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 45/236 (19%)
Query: 274 EISSLLSLSH--PNIMHFLCGFTDEEKKECFLIMELMS--RDLCSYIKEICCPRKRIPFS 329
E+ L +S ++ L F E LI+E +DL +I E R +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITE----RGAL--Q 147
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+A Q+ + + H+ + H ++ NIL+ K+ FG
Sbjct: 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN------RGELKLIDFGSG---A 198
Query: 390 FGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGK 446
+ GT + PE + +Y + V+S G++ ++++ G
Sbjct: 199 LLKDTVYTDFDGTRV---YSPPEWI---------RYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
+PFE I G+ F +L + C P+ RP+F I
Sbjct: 247 IPFEH--------DEEIIRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 48/223 (21%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 278 LLSLSHPNIMHFLCG----FTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
+ L HP FL F DEE F++++L+ DL ++ ++ + F
Sbjct: 69 MQGLEHP----FLVNLWYSFQDEED--MFMVVDLLLGGDLRYHL------QQNVHFKEET 116
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP 392
+ ++ ++YL +++I H ++ P NILL G H I+ F ++++
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-------HVHITDFNIAAMLPRET 169
Query: 393 KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED- 451
+ + +GT P++ APE+ + YS D +S G+ +E+L G+ P+
Sbjct: 170 QITTMAGTK-PYM--APEMFSSRKGAG------YSFAVDWWSLGVTAYELLRGRRPYHIR 220
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ ++ +P + + +L K+ +P+QR
Sbjct: 221 SSTSSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 9e-20
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 30/179 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EIS L L H NI+ +++ L+ E + +DL + A
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLD-----VCEGGLESVTA 102
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+LQ+ G+ Y H +++ H +L P N+L+ + EG L KI+ FGL+ + FG
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI-----NREGEL--KIADFGLA--RAFG-- 151
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P + TH + W+ AP+VL +++ YS D++S G I E++ G F
Sbjct: 152 IPVRK-YTHEIVTLWYRAPDVLMGSKK--------YSTTIDIWSVGCIFAEMVNGTPLF 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
+ L HP + F D+EK + + +L YI RK F
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYI------RKIGSFDETCTRFY 135
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+I +EYLH K I H +L P NILL H +I+ FG + V S
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDM-------HIQITDFGTAKV----LSPES 184
Query: 397 QSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
+ + F+ + +PE+L E + SD+++ G I ++++ G PF
Sbjct: 185 KQARANSFVGTAQYVSPELLTEKS---------ACKSSDLWALGCIIYQLVAGLPPFRAG 235
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ + I E FP +L ++ D +R
Sbjct: 236 --NEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 35/187 (18%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L LSHPNI+ L F + L+ + M DL IK + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIK-----DNSLVLTPSHI 114
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
ML +G+EYLH I H +L P+N+LL G K++ FGL+ K+FG
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-------VLKLADFGLA--KSFG-- 163
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
SP+++ TH + W+ APE+L Y D+++ G I E+L PF
Sbjct: 164 SPNRA-YTHQVVTRWYRAPELLFGARM--------YGVGVDMWAVGCILAELLLRV-PF- 212
Query: 451 DAHLQGD 457
L GD
Sbjct: 213 ---LPGD 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 53/238 (22%), Positives = 90/238 (37%), Gaps = 47/238 (19%)
Query: 274 EISSLLSLS----HPNIMHFLCGFTDEEKKECFLIMELMSR--DLCSYIKEICCPRKRIP 327
E++ L + HP ++ L F E ++ L++E DL YI E + +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPAQDLFDYITE----KGPL- 136
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
+ Q+ +++ HS+ + H ++ NIL+ R AK+ FG
Sbjct: 137 -GEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR------RGCAKLIDFGSG-- 187
Query: 388 KNFGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILT 444
P GT + PE + S +Y + V+S G++ ++++
Sbjct: 188 -ALLHDEPYTDFDGTRV---YSPPEWI---------SRHQYHALPATVWSLGILLYDMVC 234
Query: 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
G +PFE + I E FP H L +RC P+ RPS I
Sbjct: 235 GDIPFERD--------QEILEAELH-FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 30/179 (16%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
E+S L L H NI+ E+ L+ E + +DL Y+ ++
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLD-----DCGNIINMHNV 102
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q+ RG+ Y H +K+ H +L P N+L+ RG K++ FGL+ +
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-------ELKLADFGLA--RAKS-- 151
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P+++ + + W+ P++L + YS + D++ G I +E+ TG+ F
Sbjct: 152 IPTKT-YDNEVVTLWYRPPDILLGSTD--------YSTQIDMWGVGCIFYEMATGRPLF 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-19
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 256 GESFALRHFFGDIEPL--VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLC 313
+ +AL+ G + EI+ L L HPN++ F ++ +L+ + DL
Sbjct: 48 DKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW 107
Query: 314 SYIK---EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370
IK +K + + L+ QI G+ YLH+ + H +L P+NIL+ G
Sbjct: 108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167
Query: 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF----IW-HAPEVLEENEQTESASNSK 425
G + KI+ G + + F SP + W APE+L
Sbjct: 168 R-GRV--KIADMGFA--RLFN--SPLKPLADLDPVVVTFWYRAPELLLGARH-------- 212
Query: 426 YSEKSDVYSFGMICFEILTGKVPF 449
Y++ D+++ G I E+LT + F
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEPIF 236
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKEC------FLIMELMSRDLCSYIKEICCPRKRIP 327
EI L L H N+++ + + +L+ + DL + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-----NVLVK 120
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
F+L +M + G+ Y+H KI H ++ +N+L+ + +G L K++ FGL+
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI-----TRDGVL--KLADFGLARA 173
Query: 388 KNFGPKSPSQSGT-THPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
F SQ T+ + W+ PE+L Y D++ G I E+
Sbjct: 174 --FSLAKNSQPNRYTNRVVTLWYRPPELLLGERD--------YGPPIDLWGAGCIMAEMW 223
Query: 444 TGKVPFEDAHLQGD 457
T P +QG+
Sbjct: 224 TRS-PI----MQGN 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 55/281 (19%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFA-----LRHFFGDIEPLVPEISSLLSLSHP 284
E + ++G GS +K I + A L +IE + EI+ L P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 285 NIMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
+ + + + K ++IME + DL + P ++ +I
Sbjct: 81 YVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL----------EPGPLDETQIATILREI 128
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSG 399
+G++YLHS+K H ++ +N+LL G K++ FG++ + + K + G
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHG-------EVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH----LQ 455
T PF W APEV+++ S Y K+D++S G+ E+ G+ P + H L
Sbjct: 182 T--PF-WMAPEVIKQ---------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
+ +N P + K + + C + +P+ RP+
Sbjct: 230 --LIPKN----NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 49/254 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI + H N++ L GF+ + C L+ M S + + C P S +
Sbjct: 80 EIKVMAKCQHENLVE-LLGFSSDGDDLC-LVYVYMPNG--SLLDRLSCLDGTPPLSWHMR 135
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ A G+ +LH H ++ +NILL + AKIS FGL+ +
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILL-------DEAFTAKISDFGLA-------R 181
Query: 394 SPSQSGTTH-------PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
+ + T + APE A + + KSD+YSFG++ EI+TG
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPE----------ALRGEITPKSDIYSFGVVLLEIITGL 231
Query: 447 VPFEDAHLQGDKM---SRNIRAGERPL----------FPFHSPKYVTNLTKRCWHADPNQ 493
D H + + I E+ + S + + ++ +C H N+
Sbjct: 232 PAV-DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNK 290
Query: 494 RPSFSSICRILRYI 507
RP + ++L+ +
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 274 EISSLLSLS---HPNIMHFL---CGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
E++ L L HPN++ + + + + L+ E + +DL +Y+ +
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPG 116
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
DLM Q RG+++LH+ I H +L P NIL+ G K++ FGL+
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-------TVKLADFGLA-- 167
Query: 388 KNFGPKSPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ + + T + W+ APEVL S Y+ D++S G I E+
Sbjct: 168 RIYSYQMA----LTPVVVTLWYRAPEVL---------LQSTYATPVDMWSVGCIFAEMFR 214
Query: 445 GK 446
K
Sbjct: 215 RK 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 69/295 (23%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF---FGDIEPLVPEISSLLSLS-HPN 285
+ +++ +G+G+ YK + G+ A++ + E + EI+ L S H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 286 IMH----FLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLM 337
I F+ + +L+ME DL K + I + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-------IC 135
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPS 396
+I RG+ +LH K+ H ++ N+LL K+ FG+S+ + + +
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENA-------EVKLVDFGVSAQLDRTVGRRNT 188
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH--- 453
GT P+ W APEV+ +E ++ Y KSD++S G+ E+ G P D H
Sbjct: 189 FIGT--PY-WMAPEVIACDENPDAT----YDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 454 ------------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
L+ K S+ + + + C + +QRP+
Sbjct: 242 ALFLIPRNPAPRLKSKKWSKKFQ----------------SFIESCLVKNHSQRPA 280
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 35/182 (19%)
Query: 274 EISSLLSLS---HPNIMHFLC---GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIP 327
E++ L L HPN++ + + + L+ E + +DL +Y+ ++
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPG 116
Query: 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387
D+M Q+ RG+++LHS ++ H +L P NIL+ G K++ FGL+
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------QIKLADFGLA-- 167
Query: 388 KNFGPKSPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444
+ + + T + W+ APEVL S Y+ D++S G I E+
Sbjct: 168 RIYSFQMA----LTSVVVTLWYRAPEVL---------LQSSYATPVDLWSVGCIFAEMFR 214
Query: 445 GK 446
K
Sbjct: 215 RK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 61/283 (21%), Positives = 121/283 (42%), Gaps = 50/283 (17%)
Query: 227 PSRILIKSEDYQVRRRLGSGS-------QYKEILWLGESFALRHF-------FGDIEPLV 272
PS+ + + + + LG+GS ++KE G +A++ IE +
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTL 89
Query: 273 PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLP 331
E L +++ P ++ F D +++ME ++ ++ S++ R+ FS P
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHL------RRIGRFSEP 141
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
A QI EYLHS + + +L P N+L+ +G + +++ FG + K
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-------YIQVTDFGFA--KRVK 192
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451
++ + GT APE++ + Y++ D ++ G++ +E+ G PF
Sbjct: 193 GRTWTLCGTPE---ALAPEIIL---------SKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
Q ++ I +G + FP H + +L + D +R
Sbjct: 241 D--QPIQIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 26/220 (11%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L + I+ F + L+M +M+ D+ +I + F P A+
Sbjct: 239 LAKVHSRFIVSLAYAFETKTD--LCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFY 294
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
QI G+E+LH + I + +L P N+LL G + +IS GL+ G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-------NVRISDLGLAVELKAGQTKTK 347
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHL 454
T F+ APE+L E S D ++ G+ +E++ + PF +
Sbjct: 348 GYAGTPGFM--APELLLGEEYDFSV---------DYFALGVTLYEMIAARGPFRARGEKV 396
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ ++ + + +P + + DP +R
Sbjct: 397 ENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L + HP + F ++ +ME + +L ++ R+R+ F+ A
Sbjct: 59 LQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLS-----RERV-FTEERARFY 110
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+I +EYLHS+ + + ++ N++L G H KI+ FGL K +
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITDFGLC--KEGISDGAT 161
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
++ GT ++ APEVLE+N Y D + G++ +E++ G++PF +
Sbjct: 162 MKTFCGTPE-YL--APEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQ- 208
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+++ I E FP +L DP QR
Sbjct: 209 -DHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 59/279 (21%), Positives = 115/279 (41%), Gaps = 50/279 (17%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF----FGDIEPLVPEISSLLSLSHPN 285
+ Y ++G G+ Y + + G+ A+R E ++ EI + +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 286 IMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
I+++L + ++ +++ME ++ D+ + E C +I + +
Sbjct: 79 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDV---VTETCMDEGQIAA-------VCRECL 126
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGT 400
+ +E+LHS ++ H ++ NILL G K++ FG + + K + GT
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH-LQGDKM 459
P+ W APEV+ Y K D++S G++ E++ G+ P+ + + L+ +
Sbjct: 180 --PY-WMAPEVVTRKA---------YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 460 SRNIRAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPS 496
I P P + RC D +R S
Sbjct: 228 ---IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 34/176 (19%), Positives = 65/176 (36%), Gaps = 30/176 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L HPN+++ L F + + L+ E + + R + +
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRR--LHLVFEYCDHTVLHELD-----RYQRGVPEHLV 104
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ Q + + + H H ++ P NIL+ K+ FG + +
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-------VIKLCDFGFA--RLLTGP 155
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
S W+ +PE+L +++Y DV++ G + E+L+G
Sbjct: 156 SDY---YDDEVATRWYRSPELL--------VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 58/264 (21%), Positives = 91/264 (34%), Gaps = 64/264 (24%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI L H NI + + E E ++I ELM DL I I +
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-- 116
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ Q R ++ LH + H +L PSN+L+ K+ FGL+ + +
Sbjct: 117 -----FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-------DLKVCDFGLARIIDE 164
Query: 391 GPKSPSQSGTTHPFI-------W-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
S+ + W APEV+ +++KYS DV+S G I E+
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVM--------LTSAKYSRAMDVWSCGCILAEL 216
Query: 443 LTGKVPF----------------------EDAHLQGDKMSRNI--RAGERP------LFP 472
+ F D +R P +FP
Sbjct: 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP 276
Query: 473 FHSPKYVTNLTKRCWHADPNQRPS 496
+PK + +L +R DP +R +
Sbjct: 277 RVNPKGI-DLLQRMLVFDPAKRIT 299
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 60/347 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L ++ ++ + ++ L++ LM+ DL +I + + F AV
Sbjct: 238 LEKVNSRFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHM----GQAGFPEARAVFY 291
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+I G+E LH ++I + +L P NILL G H +IS GL+ +
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHG-------HIRISDLGLA--VHVPEGQTI 342
Query: 397 QS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDA 452
+ G T ++ APEV++ N +Y+ D ++ G + +E++ G+ PF
Sbjct: 343 KGRVG-TVGYM--APEVVK---------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR--------------PSFS 498
++ +++ R ++ + +L + DP +R P F
Sbjct: 391 KIKREEVERLVKEVP-EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
Query: 499 SICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPFQ 558
+ M+ P + P D DIE K + P + +Q
Sbjct: 450 KLNFKRLGAG---MLEPPFKPDPQAIYCK-DVLDIEQFSTVKGV-----ELEPTDQDFYQ 500
Query: 559 MFVYRVV----EKEKISSSPKDTSDSGSDKASVSGDENMTTPEDPSP 601
F V + E + + + SV D + P
Sbjct: 501 KFATGSVPIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQPPAPP 547
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 30/176 (17%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L L H N+++ L +++ +L+ E + + ++ V
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKR--WYLVFEFVDHTILDDLE-----LFPNGLDYQVV 126
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
+ QI G+ + HS I H ++ P NIL+ S G + K+ FG + +
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILV-----SQSGVV--KLCDFGFA--RTLAAP 177
Query: 394 SPSQSGTTHPFI--WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
W+ APE+L + + Y + DV++ G + E+ G+
Sbjct: 178 GEV---YDDEVATRWYRAPELLVGDVK--------YGKAVDVWAIGCLVTEMFMGE 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 49/238 (20%), Positives = 97/238 (40%), Gaps = 42/238 (17%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS----RDLCSYIKEICCP 322
E L E+ + H N++ + E E +++ME + D+ + ++
Sbjct: 85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDI---VSQVRLN 139
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
++I + + + + YLH++ + H ++ +ILL G K+S F
Sbjct: 140 EEQIAT-------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-------RVKLSDF 185
Query: 383 GLSS-VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
G + + PK S GT P+ W APEV+ + Y+ + D++S G++ E
Sbjct: 186 GFCAQISKDVPKRKSLVGT--PY-WMAPEVISRSL---------YATEVDIWSLGIMVIE 233
Query: 442 ILTGKVPFEDAH-LQGDKMSRNIRAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPS 496
++ G+ P+ +Q K +R P + + +R DP +R +
Sbjct: 234 MVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDL 336
L ++HP I+ F D ++ F+IM+ + +L S + RK F PVA
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLL------RKSQRFPNPVAKFY 111
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
++ +EYLHSK I + +L P NILL G H KI+ FG + K + +
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNG-------HIKITDFGFA--KYVPDVTYT 162
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
GT +I APEV+ +S D +SFG++ +E+L G PF D+
Sbjct: 163 LCGTPD-YI--APEVVSTKPYNKSI---------DWWSFGILIYEMLAGYTPFYDS--NT 208
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
K I E FP + V +L R D +QR
Sbjct: 209 MKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 51/256 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKRIPFSLPV 332
E+ + H N++ L GF E L+ M+ + S ++E P + P P
Sbjct: 77 EVEMISMAVHRNLLR-LRGFCMTPT-ERLLVYPYMANGSVASCLRER--PESQPPLDWPK 132
Query: 333 AVDLMLQIARGMEYLHSK---KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
+ L ARG+ YLH KI H ++ +NILL + A + FGL+ K
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-------DEEFEAVVGDFGLA--KL 183
Query: 390 FGPKSPSQS----GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
K + GT APE S K SEK+DV+ +G++ E++TG
Sbjct: 184 MDYKDTHVTTAVRGT---IGHIAPEY---------LSTGKSSEKTDVFGYGVMLLELITG 231
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPL-----------------FPFHSPKYVTNLTKRCWH 488
+ F+ A L D + + L + + + + C
Sbjct: 232 QRAFDLARLANDD-DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 290
Query: 489 ADPNQRPSFSSICRIL 504
+ P +RP S + R+L
Sbjct: 291 SSPMERPKMSEVVRML 306
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 70/345 (20%), Positives = 132/345 (38%), Gaps = 44/345 (12%)
Query: 164 GKQYLITPDFCYRIDTVWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSG 223
Q+ + + ++T + + W + + E + G+ +
Sbjct: 77 CLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV 136
Query: 224 KLLPSRILIKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHF-------FGDIEPLV 272
L + + +++ + LG G+ K IL G +A++ ++ +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196
Query: 273 PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331
E L + HP + F ++ +ME + +L ++ R+R+ FS
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLS-----RERV-FSED 248
Query: 332 VAVDLMLQIARGMEYLHSKK-IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-N 389
A +I ++YLHS+K + + +L N++L G H KI+ FGL
Sbjct: 249 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------HIKITDFGLCKEGIK 301
Query: 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
G + GT ++ APEVLE+N Y D + G++ +E++ G++PF
Sbjct: 302 DGATMKTFCGTPE-YL--APEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPF 349
Query: 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ +K+ I E FP +L DP QR
Sbjct: 350 YNQ--DHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 60/288 (20%), Positives = 105/288 (36%), Gaps = 61/288 (21%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF----FGDIEPLVPEISSLLSLSHPN 285
+E +++ LG G+ YK G A + ++E + EI L + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
I+ L + + K ++++E I + P + Q+ +
Sbjct: 78 IVKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALN 131
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKSPSQSGTTHPF 404
+LHSK+I H +L N+L+ G +++ FG+S+ K S GT P+
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEG-------DIRLADFGVSAKNLKTLQKRDSFIGT--PY 182
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH----------- 453
W APEV+ + + Y K+D++S G+ E+ + P + +
Sbjct: 183 -WMAPEVVMCETMKD----TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237
Query: 454 -----LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
L K S R + K +P RPS
Sbjct: 238 DPPTLLTPSKWSVEFR----------------DFLKIALDKNPETRPS 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 61/289 (21%), Positives = 99/289 (34%), Gaps = 68/289 (23%)
Query: 234 SEDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF-------FGDIEPLVPEISSLLSLS 282
+ + R +G GS Y + E A++ + ++ E+ L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
HPN + + + E +L+ME ++ P + +
Sbjct: 113 HPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQ 165
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
G+ YLHS + H ++ NILL G K+ FG +S+ + S GT
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDFGSASIMA---PANSFVGT-- 213
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH--------- 453
P+ W APEV+ ++ + Y K DV+S G+ C E+ K P + +
Sbjct: 214 PY-WMAPEVILAMDEGQ------YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266
Query: 454 ------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
LQ S F N C P RP+
Sbjct: 267 QNESPALQSGHWSE----------YFR------NFVDSCLQKIPQDRPT 299
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 46/226 (20%), Positives = 94/226 (41%), Gaps = 36/226 (15%)
Query: 233 KSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIM-- 287
+ Y + +G+GS ++ L + A++ D E+ + + HPN++
Sbjct: 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 288 --HFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL-MLQIARGM 344
F +++ L++E + + + ++ +P + + L M Q+ R +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP---MLLIKLYMYQLLRSL 154
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
Y+HS I H ++ P N+LL P G L K+ FG + K P+ +
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDP----PSGVL--KLIDFGSA--KILIAGEPN----VS-Y 201
Query: 405 I---W-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
I + APE++ + Y+ D++S G + E++ G+
Sbjct: 202 ICSRYYRAPELI--------FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/257 (20%), Positives = 80/257 (31%), Gaps = 59/257 (22%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI L HPNI F + + +L+ ELM DL I +RI S
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISP 133
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
M I G+ LH + H +L+P NILL I F L+
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-------DITICDFNLAREDTA 186
Query: 391 GPKSPSQSGTTHPFIW-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
W APE++ +++ D++S G + E+ K F
Sbjct: 187 DANKTHYVTH----RWYRAPELV--------MQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
Query: 450 ---------------------EDAHLQGDKMSRNIRAGERP---------LFPFHSPKYV 479
ED + +R+ + P P +
Sbjct: 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294
Query: 480 TNLTKRCWHADPNQRPS 496
+L + +P +R S
Sbjct: 295 -DLIAKMLEFNPQRRIS 310
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 38/205 (18%), Positives = 71/205 (34%), Gaps = 27/205 (13%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L++ I F DE +L+ME DL + + + +A
Sbjct: 115 LVNGDRRWITQLHFAFQDENY--LYLVMEYYVGGDLLTLLS-----KFGERIPAEMARFY 167
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+ +I ++ +H H ++ P NILL G H +++ FG
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-------HIRLADFGSC--LKLRADGTV 218
Query: 397 QSGT---THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+S T ++ +PE+L+ Y + D ++ G+ +E+ G+ PF
Sbjct: 219 RSLVAVGTPDYL--SPEILQ--AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 454 LQGDKMSRNIRAGERPL-FPFHSPK 477
+ I + L P
Sbjct: 275 T--AETYGKIVHYKEHLSLPLVDEG 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 30/217 (13%)
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLML 338
+ P I+ F +K I++LM+ DL ++ + FS
Sbjct: 248 TGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAA 299
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+I G+E++H++ + + +L P+NILL G H +IS GL+ +F K P S
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLA--CDFSKKKPHAS 350
Query: 399 GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-GD 457
TH ++ APEVL++ Y +D +S G + F++L G PF +
Sbjct: 351 VGTHGYM--APEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++ R P + +L + D N+R
Sbjct: 401 EIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 237 YQVRRRLGSGSQ---YKEILWL-GESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCG 292
Y + +G+GS Y+ L GE A++ D E+ + L H NI+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 293 F--TDEEKKECFL--IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL-MLQIARGMEYL 347
F + E+K E +L +++ + + + ++ +P + V L M Q+ R + Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP---VIYVKLYMYQLFRSLAYI 172
Query: 348 HSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI-- 405
HS I H ++ P N+LL P L K+ FG + K P+ S +I
Sbjct: 173 HSFGICHRDIKPQNLLLDPDT----AVL--KLCDFGSA--KQLVRGEPNVS-----YICS 219
Query: 406 -W-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
+ APE++ + Y+ DV+S G + E+L G+
Sbjct: 220 RYYRAPELI--------FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 46/237 (19%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L+ HP + H C F +E F +ME ++ DL +I + F L A
Sbjct: 72 SLAWEHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHI------QSCHKFDLSRATFY 123
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+I G+++LHSK I + +L NILL G H KI+ FG+ K N +
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------HIKIADFGMC--KENMLGDAK 174
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT +I APE+L KY+ D +SFG++ +E+L G+ PF
Sbjct: 175 TNTFCGTPD-YI--APEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSPFHGQ- 221
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR----------PSFSSI 500
+++ +IR P +P K +L + + +P +R P F I
Sbjct: 222 -DEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 43/213 (20%), Positives = 81/213 (38%), Gaps = 31/213 (14%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L++ I F D+ +L+M+ DL + + + +A
Sbjct: 128 LVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLLS-----KFEDRLPEEMARFY 180
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+ ++ ++ +H H ++ P NIL+ G H +++ FG
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-------HIRLADFGSC--LKLMEDGTV 231
Query: 397 QSGT---THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
QS T +I +PE+L Q +Y + D +S G+ +E+L G+ PF
Sbjct: 232 QSSVAVGTPDYI--SPEIL----QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRC 486
L + I + F F P VT++++
Sbjct: 286 LV--ETYGKIMNHKER-FQF--PTQVTDVSENA 313
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
P ++ F E K LI++ ++ +L +++ +R F+ + +I
Sbjct: 118 SPFLVTLHYAFQTETK--LHLILDYINGGELFTHL------SQRERFTEHEVQIYVGEIV 169
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS--SVKNFGPKSPSQSG 399
+E+LH I + ++ NILL G H ++ FGLS V + ++ G
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNG-------HVVLTDFGLSKEFVADETERAYDFCG 222
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHLQGD 457
T ++ AP+++ + + + D +S G++ +E+LTG PF +
Sbjct: 223 TIE-YM--APDIVRGGDS-------GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
++SR I E P +P +L +R DP +R
Sbjct: 273 EISRRILKSE-PPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 55/267 (20%), Positives = 92/267 (34%), Gaps = 69/267 (25%)
Query: 274 EISSLLSLSHPNI------------MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICC 321
EI + L H NI + E +++ E M DL + +++
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL 117
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
+ M Q+ RG++Y+HS + H +L P+N+ + L KI
Sbjct: 118 LEEHARL-------FMYQLLRGLKYIHSANVLHRDLKPANLFINTED------LVLKIGD 164
Query: 382 FGLS-SVKNFGPKSPSQSG--TTHPFIWH-APEVLEENEQTESASNSKYSEKSDVYSFGM 437
FGL+ + S T W+ +P +L S + Y++ D+++ G
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTK---WYRSPRLL--------LSPNNYTKAIDMWAAGC 213
Query: 438 ICFEILTGKVPF---------------------EDAHLQGDKMSRNIRA-GERP------ 469
I E+LTGK F ED + IR P
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
Query: 470 LFPFHSPKYVTNLTKRCWHADPNQRPS 496
L P S + V + ++ P R +
Sbjct: 274 LLPGISREAV-DFLEQILTFSPMDRLT 299
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 68/259 (26%)
Query: 274 EISSLLSLSHPNIMH----FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ F + + +L+M M DL + ++I +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE-EKIQY- 130
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ +G++Y+HS + H +L P N+ + KI FGL+ +
Sbjct: 131 ------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-------ELKILDFGLARHAD 177
Query: 390 FGPKSPSQSG--TTHPFIW-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
+G T W APEV+ S Y++ D++S G I E+LTGK
Sbjct: 178 -----AEMTGYVVTR---WYRAPEVI--------LSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 447 VPF---------------------EDAHLQGDKMSRNI--RAGERP------LFPFHSPK 477
F E DK +++ + P LFP SP+
Sbjct: 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 281
Query: 478 YVTNLTKRCWHADPNQRPS 496
+L ++ D ++R +
Sbjct: 282 AA-DLLEKMLELDVDKRLT 299
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 33/181 (18%)
Query: 274 EISSLLSLSHPNIMH----FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ + ++H NI+ F + EE ++ +++MELM +LC I+
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--------ELD 125
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G+++LHS I H +L PSNI++K KI FGL+
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKILDFGLARTAG 178
Query: 390 FGPKSPSQSGTTHPFIW-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
T + APEV+ Y E D++S G I E++ G V
Sbjct: 179 TSFMMTPYVVT----RYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMIKGGVL 225
Query: 449 F 449
F
Sbjct: 226 F 226
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 5e-15
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
L P + F ++ + +ME ++ DL +I+ + F P AV
Sbjct: 397 LPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQ-----QVGR-FKEPHAVFYA 448
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+IA G+ +L SK I + +L N++L G H KI+ FG+ +N ++
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------HIKIADFGMCK-ENIWDGVTTK 500
Query: 398 S--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
+ GT +I APE++ +S D ++FG++ +E+L G+ PFE
Sbjct: 501 TFCGTPD-YI--APEIIAYQPYGKSV---------DWWAFGVLLYEMLAGQAPFEGE--D 546
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D++ ++I +P K + K P +R
Sbjct: 547 EDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L+ +HP + C F ++ F +ME ++ DL +I+ K F A
Sbjct: 78 SLARNHPFLTQLFCCFQTPDR--LFFVMEFVNGGDLMFHIQ------KSRRFDEARARFY 129
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+I + +LH K I + +L N+LL G H K++ FG+ K
Sbjct: 130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-------HCKLADFGMC--KEGICNGVT 180
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT +I APE+L+E Y D ++ G++ +E+L G PFE
Sbjct: 181 TATFCGTPD-YI--APEILQEM---------LYGPAVDWWAMGVLLYEMLCGHAPFEAE- 227
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D + I E ++P + T + K +P R
Sbjct: 228 -NEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 61/259 (23%), Positives = 95/259 (36%), Gaps = 67/259 (25%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT +E + F L+M M DL +K RI F
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF- 132
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ +G+ Y+H+ I H +L P N+ + KI FGL+
Sbjct: 133 ------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-------ELKILDFGLARQ-- 177
Query: 390 FGPKSPSQSG--TTHPFIW-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK 446
+G T W APEV+ + +Y++ D++S G I E++TGK
Sbjct: 178 ---ADSEMTGYVVTR---WYRAPEVI--------LNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 447 VPF---------------------EDAHLQGDKMSRNI--RAGERP------LFPFHSPK 477
F E ++N E + SP
Sbjct: 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 283
Query: 478 YVTNLTKRCWHADPNQRPS 496
V NL ++ D QR +
Sbjct: 284 AV-NLLEKMLVLDAEQRVT 301
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 77/264 (29%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECF----LIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ L + H N++ L FT E F L+ LM DL + +K + F
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 136
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ QI RG++Y+HS I H +L PSN+ + KI FGL+
Sbjct: 137 ------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-------ELKILDFGLAR--- 180
Query: 390 FGPKSPSQSGTTHPFI-------W-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
T + W APE++ + Y++ D++S G I E
Sbjct: 181 ----------HTADEMTGYVATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAE 222
Query: 442 ILTGKVPF---------------------EDAHLQGDKMSRNI--RAGERP------LFP 472
+LTG+ F E + +RN + P +F
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 473 FHSPKYVTNLTKRCWHADPNQRPS 496
+P V +L ++ D ++R +
Sbjct: 283 GANPLAV-DLLEKMLVLDSDKRIT 305
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 45/227 (19%), Positives = 92/227 (40%), Gaps = 39/227 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
+ +HP ++ F E + F ++E ++ DL +++ ++ A
Sbjct: 107 EQASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQ------RQRKLPEEHARFY 158
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+I+ + YLH + I + +L N+LL G H K++ +G+ + P +
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------HIKLTDYGMCK-EGLRPGDTT 210
Query: 397 QS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
+ GT + +I APE+L + S D ++ G++ FE++ G+ PF+
Sbjct: 211 STFCGTPN-YI--APEILRGEDYGFSV---------DWWALGVLMFEMMAGRSPFDIVGS 258
Query: 455 QG-------DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D + + I + P ++ K + DP +R
Sbjct: 259 SDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 32/211 (15%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDL 336
+ + P ++ F D+ +++ME M DL + + A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMS-------NYDVPEKWARFY 173
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
++ ++ +HS H ++ P N+LL G H K++ FG +
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HLKLADFGTC--MKMNKEGMV 224
Query: 397 QSGT---THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ T T +I +PEVL+ + Y + D +S G+ +E+L G PF
Sbjct: 225 RCDTAVGTPDYI--SPEVLKSQG-----GDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTK 484
L I + L F ++ K
Sbjct: 278 LV--GTYSKIMNHKNSL-TFPDDNDISKEAK 305
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 49/284 (17%), Positives = 92/284 (32%), Gaps = 60/284 (21%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI+ L L+H ++ + + E+ E ++++E+ D R + +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF------RTPVYLTE 155
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
L+ + G++Y+HS I H +L P+N L+ + + + K+ FGL+ ++
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV-----NQDCSV--KVCDFGLARTVDY 208
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESA-----------------SNSKYSEKSDVY 433
SQ + + + Y+E DV+
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
Query: 434 SFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQ 493
S G I E+L H PLFP S ++ K +
Sbjct: 269 SIGCIFAELLNMIKENVAYHADR-----------GPLFPGSSCFPLSPDQKAGNDFKFHT 317
Query: 494 RPSFSSICRILRYI----------------KRFIMMNPHYNSQP 521
R + + I + KR+I + P
Sbjct: 318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 46/228 (20%), Positives = 92/228 (40%), Gaps = 41/228 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
+ +HP ++ F E + F ++E ++ DL ++ +++ A
Sbjct: 64 EQASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHM------QRQRKLPEEHARFY 115
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+I+ + YLH + I + +L N+LL G H K++ +G+ K P
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------HIKLTDYGMC--KEGLRPGDT 166
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT + +I APE+L + S D ++ G++ FE++ G+ PF+
Sbjct: 167 TSTFCGTPN-YI--APEILRGEDYGFSV---------DWWALGVLMFEMMAGRSPFDIVG 214
Query: 454 LQG-------DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D + + I + P ++ K + DP +R
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 58/247 (23%)
Query: 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRI 326
D++ ++ EIS + P+++ + + +++ME S I +
Sbjct: 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIIRLRNK---- 120
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
+ ++ +G+EYLH + H ++ NILL G HAK++ FG++
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-------HAKLADFGVAG 173
Query: 387 -VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445
+ + K + GT PF W APEV++E Y+ +D++S G+ E+ G
Sbjct: 174 QLTDTMAKRNTVIGT--PF-WMAPEVIQEIG---------YNCVADIWSLGITAIEMAEG 221
Query: 446 KVPFEDAH---------------LQG-DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHA 489
K P+ D H + + S N + K+C
Sbjct: 222 KPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT----------------DFVKQCLVK 265
Query: 490 DPNQRPS 496
P QR +
Sbjct: 266 SPEQRAT 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337
L P + F ++ + +ME ++ DL +I+ + F P AV
Sbjct: 76 LPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQ-----QVGR-FKEPHAVFYA 127
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSPS 396
+IA G+ +L SK I + +L N++L G H KI+ FG+ K N +
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------HIKIADFGMC--KENIWDGVTT 178
Query: 397 QS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454
++ GT +I APE++ +S D ++FG++ +E+L G+ PFE
Sbjct: 179 KTFCGTPD-YI--APEIIAYQPYGKSV---------DWWAFGVLLYEMLAGQAPFEGE-- 224
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
D++ ++I +P K + K P +R
Sbjct: 225 DEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 70/263 (26%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI LL H NI + T E+ K+ +++ +LM DL +K I +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-- 132
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
+ QI RG++Y+HS + H +L PSN+LL KI FGL+
Sbjct: 133 -----FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-------DLKICDFGLA----- 175
Query: 391 GPKSPSQSGTTHPFI-------WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
+ F+ W+ APE++ ++ Y++ D++S G I E+
Sbjct: 176 --RVADPDHDHTGFLTEYVATRWYRAPEIM--------LNSKGYTKSIDIWSVGCILAEM 225
Query: 443 LTGKVPF---------------------EDAHLQGDKMSRNI--RAGERP------LFPF 473
L+ + F ED + + +RN + LFP
Sbjct: 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 285
Query: 474 HSPKYVTNLTKRCWHADPNQRPS 496
K + +L + +P++R
Sbjct: 286 ADSKAL-DLLDKMLTFNPHKRIE 307
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 44/276 (15%), Positives = 82/276 (29%), Gaps = 52/276 (18%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSL 330
EI+ L L I + + E ++++E+ DL + I +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF------KTPIFLTE 128
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
++ + G ++H I H +L P+N LL K+ FGL+ N
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-------SVKVCDFGLARTINS 181
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESA------------SNSKYSEKSDVYSFGMI 438
+ + + + T Y++ D++S G I
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241
Query: 439 CFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR---- 494
E+L N PLFP S ++ + + R
Sbjct: 242 FAELLNMLQS-----------HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLN 290
Query: 495 --------PSFSSICRIL-RYIKRFIMMNPHYNSQP 521
P+ + I + ++I + PH
Sbjct: 291 IIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L+ ++HP I+ F E K +LI++ + DL + + K + F+
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGK--LYLILDFLRGGDLFTRL------SKEVMFTEEDVKFY 131
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+ ++A +++LHS I + +L P NILL G H K++ FGLS K +S
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEG-------HIKLTDFGLS--K----ESID 178
Query: 397 QSGTTHPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452
+ F + APEV+ +++ +D +SFG++ FE+LTG +PF+
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRR---------GHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+ I + P +L + + +P R
Sbjct: 230 DR--KETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 43/196 (21%), Positives = 84/196 (42%), Gaps = 38/196 (19%)
Query: 274 EISSLLSLSHPNI---MHFLCGFTDEEKKECFL--IMELMSRDLCSYIKEICCPRKRIPF 328
+ L L HPNI + + ++++ +L +ME + L + + P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP- 127
Query: 329 SLPVAVDL-MLQIARGMEYLH--SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
P+ + + + Q+ R + LH S + H ++ P N+L+ +G L K+ FG +
Sbjct: 128 --PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE----ADGTL--KLCDFGSA 179
Query: 386 SVKNFGPKSPSQSGTTHPFI---WH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
K P P+ +I ++ APE++ N Y+ D++S G I E
Sbjct: 180 --KKLSPSEPN----VA-YICSRYYRAPELI--------FGNQHYTTAVDIWSVGCIFAE 224
Query: 442 ILTGKVPF--EDAHLQ 455
++ G+ F +++ Q
Sbjct: 225 MMLGEPIFRGDNSAGQ 240
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 33/181 (18%)
Query: 274 EISSLLSLSHPNIMH----FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
E+ + ++H NI+ F T EE ++ +L+MELM +LC I+
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELD 162
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389
L+ Q+ G+++LHS I H +L PSNI++K KI FGL+
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKILDFGLARTAG 215
Query: 390 FGPKSPSQSGTTHPFIW-HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448
T + APEV+ Y E D++S G I E++ K+
Sbjct: 216 TSFMMTPYVVT----RYYRAPEVI---------LGMGYKENVDIWSVGCIMGEMVRHKIL 262
Query: 449 F 449
F
Sbjct: 263 F 263
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 25/224 (11%), Positives = 55/224 (24%), Gaps = 64/224 (28%)
Query: 280 SLSHPNIMHFLCGFTD--EEKKECFLIMELM-SRDLCSYIKEICCPRKRIPFSLPVAVDL 336
+ P + L D + ++ E + L S A+
Sbjct: 87 RIDKPGVARVL----DVVHTRAGGLVVAEWIRGGSLQEVADT--------SPSPVGAIRA 134
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
M +A + H + +PS + + G ++ +P
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-------DVVLAYPATMP-----DANP- 181
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
+ D+ G + +L + P +A ++
Sbjct: 182 --------------------------------QDDIRGIGASLYALLVNRWPLPEAGVRS 209
Query: 457 DKMSRNIRAGERPLFPFHS----PKYVTNLTKRCWHADPNQRPS 496
+P+ P P ++ + R D R +
Sbjct: 210 GLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L + HP I+ + F K +LI+E +S +L ++ R+ I F A
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGK--LYLILEYLSGGELFMQLE-----REGI-FMEDTACFY 126
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+ +I+ + +LH K I + +L P NI+L +G H K++ FGL K + +
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQG-------HVKLTDFGLC--KESIHDGTV 177
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT ++ APE+L + ++ D +S G + +++LTG PF +
Sbjct: 178 THTFCGTIE-YM--APEILMRS---------GHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
K I + P + + +L K+ + R
Sbjct: 226 R--KKTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDL 336
L ++ HP ++ F +K + +++ ++ +L +++ R+R F P A
Sbjct: 93 LKNVKHPFLVGLHFSFQTADK--LYFVLDYINGGELFYHLQ-----RERC-FLEPRARFY 144
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK-NFGPKSP 395
+IA + YLHS I + +L P NILL +G H ++ FGL K N S
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQG-------HIVLTDFGLC--KENIEHNST 195
Query: 396 SQS--GTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT ++ APEVL + Y D + G + +E+L G PF
Sbjct: 196 TSTFCGTPE-YL--APEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSR- 242
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
+M NI + +L + D +R
Sbjct: 243 -NTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 42/196 (21%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPV 332
EI L LS H NI++ L + ++ +L+ + M DL + I+ +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY---- 113
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS------- 385
++ Q+ + ++YLHS + H ++ PSNILL H K++ FGLS
Sbjct: 114 ---VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-------HVKVADFGLSRSFVNIR 163
Query: 386 ----SVKNFGPKSPSQSGTTHPFI-------WH-APEVLEENEQTESASNSKYSEKSDVY 433
++ ++ P + W+ APE+L ++KY++ D++
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL--------LGSTKYTKGIDMW 215
Query: 434 SFGMICFEILTGKVPF 449
S G I EIL GK F
Sbjct: 216 SLGCILGEILCGKPIF 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 35/180 (19%), Positives = 63/180 (35%), Gaps = 32/180 (17%)
Query: 274 EISSLLSLS-HPNIMHFLCGFTDEEKKECFLIME-LMSRDLCSYIKEICCPRKRIPFSLP 331
EI L +L PNI+ D + L+ E + + D + +
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDY 130
Query: 332 VAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
M +I + ++Y HS I H ++ P N+++ L ++ +GL+
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH----EHRKL--RLIDWGLAEF---- 180
Query: 392 PKSPSQSGTTHPF-IWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
P Q + PE+L Y D++S G + ++ K PF
Sbjct: 181 -YHPGQEYNVRVASRYFKGPELL--------VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/272 (20%), Positives = 101/272 (37%), Gaps = 77/272 (28%)
Query: 234 SEDYQVRRRLGSGS-------QYKEILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNI 286
S+ Y + + LG+GS E G+ FAL+ D E+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIES---GKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 287 MHFLCGFTDEEKKECF------------------------------------LIMELMSR 310
+ + F +E +IME +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 311 DLCSYIKEICCPRKRIPFSLPVAVDL-MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369
L +K + IP + + + Q+ R + ++HS I H ++ P N+L+
Sbjct: 123 TLHKVLKSFIRSGRSIP---MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS--- 176
Query: 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI---WH-APEVLEENEQTESASNSK 425
+ L K+ FG + K P PS + +I ++ APE++ ++
Sbjct: 177 -KDNTL--KLCDFGSA--KKLIPSEPSVA-----YICSRFYRAPELM--------LGATE 218
Query: 426 YSEKSDVYSFGMICFEILTGKVPF--EDAHLQ 455
Y+ D++S G + E++ GK F E + Q
Sbjct: 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQ 250
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 83/598 (13%), Positives = 172/598 (28%), Gaps = 158/598 (26%)
Query: 11 MGSMKALMVFRDSIQINQRQCCLLLDIFSFAYDSIAEEMRQNLRFEERRAKWKILEQP-- 68
G + ++D + + + D D + + + L EE I+
Sbjct: 11 TGEHQ--YQYKDILSVFEDAFVDNFDC----KD-VQDMPKSILSKEEID---HIIMSKDA 60
Query: 69 LKELFRIF----KEGENYIKQCLEIR-----DWWAKAITLYQNTDCVEFYIHNLLSCIPI 119
+ R+F + E +++ +E + I T+ + P
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI----KTEQRQ----------PS 106
Query: 120 LIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWR------------YGKQY 167
++ + ++ +Q+ K V + + + L + R GK +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTW 165
Query: 168 L---------ITPDFCYRIDTVWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGS 218
+ + ++I W+ + Q L+ + N
Sbjct: 166 VALDVCLSYKVQCKMDFKI-------FWLNLK--NCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 219 GSLSGKLLPSRILIKSEDYQVR-RRLGSGSQYKE---IL---WLGESFALRHF-FG---- 266
S S I ++ Q RRL Y+ +L + A F
Sbjct: 217 SDHS-----SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ--NAKAWNAFNLSCKIL 269
Query: 267 ----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL-IMELMSRDLCSYIKEICC 321
+ V + S + +H ++ H T +E K L ++ +DL +E+
Sbjct: 270 LTTRFKQ--VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---REVL- 323
Query: 322 PRKRIPFSLPVAVDLMLQ-IARGMEYLHSKKIYHGNLNPSNI-LLKPRGASTEGYLHAKI 379
P L + + + +A + H + S++ +L+P A
Sbjct: 324 --TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP--AEYRKMFDR-- 377
Query: 380 SGFGLSSVKNFGPKS---PSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-----EKSD 431
+ F P S P+ IW +V++ + KYS K
Sbjct: 378 --LSV-----F-PPSAHIPTI---LLSLIWF--DVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 432 VYSFGMICFEILTGKVPFEDAHLQGDK-MSRNIRAGERPLFPFHSPKYVTNLTKRCWHAD 490
S I E+ L+ + + R+I Y T
Sbjct: 425 TISIPSIYLELK--------VKLENEYALHRSIVD-----------HYNIPKTFDSDDLI 465
Query: 491 PNQRPSFSSICRILRYIKRFIM--MNPHYNSQPDPPMPLV--DYSDIESRLLRKFPSW 544
P + +Y I + + + +V D+ +E ++ +W
Sbjct: 466 PPY---------LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 35/173 (20%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 285 NIMHFLCGFT--DEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
+I+ L F ++ E++ +L + IK+ + L + Q+
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLL 142
Query: 343 GMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G++Y+H + I H ++ P N+L++ S E + KI+ G + +
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNACWYD---------EHY 192
Query: 402 HPFI----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
I + +PEVL + + +D++S + FE++TG FE
Sbjct: 193 TNSIQTREYRSPEVLLG---------APWGCGADIWSTACLIFELITGDFLFE 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 31/152 (20%)
Query: 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361
+ EL+S +L IK+ K FSLP+ I + ++ LH +I H +L P N
Sbjct: 175 CMTFELLSMNLYELIKK----NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPEN 230
Query: 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEENEQ 417
ILLK +G S K+ FG S ++ + +I + APEV+
Sbjct: 231 ILLKQQGRSG-----IKVIDFGSSCYEH---------QRVYTYIQSRFYRAPEVILG--- 273
Query: 418 TESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
++Y D++S G I E+LTG
Sbjct: 274 ------ARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 24/117 (20%), Positives = 47/117 (40%), Gaps = 10/117 (8%)
Query: 270 PLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFS 329
V + L S I + GF + K FL++ + R L S + P+ S
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCM-GFGVHQDKYRFLVLPSLGRSLQSALDV--SPKH--VLS 157
Query: 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
+ + ++ +E+LH + HGN+ NI + + + ++G+G +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---DPEDQSQVT--LAGYGFAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 39/191 (20%), Positives = 69/191 (36%), Gaps = 61/191 (31%)
Query: 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSN 361
++ E++ L +I + +P LP ++ Q+ +G++YLH+K +I H ++ P N
Sbjct: 122 MVFEVLGHHLLKWII--KSNYQGLP--LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 362 ILLK------------------------------------------PRGASTEGYLHAKI 379
ILL P L KI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439
+ G + + K ++ T + + EVL S Y+ +D++S +
Sbjct: 238 ADLGNAC---WVHKHFTEDIQTRQY--RSLEVLIG---------SGYNTPADIWSTACMA 283
Query: 440 FEILTGKVPFE 450
FE+ TG FE
Sbjct: 284 FELATGDYLFE 294
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/161 (19%), Positives = 61/161 (37%), Gaps = 26/161 (16%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCG 292
Y+V RR+G GS ++ L + A++ EP + L L G
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYR--TYKLLAG 64
Query: 293 --------FTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
+ +E L+++L+ L + C RK FS+ Q+ +
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRK---FSVKTVAMAAKQMLARV 119
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+ +H K + + ++ P N L+ + ++ + FG+
Sbjct: 120 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY--VVDFGMV 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 33/180 (18%), Positives = 64/180 (35%), Gaps = 36/180 (20%)
Query: 232 IKSEDYQVRRRLGSGS---------QYKEILWLGESFALRHFFGDIEPLVPEISSLLSLS 282
+ + ++V +G G E + ++ D PL E+ +
Sbjct: 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 283 HPNIMHFL----------------CGFTDEEKKEC-FLIMELMSRDLCSYIKEICCPRKR 325
P + G D+ K F+IM+ DL + ++
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA--NAKR- 148
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
FS + L L+I +EY+H + HG++ SN+LL + ++ + +GL+
Sbjct: 149 --FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ---VY--LVDYGLA 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 40/159 (25%), Positives = 60/159 (37%), Gaps = 24/159 (15%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFALR--HFFGDIEPLVPEISSLLSLSH----PNI 286
Y++ R++GSGS Y + GE A++ L E + P I
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 287 MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEY 346
E ++MEL+ L C RK FSL + L Q+ +EY
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFNF--CSRK---FSLKTVLLLADQMISRIEY 120
Query: 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+HSK H ++ P N L+ Y+ FGL+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYI----IDFGLA 155
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 30/163 (18%)
Query: 237 YQVRRRLGSGSQYKEILWLG------ESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFL 290
++V +++G G+ L LG E A++ +EP+ L L
Sbjct: 11 FRVGKKIGCGNF--GELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYR--FYKQL 61
Query: 291 CG--------FTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
+ K +++EL+ L C R FSL + + +Q+
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRT---FSLKTVLMIAIQLIS 116
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
MEY+HSK + + ++ P N L+ G T+ +H I F L+
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIH--IIDFALA 157
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 26/174 (14%)
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
+ F + EL+ ++ ++KE P+ LP + Q+ +
Sbjct: 83 LCVLMSDWF--NFHGHMCIAFELLGKNTFEFLKE----NNFQPYPLPHVRHMAYQLCHAL 136
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL--SSVK--NFGPKSPSQSGT 400
+LH ++ H +L P NIL T H + +S++ +FG S +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 194
Query: 401 THPFI-----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
H I + PEV+ E +++ DV+S G I FE G F
Sbjct: 195 HHTTIVATRHYRPPEVILE---------LGWAQPCDVWSIGCILFEYYRGFTLF 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 33/154 (21%)
Query: 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNP 359
L+ E++S +L ++ SL + Q+ + +L + + I H +L P
Sbjct: 132 CLVFEMLSYNLYDLLRN----TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187
Query: 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI----WHAPEVLEEN 415
NILL S KI FG S + +I + +PEVL
Sbjct: 188 ENILLCNPKRSA-----IKIVDFGSSCQLG---------QRIYQYIQSRFYRSPEVLLG- 232
Query: 416 EQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
Y D++S G I E+ TG+ F
Sbjct: 233 --------MPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 40/157 (25%), Positives = 61/157 (38%), Gaps = 24/157 (15%)
Query: 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361
++ EL+ +IKE +PF L + QI + + +LHS K+ H +L P N
Sbjct: 93 CIVFELLGLSTYDFIKE----NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPEN 148
Query: 362 ILLKPRGASTEGYLHAKISGFGL--SSVK--NFGPKSPSQSGTTHPFI-----WHAPEVL 412
IL + K L +K +FG S + H + + APEV+
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG--SATYDDEHHSTLVSTRHYRAPEVI 206
Query: 413 EENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+S+ DV+S G I E G F
Sbjct: 207 LA---------LGWSQPCDVWSIGCILIEYYLGFTVF 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 36/173 (20%), Positives = 57/173 (32%), Gaps = 37/173 (21%)
Query: 299 KECF-------LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK 351
F LI E + L I F + ++I + + YL
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSLYEIITR----NNYNGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 352 IYHGNLNPSNILLK--------PRGASTEGYLHAKISGFGLSSVK--NFGPKSPSQSGTT 401
+ H +L P NILL +I + +K +FG +
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--CATFKSDY 215
Query: 402 HPFI-----WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
H I + APEV+ + SD++SFG + E+ TG + F
Sbjct: 216 HGSIINTRQYRAPEVILN---------LGWDVSSDMWSFGCVLAELYTGSLLF 259
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 22/103 (21%), Positives = 44/103 (42%), Gaps = 14/103 (13%)
Query: 284 PNIMHFLCGFTDEEKKEC-FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
P G T+ + + F++ME + DL F + L +++
Sbjct: 111 PLFYGS--GLTEFKGRSYRFMVMERLGIDLQKISG--QNGT----FKKSTVLQLGIRMLD 162
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
+EY+H + HG++ +N+LL G ++ ++ +GLS
Sbjct: 163 VLEYIHENEYVHGDIKAANLLL---GYKNPDQVY--LADYGLS 200
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 20/149 (13%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFALR--HFFGDIEPLVPEISSLLSLSH----PNI 286
+++ R++GSGS Y + E A++ + L+ E L PN+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 287 MHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEY 346
F E L+M+L+ L C RK SL + L Q+ +E+
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFNF--CSRK---LSLKTVLMLADQMINRVEF 118
Query: 347 LHSKKIYHGNLNPSNILLKPRGASTEGYL 375
+HSK H ++ P N L+ + + Y+
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYI 147
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 98.29 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 98.28 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 98.28 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 98.27 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 98.25 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 98.23 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 98.22 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 98.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.2 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 98.18 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 98.18 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 98.16 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 98.16 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 98.16 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 98.15 | |
| 1mil_A | 104 | SHC adaptor protein; SH2 domain, phosphorylation, | 98.14 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 98.12 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 98.11 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 98.09 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 98.08 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 98.08 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 98.07 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 98.07 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 98.07 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 98.06 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 98.06 | |
| 1wqu_A | 114 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.05 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 98.05 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 98.05 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 98.04 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 98.04 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 98.04 | |
| 2kk6_A | 116 | Proto-oncogene tyrosine-protein kinase FER; method | 98.03 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 98.0 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 98.0 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 97.98 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 97.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.97 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 97.97 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 97.95 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 97.89 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 97.87 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 97.84 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 97.82 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 96.98 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 97.78 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.68 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 97.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 97.64 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 97.62 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 97.61 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 97.52 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 97.5 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 97.47 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 97.39 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 97.39 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 97.38 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 97.35 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 97.34 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 97.11 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 97.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 96.91 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 96.89 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 96.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.76 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 96.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.67 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 96.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.62 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 96.47 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 96.4 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 96.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.1 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 96.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.91 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 95.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.53 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 94.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.23 | |
| 1uur_A | 473 | Stata protein, STAT protein; transcription activat | 86.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 82.88 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=441.19 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=218.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.+..++|.+.+.||+|+|+.|++. +|..||||+++.. .+.|.+|+++|++|+|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-- 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-- 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--
Confidence 345678999999999998777753 4778999999653 3568999999999999999999999854
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhc-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 298 KKECFLIMELMS-RDLCSYIKEIC-------CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~-------~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
.+.+|||||||+ |+|.++|.+.. .......|++.+++.|+.||+.||.|||+++||||||||+||||+.++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~- 165 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL- 165 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-
Confidence 467999999998 69999998632 112345799999999999999999999999999999999999998877
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||+|+...............||+.|||||++.+. .|+.++|||||||++|||+| |+.|
T Consensus 166 ------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---------~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 166 ------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp ------CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ------cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC---------CCCchhhHHHHHHHHHHHHcCCCCC
Confidence 7999999999876543332233445689999999999865 49999999999999999998 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|.+.+ ..++...+..+.++..|..+|+++.+|+.+||+.||++|||+.+|.+.|+.+.+
T Consensus 231 f~~~~--~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 231 WYQLS--NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TTTSC--HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC--HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 98765 345777888888888999999999999999999999999999999999888764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=442.40 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=212.6
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.+..++|.+.++||+|+|+.|++. +|..||||+++.. .+.|.+|+++|++|+|||||+++++|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-- 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-- 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 455678999999999998888863 4778999999753 3568999999999999999999999854
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCP---------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR 367 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~ 367 (683)
...+|||||||+ |+|.++|++.... ....++++.+++.|+.||+.||.|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 467999999998 5999999863211 123579999999999999999999999999999999999999888
Q ss_pred CCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CC
Q 038696 368 GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GK 446 (683)
Q Consensus 368 g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~ 446 (683)
+ .+||+|||+|+...............||+.|||||++.+. .|+.++|||||||+||||+| |+
T Consensus 195 ~-------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~---------~~~~~sDvwS~Gvvl~Ellt~G~ 258 (329)
T 4aoj_A 195 L-------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---------KFTTESDVWSFGVVLWEIFTYGK 258 (329)
T ss_dssp T-------EEEECCCC----------------CCCCGGGCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred C-------cEEEcccccceeccCCCcceecCcccccccccChhhhcCC---------CCCccccccchHHHHHHHHcCCC
Confidence 7 8999999999876544333344456799999999999755 59999999999999999998 99
Q ss_pred CCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 447 VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 447 ~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.||.+.+. .++...+..+.++..|..+++++.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 259 ~Pf~~~~~--~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 259 QPWYQLSN--TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CTTCSSCH--HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCH--HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99987653 45667788888888999999999999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=458.38 Aligned_cols=357 Identities=24% Similarity=0.368 Sum_probs=272.8
Q ss_pred hhhHHHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeeech---hhhhhhhhhhcccchhhhhhhhh
Q 038696 118 PILIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLITP---DFCYRIDTVWKEDRWILFNKIQQ 194 (683)
Q Consensus 118 ~~~~~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l~~---~~~~~~~~~~~~~~~~l~~~~~~ 194 (683)
+.....++.++||||.++|++|+.+|..+|+|+||.|+.+. .|+|+. ..++||.|...++.|. .....|
T Consensus 4 ~~~~~~l~~~~wyhg~i~r~~a~~lL~~~G~flvR~s~~~~-------~~~lsv~~~~~~~h~~i~~~~~~~~-~~~~~F 75 (377)
T 3cbl_A 4 PEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQ-------EYVLSVLWDGLPRHFIIQSLDNLYR-LEGEGF 75 (377)
T ss_dssp CGGGSCGGGCTTBCTTCCHHHHHHHCCSTTEEEEEECC--C-------CEEEEC-----CCEEEC----CCCC-C----C
T ss_pred cccccccccCCccCCCCCHHHHHHHHhcCCCEEEEEeCCCC-------cEEEEEEECCCccchhhccccceEE-ecceec
Confidence 44456788999999999999999999999999999997433 488843 4588999976555443 344455
Q ss_pred hhccCCchhhhchHHHHhhhcCCCCCCCCCcccceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---
Q 038696 195 KKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD--- 267 (683)
Q Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~--- 267 (683)
.++.....++....+.+.... ............|.+..++|.+.+.||+|+++.|+.. +|+.||||.++..
T Consensus 76 ~sl~~LI~~y~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~ 153 (377)
T 3cbl_A 76 PSIPLLIDHLLSTQQPLTKKS--GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP 153 (377)
T ss_dssp CSHHHHHHHHHHHTCCC-------CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH
T ss_pred cchHHHHHHHhhccCCccccc--CcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH
Confidence 555444333332221111100 0011112233567888899999999999998877753 5889999998653
Q ss_pred --cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 038696 268 --IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344 (683)
Q Consensus 268 --~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL 344 (683)
.+.+.+|+++|+.++||||+++++++.+ ...+||||||++ |+|.+++... ...+++..+..++.||+.||
T Consensus 154 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l 226 (377)
T 3cbl_A 154 DLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTE-----GARLRVKTLLQMVGDAAAGM 226 (377)
T ss_dssp HHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHH
Confidence 2467899999999999999999998854 367899999997 5999999863 24589999999999999999
Q ss_pred HHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCC
Q 038696 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNS 424 (683)
Q Consensus 345 ~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~ 424 (683)
.|||++||+||||||+|||++.++ .+||+|||+++...............+++.|+|||++.+.
T Consensus 227 ~~LH~~~ivHrDlkp~Nil~~~~~-------~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------- 290 (377)
T 3cbl_A 227 EYLESKCCIHRDLAARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG--------- 290 (377)
T ss_dssp HHHHHTTEECSCCSGGGEEECTTC-------CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC---------
T ss_pred HHHHHCCcCCcccCHHHEEEcCCC-------cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC---------
Confidence 999999999999999999998887 7999999999865432221222233457789999999755
Q ss_pred CCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 425 KYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 425 ~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.++.++|||||||++|||++ |..||.+... ..+...+..+.+...|..++..+.+||.+||+.||.+|||+.++++.
T Consensus 291 ~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 291 RYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 38899999999999999998 9999987653 34666777788888888999999999999999999999999999999
Q ss_pred HHHHHH
Q 038696 504 LRYIKR 509 (683)
Q Consensus 504 L~~i~~ 509 (683)
|+.+.+
T Consensus 369 L~~i~~ 374 (377)
T 3cbl_A 369 LQSIRK 374 (377)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=437.90 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=211.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..|++..++|++.++||+|+|+.|++. ....||||+++.. .+.|.+|+++|++|+|||||++++++.. +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---Ce
Confidence 458889999999999999998888864 3457999998631 3568999999999999999999987632 45
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|||||||+ |+|.++|.. ...++++.++..|+.||+.||.|||++|||||||||+||||+.++ .+||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-------~~Ki 173 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV-----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-------TVKI 173 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT-----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-------EEEE
T ss_pred EEEEEEcCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-------cEEE
Confidence 899999998 599999975 345799999999999999999999999999999999999998887 8999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+|+...............||+.|||||++.+.. ...|+.++|||||||+||||+||+.||.+.+.. ..+
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~------~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~ 246 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD------NNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQI 246 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCS------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHH
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccC------CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHH
Confidence 9999998765433333344568999999999997542 346999999999999999999999999876533 334
Q ss_pred HHHHHcCCCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 460 SRNIRAGERP----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 460 ~~~i~~~~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
...+..+... ..+..+++.+.+||.+||+.||++|||+.+|+++|+.++
T Consensus 247 ~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 247 IFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4455554332 345678999999999999999999999999999998875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=450.17 Aligned_cols=245 Identities=25% Similarity=0.434 Sum_probs=205.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++++.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.++ +.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence 68999999999998888764 6899999998532 35688999999999999999999999654 789999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||+ |+|.++|... +...+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||
T Consensus 102 mEy~~gg~L~~~i~~~----~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------~vKl~DFG 170 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ----KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-------TVQLGDFG 170 (350)
T ss_dssp EECCTTCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-------CEEECSTT
T ss_pred EeCCCCCcHHHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-------CEEEcccc
Confidence 99998 5999999862 446689999999999999999999999999999999999999888 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+|+....... .....+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...+
T Consensus 171 la~~~~~~~~--~~~~~~GT~~YmAPE~l~~~---------~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i 237 (350)
T 4b9d_A 171 IARVLNSTVE--LARACIGTPYYLSPEICENK---------PYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKI 237 (350)
T ss_dssp EESCCCHHHH--HHHHHHSCCTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred cceeecCCcc--cccccCCCccccCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH
Confidence 9987642211 11235699999999999765 499999999999999999999999987653 3456667
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+..+..+..++.++.+||.+||+.||++|||+.++++|-+
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 777777788889999999999999999999999999988743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=438.54 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=211.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++++.||+|+|+.|++. +|+.||||++. ...+.+.+|+++|+.|+|||||+++++|.++ +.+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 468999999999999888874 68999999984 2346789999999999999999999999654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||||+| +|.++|.+. +.|++.++..|+.||+.||+|||++||+||||||+||||+.++ ++||+|
T Consensus 109 ivmEy~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-------~vKl~D 175 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-------HIQITD 175 (311)
T ss_dssp EEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------CEEECC
T ss_pred EEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-------CEEEEE
Confidence 99999985 999999864 5699999999999999999999999999999999999999888 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+|+..............+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+..
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~ 244 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEK---------SACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFA 244 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS---------CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 9999987654444445567899999999999876 489999999999999999999999987653 34556
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+. ..+|..+++++.+||.+||..||++|||+.+++.+
T Consensus 245 ~i~~~~-~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 245 KIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHTC-CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHcCC-CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 666654 35778889999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=435.18 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=217.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+...++++.++||+|+|+.|++. +++.||||+++.. .+.|.+|+.+|++|+|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-- 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--
Confidence 44558899999999998777752 4678999999642 3579999999999999999999999854
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP 366 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~ 366 (683)
...+|||||||+ |+|.++|...... .....+++.+++.|+.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 367899999997 6999999753211 11356999999999999999999999999999999999999988
Q ss_pred CCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-C
Q 038696 367 RGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-G 445 (683)
Q Consensus 367 ~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G 445 (683)
++ .+||+|||+|+...............||+.|||||++.+. .|+.++|||||||+||||+| |
T Consensus 181 ~~-------~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~~s~ksDVwSfGvvl~El~t~g 244 (308)
T 4gt4_A 181 KL-------NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---------KFSIDSDIWSYGVVLWEVFSYG 244 (308)
T ss_dssp GG-------CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTT
T ss_pred CC-------CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC---------CCCccchhhhHHHHHHHHHhCC
Confidence 77 7999999999876544333344566799999999999765 59999999999999999998 9
Q ss_pred CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..||.+.+. ..+...+..+.++..|..+|.++.+|+.+||+.||++||||.+|+++|+.
T Consensus 245 ~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 245 LQPYCGYSN--QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp CCTTTTCCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCCCH--HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999988653 45777888888888999999999999999999999999999999998874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=434.73 Aligned_cols=241 Identities=20% Similarity=0.339 Sum_probs=206.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC----CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF----GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+.|+++++||+|+|+.|++. +|+.||||++. ...+.+.+|+++|+.|+|||||+++++|.++ +.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEe
Confidence 47999999999998888864 68999999984 2456789999999999999999999999765 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.+++.+ ..+++.++..|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|
T Consensus 152 y~~gg~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------~vKl~DFGla 217 (346)
T 4fih_A 152 FLEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-------RVKLSDFGFC 217 (346)
T ss_dssp CCTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCTTC
T ss_pred CCCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-------CEEEecCcCc
Confidence 9985 99999875 4599999999999999999999999999999999999999888 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...+..
T Consensus 218 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~ 284 (346)
T 4fih_A 218 AQVSKEV--PRRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRD 284 (346)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH
T ss_pred eecCCCC--CcccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHc
Confidence 8765432 233456899999999999755 489999999999999999999999987653 335556665
Q ss_pred CCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+..+.+ +..+++++.+||.+||..||++|||+.++++|-
T Consensus 285 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 285 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 544333 345789999999999999999999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=422.62 Aligned_cols=242 Identities=29% Similarity=0.383 Sum_probs=196.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||+++++|.++ +.+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 48999999999998877764 689999999843 234688999999999999999999999654 78999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||||+|+|.+++.+. .++++.++..++.||+.||+|||++||+||||||+|||++.++ ++||+|||
T Consensus 91 vmEy~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-------~vkl~DFG 157 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-------NVKIADFG 157 (275)
T ss_dssp EEECCCEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-------CEEECCSS
T ss_pred EEeCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-------CEEEeecC
Confidence 9999999999999862 5799999999999999999999999999999999999999887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+|+...... ......||+.|||||++.+.. .++.++|||||||++|||++|+.||.+.+. ..+.+.+
T Consensus 158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~--------y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i 224 (275)
T 3hyh_A 158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKL--------YAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNI 224 (275)
T ss_dssp CC------------------CTTSCHHHHSSSS--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred CCeecCCCC---ccCCeeECcccCChhhhcCCC--------CCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence 998764332 223567999999999997553 356899999999999999999999987653 3456666
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+. ..+|..+++++.+||.+||+.||++|||+.++++|-+
T Consensus 225 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 225 SNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred HcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 6654 3467788999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=453.81 Aligned_cols=354 Identities=23% Similarity=0.388 Sum_probs=278.7
Q ss_pred HHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKK 196 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~ 196 (683)
..++.++||||.++|++|+.+|. .+|+|+||.|+...|. |+|+ ...++||.+....+.+++.....+.+
T Consensus 75 ~~~~~~~wyhg~i~r~~ae~~L~~~~~G~FlvR~S~~~~g~------~~Lsv~~~~~v~H~~I~~~~~~~~i~~~~~F~s 148 (450)
T 1k9a_A 75 TKLSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPGD------YTLCVSCEGKVEHYRIMYHASKLSIDEEVYFEN 148 (450)
T ss_dssp TTEESCTTBCTTCCHHHHHHHTCSCCTTEEEEEECSSSTTS------EEEEEECSSSEEEEEEEEETTEEESSSSSCBSS
T ss_pred cccccccccccCcCHHHhhhhhccCCCceEEEEecCCCCCc------eEEEEEeCCeeeEEEEEecCCceEecccccccc
Confidence 34678899999999999999998 4799999999877766 6663 34578998866666677766655554
Q ss_pred ccCCchhhhchHHHHhhhcCCCCCCCCCc------ccceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC--
Q 038696 197 ISGSTKQEQGLIDVLFKNLDGSGSLSGKL------LPSRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-- 266 (683)
Q Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-- 266 (683)
+.+...++....+.+...+.......+.. ....|.+..++|++.+.||+|+++.|++ +.|+.||||+++.
T Consensus 149 l~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~ 228 (450)
T 1k9a_A 149 LMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA 228 (450)
T ss_dssp HHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT
T ss_pred HHHHHhhhcccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch
Confidence 44333332222222211111111111111 1356778889999999999999888875 5789999999975
Q ss_pred CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038696 267 DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345 (683)
Q Consensus 267 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 345 (683)
..+.+.+|+++|+.++|||||++++++..+ ...+||||||++ |+|.+++... ....+++..+..++.||+.||.
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~ 303 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAME 303 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEECCTTCBHHHHHHHH----CTTTCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEEecCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999987653 347899999997 5999999874 2344799999999999999999
Q ss_pred HHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCC
Q 038696 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSK 425 (683)
Q Consensus 346 yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~ 425 (683)
|||++||+||||||+|||++.++ .+||+|||+++..... .....+++.|+|||++.+. .
T Consensus 304 ~LH~~~ivHrDlkp~Nill~~~~-------~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~---------~ 362 (450)
T 1k9a_A 304 YLEGNNFVHRDLAARNVLVSEDN-------VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREK---------K 362 (450)
T ss_dssp HHHHTTEECSCCCGGGEEECTTS-------CEEECCCTTCEECC-----------CCCTTTSCHHHHHSS---------C
T ss_pred HHHhCCeeCCCCCHhhEEECCCC-------CEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCC---------C
Confidence 99999999999999999998887 7999999999864321 1223567889999999754 5
Q ss_pred CCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 426 YSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 426 ~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
++.++|||||||++|||++ |+.||.+.... .+...+..+.++..|..++..+.+||.+||+.||.+|||+.++++.|
T Consensus 363 ~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 8999999999999999998 99999876543 35667778888888999999999999999999999999999999999
Q ss_pred HHHHH
Q 038696 505 RYIKR 509 (683)
Q Consensus 505 ~~i~~ 509 (683)
+.+..
T Consensus 441 ~~i~~ 445 (450)
T 1k9a_A 441 EHIRT 445 (450)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=437.61 Aligned_cols=265 Identities=26% Similarity=0.461 Sum_probs=224.6
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCC-Cceeeeee
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSH-PNIMHFLC 291 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~H-pnIv~l~~ 291 (683)
.+.|++..++|++.+.||+|+|+.|++. .++.||||.+... .+.|.+|+++|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4678899999999999999999888863 2357999999653 3468899999999975 99999999
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~ 360 (683)
+|.. +...+|||||||+ |+|.++|++.... .....+++.+++.|+.||+.||+|||+++||||||||+
T Consensus 136 ~~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 136 ACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 8854 3357899999998 5999999864211 12356899999999999999999999999999999999
Q ss_pred cEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHH
Q 038696 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440 (683)
Q Consensus 361 NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ 440 (683)
|||++.++ .+||+|||+|+...............||+.|||||++.+. .|+.++|||||||+||
T Consensus 215 NILl~~~~-------~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~---------~y~~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 215 NILLSEKN-------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLW 278 (353)
T ss_dssp GEEECGGG-------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHH
T ss_pred ceeeCCCC-------CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC---------CCCCcccEeehHHHHH
Confidence 99998887 7999999999876544333334456789999999999865 4999999999999999
Q ss_pred HHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 441 EILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 441 Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
||+| |+.||.+.... ..+...+..+.++..|..+++++.+||.+||+.||++|||+.+|+++|+.+.+
T Consensus 279 El~t~G~~Pf~~~~~~-~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 279 EIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHTTTSCCSSTTCCCS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 9998 99999886543 45667788888899999999999999999999999999999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=431.14 Aligned_cols=251 Identities=21% Similarity=0.253 Sum_probs=207.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
..+.|++.++||+|+|+.|++. +|+.||||+++.+. ...+|+.+|+.|+|||||+++++|.++ +.+|||||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ivmEy~ 132 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREG--PWVNIFMELL 132 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEET--TEEEEEECCC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEecc
Confidence 4457999999999999888864 68999999996432 235799999999999999999999654 7899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+| +|.++|++. .+|++.++..|+.||+.||+|||++|||||||||+||||+.+|. ++||+|||+|+.
T Consensus 133 ~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~------~vKl~DFGla~~ 200 (336)
T 4g3f_A 133 EGGSLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS------RAALCDFGHALC 200 (336)
T ss_dssp TTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC------CEEECCCTTCEE
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC------EEEEeeCCCCeE
Confidence 85 999999864 56999999999999999999999999999999999999988762 599999999987
Q ss_pred cCCCCC---CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 388 KNFGPK---SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 388 ~~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
...... .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+..... +...+.
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---------~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~ 269 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGK---------PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIA 269 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHH
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH
Confidence 654321 1122345799999999999765 49999999999999999999999998765432 334444
Q ss_pred cCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 465 AGERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 465 ~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
....+ .++..+++.+.+||.+||+.||.+|||+.+++++|.....
T Consensus 270 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 270 SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp HSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 44432 3677889999999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=437.79 Aligned_cols=241 Identities=20% Similarity=0.327 Sum_probs=207.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+.|+++++||+|+|+.|++. +|+.||||++.. ..+.+.+|+.+|+.|+|||||+++++|.++ +.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEEEe
Confidence 47999999999998888864 689999999842 356789999999999999999999999764 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.++++. ..|++.++..|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|
T Consensus 229 y~~gG~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-------~vKl~DFGla 294 (423)
T 4fie_A 229 FLEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-------RVKLSDFGFC 294 (423)
T ss_dssp CCTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-------CEEECCCTTC
T ss_pred CCCCCcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-------CEEEecCccc
Confidence 9985 99999975 4599999999999999999999999999999999999999888 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...+..
T Consensus 295 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~---------~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~ 361 (423)
T 4fie_A 295 AQVSKEV--PRRKSLVGTPYWMAPELISRL---------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRD 361 (423)
T ss_dssp EECCSSC--CCBCCCEECTTTCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH
T ss_pred eECCCCC--ccccccccCcCcCCHHHHCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHc
Confidence 8765432 233466899999999999755 489999999999999999999999987653 335556655
Q ss_pred CCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 GERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 ~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+..+. .+..+++++.+||.+||..||++|||+.++++|-
T Consensus 362 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 362 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 54333 3456789999999999999999999999998763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=420.85 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=200.4
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcC--CCCeEEEE
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDE--EKKECFLI 304 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e--~~~~~~LV 304 (683)
|++.+.||+|+|+.|++. +|..||||++.. ..+.|.+|+++|+.|+|||||+++++|.+. ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999998888863 588999999843 235689999999999999999999988642 23568999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCC-CCCCCCCcceEEEe
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKP-RGASTEGYLHAKIS 380 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~-~g~~~~~~~~vKL~ 380 (683)
||||+ |+|.++|.+. ..+++..+..|+.||+.||.|||++| ||||||||+||||+. ++ .+||+
T Consensus 108 mEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g-------~vKl~ 174 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-------SVKIG 174 (290)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS-------CEEEC
T ss_pred EeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC-------CEEEE
Confidence 99998 5999999863 56999999999999999999999998 999999999999974 55 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+|+.... .......||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.... ..+.
T Consensus 175 DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~----------~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~ 239 (290)
T 3fpq_A 175 DLGLATLKRA----SFAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIY 239 (290)
T ss_dssp CTTGGGGCCT----TSBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHH
T ss_pred eCcCCEeCCC----CccCCcccCccccCHHHcCC----------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHH
Confidence 9999986432 22345679999999999853 3899999999999999999999999765433 3455
Q ss_pred HHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 461 RNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+..+..+ .++..+++++.+||.+||+.||++|||+.++++|
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 666665543 3556678899999999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=456.06 Aligned_cols=355 Identities=24% Similarity=0.374 Sum_probs=279.9
Q ss_pred HHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccc-hhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDR-WILFNKIQQK 195 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~-~~l~~~~~~~ 195 (683)
.+++.++||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|....++ +++.....+.
T Consensus 100 ~~le~~~wyhg~i~r~~ae~ll~~~~~G~fLvR~s~~~~~~------~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~ 173 (495)
T 1opk_A 100 NSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQ------RSISLRYEGRVYHYRINTASDGKLYVSSESRFN 173 (495)
T ss_dssp SSGGGSTTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEECEECTTSCEESSTTSCBS
T ss_pred ccccchhhhccCCCHHHHHHHhhCCCCceEEEEeCCCCCCc------eEEEEeeCCeEEEEEEEecCCCceEeccCccch
Confidence 567889999999999999999987 899999999977766 7773 446899999754444 5554444555
Q ss_pred hccCCchhhhchHHHHhhhcCCCCCCCC-------CcccceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEe
Q 038696 196 KISGSTKQEQGLIDVLFKNLDGSGSLSG-------KLLPSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHF 264 (683)
Q Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~ 264 (683)
++.+...++....+.+...+........ ......|.+..++|++.+.||+|+++.|+.. ++..||||.+
T Consensus 174 sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~ 253 (495)
T 1opk_A 174 TLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253 (495)
T ss_dssp SHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEEC
T ss_pred hHHHHhhhhcccccccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEe
Confidence 5444444433333333222211110000 1123567888889999999999997666642 4789999999
Q ss_pred CC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 038696 265 FG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340 (683)
Q Consensus 265 ~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi 340 (683)
+. ..+.+.+|+.+|+.++|||||++++++.+. ..+||||||+. |+|.+++... ....+++..++.++.||
T Consensus 254 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi 327 (495)
T 1opk_A 254 KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLREC----NRQEVSAVVLLYMATQI 327 (495)
T ss_dssp CSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHS----CTTTSCHHHHHHHHHHH
T ss_pred cCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEEEEccCCCCHHHHHHhc----CcCCCCHHHHHHHHHHH
Confidence 64 356789999999999999999999988543 67899999998 5999999863 33568999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccc
Q 038696 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES 420 (683)
Q Consensus 341 ~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ 420 (683)
+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ........+|+.|+|||++.+.
T Consensus 328 ~~~L~~LH~~~ivHrDlkp~NIll~~~~-------~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~----- 394 (495)
T 1opk_A 328 SSAMEYLEKKNFIHRNLAARNCLVGENH-------LVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN----- 394 (495)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECGGG-------CEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHC-----
T ss_pred HHHHHHHHhCCcccCCCChhhEEECCCC-------cEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcC-----
Confidence 9999999999999999999999998777 79999999998764332 1223345567889999999765
Q ss_pred ccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 421 ASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 421 ~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
.++.++|||||||++|||++ |..||.+.... .+...+..+.+...+..++..+.+||.+||+.||.+|||+.+
T Consensus 395 ----~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 395 ----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp ----EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 38899999999999999999 99999876543 466677778788888899999999999999999999999999
Q ss_pred HHHHHHHH
Q 038696 500 ICRILRYI 507 (683)
Q Consensus 500 il~~L~~i 507 (683)
|++.|+.+
T Consensus 469 l~~~L~~~ 476 (495)
T 1opk_A 469 IHQAFETM 476 (495)
T ss_dssp HHHHHHTS
T ss_pred HHHHHHHH
Confidence 99888753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=450.93 Aligned_cols=354 Identities=22% Similarity=0.361 Sum_probs=278.4
Q ss_pred HHHhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeeec--------hhhhhhhhhhhc-ccchhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLIT--------PDFCYRIDTVWK-EDRWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l~--------~~~~~~~~~~~~-~~~~~l 188 (683)
+.++.++||||.++|++|+++|. ..|+|+||.|+..++. |+|+ ...++||.|... ++.+++
T Consensus 65 ~~le~~~W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~------y~lsv~~~~~~~~~~v~H~~I~~~~~g~~~i 138 (454)
T 1qcf_A 65 DSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGS------YSLSVRDYDPRQGDTVKHYKIRTLDNGGFYI 138 (454)
T ss_dssp TCGGGSTTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTS------EEEEEEEEETTTEEEEEEEEEEECTTSCEES
T ss_pred cccccccccccccchhhhhhhhhcCCCCCceEEEEECcCCCCe------EEEEEEecccCCCCceEEEEEEEcCCCcEEE
Confidence 56788999999999999999995 5799999999977776 7763 335889988653 344666
Q ss_pred hhhhhhhhccCCchhhhchHHHHhhhcCCCCCC---CCCcccceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEE
Q 038696 189 FNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSL---SGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALR 262 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK 262 (683)
.....+.++.+....+....+.+...+...... ........|.+..++|++.+.||+|+++.|++. .+..||||
T Consensus 139 ~~~~~F~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK 218 (454)
T 1qcf_A 139 SPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVK 218 (454)
T ss_dssp SSSSCBSSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEE
T ss_pred eCccccCCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEE
Confidence 655555554444333333222222222111111 112234678889999999999999998877753 47789999
Q ss_pred EeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 038696 263 HFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLML 338 (683)
Q Consensus 263 ~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 338 (683)
+++. ..+.+.+|+++|+.++|||||++++++. ...+||||||+. |+|.+++... ....+++..++.++.
T Consensus 219 ~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~~ 291 (454)
T 1qcf_A 219 TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSA 291 (454)
T ss_dssp EECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEECCCTTCBHHHHHHSH----HHHTCCHHHHHHHHH
T ss_pred EecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEEEeecCCCcHHHHHHhc----cCCCCCHHHHHHHHH
Confidence 9965 3567899999999999999999998874 256899999997 5999999752 123588999999999
Q ss_pred HHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccc
Q 038696 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQT 418 (683)
Q Consensus 339 qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~ 418 (683)
||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... .......+|+.|+|||++...
T Consensus 292 qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-------~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--- 360 (454)
T 1qcf_A 292 QIAEGMAFIEQRNYIHRDLRAANILVSASL-------VCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG--- 360 (454)
T ss_dssp HHHHHHHHHHHTTCCCSSCSGGGEEECTTC-------CEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHC---
T ss_pred HHHHHHHHHHhCCccCCCCCHHHEEECCCC-------cEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccC---
Confidence 999999999999999999999999998887 799999999987643211 122344567889999999754
Q ss_pred ccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 038696 419 ESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497 (683)
Q Consensus 419 ~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~ 497 (683)
.++.++|||||||++|||++ |+.||.+... ..+...+..+.+...+..++..+.+||.+||+.||.+|||+
T Consensus 361 ------~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 432 (454)
T 1qcf_A 361 ------SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 432 (454)
T ss_dssp ------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ------CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 48999999999999999999 9999987653 34666777788888888999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 038696 498 SSICRILRYI 507 (683)
Q Consensus 498 ~eil~~L~~i 507 (683)
.+|++.|+.+
T Consensus 433 ~~i~~~L~~~ 442 (454)
T 1qcf_A 433 EYIQSVLDDF 442 (454)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHHH
Confidence 9999888764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=423.52 Aligned_cols=240 Identities=25% Similarity=0.380 Sum_probs=198.1
Q ss_pred CCeEEEeEecccccEEEEEE-------cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW-------LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
++|++++.||+|+|+.|++. +|+.||||++.. ....+.+|+++|+.|+|||||+++++|.++ +.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 58999999999998888864 467899999853 234688999999999999999999999764 789
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|||||||+ |+|.++|.+. ..+++.++..|+.||+.||+|||++||+||||||+|||++.+| ++||+
T Consensus 102 ~ivmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------~vKl~ 168 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-------HIKLT 168 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-------CEEEE
T ss_pred EEEEEcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-------CEEec
Confidence 99999998 5999999864 5699999999999999999999999999999999999999888 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+|+....... ......||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+. .++.
T Consensus 169 DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~---------~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~ 235 (304)
T 3ubd_A 169 DFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRR---------GHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETM 235 (304)
T ss_dssp SSEEEEC-----C--CCCSCCCCGGGCCHHHHHTS---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred ccccceeccCCCc--cccccccCcccCCHHHhccC---------CCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHH
Confidence 9999986543222 23456799999999999765 489999999999999999999999987653 3455
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~ 503 (683)
..+..+. +.+|..+++++.+||.+||+.||++||| ++++++|
T Consensus 236 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 236 TMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHcCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 5565554 4567889999999999999999999998 4677655
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=447.82 Aligned_cols=354 Identities=21% Similarity=0.334 Sum_probs=275.6
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeech--------hhhhhhhhhhcc-cchhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWKE-DRWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~~-~~~~l 188 (683)
+.++.++||||.++|++|+.+|+. .|+|+||.|+..++. |+|+. ..++||.|.... +.|++
T Consensus 60 ~~le~~~w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~------y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~ 133 (452)
T 1fmk_A 60 DSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGA------YCLSVSDFDNAKGLNVKHYKIRKLDSGGFYI 133 (452)
T ss_dssp TSGGGSTTEEETCCHHHHHHHHTCTTSCTTEEEEEECSSSTTC------EEEEEEEEETTTEEEEEEEEEEECTTSCEES
T ss_pred ccccccccccCCccHHHHHHHhccCCCCCceEEEEeCCCCCCc------eEEEEEeeccCCCCcEEEEEEEEcCCCCEEE
Confidence 567889999999999999999985 399999999877666 77743 358999997644 44776
Q ss_pred hhhhhhhhccCCchhhhchHHHHhhhcCCCCC----CCCCcccceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEE
Q 038696 189 FNKIQQKKISGSTKQEQGLIDVLFKNLDGSGS----LSGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFAL 261 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAv 261 (683)
.....+.++.+...++....+.+...+..... ....+....|.+..++|++.+.||+|+++.|+.. .+..|||
T Consensus 134 ~~~~~F~Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vav 213 (452)
T 1fmk_A 134 TSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAI 213 (452)
T ss_dssp STTSEESSHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEE
T ss_pred ecCcccCCHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEE
Confidence 66666666555555444444433332221111 1122335678888999999999999998777753 3567999
Q ss_pred EEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 038696 262 RHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLM 337 (683)
Q Consensus 262 K~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~ 337 (683)
|+++. ..+.+.+|+++|+.++||||+++++++.+ ..+||||||+. |+|.+++... ....+++..+..++
T Consensus 214 K~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~ 286 (452)
T 1fmk_A 214 KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMA 286 (452)
T ss_dssp EECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHH----HHTTCCHHHHHHHH
T ss_pred EEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehhhcCCCHHHHHHhc----CCCCCCHHHHHHHH
Confidence 99964 34678999999999999999999988743 56899999997 5999999752 12458999999999
Q ss_pred HHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccc
Q 038696 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQ 417 (683)
Q Consensus 338 ~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~ 417 (683)
.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ........+|+.|+|||++.+.
T Consensus 287 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-------~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-- 356 (452)
T 1fmk_A 287 AQIASGMAYVERMNYVHRDLRAANILVGENL-------VCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG-- 356 (452)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEEECCCCTTC---------------CCGGGSCHHHHHHC--
T ss_pred HHHHHHHHHHHhCCeeCCCCChhhEEECCCC-------CEEECCCccceecCCCc-eecccCCcccccccCHhHHhcC--
Confidence 9999999999999999999999999998776 79999999998765332 1222345567889999999754
Q ss_pred cccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 038696 418 TESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496 (683)
Q Consensus 418 ~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt 496 (683)
.++.++|||||||++|||++ |+.||.+... .++...+..+.+...+..++..+.+||.+||+.||++|||
T Consensus 357 -------~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 357 -------RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 427 (452)
T ss_dssp -------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 48999999999999999999 9999987653 3466777788888888899999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 038696 497 FSSICRILRYI 507 (683)
Q Consensus 497 ~~eil~~L~~i 507 (683)
+.++++.|+.+
T Consensus 428 ~~~l~~~L~~~ 438 (452)
T 1fmk_A 428 FEYLQAFLEDY 438 (452)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHH
Confidence 99999888764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=455.47 Aligned_cols=354 Identities=21% Similarity=0.339 Sum_probs=281.2
Q ss_pred HHHhhhccccCCCchhHHHHHHhhc----CCceeeeccccccccccCeeeeech--------hhhhhhhhhhcc-cchhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVHS----GKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWKE-DRWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~~----g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~~-~~~~l 188 (683)
+.++.++||||.++|++++.+|... |+|+||.|+...+. |+|+. ..++||.|.... +.|++
T Consensus 143 ~~l~~~~wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~~~~g~------y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i 216 (535)
T 2h8h_A 143 DSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGA------YCLSVSDFDNAKGLNVKHYKIRKLDSGGFYI 216 (535)
T ss_dssp TSGGGSTTBCCSCCHHHHHHHHTCTTCCTTEEEEEECSSSTTC------EEEEEEEEETTTEEEEEEEEEBC-CCSCEEE
T ss_pred ccccccceeccccCHHHHHHHhccCCCCCCeEEEEecCCCCCc------EEEEEEeeccCCCCceEEEEEEEcCCCcEEe
Confidence 4568899999999999999999864 99999999877666 77733 358899997644 44777
Q ss_pred hhhhhhhhccCCchhhhchHHHHhhhcCCCCC----CCCCcccceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEE
Q 038696 189 FNKIQQKKISGSTKQEQGLIDVLFKNLDGSGS----LSGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFAL 261 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAv 261 (683)
.....|.++.+...++....+.+...+..... ....+....|.+..++|++.+.||+|+++.|++. .+..|||
T Consensus 217 ~~~~~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vav 296 (535)
T 2h8h_A 217 TSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAI 296 (535)
T ss_dssp ETTEEESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEE
T ss_pred eccccccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEE
Confidence 66666766666555555444444333321111 1122335678899999999999999998777753 3467999
Q ss_pred EEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 038696 262 RHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLM 337 (683)
Q Consensus 262 K~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~ 337 (683)
|+++. ..+.+.+|+++|+.|+|||||++++++.+ ..+||||||+.| +|.++|... ....+++.+++.++
T Consensus 297 K~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~ 369 (535)
T 2h8h_A 297 KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMA 369 (535)
T ss_dssp EEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTEEHHHHHSHH----HHTTCCHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeeehhcCCcHHHHHhhc----CCCCCCHHHHHHHH
Confidence 99965 34678999999999999999999988743 568999999985 999999752 12458999999999
Q ss_pred HHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccc
Q 038696 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQ 417 (683)
Q Consensus 338 ~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~ 417 (683)
.||+.||.|||++||+||||||+||||+.++ .+||+|||+++...... ........+++.|+|||++.+.
T Consensus 370 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-------~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-- 439 (535)
T 2h8h_A 370 AQIASGMAYVERMNYVHRDLRAANILVGENL-------VCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG-- 439 (535)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC--
T ss_pred HHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-------cEEEcccccceecCCCc-eecccCCcCcccccCHHHhccC--
Confidence 9999999999999999999999999998776 79999999998654321 1122344567889999999754
Q ss_pred cccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 038696 418 TESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496 (683)
Q Consensus 418 ~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt 496 (683)
.++.++|||||||++|||++ |+.||.+... .++...+..+.+...+..++..+.+||.+||+.||++|||
T Consensus 440 -------~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 440 -------RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp -------CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 48999999999999999999 9999987653 3466777788888888899999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 038696 497 FSSICRILRYI 507 (683)
Q Consensus 497 ~~eil~~L~~i 507 (683)
+.+|++.|+.+
T Consensus 511 ~~~l~~~L~~~ 521 (535)
T 2h8h_A 511 FEYLQAFLEDY 521 (535)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHHH
Confidence 99999888754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=447.43 Aligned_cols=357 Identities=23% Similarity=0.326 Sum_probs=274.5
Q ss_pred HHHhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhc-ccchhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK-EDRWILFNKIQ 193 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~-~~~~~l~~~~~ 193 (683)
.+++.++||||.++|++|+.+|. .+|+|+||.| ...+. |+| ....++||.|.+. ++.|++.....
T Consensus 156 ~~~~~~~wyhg~i~r~~ae~~L~~~~~~~G~FLvR~s-~~~~~------~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~ 228 (613)
T 2ozo_A 156 TAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQGT------YALSLIYGKTVYHYLISQDKAGKYCIPEGTK 228 (613)
T ss_dssp SCTTTSTTBCTTCCHHHHHHHHSSSCCCTTCEEEEEC-SSTTE------EEEEEEETTEEEEEEEEECTTCCEECTTSCE
T ss_pred cccccCCccccCCCHHHHHHHHhhcCCCCceEEEEec-CCCCC------EEEEEEECCeEEEEEEEECCCCCEEECCCCC
Confidence 34678899999999999999998 4899999998 44444 777 3456899999753 45577665667
Q ss_pred hhhccCCchhhhchHHHHhhhcCCCCCCC---------------------------------------------------
Q 038696 194 QKKISGSTKQEQGLIDVLFKNLDGSGSLS--------------------------------------------------- 222 (683)
Q Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--------------------------------------------------- 222 (683)
|.++.+...++....+.+...+...+...
T Consensus 229 F~sl~~Lv~~y~~~~~~l~~~L~~pC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (613)
T 2ozo_A 229 FDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPM 308 (613)
T ss_dssp ESSHHHHHHHHHHCCTTCSSCCCSBCCC----------------------------------------------------
T ss_pred cCCHHHHHHHHhhCCCCceeccccccccccccccccccCcccCCCCccccccccccccccccCCCCCccccCCCCCCCCC
Confidence 77777666666544443322222111000
Q ss_pred --------------CCcccceeEeeCCCeEEEe-EecccccEEEEEE------cCcEEEEEEeCC-----CcchHHHHHH
Q 038696 223 --------------GKLLPSRILIKSEDYQVRR-RLGSGSQYKEILW------LGESFALRHFFG-----DIEPLVPEIS 276 (683)
Q Consensus 223 --------------~~~~~~~~~~~~~~y~i~~-~LG~G~~~~v~l~------~g~~vAvK~~~~-----~~~~~~~Ei~ 276 (683)
..+....+.+..++|.+.+ .||+|+|+.|++. .+..||||+++. ..+.+.+|++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~ 388 (613)
T 2ozo_A 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388 (613)
T ss_dssp -CCCCSCSSSSSCSCSSCCCCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHH
T ss_pred CCccccccCCcCChhHhcccceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHH
Confidence 0001123445566777777 8999998777742 355799999964 3467899999
Q ss_pred HHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 038696 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHG 355 (683)
Q Consensus 277 iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 355 (683)
+|+.++|||||++++++.+ ..+||||||+.| +|.+++.. ....+++..+..++.||+.||.|||++||+||
T Consensus 389 il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr 460 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHTT-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHhCCCCCEeeEEEEecc---CCeEEEEEeCCCCcHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 9999999999999998864 358999999985 99999964 34569999999999999999999999999999
Q ss_pred CCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHh
Q 038696 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434 (683)
Q Consensus 356 DLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwS 434 (683)
||||+||||+.++ .+||+|||+++....... ........+|+.|+|||++.+. .++.++||||
T Consensus 461 Dlkp~NILl~~~~-------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~---------~~~~~sDvwS 524 (613)
T 2ozo_A 461 NLAARNVLLVNRH-------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWS 524 (613)
T ss_dssp CCSGGGEEEEETT-------EEEECCCSTTTTCC--------------CCTTSCHHHHHHC---------CCCHHHHHHH
T ss_pred cCCHHHEEEcCCC-------cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC---------CCCcHHHHHH
Confidence 9999999998887 899999999987643321 1122234566889999999755 4899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 435 FGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 435 lGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
|||++|||++ |+.||.+... .++...+..+.++..+..++.++.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 525 lGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 525 YGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999998 9999987653 3467778888888889999999999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=416.11 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=200.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC----CCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE----EKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e----~~~ 299 (683)
.++|++++.||+|+|+.|++. +|+.||||+++.. .+.+.+|+++|+.|+|||||++++++... +.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 358999999999998888864 6899999999642 34578999999999999999999987532 346
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+|||||||+|+|.+++.+ ..+|++.++..|++||+.||.|||++|||||||||+|||++.+| .+||
T Consensus 133 ~~~ivmE~~~g~L~~~i~~------~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-------~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHS------SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-------ELKI 199 (398)
T ss_dssp CEEEEEECCSEEHHHHHTS------SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-------CEEE
T ss_pred EEEEEEeCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-------CEEE
Confidence 7999999999999999974 36799999999999999999999999999999999999999888 7999
Q ss_pred ecccCccccCCCC--CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 380 SGFGLSSVKNFGP--KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 380 ~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
+|||+|+.+.... ........+||+.|+|||++.+.. .|+.++||||+|||+|||++|++||.+.+...
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~--------~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~- 270 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH--------EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH- 270 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCC--------CCCChhheehhHHHHHHHHHCCCCCCCCCHHH-
Confidence 9999998764332 122334568999999999987542 57999999999999999999999998765321
Q ss_pred HHHHHHHc-CCC---------------------CCC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 458 KMSRNIRA-GER---------------------PLF-------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~-~~~---------------------~~~-------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...+.. +.. ... ....++++.+||.+||..||.+|||+.++++|-+
T Consensus 271 ~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 12211111 110 000 1245788999999999999999999999988743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=405.55 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=184.3
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC--------
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK-------- 298 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~-------- 298 (683)
+|++++.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 7999999999998888864 6889999998521 3467899999999999999999999865432
Q ss_pred --CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 299 --KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 299 --~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..+|||||||+ |+|.+++.... ......+..++.|+.||+.||+|||++||+||||||+||||+.++
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~------- 155 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD------- 155 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC---SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC---CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-------
Confidence 24799999998 59999998521 112356677899999999999999999999999999999999888
Q ss_pred eEEEecccCccccCCCCCC----------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC
Q 038696 376 HAKISGFGLSSVKNFGPKS----------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG 445 (683)
.+||+|||+|+........ ......+||+.|||||++.+. .|+.++|||||||++|||++
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---------~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---------SYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHS-
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---------CCCCHHHHHHHHHHHHHHcc-
Confidence 7999999999876543211 112345799999999999765 49999999999999999996
Q ss_pred CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
||.+.... ......+.....+......++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 --Pf~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 226 --PFSTQMER-VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp --CCSSHHHH-HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCccHH-HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 88653221 12233344444332223334567899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=404.22 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=197.4
Q ss_pred CCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC-cchHH--HHHHHHHcCCCCceeeeeeeEEcCCC--CeEEEEEec
Q 038696 235 EDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD-IEPLV--PEISSLLSLSHPNIMHFLCGFTDEEK--KECFLIMEL 307 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~-~~~~~--~Ei~iL~~L~HpnIv~l~~~~~~e~~--~~~~LVmEy 307 (683)
++|.+.++||+|+|+.|++ ++|+.||||++... ...+. .|+..+..++|||||++++++..++. ..+||||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 4799999999999877775 68999999999643 23344 45555677899999999999875432 368999999
Q ss_pred CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 308 MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK--------KIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 308 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
|+ |+|.++|+. .++++..+..++.|++.||.|||++ +||||||||+||||+.++ ++|
T Consensus 83 ~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-------~~K 148 (303)
T 3hmm_A 83 HEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------TCC 148 (303)
T ss_dssp CTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-------CEE
T ss_pred CCCCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-------CEE
Confidence 98 599999986 4699999999999999999999987 999999999999999887 799
Q ss_pred EecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc---
Q 038696 379 ISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH--- 453 (683)
Q Consensus 379 L~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~--- 453 (683)
|+|||+|+........ .......||+.|||||++.+.... ....|+.++|||||||+||||+||..||....
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~---~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~ 225 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccc---cCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence 9999999876543321 122345799999999999754100 11136789999999999999999987664321
Q ss_pred -------c---chhHHHHHH-HcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 -------L---QGDKMSRNI-RAGERPLFPFH-----SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 -------~---~~~~~~~~i-~~~~~~~~p~~-----~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
. ....+...+ ..+.++.+|.. ++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 226 ~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1 112233333 33445555533 24578999999999999999999999999998864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=437.92 Aligned_cols=353 Identities=22% Similarity=0.329 Sum_probs=269.1
Q ss_pred HHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhh-cccchhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVW-KEDRWILFNKIQQ 194 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~-~~~~~~l~~~~~~ 194 (683)
..+.++||||-+.|++|+++|.. +|.|+||.| ..+|. |+| ....++||.|.. ..+.|++.....|
T Consensus 162 ~~~~~~Wy~g~isr~~ae~~L~~~~~~~G~FLvR~s-~~~g~------y~lsv~~~~~v~h~~i~~~~~g~~~~~~~~~F 234 (635)
T 4fl3_A 162 AHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNGS------YALCLLHEGKVLHYRIDKDKTGKLSIPEGKKF 234 (635)
T ss_dssp CGGGSTTBCCSCCHHHHHHHHHSSSCCTTCEEEEES-SSSSC------EEEEEEETTEEEEEEEEECTTSCEESTTCCCB
T ss_pred ccccCCceeccCCHHHHHHHHHcCCCCCceEEEEec-CCCCC------EEEEEEECCEEEEEEEEECCCCCEEeCCCCcc
Confidence 34678999999999999999975 799999988 34454 777 455689999965 3445777665567
Q ss_pred hhccCCchhhhchHHHHhhhcCCCCCCC----------------------------------------------------
Q 038696 195 KKISGSTKQEQGLIDVLFKNLDGSGSLS---------------------------------------------------- 222 (683)
Q Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~---------------------------------------------------- 222 (683)
.++.+...+++...+.+...|...+.-.
T Consensus 235 ~sl~~Lv~~y~~~~~~l~~~L~~p~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (635)
T 4fl3_A 235 DTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQ 314 (635)
T ss_dssp SSHHHHHHHHTTCCTTSSSCCCSBCCC-----------------------------------------------------
T ss_pred CCHHHHHHHhhhCCCCCccccCccCcCccccccccccCCCCCCCcCccccccccccccccccccCCccccccccccccCC
Confidence 6666555555544433332222111100
Q ss_pred -----------------------------------------CCcccceeEeeCCCeEEE-eEecccccEEEEEE------
Q 038696 223 -----------------------------------------GKLLPSRILIKSEDYQVR-RRLGSGSQYKEILW------ 254 (683)
Q Consensus 223 -----------------------------------------~~~~~~~~~~~~~~y~i~-~~LG~G~~~~v~l~------ 254 (683)
..+.+..+.+....+.+. +.||+|+++.|++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~ 394 (635)
T 4fl3_A 315 ESTVSFNPYEPELAPWAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK 394 (635)
T ss_dssp -----------------------CCCCGGGSTTSSCTTCSTTSCCCSSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSS
T ss_pred cccccCCCCCCCCCccccccCcccccCCCcccccccccCChhHcCcccccccchhccccCCEeccCCCEEEEEEEEcCCC
Confidence 000112233333445554 47999998877753
Q ss_pred cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCC
Q 038696 255 LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIP 327 (683)
Q Consensus 255 ~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~ 327 (683)
.++.||||+++.. .+.+.+|+++|+.++|||||++++++.. ..++|||||+.| +|.+++.. ...
T Consensus 395 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~------~~~ 465 (635)
T 4fl3_A 395 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQ------NRH 465 (635)
T ss_dssp CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHH------CTT
T ss_pred cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEccCCCCHHHHHhh------CCC
Confidence 4578999999642 3578999999999999999999998853 358999999985 99999975 256
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCC-CCCCCCCCcCccc
Q 038696 328 FSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK-SPSQSGTTHPFIW 406 (683)
Q Consensus 328 l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y 406 (683)
+++..+..|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++....... ........+|+.|
T Consensus 466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y 538 (635)
T 4fl3_A 466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-------YAKISDFGLSKALRADENYYKAQTHGKWPVKW 538 (635)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------EEEECCTTHHHHTTC-------------CGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-------CEEEEEcCCccccccCccccccccCCCCceee
Confidence 99999999999999999999999999999999999998887 899999999987654322 1222344567889
Q ss_pred CChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHH
Q 038696 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKR 485 (683)
Q Consensus 407 ~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~ 485 (683)
+|||++.+. .++.++|||||||++|||++ |+.||.+... ..+...+..+.++..+..++.++.+||..
T Consensus 539 ~APE~~~~~---------~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 539 YAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp SCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eChhhhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 999999765 48999999999999999998 9999987653 45777888888888899999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 486 CWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 486 cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
||+.||++|||+.+|++.|+.+..
T Consensus 608 cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 608 CWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999988754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=421.44 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=202.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHH---HHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPE---ISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~E---i~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
-++|++++.||+|+|+.|++. +|+.||||++.. ....+.+| +.+++.++|||||+++++|.++ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--C
Confidence 358999999999999999874 789999999842 22334444 5666778999999999999765 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||||||+ |+|.++|.+. ..|++..+..|+.||+.||+|||++|||||||||+||||+.+| ++|
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-------~vK 332 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVR 332 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-------CEE
T ss_pred EEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-------CEE
Confidence 8999999998 5999999864 5699999999999999999999999999999999999999988 899
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-h
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-D 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~ 457 (683)
|+|||+|+..... .....+||+.|||||++.+. ..|+.++||||||||+|||++|+.||.+..... .
T Consensus 333 L~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~--------~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~ 400 (689)
T 3v5w_A 333 ISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKG--------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400 (689)
T ss_dssp ECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred ecccceeeecCCC----CCCCccCCcCccCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999876543 23456899999999999632 258999999999999999999999998654332 2
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L~ 505 (683)
.+...+... ...+|..+++++.+||.+||..||.+|++ +.+|++|-+
T Consensus 401 ~i~~~i~~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 401 EIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp HHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred HHHHhhcCC-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 344444443 34577889999999999999999999997 688887744
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=397.11 Aligned_cols=245 Identities=19% Similarity=0.272 Sum_probs=192.4
Q ss_pred CCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC--cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD--IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~--~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++.+.||+|+|+.|++. +++.||||++... ...+.+|+++|+.+ +|||||+++++|.+. +.+||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEE
Confidence 358999999999998888864 3578999998643 45678999999998 699999999999654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CCCCCCcceEEEec
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR-GASTEGYLHAKISG 381 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~-g~~~~~~~~vKL~D 381 (683)
|||||+ |+|.++++ .+++.++..|+.||+.||+|||++||+||||||+|||++.+ + .+||+|
T Consensus 98 vmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~-------~~kl~D 161 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK-------KYALVD 161 (361)
T ss_dssp EEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-------EEEECC
T ss_pred EEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC-------eEEECc
Confidence 999998 59999884 38999999999999999999999999999999999999876 4 799999
Q ss_pred ccCccccCCCCC--------------------------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 382 FGLSSVKNFGPK--------------------------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 382 FGla~~~~~~~~--------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
||+|+....... .......+||+.|+|||++.+. ..|+.++||||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~y~~~~DiWSl 233 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--------PNQTTAIDMWSA 233 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--------SCCCTHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--------CCCCCccchhhh
Confidence 999976533210 0112345799999999999754 258999999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhHHHHHHH-------------------------------------cCC-----------
Q 038696 436 GMICFEILTGKVPFEDAHLQGDKMSRNIR-------------------------------------AGE----------- 467 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~~~~~~~i~-------------------------------------~~~----------- 467 (683)
|||+|||++|+.||...+...+.+...+. ...
T Consensus 234 G~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~ 313 (361)
T 4f9c_A 234 GVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQ 313 (361)
T ss_dssp HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccc
Confidence 99999999999999654432222211110 000
Q ss_pred ----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 468 ----RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 468 ----~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
........++++.+||.+||..||.+|||++++++|-
T Consensus 314 ~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 314 GHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp --------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0001234578899999999999999999999998763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=412.37 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=204.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++++.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.++ ..+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEe
Confidence 58999999999998888863 7899999998542 35688999999999999999999999654 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+ |+|.++|.+ ....|++.++..|+.||+.||+|||++||+||||||+|||++.+. . -.+||+|||+|
T Consensus 235 ~~~gg~L~~~i~~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~---~--~~vKl~DFG~a 304 (573)
T 3uto_A 235 FMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR---S--NELKLIDFGLT 304 (573)
T ss_dssp CCCCCBHHHHHTC-----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS---C--CCEEECCCSSC
T ss_pred ecCCCcHHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC---C--CCEEEeeccce
Confidence 998 499999964 345799999999999999999999999999999999999997652 0 16999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... .....+||+.|||||++.+. .|+.++|||||||++|||++|..||.+.+. ..+...+..
T Consensus 305 ~~~~~~~---~~~~~~GT~~y~APEv~~~~---------~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~i~~ 370 (573)
T 3uto_A 305 AHLDPKQ---SVKVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS 370 (573)
T ss_dssp EECCTTS---EEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHT
T ss_pred eEccCCC---ceeeeEECccccCHHHhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHh
Confidence 8875432 22345799999999999765 489999999999999999999999987653 345556655
Q ss_pred CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.... ....+++++.+||.+||..||.+|||+.++++|
T Consensus 371 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54322 224678999999999999999999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=372.16 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=218.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE-----------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW-----------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~-----------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
+.+..++|++.+.||+|+++.|++. ++..||||+++.. .+.+.+|+.+|+.+ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4556679999999999998888764 2347999999653 34688999999999 89999999998
Q ss_pred EEcCCCCeEEEEEecCCC-CHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 038696 293 FTDEEKKECFLIMELMSR-DLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSN 361 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~N 361 (683)
+.+ .+.+|+||||++| +|.+++...... .....+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 156 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 156 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred Ecc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 854 3678999999985 999999874211 112458999999999999999999999999999999999
Q ss_pred EEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 362 ILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 362 ILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++||
T Consensus 234 Ill~~~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DvwslG~il~e 297 (370)
T 2psq_A 234 VLVTENN-------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLMWE 297 (370)
T ss_dssp EEECTTC-------CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC---------CCCHHHHHHHHHHHHHH
T ss_pred EEECCCC-------CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC---------CCCcHHHHHHHHHHHHH
Confidence 9998887 7999999999876544333334455678899999999754 48999999999999999
Q ss_pred HHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 442 ILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 442 llt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|++ |..||.+.... .+...+..+.++..+..++.++.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 298 llt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 298 IFTLGGSPYPGIPVE--ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999 99999876543 4667777888888888999999999999999999999999999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.84 Aligned_cols=255 Identities=27% Similarity=0.500 Sum_probs=216.5
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.|.+..++|++.+.||+|+++.|++. ++..||||++.. ..+.+.+|+++++.++||||+++++++.+ ...+|
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPIC 81 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceE
Confidence 46677789999999999997777653 678899999965 34678999999999999999999998854 46799
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------VIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-------CEEECC
T ss_pred EEEEeCCCCcHHHHHHh-----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-------CEEecc
Confidence 99999975 99999975 345699999999999999999999999999999999999998777 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~ 460 (683)
||+++...... ........+|+.|+|||++.+. .++.++||||||+++|+|++ |..||..... ....
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~ 217 (269)
T 4hcu_A 150 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV 217 (269)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH
T ss_pred ccccccccccc-cccccCcccccccCCHHHhcCC---------CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Confidence 99998654321 1123345567889999999755 48999999999999999999 9999987553 3466
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+..+.....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 218 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 6777777777788889999999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.11 Aligned_cols=242 Identities=21% Similarity=0.365 Sum_probs=202.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++... +.+|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEEEE
Confidence 358999999999998888864 688999999842 345688999999999999999999998654 6899999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 97 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-------~~kl~Dfg~ 162 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGF 162 (297)
T ss_dssp ECCTTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCTT
T ss_pred ECCCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-------CEEEeeCCC
Confidence 9997 599999986 3589999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+..... .......
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~ 230 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIAT 230 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCS---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Confidence 987654322 33456789999999999755 48999999999999999999999998765432 2222222
Q ss_pred c-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. ......+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2 22334466778999999999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.05 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=204.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.++ +.+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEE
Confidence 458999999999998888763 6899999998532 34578999999999999999999998654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 92 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-------~~kl~DF 158 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-------NIKIADF 158 (328)
T ss_dssp EECCCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEECST
T ss_pred EEECCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-------CEEEeec
Confidence 999997 5999999763 5699999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++...... ......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+.. .+...
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~ 225 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKK--------YDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRER 225 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCC--------CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCC--------cCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 9998765432 223457899999999997552 2458999999999999999999999876543 34455
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+..+. ..+|...+.++.+|+.+||..||.+|||+.++++|-
T Consensus 226 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 226 VLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp HHHCC-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred HHhCC-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 55553 346777899999999999999999999999998763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=360.23 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=208.7
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..+..++|.+.+.||+|+++.|+.. +|+.||||.+... .+.+.+|+++|+.++||||+++++++.++ ..+
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence 4456679999999999998888763 5889999988542 45688999999999999999999998654 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
++||||++| +|.+++.. ....+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl~ 150 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKS-----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-------NVVVA 150 (310)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-------CEEEC
T ss_pred EEEEEecCCCcHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-------CEEEe
Confidence 999999975 99999986 245699999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCC------------CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCC
Q 038696 381 GFGLSSVKNFGPKSP------------SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448 (683)
Q Consensus 381 DFGla~~~~~~~~~~------------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~P 448 (683)
|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|..|
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~g~~~ 221 (310)
T 3s95_A 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---------SYDEKVDVFSFGIVLCEIIGRVNA 221 (310)
T ss_dssp CCTTCEECC--------------------CCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHTCCS
T ss_pred ecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC---------CCCcHHHHHHHHHHHHHHhcCCCC
Confidence 999998764332111 11145789999999999754 489999999999999999999999
Q ss_pred CCCCccchh----HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 038696 449 FEDAHLQGD----KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIM 512 (683)
Q Consensus 449 f~~~~~~~~----~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~ 512 (683)
|........ ........ ..+..++..+.+|+.+||+.||.+|||+.++++.|+.+...+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 222 DPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp STTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 875432211 11112221 2466778889999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.98 Aligned_cols=262 Identities=27% Similarity=0.469 Sum_probs=204.5
Q ss_pred CcccceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 224 KLLPSRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 224 ~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
......+.+..++|++.+.||+|+++.|++ ..|..||||++... .+.+.+|+++|+.++||||+++++++.+
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 344466777788999999999999887775 47899999998642 2467899999999999999999998854
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCCCCC
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g~~~~ 372 (683)
...+|+||||++| +|.+++... .....+++..+..++.||+.||.|||++| |+||||||+|||++.++
T Consensus 106 --~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~---- 176 (309)
T 3p86_A 106 --PPNLSIVTEYLSRGSLYRLLHKS---GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY---- 176 (309)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHST---THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC----
T ss_pred --CCceEEEEecCCCCcHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC----
Confidence 3678999999975 999999752 11123899999999999999999999999 99999999999998887
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 177 ---~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 177 ---TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDE---------PSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ---CEEECCCC-------------------CCTTSCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ---cEEECCCCCCccccccc--cccccCCCCccccChhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 79999999997654321 123345789999999999755 4789999999999999999999999876
Q ss_pred ccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
... ...............+..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 243 NPA-QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CHH-HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CHH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 533 22223333555666788899999999999999999999999999999988753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=366.48 Aligned_cols=266 Identities=26% Similarity=0.449 Sum_probs=220.5
Q ss_pred ccceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 226 LPSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 226 ~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
....|.+..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 44677888899999999999998888764 3478999999653 24588999999999 799999999
Q ss_pred eeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCC----------------------------------------------
Q 038696 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR---------------------------------------------- 323 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~---------------------------------------------- 323 (683)
+++.+. ...+++||||++| +|.+++.......
T Consensus 93 ~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 93 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 988653 3568999999985 9999998632100
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 324 --------------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 324 --------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-------~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-------VVKICDFGLARDIY 244 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEEECCCGGGSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-------cEEEEeccceeeec
Confidence 012389999999999999999999999999999999999998777 79999999998765
Q ss_pred CCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCC
Q 038696 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 390 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
............||+.|+|||++.+. .++.++|||||||++|||++ |..||.+.... ..+...+..+..
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~ 314 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTR 314 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCC
T ss_pred ccccchhccccCCCceeEChhhhcCC---------CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCC
Confidence 44333334456688899999999755 48999999999999999998 99999876544 345566777777
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 469 PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+..++.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 77888899999999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.74 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=211.9
Q ss_pred EeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.+..++|++.+.||+|+++.|++. .+..||||+++.. .+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--G 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--G
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 445679999999999998888753 2346999999753 3468899999999999999999998854 4
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------~~ 190 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRT-----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-------VC 190 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHT-----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------CE
T ss_pred CccEEEeeCCCCCcHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-------CE
Confidence 678999999975 99999975 335699999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
||+|||+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~p~~~~~~- 260 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR---------TFSSASDVWSFGVVMWEVLAYGERPYWNMTN- 260 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCC---------CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 99999999876543221 122344567889999999765 38899999999999999999 9999987653
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+...+..+.....+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 261 -RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34667777777777888999999999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.26 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=209.1
Q ss_pred eeCCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++...+..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34569999999999998888763 5789999999653 24678999999999999999999988655446
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-------~~k 154 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH-----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-------RVK 154 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC-----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------EEE
T ss_pred ceEEEEEeCCCCCHHHHHHhc-----ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-------eEE
Confidence 6899999997 5999999862 34599999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--
Q 038696 379 ISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-- 455 (683)
Q Consensus 379 L~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-- 455 (683)
|+|||+++........ .......+|..|+|||++.+. .++.++||||||+++|||++|..||......
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~ 225 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 225 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCC---------CCChHHHHHHHHHHHHHHHhcccccCCChHHHH
Confidence 9999999876543221 122344567789999999765 4899999999999999999999998653211
Q ss_pred ------------hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 ------------GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ------------~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+...+..+.+...+..++.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 226 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 012344556666777888899999999999999999999999999999998864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.21 Aligned_cols=263 Identities=22% Similarity=0.353 Sum_probs=216.7
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+..++|++++.||+|+++.|++. ++..||||++... ...+.+|+.+|+.++|||||++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 344568999999999997766652 3568999998642 3357899999999999999999998854
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCP-RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
....||||||+.| +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~ 220 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG----PG 220 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----TT
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----CC
Confidence 3667999999975 999999875321 1224699999999999999999999999999999999999998654 12
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
..+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+..
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 26999999999765333222333445678899999999765 48999999999999999998 999998765
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
. ..+...+..+.....+..++..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus 292 ~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 292 N--QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp H--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H--HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3 456677777777778888999999999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.03 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=215.2
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
...|.+..++|++.+.||+|+++.|+.. .+..||||++.. ..+.+.+|+++++.++||||+++++++.+ ...
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 93 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRP 93 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec--CCC
Confidence 3567788889999999999997777653 566899999965 34678999999999999999999998854 467
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-------~~kl 161 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-------VVKV 161 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG-----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-------CEEE
T ss_pred eEEEEeccCCCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-------CEEE
Confidence 999999997 5999999752 35699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
+|||+++...... ........+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||..... ..
T Consensus 162 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~ 229 (283)
T 3gen_A 162 SDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SE 229 (283)
T ss_dssp CSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HH
T ss_pred ccccccccccccc-cccccCCccCcccCCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCccccCh--hH
Confidence 9999998654321 1122345567889999999755 48999999999999999998 9999987653 34
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
....+..+.....+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 230 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 666777777777888889999999999999999999999999999988754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.15 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=201.6
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~ 298 (683)
.+..++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|..+ +||||++++++|.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-- 96 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-- 96 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Confidence 345579999999999998888864 588999999853 345678999999988 699999999999654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++| +|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-------~i 163 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-------HC 163 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CE
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-------CE
Confidence 789999999985 999999863 5699999999999999999999999999999999999999888 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++...... .......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+. .
T Consensus 164 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~G~~Pf~~~~~--~ 230 (353)
T 3txo_A 164 KLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEML---------YGPAVDWWAMGVLLYEMLCGHAPFEAENE--D 230 (353)
T ss_dssp EECCCTTCBCSCC-----------CCGGGCCHHHHHHHH---------CTTHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred EEccccceeecccCC--ccccccCCCcCeEChhhcCCCC---------cCCccCCCcchHHHHHHHhCCCCCCCCCH--H
Confidence 999999998643221 1233557899999999998764 89999999999999999999999987653 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF------SSICRIL 504 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~------~eil~~L 504 (683)
.+...+..+. ..+|...+..+.+||++||..||.+||++ .++++|-
T Consensus 231 ~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 231 DLFEAILNDE-VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp HHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred HHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 4555565554 34677789999999999999999999998 7777653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=354.69 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=218.6
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGF 293 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~ 293 (683)
..+.+..++|.+.+.||+|+++.|+.. .|..||||++... .+.+.+|+++|+.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 456677789999999999998777754 2378999999653 35678999999999999999999988
Q ss_pred EcCCCCeEEEEEecCC-CCHHHHHHHhcCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 038696 294 TDEEKKECFLIMELMS-RDLCSYIKEICCP------------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYH 354 (683)
Q Consensus 294 ~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiH 354 (683)
.+ ...+|+||||++ |+|.+++...... .....+++.++..++.||+.||.|||++||+|
T Consensus 96 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 96 SQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 54 467899999998 5999999874210 01234899999999999999999999999999
Q ss_pred CCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHh
Q 038696 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434 (683)
Q Consensus 355 rDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwS 434 (683)
|||||+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++||||
T Consensus 174 ~dikp~NIli~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s 237 (314)
T 2ivs_A 174 RDLAARNILVAEGR-------KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---------IYTTQSDVWS 237 (314)
T ss_dssp CCCSGGGEEEETTT-------EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC---------EECHHHHHHH
T ss_pred cccchheEEEcCCC-------CEEEccccccccccccccceeccCCCCcccccChhhhcCC---------CcCchhhHHH
Confidence 99999999999887 7999999999876544332233455678889999999765 3889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 435 FGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 435 lGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|||++|||++ |..||.+.... .+...+..+.....+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 238 lG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPE--RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHH--HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999 99999876543 4667777777777888899999999999999999999999999999988753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=359.71 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=205.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||++++++|.+. ..+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 468999999999998888864 688999999842 345688999999999999999999999654 6899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| ++||+|
T Consensus 82 lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------~vkL~D 148 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITD 148 (337)
T ss_dssp EEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CEEECC
T ss_pred EEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-------CEEEee
Confidence 99999985 999999763 5699999999999999999999999999999999999999888 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+..
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~ 215 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE 215 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSS---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCC---------CCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHH
Confidence 99998643221 123456789999999999654 489999999999999999999999987543 33445
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
.+.... ..+|..++.++.+||.+||+.||.+|| ++.++++|-.
T Consensus 216 ~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 216 LILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 554443 446778899999999999999999999 8999987743
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.04 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=209.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCC--CCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEE--KKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~--~~~ 300 (683)
..+.+..++|++.+.||+|+++.|++ ..|+.||||++... ......|+.+|+.++|||||++++++.... ...
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 45777888999999999999877775 47899999999643 234567888999999999999999987643 345
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEeCCCCC
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK----------KIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------gIiHrDLKp~NILl~~~g~ 369 (683)
+|+||||++| +|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~- 168 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL- 168 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-
T ss_pred EEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-
Confidence 8999999975 99999986 4599999999999999999999999 999999999999998887
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
.+||+|||+++...............||+.|+|||++.+... ....++.++|||||||++|||++|+.||
T Consensus 169 ------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 169 ------TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN----FQRDAFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp ------CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC----CCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred ------eEEEccCCcccccccccCccccccCccCccccCHhhcccccc----cCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence 799999999987765443334445678999999999975310 0113667899999999999999999999
Q ss_pred CCCcc--------------chhHHHHHHHc-CCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 450 EDAHL--------------QGDKMSRNIRA-GERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 450 ~~~~~--------------~~~~~~~~i~~-~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+... ....+...+.. ...+..+. ..+..+.+||.+||+.||++|||+.++++.|+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 75422 11122222222 22222222 124569999999999999999999999999999876
Q ss_pred H
Q 038696 510 F 510 (683)
Q Consensus 510 ~ 510 (683)
.
T Consensus 319 ~ 319 (322)
T 3soc_A 319 L 319 (322)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=359.67 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=205.5
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCCC--CceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLSH--PNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~e~~ 298 (683)
+.+..++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+|..++| |||+++++++.+.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 81 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 81 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence 4567788999999999998888764 6789999998532 2567899999999986 9999999988654
Q ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 299 ~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..+||||||.+|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++. + .+|
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~-------~~k 147 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-------MLK 147 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-------EEE
T ss_pred CEEEEEEeCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C-------cEE
Confidence 78999999878899999986 256999999999999999999999999999999999999964 4 699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccc--ccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES--ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~--~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
|+|||+++...............||+.|+|||++.+...... .....++.++|||||||++|||++|+.||.......
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 999999987654433323345678999999999975211100 012458999999999999999999999998754433
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+...+.......++...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 34444454555566778888999999999999999999999999988654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.00 Aligned_cols=263 Identities=28% Similarity=0.470 Sum_probs=222.4
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEEc-----------CcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILWL-----------GESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~~-----------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
..+.+..++|.+.+.||+|+++.|++.. +..||||++... .+.+.+|+++++.+ +|||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 4567778899999999999988888642 247999999653 24578999999999 899999999
Q ss_pred eeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+++.. .+.+||||||++| +|.+++...... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 142 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 98854 4678999999975 999999874211 1124699999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++
T Consensus 220 ~NIll~~~~-------~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il 283 (382)
T 3tt0_A 220 RNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLL 283 (382)
T ss_dssp GGEEECTTC-------CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC---------CCCHHHHHHHHHHHH
T ss_pred ceEEEcCCC-------cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC---------CCCchhHHHHHHHHH
Confidence 999998887 7999999999876554333344456678899999999754 589999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
|||++ |..||.+... ..+...+..+.....+..++.++.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 284 ~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPV--EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHTTSCCSSTTCCH--HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99999 9999987653 456777888888888889999999999999999999999999999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=354.92 Aligned_cols=267 Identities=27% Similarity=0.431 Sum_probs=204.7
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCc---EEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGE---SFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~---~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
..+.+..++|++.+.||+|+++.|+.. ++. .||||++... .+.+.+|+++++.++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 345566779999999999998877763 232 7999998642 356889999999999999999999886
Q ss_pred cCCCC----eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 295 DEEKK----ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 295 ~e~~~----~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
..... .+++||||+.| +|.+++...........+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~- 174 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM- 174 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-
Confidence 54321 23999999985 9999998654333444799999999999999999999999999999999999998887
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 175 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 175 ------TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN---------LYTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp ------CEEECCCCC-----------------CCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------CEEEeeccccccccccccccccccccCcccccCchhhcCC---------CCCCccchhhHHHHHHHHHhCCCCC
Confidence 7999999999876544333333455677889999999765 48999999999999999999 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIM 512 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~ 512 (683)
|.+.... .+...+..+.....+..++..+.+|+.+||+.||.+|||+.++++.|+.+....+
T Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 240 YAGIENA--EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp TTTCCGG--GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccccChH--HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 9876533 4566677777777888899999999999999999999999999999999876443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.91 Aligned_cols=252 Identities=26% Similarity=0.455 Sum_probs=208.8
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+..++|++.+.||+|+++.|++. +|+ .||+|.+.. ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 45568999999999998877753 344 468888743 345789999999999999999999988653
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..++||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-------~~ 156 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVRE-----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-------HV 156 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHH-----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-------EE
T ss_pred -CeEEEEEecCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-------CE
Confidence 4788999997 599999986 245699999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+...
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 225 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-- 225 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccC---------CCCchhhhhhhHHHHHHHHhcCCCCccCCCH--
Confidence 99999999877654443344456678899999999765 48999999999999999999 9999987654
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+...+..+.....+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 226 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 34667777777777888899999999999999999999999999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=347.43 Aligned_cols=255 Identities=25% Similarity=0.452 Sum_probs=203.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
..+.+..++|++.+.||+|+++.|+.. .+..||||.+... .+.+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc
Confidence 345667789999999999998777652 2457999998642 3468899999999999999999988732
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
+.+|+||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------ 153 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQV-----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------ 153 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHH-----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------
T ss_pred ---CccEEEEecCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC------
Confidence 468999999985 99999986 235699999999999999999999999999999999999998877
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
.+||+|||+++....... .......+|+.|+|||++.+. .++.++||||||+++|||++ |..||.+..
T Consensus 154 -~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 154 -CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -EEEECC--------------------CCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred -CEEECccccccccCcccc-cccccCCCcccccChhhcccC---------CCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 799999999987654321 122344567889999999755 48999999999999999997 999998765
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.. .....+..+.....+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 223 ~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 223 NN--DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp GG--GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33 3556677777777888999999999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.31 Aligned_cols=253 Identities=24% Similarity=0.454 Sum_probs=213.2
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+.+..++|++.+.||+|+++.|++. .+..||||++.. ..+.+.+|+++++.++||||+++++++. +...+|+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~l 80 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIYI 80 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceEE
Confidence 3456779999999999998777753 566899999964 3456899999999999999999999884 4467999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~~l~Df 148 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH-----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-------CVKVSDF 148 (268)
T ss_dssp EEECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-------CEEECCT
T ss_pred EEEccCCCcHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-------CEEEccC
Confidence 9999974 899999863 24599999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~ 461 (683)
|++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||..... .....
T Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~ 216 (268)
T 3sxs_A 149 GMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFK---------YSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVL 216 (268)
T ss_dssp TCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSE---------EETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH
T ss_pred ccceecchhhh-hcccCCCcCcccCCHHHHhccC---------CchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHHH
Confidence 99987654321 1223455677899999997653 7889999999999999999 9999987553 34556
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.+..+.....+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 66777777778888999999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.47 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=214.5
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE--c-------CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW--L-------GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~--~-------g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
.+.+..++|++.+.||+|+++.|++. . ++.||||+++.. .+.+.+|+.+|+.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34556779999999999998777753 2 278999999653 346889999999999999999999885
Q ss_pred cCCCCeEEEEEecCCC-CHHHHHHHhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 038696 295 DEEKKECFLIMELMSR-DLCSYIKEICCPR------------------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHG 355 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 355 (683)
+ ...+||||||++| +|.+++....... ....+++.+++.++.||+.||.|||++||+||
T Consensus 121 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 121 V--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred c--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4 4678999999985 9999998632110 12579999999999999999999999999999
Q ss_pred CCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 356 DLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
||||+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++|||||
T Consensus 199 Dlkp~NIl~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~sl 262 (343)
T 1luf_A 199 DLATRNCLVGENM-------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTESDVWAY 262 (343)
T ss_dssp CCSGGGEEECGGG-------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---------CCCHHHHHHHH
T ss_pred CCCcceEEECCCC-------eEEEeecCCCcccccCccccccCCCcccceecChhhhccC---------CcCcccccHHH
Confidence 9999999998877 7999999999765433222233455678899999999755 48999999999
Q ss_pred HHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 436 GMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 436 Gvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
|+++|||++ |..||.+... ..+...+..+..+..+..++..+.+|+.+||+.||.+|||+.+++++|+.+.
T Consensus 263 G~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAH--EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHhcCCCcCCCCCh--HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 999999999 9999987653 3466677777777788899999999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.59 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=218.6
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..+.+..++|++.+.||+|+++.|+.. +++.||||++... .+.+.+|+.+|+.+ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456677789999999999998888764 3578999999643 35688999999999 89999999998
Q ss_pred EEcCCCCeEEEEEecCCC-CHHHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 293 FTDEEKKECFLIMELMSR-DLCSYIKEICCP------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+.+ .+..++||||++| +|.+++...... .....+++..+..++.||+.||.|||++||+||||||
T Consensus 96 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 96 CTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp ECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred Eec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 854 3678999999975 999999864211 1123589999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++
T Consensus 174 ~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il 237 (313)
T 1t46_A 174 RNILLTHGR-------ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGIFL 237 (313)
T ss_dssp GGEEEETTT-------EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHH
T ss_pred ceEEEcCCC-------CEEEccccccccccccccceeccCCCCcceeeChHHhcCC---------CCChHHHHHHHHHHH
Confidence 999998887 7999999999876554332233445678889999999755 489999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|+|++ |..||.+.... ......+..+.....+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 238 ~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 238 WELFSLGSSPYPGMPVD-SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHTTTCCSSTTCCSS-HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcccch-hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 99998 99999876543 34556666676777778889999999999999999999999999999988654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=365.35 Aligned_cols=248 Identities=21% Similarity=0.420 Sum_probs=205.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||+++++|.+. .
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 88 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--E 88 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 344569999999999998877764 678999999842 346788999999999999999999999754 6
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+| ++|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-------HVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEE
T ss_pred EEEEEEecCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-------CEE
Confidence 89999999975 99999975 35699999999999999999999999999999999999999888 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-hh
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-GD 457 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-~~ 457 (683)
|+|||+++..... .......||+.|+|||++.+. .+..|+.++|||||||++|||++|+.||...... ..
T Consensus 156 L~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~------~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~ 226 (384)
T 4fr4_A 156 ITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSR------KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226 (384)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCC------SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH
T ss_pred EeccceeeeccCC---CceeccCCCccccCCeeeccC------CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH
Confidence 9999999876433 233456789999999999643 1335889999999999999999999999754322 22
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-FSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-~~eil~~ 503 (683)
.+...+... ...+|..++..+.+||.+||+.||.+||+ +.++++|
T Consensus 227 ~~~~~~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 227 EIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 333333333 44577888999999999999999999998 7777654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.20 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=215.1
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.|.+..++|++.+.||+|+++.|+.. ++..||||++... .+.+.+|+++++.++||||+++++++.+ ...+|
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPIC 79 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeE
Confidence 45677789999999999998777753 6779999999653 4578999999999999999999998854 36789
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-------~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------VIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-------CEEECC
T ss_pred EEEeCCCCCcHHHHHhh-----CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-------CEEEcc
Confidence 99999975 99999986 235689999999999999999999999999999999999998777 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~ 460 (683)
||++....... ........+|+.|+|||++.+. .++.++||||||+++|+|++ |..||..... ....
T Consensus 148 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~ 215 (267)
T 3t9t_A 148 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV 215 (267)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH
T ss_pred ccccccccccc-ccccccccccccccChhhhcCC---------CccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHH
Confidence 99998654321 1122345567889999999755 48899999999999999999 9999987543 3455
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+..+.....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 216 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 216 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6677777777788889999999999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.02 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++.++ ..+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 58999999999998777764 6889999998532 25678999999999999999999998654 789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 80 ~e~~~~~l~~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-------~~kl~Dfg~ 147 (292)
T 3o0g_A 80 FEFCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-------ELKLANFGL 147 (292)
T ss_dssp EECCSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECCCTT
T ss_pred EecCCCCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------CEEEeeccc
Confidence 99999999888875 246699999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++...... .......||+.|+|||++.+. ..++.++|||||||++|||++|..||.........+.....
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTC--------SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCC--------CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 98764332 223445788999999999643 24799999999999999999988875443333222322222
Q ss_pred cCCC---------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 AGER---------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~~~~---------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.... .......+..+.+||.+||+.||++|||+.++++|-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 1000 011234678899999999999999999999998763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.70 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=211.5
Q ss_pred EeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.+..++|++.+.||+|+++.|+. ..|+.||||++... .+.+.+|+.+++.++||||+++++++.+.+...++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 34556999999999999877775 47899999999642 34688999999999999999999998765557889
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||++| +|.+++... ....+++..+..++.||+.||.|||++| |+||||||+|||++.++ .++|
T Consensus 86 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-------~~~l 154 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG----TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARI 154 (271)
T ss_dssp EEEECCTTCBHHHHHHSC----SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-------CEEE
T ss_pred eeecccCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-------ceeE
Confidence 99999985 999999852 3346999999999999999999999999 99999999999998887 6899
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++... ......+|+.|+|||++.+.. ...++.++||||||+++|||++|+.||.+.... ...
T Consensus 155 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~ 220 (271)
T 3kmu_A 155 SMADVKFSF-------QSPGRMYAPAWVAPEALQKKP------EDTNRRSADMWSFAVLLWELVTREVPFADLSNM-EIG 220 (271)
T ss_dssp EGGGSCCTT-------SCTTCBSCGGGSCHHHHHSCG------GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-HHH
T ss_pred Eeccceeee-------cccCccCCccccChhhhccCC------CCCCCchhhHHHHHHHHHHHHhCCCCccccChH-HHH
Confidence 988887543 223456789999999997653 123456899999999999999999999876533 233
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
......+..+..+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 4555667777788889999999999999999999999999999998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=355.86 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=209.8
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+..++|++.+.||+|+++.|++. +|+ +||+|.+.. ....+.+|+.++..++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---C
Confidence 34569999999999998777753 344 388888743 2456789999999999999999999874 2
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
...++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-------~~ 154 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ-----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-------QV 154 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS-----SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-------CE
T ss_pred CccEEEEEeCCCCCHHHHHHH-----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-------eE
Confidence 56899999998 599999975 235689999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 224 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG---------KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA- 224 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccC---------CCChhhHhHHhHHHHHHHHhCCCCCccccCHH-
Confidence 99999999887654443344456678889999999765 48999999999999999999 99999876543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.+...+..+.....+..++..+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 225 -EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -HHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -HHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 466777777777788888999999999999999999999999999998874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=358.87 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=201.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+ .+..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEE
Confidence 358999999999998888864 688999999843 23668999999999999999999998864 3789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 84 ~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------~~kl~Dfg 150 (323)
T 3tki_A 84 LEYCSGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-------NLKISDFG 150 (323)
T ss_dssp EECCTTEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------CEEECCCT
T ss_pred EEcCCCCcHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-------CEEEEEee
Confidence 999985 99988863 35699999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++...............||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..............
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 222 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSS--------BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCC--------CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 998764433333344567899999999997542 347799999999999999999999987654433333333
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...........++..+.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 3333222335578899999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=351.92 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=199.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------------------------------cchHHHHHHHH
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------------------------------IEPLVPEISSL 278 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------------------------------~~~~~~Ei~iL 278 (683)
..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3469999999999998877764 6889999998432 25688999999
Q ss_pred HcCCCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 038696 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357 (683)
Q Consensus 279 ~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDL 357 (683)
+.++||||+++++++.+.....+||||||++| +|.+++. ..++++..+..++.||+.||.|||++||+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 99999999999999976556789999999985 7766432 357999999999999999999999999999999
Q ss_pred CCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHH
Q 038696 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437 (683)
Q Consensus 358 Kp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGv 437 (683)
||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+.. ...++.++|||||||
T Consensus 164 kp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~Di~slG~ 228 (298)
T 2zv2_A 164 KPSNLLVGEDG-------HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETR------KIFSGKALDVWAMGV 228 (298)
T ss_dssp CGGGEEECTTS-------CEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTC------CCEESHHHHHHHHHH
T ss_pred CHHHEEECCCC-------CEEEecCCCccccccccc--cccCCcCCccccChhhhccCC------CCCCCchhhhHhHHH
Confidence 99999998887 799999999987653321 223457899999999996542 112478999999999
Q ss_pred HHHHHHhCCCCCCCCccchhHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 438 ICFEILTGKVPFEDAHLQGDKMSRNIRAGE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 438 il~ElltG~~Pf~~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
++|+|++|..||.+.... .+...+.... .......++..+.+||.+||+.||.+|||+.++++|-+
T Consensus 229 ~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 229 TLYCFVFGQCPFMDERIM--CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHCCCCCCCccHH--HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 999999999999875432 2334443332 22233567899999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=362.94 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=203.3
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~ 298 (683)
.+..++|++++.||+|+++.|++. +|+.||||+++. ..+.+..|+.+|..+ +|||||+++++|.++
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-- 125 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-- 125 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--
Confidence 344569999999999998888864 578999999853 245688999999887 899999999999654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++ ++
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-------~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------HI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CE
T ss_pred CEEEEEEEcCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-------CE
Confidence 789999999985 999999863 5699999999999999999999999999999999999999888 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc---
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--- 454 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--- 454 (683)
||+|||+|+...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.....
T Consensus 193 kL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~---------~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~ 261 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261 (396)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---
T ss_pred EEeecceeeecccCC--CccccccCCcccCCchhhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCcccccccc
Confidence 999999998643221 233456799999999999765 489999999999999999999999964321
Q ss_pred ----chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHHH
Q 038696 455 ----QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF------SSICRIL 504 (683)
Q Consensus 455 ----~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~------~eil~~L 504 (683)
....+...+... ...+|..++.++.+||++||+.||.+||++ .++++|-
T Consensus 262 ~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 262 PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ---CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred cchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 112344444443 445778899999999999999999999985 6666653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.47 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=203.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|.+.+.||+|+++.|++. +|+.||||++.. ....+.+|+.+|+.++||||+++++++.+. ..+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 58999999999998888863 688999999842 245788999999999999999999998654 78999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||++|+|.+++.+. ..+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 87 v~E~~~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------~~kl~DFG 153 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-------NVKIADFG 153 (336)
T ss_dssp EECCCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-------CEEECCSS
T ss_pred EEECCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-------CEEEEEec
Confidence 9999988999999763 5699999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+..... +...+
T Consensus 154 ~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i 220 (336)
T 3h4j_B 154 LSNIMTDGN---FLKTSCGSPNYAAPEVINGKL--------YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKV 220 (336)
T ss_dssp CTBTTTTSB---TTCCCTTSTTTSCGGGSCCSG--------GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--CBCCC
T ss_pred cceeccCCc---ccccccCCcCcCCHHHHcCCC--------CCCCccchhHHHHHHHHHHhCCCCCCCccHHH--HHHHH
Confidence 998765432 223456899999999997542 23789999999999999999999998754321 11112
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+ ...+|...+..+.+||.+||..||.+|||+.+++++-+.
T Consensus 221 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 221 NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 111 234567788999999999999999999999999988654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.38 Aligned_cols=262 Identities=17% Similarity=0.198 Sum_probs=207.2
Q ss_pred eeCCCeEEEeEecccccEEEEE----EcCcEEEEEEeCC--CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL----WLGESFALRHFFG--DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l----~~g~~vAvK~~~~--~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+..++|++.+.||+|+++.|++ .+|+.||||++.. ..+.+.+|+++++.| +||||+++++++.+. ...|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv 83 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMV 83 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEE
Confidence 3457999999999999766665 3688999999853 456799999999999 899999999988654 789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. .....+||+|||+
T Consensus 84 ~e~~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~--~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELLGPSLEDLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN--KTQQVIHIIDFAL 156 (330)
T ss_dssp EECCCCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG--TCTTSEEECCCTT
T ss_pred EEeCCCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC--CCCceEEEEEccc
Confidence 999977999999862 357999999999999999999999999999999999999988761 1222399999999
Q ss_pred ccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hH
Q 038696 385 SSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DK 458 (683)
Q Consensus 385 a~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~ 458 (683)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... ..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK---------EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCC---------CCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 9876443211 112456789999999999755 48999999999999999999999998754322 12
Q ss_pred HHHHHHcCCCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 038696 459 MSRNIRAGERP----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIM 512 (683)
Q Consensus 459 ~~~~i~~~~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~ 512 (683)
....+.....+ .....+| ++.+++..||+.||.+||++.+|.+.|+.+.....
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 228 RYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 22222211111 1123356 89999999999999999999999999998776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=342.87 Aligned_cols=262 Identities=13% Similarity=0.150 Sum_probs=210.4
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
+..++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|++++..+ +|+||+++++++.+ ....|+|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEE
Confidence 34669999999999998777753 688999999853 456789999999999 79999999988854 3789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++|+|.+++... ..++++..+..++.||+.||.|||++||+||||||+|||++.++. .....+||+|||+
T Consensus 85 ~e~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS--KNANMIYVVDFGM 157 (298)
T ss_dssp EECCCCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS--TTTTCEEECCCTT
T ss_pred EEecCCCHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC--CCCCeEEEEECcc
Confidence 999977999999862 346999999999999999999999999999999999999987761 2233599999999
Q ss_pred ccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-hhH
Q 038696 385 SSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-GDK 458 (683)
Q Consensus 385 a~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-~~~ 458 (683)
++........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCC---------CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 9876543221 123456789999999999754 4899999999999999999999999875422 112
Q ss_pred HHHHHHc----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 459 MSRNIRA----GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 459 ~~~~i~~----~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
....+.. ...+.....++..+.+|+.+||+.||.+|||+.+|++.|+.+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 229 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 2222211 1112233467899999999999999999999999999999887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.53 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=204.6
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCC--CCceeeeeeeEEcCC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLS--HPNIMHFLCGFTDEE 297 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~e~ 297 (683)
.+.+...+|++++.||+|+++.|++. .|+.||||++... .+.+.+|+.+|..|+ ||||+++++++..+
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~- 128 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD- 128 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-
Confidence 35556668999999999998888764 5789999998532 356889999999996 59999999988654
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|||||+.+|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++. + .+
T Consensus 129 -~~~~lv~E~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~-------~~ 193 (390)
T 2zmd_A 129 -QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-------ML 193 (390)
T ss_dssp -SEEEEEEECCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S-------CE
T ss_pred -CEEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C-------eE
Confidence 679999997778999999862 46899999999999999999999999999999999999964 4 69
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccc--ccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES--ASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~--~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
||+|||+++...............||+.|+|||++.+...... .....++.++|||||||++|||++|+.||......
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 9999999987654333223345679999999999975311000 01235899999999999999999999999875433
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+...+.......++...+..+.+||.+||..||.+|||+.+++++.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 333444444444555677778999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=357.03 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=216.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..+.+..++|++.+.||+|+++.|+.. ++..||||++.. ..+.+.+|+.+|..+ +||||++++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356677889999999999998777753 345799999863 345789999999999 89999999998
Q ss_pred EEcCCCCeEEEEEecCCC-CHHHHHHHhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 038696 293 FTDEEKKECFLIMELMSR-DLCSYIKEICCP-----------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYH 354 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiH 354 (683)
+.. .+.+||||||++| +|.+++...... .....+++..+..++.||+.||.|||++||+|
T Consensus 118 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 118 CTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred Eee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 854 3678999999975 999999863210 00134899999999999999999999999999
Q ss_pred CCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHh
Q 038696 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434 (683)
Q Consensus 355 rDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwS 434 (683)
|||||+|||++.++ .+||+|||++................+|+.|+|||++.+. .++.++||||
T Consensus 196 ~Dikp~NIll~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~s 259 (344)
T 1rjb_A 196 RDLAARNVLVTHGK-------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---------IYTIKSDVWS 259 (344)
T ss_dssp TTCSGGGEEEETTT-------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHH
T ss_pred CCCChhhEEEcCCC-------cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC---------CCChhHhHHH
Confidence 99999999998887 8999999999876544332233445678889999999755 4899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 435 FGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 435 lGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
|||++|+|++ |..||.+.... ..+...+..+..+..+..++..+.+|+.+||..||.+|||+.+++++|+.+.
T Consensus 260 lG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 260 YGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCcccCCcH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999999998 99999876543 3455666677777778889999999999999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.21 Aligned_cols=245 Identities=26% Similarity=0.348 Sum_probs=196.9
Q ss_pred CCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.+ ...+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEEE
Confidence 568999999999997777653 6889999998532 2467899999999999999999999854 4789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 98 ~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-------~~kl~Dfg~ 165 (311)
T 3niz_A 98 FEFMEKDLKKVLDE-----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-------ALKLADFGL 165 (311)
T ss_dssp EECCSEEHHHHHHT-----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECCCTT
T ss_pred EcCCCCCHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-------CEEEccCcC
Confidence 99999999999875 345699999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+.....
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~ 234 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGS--------KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFS 234 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTC--------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHH
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCC--------CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 987643321 22345678999999999643 258999999999999999999999998765432 2222111
Q ss_pred c-CCCC--C-------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-GERP--L-------------------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~~~~--~-------------------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. +... . .....++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 1100 0 112356789999999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.71 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++||||++++++|.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 358999999999998888764 6889999998531 2468899999999999999999999864 37
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+||||||++ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .....+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~---~~~~~vk 159 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN---IPIPHIK 159 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT------CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT---SSSCCEE
T ss_pred EEEEEEEcCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC---CCccCEE
Confidence 8999999997 599999964 35699999999999999999999999999999999999998765 2223699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..
T Consensus 160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~ 225 (361)
T 2yab_A 160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTK--QE 225 (361)
T ss_dssp ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HH
T ss_pred EEecCCceEcCCCC---ccccCCCCccEECchHHcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH
Confidence 99999998765432 22345789999999999754 489999999999999999999999987653 33
Q ss_pred HHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 459 MSRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+..+.... +....+..+.+||.+||..||.+|||+.++++|
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 455555543321 124578889999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.37 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=218.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..|.+..++|++.+.||+|+++.|+.. +|..||||++... .+.+.+|+++++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPP 83 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCC
Confidence 456777889999999999997666653 4789999999654 3568899999999999999999998854 467
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~~l 152 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------LVKV 152 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC----CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-------CEEE
T ss_pred EEEEEEcCCCCcHHHHHHhc----ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-------CEEE
Confidence 999999998 5999999863 345699999999999999999999999999999999999998777 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
+|||++....... ........+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.... .
T Consensus 153 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~ 220 (288)
T 3kfa_A 153 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q 220 (288)
T ss_dssp CCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ccCccceeccCCc-cccccCCccccCcCChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 9999998765332 1223345567889999999765 48999999999999999999 99999876543 4
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+...+........+..++..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 566677777777888899999999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=367.71 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=205.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+.+..++|++++.||+|+++.|++. +|+.||||++. ...+.+.+|+.+|..++|||||+++++|.++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 141 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-- 141 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence 3445679999999999998888864 58899999984 2456688999999999999999999999654
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-------~i 207 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------HL 207 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CE
T ss_pred CEEEEEEeCCCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-------CE
Confidence 789999999975 99999975 3589999999999999999999999999999999999999888 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+|+....... .......||+.|+|||++.+.. ....|+.++|||||||++|||++|+.||.+.+..
T Consensus 208 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-----~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-- 279 (410)
T 3v8s_A 208 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQG-----GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-- 279 (410)
T ss_dssp EECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTT-----TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--
T ss_pred EEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccC-----CCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--
Confidence 9999999987643321 1223567999999999997652 1223788999999999999999999999876532
Q ss_pred HHHHHHHcC---CCCCCCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 038696 458 KMSRNIRAG---ERPLFPFHSPKYVTNLTKRCWHADPNQ--RPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~---~~~~~p~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~L~ 505 (683)
.....+..+ ...+....++.++.+||.+||..+|.+ ||++.+|++|.+
T Consensus 280 ~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 280 GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 334444332 122223467899999999999988988 999999988754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.32 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=195.7
Q ss_pred CCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++.+. +.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEEE
Confidence 58999999999998777764 5889999998532 35678999999999999999999998654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~kl~Dfg~~ 147 (288)
T 1ob3_A 80 EHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-------ELKIADFGLA 147 (288)
T ss_dssp ECCSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEECCTTHH
T ss_pred EecCCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------CEEEeECccc
Confidence 9999999999975 335699999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......+|+.|+|||++.+. ..++.++|||||||++|||++|..||.+..... .+......
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 216 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGS--------KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRI 216 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTC--------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred cccCcccc--ccccccccccccCchheeCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 87643211 22344678999999999643 248999999999999999999999998765322 22222211
Q ss_pred -CCC---------------C-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 466 -GER---------------P-----------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 466 -~~~---------------~-----------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.. + .+....+..+.+||.+||+.||++|||+.++++|-
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 100 0 01234678899999999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.99 Aligned_cols=259 Identities=28% Similarity=0.512 Sum_probs=208.5
Q ss_pred CCcccceeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 223 GKLLPSRILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 223 ~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
..+....|.+..++|++.+.||+|+++.|++ ..|+.||||++.. ..+.+.+|+++++.++||||+++++++.. ..
T Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 87 (278)
T 1byg_A 9 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EK 87 (278)
T ss_dssp ------CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC-C-
T ss_pred hhhhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CC
Confidence 3444566777788999999999999777775 4789999999965 35678999999999999999999988654 33
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||||++| +|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~ 156 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-------VA 156 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-------CE
T ss_pred CceEEEEecCCCCCHHHHHHhc----ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-------cE
Confidence 568999999986 999999863 122488999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||++...... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......
T Consensus 157 ~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~- 221 (278)
T 1byg_A 157 KVSDFGLTKEASST-----QDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK- 221 (278)
T ss_dssp EECCCCC-----------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-
T ss_pred EEeecccccccccc-----ccCCCccccccCHHHhCCC---------CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999998765432 1233567789999999755 48999999999999999998 99999876543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+...+..+.....+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 222 -DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 3556677777777888899999999999999999999999999999998865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.67 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=188.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||+++++++.+ .+.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEE
Confidence 458999999999998777764 588999999853 23568899999999999999999999854 4789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||++|+|.+++...........+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-------~~kl~Dfg~ 154 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-------QLKLGDFGL 154 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECCCSS
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-------CEEECcCcc
Confidence 9999999999998754333445699999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
++....... ......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..... .+...+.
T Consensus 155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~ 223 (317)
T 2pmi_A 155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGS--------RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFD 223 (317)
T ss_dssp CEETTSCCC--CCCCCCSCCTTCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred ceecCCCcc--cCCCCcccccccCchHhhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 987643221 22345688999999999643 248999999999999999999999998765321 1211111
Q ss_pred c-CCC-------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 465 A-GER-------------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 465 ~-~~~-------------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
. +.. +..+...+..+.+||.+||+.||.+|||+.++++|-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp HHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred HhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 1 100 001224678899999999999999999999998763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=350.58 Aligned_cols=240 Identities=30% Similarity=0.427 Sum_probs=204.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.+. ..+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEEE
Confidence 358999999999998888863 689999999842 345678999999999999999999999654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| ++||+|
T Consensus 83 lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------~~kL~D 149 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-------HIKITD 149 (318)
T ss_dssp EEECCCCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-------CEEECC
T ss_pred EEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-------CEEEee
Confidence 99999985 999999863 5699999999999999999999999999999999999999888 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+. .....
T Consensus 150 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~ 213 (318)
T 1fot_A 150 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYE 213 (318)
T ss_dssp CSSCEECSS-----CBCCCCSCTTTCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH
T ss_pred cCcceecCC-----ccccccCCccccCHhHhcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 999987543 22345789999999999754 488999999999999999999999987553 23444
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
.+..+. ..+|...+.++.+||.+||..||.+|| ++.++++|-+
T Consensus 214 ~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 214 KILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 454443 346778899999999999999999999 8888887643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.80 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=207.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
.++|++.+.||+|+++.|++. +|+.||||++........+|+++|..+ +||||+++++++.+ ...+||||||+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 98 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTELM 98 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeCC
Confidence 347999999999998888763 588999999977666778899999888 79999999999864 47899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+..++ +....+||+|||+++.
T Consensus 99 ~gg~L~~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~---~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 99 KGGELLDKILR------QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES---GNPESIRICDFGFAKQ 169 (342)
T ss_dssp CSCBHHHHHHT------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS---CSGGGEEECCCTTCEE
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC---CCcCeEEEEECCCccc
Confidence 75 99999975 35699999999999999999999999999999999999986543 2223699999999987
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc-cchhHHHHHHHcC
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH-LQGDKMSRNIRAG 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~-~~~~~~~~~i~~~ 466 (683)
...... ......||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.. .....+...+..+
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQG---------YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHH---------HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCC---------CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence 644321 233457899999999998663 7889999999999999999999998643 2234455666655
Q ss_pred CCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 467 ERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 467 ~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.... ....++..+.+||.+||..||.+|||+.++++|-+..
T Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 4432 2246789999999999999999999999999886653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.27 Aligned_cols=246 Identities=30% Similarity=0.478 Sum_probs=204.7
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~ 297 (683)
..+..++|++.+.||+|+++.|++. +|+.||||+++. ..+.+..|.++|..+ +||||++++++|.+.
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~- 90 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK- 90 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-
Confidence 3455679999999999998888864 588999999853 345678899999876 899999999999654
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..+||||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| +
T Consensus 91 -~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------~ 156 (345)
T 1xjd_A 91 -ENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------H 156 (345)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------C
T ss_pred -CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-------C
Confidence 78999999997 5999999863 4699999999999999999999999999999999999999888 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.
T Consensus 157 vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~-- 223 (345)
T 1xjd_A 157 IKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-- 223 (345)
T ss_dssp EEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCC---------CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999998643321 123456789999999999755 489999999999999999999999987653
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS-SICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~-eil~~L 504 (683)
..+...+..+. +.+|...+.++.+||.+||..||.+||++. ++++|-
T Consensus 224 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 224 EELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp HHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred HHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 34555555543 456778899999999999999999999997 776653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.74 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=205.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||+++++++.+. ..+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEE
Confidence 458999999999998888764 688999999842 345788999999999999999999998654 7899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|
T Consensus 118 lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------~~kL~D 184 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-------YIQVTD 184 (350)
T ss_dssp EEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECC
T ss_pred EEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-------CEEEcc
Confidence 9999997 5999999864 4699999999999999999999999999999999999999887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+..
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~ 248 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYE 248 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCC---------CCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHH
Confidence 9999876432 2345789999999999754 488999999999999999999999987543 34555
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
.+..+. ..+|..++..+.+||.+||+.||.+||+ +.+|++|-
T Consensus 249 ~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 249 KIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 665553 4567788999999999999999999998 88887764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.63 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=207.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE---E----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL---W----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l---~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
..+.+..++|.+.+.||+|+++.|+. . ++..||||.+... .+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 44566677999999999998766664 2 3448999998632 245889999999999999999999887
Q ss_pred cCCCC---eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 295 DEEKK---ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 295 ~e~~~---~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
+.... .+|+||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-- 184 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-- 184 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--
Confidence 54322 46999999985 9999997543333456799999999999999999999999999999999999998887
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPF 449 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf 449 (683)
.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|+|++ |..||
T Consensus 185 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~ 250 (313)
T 3brb_A 185 -----TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRGMTPY 250 (313)
T ss_dssp -----CEEECSCSCC----------------CCGGGSCHHHHHSS---------CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred -----cEEEeecCcceecccccccCcccccCCCccccCchhhcCC---------CccchhhhHHHHHHHHHHHhcCCCCC
Confidence 7999999999876543322233345567889999999754 48999999999999999999 99999
Q ss_pred CCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+.... .+...+..+..+..+..++..+.+++.+||..||.+|||+.+++++|+.+..
T Consensus 251 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 251 PGVQNH--EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TTCCGG--GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHH--HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 876533 4556677777777888899999999999999999999999999999998765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.56 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=191.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++... ...+.+|+.+|+.+. ||||+++++++..++...+||
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 58999999999997777753 6889999998532 345779999999997 999999999998766678999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||||+|+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 89 v~e~~~~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-------~~kl~DFG 154 (388)
T 3oz6_A 89 VFDYMETDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-------HVKVADFG 154 (388)
T ss_dssp EEECCSEEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECCCT
T ss_pred EecccCcCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-------CEEecCCc
Confidence 999999999999986 4689999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCC-------------------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh
Q 038696 384 LSSVKNFGPK-------------------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444 (683)
Q Consensus 384 la~~~~~~~~-------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt 444 (683)
+|+....... ........||+.|+|||++.+. ..|+.++|||||||++|||++
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~ 226 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--------TKYTKGIDMWSLGCILGEILC 226 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--------CCCCChhhHHHHHHHHHHHHh
Confidence 9986543111 1122345789999999999742 358999999999999999999
Q ss_pred CCCCCCCCccchhHHHHHHHcCCCC---------------------------------------------CCCCCCcHHH
Q 038696 445 GKVPFEDAHLQGDKMSRNIRAGERP---------------------------------------------LFPFHSPKYV 479 (683)
Q Consensus 445 G~~Pf~~~~~~~~~~~~~i~~~~~~---------------------------------------------~~p~~~~~~l 479 (683)
|+.||.+..... .+...+.....+ ..+..+++++
T Consensus 227 g~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (388)
T 3oz6_A 227 GKPIFPGSSTMN-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305 (388)
T ss_dssp SSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred CCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence 999998765321 122211110000 0112567889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 480 TNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 480 ~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+||.+||..||.+|||+.++++|-
T Consensus 306 ~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 306 LDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred HHHHHHhhccCcccCCCHHHHhCCH
Confidence 9999999999999999999998873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.71 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=218.4
Q ss_pred CCcccceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceee
Q 038696 223 GKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMH 288 (683)
Q Consensus 223 ~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~ 288 (683)
..+.+..+.+..++|++.+.||+|+++.|+.. .+..||||.+... ...+.+|+++|+.++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34566788888899999999999997777652 4678999999643 235789999999999999999
Q ss_pred eeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 038696 289 FLCGFTDEEKKECFLIMELMSR-DLCSYIKEICC----PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNIL 363 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NIL 363 (683)
+++++.+ ...+|+||||++| +|.+++..... ......+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 93 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 93 LLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eEEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 9998854 4678999999985 99999975321 111246799999999999999999999999999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 171 i~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 234 (322)
T 1p4o_A 171 VAEDF-------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIA 234 (322)
T ss_dssp ECTTC-------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHH
T ss_pred EcCCC-------eEEECcCccccccccccccccccCCCCCCCccChhhhccC---------CCCchhhHHHHHHHHHHHH
Confidence 98887 7999999999865433222222344568889999999755 4899999999999999999
Q ss_pred h-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 444 t-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+ |..||.+... ..+...+..+.....+..++..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 235 ~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 235 TLAEQPYQGLSN--EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hcCCCccccCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 9 8999987543 345566667766777888999999999999999999999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.41 Aligned_cols=252 Identities=29% Similarity=0.457 Sum_probs=197.5
Q ss_pred eeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC--------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG--------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
+..++|++.+.||+|+++.|+. ..|+.||||++.. ..+.+.+|+++++.++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCce
Confidence 4567999999999999877775 4789999999853 23568899999999999999999998854 3678
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEeCCCCCC-CCCcce
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK---IYHGNLNPSNILLKPRGAS-TEGYLH 376 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IiHrDLKp~NILl~~~g~~-~~~~~~ 376 (683)
|+||||++| +|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.+... ......
T Consensus 82 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEEEcCCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 999999975 89888853 46999999999999999999999999 8999999999999863210 001237
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+....
T Consensus 155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 220 (271)
T 3dtc_A 155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRAS---------MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL- 220 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHC---------CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-
T ss_pred eEEccCCccccccccc----ccCCCCccceeCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999999998654322 2245688999999999765 4899999999999999999999999876532
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...............+..++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 221 AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 22233334444556778889999999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.34 Aligned_cols=266 Identities=26% Similarity=0.449 Sum_probs=218.7
Q ss_pred ccceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 226 LPSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 226 ~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
....+.+..++|++.+.||+|+++.|++. +++.||||++... .+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 33566777889999999999998887764 3478999999653 24578999999999 699999999
Q ss_pred eeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR----------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+++... ...+|+||||++| +|.+++....... ....+++..+..++.||+.||.|||++||+||||||
T Consensus 98 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 98 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 988643 3568999999985 9999998632100 022389999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++
T Consensus 177 ~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il 240 (316)
T 2xir_A 177 RNILLSEKN-------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLL 240 (316)
T ss_dssp GGEEECGGG-------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHH
T ss_pred ceEEECCCC-------CEEECCCccccccccCccceeccCCCcceeecCchhhccc---------cccchhHHHHHHHHH
Confidence 999998777 7999999999876543332233445678889999999765 489999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|+|++ |..||.+.... ..+...+..+.....+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 241 ~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 241 WEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHTTSCCSSTTCCCS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCcccchh-HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99998 99999876544 34556666777777788889999999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.47 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.++ +.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 358999999999998888763 688999999841 346789999999999999999999998654 78
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|||||||+ |+|.+++.+... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~----~~~~vkl 174 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE----NSAPVKL 174 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS----TTCCEEE
T ss_pred EEEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC----CCCcEEE
Confidence 999999998 499988875321 234589999999999999999999999999999999999998664 1225999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+
T Consensus 175 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~ 240 (351)
T 3c0i_A 175 GGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE---------PYGKPVDVWGCGVILFILLSGCLPFYGTK---ERL 240 (351)
T ss_dssp CCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHH
T ss_pred ecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC---------CCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHH
Confidence 99999987654321 23345789999999999754 48899999999999999999999998743 334
Q ss_pred HHHHHcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 460 ~~~i~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+..+.....+ ..++..+.+||.+||..||.+|||+.++++|-+.
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 4555554433222 4578899999999999999999999999987554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.97 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=216.9
Q ss_pred eEeeCCCeEEEe-EecccccEEEEEE------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRR-RLGSGSQYKEILW------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~-~LG~G~~~~v~l~------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+.+..++|.+.. .||+|+++.|+.. .+..||||++... .+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence 455667898887 9999998777753 5778999999652 3467899999999999999999998843
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+|+||||++| +|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~ 148 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-------Y 148 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTT-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-------E
T ss_pred -CCcEEEEEeCCCCCHHHHHHh-----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-------C
Confidence 458999999985 99999864 345699999999999999999999999999999999999998877 8
Q ss_pred EEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCcc
Q 038696 377 AKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~ 454 (683)
+||+|||++........ ........+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 149 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred EEECcccceeeeccCcceeeccccccccccccCHHHhccC---------CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999987643322 1122344568889999999765 38899999999999999998 9999987653
Q ss_pred chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhc
Q 038696 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMM 513 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~~ 513 (683)
..+...+..+.++.++..++..+.++|.+||+.||.+||++.+++++|+.+......
T Consensus 220 --~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 220 --PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 346667777877888889999999999999999999999999999999998765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.76 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=203.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++++.||+|+++.|++. +|+.||||++.. ..+.+..|.++|..+ +||||++++++|.+. .
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 34569999999999998888864 577899999852 345678999999988 799999999999654 7
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+||||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| ++|
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------~vk 161 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------HIK 161 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CEE
T ss_pred EEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-------cEE
Confidence 89999999975 999999863 4699999999999999999999999999999999999999888 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..
T Consensus 162 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~ 228 (353)
T 2i0e_A 162 IADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DE 228 (353)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTC---------CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH
T ss_pred EEeCCcccccccCC--cccccccCCccccChhhhcCC---------CcCCcccccchHHHHHHHHcCCCCCCCCCH--HH
Confidence 99999998643221 133456789999999999754 489999999999999999999999987553 34
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
+...+..+. ..+|..++.++.+||.+||..||.+||+ +.++++|-
T Consensus 229 ~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 229 LFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 555555543 4467788999999999999999999995 57777653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=350.08 Aligned_cols=265 Identities=27% Similarity=0.466 Sum_probs=218.5
Q ss_pred ccceeEeeCCCeEEEeEecccccEEEEEE-----------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceee
Q 038696 226 LPSRILIKSEDYQVRRRLGSGSQYKEILW-----------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMH 288 (683)
Q Consensus 226 ~~~~~~~~~~~y~i~~~LG~G~~~~v~l~-----------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~ 288 (683)
....|.+..++|++.+.||+|+++.|++. ++..||||++... .+.+.+|+++|+.+ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 33556777889999999999998777753 3568999999653 34578999999999 8999999
Q ss_pred eeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 038696 289 FLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPR----------KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNL 357 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDL 357 (683)
+++++.+ .+.+|+||||++| +|.+++....... ....+++..++.++.||+.||.|||++||+||||
T Consensus 106 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 106 LLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp EEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 9998854 4678999999975 9999998642110 1234899999999999999999999999999999
Q ss_pred CCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHH
Q 038696 358 NPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGM 437 (683)
Q Consensus 358 Kp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGv 437 (683)
||+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++||||||+
T Consensus 184 kp~NIll~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~ 247 (334)
T 2pvf_A 184 AARNVLVTENN-------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGV 247 (334)
T ss_dssp SGGGEEECTTC-------CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC---------EECHHHHHHHHHH
T ss_pred ccceEEEcCCC-------CEEEccccccccccccccccccCCCCcccceeChHHhcCC---------CcChHHHHHHHHH
Confidence 99999998887 7999999999876543322233445677889999999765 3889999999999
Q ss_pred HHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 438 ICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 438 il~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
++|||++ |..||.+... ..+...+..+.....+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 248 il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 248 LMWEIFTLGGSPYPGIPV--EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHTTSCCSSTTCCH--HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcCcCCH--HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999 9999987653 346667777777778888999999999999999999999999999999988654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.95 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=197.6
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..+.+..++|++.++||+|+++.|+.. .+..||||+++.. .+.+.+|+.+|+.++||||+++++++. ...
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCc
Confidence 456777889999999999998888863 5667999998632 356889999999999999999988552 256
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+++||||+.| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-------~~kl 161 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-------TVKI 161 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT-----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-------EEEE
T ss_pred cEEEEEecCCCcHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-------CEEE
Confidence 8999999985 99999864 345699999999999999999999999999999999999998887 8999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...............||+.|+|||++... .+..++.++||||||+++|+|++|+.||.+.... ..+
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~ 234 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ------DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQI 234 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHH
T ss_pred ccceeccccccccccccccccCCCccccCchhhccc------CCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHH
Confidence 999999865433222333455689999999999633 1335889999999999999999999999876543 334
Q ss_pred HHHHHcCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 460 SRNIRAGERPL----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 460 ~~~i~~~~~~~----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
...+..+.... ....++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp HHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 44444443222 3346789999999999999999999999999998875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.46 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=204.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
+.|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.++ ..+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 36999999999998888753 6889999998532 24578999999999999999999998654 68999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||+.|+|.+++... ..++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 132 v~e~~~g~l~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~kL~DfG 199 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDFG 199 (348)
T ss_dssp EEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-------EEEECCCT
T ss_pred EEecCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-------CEEEeecc
Confidence 9999999999988753 35699999999999999999999999999999999999999887 89999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++.... .....||+.|+|||++.+. ....++.++|||||||++|||++|+.||.+.... ..+....
T Consensus 200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~ 266 (348)
T 1u5q_A 200 SASIMAP------ANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA 266 (348)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHHTT------SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHH
T ss_pred CceecCC------CCcccCCcceeCHhhhccc------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 9976542 2345689999999999642 1335889999999999999999999999876532 2233333
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
........+..++..+.+||.+||+.||.+|||+.+++++.+.
T Consensus 267 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 267 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 3343444456789999999999999999999999999988654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.72 Aligned_cols=254 Identities=18% Similarity=0.275 Sum_probs=205.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|+++++||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|..++||||++++++|.+. .
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--N 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--C
Confidence 345679999999999998888864 578999999842 345689999999999999999999999654 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||||||. |+|.+++.+ ....+++..+..++.||+.||.|||++||+||||||+||||+.++ ++|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~-----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-------~vk 215 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK-----FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-------HIR 215 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEE
T ss_pred EEEEEEecCCCCcHHHHHHH-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-------CEE
Confidence 8999999997 599999985 235699999999999999999999999999999999999999888 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+|+....... .......||+.|+|||++..... +...|+.++|||||||++|||++|+.||.+.+.. .
T Consensus 216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~----~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~ 288 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEG----GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--E 288 (437)
T ss_dssp ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHT----SCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H
T ss_pred EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhccc----CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--H
Confidence 999999976643321 12234579999999999974310 1235899999999999999999999999876533 2
Q ss_pred HHHHHHc----CCCCCCCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 038696 459 MSRNIRA----GERPLFPFHSPKYVTNLTKRCWHADPNQ--RPSFSSICRILR 505 (683)
Q Consensus 459 ~~~~i~~----~~~~~~p~~~~~~l~~Li~~cL~~dP~~--RPt~~eil~~L~ 505 (683)
....+.. ...+.....+++++.+||++||..+|++ |+++.++++|-+
T Consensus 289 ~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 289 TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 3333322 2223333457899999999999888888 999999987743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.68 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=212.2
Q ss_pred cccceeEeeCCCeEEEe-EecccccEEEEEE------cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeee
Q 038696 225 LLPSRILIKSEDYQVRR-RLGSGSQYKEILW------LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLC 291 (683)
Q Consensus 225 ~~~~~~~~~~~~y~i~~-~LG~G~~~~v~l~------~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~ 291 (683)
+.+..+.+..++|.+.+ .||+|+++.|+.. .++.||||++... .+.+.+|+++++.++||||+++++
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34556677778999998 9999998777753 3678999999642 356889999999999999999999
Q ss_pred eEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
++.. ..+|+||||+.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 86 ~~~~---~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-- 154 (291)
T 1xbb_A 86 ICEA---ESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-- 154 (291)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--
T ss_pred EECC---CCcEEEEEeCCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--
Confidence 8832 568999999984 999999862 4599999999999999999999999999999999999998887
Q ss_pred CCCcceEEEecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||++......... .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..|
T Consensus 155 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 155 -----YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK---------FSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp -----EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE---------EEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred -----cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC---------CChhhhHHHHHHHHHHHHhcCCCC
Confidence 7999999999876443211 1122344678899999997653 7889999999999999999 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|.+... ..+...+..+..+..+..++..+.++|.+||+.||.+|||+.++++.|+.+-.
T Consensus 221 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 221 YRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp STTCCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 987553 44667777787788888999999999999999999999999999999988754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.57 Aligned_cols=257 Identities=25% Similarity=0.468 Sum_probs=215.6
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
...|.+..++|++.+.||+|+++.|+.. .+..||||.+.. ..+.+.+|+++|+.++||||+++++++.+ +.
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 81 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CC
Confidence 3457777889999999999998777753 467899999964 34678999999999999999999988743 45
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~kl 150 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-------SCKI 150 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------CEEE
T ss_pred cEEEEecCCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-------CEEE
Confidence 899999997 5999998642 113689999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
+|||++........ .......+++.|+|||++.+. .++.++||||||+++|||++ |+.||.+... ..
T Consensus 151 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 218 (279)
T 1qpc_A 151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PE 218 (279)
T ss_dssp CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH
T ss_pred CCCcccccccCccc-ccccCCCCccCccChhhhccC---------CCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HH
Confidence 99999987654321 122344567889999999755 38899999999999999999 9999987543 34
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+...+..+.....+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 566677777777888899999999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.24 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=204.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+..++|++++.||+|+++.|++. +|+ +||+|.+.. ..+.+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 45679999999999998888763 444 367777743 345789999999999999999999988653
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-------~~ 156 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-------HV 156 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-------EE
T ss_pred -CceEEEEecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-------CE
Confidence 3788999997 5999999862 45699999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+....
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~~g~~p~~~~~~~- 226 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS- 226 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCC---------CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-
Confidence 99999999876544433344456678889999999765 48999999999999999999 99999876543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.+...+..+.....+..++.++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 227 -EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 466777777777788889999999999999999999999999999998875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.20 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=197.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++.+.||+|+++.|++. +|..||||.+... .+.+.+|+.+++.++||||+++++++.+ .+.+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 458999999999998888864 6889999998421 3467899999999999999999998854 47899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... .++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 88 lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-------~~kl~D 154 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-------TLKIFD 154 (294)
T ss_dssp EEEECCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEECC
T ss_pred EEEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-------CEEEEe
Confidence 99999985 999999863 5699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+..... ....
T Consensus 155 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~ 223 (294)
T 4eqm_A 155 FGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGE---------ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-IAIK 223 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-HHHH
T ss_pred CCCcccccccc-ccccCccccCccccCHhHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHH
Confidence 99998764332 1223345689999999999755 47889999999999999999999998765332 2222
Q ss_pred HHHcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHH
Q 038696 462 NIRAGERP---LFPFHSPKYVTNLTKRCWHADPNQRP-SFSSICRILRYI 507 (683)
Q Consensus 462 ~i~~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RP-t~~eil~~L~~i 507 (683)
.+...... ..+..++..+.++|.+||+.||.+|| ++.++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 23222211 13456789999999999999999998 888888777653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.92 Aligned_cols=253 Identities=27% Similarity=0.441 Sum_probs=210.0
Q ss_pred CCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 457999999999998888763 578999999863 2367899999999999999999999998765577
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++| +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~kl 167 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-------QVKI 167 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-------EEEE
T ss_pred EEEEEEeCCCCcHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-------CEEE
Confidence 9999999975 999999753 35699999999999999999999999999999999999998887 8999
Q ss_pred ecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc-----
Q 038696 380 SGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH----- 453 (683)
Q Consensus 380 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~----- 453 (683)
+|||++......... .......+|..|+|||++.+.. ++.++||||||+++|+|++|..|+....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 238 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK---------FYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE---------EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCCC---------CCcchhHHHHHHHHHHHHHccCCCcchhhHHhh
Confidence 999999876543221 2233456788899999997653 7889999999999999999998864321
Q ss_pred --------cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 454 --------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 454 --------~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.....+...+..+.....+..++..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 112334456667777778889999999999999999999999999999998875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.82 Aligned_cols=247 Identities=22% Similarity=0.258 Sum_probs=203.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.++|++.+.||+|+++.|++. +|+.||+|.+... .+.+.+|+.+|+.++||||+++++++.+. ..+|+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM--EELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEEEEE
Confidence 468999999999998888864 5889999998643 34578999999999999999999999654 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++
T Consensus 82 ~~~g~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-----~~~~kl~Dfg~a 151 (321)
T 1tki_A 82 FISGLDIFERINT-----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-----SSTIKIIEFGQA 151 (321)
T ss_dssp CCCCCBHHHHHTS-----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-----CCCEEECCCTTC
T ss_pred eCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-----CCCEEEEECCCC
Confidence 9985 99999964 335699999999999999999999999999999999999998631 117999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+..
T Consensus 152 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~ 217 (321)
T 1tki_A 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMN 217 (321)
T ss_dssp EECCTTC---EEEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHH
T ss_pred eECCCCC---ccccccCChhhcCcHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHc
Confidence 8765332 12335688999999999755 378999999999999999999999987653 334455555
Q ss_pred CCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 466 GERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 466 ~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..... ...++.++.+||.+||..||.+|||+.++++|-+.
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 443221 13578899999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.60 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=213.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+....|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.+...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 44444599999999998888642 6889999999753 3457899999999999999999999987656
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+|+||||++| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-------~~ 173 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-------LV 173 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------CE
T ss_pred ceEEEEEecccCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-------CE
Confidence 789999999975 99999975 3499999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-
Q 038696 378 KISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ- 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~- 455 (683)
||+|||++......... .......+|..|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK---------FYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE---------EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCC---------CCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 99999999876543211 1223455778899999997653 788999999999999999999999753211
Q ss_pred ------------hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 456 ------------GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 456 ------------~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
...+...+..+.....+..++..+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11234556667777788889999999999999999999999999999999887543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=349.95 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=196.3
Q ss_pred EeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC--------cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD--------IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~--------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
.+..++|++.+.||+|+++.|++. +|+.||||+++.. ...+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345569999999999998877752 6789999998642 3457789999999999999999999865
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
. +.+||||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~------ 158 (327)
T 3a62_A 93 G--GKLYLILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------ 158 (327)
T ss_dssp S--SCEEEEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS------
T ss_pred C--CEEEEEEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC------
Confidence 4 679999999985 999999863 4689999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 159 -~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 159 -HVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS---------GHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp -CEEECCCSCC------------CTTSSCCTTSCHHHHTTS---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -cEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCC---------CCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 799999999976433211 22345789999999999654 488999999999999999999999987653
Q ss_pred chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
. .....+.... ..+|...+..+.+||.+||..||.+|| ++.++++|-+
T Consensus 227 ~--~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 227 K--KTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp H--HHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred H--HHHHHHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 2 3344444433 346777899999999999999999999 7788877643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=352.99 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=201.7
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+|..+ +||||++++++|.++ ..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 3458999999999998888864 5889999998532 24578899999988 899999999999654 78
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------~~kL 151 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------HIKL 151 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CEEE
T ss_pred EEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-------CEEE
Confidence 9999999975 999999863 4699999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-----
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL----- 454 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~----- 454 (683)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 152 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 152 TDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp CCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred EeccccccccCCC--CcccccCCCccccCccccCCC---------CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 9999998643221 123456789999999999754 489999999999999999999999975211
Q ss_pred --chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHHH
Q 038696 455 --QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF------SSICRIL 504 (683)
Q Consensus 455 --~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~------~eil~~L 504 (683)
....+...+... ...+|...+..+.+||.+||..||.+||++ .++++|-
T Consensus 221 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 221 QNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp --CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred cccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 122344444444 345778889999999999999999999985 6666553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.53 Aligned_cols=254 Identities=26% Similarity=0.465 Sum_probs=201.4
Q ss_pred EeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.+..++|++.+.||+|+++.|+.. .+..||||+++.. .+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--S 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 344568999999999998888753 3567999998643 3468899999999999999999998854 4
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++ |+|.+++.+ ....+++.++..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~ 186 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRK-----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-------VC 186 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHT-----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------CE
T ss_pred CceEEEEeCCCCCcHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-------CE
Confidence 67899999997 599999985 335699999999999999999999999999999999999998887 79
Q ss_pred EEecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 378 KISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
||+|||+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+...
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~- 256 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR---------KFTSASDVWSYGIVLWEVMSYGERPYWEMSN- 256 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccC---------CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999876543211 122234457789999999765 48999999999999999998 9999987653
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+...+..+.....+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 257 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 257 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 34566677776667778899999999999999999999999999999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=359.32 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=201.9
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcC----------
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDE---------- 296 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e---------- 296 (683)
....++|++.+.||+|+++.|++. +|+.||||++..+.....+|+++|+.++|||||+++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 445679999999999998888764 689999999977666677899999999999999999988542
Q ss_pred --------------------------CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038696 297 --------------------------EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK 350 (683)
Q Consensus 297 --------------------------~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 350 (683)
+...+++||||++|+|.+.+..... ....+++..+..++.||+.||.|||++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2345899999999999888875322 335699999999999999999999999
Q ss_pred CcccCCCCCCcEEeC-CCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCch
Q 038696 351 KIYHGNLNPSNILLK-PRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEK 429 (683)
Q Consensus 351 gIiHrDLKp~NILl~-~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~k 429 (683)
||+||||||+|||++ .++ .+||+|||+++...... ......+|+.|+|||++.+. ..++.+
T Consensus 161 gi~H~Dikp~Nil~~~~~~-------~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~ 222 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDN-------TLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGA--------TEYTPS 222 (383)
T ss_dssp TEECSCCCGGGEEEETTTT-------EEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTC--------SSCCTH
T ss_pred cCccCccCHHHEEEcCCCC-------cEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCC--------CCCCcc
Confidence 999999999999997 455 79999999998764332 22345678899999998643 248999
Q ss_pred hHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCC---------------------------CCCCCCCcHHHHHH
Q 038696 430 SDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGER---------------------------PLFPFHSPKYVTNL 482 (683)
Q Consensus 430 sDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~---------------------------~~~p~~~~~~l~~L 482 (683)
+|||||||++|||++|+.||.+.... +.+...+..... ..++...+..+.+|
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999999999876532 222222221000 01345578889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 038696 483 TKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 483 i~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|.+||..||.+|||+.++++|-+
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999998744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=340.89 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=208.2
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+.+..++|++.+.||+|+++.|+.. .+..||||.+... .+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--
Confidence 4556779999999999997777653 1235999998653 3568899999999999999999998743
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
...|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~ 151 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERN-----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-------C 151 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH-----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-------E
T ss_pred -CCCEEEEecCCCCCHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-------c
Confidence 34689999998 5999999863 35689999999999999999999999999999999999998887 8
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
+||+|||++........ .......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||......
T Consensus 152 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR---------RFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred EEeCccCCCcccccccc-cccccCCCCcceeCchhhccC---------CCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 99999999987654321 122344567889999999755 48999999999999999998 99999865433
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.....+..+.....+..+++.+.+++.+||..||.+|||+.+++++|+.+..
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 222 --DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --GHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 3556666677777788899999999999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=364.44 Aligned_cols=265 Identities=18% Similarity=0.278 Sum_probs=207.6
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|..++||||++++++|.++ .
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--N 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--C
Confidence 345679999999999998888763 689999999852 345689999999999999999999999754 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+||||||++ |+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ ++|
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-------~vk 202 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF-----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-------HIR 202 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEE
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-------CEE
Confidence 8999999997 5999999863 24699999999999999999999999999999999999999888 899
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+++....... .......||+.|+|||++...... .....|+.++|||||||++|||++|+.||.+.+.. .
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~--~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~ 277 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGG--PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--E 277 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTC--TTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccC--cCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--H
Confidence 999999987643321 112345789999999999753100 01235899999999999999999999999876533 2
Q ss_pred HHHHHHc----CCCCCCCCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHHHHHHHHHHhcCCCCCC
Q 038696 459 MSRNIRA----GERPLFPFHSPKYVTNLTKRCWHADPNQR---PSFSSICRILRYIKRFIMMNPHYNS 519 (683)
Q Consensus 459 ~~~~i~~----~~~~~~p~~~~~~l~~Li~~cL~~dP~~R---Pt~~eil~~L~~i~~~~~~~~~~~~ 519 (683)
....+.. ...+..+..++.++.+||++||. +|.+| |+++++++|-. +..++++...
T Consensus 278 ~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf----f~~i~w~~l~ 340 (412)
T 2vd5_A 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF----FFGLDWDGLR 340 (412)
T ss_dssp HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG----GTTCCSTTST
T ss_pred HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC----cCCCCHHHHh
Confidence 3333322 22233346789999999999999 99998 58999877643 3345555443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.90 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=203.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++||||+++++++.++ ..+|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence 47999999999998887763 5889999998542 24678999999999999999999998654 789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 107 ~e~~~gg~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~----~~~~~kl~DfG 176 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA------REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA----KGAAVKLADFG 176 (362)
T ss_dssp ECCCCSCBHHHHHTT------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS----TTCCEEECCCT
T ss_pred EecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC----CCCCEEEeecC
Confidence 999985 99998864 35699999999999999999999999999999999999998654 11269999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+
T Consensus 177 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i 242 (362)
T 2bdw_A 177 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQI 242 (362)
T ss_dssp TCBCCTTCC---SCCCSCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred cceEecCCc---ccccCCCCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence 998765332 22346789999999999754 489999999999999999999999987553 3455555
Q ss_pred HcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+...... ..++.++.+||.+||..||.+|||+.++++|-+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp HHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 555432211 3468899999999999999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=362.99 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=201.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.|++. +|+.||+|++... .+.+.+|+++|+.++|||||++++++.+ .+.+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEE
Confidence 48999999999998777753 6889999998542 3457899999999999999999999864 4789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+. ....+||+|||
T Consensus 89 ~E~~~gg~L~~~i~~------~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~----~~~~vkL~DFG 158 (444)
T 3soa_A 89 FDLVTGGELFEDIVA------REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL----KGAAVKLADFG 158 (444)
T ss_dssp ECCCBCCBHHHHHHH------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS----TTCCEEECCCS
T ss_pred EEeCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC----CCCcEEEccCc
Confidence 999975 99999986 25699999999999999999999999999999999999998532 11269999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++....... ......||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+... ..+...+
T Consensus 159 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i 225 (444)
T 3soa_A 159 LAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD---------PYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQI 225 (444)
T ss_dssp SCBCCCTTCC--BCCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred eeEEecCCCc--eeecccCCcccCCHHHhcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHH
Confidence 9977654321 22356789999999999754 489999999999999999999999987553 3455566
Q ss_pred HcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+...... ..+++++.+||.+||+.||.+|||+.++++|-+
T Consensus 226 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 226 KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 655433222 356899999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=342.64 Aligned_cols=258 Identities=20% Similarity=0.326 Sum_probs=197.5
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCc------chHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDI------EPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~------~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
+.+..++|++.+.||+|+++.|++. +|+.||||++.... +.+..+...++.++||||+++++++.++ +
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~ 79 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--G 79 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--C
Confidence 4566779999999999998888763 68899999996431 2234455567888999999999998654 6
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..|+||||++|+|.+++..... ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-------~~k 150 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-------QVK 150 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-------CEE
T ss_pred CEEEEEehhccchHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-------CEE
Confidence 7999999999999888865321 235799999999999999999999998 999999999999998877 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+++...... ......||+.|+|||++.... ....++.++||||||+++|+|++|..||.........
T Consensus 151 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 222 (290)
T 3fme_A 151 MCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPEL-----NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCT-----TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH
T ss_pred EeecCCcccccccc---cccccCCCccccChhhcChhh-----cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH
Confidence 99999998764332 223346888999999974221 2335899999999999999999999999865544444
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+...+........+..++..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 555555555554556789999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=353.63 Aligned_cols=252 Identities=28% Similarity=0.309 Sum_probs=192.8
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
....++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+. ..+||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 93 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 93 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEEE
Confidence 445679999999999997766653 688999999854 246788999999999999999999999654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+||
T Consensus 94 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-----~~~~kl~Df 162 (361)
T 3uc3_A 94 IMEYASGGELYERICNA------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-----APRLKICDF 162 (361)
T ss_dssp EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-----SCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-----CceEEEeec
Confidence 999997 5999999763 4699999999999999999999999999999999999997665 114999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCC-chhHHHhHHHHHHHHHhCCCCCCCCccch--hHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYS-EKSDVYSFGMICFEILTGKVPFEDAHLQG--DKM 459 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s-~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~ 459 (683)
|+++...... ......||+.|+|||++.+.. ++ .++|||||||++|+|++|+.||.+..... ...
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 230 (361)
T 3uc3_A 163 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQE---------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred CccccccccC---CCCCCcCCCCcCChhhhcCCC---------CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 9997543221 223456899999999997542 44 45999999999999999999998654321 122
Q ss_pred HHHHHcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 460 SRNIRAG-ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 460 ~~~i~~~-~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
...+... ........++..+.+||.+||..||.+|||+.++++|-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 2333322 22223335789999999999999999999999999986653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.66 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=203.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
...++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||+++++++.......+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34568999999999998888763 488999999853 345678999999999999999999998776666899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|||||++ |+|.+++.... ....+++.++..++.||+.||.|||++||+||||||+|||+..+. ++...+||+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~~~~~kL~D 159 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---DGQSVYKLTD 159 (319)
T ss_dssp EEEECCTTCBHHHHHHSGG---GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT---TSCEEEEECC
T ss_pred EEEeCCCCCCHHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC---CCCceEEEcc
Confidence 9999997 59999998631 223499999999999999999999999999999999999982211 1223799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--hhHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--GDKM 459 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~~~~ 459 (683)
||+++...... ......||+.|+|||++...... ...+..++.++|||||||++|||++|+.||...... ...+
T Consensus 160 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLR-KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSC-CCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred CCCceecCCCC---ceeecccCCCccCHHHhhhcccc-ccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 99998765432 22345689999999998642110 001346889999999999999999999999643321 1222
Q ss_pred HHHHHcCCCC------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 460 SRNIRAGERP------------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 460 ~~~i~~~~~~------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
...+..+... .++...+..+.++|.+||+.||++|||+.+++++....
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3333322211 01122356789999999999999999999999998763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=356.84 Aligned_cols=257 Identities=18% Similarity=0.225 Sum_probs=199.0
Q ss_pred eCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCCcchHHH---------------HHHHHHcCCCCceee
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGDIEPLVP---------------EISSLLSLSHPNIMH 288 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~~~~~~~---------------Ei~iL~~L~HpnIv~ 288 (683)
..++|++.+.||+|+++.|++. .++.||||++......+.+ |+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999998777764 2578999998655444444 444556677999999
Q ss_pred eeeeEEcCC--CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-
Q 038696 289 FLCGFTDEE--KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK- 365 (683)
Q Consensus 289 l~~~~~~e~--~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~- 365 (683)
+++++.... ...+||||||++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 999886532 256899999996699999986 235699999999999999999999999999999999999998
Q ss_pred -CCCCCCCCcceEEEecccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 366 -PRGASTEGYLHAKISGFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 366 -~~g~~~~~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
.++ .+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 188 ~~~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l 251 (364)
T 3op5_A 188 KNPD-------QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV---------APSRRGDLEILGYCM 251 (364)
T ss_dssp SCTT-------CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC---------CCCHHHHHHHHHHHH
T ss_pred CCCC-------eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC---------CCCchhhHHHHHHHH
Confidence 555 7999999999776433211 112345589999999999754 489999999999999
Q ss_pred HHHHhCCCCCCCCccchhHHHHHHHcCCC---------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 440 FEILTGKVPFEDAHLQGDKMSRNIRAGER---------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 440 ~ElltG~~Pf~~~~~~~~~~~~~i~~~~~---------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
|||++|+.||.+........ ........ ......++.++.+++..||+.||.+||++.+|++.|+.+...
T Consensus 252 ~el~~g~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 252 IQWLTGHLPWEDNLKDPKYV-RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHSCCTTGGGTTCHHHH-HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCccccccCHHHH-HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 99999999998643322111 11110000 001256789999999999999999999999999999988764
Q ss_pred H
Q 038696 511 I 511 (683)
Q Consensus 511 ~ 511 (683)
.
T Consensus 331 ~ 331 (364)
T 3op5_A 331 I 331 (364)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=358.15 Aligned_cols=238 Identities=23% Similarity=0.337 Sum_probs=192.4
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHH-HHcCCCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISS-LLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|++++.||+|+++.|++. +|+.||||++.. ....+..|..+ ++.++||||++++++|.+. ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS--SE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CE
Confidence 4468999999999998888864 578999999843 23456677776 4678999999999999654 78
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+| ++||
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------~ikL 180 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-------HIVL 180 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEE
T ss_pred EEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-------CEEE
Confidence 9999999985 999999863 4689999999999999999999999999999999999999888 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+. ..+
T Consensus 181 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~ 247 (373)
T 2r5t_A 181 TDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEM 247 (373)
T ss_dssp CCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHH
T ss_pred eeCccccccccCC--CccccccCCccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHH
Confidence 9999998643321 233456789999999999755 489999999999999999999999987553 345
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
...+.... ..++..++..+.+||.+||+.||.+||++.+
T Consensus 248 ~~~i~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 248 YDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 55555543 3467788999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=340.07 Aligned_cols=252 Identities=30% Similarity=0.513 Sum_probs=207.0
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----------cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----------IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
+..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45679999999999997766653 6889999998421 25688999999999999999999988432
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCCCCCCCCC
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~~g~~~~~ 373 (683)
. ++||||++ |+|.+++.+ ....+++..+..++.|++.||.|||++| |+||||||+|||++.++ .+.
T Consensus 96 --~--~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~--~~~ 164 (287)
T 4f0f_A 96 --P--RMVMEFVPCGDLYHRLLD-----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD--ENA 164 (287)
T ss_dssp --T--EEEEECCTTCBHHHHHHC-----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC--TTC
T ss_pred --C--eEEEEecCCCCHHHHHhc-----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC--CCC
Confidence 2 79999998 599999875 3457999999999999999999999999 99999999999998776 133
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
...+||+|||+++.... ......||+.|+|||++.+. ...++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAE-------EESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCS-------SCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ceeEEeCCCCccccccc-----cccccCCCccccCchhhccC-------CCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 44599999999975432 22345688999999998432 2247889999999999999999999998766
Q ss_pred cchhHHH-HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 454 LQGDKMS-RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 454 ~~~~~~~-~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
....... .....+..+..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 5443333 3344566677888899999999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.43 Aligned_cols=263 Identities=26% Similarity=0.442 Sum_probs=217.1
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cC-----cEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LG-----ESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g-----~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..+.+..++|++.+.||+|+++.|+.. +| ..||||.+... .+.+.+|+.+|+.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 457778889999999999998888764 22 47999999653 34688999999999 89999999998
Q ss_pred EEcCCCCeEEEEEecCCC-CHHHHHHHhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 038696 293 FTDEEKKECFLIMELMSR-DLCSYIKEICCP--------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNIL 363 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NIL 363 (683)
+.+ .+.+|+||||++| +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 119 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp ECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred Eec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 854 3678999999985 999999763210 01246899999999999999999999999999999999999
Q ss_pred eCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 364 LKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 364 l~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
++.++ .+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||+
T Consensus 197 ~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 197 LTNGH-------VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIF 260 (333)
T ss_dssp EEGGG-------EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHT
T ss_pred ECCCC-------eEEECccccccccccccceeecCCCCCCccccCHHHhccC---------CCChHHHHHHHHHHHHHHH
Confidence 98877 8999999999876543332233445678889999999755 4899999999999999999
Q ss_pred h-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 444 t-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+ |..||.+.... ..+...+..+.....+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 261 t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 261 SLGLNPYPGILVN-SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp TTSCCSSTTCCSS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcccchh-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 8 99999876543 34555666676777788889999999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=344.39 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=196.2
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCC---CCceeeeeeeEEcCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLS---HPNIMHFLCGFTDEE 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~ 297 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ....+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 569999999999998777763 688999999842 1246778988888775 999999999887543
Q ss_pred C---CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 298 K---KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 298 ~---~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
. ..+++||||++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~------ 157 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKA----PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG------ 157 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTC----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS------
T ss_pred CCCceeEEEEehhhhcCHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------
Confidence 2 258999999999999999862 234499999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 158 -~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 158 -TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp -CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTS---------CCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred -CEEEeeCccccccCCCc---ccCCccccccccCchHHcCC---------CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 79999999998664321 22345689999999999754 489999999999999999999999987653
Q ss_pred chhHHHHHHHc-CCCC--C----------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 455 QGDKMSRNIRA-GERP--L----------------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 455 ~~~~~~~~i~~-~~~~--~----------------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.. .+...+.. +..+ . .....+..+.+||.+||+.||.+|||+.++++|-
T Consensus 225 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 225 AD-QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HH-HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HH-HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 32 22222211 1110 0 1134678899999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.70 Aligned_cols=252 Identities=29% Similarity=0.532 Sum_probs=204.6
Q ss_pred eeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+..++|++.+.||+|+++.|+. +.++.||||++... .+.+.+|+++|+.++||||+++++++. +..|+||||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~lv~e~ 80 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCLVMEY 80 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEEEEEC
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEEEEEc
Confidence 3456899999999999877775 47899999999653 456889999999999999999998774 237999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS---KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
++| +|.+++... .....++...++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~------~~kl~Dfg 151 (307)
T 2eva_A 81 AEGGSLYNVLHGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT------VLKICDFG 151 (307)
T ss_dssp CTTCBHHHHHHCS---SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT------EEEECCCC
T ss_pred CCCCCHHHHHhcc---CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC------EEEEcccc
Confidence 975 999999752 112347899999999999999999999 89999999999999987761 48999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++...... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.........+...+
T Consensus 152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 217 (307)
T 2eva_A 152 TACDIQTH-----MTNNKGSAAWMAPEVFEGS---------NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217 (307)
T ss_dssp C-----------------CCTTSSCHHHHTCC---------CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH
T ss_pred cccccccc-----cccCCCCCceEChhhhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH
Confidence 99765322 2234588999999999654 489999999999999999999999987554444455556
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
..+..+..+..++..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 218 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 66777777888999999999999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=347.69 Aligned_cols=268 Identities=22% Similarity=0.357 Sum_probs=197.7
Q ss_pred CCcccceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCC-CCceeeeeeeE
Q 038696 223 GKLLPSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLS-HPNIMHFLCGF 293 (683)
Q Consensus 223 ~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~-HpnIv~l~~~~ 293 (683)
..+....+.+...+|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.++..+. ||||+++++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 16 SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp CSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred HHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 34556788888889999999999998888763 6889999988432 346789999999996 99999999888
Q ss_pred Ec------CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeC
Q 038696 294 TD------EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLK 365 (683)
Q Consensus 294 ~~------e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~ 365 (683)
.. .....+++||||++|+|.+++.... ...++++..+..++.||+.||.|||++| |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCSEEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred cccccccccCCceEEEEEEecCCCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence 42 3345689999999999999997632 2356999999999999999999999999 99999999999998
Q ss_pred CCCCCCCCcceEEEecccCccccCCCCCCC----------CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 366 PRGASTEGYLHAKISGFGLSSVKNFGPKSP----------SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 366 ~~g~~~~~~~~vKL~DFGla~~~~~~~~~~----------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
.++ .+||+|||+++......... ......||+.|+|||++... .+..++.++|||||
T Consensus 173 ~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 173 NQG-------TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY------SNFPIGEKQDIWAL 239 (337)
T ss_dssp TTS-------CEEBCCCTTCBCCSSCC-------------------------------CC------TTSCSSHHHHHHHH
T ss_pred CCC-------CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc------ccCCCChHHhHHHH
Confidence 887 79999999998765432111 11134588999999998422 13358899999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 436 GMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
||++|+|++|..||.+.... ..+........+...+..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 240 G~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 240 GCILYLLCFRQHPFEDGAKL-----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp HHHHHHHHHSSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCcchhHH-----HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999999999999764322 222223333344566778999999999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.75 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=214.4
Q ss_pred eeCCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++++.++||||+++++++..++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 44569999999999998888753 5789999999653 34588999999999999999999988876778
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-------~~k 167 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH-----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-------HVK 167 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-------EEE
T ss_pred eEEEEEeecCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-------CEE
Confidence 8999999996 5999999863 24599999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--
Q 038696 379 ISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-- 455 (683)
Q Consensus 379 L~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-- 455 (683)
|+|||+++........ .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 238 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN---------IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccC---------CCChHHhHHHHHHHHHHHHhCCCCCccccchhh
Confidence 9999999876543211 123345678889999999765 3788999999999999999999998653321
Q ss_pred -----------hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 456 -----------GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 456 -----------~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
...+...+..+.....+..++..+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12344566677777788889999999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.81 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=205.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----c----CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----L----GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~----g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
..+..++|++.+.||+|+++.|+.. + +..||||++... ...+.+|+++++.++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK- 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-
Confidence 3556779999999999997777652 1 235999999653 2357899999999999999999998854
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
.+.+||||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------- 184 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLRE-----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------- 184 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHH-----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------
T ss_pred -CCCcEEEEeCCCCCcHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-------
Confidence 4779999999985 99999986 235699999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 376 HAKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
.+||+|||+++....... ........+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cEEECCCCcchhhccccccccccCCCCccccccCchhcccC---------CCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 799999999987654321 1122334567889999999654 48999999999999999998 999998754
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
. ..+...+..+.....+..++..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 256 ~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 256 N--HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp H--HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H--HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3 34566677777777788899999999999999999999999999999988754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.49 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=200.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 47999999999998888764 588999999843 13568899999999999999999999865 378
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .....+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~---~~~~~~kl 159 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN---VPKPRIKI 159 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT------SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS---SSSCCEEE
T ss_pred EEEEEEcCCCCCHHHHHHh------cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC---CCCCCEEE
Confidence 999999997 599999964 35699999999999999999999999999999999999998765 22336999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~ 225 (326)
T 2y0a_A 160 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQ--ET 225 (326)
T ss_dssp CCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH
T ss_pred EECCCCeECCCCC---ccccccCCcCcCCceeecCC---------CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HH
Confidence 9999998765332 22345689999999999654 4899999999999999999999999875532 23
Q ss_pred HHHHHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+....... .....+..+.+||.+||..||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 34444332221 124678889999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=356.34 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=200.3
Q ss_pred ceeEeeCCCeEEEeEeccc--ccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 228 SRILIKSEDYQVRRRLGSG--SQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G--~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
+++....++|++++.||+| +++.|++. +|+.||||++... .+.+.+|+.+|+.++|||||+++++|.+
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 4555667799999999999 88777763 6889999998532 3457889999999999999999999975
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
. +.+||||||++ |+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~--~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------ 165 (389)
T 3gni_B 98 D--NELWVVTSFMAYGSAKDLICTH----FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------ 165 (389)
T ss_dssp T--TEEEEEEECCTTCBHHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------
T ss_pred C--CEEEEEEEccCCCCHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------
Confidence 4 78999999998 5999999863 335699999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCC-----CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 375 LHAKISGFGLSSVKNFGP-----KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~-----~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
.+||+|||++....... .........||+.|+|||++.+. ...++.++|||||||++|||++|+.||
T Consensus 166 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 166 -KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-------LQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp -CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-------SSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -CEEEcccccceeeccccccccccccccccccccccccCHHHHhcc-------CCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 79999999986543211 11122334788899999999752 135899999999999999999999999
Q ss_pred CCCccchhHHHHHHHcC--------------------------------------------CCCCCCCCCcHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAG--------------------------------------------ERPLFPFHSPKYVTNLTKR 485 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~--------------------------------------------~~~~~p~~~~~~l~~Li~~ 485 (683)
.+...... +...+... ....++..++..+.+||.+
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 238 KDMPATQM-LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp TTCCSTTH-HHHC--------------------------------------------------------CCHHHHHHHHH
T ss_pred CCCCHHHH-HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 87543321 11111000 0011344567889999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 038696 486 CWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 486 cL~~dP~~RPt~~eil~~L 504 (683)
||+.||.+|||+.++++|-
T Consensus 317 ~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp HTCSCTTTSCCHHHHTTSG
T ss_pred HhhcCcccCCCHHHHhcCH
Confidence 9999999999999998763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=350.02 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=191.9
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
..++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++||||+++++++.++ ..+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--TEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CEEE
Confidence 3458999999999998777764 6889999998532 34567999999999999999999998654 7899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +....+||+||
T Consensus 110 lv~e~~~~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA--SETPVLKIGDF 181 (329)
T ss_dssp EEEECCSEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-------CCEEEECCT
T ss_pred EEEecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC--CccceEEECcC
Confidence 99999999999999863 45999999999999999999999999999999999999965541 22337999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++....... ......+|+.|+|||++.+. ..++.++|||||||++|||++|..||.+.... +.+...
T Consensus 182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~ 250 (329)
T 3gbz_A 182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGS--------RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKI 250 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred CCccccCCccc--ccCCCcCCccccCHHHhcCC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHH
Confidence 99987643221 22345678899999999653 24899999999999999999999999876533 222222
Q ss_pred HHc-CCCCC--C-------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 463 IRA-GERPL--F-------------------------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 463 i~~-~~~~~--~-------------------------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
+.. +.... + +...+.++.+||.+||+.||.+|||+.++++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 221 11100 0 011568899999999999999999999998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.89 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=203.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.|+.. +|+.||||++.. ....+.+|+.+++.++|+|++..+..+.. +....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEEEEEc
Confidence 468999999999998777753 688999998743 45678999999999999888877766543 34788999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCCCCCCcceEEEecccC
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL---KPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl---~~~g~~~~~~~~vKL~DFGl 384 (683)
++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+
T Consensus 87 ~~~~L~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-------~~kL~Dfg~ 154 (296)
T 4hgt_A 87 LGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-------LVYIIDFGL 154 (296)
T ss_dssp CCCBHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-------CEEECCCTT
T ss_pred cCCCHHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-------eEEEecCcc
Confidence 97799999985 23569999999999999999999999999999999999999 4555 799999999
Q ss_pred ccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--h
Q 038696 385 SSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--D 457 (683)
Q Consensus 385 a~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~ 457 (683)
++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCC---------CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 9876543221 123356789999999999754 48999999999999999999999998643221 1
Q ss_pred HHHHHH---HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhc
Q 038696 458 KMSRNI---RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMM 513 (683)
Q Consensus 458 ~~~~~i---~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~~ 513 (683)
.+.... ...........++..+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 111111 11111112356788999999999999999999999999999998765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.95 Aligned_cols=259 Identities=21% Similarity=0.404 Sum_probs=199.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+.+++.++||||+++++++... +.+++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 109 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 109 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEEE
Confidence 48999999999997777753 6889999998631 34578999999999999999999988654 68999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 110 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-------~~kl~Df 180 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-------VVKLGDL 180 (310)
T ss_dssp EEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEECCC
T ss_pred EEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-------CEEEEec
Confidence 9999985 99999875321 235689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.......+...
T Consensus 181 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 181 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp --------------------CCSSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred cceeeecCCCc--cccccCCCeeEeChHHhCCC---------CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 99976543221 22345688899999999754 48999999999999999999999998765544455556
Q ss_pred HHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhcCC
Q 038696 463 IRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNP 515 (683)
Q Consensus 463 i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~~~~ 515 (683)
+..+..+..+ ..++.++.+|+.+||+.||.+|||+.+++++|+.+.......+
T Consensus 250 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 6655544433 5678999999999999999999999999999999987655443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.22 Aligned_cols=256 Identities=19% Similarity=0.208 Sum_probs=204.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++|++++..+..+.. +....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEEEe
Confidence 569999999999998877763 688999999853 45679999999999999887776665543 44788999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCCCCCCcceEEEecccC
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK---PRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~---~~g~~~~~~~~vKL~DFGl 384 (683)
++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+
T Consensus 87 ~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-------~~kl~Dfg~ 154 (296)
T 3uzp_A 87 LGPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-------LVYIIDFGL 154 (296)
T ss_dssp CCCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-------CEEECCCTT
T ss_pred cCCCHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-------eEEEeeCCC
Confidence 977999999852 35699999999999999999999999999999999999995 444 799999999
Q ss_pred ccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hH
Q 038696 385 SSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DK 458 (683)
Q Consensus 385 a~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~ 458 (683)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred cccccccccccccccccccccccccccCChhhhcCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh
Confidence 9876543221 122456789999999999754 48999999999999999999999998643211 11
Q ss_pred HHHHH----HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 459 MSRNI----RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 459 ~~~~i----~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
....+ ........+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 11111 111111233567899999999999999999999999999999887543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.34 Aligned_cols=241 Identities=19% Similarity=0.353 Sum_probs=200.1
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.|+..+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEec
Confidence 4788889999998888764 689999999853 245688999999999999999999988654 689999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 124 ~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg~~~ 189 (321)
T 2c30_A 124 LQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-------RVKLSDFGFCA 189 (321)
T ss_dssp CCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCTTCE
T ss_pred CCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------cEEEeeeeeee
Confidence 975 89998763 4699999999999999999999999999999999999998887 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcC
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~ 466 (683)
...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+...
T Consensus 190 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 256 (321)
T 2c30_A 190 QISKDV--PKRKSLVGTPYWMAPEVISRS---------LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDS 256 (321)
T ss_dssp ECCSSS--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS
T ss_pred ecccCc--cccccccCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcC
Confidence 765432 123456789999999999654 4889999999999999999999999875432 334445444
Q ss_pred CCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 467 ERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 467 ~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+.. +...+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 257 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 43332 3356888999999999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.95 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=210.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+..++|++.+.||+|+++.|++. +|..||||.+... ...+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-
Confidence 345679999999999987666642 4668999998542 3467899999999999999999998854
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCP-RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
...+||||||++ |+|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~----~~ 179 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG----PG 179 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----TT
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC----Cc
Confidence 367899999996 5999999874211 1124589999999999999999999999999999999999998554 12
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
..+||+|||++................+|+.|+|||++.+. .++.++||||||+++|+|++ |..||....
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG---------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC---------CCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 26999999999765433322233345678899999999755 48999999999999999998 999998754
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
. ..+...+..+..+..+..++..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 251 ~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 251 N--QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp H--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 3 34566677777777888899999999999999999999999999999998865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=363.21 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=197.9
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+..++|++++.||+|+++.|++. +|+.||||++.. ....+.+|+++|+.++||||++++++|.+. +
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~ 221 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--D 221 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--T
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--C
Confidence 345568999999999998888863 688999999852 245678899999999999999999999654 6
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
.+||||||++| +|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-------~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------HI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-------CE
T ss_pred EEEEEEeeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-------CE
Confidence 89999999985 999999763 569999999999999999999998 9999999999999998887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... .
T Consensus 289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~ 355 (446)
T 4ejn_A 289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E 355 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTS---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred EEccCCCceeccCCC--cccccccCCccccCHhhcCCC---------CCCCccchhhhHHHHHHHhhCCCCCCCCCH--H
Confidence 999999998643321 123456789999999999754 489999999999999999999999987553 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
.+...+.... ..+|...+..+.+||.+||+.||.+|| ++.++++|-.
T Consensus 356 ~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 356 KLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 3444444443 346778899999999999999999999 9999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.13 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=198.7
Q ss_pred CCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC-CcchHHHHHHHHHc--CCCCceeeeeeeEEcC--CCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-DIEPLVPEISSLLS--LSHPNIMHFLCGFTDE--EKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~e--~~~~~~LVmE 306 (683)
.++|++.+.||+|+++.|+. .+|+.||||++.. ....+..|.+++.. ++||||+++++++.+. ....+|+|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 46899999999999877775 4899999999964 34456778877776 7899999999876542 3356899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH--------SKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
|++| +|.++++. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+
T Consensus 87 ~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-------~~ 152 (301)
T 3q4u_A 87 YHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-------QC 152 (301)
T ss_dssp CCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-------CE
T ss_pred hccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-------CE
Confidence 9985 99999953 46999999999999999999999 99999999999999998887 79
Q ss_pred EEecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC----------
Q 038696 378 KISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG---------- 445 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG---------- 445 (683)
||+|||+++........ .......||+.|+|||++.+.... ....++.++|||||||++|||++|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV---DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT---TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC---CcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999765443211 112344789999999999754210 000255799999999999999999
Q ss_pred CCCCCCCccch---hHHHHHHH-cCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 446 KVPFEDAHLQG---DKMSRNIR-AGERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 446 ~~Pf~~~~~~~---~~~~~~i~-~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
..||....... ..+...+. ....+..+. ..+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88886543221 22222222 223333332 2457799999999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.82 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=198.6
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcC----CCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDE----EKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e----~~~~~~LVmEy 307 (683)
+|++.+.||+|+++.|++. +|+.||||++........+|+++|+.|+|||||+++++|... +...+++||||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 7999999999998888763 589999999976666667899999999999999999887542 22357899999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
++++|.+.+..... ....+++..+..++.||+.||.|||++||+||||||+||||+.++. .+||+|||+++.
T Consensus 135 ~~~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~------~~kl~DFG~a~~ 206 (420)
T 1j1b_A 135 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA------VLKLCDFGSAKQ 206 (420)
T ss_dssp CCEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT------EEEECCCTTCEE
T ss_pred ccccHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC------eEEeccchhhhh
Confidence 99988887764321 2356999999999999999999999999999999999999986531 689999999987
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-C
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-G 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~ 466 (683)
..... ......||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.... +.+.+.+.. +
T Consensus 207 ~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg 274 (420)
T 1j1b_A 207 LVRGE---PNVSYICSRYYRAPELIFGA--------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLG 274 (420)
T ss_dssp CCTTC---CCCSCCSCTTSCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred cccCC---CceeeeeCCCcCCHHHHcCC--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 64332 22345688999999999643 25899999999999999999999999876532 222222221 0
Q ss_pred -------------C-CCC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 467 -------------E-RPL------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 467 -------------~-~~~------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
. ... ++...+.++.+||.+||..||.+|||+.++++|-+
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 0 000 23456789999999999999999999999988744
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.78 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=193.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|.+.+.||+|+++.|++. +|..||||++.. ..+.+.+|+++|+.++||||+++++++.+. ..+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEEEEE
Confidence 48999999999998888763 588999999853 246789999999999999999999998643 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 100 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~----~~~~~kl~Dfg~ 173 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS----PHSPIKIIDFGL 173 (285)
T ss_dssp CCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS----TTCCEEECCCCC
T ss_pred EeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC----CCCCEEEEeeec
Confidence 99985 99999865321 235699999999999999999999999999999999999995432 112799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.+.... .....+.
T Consensus 174 a~~~~~~~---~~~~~~~t~~y~aPE~~~~----------~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~ 238 (285)
T 3is5_A 174 AELFKSDE---HSTNAAGTALYMAPEVFKR----------DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKAT 238 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHTT----------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred ceecCCcc---cCcCcccccCcCChHHhcc----------CCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhc
Confidence 97664332 2234568899999999853 3789999999999999999999999876543 2333333
Q ss_pred cCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGER--PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~--~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3322 22223468899999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=366.90 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=191.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++|||||+++++|.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 469999999999998888764 6889999998542 356789999999999999999999986532 25
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+||||||++|+|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 141 ~~~lv~E~~~~~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-------~~kl 205 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 205 (464)
T ss_dssp EEEEEEECCSEEHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEE
T ss_pred eEEEEEeCCCCCHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-------CEEE
Confidence 789999999999888875 2489999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.... +.+
T Consensus 206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~ 272 (464)
T 3ttj_A 206 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQW 272 (464)
T ss_dssp CCCCCC-----CC---CC----CCCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH
T ss_pred EEEEeeeecCCCc---ccCCCcccccccCHHHHcCC---------CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 9999998764321 23446789999999999754 4899999999999999999999999876532 112
Q ss_pred HHHHHc-CC-------------------CCCCC--------------CC------CcHHHHHHHHHhhhcCCCCCCCHHH
Q 038696 460 SRNIRA-GE-------------------RPLFP--------------FH------SPKYVTNLTKRCWHADPNQRPSFSS 499 (683)
Q Consensus 460 ~~~i~~-~~-------------------~~~~p--------------~~------~~~~l~~Li~~cL~~dP~~RPt~~e 499 (683)
...+.. +. .+.+. .. .+.++.+||.+||..||.+|||+.+
T Consensus 273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 221111 00 00000 00 0456899999999999999999999
Q ss_pred HHHHHH
Q 038696 500 ICRILR 505 (683)
Q Consensus 500 il~~L~ 505 (683)
+++|-+
T Consensus 353 ~L~Hp~ 358 (464)
T 3ttj_A 353 ALQHPY 358 (464)
T ss_dssp HHTSTT
T ss_pred HhcChh
Confidence 998743
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.91 Aligned_cols=246 Identities=28% Similarity=0.348 Sum_probs=186.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
..++|++.+.||+|+++.|++. +++.||||++.. ..+.+.+|+.+|+.++||||+++++++.+. ..+|+|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEEEEE
Confidence 3568999999999998888763 578999999965 345688999999999999999999998653 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||++
T Consensus 129 ~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~----~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 129 LVTGGELFDRIVE------KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA----PDAPLKIADFGLS 198 (349)
T ss_dssp CCCSCBHHHHHTT------CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS----TTCCEEECCCC--
T ss_pred eCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC----CCCCEEEccCccc
Confidence 997 599999864 35699999999999999999999999999999999999997521 1127999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..+...+..
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~i~~ 265 (349)
T 2w4o_A 199 KIVEHQV---LMKTVCGTPGYCAPEILRGC---------AYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILN 265 (349)
T ss_dssp -----------------CGGGSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHHHHT
T ss_pred cccCccc---ccccccCCCCccCHHHhcCC---------CCCcccchHHHHHHHHHHHhCCCCCCCCccc-HHHHHHHHh
Confidence 8764321 22345689999999999754 4899999999999999999999999875533 224444444
Q ss_pred CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..... .....+..+.+||.+||..||++|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 43222 224678899999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.95 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=183.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC---CCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE---EKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e---~~~~ 300 (683)
.++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++|||||++++++... ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999997777753 6889999998542 34678999999999999999999988543 2257
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+||||||++|+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 132 ~~lv~e~~~~~L~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-------~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT------PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-------SVKVC 198 (458)
T ss_dssp EEEEECCCSEEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-------CEEEC
T ss_pred EEEEEeccccchhhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-------CEeec
Confidence 999999999999999974 35699999999999999999999999999999999999999887 79999
Q ss_pred cccCccccCCCCCC-------------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 381 GFGLSSVKNFGPKS-------------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 381 DFGla~~~~~~~~~-------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
|||+++........ .......||+.|+|||++... ..|+.++|||||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~~~~~~DiwSl 270 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ--------ENYTEAIDVWSI 270 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC--------CCCCTHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC--------CCCCcHhHHHHH
Confidence 99999876432211 122345789999999987532 358999999999
Q ss_pred HHHHHHHHh-----------CCCCCCCCccc-------------------hhHHHHHHHc-CCC----------------
Q 038696 436 GMICFEILT-----------GKVPFEDAHLQ-------------------GDKMSRNIRA-GER---------------- 468 (683)
Q Consensus 436 Gvil~Ellt-----------G~~Pf~~~~~~-------------------~~~~~~~i~~-~~~---------------- 468 (683)
|||+|||++ |+++|.+.... .+.+...+.. +..
T Consensus 271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence 999999998 66777553310 0001100000 000
Q ss_pred ------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 469 ------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 469 ------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.......+.++.+||.+||..||.+|||+.++++|-+
T Consensus 351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 0011345788999999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.31 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=210.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE--------cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW--------LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~--------~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++++.||+|+++.|+.. +|+.||||++... .+.+.+|+++|+.++||||+++++++...+..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 34568999999999998888753 5789999999653 34688999999999999999999988665555
Q ss_pred eEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+++||||++| +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-------~~k 185 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-------RVK 185 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-----TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-------EEE
T ss_pred ceEEEEECCCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-------cEE
Confidence 78999999975 999999862 34699999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc---
Q 038696 379 ISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--- 454 (683)
Q Consensus 379 L~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--- 454 (683)
|+|||+++........ .......++..|+|||++.+. .++.++||||||+++|||++|..||.....
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 256 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 256 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCC---------CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence 9999999876543211 112334567789999999765 378899999999999999999999864310
Q ss_pred -------c----hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 455 -------Q----GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 455 -------~----~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
. ...+...+..+.....+..++..+.+||.+||+.||.+|||+.++++.|+.+...+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 257 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 01233445556666678889999999999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.16 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=206.0
Q ss_pred CCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.+|++.+.||+|+++.|++. .+..||||.+... .+.+.+|+.+++.++||||+++++++.. ..+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCceE
Confidence 37999999999998877753 1235999998642 3567899999999999999999987654 336789
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 104 ~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-------~~kl~D 171 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-------TVKVAD 171 (298)
T ss_dssp EEEECCTTCBHHHHHHC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-------CEEECS
T ss_pred EEEeCCCCCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-------CEEECc
Confidence 99999985 99999974 345689999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhH
Q 038696 382 FGLSSVKNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDK 458 (683)
Q Consensus 382 FGla~~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~ 458 (683)
||+++....... ........+|+.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.... .
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~ 240 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--D 240 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--T
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--H
Confidence 999986643321 1223345678889999999765 48999999999999999999 66777665433 3
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
....+..+.....+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 241 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 555666777777788899999999999999999999999999999988764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.50 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=205.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEc--------------C
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTD--------------E 296 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--------------e 296 (683)
++|++.+.||+|+++.|++. +|+.||||++....+.+.+|+++++.++||||+++++++.. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 47999999999987666653 68999999998777889999999999999999999988753 1
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
....+|+||||++| +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------- 159 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKR----RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK------- 159 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHG----GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-------
T ss_pred CcceEEEEEeccCCCCHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-------
Confidence 23568999999985 999999863 235699999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~~~~~~~~--- 224 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQ---------DYGKEVDLYALGLILAELLHVCDTAFET--- 224 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCS---------CCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccC---------CCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence 79999999998765432 22345688999999999754 4889999999999999999999988532
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
......+..+ ..+...+..+.++|.+||+.||.+|||+.+++++|+.+.+
T Consensus 225 -~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 -SKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -HHHHHHHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -HHHHHHhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 2233334333 2456778999999999999999999999999999988754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.09 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=206.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
++|++.+.||+|+++.|+.. +|..||||++.. ..+.+.+|+.+++.++||||+++++++.+++...+|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 58999999999998777753 678999999853 235688999999999999999999998766667899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
+||||++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 85 lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-------~~kl~df 153 (305)
T 2wtk_C 85 MVMEYCVCGMQEMLDSV----PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-------TLKISAL 153 (305)
T ss_dssp EEEECCSEEHHHHHHHS----TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------CEEECCC
T ss_pred EEehhccCCHHHHHHhC----cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-------cEEeecc
Confidence 99999998888888763 345699999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++................||+.|+|||++.+.. ..++.++||||||+++|||++|..||.+.... .+...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~ 224 (305)
T 2wtk_C 154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-------TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFEN 224 (305)
T ss_dssp TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCS-------CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred ccccccCccccccccccCCCCCCCcChhhccCcc-------cCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHH
Confidence 9998765332222333556889999999996431 12478999999999999999999999875532 34455
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+. ..++..++..+.+||.+||..||.+|||+.+++++.+.
T Consensus 225 i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 225 IGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp HHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred HhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 55543 34677889999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.86 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=196.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC------C
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE------K 298 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~------~ 298 (683)
++|++++.||+|+++.|++. +|+.||||++... ...+.+|+++|+.++||||+++++++.... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 58999999999997666653 6889999998432 346789999999999999999999887543 3
Q ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 299 ~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
+.+||||||++|+|.+.+.. ....+++.++..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-------~~k 164 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-------VLK 164 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHC-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEE
T ss_pred ceEEEEEeccCCCHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-------CEE
Confidence 57899999999999998875 335699999999999999999999999999999999999998887 799
Q ss_pred EecccCccccCCCC--CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 379 ISGFGLSSVKNFGP--KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
|+|||+++...... .........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.....
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--------RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC--------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCC--------CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999998764322 11223455789999999999643 248899999999999999999999998765332
Q ss_pred hHHHHHHHc--CC-CCC-CCCC---------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 DKMSRNIRA--GE-RPL-FPFH---------------------------SPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~--~~-~~~-~p~~---------------------------~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
....+.. +. .+. ++.. .++.+.+||.+||+.||.+|||+.++++|-
T Consensus 237 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 237 --QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp --HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred --HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 2222211 11 111 1110 156789999999999999999999998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.61 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=201.2
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|++. ++..||||++.. ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 4468999999999998877764 567899999842 245688999999999999999999998654 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-------~~~l~ 151 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-------ELKIA 151 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-------CEEEC
T ss_pred EEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-------CEEEE
Confidence 999999985 999999864 4599999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...... ...
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~ 216 (279)
T 3fdn_A 152 DFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGR---------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY 216 (279)
T ss_dssp SCCEESCC------------CCCCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH
T ss_pred eccccccCCcc----cccccCCCCCccCHhHhccC---------CCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHH
Confidence 99998654332 22345678899999999654 4788999999999999999999999876533 233
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+... ...++...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 217 KRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp HHHHHT-CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHhC-CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 444433 334677789999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=355.72 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=193.6
Q ss_pred CCeEEE-eEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHH-cCCCCceeeeeeeEEc--CCCCeEEEEEe
Q 038696 235 EDYQVR-RRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLL-SLSHPNIMHFLCGFTD--EEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~-~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~--e~~~~~~LVmE 306 (683)
++|.+. +.||+|+++.|++. +|+.||||++.. ...+.+|+.++. .++||||++++++|.. .+...+|||||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 478887 68999998888864 688999999964 456788999874 4589999999988753 23467899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 140 ~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----~~~~~kl~DFG~a 211 (400)
T 1nxk_A 140 CLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----PNAILKLTDFGFA 211 (400)
T ss_dssp CCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS----TTCCEEECCCTTC
T ss_pred eCCCCcHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC----CCccEEEEecccc
Confidence 9985 999999852 234699999999999999999999999999999999999998732 1127999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSRNI 463 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~~i 463 (683)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..... ..+...+
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EECC--------------CTTCCGGGSCCC---------CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCC---------CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 8654321 22345689999999999644 58999999999999999999999997654321 1133444
Q ss_pred HcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 464 RAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 464 ~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
..+..... ...++.++.+||.+||..||.+|||+.++++|.+..
T Consensus 280 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 44432211 145789999999999999999999999999986643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.26 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=191.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC--Ce
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK--KE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~--~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||++... ...+.+|+.+++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 568999999999998888763 6789999999643 2357899999999999999999998865432 24
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| +|.+++... .++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl 157 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-------AVKV 157 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-------CEEE
T ss_pred cEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-------CEEE
Confidence 6999999974 999999863 5699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.+.... ..
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~ 227 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SV 227 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence 999999876543221 222345689999999999754 4899999999999999999999999876533 22
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 459 MSRNIRAGERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+.....+. ....++.++.+||.+||+.||.+||+..+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 223333332221 234578899999999999999999977666554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.62 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=207.2
Q ss_pred CCCCcccceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCC--CCceeee
Q 038696 221 LSGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLS--HPNIMHF 289 (683)
Q Consensus 221 ~~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~--HpnIv~l 289 (683)
....+..+.+.+..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.++..++ ||||+++
T Consensus 14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp ------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 3445667888999999999999999998877764 5889999998532 356789999999997 5999999
Q ss_pred eeeEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 290 LCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 290 ~~~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
++++... ..+|+|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus 94 ~~~~~~~--~~~~lv~e~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~- 163 (313)
T 3cek_A 94 YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G- 163 (313)
T ss_dssp EEEEECS--SEEEEEECCCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-
T ss_pred EEEeecC--CEEEEEEecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C-
Confidence 9988654 689999997778999999862 46899999999999999999999999999999999999964 4
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccc--ccCCCCCchhHHHhHHHHHHHHHhCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES--ASNSKYSEKSDVYSFGMICFEILTGKV 447 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~--~~~~~~s~ksDVwSlGvil~ElltG~~ 447 (683)
.+||+|||+++...............||+.|+|||++.+...... .....++.++||||||+++|+|++|..
T Consensus 164 ------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 164 ------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp ------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 699999999987654332223345568999999999975211000 012358899999999999999999999
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
||.........+...+.......++...+..+.++|.+||+.||.+|||+.+++++.+.
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp TTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred chhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 99876544334444444455556777788999999999999999999999999987554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=364.90 Aligned_cols=256 Identities=19% Similarity=0.211 Sum_probs=202.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ....+..|+++++.|+|++++..+..+.. +....||||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEEEEEEC
Confidence 569999999999998877764 488999998753 45678999999999987555444444433 34788999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC---CCCCCCCCcceEEEecccC
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK---PRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~---~~g~~~~~~~~vKL~DFGl 384 (683)
+.++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+||||+ .++ .+||+|||+
T Consensus 85 ~g~sL~~ll~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-------~vkL~DFGl 152 (483)
T 3sv0_A 85 LGPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-------QVYIIDFGL 152 (483)
T ss_dssp CCCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-------CEEECCCTT
T ss_pred CCCCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-------eEEEEeCCc
Confidence 988999999852 35699999999999999999999999999999999999994 444 799999999
Q ss_pred ccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-hH
Q 038696 385 SSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-DK 458 (683)
Q Consensus 385 a~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-~~ 458 (683)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI---------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCC---------CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence 9876543221 122356789999999999755 48999999999999999999999998754321 11
Q ss_pred HHHHH----HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 459 MSRNI----RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 459 ~~~~i----~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
....+ .......++..++.++.+||..||+.||++||++.+|++.|+.+....
T Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 224 KYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11111 111111223567899999999999999999999999999999886543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.60 Aligned_cols=246 Identities=22% Similarity=0.390 Sum_probs=193.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC-------
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK------- 298 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~------- 298 (683)
++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 37999999999998777753 689999999852 23568899999999999999999998864321
Q ss_pred ------------------------------------------------CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCC
Q 038696 299 ------------------------------------------------KECFLIMELMSR-DLCSYIKEICCPRKRIPFS 329 (683)
Q Consensus 299 ------------------------------------------------~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~ 329 (683)
..+|+|||||+| +|.+++.... .....+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~ 162 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---SLEDRE 162 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---SGGGSC
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---Cccchh
Confidence 248999999985 9999998632 223456
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCC----------CCCCCC
Q 038696 330 LPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK----------SPSQSG 399 (683)
Q Consensus 330 ~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~----------~~~~~~ 399 (683)
+..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ......
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-------VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECCCTTCEECSCC--------------CCCS
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-------CEEEeecCcccccccchhhccccccccccccccc
Confidence 778999999999999999999999999999999998887 799999999987654321 112234
Q ss_pred CCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHH
Q 038696 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYV 479 (683)
Q Consensus 400 ~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 479 (683)
..||+.|+|||++.+. .++.++|||||||++|||++|..|+... ......+.....+......++.+
T Consensus 236 ~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGN---------NYSHKVDIFSLGLILFELLYSFSTQMER----VRIITDVRNLKFPLLFTQKYPQE 302 (332)
T ss_dssp CC-CGGGSCHHHHHCC---------CCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHHHHHTTCCCHHHHHHCHHH
T ss_pred cCCCcCccChHHhcCC---------CCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHHHhhccCCCcccccCChhH
Confidence 5789999999999754 4899999999999999999997776421 22333344443333333445778
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 480 TNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 480 ~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+||.+||+.||.+|||+.+++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=331.54 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=202.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+.+++.++||||+++++++.+. ...|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEEEE
Confidence 468999999999998877763 5889999998532 35678999999999999999999998643 78899
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+.| +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ ....+||+||
T Consensus 83 v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~~~~kl~Df 152 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA----KGAAVKLADF 152 (284)
T ss_dssp EECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS----TTCCEEECCC
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC----CCCcEEEeec
Confidence 9999985 999988763 5699999999999999999999999999999999999998665 1225999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+... ......
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~ 218 (284)
T 3kk8_A 153 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQ 218 (284)
T ss_dssp TTCEECCSSC---BCCCSCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred eeeEEcccCc---cccCCCCCcCCcCchhhcCC---------CCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHH
Confidence 9997765332 22345688999999999754 488999999999999999999999987553 234444
Q ss_pred HHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+.... ....+++.+.+|+.+||+.||.+|||+.+++++-+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 44443221 22467889999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.13 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=193.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++++.||+|+++.|++. +|+.||||++... ...+.+|+++|+.++||||+++++++.++ ..+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEEe
Confidence 58999999999998888764 6889999998532 22456799999999999999999998654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-------~~kl~Dfg~a 147 (324)
T 3mtl_A 80 EYLDKDLKQYLDDC-----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-------ELKLADFGLA 147 (324)
T ss_dssp ECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-------CEEECSSSEE
T ss_pred cccccCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-------CEEEccCccc
Confidence 99999999999862 35699999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+......
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~ 216 (324)
T 3mtl_A 148 RAKSIPTK--TYDNEVVTLWYRPPDILLGS--------TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRI 216 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred ccccCCcc--ccccccCcccccChhhhcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 76543221 22345678999999999643 258999999999999999999999998765332 12111111
Q ss_pred -CC--CCC-------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 -GE--RPL-------------------------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 -~~--~~~-------------------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+. ... .....+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 10 000 01245778999999999999999999999987644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=331.57 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=200.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++.+.||+|+++.|++. ++..||+|++.. ..+.+.+|+++++.++||||+++++++.+ ...+|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEEEe
Confidence 47999999999998888764 567899999843 45678999999999999999999999864 378999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCCCCCCcceEEEecc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL---KPRGASTEGYLHAKISGF 382 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl---~~~g~~~~~~~~vKL~DF 382 (683)
|++| +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++ .+||+||
T Consensus 87 ~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-------~~~l~Df 153 (277)
T 3f3z_A 87 LCTGGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-------PLKLIDF 153 (277)
T ss_dssp CCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-------CEEECCC
T ss_pred ccCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-------cEEEEec
Confidence 9975 999998763 558999999999999999999999999999999999999 4444 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ......
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~ 218 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEGL----------YGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLK 218 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTTC----------BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred ccceeccCcc---chhccCCCCCccChHHhccc----------CCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence 9998765332 23345688999999998542 78899999999999999999999987553 334455
Q ss_pred HHcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+..+...... ..++..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 219 IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 5555433221 2578899999999999999999999999987554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.08 Aligned_cols=237 Identities=20% Similarity=0.282 Sum_probs=190.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.++||+|+++.|++. +|+.||||++... ......|+..+..+ +||||+++++++.+ .+.+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 47999999999998888763 6889999998542 12344555555554 89999999999864 478999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 304 IMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 304 VmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 135 v~e~~~~~L~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-------~~kl~DFG 202 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAW-----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-------RCKLGDFG 202 (311)
T ss_dssp EEECCCCBHHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-------CEEECCCT
T ss_pred EEeccCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-------CEEEccce
Confidence 9999999999999864 35699999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~ 264 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG----------SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQL 264 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT----------CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHH
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC----------CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHH
Confidence 997764332 2234568999999999864 38899999999999999999977765422 12233
Q ss_pred HcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RAGE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~~~-~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+. .+.++..++.++.+||.+||+.||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 3322 222445678999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.82 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=206.0
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..+....++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+++|+.++||||+++++++.+ .+.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 109 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNE 109 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCe
Confidence 344456779999999999997777753 5889999998542 3568899999999999999999998854 467
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ |+|.+++.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl 180 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-------VPKI 180 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-------CEEE
T ss_pred EEEEEEcCCCCcHHHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-------CEEE
Confidence 899999997 59998886421 1234699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh-H
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-K 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~-~ 458 (683)
+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG---------RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC---------BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCC---------CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 999999875443333333455689999999999765 488999999999999999999999976432210 0
Q ss_pred HH----HHHHcCC---------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MS----RNIRAGE---------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~----~~i~~~~---------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.. .....+. ....+...+..+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11 1111111 111223346778999999999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.14 Aligned_cols=259 Identities=15% Similarity=0.208 Sum_probs=203.8
Q ss_pred CCCeEEEeEecccccEEEEEE------------cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceee-------------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW------------LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMH------------- 288 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~------------~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~------------- 288 (683)
.++|++.+.||+|+++.|++. .|+.||||++... +.+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 479999999999998777763 3789999999654 67899999999999999998
Q ss_pred --eeeeEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC
Q 038696 289 --FLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP 366 (683)
Q Consensus 289 --l~~~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~ 366 (683)
+++++.. +...+||||||+.|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 120 PTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVS----PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred cchhhcccc-CCcEEEEEecCCCcCHHHHHHhC----CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 4445543 34789999999966999999862 2356999999999999999999999999999999999999976
Q ss_pred CCCCCCCcceEEEecccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHH
Q 038696 367 RGASTEGYLHAKISGFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441 (683)
Q Consensus 367 ~g~~~~~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~E 441 (683)
++ ...+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++||
T Consensus 195 ~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 195 ED-----QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---------GPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp TE-----EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHH
T ss_pred CC-----CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---------CCCchhhHHHHHHHHHH
Confidence 64 136999999999776432211 112345789999999999754 48999999999999999
Q ss_pred HHhCCCCCCCCccchhHHHHHHH--cCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 038696 442 ILTGKVPFEDAHLQGDKMSRNIR--AGERPLFP------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIM 512 (683)
Q Consensus 442 lltG~~Pf~~~~~~~~~~~~~i~--~~~~~~~p------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~~ 512 (683)
|++|+.||.........+..... ......+. ..++..+.+|+.+||..||.+|||+.++++.|+.+.....
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 99999999876433333322221 11111122 2458999999999999999999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=359.98 Aligned_cols=244 Identities=26% Similarity=0.397 Sum_probs=205.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|.+.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.+. ..+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 358999999999998777753 689999999842 245688999999999999999999998654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|||||++| +|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 93 lv~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-------~vkL~D 159 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK------NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-------NAKIAD 159 (476)
T ss_dssp EEEECCSSEEHHHHTTS------SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-------CEEECC
T ss_pred EEEeCCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-------CeEEEe
Confidence 99999974 99999864 35699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.... .+..
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~ 226 (476)
T 2y94_A 160 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRL--------YAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFK 226 (476)
T ss_dssp CSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCC--------BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHH
T ss_pred ccchhhccccc---cccccCCCcCeEChhhccCCC--------CCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHH
Confidence 99998765432 223457899999999997542 3478999999999999999999999876543 3555
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+. ...|...+..+.+||.+||..||.+|||+.++++|-+.
T Consensus 227 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 227 KICDGI-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp HHHTTC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HHhcCC-cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 555553 34567788999999999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.17 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=198.0
Q ss_pred CeEEEeEecccccEEEEEE----c---CcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----L---GESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~---g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.|++.+.||+|+++.|+.. . +..||||.+... .+.+.+|+.+|+.++||||+++++++.. ..+..|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCCCeEE
Confidence 5889999999997777742 1 236999998642 3568899999999999999999987654 3357899
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 169 v~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------~~kL~DF 236 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-------TVKVADF 236 (373)
T ss_dssp EEECCTTCBHHHHHHC-----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------CEEECCC
T ss_pred EEECCCCCCHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-------CEEEeec
Confidence 9999985 99999975 345689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHH
Q 038696 383 GLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459 (683)
Q Consensus 383 Gla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~ 459 (683)
|+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.... .+
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~ 305 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI 305 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CH
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCC---------CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HH
Confidence 999865432211 122345677889999999765 48999999999999999999 78888776543 24
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+..+.+...+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 306 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 306 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 55667777777888899999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=341.03 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=207.4
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcE--EEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGES--FALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~--vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|++.+.||+|+++.|+.. +|.. ||||.+.. ..+.+.+|+++|+.+ +||||+++++++.+. +.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence 3468999999999997777653 5654 49998853 356789999999999 899999999998654 78
Q ss_pred EEEEEecCCC-CHHHHHHHhcC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 301 CFLIMELMSR-DLCSYIKEICC----------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
+|+||||++| +|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~- 179 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY- 179 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-
Confidence 9999999975 99999985310 01224699999999999999999999999999999999999998776
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVP 448 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~P 448 (683)
.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 180 ------~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 180 ------VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp ------CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------eEEEcccCcCccccccc---cccCCCCCccccChhhhccc---------cCCchhcchHHHHHHHHHHcCCCCC
Confidence 79999999997543221 12234567789999999765 37899999999999999998 9999
Q ss_pred CCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 449 FEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 449 f~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|.+... ..+...+..+.....+..++..+.+||.+||..||.+|||+.+++++|..+..
T Consensus 242 f~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 242 YCGMTC--AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp TTTCCH--HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcH--HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 987653 34556666776777788889999999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.79 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=206.6
Q ss_pred CeEEEeEecccccEEEEEE----cCc---EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGE---SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~---~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.|.+.+.||+|+++.|+.. ++. .||||.+... .+.+.+|+.+++.++||||+++++++.+.+ ...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence 5778899999998877753 222 7999998642 356789999999999999999999886532 44589
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 101 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-------~~kl~Df 168 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS-----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-------TVKVADF 168 (298)
T ss_dssp EECCCTTCBHHHHHHC-----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-------CEEECCT
T ss_pred EEecccCCCHHHHHhc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-------cEEeCcC
Confidence 999996 599999975 346689999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCC--CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC-CCCCCccchhHH
Q 038696 383 GLSSVKNFGP--KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV-PFEDAHLQGDKM 459 (683)
Q Consensus 383 Gla~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~-Pf~~~~~~~~~~ 459 (683)
|+++...... .........+|+.|+|||++.+. .++.++||||||+++|+|++|.. ||.... ...+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~ 237 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY---------RFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDL 237 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGH
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccC---------CCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHH
Confidence 9997654322 11233345678899999999754 48999999999999999999554 554433 2346
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
...+..+.....+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 666777777778888999999999999999999999999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.51 Aligned_cols=255 Identities=19% Similarity=0.274 Sum_probs=194.1
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
.+.+ .++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.....
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 3444 459999999999998888764 5789999999642 3467899999999999999999998865422
Q ss_pred ---CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 299 ---KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 299 ---~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..+||||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~------- 166 (432)
T 3n9x_A 100 LKFDELYIVLEIADSDLKKLFKT------PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC------- 166 (432)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------
T ss_pred CcCCeEEEEEecCCcCHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-------
Confidence 56899999999999999974 35699999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCC--------------------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 376 HAKISGFGLSSVKNFGPKS--------------------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~--------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
.+||+|||+++........ .......||+.|+|||++... ..|+.++|||||
T Consensus 167 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--------~~~~~~~DiwSl 238 (432)
T 3n9x_A 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--------ENYTKSIDIWST 238 (432)
T ss_dssp CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC--------SCCCTHHHHHHH
T ss_pred CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC--------CCCCcccccchH
Confidence 7999999999876543211 112456789999999997532 358999999999
Q ss_pred HHHHHHHHhCCCC-----------CCCCccc----------------hh-----------------------HHHHHHHc
Q 038696 436 GMICFEILTGKVP-----------FEDAHLQ----------------GD-----------------------KMSRNIRA 465 (683)
Q Consensus 436 Gvil~ElltG~~P-----------f~~~~~~----------------~~-----------------------~~~~~i~~ 465 (683)
||++|||++|..| |.+.... .+ .....+..
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 9999999985444 4332200 00 01111111
Q ss_pred CCC-CCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GER-PLF-----PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~-~~~-----p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
... ... ....++.+.+||.+||..||.+|||+.++++|-.
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 110 000 1346888999999999999999999999988743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=338.05 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=207.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++.+.||+|+++.|+.. +|+.||||.+... .+.+.+|+.+++.++||||+++++++.++....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 458999999999997777653 6889999998532 345789999999999999999999887666678999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK-----IYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
||||++| +|.+++..... ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++ .+
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-------~~ 155 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------NV 155 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-------CE
T ss_pred EEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-------CE
Confidence 9999985 99999976321 2345999999999999999999999999 99999999999998877 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||..... .
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~ 222 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--K 222 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC----------CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccC---------CCCchhhHHHHHHHHHHHHHCCCCCcccCH--H
Confidence 9999999976543211 11123578889999999754 488999999999999999999999987653 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...+..+..+.++..++..+.++|.+||+.||.+|||+.+++++++
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 223 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 456677777777788889999999999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.68 Aligned_cols=270 Identities=22% Similarity=0.340 Sum_probs=209.6
Q ss_pred CCcccceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 223 GKLLPSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 223 ~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
.......+.+..++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp CSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred eeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34444667788889999999999998877753 688999998843 2456889999999999999999999886
Q ss_pred cC--CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 295 DE--EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 295 ~e--~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
.+ ....+|+||||+.| +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--- 171 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--- 171 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---
Confidence 32 33578999999985 99999986422 245699999999999999999999999999999999999998887
Q ss_pred CCcceEEEecccCccccCCCCCCC-------CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSP-------SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~-------~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt 444 (683)
.+||+|||++.......... ......||+.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 172 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~Di~slG~il~el~~ 241 (317)
T 2buj_A 172 ----QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS------HCVIDERTDVWSLGCVLYAMMF 241 (317)
T ss_dssp ----CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS------EEEECTHHHHHHHHHHHHHHHH
T ss_pred ----CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC------CcCCCchhhHHHHHHHHHHHHh
Confidence 79999999987543211000 001234588899999986431 1136889999999999999999
Q ss_pred CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 445 GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 445 G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
|+.||.............+........+..++..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 242 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 242 GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp SSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 999996532222233344444444445567889999999999999999999999999998875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=367.58 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=206.4
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|++. +|+.||||++.. ....+.+|+++|..++|||||+++++|.+. ..+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEE
Confidence 4568999999999998888863 689999999842 345678999999999999999999998654 789
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
||||||++ |+|.+++... ....+++..+..|+.||+.||.|||++||+||||||+||||+.+| ++||+
T Consensus 260 ~lVmEy~~gg~L~~~l~~~----~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-------~vKL~ 328 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHM----GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-------HIRIS 328 (576)
T ss_dssp EEEECCCCSCBHHHHHHSS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-------CEEEC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-------CeEEE
Confidence 99999997 5999999752 234599999999999999999999999999999999999999888 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--chhH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QGDK 458 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~~~ 458 (683)
|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+... ....
T Consensus 329 DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~---------~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~ 396 (576)
T 2acx_A 329 DLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396 (576)
T ss_dssp CCTTCEECCTTC---CEECCCSCGGGCCHHHHTTC---------EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH
T ss_pred ecccceecccCc---cccccCCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH
Confidence 999998765332 22345789999999999765 388999999999999999999999987542 2233
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILR 505 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~ 505 (683)
+...+... ...++..++.++.+||.+||..||.+|| ++.++++|-+
T Consensus 397 i~~~i~~~-~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 397 VERLVKEV-PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred HHHHhhcc-cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 44444443 3456778899999999999999999999 7888887743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=344.24 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=195.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
.++|++.+.||+|+++.|+.. +|+.||||++... ...+.+|+++++.++||||+++++++.+ ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCc
Confidence 468999999999998888864 5889999998531 2467899999999999999999998854 467
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|+||||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 87 ~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-------~~kl~ 154 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-------VLKLA 154 (346)
T ss_dssp CEEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------CEEEC
T ss_pred eEEEEEcCCCCHHHHHHh-----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-------CEEEE
Confidence 899999999999998874 335689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+++....... ......+|+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.... ..+.
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~ 223 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA--------RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLT 223 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTC--------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCC--------CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHH
Confidence 9999987643321 23345689999999999643 24889999999999999999999999876532 2222
Q ss_pred HHHHc-CCC--CCC-----------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 461 RNIRA-GER--PLF-----------------------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 461 ~~i~~-~~~--~~~-----------------------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+.. +.. ..+ ....+..+.+||.+||..||.+|||+.++++|.+
T Consensus 224 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 22221 110 000 1345688999999999999999999999988743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.31 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=204.9
Q ss_pred cccceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 225 LLPSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 225 ~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
+....+.+..++|++.+.||+|+++.|++. +|+.||||++.. ....+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 98 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT- 98 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-
Confidence 444666777889999999999998777764 688999999854 23468999999999999999999998854
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEeCCCCCCCC
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK---KIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIiHrDLKp~NILl~~~g~~~~ 372 (683)
....++||||+.| +|.+++.... ....++++..+..++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~---- 171 (326)
T 3uim_A 99 -PTERLLVYPYMANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF---- 171 (326)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC----
T ss_pred -CCceEEEEEeccCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC----
Confidence 3678999999975 9999998632 2334699999999999999999999999 999999999999998887
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 172 ---~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 172 ---EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG---------KSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp ---CEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS---------EECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred ---CEEeccCccccccCcccc-cccccccCCcCccCHHHhccC---------CCCccccchhHHHHHHHHHhCCCccccc
Confidence 799999999987653322 223345589999999999765 3889999999999999999999999621
Q ss_pred ccc---hhHHHHHHHcC-------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 453 HLQ---GDKMSRNIRAG-------------ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 453 ~~~---~~~~~~~i~~~-------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
... .......+... ....++...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 100 00011111110 0111122234779999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.39 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=197.8
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cC-------cEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LG-------ESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g-------~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
+..++|++.+.||+|+++.|++. +| ..||+|++.. ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC- 83 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-
Confidence 44569999999999998777753 33 4799999854 24568899999999999999999998854
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC-CCCc
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS-TEGY 374 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~-~~~~ 374 (683)
....|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+.
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKN-----KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHT-----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred -CCCCEEEEECCCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 367899999998 5999999862 3448999999999999999999999999999999999999877610 0111
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC-CCCCCCCc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG-KVPFEDAH 453 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG-~~Pf~~~~ 453 (683)
..+||+|||++..... .....+|+.|+|||++.+. ..++.++|||||||++|||++| .+||....
T Consensus 158 ~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP------KDILQERIPWVPPECIENP--------KNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCG--------GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceeeeccCcccccccC------ccccCCcCcccCHHHhCCC--------CCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 2399999999865432 1223567889999999752 2489999999999999999995 55555433
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
.. ........ ....+...+.++.+|+.+||+.||.+|||+.+++++|+.+
T Consensus 224 ~~--~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 224 SQ--RKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HH--HHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred hH--HHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22 12222222 3345666788899999999999999999999999998875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=345.57 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=200.7
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC---CCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE---KKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~---~~~ 300 (683)
..++|++++.||+|+++.|++. +|..||||++... .+.+.+|+++|+.++||||+++++++.... ...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3569999999999998888764 6789999999642 256789999999999999999999885432 246
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|+||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 105 ~~iv~e~~~~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-------~~kl~ 170 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-------DLKIC 170 (364)
T ss_dssp EEEEEECCSEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEEC
T ss_pred EEEEEcccCcCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-------CEEEE
Confidence 899999999999999975 4599999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 381 GFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 381 DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
|||+++........ .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~ 241 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS--------KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QL 241 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB--------CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HH
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCC--------CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HH
Confidence 99999876543221 123445789999999998643 248899999999999999999999998765332 11
Q ss_pred HHHHHc-CC-----------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 460 SRNIRA-GE-----------------------RPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 460 ~~~i~~-~~-----------------------~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+.. +. ... .....+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 242 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 111110 00 000 12456788999999999999999999999988743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.12 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=199.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+. +..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEEEE
Confidence 47999999999998777764 688999999853 135688999999999999999999988654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 85 e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~kl~dfg~ 151 (276)
T 2yex_A 85 EYCSGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-------NLKISDFGL 151 (276)
T ss_dssp ECCTTEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------CEEECCCTT
T ss_pred EecCCCcHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-------CEEEeeCCC
Confidence 99985 99988753 35699999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+................||+.|+|||++.+.. .++.++||||||+++|+|++|..||...............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSS--------BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCC--------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh
Confidence 98654332222334567889999999996442 2477999999999999999999999876543322322222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...........+..+.+||.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 222222234578899999999999999999999999765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.69 Aligned_cols=246 Identities=21% Similarity=0.396 Sum_probs=208.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.+.|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.++ ..+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 457999999999998777764 588999999853 346789999999999999999999988654 689999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 99 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~kl~Dfg 164 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-------EVKLADFG 164 (303)
T ss_dssp EECCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECCCT
T ss_pred EEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-------CEEEeecc
Confidence 999986 99998863 5699999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||..... ......+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~ 231 (303)
T 3a7i_A 165 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLI 231 (303)
T ss_dssp TCEECBTTB--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH
T ss_pred cceecCccc--cccCccCCCcCccCHHHHhcC---------CCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHh
Confidence 997765332 123345688999999999654 478899999999999999999999987543 3344555
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
..+..+..+..++..+.+||.+||+.||.+|||+.+++++.....
T Consensus 232 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 666667778888999999999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.72 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=196.8
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC-----CCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS-----HPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~-----HpnIv~l~~~~~~e~ 297 (683)
..+..++|+++++||+|+++.|++. +|+.||||++... ...+..|+.+++.+. ||||+++++++...
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~- 108 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY- 108 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-
Confidence 3345679999999999998888863 6889999999643 345778999999996 99999999998654
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC------
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST------ 371 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~------ 371 (683)
..+||||||++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++......
T Consensus 109 -~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 -DHMCLIFEPLGPSLYEIITRN----NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp -TEEEEEECCCCCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred -CeeEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 689999999988999999863 334699999999999999999999999999999999999997521000
Q ss_pred ------------CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 372 ------------EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 372 ------------~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
.....+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il 249 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNL---------GWDVSSDMWSFGCVL 249 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTC---------CCCTTHHHHHHHHHH
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCC---------CCCCccchHHHHHHH
Confidence 01227999999999865332 2345689999999999754 489999999999999
Q ss_pred HHHHhCCCCCCCCccchhHHHHHHHcCCCC-------------------------CCC--------------------CC
Q 038696 440 FEILTGKVPFEDAHLQGDKMSRNIRAGERP-------------------------LFP--------------------FH 474 (683)
Q Consensus 440 ~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~-------------------------~~p--------------------~~ 474 (683)
|+|++|+.||....... ....+.....+ .++ ..
T Consensus 250 ~ell~g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 250 AELYTGSLLFRTHEHME--HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHSSCSCCCSSHHH--HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHCCCCCCCCcHHH--HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 99999999998754321 22222111100 001 11
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 475 SPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 475 ~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.++.+.+||.+||+.||.+|||+.++++|
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 23668899999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.40 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++.+.||+|+++.|+.. +|+.||+|++... ...+.+|+++|+.++||||+++++++.+. ..+|||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEEEEE
Confidence 58999999999998888763 6889999998643 34688999999999999999999998653 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|+.| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++
T Consensus 129 ~~~gg~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-----~~~vkL~DFG~a 198 (387)
T 1kob_A 129 FLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-----ASSVKIIDFGLA 198 (387)
T ss_dssp CCCCCBHHHHTTC-----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-----CCCEEECCCTTC
T ss_pred cCCCCcHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-----CCceEEEecccc
Confidence 9975 99998864 335699999999999999999999999999999999999997542 116999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... .....+..
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~ 264 (387)
T 1kob_A 199 TKLNPDE---IVKVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKR 264 (387)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH
T ss_pred eecCCCc---ceeeeccCCCccCchhccCC---------CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 8764322 22234689999999999754 4889999999999999999999999875432 33344444
Q ss_pred CCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... .....++.++.+||.+||..||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 3322 2234578999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.90 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=193.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
..+.+ .++|++++.||+|+++.|+.. +|+.||||++... .+.+.+|+++|+.++||||+++++++....
T Consensus 19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 33444 458999999999997777753 6899999998532 345789999999999999999999886542
Q ss_pred C----CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 298 K----KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 298 ~----~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
. ..+|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----- 165 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFMGTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC----- 165 (367)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----
T ss_pred ccccCceEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-----
Confidence 1 45799999997799999975 4589999999999999999999999999999999999999887
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
.+||+|||+++..... .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..
T Consensus 166 --~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 166 --ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNW--------MRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp --CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTT--------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCC--------CCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7999999999875432 2345788999999999752 258999999999999999999999998755
Q ss_pred cchhHHHHHHHc-CC----------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 454 LQGDKMSRNIRA-GE----------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 454 ~~~~~~~~~i~~-~~----------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... .+...+.. +. ........+..+.+||.+||..||.+|||+.++++|-
T Consensus 231 ~~~-~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 231 HLD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHH-HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHH-HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 321 11111110 00 0012245688899999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.02 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=201.2
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--T 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 347999999999998888764 588999999843 134688999999999999999999998643 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .....+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~---~~~~~~k 159 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN---IPIPHIK 159 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT------CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT---SSSCCEE
T ss_pred EEEEEEEcCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC---CCcCCEE
Confidence 8999999997 599999974 35689999999999999999999999999999999999998775 2223699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.... .
T Consensus 160 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 225 (321)
T 2a2a_A 160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTKQ--E 225 (321)
T ss_dssp ECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--H
T ss_pred EccCccceecCccc---cccccCCCCCccCcccccCC---------CCCCccccHHHHHHHHHHHHCCCCCCCCCHH--H
Confidence 99999998765432 22345689999999999654 4889999999999999999999999875532 3
Q ss_pred HHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 459 MSRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+....... .+...+..+.+||.+||..||.+|||+.++++|
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 444444433221 124678889999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=334.25 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=199.1
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcC--CCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDE--EKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e--~~~~ 300 (683)
....|.+.+.||+|+++.|+.. ++..||+|.+.. ..+.+.+|+.+|+.++||||+++++++... ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 4456899999999998777763 577999999853 234578999999999999999999987542 3467
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeC-CCCCCCCCcce
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLK-PRGASTEGYLH 376 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~-~~g~~~~~~~~ 376 (683)
+|+||||++| +|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++ .++ .
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-------~ 170 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-------S 170 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-------C
T ss_pred EEEEEEecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC-------C
Confidence 8999999975 999999863 56899999999999999999999999 99999999999997 555 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......
T Consensus 171 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~----------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 235 (290)
T 1t4h_A 171 VKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQNA- 235 (290)
T ss_dssp EEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-
T ss_pred EEEeeCCCccccccc----ccccccCCcCcCCHHHHhc----------cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-
Confidence 999999999765332 2234568899999999853 3889999999999999999999999875433
Q ss_pred hHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 DKMSRNIRAGER-PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~~~~-~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
......+..+.. ..++...++.+.+||.+||+.||.+|||+.++++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 234444444432 234556678999999999999999999999998763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.92 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=204.0
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|+.. ++..||||++.. ..+.+.+|+++++.++||||+++++++.+. +.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence 3458999999999998877764 577899999842 245688999999999999999999998653 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~kl~ 156 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH------GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-------ELKIA 156 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-------CEEEC
T ss_pred EEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-------CEEEe
Confidence 999999975 999999864 4689999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++...... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||...... ...
T Consensus 157 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 221 (284)
T 2vgo_A 157 DFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGK---------THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETH 221 (284)
T ss_dssp CCTTCEECSSS----CBCCCCSCGGGCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH
T ss_pred cccccccCccc----ccccccCCCCcCCHHHhccC---------CCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHH
Confidence 99998765432 22345688999999999754 4788999999999999999999999875432 233
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+... ...++...+..+.++|.+||+.||.+|||+.++++|-+.
T Consensus 222 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 222 RRIVNV-DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp HHHHTT-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred HHHhcc-ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 344433 344677789999999999999999999999999987554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.06 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=195.7
Q ss_pred CCCeEEE-eEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVR-RRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~-~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.+.|++. +.||+|+++.|++. +|+.||||++... .+.+.+|+.+|..+ +||||+++++++.++ +.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence 3579985 78999998888864 6889999998542 45688999999985 799999999998654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+||
T Consensus 89 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~~~~kl~Df 158 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN----QVSPVKICDF 158 (316)
T ss_dssp EEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS----SSCSEEECCT
T ss_pred EEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC----CcCceEEEEc
Confidence 999998 5999999863 4689999999999999999999999999999999999998765 1124999999
Q ss_pred cCccccCCCCC-----CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--
Q 038696 383 GLSSVKNFGPK-----SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-- 455 (683)
Q Consensus 383 Gla~~~~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~-- 455 (683)
|++........ ........||+.|+|||++.+.... ...++.++|||||||++|||++|+.||.+....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE----ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHH----HHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhccccc----ccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence 99976542211 1112234589999999999752100 013788999999999999999999999765422
Q ss_pred -----------hhHHHHHHHcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 456 -----------GDKMSRNIRAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 456 -----------~~~~~~~i~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
...+...+..+... ++ ..++..+.+||.+||+.||.+|||+.++++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 235 GWDRGEACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp CC----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred cccccccchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 12344455554332 22 35788899999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.90 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=205.2
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||++++++|.+. ..+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEE
Confidence 3468999999999998888863 689999999842 345688999999999999999999998654 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
||||||++| +|.+++.... .....+++..+..|+.||+.||.|||++||+||||||+|||++.+| ++||+
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-------~vkL~ 331 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-------NVRIS 331 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-------CEEEC
T ss_pred EEEEEeccCCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-------CEEEe
Confidence 999999985 9999997531 1234699999999999999999999999999999999999999888 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--chhH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL--QGDK 458 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~--~~~~ 458 (683)
|||+++....... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+... ....
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~---------~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~ 400 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE---------EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCC---------CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH
Confidence 9999987654321 23345789999999999754 489999999999999999999999986532 2234
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF-----SSICRI 503 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~-----~eil~~ 503 (683)
+...+... ...+|..++.++.+||.+||..||.+||++ .+|++|
T Consensus 401 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 401 LKQRVLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 44555444 344677889999999999999999999965 666655
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.75 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=190.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++++.++||||+++++++.+. +.+++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEE
Confidence 58999999999998877763 5889999998542 24577899999999999999999998654 789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++| +|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 81 ~e~~~~~~l~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg 147 (311)
T 4agu_A 81 FEYCDHTVLHELDRY------QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-------VIKLCDFG 147 (311)
T ss_dssp EECCSEEHHHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECCCT
T ss_pred EEeCCCchHHHHHhh------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-------CEEEeeCC
Confidence 999996 66666653 35699999999999999999999999999999999999998887 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++........ ......||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+...... .....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~ 216 (311)
T 4agu_A 148 FARLLTGPSD--YYDDEVATRWYRSPELLVGD--------TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIR 216 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTC--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred CchhccCccc--ccCCCcCCccccChHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 9987653221 22345688899999999753 2589999999999999999999999987653321 11111
Q ss_pred Hc-------------------CCCCCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 464 RA-------------------GERPLF----------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 464 ~~-------------------~~~~~~----------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.. +..... ....+..+.+||.+||+.||.+|||+.++++|-
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 00 000000 134678899999999999999999999998763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.79 Aligned_cols=246 Identities=31% Similarity=0.385 Sum_probs=202.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----------------CcchHHHHHHHHHcCCCCceeeeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----------------DIEPLVPEISSLLSLSHPNIMHFLCG 292 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----------------~~~~~~~Ei~iL~~L~HpnIv~l~~~ 292 (683)
.++|+++++||+|+++.|++. +|..||||++.. ..+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999998888863 578999999853 13467899999999999999999999
Q ss_pred EEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 293 FTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
+.+ ...+|||||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--- 183 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--- 183 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT---
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC---
Confidence 964 4789999999975 999999763 5699999999999999999999999999999999999998764
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~ 451 (683)
....+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 184 -~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 184 -SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK----------KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp -CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT----------CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc----------CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 22369999999998765432 2344568999999999863 388999999999999999999999987
Q ss_pred CccchhHHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 452 AHLQGDKMSRNIRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 452 ~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
... ..+...+..+..... ...++.++.+||.+||..||.+|||+.++++|-+.
T Consensus 250 ~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 250 QND--QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp SSH--HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCH--HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 653 345555655543211 14578899999999999999999999999988554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.48 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=201.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.|++. +|+.||||++. .....+.+|+++|+.++|||||++++++.+ ...+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEE
Confidence 48999999999998777763 68899999983 245678999999999999999999999865 4789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus 100 ~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~----~~~~~kl~Dfg 169 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE----KDCDIKIIDFG 169 (486)
T ss_dssp ECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS----TTCCEEECSCS
T ss_pred EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC----CCCCEEEEECC
Confidence 999975 999998763 5699999999999999999999999999999999999996543 12269999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+... ..+...+
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i 234 (486)
T 3mwu_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG----------TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRV 234 (486)
T ss_dssp CTTTBCCC-------CCTTGGGGCCGGGGGS----------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred cCeECCCCC---ccCCCcCCCCCCCHHHhCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 998765332 2234578999999999864 389999999999999999999999987653 3345555
Q ss_pred HcCCCCCC-C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLF-P--FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~-p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+..... + ..++..+.+||.+||..||.+|||+.++++|-+.
T Consensus 235 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 55543221 1 3467889999999999999999999999988554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.90 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=197.3
Q ss_pred CCeEEEeEecccccEEEEEE---cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcCC----CCeEEEEEec
Q 038696 235 EDYQVRRRLGSGSQYKEILW---LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KKECFLIMEL 307 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~~~~LVmEy 307 (683)
.+|++.+.||+|+++.|++. .+..||+|++........+|+++|+.++||||++++++|.... ...+|+||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 47999999999998888764 4567999998765555668999999999999999999886432 2347899999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCCCCCCcceEEEecccCcc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK-PRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~-~~g~~~~~~~~vKL~DFGla~ 386 (683)
+++++.+.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++
T Consensus 120 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-------~~kL~DFG~a~ 190 (394)
T 4e7w_A 120 VPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-------VLKLIDFGSAK 190 (394)
T ss_dssp CSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-------EEEECCCTTCE
T ss_pred cCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC-------cEEEeeCCCcc
Confidence 99987776654221 235699999999999999999999999999999999999998 565 79999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA- 465 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~- 465 (683)
...... ......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.... +.+...+..
T Consensus 191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~ 258 (394)
T 4e7w_A 191 ILIAGE---PNVSYICSRYYRAPELIFGA--------TNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVL 258 (394)
T ss_dssp ECCTTC---CCCSSCSCGGGCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred cccCCC---CCcccccCcCccCHHHHcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 764432 22345678999999999643 25899999999999999999999999876532 122222211
Q ss_pred C-----------------CCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 G-----------------ERP---------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~-----------------~~~---------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+ ..+ .++...+.++.+||.+||..||.+|||+.++++|-+
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 0 000 123457789999999999999999999999988643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.73 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=202.4
Q ss_pred ccceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---CcchHHHHHHHHHcC-CCCceeeeeeeEEcCC
Q 038696 226 LPSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEE 297 (683)
Q Consensus 226 ~~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~ 297 (683)
....+....++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34455566789999999999998888763 688999999853 356789999999999 7999999999987632
Q ss_pred ----CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 298 ----KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 298 ----~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
...+|+||||++| +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~---- 166 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA---- 166 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC----
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC----
Confidence 4689999999985 999999863 235699999999999999999999999999999999999998887
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||++....... .......||+.|+|||++..... ....++.++|||||||++|+|++|..||.+.
T Consensus 167 ---~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 167 ---EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDEN----PDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp ---CEEECCCTTTC---------------CCGGGCCHHHHC------------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ---CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccc----cCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 79999999997654321 12234568899999999964210 1235889999999999999999999999875
Q ss_pred ccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
... ...............+..++..+.+||.+||..||.+|||+.+++++-.
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 238 HPM-RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp CHH-HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred cHH-HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 532 2222223333333345667899999999999999999999999988743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.96 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=200.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|++. +|+.||||++... ...+.+|+.++..+ +||||+++++++.+. +.+|+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 48999999999998777763 6899999998642 34578899999999 899999999998654 68999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC------------
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS------------ 370 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~------------ 370 (683)
||||++| +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++..
T Consensus 89 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999975 99999986321 12568999999999999999999999999999999999999855410
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
......+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+++.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQEN--------YTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTC--------CTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCC--------CCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 013347999999999876432 233588899999999743 246789999999999999999998775
Q ss_pred CCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... ....+..+..+..+..++..+.+||.+||+.||.+|||+.++++|-
T Consensus 233 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 233 NGD-----QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp SSH-----HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred chh-----HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 432 3455666777778888999999999999999999999999998763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=331.16 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=180.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeEEE
Confidence 48999999999998777764 688999999842 236788999999999999999999998653 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+++ +|.+++.. ...++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 89 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-------~~kl~df 156 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN-----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-------NIKIADF 156 (278)
T ss_dssp EEECCTTEEHHHHHHT-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-------CEEECCC
T ss_pred EEecCCCCcHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------CEEEEee
Confidence 9999975 99999985 335799999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... ....
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~ 223 (278)
T 3cok_A 157 GLATQLKMPHE--KHYTLCGTPNYISPEIATRS---------AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNK 223 (278)
T ss_dssp TTCEECC---------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------
T ss_pred cceeeccCCCC--cceeccCCCCcCCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HHHH
Confidence 99987643221 22245688899999998754 47889999999999999999999998755432 1111
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+... ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 224 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 VVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCSS-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Hhhc-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1111 223566678999999999999999999999999765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.56 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=202.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCC--------CcchHHHHHHHHHcC-CCCceeeeeeeEEc
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFG--------DIEPLVPEISSLLSL-SHPNIMHFLCGFTD 295 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 295 (683)
+..++|++.+.||+|+++.|++. +|+.||||+++. ..+.+.+|+.+|..+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34469999999999998877752 678999999853 235677899999999 69999999998865
Q ss_pred CCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
+ ..+||||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 131 ~--~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------ 196 (355)
T 1vzo_A 131 E--TKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------ 196 (355)
T ss_dssp T--TEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------
T ss_pred C--ceEEEEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------
Confidence 4 689999999985 999999863 4699999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+++....... .......||+.|+|||++.+. ...++.++|||||||++|||++|+.||.....
T Consensus 197 -~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 197 -HVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGG-------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp -CEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTC-------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred -cEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCC-------CCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 799999999986543211 122345689999999999742 12478899999999999999999999975432
Q ss_pred c--hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHH
Q 038696 455 Q--GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRILRY 506 (683)
Q Consensus 455 ~--~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L~~ 506 (683)
. ...+...+... .+.++..++..+.+||.+||..||.+|| |+.+++++...
T Consensus 268 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 268 KNSQAEISRRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred cchHHHHHHHHhcc-CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 2 22333344333 3456778899999999999999999999 99999887654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.39 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=193.3
Q ss_pred CeEE--EeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 236 DYQV--RRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 236 ~y~i--~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.|.+ .+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.+. ..+||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEE
Confidence 4555 678999997777753 6889999999652 45688999999999999999999998654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC--CCCCCCCCcceEEEecc
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK--PRGASTEGYLHAKISGF 382 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~--~~g~~~~~~~~vKL~DF 382 (683)
||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+. .++ .+||+||
T Consensus 166 E~~~~~~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-------~~kl~DF 233 (373)
T 2x4f_A 166 EYVDGGELFDRIID-----ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-------QIKIIDF 233 (373)
T ss_dssp ECCTTCEEHHHHHH-----TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT-------EEEECCC
T ss_pred eCCCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC-------cEEEEeC
Confidence 99975 99999875 234689999999999999999999999999999999999994 344 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... .....
T Consensus 234 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~ 299 (373)
T 2x4f_A 234 GLARRYKPRE---KLKVNFGTPEFLAPEVVNYD---------FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNN 299 (373)
T ss_dssp SSCEECCTTC---BCCCCCSSCTTCCHHHHTTC---------BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH
T ss_pred CCceecCCcc---ccccccCCCcEeChhhccCC---------CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 9998765432 22344689999999999654 4899999999999999999999999876532 23344
Q ss_pred HHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+....... ....++.++.+||.+||..||.+|||+.++++|-+.
T Consensus 300 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp HHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 44333221 124578999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=370.56 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=205.1
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~ 298 (683)
.+..++|++++.||+|+++.|++. +|+.||||+++. ..+.+..|.++|..+ +||||++++++|.+ .
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~ 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--M 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--S
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--C
Confidence 445679999999999998888763 678999999852 355678999999988 69999999998854 4
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..+||||||++| +|.+++... ..|++..+..|+.||+.||.|||++||+||||||+||||+.++ ++
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-------~i 481 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------HI 481 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-------CE
T ss_pred CEEEEEEeCcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-------cE
Confidence 789999999985 999999864 4699999999999999999999999999999999999999888 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. .
T Consensus 482 kL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~---------~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~ 548 (674)
T 3pfq_A 482 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--D 548 (674)
T ss_dssp EECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCC---------CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred EEeecceeeccccCC--cccccccCCCcccCHhhhcCC---------CCCccceEechHHHHHHHHcCCCCCCCCCH--H
Confidence 999999998643322 233456799999999999754 489999999999999999999999987653 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF-----SSICRIL 504 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~-----~eil~~L 504 (683)
.+...+.... ..+|..++.++.+||++||+.||.+||++ .+|++|-
T Consensus 549 ~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 549 ELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp HHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 4556666543 45778899999999999999999999987 6766653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=358.10 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=195.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC-CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG-DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~-~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~ 302 (683)
..+.++..+|.+.+.||+|+++.|+. .+|+.||||++.. ....+.+|+++|+.+ +|||||++++++.+. ..+|
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~ 94 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQY 94 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEE
Confidence 45677777899999999999776553 4789999999854 456678999999999 799999999988654 7899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||||+|+|.+++... ...+....+..++.||+.||.|||++||+||||||+|||++.++ .++.+.+||+||
T Consensus 95 lv~E~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~--~~~~~~~kL~DF 167 (432)
T 3p23_A 95 IAIELCAATLQEYVEQK-----DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN--AHGKIKAMISDF 167 (432)
T ss_dssp EEEECCSEEHHHHHHSS-----SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB--TTTBCCEEECCT
T ss_pred EEEECCCCCHHHHHHhc-----CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC--CCCceeEEEecc
Confidence 99999999999999852 33455556789999999999999999999999999999997553 245567999999
Q ss_pred cCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHH
Q 038696 383 GLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMS 460 (683)
Q Consensus 383 Gla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~ 460 (683)
|+++........ .......||+.|+|||++.+. ....++.++|||||||++|||++ |..||....... ..
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~ 239 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED------CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--AN 239 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcc------cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HH
Confidence 999876543211 223456789999999999643 12357889999999999999999 999997644221 11
Q ss_pred HHHHcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 461 RNIRAGERPLF--PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 461 ~~i~~~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..+........ +...+..+.+||.+||+.||.+|||+.++++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 11111111111 122355688999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.17 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=196.5
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 3469999999999998777763 688999999842 245788999999999999999999988654 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~~l~ 153 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-------NAKIA 153 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-------CEEEC
T ss_pred EEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-------CEEEe
Confidence 999999975 999999863 4589999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||++....... ......+|+.|+|||++.+.. ..+.++||||||+++|+|++|..||..... ..+.
T Consensus 154 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~ 220 (276)
T 2h6d_A 154 DFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRL--------YAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLF 220 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSC--------CCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred ecccccccCCCc---ceecccCCccccCHHHHcCCC--------CCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHH
Confidence 999998764322 123446788999999997542 246899999999999999999999987543 2344
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 461 ~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+..+. ...+...+..+.++|.+||+.||.+|||+.++++|-+
T Consensus 221 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 221 KKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 5555543 3456778899999999999999999999999998744
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.34 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=188.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC----CC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE----KK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~----~~ 299 (683)
.++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 369999999999998888764 6889999998542 245789999999999999999999886532 23
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
.+||||||++|+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 104 ~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-------~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKI 168 (371)
T ss_dssp EEEEEEECCSEEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEE
T ss_pred ceEEEEEcCCCCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-------CEEE
Confidence 789999999999999886 2489999999999999999999999999999999999999887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... . .
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~-~ 234 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-D-Q 234 (371)
T ss_dssp CCCCC-------------------CTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H-H
T ss_pred EEeeccccccccc---ccCCceecCCccCHHHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-H
Confidence 9999998654321 22345788999999999754 4889999999999999999999999875432 1 1
Q ss_pred HHHHHcCCC---------------------CCC--------------CCC------CcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 460 SRNIRAGER---------------------PLF--------------PFH------SPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 460 ~~~i~~~~~---------------------~~~--------------p~~------~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
...+..... +.+ +.. .+..+.+||.+||..||.+|||+.
T Consensus 235 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 314 (371)
T 2xrw_A 235 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314 (371)
T ss_dssp HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHH
Confidence 122211110 000 111 146789999999999999999999
Q ss_pred HHHHHHHH
Q 038696 499 SICRILRY 506 (683)
Q Consensus 499 eil~~L~~ 506 (683)
++++|-+.
T Consensus 315 e~l~hp~~ 322 (371)
T 2xrw_A 315 EALQHPYI 322 (371)
T ss_dssp HHHHSHHH
T ss_pred HHhCCcch
Confidence 99998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.37 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=198.4
Q ss_pred eEEEeEecccccEEEEE--EcCcEEEEEEeCCC--------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 237 YQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
|...+.||+|+++.|+. .+|+.||||++... .+.+.+|+.+++.++||||+++++++.+ ....|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEEEE
Confidence 33458899999877775 37889999998532 3468899999999999999999998854 367899999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++.... ...++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 111 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-------~~kl~Dfg~~ 180 (307)
T 2nru_A 111 YMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-------TAKISDFGLA 180 (307)
T ss_dssp CCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-------CEEECCCTTC
T ss_pred ecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-------cEEEeecccc
Confidence 997 59999997531 235699999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSRNI 463 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~~i 463 (683)
+...............||+.|+|||++.+. ++.++||||||+++|+|++|..||....... ..+...+
T Consensus 181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (307)
T 2nru_A 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE----------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250 (307)
T ss_dssp EECCSCSSCEECSSCCSCGGGCCHHHHTTE----------ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH
T ss_pred cccccccccccccccCCCcCcCChHHhcCC----------CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh
Confidence 876543222223345789999999998643 7889999999999999999999997654321 1122222
Q ss_pred HcC----------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 464 RAG----------ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 464 ~~~----------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 211 111223334677999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.04 Aligned_cols=247 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+.+++.++||||+++++++.++ +.+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeEE
Confidence 458999999999998777764 6889999998532 25678999999999999999999988654 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 111 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-------~~kl~D 177 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-------FAYLVD 177 (309)
T ss_dssp EEEECCCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEECS
T ss_pred EEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-------CEEEec
Confidence 99999986 999999863 4699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||++....... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.... .+..
T Consensus 178 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~ 245 (309)
T 2h34_A 178 FGIASATTDEK-LTQLGNTVGTLYYMAPERFSES---------HATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGA 245 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC-------------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHH
T ss_pred CccCccccccc-cccccccCCCcCccCHHHHcCC---------CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHH
Confidence 99997664332 1122345688999999999654 4788999999999999999999999875432 3333
Q ss_pred HHHcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHH
Q 038696 462 NIRAGERP--LFPFHSPKYVTNLTKRCWHADPNQRP-SFSSICRILRYI 507 (683)
Q Consensus 462 ~i~~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RP-t~~eil~~L~~i 507 (683)
.+...... ..+..++..+.++|.+||+.||.+|| ++.++++.|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 246 HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 44433221 24567888999999999999999999 999999888764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=343.00 Aligned_cols=234 Identities=21% Similarity=0.281 Sum_probs=195.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++||||++++++|.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-- 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-- 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC--
Confidence 48999999999997777653 6889999998532 34678899999999999999999998643
Q ss_pred CeEEEEEecCC-C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 299 KECFLIMELMS-R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 299 ~~~~LVmEy~~-g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+++||||+. | +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------~ 168 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR------HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-------T 168 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT------CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------C
T ss_pred CEEEEEEEeCCCCccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-------c
Confidence 78999999985 6 99999975 35699999999999999999999999999999999999998887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNP--------YRGPELEMWSLGVTLYTLVFEENPFCELEET- 236 (335)
T ss_dssp EEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCC--------BCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-
T ss_pred EEEeecccceECCCCC---ceeccCCCccccChhhhcCCC--------CCCCcccchhHHHHHHHHHhCCCchhhHHHH-
Confidence 9999999998765432 223456899999999997542 2488999999999999999999999763321
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 237 --------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233456688999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.88 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=203.9
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
...++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++||||+++++++.+.....+|
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34568999999999998888864 488999999863 345678999999999999999999998876666889
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|||||++| +|.+++.... ....+++..+..++.||+.||.|||++||+||||||+|||+..+. ++...+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~~~~~kL~D 159 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---DGQSVYKLTD 159 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG---GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT---TSCEEEEECC
T ss_pred EEEecCCCCCHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC---CCceeEEEec
Confidence 99999975 9999997531 223499999999999999999999999999999999999982211 2223799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc--hhHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ--GDKM 459 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~--~~~~ 459 (683)
||+++...... ......||+.|+|||++.+..... .....++.++|||||||++|||++|+.||...... ...+
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRK-DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC---CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred CCCceEccCCC---ccccccCCccccCHHHhhcccccc-ccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 99998765432 223456899999999987521000 00013788999999999999999999999643221 1223
Q ss_pred HHHHHcCCCCC------------------CC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPL------------------FP------FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 460 ~~~i~~~~~~~------------------~p------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+..+.++. ++ ...+..+.+++.+||+.||++|||+.++++.+..+..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 33333333211 11 1235678899999999999999999999998887653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.82 Aligned_cols=245 Identities=30% Similarity=0.405 Sum_probs=201.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++++.||+|+++.|++. +|..||||++.. ....+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 47999999999998877763 678999999853 24568899999999999999999999964 4789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus 115 ~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~----~~~~~kl~DfG 184 (494)
T 3lij_A 115 MECYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE----KDALIKIVDFG 184 (494)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----TTCCEEECCCT
T ss_pred EecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC----CCCcEEEEECC
Confidence 999975 999998763 5699999999999999999999999999999999999997653 12269999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+... ..+...+
T Consensus 185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i 249 (494)
T 3lij_A 185 LSAVFENQK---KMKERLGTAYYIAPEVLRK----------KYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKV 249 (494)
T ss_dssp TCEECBTTB---CBCCCCSCTTTCCHHHHTT----------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred CCeECCCCc---cccccCCCcCeeCHHHHcc----------cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 998765432 2334578999999999853 388999999999999999999999987653 3455555
Q ss_pred HcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+...... ..++..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 555433222 3578899999999999999999999999988554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.31 Aligned_cols=246 Identities=23% Similarity=0.401 Sum_probs=197.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
..++|++.+.||+|+++.|+.. +|+.||||.+.. ..+.+.+|+.+++.++||||+++++++... ..+|+|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEee
Confidence 3568999999999997777653 588999999854 456789999999999999999999988654 68999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 105 ~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~kl~dfg~~ 172 (314)
T 3com_A 105 YCGAGSVSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-------HAKLADFGVA 172 (314)
T ss_dssp CCTTEEHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCTTC
T ss_pred cCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-------CEEEeecccc
Confidence 9986 999999742 35699999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||....... ....+..
T Consensus 173 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~ 239 (314)
T 3com_A 173 GQLTDTM--AKRNTVIGTPFWMAPEVIQEI---------GYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPT 239 (314)
T ss_dssp EECBTTB--SCBCCCCSCGGGCCHHHHSSS---------CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH
T ss_pred hhhhhhc--cccCccCCCCCccChhhcCCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhc
Confidence 7764321 123345688999999999654 48889999999999999999999998755322 2223333
Q ss_pred CCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GERPL--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+. .+..++..+.+||.+||..||.+|||+.+++++-+
T Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 32222 34556889999999999999999999999988744
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.70 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=195.9
Q ss_pred eEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCC-CcchHHHHHHHHH--cCCCCceeeeeeeEE---cCCCCeE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-DIEPLVPEISSLL--SLSHPNIMHFLCGFT---DEEKKEC 301 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-~~~~~~~Ei~iL~--~L~HpnIv~l~~~~~---~e~~~~~ 301 (683)
..+..++|++.+.||+|+++.|++ .+|+.||||++.. ....+..|.+++. .++||||+++++.+. .+....+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 345567999999999999877775 4789999999854 3344555555544 589999999986443 2334578
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEeCCCCCCC
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK---------KIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------gIiHrDLKp~NILl~~~g~~~ 371 (683)
||||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 88 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--- 157 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--- 157 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS---
T ss_pred EEEEecCCCCcHHHHHhh-------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC---
Confidence 99999997 599999976 3468999999999999999999999 999999999999998887
Q ss_pred CCcceEEEecccCccccCCCCC------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPK------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG 445 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG 445 (683)
.+||+|||+++....... ........||+.|+|||++.+..... ....++.++|||||||++|||++|
T Consensus 158 ----~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 158 ----TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR--DXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp ----CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG--GHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc--cccccccccchHHHHHHHHHHHhc
Confidence 799999999987643211 11223456899999999997521000 001367899999999999999999
Q ss_pred CCCCCCCcc-c---------------hhHHHHH-HHcCCCCCCCCCC------cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 446 KVPFEDAHL-Q---------------GDKMSRN-IRAGERPLFPFHS------PKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 446 ~~Pf~~~~~-~---------------~~~~~~~-i~~~~~~~~p~~~------~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
..||..... . ...+... .....++.++..+ +..+.+||.+||+.||++|||+.++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 776643211 0 0111111 1223344444443 457999999999999999999999999
Q ss_pred HHHHHHH
Q 038696 503 ILRYIKR 509 (683)
Q Consensus 503 ~L~~i~~ 509 (683)
.|+.+..
T Consensus 312 ~L~~ll~ 318 (336)
T 3g2f_A 312 RMAELMM 318 (336)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.13 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=200.2
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
..++|++.+.||+|+++.|++. +|..||+|++... .+.+.+|+.+|+.++||||+++++++.+. +.+||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEE
Confidence 4568999999999998777763 5889999998643 34678999999999999999999988654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||++| +|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|
T Consensus 109 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-------~~kl~D 175 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCD 175 (360)
T ss_dssp EECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-------CEEECC
T ss_pred EEECCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-------CEEEEE
Confidence 9999985 999999863 4689999999999999999999996 999999999999999887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh----
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD---- 457 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~---- 457 (683)
||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 176 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 176 FGVSGQLIDS----MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp CCCCHHHHHH----C----CCCCTTCCHHHHTTC---------CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred CCCCcccccc----cccCCCCCCCeECHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 9999765322 22345688899999999754 489999999999999999999999976442211
Q ss_pred ------------------------------------HHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 458 ------------------------------------KMSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 458 ------------------------------------~~~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
.....+.....+..+ ..++.++.+||.+||+.||.+|||+.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 322 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence 111222233333333 3468899999999999999999999999
Q ss_pred HHHHHHH
Q 038696 501 CRILRYI 507 (683)
Q Consensus 501 l~~L~~i 507 (683)
++|-+.-
T Consensus 323 l~hp~~~ 329 (360)
T 3eqc_A 323 MVHAFIK 329 (360)
T ss_dssp HTSHHHH
T ss_pred hhChHhh
Confidence 9986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.28 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
++|++.+.||+|+++.|+.. +|+.||||+++. ..+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--Ce
Confidence 47999999999998887764 688999999843 135689999999999999999999988653 78
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .....+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~~~~kl 153 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN---VPNPRIKL 153 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS---SSSCCEEE
T ss_pred EEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC---CCCCceEE
Confidence 999999997 5999999763 4699999999999999999999999999999999999998765 23346999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.... ..
T Consensus 154 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~ 219 (283)
T 3bhy_A 154 IDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGETKQ--ET 219 (283)
T ss_dssp CCCTTCEECC-----------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH
T ss_pred EecccceeccCCC---cccccCCCcCccCcceecCC---------CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HH
Confidence 9999998764332 22345688899999999654 4889999999999999999999999876532 23
Q ss_pred HHHHHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 460 SRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 460 ~~~i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
...+....... .....+..+.+|+.+||..||.+|||+.+++++-.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 34444333221 12456888999999999999999999999998744
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.04 Aligned_cols=245 Identities=27% Similarity=0.359 Sum_probs=196.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcC------CCCceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSL------SHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~e~~~~ 300 (683)
..+|++++.||+|+++.|++. +|+.||||++... ...+.+|++++..+ +|+||+++++++... ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence 458999999999998888864 5789999999754 24577899988887 577999999998654 78
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+||||||++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++. ..+||+
T Consensus 174 ~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-----~~vkL~ 244 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKN----KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-----SGIKVI 244 (429)
T ss_dssp EEEEECCCCCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-----CCEEEC
T ss_pred EEEEEeccCCCHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-----cceEEe
Confidence 9999999999999999873 3345999999999999999999999999999999999999988761 139999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+..... .+.
T Consensus 245 DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~ 309 (429)
T 3kvw_A 245 DFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGA---------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLA 309 (429)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHHTB---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred ecccceecCC-----cccccCCCCCccChHHHhCC---------CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 9999976532 22345788999999999765 48999999999999999999999998765321 222
Q ss_pred HHHHc-CCC--------------------C------------------------------------CCCCCCcHHHHHHH
Q 038696 461 RNIRA-GER--------------------P------------------------------------LFPFHSPKYVTNLT 483 (683)
Q Consensus 461 ~~i~~-~~~--------------------~------------------------------------~~p~~~~~~l~~Li 483 (683)
..+.. +.. + .++...++.+.+||
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 11111 000 0 01122367799999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 038696 484 KRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 484 ~~cL~~dP~~RPt~~eil~~L 504 (683)
.+||+.||.+|||+.++++|-
T Consensus 390 ~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTST
T ss_pred HHHCCCChhhCCCHHHHhCCh
Confidence 999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.67 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=196.7
Q ss_pred CCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC-cchHHHHHHHHHcC--CCCceeeeeeeEEcCCC--CeEEEEEec
Q 038696 235 EDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD-IEPLVPEISSLLSL--SHPNIMHFLCGFTDEEK--KECFLIMEL 307 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~-~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~e~~--~~~~LVmEy 307 (683)
++|++.+.||+|+++.|++ ..|+.||||++... ...+..|.+++..+ +||||+++++++..... ..+|+||||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 4899999999999887775 47899999998543 34556677777665 89999999998865432 678999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK--------KIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
++| +|.++++. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+|
T Consensus 117 ~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-------~~k 182 (337)
T 3mdy_A 117 HENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-------TCC 182 (337)
T ss_dssp CTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-------CEE
T ss_pred cCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-------CEE
Confidence 975 99999976 4599999999999999999999999 999999999999998887 799
Q ss_pred EecccCccccCCCCCCC--CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC----------C
Q 038696 379 ISGFGLSSVKNFGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG----------K 446 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG----------~ 446 (683)
|+|||+++......... ......||+.|+|||++.+..... ...++.++|||||||++|||++| .
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN---HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT---CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc---cccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999997664332211 123457899999999997542100 00111259999999999999999 7
Q ss_pred CCCCCCccch---hHHHHHHH-cCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 447 VPFEDAHLQG---DKMSRNIR-AGERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 447 ~Pf~~~~~~~---~~~~~~i~-~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.||....... ..+...+. ....+.++. .++.++.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 7776532211 22222222 223333333 456779999999999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.10 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=193.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.++|.+.+.||+|+++.|++. +|+.||||++.. ....+.+|+++|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 468999999999998888763 678999999842 12358899999999999999999998743
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..+||||||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ....
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~----~~~~ 280 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE----EDCL 280 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS----SSCC
T ss_pred -CceEEEEEcCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC----Ccce
Confidence 458999999975 99888753 35699999999999999999999999999999999999997654 2236
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... ......||+.|+|||++.+. ....++.++|||||||++|+|++|..||......
T Consensus 281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~- 350 (419)
T 3i6u_A 281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ- 350 (419)
T ss_dssp EEECCSSTTTSCC--------------CTTCCTTTTC----------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-
T ss_pred EEEeecccceecCCCc---cccccCCCCCccCceeeecC------CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-
Confidence 9999999998764321 22345689999999998642 1235889999999999999999999999865432
Q ss_pred hHHHHHHHcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..+...+..+.....+ ..++..+.+||.+||+.||.+|||+.++++|-
T Consensus 351 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 351 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp CCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 2344555555433322 45788999999999999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.42 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=197.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++ ||||+++++++.+......++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 468999999999998888764 688999999964 4567899999999997 9999999999987556789999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++| +|.+++.. +++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++
T Consensus 115 ~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~------~~kl~Dfg~a~ 179 (330)
T 3nsz_A 115 VNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR------KLRLIDWGLAE 179 (330)
T ss_dssp CCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT------EEEECCCTTCE
T ss_pred cCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC------EEEEEeCCCce
Confidence 985 88887753 899999999999999999999999999999999999986652 69999999998
Q ss_pred ccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH-----
Q 038696 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR----- 461 (683)
Q Consensus 387 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~----- 461 (683)
...... ......+|..|+|||++.+. ..++.++|||||||++|+|++|..||.......+.+..
T Consensus 180 ~~~~~~---~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~ 248 (330)
T 3nsz_A 180 FYHPGQ---EYNVRVASRYFKGPELLVDY--------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248 (330)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred EcCCCC---ccccccccccccChhhhcCC--------CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence 765432 22345678889999999642 25899999999999999999999999654332222211
Q ss_pred -------HHHcCCCC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 462 -------NIRAGERP-----------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 462 -------~i~~~~~~-----------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.+...... ..+...+.++.+||.+||+.||.+|||+.++++|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 11111110 11122688999999999999999999999998763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.30 Aligned_cols=244 Identities=28% Similarity=0.378 Sum_probs=203.5
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|.+.+.||+|+++.|+.. +|+.||+|++... .+.+.+|+.+++.++||||+++++++.+. +.+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CEEE
Confidence 357999999999998888763 5789999998432 34678899999999999999999998643 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 92 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~~kl~d 158 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-------EVKIGD 158 (294)
T ss_dssp EEEECCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECC
T ss_pred EEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-------CEEEEe
Confidence 99999984 999988763 4699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~ 225 (294)
T 2rku_A 159 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYL 225 (294)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTS---------CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH
T ss_pred ccCceecccCcc--ccccccCCCCcCCcchhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 999987643221 23345688999999999654 4788999999999999999999999876533 2333
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+... ....+...+..+.+++.+||+.||.+|||+.+++++...
T Consensus 226 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 226 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHHTT-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHhhc-cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 34433 334667788999999999999999999999999987554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.55 Aligned_cols=244 Identities=28% Similarity=0.383 Sum_probs=203.7
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|.+.+.||+|+++.|+.. +|+.||+|++... .+.+.+|+.+++.++||||+++++++.+. +.+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEE
Confidence 457999999999998888764 5789999998532 35678999999999999999999998653 7899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||++| +|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 118 lv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-------~~kl~D 184 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-------EVKIGD 184 (335)
T ss_dssp EEECCCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-------CEEECC
T ss_pred EEEecCCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-------CEEEee
Confidence 99999985 999988763 5699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 185 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~ 251 (335)
T 2owb_A 185 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYL 251 (335)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTS---------CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH
T ss_pred ccCceecccCcc--cccccCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHH
Confidence 999987643221 23345688999999999754 4788999999999999999999999876533 2333
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+.... ..++..++..+.+||.+||+.||.+|||+.+++++-+.
T Consensus 252 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 252 RIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp HHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 344332 34567788999999999999999999999999887543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=342.13 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=181.1
Q ss_pred CeEEE---eEecccccEEEEEE----cCcEEEEEEeCCC-cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQVR---RRLGSGSQYKEILW----LGESFALRHFFGD-IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i~---~~LG~G~~~~v~l~----~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+|++. +.||+|+++.|++. +|+.||||++... ...+.+|+.+++.+. ||||+++++++.++ ...|||||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e 86 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME 86 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence 56665 78999998888763 5889999999653 456889999999997 99999999999654 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++ +...+||+|||++
T Consensus 87 ~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~----~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 87 LLNGGELFERIKK------KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN----DNLEIKIIDFGFA 156 (325)
T ss_dssp CCCSCBHHHHHHH------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC--------CEEEECCCTTC
T ss_pred ccCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC----CcccEEEeccccc
Confidence 9975 99999986 25699999999999999999999999999999999999997654 2347999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc-----chhHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL-----QGDKMS 460 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~-----~~~~~~ 460 (683)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....+.
T Consensus 157 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 225 (325)
T 3kn6_A 157 RLKPPDNQ--PLKTPCFTLHYAAPELLNQN---------GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225 (325)
T ss_dssp EECCC------------------------C---------CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH
T ss_pred eecCCCCC--cccccCCCcCccCHHHhcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH
Confidence 86543321 22345678999999999654 489999999999999999999999976432 122344
Q ss_pred HHHHcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 461 RNIRAGERPLFP---FHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 461 ~~i~~~~~~~~p---~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..+..+...... ..++.++.+||.+||..||.+|||+.++++|-
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 555554432211 24688999999999999999999999998663
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.64 Aligned_cols=246 Identities=30% Similarity=0.437 Sum_probs=202.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
.++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 458999999999998888763 688999999842 34568999999999999999999999865 47899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|
T Consensus 103 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~----~~~~~kl~D 172 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS----KDANIRIID 172 (484)
T ss_dssp EEECCCCSCBHHHHHHT------CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS----TTCCEEECC
T ss_pred EEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC----CCCcEEEEe
Confidence 9999997 599999975 35699999999999999999999999999999999999995321 112799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+... ..+..
T Consensus 173 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~ 237 (484)
T 3nyv_A 173 FGLSTHFEASK---KMKDKIGTAYYIAPEVLHG----------TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILK 237 (484)
T ss_dssp TTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT----------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred eeeeEEccccc---ccccCCCCccccCceeecC----------CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence 99998765332 2223468999999999964 388999999999999999999999987653 33555
Q ss_pred HHHcCCCCC-CC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 462 NIRAGERPL-FP--FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 462 ~i~~~~~~~-~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+..+.... .+ ..++..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 555554322 12 3568899999999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.86 Aligned_cols=262 Identities=15% Similarity=0.120 Sum_probs=203.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCC-CcchHHHHHHHHHcCC---CCceeeeeeeEE
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFG-DIEPLVPEISSLLSLS---HPNIMHFLCGFT 294 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~ 294 (683)
..+.+..++|.+.+.||+|+++.|++. +|+.||||++.. ....+..|++++..++ |+||+++++++.
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 677788889999999999998777754 578899999965 4567889999999997 999999999886
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC----
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA---- 369 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~---- 369 (683)
.. +..||||||++ |+|.+++..... .....+++..++.|+.||+.||+|||++||+||||||+||||+.+..
T Consensus 138 ~~--~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQ--NGSVLVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CS--SCEEEEECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred cC--CCcEEEEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 54 67899999997 599999986422 12356999999999999999999999999999999999999987100
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
..+....+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK---------PWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC---------CBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC---------CCCccccHHHHHHHHHHHHhCCCcc
Confidence 0011227999999999765432222333456789999999999755 4899999999999999999999999
Q ss_pred CCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHH
Q 038696 450 EDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR-PSFSSICRILRYIK 508 (683)
Q Consensus 450 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R-Pt~~eil~~L~~i~ 508 (683)
......... + .. .......++.+.+++..||+.+|.+| |++.++.+.|+.+-
T Consensus 286 ~~~~~~~~~----~-~~--~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 286 VKNEGGECK----P-EG--LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EEEETTEEE----E-CS--CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCCCcee----e-ch--hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 653321100 0 00 01112346778999999999999999 57888877777654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.71 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=202.3
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
+....++|.....||+|+++.|+.. +|..||||.+... .+.+.+|+.+++.++||||+++++++... +.+
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 94 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFI 94 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcE
Confidence 3344446666668999998777753 5789999998542 45688999999999999999999998654 689
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCC-CCCCCCCcceEEE
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKP-RGASTEGYLHAKI 379 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~-~g~~~~~~~~vKL 379 (683)
++||||++ ++|.+++... .....+++..+..++.||+.||.|||++||+||||||+|||++. ++ .+||
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-------~~kl 164 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSK---WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG-------VLKI 164 (295)
T ss_dssp EEEEECCSEEEHHHHHHHT---TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC-------CEEE
T ss_pred EEEEEeCCCCCHHHHHHhh---ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC-------CEEE
Confidence 99999997 5999999863 12345779999999999999999999999999999999999987 55 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||++....... .......||+.|+|||++.+.. ..++.++||||||+++|+|++|+.||..........
T Consensus 165 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 235 (295)
T 2clq_A 165 SDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGP-------RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235 (295)
T ss_dssp CCTTTCEESCC-------CCCCCCGGGCCHHHHHHGG-------GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH
T ss_pred eecccccccCCCC--CcccccCCCccccChhhhcCCC-------CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH
Confidence 9999998764321 1223456889999999997541 137889999999999999999999997654333333
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.........+.++..++..+.+||.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 34444455666788889999999999999999999999999865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.32 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=198.3
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE-----cCc--EEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW-----LGE--SFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~-----~g~--~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
...+..++|++.+.||+|+++.|+.. ++. .||||++... .+.+.+|+++++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 35566779999999999986555542 223 6999998532 356789999999999999999999885
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
.+ ..++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 92 ~~---~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~----- 158 (291)
T 1u46_A 92 TP---PMKMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----- 158 (291)
T ss_dssp SS---SCEEEEECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-----
T ss_pred cC---CceeeEecccCCCHHHHHHhc-----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-----
Confidence 43 3799999998 5999999863 24589999999999999999999999999999999999998877
Q ss_pred cceEEEecccCccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCC
Q 038696 374 YLHAKISGFGLSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFED 451 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~ 451 (683)
.+||+|||++......... .......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+
T Consensus 159 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 159 --LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp --EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --CEEEccccccccccccccchhhhccCCCCceeeCchhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 7999999999876443211 122344567789999999765 37889999999999999999 9999987
Q ss_pred CccchhHHHHHH-HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 452 AHLQGDKMSRNI-RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 452 ~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
.... .....+ ........+..++..+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 228 ~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 228 LNGS--QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCHH--HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCHH--HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 6532 333333 344455567788999999999999999999999999999988764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.04 Aligned_cols=241 Identities=27% Similarity=0.364 Sum_probs=198.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|.+.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++.+. ..+|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEEEEE
Confidence 48999999999998888763 688999999864 235688999999999999999999988643 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEe---CCCCCCCCCcceEEEecc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILL---KPRGASTEGYLHAKISGF 382 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl---~~~g~~~~~~~~vKL~DF 382 (683)
|++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++ .+||+||
T Consensus 87 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-------~~kl~Df 153 (304)
T 2jam_A 87 LVSGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-------KIMITDF 153 (304)
T ss_dssp CCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-------CEEBCSC
T ss_pred cCCCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-------CEEEccC
Confidence 9975 999999763 468999999999999999999999999999999999999 4444 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++..... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||..... ..+...
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~ 218 (304)
T 2jam_A 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQK---------PYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEK 218 (304)
T ss_dssp STTCCCCCB----TTHHHHSCCCBCCTTTBSSC---------SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH
T ss_pred CcceecCCC----ccccccCCCCccChHHhccC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence 998754321 12234578899999998644 489999999999999999999999987543 334455
Q ss_pred HHcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+... ......+..+.++|.+||..||.+|||+.+++++.+
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 219 IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 5554322 233567899999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.78 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=191.1
Q ss_pred CCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC---------------cchHHHHHHHHHcCCCCceeeeeeeEEc
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD---------------IEPLVPEISSLLSLSHPNIMHFLCGFTD 295 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~---------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 295 (683)
.++|++.+.||+|+++.|+.. .|..||||++... .+.+.+|+++|+.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 568999999999998877764 6889999998421 1568899999999999999999998854
Q ss_pred ---CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 296 ---EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 296 ---e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
.....+|+||||++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~---- 171 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN---- 171 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC----
Confidence 23357899999999999999984 345799999999999999999999999999999999999998887
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||+++...... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.
T Consensus 172 ---~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 172 ---DITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQF--------KGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp ---CEEECCTTC------------------CGGGCCHHHHTTC--------TTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---CEEEEecCccccccccc---ccceecccceecCcHHhcCC--------CCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 79999999997544322 22345688899999999752 25899999999999999999999999876
Q ss_pred ccchhHHHHHHHcC----------------------CCCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 038696 453 HLQGDKMSRNIRAG----------------------ERPL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502 (683)
Q Consensus 453 ~~~~~~~~~~i~~~----------------------~~~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~ 502 (683)
.... .+...+... .... .+...++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 238 TFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 5321 111111100 0000 12345778999999999999999999999987
Q ss_pred HH
Q 038696 503 IL 504 (683)
Q Consensus 503 ~L 504 (683)
|-
T Consensus 317 hp 318 (362)
T 3pg1_A 317 HP 318 (362)
T ss_dssp SG
T ss_pred Cc
Confidence 63
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.74 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=196.6
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
..++|++.+.||+|+++.|++. ++..||||++.. ..+.+.+|+++|+.++||||+++++++.+ ..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~ 101 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQ 101 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CC
Confidence 3458999999999998777753 678999999842 23568899999999999999999999865 37
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCC----------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPR----------------------------------KRIPFSLPVAVDLMLQIARGM 344 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~qi~~aL 344 (683)
.+||||||++ |+|.+++....... ....+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 8999999997 59999885211000 012346778899999999999
Q ss_pred HHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCC--CCCCCCCCCcCcccCChhhhhhcccccccc
Q 038696 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP--KSPSQSGTTHPFIWHAPEVLEENEQTESAS 422 (683)
Q Consensus 345 ~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~ 422 (683)
.|||++||+||||||+|||++.++ ...+||+|||+++...... .........||+.|+|||++.+.
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------- 249 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNK-----SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT------- 249 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSS-----SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-------
T ss_pred HHHHHCCccccCCChhhEEEecCC-----CceEEEeeccccccccccCccccccccccCCCccccCchhhccC-------
Confidence 999999999999999999997654 2369999999998654321 11123456789999999999642
Q ss_pred CCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 423 NSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 423 ~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
...++.++|||||||++|||++|+.||.+.... +.....+........+ ..++..+.+||.+||+.||.+|||+.++
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 235889999999999999999999999876533 2233333333222222 2368899999999999999999999999
Q ss_pred HHHHH
Q 038696 501 CRILR 505 (683)
Q Consensus 501 l~~L~ 505 (683)
+++-+
T Consensus 329 l~hp~ 333 (345)
T 3hko_A 329 LQHPW 333 (345)
T ss_dssp HHSHH
T ss_pred hcChh
Confidence 98754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=343.98 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=191.9
Q ss_pred CCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCCc---------------chHHHHHHHHHcCCCCceeeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGDI---------------EPLVPEISSLLSLSHPNIMHFLC 291 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~~---------------~~~~~Ei~iL~~L~HpnIv~l~~ 291 (683)
.++|++.+.||+|+++.|++. .+..||||++.... ..+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 568999999999997777653 56789999986432 23567788888899999999999
Q ss_pred eEEcC--CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCC
Q 038696 292 GFTDE--EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 292 ~~~~e--~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~ 369 (683)
++..+ +...+||||||++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~- 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN- 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-
Confidence 88652 24789999999966999998753 3799999999999999999999999999999999999997664
Q ss_pred CCCCcceEEEecccCccccCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT 444 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt 444 (683)
. ..+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 189 --~--~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 189 --P--DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---------ALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp --T--TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHH
T ss_pred --C--CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHh
Confidence 1 16999999999876432211 111345789999999999754 48999999999999999999
Q ss_pred CCCCCCCCccchhHHHH---HHHcCCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 445 GKVPFEDAHLQGDKMSR---NIRAGERPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 445 G~~Pf~~~~~~~~~~~~---~i~~~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
|+.||.+.......... ......... ....++.++.++|.+||..||.+|||+.+|++.|+.
T Consensus 256 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred CCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 99999653322221111 111111000 112678899999999999999999999999988765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.14 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=196.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC---CCCeE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE---EKKEC 301 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e---~~~~~ 301 (683)
.++|++.+.||+|+++.|++. +|+.||||++... ...+.+|+++|+.++||||+++++++..+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 469999999999998887764 5889999999642 23567999999999999999999876532 23678
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 302 FLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 302 ~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
|+||||+.|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-------~~kl~D 155 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-------DLKVCD 155 (353)
T ss_dssp EEEECCCSEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-------CEEECC
T ss_pred EEEEeccCccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-------cEEEEe
Confidence 99999999999999975 4699999999999999999999999999999999999998887 799999
Q ss_pred ccCccccCCCCCC--------CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 382 FGLSSVKNFGPKS--------PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 382 FGla~~~~~~~~~--------~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
||+++........ .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--------AKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSC--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccC--------CCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876432211 012235689999999998642 358999999999999999999999998765
Q ss_pred cchhHHHHHHHc-CCC---------------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 454 LQGDKMSRNIRA-GER---------------------PL--------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 454 ~~~~~~~~~i~~-~~~---------------------~~--------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
... .+...... +.. +. ....++..+.+||.+||+.||.+|||+.++++|
T Consensus 228 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 228 YRH-QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHH-HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHH-HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 321 11111110 000 00 113567889999999999999999999999876
Q ss_pred HH
Q 038696 504 LR 505 (683)
Q Consensus 504 L~ 505 (683)
-+
T Consensus 307 p~ 308 (353)
T 2b9h_A 307 PY 308 (353)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=339.45 Aligned_cols=268 Identities=20% Similarity=0.363 Sum_probs=208.9
Q ss_pred cccceeEeeCCCeEEEeEecccccEEEEEE-cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 225 LLPSRILIKSEDYQVRRRLGSGSQYKEILW-LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 225 ~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
.....+.+..++|++.+.||+|+++.|+.. .+..||||++.. ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 101 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP- 101 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-
Confidence 344677788889999999999998777753 445699999853 245678999999999999999999998654
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..+++||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++ ++ .
T Consensus 102 -~~~~iv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-------~ 167 (319)
T 2y4i_B 102 -PHLAIITSLCKGRTLYSVVRD-----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-------K 167 (319)
T ss_dssp -SCEEEECBCCCSEEHHHHTTS-----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----------C
T ss_pred -CceEEEeecccCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-------C
Confidence 679999999985 99999864 335699999999999999999999999999999999999997 34 6
Q ss_pred EEEecccCccccCCCC---CCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 377 AKISGFGLSSVKNFGP---KSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 377 vKL~DFGla~~~~~~~---~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
+||+|||+++...... .........||+.|+|||++.+...........++.++||||||+++|||++|..||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987653221 1122234568899999999975422221223458999999999999999999999998765
Q ss_pred cchhHHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
. ..+...+..+..+... ..++..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus 248 ~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 248 A--EAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp H--HHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred H--HHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 3 3344555555444333 4678889999999999999999999999999887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.77 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=183.9
Q ss_pred CeEE-EeEecccccEEEEEE------cCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 236 DYQV-RRRLGSGSQYKEILW------LGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 236 ~y~i-~~~LG~G~~~~v~l~------~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.|++ .++||+|+++.|++. +++.||||++... ...+.+|+.+|+.|+|||||+++++|.......+|||||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 4666 457999998877764 3678999999643 457889999999999999999999997766688999999
Q ss_pred cCCCCHHHHHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 307 LMSRDLCSYIKEICC---PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 307 y~~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|++|+|.+++..... ......+++..+..++.||+.||.|||++||+||||||+||||..++ +....+||+|||
T Consensus 101 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~~~~~kl~Dfg 177 (405)
T 3rgf_A 101 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---PERGRVKIADMG 177 (405)
T ss_dssp CCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS---TTTTCEEECCTT
T ss_pred CCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC---CCCCcEEEEECC
Confidence 999999998864321 11234599999999999999999999999999999999999994332 122279999999
Q ss_pred CccccCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc-------
Q 038696 384 LSSVKNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ------- 455 (683)
Q Consensus 384 la~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~------- 455 (683)
+++........ .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTC--------CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCC--------CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99876533211 223356789999999999753 25899999999999999999999999754321
Q ss_pred -hhHHHHHHHcCCCCC------------------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 456 -GDKMSRNIRAGERPL------------------------------------FPFHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 456 -~~~~~~~i~~~~~~~------------------------------------~p~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
.+.+...+.....+. .....+..+.+||.+||..||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 112222211111000 0011256788999999999999999999
Q ss_pred HHHHHHH
Q 038696 499 SICRILR 505 (683)
Q Consensus 499 eil~~L~ 505 (683)
++++|-+
T Consensus 330 e~L~hp~ 336 (405)
T 3rgf_A 330 QAMQDPY 336 (405)
T ss_dssp HHHTSGG
T ss_pred HHhcChh
Confidence 9988744
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.89 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=185.3
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
.+.+..++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++||||+++++++... +
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--D 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS--S
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--C
Confidence 35667789999999999987666653 688999998853 345678999999999999999999998654 6
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCP--RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..|+||||++ |+|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------~ 159 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-------S 159 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-------C
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-------C
Confidence 7999999997 5999998753211 1245699999999999999999999999999999999999998887 7
Q ss_pred EEEecccCccccCCCCC---CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 377 AKISGFGLSSVKNFGPK---SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
+||+|||++........ ........||+.|+|||++.+.. .++.++||||||+++|+|++|..||....
T Consensus 160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--------GYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp EEECCCHHHHHCC---------------CCCTTCCHHHHHHHH--------CCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc--------CCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 99999999976543221 11223456889999999997532 47899999999999999999999998765
Q ss_pred cchhHHHHHHHcCCCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERP---------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~---------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
... ... .......+ .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 232 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 232 PMK-VLM-LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp GGG-HHH-HHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhh-HHH-HHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 432 122 22222211 1234567899999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.55 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=196.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
++|++.+.||+|+++.|++. +|+.||||++... ...+.+|+++|+.++||||+++++++..+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 47999999999998888764 5789999998532 23578999999999999999999988543
Q ss_pred CeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
.+|+||||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~----~~~~~ 156 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE----EDCLI 156 (322)
T ss_dssp -SEEEEEECCTTEETHHHHST------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS----SSCCE
T ss_pred -ceEEEEecCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC----CCCeE
Confidence 38999999975 99998864 35699999999999999999999999999999999999998764 12359
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++...... ......||+.|+|||++.+. ....++.++|||||||++|+|++|..||.......
T Consensus 157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 226 (322)
T 2ycf_A 157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV- 226 (322)
T ss_dssp EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHT------TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-
T ss_pred EEccCccceeccccc---ccccccCCcCccCchhhccC------CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-
Confidence 999999998754221 11234578899999998542 13358899999999999999999999997654332
Q ss_pred HHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+...+..+..... ...++..+.+||.+||..||.+|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 23444544443322 24578899999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=364.37 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=210.4
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+.+..++|++.+.||+|+++.|+.. .+..||||.+... .+.+.+|+.+|+.++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 44556678999999999997777653 2457999998643 2568899999999999999999988732
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
+.+|+||||++ |+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 463 --~~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~------- 528 (656)
T 2j0j_A 463 --NPVWIIMELCTLGELRSFLQV-----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------- 528 (656)
T ss_dssp --SSCEEEEECCTTCBHHHHHHH-----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------
T ss_pred --CceEEEEEcCCCCcHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-------
Confidence 45899999998 599999986 235689999999999999999999999999999999999999887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCcc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~ 454 (683)
.+||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 529 ~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 529 CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCC---------CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 899999999987644321 122344567889999999755 48999999999999999997 9999987653
Q ss_pred chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
..+...+..+.+...+..++..+.+||.+||+.||.+|||+.++++.|..+...
T Consensus 599 --~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 599 --NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 345566777777778889999999999999999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.29 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=197.9
Q ss_pred eCCCeEEEeEecccccEEEEEE-----cCcEEEEEEeCC------CcchHHHHHHHHHcC---CCCceeeeeeeEEc---
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW-----LGESFALRHFFG------DIEPLVPEISSLLSL---SHPNIMHFLCGFTD--- 295 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~--- 295 (683)
..++|++.+.||+|+++.|++. +|+.||||++.. ....+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3568999999999998777763 467899999842 234678898888777 89999999998862
Q ss_pred CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 296 EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 296 e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
+....+++||||++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~------- 157 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------- 157 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------
T ss_pred CCCceEEEEEecCCCCHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-------
Confidence 234678999999999999999863 334599999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CEEEecCcccccccCCC---CccccccccceeCHHHHhcC---------CCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 79999999997654321 22345678899999999654 4899999999999999999999999876532
Q ss_pred hhHHHHHHHc-CC------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 456 GDKMSRNIRA-GE------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 456 ~~~~~~~i~~-~~------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+...+.. +. ...+...++..+.+||.+||+.||.+|||+.++++|
T Consensus 226 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 226 -DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp -HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122222211 00 001234578899999999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.09 Aligned_cols=253 Identities=17% Similarity=0.193 Sum_probs=187.1
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHH---HHHcCCCCceeeee-------e
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEIS---SLLSLSHPNIMHFL-------C 291 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~---iL~~L~HpnIv~l~-------~ 291 (683)
..++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+. +|+.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3568999999999998888763 588999999842 2356889994 55556899999988 5
Q ss_pred eEEcCCC----------C-----eEEEEEecCCCCHHHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 038696 292 GFTDEEK----------K-----ECFLIMELMSRDLCSYIKEICCP-RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHG 355 (683)
Q Consensus 292 ~~~~e~~----------~-----~~~LVmEy~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 355 (683)
++.+.+. . ..||||||++|+|.+++...... .....+++..+..|+.||+.||.|||++||+||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5543211 1 37999999999999999864211 011234458888999999999999999999999
Q ss_pred CCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccc--ccccCCCCCchhHHH
Q 038696 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQT--ESASNSKYSEKSDVY 433 (683)
Q Consensus 356 DLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~--~~~~~~~~s~ksDVw 433 (683)
||||+|||++.++ .+||+|||+++.... ......| +.|+|||++.+.... .......++.++|||
T Consensus 231 Dikp~NIll~~~~-------~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 231 YLRPVDIVLDQRG-------GVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp CCCGGGEEECTTC-------CEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCCHHHEEEcCCC-------CEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999887 799999999986432 1223445 789999999865000 000001389999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 434 SFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 434 SlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
||||++|||++|+.||.+..... ....+.. ....++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~--~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALG--GSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHHHHHSSCCC------C--CSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHHHHHHCCCCCccccccc--chhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 99999999999999997644221 1111111 23567899999999999999999999999998643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.99 Aligned_cols=258 Identities=21% Similarity=0.397 Sum_probs=202.9
Q ss_pred CCeEEEeEecccccEEEEE--EcCcEEEEEEeCC-CcchHHHHHHHHHc--CCCCceeeeeeeEEcCCC--CeEEEEEec
Q 038696 235 EDYQVRRRLGSGSQYKEIL--WLGESFALRHFFG-DIEPLVPEISSLLS--LSHPNIMHFLCGFTDEEK--KECFLIMEL 307 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~-~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~e~~--~~~~LVmEy 307 (683)
++|++.+.||+|+++.|+. .+|+.||||++.. ....+.+|++++.. ++||||+++++++..... ..+|+||||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 4899999999999877775 4799999999964 34567889999987 789999999998876432 278999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH--------SKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
++| +|.+++.+ ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+|
T Consensus 122 ~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-------~~k 187 (342)
T 1b6c_B 122 HEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------TCC 187 (342)
T ss_dssp CTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-------CEE
T ss_pred cCCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-------CEE
Confidence 985 99999976 35899999999999999999999 89999999999999998887 799
Q ss_pred EecccCccccCCCCCCC--CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhC----------C
Q 038696 379 ISGFGLSSVKNFGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG----------K 446 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG----------~ 446 (683)
|+|||++.......... ......||+.|+|||++.+.... ....++.++|||||||++|||++| .
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT---TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccc---cccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999997765432110 22345789999999999754200 000234789999999999999999 7
Q ss_pred CCCCCCccc---hhHHHHHHHc-CCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 447 VPFEDAHLQ---GDKMSRNIRA-GERPLFPF-----HSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 447 ~Pf~~~~~~---~~~~~~~i~~-~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.||...... ...+...+.. ...+.++. .++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 898764322 2233333332 33333332 234679999999999999999999999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.39 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=196.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++|++.+.||+|+++.|+.. +|..||+|++.. ..+.+.+|+++++.++||||+++++++.+. +.+|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEEEE
Confidence 458999999999997766653 588999999853 346788999999999999999999988654 6799999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++| +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 96 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------~~kl~Dfg~ 163 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-------DIRLADFGV 163 (302)
T ss_dssp ECCTTEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-------CEEECCCHH
T ss_pred EeCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-------CEEEEECCC
Confidence 99985 899988753 35699999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
+........ ......||+.|+|||++.... .....++.++||||||+++|+|++|..||...... .....+.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~ 235 (302)
T 2j7t_A 164 SAKNLKTLQ--KRDSFIGTPYWMAPEVVMCET----MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA 235 (302)
T ss_dssp HHHHHHHHH--C-----CCGGGCCHHHHHHHH----TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred Ccccccccc--ccccccCChhhcCCeeecccc----CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHh
Confidence 754321100 122346788999999985321 11335889999999999999999999999876533 2233333
Q ss_pred cCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
....+ ..+..++..+.++|.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 33332 2355678899999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.48 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=200.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------------cchHHHHHHHHHcC-CCCceeeeeeeEEcCC
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEE 297 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~ 297 (683)
++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 47999999999998777753 6899999998532 24578999999999 79999999998854
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
....||||||++| +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-------~ 238 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-------Q 238 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------C
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------C
Confidence 4789999999985 999999863 4699999999999999999999999999999999999999887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||++....... ......||+.|+|||++.+.... ....++.++|||||||++|+|++|..||.+...
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-- 310 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDE---THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-- 310 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCT---TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccc---cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--
Confidence 9999999998765432 23346789999999999754210 123488899999999999999999999987542
Q ss_pred hHHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 457 DKMSRNIRAGERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
......+..+..... ....+..+.+||.+||+.||.+|||+.++++|
T Consensus 311 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 234444544433221 13567889999999999999999999999876
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=329.95 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=191.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEc----------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTD---------- 295 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---------- 295 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 469999999999987666653 5889999998542 3567899999999999999999987742
Q ss_pred --CCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 296 --EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 296 --e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
.+...+|+||||++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----- 157 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED----- 157 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-----
T ss_pred cccccCceeEEeeccCCCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----
Confidence 23367899999999999999863 5699999999999999999999999999999999999997432
Q ss_pred cceEEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 374 YLHAKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
..+||+|||+++....... ........+|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.
T Consensus 158 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 158 -LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP--------NNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp -TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -CeEEEccCccccccCCCcccccccccccccccccCcHHhcCc--------ccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 1799999999987643211 1122344568889999998642 25899999999999999999999999876
Q ss_pred ccchhHHHHHHHcCC-----------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGE-----------------------RPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~-----------------------~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
.... .+...+.... .+. ....++.++.+||.+||+.||.+|||+.++++|-
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 229 HELE-QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp SHHH-HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred CHHH-HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 5321 1111111100 000 1245788999999999999999999999999875
Q ss_pred HH
Q 038696 505 RY 506 (683)
Q Consensus 505 ~~ 506 (683)
+.
T Consensus 308 ~~ 309 (320)
T 2i6l_A 308 YM 309 (320)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.70 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=190.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEEE
Confidence 458999999999997666653 4889999998532 23467899999999999999999998654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 102 v~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-------~~kl~Df 168 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF------PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-------VVKLCDF 168 (331)
T ss_dssp EEECCSEEHHHHHHHS------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEECCC
T ss_pred EEecCCcchHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-------cEEEEeC
Confidence 9999997 55555442 35699999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..... .+...
T Consensus 169 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~ 237 (331)
T 4aaa_A 169 GFARTLAAPGE--VYDDEVATRWYRAPELLVGD--------VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHI 237 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTC--------TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred CCceeecCCcc--ccCCCcCCccccCcccccCC--------CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHH
Confidence 99976543221 22345688899999999643 258899999999999999999999998765322 12111
Q ss_pred HHc-C------------------CC-CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 463 IRA-G------------------ER-PL---------FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 463 i~~-~------------------~~-~~---------~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
+.. + .. +. ....++..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 110 0 00 00 012467889999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=347.85 Aligned_cols=248 Identities=17% Similarity=0.175 Sum_probs=178.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcC--CCCceeeee-------eeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSL--SHPNIMHFL-------CGFT 294 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L--~HpnIv~l~-------~~~~ 294 (683)
.+|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35999999999998877763 6889999999652 23467785444444 699988755 3343
Q ss_pred cCCC---------------CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcc
Q 038696 295 DEEK---------------KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA------VDLMLQIARGMEYLHSKKIY 353 (683)
Q Consensus 295 ~e~~---------------~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~gIi 353 (683)
.+.. ..+||||||++|+|.+++.... ..+.+..+ ..++.||+.||.|||++||+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 2221 4589999999999999998641 23444455 67779999999999999999
Q ss_pred cCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHH
Q 038696 354 HGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVY 433 (683)
Q Consensus 354 HrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVw 433 (683)
||||||+||||+.++ .+||+|||+++..... .....+|+.|+|||++.+. ...++.++|||
T Consensus 217 HrDikp~NIll~~~~-------~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-------~~~~~~~~Diw 277 (371)
T 3q60_A 217 HGHFTPDNLFIMPDG-------RLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNAS-------TATFTHALNAW 277 (371)
T ss_dssp ETTCSGGGEEECTTS-------CEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCS-------EEECCHHHHHH
T ss_pred cCcCCHHHEEECCCC-------CEEEEecceeeecCCC-----ccCccCCcCCcChhhccCC-------CCCcCccccHH
Confidence 999999999999887 7999999999865421 1134566889999999651 12489999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccchhHHHHH---H-H--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 434 SFGMICFEILTGKVPFEDAHLQGDKMSRN---I-R--AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 434 SlGvil~ElltG~~Pf~~~~~~~~~~~~~---i-~--~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
||||++|||++|+.||.+........... . . ..........++..+.+||.+||+.||++|||+.++++|-+.
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 99999999999999998763221100000 0 0 011111224678999999999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.67 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=194.0
Q ss_pred CCCeEEEeEecccccEEEEEE-----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCC------ceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-----LGESFALRHFFGD---IEPLVPEISSLLSLSHP------NIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~Hp------nIv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++++.++|+ +|+++++++... +
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--G 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--C
Confidence 569999999999998888763 5789999999753 35678999999998765 499999988654 6
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC---------
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS--------- 370 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~--------- 370 (683)
.+||||||++++|.+++... ...++++..+..++.||+.||.|||++||+||||||+|||++.++..
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKEN----GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCCCCCHHHHHHhc----CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 89999999988999999863 33468999999999999999999999999999999999999863200
Q ss_pred ---CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC
Q 038696 371 ---TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447 (683)
Q Consensus 371 ---~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~ 447 (683)
......+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILAL---------GWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTS---------CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCC---------CCCcchhhHHHHHHHHHHHhCCC
Confidence 000226999999999865422 2345688999999999754 48999999999999999999999
Q ss_pred CCCCCccchhHHHHHHHc--CCC-----------------------------------------CCCCCCCcHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRA--GER-----------------------------------------PLFPFHSPKYVTNLTK 484 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~--~~~-----------------------------------------~~~p~~~~~~l~~Li~ 484 (683)
||....... ....+.. +.. ...+...++.+.+||.
T Consensus 233 pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 233 VFPTHDSKE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp SCCCSCHHH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCChHH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence 998754322 1111110 100 0011223567899999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 038696 485 RCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 485 ~cL~~dP~~RPt~~eil~~ 503 (683)
+||+.||.+|||+.++++|
T Consensus 311 ~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhCcCcccccCHHHHhcC
Confidence 9999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.72 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=200.5
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++++.++||||+++++++.+. ..+|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 99 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYIV 99 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEEEE
Confidence 48999999999998887764 688999999842 345788999999999999999999988653 789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 100 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~----~~~~~kL~Dfg 169 (287)
T 2wei_A 100 GELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE----KDCDIKIIDFG 169 (287)
T ss_dssp ECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----TTCCEEECSTT
T ss_pred EEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC----CcccEEEeccC
Confidence 999975 999988763 4689999999999999999999999999999999999997653 12369999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
++....... ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ..+...+
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~ 234 (287)
T 2wei_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG----------TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRV 234 (287)
T ss_dssp GGGTBCCCS---SCSCHHHHHTTCCHHHHTT----------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred cceeecCCC---ccccccCcccccChHHhcC----------CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 998764322 2233457889999999864 278999999999999999999999987653 2344555
Q ss_pred HcCCCCC-CC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPL-FP--FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~-~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+.... .+ ..++..+.++|.+||..||.+|||+.+++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp HHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 5544322 12 457889999999999999999999999998744
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.75 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=201.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------------cchHHHHHHHHHcCC-CCceeeeeeeEEc
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------------IEPLVPEISSLLSLS-HPNIMHFLCGFTD 295 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 295 (683)
.++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+++|+.+. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 469999999999998777763 6789999998532 245779999999995 9999999998854
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
...+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------ 161 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------ 161 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------
T ss_pred --CCeEEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC------
Confidence 478999999998 5999999863 5699999999999999999999999999999999999998887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||++....... ......+|+.|+|||++.+... .....++.++||||||+++|+|++|..||.....
T Consensus 162 -~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 162 -NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMN---DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp -CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHC---TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -cEEEecccchhhcCCCc---ccccccCCccccCHHHhccccc---cccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 79999999998765332 2234568889999999864321 0133578899999999999999999999987543
Q ss_pred chhHHHHHHHcCCCCCC-C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 QGDKMSRNIRAGERPLF-P--FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~-p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
......+..+..... + ..++..+.+||.+||+.||.+|||+.+++++
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 --MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp --HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 234444444432221 1 3568899999999999999999999999765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=338.66 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=195.7
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
...+.+. ++|.+.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3556664 59999999999998888864 6889999999642 34678999999999999999999998654
Q ss_pred CCC----eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCC
Q 038696 297 EKK----ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 297 ~~~----~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
+.. .+|+||||+.|+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---- 181 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC---- 181 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----
T ss_pred CCcccceeEEEEEccccccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC----
Confidence 321 349999999999988774 3499999999999999999999999999999999999999887
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
.+||+|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.
T Consensus 182 ---~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 182 ---ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW--------MHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ---CEEECSTTCC-------------CTTCCCTTSCHHHHSCC--------SCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---CEEEEecCcccccccC-----cCCcccCccccCHHHhcCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 7999999999865432 2345678999999999642 35899999999999999999999999875
Q ss_pred ccchhHHHHHHHcCCC-----------------------C------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 453 HLQGDKMSRNIRAGER-----------------------P------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 453 ~~~~~~~~~~i~~~~~-----------------------~------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... .+...+..... . ......+..+.+||.+||+.||.+|||+.++++|
T Consensus 246 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 246 DYLD-QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SHHH-HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ChHH-HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 5321 11111110000 0 0123567889999999999999999999999876
Q ss_pred HH
Q 038696 504 LR 505 (683)
Q Consensus 504 L~ 505 (683)
-+
T Consensus 325 p~ 326 (371)
T 4exu_A 325 PF 326 (371)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.00 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=182.2
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC-
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE- 296 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e- 296 (683)
..+.+. ++|++++.||+|+++.|+.. +|+.||||++... .+.+.+|+++|+.++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 445554 69999999999997777653 6889999998542 34677999999999999999999988643
Q ss_pred ---CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 297 ---EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 297 ---~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
+...+|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~----- 169 (367)
T 2fst_X 102 SLEEFNDVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----- 169 (367)
T ss_dssp SGGGCCCCEEEEECCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----
T ss_pred ccccCCeEEEEecccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-----
Confidence 2256899999998899998864 4699999999999999999999999999999999999998887
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
.+||+|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..
T Consensus 170 --~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 170 --ELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp --CEEECC--------------------CCCTTCCHHHHTTC--------CSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --CEEEeecccccccccc-----CCCcCcCcCccChHHHcCC--------cCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7999999999865422 2345788999999999752 258999999999999999999999998765
Q ss_pred cchhHHHHHHHc-CC-----------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 454 LQGDKMSRNIRA-GE-----------------------RPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 454 ~~~~~~~~~i~~-~~-----------------------~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... .+...+.. +. .+. .....++.+.+||.+||..||.+|||+.++++|-
T Consensus 235 ~~~-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 235 HID-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHH-HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHH-HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 321 11111110 00 000 0124577899999999999999999999998874
Q ss_pred H
Q 038696 505 R 505 (683)
Q Consensus 505 ~ 505 (683)
.
T Consensus 314 ~ 314 (367)
T 2fst_X 314 Y 314 (367)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.63 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=188.4
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCC-----CCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEE-----KKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~-----~~~ 300 (683)
..++|++.+.||+|+++.|++. +|+.||||++... .....+|++.+..++||||++++++|.... ...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3468999999999997777653 5889999988542 456778888889999999999999886422 224
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEeCC-CCCCCCCcceE
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH--SKKIYHGNLNPSNILLKP-RGASTEGYLHA 377 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIiHrDLKp~NILl~~-~g~~~~~~~~v 377 (683)
+++||||++|+|.+.+.... .....+++..+..++.||+.||.||| ++||+||||||+|||++. ++ .+
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-------~~ 171 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-------TL 171 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-------EE
T ss_pred EEEEeecccccHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-------cE
Confidence 78999999998887776532 23466899999999999999999999 999999999999999986 55 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.....
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 239 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGN--------QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG- 239 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-
Confidence 999999998765432 22345678999999999643 248999999999999999999999998765321
Q ss_pred HHHHHHHc-CC-----------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 458 KMSRNIRA-GE-----------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 458 ~~~~~i~~-~~-----------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
.+...+.. +. .+..+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 12222111 00 01122335788999999999999999999999988744
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=340.41 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=195.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC--------CCceeeeeeeEEcC--
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS--------HPNIMHFLCGFTDE-- 296 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~--------HpnIv~l~~~~~~e-- 296 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++ |+||++++++|...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 469999999999998888864 5789999999753 356789999999985 78899999988632
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCC------
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGA------ 369 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~------ 369 (683)
+...+||||||++|+|.+++... ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKS----NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 34679999999998999888762 335699999999999999999999998 9999999999999986530
Q ss_pred ------------------------------------CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhh
Q 038696 370 ------------------------------------STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLE 413 (683)
Q Consensus 370 ------------------------------------~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~ 413 (683)
.......+||+|||+++..... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 0001236999999999876432 23456899999999997
Q ss_pred hccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch-----hHHHHHHH-cCCCC------------------
Q 038696 414 ENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG-----DKMSRNIR-AGERP------------------ 469 (683)
Q Consensus 414 ~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~-----~~~~~~i~-~~~~~------------------ 469 (683)
+. .++.++|||||||++|||++|+.||....... ..+...+. .+..+
T Consensus 267 ~~---------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 267 GS---------GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp TS---------CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred CC---------CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 55 48999999999999999999999997643211 11111111 01100
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 470 ---------------------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 470 ---------------------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.++...+..+.+||.+||+.||.+|||+.++++|
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 1122234668899999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=334.35 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=198.2
Q ss_pred CcccceeEeeCCCeEEE-eEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCC-CCceeeeee
Q 038696 224 KLLPSRILIKSEDYQVR-RRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLS-HPNIMHFLC 291 (683)
Q Consensus 224 ~~~~~~~~~~~~~y~i~-~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~-HpnIv~l~~ 291 (683)
.+.......-.+.|.+. +.||+|+++.|++. +|+.||||++.. ....+.+|+.++..+. ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 33333333334578887 88999998888764 588999999853 2356889999999995 799999999
Q ss_pred eEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS 370 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~ 370 (683)
++.+ ...+|+||||+.| +|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||++...
T Consensus 97 ~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-- 168 (327)
T 3lm5_A 97 VYEN--TSEIILILEYAAGGEIFSLCLP----ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-- 168 (327)
T ss_dssp EEEC--SSEEEEEEECCTTEEGGGGGSS----CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT--
T ss_pred EEEe--CCeEEEEEEecCCCcHHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC--
Confidence 9864 4789999999985 99888753 2346799999999999999999999999999999999999998721
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
....+||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.
T Consensus 169 --~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 169 --PLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYD---------PITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp --TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --CCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCC---------CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 01179999999998765332 22345689999999999654 48899999999999999999999998
Q ss_pred CCccchhHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGE---RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.... .....+.... .......++..+.+||.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 235 GEDNQ--ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CSSHH--HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCch--HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 76533 2333333322 223335678999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.35 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=184.8
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHH-HHHcCCCCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEIS-SLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~e~ 297 (683)
..+.+..++|++.+.||+|+++.|+.. +|+.||||++... ...+..|+. +++.++||||+++++++.++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~- 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE- 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-
Confidence 567778889999999999998877753 5889999999643 224455665 67778999999999998654
Q ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+|+||||++|+|.+++..... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .
T Consensus 94 -~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-------~ 164 (327)
T 3aln_A 94 -GDCWICMELMSTSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-------N 164 (327)
T ss_dssp -SEEEEEECCCSEEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-------E
T ss_pred -CceEEEEeecCCChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-------C
Confidence 68999999999999888864221 1245799999999999999999999999 999999999999998887 8
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... ......||+.|+|||++.... .+..++.++|||||||++|+|++|..||.+.....
T Consensus 165 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (327)
T 3aln_A 165 IKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSA-----SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236 (327)
T ss_dssp EEECCCSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----
T ss_pred EEEccCCCceeccccc---ccccCCCCccccCceeecccc-----CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH
Confidence 9999999997764322 122346888999999984321 12358899999999999999999999998643221
Q ss_pred hHHHHHHHcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
. ....+..+..+.++ ..++..+.+|+.+||+.||.+|||+.+++++.+...
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 237 D-QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred H-HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1 11112222222222 357889999999999999999999999998765543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.65 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=194.7
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
..+.+. ++|.+.+.||+|+++.|+.. +|+.||||++... .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 344443 58999999999998888764 5889999998542 245789999999999999999999886543
Q ss_pred C----CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 298 K----KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 298 ~----~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
. ..+|+||||+.|+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~----- 163 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQTDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC----- 163 (353)
T ss_dssp SGGGCCCCEEEEECCSEEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-----
T ss_pred ccccceeEEEEeccccCCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-----
Confidence 2 2469999999999887764 3499999999999999999999999999999999999999887
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
.+||+|||+++..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+..
T Consensus 164 --~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 164 --ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW--------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp --CEEECSTTCTTC-------------CCSBCCSCHHHHSCC--------SCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred --cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7999999999765422 2345678899999998642 258899999999999999999999998765
Q ss_pred cchhHHHHHHHc--------------------------C---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 454 LQGDKMSRNIRA--------------------------G---ERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 454 ~~~~~~~~~i~~--------------------------~---~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... .+...+.. . .........+..+.+||.+||..||.+|||+.++++|-
T Consensus 229 ~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 229 YLD-QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHH-HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHH-HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 321 11111110 0 01112345688999999999999999999999998764
Q ss_pred H
Q 038696 505 R 505 (683)
Q Consensus 505 ~ 505 (683)
+
T Consensus 308 ~ 308 (353)
T 3coi_A 308 F 308 (353)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.67 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=177.5
Q ss_pred ceeEeeCCCeEEEe-EecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEcC--CCCe
Q 038696 228 SRILIKSEDYQVRR-RLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTDE--EKKE 300 (683)
Q Consensus 228 ~~~~~~~~~y~i~~-~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e--~~~~ 300 (683)
....+ .++|.+.+ .||+|+++.|++. +|+.||||++.............++.++||||+++++++... ....
T Consensus 22 ~~~~~-~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 22 KKYAV-TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp BCSCG-GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CCccc-cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 33433 45899965 6999998888864 688999999976544444444556778999999999988642 2356
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| +|.+++... ....+++.++..++.||+.||.|||++||+||||||+|||++.++ ....+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~----~~~~~kl 172 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER----GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE----KDAVLKL 172 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----TTCCEEE
T ss_pred EEEEEeccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC----CCceEEE
Confidence 8999999986 999999862 335699999999999999999999999999999999999997653 1226999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh--
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-- 457 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~-- 457 (683)
+|||+++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 173 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (336)
T 3fhr_A 173 TDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239 (336)
T ss_dssp CCCTTCEEC--------------------------C---------HHHHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred eccccceecccc----ccccCCCCcCccChhhhCCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh
Confidence 999999865432 22345678899999998654 478899999999999999999999976543211
Q ss_pred HHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 458 KMSRNIRAGE---RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 458 ~~~~~i~~~~---~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.....+..+. .......++..+.+||.+||+.||.+|||+.++++|.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 1111222111 112224678999999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.05 Aligned_cols=245 Identities=24% Similarity=0.401 Sum_probs=190.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcC-----------
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDE----------- 296 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e----------- 296 (683)
++|++.+.||+|+++.|+.. +|+.||||++... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 47999999999998877764 6889999998542 35678999999999999999999887642
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
....+|+||||++| +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~------- 153 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS-----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR------- 153 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH-----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------
T ss_pred cCCceEEEEecCCCCCHHHhhhc-----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-------
Confidence 24678999999975 99999986 234678899999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCC------------CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHH
Q 038696 376 HAKISGFGLSSVKNFGPK------------SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ell 443 (683)
.+||+|||++........ ........||+.|+|||++.+. ..++.++|||||||++|+|+
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--------GHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC--------SCCCTHHHHHHHHHHHHHHH
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--------CCCcchhhHHHHHHHHHHHH
Confidence 799999999976542210 1122345688899999999643 25889999999999999999
Q ss_pred hCCCCCCCCccchhHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 444 TGKVPFEDAHLQGDKMSRNIRAGE---RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 444 tG~~Pf~~~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+ ||..... .......+.... .+.++...+..+.++|.+||+.||.+|||+.+++++
T Consensus 226 ~---p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 226 Y---PFSTGME-RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp S---CCSSHHH-HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---ccCCchh-HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 8 5653221 122333443322 233455667889999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.24 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=192.0
Q ss_pred CCCeEEEeEecccccEEEEEE----cC-cEEEEEEeCCC---cchHHHHHHHHHcCCCCc------eeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LG-ESFALRHFFGD---IEPLVPEISSLLSLSHPN------IMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g-~~vAvK~~~~~---~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~e~~~ 299 (683)
.++|++.+.||+|+++.|++. ++ ..||||++... .+.+.+|+.+++.++|+| |+.+++++... +
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--G 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--C
Confidence 569999999999998888764 34 68999999753 356788999999997665 88888888654 6
Q ss_pred eEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCC---------
Q 038696 300 ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAS--------- 370 (683)
Q Consensus 300 ~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~--------- 370 (683)
.+||||||++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++..+..
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKEN----NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEeccCCChHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 89999999998999988863 33569999999999999999999999999999999999999432100
Q ss_pred ---CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCC
Q 038696 371 ---TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKV 447 (683)
Q Consensus 371 ---~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~ 447 (683)
.+....+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILEL---------GWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecC---------CCCCccchHHHHHHHHHHHhCCC
Confidence 011237999999999864322 2345689999999999754 48999999999999999999999
Q ss_pred CCCCCccchhHHHHHHH--cCCCC-----------------------------------------CCCCCCcHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIR--AGERP-----------------------------------------LFPFHSPKYVTNLTK 484 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~--~~~~~-----------------------------------------~~p~~~~~~l~~Li~ 484 (683)
||....... ....+. .+..+ ......+..+.+||.
T Consensus 238 pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 238 LFQTHENRE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCCCSSHHH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCHHH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 998755322 111111 11100 001112457889999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 038696 485 RCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 485 ~cL~~dP~~RPt~~eil~~ 503 (683)
+||+.||.+|||+.++++|
T Consensus 316 ~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhcCChhhCcCHHHHhcC
Confidence 9999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.60 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=196.8
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC-----------CCceeeeeee
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS-----------HPNIMHFLCG 292 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~-----------HpnIv~l~~~ 292 (683)
.+..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.++..++ ||||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345679999999999998888864 6889999999753 356789999999886 8999999998
Q ss_pred EEcCC--CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCC
Q 038696 293 FTDEE--KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGA 369 (683)
Q Consensus 293 ~~~e~--~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~ 369 (683)
+.... ...+++||||++++|.+++... ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~- 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD- 169 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE-
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHh----hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC-
Confidence 86532 2378999999977999999873 335699999999999999999999998 999999999999996443
Q ss_pred CCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCC
Q 038696 370 STEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449 (683)
Q Consensus 370 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf 449 (683)
..+....+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC---------CCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC---------CCCchHhHHHHHHHHHHHHhCCCCC
Confidence 1133447999999999876432 2334688999999999755 4899999999999999999999999
Q ss_pred CCCccc-----hhHHHHHHHc-CC---------------------------------------CCCCCCCCcHHHHHHHH
Q 038696 450 EDAHLQ-----GDKMSRNIRA-GE---------------------------------------RPLFPFHSPKYVTNLTK 484 (683)
Q Consensus 450 ~~~~~~-----~~~~~~~i~~-~~---------------------------------------~~~~p~~~~~~l~~Li~ 484 (683)
...... ...+...+.. +. ...++...+..+.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 764311 1111111110 00 01123344678899999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 038696 485 RCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 485 ~cL~~dP~~RPt~~eil~~L 504 (683)
+||+.||.+|||+.++++|-
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCG
T ss_pred HHhccCccccCCHHHHhhCh
Confidence 99999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=334.99 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=199.7
Q ss_pred CCCeEEEeEecccccEEEEEE--cCcEEEEEEeCCC-------c--------------chHHHHHHHHHcCCCCceeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW--LGESFALRHFFGD-------I--------------EPLVPEISSLLSLSHPNIMHFL 290 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~--~g~~vAvK~~~~~-------~--------------~~~~~Ei~iL~~L~HpnIv~l~ 290 (683)
.++|++.+.||+|+++.|++. +|+.||||++... . +.+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 359999999999987666543 8999999998421 1 7789999999999999999999
Q ss_pred eeEEcCCCCeEEEEEecCCC-CHHHHHHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCC
Q 038696 291 CGFTDEEKKECFLIMELMSR-DLCSYIKEIC--CPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKP 366 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~ 366 (683)
+++.+. +.+|+||||++| +|.+++.... .......+++..+..++.||+.||.|||+ +||+||||||+|||++.
T Consensus 110 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 998654 789999999986 9988832110 01125679999999999999999999999 99999999999999988
Q ss_pred CCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCc-hhHHHhHHHHHHHHHhC
Q 038696 367 RGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSE-KSDVYSFGMICFEILTG 445 (683)
Q Consensus 367 ~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~-ksDVwSlGvil~ElltG 445 (683)
++ .+||+|||++...... ......||+.|+|||++.+.. .++. ++||||||+++|||++|
T Consensus 188 ~~-------~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~--------~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 188 NG-------RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES--------SYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp TS-------CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC--------CEEHHHHHHHHHHHHHHHHHHS
T ss_pred CC-------cEEEeccccccccccc----cccCCCCCcCccCchhhcCCC--------CCCcchhhHHHHHHHHHHHHhC
Confidence 87 7999999999876432 233456889999999996431 3555 99999999999999999
Q ss_pred CCCCCCCccchhHHHHHHHcCCCCCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 446 KVPFEDAHLQGDKMSRNIRAGERPLFP-------------------FHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 446 ~~Pf~~~~~~~~~~~~~i~~~~~~~~p-------------------~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..||...... ..+...+..+.. .++ ..++..+.+||.+||+.||.+|||+.++++|
T Consensus 249 ~~pf~~~~~~-~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 249 VVPFSLKISL-VELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCSSCCSSCS-HHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCcH-HHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999876542 334455554432 233 5678999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=322.26 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=188.2
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCCc------chHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGDI------EPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~------~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
...+....++|++.+.||+|+++.|++. +|+.||||++.... +.+..+..+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3566667789999999999997766653 68999999996421 2234455678888999999999998654
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..+|+||||+++.+..++.. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 97 --~~~~lv~e~~~~~~~~l~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------- 162 (318)
T 2dyl_A 97 --TDVFIAMELMGTCAEKLKKR-----MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG------- 162 (318)
T ss_dssp --SEEEEEECCCSEEHHHHHHH-----HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-------
T ss_pred --CcEEEEEeccCCcHHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-------
Confidence 68999999996566655543 235699999999999999999999996 999999999999998887
Q ss_pred eEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 376 HAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
.+||+|||++....... ......+|+.|+|||++.... .....++.++||||||+++|+|++|+.||......
T Consensus 163 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 163 QIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPD----PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp CEEECCCTTC-----------------CCTTCCHHHHC------------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred CEEEEECCCchhccCCc---cccccCCCccccChhhccccc----ccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 79999999997654322 223446888999999995321 01235889999999999999999999999875433
Q ss_pred hhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFP--FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
. .....+..+..+..+ ..++..+.+||.+||+.||.+|||+.+++++-..
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 236 F-EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp H-HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred H-HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 2 334444445444444 3578999999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.18 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=196.4
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCC--CCceeeeeeeEE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLS--HPNIMHFLCGFT 294 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~ 294 (683)
....++|++.+.||+|+++.|+.. +|+.||||++.. ..+.+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344678999999999998777764 688999999843 2256778999999996 599999999986
Q ss_pred cCCCCeEEEEEecCC--CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCCCC
Q 038696 295 DEEKKECFLIMELMS--RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK-PRGAST 371 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~--gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~-~~g~~~ 371 (683)
.. ..+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 119 ~~--~~~~lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--- 187 (320)
T 3a99_A 119 RP--DSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--- 187 (320)
T ss_dssp CS--SEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---
T ss_pred cC--CcEEEEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC---
Confidence 54 78999999996 5999999863 5689999999999999999999999999999999999998 555
Q ss_pred CCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCC
Q 038696 372 EGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED 451 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~ 451 (683)
.+||+|||+++..... ......||+.|+|||++.+.. .++.++||||||+++|||++|+.||..
T Consensus 188 ----~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~--------~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 188 ----ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp ----EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSC--------BCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ----CEEEeeCccccccccc----cccCCCCCccCCChHHhccCC--------CCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 7999999999876532 223456889999999997542 347889999999999999999999975
Q ss_pred CccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 452 AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 452 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. . +..+ ...++..++..+.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~-------~-~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 252 DE-------E-IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH-------H-HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hh-------h-hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 32 1 1112 234567789999999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.28 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=187.0
Q ss_pred CCeEEEeEecccccEEEEE---EcCcEEEEEEeCCC-cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecCC
Q 038696 235 EDYQVRRRLGSGSQYKEIL---WLGESFALRHFFGD-IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~-~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+.|.+.+.||+|+++.|+. .+|+.||||++..+ .+.+.+|+.+|..+ +|||||++++++.+ ...+|||||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEecCC
Confidence 4567788999999776653 47899999998543 45678999999876 89999999988854 378999999999
Q ss_pred CCHHHHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC------CCCCCcceEEEecc
Q 038696 310 RDLCSYIKEICCPRKR-IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG------ASTEGYLHAKISGF 382 (683)
Q Consensus 310 gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g------~~~~~~~~vKL~DF 382 (683)
|+|.+++......... ...++..++.++.||+.||.|||++||+||||||+|||++.++ ...++...+||+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999999853111110 1113335678999999999999999999999999999997542 01133458999999
Q ss_pred cCccccCCCCCCC--CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHH
Q 038696 383 GLSSVKNFGPKSP--SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKM 459 (683)
Q Consensus 383 Gla~~~~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~ 459 (683)
|+++......... ......||+.|+|||++.+.... .....++.++|||||||++|||++ |..||.+.....
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL--QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTT--SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhcccccc--ccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 9998765432211 22345789999999999752100 012468999999999999999999 999997654332
Q ss_pred HHHHHcCCCCC--C----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 460 SRNIRAGERPL--F----PFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 460 ~~~i~~~~~~~--~----p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
..+..+.... . +..++.++.+||.+||+.||.+|||+.++++|.
T Consensus 248 -~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp -HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1222222111 1 112357899999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.13 Aligned_cols=196 Identities=24% Similarity=0.301 Sum_probs=163.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC-CC-----ceeeeeeeEEcCCCCe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS-HP-----NIMHFLCGFTDEEKKE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~~e~~~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||++... ...+..|++++..++ |+ +|+++++++... ..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--Cc
Confidence 569999999999998888864 5789999999754 345678999998885 55 489999888654 78
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH--SKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
+||||||++|+|.+++... ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ ...+|
T Consensus 131 ~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~-----~~~~k 201 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNT----NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-----RSAIK 201 (382)
T ss_dssp EEEEEECCCCBHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-----SCCEE
T ss_pred eEEEEecCCCCHHHHHhhc----CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-----CCcEE
Confidence 9999999999999999863 2346999999999999999999999 57999999999999996422 11699
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
|+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM---------PYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876432 2345788999999999754 489999999999999999999999987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=322.22 Aligned_cols=237 Identities=22% Similarity=0.371 Sum_probs=189.7
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----------cchHHHHHHHHHcC----CCCceeeeeeeE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----------IEPLVPEISSLLSL----SHPNIMHFLCGF 293 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----------~~~~~~Ei~iL~~L----~HpnIv~l~~~~ 293 (683)
.-.++|++.+.||+|+++.|+.. +|+.||||++... ...+.+|+.++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999998888864 6789999998532 23456899999998 899999999988
Q ss_pred EcCCCCeEEEEEec-CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC-CCCCC
Q 038696 294 TDEEKKECFLIMEL-MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK-PRGAS 370 (683)
Q Consensus 294 ~~e~~~~~~LVmEy-~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~-~~g~~ 370 (683)
.+. +..++|||| +. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 108 ~~~--~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-- 177 (312)
T 2iwi_A 108 ETQ--EGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-- 177 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--
T ss_pred ecC--CeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--
Confidence 543 678999998 56 5999999863 4699999999999999999999999999999999999998 555
Q ss_pred CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 371 TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 371 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
.+||+|||+++..... ......||..|+|||++.+.. .++.++||||||+++|+|++|+.||.
T Consensus 178 -----~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 178 -----CAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQ--------YHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp -----EEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSC--------BCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -----eEEEEEcchhhhcccC----cccccCCcccccCceeeecCC--------CCCccchHHHHHHHHHHHHHCCCCCC
Confidence 7999999999876533 223456888999999997542 23568999999999999999999997
Q ss_pred CCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 451 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
... ... . ....++..++..+.+||.+||+.||++|||+.+++++.
T Consensus 241 ~~~-------~~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 241 RDQ-------EIL-E-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp SHH-------HHH-H-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ChH-------HHh-h-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 532 111 1 12346677899999999999999999999999998763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.43 Aligned_cols=221 Identities=14% Similarity=0.138 Sum_probs=176.7
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
..++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.++..++||||+++++++.+. +.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcE
Confidence 3468999999999998777753 4889999999643 15688999999999999999999998654 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
||||||++| +|.++++. . ....++..++.||+.||.|||++||+||||||+|||++.+| .+||+
T Consensus 107 ~lv~e~~~g~~L~~~l~~-------~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-------~~kl~ 171 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-------S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-------DVVLA 171 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-------C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-------CEEEC
T ss_pred EEEEEecCCCCHHHHHhc-------C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-------CEEEE
Confidence 999999985 99999853 2 35667899999999999999999999999999999999887 78987
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH--
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK-- 458 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~-- 458 (683)
++| |++ .++.++|||||||++|||++|+.||.+.......
T Consensus 172 ~~~----------------------~~~----------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~ 213 (286)
T 3uqc_A 172 YPA----------------------TMP----------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213 (286)
T ss_dssp SCC----------------------CCT----------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE
T ss_pred ecc----------------------ccC----------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH
Confidence 543 322 2678999999999999999999999875432100
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 459 ~~~~i~~~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+.+.....+ .....++.++.+||.+||+.||.+| |+.++++.|+.+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000111000 1235678999999999999999999 99999999988753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.88 Aligned_cols=229 Identities=25% Similarity=0.395 Sum_probs=177.9
Q ss_pred CCeEEE-eEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHH-HcCCCCceeeeeeeEEc--CCCCeEEEEEe
Q 038696 235 EDYQVR-RRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSL-LSLSHPNIMHFLCGFTD--EEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~-~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~--e~~~~~~LVmE 306 (683)
++|.+. +.||+|+++.|+.. +|+.||||++.. ...+.+|+.++ +.++||||+++++++.. .+...+|||||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 478887 78999998888763 688999999964 45678899988 66689999999998854 23467899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++| +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 96 ~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 96 CLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----PNAILKLTDFGFA 167 (299)
T ss_dssp CCCSCBHHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS----TTCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC----CCCcEEEeccccc
Confidence 9975 999999872 335699999999999999999999999999999999999998732 1127999999998
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH--HHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK--MSRNI 463 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~--~~~~i 463 (683)
..... ..++.++|||||||++|||++|..||.+....... +...+
T Consensus 168 ~~~~~---------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 214 (299)
T 3m2w_A 168 KETTG---------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214 (299)
T ss_dssp EECTT---------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS
T ss_pred ccccc---------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH
Confidence 64321 12677999999999999999999999764321100 00000
Q ss_pred HcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 464 RAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 464 ~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
..+ ...++ ..++.++.+||.+||+.||.+|||+.++++|.+.
T Consensus 215 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 215 RMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp CTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 111 11122 4578899999999999999999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=337.83 Aligned_cols=235 Identities=19% Similarity=0.234 Sum_probs=184.8
Q ss_pred CCCeEEEeEecccccEEEEEE-----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCC---Ce
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK---KE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~---~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|..++|||||++++++...+. ..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 469999999999998888763 4789999998532 2357899999999999999999998875432 12
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++| +|.+++. ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--------~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--------QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--------CEEE
T ss_pred eEEEEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--------cEEE
Confidence 6999999986 8887664 269999999999999999999999999999999999999764 5999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-- 284 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG----------PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-- 284 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC----------SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC----------CCCceehhhhHHHHHHHHhCCCCCcccccccc--
Confidence 999999876432 345689999999999653 58899999999999999999999875432110
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-FSSICRILRYIKR 509 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-~~eil~~L~~i~~ 509 (683)
.........+..+.+||.+||+.||.+||+ ++++.+.|..+.+
T Consensus 285 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 -------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000000112467999999999999999995 6666666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.92 Aligned_cols=251 Identities=19% Similarity=0.173 Sum_probs=184.2
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCC-Cceee-------------
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSH-PNIMH------------- 288 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~H-pnIv~------------- 288 (683)
..+|.+.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+.++..++| .|+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346889999999998888864 489999999862 25678899999999987 32211
Q ss_pred --------eeeeEEcCC---CCeEEEEEecCCCCHHHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 038696 289 --------FLCGFTDEE---KKECFLIMELMSRDLCSYIKEICC-PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGN 356 (683)
Q Consensus 289 --------l~~~~~~e~---~~~~~LVmEy~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrD 356 (683)
++..+.... ...++++|+++.++|.+++..... ......+++..++.++.||+.||.|||++||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111111111 235789999999999998863211 12235688889999999999999999999999999
Q ss_pred CCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhcccccc-ccCCCCCchhHHHhH
Q 038696 357 LNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTES-ASNSKYSEKSDVYSF 435 (683)
Q Consensus 357 LKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~-~~~~~~s~ksDVwSl 435 (683)
|||+||||+.++ .+||+|||+++..... .....| +.|+|||++.+...... .....++.++|||||
T Consensus 237 iKp~NILl~~~~-------~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 237 LRPVDIVLDQRG-------GVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CCGGGEEECTTC-------CEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cccceEEEecCC-------eEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999888 6999999998865432 223455 78999999953210000 012248889999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 436 GMICFEILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 436 Gvil~ElltG~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
||++|||++|+.||....... ....+.. ....++..+.+||.+||+.||.+|||+.+++++-
T Consensus 304 Gvil~elltg~~Pf~~~~~~~--~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~ 365 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG--GSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS--CSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HHHHHHHHHCCCCCCCcchhh--hHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 999999999999998754321 1111111 1235689999999999999999999999998763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=341.96 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=188.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEc----CCCCeE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTD----EEKKEC 301 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----e~~~~~ 301 (683)
++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++||||+++++++.. ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999998777753 6889999998653 3568899999999999999999987643 124678
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|+||||++ |+|.+++... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++ ....+||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~---~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g----~~~~vKL~ 166 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF---ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP----QRLIHKII 166 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS---SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS----SSCEEEEC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC----CceeEEEc
Confidence 99999997 5999999853 1224689999999999999999999999999999999999998765 23469999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh---
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD--- 457 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~--- 457 (683)
|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~---------~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQK---------KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCS---------CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred cccccccccccc---ccccccCCcccCChHHhccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 999998765432 22345788999999998644 589999999999999999999999975321100
Q ss_pred ----HHHHHHH-----cC-----CCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 ----KMSRNIR-----AG-----ERP----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ----~~~~~i~-----~~-----~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.....+. .+ ... ......+..+.+||.+||..||.+|||+.+++++
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 0000000 00 000 1122356889999999999999999999886544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.88 Aligned_cols=240 Identities=14% Similarity=0.111 Sum_probs=177.1
Q ss_pred CCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC------------cchHHHHHHHHHcCC---------CCceeeee
Q 038696 234 SEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD------------IEPLVPEISSLLSLS---------HPNIMHFL 290 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~---------HpnIv~l~ 290 (683)
.++|++.+.||+|+++.|++ .+|+.||||++... .+.+.+|+.+|+.++ |||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 45899999999999877775 47899999998532 166889999999886 66666655
Q ss_pred eeEE-----------------c-----------CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 038696 291 CGFT-----------------D-----------EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341 (683)
Q Consensus 291 ~~~~-----------------~-----------e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~ 341 (683)
+.+. + .+...+||||||+. |++.+.+.+ ..+++..+..++.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHH
Confidence 5432 1 01478999999997 556666532 4589999999999999
Q ss_pred HHHHHHH-hCCcccCCCCCCcEEeCCCCCC-------------CCCcceEEEecccCccccCCCCCCCCCCCCCcCcccC
Q 038696 342 RGMEYLH-SKKIYHGNLNPSNILLKPRGAS-------------TEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWH 407 (683)
Q Consensus 342 ~aL~yLH-~~gIiHrDLKp~NILl~~~g~~-------------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 407 (683)
.||.||| ++||+||||||+|||++.++.. ......+||+|||+|+..... ...||+.|+
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 9999999 9999999999999999876410 001237999999999876432 347899999
Q ss_pred ChhhhhhccccccccCCCCCchhHHHhHHHH-HHHHHhCCCCCCCCccchhHHHHHHH-cCCCCC-C----CCCCcHHHH
Q 038696 408 APEVLEENEQTESASNSKYSEKSDVYSFGMI-CFEILTGKVPFEDAHLQGDKMSRNIR-AGERPL-F----PFHSPKYVT 480 (683)
Q Consensus 408 APEvl~~~~~~~~~~~~~~s~ksDVwSlGvi-l~ElltG~~Pf~~~~~~~~~~~~~i~-~~~~~~-~----p~~~~~~l~ 480 (683)
|||++.+. .+.++||||||++ .++++.|..||.+...... ....+. ...... . +..+++++.
T Consensus 245 aPE~~~g~----------~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGD----------GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY-LTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCC----------SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH-HHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCC----------CccceehhhhhCCCCcccccccCCCcchhhhhH-HHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 99999754 3789999998777 7788889999964221111 122222 111111 1 123567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHH-HH
Q 038696 481 NLTKRCWHADPNQRPSFSSIC-RI 503 (683)
Q Consensus 481 ~Li~~cL~~dP~~RPt~~eil-~~ 503 (683)
+||.+||+.| |+.+++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999977 899988 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=297.35 Aligned_cols=165 Identities=18% Similarity=0.231 Sum_probs=123.0
Q ss_pred EcCcEEEEEEeCCC--------------cchHHHHHHHHHcC-CCCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHH
Q 038696 254 WLGESFALRHFFGD--------------IEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIK 317 (683)
Q Consensus 254 ~~g~~vAvK~~~~~--------------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~ 317 (683)
..|+.||||.+..+ .++|.+|+++|+++ .|+||+++++++.++ +.+|||||||+| +|.++|.
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yLVMEyv~G~~L~d~i~ 334 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWLVMEKLPGRLLSDMLA 334 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEEEEECCCSEEHHHHHH
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEEEEecCCCCcHHHHHH
Confidence 58999999998532 24689999999999 699999999999544 789999999997 9999998
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCC
Q 038696 318 EICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397 (683)
Q Consensus 318 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~ 397 (683)
. ..+++.. .|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+...... ...
T Consensus 335 ~------~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-------~vKL~DFGlAr~~~~~~--~~~ 396 (569)
T 4azs_A 335 A------GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-------HARLIDFGSIVTTPQDC--SWP 396 (569)
T ss_dssp T------TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-------CEEECCCTTEESCC-----CCS
T ss_pred h------CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-------CEEEeecccCeeCCCCC--ccc
Confidence 5 3567654 5889999999999999999999999999999888 79999999998765432 223
Q ss_pred CCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCC
Q 038696 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVP 448 (683)
Q Consensus 398 ~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~P 448 (683)
...+||+.|+|||++.+. +..++|+||+|+++++|.+|..+
T Consensus 397 ~t~vGTp~YmAPE~l~g~----------~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN----------KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC---------------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhCCC----------CCCcccccccccchhhhccccch
Confidence 346799999999999754 66789999999999887766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-24 Score=243.79 Aligned_cols=181 Identities=14% Similarity=0.156 Sum_probs=133.8
Q ss_pred EEEeEecccccEEEEE--EcCcEEEEEEeCCC------------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 238 QVRRRLGSGSQYKEIL--WLGESFALRHFFGD------------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
...+.||+|+++.|+. +.+..+|+|+.... .+.+.+|+++|+.++||||+++..++.++ ...||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTTEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--CccEE
Confidence 3456899999877775 47889999986421 23478999999999999999443333333 34699
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||++ |+|.+++.+ +..++.||+.||.|||++||+||||||+|||++. .+||+||
T Consensus 417 VmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---------~~kL~DF 473 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---------DLYIIDF 473 (540)
T ss_dssp EEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---------SEEECCC
T ss_pred EEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---------eEEEEEC
Confidence 999998 599998863 5689999999999999999999999999999975 3999999
Q ss_pred cCccccCCCCCCC-----CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 383 GLSSVKNFGPKSP-----SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 383 Gla~~~~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
|+++......... ......||+.|+|||++.... ..|+..+|+||.++-..+.+.++.+|.
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-------~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-------EGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-------HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH-------HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9998764321100 012456899999999998621 127778899999999999888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7.4e-21 Score=198.39 Aligned_cols=139 Identities=17% Similarity=0.147 Sum_probs=109.9
Q ss_pred CCCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC----------------------cchHHHHHHHHHcCCCCceee
Q 038696 234 SEDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD----------------------IEPLVPEISSLLSLSHPNIMH 288 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~----------------------~~~~~~Ei~iL~~L~HpnIv~ 288 (683)
...|.+.+.||+|+++.|+.. +|+.||||++... ...+.+|+.+|+.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 346788899999997777753 5889999998531 234789999999999 4 66
Q ss_pred eeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC
Q 038696 289 FLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR 367 (683)
Q Consensus 289 l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~ 367 (683)
+++++.. +..|+||||++| +|.+ +. . .....++.||+.||.|||++||+||||||+|||++ +
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T
T ss_pred cCeEEec---cceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C
Confidence 6655532 346999999986 8876 32 1 23557999999999999999999999999999999 7
Q ss_pred CCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhh
Q 038696 368 GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEE 414 (683)
Q Consensus 368 g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~ 414 (683)
+ .+||+|||+|+.. ..|+|||++..
T Consensus 229 ~-------~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 229 E-------GIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp T-------EEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred C-------cEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 6 7999999998643 23789999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.2e-18 Score=172.83 Aligned_cols=129 Identities=12% Similarity=0.161 Sum_probs=99.7
Q ss_pred CeEEEeEecccccEEEEE----EcCcE--EEEEEeCCCc----------------------------chHHHHHHHHHcC
Q 038696 236 DYQVRRRLGSGSQYKEIL----WLGES--FALRHFFGDI----------------------------EPLVPEISSLLSL 281 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l----~~g~~--vAvK~~~~~~----------------------------~~~~~Ei~iL~~L 281 (683)
-|++.+.||+|+++.|+. .+|+. ||||+++... ..+.+|+++|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999766664 37888 9999874320 1578899999999
Q ss_pred CCCce--eeeeeeEEcCCCCeEEEEEecCC--C----CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCc
Q 038696 282 SHPNI--MHFLCGFTDEEKKECFLIMELMS--R----DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH-SKKI 352 (683)
Q Consensus 282 ~HpnI--v~l~~~~~~e~~~~~~LVmEy~~--g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gI 352 (683)
.|++| +.+++ + ...+|||||++ | +|.++... +++..+..++.||+.||.||| +.||
T Consensus 128 ~~~~i~~p~~~~-~-----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYT-Y-----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAEL 192 (258)
T ss_dssp HHTTCCCCCEEE-E-----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSCE
T ss_pred HhCCCCCCeEEE-c-----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCCE
Confidence 88864 33332 1 23589999995 3 56655432 234567899999999999999 9999
Q ss_pred ccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 353 YHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 353 iHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
+||||||+|||++. . ++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~-~--------~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID-K--------VYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS-S--------EEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC-c--------EEEEECcccccC
Confidence 99999999999965 3 999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=155.71 Aligned_cols=136 Identities=18% Similarity=0.193 Sum_probs=91.8
Q ss_pred CeEEEeEecccccEEEEEE---cCcEEEEEEeCCCc------------------ch--------HHHHHHHHHcCCCCce
Q 038696 236 DYQVRRRLGSGSQYKEILW---LGESFALRHFFGDI------------------EP--------LVPEISSLLSLSHPNI 286 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~~------------------~~--------~~~Ei~iL~~L~HpnI 286 (683)
-|++.+.||.|++..|++. +|+.||||+++... .. ..+|...|..|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4999999999997777764 68999999874210 01 1345666666644333
Q ss_pred eeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeC
Q 038696 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLK 365 (683)
Q Consensus 287 v~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~ 365 (683)
.-. ..+... ..+|||||++| .|.++. .......++.||+.+|.|||+.|||||||||.|||++
T Consensus 176 ~vp-~p~~~~---~~~LVME~i~G~~L~~l~------------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVP-EPIAQS---RHTIVMSLVDALPMRQVS------------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCC-CEEEEE---TTEEEEECCSCEEGGGCC------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred CCC-eeeecc---CceEEEEecCCccHhhhc------------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 211 111111 12799999997 664321 1124567889999999999999999999999999998
Q ss_pred CCCCCC---CCcceEEEecccCccc
Q 038696 366 PRGAST---EGYLHAKISGFGLSSV 387 (683)
Q Consensus 366 ~~g~~~---~~~~~vKL~DFGla~~ 387 (683)
.+|... .....+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 765111 1123489999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=6e-11 Score=121.05 Aligned_cols=131 Identities=18% Similarity=0.108 Sum_probs=100.1
Q ss_pred CeEEEeEecccccEEEEEE--cCcEEEEEEeC----CCcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 236 DYQVRRRLGSGSQYKEILW--LGESFALRHFF----GDIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~--~g~~vAvK~~~----~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
.|++...+|.|+...++.. .|..+++|+.. .....+.+|+++|+.|. +.++.++++++.+ .+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEEEec
Confidence 6888888887764444433 47899999985 34557999999999995 6778888877754 36789999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-------------------------------------- 349 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------- 349 (683)
+| +|.+.+. +......++.+++.+|..||+
T Consensus 93 ~G~~l~~~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 93 DGVLCSEEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp SSEEHHHHCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred CCeehhhccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 98 7765421 112234788999999999998
Q ss_pred ---------------------CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 350 ---------------------KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 ---------------------~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
..++|+|++|.|||++.++ .+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-------~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-------VSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-------EEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-------EEEEEEchhcc
Confidence 4589999999999997654 56799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.4e-09 Score=109.82 Aligned_cols=128 Identities=16% Similarity=0.157 Sum_probs=87.3
Q ss_pred CeEEEeEecccccEEEEEE---cCcEEEEEEeCCC-cchHHHHHHHHHcCCCCc--eeeeeeeEEcCCCCeEEEEEecCC
Q 038696 236 DYQVRRRLGSGSQYKEILW---LGESFALRHFFGD-IEPLVPEISSLLSLSHPN--IMHFLCGFTDEEKKECFLIMELMS 309 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~e~~~~~~LVmEy~~ 309 (683)
+|.+....+.|+...++.. +|..++||+.... ...+.+|+.+|+.+.+.+ +.++++...+. +..|+||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEecC
Confidence 5555443334433344432 4678999998643 456889999999996445 45577666433 56899999999
Q ss_pred C-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 038696 310 R-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK------------------------------------- 351 (683)
Q Consensus 310 g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g------------------------------------- 351 (683)
| +|. .. ... ...++.+++..|..||+..
T Consensus 99 G~~l~--~~---------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 99 GQDLL--SS---------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SEETT--TS---------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CcccC--cC---------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 8 663 11 011 2256677777777777643
Q ss_pred ---------------------cccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 352 ---------------------IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 352 ---------------------IiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
++|+|++|.|||++.++ .+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-------~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-------FSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-------EEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-------EEEEEcchhcc
Confidence 99999999999997654 56799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=3e-09 Score=113.77 Aligned_cols=135 Identities=17% Similarity=0.240 Sum_probs=96.1
Q ss_pred EeEecccccEEEEE--EcCcEEEEEEeC--C-----CcchHHHHHHHHHcCC--CCceeeeeeeEEcCCC-CeEEEEEec
Q 038696 240 RRRLGSGSQYKEIL--WLGESFALRHFF--G-----DIEPLVPEISSLLSLS--HPNIMHFLCGFTDEEK-KECFLIMEL 307 (683)
Q Consensus 240 ~~~LG~G~~~~v~l--~~g~~vAvK~~~--~-----~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~e~~-~~~~LVmEy 307 (683)
++.|+.|....++. ..+..+++|+.. . ....+.+|+++|+.|. +..+++++..+.+.+. +..|+||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45677776433333 246788899876 2 2457889999999997 4557778776643221 457999999
Q ss_pred CCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 038696 308 MSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS------------------------------------- 349 (683)
Q Consensus 308 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------- 349 (683)
++| .+.+. ....++..+...++.+++..|..||+
T Consensus 123 v~G~~l~~~--------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 123 VSGRVLWDQ--------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCBCCCCT--------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred cCCeecCCC--------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 998 55321 11347788889999999999999997
Q ss_pred ---------------------CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 350 ---------------------KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 350 ---------------------~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.+++|+|+++.|||++.++. -.+.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECcccccc
Confidence 36899999999999987641 1479999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.2e-09 Score=114.26 Aligned_cols=183 Identities=17% Similarity=0.199 Sum_probs=115.7
Q ss_pred EecccccEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCC-CCc--eeeeeeeEEcCCC-CeEEEEEecCCC-CHHH
Q 038696 242 RLGSGSQYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLS-HPN--IMHFLCGFTDEEK-KECFLIMELMSR-DLCS 314 (683)
Q Consensus 242 ~LG~G~~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~-Hpn--Iv~l~~~~~~e~~-~~~~LVmEy~~g-sL~~ 314 (683)
.++.|....++. .+..++||+.... ...+.+|+++|+.+. +.. +.+++......+. ...|+||++++| +|.+
T Consensus 27 ~~~~G~~n~v~~-v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~ 105 (304)
T 3sg8_A 27 ISGEGNDCIAYE-INRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTP 105 (304)
T ss_dssp EEEECSSEEEEE-STTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCH
T ss_pred ecCCCCcceEEE-ECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCc
Confidence 477887666654 3467889987643 456889999998883 433 3344332211111 234899999998 6654
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 038696 315 YIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS--------------------------------------------- 349 (683)
Q Consensus 315 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------------------------------------------- 349 (683)
.... .++..+...++.|++..|..||+
T Consensus 106 ~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 106 LLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp HHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred cccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 3332 36777888888888888888885
Q ss_pred -------------CCcccCCCCCCcEEeCCC-CCCCCCcceEEEecccCccccCCCCCCCCCCCC---Cc---------C
Q 038696 350 -------------KKIYHGNLNPSNILLKPR-GASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT---TH---------P 403 (683)
Q Consensus 350 -------------~gIiHrDLKp~NILl~~~-g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~---~g---------t 403 (683)
..++|+|++|.|||++.+ + -.+.|+||+.+............... .+ .
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~------~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKN------TICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTT------EEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCC------CEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999874 2 15889999998654321100000000 00 0
Q ss_pred cccCC-hhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCC
Q 038696 404 FIWHA-PEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450 (683)
Q Consensus 404 ~~Y~A-PEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~ 450 (683)
+.+.. |+.... .....+.|++|.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r-----------~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK-----------YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH-----------HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11112 232221 1234689999999999999988774
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=98.37 E-value=2.1e-08 Score=86.85 Aligned_cols=77 Identities=8% Similarity=0.038 Sum_probs=58.2
Q ss_pred HHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKI 197 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 197 (683)
+|+.++||||.++|++|+.+|. .+|+|+||.|+..++. |+| ....++||.|...+++|++.....|.++
T Consensus 1 ~L~~~~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl 74 (98)
T 3us4_A 1 GLSLMPWFHGKISGQEAVQQLQPPEDGLFLVRESARHPGD------YVLCVSFGRDVIHYRVLHRDGHLTIDEAVFFCNL 74 (98)
T ss_dssp -CTTCTTBCCSCCHHHHHHHTCSCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEEETTEEESSSSSEESSH
T ss_pred CCccCcccCCCCCHHHHHHHccCCCCcEEEEEeCCCCCCc------EEEEEEECCceEEEEEEEeCCEEEECCCCccCCH
Confidence 3678999999999999999999 6999999999876665 777 4455889999877777777655555444
Q ss_pred cCCchhhh
Q 038696 198 SGSTKQEQ 205 (683)
Q Consensus 198 ~~~~~~~~ 205 (683)
.+...++.
T Consensus 75 ~~Lv~~y~ 82 (98)
T 3us4_A 75 MDMVEHYS 82 (98)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 44444333
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.3e-06 Score=88.25 Aligned_cols=135 Identities=21% Similarity=0.188 Sum_probs=86.0
Q ss_pred eEecccccEEEEEEcCcEEEEEEeCCC--cchHHHHHHHHHcCCCC---ceeeeeeeEEcCCCCeEEEEEecCCC-CHHH
Q 038696 241 RRLGSGSQYKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHP---NIMHFLCGFTDEEKKECFLIMELMSR-DLCS 314 (683)
Q Consensus 241 ~~LG~G~~~~v~l~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~ 314 (683)
..++.|....++.. |..++||+.... ...+.+|+++|..|.+. .+.+++..... ..+..|+||||++| .|.+
T Consensus 25 ~~l~~G~~n~v~~v-g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp EEEEECSSEEEEEE-TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCSEECHH
T ss_pred eecCCCcceeEEEE-CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCCeECch
Confidence 34667765555544 778889986432 35688999999999742 24455544432 33567899999998 6655
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 038696 315 YIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-------------------------------------------- 350 (683)
Q Consensus 315 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------------------------------------------- 350 (683)
... ..++..+...++.++...|..||+.
T Consensus 103 ~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 103 DGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp HHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred hhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 322 1234445555555555555555532
Q ss_pred ----------------CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcccc
Q 038696 351 ----------------KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 351 ----------------gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
.++|+|+++.|||++.++ ++.-.+.|+||+.+...
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~---~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS---RQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC---SSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCC---CCCceEEEEehhhcCCC
Confidence 459999999999998721 00114689999987543
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.9e-08 Score=87.06 Aligned_cols=78 Identities=9% Similarity=0.072 Sum_probs=58.6
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec---hhhhhhhhhhh-cccchhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVW-KEDRWILFNKIQ 193 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~-~~~~~~l~~~~~ 193 (683)
+.++.++||||.++|++|+.+|.. +|+|+||.|+...+. |+|+ ...++||.|.. .++.|++.....
T Consensus 11 ~~l~~~~WyhG~isR~eAe~lL~~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~ 84 (121)
T 2dly_A 11 RSLQAEPWFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGD------FSLSVLDEGVVKHYRIRRLDEGGFFLTRRKV 84 (121)
T ss_dssp GGGGGCSSBCSSCCHHHHHHHHTSSSCCTTCEEEEECSSSSSC------EEEEEESSSCEEEEEEEECSSSCEEEETTEE
T ss_pred cccCcCCccccCCCHHHHHHHHhcCCCCCCEEEEEcCCCCCCc------eEEEEEECCeEEEEEEEEcCCCCEEECCCCc
Confidence 568899999999999999999985 499999999866655 8873 34588999976 455577765556
Q ss_pred hhhccCCchhhh
Q 038696 194 QKKISGSTKQEQ 205 (683)
Q Consensus 194 ~~~~~~~~~~~~ 205 (683)
|.++.+...++.
T Consensus 85 F~sl~eLV~~y~ 96 (121)
T 2dly_A 85 FSTLNEFVNYYT 96 (121)
T ss_dssp ESSHHHHHHHHT
T ss_pred cCCHHHHHHHHh
Confidence 655554444443
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=98.28 E-value=4.3e-08 Score=86.24 Aligned_cols=78 Identities=6% Similarity=0.057 Sum_probs=58.8
Q ss_pred HHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKK 196 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~ 196 (683)
..|+.++||||.++|++|+.+|. .+|+|+||.|+..++. |+| ....++||.|...++.|++.....|.+
T Consensus 3 ~~L~~~~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~g~~~l~~~~~F~s 76 (106)
T 3eaz_A 3 TKLSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPGD------YTLCVSSDGKVEHYRIMYHASKLSIDEEVYFEN 76 (106)
T ss_dssp CTGGGCTTBCCSCCHHHHHHHTCSCCTTEEEEEECTTSTTC------EEEEEEETTEEEEEECEEETTEEESSSSSCBSS
T ss_pred cccccCCCcCCCCCHHHHHHHhCCCCCCEEEEEECCCCCCc------EEEEEEeCCceEEEEEEecCCEEEECCCCccCC
Confidence 35788999999999999999999 7999999999866665 777 344588999976666677765555544
Q ss_pred ccCCchhhh
Q 038696 197 ISGSTKQEQ 205 (683)
Q Consensus 197 ~~~~~~~~~ 205 (683)
+.+...++.
T Consensus 77 l~~Lv~~y~ 85 (106)
T 3eaz_A 77 LMQLVEHYT 85 (106)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 444444333
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.28 E-value=6.2e-08 Score=86.93 Aligned_cols=76 Identities=4% Similarity=-0.140 Sum_probs=56.7
Q ss_pred HhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec-------hhhhhhhhhhhcccchhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT-------PDFCYRIDTVWKEDRWILFNKIQ 193 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~-------~~~~~~~~~~~~~~~~~l~~~~~ 193 (683)
++.++||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|...++.|++.....
T Consensus 18 ~~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~v~H~~I~~~~g~~~i~~~~~ 91 (118)
T 2el8_A 18 ALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADG------VSVTTRQMHNGTHVVRHYKVKREGPKYVIDVEQP 91 (118)
T ss_dssp CSSSCTTCCCCCHHHHHHHHHHSSTTCSBEEEECCSSSSS------EEEEECCCBTTBCCCEEECBCCBTTBCCBSSSSC
T ss_pred ccCCCceecCCCHHHHHHHHhhCCCCcEEEEeeCCCCCCc------eEEEEEEecCCCCcEEEEEEEEcCCEEEEeCCCe
Confidence 4678999999999999999975 899999999877666 7773 34589999976666677665445
Q ss_pred h--hhccCCchhhh
Q 038696 194 Q--KKISGSTKQEQ 205 (683)
Q Consensus 194 ~--~~~~~~~~~~~ 205 (683)
| .++.+.+.++.
T Consensus 92 F~~~sL~eLV~~y~ 105 (118)
T 2el8_A 92 FSCTSLDAVVNYFV 105 (118)
T ss_dssp CCCSSHHHHHHHHH
T ss_pred ECCCCHHHHHHHHh
Confidence 5 44444444443
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.5e-08 Score=85.34 Aligned_cols=76 Identities=7% Similarity=0.048 Sum_probs=56.3
Q ss_pred HhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeeech--------hhhhhhhhhhc-ccchhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWK-EDRWILFN 190 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~-~~~~~l~~ 190 (683)
|+.++||||.++|++|+.+|. .+|+|+||.|+..++. |+|+. ..++||.|... ++.|++..
T Consensus 1 l~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~~~~~~v~H~~I~~~~~g~~~l~~ 74 (105)
T 1lkk_A 1 LEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGS------FSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISP 74 (105)
T ss_dssp CCCCTTBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTTC------EEEEEEEEETTTEEEEEEEEEEECTTSCEESST
T ss_pred CCcCceecCCCCHHHHHHHHHhcCCCCceEEEEECCCCCCc------EEEEEEEcccCCCCcEEEEEEEECCCCCEEECC
Confidence 467899999999999999997 5899999999876665 77733 45899999764 45677765
Q ss_pred hhhhhhccCCchhhh
Q 038696 191 KIQQKKISGSTKQEQ 205 (683)
Q Consensus 191 ~~~~~~~~~~~~~~~ 205 (683)
...|.++.+...++.
T Consensus 75 ~~~F~sl~~LI~~y~ 89 (105)
T 1lkk_A 75 RITFPGLHELVRHYT 89 (105)
T ss_dssp TSCBSSHHHHHHHHH
T ss_pred CceeCCHHHHHHHHh
Confidence 556655444444443
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=98.25 E-value=1.3e-07 Score=85.12 Aligned_cols=79 Identities=11% Similarity=0.076 Sum_probs=60.5
Q ss_pred HHHHhhhccccCCCchhHHHHHHhh--cCCceeeecccc-ccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHK-LFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQ 194 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~-~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~ 194 (683)
.+.|+.++||||.++|++|+.+|.. +|+|+||.|+.. ++. |+|+ ...++||.|...++.|.+.....|
T Consensus 5 ~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~g~------y~LSv~~~~~v~H~~I~~~~g~~~l~~~~~F 78 (120)
T 2iug_A 5 NMSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGD------YTLTLRKGGNNKLIKIFHRDGKYGFSDPLTF 78 (120)
T ss_dssp CHHHHTCTTBCCSCCHHHHHHHHTTCCTTEEEEEECSSGGGCS------EEEEEEETTEEEEEEEEEETTEEESSSSCCB
T ss_pred ccccccCCccccCCCHHHHHHHhcCCCCcEEEEECCCCCCCCc------EEEEEEECCEEEEEEEEEcCCEEEECCCCcc
Confidence 4678999999999999999999998 999999999866 555 7773 345889999777667877655566
Q ss_pred hhccCCchhhh
Q 038696 195 KKISGSTKQEQ 205 (683)
Q Consensus 195 ~~~~~~~~~~~ 205 (683)
.++.+...++.
T Consensus 79 ~sl~~LI~~y~ 89 (120)
T 2iug_A 79 SSVVELINHYR 89 (120)
T ss_dssp SSHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 55554444443
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.23 E-value=2.3e-07 Score=85.98 Aligned_cols=86 Identities=8% Similarity=0.070 Sum_probs=67.3
Q ss_pred hhhhHHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhh--
Q 038696 117 IPILIEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILF-- 189 (683)
Q Consensus 117 ~~~~~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~-- 189 (683)
+....+.++.++||||.++|++|+.+|.. +|+|+||.|+...+. |+|+ ...++||.|...++.|++.
T Consensus 14 ~v~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~~------~~LSv~~~~~v~H~~I~~~~g~~~l~~~ 87 (141)
T 2vif_A 14 LTEELKKLAKQGWYWGPITRWEAEGKLANVPDGSFLVRDSSDDRYL------LSLSFRSHGKTLHTRIEHSNGRFSFYEQ 87 (141)
T ss_dssp HHHHHHHHHHHTCBCCSCCHHHHHHHTTTSCTTCEEEEECSSTTCS------EEEEEEETTEEEEEEEEEETTEEEETTC
T ss_pred hhcchhhhccCCCcccCCCHHHHHHHhcCCCCceEEEEecCCCCCC------EEEEEEECCEEEEEEEEEECCEEEEeec
Confidence 33345788999999999999999999987 999999999865554 7773 4568999998777778887
Q ss_pred -hhhhhhhccCCchhhhchH
Q 038696 190 -NKIQQKKISGSTKQEQGLI 208 (683)
Q Consensus 190 -~~~~~~~~~~~~~~~~~~~ 208 (683)
....|.++.+...++....
T Consensus 88 ~~~~~F~sl~eLI~~y~~~~ 107 (141)
T 2vif_A 88 PDVEGHTSIVDLIEHSIGDS 107 (141)
T ss_dssp CSCCCBSSHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHhhCC
Confidence 4667777777766666444
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-07 Score=84.54 Aligned_cols=78 Identities=13% Similarity=0.043 Sum_probs=57.1
Q ss_pred HHHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeech---------hhhhhhhh--hh-cccch
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLITP---------DFCYRIDT--VW-KEDRW 186 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~~---------~~~~~~~~--~~-~~~~~ 186 (683)
+.|+.++||||.++|++|+.+|.. +|.|+||.| ..++. |+|+. ..++||.| .. .++.|
T Consensus 4 ~~l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S-~~~g~------y~LSv~~~~~~~~~~~v~H~~I~~~~~~~g~~ 76 (118)
T 3s9k_A 4 NNLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDS-RTPGT------YTVSVFTKAIISENPCIKHYHIKETNDSPKRY 76 (118)
T ss_dssp -CGGGSTTBCTTCCHHHHHHHHHHHCCTTCEEEEEC-SSTTC------EEEEEEECCSCSSSCEEEEEEEEECSCSSCCE
T ss_pred cccccCceecCCCCHHHHHHHHHhcCCCCeEEEEee-CCCCC------EEEEEEecccccCCCceEEEEEeEEECCCCCE
Confidence 568899999999999999999986 899999999 66665 77732 56899999 32 34456
Q ss_pred hhhhhhhhhhccCCchhhhc
Q 038696 187 ILFNKIQQKKISGSTKQEQG 206 (683)
Q Consensus 187 ~l~~~~~~~~~~~~~~~~~~ 206 (683)
++.....|.++.+.+.++..
T Consensus 77 ~~~~~~~F~sl~~LV~~y~~ 96 (118)
T 3s9k_A 77 YVAEKYVFDSIPLLIQYHQY 96 (118)
T ss_dssp EEECSCCCSCHHHHHHHHHH
T ss_pred EECCCcccCCHHHHHHHhee
Confidence 66655566555555444443
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.6e-07 Score=84.24 Aligned_cols=76 Identities=16% Similarity=0.080 Sum_probs=57.9
Q ss_pred HHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKK 196 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~ 196 (683)
..++.++||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|...++.|++.....|.+
T Consensus 11 ~~l~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~g~~~l~~~~~F~s 84 (118)
T 2dlz_A 11 IDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAER------FAISIKFNDEVKHIKVVEKDNWIHITEAKKFDS 84 (118)
T ss_dssp CCGGGSTTEEESCCHHHHHHHHHHSCTTBEEEECCSCSSCC------EEEEEECSSSEEEEEEEEETTEEESTTSCCBSS
T ss_pred cccccCCceecCCCHHHHHHHhcCCCCCEEEEEeCCCCCCC------EEEEEEECCcEEEEEEEEcCCEEEEeCCcccCC
Confidence 346788999999999999999998 999999999865555 8773 34588999987666677765555644
Q ss_pred ccCCchh
Q 038696 197 ISGSTKQ 203 (683)
Q Consensus 197 ~~~~~~~ 203 (683)
+.+...+
T Consensus 85 l~~LV~~ 91 (118)
T 2dlz_A 85 LLELVEY 91 (118)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4443333
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.20 E-value=3.6e-08 Score=109.37 Aligned_cols=174 Identities=10% Similarity=0.084 Sum_probs=83.0
Q ss_pred hHHHHHHHHhcccchhHHHHhhcccchhhhHHHHhhhccc-----cCCCchhHHHHHHhh-cCCceeeeccccccccccC
Q 038696 91 DWWAKAITLYQNTDCVEFYIHNLLSCIPILIEAIETAAEF-----SGWDPDQMHKKKLVH-SGKYKKEWKDHKLFQWRYG 164 (683)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~g~~~~e~~~~~l~~-~g~~~~r~~~~~~~~~~~~ 164 (683)
+||.......+..- ....|..+. ..++.++|| ||.++|++|+++|.. +|+|+||.|+..+|.
T Consensus 18 ~ww~~~~~~~~~~g---~~P~~~v~~-----~~~~~~~wy~~~w~hg~i~r~~ae~lL~~~~G~FLvR~S~~~~g~---- 85 (463)
T 3cxl_A 18 GVWKSYLYQLQQEA---PHPRRITCT-----CEVENRPKYYGREFHGMISREAADQLLIVAEGSYLIRESQRQPGT---- 85 (463)
T ss_dssp CCSCCHHHHHHHHS---CCCEECCCC-----CCCTTCCTTCCTTBCCSCCHHHHHHHHTTSTTEEEEEECSSSTTC----
T ss_pred CEEEEEecCcCccC---CCCcCccCC-----ccccCCCCccccccccCCCHHHHHHHHcCCCCeEEEeccCCCCCC----
Confidence 58876655444221 133333332 246778888 999999999999986 899999999977766
Q ss_pred eeeeec---hhhhhhhhhhhcccchhhhhhhhhhhccCCchhhhchHHHHhhhcCCCCCCCCCcccceeEeeCCCeEEEe
Q 038696 165 KQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKKISGSTKQEQGLIDVLFKNLDGSGSLSGKLLPSRILIKSEDYQVRR 241 (683)
Q Consensus 165 ~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~ 241 (683)
|+|+ ...++||.|.. ++.|++.. ..|.++.+... .++...+.... .+ . +.+....-.+.+
T Consensus 86 --~~Lsv~~~~~v~H~~I~~-~g~~~~~~-~~F~sl~~Lv~--dGl~~~~~~~~---~~---~-----~~l~~~i~~l~~ 148 (463)
T 3cxl_A 86 --YTLALRFGSQTRNFRLYY-DGKHFVGE-KRFESIHDLVT--DGLITLYIETK---AA---E-----YIAKMTINPIYE 148 (463)
T ss_dssp --EEEEEECSSSEEEEECEE-SSSEESSS-CCBSCHHHHHH--HHHHHHHHHHH---TH---H-----HHHHTTSSCSTT
T ss_pred --EEEEEEECCEEEEEEEec-CCeEEECC-CccCCHHHHHH--HHHHhhhccCC---Cc---c-----hhhccccccccc
Confidence 8873 44589999975 55566543 35555444443 11111211110 00 0 000000013445
Q ss_pred EecccccEEEEEEc-CcEEEE------EEeCC------CcchHHHHHHHHHcCCCCceeeeeeeE
Q 038696 242 RLGSGSQYKEILWL-GESFAL------RHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGF 293 (683)
Q Consensus 242 ~LG~G~~~~v~l~~-g~~vAv------K~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 293 (683)
.||-|.++++.+.. ...||| |..+. ....+.+|..++..++|||+++.+.+.
T Consensus 149 ~lGfG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 149 HVGYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TSSBCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cCCchhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 67777777666432 357888 76543 234678899999999999999987544
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=98.18 E-value=6e-08 Score=85.24 Aligned_cols=76 Identities=9% Similarity=0.089 Sum_probs=56.0
Q ss_pred HhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec--------hhhhhhhhhhhc-ccchhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT--------PDFCYRIDTVWK-EDRWILFN 190 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~--------~~~~~~~~~~~~-~~~~~l~~ 190 (683)
|+.++||||.++|++|+.+|.. +|.|+||.|+..++. |+|+ ...++||.|... ++.|++..
T Consensus 2 l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------~~LSv~~~~~~~~~~v~H~~I~~~~~g~~~l~~ 75 (106)
T 1aot_F 2 IQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGA------YSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITT 75 (106)
T ss_dssp CCSSSSCCBSCCHHHHHHHHHTTTCCTTEECCBCBSSSSSB------BCCEEECCBTTTBCCEEECCBEEETTTEEEEET
T ss_pred CccCccCCCCCCHHHHHHHHhhCCCCCcEEEEEeCCCCCCC------EEEEEEecccCCCCcEEEEEEEEeCCCCEEECC
Confidence 6788999999999999999974 799999999876665 7773 345889999764 45577765
Q ss_pred hhhhhhccCCchhhh
Q 038696 191 KIQQKKISGSTKQEQ 205 (683)
Q Consensus 191 ~~~~~~~~~~~~~~~ 205 (683)
...|.++.+...++.
T Consensus 76 ~~~F~sl~~LV~~y~ 90 (106)
T 1aot_F 76 RAQFETLQQLVQHYS 90 (106)
T ss_dssp TEEESSHHHHHHHHT
T ss_pred CCccCCHHHHHHHhc
Confidence 555654444444333
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=98.18 E-value=1.4e-07 Score=82.06 Aligned_cols=74 Identities=9% Similarity=0.109 Sum_probs=54.8
Q ss_pred hhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc-ccchhhhhhhhhhhc
Q 038696 126 TAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK-EDRWILFNKIQQKKI 197 (683)
Q Consensus 126 ~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~-~~~~~l~~~~~~~~~ 197 (683)
+++||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|... ++.|++.....|.++
T Consensus 1 ~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl 74 (100)
T 1rja_A 1 SEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSAD------YVLSVRDTQAVRHYKIWRRAGGRLHLNEAVSFLSL 74 (100)
T ss_dssp CCCCBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSSC------EEEEECTTSSCEEEEEEECSSSCEEEETTEEESSH
T ss_pred CCCcccCCCCHHHHHHHHhccCCCCCEEEEEeCCCCCCC------EEEEEEECCEEEEEEEEEcCCCcEEECCCCccCCH
Confidence 36899999999999999986 899999999866655 8883 445889999764 455776655566555
Q ss_pred cCCchhhh
Q 038696 198 SGSTKQEQ 205 (683)
Q Consensus 198 ~~~~~~~~ 205 (683)
.+...++.
T Consensus 75 ~~LV~~y~ 82 (100)
T 1rja_A 75 PELVNYHR 82 (100)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 44444433
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=8.8e-08 Score=83.92 Aligned_cols=60 Identities=17% Similarity=0.219 Sum_probs=47.9
Q ss_pred HhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccc-hhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDR-WILF 189 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~-~~l~ 189 (683)
++.++||||.++|++|+.+|. .+|+|+||.|+..++. |+|+ ...++||.|...+++ |.+.
T Consensus 1 l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~ 67 (104)
T 1d4t_A 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGV------YCLCVLYHGYIYTYRVSQTETGSWSAE 67 (104)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEEEC
T ss_pred CCCCceEccCCCHHHHHHHHHhcCCCCEEEEeeCCCCCCC------EEEEEEECCeEEEEEEEECCCCeEEEe
Confidence 467899999999999999998 6899999999866665 7773 456889999754444 5554
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-07 Score=85.02 Aligned_cols=78 Identities=9% Similarity=0.062 Sum_probs=58.4
Q ss_pred HHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc-ccchhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK-EDRWILFNKIQQK 195 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~-~~~~~l~~~~~~~ 195 (683)
..++.++||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|... ++.|++.....|.
T Consensus 11 ~~l~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~ 84 (119)
T 2ecd_A 11 NSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPGQ------LSISLRYEGRVYHYRINTTADGKVYVTAESRFS 84 (119)
T ss_dssp CCCCCSSSEEEECCHHHHHHHHHTSCTTBEEEEEESSSTTE------EEEEEECSSCEEEECCCCCSSSCCCCCSSCCCS
T ss_pred cccccCccccCCCCHHHHHHHhcCCCCCeEEEEeCCCCCCC------EEEEEEECCeEEEEEEEEcCCCCEEEcCCCcCC
Confidence 457788999999999999999986 899999999866665 7773 345889999764 4456665555665
Q ss_pred hccCCchhhh
Q 038696 196 KISGSTKQEQ 205 (683)
Q Consensus 196 ~~~~~~~~~~ 205 (683)
++.+...++.
T Consensus 85 sl~~LV~~y~ 94 (119)
T 2ecd_A 85 TLAELVHHHS 94 (119)
T ss_dssp SHHHHHHHHH
T ss_pred CHHHHHHHHh
Confidence 5555554444
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-07 Score=85.83 Aligned_cols=89 Identities=17% Similarity=0.061 Sum_probs=63.2
Q ss_pred HhhcccchhhhHHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc
Q 038696 110 IHNLLSCIPILIEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED 184 (683)
Q Consensus 110 ~~~~~~~~~~~~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~ 184 (683)
-|.-|+-..-....|+.++||||.++|++|+.+|.. +|+|+||.|+..++. |+| ....++||.|...++
T Consensus 5 ~~~~~~~~~~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~ 78 (122)
T 2lnw_A 5 HHHHMSRPPSREIDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAER------FAISIKFNDEVKHIKVVEKDN 78 (122)
T ss_dssp -----CCSCCSCCCSTTSTTBCCSCCHHHHHHHHHHSCTTBEEEEECCCSSEE------EEEEEECSSCEEEEEEEEETT
T ss_pred cccccCCCCCccCCcccCcCCCcCCCHHHHHHHhcCCCCCeEEEEeCCCCCCc------EEEEEEeCCcEEEEEEEEcCC
Confidence 344455555556778899999999999999999974 999999999865555 777 345588999987767
Q ss_pred chhhhhhhhhhhccCCchhh
Q 038696 185 RWILFNKIQQKKISGSTKQE 204 (683)
Q Consensus 185 ~~~l~~~~~~~~~~~~~~~~ 204 (683)
.|++.....|.++.+.+.++
T Consensus 79 ~~~l~~~~~F~sl~eLV~~y 98 (122)
T 2lnw_A 79 WIHITEAKKFDSLLELVEYY 98 (122)
T ss_dssp EEESSSSCCBSSHHHHHHHH
T ss_pred EEEECCCCeECCHHHHHHHH
Confidence 77776655665554444433
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-07 Score=84.37 Aligned_cols=78 Identities=9% Similarity=0.035 Sum_probs=58.5
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcc-cchhhhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKE-DRWILFNKIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~-~~~~l~~~~~~~~ 196 (683)
+|+.++||||.+.|++|+.+|.. +|.|+||.|+...+. |+| ....++||.|.... +.+++.....|.+
T Consensus 1 sL~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~~~~~~~F~s 74 (112)
T 3k2m_A 1 SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQ------RSISLRYEGRVYHYRINTASDGKLYVSSESRFNT 74 (112)
T ss_dssp CGGGSTTEEESCCHHHHHHHTTTCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEESSTTCCBSS
T ss_pred CCccCcceeeCCCHHHHHHHhccCCCceEEEEeCCCCCCC------EEEEEEeCCcEEEEEEEECCCCcEEECCCCeECC
Confidence 37889999999999999999987 999999999876665 777 34558899997643 4466655556655
Q ss_pred ccCCchhhhc
Q 038696 197 ISGSTKQEQG 206 (683)
Q Consensus 197 ~~~~~~~~~~ 206 (683)
+.+...++..
T Consensus 75 l~~LV~~y~~ 84 (112)
T 3k2m_A 75 LAELVHHHST 84 (112)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 5555554443
|
| >1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.1e-07 Score=83.37 Aligned_cols=71 Identities=14% Similarity=0.024 Sum_probs=52.2
Q ss_pred HHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhhhcc
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKKIS 198 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 198 (683)
+.|+.++||||.++|++|+.+|..+|+|+||.|+..++. |+|+ ...++||.|...++.|.+ ....|.++.
T Consensus 2 ~~l~~~~Wyhg~isR~~Ae~lL~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~g~~~~-~~~~F~sl~ 74 (104)
T 1mil_A 2 SQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPGQ------YVLTGLQSGQPKHLLLVDPEGVVRT-KDHRFESVS 74 (104)
T ss_dssp CSTTTCTTBCSSCCHHHHHTTCCSTTEEEEEECCSSCSS------EEEEEEETTEEEEEEEBCTTSSEEC-SSCEESSHH
T ss_pred CccccCCcCCCCCCHHHHHHHhccCCcEEEEeCCCCCCC------EEEEEEECCEEEEEEEEeCCCEEEE-CCceeCCHH
Confidence 357889999999999999999999999999999866655 7773 345889988633344443 334444433
Q ss_pred C
Q 038696 199 G 199 (683)
Q Consensus 199 ~ 199 (683)
+
T Consensus 75 ~ 75 (104)
T 1mil_A 75 H 75 (104)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.5e-07 Score=83.13 Aligned_cols=75 Identities=12% Similarity=0.032 Sum_probs=54.2
Q ss_pred HHHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccc-hhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDR-WILFNKIQQ 194 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~-~~l~~~~~~ 194 (683)
+.++.++||||.++|++|+.+|.. .|.|+||.|+..++. |+|+ ...++||.|.+.+++ |++. ...|
T Consensus 11 ~~l~~~~WyhG~isR~~Ae~lL~~~g~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~-~~~F 83 (119)
T 2gsb_A 11 DPHEGKIWFHGKISKQEAYNLLMTVGQVCSFLVRPSDNTPGD------YSLYFRTNENIQRFKICPTPNNQFMMG-GRYY 83 (119)
T ss_dssp CSGGGCSSBCCSSCHHHHHHHHHHTCCSSEEEEEECSSSTTC------EEEEEECSSCBCCCCEEEETTTEEEES-SCCB
T ss_pred cccccCCcccCCCCHHHHHHHHhhcCCCCeEEEEeCCCCCCc------eEEEEEECCEEEEEEEEEcCCCCEEEC-Cccc
Confidence 457889999999999999999986 479999999866665 7873 346899999765444 5543 3345
Q ss_pred hhccCCchh
Q 038696 195 KKISGSTKQ 203 (683)
Q Consensus 195 ~~~~~~~~~ 203 (683)
.++.+...+
T Consensus 84 ~sl~~LI~~ 92 (119)
T 2gsb_A 84 NSIGDIIDH 92 (119)
T ss_dssp SCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 444443333
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2.1e-07 Score=82.82 Aligned_cols=78 Identities=8% Similarity=0.082 Sum_probs=58.1
Q ss_pred HHHhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeeec-------hhhhhhhhhhhc-ccchhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLIT-------PDFCYRIDTVWK-EDRWILF 189 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l~-------~~~~~~~~~~~~-~~~~~l~ 189 (683)
+.++.++||||.++|++|+.+|. .+|.|+||.|+..++. |+|+ ...++||.|... ++.|++.
T Consensus 7 ~~l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~v~H~~I~~~~~g~~~l~ 80 (114)
T 1blj_A 7 ETLEVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGA------FSLSVKDITTQGEVVKHYKIRSLDNGGYYIS 80 (114)
T ss_dssp CCSCCSSSBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSSC------EEEEECBCCTTTCBCCCEEEEEETTTEEEEE
T ss_pred CccccCCccCCCCCHHHHHHHHhhCCCCCceEEEEeCCCCCCC------EEEEEEEecCCCCcEEEEEEEEcCCCCEEEC
Confidence 35678899999999999999997 5799999999866665 8883 346899999764 4557776
Q ss_pred hhhhhhhccCCchhhh
Q 038696 190 NKIQQKKISGSTKQEQ 205 (683)
Q Consensus 190 ~~~~~~~~~~~~~~~~ 205 (683)
....|.++.+...++.
T Consensus 81 ~~~~F~sl~~LV~~y~ 96 (114)
T 1blj_A 81 PRITFPTLQALVQHYS 96 (114)
T ss_dssp TTEEESSHHHHHHHHH
T ss_pred CCcccCCHHHHHHHhh
Confidence 5556655554444443
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.3e-06 Score=75.92 Aligned_cols=61 Identities=13% Similarity=0.099 Sum_probs=49.3
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhc-ccchhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK-EDRWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~-~~~~~l~ 189 (683)
+|+.++||||.++|++|+.+|.. +|+|+||.|+..++. |+| ....++||.|... ++.|++.
T Consensus 5 ~l~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~ 71 (100)
T 1r1p_A 5 DIEFPEWFHEGLSRHQAENLLMGKDIGFFIIRASQSSPGD------FSISVRHEDDVQHFKVMRDTKGNYFLW 71 (100)
T ss_dssp -CTTTTTSCTTCCHHHHHHHHHTSCTTBEEEEECSSSTTC------EEEEEECSSSEEEEECEECTTCCEESS
T ss_pred EeccCCccccCCCHHHHHHHhcCCCCCEEEEEecCCCCCC------EEEEEEECCEEEEEEEEEcCCCCEEEe
Confidence 47889999999999999999998 999999999877665 777 3345889999764 3456654
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=98.08 E-value=4e-07 Score=80.41 Aligned_cols=74 Identities=8% Similarity=0.032 Sum_probs=51.1
Q ss_pred HHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~ 196 (683)
.+++++||||.++|++|+.+|.. +|+|+||.|+..++. |+| ....++||.|....+.|.+.....|.+
T Consensus 3 ~l~~~~Wyhg~isr~~Ae~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F~s 76 (109)
T 3tkz_A 3 HMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGD------FTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFAT 76 (109)
T ss_dssp ----CCSBCTTCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECSSCEESSSSCCBSS
T ss_pred ccccCCceecCCCHHHHHHHHhcCCCCCEEEEEecCCCCCC------EEEEEEECCEEEEEEEEeCCCEEEecCCcccCC
Confidence 46789999999999999999986 899999999876665 777 445588999875444354544444544
Q ss_pred ccCCch
Q 038696 197 ISGSTK 202 (683)
Q Consensus 197 ~~~~~~ 202 (683)
+.+...
T Consensus 77 l~~LV~ 82 (109)
T 3tkz_A 77 LAELVQ 82 (109)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 333333
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=6.5e-07 Score=85.52 Aligned_cols=70 Identities=11% Similarity=0.104 Sum_probs=55.8
Q ss_pred chhhhHHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhh
Q 038696 116 CIPILIEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFN 190 (683)
Q Consensus 116 ~~~~~~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~ 190 (683)
|+.-..+.++.++||||.++|++|+++|.. +|+|+||.|+...+. |+|+ ...++||.|...++.|.+..
T Consensus 6 ~i~~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~~------~~LSv~~~~~v~H~rI~~~~g~~~l~~ 79 (169)
T 2c9w_A 6 RLAKALRELGQTGWYWGSMTVNEAKEKLKEAPEGTFLIRDSSHSDYL------LTISVKTSAGPTNLRIEYQDGKFRLDS 79 (169)
T ss_dssp HHHHHHHHHHHTSCBCTTCCHHHHHHHHTTSCTTCEEEEECCSTTCS------EEEEEEETTEEEEEEEEEETTEEEECT
T ss_pred HHHHHHHhcccCCccccCCCHHHHHHHcCCCCCcEEEEecCCCCCCe------EEEEEEECCeeEEEEEEEeCCEEEEcc
Confidence 344456789999999999999999999986 899999999865555 7773 44588999987766677765
Q ss_pred h
Q 038696 191 K 191 (683)
Q Consensus 191 ~ 191 (683)
.
T Consensus 80 ~ 80 (169)
T 2c9w_A 80 I 80 (169)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=4.3e-07 Score=78.28 Aligned_cols=58 Identities=12% Similarity=0.156 Sum_probs=46.5
Q ss_pred hhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcc-cchhhh
Q 038696 126 TAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKE-DRWILF 189 (683)
Q Consensus 126 ~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~-~~~~l~ 189 (683)
+++||||.++|++|+.+|.. +|+|+||.|+..++. |+| ....++||.|.... +.|++.
T Consensus 2 ~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~ 66 (96)
T 1jyr_A 2 SMAWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGD------FSLSVKFGNDVQHFKVLRDGAGKYFLW 66 (96)
T ss_dssp CCTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTTC------EEEEEEETTEEEEEECEECTTSCEESS
T ss_pred CcceeccCCCHHHHHHHHhcCCCCcEEEEEecCCCCCC------EEEEEEeCCeEEEEEEEEcCCCCEEEC
Confidence 36899999999999999997 899999999876665 777 34568899997643 446654
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=98.07 E-value=2.1e-07 Score=84.70 Aligned_cols=76 Identities=18% Similarity=0.191 Sum_probs=54.9
Q ss_pred HhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhccc-chhhhh-----h
Q 038696 124 IETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKED-RWILFN-----K 191 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~-~~~l~~-----~ 191 (683)
|+.++||||.++|++|+.+|. .+|.|+||.|+..++. |+|+ ...++||.|...++ .|.+.. .
T Consensus 1 l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~g~~~ 74 (128)
T 1ka6_A 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGV------YCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHK 74 (128)
T ss_dssp CCCCSSBCCSCCHHHHHHHHHHHCCTTCEEEEECSSSTTC------EEEEEESSSCEEEEEEEECTTSCEEEECSTTSCC
T ss_pred CCCCcccCCCCCHHHHHHHHhcCCCCCEEEEeecCCCCCC------EEEEEEeCCEEEEEEEEECCCCeEEEeecCCCCC
Confidence 467899999999999999998 5899999999866665 8873 44588999975444 465552 3
Q ss_pred hhhhhccCCchhhh
Q 038696 192 IQQKKISGSTKQEQ 205 (683)
Q Consensus 192 ~~~~~~~~~~~~~~ 205 (683)
..|.++.+...++.
T Consensus 75 ~~F~sl~~LV~~y~ 88 (128)
T 1ka6_A 75 RYFRKIKNLISAFQ 88 (128)
T ss_dssp CEESSHHHHHHHTT
T ss_pred CccCCHHHHHHHHh
Confidence 45544444444433
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=98.07 E-value=3.4e-07 Score=81.19 Aligned_cols=69 Identities=7% Similarity=0.077 Sum_probs=52.5
Q ss_pred HHHhhhccccCCCchhHHHHHHh-----hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcc-cchhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV-----HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKE-DRWILFNKI 192 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~-----~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~-~~~~l~~~~ 192 (683)
+.++.++||||.++|++|+.+|. .+|+|+||.|+..++. |+|+ ...++||.|...+ +.|++. ..
T Consensus 4 ~~l~~~~WyhG~isR~~Ae~lL~~~g~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~-~~ 76 (111)
T 2hdv_A 4 QPLSGYPWFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGE------CVLTFNFQGKAKHLRLSLNAAGQCRVQ-HL 76 (111)
T ss_dssp CCGGGSTTEEEECCHHHHHHHHHTTGGGGTTEEEEEECSSCTTE------EEEEEEETTEEEEEEEEECTTCCEEET-TE
T ss_pred cccccCCCcCCCCCHHHHHHHHHHcCCCCCCeEEEEecCCCCCC------EEEEEEeCCeEEEEEEEEcCCCCEEeC-Cc
Confidence 45788999999999999999998 6899999999876665 7773 4458899997643 446553 34
Q ss_pred hhhhc
Q 038696 193 QQKKI 197 (683)
Q Consensus 193 ~~~~~ 197 (683)
.|.++
T Consensus 77 ~F~sl 81 (111)
T 2hdv_A 77 HFQSI 81 (111)
T ss_dssp EESSH
T ss_pred eeCCH
Confidence 44333
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.06 E-value=6e-07 Score=84.12 Aligned_cols=67 Identities=6% Similarity=-0.017 Sum_probs=53.6
Q ss_pred hhhHHHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhh
Q 038696 118 PILIEAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFN 190 (683)
Q Consensus 118 ~~~~~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~ 190 (683)
....+.++.++||||.++|++|+.+|. .+|.|+||.|+..++. |+| ....++||.|...++.|+|..
T Consensus 25 ~~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~rI~~~~g~f~l~~ 96 (152)
T 2hmh_A 25 VNAVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRHF------FTLSVKTQSGTKNLRIQXEGGSFSLQS 96 (152)
T ss_dssp HHHHHHHHHTSSEETTCCHHHHHHHHHTSCTTEEEEEECCSTTCS------EEEEEEETTEEEEEEEECGGGCBEECB
T ss_pred hhhhhhhccCCCcCCCCCHHHHHHHhcCCCCCcEEEEeCCCCCCc------EEEEEEcCCceEEEEEEecCCEEEEec
Confidence 334577889999999999999999997 5899999999866655 777 345689999976556676654
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=2e-07 Score=82.48 Aligned_cols=76 Identities=9% Similarity=0.060 Sum_probs=55.4
Q ss_pred HHHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeech---------hhhhhhhhhhcc-cchhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLITP---------DFCYRIDTVWKE-DRWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~~---------~~~~~~~~~~~~-~~~~l 188 (683)
+.++.++||||.++|++|+.+|. .+|.|+||.| ..++. |+|+. ..++||.|.... +.|++
T Consensus 6 ~~l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S-~~~g~------y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l 78 (110)
T 2ekx_A 6 SGLDDYDWFAGNISRSQSEQLLRQKGKEGAFMVRNS-SQVGM------YTVSLFSKAVNDKKGTVKHYHVHTNAENKLYL 78 (110)
T ss_dssp SCTTTSSSBCCSCCHHHHHHHHHHTCCTTEEEEEEC-SSTTC------EEEEECCCCSSCSSCCCEEEECEECTTCCEES
T ss_pred CcccCCCeecCCCCHHHHHHHHhccCCCceEEEEec-CCCCC------EEEEEEeccccCCCCcEEEEEEEECCCCCEEE
Confidence 35788999999999999999998 6899999999 44444 88833 368999997654 44777
Q ss_pred hhhhhhhhccCCchhh
Q 038696 189 FNKIQQKKISGSTKQE 204 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~ 204 (683)
.....|.++.+.+.++
T Consensus 79 ~~~~~F~sl~~LV~~y 94 (110)
T 2ekx_A 79 AENYCFDSIPKLIHYH 94 (110)
T ss_dssp STTCCCSCHHHHHHHH
T ss_pred CCCCccCCHHHHHHHH
Confidence 6555554444443333
|
| >1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A | Back alignment and structure |
|---|
Probab=98.05 E-value=1.9e-07 Score=83.21 Aligned_cols=80 Identities=14% Similarity=0.086 Sum_probs=58.3
Q ss_pred hhhHHHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhh
Q 038696 118 PILIEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQ 194 (683)
Q Consensus 118 ~~~~~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~ 194 (683)
+.+.+.++.++||||.++|++|+.+|..+|+|+||.|+... .|+|+ ...++||.|...++.|.+ ....|
T Consensus 7 p~~~~~l~~~~WyhG~isR~eAe~lL~~~G~FLVR~S~~~~-------~y~LSv~~~~~v~H~~I~~~~g~~~~-~~~~F 78 (114)
T 1wqu_A 7 GEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQ-------EYVLSVLWDGLPRHFIIQSLDNLYRL-EGEGF 78 (114)
T ss_dssp CGGGSCGGGCTTEEESCCHHHHHTTCCSTTEEEEEECSSSC-------CEEEEEEETTEEEEEECEECSSSEES-SSCCB
T ss_pred CCcccccccCCcEeeCCCHHHHHHHhccCCeEEEEEcCCCC-------CEEEEEEECCEEEEEEEEecCCEEEE-CCCCC
Confidence 44566788999999999999999999999999999997433 48873 345889999755554554 34455
Q ss_pred hhccCCchhhh
Q 038696 195 KKISGSTKQEQ 205 (683)
Q Consensus 195 ~~~~~~~~~~~ 205 (683)
.++.+...++.
T Consensus 79 ~sl~~LV~~y~ 89 (114)
T 1wqu_A 79 PSIPLLIDHLL 89 (114)
T ss_dssp SSHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 44444444433
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.8e-07 Score=83.76 Aligned_cols=85 Identities=11% Similarity=0.072 Sum_probs=60.8
Q ss_pred cchhhhHHHHhhhccccCCCchhHHHHHHh---hcCCceeeeccc--cccccccCeeeee---chhhhhhhhhhh-cccc
Q 038696 115 SCIPILIEAIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDH--KLFQWRYGKQYLI---TPDFCYRIDTVW-KEDR 185 (683)
Q Consensus 115 ~~~~~~~~~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~--~~~~~~~~~~y~l---~~~~~~~~~~~~-~~~~ 185 (683)
+|+....+.++.++||||.++|++|+++|. .+|+|+||.|+. ..+. |+| ....++||.|.+ .+++
T Consensus 11 ~~~~~~~~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~ 84 (141)
T 2eo6_A 11 STFADQEAELLGKPWYAGACDRKSAEEALHRSNKDGSFLIRKSSGHDSKQP------YTLVAFFNKRVYNIPVRFIEATK 84 (141)
T ss_dssp CHHHHHHHTTTTCSSEEESCCHHHHHHHHHHHCCTTCBCEEECSTTCSSCS------EEEEEEETTEEEEEEECEETTTT
T ss_pred CCCCccccccCCCCeEecCCCHHHHHHHhhccCCCceEEEEECCCCCCCCC------EEEEEEECCEEEEEEEEEeCCCC
Confidence 455666788999999999999999999995 589999999985 3444 877 345688999875 3455
Q ss_pred -hhhhh----hhhhhhccCCchhhh
Q 038696 186 -WILFN----KIQQKKISGSTKQEQ 205 (683)
Q Consensus 186 -~~l~~----~~~~~~~~~~~~~~~ 205 (683)
|.+.. ...|.++.+.+.++.
T Consensus 85 ~~~l~~~~~~~~~F~sl~eLV~~y~ 109 (141)
T 2eo6_A 85 QYALGKKKNGEEYFGSVVEIVNSHQ 109 (141)
T ss_dssp EECSSSCCTTCCCBSSHHHHHHHHH
T ss_pred EEEEccccCCCCccCCHHHHHHHHh
Confidence 44442 345555554444444
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.2e-07 Score=82.25 Aligned_cols=70 Identities=10% Similarity=0.039 Sum_probs=52.1
Q ss_pred HHHHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQ 194 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~ 194 (683)
.+.++.++||||.++|++|+.+|. .+|+|+||.|+ .++. |+|+ ...++||.|....+.|.+.....|
T Consensus 13 ~~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~-~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F 85 (124)
T 2eob_A 13 PNPHESKPWYYDRLSRGEAEDMLMRIPRDGAFLIRKRE-GTDS------YAITFRARGKVKHCRINRDGRHFVLGTSAYF 85 (124)
T ss_dssp SCSTTTSTTEESSCCHHHHHHHHHHCCSSSEEEEECCT-TSSC------EEEEEEETTEEEEEEEEESSSCEESSSSCCB
T ss_pred ccccCcCCCeecCCCHHHHHHHHhcCCCCCEEEEEecC-CCCC------EEEEEEeCCeEEEEEEEECCCEEEECCCCcC
Confidence 356788999999999999999999 57999999998 6555 8873 445889999755444555443334
Q ss_pred hhc
Q 038696 195 KKI 197 (683)
Q Consensus 195 ~~~ 197 (683)
.++
T Consensus 86 ~sl 88 (124)
T 2eob_A 86 ESL 88 (124)
T ss_dssp SSH
T ss_pred CCH
Confidence 333
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=98.05 E-value=4.5e-07 Score=81.20 Aligned_cols=66 Identities=9% Similarity=0.139 Sum_probs=50.5
Q ss_pred HhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc-chhhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED-RWILFNKIQQKK 196 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~-~~~l~~~~~~~~ 196 (683)
|+.++||||.+.|++|+.+|.. +|+|+||.|+...+. |+| ....++||.|...++ .|++.. ..|.+
T Consensus 3 L~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~-~~F~s 75 (117)
T 3ov1_A 3 MKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGD------FSLSVKFGNDVQHFKVLRDGAGKYFLWV-VKFNS 75 (117)
T ss_dssp CCCCTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTTC------EEEEEEETTEEEEEECEECTTSCEESSS-CEESS
T ss_pred cccCCcccCCCCHHHHHHHHhCCCCCCcEEEEeCCCCCCC------EEEEEecCCceEEEEEEECCCCeEEECC-CCcCC
Confidence 5678999999999999999998 699999999876665 777 345588998865444 465543 34433
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.5e-07 Score=82.89 Aligned_cols=77 Identities=12% Similarity=0.074 Sum_probs=55.9
Q ss_pred HHHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeech---------hhhhhhhhhhccc-chhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLITP---------DFCYRIDTVWKED-RWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~~---------~~~~~~~~~~~~~-~~~l 188 (683)
+.++..+||||.++|++|+.+|. .+|+|+||.| ..++ .|+|+. ..++||.|....+ .|++
T Consensus 11 ~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S-~~~g------~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l 83 (125)
T 2dm0_A 11 TNLEIYEWYHRNITRNQAEHLLRQESKEGAFIVRDS-RHLG------SYTISVFMGARRSTEAAIKHYQIKKNDSGQWYV 83 (125)
T ss_dssp CCCTTSSSBCCSCCHHHHHHHHHHHCSTTCBCEEEE-TTEE------EEEEEEECCCSSSSSCCEEEEEEEECTTCCEES
T ss_pred cccccCCcccCCCCHHHHHHHHhhcCCCCEEEEEec-CCCC------CEEEEEEeccccCCCCcEEEEEEEEcCCCCEEE
Confidence 45678899999999999999998 7899999999 4444 488833 3589999976544 4776
Q ss_pred hhhhhhhhccCCchhhh
Q 038696 189 FNKIQQKKISGSTKQEQ 205 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~~ 205 (683)
.....|.++.+.+.++.
T Consensus 84 ~~~~~F~sl~eLV~~y~ 100 (125)
T 2dm0_A 84 AERHAFQSIPELIWYHQ 100 (125)
T ss_dssp SSSCCCSSHHHHHHHHT
T ss_pred CCCCccCCHHHHHHHhh
Confidence 55555655444444443
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=5e-07 Score=78.78 Aligned_cols=68 Identities=4% Similarity=-0.008 Sum_probs=50.4
Q ss_pred hhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhhhcc
Q 038696 125 ETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKKIS 198 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 198 (683)
+.++||||.++|++|+++|. .+|+|+||.|+...+. |+|+ ...++||.|...++.|.+.. ..|.++.
T Consensus 3 ~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~g~~~l~~-~~F~sl~ 75 (102)
T 2cia_A 3 LGSEWYYGNVTRHQAECALNERGVEGDFLIRDSESSPSD------FSVSLKASGKNKHFKVQLVDNVYCIGQ-RRFHTMD 75 (102)
T ss_dssp --CTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEECCSSSCEEEEEEEETTEEEETT-EEESSHH
T ss_pred cCCccccCCCCHHHHHHHHhhCCCCcEEEEEECCCCCCC------EEEEEEeCCeeEEEEEEecCCEEEECC-cCcCCHH
Confidence 67899999999999999996 6999999999876665 8873 34588999875555676654 3454433
Q ss_pred C
Q 038696 199 G 199 (683)
Q Consensus 199 ~ 199 (683)
+
T Consensus 76 ~ 76 (102)
T 2cia_A 76 E 76 (102)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.8e-07 Score=83.53 Aligned_cols=76 Identities=14% Similarity=0.066 Sum_probs=56.2
Q ss_pred HHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeech---------hhhhhhhhhhccc-chhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLITP---------DFCYRIDTVWKED-RWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~~---------~~~~~~~~~~~~~-~~~l~ 189 (683)
.++.++||||.++|++|+.+|. .+|+|+||.| ..++. |+|+. ..++||.|....+ .|++.
T Consensus 7 ~l~~~~WyhG~isR~eAe~lL~~~g~~G~FLVR~S-s~~g~------y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l~ 79 (125)
T 2ge9_A 7 SIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDS-SKAGK------YTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLA 79 (125)
T ss_dssp SSCCSSSEETTCCHHHHHHHHHHHTCTTEEEEEEC-SSSCC------EEEEEEESSSSSTTCEEEEEECEEETTTEEESS
T ss_pred ccccCCccccCCCHHHHHHHHhhcCCCceEEEEec-CCCCC------EEEEEEeccccCCCCeEEEEEEEEcCCCCEEEC
Confidence 4678899999999999999999 6899999999 44444 88743 3589999976544 47776
Q ss_pred hhhhhhhccCCchhhh
Q 038696 190 NKIQQKKISGSTKQEQ 205 (683)
Q Consensus 190 ~~~~~~~~~~~~~~~~ 205 (683)
....|.++.+.+.++.
T Consensus 80 ~~~~F~sl~eLV~~y~ 95 (125)
T 2ge9_A 80 EKHLFSTIPELINYHQ 95 (125)
T ss_dssp TTSCBSSHHHHHHHHH
T ss_pred CCCcCCCHHHHHHHhh
Confidence 5556655555444444
|
| >2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.03 E-value=3e-07 Score=82.16 Aligned_cols=74 Identities=9% Similarity=0.072 Sum_probs=54.5
Q ss_pred HhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccCC
Q 038696 124 IETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISGS 200 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 200 (683)
++.++||||.++|++|+.+|..+|+|+||.|+..++. |+| ....++||.|...++.|.+. ...|.++.+.
T Consensus 14 ~~~~~WyhG~isR~eAe~lL~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~g~y~~~-~~~F~sl~eL 86 (116)
T 2kk6_A 14 LAEQDWYHGAIPRIEAQELLKKQGDFLVRESHGKPGE------YVLSVYSDGQRRHFIIQYVDNMYRFE-GTGFSNIPQL 86 (116)
T ss_dssp TTTCTTEEESCCHHHHHHTCCSTTCEEEEECTTCTTC------EEEEEEETTEEEEEEEEEETTEEESS-SCEESCHHHH
T ss_pred cccCCCccCCCCHHHHHHHhccCCcEEEEECCCCCCc------EEEEEEECCeEEEEEEEecCCEEEEC-CCEeCCHHHH
Confidence 3678999999999999999999999999999876665 777 34458899997555555553 3455444443
Q ss_pred chhh
Q 038696 201 TKQE 204 (683)
Q Consensus 201 ~~~~ 204 (683)
+.++
T Consensus 87 V~~y 90 (116)
T 2kk6_A 87 IDHH 90 (116)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 3333
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=98.00 E-value=4e-07 Score=81.47 Aligned_cols=56 Identities=7% Similarity=-0.012 Sum_probs=45.3
Q ss_pred HHHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhc
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK 182 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~ 182 (683)
.+..+.++||||.+.|++|+.+|.. +|.|+||.|+..++. |+| ....++||.|...
T Consensus 8 ~~~~~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~ 70 (117)
T 3pqz_A 8 AAIHRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQG------FVLSLCHLQKVKHYLILPS 70 (117)
T ss_dssp -CGGGGCTTBCCSCCHHHHHHHHHHTTCCTTEEEEEECCC-CCC------EEEEEEETTEEEEEEEEEE
T ss_pred hhhcccCccccCCCCHHHHHHHHhcCCCCCCEEEEEecCCCCCc------EEEEEEeCCeeEEEEEEEe
Confidence 4567788999999999999999986 899999999866555 777 4455889999763
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=7.2e-07 Score=82.25 Aligned_cols=76 Identities=11% Similarity=0.057 Sum_probs=56.9
Q ss_pred HhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhhhcc
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQKKIS 198 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 198 (683)
++.++||||.++|++|+++|.. +|.|+||.|+..++. |+|+ ...++||.|...++.|+|.....|.++.
T Consensus 23 ~~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~g~~~l~~~~~F~sl~ 96 (138)
T 2crh_A 23 LSVHLWYAGPMERAGAESILANRSDGTFLVRQRVKDAAE------FAISIKYNVEVKHIKIMTAEGLYRITEKKAFRGLT 96 (138)
T ss_dssp GGGSSSBCCSCCHHHHHHHTTTSCTTEEEEECCSSTTCC------CEEEEEETTEEEEEECEEETTEEESSTTCCBSSHH
T ss_pred CCcCCcccCCCCHHHHHHHhcCCCCCEEEEEECCCCCCC------EEEEEEECCeEEEEEEEeCCCEEEECCCCccCCHH
Confidence 3778999999999999999998 999999999866555 7773 4458899996455557776555665555
Q ss_pred CCchhhh
Q 038696 199 GSTKQEQ 205 (683)
Q Consensus 199 ~~~~~~~ 205 (683)
+++.++.
T Consensus 97 eLV~~y~ 103 (138)
T 2crh_A 97 ELVEFYQ 103 (138)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 4444443
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-07 Score=80.00 Aligned_cols=58 Identities=7% Similarity=0.076 Sum_probs=46.0
Q ss_pred hhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhccc-chhhh
Q 038696 126 TAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKED-RWILF 189 (683)
Q Consensus 126 ~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~-~~~l~ 189 (683)
+.+||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|...++ .|++.
T Consensus 2 ~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~ 66 (103)
T 1i3z_A 2 DLPYYHGCLTKRECEALLLKGGVDGNFLIRDSESVPGA------LCLCVSFKKLVYSYRIFREKHGYYRIE 66 (103)
T ss_dssp CCTTEESSCCHHHHHHHHHTTCSTTEEEEEECSSSTTC------EEEEEECSSSEEEEEEEECTTSCEEEC
T ss_pred CCccccCCCCHHHHHHHHhhcCCCceEEEEeCCCCCCC------EEEEEEECCEEEEEEEEECCCCeEEEe
Confidence 46899999999999999986 899999999866665 7773 44588999975444 45554
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.98 E-value=5.9e-07 Score=79.62 Aligned_cols=67 Identities=10% Similarity=0.015 Sum_probs=50.9
Q ss_pred HHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhh-cccchhhhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVW-KEDRWILFNKIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~-~~~~~~l~~~~~~~~ 196 (683)
+++.++||||.++|++|+.+|. .+|+|+||.|+..++. |+| ....++||.|.. .++.|.+. ...|.+
T Consensus 15 ~~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~-~~~F~s 87 (111)
T 2eo3_A 15 SSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGD------YVLSVSENSRVSHYIINSLPNRRFKIG-DQEFDH 87 (111)
T ss_dssp TTCHHHHEEESCCHHHHHHHHSSCCTTCEEEEECSSSSSC------EEEEEEETTEEEEEEEEEETTTEEEET-TCCBSS
T ss_pred ccCCCCcccCCCCHHHHHHHhcCCCCceEEEEeecCCCCC------EEEEEEeCCeEEEEEEEEcCCCCEEEC-CcccCC
Confidence 4577899999999999999999 7899999999866655 777 344588999976 34446653 334433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.2e-05 Score=79.83 Aligned_cols=113 Identities=14% Similarity=0.154 Sum_probs=78.0
Q ss_pred cCcEEEEEEeCCC-cchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHH
Q 038696 255 LGESFALRHFFGD-IEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLP 331 (683)
Q Consensus 255 ~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~ 331 (683)
.+..+.||+.... ...+.+|..+|+.|. +--+.+++.++.+. +..|+|||+++| ++.+.... ...
T Consensus 49 ~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~~~~~~----------~~~ 116 (272)
T 4gkh_A 49 NAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAFQVLEE----------YPD 116 (272)
T ss_dssp TCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHHHHHHH----------CGG
T ss_pred CCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccccccccC----------CHH
Confidence 3567899987543 346788999999885 33356677666544 678999999998 66665432 111
Q ss_pred HHHHHHHHHHHHHHHHHhC----------------------------------------------------------Ccc
Q 038696 332 VAVDLMLQIARGMEYLHSK----------------------------------------------------------KIY 353 (683)
Q Consensus 332 ~~~~i~~qi~~aL~yLH~~----------------------------------------------------------gIi 353 (683)
....++.+++..|.-||.. .++
T Consensus 117 ~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 196 (272)
T 4gkh_A 117 SGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVT 196 (272)
T ss_dssp GHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEE
T ss_pred HHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEE
Confidence 2334555556666666531 268
Q ss_pred cCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 354 HGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 354 HrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|+|+++.|||++.++ .+-|+||+.+.
T Consensus 197 HGDl~~~Nil~~~~~-------~~~viDwe~a~ 222 (272)
T 4gkh_A 197 HGDFSLDNLIFDEGK-------LIGCIDVGRVG 222 (272)
T ss_dssp CSCCCTTSEEEETTE-------EEEECCCTTCE
T ss_pred cCCCCCCeEEEECCe-------EEEEEECcccc
Confidence 999999999998765 56799999764
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.97 E-value=1.4e-06 Score=82.63 Aligned_cols=66 Identities=6% Similarity=0.014 Sum_probs=52.9
Q ss_pred hHHHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhh
Q 038696 120 LIEAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNK 191 (683)
Q Consensus 120 ~~~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~ 191 (683)
....++.++||||.+.|++|+.+|. .+|+|+||.|+...+. |+| ....++||.|...++.|++...
T Consensus 16 ~~~~L~~~~WyhG~IsR~eAe~lL~~~~~GtFLVR~S~s~~g~------y~LSvr~~~~v~H~rI~~~~g~f~l~~~ 86 (164)
T 2bbu_A 16 AVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRHF------FTLSVKTQSGTKNLRIQCEGGSFSLQSD 86 (164)
T ss_dssp HHHHHHHTSCCCTTSCHHHHHHHHHHSSTTCCEEEECSTTSCC------EEEEECCTTCCEEEECEEETTEEESSSC
T ss_pred hhhhhccCCccCCCCCHHHHHHHhcCCCCCCEEEEECCCCCCC------EEEEEEECCceEEEEEEeCCCeEEEecC
Confidence 4467889999999999999999996 4899999999866555 877 3456899999866666776543
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.5e-07 Score=82.16 Aligned_cols=61 Identities=10% Similarity=0.081 Sum_probs=48.6
Q ss_pred HHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc-ccchhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK-EDRWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~-~~~~~l~ 189 (683)
+++.++||||.++|++|+.+|.. +|.|+||.|+...+. |+|+ ...++||.|... ++.|+|.
T Consensus 6 ~~~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~ 73 (119)
T 2ysx_A 6 SGMVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRA------YALCVLYRNCVYTYRILPNEDDKFTVQ 73 (119)
T ss_dssp SSCCCSSEEESCCHHHHHHHHHHHCCTTEEEEEECSSCTTS------EEEEEECSSCEEEEEEEECTTSCEEEC
T ss_pred CCCCCccccCCCCHHHHHHHHhhcCCCCEEEEEeCCCCCCC------EEEEEEECCEEEEEEEEEcCCCCEEEe
Confidence 46778999999999999999987 899999999866665 7773 345889999754 4446554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.9e-05 Score=83.84 Aligned_cols=55 Identities=9% Similarity=0.001 Sum_probs=38.0
Q ss_pred CcEEEEEEeCCC-------cchHHHHHHHHHcCC-C--CceeeeeeeEEcCC-CCeEEEEEecCCC
Q 038696 256 GESFALRHFFGD-------IEPLVPEISSLLSLS-H--PNIMHFLCGFTDEE-KKECFLIMELMSR 310 (683)
Q Consensus 256 g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~e~-~~~~~LVmEy~~g 310 (683)
|..+++|+.... ...+.+|+.+|+.|. + -.+.+++....+.+ .+..|+||||++|
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCC
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCC
Confidence 678999987542 256889999999885 3 34666766553321 1346899999987
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.95 E-value=8.8e-07 Score=81.66 Aligned_cols=77 Identities=10% Similarity=0.023 Sum_probs=57.2
Q ss_pred HHHhhhccccCCC-chhHHHHHHh--------hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhccc----c
Q 038696 122 EAIETAAEFSGWD-PDQMHKKKLV--------HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKED----R 185 (683)
Q Consensus 122 ~~i~~~~~~~g~~-~~e~~~~~l~--------~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~----~ 185 (683)
+.++.++||||.+ +|++|+++|. .+|.|+||.|+...+. |+|+ ...++||.|....+ .
T Consensus 17 ~~~~~~~WyhG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~gg~~~ 90 (138)
T 2dx0_A 17 ELHFGEKWFHKKVESRTSAEKLLQEYCAETGAKDGTFLVRESETFPND------YTLSFWRSGRVQHCRIRSTMENGVMK 90 (138)
T ss_dssp GTTSCCTTBCTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEEEEETTEEE
T ss_pred ccccCCCcccCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCCCCCCC------eEEEEEECCeEEEEEEEEecCCCceE
Confidence 4567889999999 8999999998 5899999999866665 8773 44588999976533 4
Q ss_pred hhhhhhhhhhhccCCchhh
Q 038696 186 WILFNKIQQKKISGSTKQE 204 (683)
Q Consensus 186 ~~l~~~~~~~~~~~~~~~~ 204 (683)
|++.....|.++.+++.++
T Consensus 91 ~~l~~~~~F~sl~eLI~~y 109 (138)
T 2dx0_A 91 YYLTDNLTFNSIYALIQHY 109 (138)
T ss_dssp EESSTTSCBSSHHHHHHHT
T ss_pred EEeCCCCcCCCHHHHHHHH
Confidence 7776666665554444443
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=97.89 E-value=1.4e-06 Score=77.28 Aligned_cols=71 Identities=7% Similarity=-0.112 Sum_probs=53.1
Q ss_pred HHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhh-hhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFN-KIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~-~~~~~~ 196 (683)
.++.++||||.++|++|+.+|. .+|.|+||.| ..++. |+|+ ...++||.|....++|++.. ...|.+
T Consensus 6 ~~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S-~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~~~~~~~F~s 78 (112)
T 1h9o_A 6 HHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRES-SKQGC------YACSVVVDGEVKHCVINKTATGYGFAEPYNLYSS 78 (112)
T ss_dssp GGSGGGTBCCSCCHHHHHHHHTTCCTTEEEEEEC-SSTTC------EEEEEEETTEEEEEEEEEETTEEESSTTCCCBSS
T ss_pred cccCCCcccCCCCHHHHHHHhcCCCCceEEEeec-CCCCC------EEEEEEECCEEEEEEEEEcCCceEEeCCCCCcCC
Confidence 4678899999999999999995 6899999999 66655 7773 44589999987777765543 334444
Q ss_pred ccCC
Q 038696 197 ISGS 200 (683)
Q Consensus 197 ~~~~ 200 (683)
+.+.
T Consensus 79 l~~L 82 (112)
T 1h9o_A 79 LKEL 82 (112)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4333
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.87 E-value=8.1e-07 Score=80.55 Aligned_cols=63 Identities=3% Similarity=-0.022 Sum_probs=48.2
Q ss_pred hHHHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc--ccchhh
Q 038696 120 LIEAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK--EDRWIL 188 (683)
Q Consensus 120 ~~~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~--~~~~~l 188 (683)
..+.++.++||||.++|++|+.+|.. +|.|+||.|+..++. |+|+ ...++||.|... +++|++
T Consensus 19 ~~~~l~~~~WyhG~isR~eAe~lL~~~g~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~G~~~~ 90 (126)
T 2aug_A 19 SHMIHRSQPWFHHKISRDEAQRLIIQQGLVDGVFLVRDSQSNPKT------FVLSMSHGQKIKHFQIIPVEDDGEMFH 90 (126)
T ss_dssp ---CGGGSTTEETTCCHHHHHHHHHTTTCCTTEEEEEECSSSSCC------EEEEEEETTEEEEEEEEEEEETTEEEE
T ss_pred CccccccCCcccCCCCHHHHHHHHhccCCCCCEEEEeecCCCCCC------EEEEEEcCCeEEEEEEEEECCCCeEEE
Confidence 44778899999999999999999986 799999999866655 8873 445889999763 344543
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=97.84 E-value=1e-06 Score=77.12 Aligned_cols=52 Identities=10% Similarity=0.046 Sum_probs=42.9
Q ss_pred hhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK 182 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~ 182 (683)
+.++||||.++|++|+.+|.. +|.|+||.|+..++. |+|+ ...++||.|...
T Consensus 3 ~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~ 61 (105)
T 1nrv_A 3 RTQHWFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKA------FVLTLCHHQKIKNFQILPC 61 (105)
T ss_dssp TTSTTBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTTC------EEEEEEETTEEEEEEEEEC
T ss_pred ccCcccCCCCCHHHHHHHHHhcCCCCceEEEEeCCCCCCC------EEEEEEeCCEEEEEEEEEE
Confidence 457899999999999999985 799999999866665 7773 355889999753
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=97.82 E-value=1e-06 Score=80.39 Aligned_cols=60 Identities=5% Similarity=-0.129 Sum_probs=48.5
Q ss_pred HHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeec---h---------------hhhhhhhhhhc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLIT---P---------------DFCYRIDTVWK 182 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~---~---------------~~~~~~~~~~~ 182 (683)
.++.++||||.++|++|+++|. ..|.|+||.|+..++. |+|+ . ..++||.|...
T Consensus 16 ~~~~~~Wyhg~isR~eAe~lL~~~~~G~FLVR~S~s~~g~------y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~~ 89 (131)
T 2kno_A 16 SDTSKFWYKPHLSRDQAIALLKDKDPGAFLIRDSHSFQGA------YGLALKVATPPPSAQPWKGDPVEQLVRHFLIETG 89 (131)
T ss_dssp CCCHHHHBCTTCCHHHHHHHHTTSCTTBEEEEECSSSTTE------EEEEEECSCCSSSSSSCCSCHHHHHEEEEEEECC
T ss_pred ccccCCceecCCCHHHHHHHhcCCCCCeEEEecCCCCCCC------EEEEEEeCCCCcccccccccccCCceEEEEEEEC
Confidence 3467899999999999999996 5899999999877665 7772 1 36889999766
Q ss_pred ccchhh
Q 038696 183 EDRWIL 188 (683)
Q Consensus 183 ~~~~~l 188 (683)
+++|+|
T Consensus 90 ~~g~~l 95 (131)
T 2kno_A 90 PKGVKI 95 (131)
T ss_dssp SSCCCE
T ss_pred CCCCEE
Confidence 666766
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=3.2e-06 Score=88.43 Aligned_cols=80 Identities=9% Similarity=-0.004 Sum_probs=62.8
Q ss_pred HHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQK 195 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~ 195 (683)
.+.++..+||||.++|++|+.+|.. .|.||||.|+...+. |+|+ ...++||.|....++++......|.
T Consensus 6 ~d~~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLvR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~~~~~~F~ 79 (303)
T 2lqn_A 6 FDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGD------YVLSVSENSRVSHYIINSLPNRRFKIGDQEFD 79 (303)
Confidence 4678899999999999999999998 999999999877665 7774 3458999998655554444456787
Q ss_pred hccCCchhhhc
Q 038696 196 KISGSTKQEQG 206 (683)
Q Consensus 196 ~~~~~~~~~~~ 206 (683)
++.+++.++..
T Consensus 80 sl~~Lv~~y~~ 90 (303)
T 2lqn_A 80 HLPALLEFYKI 90 (303)
Confidence 77777666653
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=97.78 E-value=2.1e-06 Score=76.97 Aligned_cols=74 Identities=11% Similarity=0.172 Sum_probs=53.4
Q ss_pred HHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhccc-chhhh-hhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKED-RWILF-NKIQQ 194 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~-~~~l~-~~~~~ 194 (683)
+.++.++||||.++|++|+.+|.. +|.|+||.|+... . |+|+ ...++||.|....+ +|++. ....|
T Consensus 11 ~~~~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~------~-y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~~F 83 (119)
T 2cs0_A 11 AQDGVPEWFHGAISREDAENLLESQPLGSFLIRVSHSHV------G-YTLSYKAQSSCCHFMVKLLDDGTFMIPGEKVAH 83 (119)
T ss_dssp CSSSCCSSBCSSCCHHHHHHHHHTSCTTCEEEEECSSSS------S-EEEEECCSSSCEEEEEEECTTSCEECTTCSCCB
T ss_pred ccccCCCccccCCCHHHHHHHhcCCCCCEEEEEecCCCC------C-EEEEEEECCEEEEEEEEEcCCCcEEEecCCCcC
Confidence 455678999999999999999987 8999999997432 2 7773 34588999976544 56665 34455
Q ss_pred hhccCCch
Q 038696 195 KKISGSTK 202 (683)
Q Consensus 195 ~~~~~~~~ 202 (683)
.++.+...
T Consensus 84 ~sl~eLV~ 91 (119)
T 2cs0_A 84 TSLDALVT 91 (119)
T ss_dssp SSHHHHHH
T ss_pred CCHHHHHH
Confidence 44444333
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.76 E-value=1.3e-06 Score=78.11 Aligned_cols=91 Identities=7% Similarity=-0.079 Sum_probs=68.5
Q ss_pred HHHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec------hhhhhhhhhhhcccchhhh--h
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT------PDFCYRIDTVWKEDRWILF--N 190 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~------~~~~~~~~~~~~~~~~~l~--~ 190 (683)
..++.++||||-+.|.+|+.+|.. .|.|+||.|++.+ . |.|+ .+.|+||.|....++|+|. +
T Consensus 10 ~~l~~epWff~~isR~eAE~lL~~~~~~GaFLVR~Se~~~-~------ySLSVR~~~~~~~VKHYkI~~~~G~y~I~~~~ 82 (125)
T 3maz_A 10 DVLNPMPACFYTVSRKEATEMLQKNPSLGNMILRPGSDSR-N------YSITIRQEIDIPRIKHYKVMSVGQNYTIELEK 82 (125)
T ss_dssp -CCCCCCTTBCCCCHHHHHHHHHHCGGGCSEEEEECTTSS-S------EEEEEEECSSSCEEEEEEEEEETTEEEECSSS
T ss_pred ccccCCCCCcCCCCHHHHHHHHhccCCCCcEEEEeCCCCC-C------EEEEEEecCCCCCEeeeEEEEeCCEEEEecCC
Confidence 446678999999999999998863 6999999997543 3 6662 3469999998676668877 4
Q ss_pred hhhhhhccCCchhhhchHHHHhhhcCCCC
Q 038696 191 KIQQKKISGSTKQEQGLIDVLFKNLDGSG 219 (683)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 219 (683)
...|.++.+.+.++....+.+...+...+
T Consensus 83 ~~~F~SL~eLV~yY~~~adGl~~~L~~~c 111 (125)
T 3maz_A 83 PVTLPNLFSVIDYFVKETRGNLRPFIAST 111 (125)
T ss_dssp CEEESSHHHHHHHHHHHTTTCCCBCCC--
T ss_pred CcCcCCHHHHHHHHHhCCCcCcccccccc
Confidence 56788888888888877777766665443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00015 Score=75.78 Aligned_cols=30 Identities=17% Similarity=0.224 Sum_probs=25.7
Q ss_pred CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 ~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-------~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-------QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-------CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC-------cEEEEehhhcc
Confidence 5799999999999997655 69999999763
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=3.6e-06 Score=80.75 Aligned_cols=79 Identities=6% Similarity=0.062 Sum_probs=58.7
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeech--------hhhhhhhhhhcc-cchhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWKE-DRWIL 188 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~~-~~~~l 188 (683)
..++.++||||-+.|++|+.+|.. .|.|+||.|+...+. |+|+. ..++||.|.... +.|++
T Consensus 69 ~~l~~~~w~~g~isr~~ae~lL~~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~~v~H~~I~~~~~g~~~~ 142 (175)
T 4d8k_A 69 NSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGS------FSLSVRDFDQNQGEVVKHYKIRNLDNGGFYI 142 (175)
T ss_dssp TCSTTCTTBCSSCCHHHHHHHHHSTTCCTTCEEEEECSSSTTC------EEEEEEEECTTSCEEEEEEEEEECSSSCEES
T ss_pred ccccccceecCcccHHHHHHHHhcCCCCCCEEEEEECCCCCCe------EEEEEEeCcccCCCceEEEEEEECCCCCEEE
Confidence 347889999999999999999975 899999999866666 77732 358999997544 45766
Q ss_pred hhhhhhhhccCCchhhhc
Q 038696 189 FNKIQQKKISGSTKQEQG 206 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~ 206 (683)
.....|.++.++..+++.
T Consensus 143 ~~~~~F~sl~~LV~~y~~ 160 (175)
T 4d8k_A 143 SPRITFPGLHELVRHYTN 160 (175)
T ss_dssp STTSEESSHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHhh
Confidence 655566555555554443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00014 Score=78.45 Aligned_cols=67 Identities=16% Similarity=0.233 Sum_probs=41.9
Q ss_pred EeEecccccEEEEEE----cCcEEEEEEeCC-----------CcchHHHHHHHHHcCCC--Cce-eeeeeeEEcCCCCeE
Q 038696 240 RRRLGSGSQYKEILW----LGESFALRHFFG-----------DIEPLVPEISSLLSLSH--PNI-MHFLCGFTDEEKKEC 301 (683)
Q Consensus 240 ~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----------~~~~~~~Ei~iL~~L~H--pnI-v~l~~~~~~e~~~~~ 301 (683)
.+.||.|....++.. .++.|+||.... ..+.+..|+++|..+.. +.. .+++. + +. ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DT--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ET--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cC--Ccc
Confidence 456888875555443 467899997532 13456889999988742 444 44543 3 23 235
Q ss_pred EEEEecCCC
Q 038696 302 FLIMELMSR 310 (683)
Q Consensus 302 ~LVmEy~~g 310 (683)
++||||++|
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 899999976
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=97.64 E-value=5.4e-06 Score=73.09 Aligned_cols=50 Identities=10% Similarity=-0.069 Sum_probs=41.3
Q ss_pred ccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcc
Q 038696 128 AEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKE 183 (683)
Q Consensus 128 ~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~ 183 (683)
+||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++||.|....
T Consensus 1 ~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~ 55 (109)
T 1ju5_A 1 SWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGD------YVLSVSENSRVSHYIINSSG 55 (109)
T ss_dssp CCEETTCCHHHHHHHHTTCCTTEEEEEECSSSTTE------EEEEEECSSCEEEEEEECCS
T ss_pred CccccCCCHHHHHHHhcCCCCCEEEEEecCCCCCC------EEEEEEECCeEEEEEEEECC
Confidence 599999999999999987 899999999866665 8873 3458899886544
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=97.62 E-value=6.4e-06 Score=79.62 Aligned_cols=70 Identities=7% Similarity=-0.031 Sum_probs=53.4
Q ss_pred cchhhhHHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhh
Q 038696 115 SCIPILIEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILF 189 (683)
Q Consensus 115 ~~~~~~~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~ 189 (683)
.|...-...|+.++||||.++|++|+++|.. +|.|+||.|++..+. |.| ....++||.|...+++|.+.
T Consensus 22 ~~~v~~~~~l~~~~WYhG~isR~eAE~lL~~~~dGtFLVR~S~~~~~~------lsLSvr~~~~v~H~rI~~~~g~f~l~ 95 (187)
T 2izv_A 22 SMLVPDLLQINNNPCYWGVMDKYAAEALLEGKPEGTFLLRDSAQEDYL------FSVSFRRYSRSLHARIEQWNHNFSFD 95 (187)
T ss_dssp EEECTTHHHHHHCTTEEEECCHHHHHHHHTTCCTTEEEEEECSSTTCS------EEEEEEETTEEEEEECEEETTEEESC
T ss_pred cccccchhhcccCCccccCCCHHHHHHHhcCCCCCcEEEEECCCCCce------EEEEEeeCCeEEEEEEEECCCEEEEe
Confidence 3443345678999999999999999999985 899999999854433 555 33568999998776666665
Q ss_pred h
Q 038696 190 N 190 (683)
Q Consensus 190 ~ 190 (683)
.
T Consensus 96 ~ 96 (187)
T 2izv_A 96 A 96 (187)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=6.2e-06 Score=82.72 Aligned_cols=55 Identities=11% Similarity=-0.045 Sum_probs=46.0
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKE 183 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~ 183 (683)
+++.++||||.+.|++|+++|.. +|+||||.|+...+. |+|+ ...++||.|....
T Consensus 9 ~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~ 68 (230)
T 2dvj_A 9 SEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGD------YVLSVSENSRVSHYIINSSG 68 (230)
T ss_dssp SSSSSSSCCSSCCTTHHHHHHTTSSSSCBEEECCSSCTTS------CEEECCCSSSCCCEECBCCC
T ss_pred cccCCCcccCCCCHHHHHHHhcCCCCceEEEEeCCCCCCC------EEEEEEECCEEEEEEEEeCC
Confidence 57788999999999999999986 899999999876665 7874 3458899887554
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=97.52 E-value=8.6e-06 Score=82.95 Aligned_cols=77 Identities=8% Similarity=-0.076 Sum_probs=57.8
Q ss_pred HhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhh-cccchhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVW-KEDRWILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~-~~~~~~l~~~~~~~ 195 (683)
++.++||||.+.|++|+.+|. ..|.|+||.|+..++. |+| ....++||.|.. .++.|++.....|.
T Consensus 3 ~~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~ 76 (254)
T 2oq1_A 3 AAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGG------YVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHC 76 (254)
T ss_dssp TTTCTTBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEEETTSCCBS
T ss_pred cccCCccCCCCCHHHHHHHHhccCCCCcEEEEEeCCCCCCC------EEEEEEECCeEEEEEEEEeCCCCEEeCCCCccC
Confidence 567899999999999999995 4899999999866665 777 345689999976 45557776555665
Q ss_pred hccCCchhhhc
Q 038696 196 KISGSTKQEQG 206 (683)
Q Consensus 196 ~~~~~~~~~~~ 206 (683)
++.+.+.++..
T Consensus 77 sl~~LV~~y~~ 87 (254)
T 2oq1_A 77 GPAELCEFYSR 87 (254)
T ss_dssp SHHHHHHHHHH
T ss_pred CHHHHHHHHHh
Confidence 55555554443
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=97.50 E-value=1.2e-05 Score=82.00 Aligned_cols=78 Identities=10% Similarity=0.050 Sum_probs=58.0
Q ss_pred HHHHhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhc-ccchhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK-EDRWILFNKI 192 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~-~~~~~l~~~~ 192 (683)
..+++..+||||.++|++|+.+|. .+|.|+||.| ..++. |+| ....++||.|... ++.|++....
T Consensus 153 ~~~l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~~~~~~ 225 (254)
T 2oq1_A 153 TTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQGT------YALSLIYGKTVYHYLISQDKAGKYCIPEGT 225 (254)
T ss_dssp HHGGGGSTTBCSSCCHHHHHHHHHSSCCCTTEEEEEEC-SSTTE------EEEEEEETTEEEEEEEEECTTSCEESTTSC
T ss_pred ccccCCCcccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCCC------EEEEEEECCeEEEEEEEEcCCCCEEECCCc
Confidence 467788999999999999999998 5799999999 55554 777 3456899999754 4557666555
Q ss_pred hhhhccCCchhhh
Q 038696 193 QQKKISGSTKQEQ 205 (683)
Q Consensus 193 ~~~~~~~~~~~~~ 205 (683)
.|.++.+...++.
T Consensus 226 ~F~sl~~LV~~y~ 238 (254)
T 2oq1_A 226 KFDTLWQLVEYLK 238 (254)
T ss_dssp CBSSHHHHHHHHH
T ss_pred eECCHHHHHHHHH
Confidence 6655555444443
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=97.47 E-value=1.2e-05 Score=76.91 Aligned_cols=53 Identities=11% Similarity=-0.026 Sum_probs=44.3
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhh---hhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDF---CYRIDTVW 181 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~---~~~~~~~~ 181 (683)
+.++.++||||.++|++|+++|.. +|.|+||.| ..++. |+| ...- ++||.|..
T Consensus 7 ~~l~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S-~~~g~------y~LSv~~~~~~~~v~H~~I~~ 69 (174)
T 3qwx_X 7 DPFEWRSFYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGE------YSLTVREADEGNAVCHYLIER 69 (174)
T ss_dssp CGGGGGGGEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTTC------EEEEEECCSSSSCEEEEEEEE
T ss_pred CccccCCCccCCCCHHHHHHHHhccCCCCCeEEEEec-CCCCC------EEEEEEECCCCCceEEEEEEe
Confidence 467889999999999999999987 799999999 66666 777 3333 89999965
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=97.39 E-value=1.1e-05 Score=84.27 Aligned_cols=54 Identities=11% Similarity=-0.013 Sum_probs=45.5
Q ss_pred HHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVW 181 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~ 181 (683)
++++.++||||.++|++|+.+|. ..|+||||.|+...+. |+|+ ...++||.|..
T Consensus 6 ~~~~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~ 64 (304)
T 2eyz_A 6 DSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGD------YVLSVSENSRVSHYIINS 64 (304)
T ss_dssp CCSSSSSSCCCCCCSSHHHHTTTTCCSSCEECCSCCSSSSC------CEEEECSSSSCEEEECCC
T ss_pred ccccCCCCccCCCCHHHHHHHhcCCCCCEEEEEeCCCCCCC------EEEEEEECCEEEEEEEee
Confidence 45678899999999999999999 6899999999876665 8884 34588999975
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=97.39 E-value=1.9e-05 Score=84.27 Aligned_cols=78 Identities=12% Similarity=0.084 Sum_probs=59.8
Q ss_pred HHHhhhccccCCCchhHHHHHHh--hcCCceeeecccc-ccccccCeeeeec---hhhhhhhhhhhcccchhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHK-LFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILFNKIQQK 195 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~-~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~~~~~~~ 195 (683)
.+|+.++||||.++|++|+.+|. .+|+|+||.|+.. ++. |+|+ ...++||.|...++.|++.....|.
T Consensus 5 ~sL~~~~WYhG~IsR~eAE~lL~~~~dG~FLVR~S~s~~~g~------y~LSvr~~~~v~H~rI~~~~g~y~l~~~~~F~ 78 (373)
T 3hhm_B 5 MSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGD------YTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFS 78 (373)
T ss_dssp CGGGGCTTEEESCCHHHHHHHTTTCCTTEEEEEECSCC--CC------EEEEEEETTEEEEEEECCSSSCBCSSSSCCBS
T ss_pred CCcccCCccCCCCCHHHHHHHhcCCCCCCEEEeccCCCCCCC------EEEEEEECCeeEEEEEEecCCeEEeCCCCCcC
Confidence 35788999999999999999999 6899999999866 555 7773 4458899998777778776655665
Q ss_pred hccCCchhhh
Q 038696 196 KISGSTKQEQ 205 (683)
Q Consensus 196 ~~~~~~~~~~ 205 (683)
++.+.+.++.
T Consensus 79 SL~eLV~~Y~ 88 (373)
T 3hhm_B 79 SVVELINHYR 88 (373)
T ss_dssp SSHHHHHHHH
T ss_pred CHHHHHHHHh
Confidence 5555544443
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=1.3e-05 Score=81.50 Aligned_cols=78 Identities=9% Similarity=0.018 Sum_probs=56.5
Q ss_pred HHHHhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhc-ccchhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK-EDRWILFNKI 192 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~-~~~~~l~~~~ 192 (683)
...++.++||||.++|++|+.+|. .+|.|+||.| ..++. |+| ....++||.|... ++.|++....
T Consensus 152 ~~~~~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~l~~~~ 224 (254)
T 1a81_A 152 TTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNGS------YALCLLHEGKVLHYRIDKDKTGKLSIPEGK 224 (254)
T ss_dssp HTSGGGSTTEEEECCHHHHHHHHHSSCCCTTCEEEEEC-SSSSC------EEEEEEETTEEEEEEEEECTTSCEECTTSC
T ss_pred ccccccCCccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCCC------EEEEEEECCEEEEEEEEEcCCCCEEecCCc
Confidence 356778899999999999999998 5899999999 55555 777 3456889999754 4456665555
Q ss_pred hhhhccCCchhhh
Q 038696 193 QQKKISGSTKQEQ 205 (683)
Q Consensus 193 ~~~~~~~~~~~~~ 205 (683)
.|.++.+...++.
T Consensus 225 ~F~sl~~LV~~y~ 237 (254)
T 1a81_A 225 KFDTLWQLVEHYS 237 (254)
T ss_dssp CBSCHHHHHHHHT
T ss_pred ccCCHHHHHHHHH
Confidence 5644444444333
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=1.4e-05 Score=81.33 Aligned_cols=76 Identities=9% Similarity=-0.006 Sum_probs=55.8
Q ss_pred HhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhh-cccchhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVW-KEDRWILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~-~~~~~~l~~~~~~~ 195 (683)
.+.++||||.++|++|+++|. ..|.|+||.|+..++. |+| ....++||.|.. .++.|++.....|.
T Consensus 2 ~~~~~Wy~g~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~ 75 (254)
T 1a81_A 2 ANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGG------FALSVAHGRKAHHYTIERELNGTYAIAGGRTHA 75 (254)
T ss_dssp TTSSTTBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEEETTSCCBS
T ss_pred CccCccccCCCCHHHHHHHHhcCCCCCcEEEEEecCCCCCC------EEEEEEECCeeEEEEEEEcCCCCEEeCCCCCcC
Confidence 356899999999999999995 4899999999866665 777 345689999976 44557776555564
Q ss_pred hccCCchhhh
Q 038696 196 KISGSTKQEQ 205 (683)
Q Consensus 196 ~~~~~~~~~~ 205 (683)
++.+...++.
T Consensus 76 sl~eLv~~y~ 85 (254)
T 1a81_A 76 SPADLCHYHS 85 (254)
T ss_dssp SHHHHHHHHT
T ss_pred CHHHHHHHHH
Confidence 4444444333
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=2.5e-05 Score=79.01 Aligned_cols=74 Identities=11% Similarity=0.109 Sum_probs=56.9
Q ss_pred hhccccCCC-----chhHHHHHHh--------hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccc----
Q 038696 126 TAAEFSGWD-----PDQMHKKKLV--------HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDR---- 185 (683)
Q Consensus 126 ~~~~~~g~~-----~~e~~~~~l~--------~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~---- 185 (683)
+++||||-+ .|++|+++|. ..|.||||.|+..+|. |+|+ ..-++||.|....+.
T Consensus 3 ~e~WfhG~i~~~~~sR~~AE~lL~~~~~~~~~~dG~FLVR~S~s~~G~------y~LSv~~~~~v~H~~I~~~~~~g~~~ 76 (246)
T 4fbn_A 3 NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGD------YTLSFWRNGKVQHCRIHSRQDAGTPK 76 (246)
T ss_dssp CCTTBCCCCSCC-CHHHHHHHHHHHHHHHHTCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEEECGGGCCE
T ss_pred CCCCcCCccccccCCHHHHHHHHHHhhhccCCCCCEEEEEcCCCCCCC------EEEEEEECCEEEEEEEEEECCCCcee
Confidence 578999999 6999999996 3699999999988777 8884 455889999765543
Q ss_pred hhhhhhhhhhhccCCchhhh
Q 038696 186 WILFNKIQQKKISGSTKQEQ 205 (683)
Q Consensus 186 ~~l~~~~~~~~~~~~~~~~~ 205 (683)
+++.....|.++.+.+.+++
T Consensus 77 ~~~~~~~~F~sl~~LV~~y~ 96 (246)
T 4fbn_A 77 FFLTDNLVFDSLYDLITHYQ 96 (246)
T ss_dssp EEEETTEEESSHHHHHHHHH
T ss_pred EEecCCcccCCHHHHHHhHh
Confidence 56666667766666665554
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=97.27 E-value=3e-05 Score=81.21 Aligned_cols=53 Identities=13% Similarity=-0.009 Sum_probs=44.9
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeec---hhh---hhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLIT---PDF---CYRIDTVW 181 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~---~~~---~~~~~~~~ 181 (683)
+.++.++||||.++|++|+++|.. +|+||||.| ..++. |+|+ ... ++||.|..
T Consensus 36 ~~l~~~~Wyhg~i~R~~Ae~lL~~~~~~~G~FLVR~S-~~~g~------y~LSv~~~~~~~~v~H~~I~~ 98 (308)
T 3qwy_A 36 DPFEWRSFYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGE------YSLTVREADEGNAVCHYLIER 98 (308)
T ss_dssp CGGGGGGGEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTTC------EEEEEECCSSSSCEEEEEEEE
T ss_pred CcccccccccCCCCHHHHHHHHhccCCCCceEEEEcc-CCCCC------EEEEEEeCCCCCceEEEEEee
Confidence 568899999999999999999987 899999999 77776 8772 333 89999965
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0011 Score=69.51 Aligned_cols=126 Identities=11% Similarity=0.109 Sum_probs=69.4
Q ss_pred CcEEEEEEeCCCc-chHHHHHHHHHcCC-C-CceeeeeeeEEcCCCCeEEEEEecCCC-CHHHHHHHh------------
Q 038696 256 GESFALRHFFGDI-EPLVPEISSLLSLS-H-PNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEI------------ 319 (683)
Q Consensus 256 g~~vAvK~~~~~~-~~~~~Ei~iL~~L~-H-pnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~~~l~~~------------ 319 (683)
|..+.+|...... +.+..|+.++..|. + -.+.+++... .+.+ ++|||+++| .+.+++...
T Consensus 43 ~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~~~~~~~ 118 (333)
T 3csv_A 43 GAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDALFTEVINNDPAQEMPLYRAAV 118 (333)
T ss_dssp CCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCBHHHHHHHCGGGHHHHHHHHH
T ss_pred CCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcchHHHhcCCCccHHHHHHHHH
Confidence 6677788765443 66778898888874 2 2345555432 2323 789999986 665544321
Q ss_pred ------cCCC--CCCCCCHHHHH-------H-HH------------HHHHHHHHHH------HhCCcccCCCCCCcEEeC
Q 038696 320 ------CCPR--KRIPFSLPVAV-------D-LM------------LQIARGMEYL------HSKKIYHGNLNPSNILLK 365 (683)
Q Consensus 320 ------~~~~--~~~~l~~~~~~-------~-i~------------~qi~~aL~yL------H~~gIiHrDLKp~NILl~ 365 (683)
.... ....+...... . +. ..+...+..+ +...++|||+++.|||++
T Consensus 119 ~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~Nil~~ 198 (333)
T 3csv_A 119 DLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQNLLWL 198 (333)
T ss_dssp HHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGGEEEC
T ss_pred HHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCcccEEec
Confidence 0000 00112221111 0 00 0111222223 235799999999999997
Q ss_pred CCCCCCCCcceEEEecccCcccc
Q 038696 366 PRGASTEGYLHAKISGFGLSSVK 388 (683)
Q Consensus 366 ~~g~~~~~~~~vKL~DFGla~~~ 388 (683)
.+. ++.-.+.|+||+.+...
T Consensus 199 ~~~---~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 199 PER---EGLARVGVIDFQDAKLG 218 (333)
T ss_dssp TTS---CGGGGEEECCCTTCEEE
T ss_pred cCc---CCCCCeEEEeCCCcCcC
Confidence 641 01116899999988643
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.11 E-value=5.8e-05 Score=78.16 Aligned_cols=60 Identities=8% Similarity=-0.067 Sum_probs=48.8
Q ss_pred HHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccchhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~~l~ 189 (683)
.++..+||||.++|++|+.+|. ..|.|+||.| ..++. |+|+ ...++||.|....++|++.
T Consensus 190 ~l~~~~WyhG~IsR~eAE~lL~~~~~GtFLVR~S-s~~g~------y~LSv~~~~~V~H~rI~~~~~g~~~~ 254 (302)
T 2y3a_B 190 HHEERTWYVGKINRTQAEEMLSGKRDGTFLIRES-SQRGC------YACSVVVDGDTKHCVIYRTATGFGFA 254 (302)
T ss_dssp GGSSTTTBCCSCCHHHHHHHHTTSCTTBEEBCCC-SSTTC------EEEEEECSSSEEEEEEEEETTEEESB
T ss_pred cccCCCccCCCCCHHHHHHHhcCCCCCcEEEEec-cCCCc------eEEEEEeCCeeEEEEEEECCCceEEe
Confidence 5677899999999999999994 6899999999 66665 8773 3458999998777776554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=5.3e-05 Score=87.33 Aligned_cols=85 Identities=11% Similarity=0.024 Sum_probs=64.5
Q ss_pred HHHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhc-ccchhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWK-EDRWILFNKI 192 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~-~~~~~l~~~~ 192 (683)
.+.++.++||||-+.|++|+++|.. .|.|+||.|+..+|. |+| ....++||.|... .+.|++....
T Consensus 7 ~~~l~~~~Wy~g~isr~~Ae~~L~~~~~~~G~FLvR~S~~~~g~------y~lsv~~~~~v~h~~i~~~~~g~~~~~~~~ 80 (635)
T 4fl3_A 7 ADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGG------FALSVAHGRKAHHYTIERELNGTYAIAGGR 80 (635)
T ss_dssp --CCTTCTTBCBSCCHHHHHHHHHHTTCCTTEEEEEECTTSSSC------EEEEEEETTEEEEEEEEECTTSCEESTTCC
T ss_pred cchhhcCCccCCCCCHHHHHHHHhcCCCCCceEEEeecccCCCC------EEEEEEeCCEEEeEEEEEcCCCCEEeCCCC
Confidence 4778899999999999999999976 799999999877776 888 4556899999655 4557776666
Q ss_pred hhhhccCCchhhhchHHHH
Q 038696 193 QQKKISGSTKQEQGLIDVL 211 (683)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~l 211 (683)
.|.++.+...++....+.+
T Consensus 81 ~f~sl~~Lv~~y~~~~~~l 99 (635)
T 4fl3_A 81 THASPADLCHYHSQESDGL 99 (635)
T ss_dssp CBSSHHHHHHHHTTCCTTS
T ss_pred ccCCHHHHHHHHhhCCCCC
Confidence 7766666666665544444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0054 Score=60.29 Aligned_cols=121 Identities=12% Similarity=0.050 Sum_probs=78.6
Q ss_pred CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccccC
Q 038696 311 DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLH-SKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 311 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~ 389 (683)
+|.+.|+.. ..++++++++.+++|.+.+|.-+- .+.-..+=+-|..|+|..+| .|.+.+ +.+.
T Consensus 34 SL~eIL~~~-----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-------~V~f~~-~~s~--- 97 (229)
T 2yle_A 34 SLEEILRLY-----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-------AVTLAP-AADD--- 97 (229)
T ss_dssp EHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-------CEEECC-C------
T ss_pred cHHHHHHHc-----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-------ceeccc-cccc---
Confidence 799999863 578999999999999999988762 11112334457889998887 455443 1110
Q ss_pred CCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCC
Q 038696 390 FGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGER 468 (683)
Q Consensus 390 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~ 468 (683)
.....+.+||.... ..+.+.=|||||+++|..+- |-.+-
T Consensus 98 -----------~~~~~~~~pe~~~~----------~~te~~~IysLG~tLY~ALDygL~e~------------------- 137 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGYS----------QCMETEVIESLGIIIYKALDYGLKEN------------------- 137 (229)
T ss_dssp --------------------CCSSS----------SSCHHHHHHHHHHHHHHHHTTTCCTT-------------------
T ss_pred -----------ccccCCCChhhccc----------cchHHHHHHHHHHHHHHHhhcCCCcc-------------------
Confidence 01112568887631 25788999999999998884 32221
Q ss_pred CCCCCCCcHHHHHHHHHhhhc
Q 038696 469 PLFPFHSPKYVTNLTKRCWHA 489 (683)
Q Consensus 469 ~~~p~~~~~~l~~Li~~cL~~ 489 (683)
.+...++.|..||..|...
T Consensus 138 --eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 138 --EERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --EEECCCHHHHHHHHHHTTC
T ss_pred --cchhhCHHHHHHHHHHHhc
Confidence 3445677899999988765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0017 Score=67.14 Aligned_cols=65 Identities=8% Similarity=-0.103 Sum_probs=39.0
Q ss_pred EeEecccccEEEEEEcCcEEEEEEeCCCc---chHHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecC-CC
Q 038696 240 RRRLGSGSQYKEILWLGESFALRHFFGDI---EPLVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELM-SR 310 (683)
Q Consensus 240 ~~~LG~G~~~~v~l~~g~~vAvK~~~~~~---~~~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~-~g 310 (683)
++.|+.|..-.++.. ..+.+|+..... -...+|+.+++.+..-.+ .++++.+ .+ .-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~--~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA--GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE--TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred eeEcCCcccccccee--eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence 456766754444444 678889885432 234679988888752233 4555432 22 237899999 76
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00013 Score=82.20 Aligned_cols=75 Identities=8% Similarity=-0.001 Sum_probs=55.4
Q ss_pred HhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhc
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKI 197 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 197 (683)
|+.++||||.++|++|+.+|.. +|+|+||.|+..++. |+| ....++||.|...++.|.+.....|.++
T Consensus 1 l~~~~Wyhg~i~r~~Ae~lL~~~~~~G~FLvR~S~~~~g~------~~Lsv~~~~~v~H~~I~~~~~~~~l~~~~~F~sl 74 (525)
T 2shp_A 1 MKSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGD------LTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATL 74 (525)
T ss_dssp -CCSTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEECSSSCEEETTSCEESSH
T ss_pred CCCCCcccCCCCHHHHHHHHHhCCCCCcEEeeccCCCCCc------EEEEEEECCEEEEEEEEecCCeEEECCCCeECCH
Confidence 4678999999999999999975 799999999877766 777 3456889999765565666554455554
Q ss_pred cCCchhh
Q 038696 198 SGSTKQE 204 (683)
Q Consensus 198 ~~~~~~~ 204 (683)
.++..++
T Consensus 75 ~eLv~~y 81 (525)
T 2shp_A 75 AELVQYY 81 (525)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4444433
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00015 Score=77.41 Aligned_cols=68 Identities=7% Similarity=-0.119 Sum_probs=0.0
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeeec---hhhhhhhhhhhcccch-hhhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWKEDRW-ILFNKIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~~~~~-~l~~~~~~~~ 196 (683)
.++.++||||.++|++|+.+|.. .|+|+||.| ..+|. |+|+ ...|+||.|....+++ ++.....|.+
T Consensus 297 ~~~~~~WyhG~isR~~AE~LL~~~~~G~FLVR~S-s~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~~~~~~~F~S 369 (373)
T 3hhm_B 297 HHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRES-SKQGC------YACSVVVDGEVKHCVINKTATGYGFAEPYNLYSS 369 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCCCCcCCCCCHHHHHHHhccCCCCcEEEEec-CCCCC------EEEEEEECCeEEEEEEEEcCCCcEEeCCCCCCCC
Confidence 45678999999999999999987 899999999 66666 7773 4459999997666654 4443355544
Q ss_pred c
Q 038696 197 I 197 (683)
Q Consensus 197 ~ 197 (683)
+
T Consensus 370 L 370 (373)
T 3hhm_B 370 L 370 (373)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.86 E-value=4.4e-05 Score=68.98 Aligned_cols=73 Identities=11% Similarity=0.089 Sum_probs=51.3
Q ss_pred HHHHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeeec---h--hhhhhhhhhhcccchhhhhhhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLIT---P--DFCYRIDTVWKEDRWILFNKIQQK 195 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l~---~--~~~~~~~~~~~~~~~~l~~~~~~~ 195 (683)
.+.++.++|||+++++++ ..+|.||||.|+ .++. |+|+ . ..++||.|...++++++.....|.
T Consensus 24 ~~~l~~~~Wyh~Ll~~g~-----~~dG~FLVR~S~-~~g~------y~LSv~~~~~~~vkH~rI~~~~~~~~i~~~~~F~ 91 (126)
T 2cr4_A 24 TESCEVERLFKATSPRGE-----PQDGLYCIRNSS-TKSG------KVLVVWDETSNKVRNYRIFEKDSKFYLEGEVLFV 91 (126)
T ss_dssp CCHHHHHHHHHHHSTTSC-----CCTTCEEEEECS-STTC------EEEEEEETTTTEECCEECEEETTEEESSSSCEES
T ss_pred ccccccCCCHHHHhhCCC-----CCCCeEEEEecC-CCCC------EEEEEEeCCCCCEEEEEEEECCCeEEEcCCccCC
Confidence 567899999996665543 124999999998 6665 8883 3 568999998777777776666665
Q ss_pred hccCCchhhh
Q 038696 196 KISGSTKQEQ 205 (683)
Q Consensus 196 ~~~~~~~~~~ 205 (683)
++.+++.+++
T Consensus 92 sL~eLV~hY~ 101 (126)
T 2cr4_A 92 SVGSMVEHYH 101 (126)
T ss_dssp SHHHHHHHHT
T ss_pred CHHHHHHHHh
Confidence 5554444443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0063 Score=63.08 Aligned_cols=141 Identities=15% Similarity=0.116 Sum_probs=73.4
Q ss_pred EEeEecccccEEEEE--EcCcEEEEEEeCC--CcchHHHHHHHHHcCCCCc--eeeeeeeEE----cCCCCeEEEEEecC
Q 038696 239 VRRRLGSGSQYKEIL--WLGESFALRHFFG--DIEPLVPEISSLLSLSHPN--IMHFLCGFT----DEEKKECFLIMELM 308 (683)
Q Consensus 239 i~~~LG~G~~~~v~l--~~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~----~e~~~~~~LVmEy~ 308 (683)
-.+.|+.|....++. ..+..+++|+... ..+.+..|+.++..|.... +.+++.... ....+..++||+|+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 345666664333332 2344788999865 4567888999988874212 333332100 00124578999999
Q ss_pred CC-CHH-----------HH---HHHhcCCC--CC-CCCC---HHHHHH------------HHHHHHHHHHHHHh------
Q 038696 309 SR-DLC-----------SY---IKEICCPR--KR-IPFS---LPVAVD------------LMLQIARGMEYLHS------ 349 (683)
Q Consensus 309 ~g-sL~-----------~~---l~~~~~~~--~~-~~l~---~~~~~~------------i~~qi~~aL~yLH~------ 349 (683)
+| .+. .. +......- .. .... |..... +...+...+.+++.
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 87 321 11 11111000 00 0011 111000 00113344555542
Q ss_pred -CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 350 -KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 -~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~-------~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDE-------LSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTE-------EEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCc-------eEEEecchhcc
Confidence 4789999999999998664 45899998763
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00023 Score=71.92 Aligned_cols=75 Identities=9% Similarity=0.059 Sum_probs=53.5
Q ss_pred HHHhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQK 195 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~ 195 (683)
...+.++||||.+.|++|+.+|.. +|.|+||.++ +.+ .|+| ....++|+.|.. ++++++.....|.
T Consensus 117 ~~~~~~~Wyhg~isr~~Ae~lL~~~~~~G~FLVR~s~-~~g------~y~Lsv~~~~~v~H~~I~~-~~~~~~~~~~~F~ 188 (246)
T 4fbn_A 117 NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRN-EPN------SYAISFRAEGKIKHCRVQQ-EGQTVMLGNSEFD 188 (246)
T ss_dssp CGGGGSTTEESSCCHHHHHHHHHTSCCTTEEEEEECS-STT------EEEEEEEETTEEEEEEEEE-ETTEEEETTEEES
T ss_pred CCcccCCeeecCccHHHHHHHHhhCCCCCeEEEEecC-CCC------CEEEEEEeCCCeEEEEEEe-CCCEEEeCCCccC
Confidence 556789999999999999999974 6999999874 333 4777 455588999974 4554455555665
Q ss_pred hccCCchhh
Q 038696 196 KISGSTKQE 204 (683)
Q Consensus 196 ~~~~~~~~~ 204 (683)
++.++..++
T Consensus 189 sL~~Lv~~y 197 (246)
T 4fbn_A 189 SLVDLISYY 197 (246)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHh
Confidence 544444433
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.012 Score=60.10 Aligned_cols=70 Identities=17% Similarity=0.105 Sum_probs=47.6
Q ss_pred CCeEEEeEecccc---cEEEEEEcCcEEEEEEeCCC----cchHHHHHHHHHcCC-C-C-ceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGS---QYKEILWLGESFALRHFFGD----IEPLVPEISSLLSLS-H-P-NIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~---~~~v~l~~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~-H-p-nIv~l~~~~~~e~~~~~~LV 304 (683)
....-+..+|.|. +|++.+.+|+.|.||+.... ...+..|++.|+.|. . + -+.++++. ++ -++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceEE
Confidence 3566678888886 46666668999999987532 245789999999884 2 2 24445432 22 2789
Q ss_pred EecCCC
Q 038696 305 MELMSR 310 (683)
Q Consensus 305 mEy~~g 310 (683)
|||+.+
T Consensus 89 ~e~l~~ 94 (288)
T 3f7w_A 89 MEWVDE 94 (288)
T ss_dssp EECCCC
T ss_pred EEeecc
Confidence 999863
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00028 Score=80.55 Aligned_cols=73 Identities=10% Similarity=-0.030 Sum_probs=56.2
Q ss_pred hccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccCC
Q 038696 127 AAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISGS 200 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 200 (683)
++||||.++|++|+.+|. ..|.||||.|+..+|. |+| ..+.++||.|....+.|++.....|.++.++
T Consensus 2 ~~Wy~g~isr~~Ae~lL~~~~~~G~FLvR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl~eL 75 (595)
T 3ps5_A 2 VRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGD------FSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTEL 75 (595)
T ss_dssp CSCCCSSCCHHHHHHHHHHHCCTTCEEEEECSSSTTS------EEEEEEETTEEEEEEEEECSSCEESSSSCCBSSHHHH
T ss_pred CCccCCCCCHHHHHHHHhhCCCCCEEEEeecCCCCCc------eEEEEEECCEEEEEEEEeCCCcEEEecCccccchhhh
Confidence 689999999999999998 4699999999977776 777 4456899999756666767666666665554
Q ss_pred chhhh
Q 038696 201 TKQEQ 205 (683)
Q Consensus 201 ~~~~~ 205 (683)
..++.
T Consensus 76 v~~y~ 80 (595)
T 3ps5_A 76 VEYYT 80 (595)
T ss_dssp HHHHH
T ss_pred hhhhc
Confidence 44443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0099 Score=64.86 Aligned_cols=49 Identities=20% Similarity=0.230 Sum_probs=35.2
Q ss_pred CcEEEEEEeCC-Cc-chHHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 256 GESFALRHFFG-DI-EPLVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 256 g~~vAvK~~~~-~~-~~~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
+..+.+|+... .. +.+..|..++..|...++ .++++.+ ++ .+||||++|
T Consensus 105 ~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v~e~l~G 156 (429)
T 1nw1_A 105 PNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRLEEYIPS 156 (429)
T ss_dssp CSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEEECCCCE
T ss_pred CceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEEEEEeCC
Confidence 47899999854 44 677889999998853334 5666554 32 389999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0069 Score=65.71 Aligned_cols=32 Identities=13% Similarity=0.347 Sum_probs=27.4
Q ss_pred HhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 348 HSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 348 H~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--------~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--------TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--------EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--------CEEEeCccccc
Confidence 467899999999999997654 89999998754
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0004 Score=78.18 Aligned_cols=72 Identities=10% Similarity=-0.031 Sum_probs=52.5
Q ss_pred hccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccCC
Q 038696 127 AAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISGS 200 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 200 (683)
++||||.++|++|+.+|. .+|.|+||.|+..+|. |+| ....++||.|....+.|.+.....|.++.+.
T Consensus 2 ~~Wyhg~i~r~~Ae~lL~~~~~~G~FLvR~S~~~~g~------~~Lsv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl~~L 75 (532)
T 2b3o_A 2 VRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGD------FSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTEL 75 (532)
T ss_dssp CTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSSSE------EEEEEEETTEEEEEEEECSSSCEEETTSCEESCHHHH
T ss_pred CCceeCCCCHHHHHHHHHhcCCCCCEEEecCCCCCCc------eEEEEEECCEEEEEEEEecCCEEEECCCcccCCHHHH
Confidence 689999999999999998 4799999999876666 777 3456889999754444545444455555444
Q ss_pred chhh
Q 038696 201 TKQE 204 (683)
Q Consensus 201 ~~~~ 204 (683)
..++
T Consensus 76 v~~y 79 (532)
T 2b3o_A 76 VEYY 79 (532)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.00047 Score=77.63 Aligned_cols=74 Identities=5% Similarity=0.010 Sum_probs=54.9
Q ss_pred HhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hh---------hhhhhhhhhcccchhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PD---------FCYRIDTVWKEDRWIL 188 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~---------~~~~~~~~~~~~~~~l 188 (683)
.+.++||||.++|++|+.+|. .+|.|+||.|+..+|. |+|+ .+ .++||.|....+.|++
T Consensus 105 p~~~~w~~g~i~r~~Ae~lL~~~~~~G~FLVR~S~~~~g~------y~Lsv~~~~~~~~~~~~~~v~h~~I~~~~g~~~l 178 (532)
T 2b3o_A 105 PTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGD------FVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTV 178 (532)
T ss_dssp GGGCTTBCTTCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEEEEEC----CCEEEEEEEEBCCTTSBBS
T ss_pred cccccccccccchHHHHHHHhcCCCCceEEEecCCCCCCc------eEEEEEecCccccccCCCceEEEEEEEcCCceee
Confidence 366899999999999999998 4689999999988776 7762 22 6889998777666776
Q ss_pred hhhhhhhhccCCchh
Q 038696 189 FNKIQQKKISGSTKQ 203 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~ 203 (683)
.....|.++.+...+
T Consensus 179 ~~~~~F~sl~eLV~~ 193 (532)
T 2b3o_A 179 GGLETFDSLTDLVEH 193 (532)
T ss_dssp SSSCCBSSHHHHHHH
T ss_pred CCCcccCcHHHHHhh
Confidence 544455444444333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0004 Score=79.59 Aligned_cols=86 Identities=12% Similarity=-0.047 Sum_probs=61.4
Q ss_pred HhhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeeec---hhhhhhhhhhhc-ccchhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLIT---PDFCYRIDTVWK-EDRWILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l~---~~~~~~~~~~~~-~~~~~l~~~~~~~ 195 (683)
.+..+||||-+.|++|+++|. ..|.|+||.|+..+|. |+|+ ...++||.|... ++.|++.....|.
T Consensus 5 ~~~~~W~~g~i~r~~ae~~L~~~~~~~G~fLvR~s~~~~g~------~~ls~~~~~~~~h~~i~~~~~g~~~~~~~~~f~ 78 (613)
T 2ozo_A 5 AAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGG------YVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHC 78 (613)
T ss_dssp TSSCTTBCBSCCHHHHHHHHHTTTCCTTEEEEEECTTBTTC------EEEEEEETTEEEEEEEEECTTSCEEETTSCCBS
T ss_pred CCCCCCcCccCCHHHHHHHHhccCCCCCeEEEEecCCCCCC------EEEEEEECCeEEEEEEEECCCCcEEECCCCCcC
Confidence 345689999999999999994 3699999999877766 8873 445889999654 4457776666676
Q ss_pred hccCCchhhhchHHHHhhhc
Q 038696 196 KISGSTKQEQGLIDVLFKNL 215 (683)
Q Consensus 196 ~~~~~~~~~~~~~~~l~~~~ 215 (683)
++.+...++....+.+...|
T Consensus 79 sl~~Lv~~y~~~~~~l~~~L 98 (613)
T 2ozo_A 79 GPAELCEFYSRDPDGLPCNL 98 (613)
T ss_dssp SHHHHHHHHTSCCTTSSSCC
T ss_pred CHHHHHHHHhhCCCCCCccC
Confidence 66665555554444443333
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.017 Score=59.87 Aligned_cols=55 Identities=9% Similarity=0.117 Sum_probs=35.2
Q ss_pred cCcEEEEEEeCC---CcchHHHHHHHHHcCCCC--ceeeeeeeEEc----CCCCeEEEEEecCCC
Q 038696 255 LGESFALRHFFG---DIEPLVPEISSLLSLSHP--NIMHFLCGFTD----EEKKECFLIMELMSR 310 (683)
Q Consensus 255 ~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~----e~~~~~~LVmEy~~g 310 (683)
+|+.+++|.... ..+.+..|..++..|... .+++++.. .. ...+..++||+|++|
T Consensus 48 ~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 48 DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECCCC
T ss_pred CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEecCC
Confidence 466799999863 345678899988887421 24444432 10 012467899999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0087 Score=63.58 Aligned_cols=48 Identities=15% Similarity=0.149 Sum_probs=32.4
Q ss_pred cEEEEEEeCCCcc---hHHHHHHHHHcCCCCc-eeeeeeeEEcCCCCeEEEEEecCCC
Q 038696 257 ESFALRHFFGDIE---PLVPEISSLLSLSHPN-IMHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 257 ~~vAvK~~~~~~~---~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
..+.+|+.....+ ....|.+++..|...+ +.++++.+ + + ++||||++|
T Consensus 67 ~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~~v~e~i~G 118 (369)
T 3c5i_A 67 TRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--GRIEEWLYG 118 (369)
T ss_dssp CEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EEEEECCCS
T ss_pred ceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--C--cEEEEEecC
Confidence 6889998854433 3468999998885333 44666443 2 2 689999987
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.00084 Score=76.59 Aligned_cols=75 Identities=7% Similarity=0.038 Sum_probs=56.3
Q ss_pred HhhhccccCCCchhHHHHHHhhcCC---ceeeeccccccccccCeeeee---chh---------hhhhhhhhhcccchhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVHSGK---YKKEWKDHKLFQWRYGKQYLI---TPD---------FCYRIDTVWKEDRWIL 188 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~~g~---~~~r~~~~~~~~~~~~~~y~l---~~~---------~~~~~~~~~~~~~~~l 188 (683)
.+.++||||.++|++|+++|...|+ ||||.|+..+|. |+| ... -++||.|....++|++
T Consensus 105 p~~~~Wy~g~~~r~eAe~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~~~~~~v~H~~I~~~~~~~~~ 178 (595)
T 3ps5_A 105 PTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGD------FVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTV 178 (595)
T ss_dssp SCCSTTEEESCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEEEEESSSTTSCEEEEEEEEBCGGGCBBS
T ss_pred ccccccccccCCHHHHHHHHhccCCCceEEEEecCCCCCc------EEEEEEECCccccccCCCceEEEEEEEeCCEEEE
Confidence 3577899999999999999987555 999999988887 777 222 5889999876677877
Q ss_pred hhhhhhhhccCCchhh
Q 038696 189 FNKIQQKKISGSTKQE 204 (683)
Q Consensus 189 ~~~~~~~~~~~~~~~~ 204 (683)
.....|.++.++..++
T Consensus 179 ~~~~~F~sl~~LV~~y 194 (595)
T 3ps5_A 179 GGLETFDSLTDLVEHF 194 (595)
T ss_dssp SSSCCBSSHHHHHHHH
T ss_pred cCCcCCCCHHHHHHHH
Confidence 7655665544443333
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.057 Score=56.19 Aligned_cols=69 Identities=16% Similarity=0.107 Sum_probs=48.1
Q ss_pred EeEecccccEEEEEE--cCcEEEEEEeCCC-cchHHHHHHHHHcCC---CCceeeeeeeEEcCCCCeEEEEEecCCC
Q 038696 240 RRRLGSGSQYKEILW--LGESFALRHFFGD-IEPLVPEISSLLSLS---HPNIMHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 240 ~~~LG~G~~~~v~l~--~g~~vAvK~~~~~-~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
.+.|+.|..-.++.. .+..++||+.... ...+..|++.|+.|. ...+++++...... +..|+||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccC
Confidence 456777764444332 5678899987543 456789999998884 35677777665433 678999999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.015 Score=62.29 Aligned_cols=122 Identities=19% Similarity=0.134 Sum_probs=70.8
Q ss_pred CcEEEEEEeCC---CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCCC-CHH--------------HHH
Q 038696 256 GESFALRHFFG---DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLC--------------SYI 316 (683)
Q Consensus 256 g~~vAvK~~~~---~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~g-sL~--------------~~l 316 (683)
++.+.+|+.-. ....+.+|.++++.|. +.-..++++.+ ++ .+||||++| .|. +.|
T Consensus 82 ~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 82 PREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 46788888633 3456678999998885 33335666554 32 289999987 332 222
Q ss_pred HHhcCCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHHH----h----CCcccCCCCCCcEEeC
Q 038696 317 KEICCPR--KRIPFS--LPVAVDLMLQIAR-------------------GMEYLH----S----KKIYHGNLNPSNILLK 365 (683)
Q Consensus 317 ~~~~~~~--~~~~l~--~~~~~~i~~qi~~-------------------aL~yLH----~----~gIiHrDLKp~NILl~ 365 (683)
.+..... ...... +.++.++..++.. .+..|. . ..++|+|+.+.|||++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 2222211 111222 3455555544422 233332 2 2589999999999998
Q ss_pred CCCCCCCCcceEEEecccCcc
Q 038696 366 PRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 366 ~~g~~~~~~~~vKL~DFGla~ 386 (683)
.+. +..-.+.|+||..+.
T Consensus 236 ~~~---~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEP---ENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC------CCEEECCCTTCE
T ss_pred CCC---CccCcEEEEecccCC
Confidence 761 000158999998764
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0011 Score=74.61 Aligned_cols=70 Identities=10% Similarity=0.072 Sum_probs=53.1
Q ss_pred HhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeec---hh----------hhhhhhhhhcccchh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLIT---PD----------FCYRIDTVWKEDRWI 187 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~---~~----------~~~~~~~~~~~~~~~ 187 (683)
.+.++||||.+.|++|+.+|. .+|.|+||.|+..+|. |+|+ .+ .++||.|....+.|+
T Consensus 107 p~~~~w~~g~~~r~~Ae~lL~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~~~~~~~v~H~~I~~~~g~~~ 180 (525)
T 2shp_A 107 PTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGD------FVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYD 180 (525)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHTCCTTEEEEEECSSSTTC------EEEEEEECC-----CCCCCEEEEEEEEEETTEEE
T ss_pred cccceeecccCCHHHHHHHHhccCCCceEEEEecCCCCCC------EEEEEEECCccccccccccceEEEEEEecCCeEE
Confidence 366899999999999999998 4799999999977776 7772 22 588999977766677
Q ss_pred hhhhhhhhhccC
Q 038696 188 LFNKIQQKKISG 199 (683)
Q Consensus 188 l~~~~~~~~~~~ 199 (683)
+.....|.++.+
T Consensus 181 l~~~~~F~sL~e 192 (525)
T 2shp_A 181 VGGGERFDSLTD 192 (525)
T ss_dssp SSSSCCBSSHHH
T ss_pred ECCCceeCcHHH
Confidence 664444544333
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.047 Score=59.99 Aligned_cols=64 Identities=17% Similarity=0.070 Sum_probs=38.4
Q ss_pred eEecccc---cEEEEEEc-CcEEEEEEeCCCcch---HHHHHHHHHcCCCCce-eeeeeeEEcCCCCeEEEEEecCCC
Q 038696 241 RRLGSGS---QYKEILWL-GESFALRHFFGDIEP---LVPEISSLLSLSHPNI-MHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 241 ~~LG~G~---~~~v~l~~-g~~vAvK~~~~~~~~---~~~Ei~iL~~L~HpnI-v~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
+.|+.|- .|.+.... +..+.+|+.....+. -.+|..+|..|...++ .++++.+ ++ .+||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCC
Confidence 4566553 24433212 378999988543332 2689999999975555 4566655 32 259999986
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=94.04 E-value=0.0069 Score=59.54 Aligned_cols=58 Identities=12% Similarity=0.129 Sum_probs=44.9
Q ss_pred hhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hhh
Q 038696 125 ETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WIL 188 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~l 188 (683)
...+||||-++|++++.+|. ..|.|++|.+++.++. |.| ..+.++||.|....+. |++
T Consensus 56 ~~~~w~~g~isr~~ae~lL~~~~~~G~fLvR~S~~~~g~------~~LSv~~~~~v~h~~I~~~~~g~~~~ 120 (217)
T 1gri_A 56 KPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGD------FSLSVKFGNDVQHFKVLRDGAGKYFL 120 (217)
T ss_dssp CCCSSBCTTCCHHHHHHHHHTCSSTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEECSSSCEES
T ss_pred ccchhhcccCCHHHHHHHHhccCCCceEEEEccCCCCCC------EEEEEEECCEEEEEEEEEcCCCCEEE
Confidence 45789999999999999993 5899999999877776 666 3456889888654444 443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.65 E-value=0.66 Score=50.29 Aligned_cols=49 Identities=14% Similarity=0.083 Sum_probs=33.0
Q ss_pred CcEEEEEEeCCCc---chHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecCCC
Q 038696 256 GESFALRHFFGDI---EPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 256 g~~vAvK~~~~~~---~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~~g 310 (683)
+..+.+|+..... -+..+|.++++.|. +.-..++++.+ . + ++||||++|
T Consensus 102 ~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~~I~efI~G 154 (424)
T 3mes_A 102 HPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--E--GRIEEFIDG 154 (424)
T ss_dssp CSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EEEEECCCS
T ss_pred CCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--CEEEEEeCC
Confidence 6789999874432 23468999998885 33345565533 2 1 789999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.23 E-value=0.81 Score=48.98 Aligned_cols=35 Identities=23% Similarity=0.227 Sum_probs=24.3
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.++|+|+.+.|||+..+.. .+..-.+.|+||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcc-cCcCCeEEEechHhcc
Confidence 3689999999999954220 0111269999998774
|
| >1uur_A Stata protein, STAT protein; transcription activator, SH2, signal transduction, transducer, transcription factor; HET: PTR; 2.7A {Dictyostelium discoideum} SCOP: a.47.1.1 b.2.5.5 d.93.1.1 PDB: 1uus_A* | Back alignment and structure |
|---|
Probab=86.96 E-value=0.54 Score=50.96 Aligned_cols=34 Identities=15% Similarity=0.173 Sum_probs=31.3
Q ss_pred hccccCCCchhHHHHHHhh--cCCceeeeccccccc
Q 038696 127 AAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQ 160 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~ 160 (683)
.+|+|||+.+++++.+|.. .|.|++|+||..+|.
T Consensus 351 dg~I~GFIsk~ea~~lL~~~~~GTFLLRFSeS~~Gg 386 (473)
T 1uur_A 351 EGIIYGYMGRQEVNDALQNQDPGTFIIRFSERNPGQ 386 (473)
T ss_dssp HTSSCBSCCHHHHHHTTSSCCTTCEEEEECSSSTTC
T ss_pred cCcEEEEecHHHHHHHhhCCCCCeEEEEeccCCCce
Confidence 4899999999999999996 799999999988877
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=82.88 E-value=0.7 Score=48.26 Aligned_cols=31 Identities=13% Similarity=0.249 Sum_probs=26.3
Q ss_pred CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 350 ~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
..++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-------~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-------SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-------CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-------eEEEEECCCCee
Confidence 4689999999999998665 589999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 683 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFAL------RHFFGDIEPLVPEISSLLSLS 282
I V +R+GSGS YK A+ ++ E+ L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
H NI+ F+ G++ + ++ + L ++ F + +D+ Q A
Sbjct: 63 HVNILLFM-GYSTAPQ--LAIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 114
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
+GM+YLH+K I H +L +NI L KI FGL++VK+ S +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDL-------TVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG---DK 458
+W APEV+ + + YS +SDVY+FG++ +E++TG++P+ + + +
Sbjct: 168 GSILWMAPEVIRMQD------KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221
Query: 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ R + + + PK + L C ++RP F I + + R
Sbjct: 222 VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-48
Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 36/285 (12%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALRHFFGD--IEPLVPEISSLLSLSHPNI 286
+ ++ ++ + +G G + G A++ D + + E S + L H N+
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL 62
Query: 287 MHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ L G EEK +++ E M++ L Y++ R R + L + ME
Sbjct: 63 VQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCEAME 117
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YL H +L N+L+ AK+S FGL+ S +Q P
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDN-------VAKVSDFGLTKE-----ASSTQDTGKLPVK 165
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464
W APE L K+S KSDV+SFG++ +EI + G+VP+ L+ + +
Sbjct: 166 WTAPEAL---------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE 214
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
G + P P V + K CWH D RPSF + L +IK
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 59/284 (20%), Positives = 113/284 (39%), Gaps = 38/284 (13%)
Query: 233 KSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF------GDIEPLVPEISSLLSLS 282
++EDY+V +G+GS K G+ + + + LV E++ L L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HPNI+ + D +++ME DL S I + ++R + +M Q+
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLT 119
Query: 342 RGMEYLHSK-----KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
++ H + + H +L P+N+ L + + K+ FGL+ + +
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------NVKLGDFGLA--RILNHDTSF 170
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456
+ +PE + + Y+EKSD++S G + +E+ PF +
Sbjct: 171 AKAFVGTPYYMSPEQM---------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK- 220
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+++ IR G+ P+ + + R + RPS I
Sbjct: 221 -ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-45
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFA---LRHFFGDIEPLVPEISSLLSLSHPN 285
+ E ++ RLG+G + A L+ + + E + + L H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRD-LCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
++ T E ++I E M L ++K I ++ +D+ QIA GM
Sbjct: 70 LVRLYAVVTQEP---IYIITEYMENGSLVDFLKT----PSGIKLTINKLLDMAAQIAEGM 122
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
++ + H +L +NIL+ KI+ FGL+ + + ++ G P
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTL-------SCKIADFGLARLIEDN-EYTAREGAKFPI 174
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
W APE + + ++ KSDV+SFG++ EI+T + ++ +N+
Sbjct: 175 KWTAPEAI---------NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLE 224
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504
G R + P + P+ + L + CW P RP+F + +L
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 9e-45
Identities = 58/279 (20%), Positives = 102/279 (36%), Gaps = 31/279 (11%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFAL----RHFFGDIEPLVPEISSLLSLSHPN 285
+ +++ LG G+ YK + A ++E + EI L S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
I+ L F E ++++E + + P + + Q +
Sbjct: 71 IVKLLDAFYYENN--LWILIEFCAGGAVDAV----MLELERPLTESQIQVVCKQTLDALN 124
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YLH KI H +L NIL G K++ FG+S +
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDG-------DIKLADFGVS--AKNTRTIQRRDSFIGTPY 175
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465
W APEV+ E++ + Y K+DV+S G+ E+ + P + + ++ I
Sbjct: 176 WMAPEVV----MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAK 229
Query: 466 GERPLFPFHS--PKYVTNLTKRCWHADPNQRPSFSSICR 502
E P S + K+C + + R + S + +
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 5e-43
Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 30/285 (10%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEIL-WLGESFA---LRHFFGDIEPLVPEISSLLSLSHP 284
++ D ++ +LG G Y+ + + A L+ ++E + E + + + HP
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 73
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
N++ L T E ++I E M+ + R S V + + QI+ M
Sbjct: 74 NLVQLLGVCTREPP--FYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
EYL K H +L N L+ K++ FGLS + G + +G P
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENH-------LVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
W APE L + +K+S KSDV++FG++ +EI T + + ++ +
Sbjct: 181 KWTAPESL---------AYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLE 230
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
R P P+ V L + CW +P+ RPSF+ I + + +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-42
Identities = 63/301 (20%), Positives = 112/301 (37%), Gaps = 39/301 (12%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFA---LRHFFGDIEPLVPEISSLLSLSHPN 285
I E ++ +LG G + A L+ E + E + L H
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
++ ++E +++ E MS+ + LP VD+ QIA GM
Sbjct: 74 LVQLYAVVSEEP---IYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
Y+ H +L +NIL+ K++ FGL+ + + ++ G P
Sbjct: 128 YVERMNYVHRDLRAANILVGENL-------VCKVADFGLARLIE-DNEYTARQGAKFPIK 179
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465
W APE +++ KSDV+SFG++ E+ T + + + +
Sbjct: 180 WTAPEAAL---------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVER 229
Query: 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPDPPM 525
G R P P+ + +L +CW +P +RP+F + L ++ S
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE---------DYFTSTEPQYQ 280
Query: 526 P 526
P
Sbjct: 281 P 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 5e-42
Identities = 66/332 (19%), Positives = 123/332 (37%), Gaps = 43/332 (12%)
Query: 231 LIKSEDYQVRRRLGSGSQ---YK-EILWLGESFAL---------RHFFGDIEPLVPEISS 277
++K +++ + LGSG+ YK + GE + + ++ E
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 278 LLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
+ S+ +P++ L + + L + ++
Sbjct: 65 MASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLD-----YVREHKDNIGSQYLLNWC 117
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
+QIA+GM YL +++ H +L N+L+K H KI+ FGL+ + K
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-------HVKITDFGLAKLLGAEEKEYHA 170
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456
G P W A E + + Y+ +SDV+S+G+ +E++T G P++
Sbjct: 171 EGGKVPIKWMALESI---------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS- 220
Query: 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPH 516
++S + GER P V + +CW D + RP F + + R +P
Sbjct: 221 -EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR----DPQ 275
Query: 517 YNSQPDPPMPLVDYSDIESRLLRKFPSWETHN 548
+ S +S R E +
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 307
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 5e-42
Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 30/283 (10%)
Query: 231 LIKSEDYQVRRRLGSGSQ---YKEILWLGESFA---LRHFFGDIEPLVPEISSLLSLSHP 284
+I + + +GSG + + A +R E + E ++ LSHP
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
++ ++ L+ E M S +R F+ + + L + GM
Sbjct: 61 KLVQLYGVCLEQA--PICLVFEFMEHGCLSDY----LRTQRGLFAAETLLGMCLDVCEGM 114
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
YL + H +L N L+ K+S FG++ + S +GT P
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQ-------VIKVSDFGMTRFVL-DDQYTSSTGTKFPV 166
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
W +PEV S+YS KSDV+SFG++ +E+ + + + ++ +I
Sbjct: 167 KWASPEVFS---------FSRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDIS 216
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
G R P + +V + CW P RP+FS + R L I
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 6e-42
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 47/319 (14%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFAL-------RHFFGDIEPLVPEISSLLSLS 282
+ + R +G GS Y + E A+ + + ++ E+ L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
HPN + + + E +L+ME ++ + P + +
Sbjct: 74 HPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQ 126
Query: 343 GMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
G+ YLHS + H ++ NILL G K+ FG +S+ + S GT +
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDFGSASIMA---PANSFVGTPY 176
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
W APEV+ + +Y K DV+S G+ C E+ K P + + +
Sbjct: 177 ---WMAPEVI------LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHI 226
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQPD 522
+ L H +Y N C P RP+ + + R++ R P
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-HRFVLR--------ERPPT 277
Query: 523 PPMPLVDYSDIESRLLRKF 541
M L+ + R L
Sbjct: 278 VIMDLIQRTKDAVRELDNL 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-42
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 32/281 (11%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFA---LRHFFGDIEPLVPEISSLLSLSHPN 285
I +D + LG+G A ++ + + E +++LSH
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
++ T + F+I E M+ R F +++ + ME
Sbjct: 61 LVQLYGVCTKQR--PIFIITEYMANGCLLNY----LREMRHRFQTQQLLEMCKDVCEAME 114
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YL SK+ H +L N L+ +G K+S FGLS + S G+ P
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQG-------VVKVSDFGLSRYVL-DDEYTSSVGSKFPVR 166
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464
W PEVL SK+S KSD+++FG++ +EI + GK+P+E + + +I
Sbjct: 167 WSPPEVLM---------YSKFSSKSDIWAFGVLMWEIYSLGKMPYER--FTNSETAEHIA 215
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
G R P + + V + CWH ++RP+F + +
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 68/294 (23%), Positives = 127/294 (43%), Gaps = 41/294 (13%)
Query: 229 RILIKSEDYQVR-RRLGSGSQ---YKEILWL---GESFALRHF-----FGDIEPLVPEIS 276
++ +K ++ + LG G+ + + + A++ D E ++ E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVD 335
+ L +P I+ + + + L+ME+ L ++ KR + +
Sbjct: 62 IMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAE 113
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS-VKNFGPKS 394
L+ Q++ GM+YL K H +L N+LL R +AKIS FGLS +
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-------YAKISDFGLSKALGADDSYY 166
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453
++S P W+APE + + K+S +SDV+S+G+ +E L+ G+ P++
Sbjct: 167 TARSAGKWPLKWYAPECI---------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-- 215
Query: 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
++G ++ I G+R P P + L CW RP F ++ + +R
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 53/307 (17%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGE-----------SFALRHFFGDIEPLVPEISS 277
E+ + + LGSG+ + + + E L+ E+
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 278 LLSL-SHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE----------------- 318
+ L SH NI++ L T +LI E DL +Y++
Sbjct: 94 MTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 319 ICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378
+ + + Q+A+GME+L K H +L N+L+ K
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVK 204
Query: 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMI 438
I FGL+ + P W APE L Y+ KSDV+S+G++
Sbjct: 205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL---------FEGIYTIKSDVWSYGIL 255
Query: 439 CFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF 497
+EI + G P+ + + + I+ G + PF++ + + + + CW D +RPSF
Sbjct: 256 LWEIFSLGVNPYPGIPVDAN-FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 498 SSICRIL 504
++ L
Sbjct: 315 PNLTSFL 321
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 3e-40
Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 40/294 (13%)
Query: 232 IKSEDYQVRRRLGSGS-------QYKEILWLGESFALRHFF-----GDIEPLVPEISSLL 279
I ++ + +G+G K A++ + E S +
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
HPN++H T +I E M + F++ V ++
Sbjct: 83 QFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDS----FLRQNDGQFTVIQLVGMLRG 136
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
IA GM+YL H +L NIL+ K+S FGLS P+ +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNL-------VCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 400 TTH---PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455
P W APE ++ K++ SDV+S+G++ +E+++ G+ P+ D Q
Sbjct: 190 ALGGKIPIRWTAPEAIQ---------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509
+ I R P P + L CW D N RP F I L + R
Sbjct: 241 --DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 70/279 (25%), Positives = 108/279 (38%), Gaps = 41/279 (14%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF-------GDIEPLVPEISSLLSLSH 283
ED+++ R LG G Y AL+ F G L E+ L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
PNI+ F D + +LI+E +K F + ++A
Sbjct: 66 PNILRLYGYFHDATR--VYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 118
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+ Y HSK++ H ++ P N+LL G KI+ FG S + + GT
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAG-------ELKIADFGWSVHAP-SSRRTTLCGTLD- 169
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ PE++E + EK D++S G++C+E L GK PFE Q + + I
Sbjct: 170 --YLPPEMIE---------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRI 216
Query: 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
E FP + +L R +P+QRP +
Sbjct: 217 SRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 58/278 (20%), Positives = 103/278 (37%), Gaps = 33/278 (11%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHPN 285
ED+ + + LG G+ E+ A+ + E + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLC-SYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
++ F + + +L +E S I I P A Q+ G+
Sbjct: 65 VVKFYGHRREGNIQ--YLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGV 116
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
YLH I H ++ P N+LL R + KIS FGL++V + + +
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERD-------NLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
+ APE+L+ E ++E DV+S G++ +L G++P++ + S
Sbjct: 170 PYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221
Query: 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
L + +P+ R + I +
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 40/291 (13%)
Query: 231 LIKSEDYQVRRRLGSGS-------QYKEILWLGESFALRHFFGD-------IEPLVPEIS 276
LI +D ++ +LG GS ++ S A++ D ++ + E++
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336
++ SL H N++ ++ EL + + F L
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRY 116
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+Q+A GM YL SK+ H +L N+LL R KI FGL
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYV 169
Query: 397 QSGTTH-PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454
PF W APE L+ +S SD + FG+ +E+ T G+ P+ +
Sbjct: 170 MQEHRKVPFAWCAPESLK---------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ + + GER P P+ + N+ +CW P RP+F ++ L
Sbjct: 221 S-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPV 332
E + + L +P I+ + E L+ME+ L Y+ ++
Sbjct: 58 EANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYL------QQNRHVKDKN 108
Query: 333 AVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFG 391
++L+ Q++ GM+YL H +L N+LL + +AKIS FGLS +++
Sbjct: 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-------YAKISDFGLSKALRADE 161
Query: 392 PKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFE 450
+Q+ P W+APE + K+S KSDV+SFG++ +E + G+ P+
Sbjct: 162 NYYKAQTHGKWPVKWYAPECIN---------YYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510
++G +++ + GER P P+ + +L CW D RP F+++ LR
Sbjct: 213 G--MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
Query: 511 IMMNPHY 517
++ H+
Sbjct: 271 VVNEGHH 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 6e-39
Identities = 64/306 (20%), Positives = 111/306 (36%), Gaps = 52/306 (16%)
Query: 235 EDYQVRRRLGSGS-------QYKEILWL--GESFAL-----RHFFGDIEPLVPEISSLLS 280
+ + R +G G+ + +L A+ E + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE------------------ICC 321
+PNI+ L K L+ E M+ DL +++
Sbjct: 73 FDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
P S + + Q+A GM YL +K H +L N L+ KI+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIAD 183
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
FGLS + P W PE + ++Y+ +SDV+++G++ +E
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESI---------FYNRYTTESDVWAYGVVLWE 234
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
I + + + +++ +R G P + P + NL + CW P RPSF SI
Sbjct: 235 IFSYGLQPYYG-MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 502 RILRYI 507
RIL+ +
Sbjct: 294 RILQRM 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-39
Identities = 52/278 (18%), Positives = 104/278 (37%), Gaps = 36/278 (12%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFAL----RHFFGDIEPLVPEISSLLSLSHPN 285
+ Y ++G G+ Y + G+ A+ E ++ EI + +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
I+++L + + E +++ME ++ + + + + + +E
Sbjct: 79 IVNYLDSYLVGD--ELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALE 130
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
+LHS ++ H ++ NILL G K++ FG + S T
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGFCAQITPEQSKRSTMVGTPY-- 181
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465
W APEV+ + Y K D++S G++ E++ G+ P+ + + +
Sbjct: 182 WMAPEVV---------TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATN 231
Query: 466 GERPL-FPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
G L P + RC D +R S + +
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 7e-39
Identities = 70/335 (20%), Positives = 133/335 (39%), Gaps = 48/335 (14%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL----RHFFGDIEPLVPEISSLLSLSHPNI 286
+ Y + LG+G+ ++ G +FA D E + EI ++ L HP +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 287 MHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
++ F D+ E +I E MS +L + + S AV+ M Q+ +G+
Sbjct: 86 VNLHDAFEDDN--EMVMIYEFMSGGELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
++H H +L P NI+ +T+ K+ FGL+ + PK + T
Sbjct: 139 HMHENNYVHLDLKPENIMF-----TTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAE- 190
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465
+ APEV E +D++S G++ + +L+G PF + + RN+++
Sbjct: 191 FAAPEVAE---------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS 239
Query: 466 GERPLFPFHSPKYVT----NLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQP 521
+ + ++ + ++ ADPN R + ++ P
Sbjct: 240 CDWN-MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE-HPWLT------PGNAPGR 291
Query: 522 DPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIP 556
D +P Y+ I + K+ +W + P+ I
Sbjct: 292 DSQIPSSRYTKIRDSIKTKYDAWP-EPLPPLGRIS 325
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 62/278 (22%), Positives = 103/278 (37%), Gaps = 39/278 (14%)
Query: 237 YQVRRRLGSGSQ---YKEILW-LGESFALRHFF------GDIEPLVPEISSLLSLSHPNI 286
+ +G GS YK + A + + E L L HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 287 MHFLCGFTD--EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
+ F + + KK L+ ELM+ ++ + V QI +G+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGL 125
Query: 345 EYLHSKK--IYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTH 402
++LH++ I H +L NI + T KI GL+++K + + GT
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFI------TGPTGSVKIGDLGLATLKR-ASFAKAVIGTPE 178
Query: 403 PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462
+ APE+ EE KY E DVY+FGM E+ T + P+ + R
Sbjct: 179 ---FMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225
Query: 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ F + V + + C + ++R S +
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (360), Expect = 3e-38
Identities = 67/342 (19%), Positives = 133/342 (38%), Gaps = 52/342 (15%)
Query: 224 KLLPSRILIK----SEDYQVRRRLGSGSQ---YKEI-LWLGESFAL----RHFFGDIEPL 271
K +P + +K + Y + LGSG+ ++ + G F + D +
Sbjct: 14 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 73
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSL 330
EIS + L HP +++ F D+ E LI+E +S +L I + S
Sbjct: 74 KNEISIMNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIA-----AEDYKMSE 126
Query: 331 PVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNF 390
++ M Q G++++H I H ++ P NI+ + + AS KI FGL++ N
Sbjct: 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-----SVKIIDFGLATKLNP 181
Query: 391 GPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFE 450
+ T + APE+++ +D+++ G++ + +L+G PF
Sbjct: 182 DEIVKVTTATAE---FAAPEIVD---------REPVGFYTDMWAIGVLGYVLLSGLSPFA 229
Query: 451 DAHLQGDKMSRNIRAGERPLFPFHSPKYVT----NLTKRCWHADPNQRPSFSSICRILRY 506
+ +N++ + F + V+ + K +P +R + +
Sbjct: 230 GEDDL--ETLQNVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE-HPW 285
Query: 507 IKRFIMMNPHYNSQPDPPMPLVDYSDIESRLLRKFPSWETHN 548
+K +S +P Y+ I ++ K+ W
Sbjct: 286 LKG-------DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 41/306 (13%)
Query: 227 PSRILIKSEDYQVRRRLGSGSQ---YKEILWL------GESFAL-----RHFFGDIEPLV 272
S+ + ++ + LG G+ + + + A+ + L+
Sbjct: 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64
Query: 273 PEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKE----------ICC 321
E+ L+ + H + L G + +I+E +L +Y++
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 322 PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381
+ +L + Q+A+GME+L S+K H +L NILL + KI
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-------VVKICD 177
Query: 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFE 441
FGL+ P + P W APE + + Y+ +SDV+SFG++ +E
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETI---------FDRVYTIQSDVWSFGVLLWE 228
Query: 442 ILTGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
I + ++ R ++ G R P ++ + CWH +P+QRP+FS +
Sbjct: 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
Query: 502 RILRYI 507
L +
Sbjct: 289 EHLGNL 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-38
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 46/301 (15%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWL------GESFAL-----RHFFGDIEPLVPEISS 277
+ LG+G+ + + + A+ + E L+ E+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 278 LLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE------------ICCPR 323
L L H NI++ L T +I E DL ++++
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
+ L + Q+A+GM +L SK H +L NILL KI FG
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-------ITKICDFG 190
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
L+ + P W APE + N Y+ +SDV+S+G+ +E+
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIF---------NCVYTFESDVWSYGIFLWELF 241
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
+ K + I+ G R L P H+P + ++ K CW ADP +RP+F I ++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 504 L 504
+
Sbjct: 302 I 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 9e-38
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 46/299 (15%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL-------------RHFFGDIEPLVPEISS 277
E+Y+ + LG G + + +A+ E + E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 278 LLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVD 335
L +S HPNI+ + FL+ +LM + +L Y+ +++ S
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYL------TEKVTLSEKETRK 114
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP 395
+M + + LH I H +L P NILL + K++ FG S + G K
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDM-------NIKLTDFGFSCQLDPGEKLR 167
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
GT + APE++E + + Y ++ D++S G+I + +L G PF
Sbjct: 168 EVCGTPS---YLAPEIIECSMNDN---HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 456 GDKMSRNIRAGERPLFPFHSPKY---VTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511
M R I +G Y V +L R P +R + + ++++
Sbjct: 222 --LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA-HPFFQQYV 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 37/288 (12%)
Query: 232 IKSEDYQVRRRLGSGS-------QYKEILWLGESFALRHFF-----GDIEPLVPEISSLL 279
I+ E ++ R +G G Y + A++ E + E ++
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
HP+I+ + T+ ++IMEL + ++ L + Q
Sbjct: 64 QFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSF----LQVRKYSLDLASLILYAYQ 116
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
++ + YL SK+ H ++ N+L+ K+ FGLS + G
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSND-------CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
P W APE + +++ SDV+ FG+ +EIL V ++ + +
Sbjct: 170 KL-PIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDV 218
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507
I GER P + P + +L +CW DP++RP F+ + L I
Sbjct: 219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 74/313 (23%), Positives = 115/313 (36%), Gaps = 47/313 (15%)
Query: 232 IKSEDYQVRRRLGSGSQ---YKEILWLGESFALR----------HFFGDIEPLVPEISSL 278
I ++ +G+G YK +L + + E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
SH NI+ + + +I E M K FS+ V ++
Sbjct: 64 GQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKF----LREKDGEFSVLQLVGMLR 117
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGP-KSPSQ 397
IA GM+YL + H +L NIL+ K+S FGLS V P + +
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTT 170
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
SG P W APE + S K++ SDV+SFG++ +E++T L
Sbjct: 171 SGGKIPIRWTAPEAI---------SYRKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNH 220
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHY 517
++ + I G R P P + L +CW + +RP F+ I IL + R
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-------- 272
Query: 518 NSQPDPPMPLVDY 530
PD L D+
Sbjct: 273 --APDSLKTLADF 283
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 39/280 (13%)
Query: 235 EDYQVRRRLGSGSQ---YKEI-LWLGESFA---LRHFFGDIEPLVPEISSLLSLSHPNIM 287
E Y + LG G ++ + +++ ++ D + EIS L H NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 288 HFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEY 346
H F E E +I E +S D+ I + V + Q+ +++
Sbjct: 65 HLHESFESME--ELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQF 117
Query: 347 LHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIW 406
LHS I H ++ P NI+ T KI FG + G +
Sbjct: 118 LHSHNIGHFDIRPENIIY-----QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAG 466
E + S +D++S G + + +L+G PF Q ++ NI
Sbjct: 173 ------------EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA 218
Query: 467 ERPLFPFHSPKYVT----NLTKRCWHADPNQRPSFSSICR 502
E F + K ++ + R + R + S +
Sbjct: 219 E-YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 69/326 (21%), Positives = 124/326 (38%), Gaps = 55/326 (16%)
Query: 232 IKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFFGDIEPLVP-----EISSLLSLS 282
+K +D++ LG+G+ +K G A + +I+P + E+ L +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIAR 342
P I+ F F + E + ME M + +K + + + + +
Sbjct: 63 SPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIK 115
Query: 343 GMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G+ YL K KI H ++ PSNIL+ RG K+ FG+S + + S GT
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRG-------EIKLCDFGVS-GQLIDSMANSFVGTR 167
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
+ +PE L + YS +SD++S G+ E+ G+ P + ++
Sbjct: 168 S---YMSPERL---------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQP 521
+ +P + + RP +I +L YI +P
Sbjct: 216 GCQVEGDAAE---TPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVN----------EP 261
Query: 522 DPPMPLVDYS----DIESRLLRKFPS 543
P +P +S D ++ L K P+
Sbjct: 262 PPKLPSGVFSLEFQDFVNKCLIKNPA 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 25/254 (9%)
Query: 266 GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKR 325
G++ + E + SHPN++ L G + +++ M +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLL-GICLRSEGSPLVVLPYMKHGDLRNF----IRNET 124
Query: 326 IPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385
++ + LQ+A+GM++L SKK H +L N +L + K++ FGL+
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-------DEKFTVKVADFGLA 177
Query: 386 SVKNFGPKSPSQSGTTH--PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
+ T P W A E L+ K++ KSDV+SFG++ +E++
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQ---------TQKFTTKSDVWSFGVLLWELM 228
Query: 444 TGKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503
T P + ++ + G R L P + P + + +CWH RPSFS +
Sbjct: 229 TRGAPPYP-DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 504 LRYIKRFIMMNPHY 517
+ I + HY
Sbjct: 288 ISAIFST-FIGEHY 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 49/305 (16%)
Query: 232 IKSEDYQVRRRLGSGS-----------QYKEILWLGESFAL-----RHFFGDIEPLVPEI 275
+ + + + LG G+ K+ A+ D+ L+ E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 276 SSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCP----------R 323
+ + H NI++ L T + ++I+E S+ +L Y++ P
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 324 KRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383
S V Q+ARGMEYL SKK H +L N+L+ KI+ FG
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-------VMKIADFG 180
Query: 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEIL 443
L+ + + P W APE L + Y+ +SDV+SFG++ +EI
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLLWEIF 231
Query: 444 T-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
T G P+ ++ ++ + ++ G R P + + + + CWHA P+QRP+F +
Sbjct: 232 TLGGSPYPGVPVE--ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 503 ILRYI 507
L I
Sbjct: 290 DLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 59/281 (20%), Positives = 102/281 (36%), Gaps = 39/281 (13%)
Query: 232 IKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF-------GDIEPLVPEISSLLS 280
+ ED++ + LG GS L +A++ + + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
L HP + F D+EK + + +L YI RK F +
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYI------RKIGSFDETCTRFYTAE 116
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
I +EYLH K I H +L P NILL H +I+ FG + V + K +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDM-------HIQITDFGTAKVLSPESKQARANS 169
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
+ +PE+L + + SD+++ G I ++++ G PF + +
Sbjct: 170 FVGTAQYVSPELL---------TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LI 218
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ I E FP +L ++ D +R +
Sbjct: 219 FQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 71/319 (22%), Positives = 119/319 (37%), Gaps = 52/319 (16%)
Query: 227 PSRI-LIKSEDYQVRRRLGSGSQ---YK-EILWLGESFAL-------RHFFGDIEPLVPE 274
P+ ++ D + + +G G+ K I G D E
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 275 ISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKE----------ICCP 322
+ L L HPNI++ L E + +L +E +L ++++
Sbjct: 61 LEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 323 RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382
S + +ARGM+YL K+ H +L NIL+ AKI+ F
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-------VAKIADF 171
Query: 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442
GLS + K W A E L S Y+ SDV+S+G++ +EI
Sbjct: 172 GLSRGQEVYVKKTMGRLPVR---WMAIESLN---------YSVYTTNSDVWSYGVLLWEI 219
Query: 443 LT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSIC 501
++ G P+ ++ + G R P + V +L ++CW P +RPSF+ I
Sbjct: 220 VSLGGTPYCGMTCA--ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 502 RILRYI----KRFIMMNPH 516
L + K ++ +
Sbjct: 278 VSLNRMLEERKTYVNTTLY 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 55/319 (17%), Positives = 111/319 (34%), Gaps = 66/319 (20%)
Query: 234 SEDYQVRRRLGSGSQ---YKEILWLGESFAL--------RHFFGDIEPLVPEISSLLSLS 282
+ ++ +G G ++ W GE A+ R +F + E I + L
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAE-----IYQTVMLR 55
Query: 283 HPNIMHFLCGFTDEE--KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
H NI+ F+ + + +L+ + L Y+ R ++ + L L
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALS 108
Query: 340 IARGMEYLHS--------KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFG 391
A G+ +LH I H +L NIL+K G I+ GL+ +
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------TCCIADLGLAVRHDSA 161
Query: 392 PKSPSQSGTTH--PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF 449
+ + + APEVL+++ + + + +++D+Y+ G++ +EI
Sbjct: 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMK---HFESFKRADIYAMGLVFWEIARRCSIG 218
Query: 450 EDAHLQGDKMS--------------RNIRAGERPLFPFH-----SPKYVTNLTKRCWHAD 490
RP P + + + + + CW+A+
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 491 PNQRPSFSSICRILRYIKR 509
R + I + L + +
Sbjct: 279 GAARLTALRIKKTLSQLSQ 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 40/300 (13%)
Query: 226 LPSRILIKSEDYQVRRRLGSGSQ---YKEILWL------GESFAL-----RHFFGDIEPL 271
+P + E + R LG GS Y+ + A+ +
Sbjct: 11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF 70
Query: 272 VPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCP----RKRI 326
+ E S + + +++ L + + +IMELM+R DL SY++ +
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 327 PFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386
P SL + + +IA GM YL++ K H +L N ++ KI FG++
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-------TVKIGDFGMTR 181
Query: 387 VKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTG- 445
P W +PE L+ + ++ SDV+SFG++ +EI T
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLK---------DGVFTTYSDVWSFGVVLWEIATLA 232
Query: 446 KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ P++ L +++ R + G P + P + L + CW +P RPSF I ++
Sbjct: 233 EQPYQG--LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 2e-35
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 39/282 (13%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHP 284
+ Y R LG+G+ E + A+ + G + EI+ L + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
NI+ + +LIM+L+S +L I ++ ++ A L+ Q+
Sbjct: 68 NIVALDDIYESGGH--LYLIMQLVSGGELFDRI------VEKGFYTERDASRLIFQVLDA 119
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
++YLH I H +L P N+L S + IS FGLS +++ G + GT
Sbjct: 120 VKYLHDLGIVHRDLKPENLLY----YSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG- 174
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ APEVL + YS+ D +S G+I + +L G PF D + K+ I
Sbjct: 175 --YVAPEVL---------AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQI 221
Query: 464 RAGERPLFPFHSPKY---VTNLTKRCWHADPNQRPSFSSICR 502
E + + + DP +R + +
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-34
Identities = 83/344 (24%), Positives = 134/344 (38%), Gaps = 46/344 (13%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL-------RHFFGDIEPLVPEISSL-LSLS 282
ED+ + + LG GS + E + FA+ D+E + E L L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 283 HPNIMHFLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIA 341
HP + H C F +E F +ME ++ DL +I + F L A +I
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHI------QSCHKFDLSRATFYAAEII 113
Query: 342 RGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTT 401
G+++LHSK I + +L NILL G H KI+ FG+ G + T
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDG-------HIKIADFGMCKENMLGDAKTNTFCGT 166
Query: 402 HPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461
+ APE+L KY+ D +SFG++ +E+L G+ PF + ++
Sbjct: 167 PD--YIAPEIL---------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH 213
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQP 521
+IR P +P K +L + + +P +R R +
Sbjct: 214 SIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 272
Query: 522 DPPMPLV----DYSDIESRLLRKFPSWETHNVLPISEIPFQMFV 561
P P V D S+ + L + P + I+ + MF
Sbjct: 273 PPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (326), Expect = 2e-33
Identities = 71/374 (18%), Positives = 141/374 (37%), Gaps = 51/374 (13%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL----------RHFFGDIEPLVPEISSLLS 280
D+ V R +G G Y G+ +A+ + +S + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
P I+ F +K I++LM+ Y + FS +I
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHY-----HLSQHGVFSEADMRFYAAEI 116
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
G+E++H++ + + +L P+NILL G H +IS GL+ +F K P S
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHG-------HVRISDLGLA--CDFSKKKPHASVG 167
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
TH + APEVL++ Y +D +S G + F++L G PF +
Sbjct: 168 TH--GYMAPEVLQKGV--------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS--FSSICRILR--YIKRFIMMNPH 516
+ P + +L + D N+R + + + +
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS-LDWQMV 276
Query: 517 YNSQPDPPM--PLVDYSDIESRLLRKFPSWETHNV--LPISEIPFQMFVYRVVE--KEKI 570
+ + PP+ P + + ++ + F +T + L + ++ F + E ++++
Sbjct: 277 FLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEV 336
Query: 571 SSSPKDTSDSGSDK 584
+ + DT ++ +D+
Sbjct: 337 AETVFDTINAETDR 350
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (314), Expect = 1e-32
Identities = 39/302 (12%), Positives = 94/302 (31%), Gaps = 35/302 (11%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFALR--HFFGDIEPLVPEISSLLSLSHPNIMHFL 290
Y+V RR+G GS ++ L + A++ D L E + L+ + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 291 CGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK 350
F +E L+++L+ L + FS+ Q+ ++ +H K
Sbjct: 67 YYF-GQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI----- 405
+ + ++ P N L+ + + + FG+ +
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMI--YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF-----EDAHLQGDKMS 460
+ + E S + D+ + G + L G +P+ + +++
Sbjct: 179 YMSINTHLGRE---------QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHYNSQ 520
++ P+ + + P + + + + +N +
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV--LERLNTTEDEN 287
Query: 521 PD 522
D
Sbjct: 288 FD 289
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 2e-32
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 35/280 (12%)
Query: 235 EDYQVRRR-LGSGSQ---YK-EILWLGESFALRHFFGDIEPLVPEISSLLSLS-HPNIMH 288
+DY+V + LG G + E FAL+ D E+ S P+I+
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVR 69
Query: 289 FLCGFTD--EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
+ + + +K ++ME + +L S I++ R F+ A ++M I ++
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEAIQ 125
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
YLHS I H ++ P N+L S K++ FG + + T +
Sbjct: 126 YLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY--- 178
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH--LQGDKMSRNI 463
+ APEVL KY + D++S G+I + +L G PF H M I
Sbjct: 179 YVAPEVL---------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 464 RAGERPLFPFHSPKY---VTNLTKRCWHADPNQRPSFSSI 500
R G+ + V L + +P QR + +
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 2e-32
Identities = 51/285 (17%), Positives = 100/285 (35%), Gaps = 39/285 (13%)
Query: 227 PSRILIKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFFGD-------IEPLVPEI 275
PS + S+ Y++ LG G + L L A++ D E
Sbjct: 2 PSHL---SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58
Query: 276 SSLLSLSHPNIMHFLCGFTDEEKKEC--FLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
+ +L+HP I+ E +++ME + I P + A
Sbjct: 59 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRA 113
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
++++ + + + H I H ++ P+NI++ A+ + ++ N +
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453
+ + GT + +PE +SDVYS G + +E+LTG+ PF
Sbjct: 171 TAAVIGTAQ---YLSPEQAR---------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218
Query: 454 LQGDKMSRNIRAGERPLFPFHS--PKYVTNLTKRCWHADPNQRPS 496
+++R P H + + + +P R
Sbjct: 219 PV-SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 64/286 (22%), Positives = 111/286 (38%), Gaps = 41/286 (14%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFALRHF----------FGDIEPLVPEISSLL 279
+ Y LGSG K G +A + E + E+S L
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 280 SLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQ 339
+ HPN++ + E K + LI+EL++ ++ + A + + Q
Sbjct: 69 EIQHPNVITLHEVY--ENKTDVILILELVAGGELFD-----FLAEKESLTEEEATEFLKQ 121
Query: 340 IARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSG 399
I G+ YLHS +I H +L P NI+L R KI FGL+ +FG + + G
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK---PRIKIIDFGLAHKIDFGNEFKNIFG 178
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T + APE++ ++D++S G+I + +L+G PF Q +
Sbjct: 179 TPE---FVAPEIVN---------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ET 224
Query: 460 SRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
N+ A + ++ + +R DP +R + +
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 3e-31
Identities = 79/341 (23%), Positives = 134/341 (39%), Gaps = 46/341 (13%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFALRHF-------FGDIEPLVPEISSLLSLSH 283
+D+Q+ R LG+GS + G +A++ +E E L ++H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
P I+ F D + + F+IM+ + + F PVA ++
Sbjct: 64 PFIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLA 116
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
+EYLHSK I + +L P NILL G H KI+ FG + K + + GT
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNG-------HIKITDFGFA--KYVPDVTYTLCGTPD- 166
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463
+ APEV+ S Y++ D +SFG++ +E+L G PF D++ K I
Sbjct: 167 --YIAPEVV---------STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKI 213
Query: 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSF--SSICRILR--YIKRFIMMNPHYNS 519
E PF + V +L R D +QR + + + K + +
Sbjct: 214 LNAELRFPPFFNED-VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 272
Query: 520 QPDPPMPLVDYSDIESRLLRKFPSWETHNVLPISEIPFQMF 560
P P + ++ K+P + + + + +F
Sbjct: 273 IETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 2e-30
Identities = 48/284 (16%), Positives = 95/284 (33%), Gaps = 33/284 (11%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFALR--HFFGDIEPLVPEISSLLSLSHPNIMHFL 290
Y++ R++GSGS Y + GE A++ L E + + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 291 CGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK 350
+ E ++MEL+ L E FSL + L Q+ +EY+HSK
Sbjct: 69 -RWCGAEGDYNVMVMELLGPSL-----EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 351 KIYHGNLNPSNILLKPRGASTE----GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIW 406
H ++ P N L+ + AK + ++ + +GT +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR---Y 179
Query: 407 HAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF-----EDAHLQGDKMSR 461
+ + S + D+ S G + G +P+ + +++S
Sbjct: 180 ASINTH---------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505
+ + P C + +P +S + ++ R
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 60/337 (17%), Positives = 111/337 (32%), Gaps = 64/337 (18%)
Query: 233 KSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFFGDIEPLVPEISSLLSLSHPNIMH 288
+ Y + +G+GS Y+ ++ GE A++ D E+ + L H NI+
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 289 FLCGFTDEEKKE----CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
F +K+ L+++ + + + R + + M Q+ R +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
Y+HS I H ++ P N+LL P A K+ FG + K P+ S +
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTA------VLKLCDFGSA--KQLVRGEPNVSYICSRY 187
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHLQGDKMSRN 462
+ Y+ DV+S G + E+L G+ F + Q ++ +
Sbjct: 188 YRAPELIFGAT---------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 463 IRAGERPLFPFHSPKYVT------------------------NLTKRCWHADPNQRPSFS 498
+ R +P Y L R P R +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 499 SICRILRYIKRFIMMNPHYNSQPDPPMPLVDYSDIES 535
C + ++ DP + L + D +
Sbjct: 299 EACA-----------HSFFDELRDPNVKLPNGRDTPA 324
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 7e-28
Identities = 53/285 (18%), Positives = 97/285 (34%), Gaps = 53/285 (18%)
Query: 236 DYQVRRRLGSGSQ---YKEI-LWLGESFAL----------RHFFGDIEPLVPEISSLLSL 281
YQV LGSG Y I + A+ + + E+ L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 282 S--HPNIMHFLCGFTDEEKKECFLIMELM--SRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
S ++ L F + LI+E +DL +I +R +A
Sbjct: 65 SSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFIT------ERGALQEELARSFF 116
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+ + + H+ + H ++ NIL+ K+ FG ++ +
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILI------DLNRGELKLIDFGSGALLKDTVYT-DF 169
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
GT + PE + + + + V+S G++ ++++ G +PFE
Sbjct: 170 DGTRV---YSPPEWI--------RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICR 502
I G+ F +L + C P+ RP+F I
Sbjct: 215 ----EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 7e-28
Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 39/282 (13%)
Query: 232 IKSEDYQVRRRLGSGS-------QYKEILWLGESFALRHF--------FGDIEPLVPEIS 276
+ E++++ + LG+G+ + G+ +A++ E E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 277 SLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDL 336
L + + L E K ++ + +L +++ +R F+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL------SQRERFTEHEVQIY 134
Query: 337 MLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPS 396
+ +I +E+LH I + ++ NILL G H ++ FGLS +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNG-------HVVLTDFGLSKEFVADETERA 187
Query: 397 QSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHL 454
V +S + + D +S G++ +E+LTG PF +
Sbjct: 188 YDFCGTIEYMAPDIVR--------GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
++SR I E P S +L +R DP +R
Sbjct: 240 SQAEISRRILKSEPPYPQEMSAL-AKDLIQRLLMKDPKKRLG 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 57/277 (20%), Positives = 105/277 (37%), Gaps = 41/277 (14%)
Query: 232 IKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF-------GDIEPLVPEISSLLS 280
+ D+ + LG G+ G +A++ ++ V E L +
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 281 LSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
HP + F ++ CF++ +L ++ + F+ A +I
Sbjct: 62 TRHPFLTALKYAFQTHDRL-CFVMEYANGGELFFHLS------RERVFTEERARFYGAEI 114
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS-SVKNFGPKSPSQSG 399
+EYLHS+ + + ++ N++L G H KI+ FGL + G + G
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITDFGLCKEGISDGATMKTFCG 167
Query: 400 TTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459
T + APEVLE ++ Y D + G++ +E++ G++PF + + ++
Sbjct: 168 TPE---YLAPEVLE---------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL 213
Query: 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS 496
I E FP +L DP QR
Sbjct: 214 FELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (271), Expect = 7e-27
Identities = 66/303 (21%), Positives = 103/303 (33%), Gaps = 59/303 (19%)
Query: 235 EDYQVRRRLGSGSQ---YKEILWLGESFALRHFF------GDIEPLVPEISSLLSLSHPN 285
E Y ++G G+ YK GE+FAL+ G + EIS L L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 286 IMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGME 345
I+ + K L+ E + +DL + A +LQ+ G+
Sbjct: 62 IVKLYDVIHTK--KRLVLVFEHLDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIA 114
Query: 346 YLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFI 405
Y H +++ H +L P N+L+ G KI+ FGL+ + FG +
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREG-------ELKIADFGLA--RAFGIPVRKYTHEIVTLW 165
Query: 406 WHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH------------ 453
+ AP+VL + KYS D++S G I E++ G F
Sbjct: 166 YRAPDVLM--------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 454 --------------LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSS 499
+ D F + +L + DPNQR +
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 500 ICR 502
Sbjct: 278 ALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 62/309 (20%), Positives = 111/309 (35%), Gaps = 64/309 (20%)
Query: 235 EDYQVRRRLGSGS-----QYKEILWLGESFAL---------RHFFGDIEPLVPEISSLLS 280
+ Y+ +G G+ + +++ G AL V + L +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 281 LSHPNIMHFLCGFTD---EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLM 337
HPN++ T + + + L+ E + +DL +Y+ ++ P D+M
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMM 122
Query: 338 LQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+ RG+++LHS ++ H +L P NIL+ G K++ FGL+ + +F S
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------QIKLADFGLARIYSFQMALTSV 175
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ-- 455
T + APEVL S Y+ D++S G I E+ K F +
Sbjct: 176 VVTLW---YRAPEVLL---------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223
Query: 456 ----------------------GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQ 493
+ + A F + +L +C +P +
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
Query: 494 RPSFSSICR 502
R S S
Sbjct: 284 RISAYSALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 3e-26
Identities = 52/280 (18%), Positives = 100/280 (35%), Gaps = 42/280 (15%)
Query: 227 PSRILIKSEDYQVRRRLGSGSQ---YK-EILWLGESFALRHF-------FGDIEPLVPEI 275
PS+ + + + + LG+GS + G +A++ IE + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 276 SSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVD 335
L +++ P ++ F D + R+ FS P A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-------HLRRIGRFSEPHARF 145
Query: 336 LMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSP 395
QI EYLHS + + +L P N+L+ +G + +++ FG + +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-------YIQVTDFGFAKRVKGRTWT- 197
Query: 396 SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455
APE++ Y++ D ++ G++ +E+ G PF
Sbjct: 198 ----LCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP 495
++ I +G+ FP H + +L + D +R
Sbjct: 245 --QIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 59/304 (19%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFAL------RHFFGDIEPLVPEISSLLSLSHP 284
E++Q ++G G+ YK GE AL G + EIS L L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
NI+ L E + +L+ E + +DL ++ LP+ + Q+ +G+
Sbjct: 62 NIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGL 115
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
+ HS ++ H +L P N+L+ G K++ FGL+ + FG + +
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEG-------AIKLADFGLA--RAFGVPVRTYTHEVVTL 166
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHLQGDKMSRN 462
+ APE+L YS D++S G I E++T + F + Q ++ R
Sbjct: 167 WYRAPEIL--------LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
Query: 463 IRAGERPLFPFHS---------PKYVT---------------NLTKRCWHADPNQRPSFS 498
+ + ++P + PK+ +L + H DPN+R S
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
Query: 499 SICR 502
+
Sbjct: 279 AALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-24
Identities = 65/347 (18%), Positives = 116/347 (33%), Gaps = 69/347 (19%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFAL-----RHFFGDIEPLVPEISSLLSLSHPNIM 287
Y +G G+ A+ + + EI LL H NI+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 288 HFLCGFTD---EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
E+ K+ +L+ LM DL +K S + QI RG+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-------TQHLSNDHICYFLYQILRGL 122
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
+Y+HS + H +L PSN+LL KI FGL+ V +
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTC-------DLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 405 IWH-APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED------------ 451
W+ APE++ ++ Y++ D++S G I E+L+ + F
Sbjct: 176 RWYRAPEIMLNSK--------GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 452 -----------------AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQR 494
A + + LFP K + +L + +P++R
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKR 286
Query: 495 PSFSSICRILRYIKRFIMMNPHYNSQPDPPMPL-VDYSDIESRLLRK 540
Y++++ +P + P ++ D+ L++
Sbjct: 287 IEVEQALA-HPYLEQY--YDPSDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-24
Identities = 55/254 (21%), Positives = 89/254 (35%), Gaps = 49/254 (19%)
Query: 274 EISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVA 333
EI L LSHPNI+ L K L+ + M DL I + +
Sbjct: 50 EIKLLQELSHPNIIGLLD--AFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHI 102
Query: 334 VDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPK 393
ML +G+EYLH I H +L P+N+LL G K++ FGL+ K+FG
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-------VLKLADFGLA--KSFGSP 153
Query: 394 SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF---- 449
+ + + + APE+L Y D+++ G I E+L
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGAR--------MYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 450 ----------------EDAHLQGDKMSRNIRAGERPLFPFHS-----PKYVTNLTKRCWH 488
E+ + + P P H + +L + +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
Query: 489 ADPNQRPSFSSICR 502
+P R + + +
Sbjct: 266 FNPCARITATQALK 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-24
Identities = 53/315 (16%), Positives = 97/315 (30%), Gaps = 67/315 (21%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF------GDIEPLVPEISSLLSLSHP 284
Y+ ++G G+ +K G+ AL+ G + EI L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 285 NIMHFLCGFTD------EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
N+++ + K +L+ + DL + F+L +M
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVMQ 124
Query: 339 QIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQS 398
+ G+ Y+H KI H ++ +N+L+ G K++ FGL+ + S
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDG-------VLKLADFGLARAFSLAKNSQPNR 177
Query: 399 GTTH--PFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFED----- 451
T + PE+L Y D++ G I E+ T +
Sbjct: 178 YTNRVVTLWYRPPELL--------LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 452 ------------------------AHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCW 487
+ + + + R + L + Y +L +
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
Query: 488 HADPNQRPSFSSICR 502
DP QR
Sbjct: 290 VLDPAQRIDSDDALN 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99 bits (248), Expect = 2e-23
Identities = 48/310 (15%), Positives = 97/310 (31%), Gaps = 68/310 (21%)
Query: 235 EDYQVRRRLGSGSQ---YKEI-LWLGESFALRHF-FGDIEPLVPEISSLLSLS-HPNIMH 288
+DYQ+ R+LG G ++ I + E ++ + + EI L +L PNI+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 289 FLCGFTDEEKKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYL 347
D + L+ E ++ D + + M +I + ++Y
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYC 145
Query: 348 HSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWH 407
HS I H ++ P N+++ ++ +GL+ + G + + + + +
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHR------KLRLIDWGLAEFYHPGQEYNVRVASRY---FK 196
Query: 408 APEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRAGE 467
PE Y D++S G + ++ K PF H D++ R +
Sbjct: 197 GPE--------LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 468 RPLFPFHSPKYVT-----------------------------------NLTKRCWHADPN 492
+ KY + + D
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 493 QRPSFSSICR 502
R +
Sbjct: 309 SRLTAREAME 318
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 1e-22
Identities = 55/305 (18%), Positives = 96/305 (31%), Gaps = 61/305 (20%)
Query: 235 EDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF------GDIEPLVPEISSLLSLSHP 284
+ Y+ ++G G+ +K + E AL+ G + EI L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 285 NIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGM 344
NI+ K+ L+ E C + + + Q+ +G+
Sbjct: 62 NIVRLHDVL--HSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 345 EYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPF 404
+ HS+ + H +L P N+L+ G K++ FGL+ + S T
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNG-------ELKLANFGLARAFGIPVRCYSAEVVTLW- 166
Query: 405 IWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464
+ P+VL + YS D++S G I E+ P + D++ R R
Sbjct: 167 -YRPPDVLFGAKL--------YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
Query: 465 AGERPL---------------------------FPFHSPKYVTNLTKRCWHADPNQRPSF 497
P +L + +P QR S
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
Query: 498 SSICR 502
+
Sbjct: 278 EEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 2e-22
Identities = 54/310 (17%), Positives = 104/310 (33%), Gaps = 69/310 (22%)
Query: 235 EDYQVRRRLGSGSQ---YKEI-LWLGESFALRHFF------GDIEPLVPEISSLLSLSHP 284
Y+ + +GSG+ + G A++ + + E+ L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 285 NIMHFLCGFTDEEKK----ECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
N++ L FT +E + +L+M M DL +K L+ Q+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-------HEKLGEDRIQFLVYQM 130
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
+G+ Y+H+ I H +L P N+ + KI FGL+ + S
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDC-------ELKILDFGLARQAD----SEMTGYV 179
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG---- 456
+ +L +Y++ D++S G I E++TGK F+ +
Sbjct: 180 VTRWYRAPEVILNWM---------RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 457 ---------DKMSRNIRAGERPLFPFHSPKYVT---------------NLTKRCWHADPN 492
+ + +++ E + P+ NL ++ D
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 493 QRPSFSSICR 502
QR +
Sbjct: 291 QRVTAGEALA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 6e-18
Identities = 62/299 (20%), Positives = 110/299 (36%), Gaps = 41/299 (13%)
Query: 234 SEDYQVRRRLGSGSQ---YK-EILWLGESFALRHFF------GDIEPLVPEISSLLSLSH 283
E YQ +GSG+ G A++ + E+ L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 284 PNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARG 343
N++ L FT E F + L++ + + + I K + L+ QI RG
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRG 133
Query: 344 MEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHP 403
++Y+HS I H +L PSN+ + KI FGL+ +
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDC-------ELKILDFGLARHTDDEMTGY-----VAT 181
Query: 404 FIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPF--EDAHLQGDKMSR 461
+ APE++ Y++ D++S G I E+LTG+ F D Q + R
Sbjct: 182 RWYRAPEIMLNWMH--------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 462 NIRAGERPLFPFHSP----KYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPH 516
+ L S Y+ +LT+ N + + L +++ ++++
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL--LEKMLVLDSD 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 5e-17
Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 43/280 (15%)
Query: 235 EDYQVRRRLGSGSQ---YKEI-LWLGESFALRHFF------GDIEPLVPEISSLLSLSHP 284
+ YQ + +GSG+Q L + A++ + E+ + ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 285 NIMHFLCGFTD----EEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQI 340
NI+ L FT EE ++ +L+MELM +LC I+ L+ Q+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQM 128
Query: 341 ARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGT 400
G+++LHS I H +L PSNI++K KI FGL+ T
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKILDFGLARTAGTSFMMTPYVVT 181
Query: 401 THPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460
+ + APEV+ Y E D++S G I E++ K+ F
Sbjct: 182 RY---YRAPEVI---------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQW 227
Query: 461 RNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSI 500
+ P K + + +F +
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.9 bits (180), Expect = 1e-14
Identities = 50/326 (15%), Positives = 114/326 (34%), Gaps = 42/326 (12%)
Query: 237 YQVRRRLGSGSQ---YK-EILWLGESFAL----------RHFFGDIEPL----VPEISSL 278
Y + R+LG G + + + A+ +I+ L + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 279 LSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLML 338
S+ +I+ L F + ++M + + L +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL--ALIKKYEHRGIPLIYVKQISK 132
Query: 339 QIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQ 397
Q+ G++Y+H + I H ++ P N+L++ S E + KI+ G + +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVD-SPENLIQIKIADLGNACWYD-----EHY 186
Query: 398 SGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457
+ + + +PEVL + + +D++S + FE++TG FE +G
Sbjct: 187 TNSIQTREYRSPEVLL---------GAPWGCGADIWSTACLIFELITGDFLFEPD--EGH 235
Query: 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFIMMNPHY 517
+++ + + + N R +I ++ + ++ +
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
Query: 518 NSQPDPPMPLVDYSDIESRLLRKFPS 543
S+ + + SD S +L+ P
Sbjct: 296 FSKDEAK----EISDFLSPMLQLDPR 317
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.6 bits (128), Expect = 9e-09
Identities = 22/161 (13%), Positives = 45/161 (27%), Gaps = 42/161 (26%)
Query: 275 ISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAV 334
+L L + + ++MEL+ ++
Sbjct: 65 FRALQKLQGLAVPKVY------AWEGNAVLMELIDAKELYRVRVENPDE----------- 107
Query: 335 DLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKS 394
++ I + + + I HG+L+ N+L+ G I F S
Sbjct: 108 -VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--------IWIIDFPQS--------- 149
Query: 395 PSQSGTTHPFIWHAPEVLEENEQTESAS-NSKYSEKSDVYS 434
E+LE + + + Y + D+ S
Sbjct: 150 ---VEVGEE---GWREILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 98.39 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 98.35 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.22 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 98.22 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 98.15 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 98.15 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 98.12 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.06 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 98.06 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 98.04 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 98.04 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 98.03 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 97.97 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 97.95 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 97.94 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 97.93 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 97.9 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 97.9 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 97.84 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 97.79 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 97.79 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 97.78 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 97.68 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 97.66 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 97.62 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 97.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.57 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 97.49 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 97.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1qada_ | 107 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 97.27 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 97.13 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 97.1 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 97.1 | |
| d1uura3 | 131 | STAT homologue {Dictyostelium discoideum [TaxId: 4 | 97.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.12 | |
| d1bg1a3 | 141 | STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | 95.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.28 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=420.66 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=210.8
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE-cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW-LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~-~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
.|++..++|++.+.||+|+|+.|++. .+..||||+++. ..+.|.+|+.+|++++|||||++++++.. ..+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 57788899999999999998888864 455799999853 23568899999999999999999987632 458
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 302 FLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 302 ~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
|||||||+ |+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+||||+.++ .+||+
T Consensus 79 ~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-------~~Kl~ 146 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI-----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-------TVKIG 146 (276)
T ss_dssp EEEEECCCEEEHHHHHHT-----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-------SEEEC
T ss_pred EEEEecCCCCCHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-------CEEEc
Confidence 99999998 599999975 345699999999999999999999999999999999999998887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+|+...............||+.|+|||++.+.. ...|+.++|||||||++|||+||+.||.+.... ..+.
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~ 219 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD------KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQII 219 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCS------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHH
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhccc------CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-HHHH
Confidence 999998765443333445567899999999997542 335899999999999999999999999876543 2344
Q ss_pred HHHHcCCCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 461 RNIRAGERP----LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 461 ~~i~~~~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+..+... ..+..+++++.+||.+||+.||.+|||+.+|+++|+.+.+
T Consensus 220 ~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 455554432 2456789999999999999999999999999999998875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=417.87 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=203.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||++++++.++ +.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEEEE
Confidence 58999999999998888863 688999999843 245689999999999999999999999654 7899999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+| +|.++|.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 83 Ey~~gg~L~~~l~~------~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-------~~KL~DFG~ 149 (271)
T d1nvra_ 83 EYCSGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-------NLKISDFGL 149 (271)
T ss_dssp ECCTTEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-------CEEECCCTT
T ss_pred eccCCCcHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-------CEEEccchh
Confidence 99985 99998863 35799999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+...............||+.|+|||++.+.. .++.++|||||||++|||++|+.||...............
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--------~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~ 221 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE--------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS--------BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCC--------CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 98775443333445678999999999997553 3467899999999999999999999876544333333333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..........+++++.+||.+||+.||++|||+.++++|
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333333335678899999999999999999999998765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=415.15 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=218.0
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
...|++..++|++.+.||+|+|+.|++. +|+.||||+++. ..+.+.+|+++|+.++|||||+++++|.+ ..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~ 86 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP 86 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee--CC
Confidence 3568888899999999999997666653 588999999964 35678999999999999999999999854 36
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||||||+ |+|.+++.+. ....+++..+..++.||+.||+|||++||+||||||+||||+.++ .+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-------~~K 155 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------LVK 155 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHS----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEE
T ss_pred eeEEEeecccCcchHHHhhhc----cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-------cEE
Confidence 7899999998 6999999762 346799999999999999999999999999999999999998877 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+|+...... ........||+.|+|||++.+. .|+.++|||||||++|||++|..||..... ...
T Consensus 156 l~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~---------~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~ 224 (287)
T d1opja_ 156 VADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ 224 (287)
T ss_dssp ECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH
T ss_pred EccccceeecCCCC-ceeeccccccccccChHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHH
Confidence 99999998765432 2223455688999999999765 489999999999999999997666544332 345
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+.+.+..+.++..+..+++.+.+||.+||+.||++|||+.+|++.|+.+
T Consensus 225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 6677788888888999999999999999999999999999998887754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=412.84 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=200.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
.++|++++.||+|+++.|++. +|+.||||.+... .+.+.+|+++|+.++|||||++++++.++..+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999998888764 6889999998532 245789999999999999999999998766677999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK-----IYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
|||||+| +|.+++.+... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+
T Consensus 83 vmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-------~v 153 (269)
T d2java1 83 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------NV 153 (269)
T ss_dssp EEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-------CE
T ss_pred EEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-------cE
Confidence 9999984 99999875321 2356999999999999999999999976 99999999999999887 79
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD 457 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~ 457 (683)
||+|||+|+....... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. .
T Consensus 154 kl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~ 220 (269)
T d2java1 154 KLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--K 220 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--H
T ss_pred EEeeccceeecccCCC--ccccCCCCcccCCHHHHcCC---------CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--H
Confidence 9999999987654322 23356789999999999754 489999999999999999999999987553 4
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 458 KMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 458 ~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+...+..+..+..|..+++++.+||.+||+.||.+|||+.++++|
T Consensus 221 ~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 221 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 5667777887777888899999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=406.23 Aligned_cols=240 Identities=28% Similarity=0.450 Sum_probs=206.7
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||++++++.++ +.+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEE
Confidence 48999999999998888763 688999999842 345688999999999999999999999654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||||+ |+|.+++.+. ..+++..+..|+.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 84 vmEy~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-------~~kl~DF 150 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-------ELKIADF 150 (263)
T ss_dssp EEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------CEEECCC
T ss_pred EEeecCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-------CEeeccc
Confidence 999998 5999999863 5699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+..... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.. .+...
T Consensus 151 G~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~---------~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~ 215 (263)
T d2j4za1 151 GWSVHAPSS----RRTTLCGTLDYLPPEMIEGR---------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKR 215 (263)
T ss_dssp CSCSCCCCC----CCEETTEEGGGCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH
T ss_pred ceeeecCCC----cccccCCCCcccCHHHHcCC---------CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 999866432 22345799999999999765 4899999999999999999999999876533 35555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+. +.+|..+++++.+||.+||+.||++|||+.++++|-+
T Consensus 216 i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 216 ISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp HHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred HHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 55543 4577788999999999999999999999999998743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=406.30 Aligned_cols=252 Identities=27% Similarity=0.509 Sum_probs=205.3
Q ss_pred eeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 232 IKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+..++|++++.||+|+|+.|++ .++..||||++.. ..+++.+|+++|+.++|||||++++++..+ ..+||||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC--CceEEEE
Confidence 4567999999999999766664 3678899999864 346789999999999999999999998644 6789999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
||++ |+|.+++.. ....+++..+..|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 80 E~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-------~~Kl~DFGl 147 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------VIKVSDFGM 147 (263)
T ss_dssp ECCTTCBHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-------CEEECSCC-
T ss_pred EecCCCcHHHHhhc-----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-------CeEecccch
Confidence 9997 599999875 346689999999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i 463 (683)
++....... .......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.... ...+...+
T Consensus 148 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~---------~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i 215 (263)
T d1sm2a_ 148 TRFVLDDQY-TSSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI 215 (263)
T ss_dssp ------------------CTTSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHH
T ss_pred heeccCCCc-eeecceecCcccCChHHhcCC---------CCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHH
Confidence 987654322 223346789999999999754 59999999999999999999 566666543 34567778
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+.++..|..+++++.+|+.+||+.||++|||+++|+++|+.+.+
T Consensus 216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 8888888899999999999999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=412.80 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=205.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++. ...+.+.+|+++|+.++|||||+++++|.++ +.+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 58999999999998888763 68899999984 2345689999999999999999999999654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||||+| +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 86 vmEy~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-------~vkl~DF 152 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-------HIQITDF 152 (288)
T ss_dssp EECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------CEEECCC
T ss_pred EEEccCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-------eEEeccc
Confidence 9999985 999998864 5699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+...............||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~ 221 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEK---------SACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQK 221 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred ccceecccCCcccccccccCCccccCceeeccC---------CCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHH
Confidence 999887544333344456799999999999765 489999999999999999999999987653 345555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..+. ..+|..+++++.+||.+||+.||.+|||+++++++.+
T Consensus 222 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 222 IIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp HHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred HHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 65554 4567888999999999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=412.53 Aligned_cols=241 Identities=22% Similarity=0.379 Sum_probs=203.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||+++++|.++ +.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEEEE
Confidence 47999999999998888864 689999999842 345689999999999999999999999764 68999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.+++.+ ..+++.++..|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 98 y~~gg~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-------~vkl~DFG~a 163 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-------SVKLTDFGFC 163 (293)
T ss_dssp CCTTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCTTC
T ss_pred ecCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-------cEeeccchhh
Confidence 9985 99988775 4599999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.. ..+...+..
T Consensus 164 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~ 231 (293)
T d1yhwa1 164 AQITPEQ--SKRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATN 231 (293)
T ss_dssp EECCSTT--CCBCCCCSCGGGCCHHHHSSS---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHH
T ss_pred eeecccc--ccccccccCCCccChhhhcCC---------CCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhC
Confidence 8765432 233456799999999999755 4899999999999999999999999876533 233333433
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GE-RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~-~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+. ....+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 33 233456788999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=407.79 Aligned_cols=255 Identities=24% Similarity=0.466 Sum_probs=214.5
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
-..|++..++|++.+.||+|+|+.|+. .++..||||+++. ..+.+.+|+++|++++|||||++++++.+ +.
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~ 81 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CC
Confidence 356788888999999999999877775 2567899999964 34678999999999999999999987743 45
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+||||||++ |+|.+++... ....+++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~----~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-------~~Kl 150 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-------SCKI 150 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------CEEE
T ss_pred eEEEEEeCCCCcHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-------ceee
Confidence 799999997 5999877542 224599999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCC-CCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK-VPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~-~Pf~~~~~~~~~ 458 (683)
+|||+|+...... ........||+.|+|||++.+. .++.++|||||||++|||+||. +||.... ...
T Consensus 151 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~---------~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~ 218 (272)
T d1qpca_ 151 ADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPE 218 (272)
T ss_dssp CCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHH
T ss_pred ccccceEEccCCc-cccccccCCcccccChHHHhCC---------CCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHH
Confidence 9999998775432 2233456788999999999765 4899999999999999999954 4554433 345
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+...+..+.++..|..+++++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 219 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 6677888888889999999999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=405.82 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=216.7
Q ss_pred eEeeCCCeEEEeE-ecccccEEEEEE------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRR-LGSGSQYKEILW------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~-LG~G~~~~v~l~------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
+.+..++|.+... ||+|+|+.|++. ++..||||+++.. .+.|.+|+++|++++|||||++++++.+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--
Confidence 4456678999885 999998877753 3457999999642 3568899999999999999999998854
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+|||||||+| +|.+++.. .+..+++.++..|+.||+.||.|||++||+||||||+|||++.++ .
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-------~ 147 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-------Y 147 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTT-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-------E
T ss_pred -CeEEEEEEeCCCCcHHHHhhc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-------c
Confidence 358999999985 99998864 345799999999999999999999999999999999999998887 8
Q ss_pred EEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCcc
Q 038696 377 AKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHL 454 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~ 454 (683)
+||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+...
T Consensus 148 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred eeeccchhhhcccccccccccccccccCccccChHHHhCC---------CCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 99999999987654322 1223345688999999999765 38999999999999999998 9999987653
Q ss_pred chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
.++...+..+.++..|..+|+++.+||.+||+.||++|||+.+|.+.|+.+...
T Consensus 219 --~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 219 --PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 456778888999999999999999999999999999999999999999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=414.82 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=215.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cC-----cEEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LG-----ESFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g-----~~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..|++..++|++.+.||+|+|+.|++. .+ ..||||.+.. ....+.+|+.+|.++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 346677789999999999998888763 12 2699999853 345688999999998 89999999999
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICCP-----------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYH 354 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiH 354 (683)
+.++ +.+|||||||+ |+|.++|+..... .....+++..++.|+.||+.||.|||++||||
T Consensus 110 ~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 110 CTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EeeC--CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9654 67899999998 5999999863211 11245899999999999999999999999999
Q ss_pred CCCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHh
Q 038696 355 GNLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYS 434 (683)
Q Consensus 355 rDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwS 434 (683)
|||||+|||++.++ .+||+|||+|+...............||+.|+|||++.+. .|+.++||||
T Consensus 188 RDlKp~Nill~~~~-------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---------~~~~~~DiwS 251 (325)
T d1rjba_ 188 RDLAARNVLVTHGK-------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---------IYTIKSDVWS 251 (325)
T ss_dssp TTCSGGGEEEETTT-------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC---------CCCHHHHHHH
T ss_pred ccCchhccccccCC-------eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC---------CCCcceeccc
Confidence 99999999999887 8999999999876654433333456689999999999765 4999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 435 FGMICFEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 435 lGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
|||++|||++ |+.||.+.... ..+.+.+..+.++..|..+++++.+||.+||+.||++|||+++|+++|.
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~~-~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9999999997 99999876543 3466777888888889999999999999999999999999999999885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-48 Score=405.56 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=202.0
Q ss_pred eCCCeEEEeEecccccEEEEEE----cCc---EEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 233 KSEDYQVRRRLGSGSQYKEILW----LGE---SFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l~----~g~---~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..++|++.+.||+|+|+.|++. +|+ .||||.+... .+.|.+|+++|++|+|||||++++++.++ +.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence 3458999999999998777753 232 6999998542 34689999999999999999999998543 67
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|||||||+| +|.+++.. ....+++.++..++.||+.||.|||++||+||||||+||||+.++ ++||
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~-----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-------~~Kl 169 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQ-----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-------VCKV 169 (299)
T ss_dssp CEEEEECCTTEEHHHHHHT-----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------CEEE
T ss_pred EEEEEEecCCCcceeeecc-----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-------cEEE
Confidence 9999999985 99998875 345699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCCC---CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 380 SGFGLSSVKNFGPKS---PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 380 ~DFGla~~~~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
+|||+|+........ ....+..||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---------KFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcC---------CCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 999999876543221 122334678999999999754 59999999999999999998 8999987653
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
..+...+..+.++..+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 -QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 35667788888888899999999999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=408.40 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=204.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+.|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||++++++.++ +.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEEEe
Confidence 46999999999998888864 688999999853 346789999999999999999999999764 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.+++.+. ..++++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 90 y~~~g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-------~~Kl~DFG~a 157 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-------DIKLADFGVS 157 (288)
T ss_dssp CCTTEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECCCTTC
T ss_pred cCCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-------CEEEEechhh
Confidence 9985 999988753 35699999999999999999999999999999999999999887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......||+.|+|||++..... ....|+.++|||||||++|||++|+.||.+.+.. .+...+..
T Consensus 158 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~----~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~ 229 (288)
T d2jfla1 158 AKNTRTIQ--RRDSFIGTPYWMAPEVVMCETS----KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAK 229 (288)
T ss_dssp EECHHHHH--HHTCCCSCCTTCCHHHHTTCST----TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHH
T ss_pred hccCCCcc--cccccccccccCCHHHHhhccc----CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHc
Confidence 76532111 1234578999999999964421 2345899999999999999999999999876543 24444555
Q ss_pred CCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERP--LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~--~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+..+ ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4433 3356778999999999999999999999999765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-48 Score=406.90 Aligned_cols=242 Identities=23% Similarity=0.360 Sum_probs=201.2
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|++++.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.++ +.+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEEE
Confidence 5999999999998888763 6889999998532 24578999999999999999999999754 789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
||||.| +|..++.. ..++++.++..|+.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 94 ~E~~~~g~l~~~~~~------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-------~~Kl~DFG 160 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------LVKLGDFG 160 (309)
T ss_dssp EECCSEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-------EEEECCCT
T ss_pred EEecCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-------CEEEeecc
Confidence 999986 55555543 35799999999999999999999999999999999999999887 89999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
+|+.... .....||+.|+|||++.+.. ...|+.++|||||||++|||++|..||.+.... ..+...+
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~------~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~ 227 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMD------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA 227 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTT------SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHH
T ss_pred cccccCC------CCccccCccccCHHHHhccC------CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 9986542 23457999999999997542 335899999999999999999999999876533 2333334
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
........+..+++.+.+||.+||+.||.+|||+.++++|-+
T Consensus 228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 444444455668999999999999999999999999988743
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=395.71 Aligned_cols=248 Identities=27% Similarity=0.480 Sum_probs=214.7
Q ss_pred eCCCeEEEeEecccccEEEEE---EcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 233 KSEDYQVRRRLGSGSQYKEIL---WLGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 233 ~~~~y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
..++|++++.||+|+|+.|++ .++..||||+++. ..+++.+|+.+++.++|||||++++++.+ .+.+|+|||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~E 79 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEE
Confidence 346899999999999877775 2567899999864 45679999999999999999999998854 367999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
|++ |+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 y~~~g~l~~~~~~-----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-------~~kl~DfG~a 147 (258)
T d1k2pa_ 80 YMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-------VVKVSDFGLS 147 (258)
T ss_dssp CCTTEEHHHHHHS-----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-------CEEECCCSSC
T ss_pred ccCCCcHHHhhhc-----cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-------cEEECcchhh
Confidence 997 689998775 235689999999999999999999999999999999999998887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~ 464 (683)
+....... .......+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+. .++...+.
T Consensus 148 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~ 215 (258)
T d1k2pa_ 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIA 215 (258)
T ss_dssp CBCSSSSC-CCCCCSCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHH
T ss_pred eeccCCCc-eeecccCCCCCcCCcHHhcCC---------CCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHHH
Confidence 87654322 233456789999999999865 48999999999999999998 8999988763 45777888
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 465 AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 465 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.+.++..|..+++.+.+||.+||+.||++|||+++|+++|..
T Consensus 216 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 888888999999999999999999999999999999998853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=399.18 Aligned_cols=239 Identities=26% Similarity=0.426 Sum_probs=199.3
Q ss_pred eEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEc--CCCCeEEEE
Q 038696 237 YQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTD--EEKKECFLI 304 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--e~~~~~~LV 304 (683)
|++.++||+|+|+.|++. +|..||||.+.. ..+.+.+|+++|++++|||||+++++|.+ .....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 478889999998888863 578999999843 23468899999999999999999998864 234578999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEeCC-CCCCCCCcceEEEe
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKK--IYHGNLNPSNILLKP-RGASTEGYLHAKIS 380 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDLKp~NILl~~-~g~~~~~~~~vKL~ 380 (683)
||||+| +|.+++.+. ..+++.++..++.||+.||+|||++| |+||||||+|||++. ++ .+||+
T Consensus 91 mE~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~-------~~Kl~ 157 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-------SVKIG 157 (270)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-------CEEEC
T ss_pred EeCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC-------CEEEe
Confidence 999985 999999864 56999999999999999999999998 999999999999964 45 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.... ..+.
T Consensus 158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~----------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~ 222 (270)
T d1t4ha_ 158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIY 222 (270)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHH
T ss_pred ecCcceeccCC----ccCCcccCccccCHHHhCC----------CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHH
Confidence 99999865322 2335679999999999864 3899999999999999999999999865533 3455
Q ss_pred HHHHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 461 RNIRAGERP-LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 461 ~~i~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.+..+..+ .++...++++.+||.+||+.||++|||+.++++|
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 666655443 3556678899999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=396.90 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=205.6
Q ss_pred eEeeCCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 230 ILIKSEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 230 ~~~~~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
|++..++|++.+.||+|+|+.|+.. .+..||||.++.. .+.+.+|+.+|+.++|||||++++++.+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 6677889999999999998777752 2346999998542 3468899999999999999999998842
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
+.+||||||++ |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~-----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-------~ 146 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV-----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-------C 146 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH-----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------E
T ss_pred -CeEEEEEEeccCCcHHhhhhc-----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-------c
Confidence 56899999998 589988775 346799999999999999999999999999999999999999887 8
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccc
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQ 455 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~ 455 (683)
+||+|||+|+....... .......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+....
T Consensus 147 ~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~---------~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp EEECC--------------------CCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred EEEccchhheeccCCcc-eeccceecCcccchhhHhccC---------CCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 99999999987654322 233345688999999999765 48999999999999999998 89999876543
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
.+...+..+.++.++..+++.+.+||.+||+.||++|||+.+|+++|+.+..
T Consensus 217 --~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 217 --DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp --GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4667788888888999999999999999999999999999999999988754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=397.69 Aligned_cols=240 Identities=28% Similarity=0.482 Sum_probs=202.9
Q ss_pred eEecccccEEEEEE------cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 241 RRLGSGSQYKEILW------LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 241 ~~LG~G~~~~v~l~------~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
++||+|+|+.|++. .++.||||+++.. .+.+.+|+++|++++|||||++++++.+ +.+|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 57999998877753 2467999998542 3468999999999999999999998853 3478999999
Q ss_pred C-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 S-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
+ |+|.+++.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 90 ~~g~L~~~l~~------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-------~~kl~DFGla~~ 156 (277)
T d1xbba_ 90 ELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-------YAKISDFGLSKA 156 (277)
T ss_dssp TTEEHHHHHHH------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-------EEEECCCTTCEE
T ss_pred CCCcHHHHHhh------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-------cccccchhhhhh
Confidence 8 599999986 25699999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCC-CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHHHHc
Q 038696 388 KNFGPKS-PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 388 ~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~i~~ 465 (683)
....... .......||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.. ..++...+..
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~ 225 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEK 225 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT
T ss_pred ccccccccccccccCCCceecCchhhcCC---------CCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHc
Confidence 6543221 223345689999999999765 38899999999999999998 999998765 3457778888
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 466 GERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 466 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
+.++..|..+|.++.+||.+||+.||++|||+.+|.+.|+..
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 889999999999999999999999999999999998888764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=396.52 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=212.0
Q ss_pred eeEeeCCCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC--cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD--IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~--~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
.|++..++|++++.||+|+++.|++ +.|..||||+++.+ .+.+.+|+++|++++|||||++++++.++ .+.+|||
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 79 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 79 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEE
Confidence 3778888999999999999777764 58999999999653 56799999999999999999999987543 3568999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||++ |+|.++|.+. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 80 ~ey~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-------~~kl~dfg 148 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-------VAKVSDFG 148 (262)
T ss_dssp ECCCTTEEHHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-------CEEECCCC
T ss_pred EeccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-------CEeecccc
Confidence 99997 5999999753 223589999999999999999999999999999999999999888 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccchhHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~~~~~~~ 462 (683)
+++..... .....+|+.|+|||++.+. .++.++|||||||++|||++ |++||...... .+...
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~---------~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~ 212 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR 212 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH
T ss_pred cceecCCC-----CccccccccCCChHHHhCC---------CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHH
Confidence 99865432 2234577889999999765 48999999999999999998 78888876543 46777
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+..+.++.++..+++++.+||.+||+.||.+|||+.+++++|+.++.
T Consensus 213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 88889999999999999999999999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=394.22 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=204.5
Q ss_pred EeeCCCeEEEeEecccccEEEEEE---c-C----cEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW---L-G----ESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE 297 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~---~-g----~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~ 297 (683)
++..+.|++.+.||+|+|+.|+.. . + ..||||++... ...|.+|+++|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-- 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--
Confidence 455678999999999997777642 1 2 36999998642 2468899999999999999999998854
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
...+++|||||.+ +|.+++.+ ....+++.++..++.||+.||.|||++||+||||||+||||+.++ .
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-------~ 148 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLRE-----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-------V 148 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH-----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------C
T ss_pred CCceEEEEEecccCcchhhhhc-----ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-------e
Confidence 3678999999985 78887775 345799999999999999999999999999999999999998887 7
Q ss_pred EEEecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccc
Q 038696 377 AKISGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQ 455 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~ 455 (683)
+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||.... .
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---------~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~ 218 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYWEL-S 218 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTC-C
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC---------CCCCcccccccHHHHHHHHhCCCCccccC-C
Confidence 99999999987654322 2233455689999999999754 59999999999999999999655554332 2
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 456 GDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 456 ~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
...+...+..+.++..+..++..+.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus 219 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 345777888888888999999999999999999999999999999999987654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=409.39 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=200.2
Q ss_pred EeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeE
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~ 301 (683)
++..++|++++.||+|+|+.|++. +|+.||||+++.. .+.+.+|+.+|+.++|||||+++++|.++ ..+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 345679999999999998777763 6899999998532 34688999999999999999999999754 789
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 302 FLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSK-KIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 302 ~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
|||||||+| +|.+++.+. ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++ .+||
T Consensus 80 ~iVmEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-------~vkl 146 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-------EIKL 146 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-------CEEE
T ss_pred EEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-------CEEE
Confidence 999999985 999999863 5699999999999999999999975 999999999999999888 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH-
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK- 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~- 458 (683)
+|||+|+..... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.......
T Consensus 147 ~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~---------~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 147 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp CCCCCCHHHHHH----TC---CCSSCCCCHHHHHCS---------CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred eeCCCccccCCC----ccccccCCccccCchHHcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999876432 22345799999999999765 5999999999999999999999999765432111
Q ss_pred ---------------------------------------HHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 038696 459 ---------------------------------------MSRNIRAGERPLFP-FHSPKYVTNLTKRCWHADPNQRPSFS 498 (683)
Q Consensus 459 ---------------------------------------~~~~i~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPt~~ 498 (683)
....+.....+..+ ...+.++.+||.+||..||.+|||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 01111222222222 23468899999999999999999999
Q ss_pred HHHHHHH
Q 038696 499 SICRILR 505 (683)
Q Consensus 499 eil~~L~ 505 (683)
++++|-+
T Consensus 294 e~L~Hpf 300 (322)
T d1s9ja_ 294 QLMVHAF 300 (322)
T ss_dssp HHHTSHH
T ss_pred HHhhCHh
Confidence 9999743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=400.00 Aligned_cols=252 Identities=26% Similarity=0.455 Sum_probs=210.6
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc----EEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE----SFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEK 298 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~----~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~ 298 (683)
+..++|++++.||+|+|+.|++. +|+ +||||.++. ..+.+.+|+++|+.++|||||++++++.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-- 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 34568999999999998888753 343 689998853 245789999999999999999999998653
Q ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceE
Q 038696 299 KECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHA 377 (683)
Q Consensus 299 ~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~v 377 (683)
..++||||+. |+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ ++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-------~~ 150 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVRE-----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-------HV 150 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHH-----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-------EE
T ss_pred -CeeEEEEeccCCcccccccc-----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-------Ce
Confidence 4677788876 699998876 346799999999999999999999999999999999999998887 89
Q ss_pred EEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCccch
Q 038696 378 KISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAHLQG 456 (683)
Q Consensus 378 KL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~~~~ 456 (683)
||+|||+|+...............||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+....
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~- 220 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS- 220 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcC---------CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-
Confidence 99999999887654444444556789999999999765 48999999999999999998 89999876543
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 457 DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 457 ~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
++...+..+.++..|..++..+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus 221 -~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 221 -EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 4677888888888999999999999999999999999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=400.50 Aligned_cols=265 Identities=25% Similarity=0.446 Sum_probs=211.9
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeee
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLC 291 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~ 291 (683)
.+.|.+..++|++++.||+|+|+.|++. +++.||||+++.. .+.+.+|+.++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3567788889999999999998887753 3468999998642 34577888888777 6899999987
Q ss_pred eEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPS 360 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~ 360 (683)
++.. +...+++|||||+ |+|.++|...... .....+++.+++.++.||+.||+|||++||+||||||+
T Consensus 85 ~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 85 ACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EECS-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eecc-CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 7654 3467899999998 5999999763211 12345899999999999999999999999999999999
Q ss_pred cEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHH
Q 038696 361 NILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICF 440 (683)
Q Consensus 361 NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ 440 (683)
||||+.++ ++||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|
T Consensus 164 NILl~~~~-------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gvil~ 227 (299)
T d1ywna1 164 NILLSEKN-------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLW 227 (299)
T ss_dssp GEEECGGG-------CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC---------CCCHHHHHHHHHHHHH
T ss_pred ceeECCCC-------cEEEccCcchhhccccccccccCceeeCccccchhHhhcC---------CCCcccceeehHHHHH
Confidence 99998877 7999999999876554444444556799999999999865 4899999999999999
Q ss_pred HHHhC-CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 441 EILTG-KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 441 ElltG-~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
||++| ..||.+.... ..+...+..+.++..|..+++++.+||.+||+.||++|||+.+++++|+.+.+
T Consensus 228 ellt~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 228 EIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHTTSCCSSTTCCCS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99986 5688766543 45667788888888899999999999999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-47 Score=401.66 Aligned_cols=243 Identities=27% Similarity=0.365 Sum_probs=188.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
+.|++.+.||+|+++.|++. +|+.||||++.. ..+.+.+|+++|+.++|||||+++++|.++ +.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 46999999999998777763 688999999853 234578999999999999999999999654 7899999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+ |+|.++|.+ ...+++.++..++.||+.||+|||++||+||||||+|||+.... ....+||+|||+
T Consensus 87 E~~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~----~~~~vkl~DFG~ 156 (307)
T d1a06a_ 87 QLVSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD----EDSKIMISDFGL 156 (307)
T ss_dssp CCCCSCBHHHHHHT------CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS----TTCCEEECCC--
T ss_pred eccCCCcHHHhhhc------ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC----CCceEEEeccce
Confidence 9998 599999975 35799999999999999999999999999999999999996421 112799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+... ..+...+.
T Consensus 157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~ 222 (307)
T d1a06a_ 157 SKMEDPGS---VLSTACGTPGYVAPEVLAQK---------PYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQIL 222 (307)
T ss_dssp -------------------CTTSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred eEEccCCC---eeeeeeeCccccCcHHHcCC---------CCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 98765332 22346799999999999755 489999999999999999999999987653 33555555
Q ss_pred cCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+... ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus 223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 54432 2335678999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=401.67 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=208.3
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEE
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
-++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++|||||+++++|.++ ..+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 358999999999998888863 689999999842 356688999999999999999999999654 7899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||||+ |+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+| ++||+|
T Consensus 82 iv~ey~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-------~vkl~D 148 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-------HIKITD 148 (337)
T ss_dssp EEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CEEECC
T ss_pred cceeccCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-------CEEEee
Confidence 9999998 5999999864 5699999999999999999999999999999999999999888 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+|+...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+.+
T Consensus 149 FG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~---------~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~ 215 (337)
T d1o6la_ 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE 215 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSS---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred cccccccccCC--cccccceeCHHHhhhhhccCC---------CCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHH
Confidence 99998754322 233456899999999999765 489999999999999999999999988664 34556
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
.+..+. ..+|..+++++.+||.+||+.||.+|++ +.++++|-
T Consensus 216 ~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 216 LILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 666654 4578889999999999999999999994 78887763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.21 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=204.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
++|++++.||+|+|+.|++. +|+.||||++.. ..+.+.+|+.+|+.|+|||||+++++|.++ ..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 47999999999998888863 688999999842 135689999999999999999999999654 78
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|||||||+ |+|.++|.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .....+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~---~~~~~vkl 158 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN---VPKPRIKI 158 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS---SSSCCEEE
T ss_pred EEEEEEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC---CcccceEe
Confidence 999999998 5999999863 5699999999999999999999999999999999999998776 23346999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+. ...
T Consensus 159 ~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~ 224 (293)
T d1jksa_ 159 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTK--QET 224 (293)
T ss_dssp CCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH
T ss_pred cchhhhhhcCCCc---cccccCCCCcccCHHHHcCC---------CCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHH
Confidence 9999998775432 22345688899999999754 489999999999999999999999987653 334
Q ss_pred HHHHHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 460 SRNIRAGERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 460 ~~~i~~~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
...+..+.... .+..++..+.+||++||+.||.+|||+.++++|
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 55555554322 235678899999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-47 Score=405.16 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=202.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++++.||+|+|+.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.++ +.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEE
Confidence 48999999999998888864 6899999998643 35678999999999999999999999754 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+ |+|.+++.+ ....+++..+..|+.||+.||+|||++|||||||||+|||++.++ + ..+||+|||+|
T Consensus 104 ~~~gg~L~~~l~~-----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~---~--~~vkL~DFG~a 173 (350)
T d1koaa2 104 FMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR---S--NELKLIDFGLT 173 (350)
T ss_dssp CCCSCBHHHHHTC-----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT---S--CCEEECCCTTC
T ss_pred cCCCCCHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC---C--CeEEEeecchh
Confidence 998 599999864 345799999999999999999999999999999999999996532 1 16999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...+..
T Consensus 174 ~~~~~~~---~~~~~~gT~~Y~aPEv~~~~---------~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~ 239 (350)
T d1koaa2 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS 239 (350)
T ss_dssp EECCTTS---CEEEECSCTTTCCHHHHHTC---------CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred eeccccc---ccceecCcccccCHHHHcCC---------CCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence 8765332 22345789999999999765 489999999999999999999999987653 345555555
Q ss_pred CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERPL---FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~~---~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.... ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 44322 224578899999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-46 Score=395.14 Aligned_cols=238 Identities=30% Similarity=0.435 Sum_probs=204.2
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++. ...+.+.+|+.+|+.++|||||++++++.++ +.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceeee
Confidence 48999999999998777763 68999999984 2356788999999999999999999999654 78999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||||.| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+| .+||+||
T Consensus 82 vmE~~~gg~l~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-------~vkL~DF 148 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-------HIKITDF 148 (316)
T ss_dssp EECCCCSCBHHHHHHH------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-------CEEECCC
T ss_pred EeeecCCccccccccc------cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-------CEEEecC
Confidence 9999985 88888875 35689999999999999999999999999999999999999888 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+..... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~---------~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~ 212 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEK 212 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCC---------CCCchhhccccchhHHHHHhCCCCCCCcCH--HHHHHH
Confidence 999876532 2346799999999999755 489999999999999999999999987653 335555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
+..+. ..+|..+++++.+++.+||..||.+|+ |++++++|-
T Consensus 213 i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 213 ILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp HHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHcCC-CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 55554 346778899999999999999999996 899998763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-47 Score=395.90 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=215.2
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEE
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFT 294 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 294 (683)
++++..++|++++.||+|+|+.|++. +++.||||+++.. .+.+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 45566779999999999998888753 2468999998643 356899999999999999999999885
Q ss_pred cCCCCeEEEEEecCC-CCHHHHHHHhcC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 038696 295 DEEKKECFLIMELMS-RDLCSYIKEICC------------------PRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHG 355 (683)
Q Consensus 295 ~e~~~~~~LVmEy~~-gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 355 (683)
+ ....++||||+. |+|.++|..... ......+++..++.|+.||+.||.|||++|||||
T Consensus 87 ~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 87 V--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred c--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 4 467899999997 699999975321 1122358999999999999999999999999999
Q ss_pred CCCCCcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhH
Q 038696 356 NLNPSNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSF 435 (683)
Q Consensus 356 DLKp~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSl 435 (683)
||||+||||+.++ .+||+|||+|+...............+|+.|+|||++.+. .|+.++|||||
T Consensus 165 DlKp~NILld~~~-------~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~t~ksDVwS~ 228 (301)
T d1lufa_ 165 DLATRNCLVGENM-------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---------RYTTESDVWAY 228 (301)
T ss_dssp CCSGGGEEECGGG-------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC---------CCCHHHHHHHH
T ss_pred EEcccceEECCCC-------cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC---------CCChhhhhccc
Confidence 9999999998776 7999999999876544333344456788999999999865 49999999999
Q ss_pred HHHHHHHHhCC-CCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 436 GMICFEILTGK-VPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 436 Gvil~ElltG~-~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
||++|||++|. +||.+... .++...+..+.++..|..+++++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 229 Gvvl~ell~~~~~p~~~~~~--~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAH--EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hhhHHHHHccCCCCCCCCCH--HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99999999985 67876543 456677888888888999999999999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=392.56 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred cceeEeeCCCeEEEeEecccccEEEEEE---cCcEEEEEEeCC---CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCe
Q 038696 227 PSRILIKSEDYQVRRRLGSGSQYKEILW---LGESFALRHFFG---DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKE 300 (683)
Q Consensus 227 ~~~~~~~~~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~ 300 (683)
..+|.+..++|++.+.||+|+|+.|++. ++..||||+++. ..+.|.+|+.+|+.++|||||++++++.+ +.
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~ 85 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 85 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CC
Confidence 3567888899999999999997777653 566899999964 34679999999999999999999998743 45
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|+||||+. |+|..++... ....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~----~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-------~~kl 154 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-------VCKV 154 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEEE
T ss_pred eEEEEEecCCCchhhhhhhc----ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-------cEEE
Confidence 799999998 5888887642 224699999999999999999999999999999999999998877 7999
Q ss_pred ecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHH
Q 038696 380 SGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKM 459 (683)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~ 459 (683)
+|||+++....... .......||+.|+|||++... .++.++|||||||++|||++|..||..... ..++
T Consensus 155 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~ 223 (285)
T d1fmka3 155 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREV 223 (285)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHH
T ss_pred cccchhhhccCCCc-eeeccccccccccChHHHhCC---------CCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHH
Confidence 99999987644322 233446789999999999765 489999999999999999996555544332 2446
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 460 SRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 460 ~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
...+..+.++..+..+++++.+||.+||+.||++|||+++|++.|+.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 66777788888899999999999999999999999999999877664
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-47 Score=404.26 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=202.1
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC----cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD----IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|.++ ..+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEE
Confidence 57999999999998888864 6899999998542 34678999999999999999999999654 78999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+ |+|.+++.. ...+|++.++..|+.||+.||.|||++||+||||||+||||+..+ + ..+||+|||+|
T Consensus 107 ~~~gg~L~~~~~~-----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~---~--~~vkL~DFGla 176 (352)
T d1koba_ 107 FLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK---A--SSVKIIDFGLA 176 (352)
T ss_dssp CCCCCBHHHHTTC-----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT---C--CCEEECCCTTC
T ss_pred cCCCChHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccC---C--CeEEEeecccc
Confidence 998 499988764 345799999999999999999999999999999999999997432 1 17999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.. .....+..
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~ 242 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKR 242 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 8875432 22345688999999999765 4899999999999999999999999876533 34455555
Q ss_pred CCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 GERP---LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 ~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+... .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4432 2335678999999999999999999999999775
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-46 Score=399.57 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=200.2
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-------CcchHHHH---HHHHHcCCCCceeeeeeeEEcCCCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-------DIEPLVPE---ISSLLSLSHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-------~~~~~~~E---i~iL~~L~HpnIv~l~~~~~~e~~~ 299 (683)
-++|++++.||+|+++.|++. +|+.||||++.. ....+.+| +++++.++|||||+++++|.++ +
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence 468999999999998888763 689999999842 22234444 6777788899999999999654 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 300 ECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
.+|||||||+ |+|.++|.+. ..+++..+..|+.||+.||.|||++|||||||||+|||++.+| .+|
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-------~iK 147 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-------HVR 147 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-------CEE
T ss_pred EEEEEEEecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-------cEE
Confidence 8999999998 5999999863 5689999999999999999999999999999999999999888 799
Q ss_pred EecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 379 ISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
|+|||+|+..... ......||+.|+|||++... ..|+.++|||||||++|||++|+.||.+.......
T Consensus 148 l~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 215 (364)
T d1omwa3 148 ISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKG--------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215 (364)
T ss_dssp ECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred EeeeceeeecCCC----cccccccccccchhHHhhcC--------CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999876543 23345799999999999632 25899999999999999999999999876543322
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 038696 459 MSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPS-----FSSICRIL 504 (683)
Q Consensus 459 ~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt-----~~eil~~L 504 (683)
............++..+++++.+||.+||+.||.+||| ++++++|-
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 216 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp HHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred HHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 22222233445567788999999999999999999999 68888763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-46 Score=383.47 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=200.4
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcCCC--Ce
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEK--KE 300 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~--~~ 300 (683)
.++|++.+.||+|+++.|++. +|+.||||+++.. .+.+.+|+++|+.++|||||++++++..++. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999998888864 6889999998532 2357899999999999999999998875432 45
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEE
Q 038696 301 CFLIMELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKI 379 (683)
Q Consensus 301 ~~LVmEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL 379 (683)
+|||||||+| +|.+++... .++++.++..++.||+.||+|||++||+||||||+|||++.++ .++|
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-------~~~l 152 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-------AVKV 152 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-------CEEE
T ss_pred EEEEEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-------ccee
Confidence 8999999985 999988763 5699999999999999999999999999999999999998887 7999
Q ss_pred ecccCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH
Q 038696 380 SGFGLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK 458 (683)
Q Consensus 380 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~ 458 (683)
+|||++........ ........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.. +.
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~ 222 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SV 222 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCC---------CCCcceecccchHHHHHHHhCCCCCCCcCHH-HH
Confidence 99999876543322 2233456799999999999754 4899999999999999999999999876533 23
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 038696 459 MSRNIRAGERPL--FPFHSPKYVTNLTKRCWHADPNQRP-SFSSICRILRYIK 508 (683)
Q Consensus 459 ~~~~i~~~~~~~--~p~~~~~~l~~Li~~cL~~dP~~RP-t~~eil~~L~~i~ 508 (683)
..+.+.....+. ....+++++.+||.+||+.||.+|| |++++++.|..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 334444443322 3456789999999999999999999 8999988887653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=389.03 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=217.5
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE-----------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW-----------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFL 290 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~-----------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~ 290 (683)
..|.+..++|++++.||+|+|+.|++. ++..||||+++.+ ...+.+|+..+.++ +|||||+++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 448888899999999999998777753 1247999999653 34578899999888 799999999
Q ss_pred eeEEcCCCCeEEEEEecCC-CCHHHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 291 CGFTDEEKKECFLIMELMS-RDLCSYIKEICCP----------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 291 ~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
++|.+ ...+|+|||||. |+|.++|...... .....+++.+++.++.||+.||+|||++|||||||||
T Consensus 86 ~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 99854 367999999997 5999999763211 1234689999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............+|+.|+|||++.+. .|+.++|||||||++
T Consensus 164 ~NiLl~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 164 RNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLL 227 (299)
T ss_dssp GGEEECTTC-------CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC---------CCCHHHHHHHHHHHH
T ss_pred cceeecCCC-------CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC---------CCCchhhhHHhHHHH
Confidence 999999887 7999999999887665444445566789999999999765 599999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
|||++ |.+||.+... ..+...+..+.++..|..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 228 ~ell~~g~~p~~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPV--EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTSCCSSTTCCH--HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCH--HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 99998 7999987654 35677888899999999999999999999999999999999999999988743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=387.97 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=199.7
Q ss_pred EeeCCCeEEEeEecccccEEEEEE-----c--CcEEEEEEeCCC-------cchHHHHHHHHHcCCCCceeeeeeeEEcC
Q 038696 231 LIKSEDYQVRRRLGSGSQYKEILW-----L--GESFALRHFFGD-------IEPLVPEISSLLSLSHPNIMHFLCGFTDE 296 (683)
Q Consensus 231 ~~~~~~y~i~~~LG~G~~~~v~l~-----~--g~~vAvK~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e 296 (683)
.+..++|++++.||+|+|+.|++. + +..||||++... .+.|.+|+++|+.++|||||++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 456679999999999997666642 1 237999998532 3568999999999999999999998843
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcc
Q 038696 297 EKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYL 375 (683)
Q Consensus 297 ~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~ 375 (683)
..+++||||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~------- 148 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD------- 148 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-------
T ss_pred --cchheeeeeecCcchhhhhhcc-----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-------
Confidence 35789999997 5999888763 35699999999999999999999999999999999999998887
Q ss_pred eEEEecccCccccCCCCCCC-CCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHh-CCCCCCCCc
Q 038696 376 HAKISGFGLSSVKNFGPKSP-SQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILT-GKVPFEDAH 453 (683)
Q Consensus 376 ~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~Ellt-G~~Pf~~~~ 453 (683)
.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC---------CCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 89999999999875443221 22344578889999999876 48899999999999999998 899998766
Q ss_pred cchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 038696 454 LQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRY 506 (683)
Q Consensus 454 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~ 506 (683)
.. +.+......+.++..+..++..+.+||.+||+.||++|||+.+|.+.|..
T Consensus 220 ~~-~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 220 GS-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HH-HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 43 23334445667777888899999999999999999999999999888765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-45 Score=395.00 Aligned_cols=238 Identities=23% Similarity=0.367 Sum_probs=204.9
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFL 303 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~L 303 (683)
++|++++.||+|+++.|++. +|+.||||++. ...+.+.+|+++|+.++|||||+++++|.+. ..+|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccccc
Confidence 58999999999998888763 68999999984 2345688999999999999999999999654 78999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 304 IMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 304 VmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
||||+. |+|.+++.+. ..+++..+..|+.||+.||.|||++|||||||||+||||+.+| ++||+||
T Consensus 119 v~e~~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-------~ikL~DF 185 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-------YIQVTDF 185 (350)
T ss_dssp EEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------CEEECCC
T ss_pred ccccccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-------CEEeeec
Confidence 999997 5999999764 5699999999999999999999999999999999999999887 7999999
Q ss_pred cCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 383 GLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 383 Gla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
|+|+..... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+...
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~---------~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~ 249 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEK 249 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCC---------CCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHH
Confidence 999876432 2356799999999999765 489999999999999999999999987653 345555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRIL 504 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~L 504 (683)
+..+. +.+|..+++++.+||++||..||.+|+ |++++++|-
T Consensus 250 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 250 IVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HhcCC-CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 65554 346778899999999999999999994 899988763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-45 Score=381.21 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=205.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-------------cchHHHHHHHHHcCC-CCceeeeeeeEEc
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-------------IEPLVPEISSLLSLS-HPNIMHFLCGFTD 295 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-------------~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 295 (683)
.++|++.+.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.|+ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 369999999999998888864 7889999998431 135789999999997 9999999999965
Q ss_pred CCCCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 296 EEKKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 296 e~~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
+ +.+|||||||+ |+|.++|+.. .++++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------ 147 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------ 147 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------
T ss_pred C--cceEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC------
Confidence 4 78999999998 5999999864 5699999999999999999999999999999999999999887
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+++...... ......||+.|+|||++.+.... ....++.++||||+||++|||++|+.||.+.+.
T Consensus 148 -~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~---~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 148 -NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMND---NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp -CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCT---TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccc---cCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 79999999998775432 23446789999999999865321 233578999999999999999999999987653
Q ss_pred chhHHHHHHHcCCCC-C--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 QGDKMSRNIRAGERP-L--FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~-~--~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. .....+..+... . ....+++++.+|+.+||+.||.+|||+.++++|
T Consensus 221 ~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 M--LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H--HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred H--HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3 344445544322 2 223678999999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=387.61 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=219.8
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcC-CCCceeeeeee
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSL-SHPNIMHFLCG 292 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L-~HpnIv~l~~~ 292 (683)
..|.+..++|++.++||+|+|+.|+.. .++.||||+++.. ...+.+|+.+++.+ +|||||+++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 468888899999999999998888753 3458999999642 34588999999999 69999999999
Q ss_pred EEcCCCCeEEEEEecCC-CCHHHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 038696 293 FTDEEKKECFLIMELMS-RDLCSYIKEICCP------------RKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNP 359 (683)
Q Consensus 293 ~~~e~~~~~~LVmEy~~-gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp 359 (683)
+.+ ...+|||||||+ |+|.+++...... .....+++..+..|+.||+.||+|||++||+||||||
T Consensus 96 ~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 96 CTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp ECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred Eee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 854 367899999998 5999999864211 1234699999999999999999999999999999999
Q ss_pred CcEEeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHH
Q 038696 360 SNILLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMIC 439 (683)
Q Consensus 360 ~NILl~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil 439 (683)
+|||++.++ .+||+|||+++...............||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~NIl~~~~~-------~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 174 RNILLTHGR-------ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGIFL 237 (311)
T ss_dssp GGEEEETTT-------EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHH
T ss_pred ccccccccC-------cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC---------CCCCcccccchHHHH
Confidence 999998887 8999999999877654444444566789999999999755 489999999999999
Q ss_pred HHHHh-CCCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038696 440 FEILT-GKVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIK 508 (683)
Q Consensus 440 ~Ellt-G~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~ 508 (683)
|||++ |.+||..... ...+.+.+..+.++..+..++..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 238 ~ellt~g~p~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPV-DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHTTTCCSSTTCCS-SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 99999 5666655543 34566778888888889999999999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=388.11 Aligned_cols=240 Identities=30% Similarity=0.492 Sum_probs=203.6
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeC-------CCcchHHHHHHHHH-cCCCCceeeeeeeEEcCCCCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFF-------GDIEPLVPEISSLL-SLSHPNIMHFLCGFTDEEKKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~-------~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~e~~~~~~ 302 (683)
++|++++.||+|+++.|++. +|+.||||++. ...+.+..|+.++. .++|||||++++++.+. +.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 58999999999998777753 78999999984 23456777887765 68999999999999654 7899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEec
Q 038696 303 LIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISG 381 (683)
Q Consensus 303 LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~D 381 (683)
||||||+ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 80 ivmEy~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-------~~kl~D 146 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------HIKIAD 146 (320)
T ss_dssp EEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------CEEECC
T ss_pred EEEeecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-------ceeccc
Confidence 9999998 5999999864 5689999999999999999999999999999999999999887 799999
Q ss_pred ccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 382 FGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 382 FGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
||+++...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ..+..
T Consensus 147 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~ 213 (320)
T d1xjda_ 147 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFH 213 (320)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred cchhhhccccc--ccccccCCCCCcCCHHHHcCC---------CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 99998654332 233456799999999999765 489999999999999999999999987653 34556
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 038696 462 NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFS-SICRI 503 (683)
Q Consensus 462 ~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~-eil~~ 503 (683)
.+..+. +.+|..+++++.+||.+||..||.+|||+. ++++|
T Consensus 214 ~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 214 SIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 666554 567888899999999999999999999985 67664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=386.55 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=222.0
Q ss_pred CCCcccceeEeeCCCeEEEeEecccccEEEEEE---------cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCcee
Q 038696 222 SGKLLPSRILIKSEDYQVRRRLGSGSQYKEILW---------LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIM 287 (683)
Q Consensus 222 ~~~~~~~~~~~~~~~y~i~~~LG~G~~~~v~l~---------~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv 287 (683)
.....+..|++..++|++.+.||+|+|+.|++. ++..||||+++.. ...+.+|+.+++.++|||||
T Consensus 7 ~~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 86 (308)
T d1p4oa_ 7 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86 (308)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEe
Confidence 345677889999999999999999998777642 3578999999642 23578999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEecCC-CCHHHHHHHhc----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 038696 288 HFLCGFTDEEKKECFLIMELMS-RDLCSYIKEIC----CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNI 362 (683)
Q Consensus 288 ~l~~~~~~e~~~~~~LVmEy~~-gsL~~~l~~~~----~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NI 362 (683)
++++++..+ ...++|||||. |+|.+++.... .......+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 87 ~~~~~~~~~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 87 RLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164 (308)
T ss_dssp CEEEEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred eeeeEEecC--CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCce
Confidence 999988544 67899999997 69999886421 112234579999999999999999999999999999999999
Q ss_pred EeCCCCCCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHH
Q 038696 363 LLKPRGASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEI 442 (683)
Q Consensus 363 Ll~~~g~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~El 442 (683)
|++.++ ++||+|||+|+...............||+.|+|||.+.+. .++.++|||||||++|||
T Consensus 165 Lld~~~-------~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~---------~~~~~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 165 MVAEDF-------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEI 228 (308)
T ss_dssp EECTTC-------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHH
T ss_pred eecCCc-------eEEEeecccceeccCCcceeeccceecccccCCHHHHccC---------CCCcccccccHHHHHHHH
Confidence 998887 8999999999876544333334455789999999999765 489999999999999999
Q ss_pred HhC-CCCCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 038696 443 LTG-KVPFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYI 507 (683)
Q Consensus 443 ltG-~~Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i 507 (683)
++| ..||.+.+. .++...+..+.++..|..++..+.+||.+||+.||++|||+.+|+++|+..
T Consensus 229 ~t~~~~p~~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 229 ATLAEQPYQGLSN--EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HhCCCCCCCCCCH--HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 997 578876543 346667778888888899999999999999999999999999999988653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=385.33 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=210.2
Q ss_pred eeCCCeEEEeEecccccEEEEEE----cCc--EEEEEEeCC-----CcchHHHHHHHHHcC-CCCceeeeeeeEEcCCCC
Q 038696 232 IKSEDYQVRRRLGSGSQYKEILW----LGE--SFALRHFFG-----DIEPLVPEISSLLSL-SHPNIMHFLCGFTDEEKK 299 (683)
Q Consensus 232 ~~~~~y~i~~~LG~G~~~~v~l~----~g~--~vAvK~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~e~~~ 299 (683)
+..++|++.+.||+|+|+.|++. +|. .||||.+.. ..+.+.+|+++|+.+ +|||||++++++.++ +
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--C
Confidence 34579999999999998777752 444 478888742 356799999999999 799999999999754 7
Q ss_pred eEEEEEecCC-CCHHHHHHHhc----------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCC
Q 038696 300 ECFLIMELMS-RDLCSYIKEIC----------CPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRG 368 (683)
Q Consensus 300 ~~~LVmEy~~-gsL~~~l~~~~----------~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g 368 (683)
.+||||||++ |+|.++|.... .......+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 8999999998 59999997531 012345799999999999999999999999999999999999998877
Q ss_pred CCCCCcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCC-C
Q 038696 369 ASTEGYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGK-V 447 (683)
Q Consensus 369 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~-~ 447 (683)
.+||+|||+++...... ......||..|+|||.+.+. .|+.++|||||||++|||++|. +
T Consensus 165 -------~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~---------~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 165 -------VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp -------CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------ceEEccccccccccccc---cccceecCCcccchHHhccC---------CCCccceeehhHHHHHHHHhcCCC
Confidence 79999999998654322 22344688899999999765 4899999999999999999965 5
Q ss_pred CCCCCccchhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 448 PFEDAHLQGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 448 Pf~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
||.+.+ ...+...+..+.++..+..+++++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus 226 p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 226 PYCGMT--CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TTTTCC--HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC--HHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 777654 345667788888888899999999999999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=388.72 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=204.1
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmE 306 (683)
.++|++++.||+|+|+.|++. +|+.||||+++.. ...+.+|+++|+.++|||||+++++|.++ +.+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM--EELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEe
Confidence 468999999999998888763 6889999999653 23578999999999999999999999654 78999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.++|.+ ....+++.++..|+.||+.||+|||++||+||||||+|||++.++ ...+||+|||++
T Consensus 82 ~~~gg~L~~~i~~-----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-----~~~ikl~DFG~~ 151 (321)
T d1tkia_ 82 FISGLDIFERINT-----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-----SSTIKIIEFGQA 151 (321)
T ss_dssp CCCCCBHHHHHTS-----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-----CCCEEECCCTTC
T ss_pred cCCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-----ceEEEEcccchh
Confidence 9985 99999974 335799999999999999999999999999999999999997543 236999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+...... ......+|+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+.. .+...+..
T Consensus 152 ~~~~~~~---~~~~~~~t~~y~ape~~~~~---------~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~ 217 (321)
T d1tkia_ 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMN 217 (321)
T ss_dssp EECCTTC---EEEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH
T ss_pred hccccCC---cccccccccccccchhccCC---------CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 8764322 22345678899999999755 4899999999999999999999999876533 35555555
Q ss_pred CCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 466 GERPLF---PFHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 466 ~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
+..... ...+++++.+||.+||..||.+|||+.++++|-+
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 543221 1357889999999999999999999999998743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=379.79 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|++++.||+|+++.|++. +|+.||||+++. ..+.+.+|+++|++++|||||+++++|.+. ..+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeEE
Confidence 58999999999998888763 589999999853 245788999999999999999999999754 789999
Q ss_pred EecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 305 MELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 305 mEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+.|++.+++... ....+++..+..++.||+.||.|||++|||||||||+|||++.++ .+||+|||+
T Consensus 80 ~e~~~~~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-------~~kl~DFG~ 148 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-------AIKLADFGL 148 (298)
T ss_dssp EECCSEEHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEECSTTH
T ss_pred EeecCCchhhhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-------cceeccCCc
Confidence 999999888877652 346699999999999999999999999999999999999998887 799999999
Q ss_pred ccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH
Q 038696 385 SSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR 464 (683)
Q Consensus 385 a~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~ 464 (683)
|+...... .......||+.|+|||++.... .++.++|||||||++|+|++|+.||.+.+.. +.+...+.
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~--------~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~ 217 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCK--------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFR 217 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCS--------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred ceeccCCc--ccceeecccceeeehhhhcccc--------CCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHH
Confidence 98765432 2334557899999999987542 4688999999999999999999999876532 22222221
Q ss_pred c-CCC---------------CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 A-GER---------------PLF-----------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~-~~~---------------~~~-----------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
. +.. ..+ ....++++.+||.+||..||.+|||+.++++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 100 000 12346789999999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=377.27 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=191.6
Q ss_pred EEeEecccccEEEEEE----cCcEEEEEEeCCC---------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 239 VRRRLGSGSQYKEILW----LGESFALRHFFGD---------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 239 i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.++.||+|+|+.|++. +|+.||||+++.. .+.+.+|+.+|+.++|||||+++++|.++ +.+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehh
Confidence 4688999998888864 6889999998421 34688999999999999999999999654 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.|++...+.. ....+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 80 E~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-------~~KL~DFG~a 147 (299)
T d1ua2a_ 80 DFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-------VLKLADFGLA 147 (299)
T ss_dssp ECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------CEEECCCGGG
T ss_pred hhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-------ccccccCccc
Confidence 9999866665543 346799999999999999999999999999999999999999887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA 465 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~ 465 (683)
+....... ......||+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.+.. +.+......
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~ 216 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGA--------RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFET 216 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTC--------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred cccCCCcc--cccceecChhhccHHHHccC--------CCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHh
Confidence 87654322 23345789999999998643 25899999999999999999999999876533 222222111
Q ss_pred -CCCC--------------------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 466 -GERP--------------------L-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 466 -~~~~--------------------~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+... . .....++++.+||.+||..||++|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 0 012456789999999999999999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=387.36 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=197.7
Q ss_pred CCeEEEe-EecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHc-CCCCceeeeeeeEEc--CCCCeEEEEEe
Q 038696 235 EDYQVRR-RLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLS-LSHPNIMHFLCGFTD--EEKKECFLIME 306 (683)
Q Consensus 235 ~~y~i~~-~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~--e~~~~~~LVmE 306 (683)
++|+++. .||+|+++.|++. +|+.||||++.. ...+.+|+.++.+ ++|||||+++++|.+ .....+|||||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 4899875 5999998888864 688999999964 4668899998765 489999999999864 23467899999
Q ss_pred cCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 307 LMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 307 y~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+| +|.++|.+. ....|++.++..|+.||+.||+|||++||+||||||+|||++.++ +...+||+|||+|
T Consensus 90 y~~gg~L~~~i~~~----~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~----~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 90 CLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----PNAILKLTDFGFA 161 (335)
T ss_dssp CCCSEEHHHHHHSC----SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS----TTCCEEECCCTTC
T ss_pred CCCCCcHHHHHHhc----CCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc----cccccccccccee
Confidence 9985 999999852 235699999999999999999999999999999999999998643 2237999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch--hHHHHHH
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG--DKMSRNI 463 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~--~~~~~~i 463 (683)
+...... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+... ..+...+
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGG---------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCC---------CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 8765432 23456799999999999765 48999999999999999999999997654321 1111112
Q ss_pred HcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 038696 464 RAGERPLFP----FHSPKYVTNLTKRCWHADPNQRPSFSSICRILR 505 (683)
Q Consensus 464 ~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~ 505 (683)
..+. ..+| ..+++++.+||.+||+.||++|||+.++++|-+
T Consensus 230 ~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 230 RMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp CSCS-SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred hcCC-CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 2221 1122 246788999999999999999999999998744
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=375.64 Aligned_cols=234 Identities=22% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC----------CcchHHHHHHHHHcCC--CCceeeeeeeEEcCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG----------DIEPLVPEISSLLSLS--HPNIMHFLCGFTDEE 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~----------~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~e~ 297 (683)
.++|++.+.||+|+|+.|++. +|+.||||++.. ....+.+|+.+|+.++ |||||+++++|.++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 358999999999998888763 689999999842 1244678999999996 99999999999654
Q ss_pred CCeEEEEEecCCC--CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCC-CCCCCCc
Q 038696 298 KKECFLIMELMSR--DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPR-GASTEGY 374 (683)
Q Consensus 298 ~~~~~LVmEy~~g--sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~-g~~~~~~ 374 (683)
+.+|+||||+.| ++.+++.+. ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 82 -~~~~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~------ 148 (273)
T d1xwsa_ 82 -DSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG------ 148 (273)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT------
T ss_pred -CeEEEEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC------
Confidence 789999999963 788888763 569999999999999999999999999999999999999854 4
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+|+..... ......||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+..
T Consensus 149 -~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~--------~~~~~~DiwSlGvilyell~g~~Pf~~~~- 214 (273)
T d1xwsa_ 149 -ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHR--------YHGRSAAVWSLGILLYDMVCGDIPFEHDE- 214 (273)
T ss_dssp -EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSC--------BCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred -eEEECccccceecccc----cccccccCCCcCCHHHHcCCC--------CCCcccccccceeeehhHhhCCCCCCCch-
Confidence 7999999999875432 234567999999999997653 35678999999999999999999997532
Q ss_pred chhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 QGDKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ~~~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+..+ ...++..+++++.+||.+||+.||++|||+.++++|
T Consensus 215 -------~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------HHhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 12222 234677889999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=376.83 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=204.8
Q ss_pred EEEeEecccccEEEEEE-----c--CcEEEEEEeCC-----CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 238 QVRRRLGSGSQYKEILW-----L--GESFALRHFFG-----DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 238 ~i~~~LG~G~~~~v~l~-----~--g~~vAvK~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
.+.++||+|+|+.|+.. . ...||||.++. ..++|.+|+++|++++|||||++++++... .+.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEE
Confidence 33678999998877752 1 23699999863 235689999999999999999999887643 36789999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccC
Q 038696 306 ELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGL 384 (683)
Q Consensus 306 Ey~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGl 384 (683)
|||+ |+|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+||||+.++ .+||+|||+
T Consensus 109 E~~~~g~l~~~~~~-----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-------~~kL~DFG~ 176 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-------TVKVADFGL 176 (311)
T ss_dssp ECCTTCBHHHHHHC-----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-------CEEECSSGG
T ss_pred EEeecCchhhhhcc-----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-------CEEEecccc
Confidence 9998 589988874 345678899999999999999999999999999999999998877 799999999
Q ss_pred ccccCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHH
Q 038696 385 SSVKNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRN 462 (683)
Q Consensus 385 a~~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~ 462 (683)
++....... ........||+.|+|||++... .++.++||||||+++|||++|..||..... ...+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~ 246 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVY 246 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH
T ss_pred hhhccccccccceecccccccccccChHHHhcC---------CCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHH
Confidence 987654332 2233456789999999999765 489999999999999999997777765432 2335566
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 038696 463 IRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKR 509 (683)
Q Consensus 463 i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~ 509 (683)
+..+.++..|..+++++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 77888888999999999999999999999999999999999988854
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=370.89 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=196.1
Q ss_pred CCCeEEEeEecccccEEEEEE----c-CcEEEEEEeCC------CcchHHHHHHHHHcC---CCCceeeeeeeEEc---C
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----L-GESFALRHFFG------DIEPLVPEISSLLSL---SHPNIMHFLCGFTD---E 296 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~-g~~vAvK~~~~------~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---e 296 (683)
.++|++++.||+|+++.|++. + ++.||||+++. ....+.+|+.+|+.| +||||++++++|.. +
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 358999999999998888863 2 56799999842 244677898888766 79999999998853 2
Q ss_pred CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 297 EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 297 ~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
....+|+||||++|++..++.. .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-------~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------Q 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------C
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-------C
Confidence 3357899999999876665554 2446799999999999999999999999999999999999999887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... ......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~---------~y~~~~DiwSlG~il~ell~g~~pf~~~~~~- 221 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV- 221 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCC---------CCChhehhhchHHHHHHHHHCCCCCCCCCHH-
Confidence 9999999997654322 33456789999999999755 4899999999999999999999999876532
Q ss_pred hHHHHHHHc-CC------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 457 DKMSRNIRA-GE------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 457 ~~~~~~i~~-~~------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
+.+...+.. +. ...++...++.+.+||.+||+.||++|||+.++++|
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 222222211 00 011234567889999999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-43 Score=368.10 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=194.9
Q ss_pred CCeEEEeEecccccEEEEEE---cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW---LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIM 305 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~---~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVm 305 (683)
++|+++++||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++|||||+++++|.++ +..|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEEE
Confidence 58999999999997777763 6889999998532 45789999999999999999999999755 6799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCc
Q 038696 306 ELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLS 385 (683)
Q Consensus 306 Ey~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla 385 (683)
||+.|++...+.. ....+++..+..|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 80 e~~~~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-------~~kl~DfG~a 147 (286)
T d1ob3a_ 80 EHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-------ELKIADFGLA 147 (286)
T ss_dssp ECCSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-------CEEECCTTHH
T ss_pred EeehhhhHHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-------CEEecccccc
Confidence 9999877666654 346799999999999999999999999999999999999999887 7999999999
Q ss_pred cccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHH-
Q 038696 386 SVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIR- 464 (683)
Q Consensus 386 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~- 464 (683)
........ ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+.. +.+.+...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~--------~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~ 216 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGS--------KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRI 216 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTC--------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH
T ss_pred eecccCcc--ccceecccchhhhHHHHhCC--------CCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence 87643321 23344678889999999754 25799999999999999999999999876532 12222111
Q ss_pred cCCC--------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 465 AGER--------------------------PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 465 ~~~~--------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+.. ..+....++.+.+||++||..||++|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0100 01234457889999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-43 Score=366.95 Aligned_cols=259 Identities=19% Similarity=0.194 Sum_probs=201.9
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEEEec
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
+++|++++.||+|+|+.|++. +|+.||||++.. ..+.+..|+++++.++|+|++..++.+.. +....++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEEEEE
Confidence 357999999999998888763 588999998753 45678999999999987776655544433 34788999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
++|+|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++..+ ....+||+|||+|+.
T Consensus 85 ~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~----~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 85 LGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK----KGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCCBHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG----GTTCEEECCCSSCEE
T ss_pred cCCchhhhhhh-----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC----CCceeeeeccCccee
Confidence 99998888775 345799999999999999999999999999999999999986543 223699999999987
Q ss_pred cCCCCCC-----CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhH--HH
Q 038696 388 KNFGPKS-----PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDK--MS 460 (683)
Q Consensus 388 ~~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~--~~ 460 (683)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB---------CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCC---------CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 6543221 122355799999999999765 4899999999999999999999999765432211 11
Q ss_pred H---HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038696 461 R---NIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRFI 511 (683)
Q Consensus 461 ~---~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~~ 511 (683)
. .......+.....+|+++.+++..||+.||++||++.++.+.|+.+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 227 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1 11111222234578899999999999999999999999998888765433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=378.50 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=198.5
Q ss_pred CeEEEeEecccccEEEEEE----cCcEEEEEEeCCCcchHHHHHHHHHcCCCCceeeeeeeEEc----CCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGSQYKEILW----LGESFALRHFFGDIEPLVPEISSLLSLSHPNIMHFLCGFTD----EEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----e~~~~~~LVmEy 307 (683)
+|+.+++||+|+|+.|++. +|+.||||++..+.....+|+++|+.++|||||+++++|.. .+..++||||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 7999999999998888863 68999999997766667789999999999999999998854 233568999999
Q ss_pred CCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 308 MSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
|++++.+.+.... .....+++.++..++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 101 ~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~------~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 101 VPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA------VLKLCDFGSAKQ 172 (350)
T ss_dssp CSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC------CEEECCCTTCEE
T ss_pred cCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC------ceeEecccchhh
Confidence 9987776665421 13457999999999999999999999999999999999999987642 699999999987
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHHHc-C
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNIRA-G 466 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i~~-~ 466 (683)
..... ......||..|+|||++.+. ..|+.++|||||||++|||++|+.||...+.. +.+...+.. +
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g 240 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGA--------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLG 240 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHC
T ss_pred ccCCc---ccccccccccccChHHhhcc--------cCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 65432 22345788999999998643 25899999999999999999999999875532 222222110 0
Q ss_pred -----------------CCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 467 -----------------ERP---------LFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 467 -----------------~~~---------~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
..+ ......++++.+||.+||..||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 1123467889999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=372.38 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=193.4
Q ss_pred eeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCC-
Q 038696 229 RILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEE- 297 (683)
Q Consensus 229 ~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~- 297 (683)
.|.+ .++|++++.||+|+++.|++. +|+.||||+++.. .+.+.+|+++|+.++|||||+++++|...+
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 3445 569999999999998887763 5899999999642 345789999999999999999999986543
Q ss_pred ---CCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCc
Q 038696 298 ---KKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGY 374 (683)
Q Consensus 298 ---~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~ 374 (683)
...+||||||++++|..+++. ..|++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~------ 158 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC------ 158 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------
T ss_pred ccccceEEEEEecccccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc------
Confidence 236799999997788887764 4699999999999999999999999999999999999999888
Q ss_pred ceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc
Q 038696 375 LHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL 454 (683)
Q Consensus 375 ~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~ 454 (683)
.+||+|||+|+..... .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||.+.+.
T Consensus 159 -~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 159 -ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNW--------MRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp -CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTT--------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -ccccccccceeccCCc-----cccccccccccCHHHHcCC--------CCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 7999999999876432 2356788999999999753 2578999999999999999999999987542
Q ss_pred chhHHHHHHH----------------------cCC----C---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 455 QGDKMSRNIR----------------------AGE----R---PLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 455 ~~~~~~~~i~----------------------~~~----~---~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. .+..... ... . .......++.+.+||.+||..||.+|||+.++++|
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 225 LD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HH-HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH-HHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 21 1111110 000 0 01224567889999999999999999999999887
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=368.97 Aligned_cols=259 Identities=20% Similarity=0.343 Sum_probs=196.4
Q ss_pred CCeEEEeEecccccEEEEE--EcCcEEEEEEeCCC-cchHHHHHH--HHHcCCCCceeeeeeeEEcCCC--CeEEEEEec
Q 038696 235 EDYQVRRRLGSGSQYKEIL--WLGESFALRHFFGD-IEPLVPEIS--SLLSLSHPNIMHFLCGFTDEEK--KECFLIMEL 307 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l--~~g~~vAvK~~~~~-~~~~~~Ei~--iL~~L~HpnIv~l~~~~~~e~~--~~~~LVmEy 307 (683)
.+|.+.++||+|+|+.|+. .+|+.||||++... ...+..|.+ .+..++|||||++++++.+++. ..+||||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 4789999999999766664 58999999999643 333444544 4557899999999999876443 368999999
Q ss_pred CC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 308 MS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS--------KKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 308 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
|+ |+|.++|++ ..+++.++..++.|++.||.|||+ +||+||||||+||||+.++ .+|
T Consensus 83 ~~~g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-------~~K 148 (303)
T d1vjya_ 83 HEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-------TCC 148 (303)
T ss_dssp CTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-------CEE
T ss_pred ccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-------CeE
Confidence 97 599999986 359999999999999999999996 5999999999999998887 799
Q ss_pred EecccCccccCCCCCC--CCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCcc--
Q 038696 379 ISGFGLSSVKNFGPKS--PSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHL-- 454 (683)
Q Consensus 379 L~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~-- 454 (683)
|+|||+++........ .......||+.|+|||++.+.... ....++.++|||||||+||||+||..||.....
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccc---cCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999876543221 123356789999999998754210 111367899999999999999999887743211
Q ss_pred -----------chhHHHHHHH-cCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 455 -----------QGDKMSRNIR-AGERPLFPFH-----SPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 455 -----------~~~~~~~~i~-~~~~~~~p~~-----~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
....+...+. .+.++.++.. .+..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1112222222 2333444332 235689999999999999999999999999998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.4e-42 Score=357.01 Aligned_cols=259 Identities=14% Similarity=0.144 Sum_probs=206.6
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCC--CcchHHHHHHHHHcCCC-CceeeeeeeEEcCCCCeEEEEEe
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFG--DIEPLVPEISSLLSLSH-PNIMHFLCGFTDEEKKECFLIME 306 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~--~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~e~~~~~~LVmE 306 (683)
+++|++++.||+|+|+.|++. +|+.||||++.. ....+.+|+++++.|+| +||+.+++++.. ....|+|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 579999999999998877764 688999999853 45678999999999975 899999888754 478999999
Q ss_pred cCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 307 LMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 307 y~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
|++|+|.+++.. ....++..++..++.|++.||+|||++||+||||||+|||++.... .....+||+|||+|+
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~--~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LLGPSLEDLLDL-----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS--KNANMIYVVDFGMVK 154 (293)
T ss_dssp CCCCBHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS--TTTTCEEECCCTTCE
T ss_pred ecCCCHHHHHHh-----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc--ccCCceEEcccceeE
Confidence 999999999876 3356999999999999999999999999999999999999975431 112269999999998
Q ss_pred ccCCCCC-----CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchh-HHH
Q 038696 387 VKNFGPK-----SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGD-KMS 460 (683)
Q Consensus 387 ~~~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~-~~~ 460 (683)
....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---------~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCC---------CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence 7653321 1123356799999999999765 499999999999999999999999986543321 111
Q ss_pred HHHH----cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038696 461 RNIR----AGERPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRILRYIKRF 510 (683)
Q Consensus 461 ~~i~----~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L~~i~~~ 510 (683)
..+. .......+..+|+++.+++..|+..+|++||+++.+.+.|+.+...
T Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1121 1111223456789999999999999999999999999888876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=362.98 Aligned_cols=248 Identities=20% Similarity=0.294 Sum_probs=192.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC------CcchHHHHHHHHHcCCCCceeeeeeeEEcCC------C
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG------DIEPLVPEISSLLSLSHPNIMHFLCGFTDEE------K 298 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~------~ 298 (683)
++|++++.||+|+++.|++. +|+.||||++.. ..+.+.+|+.+|+.++||||+++++++.... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 58999999999998887763 688999999842 2456889999999999999999998875422 3
Q ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEE
Q 038696 299 KECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAK 378 (683)
Q Consensus 299 ~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vK 378 (683)
..+|+||||+.+++...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-------~~k 157 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-------VLK 157 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-------CEE
T ss_pred ceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-------cEE
Confidence 46899999999876665543 346799999999999999999999999999999999999999887 799
Q ss_pred EecccCccccCCCCC--CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 379 ISGFGLSSVKNFGPK--SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 379 L~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
|+|||+++....... ........||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+...
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--------~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--------RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCC--------CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 999999976653321 1223345789999999999754 258999999999999999999999998755322
Q ss_pred hHHHHHH---HcCCCCCCCC----------------------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 038696 457 DKMSRNI---RAGERPLFPF----------------------------HSPKYVTNLTKRCWHADPNQRPSFSSICRIL 504 (683)
Q Consensus 457 ~~~~~~i---~~~~~~~~p~----------------------------~~~~~l~~Li~~cL~~dP~~RPt~~eil~~L 504 (683)
....+ .....+.... ..++++.+||.+||..||++|||+.++++|-
T Consensus 230 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 230 --QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp --HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 11111 1111110000 1245678999999999999999999998774
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=367.94 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=191.8
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC-----cchHHHHHHHHHcCCCCceeeeeeeEEcCC---CCeEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD-----IEPLVPEISSLLSLSHPNIMHFLCGFTDEE---KKECF 302 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~---~~~~~ 302 (683)
++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.|+||||+++++++..+. ...+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 47999999999998777753 6999999999642 346789999999999999999998885432 23467
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecc
Q 038696 303 LIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGF 382 (683)
Q Consensus 303 LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DF 382 (683)
|||++++|+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+||
T Consensus 88 l~~~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-------~~kl~Df 153 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-------DLKICDF 153 (345)
T ss_dssp EEEECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------CEEECCC
T ss_pred EEEeecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-------CEEEccc
Confidence 7777777899999975 4599999999999999999999999999999999999998887 7999999
Q ss_pred cCccccCCCCC-CCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHH
Q 038696 383 GLSSVKNFGPK-SPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSR 461 (683)
Q Consensus 383 Gla~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~ 461 (683)
|+|+....... ........||+.|+|||++... ..++.++||||+||++|||++|+.||.+..... ....
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~ 224 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS--------KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNH 224 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB--------CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcC--------CCCCchhhhhccCceehHHhhCCCCCCCCCHHH-HHHH
Confidence 99986544322 2223456789999999998643 257899999999999999999999998654321 1111
Q ss_pred HHH------------------------cCCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 462 NIR------------------------AGERPL-----FPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 462 ~i~------------------------~~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.+. ...... .....+.++.+|+.+||..||.+|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 000000 123456789999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=366.76 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=195.0
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCC-CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEecC
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFG-DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMELM 308 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy~ 308 (683)
++|+++++||+|+|+.|++. +|+.||||+++. ..+.+.+|+.+|+.++ ||||++++++|.......+|+|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 58999999999998888873 688999999965 4567899999999995 99999999999876667899999999
Q ss_pred CC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCccc
Q 038696 309 SR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSSV 387 (683)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~~ 387 (683)
.+ +|..+. ..|++..+..++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+.
T Consensus 115 ~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~------~vkl~DFG~a~~ 179 (328)
T d3bqca1 115 NNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR------KLRLIDWGLAEF 179 (328)
T ss_dssp CSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT------EEEECCGGGCEE
T ss_pred CCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC------eeeeccccccee
Confidence 85 775442 35999999999999999999999999999999999999986541 699999999987
Q ss_pred cCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH----
Q 038696 388 KNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI---- 463 (683)
Q Consensus 388 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i---- 463 (683)
..... ......+|+.|+|||++.+. ..++.++||||+||++|||++|+.||..............
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g 248 (328)
T d3bqca1 180 YHPGQ---EYNVRVASRYFKGPELLVDY--------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248 (328)
T ss_dssp CCTTC---CCCSCCSCGGGCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred ccCCC---cccccccCccccCcccccCC--------CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence 65432 23455688999999998754 2579999999999999999999999976543221111100
Q ss_pred --------HcCC-----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 --------RAGE-----------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 --------~~~~-----------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.... ........++++.+||++||..||.+|||++++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000112356789999999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=365.11 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred CCCeEEEeEecccccEEEEEE-------cCcEEEEEEeCC--------CcchHHHHHHHHHcCCC-CceeeeeeeEEcCC
Q 038696 234 SEDYQVRRRLGSGSQYKEILW-------LGESFALRHFFG--------DIEPLVPEISSLLSLSH-PNIMHFLCGFTDEE 297 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~-------~g~~vAvK~~~~--------~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~e~ 297 (683)
-++|++++.||+|+++.|++. +|+.||||+++. ..+.+.+|+++|++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 368999999999998888764 478999999842 24567899999999976 8999999998654
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcce
Q 038696 298 KKECFLIMELMS-RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLH 376 (683)
Q Consensus 298 ~~~~~LVmEy~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~ 376 (683)
..+|+||||+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-------~ 167 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-------H 167 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-------C
T ss_pred -CceeeeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-------C
Confidence 78999999998 5999999864 4678999999999999999999999999999999999999887 7
Q ss_pred EEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccch
Q 038696 377 AKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQG 456 (683)
Q Consensus 377 vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~ 456 (683)
+||+|||+++...... ........|++.|+|||.+.+. ...++.++|||||||+||||++|+.||.+.....
T Consensus 168 vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~-------~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 168 VVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGG-------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTC-------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred EEEeeccchhhhcccc-cccccccccccccchhHHhhcC-------CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999998764332 1123456788999999999754 2347889999999999999999999997754322
Q ss_pred --hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 038696 457 --DKMSRNIRAGERPLFPFHSPKYVTNLTKRCWHADPNQRP-----SFSSICRI 503 (683)
Q Consensus 457 --~~~~~~i~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----t~~eil~~ 503 (683)
..+...... ..+.++..++.++.+||.+||..||++|| |++++++|
T Consensus 240 ~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 240 SQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHhccc-CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 222232222 34556778999999999999999999999 47888775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=350.34 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=194.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcCCCCeEEEE
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDEEKKECFLI 304 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e~~~~~~LV 304 (683)
++|+++++||+|+|+.|++. +|+.||||+++.. .+.+.+|+.+|+.++|||||+++++|.+. ..+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeEE
Confidence 58999999999998888764 6889999998431 35678999999999999999999999654 789999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEeccc
Q 038696 305 MELMSR-DLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKISGFG 383 (683)
Q Consensus 305 mEy~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFG 383 (683)
|||+.| +|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 80 ~~~~~~~~l~~~~~~------~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-------~~kl~DFG 146 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-------ELKLANFG 146 (292)
T ss_dssp EECCSEEHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------CEEECCCT
T ss_pred eeecccccccccccc------ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-------ceeeeecc
Confidence 999987 55555543 36789999999999999999999999999999999999998877 79999999
Q ss_pred CccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHHHHH
Q 038696 384 LSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMSRNI 463 (683)
Q Consensus 384 la~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~~~i 463 (683)
.|+....... ......+++.|+|||++.+.. .++.++|||||||++|||++|+.||.......+.+....
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~--------~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK--------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCS--------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCC--------CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 9987654332 223345677899999987542 478999999999999999999999765443322222211
Q ss_pred Hc-CC--------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 464 RA-GE--------------------------RPLFPFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 464 ~~-~~--------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
.. +. ........++.+.+||.+||+.||.+|||++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 10 111223456789999999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=360.51 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=184.3
Q ss_pred CCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC----CCCe
Q 038696 235 EDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE----EKKE 300 (683)
Q Consensus 235 ~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e----~~~~ 300 (683)
++|+++++||+|+++.|++. +|+.||||++... .+.+.+|+.+|+.++|||||+++++|..+ ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 58999999999998888763 6899999999542 23578999999999999999999998643 3478
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCCcceEEEe
Q 038696 301 CFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEGYLHAKIS 380 (683)
Q Consensus 301 ~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~ 380 (683)
+|+|||||.|++.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|++
T Consensus 97 ~~iv~Ey~~~~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-------~~kl~ 161 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-------TLKIL 161 (355)
T ss_dssp EEEEEECCSEEHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------CEEEC
T ss_pred eEEEEeccchHHHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-------ceeee
Confidence 99999999998887764 3489999999999999999999999999999999999999887 79999
Q ss_pred cccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCccchhHHH
Q 038696 381 GFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAHLQGDKMS 460 (683)
Q Consensus 381 DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~~~~~~~~ 460 (683)
|||+++...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+... ...
T Consensus 162 df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~---------~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~ 228 (355)
T d2b1pa1 162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWN 228 (355)
T ss_dssp CCCC------------------CCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred chhhhhcccccc---ccccccccccccChhhhcCC---------CCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHH
Confidence 999988765432 23445688899999999754 58999999999999999999999997654221 111
Q ss_pred HHH---------------------HcCCCCC-------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 038696 461 RNI---------------------RAGERPL-------------FPF------HSPKYVTNLTKRCWHADPNQRPSFSSI 500 (683)
Q Consensus 461 ~~i---------------------~~~~~~~-------------~p~------~~~~~l~~Li~~cL~~dP~~RPt~~ei 500 (683)
..+ ....... .+. ..+.++.+||++||..||++|||++++
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 111 0111000 000 124568999999999999999999999
Q ss_pred HHHH
Q 038696 501 CRIL 504 (683)
Q Consensus 501 l~~L 504 (683)
++|-
T Consensus 309 L~Hp 312 (355)
T d2b1pa1 309 LQHP 312 (355)
T ss_dssp HTST
T ss_pred hcCc
Confidence 8873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-41 Score=356.97 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=190.9
Q ss_pred ceeEeeCCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC------cchHHHHHHHHHcCCCCceeeeeeeEEcC-
Q 038696 228 SRILIKSEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD------IEPLVPEISSLLSLSHPNIMHFLCGFTDE- 296 (683)
Q Consensus 228 ~~~~~~~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~e- 296 (683)
+.|.+ .++|++++.||+|+++.|++. +|+.||||++... .+.+.+|+++|+.|+|||||+++++|...
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 45666 468999999999997777753 6899999999642 23578999999999999999999988542
Q ss_pred ---CCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCCCC
Q 038696 297 ---EKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGASTEG 373 (683)
Q Consensus 297 ---~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~~~ 373 (683)
+...+|++|++++|+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~----- 158 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----- 158 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----
T ss_pred ccccCceEEEEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-----
Confidence 2234566555556799998853 4699999999999999999999999999999999999999888
Q ss_pred cceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCCc
Q 038696 374 YLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDAH 453 (683)
Q Consensus 374 ~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~~ 453 (683)
.+|++|||++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 159 --~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~--------~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 159 --ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp --CEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTC--------SCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --cccccccchhcccCc-----ccccccccccccCchhhcCC--------ccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 799999999976532 23356788999999998654 257889999999999999999999998754
Q ss_pred cchhHHHHHHHc--CC--------------------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 038696 454 LQGDKMSRNIRA--GE--------------------RPLF--------PFHSPKYVTNLTKRCWHADPNQRPSFSSICRI 503 (683)
Q Consensus 454 ~~~~~~~~~i~~--~~--------------------~~~~--------p~~~~~~l~~Li~~cL~~dP~~RPt~~eil~~ 503 (683)
... ....+.. +. .... ....++++.+||.+||..||.+|||+.++++|
T Consensus 224 ~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 224 HID--QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHH--HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHH--HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 321 1111110 00 0000 13457889999999999999999999999886
Q ss_pred H
Q 038696 504 L 504 (683)
Q Consensus 504 L 504 (683)
-
T Consensus 302 p 302 (348)
T d2gfsa1 302 A 302 (348)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=321.85 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=186.8
Q ss_pred CCCeEEEeEecccccEEEEEE----cCcEEEEEEeCCC---cchHHHHHHHHHcCC-----------CCceeeeeeeEEc
Q 038696 234 SEDYQVRRRLGSGSQYKEILW----LGESFALRHFFGD---IEPLVPEISSLLSLS-----------HPNIMHFLCGFTD 295 (683)
Q Consensus 234 ~~~y~i~~~LG~G~~~~v~l~----~g~~vAvK~~~~~---~~~~~~Ei~iL~~L~-----------HpnIv~l~~~~~~ 295 (683)
.++|+++++||+|+++.|++. +|+.||||++... .+.+.+|+++|+.++ |+|||++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 346999999999998888864 6899999999754 356788999998875 5789999988866
Q ss_pred CCCCeEEEEEecCC--CCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEeCCCCCCCC
Q 038696 296 EEKKECFLIMELMS--RDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHS-KKIYHGNLNPSNILLKPRGASTE 372 (683)
Q Consensus 296 e~~~~~~LVmEy~~--gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDLKp~NILl~~~g~~~~ 372 (683)
......++||+++. ++....... .....+++..+..++.||+.||.|||+ .||+||||||+||||+.++. ..
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~-~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS-PE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH----TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET-TT
T ss_pred ccccceeeeeeeccccccccccccc----ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc-cc
Confidence 55566777777764 344444443 245678999999999999999999998 89999999999999976651 12
Q ss_pred CcceEEEecccCccccCCCCCCCCCCCCCcCcccCChhhhhhccccccccCCCCCchhHHHhHHHHHHHHHhCCCCCCCC
Q 038696 373 GYLHAKISGFGLSSVKNFGPKSPSQSGTTHPFIWHAPEVLEENEQTESASNSKYSEKSDVYSFGMICFEILTGKVPFEDA 452 (683)
Q Consensus 373 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~~~~~~s~ksDVwSlGvil~ElltG~~Pf~~~ 452 (683)
....+|++|||.+..... ......||+.|+|||++.+. .|+.++||||+||++++|++|+.||...
T Consensus 167 ~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTC---------CCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeeccccccccc-----ccccccccccccChhhcccc---------CCCccccccchHHHHHHHHHCCCCCCCC
Confidence 334599999999976543 22345789999999999755 4899999999999999999999999753
Q ss_pred ccch-----hHHHHHHHc-CC---------------------------------------CCCCCCCCcHHHHHHHHHhh
Q 038696 453 HLQG-----DKMSRNIRA-GE---------------------------------------RPLFPFHSPKYVTNLTKRCW 487 (683)
Q Consensus 453 ~~~~-----~~~~~~i~~-~~---------------------------------------~~~~p~~~~~~l~~Li~~cL 487 (683)
.... +.+...+.. +. ...++...++.+.+||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 2110 111111100 00 00011223567899999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 038696 488 HADPNQRPSFSSICRI 503 (683)
Q Consensus 488 ~~dP~~RPt~~eil~~ 503 (683)
..||.+|||+.++++|
T Consensus 313 ~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNH 328 (362)
T ss_dssp CSSTTTCBCHHHHHTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.7e-21 Score=188.76 Aligned_cols=127 Identities=16% Similarity=0.131 Sum_probs=99.8
Q ss_pred eEEEeEecccccEEEEE---EcCcEEEEEEeCCC----------------------cchHHHHHHHHHcCCCCceeeeee
Q 038696 237 YQVRRRLGSGSQYKEIL---WLGESFALRHFFGD----------------------IEPLVPEISSLLSLSHPNIMHFLC 291 (683)
Q Consensus 237 y~i~~~LG~G~~~~v~l---~~g~~vAvK~~~~~----------------------~~~~~~Ei~iL~~L~HpnIv~l~~ 291 (683)
+.+.++||+|+++.|+. .+|+.||||+++.. ......|...|..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 56899999999777765 47899999987421 012346888999999999998775
Q ss_pred eEEcCCCCeEEEEEecCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEeCCCCCCC
Q 038696 292 GFTDEEKKECFLIMELMSRDLCSYIKEICCPRKRIPFSLPVAVDLMLQIARGMEYLHSKKIYHGNLNPSNILLKPRGAST 371 (683)
Q Consensus 292 ~~~~e~~~~~~LVmEy~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDLKp~NILl~~~g~~~ 371 (683)
.. . .+|||||+++... ..++...+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~--~----~~lvme~~~~~~~------------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~--- 140 (191)
T d1zara2 82 WE--G----NAVLMELIDAKEL------------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--- 140 (191)
T ss_dssp EE--T----TEEEEECCCCEEG------------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---
T ss_pred ec--C----CEEEEEeeccccc------------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---
Confidence 43 2 2799999997321 1144455678999999999999999999999999999998764
Q ss_pred CCcceEEEecccCccccC
Q 038696 372 EGYLHAKISGFGLSSVKN 389 (683)
Q Consensus 372 ~~~~~vKL~DFGla~~~~ 389 (683)
++|+|||+|....
T Consensus 141 -----~~liDFG~a~~~~ 153 (191)
T d1zara2 141 -----IWIIDFPQSVEVG 153 (191)
T ss_dssp -----EEECCCTTCEETT
T ss_pred -----EEEEECCCcccCC
Confidence 8999999997653
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.39 E-value=4.9e-08 Score=80.45 Aligned_cols=72 Identities=4% Similarity=-0.032 Sum_probs=53.4
Q ss_pred HhhhccccCCCchhHHHHHHhh-----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH-----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~-----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~ 195 (683)
|+..+||||-++|++|+.+|.. +|.|+||.|+...+. |+| ...-++|+.|.+.++.|++.....|.
T Consensus 2 l~~~pWyhg~isR~~Ae~lL~~~~~~~dG~FLvR~S~~~~g~------~~Lsv~~~~~v~h~~I~~~~~~~~~~~~~~F~ 75 (86)
T d1rpya_ 2 LSDYPWFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGE------CVLTFNFQGKAKHLRLSLNGHGQCHVQHLWFQ 75 (86)
T ss_dssp GGGSTTBCTTCCHHHHHHHHHTTGGGGTTCEEEEECSSSTTC------EEEEEEETTEEEEEEC----CCCHHHHHHHHH
T ss_pred CccCcccCCCCCHHHHHHHHHhCCCCCCceEEEEecCCCCCc------EEEEEEECCceEEEEEEEcCCceEEeCCCeeC
Confidence 5778999999999999999953 599999999866666 777 33448899998888888877766675
Q ss_pred hccCCc
Q 038696 196 KISGST 201 (683)
Q Consensus 196 ~~~~~~ 201 (683)
++.+..
T Consensus 76 sl~~LV 81 (86)
T d1rpya_ 76 SVFDML 81 (86)
T ss_dssp HHHHHH
T ss_pred CHHHHH
Confidence 544433
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=9.1e-09 Score=88.13 Aligned_cols=74 Identities=12% Similarity=-0.009 Sum_probs=55.0
Q ss_pred HHhhhccccCCCchhHHHHHHhhcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccC
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVHSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISG 199 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 199 (683)
.|+.++||||.++|++|+.+|..+|+|+||.|+..++. |+| ...-++||.|...++.|++ ....|.++.+
T Consensus 3 ~l~~~pWyhG~i~R~~Ae~lL~~~G~FLVR~S~~~~g~------~vLSv~~~~~v~H~~I~~~~~~~~~-~~~~F~sl~~ 75 (104)
T d1mila_ 3 QLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPGQ------YVLTGLQSGQPKHLLLVDPEGVVRT-KDHRFESVSH 75 (104)
T ss_dssp STTTCTTBCSSCCHHHHHTTCCSTTEEEEEECCSSCSS------EEEEEEETTEEEEEEEBCTTSSEEC-SSCEESSHHH
T ss_pred ccccCCCcCCCCCHHHHHHHHhcCCcEEEEecCCCCCC------EEEEEEEccccceEEEEeCCCEEEe-CCeeECCHHH
Confidence 57889999999999999999999999999999877766 777 4455889988655444443 3445544444
Q ss_pred Cchh
Q 038696 200 STKQ 203 (683)
Q Consensus 200 ~~~~ 203 (683)
...+
T Consensus 76 LV~~ 79 (104)
T d1mila_ 76 LISY 79 (104)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 3333
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=3.4e-08 Score=84.77 Aligned_cols=77 Identities=8% Similarity=0.046 Sum_probs=55.0
Q ss_pred HHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeechh--------hhhhhhhhhc-ccchhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITPD--------FCYRIDTVWK-EDRWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~~--------~~~~~~~~~~-~~~~~l~ 189 (683)
+||.++||||.++|++|+.+|.+ +|.|+||.|+...+. |+|+.. .|+|+.+... .+.+++.
T Consensus 1 ~l~~~~Wy~g~i~R~eAe~lL~~~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~~~~~~i~h~~i~~~~~g~~~~~ 74 (106)
T d1o48a_ 1 SIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGA------YCLSVSDFDNAKGLNVKHYKIRKLDSGGFYIT 74 (106)
T ss_dssp CGGGSTTEEESCCHHHHHHHHCCTTCCTTCEEEEECSSSTTC------EEEEEEEEETTTEEEEEEEEEEECTTSCEESS
T ss_pred CcccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEcccCCCCC------EEEEEEecccCcccceEEEEEEEecCCCEEEc
Confidence 47899999999999999999964 799999999866666 777432 2667777543 3446666
Q ss_pred hhhhhhhccCCchhhh
Q 038696 190 NKIQQKKISGSTKQEQ 205 (683)
Q Consensus 190 ~~~~~~~~~~~~~~~~ 205 (683)
....|.++.+...++.
T Consensus 75 ~~~~F~sl~eLV~~y~ 90 (106)
T d1o48a_ 75 SRTQFNSLQQLVAYYS 90 (106)
T ss_dssp TTSEESSHHHHHHHHT
T ss_pred CCeeECCHHHHHHHHh
Confidence 6656655544444443
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=4e-08 Score=84.06 Aligned_cols=76 Identities=9% Similarity=0.097 Sum_probs=55.5
Q ss_pred HHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeech--------hhhhhhhhhhcc-cchhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWKE-DRWILF 189 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~~-~~~~l~ 189 (683)
.|+.++||||.++|++|+++|.. .|.|+||.|+..++. |+|+. ..++|+.|.... +.+++.
T Consensus 2 ~l~~~~Wy~g~i~R~eAe~~L~~~g~~~G~FLVR~S~~~~g~------~~Lsv~~~~~~~~~~v~h~~i~~~~~g~~~~~ 75 (104)
T d1g83a2 2 SIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGA------YSLSIRDWDDMKGDHVKHYKIRKLDNGGYYIT 75 (104)
T ss_dssp SGGGSSSBCTTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTC------EEEEEEEECSSSCEEEEEEEEEECTTSCEEET
T ss_pred ccccCCCcCCCCCHHHHHHHHHhcCCCCCcEEEeccCCCCCC------eEEEEEEeecCcCCeEEEEEEEEcCCCCEEec
Confidence 58899999999999999999964 699999999877666 77743 237788886544 446666
Q ss_pred hhhhhhhccCCchhh
Q 038696 190 NKIQQKKISGSTKQE 204 (683)
Q Consensus 190 ~~~~~~~~~~~~~~~ 204 (683)
....|.++.....++
T Consensus 76 ~~~~F~sl~~LV~~y 90 (104)
T d1g83a2 76 TRAQFETLQQLVQHY 90 (104)
T ss_dssp TTEEESSHHHHHHHH
T ss_pred CCcccCCHHHHHHHH
Confidence 655565544444444
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=6e-08 Score=81.82 Aligned_cols=74 Identities=8% Similarity=0.017 Sum_probs=56.2
Q ss_pred hhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccC
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISG 199 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 199 (683)
...|||||.+.|++|+.+|.. +|.|+||.|+..++. |+| ....++||.|..++++|++.+...|.++.+
T Consensus 2 s~~PWy~g~isR~eAe~~L~~~~~G~FLVR~S~~~~g~------~vLSv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl~~ 75 (97)
T d1jwoa_ 2 SLMPWFHGKISGQEAVQQLQPPEDGLFLVRESARHPGD------YVLCVSFGRDVIHYRVLHRDGHLTIDEAVFFCNLMD 75 (97)
T ss_dssp TTCTTEEESCCHHHHHHHTCSCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEESSSEESSTTSCCBSCHHH
T ss_pred CcCCccCCCCCHHHHHHHhcCCCCCeEEEEecCCCCcc------EEEEEEecCceEEEEEEEcCCcEEecCCcccCCHHH
Confidence 457999999999999999986 688999999866665 777 344588999977777888877666655444
Q ss_pred Cchhh
Q 038696 200 STKQE 204 (683)
Q Consensus 200 ~~~~~ 204 (683)
...++
T Consensus 76 LI~~y 80 (97)
T d1jwoa_ 76 MVEHY 80 (97)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44433
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.15 E-value=4.4e-08 Score=85.21 Aligned_cols=80 Identities=8% Similarity=0.067 Sum_probs=59.6
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeech-------hhhhhhhhhhcc-cchhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITP-------DFCYRIDTVWKE-DRWILF 189 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~-------~~~~~~~~~~~~-~~~~l~ 189 (683)
+.|+.++||||.++|++|+++|+. .|.|+||.|+..++. |+|+. ..++||.+...+ +.|++.
T Consensus 7 ~~l~~e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~------~~Lsv~~~~~~~~~v~H~~i~~~~~g~~~l~ 80 (114)
T d1blja_ 7 ETLEVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGA------FSLSVKDITTQGEVVKHYKIRSLDNGGYYIS 80 (114)
T ss_dssp CCSCCSSSBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSSC------EEEEECBCCTTTCBCCCEEEEEETTTEEEEE
T ss_pred CccccCCCcCCCCCHHHHHHHHHhcCCCCceEEEeccCCCCCC------eEEEEEeeccCCCEEEEEEEEEcCCCCEEec
Confidence 567889999999999999999853 699999999866666 77742 347898886544 457777
Q ss_pred hhhhhhhccCCchhhhch
Q 038696 190 NKIQQKKISGSTKQEQGL 207 (683)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~ 207 (683)
....|.++.+...++...
T Consensus 81 ~~~~F~sl~eLV~~y~~~ 98 (114)
T d1blja_ 81 PRITFPTLQALVQHYSKK 98 (114)
T ss_dssp TTEEESSHHHHHHHHHHC
T ss_pred CCceECCHHHHHHHHhhC
Confidence 766676666665555443
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=8.1e-08 Score=82.22 Aligned_cols=76 Identities=7% Similarity=0.045 Sum_probs=54.4
Q ss_pred HhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeeech--------hhhhhhhhhhc-ccchhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWK-EDRWILFN 190 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~-~~~~~l~~ 190 (683)
||.++||||-+.|++|+.+|+. +|.|+||.|+..+|. |+|+. ..++|+.+... .+.+++..
T Consensus 1 le~~pWy~g~isR~eAe~~L~~~~~~~GtFLVR~S~~~~g~------~~lsv~~~~~~~~~~v~h~~i~~~~~~~~~~~~ 74 (105)
T d1lkka_ 1 LEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGS------FSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISP 74 (105)
T ss_dssp CCCCTTBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTTC------EEEEEEEEETTTEEEEEEEEEEECTTSCEESST
T ss_pred CccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEccCCCCCC------EEEEEEEcccCCCccEEEEEEEEcCCCCEEecC
Confidence 5789999999999999999953 699999999866666 66633 23788888654 44466666
Q ss_pred hhhhhhccCCchhhh
Q 038696 191 KIQQKKISGSTKQEQ 205 (683)
Q Consensus 191 ~~~~~~~~~~~~~~~ 205 (683)
...|.++.+...++.
T Consensus 75 ~~~F~sl~~LV~~y~ 89 (105)
T d1lkka_ 75 RITFPGLHELVRHYT 89 (105)
T ss_dssp TSCBSSHHHHHHHHH
T ss_pred CcccCCHHHHHHHHh
Confidence 555655555444443
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=7.8e-08 Score=81.72 Aligned_cols=73 Identities=7% Similarity=0.048 Sum_probs=55.7
Q ss_pred hhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhccC
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKISG 199 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 199 (683)
+..|||||.+.|++|+.+|.. +|.|+||.|+...+. |+| ....++||.|...++.|++.+...|.++.+
T Consensus 2 ~~~PWy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl~~ 75 (101)
T d1k9aa2 2 SLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPGD------YTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQ 75 (101)
T ss_dssp ESCTTBCTTCCHHHHHHHTCSCCTTEEEEEECSSSTTS------EEEEEECSSSEEEEEEEEETTEEESSSSSCBSSHHH
T ss_pred CcCCccCCCCCHHHHHHHHcCCCCCCEEEeccCCCCCC------EEEEEEeCCccEEEEEEEcCCCceecCCcccCCHHH
Confidence 346899999999999999975 899999999866665 777 445588999987777788766655654444
Q ss_pred Cchh
Q 038696 200 STKQ 203 (683)
Q Consensus 200 ~~~~ 203 (683)
...+
T Consensus 76 LV~~ 79 (101)
T d1k9aa2 76 LVEH 79 (101)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.06 E-value=1.1e-07 Score=80.68 Aligned_cols=71 Identities=11% Similarity=0.046 Sum_probs=52.8
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hhhhhhhhhhh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WILFNKIQQKK 196 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~l~~~~~~~~ 196 (683)
+||..+||||.++|++|+.+|.. +|.|+||.|+..++. |+| ....++|+.|....++ +++.....|.+
T Consensus 1 sLe~~~Wy~g~isR~eAe~lL~~~~~G~FLVR~S~~~~~~------~~LSv~~~~~v~H~~I~~~~~g~~~~~~~~~F~s 74 (101)
T d1opka2 1 SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQ------RSISLRYEGRVYHYRINTASDGKLYVSSESRFNT 74 (101)
T ss_dssp SGGGSTTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEECEECTTSCEESSTTSCBSS
T ss_pred CcccCcccCCCCCHHHHHHHhcCCCCCeEEEEecCCCCCC------EEEEEEcCcceEEEEeEECCCCCEEeCCCcccCC
Confidence 37889999999999999999997 777999999866665 777 4445789999755444 55555545544
Q ss_pred ccC
Q 038696 197 ISG 199 (683)
Q Consensus 197 ~~~ 199 (683)
+.+
T Consensus 75 l~~ 77 (101)
T d1opka2 75 LAE 77 (101)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=1.7e-07 Score=79.34 Aligned_cols=72 Identities=10% Similarity=0.100 Sum_probs=52.7
Q ss_pred hhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc-chhhhhhhhhhhc
Q 038696 126 TAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED-RWILFNKIQQKKI 197 (683)
Q Consensus 126 ~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~-~~~l~~~~~~~~~ 197 (683)
+++||||-+.|++|+++|.. +|.|+||.|+...+. |+| ....++||.|....+ .|++.....|.++
T Consensus 1 sepWy~g~isR~~Ae~~L~~~~~~~G~FLvR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl 74 (100)
T d1rjaa_ 1 SEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSAD------YVLSVRDTQAVRHYKIWRRAGGRLHLNEAVSFLSL 74 (100)
T ss_dssp CCCCBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSSC------EEEEECTTSSCEEEEEEECSSSCEEEETTEEESSH
T ss_pred CCCCcCCCCCHHHHHHHHhccCCCCCeEEeecCCCCCCC------EEEEEEcCCCceEEEEEECCCCCEEecCCCccCCH
Confidence 47999999999999999963 599999999866665 777 444588999865544 4766555556554
Q ss_pred cCCchh
Q 038696 198 SGSTKQ 203 (683)
Q Consensus 198 ~~~~~~ 203 (683)
.+...+
T Consensus 75 ~~LV~~ 80 (100)
T d1rjaa_ 75 PELVNY 80 (100)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444333
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=9.9e-07 Score=73.93 Aligned_cols=64 Identities=9% Similarity=0.033 Sum_probs=50.0
Q ss_pred hccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhh
Q 038696 127 AAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKK 196 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~ 196 (683)
.|||||.++|++|+.+|.. +|.|+||.|+..++. |+| ...-++||.|..+.+++++.....|.+
T Consensus 3 ~pWy~g~isR~~Ae~lL~~~~~~G~FLvR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~~~~~~F~s 72 (96)
T d1jyra_ 3 MAWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGD------FSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNS 72 (96)
T ss_dssp CTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTTC------EEEEEEETTEEEEEECEECTTSCEESSSCEESS
T ss_pred CCccCCCCCHHHHHHHHhhCCCCCeEEEEecCCCCCC------EEEEEEeCCceEEEEEEECCCCeEEeCCccCCC
Confidence 5899999999999999963 699999999866666 777 445588999987777666555545533
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=1.8e-07 Score=79.67 Aligned_cols=71 Identities=7% Similarity=0.015 Sum_probs=50.6
Q ss_pred hccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeeech--------hhhhhhhhhhcccc-hhhhhhhh
Q 038696 127 AAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLITP--------DFCYRIDTVWKEDR-WILFNKIQ 193 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l~~--------~~~~~~~~~~~~~~-~~l~~~~~ 193 (683)
|+||||.++|++|+.+|. ..|.|+||.|+..+|. |+|+. ..++|+.+....++ +++.....
T Consensus 1 e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~------~~Lsv~~~~~~~~~~v~H~~i~~~~~g~~~~~~~~~ 74 (103)
T d1qcfa2 1 EEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGS------YSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRST 74 (103)
T ss_dssp STTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTS------EEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSC
T ss_pred CCccCCCCCHHHHHHHHhhcCCCCCcEEEEccCCCCCC------eEEEEEecCCCcCceEEEEEEEEcCCCceeecCCcc
Confidence 589999999999999994 4699999999877776 77742 34788888665444 55554444
Q ss_pred hhhccCCchh
Q 038696 194 QKKISGSTKQ 203 (683)
Q Consensus 194 ~~~~~~~~~~ 203 (683)
|.++.+...+
T Consensus 75 F~sl~~LV~~ 84 (103)
T d1qcfa2 75 FSTLQELVDH 84 (103)
T ss_dssp BSSHHHHHHH
T ss_pred cCCHHHHHHH
Confidence 5444443333
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=1.6e-05 Score=77.93 Aligned_cols=76 Identities=16% Similarity=0.020 Sum_probs=48.4
Q ss_pred CeEEEeEecccc---cEEEEEEcCcEEEEEEeCC----CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeEEEEEec
Q 038696 236 DYQVRRRLGSGS---QYKEILWLGESFALRHFFG----DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKECFLIMEL 307 (683)
Q Consensus 236 ~y~i~~~LG~G~---~~~v~l~~g~~vAvK~~~~----~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~~LVmEy 307 (683)
.|+..+..+.|+ +|.+. ..+..+.||+... ....+.+|+..+..|. +--+.++++...+ .+..|+||++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~~ 91 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSE 91 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEEC
T ss_pred ceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEEe
Confidence 555555443332 33332 4667788998853 3446789999988774 4335666665543 3678999999
Q ss_pred CCC-CHHH
Q 038696 308 MSR-DLCS 314 (683)
Q Consensus 308 ~~g-sL~~ 314 (683)
++| .+.+
T Consensus 92 l~G~~~~~ 99 (263)
T d1j7la_ 92 ADGVLCSE 99 (263)
T ss_dssp CSSEEHHH
T ss_pred cccccccc
Confidence 998 5544
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.97 E-value=3.5e-07 Score=76.92 Aligned_cols=61 Identities=11% Similarity=0.009 Sum_probs=49.1
Q ss_pred HhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFN 190 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~ 190 (683)
|+..+||||-++|++|+.+|. ..|.|+||.|+..++. |+| ....++|+.|.+..+++++..
T Consensus 3 ~~~~~Wy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~~~ 68 (97)
T d1r1qa_ 3 IEFPEWFHEGLSRHQAENLLMGKDIGFFIIRASQSSPGD------FSISVRHEDDVQHFKVMRDTKGNYFLW 68 (97)
T ss_dssp CSCCTTBCTTCCHHHHHHHHHTSCTTCEEEEECSSSTTC------EEEEEECSSSEEEEECEECTTCCEESS
T ss_pred cccCCccCCCCCHHHHHHHHhcCCCCCEEEeecCCCCCC------EEEEEEecCCeEEEEEEEcCCCeEEeC
Confidence 567899999999999999996 4899999999866666 777 444588999987777655543
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.95 E-value=4.7e-07 Score=77.87 Aligned_cols=67 Identities=9% Similarity=0.010 Sum_probs=52.1
Q ss_pred hhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhc
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKI 197 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 197 (683)
++..||||.++|++|+.+|+. +|.|+||.|+...|. |+| ...-++|+.|....+.|++...-.|.++
T Consensus 1 ~~~~Wy~g~isR~~Ae~lL~~~~~~G~FLvR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~F~sl 73 (109)
T d2shpa2 1 KSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGD------LTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATL 73 (109)
T ss_dssp CCSTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEECSSSCEEETTSCEESSH
T ss_pred CCCccccCCCCHHHHHHHHhhCCCCCeEEEEecCCCCCC------EEEEEEeCCcEEEEEEEEcCCeEEEcCCcccCCH
Confidence 357899999999999999974 699999999866666 777 4445889999877777777655445443
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.94 E-value=4.2e-07 Score=78.37 Aligned_cols=77 Identities=10% Similarity=0.123 Sum_probs=55.9
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKI 197 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 197 (683)
.|++++||||.++|++|+.+|.. +|+|+||.|+... +..|+| ....+.|+.|...++.|++.....|.++
T Consensus 7 ~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~-----~~~~~ls~~~~~~~~H~~I~~~~~~~~~~~~~~F~sl 81 (111)
T d1fu6a_ 7 SLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKM-----HGDYTLTLRKGGNNKSIKIFHRDGKYGFSDPLTFNSV 81 (111)
T ss_dssp CCSCCSSCCSSCCSHHHHHHSSSCSSCCCCCBSSCCSS-----SCCSBCEEEETTEEEECCCCCTTTCCCTTTTSCCCCT
T ss_pred ccCcCcCCCCCCCHHHHHHHhCcCCCCEEEEEeccCCC-----CccEEEEEecCCceEEEEEEEcCCeEEECCCcccCCH
Confidence 36789999999999999999985 6999999986432 123555 4455889988767777887766566555
Q ss_pred cCCchhh
Q 038696 198 SGSTKQE 204 (683)
Q Consensus 198 ~~~~~~~ 204 (683)
.+...++
T Consensus 82 ~~LV~~y 88 (111)
T d1fu6a_ 82 VELINHY 88 (111)
T ss_dssp THHHHHH
T ss_pred HHHHHHH
Confidence 4444433
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=3e-06 Score=71.83 Aligned_cols=66 Identities=14% Similarity=0.121 Sum_probs=51.5
Q ss_pred hHHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhh
Q 038696 120 LIEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNK 191 (683)
Q Consensus 120 ~~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~ 191 (683)
....|+.++||||.++|++|+.+|.. +|.|+||.|+..++. |+| ....++|+.|...++.|.+...
T Consensus 8 ~~~~l~~~~Wy~g~i~R~~Ae~~L~~~~~GtFLVR~S~~~~~~------~~LSv~~~~~v~H~~I~~~~~~~~~~~~ 78 (103)
T d2c9wa2 8 ALRELGQTGWYWGSMTVNEAKEKLKEAPEGTFLIRDSSHSDYL------LTISVKTSAGPTNLRIEYQDGKFRLDSI 78 (103)
T ss_dssp HHHHHHHTSCBCTTCCHHHHHHHHTTSCTTCEEEEECCSTTCS------EEEEEEETTEEEEEEEEEETTEEEECTT
T ss_pred HHHHHhhCCCcCCCCCHHHHHHHhcCCCCCceEEeccCCCCCC------EEEEEEECCEEEEEEEEEcCCeEeeCCc
Confidence 44568899999999999999999986 688999999866666 666 4445789888766666655443
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=1.1e-06 Score=74.60 Aligned_cols=58 Identities=16% Similarity=0.153 Sum_probs=46.6
Q ss_pred HhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWI 187 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~ 187 (683)
||+++||||.+.|++|+.+|.. +|+|+||.|+..++. |+| ....++|+.|.+.+++++
T Consensus 1 le~~pwyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g~------~~Lsv~~~~~v~H~~I~~~~~~~~ 64 (104)
T d1d4ta_ 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGV------YCLCVLYHGYIYTYRVSQTETGSW 64 (104)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCE
T ss_pred CCcCCccccCCCHHHHHHHHhhCCCCCeEEEEecCCCCCC------EEEEEecCCCceEEEEEEcCCCcE
Confidence 5789999999999999999974 599999999876666 776 445588998876555543
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=5.9e-07 Score=78.99 Aligned_cols=76 Identities=11% Similarity=0.047 Sum_probs=53.5
Q ss_pred HHHhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc-chhhhhhhh
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED-RWILFNKIQ 193 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~-~~~l~~~~~ 193 (683)
.+-|..+||||.+.|++|+.+|.. +|.|+||.|+. .+ .|+| ....++||.|.+..+ .|++.....
T Consensus 24 ~~~e~~pWyhg~isR~eAe~lL~~~~~~dGtFLVR~S~~-~g------~yvLSv~~~~~v~H~~I~~~~~g~~~l~~~~~ 96 (124)
T d2oq1a2 24 TAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKE-QG------TYALSLIYGKTVYHYLISQDKAGKYCIPEGTK 96 (124)
T ss_dssp HGGGGSTTBCSSCCHHHHHHHHHSSCCCTTEEEEEECSS-TT------EEEEEEEETTEEEEEEEEECTTSCEESTTSCC
T ss_pred ccccCCCCccCCCCHHHHHHHHhhcCCCCceEEeEecCC-CC------CEEEEeecCCceEEEEEEECCCCCEEeCCCcc
Confidence 444678999999999999999964 59999999963 33 3777 445588999976544 476655555
Q ss_pred hhhccCCchhh
Q 038696 194 QKKISGSTKQE 204 (683)
Q Consensus 194 ~~~~~~~~~~~ 204 (683)
|.++.....++
T Consensus 97 F~sl~~LV~~y 107 (124)
T d2oq1a2 97 FDTLWQLVEYL 107 (124)
T ss_dssp BSSHHHHHHHH
T ss_pred cCCHHHHHHHH
Confidence 54444443333
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.84 E-value=9.9e-07 Score=75.18 Aligned_cols=71 Identities=7% Similarity=0.056 Sum_probs=49.5
Q ss_pred HhhhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhc
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKI 197 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 197 (683)
.|+++||||.++|++|+++|.. +|.|+||.|. ..+. |+| ...-++||.|... +++++.....|.++
T Consensus 6 he~~~Wy~g~i~R~eAe~lL~~~~~~G~FLVR~S~-~~~~------yvLSv~~~~~v~H~~I~~~-~~~~~~~~~~F~sl 77 (105)
T d2fcia1 6 HESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRN-EPNS------YAISFRAEGKIKHCRVQQE-GQTVMLGNSEFDSL 77 (105)
T ss_dssp TSSSCCCCSSSCSHHHHHHHHHSSSSCCEEEEECS-STTC------EEEEEEETTEECCCEEBCC-SSCEECSSSEESTT
T ss_pred cccCCCccCCCCHHHHHHHHHhCCCCCeEEEEecC-CCCC------EEEEEEeccccEEEEEEec-CCeEecCCcccCCH
Confidence 3678999999999999999974 6999999984 4444 777 4455889988644 44444444455444
Q ss_pred cCCch
Q 038696 198 SGSTK 202 (683)
Q Consensus 198 ~~~~~ 202 (683)
.+...
T Consensus 78 ~~LV~ 82 (105)
T d2fcia1 78 VDLIS 82 (105)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44333
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=8.3e-07 Score=78.52 Aligned_cols=75 Identities=9% Similarity=0.011 Sum_probs=54.9
Q ss_pred hhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc-chhhhhhhhhhh
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED-RWILFNKIQQKK 196 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~-~~~l~~~~~~~~ 196 (683)
++-|||||-+.|++|+.+|.. +|.|+||.|+..++. |+| ....++||.|....+ .+++.....|.+
T Consensus 3 ~~~PWyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~g~~~i~~~~~F~s 76 (129)
T d1a81a1 3 NHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGG------FALSVAHGRKAHHYTIERELNGTYAIAGGRTHAS 76 (129)
T ss_dssp TSSTTBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEEETTSCCBSS
T ss_pred CCCCcccCCCCHHHHHHHHHhcCCCCccEEEEccCCCCcc------eEEEeeecccceEEEEEEcCCCCeeecCCcccCC
Confidence 567999999999999999974 588999999866666 877 445588998865554 466655555655
Q ss_pred ccCCchhhh
Q 038696 197 ISGSTKQEQ 205 (683)
Q Consensus 197 ~~~~~~~~~ 205 (683)
+.+...++.
T Consensus 77 l~eLV~~Y~ 85 (129)
T d1a81a1 77 PADLCHYHS 85 (129)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 555544444
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=1.3e-06 Score=75.43 Aligned_cols=64 Identities=6% Similarity=-0.011 Sum_probs=52.3
Q ss_pred HHHHhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhh
Q 038696 121 IEAIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFN 190 (683)
Q Consensus 121 ~~~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~ 190 (683)
.+.|++.+||||-++|++|+.+|.. +|.|+||.|+...+. |+| ...-++|+.|...+++|.+..
T Consensus 5 ~~~l~~~~Wy~g~isR~~Ae~lL~~~~~GtFLVR~S~~~~~~------~~LSv~~~~~v~H~~I~~~~~~~~l~~ 73 (112)
T d2izva2 5 LLQINNNPCYWGVMDKYAAEALLEGKPEGTFLLRDSAQEDYL------FSVSFRRYSRSLHARIEQWNHNFSFDA 73 (112)
T ss_dssp HHHHHHCTTEEEECCHHHHHHHHTTCCTTEEEEEECSSTTCS------EEEEEEETTEEEEEECEEETTEEESCT
T ss_pred hHHhccCCCcCCCCCHHHHHHHHccCCCCcEEEeecCCCCCC------eEEEEEecCCceEEEEEEeCCeEEEee
Confidence 4668899999999999999999986 799999999866665 766 445578999987777776643
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.78 E-value=1e-06 Score=78.10 Aligned_cols=76 Identities=8% Similarity=-0.073 Sum_probs=55.8
Q ss_pred HhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~l~~~~~~~ 195 (683)
.+..+||||-+.|++|+.+|+. .|.|+||.|+...+. |+| ....++||.|....+. +.+.....|.
T Consensus 3 ~~~~pWy~g~i~R~~Ae~~L~~~g~~~G~FLVR~S~~~~g~------yvLSv~~~~~v~H~~I~~~~~g~~~l~~~~~F~ 76 (130)
T d2oq1a1 3 AAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGG------YVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHC 76 (130)
T ss_dssp TTTCTTBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTTC------EEEEEEETTEEEEEEEEECTTSCEEETTSCCBS
T ss_pred ccCCCCccCCCCHHHHHHHHHhcCCCCceEEEEecCCCCcc------EEEEEeeCCceEEEEEEEcCCCceeccCCCCcC
Confidence 3566899999999999999974 588999999866666 777 4555899999655544 6665555566
Q ss_pred hccCCchhhh
Q 038696 196 KISGSTKQEQ 205 (683)
Q Consensus 196 ~~~~~~~~~~ 205 (683)
++.+...++.
T Consensus 77 sl~~Lv~~Y~ 86 (130)
T d2oq1a1 77 GPAELCEFYS 86 (130)
T ss_dssp SHHHHHHHHH
T ss_pred CHHHHHHHHh
Confidence 6555555544
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.68 E-value=2e-06 Score=73.47 Aligned_cols=70 Identities=9% Similarity=0.063 Sum_probs=50.1
Q ss_pred ccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeeec-------------hhhhhhhhhhhcccchhhhhh
Q 038696 128 AEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLIT-------------PDFCYRIDTVWKEDRWILFNK 191 (683)
Q Consensus 128 ~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l~-------------~~~~~~~~~~~~~~~~~l~~~ 191 (683)
.||||.++|++|+.+|.. +|+|+||.|+..++. |+|+ ...++|+.+....+.|++...
T Consensus 1 rWyhG~i~R~~Ae~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 74 (108)
T d2shpa3 1 RWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGD------FVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGG 74 (108)
T ss_dssp TTBCCSCCHHHHHHHHHHTCCTTEEEEEECSSSTTC------EEEEEEECC-----CCCCCEEEEEEEEEETTEEESSSS
T ss_pred CCCcCCCCHHHHHHHHhhcCCCCeEEEEecCCCCCC------eEEEEEecCccccccccccceeeEEEEeCCCceEeCCC
Confidence 499999999999999973 699999999876666 6662 233567777656666776666
Q ss_pred hhhhhccCCchh
Q 038696 192 IQQKKISGSTKQ 203 (683)
Q Consensus 192 ~~~~~~~~~~~~ 203 (683)
..|.++.+..++
T Consensus 75 ~~F~sl~~LV~~ 86 (108)
T d2shpa3 75 ERFDSLTDLVEH 86 (108)
T ss_dssp CCBSSHHHHHHH
T ss_pred cccCCHHHHHHH
Confidence 566544444333
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.66 E-value=1.1e-06 Score=75.26 Aligned_cols=74 Identities=12% Similarity=0.033 Sum_probs=49.9
Q ss_pred HHhhhccccCCCchhHHHHHHh---hcCCceeeeccccccccccCeeeeech---------hhhhhhhhhhcccc---hh
Q 038696 123 AIETAAEFSGWDPDQMHKKKLV---HSGKYKKEWKDHKLFQWRYGKQYLITP---------DFCYRIDTVWKEDR---WI 187 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~---~~g~~~~r~~~~~~~~~~~~~~y~l~~---------~~~~~~~~~~~~~~---~~ 187 (683)
+||+.+||||.++|++|+++|. .+|.|+||.|+. ++. |+|+. ..++||.|....+. ++
T Consensus 2 ~l~~~~Wy~g~isR~eAe~lL~~~~~~G~FLVR~S~~-~g~------y~LSv~~~~~~~~~~~i~h~~I~~~~~~~~~~~ 74 (108)
T d1luia_ 2 NLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDSRT-PGT------YTVSVFTKAIISENPCIKHYHIKETNDSPKRYY 74 (108)
T ss_dssp CCTTSTTBCTTCCHHHHHHHHHHHCCTTEEEEEECCT-TTC------EEEEEECSCCTTTCSCEEEEECEECCCSSCCEE
T ss_pred ccccCCCcCCCCCHHHHHHHHHhcCCCCeEEEEecCC-CCC------EEEEEEecCCcccCCceeEEEEEEecCCCceee
Confidence 4688999999999999999997 469999999862 444 77742 24778888554333 44
Q ss_pred hhhhhhhhhccCCchh
Q 038696 188 LFNKIQQKKISGSTKQ 203 (683)
Q Consensus 188 l~~~~~~~~~~~~~~~ 203 (683)
+.....|.++.+..++
T Consensus 75 ~~~~~~F~sl~~LV~~ 90 (108)
T d1luia_ 75 VAEKYVFDSIPLLIQY 90 (108)
T ss_dssp SSSSCCBSSHHHHHHH
T ss_pred cCCCcccCCHHHHHHH
Confidence 4444445444443333
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=2e-06 Score=73.21 Aligned_cols=54 Identities=11% Similarity=0.078 Sum_probs=42.2
Q ss_pred hhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc
Q 038696 125 ETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED 184 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~ 184 (683)
++++||||.++|++|+.+|.. +|.|+||.|+..++. |+| ....++||.|...++
T Consensus 3 ~~~~Wyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~ 63 (105)
T d1nrva_ 3 RTQHWFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKA------FVLTLCHHQKIKNFQILPCED 63 (105)
T ss_dssp TTSTTBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTTC------EEEEEEETTEEEEEEEEEC--
T ss_pred ccCcccCCCCCHHHHHHHHhhcCCCCceEEEEeCCCCCCC------EEEEEEECCceeEEEEEEecC
Confidence 468999999999999999974 599999999866665 888 344578888865443
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=2.4e-06 Score=75.09 Aligned_cols=69 Identities=10% Similarity=0.024 Sum_probs=48.4
Q ss_pred HhhhccccCCCchhHHHHHHhh----cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc-hhhhhhhhhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH----SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR-WILFNKIQQK 195 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~----~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~-~~l~~~~~~~ 195 (683)
-|..+||||.+.|++|+++|.. +|.|+||.|+. .+ .|+| ...-++||.|....+. |++.....|.
T Consensus 26 he~~pWyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~-~~------~yvLSv~~~~~v~H~~I~~~~~g~~~~~~~~~F~ 98 (125)
T d1a81a2 26 HEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDN-NG------SYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFD 98 (125)
T ss_dssp GGGSTTEEEECCHHHHHHHHHSSCCCTTCEEEEECSS-SS------CEEEEEEETTEEEEEEEEECTTSCEECTTSCCBS
T ss_pred cccCCccCCCCCHHHHHHHHHhcCCCCceEEEEecCC-CC------CEEEEeeccccceeEeeeEcCCCcEeccCCcccC
Confidence 3567899999999999999963 69999998852 23 3766 4455889999765554 5554444454
Q ss_pred hccC
Q 038696 196 KISG 199 (683)
Q Consensus 196 ~~~~ 199 (683)
++..
T Consensus 99 sL~~ 102 (125)
T d1a81a2 99 TLWQ 102 (125)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 4333
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.57 E-value=6.8e-05 Score=72.87 Aligned_cols=62 Identities=15% Similarity=0.112 Sum_probs=41.5
Q ss_pred EEEEEEcCcEEEEEEeCC-CcchHHHHHHHHHcCCCC--ceeeeeeeEEcCCCCeEEEEEecCCC-CH
Q 038696 249 YKEILWLGESFALRHFFG-DIEPLVPEISSLLSLSHP--NIMHFLCGFTDEEKKECFLIMELMSR-DL 312 (683)
Q Consensus 249 ~~v~l~~g~~vAvK~~~~-~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~e~~~~~~LVmEy~~g-sL 312 (683)
|.+....|..+.+|.... ....+..|+..|+.|... .+.+++.+..+ .+..++||++++| ++
T Consensus 28 ~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 28 FRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp EEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred EEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccc
Confidence 444333566788898754 345688899999887532 34556655543 3678999999987 44
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.49 E-value=1.2e-05 Score=68.03 Aligned_cols=57 Identities=7% Similarity=0.090 Sum_probs=43.8
Q ss_pred hhccccCCCchhHHHHHHhh---cCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc-chhh
Q 038696 126 TAAEFSGWDPDQMHKKKLVH---SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED-RWIL 188 (683)
Q Consensus 126 ~~~~~~g~~~~e~~~~~l~~---~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~-~~~l 188 (683)
+.|||||.+.|++|+.+|.. +|.|+||.|+..++. |+| ....++||.|....+ .|++
T Consensus 2 d~PWy~g~isR~~AE~lL~~~~~~G~FLVR~S~~~~g~------~~LSv~~~~~v~H~~I~~~~~g~~~~ 65 (103)
T d1i3za_ 2 DLPYYHGCLTKRECEALLLKGGVDGNFLIRDSESVPGA------LCLCVSFKKLVYSYRIFREKHGYYRI 65 (103)
T ss_dssp CCTTEESSCCHHHHHHHHHTTCSTTEEEEEECSSSTTC------EEEEEECSSSEEEEEEEECTTSCEEE
T ss_pred CCCcccCCCCHHHHHHHHHhCCCCCeEEEEecCCCCCC------EEEEEEeCCeEEEEEeEEcCCCcEEE
Confidence 46899999999999999964 499999999877776 777 445588988854333 4544
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=3.9e-06 Score=72.41 Aligned_cols=54 Identities=9% Similarity=0.030 Sum_probs=43.3
Q ss_pred hhhccccCCCchhHHHHHHh----hcCCceeeeccccccccccCeeeee---chhhhhhhhhhhccc
Q 038696 125 ETAAEFSGWDPDQMHKKKLV----HSGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKED 184 (683)
Q Consensus 125 ~~~~~~~g~~~~e~~~~~l~----~~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~ 184 (683)
+.++||||.++|++|+.+|. .+|.|+||.|+..++. |+| ..+.++|+.|...++
T Consensus 8 ~~~~Wy~g~isR~~Ae~lL~~~g~~dG~FLvR~S~~~~g~------y~LSv~~~~~v~H~~I~~~~~ 68 (113)
T d2qmsa1 8 RTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQG------FVLSLCHLQKVKHYLILPSEE 68 (113)
T ss_dssp TCCTTEEEEBCHHHHHHHHHHTTCCTTEEEEEECSSCTTC------EEEEEEETTEEEEEEEEEEES
T ss_pred cCCCccCCCCCHHHHHHHHhccCCCCccEEEEeccCCCCC------EEEEEEeCCeEEEEEEEEeCC
Confidence 56799999999999999997 3699999999866666 777 445688988865443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00058 Score=71.21 Aligned_cols=28 Identities=18% Similarity=0.343 Sum_probs=24.5
Q ss_pred CcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 351 KIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 351 gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.++|+|+++.|||++.++ ++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~--------~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE--------TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC--------EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc--------eEEechhhcc
Confidence 589999999999998764 8999998764
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.27 E-value=1.2e-05 Score=68.59 Aligned_cols=58 Identities=9% Similarity=-0.095 Sum_probs=44.4
Q ss_pred HhhhccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhh
Q 038696 124 IETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWIL 188 (683)
Q Consensus 124 i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l 188 (683)
++..+||||.++|++|+.+|.. +|+|+||.|+ +.+. |+| ...-++|+.|....++|++
T Consensus 6 ~~~~~Wy~g~isR~eAe~lL~~~~~G~FLVR~S~-~~~~------y~Lsv~~~~~v~H~~I~~~~~g~~~ 68 (107)
T d1qada_ 6 HDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESS-KQGC------YACSVVVDGEVKHCVINKTATGYGF 68 (107)
T ss_dssp GSGGGTEEEECCHHHHHHHHTTCCTTEEEEEEC----CC------EEEEEEETTEEEEEEEEEETTEEES
T ss_pred cCCCcccCCCCCHHHHHHHHcCCCCCcEEEEecC-CCCC------EEEEEEecCCeEEEEEEECCCCeEE
Confidence 5678999999999999999975 6999999994 4444 777 3345889999776666554
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=2.4e-05 Score=69.76 Aligned_cols=70 Identities=13% Similarity=0.073 Sum_probs=50.5
Q ss_pred HHhhhccccCCCchhHHHHHHhh-cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhhhhhhhhhhcc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH-SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWILFNKIQQKKIS 198 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~-~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 198 (683)
.+...+||||.+.|++|+.+|.. +|.|+||.|+...+. |+| ...-++||.|. .++++++... .|.++.
T Consensus 31 ~~~~~~wyhG~isR~eAe~lL~~~dGsFLVR~S~~~~g~------y~LSv~~~~~v~H~~I~-~~g~~~~~~~-~F~sl~ 102 (141)
T d1xa6a2 31 PKYYGREFHGIISREQADELLGGVEGAYILRESQRQPGC------YTLALRFGNQTLNYRLF-HDGKHFVGEK-RFESIH 102 (141)
T ss_dssp SCSSCSSEEEECCHHHHHHHHCSCTTBEEEEECSSSTTC------EEEEEEETTEEEECCCE-ESSSEECSSS-CCCCSS
T ss_pred cccccceeeccCCHHHHHHHHcCCCCeEEEEecCCCCCC------EEEEEEECCEEEEEEEE-ECCCEEECCC-eECCHH
Confidence 34556899999999999999985 699999999866665 777 34458899886 4455554332 455554
Q ss_pred CC
Q 038696 199 GS 200 (683)
Q Consensus 199 ~~ 200 (683)
+.
T Consensus 103 eL 104 (141)
T d1xa6a2 103 DL 104 (141)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.10 E-value=5.5e-05 Score=64.27 Aligned_cols=55 Identities=11% Similarity=-0.083 Sum_probs=43.8
Q ss_pred ccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccchhh
Q 038696 128 AEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDRWIL 188 (683)
Q Consensus 128 ~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~~~l 188 (683)
.||||.++|++|+++|.. +|.|+||.|+...+. |+| ...-++||.|....+++.+
T Consensus 1 sWy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~~~------~~LS~~~~~~v~H~~I~~~~~~~~~ 60 (109)
T d2eyva1 1 SWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGD------YVLSVSENSRVSHYIINSSGPRPPV 60 (109)
T ss_dssp TSCCBCCCHHHHHHHCSSCSTTCEEEECCCSSSSC------EEEEEEETTEEEEEEEECCCCSSCC
T ss_pred CCCCCCCCHHHHHHHhcCCCCCeEEeeecCCCCCC------EEEEEEECCEEEEEEEEEcCCccee
Confidence 499999999999999974 799999999755554 777 4455889988777666543
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.10 E-value=4.2e-05 Score=64.86 Aligned_cols=52 Identities=13% Similarity=0.167 Sum_probs=40.7
Q ss_pred hccccCCCchhHHHHHHhh--cCCceeeeccccccccccCeeeee---chhhhhhhhhhhcccc
Q 038696 127 AAEFSGWDPDQMHKKKLVH--SGKYKKEWKDHKLFQWRYGKQYLI---TPDFCYRIDTVWKEDR 185 (683)
Q Consensus 127 ~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~~~~~~~~~~~y~l---~~~~~~~~~~~~~~~~ 185 (683)
.+||||.++|++|+.+|.. +|.|+||.|+... .|+| ....++|+.|...++.
T Consensus 9 ~pWy~g~isR~eAe~lL~~~~~G~FLvR~S~~~~-------~y~Lsv~~~~~~~h~~I~~~~~g 65 (106)
T d2cs0a1 9 PEWFHGAISREDAENLLESQPLGSFLIRVSHSHV-------GYTLSYKAQSSCCHFMVKLLDDG 65 (106)
T ss_dssp CSSBCSSCCHHHHHHHHHTSCTTCEEEEECSSSS-------SEEEEECCSSSCEEEEEEECTTS
T ss_pred CCCccCCCCHHHHHHHHcCCCCCcEEEEecCCCC-------CEEEEEEecCCceeEEEEEcCCC
Confidence 5799999999999999997 8999999986222 2677 4445788888665555
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Probab=97.05 E-value=0.00011 Score=64.72 Aligned_cols=56 Identities=11% Similarity=0.028 Sum_probs=44.1
Q ss_pred HHHhhhccccCCCchhHHHHHHh--hcCCceeeeccccccccccCeeeeech------hhhhhhhhhhcc
Q 038696 122 EAIETAAEFSGWDPDQMHKKKLV--HSGKYKKEWKDHKLFQWRYGKQYLITP------DFCYRIDTVWKE 183 (683)
Q Consensus 122 ~~i~~~~~~~g~~~~e~~~~~l~--~~g~~~~r~~~~~~~~~~~~~~y~l~~------~~~~~~~~~~~~ 183 (683)
..+-+++||+|++.|++|+.+|. .+|.|+||.|+..+|. |+|+. ..++||.+....
T Consensus 4 ~~lw~~~~~~G~isr~~ae~~L~~~~~GtFLvR~S~s~~g~------~~ls~~~~~~~~~v~h~~i~~~~ 67 (131)
T d1uura3 4 STLWQEGIIYGYMGRQEVNDALQNQDPGTFIIRFSERNPGQ------FGIAYIGVEMPARIKHYLVQPND 67 (131)
T ss_dssp HHHHHHTSSCBSCCHHHHHHTTSSCCTTCEEEEECSSSTTC------EEEEEECSSSSCCEEEEECCGGG
T ss_pred hhhhhCCcEEccCCHHHHHHHHhcCCCCeEEEEecCCCCCc------EEEEEEEecCCCcEEEEEEeecC
Confidence 45677899999999999999999 4799999999988777 66622 236777775443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.12 E-value=0.0049 Score=62.00 Aligned_cols=63 Identities=10% Similarity=0.045 Sum_probs=40.2
Q ss_pred cEEEEEEcCcEEEEEEeCC---CcchHHHHHHHHHcCCCCce--eeee---eeEEcCCCCeEEEEEecCCC
Q 038696 248 QYKEILWLGESFALRHFFG---DIEPLVPEISSLLSLSHPNI--MHFL---CGFTDEEKKECFLIMELMSR 310 (683)
Q Consensus 248 ~~~v~l~~g~~vAvK~~~~---~~~~~~~Ei~iL~~L~HpnI--v~l~---~~~~~e~~~~~~LVmEy~~g 310 (683)
+|.+...+|..|++|+... ..+++..|...|..|....| +..+ +....+.....+.|+++++|
T Consensus 38 vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 38 VYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp EEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 6777666889999999864 34668889999888742222 1111 11101123567889999976
|
| >d1bg1a3 d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT3b species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.80 E-value=0.0015 Score=57.62 Aligned_cols=38 Identities=13% Similarity=0.162 Sum_probs=33.5
Q ss_pred HHhhhccccCCCchhHHHHHHhh--cCCceeeeccc-cccc
Q 038696 123 AIETAAEFSGWDPDQMHKKKLVH--SGKYKKEWKDH-KLFQ 160 (683)
Q Consensus 123 ~i~~~~~~~g~~~~e~~~~~l~~--~g~~~~r~~~~-~~~~ 160 (683)
+|.+++||+|++.|++|+.+|.. .|.|+||.||. ..|.
T Consensus 3 ~lW~~gw~~G~isr~~a~~~L~~~~~GtFLvR~S~~s~~G~ 43 (141)
T d1bg1a3 3 ALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGG 43 (141)
T ss_dssp HHHHSSCCCBCCCTTGGGTTTTTSCTTCBCEEECSSCSSCC
T ss_pred ceecCCeEEEeCCHHHHHHHhhCCCCCeEEEEecCCccCCC
Confidence 46789999999999999999986 79999999984 4666
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.98 E-value=0.025 Score=58.14 Aligned_cols=68 Identities=19% Similarity=0.139 Sum_probs=41.3
Q ss_pred CeEEEeEecccc---cEEEEEEc--------CcEEEEEEeCC--CcchHHHHHHHHHcCC-CCceeeeeeeEEcCCCCeE
Q 038696 236 DYQVRRRLGSGS---QYKEILWL--------GESFALRHFFG--DIEPLVPEISSLLSLS-HPNIMHFLCGFTDEEKKEC 301 (683)
Q Consensus 236 ~y~i~~~LG~G~---~~~v~l~~--------g~~vAvK~~~~--~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~e~~~~~ 301 (683)
++++ +.|+.|- .|.+.... +..|.+++.-. ..-...+|..+++.+. +.-..++++++ ++
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----
Confidence 4444 4565553 35554322 35688887742 2234568999999885 43345676655 32
Q ss_pred EEEEecCCC
Q 038696 302 FLIMELMSR 310 (683)
Q Consensus 302 ~LVmEy~~g 310 (683)
.+||||++|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 689999987
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.28 E-value=0.055 Score=53.35 Aligned_cols=30 Identities=13% Similarity=0.249 Sum_probs=25.8
Q ss_pred CCcccCCCCCCcEEeCCCCCCCCCcceEEEecccCcc
Q 038696 350 KKIYHGNLNPSNILLKPRGASTEGYLHAKISGFGLSS 386 (683)
Q Consensus 350 ~gIiHrDLKp~NILl~~~g~~~~~~~~vKL~DFGla~ 386 (683)
.|+||+|+.++||+++.++ .+-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-------v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-------LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-------EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-------ceeEecccccc
Confidence 4899999999999998775 56899999874
|